ID   KCNC1_RAT               Reviewed;         585 AA.
AC   P25122;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   22-NOV-2017, entry version 146.
DE   RecName: Full=Potassium voltage-gated channel subfamily C member 1;
DE   AltName: Full=NGK2;
DE   AltName: Full=RAW2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv3.1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv4;
GN   Name=Kcnc1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2023941; DOI=10.1073/pnas.88.9.3932;
RA   Luneau C.J., Williams J.B., Marshall J., Levitan E.S., Oliva C.,
RA   Smith J.S., Antanavage J., Folander K., Stein R.B., Swanson R.,
RA   Kaczmarek L.K., Buhrow S.A.;
RT   "Alternative splicing contributes to K+ channel diversity in the
RT   mammalian central nervous system.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:3932-3936(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=1378392;
RA   Rettig J., Wunder F., Stocker M., Lichtinghagen R., Mastiaux F.,
RA   Beckh S., Kues W., Pedarzani P., Schroeter K.H., Ruppersberg J.P.,
RA   Veh R., Pongs O.;
RT   "Characterization of a Shaw-related potassium channel family in rat
RT   brain.";
RL   EMBO J. 11:2473-2486(1992).
RN   [3]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNC2, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10482766;
RA   Hernandez-Pineda R., Chow A., Amarillo Y., Moreno H., Saganich M.,
RA   Vega-Saenz de Miera E.C., Hernandez-Cruz A., Rudy B.;
RT   "Kv3.1-Kv3.2 channels underlie a high-voltage-activating component of
RT   the delayed rectifier K+ current in projecting neurons from the globus
RT   pallidus.";
RL   J. Neurophysiol. 82:1512-1528(1999).
RN   [4]
RP   SUBUNIT, INTERACTION WITH KCNC2; KCNE1 AND KCNE2, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=14679187; DOI=10.1074/jbc.M310501200;
RA   Lewis A., McCrossan Z.A., Abbott G.W.;
RT   "MinK, MiRP1, and MiRP2 diversify Kv3.1 and Kv3.2 potassium channel
RT   gating.";
RL   J. Biol. Chem. 279:7884-7892(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44; SER-130; SER-142;
RP   SER-158 AND SER-160, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-220 AND ASN-229, AND
RP   MUTAGENESIS OF ASN-220 AND ASN-229.
RX   PubMed=24161696; DOI=10.1016/j.bbagen.2013.10.025;
RA   Hall M.K., Weidner D.A., Bernetski C.J., Schwalbe R.A.;
RT   "N-Linked glycan site occupancy impacts the distribution of a
RT   potassium channel in the cell body and outgrowths of neuronal-derived
RT   cells.";
RL   Biochim. Biophys. Acta 1840:595-604(2014).
CC   -!- FUNCTION: Voltage-gated potassium channel that plays an important
CC       role in the rapid repolarization of fast-firing brain neurons. The
CC       channel opens in response to the voltage difference across the
CC       membrane, forming a potassium-selective channel through which
CC       potassium ions pass in accordance with their electrochemical
CC       gradient (PubMed:10482766, PubMed:14679187). Can form functional
CC       homotetrameric channels and heterotetrameric channels that contain
CC       variable proportions of KCNC2, and possibly other family members
CC       as well (PubMed:10482766, PubMed:14679187). Contributes to fire
CC       sustained trains of very brief action potentials at high frequency
CC       in pallidal neurons (PubMed:10482766).
CC       {ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:14679187}.
CC   -!- SUBUNIT: Heteromultimer with KCNG3, KCNG4 and KCNV2 (By
CC       similarity). Heteromultimer with KCNC2 (PubMed:10482766,
CC       PubMed:14679187). Heterotetramer with KCNC3 (By similarity).
CC       Interacts with the ancillary subunits KCNE1 and KCNE2; the
CC       interaction modulates channel activity (PubMed:14679187).
CC       {ECO:0000250, ECO:0000250|UniProtKB:P48547,
CC       ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:14679187}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10482766,
CC       ECO:0000269|PubMed:14679187, ECO:0000269|PubMed:24161696}; Multi-
CC       pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P25122-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P25122-2; Sequence=VSP_001016, VSP_001017;
CC   -!- TISSUE SPECIFICITY: Expressed in globus pallidal neurons of the
CC       basal ganglia (at protein level) (PubMed:10482766). Brain
CC       (PubMed:1378392). {ECO:0000269|PubMed:10482766,
CC       ECO:0000269|PubMed:1378392}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000305}.
CC   -!- DOMAIN: The tail may be important in modulation of channel
CC       activity and/or targeting of the channel to specific subcellular
CC       compartments. {ECO:0000305}.
CC   -!- PTM: N-glycosylated; contains sialylated glycans.
CC       {ECO:0000269|PubMed:24161696}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw) (TC
CC       1.A.1.2) subfamily. Kv3.1/KCNC1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M68880; AAA41501.1; -; mRNA.
DR   EMBL; X62840; CAA44644.1; -; mRNA.
DR   PIR; A39395; A39395.
DR   RefSeq; NP_036988.1; NM_012856.1. [P25122-1]
DR   UniGene; Rn.33095; -.
DR   ProteinModelPortal; P25122; -.
DR   SMR; P25122; -.
DR   BioGrid; 247366; 1.
DR   STRING; 10116.ENSRNOP00000015260; -.
DR   BindingDB; P25122; -.
DR   ChEMBL; CHEMBL2321617; -.
DR   GuidetoPHARMACOLOGY; 548; -.
DR   iPTMnet; P25122; -.
DR   PhosphoSitePlus; P25122; -.
DR   PaxDb; P25122; -.
DR   PRIDE; P25122; -.
DR   Ensembl; ENSRNOT00000089488; ENSRNOP00000074146; ENSRNOG00000055401. [P25122-1]
DR   GeneID; 25327; -.
DR   KEGG; rno:25327; -.
DR   UCSC; RGD:2955; rat. [P25122-1]
DR   CTD; 3746; -.
DR   RGD; 2955; Kcnc1.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231012; -.
DR   HOVERGEN; HBG105862; -.
DR   InParanoid; P25122; -.
DR   KO; K04887; -.
DR   OMA; SGGFWRR; -.
DR   OrthoDB; EOG091G0EJL; -.
DR   PhylomeDB; P25122; -.
DR   Reactome; R-RNO-1296072; Voltage gated Potassium channels.
DR   PRO; PR:P25122; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000055401; -.
DR   Genevisible; P25122; RN.
DR   GO; GO:0030673; C:axolemma; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0032590; C:dendrite membrane; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0032589; C:neuron projection membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0019894; F:kinesin binding; ISO:RGD.
DR   GO; GO:0007420; P:brain development; IEP:RGD.
DR   GO; GO:0035690; P:cellular response to drug; IEP:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0021759; P:globus pallidus development; IEP:RGD.
DR   GO; GO:0034767; P:positive regulation of ion transmembrane transport; IDA:RGD.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:RGD.
DR   GO; GO:1903818; P:positive regulation of voltage-gated potassium channel activity; IDA:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0051262; P:protein tetramerization; ISS:UniProtKB.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IMP:RGD.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; IDA:RGD.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0010996; P:response to auditory stimulus; IEP:RGD.
DR   GO; GO:0071774; P:response to fibroblast growth factor; IEP:RGD.
DR   GO; GO:0009642; P:response to light intensity; IEP:RGD.
DR   GO; GO:1990089; P:response to nerve growth factor; IEP:RGD.
DR   GO; GO:0035864; P:response to potassium ion; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR005403; K_chnl_volt-dep_Kv3.1.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01581; KV31CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    585       Potassium voltage-gated channel subfamily
FT                                C member 1.
FT                                /FTId=PRO_0000054053.
FT   TOPO_DOM      1    190       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    191    209       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    248    267       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    268    276       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    277    295       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    309    331       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    332    344       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    345    366       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    415    436       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    437    585       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       400    405       Selectivity filter. {ECO:0000250}.
FT   MOD_RES      44     44       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     130    130       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     142    142       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     158    158       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     160    160       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     474    474       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15388}.
FT   MOD_RES     483    483       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P15388}.
FT   CARBOHYD    220    220       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:24161696}.
FT   CARBOHYD    229    229       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:24161696}.
FT   VAR_SEQ     502    511       DSKLNGEVAK -> GRKPLRGMSI (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_001016.
FT   VAR_SEQ     512    585       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_001017.
FT   MUTAGEN     220    220       N->Q: Reduces extent of N-glycosylation.
FT                                Abolishes N-glycosylation; when
FT                                associated with Q-229.
FT                                {ECO:0000269|PubMed:24161696}.
FT   MUTAGEN     229    229       N->Q: Reduces extent of N-glycosylation.
FT                                Abolishes N-glycosylation; when
FT                                associated with Q-220.
FT                                {ECO:0000269|PubMed:24161696}.
SQ   SEQUENCE   585 AA;  65857 MW;  DD4E2D32848E2DCF CRC64;
     MGQGDESERI VINVGGTRHQ TYRSTLRTLP GTRLAWLAEP DAHSHFDYDP RADEFFFDRH
     PGVFAHILNY YRTGKLHCPA DVCGPLYEEE LAFWGIDETD VEPCCWMTYR QHRDAEEALD
     SFGGAPLDNS ADDADADGPG DSGDGEDELE MTKRLALSDS PDGRPGGFWR RWQPRIWALF
     EDPYSSRYAR YVAFASLFFI LVSITTFCLE THERFNPIVN KTEIENVRNG TQVRYYREAE
     TEAFLTYIEG VCVVWFTFEF LMRVVFCPNK VEFIKNSLNI IDFVAILPFY LEVGLSGLSS
     KAAKDVLGFL RVVRFVRILR IFKLTRHFVG LRVLGHTLRA STNEFLLLII FLALGVLIFA
     TMIYYAERIG AQPNDPSASE HTHFKNIPIG FWWAVVTMTT LGYGDMYPQT WSGMLVGALC
     ALAGVLTIAM PVPVIVNNFG MYYSLAMAKQ KLPKKKKKHI PRPPQLGSPN YCKSVVNSPH
     HSTQSDTCPL AQEEILEINR ADSKLNGEVA KAALANEDCP HIDQALTPDE GLPFTRSGTR
     ERYGPCFLLS TGEYACPPGG GMRKDLCKES PVIAKYMPTE AVRVT
//
ID   KCND3_HUMAN             Reviewed;         655 AA.
AC   Q9UK17; O60576; O60577; Q14D71; Q5T0M0; Q9UH85; Q9UH86; Q9UK16;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 3.
DT   20-DEC-2017, entry version 164.
DE   RecName: Full=Potassium voltage-gated channel subfamily D member 3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv4.3;
GN   Name=KCND3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, AND
RP   FUNCTION.
RC   TISSUE=Heart;
RX   PubMed=9843794;
RA   Kong W., Po S., Yamagishi T., Ashen M.D., Stetten G., Tomaselli G.F.;
RT   "Isolation and characterization of the human gene encoding Ito:
RT   further diversity by alternative mRNA splicing.";
RL   Am. J. Physiol. 275:H1963-H1970(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain, and Heart;
RX   PubMed=10200233;
RA   Dilks D., Ling H.-P., Cockett M., Sokol P., Numann R.;
RT   "Cloning and expression of the human Kv4.3 potassium channel.";
RL   J. Neurophysiol. 81:1974-1977(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RA   Calmels T.P.G., Faivre J.-F., Javre J.-L., Cheval B., Rouanet S.,
RA   Bril A.;
RT   "Long and short human isoforms of the Kv4.3 channel: cloning,
RT   expression, electrophysiology, pharmacology and phosphorylation by
RT   protein kinase C.";
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain cortex;
RX   PubMed=10729221; DOI=10.1006/geno.2000.6117;
RA   Isbrandt D., Leicher T., Waldschuetz R., Zhu X.-R., Luhmann U.,
RA   Michel U., Sauter K., Pongs O.;
RT   "Gene structures and expression profiles of three human KCND (Kv4)
RT   potassium channels mediating A-type currents I(TO) and I(SA).";
RL   Genomics 64:144-154(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Heart, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH KCNIP2; KCNE1; KCNE2; SCN1B AND KCNAB1.
RX   PubMed=12297301; DOI=10.1016/S0014-5793(02)03296-9;
RA   Deschenes I., Tomaselli G.F.;
RT   "Modulation of Kv4.3 current by accessory subunits.";
RL   FEBS Lett. 528:183-188(2002).
RN   [9]
RP   INTERACTION WITH DLG1.
RX   PubMed=19213956; DOI=10.1161/CIRCRESAHA.108.191007;
RA   El-Haou S., Balse E., Neyroud N., Dilanian G., Gavillet B., Abriel H.,
RA   Coulombe A., Jeromin A., Hatem S.N.;
RT   "Kv4 potassium channels form a tripartite complex with the anchoring
RT   protein SAP97 and CaMKII in cardiac myocytes.";
RL   Circ. Res. 104:758-769(2009).
RN   [10]
RP   INVOLVEMENT IN BRGDA9, VARIANTS BRGDA9 PHE-450 AND ARG-600, AND
RP   CHARACTERIZATION OF VARIANT BRGDA9 PHE-450.
RX   PubMed=21349352; DOI=10.1016/j.hrthm.2011.02.021;
RA   Giudicessi J.R., Ye D., Tester D.J., Crotti L., Mugione A.,
RA   Nesterenko V.V., Albertson R.M., Antzelevitch C., Schwartz P.J.,
RA   Ackerman M.J.;
RT   "Transient outward current (I(to)) gain-of-function mutations in the
RT   KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.";
RL   Heart Rhythm 8:1024-1032(2011).
RN   [11]
RP   INVOLVEMENT IN BRGDA9, VARIANTS BRGDA9 ILE-392; ARG-530 AND ARG-600,
RP   AND CHARACTERIZATION OF VARIANTS BRGDA9 ILE-392; ARG-530 AND ARG-600.
RX   PubMed=22457051; DOI=10.1002/humu.22058;
RA   Giudicessi J.R., Ye D., Kritzberger C.J., Nesterenko V.V.,
RA   Tester D.J., Antzelevitch C., Ackerman M.J.;
RT   "Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with
RT   autopsy-negative sudden unexplained death.";
RL   Hum. Mutat. 33:989-997(2012).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 29-143, AND INTERACTION WITH
RP   KCNIP1.
RX   PubMed=14980207; DOI=10.1016/S0896-6273(04)00049-2;
RA   Scannevin R.H., Wang K., Jow F., Megules J., Kopsco D.C., Edris W.,
RA   Carroll K.C., Lu Q., Xu W., Xu Z., Katz A.H., Olland S., Lin L.,
RA   Taylor M., Stahl M., Malakian K., Somers W., Mosyak L., Bowlby M.R.,
RA   Chanda P., Rhodes K.J.;
RT   "Two N-terminal domains of Kv4 K(+) channels regulate binding to and
RT   modulation by KChIP1.";
RL   Neuron 41:587-598(2004).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 6-145 IN COMPLEX WITH KCNIP1,
RP   AND SUBUNIT.
RX   PubMed=17187064; DOI=10.1038/nn1822;
RA   Wang H., Yan Y., Liu Q., Huang Y., Shen Y., Chen L., Chen Y., Yang Q.,
RA   Hao Q., Wang K., Chai J.;
RT   "Structural basis for modulation of Kv4 K+ channels by auxiliary KChIP
RT   subunits.";
RL   Nat. Neurosci. 10:32-39(2007).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-94.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [15]
RP   VARIANTS SCA19 PHE-227 DEL; GLU-338; VAL-345 AND MET-377, AND
RP   CHARACTERIZATION OF VARIANT PHE-227 DEL.
RX   PubMed=23280837; DOI=10.1002/ana.23701;
RA   Lee Y.C., Durr A., Majczenko K., Huang Y.H., Liu Y.C., Lien C.C.,
RA   Tsai P.C., Ichikawa Y., Goto J., Monin M.L., Li J.Z., Chung M.Y.,
RA   Mundwiller E., Shakkottai V., Liu T.T., Tesson C., Lu Y.C., Brice A.,
RA   Tsuji S., Burmeister M., Stevanin G., Soong B.W.;
RT   "Mutations in KCND3 cause spinocerebellar ataxia type 22.";
RL   Ann. Neurol. 72:859-869(2012).
RN   [16]
RP   VARIANTS SCA19 PRO-352; ILE-373 AND ASN-390, AND CHARACTERIZATION OF
RP   VARIANTS SCA19 PRO-352; ILE-373 AND ASN-390.
RX   PubMed=23280838; DOI=10.1002/ana.23700;
RA   Duarri A., Jezierska J., Fokkens M., Meijer M., Schelhaas H.J.,
RA   den Dunnen W.F., van Dijk F., Verschuuren-Bemelmans C., Hageman G.,
RA   van de Vlies P., Kusters B., van de Warrenburg B.P., Kremer B.,
RA   Wijmenga C., Sinke R.J., Swertz M.A., Kampinga H.H., Boddeke E.,
RA   Verbeek D.S.;
RT   "Mutations in potassium channel kcnd3 cause spinocerebellar ataxia
RT   type 19.";
RL   Ann. Neurol. 72:870-880(2012).
RN   [17]
RP   VARIANT SCA19 SER-384.
RX   PubMed=28895081; DOI=10.1007/s12311-017-0883-4;
RA   Kurihara M., Ishiura H., Sasaki T., Otsuka J., Hayashi T., Terao Y.,
RA   Matsukawa T., Mitsui J., Kaneko J., Nishiyama K., Doi K.,
RA   Yoshimura J., Morishita S., Shimizu J., Tsuji S.;
RT   "Novel de novo KCND3 mutation in a Japanese patient with intellectual
RT   disability, cerebellar ataxia, myoclonus, and dystonia.";
RL   Cerebellum 0:0-0(2017).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated rapidly
CC       inactivating A-type potassium channels. May contribute to I(To)
CC       current in heart and I(Sa) current in neurons. Channel properties
CC       are modulated by interactions with other alpha subunits and with
CC       regulatory subunits. {ECO:0000269|PubMed:10200233,
CC       ECO:0000269|PubMed:9843794}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer with KCND1 and/or KCND2.
CC       Associates with the regulatory subunits KCNIP1, KCNIP2, KCNIP3 and
CC       KCNIP4 (By similarity). Interacts with KCNE1, KCNE2, SCN1B and
CC       KCNAB1 and DLG1. {ECO:0000250, ECO:0000269|PubMed:12297301,
CC       ECO:0000269|PubMed:14980207, ECO:0000269|PubMed:17187064,
CC       ECO:0000269|PubMed:19213956}.
CC   -!- INTERACTION:
CC       Q9NZI2:KCNIP1; NbExp=3; IntAct=EBI-9825212, EBI-2120635;
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q62897}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell membrane, sarcolemma
CC       {ECO:0000250|UniProtKB:Q62897}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q62897}. Note=Interaction with
CC       palmitoylated KCNIP2 and KCNIP3 enhances cell surface expression.
CC       {ECO:0000250|UniProtKB:Q62897}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=KCND3L, Long;
CC         IsoId=Q9UK17-1; Sequence=Displayed;
CC       Name=2; Synonyms=KCND3S, Short;
CC         IsoId=Q9UK17-2; Sequence=VSP_008826;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart and brain, in
CC       particular in cortex, cerebellum, amygdala and caudate nucleus.
CC       Detected at lower levels in liver, skeletal muscle, kidney and
CC       pancreas. Isoform 1 predominates in most tissues. Isoform 1 and
CC       isoform 2 are detected at similar levels in brain, skeletal muscle
CC       and pancreas. {ECO:0000269|PubMed:10200233,
CC       ECO:0000269|PubMed:10729221, ECO:0000269|PubMed:9843794}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- PTM: Regulated through phosphorylation at Ser-569 by CaMK2D.
CC       {ECO:0000250}.
CC   -!- DISEASE: Spinocerebellar ataxia 19 (SCA19) [MIM:607346]: A form of
CC       spinocerebellar ataxia, a clinically and genetically heterogeneous
CC       group of cerebellar disorders. Patients show progressive
CC       incoordination of gait and often poor coordination of hands,
CC       speech and eye movements, due to degeneration of the cerebellum
CC       with variable involvement of the brainstem and spinal cord. SCA19
CC       is a relatively mild, cerebellar ataxic syndrome with cognitive
CC       impairment, pyramidal tract involvement, tremor and peripheral
CC       neuropathy, and mild atrophy of the cerebellar hemispheres and
CC       vermis. {ECO:0000269|PubMed:23280837, ECO:0000269|PubMed:23280838,
CC       ECO:0000269|PubMed:28895081}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Brugada syndrome 9 (BRGDA9) [MIM:616399]: A
CC       tachyarrhythmia characterized by right bundle branch block and ST
CC       segment elevation on an electrocardiogram (ECG). It can cause the
CC       ventricles to beat so fast that the blood is prevented from
CC       circulating efficiently in the body. When this situation occurs,
CC       the individual will faint and may die in a few minutes if the
CC       heart is not reset. {ECO:0000269|PubMed:21349352,
CC       ECO:0000269|PubMed:22457051}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. D (Shal) (TC
CC       1.A.1.2) subfamily. Kv4.3/KCND3 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Potassium voltage-gated channel, Shal-related
CC       subfamily, member 3 (KCND3); Note=Leiden Open Variation Database
CC       (LOVD);
CC       URL="http://www.lovd.nl/KCND3";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF048712; AAC05121.1; -; mRNA.
DR   EMBL; AF048713; AAC05122.1; -; mRNA.
DR   EMBL; AF187963; AAF01044.1; -; mRNA.
DR   EMBL; AF187964; AAF01045.1; -; mRNA.
DR   EMBL; AF205856; AAF20924.1; -; mRNA.
DR   EMBL; AF205857; AAF20925.1; -; mRNA.
DR   EMBL; AF120491; AAD38898.1; -; mRNA.
DR   EMBL; AF166011; AAF68177.1; -; Genomic_DNA.
DR   EMBL; AF166009; AAF68177.1; JOINED; Genomic_DNA.
DR   EMBL; AF166010; AAF68177.1; JOINED; Genomic_DNA.
DR   EMBL; AF166011; AAF68178.1; -; Genomic_DNA.
DR   EMBL; AF166009; AAF68178.1; JOINED; Genomic_DNA.
DR   EMBL; AF166010; AAF68178.1; JOINED; Genomic_DNA.
DR   EMBL; AL512665; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL450997; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL049557; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471122; EAW56511.1; -; Genomic_DNA.
DR   EMBL; BC113475; AAI13476.1; -; mRNA.
DR   EMBL; BC113477; AAI13478.1; -; mRNA.
DR   CCDS; CCDS843.1; -. [Q9UK17-1]
DR   CCDS; CCDS844.1; -. [Q9UK17-2]
DR   RefSeq; NP_004971.2; NM_004980.4. [Q9UK17-1]
DR   RefSeq; NP_751948.1; NM_172198.2. [Q9UK17-2]
DR   RefSeq; XP_005270908.1; XM_005270851.4. [Q9UK17-1]
DR   RefSeq; XP_006710692.1; XM_006710629.3. [Q9UK17-1]
DR   RefSeq; XP_006710693.1; XM_006710630.3. [Q9UK17-2]
DR   RefSeq; XP_016856733.1; XM_017001244.1. [Q9UK17-1]
DR   UniGene; Hs.666367; -.
DR   UniGene; Hs.730579; -.
DR   PDB; 1S1G; X-ray; 2.60 A; A/B=29-143.
DR   PDB; 2NZ0; X-ray; 3.20 A; B/D=6-145.
DR   PDBsum; 1S1G; -.
DR   PDBsum; 2NZ0; -.
DR   ProteinModelPortal; Q9UK17; -.
DR   SMR; Q9UK17; -.
DR   BioGrid; 109954; 35.
DR   CORUM; Q9UK17; -.
DR   IntAct; Q9UK17; 1.
DR   STRING; 9606.ENSP00000319591; -.
DR   BindingDB; Q9UK17; -.
DR   ChEMBL; CHEMBL1964; -.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB06637; Dalfampridine.
DR   DrugBank; DB00280; Disopyramide.
DR   DrugBank; DB00458; Imipramine.
DR   TCDB; 1.A.1.2.19; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9UK17; -.
DR   PhosphoSitePlus; Q9UK17; -.
DR   BioMuta; KCND3; -.
DR   DMDM; 92090984; -.
DR   PaxDb; Q9UK17; -.
DR   PeptideAtlas; Q9UK17; -.
DR   PRIDE; Q9UK17; -.
DR   DNASU; 3752; -.
DR   Ensembl; ENST00000302127; ENSP00000306923; ENSG00000171385. [Q9UK17-2]
DR   Ensembl; ENST00000315987; ENSP00000319591; ENSG00000171385. [Q9UK17-1]
DR   Ensembl; ENST00000369697; ENSP00000358711; ENSG00000171385. [Q9UK17-2]
DR   GeneID; 3752; -.
DR   KEGG; hsa:3752; -.
DR   UCSC; uc001ebu.2; human. [Q9UK17-1]
DR   CTD; 3752; -.
DR   DisGeNET; 3752; -.
DR   EuPathDB; HostDB:ENSG00000171385.9; -.
DR   GeneCards; KCND3; -.
DR   HGNC; HGNC:6239; KCND3.
DR   HPA; HPA029452; -.
DR   MalaCards; KCND3; -.
DR   MIM; 605411; gene.
DR   MIM; 607346; phenotype.
DR   MIM; 616399; phenotype.
DR   neXtProt; NX_Q9UK17; -.
DR   OpenTargets; ENSG00000171385; -.
DR   Orphanet; 130; Brugada syndrome.
DR   Orphanet; 98772; Spinocerebellar ataxia type 19/22.
DR   PharmGKB; PA210; -.
DR   eggNOG; KOG4390; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOVERGEN; HBG106687; -.
DR   InParanoid; Q9UK17; -.
DR   KO; K04893; -.
DR   OMA; GTCCTRR; -.
DR   OrthoDB; EOG091G18X0; -.
DR   PhylomeDB; Q9UK17; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-5576894; Phase 1 - inactivation of fast Na+ channels.
DR   EvolutionaryTrace; Q9UK17; -.
DR   GeneWiki; KCND3; -.
DR   GenomeRNAi; 3752; -.
DR   PRO; PR:Q9UK17; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000171385; -.
DR   CleanEx; HS_KCND3; -.
DR   ExpressionAtlas; Q9UK17; baseline and differential.
DR   Genevisible; Q9UK17; HS.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0005250; F:A-type (transient outward) potassium channel activity; TAS:ProtInc.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0086009; P:membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; TAS:BHF-UCL.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; IEA:GOC.
DR   GO; GO:0071435; P:potassium ion export; IDA:BHF-UCL.
DR   GO; GO:0097623; P:potassium ion export across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0099625; P:ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003975; K_chnl_volt-dep_Kv4.
DR   InterPro; IPR004056; K_chnl_volt-dep_Kv4.3.
DR   InterPro; IPR024587; K_chnl_volt-dep_Kv4_C.
DR   InterPro; IPR021645; Shal-type_N.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 4.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF11879; DUF3399; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11601; Shal-type; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01518; KV43CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01497; SHALCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Brugada syndrome; Cell membrane;
KW   Cell projection; Complete proteome; Disease mutation; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Neurodegeneration;
KW   Phosphoprotein; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Spinocerebellar ataxia;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel;
KW   Zinc.
FT   CHAIN         1    655       Potassium voltage-gated channel subfamily
FT                                D member 3.
FT                                /FTId=PRO_0000054068.
FT   TOPO_DOM      1    181       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    182    202       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    222    242       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    243    256       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    257    277       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    287    307       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    308    320       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    321    341       Helical; Name=Segment S5. {ECO:0000255}.
FT   INTRAMEM    360    380       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TRANSMEM    382    402       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    403    655       Cytoplasmic. {ECO:0000255}.
FT   REGION        2     20       Interaction with KCNIP2. {ECO:0000250}.
FT   REGION      472    487       Mediates dendritic targeting.
FT                                {ECO:0000250}.
FT   MOTIF       367    372       Selectivity filter. {ECO:0000250}.
FT   METAL       104    104       Zinc.
FT   METAL       131    131       Zinc.
FT   METAL       132    132       Zinc.
FT   MOD_RES     153    153       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z0V1}.
FT   MOD_RES     459    459       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9Z0V1}.
FT   MOD_RES     569    569       Phosphoserine; by CaMK2D.
FT                                {ECO:0000250|UniProtKB:Q62897}.
FT   MOD_RES     585    585       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z0V1}.
FT   VAR_SEQ     488    506       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10200233,
FT                                ECO:0000303|PubMed:10729221,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9843794}.
FT                                /FTId=VSP_008826.
FT   VARIANT      94     94       V -> M (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035775.
FT   VARIANT     227    227       Missing (in SCA19; results in reduced
FT                                channel activity consistent with impaired
FT                                cell surface expression of the mutant
FT                                protein). {ECO:0000269|PubMed:23280837}.
FT                                /FTId=VAR_070785.
FT   VARIANT     338    338       V -> E (in SCA19).
FT                                {ECO:0000269|PubMed:23280837}.
FT                                /FTId=VAR_070786.
FT   VARIANT     345    345       G -> V (in SCA19; dbSNP:rs797045634).
FT                                {ECO:0000269|PubMed:23280837}.
FT                                /FTId=VAR_070787.
FT   VARIANT     352    352       T -> P (in SCA19; loss of channel
FT                                activity; dbSNP:rs397515476).
FT                                {ECO:0000269|PubMed:23280838}.
FT                                /FTId=VAR_070788.
FT   VARIANT     373    373       M -> I (in SCA19; causes reduced channel
FT                                activity; dbSNP:rs397515477).
FT                                {ECO:0000269|PubMed:23280838}.
FT                                /FTId=VAR_070789.
FT   VARIANT     377    377       T -> M (in SCA19).
FT                                {ECO:0000269|PubMed:23280837}.
FT                                /FTId=VAR_070790.
FT   VARIANT     384    384       G -> S (in SCA19).
FT                                {ECO:0000269|PubMed:28895081}.
FT                                /FTId=VAR_079709.
FT   VARIANT     390    390       S -> N (in SCA19; results in impaired
FT                                cell surface expression;
FT                                dbSNP:rs397515478).
FT                                {ECO:0000269|PubMed:23280838}.
FT                                /FTId=VAR_070791.
FT   VARIANT     392    392       V -> I (in BRGDA9; gain of function
FT                                mutation; dbSNP:rs786205867).
FT                                {ECO:0000269|PubMed:22457051}.
FT                                /FTId=VAR_067694.
FT   VARIANT     450    450       L -> F (in BRGDA9; gain of function
FT                                mutation; dbSNP:rs150401343).
FT                                {ECO:0000269|PubMed:21349352}.
FT                                /FTId=VAR_073831.
FT   VARIANT     530    530       S -> R (in BRGDA9; does not affect the
FT                                electrophysiological properties of the
FT                                channel). {ECO:0000269|PubMed:22457051}.
FT                                /FTId=VAR_067695.
FT   VARIANT     600    600       G -> R (in BRGDA9; gain of function
FT                                mutation; dbSNP:rs149344567).
FT                                {ECO:0000269|PubMed:21349352,
FT                                ECO:0000269|PubMed:22457051}.
FT                                /FTId=VAR_067696.
FT   CONFLICT    239    239       V -> G (in Ref. 1; AAC05121/AAC05122 and
FT                                4; AAD38898). {ECO:0000305}.
FT   CONFLICT    375    375       P -> L (in Ref. 1; AAC05121/AAC05122 and
FT                                4; AAD38898). {ECO:0000305}.
FT   CONFLICT    408    408       R -> G (in Ref. 2; AAF01044/AAF01045).
FT                                {ECO:0000305}.
FT   CONFLICT    452    452       E -> G (in Ref. 2; AAF01044/AAF01045).
FT                                {ECO:0000305}.
FT   CONFLICT    531    531       T -> Q (in Ref. 2; AAF01044/AAF01045).
FT                                {ECO:0000305}.
FT   CONFLICT    564    564       A -> D (in Ref. 2; AAF01044/AAF01045).
FT                                {ECO:0000305}.
FT   CONFLICT    646    646       A -> T (in Ref. 1; AAC05121/AAC05122, 2;
FT                                AAF01045 and 4; AAD38898). {ECO:0000305}.
FT   CONFLICT    654    654       A -> V (in Ref. 1; AAC05121/AAC05122, 2;
FT                                AAF01044 and 4; AAD38898). {ECO:0000305}.
FT   HELIX         9     14       {ECO:0000244|PDB:2NZ0}.
FT   TURN         15     19       {ECO:0000244|PDB:2NZ0}.
FT   STRAND       20     23       {ECO:0000244|PDB:2NZ0}.
FT   HELIX        32     34       {ECO:0000244|PDB:2NZ0}.
FT   STRAND       41     46       {ECO:0000244|PDB:1S1G}.
FT   STRAND       49     54       {ECO:0000244|PDB:1S1G}.
FT   HELIX        55     58       {ECO:0000244|PDB:1S1G}.
FT   TURN         65     67       {ECO:0000244|PDB:2NZ0}.
FT   HELIX        70     73       {ECO:0000244|PDB:1S1G}.
FT   STRAND       74     76       {ECO:0000244|PDB:2NZ0}.
FT   STRAND       77     79       {ECO:0000244|PDB:1S1G}.
FT   STRAND       81     84       {ECO:0000244|PDB:1S1G}.
FT   HELIX        88    100       {ECO:0000244|PDB:1S1G}.
FT   STRAND      101    103       {ECO:0000244|PDB:2NZ0}.
FT   HELIX       111    120       {ECO:0000244|PDB:1S1G}.
FT   HELIX       125    127       {ECO:0000244|PDB:1S1G}.
FT   HELIX       130    143       {ECO:0000244|PDB:1S1G}.
SQ   SEQUENCE   655 AA;  73451 MW;  ADD1402A97204764 CRC64;
     MAAGVAAWLP FARAAAIGWM PVANCPMPLA PADKNKRQDE LIVLNVSGRR FQTWRTTLER
     YPDTLLGSTE KEFFFNEDTK EYFFDRDPEV FRCVLNFYRT GKLHYPRYEC ISAYDDELAF
     YGILPEIIGD CCYEEYKDRK RENAERLMDD NDSENNQESM PSLSFRQTMW RAFENPHTST
     LALVFYYVTG FFIAVSVITN VVETVPCGTV PGSKELPCGE RYSVAFFCLD TACVMIFTVE
     YLLRLFAAPS RYRFIRSVMS IIDVVAIMPY YIGLVMTNNE DVSGAFVTLR VFRVFRIFKF
     SRHSQGLRIL GYTLKSCASE LGFLLFSLTM AIIIFATVMF YAEKGSSASK FTSIPASFWY
     TIVTMTTLGY GDMVPKTIAG KIFGSICSLS GVLVIALPVP VIVSNFSRIY HQNQRADKRR
     AQKKARLARI RVAKTGSSNA YLHSKRNGLL NEALELTGTP EEEHMGKTTS LIESQHHHLL
     HCLEKTTGLS YLVDDPLLSV RTSTIKNHEF IDEQMFEQNC MESSMQNYPS TRSPSLSSHP
     GLTTTCCSRR SKKTTHLPNS NLPATRLRSM QELSTIHIQG SEQPSLTTSR SSLNLKADDG
     LRPNCKTSQI TTAIISIPTP PALTPEGESR PPPASPGPNT NIPSIASNVV KVSAL
//
ID   KCNQ4_HUMAN             Reviewed;         695 AA.
AC   P56696; O96025;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 2.
DT   25-OCT-2017, entry version 167.
DE   RecName: Full=Potassium voltage-gated channel subfamily KQT member 4;
DE   AltName: Full=KQT-like 4;
DE   AltName: Full=Potassium channel subunit alpha KvLQT4;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv7.4;
GN   Name=KCNQ4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), VARIANT
RP   DFNA2A SER-285, VARIANT GLN-455, AND CHARACTERIZATION OF VARIANT
RP   DFNA2A SER-285.
RC   TISSUE=Retina;
RX   PubMed=10025409; DOI=10.1016/S0092-8674(00)80556-5;
RA   Kubisch C., Schroeder B.C., Friedrich T., Luetjohann B.,
RA   El-Amraoui A., Marlin S., Petit C., Jentsch T.J.;
RT   "KCNQ4, a novel potassium channel expressed in sensory outer hair
RT   cells, is mutated in dominant deafness.";
RL   Cell 96:437-446(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   INHIBITION BY M1 MUSCARINIC RECEPTORS.
RX   PubMed=10713961; DOI=10.1111/j.1469-7793.2000.t01-2-00349.x;
RA   Selyanko A.A., Hadley J.K., Wood I.C., Abogadie F.C., Jentsch T.J.,
RA   Brown D.A.;
RT   "Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells
RT   via M1 muscarinic acetylcholine receptors.";
RL   J. Physiol. (Lond.) 522:349-355(2000).
RN   [4]
RP   PHARMACOLOGICAL CHARACTERIZATION, AND POSSIBLE FUNCTION.
RX   PubMed=11245603;
RA   Soegaard R., Ljungstroem T., Pedersen K.A., Oelesen S.-P.,
RA   Jensen B.S.;
RT   "KCNQ4 channels expressed in mammalian cells: functional
RT   characteristics and pharmacology.";
RL   Am. J. Physiol. 280:C859-C866(2001).
RN   [5]
RP   INTERACTION WITH HSP90AB1.
RX   PubMed=23431407; DOI=10.1371/journal.pone.0057282;
RA   Gao Y., Yechikov S., Vazquez A.E., Chen D., Nie L.;
RT   "Distinct roles of molecular chaperones HSP90alpha and HSP90beta in
RT   the biogenesis of KCNQ4 channels.";
RL   PLoS ONE 8:E57282-E57282(2013).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) OF 610-640, SUBUNIT, AND DOMAIN
RP   COILED-COIL.
RX   PubMed=17329207; DOI=10.1016/j.neuron.2007.02.010;
RA   Howard R.J., Clark K.A., Holton J.M., Minor D.L. Jr.;
RT   "Structural insight into KCNQ (Kv7) channel assembly and
RT   channelopathy.";
RL   Neuron 53:663-675(2007).
RN   [7]
RP   VARIANTS DFNA2A SER-276; CYS-285 AND SER-321.
RX   PubMed=10369879; DOI=10.1093/hmg/8.7.1321;
RA   Coucke P.J., Van Hauwe P., Kelley P.M., Kunst H., Schatteman I.,
RA   Van Velzen D., Meyers J., Ensink R.J., Verstreken M., Declau F.,
RA   Marres H., Kastury K., Bhasin S., McGuirt W.T., Smith R.J.H.,
RA   Cremers C.W.R.J., Van de Heyning P., Willems P.J., Smith S.D.,
RA   Van Camp G.;
RT   "Mutations in the KCNQ4 gene are responsible for autosomal dominant
RT   deafness in four DFNA2 families.";
RL   Hum. Mol. Genet. 8:1321-1328(1999).
RN   [8]
RP   VARIANT DFNA2A SER-281.
RX   PubMed=10571947;
RX   DOI=10.1002/(SICI)1098-1004(199912)14:6<493::AID-HUMU8>3.0.CO;2-P;
RA   Talebizadeh Z., Kelley P.M., Askew J.W., Beisel K.W., Smith S.D.;
RT   "Novel mutation in the KCNQ4 gene in a large kindred with dominant
RT   progressive hearing loss.";
RL   Hum. Mutat. 14:493-501(1999).
RN   [9]
RP   VARIANT DFNA2A HIS-274.
RX   PubMed=10925378;
RX   DOI=10.1002/1096-8628(20000731)93:3<184::AID-AJMG4>3.0.CO;2-5;
RA   Van Hauwe P., Coucke P.J., Ensink R.J., Huygen P., Cremers C.W.R.J.,
RA   Van Camp G.;
RT   "Mutations in the KCNQ4 K+ channel gene, responsible for autosomal
RT   dominant hearing loss, cluster in the channel pore region.";
RL   Am. J. Med. Genet. 93:184-187(2000).
RN   [10]
RP   VARIANT DFNA2A ARG-287.
RX   PubMed=21242547; DOI=10.1001/archoto.2010.234;
RA   Arnett J., Emery S.B., Kim T.B., Boerst A.K., Lee K., Leal S.M.,
RA   Lesperance M.M.;
RT   "Autosomal dominant progressive sensorineural hearing loss due to a
RT   novel mutation in the KCNQ4 gene.";
RL   Arch. Otolaryngol. Head Neck Surg. 137:54-59(2011).
CC   -!- FUNCTION: Probably important in the regulation of neuronal
CC       excitability. May underlie a potassium current involved in
CC       regulating the excitability of sensory cells of the cochlea. KCNQ4
CC       channels are blocked by linopirdin, XE991 and bepridil, whereas
CC       clofilium is without significant effect. Muscarinic agonist
CC       oxotremorine-M strongly suppress KCNQ4 current in CHO cells in
CC       which cloned KCNQ4 channels were coexpressed with M1 muscarinic
CC       receptors.
CC   -!- SUBUNIT: Homotetramer. May form heteromultimers with KCNQ3.
CC       Interacts with HSP90AB1; promotes cell surface expression of KCNQ4
CC       (PubMed:23431407). {ECO:0000269|PubMed:17329207,
CC       ECO:0000269|PubMed:23431407}.
CC   -!- SUBCELLULAR LOCATION: Basal cell membrane; Multi-pass membrane
CC       protein. Note=Situated at the basal membrane of cochlear outer
CC       hair cells. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P56696-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P56696-2; Sequence=VSP_001013;
CC   -!- TISSUE SPECIFICITY: Expressed in the outer, but not the inner,
CC       sensory hair cells of the cochlea. Slightly expressed in heart,
CC       brain and skeletal muscle.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- DOMAIN: The A-domain tail carries the major determinants of
CC       channel assembly specificity. Its coiled-coil region is Four-
CC       stranded. {ECO:0000269|PubMed:17329207}.
CC   -!- DISEASE: Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101]: A
CC       form of non-syndromic sensorineural hearing loss. Sensorineural
CC       deafness results from damage to the neural receptors of the inner
CC       ear, the nerve pathways to the brain, or the area of the brain
CC       that receives sound information. {ECO:0000269|PubMed:10025409,
CC       ECO:0000269|PubMed:10369879, ECO:0000269|PubMed:10571947,
CC       ECO:0000269|PubMed:10925378, ECO:0000269|PubMed:21242547}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: Mutagenesis experiments were carried out by
CC       expressing in Xenopus oocytes KCNQ4 mutants either individually
CC       (homomultimers) or in combination with wild-type KCNQ4 (mut/wt
CC       homomultimers) in a ratio of 1:1, to mimic the situation in a
CC       heterozygous DFNA2 patient.
CC   -!- SIMILARITY: Belongs to the potassium channel family. KQT (TC
CC       1.A.1.15) subfamily. Kv7.4/KCNQ4 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Hereditary hearing loss homepage; Note=Gene
CC       page;
CC       URL="http://hereditaryhearingloss.org/main.aspx?c=.HHH&n=86162";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF105202; AAD14680.1; -; mRNA.
DR   EMBL; AF105216; AAD14681.1; -; Genomic_DNA.
DR   EMBL; AF105203; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105204; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105205; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105206; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105207; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105208; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105209; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105210; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105211; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105212; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105213; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105214; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AF105215; AAD14681.1; JOINED; Genomic_DNA.
DR   EMBL; AC119677; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS456.1; -. [P56696-1]
DR   RefSeq; NP_004691.2; NM_004700.3. [P56696-1]
DR   RefSeq; NP_751895.1; NM_172163.2. [P56696-2]
DR   UniGene; Hs.473058; -.
DR   PDB; 2OVC; X-ray; 2.07 A; A=610-640.
DR   PDB; 4GOW; X-ray; 2.60 A; A=522-593.
DR   PDBsum; 2OVC; -.
DR   PDBsum; 4GOW; -.
DR   ProteinModelPortal; P56696; -.
DR   SMR; P56696; -.
DR   BioGrid; 114580; 6.
DR   STRING; 9606.ENSP00000262916; -.
DR   BindingDB; P56696; -.
DR   ChEMBL; CHEMBL3576; -.
DR   DrugBank; DB04953; Ezogabine.
DR   DrugBank; DB06089; ICA-105665.
DR   GuidetoPHARMACOLOGY; 563; -.
DR   TCDB; 1.A.1.15.4; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P56696; -.
DR   PhosphoSitePlus; P56696; -.
DR   BioMuta; KCNQ4; -.
DR   DMDM; 259016259; -.
DR   PaxDb; P56696; -.
DR   PeptideAtlas; P56696; -.
DR   PRIDE; P56696; -.
DR   Ensembl; ENST00000347132; ENSP00000262916; ENSG00000117013. [P56696-1]
DR   Ensembl; ENST00000509682; ENSP00000423756; ENSG00000117013. [P56696-2]
DR   GeneID; 9132; -.
DR   KEGG; hsa:9132; -.
DR   UCSC; uc001cgh.2; human. [P56696-1]
DR   CTD; 9132; -.
DR   DisGeNET; 9132; -.
DR   EuPathDB; HostDB:ENSG00000117013.14; -.
DR   GeneCards; KCNQ4; -.
DR   GeneReviews; KCNQ4; -.
DR   H-InvDB; HIX0200020; -.
DR   HGNC; HGNC:6298; KCNQ4.
DR   HPA; HPA018305; -.
DR   MalaCards; KCNQ4; -.
DR   MIM; 600101; phenotype.
DR   MIM; 603537; gene.
DR   neXtProt; NX_P56696; -.
DR   OpenTargets; ENSG00000117013; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   PharmGKB; PA30076; -.
DR   eggNOG; KOG1419; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00550000074513; -.
DR   HOGENOM; HOG000220839; -.
DR   HOVERGEN; HBG059014; -.
DR   InParanoid; P56696; -.
DR   KO; K04929; -.
DR   OMA; WAFVYHV; -.
DR   OrthoDB; EOG091G02ZT; -.
DR   PhylomeDB; P56696; -.
DR   TreeFam; TF315186; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNQ4; human.
DR   EvolutionaryTrace; P56696; -.
DR   GeneWiki; KCNQ4; -.
DR   GenomeRNAi; 9132; -.
DR   PRO; PR:P56696; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117013; -.
DR   CleanEx; HS_KCNQ4; -.
DR   ExpressionAtlas; P56696; baseline and differential.
DR   Genevisible; P56696; HS.
DR   GO; GO:0009925; C:basal plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005267; F:potassium channel activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0007605; P:sensory perception of sound; TAS:ProtInc.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003937; K_chnl_volt-dep_KCNQ.
DR   InterPro; IPR013821; K_chnl_volt-dep_KCNQ_C.
DR   InterPro; IPR015573; KCQN4.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF4; PTHR11537:SF4; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03520; KCNQ_channel; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01459; KCNQCHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Coiled coil;
KW   Complete proteome; Deafness; Disease mutation; Hearing; Ion channel;
KW   Ion transport; Membrane; Non-syndromic deafness; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    695       Potassium voltage-gated channel subfamily
FT                                KQT member 4.
FT                                /FTId=PRO_0000054037.
FT   TOPO_DOM      1     97       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     98    118       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    119    131       Extracellular. {ECO:0000255}.
FT   TRANSMEM    132    152       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    153    172       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    173    193       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    194    201       Extracellular. {ECO:0000255}.
FT   TRANSMEM    202    224       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    225    237       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    238    258       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    259    270       Extracellular. {ECO:0000255}.
FT   INTRAMEM    271    292       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    293    296       Extracellular. {ECO:0000255}.
FT   TRANSMEM    297    317       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    318    695       Cytoplasmic. {ECO:0000255}.
FT   REGION      546    650       A-domain (Tetramerization).
FT   COILED      610    645
FT   MOTIF       283    288       Selectivity filter. {ECO:0000250}.
FT   VAR_SEQ     377    430       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10025409}.
FT                                /FTId=VSP_001013.
FT   VARIANT     274    274       L -> H (in DFNA2A; dbSNP:rs80358276).
FT                                {ECO:0000269|PubMed:10925378}.
FT                                /FTId=VAR_010936.
FT   VARIANT     276    276       W -> S (in DFNA2A; dbSNP:rs80358277).
FT                                {ECO:0000269|PubMed:10369879}.
FT                                /FTId=VAR_008726.
FT   VARIANT     281    281       L -> S (in DFNA2A; dbSNP:rs80358278).
FT                                {ECO:0000269|PubMed:10571947}.
FT                                /FTId=VAR_010937.
FT   VARIANT     285    285       G -> C (in DFNA2A; loss of potassium
FT                                selectivity of the pore;
FT                                dbSNP:rs28937588).
FT                                {ECO:0000269|PubMed:10369879}.
FT                                /FTId=VAR_008727.
FT   VARIANT     285    285       G -> S (in DFNA2A; dominant negative
FT                                effect; abolishes potassium current;
FT                                dbSNP:rs28937588).
FT                                {ECO:0000269|PubMed:10025409}.
FT                                /FTId=VAR_001547.
FT   VARIANT     287    287       G -> R (in DFNA2A; dbSNP:rs137853969).
FT                                {ECO:0000269|PubMed:21242547}.
FT                                /FTId=VAR_065779.
FT   VARIANT     321    321       G -> S (in DFNA2A; dbSNP:rs28939710).
FT                                {ECO:0000269|PubMed:10369879}.
FT                                /FTId=VAR_008728.
FT   VARIANT     455    455       H -> Q (in dbSNP:rs34287852).
FT                                {ECO:0000269|PubMed:10025409}.
FT                                /FTId=VAR_058971.
FT   HELIX       526    548       {ECO:0000244|PDB:4GOW}.
FT   HELIX       612    637       {ECO:0000244|PDB:2OVC}.
SQ   SEQUENCE   695 AA;  77101 MW;  51390F5E00E8C157 CRC64;
     MAEAPPRRLG LGPPPGDAPR AELVALTAVQ SEQGEAGGGG SPRRLGLLGS PLPPGAPLPG
     PGSGSGSACG QRSSAAHKRY RRLQNWVYNV LERPRGWAFV YHVFIFLLVF SCLVLSVLST
     IQEHQELANE CLLILEFVMI VVFGLEYIVR VWSAGCCCRY RGWQGRFRFA RKPFCVIDFI
     VFVASVAVIA AGTQGNIFAT SALRSMRFLQ ILRMVRMDRR GGTWKLLGSV VYAHSKELIT
     AWYIGFLVLI FASFLVYLAE KDANSDFSSY ADSLWWGTIT LTTIGYGDKT PHTWLGRVLA
     AGFALLGISF FALPAGILGS GFALKVQEQH RQKHFEKRRM PAANLIQAAW RLYSTDMSRA
     YLTATWYYYD SILPSFRELA LLFEHVQRAR NGGLRPLEVR RAPVPDGAPS RYPPVATCHR
     PGSTSFCPGE SSRMGIKDRI RMGSSQRRTG PSKQHLAPPT MPTSPSSEQV GEATSPTKVQ
     KSWSFNDRTR FRASLRLKPR TSAEDAPSEE VAEEKSYQCE LTVDDIMPAV KTVIRSIRIL
     KFLVAKRKFK ETLRPYDVKD VIEQYSAGHL DMLGRIKSLQ TRVDQIVGRG PGDRKAREKG
     DKGPSDAEVV DEISMMGRVV KVEKQVQSIE HKLDLLLGFY SRCLRSGTSA SLGAVQVPLF
     DPDITSDYHS PVDHEDISVS AQTLSISRSV STNMD
//
ID   KCO1_ORYSJ              Reviewed;         347 AA.
AC   Q850M0; A0A0P0W378;
DT   28-JUN-2011, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   20-DEC-2017, entry version 121.
DE   RecName: Full=Two pore potassium channel a;
DE            Short=Two K(+) channel a;
DE   AltName: Full=Calcium-activated outward-rectifying potassium channel 1;
DE            Short=OsKCO1;
GN   Name=TPKA; Synonyms=KCO1;
GN   OrderedLocusNames=Os03g0752300, LOC_Os03g54100;
GN   ORFNames=OJ1112_G08.7, OsJ_12594, OSJNBa0032E21.10, OSJNBa0047E24.7;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16109971; DOI=10.1101/gr.3869505;
RG   The rice chromosome 3 sequencing consortium;
RA   Buell C.R., Yuan Q., Ouyang S., Liu J., Zhu W., Wang A., Maiti R.,
RA   Haas B., Wortman J., Pertea M., Jones K.M., Kim M., Overton L.,
RA   Tsitrin T., Fadrosh D., Bera J., Weaver B., Jin S., Johri S.,
RA   Reardon M., Webb K., Hill J., Moffat K., Tallon L., Van Aken S.,
RA   Lewis M., Utterback T., Feldblyum T., Zismann V., Iobst S., Hsiao J.,
RA   de Vazeille A.R., Salzberg S.L., White O., Fraser C.M., Yu Y., Kim H.,
RA   Rambo T., Currie J., Collura K., Kernodle-Thompson S., Wei F.,
RA   Kudrna K., Ammiraju J.S.S., Luo M., Goicoechea J.L., Wing R.A.,
RA   Henry D., Oates R., Palmer M., Pries G., Saski C., Simmons J.,
RA   Soderlund C., Nelson W., de la Bastide M., Spiegel L., Nascimento L.,
RA   Huang E., Preston R., Zutavern T., Palmer L., O'Shaughnessy A.,
RA   Dike S., McCombie W.R., Minx P., Cordum H., Wilson R., Jin W.,
RA   Lee H.R., Jiang J., Jackson S.;
RT   "Sequence, annotation, and analysis of synteny between rice chromosome
RT   3 and diverged grass species.";
RL   Genome Res. 15:1284-1291(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   "The rice annotation project database (RAP-DB): 2008 update.";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=15685292; DOI=10.1371/journal.pbio.0030038;
RA   Yu J., Wang J., Lin W., Li S., Li H., Zhou J., Ni P., Dong W., Hu S.,
RA   Zeng C., Zhang J., Zhang Y., Li R., Xu Z., Li S., Li X., Zheng H.,
RA   Cong L., Lin L., Yin J., Geng J., Li G., Shi J., Liu J., Lv H., Li J.,
RA   Wang J., Deng Y., Ran L., Shi X., Wang X., Wu Q., Li C., Ren X.,
RA   Wang J., Wang X., Li D., Liu D., Zhang X., Ji Z., Zhao W., Sun Y.,
RA   Zhang Z., Bao J., Han Y., Dong L., Ji J., Chen P., Wu S., Liu J.,
RA   Xiao Y., Bu D., Tan J., Yang L., Ye C., Zhang J., Xu J., Zhou Y.,
RA   Yu Y., Zhang B., Zhuang S., Wei H., Liu B., Lei M., Yu H., Li Y.,
RA   Xu H., Wei S., He X., Fang L., Zhang Z., Zhang Y., Huang X., Su Z.,
RA   Tong W., Li J., Tong Z., Li S., Ye J., Wang L., Fang L., Lei T.,
RA   Chen C.-S., Chen H.-C., Xu Z., Li H., Huang H., Zhang F., Xu H.,
RA   Li N., Zhao C., Li S., Dong L., Huang Y., Li L., Xi Y., Qi Q., Li W.,
RA   Zhang B., Hu W., Zhang Y., Tian X., Jiao Y., Liang X., Jin J., Gao L.,
RA   Zheng W., Hao B., Liu S.-M., Wang W., Yuan L., Cao M., McDermott J.,
RA   Samudrala R., Wang J., Wong G.K.-S., Yang H.;
RT   "The genomes of Oryza sativa: a history of duplications.";
RL   PLoS Biol. 3:266-281(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12869764; DOI=10.1126/science.1081288;
RG   The rice full-length cDNA consortium;
RT   "Collection, mapping, and annotation of over 28,000 cDNA clones from
RT   japonica rice.";
RL   Science 301:376-379(2003).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-292; VAL-303;
RP   ASN-313; LYS-326; ASP-330; GLY-333 AND TYR-338.
RX   PubMed=21224427; DOI=10.1105/tpc.110.081463;
RA   Isayenkov S., Isner J.C., Maathuis F.J.;
RT   "Rice two-pore K+ channels are expressed in different types of
RT   vacuoles.";
RL   Plant Cell 23:756-768(2011).
CC   -!- FUNCTION: Highly selective inward-rectifying potassium channel
CC       that is specifically located in the tonoplast of large vacuoles.
CC       Functions independently of the voltage difference across the
CC       membrane. {ECO:0000269|PubMed:21224427}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Vacuole membrane
CC       {ECO:0000269|PubMed:21224427}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:21224427}. Note=Tonoplast of large vacuoles.
CC   -!- DOMAIN: Each of the two pore-forming region (also called P-domain
CC       or P-loop) is enclosed by two transmembrane segments (2P/4TM) and
CC       contains the GYGD signature motif which seems to be involved in
CC       potassium selectivity.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.7) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC092556; AAR87255.1; -; Genomic_DNA.
DR   EMBL; AC135225; AAP68365.1; -; Genomic_DNA.
DR   EMBL; AF377947; AAO32309.1; -; Genomic_DNA.
DR   EMBL; DP000009; ABF98918.1; -; Genomic_DNA.
DR   EMBL; DP000009; ABF98919.1; -; Genomic_DNA.
DR   EMBL; AP008209; BAF13212.1; -; Genomic_DNA.
DR   EMBL; AP014959; BAS86423.1; -; Genomic_DNA.
DR   EMBL; CM000140; EAZ28607.1; -; Genomic_DNA.
DR   EMBL; AK069303; BAG91366.1; -; mRNA.
DR   RefSeq; XP_015630528.1; XM_015775042.1.
DR   RefSeq; XP_015630529.1; XM_015775043.1.
DR   RefSeq; XP_015630530.1; XM_015775044.1.
DR   RefSeq; XP_015630531.1; XM_015775045.1.
DR   UniGene; Os.14641; -.
DR   ProteinModelPortal; Q850M0; -.
DR   STRING; 39947.LOC_Os03g54100.1; -.
DR   PaxDb; Q850M0; -.
DR   PRIDE; Q850M0; -.
DR   EnsemblPlants; OS03T0752300-01; OS03T0752300-01; OS03G0752300.
DR   GeneID; 4334137; -.
DR   Gramene; OS03T0752300-01; OS03T0752300-01; OS03G0752300.
DR   KEGG; osa:4334137; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   InParanoid; Q850M0; -.
DR   KO; K05389; -.
DR   OMA; HPSKIPM; -.
DR   OrthoDB; EOG09360EZI; -.
DR   Proteomes; UP000059680; Chromosome 3.
DR   ExpressionAtlas; Q850M0; baseline and differential.
DR   Genevisible; Q850M0; OS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0009705; C:plant-type vacuole membrane; IDA:UniProtKB.
DR   GO; GO:0031004; C:potassium ion-transporting ATPase complex; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0030007; P:cellular potassium ion homeostasis; IC:UniProtKB.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR031144; TPK_plant.
DR   PANTHER; PTHR11003:SF137; PTHR11003:SF137; 1.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Vacuole.
FT   CHAIN         1    347       Two pore potassium channel a.
FT                                /FTId=PRO_0000410872.
FT   TOPO_DOM      1     65       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     66     86       Helical. {ECO:0000255}.
FT   INTRAMEM     99    118       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    125    145       Helical. {ECO:0000255}.
FT   TOPO_DOM    146    183       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    184    204       Helical. {ECO:0000255}.
FT   INTRAMEM    213    232       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    239    259       Helical. {ECO:0000255}.
FT   TOPO_DOM    260    347       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      276    311       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      315    347       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     289    300       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   CA_BIND     328    339       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   MUTAGEN     292    292       D->G: No effect on targeting to large
FT                                vacuole. {ECO:0000269|PubMed:21224427}.
FT   MUTAGEN     303    303       V->L: Mainly targeted to large vacuole
FT                                and partly to protein storage vacuole.
FT                                Almost completely targeted to protein
FT                                storage vacuole; when associated with S-
FT                                313. {ECO:0000269|PubMed:21224427}.
FT   MUTAGEN     313    313       N->S: Equally targeted to large vacuole
FT                                and protein storage vacuole. Almost
FT                                completely targeted to protein storage
FT                                vacuole; when associated with L-303.
FT                                {ECO:0000269|PubMed:21224427}.
FT   MUTAGEN     326    326       K->N: Mainly targeted to protein storage
FT                                vacuole. {ECO:0000269|PubMed:21224427}.
FT   MUTAGEN     330    330       D->H: Mainly targeted to large vacuole
FT                                and partly to the ER; when associated
FT                                with A-333.
FT                                {ECO:0000269|PubMed:21224427}.
FT   MUTAGEN     333    333       G->A: Mainly targeted to large vacuole
FT                                and partly to the ER; when associated
FT                                with H-330.
FT                                {ECO:0000269|PubMed:21224427}.
FT   MUTAGEN     338    338       Y->A: No effect on targeting to large
FT                                vacuole. {ECO:0000269|PubMed:21224427}.
SQ   SEQUENCE   347 AA;  39236 MW;  33F34F43014065DD CRC64;
     MDDNSIQQSL LADNPNVLQR KPSEGVNRFR RCRSTPSTDP LQGPPEKGSS VKAKELFKEM
     RPSFRLVGLL LFIYLLVGVL AFYAVMDEIS GKRTNRVLDA LYFCVVTMTT VGYGDLVPNN
     DTTKLLACAF VFMGMAVVAL FVSKVADYLV EKQEVLFFKA LHTNLKGGET KMLRAIETNR
     IKYKFYTNAL LLVLSIISGT VFLWKVEKLS LVDSFYCVCA TITTLGYGDK SFSSKLGRVF
     AVFWIITSTI IMAQFFMYLA EIYTERRQKM LANWVLTRKM TKMDLEAADL DDDRQVGAAE
     FVVYKLKELG KINQEEISSF LEEFEKLDVD HSGTLSPYDL TLAQSAQ
//
ID   KAT1_ARATH              Reviewed;         677 AA.
AC   Q39128; Q42426;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   25-OCT-2017, entry version 135.
DE   RecName: Full=Potassium channel KAT1;
GN   Name=KAT1; OrderedLocusNames=At5g46240; ORFNames=MPL12.2;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1570292; DOI=10.1073/pnas.89.9.3736;
RA   Anderson J.A., Huprikar S.S., Kochian L.V., Lucas W.J., Gaber R.F.;
RT   "Functional expression of a probable Arabidopsis thaliana potassium
RT   channel in Saccharomyces cerevisiae.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:3736-3740(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   STRAIN=cv. RLD;
RX   PubMed=7480337; DOI=10.1104/pp.109.2.371;
RA   Nakamura R.L., McKendree W.L. Jr., Hirsch R.E., Sedbrook J.C.,
RA   Gaber R.F., Sussman M.R.;
RT   "Expression of an Arabidopsis potassium channel gene in guard cells.";
RL   Plant Physiol. 109:371-374(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Landsberg erecta;
RX   PubMed=8798465; DOI=10.1074/jbc.271.37.22863;
RA   Gaymard F., Cerrutti M., Horeau C., Lemaillet G., Urbach S.,
RA   Ravallec M., Devauchelle G., Sentenac H., Thibaud J.-B.;
RT   "The baculovirus/insect cell system as an alternative to Xenopus
RT   oocytes. First characterization of the AKT1 K+ channel from
RT   Arabidopsis thaliana.";
RL   J. Biol. Chem. 271:22863-22870(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=9679202; DOI=10.1093/dnares/5.2.131;
RA   Kaneko T., Kotani H., Nakamura Y., Sato S., Asamizu E., Miyajima N.,
RA   Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence
RT   features of the regions of 1,381,565 bp covered by twenty one
RT   physically assigned P1 and TAC clones.";
RL   DNA Res. 5:131-145(1998).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION.
RX   PubMed=8966547; DOI=10.1126/science.8966547;
RA   Schachtman D.P., Schroeder J.I., Lucas W.J., Anderson J.A.,
RA   Gaber R.F.;
RT   "Expression of an inward-rectifying potassium channel by the
RT   Arabidopsis KAT1 cDNA.";
RL   Science 258:1654-1658(1992).
RN   [7]
RP   PORE SELECTIVITY, AND MUTAGENESIS OF THR-256.
RX   PubMed=7592636; DOI=10.1074/jbc.270.41.24276;
RA   Uozumi N., Gassmann W., Cao Y., Schroeder J.I.;
RT   "Identification of strong modifications in cation selectivity in an
RT   Arabidopsis inward rectifying potassium channel by mutant selection in
RT   yeast.";
RL   J. Biol. Chem. 270:24276-24281(1995).
RN   [8]
RP   PORE SELECTIVITY, AND MUTAGENESIS OF LEU-251; THR-256; THR-259;
RP   THR-260 AND 259-THR-THR-260.
RX   PubMed=8755614; DOI=10.1073/pnas.93.15.8123;
RA   Becker D., Dreyer I., Hoth S., Reid J.D., Busch H., Lehnen M.,
RA   Palme K., Hedrich R.;
RT   "Changes in voltage activation, Cs+ sensitivity, and ion permeability
RT   in H5 mutants of the plant K+ channel KAT1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:8123-8128(1996).
RN   [9]
RP   PORE SELECTIVITY, AND MUTAGENESIS OF TYR-263 AND GLY-264.
RX   PubMed=8995396; DOI=10.1074/jbc.272.2.1011;
RA   Nakamura R.L., Anderson J.A., Gaber R.F.;
RT   "Determination of key structural requirements of a K+ channel pore.";
RL   J. Biol. Chem. 272:1011-1018(1997).
RN   [10]
RP   PORE SELECTIVITY, AND MUTAGENESIS OF HIS-267 AND GLU-269.
RX   PubMed=9368418; DOI=10.1105/tpc.9.10.1843;
RA   Ichida A.M., Pei Z.-M., Baizabal-Aguirre V.M., Turner K.J.,
RA   Schroeder J.I.;
RT   "Expression of a Cs(+)-resistant guard cell K+ channel confers Cs(+)-
RT   resistant, light-induced stomatal opening in transgenic Arabidopsis.";
RL   Plant Cell 9:1843-1857(1997).
RN   [11]
RP   PORE SELECTIVITY, AND MUTAGENESIS OF THR-256 AND HIS-267.
RX   PubMed=9688573; DOI=10.1016/S0014-5793(98)00694-2;
RA   Dreyer I., Becker D., Bregante M., Gambale F., Lehnen M., Palme K.,
RA   Hedrich R.;
RT   "Single mutations strongly alter the K(+)-selective pore of the K(in)
RT   channel KAT1.";
RL   FEBS Lett. 430:370-376(1998).
RN   [12]
RP   VOLTAGE-DEPENDENT GATING, AND MUTAGENESIS OF ARG-176.
RX   PubMed=9635749; DOI=10.1016/S0006-3495(98)78002-6;
RA   Marten I., Hoshi T.;
RT   "The N-terminus of the K channel KAT1 controls its voltage-dependent
RT   gating by altering the membrane electric field.";
RL   Biophys. J. 74:2953-2962(1998).
RN   [13]
RP   VOLTAGE-DEPENDENT GATING, AND MUTAGENESIS OF ARG-176 AND ARG-177.
RX   PubMed=9834140; DOI=10.1085/jgp.112.6.679;
RA   Zei P.C., Aldrich R.W.;
RT   "Voltage-dependent gating of single wild-type and S4 mutant KAT1
RT   inward rectifier potassium channels.";
RL   J. Gen. Physiol. 112:679-713(1998).
RN   [14]
RP   INTERACTION WITH AKT2, AND MUTAGENESIS OF THR-256 AND GLY-262.
RX   PubMed=9916143; DOI=10.1007/s002329900476;
RA   Baizabal-Aguirre V.M., Clemens S., Uozumi N., Schroeder J.I.;
RT   "Suppression of inward-rectifying K+ channels KAT1 and AKT2 by
RT   dominant negative point mutations in the KAT1 alpha-subunit.";
RL   J. Membr. Biol. 167:119-125(1999).
RN   [15]
RP   PROTON SENSITIVITY, AND MUTAGENESIS OF ASP-265.
RX   PubMed=10206968; DOI=10.1074/jbc.274.17.11599;
RA   Hoth S., Hedrich R.;
RT   "Distinct molecular bases for pH sensitivity of the guard cell K+
RT   channels KST1 and KAT1.";
RL   J. Biol. Chem. 274:11599-11603(1999).
RN   [16]
RP   INTERACTION WITH KAT2.
RX   PubMed=11042178; DOI=10.1074/jbc.M007303200;
RA   Pilot G., Lacombe B., Gaymard F., Cherel I., Boucherez J.,
RA   Thibaud J.-B., Sentenac H.;
RT   "Guard cell inward K+ channel activity in Arabidopsis involves
RT   expression of the twin channel subunits KAT1 and KAT2.";
RL   J. Biol. Chem. 276:3215-3221(2001).
RN   [17]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [18]
RP   INTERACTION WITH SLAC1 AND SLAH3.
RX   PubMed=27002025; DOI=10.1105/tpc.16.01050;
RA   Zhang A., Ren H.M., Tan Y.Q., Qi G.N., Yao F.Y., Wu G.L., Yang L.W.,
RA   Hussain J., Sun S.J., Wang Y.F.;
RT   "S-type anion channels SLAC1 and SLAH3 function as essential negative
RT   regulators of inward K+ channels and stomatal opening in
RT   Arabidopsis.";
RL   Plant Cell 0:0-0(2016).
CC   -!- FUNCTION: Highly selective inward-rectifying potassium channel.
CC       This voltage-gated channel could mediate long-term potassium
CC       influx into guard cells leading to stomatal opening. Assuming
CC       opened or closed conformations in response to the voltage
CC       difference across the membrane, the channel is activated by
CC       hyperpolarization. The channel activity is enhanced upon external
CC       acidification. Also permeable to ammonium ions. Blocked by
CC       tetraethylammonium and barium ions. {ECO:0000269|PubMed:8966547}.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming subunits. May interact
CC       with AKT2 and KAT2 (Probable). Interacts with SLAC1 and SLAH3
CC       (PubMed:27002025). {ECO:0000269|PubMed:27002025, ECO:0000305}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-1552490, EBI-1552490;
CC       Q38898:AKT2; NbExp=4; IntAct=EBI-1552490, EBI-1552774;
CC       Q38849:KAT2; NbExp=3; IntAct=EBI-1552490, EBI-2117720;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in guard cells, and in roots.
CC       {ECO:0000269|PubMed:7480337}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M86990; AAA32824.1; -; mRNA.
DR   EMBL; U25088; AAC49113.1; -; Genomic_DNA.
DR   EMBL; X93022; CAA63601.1; -; mRNA.
DR   EMBL; AB010698; BAB11079.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED95356.1; -; Genomic_DNA.
DR   PIR; S32816; S32816.
DR   RefSeq; NP_199436.1; NM_123993.3.
DR   UniGene; At.305; -.
DR   ProteinModelPortal; Q39128; -.
DR   BioGrid; 19915; 16.
DR   IntAct; Q39128; 4.
DR   STRING; 3702.AT5G46240.1; -.
DR   TCDB; 1.A.1.4.7; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q39128; -.
DR   PaxDb; Q39128; -.
DR   EnsemblPlants; AT5G46240.1; AT5G46240.1; AT5G46240.
DR   GeneID; 834666; -.
DR   Gramene; AT5G46240.1; AT5G46240.1; AT5G46240.
DR   KEGG; ath:AT5G46240; -.
DR   Araport; AT5G46240; -.
DR   TAIR; locus:2170468; AT5G46240.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238230; -.
DR   InParanoid; Q39128; -.
DR   KO; K21867; -.
DR   OMA; HLFLLEM; -.
DR   OrthoDB; EOG093606I1; -.
DR   PhylomeDB; Q39128; -.
DR   BioCyc; ARA:AT5G46240-MONOMER; -.
DR   BioCyc; MetaCyc:MONOMER-14553; -.
DR   PRO; PR:Q39128; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; Q39128; baseline and differential.
DR   Genevisible; Q39128; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:TAIR.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IDA:TAIR.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    677       Potassium channel KAT1.
FT                                /FTId=PRO_0000054125.
FT   TOPO_DOM      1     63       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     64     84       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     85     90       Extracellular. {ECO:0000255}.
FT   TRANSMEM     91    111       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    112    134       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    135    155       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    156    165       Extracellular. {ECO:0000255}.
FT   TRANSMEM    166    186       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    187    200       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    201    221       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    222    248       Extracellular. {ECO:0000255}.
FT   INTRAMEM    249    268       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    269    272       Extracellular. {ECO:0000255}.
FT   TRANSMEM    273    293       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    294    677       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      612    677       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     377    496       cNMP.
FT   MUTAGEN     176    176       R->S,L: Affects the voltage-dependent
FT                                gating. {ECO:0000269|PubMed:9635749,
FT                                ECO:0000269|PubMed:9834140}.
FT   MUTAGEN     177    177       R->Q: Affects the voltage-dependent
FT                                gating. {ECO:0000269|PubMed:9834140}.
FT   MUTAGEN     251    251       L->I,F: Enhances cesium sensitivity.
FT                                {ECO:0000269|PubMed:8755614}.
FT   MUTAGEN     256    256       T->D,G,Q,E: Increases sensitivity to
FT                                ammonium and sodium.
FT                                {ECO:0000269|PubMed:7592636,
FT                                ECO:0000269|PubMed:8755614,
FT                                ECO:0000269|PubMed:9688573,
FT                                ECO:0000269|PubMed:9916143}.
FT   MUTAGEN     256    256       T->E: Increases rubidium uptake and both
FT                                cesium and calcium sensitivity;
FT                                facilitated entry of calcium ions; when
FT                                associated with A-267.
FT                                {ECO:0000269|PubMed:7592636,
FT                                ECO:0000269|PubMed:8755614,
FT                                ECO:0000269|PubMed:9688573,
FT                                ECO:0000269|PubMed:9916143}.
FT   MUTAGEN     256    256       T->F,L,P,R,W: Abolishes channel activity.
FT                                {ECO:0000269|PubMed:7592636,
FT                                ECO:0000269|PubMed:8755614,
FT                                ECO:0000269|PubMed:9688573,
FT                                ECO:0000269|PubMed:9916143}.
FT   MUTAGEN     256    256       T->S: Increases calcium sensitivity;
FT                                facilitated entry of calcium ions; when
FT                                associated with A-267.
FT                                {ECO:0000269|PubMed:7592636,
FT                                ECO:0000269|PubMed:8755614,
FT                                ECO:0000269|PubMed:9688573,
FT                                ECO:0000269|PubMed:9916143}.
FT   MUTAGEN     259    259       T->S: Increases rubidium uptake and
FT                                cesium sensitivity; additional increase
FT                                of rubidium uptake; when associated with
FT                                S-260. {ECO:0000269|PubMed:8755614}.
FT   MUTAGEN     260    260       T->S: Increases rubidium uptake;
FT                                additional increase of rubidium uptake;
FT                                when associated with S-259.
FT                                {ECO:0000269|PubMed:8755614}.
FT   MUTAGEN     262    262       G->K: Abolishes channel activity.
FT                                {ECO:0000269|PubMed:9916143}.
FT   MUTAGEN     263    263       Y->F: The only mutation at this site that
FT                                do not perturb the channel activity.
FT                                {ECO:0000269|PubMed:8995396}.
FT   MUTAGEN     264    264       G->C,F,K,L,P,S,T: Abolishes channel
FT                                activity. {ECO:0000269|PubMed:8995396}.
FT   MUTAGEN     265    265       D->N: Affects the pH-dependence.
FT                                {ECO:0000269|PubMed:10206968}.
FT   MUTAGEN     267    267       H->A: Increases calcium sensitivity;
FT                                facilitated entry of calcium ions; when
FT                                associated with S-256.
FT                                {ECO:0000269|PubMed:9368418,
FT                                ECO:0000269|PubMed:9688573}.
FT   MUTAGEN     267    267       H->T: Resistance to the cesium inhibition
FT                                of stomatal opening; when associated with
FT                                V-269. {ECO:0000269|PubMed:9368418,
FT                                ECO:0000269|PubMed:9688573}.
FT   MUTAGEN     269    269       E->V: Resistance to the cesium inhibition
FT                                of stomatal opening; when associated with
FT                                T-267. {ECO:0000269|PubMed:9368418}.
FT   CONFLICT      5      5       W -> C (in Ref. 3; CAA63601).
FT                                {ECO:0000305}.
FT   CONFLICT    330    330       Q -> E (in Ref. 3; CAA63601).
FT                                {ECO:0000305}.
FT   CONFLICT    573    573       V -> E (in Ref. 3; CAA63601).
FT                                {ECO:0000305}.
FT   CONFLICT    580    580       T -> S (in Ref. 3; CAA63601).
FT                                {ECO:0000305}.
FT   CONFLICT    629    629       L -> V (in Ref. 3; CAA63601).
FT                                {ECO:0000305}.
FT   CONFLICT    664    664       D -> N (in Ref. 3; CAA63601).
FT                                {ECO:0000305}.
SQ   SEQUENCE   677 AA;  78271 MW;  7F9C8285ED702338 CRC64;
     MSISWTRNFF ERFCVEEYNI DTIKQSSFLS ADLLPSLGAR INQSTKLRKH IISPFNPRYR
     AWEMWLVLLV IYSAWICPFQ FAFITYKKDA IFIIDNIVNG FFAIDIILTF FVAYLDSHSY
     LLVDSPKKIA IRYLSTWFAF DVCSTAPFQP LSLLFNYNGS ELGFRILSML RLWRLRRVSS
     LFARLEKDIR FNYFWIRCTK LISVTLFAIH CAGCFNYLIA DRYPNPRKTW IGAVYPNFKE
     ASLWNRYVTA LYWSITTLTT TGYGDFHAEN PREMLFDIFF MMFNLGLTAY LIGNMTNLVV
     HWTSRTRTFR DSVRAASEFA SRNQLPHDIQ DQMLSHICLK FKTEGLKQQE TLNNLPKAIR
     SSIANYLFFP IVHNIYLFQG VSRNFLFQLV SDIDAEYFPP KEDIILQNEA PTDLYILVSG
     AVDFTVYVDG HDQFQGKAVI GETFGEVGVL YYRPQPFTVR TTELSQILRI SRTSLMSAMH
     AHADDGRVIM NNLFMKLRGQ QSIAIDDSNT SGHENRDFKS MGWEEWRDSR KDGYGLDVTN
     PTSDTALMDA IHKEDTEMVK KILKEQKIER AKVERSSSET AGRSYANDSS KKDPYCSSSN
     QIIKPCKREE KRVTIHMMSE SKNGKLILLP SSIEELLRLA SEKFGGCNFT KITNADNAEI
     DDLDVIWDGD HLYFSSN
//
ID   KCNA4_RAT               Reviewed;         655 AA.
AC   P15385;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   22-NOV-2017, entry version 161.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 4;
DE   AltName: Full=RCK4 {ECO:0000303|PubMed:2348860};
DE   AltName: Full=RHK1;
DE   AltName: Full=RK3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.4;
GN   Name=Kcna4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=2555158;
RA   Stuehmer W., Ruppersberg J.P., Schroerter K.H., Sakmann B.,
RA   Stocker M., Giese K.P., Perschke A., Baumann A., Pongs O.;
RT   "Molecular basis of functional diversity of voltage-gated potassium
RT   channels in mammalian brain.";
RL   EMBO J. 8:3235-3244(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Heart;
RX   PubMed=2384173; DOI=10.1016/0014-5793(90)80973-M;
RA   Tseng-Crank J., Tseng G.-N., Schwartz A., Tanouye M.A.;
RT   "Molecular cloning and functional expression of a potassium channel
RT   cDNA isolated from a rat cardiac library.";
RL   FEBS Lett. 268:63-68(1990).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH KCNA1.
RX   PubMed=2348860; DOI=10.1038/345535a0;
RA   Ruppersberg J.P., Schroeter K.H., Sakmann B., Stocker M., Sewing S.,
RA   Pongs O.;
RT   "Heteromultimeric channels formed by rat brain potassium-channel
RT   proteins.";
RL   Nature 345:535-537(1990).
RN   [4]
RP   SUBCELLULAR LOCATION.
RX   PubMed=1497894; DOI=10.1016/0896-6273(92)90166-B;
RA   Sheng M., Tsaur M.L., Jan Y.N., Jan L.Y.;
RT   "Subcellular segregation of two A-type K+ channel proteins in rat
RT   central neurons.";
RL   Neuron 9:271-284(1992).
RN   [5]
RP   FUNCTION.
RX   PubMed=8495559; DOI=10.1161/01.RES.72.6.1326;
RA   Po S., Roberds S., Snyders D.J., Tamkun M.M., Bennett P.B.;
RT   "Heteromultimeric assembly of human potassium channels. Molecular
RT   basis of a transient outward current?";
RL   Circ. Res. 72:1326-1336(1993).
RN   [6]
RP   INTERACTION WITH KCNA2, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8361540; DOI=10.1038/365072a0;
RA   Sheng M., Liao Y.J., Jan Y.N., Jan L.Y.;
RT   "Presynaptic A-current based on heteromultimeric K+ channels detected
RT   in vivo.";
RL   Nature 365:72-75(1993).
RN   [7]
RP   INTERACTION WITH DLG1; DLG2 AND DLG4.
RX   PubMed=7477295; DOI=10.1038/378085a0;
RA   Kim E., Niethammer M., Rothschild A., Jan Y.N., Sheng M.;
RT   "Clustering of Shaker-type K+ channels by interaction with a family of
RT   membrane-associated guanylate kinases.";
RL   Nature 378:85-88(1995).
RN   [8]
RP   INTERACTION WITH KCNAB1 AND KCNAB2, AND TISSUE SPECIFICITY.
RX   PubMed=9334400;
RA   Rhodes K.J., Strassle B.W., Monaghan M.M., Bekele-Arcuri Z.,
RA   Matos M.F., Trimmer J.S.;
RT   "Association and colocalization of the Kvbeta1 and Kvbeta2 beta-
RT   subunits with Kv1 alpha-subunits in mammalian brain K+ channel
RT   complexes.";
RL   J. Neurosci. 17:8246-8258(1997).
RN   [9]
RP   INTERACTION WITH KCNA1 AND KCNA2, SUBCELLULAR LOCATION, AND
RP   GLYCOSYLATION.
RX   PubMed=10896669; DOI=10.1074/jbc.M005010200;
RA   Manganas L.N., Trimmer J.S.;
RT   "Subunit composition determines Kv1 potassium channel surface
RT   expression.";
RL   J. Biol. Chem. 275:29685-29693(2000).
RN   [10]
RP   INTERACTION WITH SIGMAR1.
RX   PubMed=11988171; DOI=10.1016/S0896-6273(02)00677-3;
RA   Aydar E., Palmer C.P., Klyachko V.A., Jackson M.B.;
RT   "The sigma receptor as a ligand-regulated auxiliary potassium channel
RT   subunit.";
RL   Neuron 34:399-410(2002).
RN   [11]
RP   SUBUNIT, AND INTERACTION WITH KCNA2.
RX   PubMed=12632190; DOI=10.1007/s00424-002-0994-7;
RA   Fergus D.J., Martens J.R., England S.K.;
RT   "Kv channel subunits that contribute to voltage-gated K+ current in
RT   renal vascular smooth muscle.";
RL   Pflugers Arch. 445:697-704(2003).
RN   [12]
RP   INTERACTION WITH LGI1; KCNA1 AND KCNAB1.
RX   PubMed=16504945; DOI=10.1016/j.neuron.2006.01.033;
RA   Schulte U., Thumfart J.-O., Kloecker N., Sailer C.A., Bildl W.,
RA   Biniossek M., Dehn D., Deller T., Eble S., Abbass K., Wangler T.,
RA   Knaus H.-G., Fakler B.;
RT   "The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1
RT   channels and inhibits inactivation by Kvbeta1.";
RL   Neuron 49:697-706(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-123, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [14]
RP   STRUCTURE BY NMR OF 1-37.
RX   PubMed=9000078; DOI=10.1038/385272a0;
RA   Antz C., Geyer M., Fakler B., Schott M.K., Guy H.R., Frank R.,
RA   Ruppersberg J.P., Kalbitzer H.R.;
RT   "NMR structure of inactivation gates from mammalian voltage-dependent
RT   potassium channels.";
RL   Nature 385:272-275(1997).
RN   [15]
RP   STRUCTURE BY NMR OF 25-75.
RX   PubMed=12590144; DOI=10.1074/jbc.M210191200;
RA   Wissmann R., Bildl W., Oliver D., Beyermann M., Kalbitzer H.-R.,
RA   Bentrop D., Fakler B.;
RT   "Solution structure and function of the 'tandem inactivation domain'
RT   of the neuronal A-type potassium channel Kv1.4.";
RL   J. Biol. Chem. 278:16142-16150(2003).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes. Forms
CC       tetrameric potassium-selective channels through which potassium
CC       ions pass in accordance with their electrochemical gradient. The
CC       channel alternates between opened and closed conformations in
CC       response to the voltage difference across the membrane. Can form
CC       functional homotetrameric channels and heterotetrameric channels
CC       that contain variable proportions of KCNA1, KCNA2, KCNA4, KCNA5,
CC       and possibly other family members as well; channel properties
CC       depend on the type of alpha subunits that are part of the channel
CC       (PubMed:2348860, PubMed:8495559, PubMed:10896669). Channel
CC       properties are modulated by cytoplasmic beta subunits that
CC       regulate the subcellular location of the alpha subunits and
CC       promote rapid inactivation. In vivo, membranes probably contain a
CC       mixture of heteromeric potassium channel complexes, making it
CC       difficult to assign currents observed in intact tissues to any
CC       particular potassium channel family member. Homotetrameric KCNA4
CC       forms a potassium channel that opens in response to membrane
CC       depolarization, followed by rapid spontaneous channel closure
CC       (PubMed:2384173). Likewise, a heterotetrameric channel formed by
CC       KCNA1 and KCNA4 shows rapid inactivation (PubMed:2348860).
CC       {ECO:0000269|PubMed:10896669, ECO:0000269|PubMed:2348860,
CC       ECO:0000269|PubMed:2384173, ECO:0000269|PubMed:8495559}.
CC   -!- SUBUNIT: Homotetramer and heterotetramer of potassium channel
CC       proteins (PubMed:10896669). Interacts with KCNAB1 and KCNAB2
CC       (PubMed:9334400). Binds PDZ domains of DLG1, DLG2 and DLG4.
CC       Interacts with SIGMAR1 (PubMed:11988171). Part of a complex
CC       containing KCNA1, KCNAB1 and LGI1 (PubMed:16504945). Detected in a
CC       complex with KCNA1 (PubMed:2348860, PubMed:10896669). Interacts
CC       with KCNA2 (PubMed:8361540, PubMed:10896669, PubMed:12632190).
CC       Interacts (via cytoplasmic N-terminal domain) with KCNRG (By
CC       similarity). {ECO:0000250|UniProtKB:P22459,
CC       ECO:0000269|PubMed:10896669, ECO:0000269|PubMed:11988171,
CC       ECO:0000269|PubMed:12632190, ECO:0000269|PubMed:16504945,
CC       ECO:0000269|PubMed:2348860, ECO:0000269|PubMed:7477295,
CC       ECO:0000269|PubMed:8361540, ECO:0000269|PubMed:9334400}.
CC   -!- INTERACTION:
CC       P78352:DLG4 (xeno); NbExp=9; IntAct=EBI-631417, EBI-80389;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10896669,
CC       ECO:0000269|PubMed:2348860, ECO:0000269|PubMed:2384173}; Multi-
CC       pass membrane protein {ECO:0000255}. Cell projection, axon
CC       {ECO:0000269|PubMed:10896669, ECO:0000269|PubMed:1497894,
CC       ECO:0000305|PubMed:8361540}.
CC   -!- TISSUE SPECIFICITY: Detected in brain (at protein level)
CC       (PubMed:8361540, PubMed:9334400). Heart and brain.
CC       {ECO:0000269|PubMed:2384173, ECO:0000269|PubMed:8361540,
CC       ECO:0000269|PubMed:9334400}.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments. {ECO:0000305}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:10896669}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.4/KCNA4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16002; CAA34133.1; -; mRNA.
DR   EMBL; M32867; AAA41469.1; -; mRNA.
DR   PIR; S11049; S11049.
DR   RefSeq; NP_037103.1; NM_012971.2.
DR   UniGene; Rn.9884; -.
DR   PDB; 1KN7; NMR; -; A=1-75.
DR   PDB; 1ZTO; NMR; -; A=1-36.
DR   PDBsum; 1KN7; -.
DR   PDBsum; 1ZTO; -.
DR   ProteinModelPortal; P15385; -.
DR   SMR; P15385; -.
DR   BioGrid; 247502; 2.
DR   IntAct; P15385; 5.
DR   MINT; MINT-222765; -.
DR   STRING; 10116.ENSRNOP00000006524; -.
DR   ChEMBL; CHEMBL5583; -.
DR   GuidetoPHARMACOLOGY; 541; -.
DR   iPTMnet; P15385; -.
DR   PhosphoSitePlus; P15385; -.
DR   PaxDb; P15385; -.
DR   PRIDE; P15385; -.
DR   GeneID; 25469; -.
DR   KEGG; rno:25469; -.
DR   UCSC; RGD:2952; rat.
DR   CTD; 3739; -.
DR   RGD; 2952; Kcna4.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; P15385; -.
DR   KO; K04877; -.
DR   PhylomeDB; P15385; -.
DR   EvolutionaryTrace; P15385; -.
DR   PRO; PR:P15385; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0032279; C:asymmetric synapse; IDA:SynGO-UCL.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:SynGO-UCL.
DR   GO; GO:0043197; C:dendritic spine; IDA:SynGO-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:RGD.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:RGD.
DR   GO; GO:0099055; C:integral component of postsynaptic membrane; IDA:SynGO-UCL.
DR   GO; GO:0099056; C:integral component of presynaptic membrane; IDA:SynGO-UCL.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005216; F:ion channel activity; IDA:RGD.
DR   GO; GO:0005267; F:potassium channel activity; IDA:RGD.
DR   GO; GO:0030955; F:potassium ion binding; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.20.5.600; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR020467; K_chnl_volt-dep_Kv1.4.
DR   InterPro; IPR012897; K_chnl_volt-dep_Kv1.4_TID.
DR   InterPro; IPR037065; K_chnl_volt-dep_Kv1.4_TID_sf.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF07941; K_channel_TID; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01511; KV14CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cell projection; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    655       Potassium voltage-gated channel subfamily
FT                                A member 4.
FT                                /FTId=PRO_0000053984.
FT   TOPO_DOM      1    306       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    307    328       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    329    372       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    373    394       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    395    405       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    406    426       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    427    441       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    442    462       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    463    477       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    478    499       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    500    513       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    514    525       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    526    533       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    534    540       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    541    569       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    570    655       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION      464    477       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       526    531       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       653    655       PDZ-binding.
FT   COMPBIAS     38     50       Poly-Ala.
FT   COMPBIAS     62     65       Poly-His.
FT   COMPBIAS     92     95       Poly-Lys.
FT   COMPBIAS    124    138       Poly-Glu.
FT   COMPBIAS    163    167       Poly-Gly.
FT   COMPBIAS    435    438       Poly-Gln.
FT   MOD_RES     123    123       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     601    601       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD    354    354       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT     42     42       A -> L (in Ref. 2; AAA41469).
FT                                {ECO:0000305}.
FT   CONFLICT     84     88       EEEAT -> RRRRQ (in Ref. 2; AAA41469).
FT                                {ECO:0000305}.
FT   CONFLICT     95     95       Missing (in Ref. 2; AAA41469).
FT                                {ECO:0000305}.
FT   CONFLICT    310    310       G -> A (in Ref. 2; AAA41469).
FT                                {ECO:0000305}.
FT   TURN         11     13       {ECO:0000244|PDB:1KN7}.
FT   HELIX        21     24       {ECO:0000244|PDB:1KN7}.
FT   HELIX        25     30       {ECO:0000244|PDB:1KN7}.
FT   HELIX        31     33       {ECO:0000244|PDB:1KN7}.
FT   HELIX        43     46       {ECO:0000244|PDB:1KN7}.
SQ   SEQUENCE   655 AA;  73390 MW;  40AEF2F901A05F43 CRC64;
     MEVAMVSAES SGCNSHMPYG YAAQARARER ERLAHSRAAA AAAVAAATAA VEGTGGSGGG
     PHHHHQTRGA YSSHDPQGSR GSREEEATRT EKKKKLHHRQ SSFPHCSDLM PSGSEEKILR
     ELSEEEEDEE EEEEEEEEGR FYYSEEDHGD GCSYTDLLPQ DDGGGGGYSS VRYSDCCERV
     VINVSGLRFE TQMKTLAQFP ETLLGDPEKR TQYFDPLRNE YFFDRNRPSF DAILYYYQSG
     GRLKRPVNVP FDIFTEEVKF YQLGEEALLK FREDEGFVRE EEDRALPENE FKKQIWLLFE
     YPESSSPARG IAIVSVLVIL ISIVIFCLET LPEFRDDRDL IMALSAGGHS RLLNDTSAPH
     LENSGHTIFN DPFFIVETVC IVWFSFEFVV RCFACPSQAL FFKNIMNIID IVSILPYFIT
     LGTDLAQQQG GGNGQQQQAM SFAILRIIRL VRVFRIFKLS RHSKGLQILG HTLRASMREL
     GLLIFFLFIG VILFSSAVYF AEADEPTTHF QSIPDAFWWA VVTMTTVGYG DMKPITVGGK
     IVGSLCAIAG VLTIALPVPV IVSNFNYFYH RETENEEQTQ LTQNAVSCPY LPSNLLKKFR
     SSTSSSLGDK SEYLEMEEGV KESLCGKEEK CQGKGDDSET DKNNCSNAKA VETDV
//
ID   KCND2_RAT               Reviewed;         630 AA.
AC   Q63881; Q00090; Q99249;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-NOV-2017, entry version 152.
DE   RecName: Full=Potassium voltage-gated channel subfamily D member 2;
DE   AltName: Full=RK5 {ECO:0000303|PubMed:1705709, ECO:0000303|PubMed:1722463};
DE   AltName: Full=Shal1 {ECO:0000303|PubMed:1840649};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv4.2 {ECO:0000303|PubMed:9093524};
GN   Name=Kcnd2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Hippocampus;
RX   PubMed=1840649; DOI=10.1016/0896-6273(91)90299-F;
RA   Baldwin T.J., Tsaur M.-L., Lopez G.A., Jan Y.N., Jan L.Y.;
RT   "Characterization of a mammalian cDNA for an inactivating voltage-
RT   sensitive K+ channel.";
RL   Neuron 7:471-483(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Heart;
RX   PubMed=1705709; DOI=10.1073/pnas.88.5.1798;
RA   Roberds S.L., Tamkun M.M.;
RT   "Cloning and tissue-specific expression of five voltage-gated
RT   potassium channel cDNAs expressed in rat heart.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:1798-1802(1991).
RN   [3]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=1722463; DOI=10.1016/0014-5793(91)81420-D;
RA   Blair T.A., Roberds S.L., Tamkun M.M., Hartshorne R.P.;
RT   "Functional characterization of RK5, a voltage-gated K+ channel cloned
RT   from the rat cardiovascular system.";
RL   FEBS Lett. 295:211-213(1991).
RN   [4]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9093524; DOI=10.1016/S0008-6363(96)00221-0;
RA   Yeola S.W., Snyders D.J.;
RT   "Electrophysiological and pharmacological correspondence between Kv4.2
RT   current and rat cardiac transient outward current.";
RL   Cardiovasc. Res. 33:540-547(1997).
RN   [5]
RP   FUNCTION, ENZYME REGULATION, AND SUBCELLULAR LOCATION.
RX   PubMed=9058605;
RA   Sanguinetti M.C., Johnson J.H., Hammerland L.G., Kelbaugh P.R.,
RA   Volkmann R.A., Saccomano N.A., Mueller A.L.;
RT   "Heteropodatoxins: peptides isolated from spider venom that block
RT   Kv4.2 potassium channels.";
RL   Mol. Pharmacol. 51:491-498(1997).
RN   [6]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9070739; DOI=10.1016/S0306-4522(96)00561-1;
RA   Alonso G., Widmer H.;
RT   "Clustering of KV4.2 potassium channels in postsynaptic membrane of
RT   rat supraoptic neurons: an ultrastructural study.";
RL   Neuroscience 77:617-621(1997).
RN   [7]
RP   PHOSPHORYLATION AT THR-38 AND SER-552 BY PKACA.
RX   PubMed=10681507; DOI=10.1074/jbc.275.8.5337;
RA   Anderson A.E., Adams J.P., Qian Y., Cook R.G., Pfaffinger P.J.,
RA   Sweatt J.D.;
RT   "Kv4.2 phosphorylation by cyclic AMP-dependent protein kinase.";
RL   J. Biol. Chem. 275:5337-5346(2000).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10860776; DOI=10.1006/jmcc.2000.1172;
RA   Takeuchi S., Takagishi Y., Yasui K., Murata Y., Toyama J., Kodama I.;
RT   "Voltage-gated K(+)Channel, Kv4.2, localizes predominantly to the
RT   transverse-axial tubular system of the rat myocyte.";
RL   J. Mol. Cell. Cardiol. 32:1361-1369(2000).
RN   [9]
RP   PHOSPHORYLATION AT THR-602; THR-607 AND SER-616.
RX   PubMed=11080179; DOI=10.1046/j.1471-4159.2000.0752277.x;
RA   Adams J.P., Anderson A.E., Varga A.W., Dineley K.T., Cook R.G.,
RA   Pfaffinger P.J., Sweatt J.D.;
RT   "The A-type potassium channel Kv4.2 is a substrate for the mitogen-
RT   activated protein kinase ERK.";
RL   J. Neurochem. 75:2277-2287(2000).
RN   [10]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH
RP   FILAMIN.
RX   PubMed=11102480;
RA   Petrecca K., Miller D.M., Shrier A.;
RT   "Localization and enhanced current density of the Kv4.2 potassium
RT   channel by interaction with the actin-binding protein filamin.";
RL   J. Neurosci. 20:8736-8744(2000).
RN   [11]
RP   INTERACTION WITH KCNIP1; KCNIP2 AND KCNIP3, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10676964; DOI=10.1038/35000592;
RA   An W.F., Bowlby M.R., Betty M., Cao J., Ling H.-P., Mendoza G.,
RA   Hinson J.W., Mattsson K.I., Strassle B.W., Trimmer J.S., Rhodes K.J.;
RT   "Modulation of A-type potassium channels by a family of calcium
RT   sensors.";
RL   Nature 403:553-556(2000).
RN   [12]
RP   INTERACTION WITH KCNIP3, FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS
RP   OF SER-552, PHOSPHORYLATION AT SER-552, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=12451113;
RA   Schrader L.A., Anderson A.E., Mayne A., Pfaffinger P.J., Sweatt J.D.;
RT   "PKA modulation of Kv4.2-encoded A-type potassium channels requires
RT   formation of a supramolecular complex.";
RL   J. Neurosci. 22:10123-10133(2002).
RN   [13]
RP   INTERACTION WITH KCNIP4, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11847232; DOI=10.1074/jbc.M200897200;
RA   Morohashi Y., Hatano N., Ohya S., Takikawa R., Watabiki T.,
RA   Takasugi N., Imaizumi Y., Tomita T., Iwatsubo T.;
RT   "Molecular cloning and characterization of CALP/KChIP4, a novel EF-
RT   hand protein interacting with presenilin 2 and voltage-gated potassium
RT   channel subunit Kv4.";
RL   J. Biol. Chem. 277:14965-14975(2002).
RN   [14]
RP   MUTAGENESIS OF 627-VAL--LEU-630, INTERACTION WITH DLG4, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11923279; DOI=10.1074/jbc.M109412200;
RA   Wong W., Newell E.W., Jugloff D.G.M., Jones O.T., Schlichter L.C.;
RT   "Cell surface targeting and clustering interactions between
RT   heterologously expressed PSD-95 and the Shal voltage-gated potassium
RT   channel, Kv4.2.";
RL   J. Biol. Chem. 277:20423-20430(2002).
RN   [15]
RP   INTERACTION WITH KCNIP4.
RX   PubMed=11805342; DOI=10.1073/pnas.022509299;
RA   Holmqvist M.H., Cao J., Hernandez-Pineda R., Jacobson M.D.,
RA   Carroll K.I., Sung M.A., Betty M., Ge P., Gilbride K.J., Brown M.E.,
RA   Jurman M.E., Lawson D., Silos-Santiago I., Xie Y., Covarrubias M.,
RA   Rhodes K.J., Distefano P.S., An W.F.;
RT   "Elimination of fast inactivation in Kv4 A-type potassium channels by
RT   an auxiliary subunit domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:1035-1040(2002).
RN   [16]
RP   PHOSPHORYLATION AT SER-552, AND SUBCELLULAR LOCATION.
RX   PubMed=12829703; DOI=10.1074/jbc.M306142200;
RA   Shibata R., Misonou H., Campomanes C.R., Anderson A.E., Schrader L.A.,
RA   Doliveira L.C., Carroll K.I., Sweatt J.D., Rhodes K.J., Trimmer J.S.;
RT   "A fundamental role for KChIPs in determining the molecular properties
RT   and trafficking of Kv4.2 potassium channels.";
RL   J. Biol. Chem. 278:36445-36454(2003).
RN   [17]
RP   SUBCELLULAR LOCATION, DENDRITIC TARGETING REGION, MUTAGENESIS OF
RP   481-LEU--LEU-482, AND FUNCTION.
RX   PubMed=12592409; DOI=10.1038/nn1020;
RA   Rivera J.F., Ahmad S., Quick M.W., Liman E.R., Arnold D.B.;
RT   "An evolutionarily conserved dileucine motif in Shal K+ channels
RT   mediates dendritic targeting.";
RL   Nat. Neurosci. 6:243-250(2003).
RN   [18]
RP   INTERACTION WITH DPP6.
RX   PubMed=12575952; DOI=10.1016/S0896-6273(02)01185-6;
RA   Nadal M.S., Ozaita A., Amarillo Y., Vega-Saenz de Miera E., Ma Y.,
RA   Mo W., Goldberg E.M., Misumi Y., Ikehara Y., Neubert T.A., Rudy B.;
RT   "The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a
RT   critical component of neuronal A-type K+ channels.";
RL   Neuron 37:449-461(2003).
RN   [19]
RP   SUBUNIT, ZINC-BINDING, SUBCELLULAR LOCATION, FUNCTION, AND MUTAGENESIS
RP   OF HIS-105; CYS-111; CYS-132 AND CYS-133.
RX   PubMed=12754210; DOI=10.1074/jbc.M304268200;
RA   Strang C., Kunjilwar K., DeRubeis D., Peterson D., Pfaffinger P.J.;
RT   "The role of Zn2+ in Shal voltage-gated potassium channel formation.";
RL   J. Biol. Chem. 278:31361-31371(2003).
RN   [20]
RP   MUTAGENESIS OF 627-VAL--LEU-630, INTERACTION WITH DLG4, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=14559911; DOI=10.1074/jbc.M304675200;
RA   Wong W., Schlichter L.C.;
RT   "Differential recruitment of Kv1.4 and Kv4.2 to lipid rafts by PSD-
RT   95.";
RL   J. Biol. Chem. 279:444-452(2004).
RN   [21]
RP   FUNCTION, INTERACTION WITH KCNIP3, AND SUBCELLULAR LOCATION.
RX   PubMed=15485870; DOI=10.1074/jbc.M409721200;
RA   Kunjilwar K., Strang C., DeRubeis D., Pfaffinger P.J.;
RT   "KChIP3 rescues the functional expression of Shal channel
RT   tetramerization mutants.";
RL   J. Biol. Chem. 279:54542-54551(2004).
RN   [22]
RP   INTERACTION WITH KCNIP1 AND KCNIP3.
RX   PubMed=15356203; DOI=10.1523/JNEUROSCI.0776-04.2004;
RA   Rhodes K.J., Carroll K.I., Sung M.A., Doliveira L.C., Monaghan M.M.,
RA   Burke S.L., Strassle B.W., Buchwalder L., Menegola M., Cao J.,
RA   An W.F., Trimmer J.S.;
RT   "KChIPs and Kv4 alpha subunits as integral components of A-type
RT   potassium channels in mammalian brain.";
RL   J. Neurosci. 24:7903-7915(2004).
RN   [23]
RP   INTERACTION WITH KCNIP1, AND MUTAGENESIS OF 7-ALA--PHE-11; GLU-71;
RP   ASP-73; PHE-74 AND GLU-79.
RX   PubMed=14980207; DOI=10.1016/S0896-6273(04)00049-2;
RA   Scannevin R.H., Wang K., Jow F., Megules J., Kopsco D.C., Edris W.,
RA   Carroll K.C., Lu Q., Xu W., Xu Z., Katz A.H., Olland S., Lin L.,
RA   Taylor M., Stahl M., Malakian K., Somers W., Mosyak L., Bowlby M.R.,
RA   Chanda P., Rhodes K.J.;
RT   "Two N-terminal domains of Kv4 K(+) channels regulate binding to and
RT   modulation by KChIP1.";
RL   Neuron 41:587-598(2004).
RN   [24]
RP   DOMAIN, FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH KCNIP2.
RX   PubMed=15452711; DOI=10.1007/s00424-004-1328-8;
RA   Pourrier M., Herrera D., Caballero R., Schram G., Wang Z., Nattel S.;
RT   "The Kv4.2 N-terminal restores fast inactivation and confers KChlP2
RT   modulatory effects on N-terminal-deleted Kv1.4 channels.";
RL   Pflugers Arch. 449:235-247(2004).
RN   [25]
RP   REVIEW.
RX   PubMed=15858231; DOI=10.1385/CBB:42:2:167;
RA   Cox R.H.;
RT   "Molecular determinants of voltage-gated potassium currents in
RT   vascular smooth muscle.";
RL   Cell Biochem. Biophys. 42:167-195(2005).
RN   [26]
RP   INTERACTION WITH DPP6 AND DPP10, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15671030; DOI=10.1074/jbc.M410613200;
RA   Zagha E., Ozaita A., Chang S.Y., Nadal M.S., Lin U., Saganich M.J.,
RA   McCormack T., Akinsanya K.O., Qi S.Y., Rudy B.;
RT   "DPP10 modulates Kv4-mediated A-type potassium channels.";
RL   J. Biol. Chem. 280:18853-18861(2005).
RN   [27]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15736227; DOI=10.1002/cne.20443;
RA   Strassle B.W., Menegola M., Rhodes K.J., Trimmer J.S.;
RT   "Light and electron microscopic analysis of KChIP and Kv4 localization
RT   in rat cerebellar granule cells.";
RL   J. Comp. Neurol. 484:144-155(2005).
RN   [28]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16207878; DOI=10.1523/JNEUROSCI.2858-05.2005;
RA   Yuan W., Burkhalter A., Nerbonne J.M.;
RT   "Functional role of the fast transient outward K+ current IA in
RT   pyramidal neurons in (rat) primary visual cortex.";
RL   J. Neurosci. 25:9185-9194(2005).
RN   [29]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=16123112; DOI=10.1113/jphysiol.2005.087858;
RA   Jerng H.H., Kunjilwar K., Pfaffinger P.J.;
RT   "Multiprotein assembly of Kv4.2, KChIP3 and DPP10 produces ternary
RT   channel complexes with ISA-like properties.";
RL   J. Physiol. (Lond.) 568:767-788(2005).
RN   [30]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH KCNIP2, AND DOMAIN.
RX   PubMed=16820361; DOI=10.1074/jbc.M604843200;
RA   Han W., Nattel S., Noguchi T., Shrier A.;
RT   "C-terminal domain of Kv4.2 and associated KChIP2 interactions
RT   regulate functional expression and gating of Kv4.2.";
RL   J. Biol. Chem. 281:27134-27144(2006).
RN   [31]
RP   FUNCTION.
RX   PubMed=17026528; DOI=10.1111/j.1471-4159.2006.04185.x;
RA   Lauver A., Yuan L.L., Jeromin A., Nadin B.M., Rodriguez J.J.,
RA   Davies H.A., Stewart M.G., Wu G.Y., Pfaffinger P.J.;
RT   "Manipulating Kv4.2 identifies a specific component of hippocampal
RT   pyramidal neuron A-current that depends upon Kv4.2 expression.";
RL   J. Neurochem. 99:1207-1223(2006).
RN   [32]
RP   REVIEW.
RX   PubMed=17917103; DOI=10.1007/s12035-007-8001-0;
RA   Baranauskas G.;
RT   "Ionic channel function in action potential generation: current
RT   perspective.";
RL   Mol. Neurobiol. 35:129-150(2007).
RN   [33]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17582333; DOI=10.1016/j.neuron.2007.05.026;
RA   Kim J., Jung S.C., Clemens A.M., Petralia R.S., Hoffman D.A.;
RT   "Regulation of dendritic excitability by activity-dependent
RT   trafficking of the A-type K+ channel subunit Kv4.2 in hippocampal
RT   neurons.";
RL   Neuron 54:933-947(2007).
RN   [34]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=18371079; DOI=10.1111/j.1460-9568.2008.06141.x;
RA   Kollo M., Holderith N., Antal M., Nusser Z.;
RT   "Unique clustering of A-type potassium channels on different cell
RT   types of the main olfactory bulb.";
RL   Eur. J. Neurosci. 27:1686-1699(2008).
RN   [35]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-552, AND MUTAGENESIS OF
RP   SER-552.
RX   PubMed=18650329; DOI=10.1523/JNEUROSCI.1951-08.2008;
RA   Hammond R.S., Lin L., Sidorov M.S., Wikenheiser A.M., Hoffman D.A.;
RT   "Protein kinase A mediates activity-dependent Kv4.2 channel
RT   trafficking.";
RL   J. Neurosci. 28:7513-7519(2008).
RN   [36]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND MISCELLANEOUS.
RX   PubMed=18276729; DOI=10.1113/jphysiol.2007.150540;
RA   Amarillo Y., De Santiago-Castillo J.A., Dougherty K., Maffie J.,
RA   Kwon E., Covarrubias M., Rudy B.;
RT   "Ternary Kv4.2 channels recapitulate voltage-dependent inactivation
RT   kinetics of A-type K+ channels in cerebellar granule neurons.";
RL   J. Physiol. (Lond.) 586:2093-2106(2008).
RN   [37]
RP   REVIEW.
RX   PubMed=18357523; DOI=10.1007/s11064-008-9650-8;
RA   Covarrubias M., Bhattacharji A., De Santiago-Castillo J.A.,
RA   Dougherty K., Kaulin Y.A., Na-Phuket T.R., Wang G.;
RT   "The neuronal Kv4 channel complex.";
RL   Neurochem. Res. 33:1558-1567(2008).
RN   [38]
RP   SUBCELLULAR LOCATION, INTERACTION WITH DPP6 AND KCNIP2,
RP   PHOSPHORYLATION AT SER-548; SER-552; SER-572 AND SER-575,
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND MUTAGENESIS OF SER-552.
RX   PubMed=19441798; DOI=10.1021/bi802316m;
RA   Seikel E., Trimmer J.S.;
RT   "Convergent modulation of Kv4.2 channel alpha subunits by structurally
RT   distinct DPPX and KChIP auxiliary subunits.";
RL   Biochemistry 48:5721-5730(2009).
RN   [39]
RP   FUNCTION, SUBUNIT, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19901547; DOI=10.4161/chan.3.6.10216;
RA   Jerng H.H., Dougherty K., Covarrubias M., Pfaffinger P.J.;
RT   "A novel N-terminal motif of dipeptidyl peptidase-like proteins
RT   produces rapid inactivation of KV4.2 channels by a pore-blocking
RT   mechanism.";
RL   Channels 3:448-461(2009).
RN   [40]
RP   INTERACTION WITH DLG1.
RX   PubMed=19213956; DOI=10.1161/CIRCRESAHA.108.191007;
RA   El-Haou S., Balse E., Neyroud N., Dilanian G., Gavillet B., Abriel H.,
RA   Coulombe A., Jeromin A., Hatem S.N.;
RT   "Kv4 potassium channels form a tripartite complex with the anchoring
RT   protein SAP97 and CaMKII in cardiac myocytes.";
RL   Circ. Res. 104:758-769(2009).
RN   [41]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19279261; DOI=10.1523/JNEUROSCI.4767-08.2009;
RA   Kaulin Y.A., De Santiago-Castillo J.A., Rocha C.A., Nadal M.S.,
RA   Rudy B., Covarrubias M.;
RT   "The dipeptidyl-peptidase-like protein DPP6 determines the unitary
RT   conductance of neuronal Kv4.2 channels.";
RL   J. Neurosci. 29:3242-3251(2009).
RN   [42]
RP   SUBCELLULAR LOCATION, SUBUNIT, INTERACTION WITH PKA; CAV3; AKAP6 AND
RP   KCND3, AND TISSUE SPECIFICITY.
RX   PubMed=20224290; DOI=10.4161/chan.4.3.11479;
RA   Alday A., Urrutia J., Gallego M., Casis O.;
RT   "Alpha1-adrenoceptors regulate only the caveolae-located subpopulation
RT   of cardiac K(V)4 channels.";
RL   Channels 4:168-178(2010).
RN   [43]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=20045463; DOI=10.1016/j.mcn.2009.12.005;
RA   Lin L., Sun W., Wikenheiser A.M., Kung F., Hoffman D.A.;
RT   "KChIP4a regulates Kv4.2 channel trafficking through PKA
RT   phosphorylation.";
RL   Mol. Cell. Neurosci. 43:315-325(2010).
RN   [44]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=22098631; DOI=10.1111/j.1460-9568.2011.07907.x;
RA   Kerti K., Lorincz A., Nusser Z.;
RT   "Unique somato-dendritic distribution pattern of Kv4.2 channels on
RT   hippocampal CA1 pyramidal cells.";
RL   Eur. J. Neurosci. 35:66-75(2012).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548; SER-552; SER-572
RP   AND SER-575, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [46]
RP   INDUCTION BY HYPOXIA, FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=25352783; DOI=10.3389/fncel.2014.00329;
RA   Liu Y.Q., Huang W.X., Sanchez R.M., Min J.W., Hu J.J., He X.H.,
RA   Peng B.W.;
RT   "Regulation of Kv4.2 A-type potassium channels in HEK-293 cells by
RT   hypoxia.";
RL   Front. Cell. Neurosci. 8:329-329(2014).
RN   [47]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=24037673; DOI=10.1002/cne.23435;
RA   Rainnie D.G., Hazra R., Dabrowska J., Guo J.D., Li C.C., Dewitt S.,
RA   Muly E.C.;
RT   "Distribution and functional expression of Kv4 family alpha subunits
RT   and associated KChIP beta subunits in the bed nucleus of the stria
RT   terminalis.";
RL   J. Comp. Neurol. 522:609-625(2014).
RN   [48]
RP   INTERACTION WITH KCNIP4.
RX   PubMed=24811166; DOI=10.1074/jbc.M114.563452;
RA   Kitazawa M., Kubo Y., Nakajo K.;
RT   "The stoichiometry and biophysical properties of the Kv4 potassium
RT   channel complex with K+ channel-interacting protein (KChIP) subunits
RT   are variable, depending on the relative expression level.";
RL   J. Biol. Chem. 289:17597-17609(2014).
RN   [49]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=24793047; DOI=10.1007/s00424-014-1521-3;
RA   Rudakova E., Wagner M., Frank M., Volk T.;
RT   "Localization of Kv4.2 and KChIP2 in lipid rafts and modulation of
RT   outward K(+) currents by membrane cholesterol content in rat left
RT   ventricular myocytes.";
RL   Pflugers Arch. 467:299-309(2015).
RN   [50]
RP   FUNCTION, PHOSPHORYLATION AT SER-438, AND SUBCELLULAR LOCATION.
RX   PubMed=24404150; DOI=10.1371/journal.pone.0084086;
RA   Labno A., Warrier A., Wang S., Zhang X.;
RT   "Local plasticity of dendritic excitability can be autonomous of
RT   synaptic plasticity and regulated by activity-based phosphorylation of
RT   Kv4.2.";
RL   PLoS ONE 9:E84086-E84086(2014).
RN   [51]
RP   SPECIFIC INHIBITION BY SCORPION TOXIN.
RX   PubMed=27346450; DOI=10.1016/j.toxicon.2016.06.014;
RA   Pucca M.B., Cerni F.A., Cordeiro F.A., Peigneur S., Cunha T.M.,
RA   Tytgat J., Arantes E.C.;
RT   "Ts8 scorpion toxin inhibits the Kv4.2 channel and produces
RT   nociception in vivo.";
RL   Toxicon 119:244-252(2016).
RN   [52]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 42-146 IN COMPLEX WITH ZINC
RP   IONS, AND MUTAGENESIS OF LEU-66 AND ARG-93.
RX   PubMed=12835418; DOI=10.1073/pnas.1432840100;
RA   Nanao M.H., Zhou W., Pfaffinger P.J., Choe S.;
RT   "Determining the basis of channel-tetramerization specificity by X-ray
RT   crystallography and a sequence-comparison algorithm: family values
RT   (FamVal).";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:8670-8675(2003).
RN   [53]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-30, FUNCTION, INTERACTION
RP   WITH KCNIP1; KCNIP2 AND KCNIP3, SUBUNIT, SUBCELLULAR LOCATION,
RP   MUTAGENESIS OF TRP-8 AND PHE-11, AND DOMAIN.
RX   PubMed=14980206; DOI=10.1016/S0896-6273(04)00045-5;
RA   Zhou W., Qian Y., Kunjilwar K., Pfaffinger P.J., Choe S.;
RT   "Structural insights into the functional interaction of KChIP1 with
RT   Shal-type K(+) channels.";
RL   Neuron 41:573-586(2004).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes,
CC       primarily in the brain, but also in rodent heart (PubMed:1840649,
CC       PubMed:1722463, PubMed:9093524, PubMed:9058605, PubMed:10676964,
CC       PubMed:12592409, PubMed:12754210, PubMed:16207878,
CC       PubMed:16123112, PubMed:19279261, PubMed:25352783,
CC       PubMed:14980206). Mediates the major part of the dendritic A-type
CC       current I(SA) in brain neurons (PubMed:16207878, PubMed:17026528).
CC       This current is activated at membrane potentials that are below
CC       the threshold for action potentials. It regulates neuronal
CC       excitability, prolongs the latency before the first spike in a
CC       series of action potentials, regulates the frequency of repetitive
CC       action potential firing, shortens the duration of action
CC       potentials and regulates the back-propagation of action potentials
CC       from the neuronal cell body to the dendrites. Contributes to the
CC       regulation of the circadian rhythm of action potential firing in
CC       suprachiasmatic nucleus neurons, which regulates the circadian
CC       rhythm of locomotor activity (By similarity). Functions downstream
CC       of the metabotropic glutamate receptor GRM5 and plays a role in
CC       neuronal excitability and in nociception mediated by activation of
CC       GRM5 (By similarity). Mediates the transient outward current I(to)
CC       in rodent heart left ventricle apex cells, but not in human heart,
CC       where this current is mediated by another family member
CC       (PubMed:9093524, PubMed:9058605). Forms tetrameric potassium-
CC       selective channels through which potassium ions pass in accordance
CC       with their electrochemical gradient. The channel alternates
CC       between opened and closed conformations in response to the voltage
CC       difference across the membrane (PubMed:1840649, PubMed:1722463,
CC       PubMed:9093524, PubMed:10676964, PubMed:12451113, PubMed:12592409,
CC       PubMed:12754210, PubMed:15452711, PubMed:16207878,
CC       PubMed:16820361, PubMed:25352783, PubMed:14980206). Can form
CC       functional homotetrameric channels and heterotetrameric channels
CC       that contain variable proportions of KCND2 and KCND3; channel
CC       properties depend on the type of pore-forming alpha subunits that
CC       are part of the channel (PubMed:25352783). In vivo, membranes
CC       probably contain a mixture of heteromeric potassium channel
CC       complexes (PubMed:12451113, PubMed:16123112). Interaction with
CC       specific isoforms of the regulatory subunits KCNIP1, KCNIP2,
CC       KCNIP3 or KCNIP4 strongly increases expression at the cell surface
CC       and thereby increases channel activity; it modulates the kinetics
CC       of channel activation and inactivation, shifts the threshold for
CC       channel activation to more negative voltage values, shifts the
CC       threshold for inactivation to less negative voltages and
CC       accelerates recovery after inactivation (PubMed:12451113,
CC       PubMed:15452711, PubMed:16123112, PubMed:16820361,
CC       PubMed:20045463, PubMed:14980206). Likewise, interaction with DPP6
CC       or DPP10 promotes expression at the cell membrane and regulates
CC       both channel characteristics and activity (PubMed:15671030,
CC       PubMed:16123112, PubMed:19441798, PubMed:19901547,
CC       PubMed:19279261). {ECO:0000250|UniProtKB:Q9Z0V2,
CC       ECO:0000269|PubMed:10676964, ECO:0000269|PubMed:11847232,
CC       ECO:0000269|PubMed:12451113, ECO:0000269|PubMed:12592409,
CC       ECO:0000269|PubMed:12754210, ECO:0000269|PubMed:14980206,
CC       ECO:0000269|PubMed:15452711, ECO:0000269|PubMed:15485870,
CC       ECO:0000269|PubMed:16123112, ECO:0000269|PubMed:16207878,
CC       ECO:0000269|PubMed:16820361, ECO:0000269|PubMed:17026528,
CC       ECO:0000269|PubMed:1722463, ECO:0000269|PubMed:17582333,
CC       ECO:0000269|PubMed:1840649, ECO:0000269|PubMed:19279261,
CC       ECO:0000269|PubMed:19441798, ECO:0000269|PubMed:19901547,
CC       ECO:0000269|PubMed:24404150, ECO:0000269|PubMed:25352783,
CC       ECO:0000269|PubMed:9058605, ECO:0000269|PubMed:9093524,
CC       ECO:0000305}.
CC   -!- ENZYME REGULATION: Inhibited by 5 mM 4-aminopyridine (4-AP)
CC       (PubMed:1840649, PubMed:1722463, PubMed:9093524). Not inhibited by
CC       dendrotoxins and by tetraethylammonium (TEA) (PubMed:1722463).
CC       Inhibited by 10 mM flecainide and 20 mM quinidine
CC       (PubMed:9093524). Inhibited by the heteropodatoxins HpTx(1),
CC       HpTx(2), and HpTx(3) (PubMed:9058605).
CC       {ECO:0000269|PubMed:1722463, ECO:0000269|PubMed:1840649,
CC       ECO:0000269|PubMed:9058605, ECO:0000269|PubMed:9093524}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Homotetrameric channels activate rapidly, i.e within a few
CC         msec (PubMed:1722463, PubMed:9093524). After that, they
CC         inactivate rapidly, i.e within about 50-100 msec
CC         (PubMed:1722463, PubMed:9093524). The voltage-dependence of
CC         activation and inactivation and other channel characteristics
CC         vary depending on the experimental conditions, the expression
CC         system and the presence or absence of ancillary subunits
CC         (PubMed:19901547, PubMed:19279261). Homotetrameric channels have
CC         a unitary conductance of about 4 pS when expressed in a
CC         heterologous system (PubMed:19279261). For the activation of
CC         homotetrameric channels expressed in xenopus oocytes, the
CC         voltage at half-maximal amplitude is about -10 mV
CC         (PubMed:12451113). The time constant for inactivation is about
CC         20 msec (PubMed:12451113). For inactivation, the voltage at
CC         half-maximal amplitude is -62 mV (PubMed:12451113). The time
CC         constant for recovery after inactivation is about 70 msec
CC         (PubMed:12451113). {ECO:0000269|PubMed:12451113,
CC         ECO:0000269|PubMed:1722463, ECO:0000269|PubMed:19279261,
CC         ECO:0000269|PubMed:19901547, ECO:0000269|PubMed:9093524,
CC         ECO:0000305|PubMed:15858231};
CC   -!- SUBUNIT: Homotetramer or heterotetramer with KCND1 or KCND3
CC       (PubMed:12754210, PubMed:15485870, PubMed:20224290,
CC       PubMed:25352783). Associates with the regulatory subunits KCNIP1,
CC       KCNIP2, KCNIP3 and KCNIP4 (PubMed:10676964, PubMed:12451113,
CC       PubMed:11847232, PubMed:11805342, PubMed:15485870,
CC       PubMed:15356203, PubMed:15452711, PubMed:16820361,
CC       PubMed:20045463, PubMed:24811166, PubMed:14980206). Interacts with
CC       DPP6, DPP10, DLG4 and DLG1 (PubMed:11923279, PubMed:12575952,
CC       PubMed:14559911, PubMed:15671030, PubMed:19213956). In vivo,
CC       probably exists as heteromeric complex containing variable
CC       proportions of KCND1, KCND2, KCND3, KCNIP1, KCNIP2, KCNIP3,
CC       KCNIP4, DPP6 and DPP10 (PubMed:16123112, PubMed:19901547). The
CC       tetrameric channel can associate with up to four regulatory
CC       subunits, such as KCNIP2 or KCNIP4 (By similarity). Interaction
CC       with KCNIP3 promotes tetramerization and formation of a functional
CC       potassium channel (PubMed:15485870). Interaction with four KCNIP4
CC       chains does not reduce interaction with DPP10 (By similarity).
CC       Probably part of a complex consisting of KCNIP1, KCNIP2 isoform 3
CC       and KCND2 (By similarity). Interacts with FLNA and FLNC
CC       (PubMed:11102480). Interacts with NCS1/FREQ (By similarity).
CC       Identified in a complex with cAMP-dependent protein kinase (PKA),
CC       CAV3, AKAP6 and KCND3 in cardiac myocytes (PubMed:20224290).
CC       {ECO:0000250|UniProtKB:Q9NZV8, ECO:0000250|UniProtKB:Q9Z0V2,
CC       ECO:0000269|PubMed:10676964, ECO:0000269|PubMed:11102480,
CC       ECO:0000269|PubMed:11805342, ECO:0000269|PubMed:11847232,
CC       ECO:0000269|PubMed:11923279, ECO:0000269|PubMed:12451113,
CC       ECO:0000269|PubMed:12575952, ECO:0000269|PubMed:12754210,
CC       ECO:0000269|PubMed:14559911, ECO:0000269|PubMed:14980206,
CC       ECO:0000269|PubMed:14980207, ECO:0000269|PubMed:15356203,
CC       ECO:0000269|PubMed:15452711, ECO:0000269|PubMed:15485870,
CC       ECO:0000269|PubMed:15671030, ECO:0000269|PubMed:16123112,
CC       ECO:0000269|PubMed:16207878, ECO:0000269|PubMed:16820361,
CC       ECO:0000269|PubMed:19213956, ECO:0000269|PubMed:20224290,
CC       ECO:0000269|PubMed:24811166, ECO:0000269|PubMed:25352783,
CC       ECO:0000305|PubMed:19441798, ECO:0000305|PubMed:19901547}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10676964,
CC       ECO:0000269|PubMed:10860776, ECO:0000269|PubMed:11102480,
CC       ECO:0000269|PubMed:11847232, ECO:0000269|PubMed:12451113,
CC       ECO:0000269|PubMed:12592409, ECO:0000269|PubMed:12754210,
CC       ECO:0000269|PubMed:12829703, ECO:0000269|PubMed:14559911,
CC       ECO:0000269|PubMed:14980206, ECO:0000269|PubMed:15452711,
CC       ECO:0000269|PubMed:15485870, ECO:0000269|PubMed:15671030,
CC       ECO:0000269|PubMed:15736227, ECO:0000269|PubMed:16123112,
CC       ECO:0000269|PubMed:16820361, ECO:0000269|PubMed:1722463,
CC       ECO:0000269|PubMed:17582333, ECO:0000269|PubMed:18371079,
CC       ECO:0000269|PubMed:1840649, ECO:0000269|PubMed:18650329,
CC       ECO:0000269|PubMed:20045463, ECO:0000269|PubMed:22098631,
CC       ECO:0000269|PubMed:24793047, ECO:0000269|PubMed:25352783,
CC       ECO:0000269|PubMed:9070739, ECO:0000269|PubMed:9093524}; Multi-
CC       pass membrane protein {ECO:0000305}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:10676964, ECO:0000269|PubMed:11102480,
CC       ECO:0000269|PubMed:12592409, ECO:0000269|PubMed:15736227,
CC       ECO:0000269|PubMed:16207878, ECO:0000269|PubMed:17582333,
CC       ECO:0000269|PubMed:18371079, ECO:0000269|PubMed:20224290,
CC       ECO:0000269|PubMed:22098631, ECO:0000269|PubMed:24037673,
CC       ECO:0000269|PubMed:24404150, ECO:0000269|PubMed:9070739}. Cell
CC       junction, synapse {ECO:0000269|PubMed:11102480,
CC       ECO:0000269|PubMed:15736227, ECO:0000269|PubMed:17582333,
CC       ECO:0000269|PubMed:9070739}. Perikaryon
CC       {ECO:0000269|PubMed:10676964, ECO:0000269|PubMed:15736227,
CC       ECO:0000269|PubMed:16207878, ECO:0000269|PubMed:18371079,
CC       ECO:0000269|PubMed:22098631, ECO:0000269|PubMed:9070739}. Cell
CC       junction, synapse, postsynaptic cell membrane
CC       {ECO:0000269|PubMed:15736227, ECO:0000269|PubMed:9070739}. Cell
CC       projection, dendritic spine {ECO:0000269|PubMed:17582333,
CC       ECO:0000269|PubMed:18650329, ECO:0000269|PubMed:22098631,
CC       ECO:0000269|PubMed:24037673, ECO:0000269|PubMed:9070739}. Cell
CC       membrane, sarcolemma {ECO:0000269|PubMed:10860776}. Cell junction
CC       {ECO:0000269|PubMed:18371079}. Membrane, caveola
CC       {ECO:0000269|PubMed:20224290}. Note=In neurons, primarily detected
CC       on dendrites, dendritic spines and on the neuron cell body, but
CC       not on axons (PubMed:9070739, PubMed:17582333, PubMed:16207878,
CC       PubMed:22098631). Localized preferentially at the dendrites of
CC       pyramidal cells in the hippocampus CA1 layer (PubMed:22098631).
CC       Detected at GABAergic synapses (By similarity). Detected at cell
CC       junctions that are distinct from synaptic cell contacts
CC       (PubMed:18371079). Detected in lipid rafts (PubMed:14559911,
CC       PubMed:20224290, PubMed:24793047). Detected primarily at the
CC       endoplasmic reticulum or Golgi when expressed by itself
CC       (PubMed:12829703, PubMed:12754210, PubMed:16820361,
CC       PubMed:19441798, PubMed:14980206). Interaction with KCNIP1,
CC       KCNIP2, KCNIP3 or KCNIP4 promotes expression at the cell membrane
CC       (PubMed:12829703, PubMed:15485870, PubMed:20045463,
CC       PubMed:14980206). Interaction with DPP6 or DPP10 promotes
CC       expression at the cell membrane (PubMed:19441798). Internalized
CC       from the cell membrane by clathrin-dependent endocytosis in
CC       response to activation of AMPA-selective glutamate receptors and
CC       PKA-mediated phosphorylation at Ser-552 (PubMed:17582333,
CC       PubMed:18650329). Redistributed from dendritic spines to the main
CC       dendritic shaft in response to activation of AMPA-selective
CC       glutamate receptors and activation of PKA (PubMed:17582333,
CC       PubMed:18650329). {ECO:0000250|UniProtKB:Q9Z0V2,
CC       ECO:0000269|PubMed:12754210, ECO:0000269|PubMed:14559911,
CC       ECO:0000269|PubMed:14980206, ECO:0000269|PubMed:15485870,
CC       ECO:0000269|PubMed:16207878, ECO:0000269|PubMed:16820361,
CC       ECO:0000269|PubMed:17582333, ECO:0000269|PubMed:18650329,
CC       ECO:0000269|PubMed:19441798, ECO:0000269|PubMed:20045463,
CC       ECO:0000269|PubMed:20224290, ECO:0000269|PubMed:22098631,
CC       ECO:0000269|PubMed:24793047, ECO:0000269|PubMed:9070739,
CC       ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Detected in brain cortex, hippocampus, dentate
CC       gyrus, thalamus and cerebellum (PubMed:16123112). Detected in
CC       neurons from the primary visual cortex (PubMed:16207878). Detected
CC       in the supraoptic nucleus in hypothalamus, in hippocampus and the
CC       habenular nucleus of the thalamus (PubMed:9070739). Detected in
CC       the bed nucleus of the stria terminalis (PubMed:24037673).
CC       Detected in dendritic fields in the hippocampus CA1 layer, in
CC       stratum radiatum, stratum oriens, stratum lacunosum-moleculare and
CC       stratum pyramidale (PubMed:10676964, PubMed:22098631). Detected in
CC       dendritic fields in the hippocampus CA3 layer and in dentate gyrus
CC       (PubMed:10676964). Detected in the cerebellum granule cell layer,
CC       where it localizes at synapses (PubMed:11102480, PubMed:10676964,
CC       PubMed:15736227). Detected in the main olfactory bulb, especially
CC       in the granule cell layer and the external plexiform layer, but
CC       also the mitral layer (PubMed:18371079). Detected in heart atrium
CC       and ventricle (PubMed:10860776). Detected in heart left ventricle
CC       (at protein level) (PubMed:24793047). Highly expressed in heart
CC       and throughout the brain, with similar levels in cortex and
CC       hypothalamus, and much higher levels in hippocampus, dentate gyrus
CC       and the habenular nucleus of the thalamus. Detected in brain, and
CC       at lower levels in heart atrium and ventricle (PubMed:1705709).
CC       Detected in neurons from the bed nucleus of the stria terminalis
CC       (PubMed:24037673). Detected in aorta, cardiac and smooth muscle.
CC       {ECO:0000269|PubMed:10676964, ECO:0000269|PubMed:11102480,
CC       ECO:0000269|PubMed:15736227, ECO:0000269|PubMed:16123112,
CC       ECO:0000269|PubMed:16207878, ECO:0000269|PubMed:1705709,
CC       ECO:0000269|PubMed:18371079, ECO:0000269|PubMed:1840649,
CC       ECO:0000269|PubMed:22098631, ECO:0000269|PubMed:24793047,
CC       ECO:0000269|PubMed:9070739}.
CC   -!- INDUCTION: Down-regulated in response to hypoxia lasting about 15
CC       min, a treatment that leads to spontaneous convulsive seizures in
CC       these pups. {ECO:0000269|PubMed:25352783}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- DOMAIN: The N-terminal cytoplasmic region can mediate N-type
CC       inactivation by physically blocking the channel (PubMed:15452711).
CC       This probably does not happen in vivo, where the N-terminal region
CC       mediates interaction with regulatory subunits, such as KCNIP1 and
CC       KCNIP2 (PubMed:16820361, PubMed:18357523, PubMed:14980206). The
CC       zinc binding sites in the N-terminal domain are important for
CC       tetramerization and assembly of a functional channel complex
CC       (PubMed:12754210). Most likely, the channel undergoes closed-state
CC       inactivation, where a subtle conformation change would render the
CC       protein less sensitive to activation.
CC       {ECO:0000250|UniProtKB:Q9NZV8, ECO:0000269|PubMed:12754210,
CC       ECO:0000269|PubMed:16820361, ECO:0000305|PubMed:14980206,
CC       ECO:0000305|PubMed:15452711, ECO:0000305|PubMed:18357523}.
CC   -!- DOMAIN: The C-terminal cytoplasmic region is important for normal
CC       expression at the cell membrane and modulates the voltage-
CC       dependence of channel activation and inactivation. It is required
CC       for interaction with KCNIP2, and probably other family members as
CC       well. {ECO:0000269|PubMed:16820361}.
CC   -!- PTM: Phosphorylation at Ser-438 in response to MAPK activation is
CC       increased in stimulated dendrites (PubMed:24404150). Interaction
CC       with KCNIP2 and DPP6 propomtes phosphorylation by PKA at Ser-552
CC       (PubMed:19441798). Phosphorylation at Ser-552 has no effect on
CC       interaction with KCNIP3, but is required for the regulation of
CC       channel activity by KCNIP3 (PubMed:12451113). Phosphorylation at
CC       Ser-552 leads to KCND2 internalization (PubMed:17582333).
CC       Phosphorylated by MAPK in response to signaling via the
CC       metabotropic glutamate receptor GRM5 (By similarity).
CC       Phosphorylation at Ser-616 is required for the down-regulation of
CC       neuronal A-type currents in response to signaling via GRM5 (By
CC       similarity). {ECO:0000250|UniProtKB:Q9Z0V2,
CC       ECO:0000269|PubMed:12451113, ECO:0000269|PubMed:17582333,
CC       ECO:0000269|PubMed:19441798, ECO:0000269|PubMed:24404150}.
CC   -!- MISCELLANEOUS: The transient neuronal A-type potassium current
CC       called I(SA) is triggered at membrane potentials that are below
CC       the threshold for action potentials. It inactivates rapidly and
CC       recovers rapidly from inactivation. It regulates the firing of
CC       action potentials and plays a role in synaptic integration and
CC       plasticity. Potassium channels containing KCND2 account for about
CC       80% of the neuronal A-type potassium current. In contrast, the
CC       potassium channel responsible for the cardiac I(to) current
CC       differs between species; it is mediated by KCND2 in rodents. In
CC       human and other non-rodents KCND3 may play an equivalent role.
CC       {ECO:0000269|PubMed:9093524, ECO:0000305|PubMed:17917103,
CC       ECO:0000305|PubMed:18357523}.
CC   -!- MISCELLANEOUS: Is specifically and reversibly inhibited by the
CC       scorpion toxin Ts8 (AC P69940). {ECO:0000269|PubMed:27346450}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. D (Shal) (TC
CC       1.A.1.2) subfamily. Kv4.2/KCND2 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA40929.1; Type=Frameshift; Positions=477; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S64320; AAB19939.1; -; mRNA.
DR   EMBL; M59980; AAA40929.1; ALT_FRAME; mRNA.
DR   PIR; I57681; I57681.
DR   PIR; JU0271; JU0271.
DR   RefSeq; NP_113918.2; NM_031730.2.
DR   UniGene; Rn.87841; -.
DR   PDB; 1NN7; X-ray; 2.10 A; A=42-146.
DR   PDB; 1S6C; X-ray; 2.00 A; B=1-30.
DR   PDBsum; 1NN7; -.
DR   PDBsum; 1S6C; -.
DR   ProteinModelPortal; Q63881; -.
DR   SMR; Q63881; -.
DR   BioGrid; 249292; 2.
DR   CORUM; Q63881; -.
DR   IntAct; Q63881; 3.
DR   MINT; MINT-104113; -.
DR   STRING; 10116.ENSRNOP00000039227; -.
DR   BindingDB; Q63881; -.
DR   ChEMBL; CHEMBL1075227; -.
DR   GuidetoPHARMACOLOGY; 553; -.
DR   iPTMnet; Q63881; -.
DR   PhosphoSitePlus; Q63881; -.
DR   PaxDb; Q63881; -.
DR   PRIDE; Q63881; -.
DR   GeneID; 65180; -.
DR   KEGG; rno:65180; -.
DR   UCSC; RGD:68393; rat.
DR   CTD; 3751; -.
DR   RGD; 68393; Kcnd2.
DR   eggNOG; KOG4390; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000231013; -.
DR   HOVERGEN; HBG106687; -.
DR   InParanoid; Q63881; -.
DR   KO; K04892; -.
DR   PhylomeDB; Q63881; -.
DR   EvolutionaryTrace; Q63881; -.
DR   PRO; PR:Q63881; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005901; C:caveola; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:RGD.
DR   GO; GO:0031226; C:intrinsic component of plasma membrane; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0097038; C:perinuclear endoplasmic reticulum; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0044853; C:plasma membrane raft; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0034705; C:potassium channel complex; IDA:RGD.
DR   GO; GO:0042383; C:sarcolemma; IDA:UniProtKB.
DR   GO; GO:0030315; C:T-tubule; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005250; F:A-type (transient outward) potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005216; F:ion channel activity; IDA:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005267; F:potassium channel activity; IDA:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:RGD.
DR   GO; GO:1905030; F:voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential; IMP:SynGO.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0001508; P:action potential; IMP:RGD.
DR   GO; GO:0086001; P:cardiac muscle cell action potential; IMP:UniProtKB.
DR   GO; GO:0035690; P:cellular response to drug; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0045475; P:locomotor rhythm; ISO:RGD.
DR   GO; GO:0019228; P:neuronal action potential; ISO:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:RGD.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0019233; P:sensory perception of pain; ISO:RGD.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003975; K_chnl_volt-dep_Kv4.
DR   InterPro; IPR004055; K_chnl_volt-dep_Kv4.2.
DR   InterPro; IPR024587; K_chnl_volt-dep_Kv4_C.
DR   InterPro; IPR021645; Shal-type_N.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 2.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF11879; DUF3399; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11601; Shal-type; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01517; KV42CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01497; SHALCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Cell projection;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Phosphoprotein; Postsynaptic cell membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome; Synapse;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel;
KW   Zinc.
FT   CHAIN         1    630       Potassium voltage-gated channel subfamily
FT                                D member 2.
FT                                /FTId=PRO_0000054067.
FT   TOPO_DOM      1    182       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    183    204       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    205    228       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    229    250       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    251    261       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    262    279       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    280    286       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    287    306       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    307    321       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    322    343       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    344    357       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    358    369       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    370    377       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    378    384       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    385    413       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    414    630       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION        2     20       Interaction with KCNIP1, KCNIP2, and
FT                                other family members.
FT                                {ECO:0000305|PubMed:14980206,
FT                                ECO:0000305|PubMed:14980207}.
FT   REGION       71     90       Interaction with KCNIP1.
FT                                {ECO:0000305|PubMed:14980207}.
FT   REGION      308    321       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION      474    630       Important for normal channel activation
FT                                and inactivation, for interaction with
FT                                KCNIP2, and probably other family members
FT                                as well. {ECO:0000305|PubMed:16820361}.
FT   REGION      474    489       Required for dendritic targeting.
FT                                {ECO:0000269|PubMed:12592409}.
FT   MOTIF       370    375       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       627    630       PDZ-binding.
FT                                {ECO:0000269|PubMed:11923279,
FT                                ECO:0000269|PubMed:14559911}.
FT   METAL       105    105       Zinc; via pros nitrogen.
FT                                {ECO:0000244|PDB:1NN7}.
FT   METAL       132    132       Zinc. {ECO:0000244|PDB:1NN7}.
FT   METAL       133    133       Zinc. {ECO:0000244|PDB:1NN7}.
FT   MOD_RES      38     38       Phosphothreonine.
FT                                {ECO:0000269|PubMed:10681507}.
FT   MOD_RES     438    438       Phosphoserine.
FT                                {ECO:0000269|PubMed:24404150}.
FT   MOD_RES     548    548       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903,
FT                                ECO:0000269|PubMed:19441798}.
FT   MOD_RES     552    552       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903,
FT                                ECO:0000269|PubMed:10681507,
FT                                ECO:0000269|PubMed:12451113,
FT                                ECO:0000269|PubMed:12829703,
FT                                ECO:0000269|PubMed:18650329,
FT                                ECO:0000269|PubMed:19441798}.
FT   MOD_RES     572    572       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903,
FT                                ECO:0000269|PubMed:19441798}.
FT   MOD_RES     575    575       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903,
FT                                ECO:0000269|PubMed:19441798}.
FT   MOD_RES     602    602       Phosphothreonine.
FT                                {ECO:0000269|PubMed:11080179}.
FT   MOD_RES     607    607       Phosphothreonine.
FT                                {ECO:0000269|PubMed:11080179}.
FT   MOD_RES     616    616       Phosphoserine.
FT                                {ECO:0000269|PubMed:11080179}.
FT   MUTAGEN       7     11       Missing: Greatly reduces interaction with
FT                                KCNIP1. {ECO:0000269|PubMed:14980207}.
FT   MUTAGEN       8      8       W->A: Abolishes interaction with KCNP1;
FT                                when associated with A-11.
FT                                {ECO:0000269|PubMed:14980206}.
FT   MUTAGEN      11     11       F->A: Abolishes interaction with KCNP1;
FT                                when associated with A-8.
FT                                {ECO:0000269|PubMed:14980206}.
FT   MUTAGEN      66     66       L->R: Abolishes expression.
FT                                {ECO:0000269|PubMed:12835418}.
FT   MUTAGEN      71     71       E->K: Abolishes interaction with KCNIP1.
FT                                {ECO:0000269|PubMed:14980207}.
FT   MUTAGEN      73     73       D->M: Abolishes interaction with KCNIP1.
FT                                {ECO:0000269|PubMed:14980207}.
FT   MUTAGEN      74     74       F->R: Abolishes interaction with KCNIP1.
FT                                {ECO:0000269|PubMed:14980207}.
FT   MUTAGEN      79     79       E->L,R: Abolishes interaction with
FT                                KCNIP1. {ECO:0000269|PubMed:14980207}.
FT   MUTAGEN      93     93       R->A: Greatly reduces expression and
FT                                changes multimerization.
FT                                {ECO:0000269|PubMed:12835418}.
FT   MUTAGEN     105    105       H->A: Abolishes tetramerization and
FT                                assembly of a functional channel.
FT                                {ECO:0000269|PubMed:12754210}.
FT   MUTAGEN     111    111       C->A: Abolishes tetramerization and
FT                                assembly of a functional channel; when
FT                                associated with A-105; A-132 and A-133.
FT                                {ECO:0000269|PubMed:12754210}.
FT   MUTAGEN     132    132       C->A: Abolishes tetramerization and
FT                                assembly of a functional channel; when
FT                                associated with A-105; A-111 and A-133.
FT                                {ECO:0000269|PubMed:12754210}.
FT   MUTAGEN     133    133       C->A: Abolishes tetramerization and
FT                                assembly of a functional channel; when
FT                                associated with A-105; A-111 and A-132.
FT                                {ECO:0000269|PubMed:12754210}.
FT   MUTAGEN     481    482       Missing: Loss of dendritic targeted
FT                                expression.
FT                                {ECO:0000269|PubMed:12592409}.
FT   MUTAGEN     552    552       S->A: Abolishes PKA-mediated modulation
FT                                of cell surface expression and channel
FT                                activity. {ECO:0000269|PubMed:12451113,
FT                                ECO:0000269|PubMed:18650329}.
FT   MUTAGEN     627    630       Missing: Abolishes interaction with DLG4.
FT                                {ECO:0000269|PubMed:11923279,
FT                                ECO:0000269|PubMed:14559911}.
FT   HELIX         1      6       {ECO:0000244|PDB:1S6C}.
FT   HELIX         9     17       {ECO:0000244|PDB:1S6C}.
FT   STRAND       43     47       {ECO:0000244|PDB:1NN7}.
FT   STRAND       50     54       {ECO:0000244|PDB:1NN7}.
FT   HELIX        56     60       {ECO:0000244|PDB:1NN7}.
FT   STRAND       64     66       {ECO:0000244|PDB:1NN7}.
FT   HELIX        70     75       {ECO:0000244|PDB:1NN7}.
FT   HELIX        78     80       {ECO:0000244|PDB:1NN7}.
FT   STRAND       81     85       {ECO:0000244|PDB:1NN7}.
FT   TURN         89     91       {ECO:0000244|PDB:1NN7}.
FT   HELIX        92    101       {ECO:0000244|PDB:1NN7}.
FT   HELIX       112    122       {ECO:0000244|PDB:1NN7}.
FT   HELIX       131    145       {ECO:0000244|PDB:1NN7}.
SQ   SEQUENCE   630 AA;  70549 MW;  FDE57E8A5113BABF CRC64;
     MAAGVAAWLP FARAAAIGWM PVASGPMPAP PRQERKRTQD ALIVLNVSGT RFQTWQDTLE
     RYPDTLLGSS ERDFFYHPET QQYFFDRDPD IFRHILNFYR TGKLHYPRHE CISAYDEELA
     FFGLIPEIIG DCCYEEYKDR RRENAERLQD DADTDNTGES ALPTMTARQR VWRAFENPHT
     STMALVFYYV TGFFIAVSVI ANVVETVPCG SSPGHIKELP CGERYAVAFF CLDTACVMIF
     TVEYLLRLAA APSRYRFVRS VMSIIDVVAI LPYYIGLVMT DNEDVSGAFV TLRVFRVFRI
     FKFSRHSQGL RILGYTLKSC ASELGFLLFS LTMAIIIFAT VMFYAEKGSS ASKFTSIPAA
     FWYTIVTMTT LGYGDMVPKT IAGKIFGSIC SLSGVLVIAL PVPVIVSNFS RIYHQNQRAD
     KRRAQKKARL ARIRAAKSGS ANAYMQSKRN GLLSNQLQSS EDEPAFVSKS GSSFETQHHH
     LLHCLEKTTN HEFVDEQVFE ESCMEVATVN RPSSHSPSLS SQQGVTSTCC SRRHKKSFRI
     PNANVSGSHR GSVQELSTIQ IRCVERTPLS NSRSSLNAKM EECVKLNCEQ PYVTTAIISI
     PTPPVTTPEG DDRPESPEYS GGNIVRVSAL
//
ID   KAT2_ARATH              Reviewed;         697 AA.
AC   Q38849; O49732; Q9C5V9;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   31-MAY-2011, sequence version 3.
DT   22-NOV-2017, entry version 138.
DE   RecName: Full=Potassium channel KAT2;
GN   Name=KAT2; OrderedLocusNames=At4g18290; ORFNames=T9A21.140;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], CHARACTERIZATION, AND INTERACTION
RP   WITH KAT1.
RC   STRAIN=cv. Columbia;
RX   PubMed=11042178; DOI=10.1074/jbc.M007303200;
RA   Pilot G., Lacombe B., Gaymard F., Cherel I., Boucherez J.,
RA   Thibaud J.-B., Sentenac H.;
RT   "Guard cell inward K+ channel activity in Arabidopsis involves
RT   expression of the twin channel subunits KAT1 and KAT2.";
RL   J. Biol. Chem. 276:3215-3221(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G.,
RA   Pohl T., Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N.,
RA   Harris B., Ansorge W., Brandt P., Grivell L.A., Rieger M.,
RA   Weichselgartner M., de Simone V., Obermaier B., Mache R., Mueller M.,
RA   Kreis M., Delseny M., Puigdomenech P., Watson M., Schmidtheini T.,
RA   Reichert B., Portetelle D., Perez-Alonso M., Boutry M., Bancroft I.,
RA   Vos P., Hoheisel J., Zimmermann W., Wedler H., Ridley P.,
RA   Langham S.-A., McCullagh B., Bilham L., Robben J.,
RA   van der Schueren J., Grymonprez B., Chuang Y.-J., Vandenbussche F.,
RA   Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R., Defoor E.,
RA   Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W.,
RA   Mooijman P., Klein Lankhorst R., Rose M., Hauf J., Koetter P.,
RA   Berneiser S., Hempel S., Feldpausch M., Lamberth S., Van den Daele H.,
RA   De Keyser A., Buysshaert C., Gielen J., Villarroel R., De Clercq R.,
RA   van Montagu M., Rogers J., Cronin A., Quail M.A., Bray-Allen S.,
RA   Clark L., Doggett J., Hall S., Kay M., Lennard N., McLay K., Mayes R.,
RA   Pettett A., Rajandream M.A., Lyne M., Benes V., Rechmann S.,
RA   Borkova D., Bloecker H., Scharfe M., Grimm M., Loehnert T.-H.,
RA   Dose S., de Haan M., Maarse A.C., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D., Herzl A.,
RA   Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R.,
RA   Schnabl S., Hiller R., Schmidt W., Lecharny A., Aubourg S.,
RA   Chefdor F., Cooke R., Berger C., Monfort A., Casacuberta E.,
RA   Gibbons T., Weber N., Vandenbol M., Bargues M., Terol J., Torres A.,
RA   Perez-Perez A., Purnelle B., Bent E., Johnson S., Tacon D., Jesse T.,
RA   Heijnen L., Schwarz S., Scholler P., Heber S., Francs P., Bielke C.,
RA   Frishman D., Haase D., Lemcke K., Mewes H.-W., Stocker S.,
RA   Zaccaria P., Bevan M., Wilson R.K., de la Bastide M., Habermann K.,
RA   Parnell L., Dedhia N., Gnoj L., Schutz K., Huang E., Spiegel L.,
RA   Sekhon M., Murray J., Sheet P., Cordes M., Abu-Threideh J.,
RA   Stoneking T., Kalicki J., Graves T., Harmon G., Edwards J.,
RA   Latreille P., Courtney L., Cloud J., Abbott A., Scott K., Johnson D.,
RA   Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D.,
RA   Du H., Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C.,
RA   Antonoiu B., Zidanic M., Strong C., Sun H., Lamar B., Yordan C.,
RA   Ma P., Zhong J., Preston R., Vil D., Shekher M., Matero A., Shah R.,
RA   Swaby I.K., O'Shaughnessy A., Rodriguez M., Hoffman J., Till S.,
RA   Granat S., Shohdy N., Hasegawa A., Hameed A., Lodhi M., Johnson A.,
RA   Chen E., Marra M.A., Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:769-777(1999).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 133-697.
RC   STRAIN=cv. Columbia;
RA   Butt A.D., Blatt M.R., Ainsworth C.C.;
RT   "Expression, evolution and genomic complexity of potassium ion channel
RT   genes of Arabidopsis thaliana.";
RL   J. Plant Physiol. 150:652-660(1997).
RN   [5]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [6]
RP   INTERACTION WITH SLAC1.
RX   PubMed=27002025; DOI=10.1105/tpc.16.01050;
RA   Zhang A., Ren H.M., Tan Y.Q., Qi G.N., Yao F.Y., Wu G.L., Yang L.W.,
RA   Hussain J., Sun S.J., Wang Y.F.;
RT   "S-type anion channels SLAC1 and SLAH3 function as essential negative
RT   regulators of inward K+ channels and stomatal opening in
RT   Arabidopsis.";
RL   Plant Cell 0:0-0(2016).
CC   -!- FUNCTION: Highly selective inward-rectifying potassium channel.
CC       This voltage-dependent channel could mediate long-term potassium
CC       influx into guard cells leading to stomatal opening. Assuming
CC       opened or closed conformations in response to the voltage
CC       difference across the membrane, the channel is activated by
CC       hyperpolarization. The channel activity is enhanced upon external
CC       acidification.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming subunits. May interact
CC       with KAT1 (Probable). Interacts with SLAC1 (PubMed:27002025).
CC       {ECO:0000269|PubMed:27002025, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q38898:AKT2; NbExp=3; IntAct=EBI-2117720, EBI-1552774;
CC       Q39128:KAT1; NbExp=3; IntAct=EBI-2117720, EBI-1552490;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in guard cells of hypocotyls, stems
CC       leaves and petioles. Detected also in the phloem of minor veins
CC       and in flower at a lower level.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAC28122.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ288900; CAC28122.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL021713; CAA16801.1; -; Genomic_DNA.
DR   EMBL; AL161548; CAB78831.1; -; Genomic_DNA.
DR   EMBL; CP002687; AEE84021.1; -; Genomic_DNA.
DR   EMBL; U25694; AAA67070.1; -; mRNA.
DR   PIR; H85205; H85205.
DR   PIR; T04931; T04931.
DR   RefSeq; NP_001329801.1; NM_001341273.1.
DR   RefSeq; NP_193563.3; NM_117939.5.
DR   UniGene; At.431; -.
DR   ProteinModelPortal; Q38849; -.
DR   BioGrid; 12848; 3.
DR   IntAct; Q38849; 2.
DR   STRING; 3702.AT4G18290.1; -.
DR   TCDB; 1.A.1.4.6; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q38849; -.
DR   EnsemblPlants; AT4G18290.1; AT4G18290.1; AT4G18290.
DR   EnsemblPlants; AT4G18290.2; AT4G18290.2; AT4G18290.
DR   GeneID; 827555; -.
DR   Gramene; AT4G18290.1; AT4G18290.1; AT4G18290.
DR   Gramene; AT4G18290.2; AT4G18290.2; AT4G18290.
DR   KEGG; ath:AT4G18290; -.
DR   Araport; AT4G18290; -.
DR   TAIR; locus:2005531; AT4G18290.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238230; -.
DR   InParanoid; Q38849; -.
DR   KO; K21867; -.
DR   OMA; EAKVIRW; -.
DR   OrthoDB; EOG093606I1; -.
DR   BioCyc; ARA:GQT-883-MONOMER; -.
DR   PRO; PR:Q38849; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; Q38849; baseline and differential.
DR   Genevisible; Q38849; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   GO; GO:0007623; P:circadian rhythm; IMP:TAIR.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0009644; P:response to high light intensity; IMP:TAIR.
DR   GO; GO:0010118; P:stomatal movement; IMP:TAIR.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    697       Potassium channel KAT2.
FT                                /FTId=PRO_0000054126.
FT   TOPO_DOM      1     63       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     64     84       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     85     91       Extracellular. {ECO:0000255}.
FT   TRANSMEM     92    112       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    113    134       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    135    155       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    156    165       Extracellular. {ECO:0000255}.
FT   TRANSMEM    166    186       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    187    200       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    201    221       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    222    248       Extracellular. {ECO:0000255}.
FT   INTRAMEM    249    268       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    269    272       Extracellular. {ECO:0000255}.
FT   TRANSMEM    273    293       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    294    697       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      629    697       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     377    496       cNMP.
FT   CARBOHYD    158    158       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    358    358       A -> R (in Ref. 4; AAA67070).
FT                                {ECO:0000305}.
FT   CONFLICT    612    612       R -> S (in Ref. 4; AAA67070).
FT                                {ECO:0000305}.
SQ   SEQUENCE   697 AA;  80150 MW;  55E1DFE6AB2A2453 CRC64;
     MSISCTRNFF KRFCVEEYNM DTFKHSSFLS ADLLPSLGAR INQSTKLRKH IISPFDPRFR
     GWEMWLVILV IYSAWICPFE FAFITYKKDA LFIIDNIVNG FFAIDIILTF FVAYLDSHSY
     LLVDKPKKIA IRYLSTWFAF DVCSTAPFQS LSLLFKYNGS EIGFRVLSML RLWRLRRVSS
     LFARLEKDIR FNYFWTRCTK LISVTLFAVH CAGCFAYLIA DQYHDPTKTW IGAVYPNFKE
     TSVWSRYVTA LYWSITTLTT TGYGDLHAEN PREMLFFVFF MLFNLGFTSY LIGNMTNLVV
     HWTSRTRNFR DTVRAASEFA SRNQLPPNIQ DQMLSHICLK FKTEGLKQQE ALNGLPKAIR
     SSIANYLFFP IVQNVYLFHG VSRNFLFQLV SDIDAEYFPP REDVILQNEA PTDLYILVSG
     AVDFTVYVGE EDQVQGKAVV GDAFGEIGVL CYTPQPFTVR TTELSQILRI SKKSLMSAMR
     AHVEDGRVIM NNLFMKLRGQ QSIAIDDPNS EPESLLKEWL VGGSKTGEGN ASDQGHGHKY
     LQLHDSENID MGSTEWRDSR RSGYGETKRV REHTIEIEEG EKPNKEFDGK GCSDADLTSF
     EFHSQEAYPY CRSNIQIKQH EAAKPKDKRV TIHLKSRDKD LSKLIILPAS IEELLRLAGE
     KFGYSFTKVT NAENAEIDDE DVIRDGDHLY ILINENS
//
ID   KCA10_HUMAN             Reviewed;         511 AA.
AC   Q16322;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 2.
DT   22-NOV-2017, entry version 144.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 10;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.8;
GN   Name=KCNA10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9177773; DOI=10.1006/geno.1997.4712;
RA   Orias M., Bray-Ward P., Curran M.E., Keating M.T., Desir G.V.;
RT   "Genomic localization of the human gene for KCNA10, a cGMP-activated K
RT   channel.";
RL   Genomics 42:33-37(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10836990;
RA   Lang R., Lee G., Liu W., Tian S., Rafi H., Orias M., Segal A.S.,
RA   Desir G.V.;
RT   "KCNA10: a novel ion channel functionally related to both voltage-
RT   gated potassium and CNG cation channels.";
RL   Am. J. Physiol. 278:F1013-F1021(2000).
RN   [6]
RP   INTERACTION WITH POMP, AND REGULATION BY CAMP.
RX   PubMed=12060596; DOI=10.1152/ajprenal.00258.2001;
RA   Tian S., Liu W., Wu Y., Rafi H., Segal A.S., Desir G.V.;
RT   "Regulation of the voltage-gated K+ channel KCNA10 by KCNA4B, a novel
RT   beta-subunit.";
RL   Am. J. Physiol. 283:F142-F149(2002).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=12444201; DOI=10.1097/01.ASN.0000036866.37886.C5;
RA   Yao X., Tian S., Chan H.-Y., Biemesderfer D., Desir G.V.;
RT   "Expression of KCNA10, a voltage-gated K channel, in glomerular
RT   endothelium and at the apical membrane of the renal proximal tubule.";
RL   J. Am. Soc. Nephrol. 13:2831-2839(2002).
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-200.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Mediates voltage-dependent potassium ion permeability of
CC       excitable membranes. Assuming opened or closed conformations in
CC       response to the voltage difference across the membrane, the
CC       protein forms a potassium-selective channel through which
CC       potassium ions may pass in accordance with their electrochemical
CC       gradient. The channel activity is up-regulated by cAMP.
CC       {ECO:0000269|PubMed:10836990}.
CC   -!- SUBUNIT: Homotetramer. Interacts with KCN4B/POMP. Interaction with
CC       KCN4B/POMP is necessary for the modulation of channel activity by
CC       cAMP. {ECO:0000269|PubMed:12060596}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10836990};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:10836990}.
CC   -!- TISSUE SPECIFICITY: Detected in kidney, in proximal tubules,
CC       glomerular endothelium, in vascular endothelium and in smooth
CC       muscle cells. {ECO:0000269|PubMed:12444201}.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.8/KCNA10 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U96110; AAC51333.1; -; Genomic_DNA.
DR   EMBL; AL358215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471122; EAW56454.1; -; Genomic_DNA.
DR   EMBL; BC074990; AAH74990.1; -; mRNA.
DR   CCDS; CCDS826.1; -.
DR   RefSeq; NP_005540.1; NM_005549.2.
DR   UniGene; Hs.248140; -.
DR   UniGene; Hs.622910; -.
DR   ProteinModelPortal; Q16322; -.
DR   BioGrid; 109946; 19.
DR   IntAct; Q16322; 5.
DR   STRING; 9606.ENSP00000358786; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 545; -.
DR   iPTMnet; Q16322; -.
DR   PhosphoSitePlus; Q16322; -.
DR   BioMuta; KCNA10; -.
DR   DMDM; 74739879; -.
DR   EPD; Q16322; -.
DR   MaxQB; Q16322; -.
DR   PaxDb; Q16322; -.
DR   PeptideAtlas; Q16322; -.
DR   PRIDE; Q16322; -.
DR   Ensembl; ENST00000369771; ENSP00000358786; ENSG00000143105.
DR   GeneID; 3744; -.
DR   KEGG; hsa:3744; -.
DR   UCSC; uc001dzt.2; human.
DR   CTD; 3744; -.
DR   DisGeNET; 3744; -.
DR   EuPathDB; HostDB:ENSG00000143105.6; -.
DR   GeneCards; KCNA10; -.
DR   H-InvDB; HIX0200074; -.
DR   HGNC; HGNC:6219; KCNA10.
DR   HPA; CAB022564; -.
DR   HPA; HPA015061; -.
DR   MIM; 602420; gene.
DR   neXtProt; NX_Q16322; -.
DR   OpenTargets; ENSG00000143105; -.
DR   PharmGKB; PA30020; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q16322; -.
DR   KO; K04881; -.
DR   OMA; MCPTTPG; -.
DR   OrthoDB; EOG091G10NU; -.
DR   PhylomeDB; Q16322; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNA10; -.
DR   GenomeRNAi; 3744; -.
DR   PRO; PR:Q16322; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143105; -.
DR   CleanEx; HS_KCNA10; -.
DR   Genevisible; Q16322; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005221; F:intracellular cyclic nucleotide activated cation channel activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Lipoprotein; Membrane; Palmitate; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    511       Potassium voltage-gated channel subfamily
FT                                A member 10.
FT                                /FTId=PRO_0000308275.
FT   TRANSMEM    218    238       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    271    292       Helical; Name=Segment S2. {ECO:0000255}.
FT   TRANSMEM    303    323       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    339    358       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TRANSMEM    375    395       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    436    456       Helical; Name=Segment S6. {ECO:0000255}.
FT   MOTIF       421    426       Selectivity filter. {ECO:0000250}.
FT   LIPID       293    293       S-palmitoyl cysteine. {ECO:0000255}.
FT   CARBOHYD    256    256       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    334    334       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    498    498       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     200    200       R -> H (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs755748044).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036778.
FT   VARIANT     220    220       V -> M (in dbSNP:rs34970857).
FT                                /FTId=VAR_036779.
FT   VARIANT     258    258       S -> N (in dbSNP:rs3748729).
FT                                /FTId=VAR_036780.
SQ   SEQUENCE   511 AA;  57785 MW;  1B09B1CD68745F29 CRC64;
     MDVCGWKEME VALVNFDNSD EIQEEPGYAT DFDSTSPKGR PGGSSFSNGK ILISESTNHE
     TAFSKLPGDY ADPPGPEPVV LNEGNQRVII NIAGLRFETQ LRTLSQFPET LLGDREKRMQ
     FFDSMRNEYF FDRNRPSFDG ILYYYQSGGK IRRPANVPID IFADEISFYE LGSEAMDQFR
     EDEGFIKDPE TLLPTNDIHR QFWLLFEYPE SSSAARAVAV VSVLVVVISI TIFCLETLPE
     FREDRELKVV RDPNLNMSKT VLSQTMFTDP FFMVESTCIV WFTFELVLRF VVCPSKTDFF
     RNIMNIIDII SIIPYFATLI TELVQETEPS AQQNMSLAIL RIIRLVRVFR IFKLSRHSKG
     LQILGQTLKA SMRELGLLIF FLFIGVILFS SAVYFAEVDE PESHFSSIPD GFWWAVVTMT
     TVGYGDMCPT TPGGKIVGTL CAIAGVLTIA LPVPVIVSNF NYFYHRETEN EEKQNIPGEI
     ERILNSVGSR MGSTDSLNKT NGGCSTEKSR K
//
ID   TWK12_CAEEL             Reviewed;         713 AA.
AC   Q19907;
DT   19-JAN-2010, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 2.
DT   25-OCT-2017, entry version 124.
DE   RecName: Full=TWiK family of potassium channels protein 12;
GN   Name=twk-12; ORFNames=F29F11.4;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000312|EMBL:CAA98271.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305}
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-53 AND ASN-77, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane
CC       protein {ECO:0000255}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000255}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z73974; CAA98271.2; -; Genomic_DNA.
DR   PIR; T21551; T21551.
DR   RefSeq; NP_505731.3; NM_073330.4.
DR   ProteinModelPortal; Q19907; -.
DR   STRING; 6239.F29F11.4; -.
DR   TCDB; 1.A.1.9.9; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q19907; -.
DR   EPD; Q19907; -.
DR   PaxDb; Q19907; -.
DR   GeneID; 192074; -.
DR   KEGG; cel:CELE_F29F11.4; -.
DR   UCSC; F29F11.4; c. elegans.
DR   CTD; 192074; -.
DR   WormBase; F29F11.4; CE48353; WBGene00006667; twk-12.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000018845; -.
DR   InParanoid; Q19907; -.
DR   KO; K05323; -.
DR   OrthoDB; EOG091G04NU; -.
DR   PRO; PR:Q19907; -.
DR   Proteomes; UP000001940; Chromosome V.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    713       TWiK family of potassium channels protein
FT                                12.
FT                                /FTId=PRO_0000390697.
FT   TOPO_DOM      1     15       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     16     36       Helical. {ECO:0000255}.
FT   INTRAMEM    112    132       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    142    162       Helical. {ECO:0000255}.
FT   TOPO_DOM    163    242       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    243    263       Helical. {ECO:0000255}.
FT   INTRAMEM    267    287       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    298    318       Helical. {ECO:0000255}.
FT   TOPO_DOM    319    713       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD     77     77       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD     98     98       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   713 AA;  82068 MW;  FC97140E09FC45B0 CRC64;
     MTLFKKIQWF CNLIRLRSYY KFLLLIAYTA FGAWLFRTYE LQADIKRRSV FGNTTNLVRR
     QLAERWIEMH KDAVLRNDSA LRFRRAAEAV EWLLDELNLS DHIRDLSEET PWTWTGAMFY
     AGQLYTTIGY GYPTTKTDEG RICTIFYALF GIPCFLMYLK IENAIEWKKD KQLGKRALKM
     HGLINDSFQS IGKTLSKKMK KYYKKLRRSR VGRILLPTRV TAMKDGFEDP EAAEERKKKP
     FPIPIAIIML IIWICFSASM FCIWEDTWVF SSAVYFFIVS ISTVGLGDML FRTPDMMVFN
     FLLILVGLAL LSMCFELITD RVAKWKQKRF DEHIKKVQKM AFQVFEKDPF IEEAPPLGIR
     MAPNLMQIAA THVSEEKRGF FAEFKDWFAG KVTDNVIQSK LEDSDDESDS EEALEEFDSP
     QIATVTANDL IVCSNGAATR RVSKQSYALS DISNLSNSKI LPGNNYGQLL DRIKAMEKFK
     PKKNDLDSRM FAKFLENKKL AKILEQTELR ELATVSCQTD LSGLVVQRRN PKGRHARIGS
     CSSQSTMSTL LPNKMHAPDE DSVMSFTFGD LKFDYKTEPF IDEYYIRESN HSIFDFDEDE
     TVRIPQKMLI SRPGMPPPPP SRPLNLASPL RTLLEKEQKY DEDPEIQLTP RRLNSLSDIQ
     ARKVKLGVDE NLQHARLVCG LLPQDFDSPS TSTSTSMIDS GYELSKRDAS TMA
//
ID   KCNA5_HUMAN             Reviewed;         613 AA.
AC   P22460; Q4KKT8; Q4VAJ1; Q4VAJ2; Q9UDA4;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 4.
DT   22-NOV-2017, entry version 176.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 5;
DE   AltName: Full=HPCN1;
DE   AltName: Full=Voltage-gated potassium channel HK2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.5;
GN   Name=KCNA5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=2001794;
RA   Tamkun M.M., Knoth K.M., Walbridge J.A., Kroemer H., Roden D.M.,
RA   Glover D.M.;
RT   "Molecular cloning and characterization of two voltage-gated K+
RT   channel cDNAs from human ventricle.";
RL   FASEB J. 5:331-337(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Insulinoma;
RX   PubMed=1986382; DOI=10.1073/pnas.88.1.53;
RA   Philipson L.H., Hice R.E., Schaefer K., Lamendola J., Bell G.I.,
RA   Nelson D.J., Steiner D.F.;
RT   "Sequence and functional expression in Xenopus oocytes of a human
RT   insulinoma and islet potassium channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:53-57(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=1349297; DOI=10.1016/0888-7543(92)90302-9;
RA   Curran M.E., Landes G.M., Keating M.T.;
RT   "Molecular cloning, characterization, and genomic localization of a
RT   human potassium channel gene.";
RL   Genomics 12:729-737(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=8505626; DOI=10.1085/jgp.101.4.513;
RA   Snyders D.J., Tamkun M.M., Bennett P.B.;
RT   "A rapidly activating and slowly inactivating potassium channel cloned
RT   from human heart. Functional analysis after stable mammalian cell
RT   culture expression.";
RL   J. Gen. Physiol. 101:513-543(1993).
RN   [6]
RP   FUNCTION, AND ALTERNATIVE SPLICING (ISOFORMS 1 AND 2).
RX   PubMed=11524461; DOI=10.1085/jgp.118.3.315;
RA   Kurata H.T., Soon G.S., Fedida D.;
RT   "Altered state dependence of c-type inactivation in the long and short
RT   forms of human Kv1.5.";
RL   J. Gen. Physiol. 118:315-332(2001).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH KCNAB1.
RX   PubMed=12130714; DOI=10.1124/jpet.102.033357;
RA   Williams C.P., Hu N., Shen W., Mashburn A.B., Murray K.T.;
RT   "Modulation of the human Kv1.5 channel by protein kinase C activation:
RT   role of the Kvbeta1.2 subunit.";
RL   J. Pharmacol. Exp. Ther. 302:545-550(2002).
RN   [8]
RP   INTERACTION WITH DLG1, AND MUTAGENESIS OF THR-15.
RX   PubMed=16466689; DOI=10.1016/j.bbrc.2006.01.110;
RA   Mathur R., Choi W.S., Eldstrom J., Wang Z., Kim J., Steele D.F.,
RA   Fedida D.;
RT   "A specific N-terminal residue in Kv1.5 is required for upregulation
RT   of the channel by SAP97.";
RL   Biochem. Biophys. Res. Commun. 342:1-8(2006).
RN   [9]
RP   INVOLVEMENT IN ATFB7.
RX   PubMed=16772329; DOI=10.1093/hmg/ddl143;
RA   Olson T.M., Alekseev A.E., Liu X.K., Park S., Zingman L.V.,
RA   Bienengraeber M., Sattiraju S., Ballew J.D., Jahangir A., Terzic A.;
RT   "Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes
RT   human atrial fibrillation.";
RL   Hum. Mol. Genet. 15:2185-2191(2006).
RN   [10]
RP   SUMOYLATION AT LYS-221 AND LYS-536, INTERACTION WITH UBE2I, AND
RP   MUTAGENESIS OF ILE-220; LYS-221; LEU-535 AND LYS-536.
RX   PubMed=17261810; DOI=10.1073/pnas.0606702104;
RA   Benson M.D., Li Q.J., Kieckhafer K., Dudek D., Whorton M.R.,
RA   Sunahara R.K., Iniguez-Lluhi J.A., Martens J.R.;
RT   "SUMO modification regulates inactivation of the voltage-gated
RT   potassium channel Kv1.5.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1805-1810(2007).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-300.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [12]
RP   VARIANTS HIS-42; MET-85; PRO-114; ARG-170 AND PRO-184.
RX   PubMed=24936649; DOI=10.1371/journal.pone.0100261;
RA   Pousada G., Baloira A., Vilarino C., Cifrian J.M., Valverde D.;
RT   "Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic
RT   parameters in patients with pulmonary arterial hypertension.";
RL   PLoS ONE 9:E100261-E100261(2014).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes. Forms
CC       tetrameric potassium-selective channels through which potassium
CC       ions pass in accordance with their electrochemical gradient. The
CC       channel alternates between opened and closed conformations in
CC       response to the voltage difference across the membrane. Can form
CC       functional homotetrameric channels and heterotetrameric channels
CC       that contain variable proportions of KCNA1, KCNA2, KCNA4, KCNA5,
CC       and possibly other family members as well; channel properties
CC       depend on the type of alpha subunits that are part of the channel
CC       (PubMed:12130714). Channel properties are modulated by cytoplasmic
CC       beta subunits that regulate the subcellular location of the alpha
CC       subunits and promote rapid inactivation (PubMed:12130714).
CC       Homotetrameric channels display rapid activation and slow
CC       inactivation (PubMed:8505626, PubMed:12130714). May play a role in
CC       regulating the secretion of insulin in normal pancreatic islets.
CC       Isoform 2 exhibits a voltage-dependent recovery from inactivation
CC       and an excessive cumulative inactivation (PubMed:11524461).
CC       {ECO:0000269|PubMed:11524461, ECO:0000269|PubMed:12130714,
CC       ECO:0000269|PubMed:8505626}.
CC   -!- SUBUNIT: Homotetramer and heterotetramer of potassium channel
CC       proteins. Interacts with DLG1, which enhances channel currents.
CC       Forms a ternary complex with DLG1 and CAV3 (By similarity).
CC       Interacts with KCNAB1 (PubMed:12130714). Interacts with UBE2I
CC       (PubMed:17261810). {ECO:0000250|UniProtKB:P19024,
CC       ECO:0000269|PubMed:11524461, ECO:0000269|PubMed:12130714,
CC       ECO:0000269|PubMed:16466689, ECO:0000269|PubMed:17261810,
CC       ECO:0000269|PubMed:8505626}.
CC   -!- INTERACTION:
CC       P35609:ACTN2; NbExp=6; IntAct=EBI-6426121, EBI-77797;
CC       Q14160:SCRIB; NbExp=2; IntAct=EBI-6426121, EBI-357345;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12130714,
CC       ECO:0000269|PubMed:8505626}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P22460-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P22460-2; Sequence=VSP_037110;
CC   -!- TISSUE SPECIFICITY: Pancreatic islets and insulinoma.
CC   -!- DOMAIN: The amino terminus may be important in determining the
CC       rate of inactivation of the channel while the C-terminal PDZ-
CC       binding motif may play a role in modulation of channel activity
CC       and/or targeting of the channel to specific subcellular
CC       compartments.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: Sumoylated on Lys-221, and Lys-536, preferentially with
CC       SUMO3. Sumoylation regulates the voltage sensitivity of the
CC       channel. {ECO:0000269|PubMed:17261810}.
CC   -!- DISEASE: Atrial fibrillation, familial, 7 (ATFB7) [MIM:612240]: A
CC       familial form of atrial fibrillation, a common sustained cardiac
CC       rhythm disturbance. Atrial fibrillation is characterized by
CC       disorganized atrial electrical activity and ineffective atrial
CC       contraction promoting blood stasis in the atria and reduces
CC       ventricular filling. It can result in palpitations, syncope,
CC       thromboembolic stroke, and congestive heart failure.
CC       {ECO:0000269|PubMed:16772329}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.5/KCNA5 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA60146.1; Type=Frameshift; Positions=579; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M60451; AAA61276.1; -; mRNA.
DR   EMBL; M55513; AAA36422.1; -; mRNA.
DR   EMBL; M83254; AAA60146.1; ALT_FRAME; mRNA.
DR   EMBL; BC096357; AAH96357.1; -; mRNA.
DR   EMBL; BC096358; AAH96358.3; -; mRNA.
DR   EMBL; BC099665; AAH99665.3; -; mRNA.
DR   EMBL; BC099666; AAH99666.3; -; mRNA.
DR   CCDS; CCDS8536.1; -. [P22460-1]
DR   PIR; A56031; A56031.
DR   RefSeq; NP_002225.2; NM_002234.3. [P22460-1]
DR   UniGene; Hs.150208; -.
DR   UniGene; Hs.741439; -.
DR   ProteinModelPortal; P22460; -.
DR   SMR; P22460; -.
DR   BioGrid; 109943; 58.
DR   DIP; DIP-42010N; -.
DR   IntAct; P22460; 10.
DR   MINT; MINT-200758; -.
DR   STRING; 9606.ENSP00000252321; -.
DR   BindingDB; P22460; -.
DR   ChEMBL; CHEMBL4306; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 542; -.
DR   TCDB; 1.A.1.2.4; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P22460; -.
DR   PhosphoSitePlus; P22460; -.
DR   BioMuta; KCNA5; -.
DR   DMDM; 146345443; -.
DR   PaxDb; P22460; -.
DR   PeptideAtlas; P22460; -.
DR   PRIDE; P22460; -.
DR   Ensembl; ENST00000252321; ENSP00000252321; ENSG00000130037. [P22460-1]
DR   GeneID; 3741; -.
DR   KEGG; hsa:3741; -.
DR   UCSC; uc001qni.5; human. [P22460-1]
DR   CTD; 3741; -.
DR   DisGeNET; 3741; -.
DR   EuPathDB; HostDB:ENSG00000130037.4; -.
DR   GeneCards; KCNA5; -.
DR   HGNC; HGNC:6224; KCNA5.
DR   HPA; CAB022562; -.
DR   HPA; HPA021516; -.
DR   MalaCards; KCNA5; -.
DR   MIM; 176267; gene.
DR   MIM; 612240; phenotype.
DR   neXtProt; NX_P22460; -.
DR   OpenTargets; ENSG00000130037; -.
DR   Orphanet; 334; Familial atrial fibrillation.
DR   PharmGKB; PA208; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; P22460; -.
DR   KO; K04878; -.
DR   OMA; LPRNEFQ; -.
DR   OrthoDB; EOG091G10NU; -.
DR   PhylomeDB; P22460; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNA5; -.
DR   GenomeRNAi; 3741; -.
DR   PRO; PR:P22460; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000130037; -.
DR   CleanEx; HS_KCNA5; -.
DR   Genevisible; P22460; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0014704; C:intercalated disc; IDA:BHF-UCL.
DR   GO; GO:0046691; C:intracellular canaliculus; IEA:Ensembl.
DR   GO; GO:0045121; C:membrane raft; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0034705; C:potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0030018; C:Z disc; IEA:Ensembl.
DR   GO; GO:0051393; F:alpha-actinin binding; IPI:BHF-UCL.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0019870; F:potassium channel inhibitor activity; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
DR   GO; GO:0005102; F:receptor binding; IEA:Ensembl.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:BHF-UCL.
DR   GO; GO:0086089; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0086087; F:voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0086090; F:voltage-gated potassium channel activity involved in SA node cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0086014; P:atrial cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0060081; P:membrane hyperpolarization; IMP:BHF-UCL.
DR   GO; GO:0098914; P:membrane repolarization during atrial cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0086050; P:membrane repolarization during bundle of His cell action potential; IMP:BHF-UCL.
DR   GO; GO:0086052; P:membrane repolarization during SA node cell action potential; IMP:BHF-UCL.
DR   GO; GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:2000288; P:positive regulation of myoblast proliferation; IEA:Ensembl.
DR   GO; GO:0071435; P:potassium ion export; IDA:BHF-UCL.
DR   GO; GO:0055075; P:potassium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; IDA:MGI.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:BHF-UCL.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL.
DR   GO; GO:0043266; P:regulation of potassium ion transport; IMP:BHF-UCL.
DR   GO; GO:0019229; P:regulation of vasoconstriction; IEA:Ensembl.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0055093; P:response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0010033; P:response to organic substance; IEA:Ensembl.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004052; K_chnl_volt-dep_Kv1.5.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01512; KV15CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Atrial fibrillation; Cell membrane;
KW   Complete proteome; Ion channel; Ion transport; Isopeptide bond;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation; Voltage-gated channel.
FT   CHAIN         1    613       Potassium voltage-gated channel subfamily
FT                                A member 5.
FT                                /FTId=PRO_0000053985.
FT   TOPO_DOM      1    247       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    248    269       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    270    323       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    324    345       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    346    356       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    357    377       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    378    395       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    396    416       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    417    431       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    432    453       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    454    467       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    468    479       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    480    487       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    488    494       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    495    523       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    524    613       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REPEAT       61     71       1.
FT   REPEAT       72     82       2.
FT   REGION       61     82       2 X 11 AA tandem repeat of D-[SP]-G-V-R-
FT                                P-L-P-P-L-P.
FT   REGION      418    431       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       480    485       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       611    613       PDZ-binding. {ECO:0000250}.
FT   COMPBIAS     94     99       Poly-Glu.
FT   COMPBIAS    382    387       Poly-Gly.
FT   MOD_RES     557    557       Phosphoserine; by PKA. {ECO:0000255}.
FT   LIPID       346    346       S-palmitoyl cysteine. {ECO:0000255}.
FT   CROSSLNK    221    221       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:17261810}.
FT   CROSSLNK    536    536       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:17261810}.
FT   VAR_SEQ       1    209       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_037110.
FT   VARIANT      42     42       L -> H (found in a patient with pulmonary
FT                                arterial hypertension; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:24936649}.
FT                                /FTId=VAR_079602.
FT   VARIANT      85     85       L -> M. {ECO:0000269|PubMed:24936649}.
FT                                /FTId=VAR_079603.
FT   VARIANT     114    114       T -> P (found in a patient with pulmonary
FT                                arterial hypertension; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:24936649}.
FT                                /FTId=VAR_079604.
FT   VARIANT     170    170       P -> R (found in a patient with pulmonary
FT                                arterial hypertension; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:24936649}.
FT                                /FTId=VAR_079605.
FT   VARIANT     184    184       R -> P (found in a patient with pulmonary
FT                                arterial hypertension; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:24936649}.
FT                                /FTId=VAR_079606.
FT   VARIANT     228    228       P -> S (in dbSNP:rs1056464).
FT                                /FTId=VAR_053856.
FT   VARIANT     300    300       G -> S (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs148708451).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035770.
FT   VARIANT     578    578       R -> K (in dbSNP:rs12720445).
FT                                /FTId=VAR_054786.
FT   MUTAGEN      15     15       T->A: Loss of DLG1 effect on channel
FT                                current. {ECO:0000269|PubMed:16466689}.
FT   MUTAGEN     220    220       I->N: Reduces sumoylation; when
FT                                associated with N-535.
FT                                {ECO:0000269|PubMed:17261810}.
FT   MUTAGEN     221    221       K->R: Abolishes sumoylation; when
FT                                associated with R-536.
FT                                {ECO:0000269|PubMed:17261810}.
FT   MUTAGEN     535    535       L->N: Reduces sumoylation; when
FT                                associated with N-220.
FT                                {ECO:0000269|PubMed:17261810}.
FT   MUTAGEN     536    536       K->R: Abolishes sumoylation; when
FT                                associated with R-221.
FT                                {ECO:0000269|PubMed:17261810}.
FT   CONFLICT     55     55       Missing (in Ref. 1; AAA61276).
FT                                {ECO:0000305}.
FT   CONFLICT    138    138       L -> Q (in Ref. 2; AAA36422).
FT                                {ECO:0000305}.
FT   CONFLICT    154    154       R -> P (in Ref. 1; AAA61276 and 2;
FT                                AAA36422). {ECO:0000305}.
FT   CONFLICT    187    188       RP -> G (in Ref. 1; AAA61276).
FT                                {ECO:0000305}.
FT   CONFLICT    214    214       R -> G (in Ref. 2; AAA36422).
FT                                {ECO:0000305}.
FT   CONFLICT    228    228       P -> V (in Ref. 2; AAA36422).
FT                                {ECO:0000305}.
FT   CONFLICT    282    282       L -> V (in Ref. 3; AAA60146).
FT                                {ECO:0000305}.
FT   CONFLICT    307    307       P -> A (in Ref. 1; AAA61276).
FT                                {ECO:0000305}.
SQ   SEQUENCE   613 AA;  67228 MW;  A5B02B27F8396E3D CRC64;
     MEIALVPLEN GGAMTVRGGD EARAGCGQAT GGELQCPPTA GLSDGPKEPA PKGRGAQRDA
     DSGVRPLPPL PDPGVRPLPP LPEELPRPRR PPPEDEEEEG DPGLGTVEDQ ALGTASLHHQ
     RVHINISGLR FETQLGTLAQ FPNTLLGDPA KRLRYFDPLR NEYFFDRNRP SFDGILYYYQ
     SGGRLRRPVN VSLDVFADEI RFYQLGDEAM ERFREDEGFI KEEEKPLPRN EFQRQVWLIF
     EYPESSGSAR AIAIVSVLVI LISIITFCLE TLPEFRDERE LLRHPPAPHQ PPAPAPGANG
     SGVMAPPSGP TVAPLLPRTL ADPFFIVETT CVIWFTFELL VRFFACPSKA GFSRNIMNII
     DVVAIFPYFI TLGTELAEQQ PGGGGGGQNG QQAMSLAILR VIRLVRVFRI FKLSRHSKGL
     QILGKTLQAS MRELGLLIFF LFIGVILFSS AVYFAEADNQ GTHFSSIPDA FWWAVVTMTT
     VGYGDMRPIT VGGKIVGSLC AIAGVLTIAL PVPVIVSNFN YFYHRETDHE EPAVLKEEQG
     TQSQGPGLDR GVQRKVSGSR GSFCKAGGTL ENADSARRGS CPLEKCNVKA KSNVDLRRSL
     YALCLDTSRE TDL
//
ID   KAT3_ARATH              Reviewed;         662 AA.
AC   P92960;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   20-DEC-2017, entry version 140.
DE   RecName: Full=Potassium channel KAT3;
DE   AltName: Full=AKT4;
DE   AltName: Full=AtKC1;
DE   AltName: Full=Potassium channel TKC;
GN   Name=KAT3; Synonyms=AKT4, KC1; OrderedLocusNames=At4g32650;
GN   ORFNames=F4D11.150;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Columbia; TISSUE=Leaf;
RA   Saalbach G.;
RT   "Characterisation of a putative chloroplast potassium channel in
RT   Arabidopsis thaliana.";
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   STRAIN=cv. Columbia;
RA   Kuech A., Reintanz B., Redhead C., Palme K.;
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G.,
RA   Pohl T., Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N.,
RA   Harris B., Ansorge W., Brandt P., Grivell L.A., Rieger M.,
RA   Weichselgartner M., de Simone V., Obermaier B., Mache R., Mueller M.,
RA   Kreis M., Delseny M., Puigdomenech P., Watson M., Schmidtheini T.,
RA   Reichert B., Portetelle D., Perez-Alonso M., Boutry M., Bancroft I.,
RA   Vos P., Hoheisel J., Zimmermann W., Wedler H., Ridley P.,
RA   Langham S.-A., McCullagh B., Bilham L., Robben J.,
RA   van der Schueren J., Grymonprez B., Chuang Y.-J., Vandenbussche F.,
RA   Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R., Defoor E.,
RA   Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W.,
RA   Mooijman P., Klein Lankhorst R., Rose M., Hauf J., Koetter P.,
RA   Berneiser S., Hempel S., Feldpausch M., Lamberth S., Van den Daele H.,
RA   De Keyser A., Buysshaert C., Gielen J., Villarroel R., De Clercq R.,
RA   van Montagu M., Rogers J., Cronin A., Quail M.A., Bray-Allen S.,
RA   Clark L., Doggett J., Hall S., Kay M., Lennard N., McLay K., Mayes R.,
RA   Pettett A., Rajandream M.A., Lyne M., Benes V., Rechmann S.,
RA   Borkova D., Bloecker H., Scharfe M., Grimm M., Loehnert T.-H.,
RA   Dose S., de Haan M., Maarse A.C., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D., Herzl A.,
RA   Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R.,
RA   Schnabl S., Hiller R., Schmidt W., Lecharny A., Aubourg S.,
RA   Chefdor F., Cooke R., Berger C., Monfort A., Casacuberta E.,
RA   Gibbons T., Weber N., Vandenbol M., Bargues M., Terol J., Torres A.,
RA   Perez-Perez A., Purnelle B., Bent E., Johnson S., Tacon D., Jesse T.,
RA   Heijnen L., Schwarz S., Scholler P., Heber S., Francs P., Bielke C.,
RA   Frishman D., Haase D., Lemcke K., Mewes H.-W., Stocker S.,
RA   Zaccaria P., Bevan M., Wilson R.K., de la Bastide M., Habermann K.,
RA   Parnell L., Dedhia N., Gnoj L., Schutz K., Huang E., Spiegel L.,
RA   Sekhon M., Murray J., Sheet P., Cordes M., Abu-Threideh J.,
RA   Stoneking T., Kalicki J., Graves T., Harmon G., Edwards J.,
RA   Latreille P., Courtney L., Cloud J., Abbott A., Scott K., Johnson D.,
RA   Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D.,
RA   Du H., Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C.,
RA   Antonoiu B., Zidanic M., Strong C., Sun H., Lamar B., Yordan C.,
RA   Ma P., Zhong J., Preston R., Vil D., Shekher M., Matero A., Shah R.,
RA   Swaby I.K., O'Shaughnessy A., Rodriguez M., Hoffman J., Till S.,
RA   Granat S., Shohdy N., Hasegawa A., Hameed A., Lodhi M., Johnson A.,
RA   Chen E., Marra M.A., Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:769-777(1999).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [6]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [7]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, CHARACTERIZATION, AND
RP   FUNCTION.
RX   PubMed=11904452; DOI=10.1073/pnas.052677799;
RA   Reintanz B., Szyroki A., Ivashikina N., Ache P., Godde M., Becker D.,
RA   Palme K., Hedrich R.;
RT   "AtKC1, a silent Arabidopsis potassium channel alpha-subunit modulates
RT   root hair K+ influx.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:4079-4084(2002).
RN   [8]
RP   FUNCTION, INTERACTION WITH AKT1 AND AKT2, TISSUE SPECIFICITY, AND
RP   INDUCTION.
RX   PubMed=12678562; DOI=10.1023/A:1022597102282;
RA   Pilot G., Gaymard F., Mouline K., Cherel I., Sentenac H.;
RT   "Regulated expression of Arabidopsis shaker K(+) channel genes
RT   involved in K(+) uptake and distribution in the plant.";
RL   Plant Mol. Biol. 51:773-787(2003).
RN   [9]
RP   INTERACTION WITH SLAC1.
RX   PubMed=27002025; DOI=10.1105/tpc.16.01050;
RA   Zhang A., Ren H.M., Tan Y.Q., Qi G.N., Yao F.Y., Wu G.L., Yang L.W.,
RA   Hussain J., Sun S.J., Wang Y.F.;
RT   "S-type anion channels SLAC1 and SLAH3 function as essential negative
RT   regulators of inward K+ channels and stomatal opening in
RT   Arabidopsis.";
RL   Plant Cell 0:0-0(2016).
CC   -!- FUNCTION: Probable modulatory (alpha) subunit of inward-rectifying
CC       potassium channels. Could mediate potassium uptake from the soil
CC       solution by plant roots in association with AKT1.
CC       {ECO:0000269|PubMed:11904452, ECO:0000269|PubMed:12678562}.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming subunits. May interact
CC       with AKT1 and AKT2 (PubMed:12678562). Interacts with SLAC1
CC       (PubMed:27002025). {ECO:0000269|PubMed:12678562,
CC       ECO:0000269|PubMed:27002025}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:11904452};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:11904452}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=A number of isoforms are produced. According to EST
CC         sequences.;
CC       Name=1;
CC         IsoId=P92960-1; Sequence=Displayed;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in root hairs and root
CC       endodermis and, at a lower level, in leaf nodes, trichomes, and
CC       hydathodes. {ECO:0000269|PubMed:11904452,
CC       ECO:0000269|PubMed:12678562}.
CC   -!- INDUCTION: Strongly reduced in roots after 2,4-
CC       dichlorophenoxyacetic acid (2,4-D) treatment and after
CC       benzyladenine (BA) treatment. Strongly induced in shoots after
CC       NaCl treatment. {ECO:0000269|PubMed:12678562}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z83202; CAB05669.1; -; mRNA.
DR   EMBL; U73325; AAC98810.1; -; Genomic_DNA.
DR   EMBL; U81239; AAD00503.1; -; mRNA.
DR   EMBL; AL022537; CAA18596.1; -; Genomic_DNA.
DR   EMBL; AL161581; CAB79982.1; -; Genomic_DNA.
DR   EMBL; CP002687; AEE86097.1; -; Genomic_DNA.
DR   EMBL; AY052233; AAK97703.1; -; mRNA.
DR   EMBL; BT003093; AAO23890.1; -; mRNA.
DR   PIR; T04461; T04461.
DR   RefSeq; NP_194991.1; NM_119417.4. [P92960-1]
DR   UniGene; At.100; -.
DR   ProteinModelPortal; P92960; -.
DR   SMR; P92960; -.
DR   BioGrid; 14686; 19.
DR   IntAct; P92960; 5.
DR   STRING; 3702.AT4G32650.1; -.
DR   TCDB; 1.A.1.4.9; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; P92960; -.
DR   EnsemblPlants; AT4G32650.1; AT4G32650.1; AT4G32650. [P92960-1]
DR   GeneID; 829400; -.
DR   Gramene; AT4G32650.1; AT4G32650.1; AT4G32650. [P92960-1]
DR   KEGG; ath:AT4G32650; -.
DR   Araport; AT4G32650; -.
DR   TAIR; locus:2005524; AT4G32650.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238230; -.
DR   InParanoid; P92960; -.
DR   KO; K21867; -.
DR   OMA; TREWPMP; -.
DR   OrthoDB; EOG093605FF; -.
DR   PhylomeDB; P92960; -.
DR   PRO; PR:P92960; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; P92960; baseline and differential.
DR   Genevisible; P92960; AT.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:TAIR.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:TAIR.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0009624; P:response to nematode; IEP:TAIR.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    662       Potassium channel KAT3.
FT                                /FTId=PRO_0000054127.
FT   TOPO_DOM      1     90       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     91    111       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    112    118       Extracellular. {ECO:0000255}.
FT   TRANSMEM    119    139       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    140    163       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    164    184       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    185    194       Extracellular. {ECO:0000255}.
FT   TRANSMEM    195    215       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    216    229       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    230    250       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    251    277       Extracellular. {ECO:0000255}.
FT   INTRAMEM    278    297       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    298    301       Extracellular. {ECO:0000255}.
FT   TRANSMEM    302    322       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    323    662       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      591    662       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     406    527       cNMP.
FT   COILED      528    558       {ECO:0000255}.
SQ   SEQUENCE   662 AA;  75598 MW;  A6E90C9EB48387AC CRC64;
     MSTTTTEARS PLPLLLRRGR SSTALSASTA EARSPLSILQ FRRRSSKDVR NITSVSSSLL
     PAFGTFIEDD NPSSKPFIVL HFDRRYRLWE LFLVILVGYS AWASLFELAF EKAAEGALLT
     IDLVVDFFFA VDIILTFFVS YLDNTTYLNV TDHKLIAKRY LKSVAFVMDV ASTLPIQFIY
     KTITGDVGRG QAFGFLNLLR LWRLRRVAEL FKRLEKDAHF NYFVIRVIKL LCVTIFWIHL
     AGCILYWIAY HYPRPTDTWI GSQVEDFKER SVWLGYTYSM YWSIVTLTTV GYGDLHAVNS
     REKTFNMFYM LFNIGLTSYI IGIMTNLVVH GALRTFAMRS AINDILRYTS KNRLPDTMRE
     QMLAHMQLKF KTAELRQEEV LQDLPKAIRS SINQHLFRSI IEEAYLFKGF PEGLLVQLVS
     QIQAEYFPPK MEIILQNEIP TDFYVIVSGG VDIIASKGVS EQVLAKLGPG SMAGEIGVVF
     NIPQPFTVRT RRLSQVIRIG HHKFKEMVQS DNDVDAKMII ANFMTYLKGL NDELKKEIPF
     LRDLLDDADA QVQETVQSEE TPQSNDEEIV TVSRHENGQI EERRREGVPK RVIIHGQAPP
     NQDNKNNGDS NGRLIILPDS IQLLFDLAEK KLGKRGSTIA MADGAHVEQI DALRENDHLY
     IF
//
ID   KAT2_ORYSJ              Reviewed;         601 AA.
AC   Q5QNI1;
DT   28-JUN-2011, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 2.
DT   20-DEC-2017, entry version 87.
DE   RecName: Full=Potassium channel KAT2;
GN   OrderedLocusNames=Os01g0210700, LOC_Os01g11250;
GN   ORFNames=P0031E09.16, P0466B10.26;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Dongjin;
RA   Hwang H., Jeong M., Kim H., Lee H., Park H., Byun M., Kim B.;
RT   "Putative potassium channel mRNA.";
RL   Submitted (JUL-2009) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12447438; DOI=10.1038/nature01184;
RA   Sasaki T., Matsumoto T., Yamamoto K., Sakata K., Baba T., Katayose Y.,
RA   Wu J., Niimura Y., Cheng Z., Nagamura Y., Antonio B.A., Kanamori H.,
RA   Hosokawa S., Masukawa M., Arikawa K., Chiden Y., Hayashi M.,
RA   Okamoto M., Ando T., Aoki H., Arita K., Hamada M., Harada C.,
RA   Hijishita S., Honda M., Ichikawa Y., Idonuma A., Iijima M., Ikeda M.,
RA   Ikeno M., Ito S., Ito T., Ito Y., Ito Y., Iwabuchi A., Kamiya K.,
RA   Karasawa W., Katagiri S., Kikuta A., Kobayashi N., Kono I.,
RA   Machita K., Maehara T., Mizuno H., Mizubayashi T., Mukai Y.,
RA   Nagasaki H., Nakashima M., Nakama Y., Nakamichi Y., Nakamura M.,
RA   Namiki N., Negishi M., Ohta I., Ono N., Saji S., Sakai K., Shibata M.,
RA   Shimokawa T., Shomura A., Song J., Takazaki Y., Terasawa K., Tsuji K.,
RA   Waki K., Yamagata H., Yamane H., Yoshiki S., Yoshihara R., Yukawa K.,
RA   Zhong H., Iwama H., Endo T., Ito H., Hahn J.H., Kim H.-I., Eun M.-Y.,
RA   Yano M., Jiang J., Gojobori T.;
RT   "The genome sequence and structure of rice chromosome 1.";
RL   Nature 420:312-316(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   "The rice annotation project database (RAP-DB): 2008 update.";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
CC   -!- FUNCTION: Probable inward-rectifying potassium channel. Assuming
CC       opened or closed conformations in response to the voltage
CC       difference across the membrane, the channel is activated by
CC       hyperpolarization (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ADJ67989.1; Type=Miscellaneous discrepancy; Note=Sequencing errors.; Evidence={ECO:0000305};
CC       Sequence=BAD73027.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAD73049.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAF04284.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ386814; ADJ67989.1; ALT_SEQ; mRNA.
DR   EMBL; AP002092; BAD73027.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AP002093; BAD73049.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AP008207; BAF04284.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AP014957; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_015614092.1; XM_015758606.1.
DR   RefSeq; XP_015614100.1; XM_015758614.1.
DR   UniGene; Os.38354; -.
DR   GeneID; 4325560; -.
DR   KEGG; osa:4325560; -.
DR   HOGENOM; HOG000238230; -.
DR   InParanoid; Q5QNI1; -.
DR   KO; K21867; -.
DR   Proteomes; UP000059680; Chromosome 1.
DR   ExpressionAtlas; Q5QNI1; baseline and differential.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    601       Potassium channel KAT2.
FT                                /FTId=PRO_0000410878.
FT   TOPO_DOM      1     42       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     43     63       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     64     71       Extracellular. {ECO:0000255}.
FT   TRANSMEM     72     92       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM     93    112       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    113    133       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    134    144       Extracellular. {ECO:0000255}.
FT   TRANSMEM    145    165       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    166    179       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    180    200       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    201    227       Extracellular. {ECO:0000255}.
FT   INTRAMEM    228    247       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    248    251       Extracellular. {ECO:0000255}.
FT   TRANSMEM    252    272       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    273    601       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      530    601       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     356    475       cNMP.
SQ   SEQUENCE   601 AA;  69807 MW;  B51B202A0C5F2C96 CRC64;
     METISNIFHN DPLPPLGARA NQSIKLRKFI ISPYDSRYRT WETFLLVLVV YSAWICPFEL
     AYLRNLSWKV SLVDNIIDSF FAIDIILTFF LAYLDQKSYL LVDDPKRIVA RYFSSWFLFD
     VCSTIPYQLL GQIFKKHENG LAYRLLSMLR LWRLRRLSEL FARLEKDIRL NYYWIRCTKL
     ISVTLFAVHC SGCFNYLIAD RYPNPARTWI GAAIPNYRSQ NLWVRYVTAI YWSITTLTTT
     GYGDLHAENQ REMLFSICYM LFNLGLTAYL IGNMTNLVVQ GSCRTRNFRD TIHAASQFAA
     RNQLPGHIKD EMLSHICLRY KTEGLKQKET LDSLPKGIRS SIACNLFLPV IEKVYLFHGV
     SFTCMIQLVT EMEAEYYPPR EVVILQNEAP RDVYILVSGA VEERVEIDGT EKVQEVLCNG
     EIFGEIGVIC SIPQPCAFHT IKVSQLLRLN TAVLKNIIKE NSDDRRVILN NLSQKMNQDH
     RFSTEVMEKS LQMMHQHFGE YNRCSALNQD NEKNELKANN GHSMALEWKR VTIHMYSQRN
     KRPEAPLAKV INLPGSLDKL FAIACQKFNN YRLTKLVNPE FAEIDDITVI RDGDHLFFME
     I
//
ID   KCNG2_CHICK             Reviewed;         518 AA.
AC   O73606;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   22-NOV-2017, entry version 118.
DE   RecName: Full=Potassium voltage-gated channel subfamily G member 2;
DE   AltName: Full=Potassium channel cKv6.2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv6.2;
GN   Name=KCNG2;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes;
OC   Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=White leghorn; TISSUE=Cochlear duct;
RX   PubMed=9473273; DOI=10.1006/abio.1997.2500;
RA   Peale F.V. Jr., Mason K., Hunter A.W., Bothwell M.;
RT   "Multiplex display polymerase chain reaction amplifies and resolves
RT   related sequences sharing a single moderately conserved domain.";
RL   Anal. Biochem. 256:158-168(1998).
CC   -!- FUNCTION: Potassium channel subunit. Modulates channel activity
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer with KCNB1. Does not form homomultimers (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. G (TC
CC       1.A.1.2) subfamily. Kv6.2/KCNG2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U62139; AAC06191.1; -; mRNA.
DR   RefSeq; NP_990370.1; NM_205039.1.
DR   RefSeq; XP_015131321.1; XM_015275835.1.
DR   RefSeq; XP_015131322.1; XM_015275836.1.
DR   RefSeq; XP_015131323.1; XM_015275837.1.
DR   RefSeq; XP_015131324.1; XM_015275838.1.
DR   UniGene; Gga.2713; -.
DR   UniGene; Gga.50733; -.
DR   ProteinModelPortal; O73606; -.
DR   STRING; 9031.ENSGALP00000020617; -.
DR   PaxDb; O73606; -.
DR   Ensembl; ENSGALT00000080410; ENSGALP00000057198; ENSGALG00000031754.
DR   GeneID; 395902; -.
DR   KEGG; gga:395902; -.
DR   CTD; 26251; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231014; -.
DR   HOVERGEN; HBG100172; -.
DR   InParanoid; O73606; -.
DR   KO; K04901; -.
DR   OMA; IINVGGC; -.
DR   OrthoDB; EOG091G05DD; -.
DR   PhylomeDB; O73606; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-GGA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-GGA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   PRO; PR:O73606; -.
DR   Proteomes; UP000000539; Chromosome 2.
DR   Bgee; ENSGALG00000012652; -.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003969; K_chnl_volt-dep_Kv6.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01492; KV6CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    518       Potassium voltage-gated channel subfamily
FT                                G member 2.
FT                                /FTId=PRO_0000054076.
FT   TOPO_DOM      1    217       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    218    238       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    258    278       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    279    292       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    293    313       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    336    356       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    357    369       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    370    390       Helical; Name=Segment S5. {ECO:0000255}.
FT   INTRAMEM    405    425       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TRANSMEM    433    453       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    454    518       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       417    422       Selectivity filter. {ECO:0000250}.
SQ   SEQUENCE   518 AA;  58769 MW;  5A1A57DC10AE6541 CRC64;
     MALLTGNADR AFSSYSFNKL ENLCEVQTKK GFFYRKAKLL HPDEDLCYLA RLDDRTRFVI
     INVGGIKYKV PWTTLENCPL TRLGKLKSCN NYDEIMNICD DYDVSCNEFF FDRNPSAFRT
     IMTFLTAGKL RLLREMCALS FQEELVYWGI EEDHLEWCCK KRLQQKEEEA AEARMYEGEM
     MFSETTQCAF QDNNWLSLCM RNLRDMVENP HSGIPGKIFA CISISFVAIT AVSLCISTMP
     DVREEEDRGE CSQKCYDIFV LETVCVAWFS FEFLLRSIQA ENKCAFLKTP LNIIDILAIL
     PFYISLIVDM ASTKNSSKPG GGAGNKYLER VGLVLRFLRA LRILYVMRLA RHSLGLQTLG
     LTVRRCTREF GLLLLFLCVA MALFSPLVYL AESELGAKQE FTSIPTSYWW AVISMTTVGY
     GDMVPRSIPG QVVALSSILS GILLMAFPVT SIFHTFSRSY SELKEQQQRA ASRQMHQLEE
     STKLAGGGSS QWITAASPPD AAREDGRPEL DQEAKRSC
//
ID   KCNA1_HUMAN             Reviewed;         495 AA.
AC   Q09470; A6NM83; Q3MIQ9;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 2.
DT   20-DEC-2017, entry version 185.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 1;
DE   AltName: Full=Voltage-gated K(+) channel HuKI {ECO:0000303|PubMed:19912772};
DE   AltName: Full=Voltage-gated potassium channel HBK1 {ECO:0000303|PubMed:2128063};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.1;
GN   Name=KCNA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND ENZYME
RP   REGULATION.
RC   TISSUE=Brain;
RX   PubMed=19912772; DOI=10.1016/1044-7431(90)90004-N;
RA   Ramaswami M., Gautam M., Kamb A., Rudy B., Tanouye M.A., Mathew M.K.;
RT   "Human potassium channel genes: molecular cloning and functional
RT   expression.";
RL   Mol. Cell. Neurosci. 1:214-223(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain cortex;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 263-315.
RX   PubMed=2128063;
RA   Freeman S.N., Conley E.C., Brennand J.C., Russell N.J.W.,
RA   Brammar W.J.;
RT   "Cloning and characterization of a cDNA encoding a human brain
RT   potassium channel.";
RL   Biochem. Soc. Trans. 18:891-892(1990).
RN   [6]
RP   INTERACTION WITH KCNA2 AND KCNAB2, SUBUNIT, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11086297;
RX   DOI=10.1002/1096-9861(20000101)429:1<166::AID-CNE13>3.0.CO;2-Y;
RA   Rasband M.N., Trimmer J.S.;
RT   "Subunit composition and novel localization of K+ channels in spinal
RT   cord.";
RL   J. Comp. Neurol. 429:166-176(2001).
RN   [7]
RP   RNA EDITING OF POSITION 400.
RX   PubMed=12907802; DOI=10.1126/science.1086763;
RA   Hoopengardner B., Bhalla T., Staber C., Reenan R.;
RT   "Nervous system targets of RNA editing identified by comparative
RT   genomics.";
RL   Science 301:832-836(2003).
RN   [8]
RP   PALMITOYLATION AT CYS-243, MUTAGENESIS OF 35-CYS--CYS-36 AND CYS-243,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15837928; DOI=10.1073/pnas.0501999102;
RA   Gubitosi-Klug R.A., Mancuso D.J., Gross R.W.;
RT   "The human Kv1.1 channel is palmitoylated, modulating voltage sensing:
RT   Identification of a palmitoylation consensus sequence.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:5964-5968(2005).
RN   [9]
RP   REVIEW.
RX   PubMed=17917103; DOI=10.1007/s12035-007-8001-0;
RA   Baranauskas G.;
RT   "Ionic channel function in action potential generation: current
RT   perspective.";
RL   Mol. Neurobiol. 35:129-150(2007).
RN   [10]
RP   INTERACTION WITH KCNRG, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19968958; DOI=10.1016/j.bbrc.2009.11.143;
RA   Usman H., Mathew M.K.;
RT   "Potassium channel regulator KCNRG regulates surface expression of
RT   Shaker-type potassium channels.";
RL   Biochem. Biophys. Res. Commun. 391:1301-1305(2010).
RN   [11]
RP   FUNCTION.
RX   PubMed=21106501; DOI=10.1093/brain/awq318;
RA   Tomlinson S.E., Tan S.V., Kullmann D.M., Griggs R.C., Burke D.,
RA   Hanna M.G., Bostock H.;
RT   "Nerve excitability studies characterize Kv1.1 fast potassium channel
RT   dysfunction in patients with episodic ataxia type 1.";
RL   Brain 133:3530-3540(2010).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   PubMed=21483673; DOI=10.1371/journal.pone.0018213;
RA   Ma Z., Lavebratt C., Almgren M., Portwood N., Forsberg L.E.,
RA   Branstrom R., Berglund E., Falkmer S., Sundler F., Wierup N.,
RA   Bjorklund A.;
RT   "Evidence for presence and functional effects of Kv1.1 channels in
RT   beta-cells: general survey and results from mceph/mceph mice.";
RL   PLoS ONE 6:E18213-E18213(2011).
RN   [13]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-446, AND MUTAGENESIS OF
RP   SER-446.
RX   PubMed=23774215; DOI=10.1158/0008-5472.CAN-12-3690;
RA   Lallet-Daher H., Wiel C., Gitenay D., Navaratnam N., Augert A.,
RA   Le Calve B., Verbeke S., Carling D., Aubert S., Vindrieux D.,
RA   Bernard D.;
RT   "Potassium channel KCNA1 modulates oncogene-induced senescence and
RT   transformation.";
RL   Cancer Res. 73:5253-5265(2013).
RN   [14]
RP   INTERACTION WITH ANK3, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23903368; DOI=10.1038/ki.2013.280;
RA   San-Cristobal P., Lainez S., Dimke H., de Graaf M.J., Hoenderop J.G.,
RA   Bindels R.J.;
RT   "Ankyrin-3 is a novel binding partner of the voltage-gated potassium
RT   channel Kv1.1 implicated in renal magnesium handling.";
RL   Kidney Int. 85:94-102(2014).
RN   [15]
RP   VARIANTS EA1 PHE-174; SER-239; ILE-249 AND ALA-408.
RX   PubMed=7842011; DOI=10.1038/ng1094-136;
RA   Browne D.L., Gancher S.T., Nutt J.G., Brunt E.R.P., Smith E.A.,
RA   Kramer P., Litt M.;
RT   "Episodic ataxia/myokymia syndrome is associated with point mutations
RT   in the human potassium channel gene, KCNA1.";
RL   Nat. Genet. 8:136-140(1994).
RN   [16]
RP   VARIANTS EA1 PHE-174; CYS-184 AND ASP-325.
RX   PubMed=8541859; DOI=10.1093/hmg/4.9.1671;
RA   Browne D.L., Brunt E.R.P., Griggs R.C., Nutt J.G., Gancher S.T.,
RA   Smith E.A., Litt M.;
RT   "Identification of two new KCNA1 mutations in episodic ataxia/myokymia
RT   families.";
RL   Hum. Mol. Genet. 4:1671-1672(1995).
RN   [17]
RP   CHARACTERIZATION OF VARIANTS EA1 CYS-184; ASP-325 AND ALA-408.
RX   PubMed=8845167; DOI=10.1016/0896-6273(95)90022-5;
RA   Adelman J.P., Bond C.T., Pessia M., Maylie J.;
RT   "Episodic ataxia results from voltage-dependent potassium channels
RT   with altered functions.";
RL   Neuron 15:1449-1454(1995).
RN   [18]
RP   VARIANT EA1 MET-226.
RX   PubMed=8871592; DOI=10.1002/ana.410400422;
RA   Comu S., Giuliani M., Narayanan V.;
RT   "Episodic ataxia and myokymia syndrome: a new mutation of potassium
RT   channel gene Kv1.1.";
RL   Ann. Neurol. 40:684-687(1996).
RN   [19]
RP   VARIANTS EA1 ARG-177; ALA-226 AND ILE-404.
RX   PubMed=9600245; DOI=10.1007/s004390050722;
RA   Scheffer H., Brunt E.R.P., Mol G.J.J., van der Vlies P., Stulp R.P.,
RA   Verlind E., Mantel G., Averyanov Y.N., Hofstra R.M.W., Buys C.H.C.M.;
RT   "Three novel KCNA1 mutations in episodic ataxia type I families.";
RL   Hum. Genet. 102:464-466(1998).
RN   [20]
RP   VARIANT EA1 ARG-226, AND CHARACTERIZATION OF VARIANT EA1 ARG-226.
RX   PubMed=10355668; DOI=10.1093/brain/122.5.817;
RA   Zuberi S.M., Eunson L.H., Spauschus A., De Silva R., Tolmie J.,
RA   Wood N.W., McWilliam R.C., Stephenson J.P.B., Kullmann D.M.,
RA   Hanna M.G.;
RT   "A novel mutation in the human voltage-gated potassium channel gene
RT   (Kv1.1) associates with episodic ataxia type 1 and sometimes with
RT   partial epilepsy.";
RL   Brain 122:817-825(1999).
RN   [21]
RP   VARIANTS MK1 PRO-242 AND HIS-244, VARIANT EA1 ILE-404,
RP   CHARACTERIZATION OF VARIANTS MK1 PRO-242 AND HIS-244, CHARACTERIZATION
RP   OF VARIANT EA1 ILE-404, AND FUNCTION.
RX   PubMed=11026449;
RX   DOI=10.1002/1531-8249(200010)48:4<647::AID-ANA12>3.3.CO;2-H;
RA   Eunson L.H., Rea R., Zuberi S.M., Youroukos S., Panayiotopoulos C.P.,
RA   Liguori R., Avoni P., McWilliam R.C., Stephenson J.B.P., Hanna M.G.,
RA   Kullmann D.M., Spauschus A.;
RT   "Clinical, genetic, and expression studies of mutations in the
RT   potassium channel gene KCNA1 reveal new phenotypic variability.";
RL   Ann. Neurol. 48:647-656(2000).
RN   [22]
RP   VARIANT EA1 ILE-329.
RX   PubMed=11013453;
RX   DOI=10.1002/1098-1004(200010)16:4<374::AID-HUMU15>3.3.CO;2-W;
RA   Knight M.A., Storey E., McKinlay Gardner R.J., Hand P., Forrest S.M.;
RT   "Identification of a novel missense mutation L329I in the episodic
RT   ataxia type 1 gene KCNA1 -- a challenging problem.";
RL   Hum. Mutat. 16:374-374(2000).
RN   [23]
RP   CHARACTERIZATION OF VARIANTS EA1 ASP-325 AND ALA-408, FUNCTION,
RP   SUBCELLULAR LOCATION, SUBUNIT, AND INTERACTION WITH KCNAB1.
RX   PubMed=12077175;
RA   Maylie B., Bissonnette E., Virk M., Adelman J.P., Maylie J.G.;
RT   "Episodic ataxia type 1 mutations in the human Kv1.1 potassium channel
RT   alter hKvbeta 1-induced N-type inactivation.";
RL   J. Neurosci. 22:4786-4793(2002).
RN   [24]
RP   VARIANT EA1 ILE-342.
RX   PubMed=15532032; DOI=10.1002/humu.9295;
RA   Lee H., Wang H., Jen J.C., Sabatti C., Baloh R.W., Nelson S.F.;
RT   "A novel mutation in KCNA1 causes episodic ataxia without myokymia.";
RL   Hum. Mutat. 24:536-536(2004).
RN   [25]
RP   CHARACTERIZATION OF VARIANTS EA1 ASP-325; ILE-404 AND ALA-408,
RP   MUTAGENESIS OF ILE-177, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17156368; DOI=10.1111/j.1460-9568.2006.05186.x;
RA   Imbrici P., D'Adamo M.C., Kullmann D.M., Pessia M.;
RT   "Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast
RT   inactivation properties of the human potassium channels Kv1.4-
RT   1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2.";
RL   Eur. J. Neurosci. 24:3073-3083(2006).
RN   [26]
RP   VARIANT MK1 LYS-226, CHARACTERIZATION OF VARIANT MK1 LYS-226,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17136396; DOI=10.1007/s10048-006-0071-z;
RA   Chen H., von Hehn C., Kaczmarek L.K., Ment L.R., Pober B.R.,
RA   Hisama F.M.;
RT   "Functional analysis of a novel potassium channel (KCNA1) mutation in
RT   hereditary myokymia.";
RL   Neurogenetics 8:131-135(2007).
RN   [27]
RP   VARIANT MK1 ASP-255, CHARACTERIZATION OF VARIANT MK1 ASP-255,
RP   FUNCTION, SUBCELLULAR LOCATION, AND ENZYME REGULATION.
RX   PubMed=19307729; DOI=10.1172/JCI36948;
RA   Glaudemans B., van der Wijst J., Scola R.H., Lorenzoni P.J.,
RA   Heister A., van der Kemp A.W., Knoers N.V., Hoenderop J.G.,
RA   Bindels R.J.;
RT   "A missense mutation in the Kv1.1 voltage-gated potassium channel-
RT   encoding gene KCNA1 is linked to human autosomal dominant
RT   hypomagnesemia.";
RL   J. Clin. Invest. 119:936-942(2009).
RN   [28]
RP   CHARACTERIZATION OF VARIANT MK1 ASP-255, MUTAGENESIS OF ASN-255,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19903818; DOI=10.1074/jbc.M109.041517;
RA   van der Wijst J., Glaudemans B., Venselaar H., Nair A.V., Forst A.L.,
RA   Hoenderop J.G., Bindels R.J.;
RT   "Functional analysis of the Kv1.1 N255D mutation associated with
RT   autosomal dominant hypomagnesemia.";
RL   J. Biol. Chem. 285:171-178(2010).
RN   [29]
RP   VARIANT LEU-405.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes,
CC       primarily in the brain and the central nervous system, but also in
CC       the kidney (PubMed:19903818). Contributes to the regulation of the
CC       membrane potential and nerve signaling, and prevents neuronal
CC       hyperexcitability (PubMed:17156368). Forms tetrameric potassium-
CC       selective channels through which potassium ions pass in accordance
CC       with their electrochemical gradient. The channel alternates
CC       between opened and closed conformations in response to the voltage
CC       difference across the membrane (PubMed:19912772). Can form
CC       functional homotetrameric channels and heterotetrameric channels
CC       that contain variable proportions of KCNA1, KCNA2, KCNA4, KCNA5,
CC       KCNA6, KCNA7, and possibly other family members as well; channel
CC       properties depend on the type of alpha subunits that are part of
CC       the channel (PubMed:12077175, PubMed:17156368). Channel properties
CC       are modulated by cytoplasmic beta subunits that regulate the
CC       subcellular location of the alpha subunits and promote rapid
CC       inactivation of delayed rectifier potassium channels
CC       (PubMed:12077175, PubMed:17156368). In vivo, membranes probably
CC       contain a mixture of heteromeric potassium channel complexes,
CC       making it difficult to assign currents observed in intact tissues
CC       to any particular potassium channel family member. Homotetrameric
CC       KCNA1 forms a delayed-rectifier potassium channel that opens in
CC       response to membrane depolarization, followed by slow spontaneous
CC       channel closure (PubMed:19912772, PubMed:19968958,
CC       PubMed:19307729, PubMed:19903818). In contrast, a heterotetrameric
CC       channel formed by KCNA1 and KCNA4 shows rapid inactivation
CC       (PubMed:17156368). Regulates neuronal excitability in hippocampus,
CC       especially in mossy fibers and medial perforant path axons,
CC       preventing neuronal hyperexcitability. Response to toxins that are
CC       selective for KCNA1, respectively for KCNA2, suggests that
CC       heteromeric potassium channels composed of both KCNA1 and KCNA2
CC       play a role in pacemaking and regulate the output of deep
CC       cerebellar nuclear neurons (By similarity). May function as down-
CC       stream effector for G protein-coupled receptors and inhibit
CC       GABAergic inputs to basolateral amygdala neurons (By similarity).
CC       May contribute to the regulation of neurotransmitter release, such
CC       as gamma-aminobutyric acid (GABA) release (By similarity). Plays a
CC       role in regulating the generation of action potentials and
CC       preventing hyperexcitability in myelinated axons of the vagus
CC       nerve, and thereby contributes to the regulation of heart
CC       contraction (By similarity). Required for normal neuromuscular
CC       responses (PubMed:11026449, PubMed:17136396). Regulates the
CC       frequency of neuronal action potential firing in response to
CC       mechanical stimuli, and plays a role in the perception of pain
CC       caused by mechanical stimuli, but does not play a role in the
CC       perception of pain due to heat stimuli (By similarity). Required
CC       for normal responses to auditory stimuli and precise location of
CC       sound sources, but not for sound perception (By similarity). The
CC       use of toxins that block specific channels suggest that it
CC       contributes to the regulation of the axonal release of the
CC       neurotransmitter dopamine (By similarity). Required for normal
CC       postnatal brain development and normal proliferation of neuronal
CC       precursor cells in the brain (By similarity). Plays a role in the
CC       reabsorption of Mg(2+) in the distal convoluted tubules in the
CC       kidney and in magnesium ion homeostasis, probably via its effect
CC       on the membrane potential (PubMed:23903368, PubMed:19307729).
CC       {ECO:0000250|UniProtKB:P10499, ECO:0000269|PubMed:11026449,
CC       ECO:0000269|PubMed:12077175, ECO:0000269|PubMed:15837928,
CC       ECO:0000269|PubMed:17136396, ECO:0000269|PubMed:17156368,
CC       ECO:0000269|PubMed:19307729, ECO:0000269|PubMed:19903818,
CC       ECO:0000269|PubMed:19912772, ECO:0000269|PubMed:19968958,
CC       ECO:0000269|PubMed:21106501, ECO:0000269|PubMed:23903368}.
CC   -!- ENZYME REGULATION: Inhibited by 1.1 mM 4-aminopyridine (4-AP) and
CC       by 20 mM tetraethylammonium (TEA), but not by charybdotoxin
CC       (CTX)(PubMed:19912772). Inhibited by dendrotoxin (DTX)
CC       (PubMed:19307729). {ECO:0000269|PubMed:19307729,
CC       ECO:0000269|PubMed:19912772}.
CC   -!- SUBUNIT: Homotetramer and heterotetramer with other channel-
CC       forming alpha subunits, such as KCNA2, KCNA4, KCNA5, KCNA6 and
CC       KCNA7 (PubMed:12077175, PubMed:17156368). Channel activity is
CC       regulated by interaction with the beta subunits KCNAB1 and KCNAB2
CC       (PubMed:12077175, PubMed:17156368). Identified in a complex with
CC       KCNA2 and KCNAB2 (PubMed:11086297). Interacts (via C-terminus)
CC       with the PDZ domains of DLG1, DLG2 and DLG4 (By similarity).
CC       Interacts with LGI1 within a complex containing LGI1, KCNA4 and
CC       KCNAB1 (By similarity). Interacts (via N-terminus) with STX1A;
CC       this promotes channel inactivation (By similarity). Interacts (via
CC       N-terminus) with the heterodimer formed by GNB1 and GNG2; this
CC       promotes channel inactivation (By similarity). Can interact
CC       simultaneously with STX1A and the heterodimer formed by GNB1 and
CC       GNG2 (By similarity). Interacts (via cytoplasmic N-terminal
CC       domain) with KCNRG; this inhibits channel activity
CC       (PubMed:19968958). Interacts with ANK3; this inhibits channel
CC       activity (PubMed:23903368). {ECO:0000250|UniProtKB:P10499,
CC       ECO:0000269|PubMed:11086297, ECO:0000269|PubMed:17156368,
CC       ECO:0000269|PubMed:19968958, ECO:0000269|PubMed:23903368,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Q62936:Dlg3 (xeno); NbExp=2; IntAct=EBI-8286599, EBI-349596;
CC       P78352:DLG4; NbExp=2; IntAct=EBI-8286599, EBI-80389;
CC       Q9Y5U9:IER3IP1; NbExp=4; IntAct=EBI-8286599, EBI-725665;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12077175,
CC       ECO:0000269|PubMed:15837928, ECO:0000269|PubMed:17136396,
CC       ECO:0000269|PubMed:17156368, ECO:0000269|PubMed:19307729,
CC       ECO:0000269|PubMed:19903818, ECO:0000269|PubMed:19912772,
CC       ECO:0000269|PubMed:19968958, ECO:0000269|PubMed:23903368}; Multi-
CC       pass membrane protein {ECO:0000305}. Membrane
CC       {ECO:0000269|PubMed:11086297}. Cell projection, axon
CC       {ECO:0000269|PubMed:11086297}. Cytoplasmic vesicle
CC       {ECO:0000269|PubMed:23774215}. Perikaryon
CC       {ECO:0000250|UniProtKB:P10499}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P10499}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:P16388}. Cell junction
CC       {ECO:0000250|UniProtKB:P16388}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:P16388}. Cell junction, synapse,
CC       presynaptic cell membrane {ECO:0000250|UniProtKB:P10499}.
CC       Note=Homotetrameric KCNA1 is primarily located in the endoplasmic
CC       reticulum. Interaction with KCNA2 and KCNAB2 or with KCNA4 and
CC       KCNAB2 promotes expression at the cell membrane (By similarity).
CC       Detected at axon terminals (By similarity).
CC       {ECO:0000250|UniProtKB:P10499, ECO:0000250|UniProtKB:P16388}.
CC   -!- TISSUE SPECIFICITY: Detected adjacent to nodes of Ranvier in
CC       juxtaparanodal zones in spinal cord nerve fibers, but also in
CC       paranodal regions in some myelinated spinal cord axons (at protein
CC       level) (PubMed:11086297). Detected in the islet of Langerhans
CC       (PubMed:21483673). {ECO:0000269|PubMed:11086297,
CC       ECO:0000269|PubMed:21483673}.
CC   -!- DOMAIN: The cytoplasmic N-terminus is important for
CC       tetramerization and for interaction with the beta subunits that
CC       promote rapid channel closure. {ECO:0000250|UniProtKB:P10499}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:P10499}.
CC   -!- PTM: Palmitoylated on Cys-243; which may be required for membrane
CC       targeting. {ECO:0000269|PubMed:15837928}.
CC   -!- PTM: Phosphorylated on tyrosine residues. Phosphorylation
CC       increases in response to NRG1; this inhibits channel activity (By
CC       similarity). Phosphorylation at Ser-446 regulates channel activity
CC       by down-regulating expression at the cell membrane
CC       (PubMed:23774215). {ECO:0000250|UniProtKB:P16388,
CC       ECO:0000269|PubMed:23774215}.
CC   -!- RNA EDITING: Modified_positions=400 {ECO:0000269|PubMed:12907802};
CC       Note=Partially edited. RNA editing varies from 17% in the caudate
CC       nucleus to 68% in the spinal cord and to 77% in the medulla.;
CC   -!- DISEASE: Episodic ataxia 1 (EA1) [MIM:160120]: An autosomal
CC       dominant disorder characterized by brief episodes of ataxia and
CC       dysarthria. Neurological examination during and between the
CC       attacks demonstrates spontaneous, repetitive discharges in the
CC       distal musculature (myokymia) that arise from peripheral nerve.
CC       Nystagmus is absent. {ECO:0000269|PubMed:10355668,
CC       ECO:0000269|PubMed:11013453, ECO:0000269|PubMed:11026449,
CC       ECO:0000269|PubMed:12077175, ECO:0000269|PubMed:15532032,
CC       ECO:0000269|PubMed:17156368, ECO:0000269|PubMed:7842011,
CC       ECO:0000269|PubMed:8541859, ECO:0000269|PubMed:8845167,
CC       ECO:0000269|PubMed:8871592, ECO:0000269|PubMed:9600245}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Myokymia isolated 1 (MK1) [MIM:160120]: A condition
CC       characterized by spontaneous involuntary contraction of muscle
CC       fiber groups that can be observed as vermiform movement of the
CC       overlying skin. Electromyography typically shows continuous motor
CC       unit activity with spontaneous oligo- and multiplet-discharges of
CC       high intraburst frequency (myokymic discharges). Isolated
CC       spontaneous muscle twitches occur in many persons and have no
CC       grave significance. {ECO:0000269|PubMed:11026449,
CC       ECO:0000269|PubMed:17136396, ECO:0000269|PubMed:19307729,
CC       ECO:0000269|PubMed:19903818}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The delay or D-type current observed in hippocampus
CC       pyramidal neurons is probably mediated by potassium channels
CC       containing KCNA2 plus KCNA1 or other family members. It is
CC       activated at about -50 mV, i.e. below the action potential
CC       threshold, and is characterized by slow inactivation, extremely
CC       slow recovery from inactivation, sensitivity to dendrotoxin (DTX)
CC       and to 4-aminopyridine (4-AP). {ECO:0000305|PubMed:17917103}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.1/KCNA1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L02750; AAA36139.1; -; mRNA.
DR   EMBL; AC006063; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471116; EAW88833.1; -; Genomic_DNA.
DR   EMBL; BC101733; AAI01734.1; -; mRNA.
DR   EMBL; BC112180; AAI12181.1; -; mRNA.
DR   CCDS; CCDS8535.1; -.
DR   PIR; I57680; I57680.
DR   RefSeq; NP_000208.2; NM_000217.2.
DR   UniGene; Hs.416139; -.
DR   PDB; 2AFL; Model; -; A/B/C/D=326-407.
DR   PDBsum; 2AFL; -.
DR   ProteinModelPortal; Q09470; -.
DR   SMR; Q09470; -.
DR   BioGrid; 109939; 7.
DR   CORUM; Q09470; -.
DR   IntAct; Q09470; 13.
DR   MINT; MINT-1900397; -.
DR   STRING; 9606.ENSP00000371985; -.
DR   BindingDB; Q09470; -.
DR   ChEMBL; CHEMBL2309; -.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB06637; Dalfampridine.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB01236; Sevoflurane.
DR   GuidetoPHARMACOLOGY; 538; -.
DR   TCDB; 1.A.1.2.12; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q09470; -.
DR   PhosphoSitePlus; Q09470; -.
DR   SwissPalm; Q09470; -.
DR   BioMuta; KCNA1; -.
DR   DMDM; 223590092; -.
DR   MaxQB; Q09470; -.
DR   PaxDb; Q09470; -.
DR   PeptideAtlas; Q09470; -.
DR   PRIDE; Q09470; -.
DR   Ensembl; ENST00000382545; ENSP00000371985; ENSG00000111262.
DR   GeneID; 3736; -.
DR   KEGG; hsa:3736; -.
DR   UCSC; uc001qnh.4; human.
DR   CTD; 3736; -.
DR   DisGeNET; 3736; -.
DR   EuPathDB; HostDB:ENSG00000111262.4; -.
DR   GeneCards; KCNA1; -.
DR   GeneReviews; KCNA1; -.
DR   HGNC; HGNC:6218; KCNA1.
DR   HPA; CAB022365; -.
DR   MalaCards; KCNA1; -.
DR   MIM; 160120; phenotype.
DR   MIM; 176260; gene.
DR   neXtProt; NX_Q09470; -.
DR   OpenTargets; ENSG00000111262; -.
DR   Orphanet; 37612; Episodic ataxia type 1.
DR   Orphanet; 972; Hereditary continuous muscle fiber activity.
DR   Orphanet; 199326; Isolated autosomal dominant hypomagnesemia, Glaudemans type.
DR   PharmGKB; PA30019; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q09470; -.
DR   KO; K04874; -.
DR   OMA; AHYRQAN; -.
DR   OrthoDB; EOG091G10NU; -.
DR   PhylomeDB; Q09470; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNA1; human.
DR   GeneWiki; Kv1.1; -.
DR   GenomeRNAi; 3736; -.
DR   PRO; PR:Q09470; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111262; -.
DR   CleanEx; HS_KCNA1; -.
DR   ExpressionAtlas; Q09470; baseline and differential.
DR   Genevisible; Q09470; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0043679; C:axon terminus; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; ISS:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0044224; C:juxtaparanode region of axon; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0033270; C:paranode region of axon; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042734; C:presynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0005267; F:potassium channel activity; TAS:ProtInc.
DR   GO; GO:0015079; F:potassium ion transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0010644; P:cell communication by electrical coupling; ISS:UniProtKB.
DR   GO; GO:0034613; P:cellular protein localization; IEA:Ensembl.
DR   GO; GO:0071286; P:cellular response to magnesium ion; ISS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; ISS:UniProtKB.
DR   GO; GO:0050976; P:detection of mechanical stimulus involved in sensory perception of touch; ISS:UniProtKB.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0010960; P:magnesium ion homeostasis; IMP:UniProtKB.
DR   GO; GO:0007405; P:neuroblast proliferation; IEA:Ensembl.
DR   GO; GO:0050905; P:neuromuscular process; IMP:UniProtKB.
DR   GO; GO:0019228; P:neuronal action potential; ISS:UniProtKB.
DR   GO; GO:0023041; P:neuronal signal transduction; ISS:UniProtKB.
DR   GO; GO:1903818; P:positive regulation of voltage-gated potassium channel activity; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:UniProtKB.
DR   GO; GO:0006937; P:regulation of muscle contraction; ISS:UniProtKB.
DR   GO; GO:0001964; P:startle response; IEA:Ensembl.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004048; K_chnl_volt-dep_Kv1.1.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01508; KV11CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Cell projection;
KW   Complete proteome; Cytoplasmic vesicle; Disease mutation;
KW   Endoplasmic reticulum; Glycoprotein; Ion channel; Ion transport;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   RNA editing; Synapse; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    495       Potassium voltage-gated channel subfamily
FT                                A member 1.
FT                                /FTId=PRO_0000053968.
FT   TOPO_DOM      1    164       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    165    186       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    187    220       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    221    242       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    243    253       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    254    274       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    275    287       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    288    308       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    309    323       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    324    345       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    346    359       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    360    371       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    372    379       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    380    386       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    387    415       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    416    495       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION        1    128       Tetramerization domain.
FT                                {ECO:0000250|UniProtKB:P10499}.
FT   REGION      310    323       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       372    377       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       493    495       PDZ-binding. {ECO:0000250}.
FT   MOD_RES      23     23       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10499}.
FT   MOD_RES     322    322       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES     437    437       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10499}.
FT   MOD_RES     439    439       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10499}.
FT   MOD_RES     446    446       Phosphoserine; by PKA.
FT                                {ECO:0000305|PubMed:23774215}.
FT   LIPID       243    243       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:15837928}.
FT   CARBOHYD    207    207       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     174    174       V -> F (in EA1; dbSNP:rs104894349).
FT                                {ECO:0000269|PubMed:7842011,
FT                                ECO:0000269|PubMed:8541859}.
FT                                /FTId=VAR_001508.
FT   VARIANT     177    177       I -> R (in EA1).
FT                                {ECO:0000269|PubMed:9600245}.
FT                                /FTId=VAR_001509.
FT   VARIANT     184    184       F -> C (in EA1; alters voltage dependence
FT                                and kinetics of activation though not of
FT                                C-type inactivation; dbSNP:rs104894357).
FT                                {ECO:0000269|PubMed:8541859,
FT                                ECO:0000269|PubMed:8845167}.
FT                                /FTId=VAR_020830.
FT   VARIANT     204    204       R -> H (in dbSNP:rs2229000).
FT                                /FTId=VAR_020051.
FT   VARIANT     226    226       T -> A (in EA1; dbSNP:rs104894354).
FT                                {ECO:0000269|PubMed:9600245}.
FT                                /FTId=VAR_001510.
FT   VARIANT     226    226       T -> K (in MK1; induces a reduced efflux
FT                                of potassium ions during depolarization
FT                                which results in increased muscle cell
FT                                activity; coexpression studies of the
FT                                mutant protein with the wild-type protein
FT                                produces significantly reduced currents
FT                                suggesting a severe effect of the
FT                                mutation; dbSNP:rs28933383).
FT                                {ECO:0000269|PubMed:17136396}.
FT                                /FTId=VAR_037100.
FT   VARIANT     226    226       T -> M (in EA1; dbSNP:rs28933383).
FT                                {ECO:0000269|PubMed:8871592}.
FT                                /FTId=VAR_020831.
FT   VARIANT     226    226       T -> R (in EA1; yields currents with a
FT                                largely reduced amplitude;
FT                                dbSNP:rs28933383).
FT                                {ECO:0000269|PubMed:10355668}.
FT                                /FTId=VAR_037101.
FT   VARIANT     239    239       R -> S (in EA1; dbSNP:rs104894348).
FT                                {ECO:0000269|PubMed:7842011}.
FT                                /FTId=VAR_001511.
FT   VARIANT     242    242       A -> P (in MK1; 10% reduction of mean
FT                                peak current amplitudes compared to wil-
FT                                dtype; mutant and wild-type expression
FT                                together is consistent with a loss-of-
FT                                function effect of the mutation;
FT                                dbSNP:rs28933381).
FT                                {ECO:0000269|PubMed:11026449}.
FT                                /FTId=VAR_037102.
FT   VARIANT     244    244       P -> H (in MK1; does not affect channel
FT                                activity; dbSNP:rs28933382).
FT                                {ECO:0000269|PubMed:11026449}.
FT                                /FTId=VAR_037103.
FT   VARIANT     249    249       F -> I (in EA1; dbSNP:rs104894356).
FT                                {ECO:0000269|PubMed:7842011}.
FT                                /FTId=VAR_001512.
FT   VARIANT     255    255       N -> D (in MK1; strongly reduces the
FT                                activity of homomeric channels with
FT                                dominant negative effects on wild-type
FT                                channels; dbSNP:rs121918067).
FT                                {ECO:0000269|PubMed:19307729}.
FT                                /FTId=VAR_072397.
FT   VARIANT     325    325       E -> D (in EA1; results in non-functional
FT                                homomeric channels; accelerates recovery
FT                                from N-type inactivation due to
FT                                interaction with KCNAB1; slows down N-
FT                                type inactivation of heteromeric channels
FT                                formed by KCNA1 and KCNA4;
FT                                dbSNP:rs104894353).
FT                                {ECO:0000269|PubMed:12077175,
FT                                ECO:0000269|PubMed:17156368,
FT                                ECO:0000269|PubMed:8541859,
FT                                ECO:0000269|PubMed:8845167}.
FT                                /FTId=VAR_020832.
FT   VARIANT     329    329       L -> I (in EA1).
FT                                {ECO:0000269|PubMed:11013453}.
FT                                /FTId=VAR_020833.
FT   VARIANT     342    342       S -> I (in EA1; phenotype without
FT                                myokymia). {ECO:0000269|PubMed:15532032}.
FT                                /FTId=VAR_020834.
FT   VARIANT     400    400       I -> V (in RNA edited version).
FT                                /FTId=VAR_016805.
FT   VARIANT     404    404       V -> I (in EA1; results in slower channel
FT                                activation compared to wild-type; slows
FT                                down N-type inactivation of heteromeric
FT                                channels formed by KCNA1 and KCNA4;
FT                                dbSNP:rs104894355).
FT                                {ECO:0000269|PubMed:11026449,
FT                                ECO:0000269|PubMed:17156368,
FT                                ECO:0000269|PubMed:9600245}.
FT                                /FTId=VAR_001513.
FT   VARIANT     405    405       P -> L (probable disease-associated
FT                                mutation found in a patient with neonatal
FT                                onset epileptic encephalopathy).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078205.
FT   VARIANT     408    408       V -> A (in EA1; channels have voltage
FT                                dependence similar to that of wild-type
FT                                channels but with faster kinetics and
FT                                increased C-type inactivation;
FT                                accelerates recovery from N-type
FT                                inactivation due to interaction with
FT                                KCNAB1; slows down N-type inactivation of
FT                                heteromeric channels formed by KCNA1 and
FT                                KCNA4; dbSNP:rs104894352).
FT                                {ECO:0000269|PubMed:12077175,
FT                                ECO:0000269|PubMed:17156368,
FT                                ECO:0000269|PubMed:7842011,
FT                                ECO:0000269|PubMed:8845167}.
FT                                /FTId=VAR_001514.
FT   MUTAGEN      35     36       CC->AA: No effect on palmitoylation, no
FT                                effect on current kinetics.
FT                                {ECO:0000269|PubMed:15837928}.
FT   MUTAGEN     177    177       I->N: Slows down N-type inactivation of
FT                                heteromeric channels formed by KCNA1 and
FT                                KCNA4. {ECO:0000269|PubMed:17156368}.
FT   MUTAGEN     243    243       C->A: Strongly decreases palmitoylation
FT                                and alters current kinetics.
FT                                {ECO:0000269|PubMed:15837928}.
FT   MUTAGEN     255    255       N->A,H,T: Slightly increases channel
FT                                activity, but does not affect expression
FT                                at the cell membrane.
FT                                {ECO:0000269|PubMed:19307729}.
FT   MUTAGEN     255    255       N->E: Abolishes channel activity, but
FT                                does not affect expression at the cell
FT                                membrane. {ECO:0000269|PubMed:19307729}.
FT   MUTAGEN     255    255       N->Q: Strongly reduces channel activity,
FT                                but does not affect expression at the
FT                                cell membrane.
FT                                {ECO:0000269|PubMed:19307729}.
FT   MUTAGEN     255    255       N->V: No effect on channel activity.
FT                                {ECO:0000269|PubMed:19307729}.
FT   MUTAGEN     446    446       S->A: Impairs phosphorylation by PKA.
FT                                {ECO:0000269|PubMed:23774215}.
FT   MUTAGEN     446    446       S->E: Impairs expression at the cell
FT                                membrane. {ECO:0000269|PubMed:23774215}.
FT   CONFLICT    265    265       Missing (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    315    315       L -> R (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    452    452       S -> Y (in Ref. 1; AAA36139).
FT                                {ECO:0000305}.
SQ   SEQUENCE   495 AA;  56466 MW;  0A1B1AB87BCDDEBA CRC64;
     MTVMSGENVD EASAAPGHPQ DGSYPRQADH DDHECCERVV INISGLRFET QLKTLAQFPN
     TLLGNPKKRM RYFDPLRNEY FFDRNRPSFD AILYYYQSGG RLRRPVNVPL DMFSEEIKFY
     ELGEEAMEKF REDEGFIKEE ERPLPEKEYQ RQVWLLFEYP ESSGPARVIA IVSVMVILIS
     IVIFCLETLP ELKDDKDFTG TVHRIDNTTV IYNSNIFTDP FFIVETLCII WFSFELVVRF
     FACPSKTDFF KNIMNFIDIV AIIPYFITLG TEIAEQEGNQ KGEQATSLAI LRVIRLVRVF
     RIFKLSRHSK GLQILGQTLK ASMRELGLLI FFLFIGVILF SSAVYFAEAE EAESHFSSIP
     DAFWWAVVSM TTVGYGDMYP VTIGGKIVGS LCAIAGVLTI ALPVPVIVSN FNYFYHRETE
     GEEQAQLLHV SSPNLASDSD LSRRSSSTMS KSEYMEIEED MNNSIAHYRQ VNIRTANCTT
     ANQNCVNKSK LLTDV
//
ID   KCNS2_MOUSE             Reviewed;         477 AA.
AC   O35174; Q543P3;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   22-NOV-2017, entry version 141.
DE   RecName: Full=Potassium voltage-gated channel subfamily S member 2;
DE   AltName: Full=Delayed-rectifier K(+) channel alpha subunit 2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv9.2;
GN   Name=Kcns2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=9305895; DOI=10.1074/jbc.272.39.24371;
RA   Salinas M., Duprat F., Heurteaux C., Hugnot J.-P., Lazdunski M.;
RT   "New modulatory alpha subunits for mammalian Shab K+ channels.";
RL   J. Biol. Chem. 272:24371-24379(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Cerebellum, and Eye;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Can form functional heterotetrameric channels
CC       with KCNB1 and KCNB2; modulates the delayed rectifier voltage-
CC       gated potassium channel activation and deactivation rates of KCNB1
CC       and KCNB2 (PubMed:9305895). {ECO:0000269|PubMed:9305895}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1 and KCNB2 (PubMed:9305895).
CC       Does not form homomultimers (PubMed:9305895).
CC       {ECO:0000269|PubMed:9305895}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9305895};
CC       Multi-pass membrane protein {ECO:0000305}. Note=May not reach the
CC       plasma membrane but remain in an intracellular compartment in the
CC       absence of KCNB1 or KCNB2 (PubMed:9305895).
CC       {ECO:0000269|PubMed:9305895}.
CC   -!- TISSUE SPECIFICITY: Detected in brain, but not in the other
CC       tissues tested. Expression was highest in the olfactory bulb,
CC       cerebral cortex, hippocampus, habenula, basolateral amygdaloid
CC       nuclei and cerebellum (PubMed:9305895).
CC       {ECO:0000269|PubMed:9305895}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. S (TC
CC       1.A.1.2) subfamily. Kv9.2/KCNS2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF008574; AAB72051.1; -; mRNA.
DR   EMBL; AK048819; BAC33468.1; -; mRNA.
DR   EMBL; AK087481; BAC39892.1; -; mRNA.
DR   EMBL; BC059833; AAH59833.1; -; mRNA.
DR   CCDS; CCDS27421.1; -.
DR   RefSeq; NP_001258633.1; NM_001271704.1.
DR   RefSeq; NP_851834.1; NM_181317.4.
DR   UniGene; Mm.487585; -.
DR   UniGene; Mm.71045; -.
DR   ProteinModelPortal; O35174; -.
DR   STRING; 10090.ENSMUSP00000072645; -.
DR   iPTMnet; O35174; -.
DR   PhosphoSitePlus; O35174; -.
DR   PaxDb; O35174; -.
DR   PRIDE; O35174; -.
DR   Ensembl; ENSMUST00000072868; ENSMUSP00000072645; ENSMUSG00000050963.
DR   GeneID; 16539; -.
DR   KEGG; mmu:16539; -.
DR   UCSC; uc007vly.2; mouse.
DR   CTD; 3788; -.
DR   MGI; MGI:1197011; Kcns2.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; O35174; -.
DR   KO; K04932; -.
DR   OMA; VGGFKKK; -.
DR   OrthoDB; EOG091G0FP3; -.
DR   PhylomeDB; O35174; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-MMU-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; Kcns2; mouse.
DR   PRO; PR:O35174; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   Bgee; ENSMUSG00000050963; -.
DR   CleanEx; MM_KCNS2; -.
DR   Genevisible; O35174; MM.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    477       Potassium voltage-gated channel subfamily
FT                                S member 2.
FT                                /FTId=PRO_0000054085.
FT   TOPO_DOM      1    184       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    185    206       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    207    225       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    226    248       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    249    259       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    260    280       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    281    290       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    291    311       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    312    326       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    327    348       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    349    361       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    362    373       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    374    381       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    382    388       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    389    417       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    418    477       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       374    379       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
SQ   SEQUENCE   477 AA;  54289 MW;  C7AD7AA3AE312B2C CRC64;
     MTRQSLWDVS DTDVEDGEIR INVGGFKRRL RSHTLLRFPE TRLGRLLLCH SREAILELCD
     DYDDVQREFY FDRNPELFPY VLHFYHTGKL HVMAELCVFS FSQEIEYWGI NEFFIDSCCS
     YSYHGRKVEP EQEKWDEQSD QESTTSSFDE ILAFYNDASK FDGQPLGNFR RQLWLALDNP
     GYSVLSRVFS VLSILVVLGS IITMCLNSLP DFQIPDSQGN PGEDPRFEIV EHFGIAWFTF
     ELVARFAVAP DFLKFFKNAL NLIDLMSIVP FYITLVVNLV VESSPTLANL GRVAQVLRLM
     RIFRILKLAR HSTGLRSLGA TLKYSYKEVG LLLLYLSVGI SIFSVVAYTI EKEENEGLAT
     IPACWWWATV SMTTVGYGDV VPGTTAGKLT ASACILAGIL VVVLPITLIF NKFSHFYRRQ
     KQLESAMRSC DFGDGMKEVP SVNLRDYYAH KVKSLMASLT NMSRSSPSEL SLDDSLH
//
ID   KCNV2_HUMAN             Reviewed;         545 AA.
AC   Q8TDN2; Q5T6X0;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   20-DEC-2017, entry version 140.
DE   RecName: Full=Potassium voltage-gated channel subfamily V member 2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv8.2;
GN   Name=KCNV2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBUNIT, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=12060745; DOI=10.1073/pnas.122617999;
RA   Ottschytsch N., Raes A., Van Hoorick D., Snyders D.J.;
RT   "Obligatory heterotetramerization of three previously uncharacterized
RT   Kv channel alpha-subunits identified in the human genome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7986-7991(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   VARIANTS RCD3B GLN-126; CYS-188; TRP-256; VAL-259; 339-ASP--VAL-341
RP   DEL AND ASP-459, AND VARIANT VAL-533.
RX   PubMed=16909397; DOI=10.1086/507568;
RA   Wu H., Cowing J.A., Michaelides M., Wilkie S.E., Jeffery G.,
RA   Jenkins S.A., Mester V., Bird A.C., Robson A.G., Holder G.E.,
RA   Moore A.T., Hunt D.M., Webster A.R.;
RT   "Mutations in the gene KCNV2 encoding a voltage-gated potassium
RT   channel subunit cause 'cone dystrophy with supernormal rod
RT   electroretinogram' in humans.";
RL   Am. J. Hum. Genet. 79:574-579(2006).
CC   -!- FUNCTION: Potassium channel subunit. Modulates channel activity by
CC       shifting the threshold and the half-maximal activation to more
CC       negative values.
CC   -!- SUBUNIT: Heteromultimer with KCNB1, KCNC1 and KCNF1. Does not form
CC       homomultimers. {ECO:0000269|PubMed:12060745}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Note=Has to be associated with KCNB1 or possibly another partner
CC       to get inserted in the plasma membrane. Remains intracellular in
CC       the absence of KCNB1.
CC   -!- TISSUE SPECIFICITY: Detected in lung, liver, kidney, pancreas,
CC       spleen, thymus, prostate, testis, ovary and colon.
CC       {ECO:0000269|PubMed:12060745}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- DISEASE: Cone dystrophy retinal 3B (RCD3B) [MIM:610356]: A rare
CC       form of cone dystrophy associated with supernormal rod responses.
CC       The disorder is characterized by reduced visual acuity,
CC       photoaversion, night blindness, and abnormal color vision. At an
CC       early age, the retina shows subtle depigmentation at the macula
CC       and, later, more obvious areas of atrophy.
CC       {ECO:0000269|PubMed:16909397}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. V (TC
CC       1.A.1.2) subfamily. Kv8.2/KCNV2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF348983; AAL83910.1; -; mRNA.
DR   EMBL; AL354723; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC101352; AAI01353.1; -; mRNA.
DR   EMBL; BC101353; AAI01354.1; -; mRNA.
DR   CCDS; CCDS6447.1; -.
DR   RefSeq; NP_598004.1; NM_133497.3.
DR   UniGene; Hs.622675; -.
DR   UniGene; Hs.624689; -.
DR   UniGene; Hs.740173; -.
DR   ProteinModelPortal; Q8TDN2; -.
DR   BioGrid; 127982; 6.
DR   IntAct; Q8TDN2; 1.
DR   STRING; 9606.ENSP00000371514; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   iPTMnet; Q8TDN2; -.
DR   PhosphoSitePlus; Q8TDN2; -.
DR   BioMuta; KCNV2; -.
DR   DMDM; 26006804; -.
DR   PaxDb; Q8TDN2; -.
DR   PeptideAtlas; Q8TDN2; -.
DR   PRIDE; Q8TDN2; -.
DR   Ensembl; ENST00000382082; ENSP00000371514; ENSG00000168263.
DR   GeneID; 169522; -.
DR   KEGG; hsa:169522; -.
DR   UCSC; uc003zho.3; human.
DR   CTD; 169522; -.
DR   DisGeNET; 169522; -.
DR   EuPathDB; HostDB:ENSG00000168263.8; -.
DR   GeneCards; KCNV2; -.
DR   H-InvDB; HIX0035118; -.
DR   HGNC; HGNC:19698; KCNV2.
DR   HPA; HPA031131; -.
DR   MalaCards; KCNV2; -.
DR   MIM; 607604; gene.
DR   MIM; 610356; phenotype.
DR   neXtProt; NX_Q8TDN2; -.
DR   OpenTargets; ENSG00000168263; -.
DR   Orphanet; 209932; Cone dystrophy with supernormal rod response.
DR   PharmGKB; PA134992655; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG095321; -.
DR   InParanoid; Q8TDN2; -.
DR   KO; K04935; -.
DR   OMA; SIPHAWW; -.
DR   OrthoDB; EOG091G0FP3; -.
DR   PhylomeDB; Q8TDN2; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNV2; -.
DR   GenomeRNAi; 169522; -.
DR   PRO; PR:Q8TDN2; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000168263; -.
DR   CleanEx; HS_KCNV2; -.
DR   Genevisible; Q8TDN2; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Cone-rod dystrophy;
KW   Disease mutation; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Polymorphism; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    545       Potassium voltage-gated channel subfamily
FT                                V member 2.
FT                                /FTId=PRO_0000054094.
FT   TOPO_DOM      1    155       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    156    176       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    177    261       Extracellular. {ECO:0000255}.
FT   TRANSMEM    262    282       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    283    336       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    337    357       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    358    374       Extracellular. {ECO:0000255}.
FT   TRANSMEM    375    395       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    396    410       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    411    431       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    432    444       Extracellular. {ECO:0000255}.
FT   INTRAMEM    445    465       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    466    471       Extracellular. {ECO:0000255}.
FT   TRANSMEM    472    492       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    493    545       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       457    462       Selectivity filter. {ECO:0000250}.
FT   CARBOHYD    440    440       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     126    126       L -> Q (in RCD3B; dbSNP:rs776275880).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027632.
FT   VARIANT     188    188       W -> C (in RCD3B; dbSNP:rs772921412).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027633.
FT   VARIANT     256    256       S -> W (in RCD3B; dbSNP:rs104894116).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027634.
FT   VARIANT     259    259       A -> V (in RCD3B).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027635.
FT   VARIANT     339    341       Missing (in RCD3B).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027636.
FT   VARIANT     459    459       G -> D (in RCD3B; dbSNP:rs104894115).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027637.
FT   VARIANT     533    533       L -> V (in dbSNP:rs12352254).
FT                                {ECO:0000269|PubMed:16909397}.
FT                                /FTId=VAR_027638.
SQ   SEQUENCE   545 AA;  62459 MW;  72D175B4C0C6B1DA CRC64;
     MLKQSERRRS WSYRPWNTTE NEGSQHRRSI CSLGARSGSQ ASIHGWTEGN YNYYIEEDED
     GEEEDQWKDD LAEEDQQAGE VTTAKPEGPS DPPALLSTLN VNVGGHSYQL DYCELAGFPK
     TRLGRLATST SRSRQLSLCD DYEEQTDEYF FDRDPAVFQL VYNFYLSGVL LVLDGLCPRR
     FLEELGYWGV RLKYTPRCCR ICFEERRDEL SERLKIQHEL RAQAQVEEAE ELFRDMRFYG
     PQRRRLWNLM EKPFSSVAAK AIGVASSTFV LVSVVALALN TVEEMQQHSG QGEGGPDLRP
     ILEHVEMLCM GFFTLEYLLR LASTPDLRRF ARSALNLVDL VAILPLYLQL LLECFTGEGH
     QRGQTVGSVG KVGQVLRVMR LMRIFRILKL ARHSTGLRAF GFTLRQCYQQ VGCLLLFIAM
     GIFTFSAAVY SVEHDVPSTN FTTIPHSWWW AAVSISTVGY GDMYPETHLG RFFAFLCIAF
     GIILNGMPIS ILYNKFSDYY SKLKAYEYTT IRRERGEVNF MQRARKKIAE CLLGSNPQLT
     PRQEN
//
ID   KCNAG_CAEEL             Reviewed;         558 AA.
AC   G5EFC3; O17535;
DT   09-JAN-2013, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 1.
DT   22-NOV-2017, entry version 55.
DE   RecName: Full=Potassium voltage-gated channel protein egl-36 {ECO:0000303|PubMed:9247272};
DE   AltName: Full=Egg-laying defective protein 36 {ECO:0000303|PubMed:9247272, ECO:0000312|EMBL:CAA91765.1};
GN   Name=egl-36 {ECO:0000312|EMBL:CAA91765.1,
GN   ECO:0000312|WormBase:R07A4.1}; ORFNames=R07A4.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000312|EMBL:CAA91765.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|EMBL:CAA91765.1};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAB95119.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-558, FUNCTION, TISSUE SPECIFICITY,
RP   DISRUPTION PHENOTYPE, AND MUTAGENESIS OF GLU-142; GLY-408; SER-424 AND
RP   PRO-439.
RX   PubMed=9247271; DOI=10.1016/S0896-6273(00)80355-4;
RA   Johnstone D.B., Wei A., Butler A., Salkoff L., Thomas J.H.;
RT   "Behavioral defects in C. elegans egl-36 mutants result from potassium
RT   channels shifted in voltage-dependence of activation.";
RL   Neuron 19:151-164(1997).
RN   [3] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF
RP   GLU-142; ALA-435 AND PRO-439.
RX   PubMed=9247272; DOI=10.1016/S0896-6273(00)80356-6;
RA   Elkes D.A., Cardozo D.L., Madison J., Kaplan J.M.;
RT   "EGL-36 Shaw channels regulate C. elegans egg-laying muscle
RT   activity.";
RL   Neuron 19:165-174(1997).
CC   -!- FUNCTION: Voltage-dependent potassium channel involved in the
CC       excitation of muscles operating egg-laying and defecation.
CC       {ECO:0000269|PubMed:9247271, ECO:0000269|PubMed:9247272}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P08510};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P08510}.
CC   -!- TISSUE SPECIFICITY: Expressed in muscles for egg-laying, anal
CC       depressor and sphincter, and the four most anterior head muscles.
CC       Found in neurons including enteric motor neurons AVL and DVB and
CC       the sensory neuron PHB, the spermatheca, and the distal tip cells
CC       of the somatic gonad. {ECO:0000269|PubMed:9247271,
CC       ECO:0000269|PubMed:9247272}.
CC   -!- DISRUPTION PHENOTYPE: Egg-laying defects; retain many more eggs in
CC       utero, laid eggs appear later in development. Moderately defective
CC       in generating the expulsion step of defecation. Hyperpolarizing
CC       shifts in the voltage dependence of channel activation.
CC       {ECO:0000269|PubMed:9247271, ECO:0000269|PubMed:9247272}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw) (TC
CC       1.A.1.2) subfamily. Shaw sub-subfamily. {ECO:0000255}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z67756; CAA91765.1; -; Genomic_DNA.
DR   EMBL; Z68010; CAA91765.1; JOINED; Genomic_DNA.
DR   EMBL; AF005246; AAB95119.1; -; mRNA.
DR   PIR; T23991; T23991.
DR   RefSeq; NP_509795.1; NM_077394.3.
DR   UniGene; Cel.580; -.
DR   ProteinModelPortal; G5EFC3; -.
DR   STRING; 6239.R07A4.1; -.
DR   PaxDb; G5EFC3; -.
DR   EnsemblMetazoa; R07A4.1; R07A4.1; WBGene00001202.
DR   GeneID; 181269; -.
DR   KEGG; cel:CELE_R07A4.1; -.
DR   UCSC; R07A4.1; c. elegans.
DR   CTD; 181269; -.
DR   WormBase; R07A4.1; CE18123; WBGene00001202; egl-36.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   InParanoid; G5EFC3; -.
DR   OMA; GFWGIDE; -.
DR   OrthoDB; EOG091G0EJL; -.
DR   PhylomeDB; G5EFC3; -.
DR   Reactome; R-CEL-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   PRO; PR:G5EFC3; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00001202; -.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IDA:WormBase.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0034220; P:ion transmembrane transport; IDA:WormBase.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 2.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    558       Potassium voltage-gated channel protein
FT                                egl-36.
FT                                /FTId=PRO_0000420622.
FT   TRANSMEM    203    223       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    258    278       Helical; Name=Segment S2. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    358    378       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TRANSMEM    390    410       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    422    442       Helical; Name=Segment S6. {ECO:0000255}.
FT   MUTAGEN     142    142       E->K: Channels open at more negative
FT                                voltages than wild-type and single
FT                                mutants; when associated with S-439.
FT                                {ECO:0000269|PubMed:9247271,
FT                                ECO:0000269|PubMed:9247272}.
FT   MUTAGEN     142    142       E->K: In n728; Channels open at more
FT                                negative voltages than wild-type.
FT                                {ECO:0000269|PubMed:9247271,
FT                                ECO:0000269|PubMed:9247272}.
FT   MUTAGEN     408    408       G->E: In sa630; Premature egg laying with
FT                                fewer eggs retained.
FT                                {ECO:0000269|PubMed:9247271}.
FT   MUTAGEN     424    424       S->L: In sa631: Reduced egg laying.
FT                                {ECO:0000269|PubMed:9247271}.
FT   MUTAGEN     435    435       A->T: Restores egg-laying activity to
FT                                n728 mutants.
FT                                {ECO:0000269|PubMed:9247272}.
FT   MUTAGEN     439    439       P->S: Channels open at more negative
FT                                voltages than wild-type; when associated
FT                                with K-142. {ECO:0000269|PubMed:9247271,
FT                                ECO:0000269|PubMed:9247272}.
FT   MUTAGEN     439    439       P->S: In n2332; Channels open at more
FT                                negative voltages than wild-type and
FT                                increase in the rate of activation.
FT                                {ECO:0000269|PubMed:9247271,
FT                                ECO:0000269|PubMed:9247272}.
FT   CONFLICT    520    520       H -> D (in Ref. 2; AAB95119).
FT                                {ECO:0000305|PubMed:9247271}.
SQ   SEQUENCE   558 AA;  63640 MW;  B8610A559EEE28F3 CRC64;
     MLDACSFNRF DSNRSSARRF SRRGSDYFGD KGISMDERIV LNVGGVRHET YQATLKKIPA
     TRLSRLTPSL ANFDPLLNEY FFDRHPAVFA MILNYYRTGK LHYPTDVCGP LFEEELQYWG
     LDASDTEPCC WMQLLHAKDT QETLAVLDRM DADHEDDPQL REQDTMKKFG WEEDYFQGKR
     TRWMKLKPQM WSLFDEPYSS QAAKLIAGIS VLFIFISIFS FCLKTHQSFR LPVLIGQNIT
     MPGGVVQPSI ERVSTEPLPI FGQIEMLCNI WFTLELIIRF VFCPSKIRFF KSPLNMIDLV
     ATLSFYADAM MVRVVEDEPK DVVEFLSMIR IFRLFKLTQH HQGLQILIHT FRASAKELIL
     LVFFLILGIV IFAALVYYAE KMEANPNNQF QSIPLGLWWA ICTMTTVGYG DMTPHTSFGR
     LVGSLCAVMG VLTIALPVPV IVSNFAMFYS HNQARDKLPK RRRRVLPVEQ IRLQARRHAA
     VLEPSASQGG LGGGQAIRRR NMPILIDQNC CDEENHNHKH REKSENSDEG TNSSSTTGVD
     TVVKLGPSET AITTTIIS
//
ID   KAT4_ORYSJ              Reviewed;         591 AA.
AC   Q652U9;
DT   28-JUN-2011, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 2.
DT   20-DEC-2017, entry version 86.
DE   RecName: Full=Potassium channel KAT4;
GN   OrderedLocusNames=Os06g0254200, LOC_Os06g14310;
GN   ORFNames=P0046H10.36, P0592E11.6;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
CC   -!- FUNCTION: Probable inward-rectifying potassium channel. Assuming
CC       opened or closed conformations in response to the voltage
CC       difference across the membrane, the channel is activated by
CC       hyperpolarization (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD45227.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAD46168.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP003490; BAD45227.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AP005518; BAD46168.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AP014962; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; Q652U9; -.
DR   STRING; 39947.LOC_Os06g14310.1; -.
DR   PaxDb; Q652U9; -.
DR   PRIDE; Q652U9; -.
DR   EnsemblPlants; OS06T0254200-00; OS06T0254200-00; OS06G0254200.
DR   Gramene; OS06T0254200-00; OS06T0254200-00; OS06G0254200.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   InParanoid; Q652U9; -.
DR   OrthoDB; EOG093605FF; -.
DR   Proteomes; UP000059680; Chromosome 6.
DR   ExpressionAtlas; Q652U9; differential.
DR   Genevisible; Q652U9; OS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    591       Potassium channel KAT4.
FT                                /FTId=PRO_0000410880.
FT   TOPO_DOM      1     32       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     33     53       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     54     63       Extracellular. {ECO:0000255}.
FT   TRANSMEM     64     84       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM     85    109       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    110    130       Helical; Name=Segment S3. {ECO:0000250}.
FT   TOPO_DOM    131    137       Extracellular. {ECO:0000255}.
FT   TRANSMEM    138    158       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    159    172       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    173    193       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    194    220       Extracellular. {ECO:0000255}.
FT   INTRAMEM    221    240       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    241    246       Extracellular. {ECO:0000255}.
FT   TRANSMEM    247    267       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    268    591       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      521    591       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     349    469       cNMP.
SQ   SEQUENCE   591 AA;  67394 MW;  D8A142974428D5FC CRC64;
     MAARSELLRP AFGEASPSLG RFVINPHSCS YRWWHMFLIM LVLYSAWASP FELSMEKAAS
     IALVVTDLVV DVFFAIDIAL SFFVAYRDTS TGLLITDRRK ITMRYLKRPC FALDVASTIP
     LQIIYQLVTG KRQGLWGLLN LLRLWRLRRV SKLFARVEKD IRFNYLWTRL IKLLCVTLFA
     LHFAACIYLW MAFNYKIKEL TWIGSQIHSF EDRSVWFCYT CAVYWSITTL ATVGYGDLHA
     TNIGEMLFSI AFMLFNMGLT SYIIGNITNL VVRETSNTFK MRDMVQRVSE FGRMNRLPEA
     MREQMLASVQ LRFRTDEQLQ QEMLSELPKA VRSGVMKHMF KSAIESCYLF QGVSDSLIVQ
     LVAEMKAEFF PPKANVILEN ETSTDCYIII SGEVEALTTL ADGTEKHVKR IGPRGMAGEI
     GVMFSIPQPF TIRSRRLTQV VRISHIHLLQ AVRPNTADGY IVFSNFIQYL ESLKVQTKDV
     AFVSDHLWNG NSMVLRRATE VAVDESKEAA HKMLPCKEPK RVVIHEQLPN ATSTALHPSP
     GKLVLLPDSM QELMKLSEKK FGKAVRGILT VEGAEVEDIE VIRDGDHLLF S
//
ID   KCNA2_MOUSE             Reviewed;         499 AA.
AC   P63141; B2RS05; P15386; Q02010; Q8C8W4;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 1.
DT   22-NOV-2017, entry version 144.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 2;
DE   AltName: Full=MK2 {ECO:0000303|PubMed:16141072};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.2;
GN   Name=Kcna2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2305265; DOI=10.1126/science.2305265;
RA   Chandy K.G., Williams C.B., Spencer R.H., Aguilar B.A., Ghanshani S.,
RA   Tempel B.L., Gutman G.A.;
RT   "A family of three mouse potassium channel genes with intronless
RT   coding regions.";
RL   Science 247:973-975(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Retina;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000312|EMBL:AAI38651.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 338-394.
RX   PubMed=1691985; DOI=10.1016/0014-5793(90)80719-Y;
RA   Betsholtz C., Baumann A., Kenna S., Ashcroft F.M., Ashcroft S.J.H.,
RA   Berggren P.-O., Grupe A., Pongs O., Rorsman P., Sandblom J., Welsh M.;
RT   "Expression of voltage-gated K+ channels in insulin-producing cells.
RT   Analysis by polymerase chain reaction.";
RL   FEBS Lett. 263:121-126(1990).
RN   [6]
RP   SUBUNIT, INTERACTION WITH KCNA1, TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=8361541; DOI=10.1038/365075a0;
RA   Wang H., Kunkel D.D., Martin T.M., Schwartzkroin P.A., Tempel B.L.;
RT   "Heteromultimeric K+ channels in terminal and juxtaparanodal regions
RT   of neurons.";
RL   Nature 365:75-79(1993).
RN   [7]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=8046438;
RA   Wang H., Kunkel D.D., Schwartzkroin P.A., Tempel B.L.;
RT   "Localization of Kv1.1 and Kv1.2, two K channel proteins, to synaptic
RT   terminals, somata, and dendrites in the mouse brain.";
RL   J. Neurosci. 14:4588-4599(1994).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH RHOA.
RX   PubMed=9635436; DOI=10.1016/S0092-8674(00)81212-X;
RA   Cachero T.G., Morielli A.D., Peralta E.G.;
RT   "The small GTP-binding protein RhoA regulates a delayed rectifier
RT   potassium channel.";
RL   Cell 93:1077-1085(1998).
RN   [9]
RP   INTERACTION WITH KCNA5, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9852577;
RA   Sobko A., Peretz A., Shirihai O., Etkin S., Cherepanova V., Dagan D.,
RA   Attali B.;
RT   "Heteromultimeric delayed-rectifier K+ channels in Schwann cells:
RT   developmental expression and role in cell proliferation.";
RL   J. Neurosci. 18:10398-10408(1998).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND ENZYME REGULATION.
RX   PubMed=12527813; DOI=10.1124/mol.63.2.409;
RA   Castle N.A., London D.O., Creech C., Fajloun Z., Stocker J.W.,
RA   Sabatier J.-M.;
RT   "Maurotoxin: a potent inhibitor of intermediate conductance Ca2+-
RT   activated potassium channels.";
RL   Mol. Pharmacol. 63:409-418(2003).
RN   [11]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=17925011; DOI=10.1186/1741-7007-5-42;
RA   Douglas C.L., Vyazovskiy V., Southard T., Chiu S.-Y., Messing A.,
RA   Tononi G., Cirelli C.;
RT   "Sleep in Kcna2 knockout mice.";
RL   BMC Biol. 5:42-42(2007).
RN   [12]
RP   DISRUPTION PHENOTYPE, FUNCTION, DEVELOPMENTAL STAGE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=17634333; DOI=10.1152/jn.00640.2006;
RA   Brew H.M., Gittelman J.X., Silverstein R.S., Hanks T.D., Demas V.P.,
RA   Robinson L.C., Robbins C.A., McKee-Johnson J., Chiu S.Y., Messing A.,
RA   Tempel B.L.;
RT   "Seizures and reduced life span in mice lacking the potassium channel
RT   subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in
RT   auditory neurons.";
RL   J. Neurophysiol. 98:1501-1525(2007).
RN   [13]
RP   REVIEW.
RX   PubMed=17917103; DOI=10.1007/s12035-007-8001-0;
RA   Baranauskas G.;
RT   "Ionic channel function in action potential generation: current
RT   perspective.";
RL   Mol. Neurobiol. 35:129-150(2007).
RN   [14]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18509034; DOI=10.1523/JNEUROSCI.4431-07.2008;
RA   Ogawa Y., Horresh I., Trimmer J.S., Bredt D.S., Peles E.,
RA   Rasband M.N.;
RT   "Postsynaptic density-93 clusters Kv1 channels at axon initial
RT   segments independently of Caspr2.";
RL   J. Neurosci. 28:5731-5739(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-429, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=18034455; DOI=10.1021/pr0701254;
RA   Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.;
RT   "Large-scale identification and evolution indexing of tyrosine
RT   phosphorylation sites from murine brain.";
RL   J. Proteome Res. 7:311-318(2008).
RN   [16]
RP   TISSUE SPECIFICITY.
RX   PubMed=18760366; DOI=10.1016/j.mcn.2008.07.025;
RA   Savvaki M., Panagiotaropoulos T., Stamatakis A., Sargiannidou I.,
RA   Karatzioula P., Watanabe K., Stylianopoulou F., Karagogeos D.,
RA   Kleopa K.A.;
RT   "Impairment of learning and memory in TAG-1 deficient mice associated
RT   with shorter CNS internodes and disrupted juxtaparanodes.";
RL   Mol. Cell. Neurosci. 39:478-490(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434; SER-440 AND
RP   SER-468, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [18]
RP   FUNCTION, MUTAGENESIS OF ILE-402, SUBCELLULAR LOCATION, MISCELLANEOUS,
RP   TISSUE SPECIFICITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=20696761; DOI=10.1074/jbc.M110.153676;
RA   Xie G., Harrison J., Clapcote S.J., Huang Y., Zhang J.Y., Wang L.Y.,
RA   Roder J.C.;
RT   "A new Kv1.2 channelopathy underlying cerebellar ataxia.";
RL   J. Biol. Chem. 285:32160-32173(2010).
RN   [19]
RP   FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND INTERACTION
RP   WITH DRD2.
RX   PubMed=21233214; DOI=10.1074/jbc.M110.153262;
RA   Fulton S., Thibault D., Mendez J.A., Lahaie N., Tirotta E.,
RA   Borrelli E., Bouvier M., Tempel B.L., Trudeau L.E.;
RT   "Contribution of Kv1.2 voltage-gated potassium channel to D2
RT   autoreceptor regulation of axonal dopamine overflow.";
RL   J. Biol. Chem. 286:9360-9372(2011).
RN   [20]
RP   TISSUE SPECIFICITY.
RX   PubMed=22649228; DOI=10.1523/JNEUROSCI.0719-12.2012;
RA   Zenker J., Poirot O., de Preux Charles A.S., Arnaud E., Medard J.J.,
RA   Lacroix C., Kuntzer T., Chrast R.;
RT   "Altered distribution of juxtaparanodal kv1.2 subunits mediates
RT   peripheral nerve hyperexcitability in type 2 diabetes mellitus.";
RL   J. Neurosci. 32:7493-7498(2012).
RN   [21]
RP   INTERACTION WITH SIGMAR1, AND SUBCELLULAR LOCATION.
RX   PubMed=23332758; DOI=10.1016/j.cell.2012.12.004;
RA   Kourrich S., Hayashi T., Chuang J.Y., Tsai S.Y., Su T.P., Bonci A.;
RT   "Dynamic interaction between sigma-1 receptor and Kv1.2 shapes
RT   neuronal and behavioral responses to cocaine.";
RL   Cell 152:236-247(2013).
RN   [22]
RP   DISRUPTION PHENOTYPE, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=23864368; DOI=10.1152/jn.00290.2013;
RA   Wang W., Kim H.J., Lv P., Tempel B., Yamoah E.N.;
RT   "Association of the Kv1 family of K+ channels and their functional
RT   blueprint in the properties of auditory neurons as revealed by genetic
RT   and functional analyses.";
RL   J. Neurophysiol. 110:1751-1764(2013).
RN   [23]
RP   FUNCTION.
RX   PubMed=23981714; DOI=10.1113/jphysiol.2013.259002;
RA   Hyun J.H., Eom K., Lee K.H., Ho W.K., Lee S.H.;
RT   "Activity-dependent downregulation of D-type K+ channel subunit Kv1.2
RT   in rat hippocampal CA3 pyramidal neurons.";
RL   J. Physiol. (Lond.) 591:5525-5540(2013).
RN   [24]
RP   SUBCELLULAR LOCATION.
RX   PubMed=25378149; DOI=10.1523/JNEUROSCI.3369-14.2014;
RA   Gordon A., Adamsky K., Vainshtein A., Frechter S., Dupree J.L.,
RA   Rosenbluth J., Peles E.;
RT   "Caspr and caspr2 are required for both radial and longitudinal
RT   organization of myelinated axons.";
RL   J. Neurosci. 34:14820-14826(2014).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes,
CC       primarily in the brain and the central nervous system, but also in
CC       the cardiovascular system. Prevents aberrant action potential
CC       firing and regulates neuronal output. Forms tetrameric potassium-
CC       selective channels through which potassium ions pass in accordance
CC       with their electrochemical gradient. The channel alternates
CC       between opened and closed conformations in response to the voltage
CC       difference across the membrane (PubMed:12527813, PubMed:21233214).
CC       Can form functional homotetrameric channels and heterotetrameric
CC       channels that contain variable proportions of KCNA1, KCNA2, KCNA4,
CC       KCNA5, KCNA6, KCNA7, and possibly other family members as well;
CC       channel properties depend on the type of alpha subunits that are
CC       part of the channel (PubMed:20696761). Channel properties are
CC       modulated by cytoplasmic beta subunits that regulate the
CC       subcellular location of the alpha subunits and promote rapid
CC       inactivation of delayed rectifier potassium channels (By
CC       similarity). In vivo, membranes probably contain a mixture of
CC       heteromeric potassium channel complexes, making it difficult to
CC       assign currents observed in intact tissues to any particular
CC       potassium channel family member. Homotetrameric KCNA2 forms a
CC       delayed-rectifier potassium channel that opens in response to
CC       membrane depolarization, followed by slow spontaneous channel
CC       closure (PubMed:23864368). In contrast, a heteromultimer formed by
CC       KCNA2 and KCNA4 shows rapid inactivation (PubMed:23864368).
CC       Contributes to the regulation of action potentials in neurons
CC       (PubMed:12527813, PubMed:17925011). KCNA2-containing channels play
CC       a presynaptic role and prevent hyperexcitability and aberrant
CC       action potential firing (PubMed:17634333, PubMed:17925011).
CC       Response to toxins that are selective for KCNA1, respectively for
CC       KCNA2, suggests that heteromeric potassium channels composed of
CC       both KCNA1 and KCNA2 play a role in pacemaking and regulate the
CC       output of deep cerebellar nuclear neurons (By similarity).
CC       Response to toxins that are selective for KCNA2-containing
CC       potassium channels suggests that in Purkinje cells, dendritic
CC       subthreshold KCNA2-containing potassium channels prevent random
CC       spontaneous calcium spikes, suppressing dendritic
CC       hyperexcitability without hindering the generation of somatic
CC       action potentials, and thereby play an important role in motor
CC       coordination (By similarity). KCNA2-containing channels play a
CC       role in GABAergic transmission from basket cells to Purkinje cells
CC       in the cerebellum, and thereby play an import role in motor
CC       coordination (PubMed:20696761). Plays a role in the induction of
CC       long-term potentiation of neuron excitability in the CA3 layer of
CC       the hippocampus (PubMed:23981714). May function as down-stream
CC       effector for G protein-coupled receptors and inhibit GABAergic
CC       inputs to basolateral amygdala neurons (By similarity). May
CC       contribute to the regulation of neurotransmitter release, such as
CC       gamma-aminobutyric acid (GABA) (By similarity). Contributes to the
CC       regulation of the axonal release of the neurotransmitter dopamine
CC       (PubMed:21233214). Reduced KCNA2 expression plays a role in the
CC       perception of neuropathic pain after peripheral nerve injury, but
CC       not acute pain (By similarity). Plays a role in the regulation of
CC       the time spent in non-rapid eye movement (NREM) sleep
CC       (PubMed:17925011). {ECO:0000250, ECO:0000269|PubMed:12527813,
CC       ECO:0000269|PubMed:17634333, ECO:0000269|PubMed:17925011,
CC       ECO:0000269|PubMed:20696761, ECO:0000269|PubMed:21233214,
CC       ECO:0000269|PubMed:23864368, ECO:0000269|PubMed:23981714,
CC       ECO:0000305}.
CC   -!- ENZYME REGULATION: Inhibited by 4-aminopyridine (4-AP),
CC       dendrotoxin (DTX) and charybdotoxin (CTX), but not by
CC       tetraethylammonium (TEA) (By similarity). Inhibited by
CC       tityustoxin-K alpha (TsTX-Kalpha), a toxin that is highly specific
CC       for KCNA2 (By similarity). Inhibited by maurotoxin
CC       (PubMed:12527813). Inhibited by kappaM conotoxins kappaM-RIIIJ and
CC       kappaM-RIIIK (By similarity). {ECO:0000250|UniProtKB:P16389,
CC       ECO:0000250|UniProtKB:P63142, ECO:0000269|PubMed:12527813}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Homotetrameric channels activate rapidly, i.e within a few
CC         msec, but inactivation is very slow, with only a marginal
CC         decrease in conductance over several seconds. The voltage-
CC         dependence of activation and inactivation and other channel
CC         characteristics vary depending on the experimental conditions,
CC         the expression system, post-translational modifications and the
CC         presence or absence of ancillary subunits. For the activation of
CC         homotetrameric channels expressed in Chinese hamster ovary (CHO)
CC         cells, the voltage at half-maximal amplitude is about -37 mV.
CC         {ECO:0000269|PubMed:20696761};
CC   -!- SUBUNIT: Homotetramer and heterotetramer with other channel-
CC       forming alpha subunits, such as KCNA1, KCNA4, KCNA5, KCNA6 and
CC       KCNA7 (PubMed:8361541, PubMed:9852577, PubMed:23864368). Channel
CC       activity is regulated by interaction with beta subunits, including
CC       KCNAB1 and KCNAB2 (By similarity). Identified in a complex with
CC       KCNA1 and KCNAB2 (By similarity). Identified in a complex with
CC       KCNA5 and KCNAB1 (By similarity). Identified in a complex with
CC       KCNA4 and FYN (By similarity). Interacts with PTK2B (By
CC       similarity). Interacts (via C-terminus) with CTTN (By similarity).
CC       Interacts with ADAM22 (By similarity). Interacts with CNTNAP2 (By
CC       similarity). Interacts (via C-terminus) with the PDZ domains of
CC       DLG1, DLG2 and DLG4 (By similarity). Interacts (via N-terminal
CC       cytoplasmic domain) with RHOA (GTP-bound form); this regulates
CC       channel activity by reducing location at the cell surface in
CC       response to CHRM1 activation (PubMed:9635436). Interacts with DRD2
CC       (PubMed:21233214). Interacts with SIGMAR1; cocaine consumption
CC       leads to increased interaction (PubMed:23332758).
CC       {ECO:0000250|UniProtKB:P16389, ECO:0000250|UniProtKB:P63142,
CC       ECO:0000250|UniProtKB:Q09081, ECO:0000269|PubMed:17634333,
CC       ECO:0000269|PubMed:21233214, ECO:0000269|PubMed:23332758,
CC       ECO:0000269|PubMed:8361541, ECO:0000269|PubMed:9635436,
CC       ECO:0000269|PubMed:9852577, ECO:0000305,
CC       ECO:0000305|PubMed:23864368}.
CC   -!- INTERACTION:
CC       Q60598:Cttn; NbExp=3; IntAct=EBI-644033, EBI-397955;
CC       O55242:Sigmar1; NbExp=3; IntAct=EBI-644033, EBI-1557700;
CC       Q9R0C9:Sigmar1 (xeno); NbExp=3; IntAct=EBI-644033, EBI-1557826;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12527813,
CC       ECO:0000269|PubMed:18509034, ECO:0000269|PubMed:20696761,
CC       ECO:0000269|PubMed:23332758, ECO:0000269|PubMed:23864368}; Multi-
CC       pass membrane protein {ECO:0000250|UniProtKB:P63142}. Membrane
CC       {ECO:0000269|PubMed:23332758, ECO:0000269|PubMed:8361541,
CC       ECO:0000269|PubMed:9852577}. Cell projection, axon
CC       {ECO:0000269|PubMed:18509034, ECO:0000269|PubMed:21233214,
CC       ECO:0000269|PubMed:8046438, ECO:0000269|PubMed:8361541}. Cell
CC       junction, synapse {ECO:0000250|UniProtKB:P63142}. Endoplasmic
CC       reticulum membrane {ECO:0000250|UniProtKB:P63142}. Cell
CC       projection, lamellipodium membrane {ECO:0000250|UniProtKB:P63142}.
CC       Cell junction, synapse, synaptosome {ECO:0000269|PubMed:21233214}.
CC       Cell junction, synapse, presynaptic cell membrane
CC       {ECO:0000269|PubMed:21233214}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:8046438}. Perikaryon
CC       {ECO:0000269|PubMed:8046438}. Cell junction, paranodal septate
CC       junction {ECO:0000269|PubMed:25378149}. Note=KCNA2 by itself is
CC       detected both at the endoplasmic reticulum and at the cell
CC       membrane. Coexpression with KCNA4 or with beta subunits promotes
CC       expression at the cell membrane. Coexpression with KCNA1 inhibits
CC       cell surface expression (By similarity). Cocaine-induced
CC       interaction with SIGMAR1 increases expression at the cell surface
CC       (PubMed:23332758). In myelinated peripheral axons, clustered in
CC       the juxtaparadonal region and at an internodal line located along
CC       the mesaxon and below the Schmidt-Lanterman incisures
CC       (PubMed:25378149). {ECO:0000250|UniProtKB:P63142,
CC       ECO:0000269|PubMed:23332758, ECO:0000269|PubMed:25378149}.
CC   -!- TISSUE SPECIFICITY: Detected in brain (PubMed:17634333). Detected
CC       in cerebellum (PubMed:20696761). Detected in mitral cells in the
CC       olfactory bulb (PubMed:8046438). Detected in cochlea
CC       (PubMed:23864368). Detected in cerebellum, particularly in the
CC       basket cell axon plexus and in the terminal regions around
CC       Purkinje cells (PubMed:8361541, PubMed:8046438, PubMed:18760366).
CC       Detected in juxtaparanodal regions in sciatic nerve
CC       (PubMed:22649228). Detected in Schwann cells from sciatic nerve
CC       (PubMed:9852577). Detected in dopamine neurons in substantia nigra
CC       (PubMed:21233214). Detected in large myelinated fibers in
CC       juxtaparanodes in the CA3 and CA1 areas of the hippocampus
CC       (PubMed:8046438, PubMed:18760366). Detected in brain, in punctae
CC       on fiber tracts in brain stem and spinal cord, and on axons in the
CC       juxtaparanodal regions of the node of Ranvier (at protein level)
CC       (PubMed:8361541). Detected in dopamine neurons in the midbrain
CC       (PubMed:21233214). {ECO:0000269|PubMed:17634333,
CC       ECO:0000269|PubMed:18760366, ECO:0000269|PubMed:20696761,
CC       ECO:0000269|PubMed:22649228, ECO:0000269|PubMed:23864368,
CC       ECO:0000269|PubMed:8046438, ECO:0000269|PubMed:8361541,
CC       ECO:0000269|PubMed:9852577}.
CC   -!- DEVELOPMENTAL STAGE: Detected at low levels in brainstem from
CC       neonates; increases tenfold during the first 29 days after birth.
CC       {ECO:0000269|PubMed:17634333}.
CC   -!- DOMAIN: The cytoplasmic N-terminus is important for
CC       tetramerization. Interactions between the different subunits
CC       modulate the gating characteristics (By similarity). Besides, the
CC       cytoplasmic N-terminal domain mediates interaction with RHOA and
CC       thus is required for RHOA-mediated endocytosis (By similarity).
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: Phosphorylated on tyrosine residues; phosphorylation
CC       increases in response to ischemia (By similarity). Phosphorylated
CC       on tyrosine residues by activated PTK2B/PYK2 (By similarity).
CC       Phosphorylation on tyrosine residues suppresses ion channel
CC       activity (By similarity). Phosphorylated on tyrosine residues in
CC       response to CHRM1 activation; this abolishes interaction with
CC       CTTN. This is probably due to endocytosis of the phosphorylated
CC       channel subunits (By similarity). Phosphorylated on serine
CC       residues in response to increased cAMP levels; phosphorylation is
CC       apparently not catalyzed by PKA (By similarity).
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: N-glycosylated, with complex, sialylated N-glycans.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- DISRUPTION PHENOTYPE: Pups are born at the expected Mendelian rate
CC       and appear normal during the first 14 days after birth. Starting
CC       at 14 to 17 days after birth, mice exhibit susceptibility to
CC       generalized seizures, followed by full tonic extension, which in
CC       mice often results in fatal apne. The average lifespan is 17 days;
CC       none survive more than 28 days (PubMed:17925011, PubMed:17634333).
CC       At P17 seizures are very rare and abnormal electroencephalograph
CC       activity is only present during the seizure. P17 pups have
CC       significantly less non-rapid eye movement (NREM) sleep (-23%) and
CC       significantly more waking (+21%) than wild-type siblings with no
CC       change in rapid eye movement (REM) sleep time. The decrease in
CC       NREM sleep is due to an increase in the number of waking episodes,
CC       with no change in number or duration of sleep episodes
CC       (PubMed:17925011). Auditory neurons from the medial nucleus of the
CC       trapezoid body in brain stem are hypoexcitable and fire fewer
CC       action potentials than wild-type neurons with significantly
CC       smaller threshold current amplitudes (PubMed:17634333). In the
CC       inner ear, spiral ganglion neurons display a hyperpolarized
CC       resting membrane potential, increased excitability and increased
CC       outward potassium currents; this might be because normally
CC       channels there are heterotetramers formed by KCNA2 and KCNA4, so
CC       the loss of KCNA2 changes channel characteristics
CC       (PubMed:23864368). {ECO:0000269|PubMed:17634333,
CC       ECO:0000269|PubMed:17925011, ECO:0000269|PubMed:23864368}.
CC   -!- MISCELLANEOUS: Mutagenesis with N-ethyl-N-nitrosourea (ENU) lead
CC       to the discovery of the Pingu (Pgu) phenotype. At P21,
CC       heterozygous mice are clearly smaller than wild-type and have
CC       abnormal gait with a higher stance and splayed hind limbs.
CC       Homozygous mice are even smaller, and about half of them die
CC       between P15 and P35. Mutant mice have difficulty staing on a
CC       rotating rod and perform poorly in a beam-walking test, where they
CC       display flattened posture, severe tremors, myoclonic jerks and
CC       ataxic movement. These symptoms are alleviated by a drug used to
CC       treat cerebellar ataxia. Measurements with Purkinje cells from
CC       cerebellar brain slices show increased frequency and amplitude of
CC       spontaneous inhibitory postsynaptic currents.
CC       {ECO:0000269|PubMed:20696761}.
CC   -!- MISCELLANEOUS: The delay or D-type current observed in hippocampus
CC       pyramidal neurons is probably mediated by potassium channels
CC       containing KCNA2 plus KCNA1 or other family members. It is
CC       activated at about -50 mV, i.e. below the action potential
CC       threshold, and is characterized by slow inactivation, extremely
CC       slow recovery from inactivation, sensitivity to dendrotoxin (DTX)
CC       and to 4-aminopyridine (4-AP). {ECO:0000305|PubMed:17917103}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.2/KCNA2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M30440; AAA39713.1; -; Genomic_DNA.
DR   EMBL; AK044342; BAC31877.1; -; mRNA.
DR   EMBL; CH466607; EDL01892.1; -; Genomic_DNA.
DR   EMBL; BC138650; AAI38651.1; -; mRNA.
DR   EMBL; BC138651; AAI38652.1; -; mRNA.
DR   CCDS; CCDS17733.1; -.
DR   PIR; B40090; I84204.
DR   RefSeq; NP_032443.3; NM_008417.5.
DR   RefSeq; XP_006501111.1; XM_006501048.3.
DR   RefSeq; XP_006501112.1; XM_006501049.3.
DR   RefSeq; XP_006501113.1; XM_006501050.3.
DR   RefSeq; XP_006501114.1; XM_006501051.3.
DR   RefSeq; XP_006501115.1; XM_006501052.3.
DR   RefSeq; XP_006501116.1; XM_006501053.3.
DR   RefSeq; XP_006501117.1; XM_006501054.3.
DR   RefSeq; XP_006501118.1; XM_006501055.3.
DR   UniGene; Mm.39285; -.
DR   ProteinModelPortal; P63141; -.
DR   SMR; P63141; -.
DR   BioGrid; 200877; 5.
DR   DIP; DIP-32239N; -.
DR   IntAct; P63141; 6.
DR   MINT; MINT-1659109; -.
DR   STRING; 10090.ENSMUSP00000041702; -.
DR   iPTMnet; P63141; -.
DR   PhosphoSitePlus; P63141; -.
DR   MaxQB; P63141; -.
DR   PaxDb; P63141; -.
DR   PeptideAtlas; P63141; -.
DR   PRIDE; P63141; -.
DR   Ensembl; ENSMUST00000038695; ENSMUSP00000041702; ENSMUSG00000040724.
DR   Ensembl; ENSMUST00000196403; ENSMUSP00000142873; ENSMUSG00000040724.
DR   Ensembl; ENSMUST00000197470; ENSMUSP00000143798; ENSMUSG00000040724.
DR   GeneID; 16490; -.
DR   KEGG; mmu:16490; -.
DR   UCSC; uc008qws.2; mouse.
DR   CTD; 3737; -.
DR   MGI; MGI:96659; Kcna2.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; P63141; -.
DR   KO; K04875; -.
DR   OMA; PEPDHEC; -.
DR   OrthoDB; EOG091G10NU; -.
DR   PhylomeDB; P63141; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-MMU-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; Kcna2; mouse.
DR   PRO; PR:P63141; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   Bgee; ENSMUSG00000040724; -.
DR   Genevisible; P63141; MM.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0043679; C:axon terminus; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0044224; C:juxtaparanode region of axon; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0031258; C:lamellipodium membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:UniProtKB.
DR   GO; GO:0033010; C:paranodal junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; IDA:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0019894; F:kinesin binding; IEA:Ensembl.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IEA:Ensembl.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0019228; P:neuronal action potential; ISS:UniProtKB.
DR   GO; GO:0021633; P:optic nerve structural organization; IMP:MGI.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0045188; P:regulation of circadian sleep/wake cycle, non-REM sleep; IMP:UniProtKB.
DR   GO; GO:0014059; P:regulation of dopamine secretion; IMP:UniProtKB.
DR   GO; GO:0019233; P:sensory perception of pain; ISS:UniProtKB.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004049; K_chnl_volt-dep_Kv1.2.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF23; PTHR11537:SF23; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01509; KV12CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Complete proteome;
KW   Endoplasmic reticulum; Glycoprotein; Ion channel; Ion transport;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome; Synapse;
KW   Synaptosome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    499       Potassium voltage-gated channel subfamily
FT                                A member 2.
FT                                /FTId=PRO_0000053973.
FT   TOPO_DOM      1    160       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    161    182       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    183    221       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    222    243       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    244    254       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    255    275       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    276    289       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    290    310       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    311    325       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    326    347       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    348    361       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    362    373       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    374    381       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    382    388       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    389    417       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    418    499       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION        1    125       Tetramerization domain.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION      312    325       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       374    379       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       497    499       PDZ-binding.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   SITE        252    252       Important for normal, slow channel
FT                                gating. {ECO:0000250|UniProtKB:P63142}.
FT   SITE        381    381       Important for binding with the scorpion
FT                                mesomartoxin; when the scorpion
FT                                mesomartoxin-rKv1.2/KCNA2 interaction is
FT                                modeled, this residue is close to the 'Y-
FT                                57' residue of the toxin.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOD_RES     429    429       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18034455}.
FT   MOD_RES     434    434       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     440    440       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     441    441       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q09081}.
FT   MOD_RES     449    449       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q09081}.
FT   MOD_RES     468    468       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   LIPID       244    244       S-palmitoyl cysteine. {ECO:0000255}.
FT   CARBOHYD    207    207       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     402    402       I->T: In Pgu; chronic motor
FT                                incoordination; decreases the number of
FT                                functional channels at the cell surface.
FT                                {ECO:0000269|PubMed:20696761}.
FT   CONFLICT     33     33       E -> G (in Ref. 2; BAC31877).
FT                                {ECO:0000305}.
SQ   SEQUENCE   499 AA;  56701 MW;  A8FEA6F3F59AF42A CRC64;
     MTVATGDPVD EAAALPGHPQ DTYDPEADHE CCERVVINIS GLRFETQLKT LAQFPETLLG
     DPKKRMRYFD PLRNEYFFDR NRPSFDAILY YYQSGGRLRR PVNVPLDIFS EEIRFYELGE
     EAMEMFREDE GYIKEEERPL PENEFQRQVW LLFEYPESSG PARIIAIVSV MVILISIVSF
     CLETLPIFRD ENEDMHGGGV TFHTYSNSTI GYQQSTSFTD PFFIVETLCI IWFSFEFLVR
     FFACPSKAGF FTNIMNIIDI VAIIPYFITL GTELAEKPED AQQGQQAMSL AILRVIRLVR
     VFRIFKLSRH SKGLQILGQT LKASMRELGL LIFFLFIGVI LFSSAVYFAE ADERDSQFPS
     IPDAFWWAVV SMTTVGYGDM VPTTIGGKIV GSLCAIAGVL TIALPVPVIV SNFNYFYHRE
     TEGEEQAQYL QVTSCPKIPS SPDLKKSRSA STISKSDYME IQEGVNNSNE DFREENLKTA
     NCTLANTNYV NITKMLTDV
//
ID   TWK7_CAEEL              Reviewed;         557 AA.
AC   P34410; P34411; Q629K0;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 3.
DT   27-SEP-2017, entry version 117.
DE   RecName: Full=TWiK family of potassium channels protein 7;
GN   Name=twk-7; Synonyms=twk-8; ORFNames=F22B7.7;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=7906398; DOI=10.1038/368032a0;
RA   Wilson R., Ainscough R., Anderson K., Baynes C., Berks M.,
RA   Bonfield J., Burton J., Connell M., Copsey T., Cooper J., Coulson A.,
RA   Craxton M., Dear S., Du Z., Durbin R., Favello A., Fraser A.,
RA   Fulton L., Gardner A., Green P., Hawkins T., Hillier L., Jier M.,
RA   Johnston L., Jones M., Kershaw J., Kirsten J., Laisster N.,
RA   Latreille P., Lightning J., Lloyd C., Mortimore B., O'Callaghan M.,
RA   Parsons J., Percy C., Rifken L., Roopra A., Saunders D., Shownkeen R.,
RA   Sims M., Smaldon N., Smith A., Smith M., Sonnhammer E., Staden R.,
RA   Sulston J., Thierry-Mieg J., Thomas K., Vaudin M., Vaughan K.,
RA   Waterston R., Watson A., Weinstock L., Wilkinson-Sproat J.,
RA   Wohldman P.;
RT   "2.2 Mb of contiguous nucleotide sequence from chromosome III of C.
RT   elegans.";
RL   Nature 368:32-38(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FO080222; CCD62137.1; -; Genomic_DNA.
DR   PIR; S44633; S44633.
DR   PIR; S44635; S44635.
DR   RefSeq; NP_498903.3; NM_066502.5.
DR   UniGene; Cel.17711; -.
DR   ProteinModelPortal; P34410; -.
DR   SMR; P34410; -.
DR   STRING; 6239.F22B7.7; -.
DR   EPD; P34410; -.
DR   PaxDb; P34410; -.
DR   EnsemblMetazoa; F22B7.7; F22B7.7; WBGene00006662.
DR   GeneID; 192073; -.
DR   KEGG; cel:CELE_F22B7.7; -.
DR   UCSC; F22B7.7; c. elegans.
DR   CTD; 192073; -.
DR   WormBase; F22B7.7; CE37508; WBGene00006662; twk-7.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00700000104522; -.
DR   HOGENOM; HOG000022416; -.
DR   InParanoid; P34410; -.
DR   KO; K05323; -.
DR   OMA; PRRDGYM; -.
DR   OrthoDB; EOG091G05MS; -.
DR   PhylomeDB; P34410; -.
DR   Reactome; R-CEL-1299344; TWIK-related spinal cord K+ channel (TRESK).
DR   PRO; PR:P34410; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00006662; -.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   3: Inferred from homology;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    557       TWiK family of potassium channels protein
FT                                7.
FT                                /FTId=PRO_0000101771.
FT   TOPO_DOM      1    165       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    166    186       Helical. {ECO:0000255}.
FT   INTRAMEM    270    290       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    295    315       Helical. {ECO:0000255}.
FT   TOPO_DOM    316    368       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    369    389       Helical. {ECO:0000255}.
FT   INTRAMEM    397    417       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    426    446       Helical. {ECO:0000255}.
FT   TOPO_DOM    447    557       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    220    220       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    237    237       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   557 AA;  64212 MW;  4A7138B4BC8AB3A3 CRC64;
     MTSSSRGYQR VDSSGDGGSL LMEEEGDNPH EALLHRNNDD YASTYHHVGV EYDSYEELER
     HEMDDRVTEI PEGFHRRQRR NLIYGDDVAT DEELRVLRRE ALFGEEVTRA GLGRAEYYED
     SHLIHSCDKS GHEDIDDESD DESKDEDEEE EETGIRKFAK LVLPHVALVL LTCTYTVIGA
     LIFYSVEQPH EQMMKEQQLK LIYTRQNEFV DDLIRLAAGN ETKRYEWESL AERHMHNMSD
     QLFVAFEKYF LTSNEVKKNA ATETWTFSSS IFFAVTVVTT IGYGNPVPVT NIGRIWCILF
     SLLGIPLTLV TIADLGKFLS EHLVWLYGNY LKLKYLILSR HRKERREHVC EHCHSHGMGH
     DMNIEEKRIP AFLVLAILIV YTAFGGVLMS KLEPWSFFTS FYWSFITMTT VGFGDLMPRR
     DGYMYIILLY IILGLAITTM CIDLVGVQYI RKIHYFGRKI QDARSALAVV GGKVVLVSEL
     YANLMQKRAR NMSREAFIVE NLYVSKHIIP FIPTDIRCIR YIDQTADAAT ISTSSSAIDM
     QSCRFCHSRY SLNRAFK
//
ID   KCNG4_HUMAN             Reviewed;         519 AA.
AC   Q8TDN1; Q96H24;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   22-NOV-2017, entry version 149.
DE   RecName: Full=Potassium voltage-gated channel subfamily G member 4;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv6.4;
GN   Name=KCNG4; Synonyms=KCNG3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=12060745; DOI=10.1073/pnas.122617999;
RA   Ottschytsch N., Raes A., Van Hoorick D., Snyders D.J.;
RT   "Obligatory heterotetramerization of three previously uncharacterized
RT   Kv channel alpha-subunits identified in the human genome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7986-7991(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNB1, AND SUBCELLULAR LOCATION.
RX   PubMed=19074135; DOI=10.1074/jbc.M808786200;
RA   Mederos y Schnitzler M., Rinne S., Skrobek L., Renigunta V.,
RA   Schlichthorl G., Derst C., Gudermann T., Daut J., Preisig-Muller R.;
RT   "Mutation of histidine 105 in the T1 domain of the potassium channel
RT   Kv2.1 disrupts heteromerization with Kv6.3 and Kv6.4.";
RL   J. Biol. Chem. 284:4695-4704(2009).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Can form functional heterotetrameric channels
CC       with KCNB1; modulates the delayed rectifier voltage-gated
CC       potassium channel activation and deactivation rates of KCNB1
CC       (PubMed:19074135). {ECO:0000269|PubMed:19074135}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1 (PubMed:19074135).
CC       {ECO:0000269|PubMed:19074135}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19074135};
CC       Multi-pass membrane protein {ECO:0000305}. Note=Has to be
CC       associated with KCNB1 or possibly another partner to get inserted
CC       in the plasma membrane. Colocalizes with KCNB1 at the plasma
CC       membrane. Remains intracellular in the absence of KCNB1
CC       (PubMed:19074135). {ECO:0000269|PubMed:19074135}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TDN1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TDN1-2; Sequence=VSP_001029, VSP_001030;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, and at lower levels
CC       in liver, small intestine and colon.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. G (TC
CC       1.A.1.2) subfamily. Kv6.4/KCNG4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF348984; AAL83911.1; -; mRNA.
DR   EMBL; BC008969; AAH08969.1; -; mRNA.
DR   CCDS; CCDS10945.1; -. [Q8TDN1-1]
DR   RefSeq; NP_758857.1; NM_172347.2. [Q8TDN1-1]
DR   UniGene; Hs.335877; -.
DR   UniGene; Hs.560407; -.
DR   UniGene; Hs.737415; -.
DR   ProteinModelPortal; Q8TDN1; -.
DR   BioGrid; 125002; 6.
DR   STRING; 9606.ENSP00000312129; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   PhosphoSitePlus; Q8TDN1; -.
DR   SwissPalm; Q8TDN1; -.
DR   BioMuta; KCNG4; -.
DR   DMDM; 26006803; -.
DR   PaxDb; Q8TDN1; -.
DR   PeptideAtlas; Q8TDN1; -.
DR   PRIDE; Q8TDN1; -.
DR   DNASU; 93107; -.
DR   Ensembl; ENST00000308251; ENSP00000312129; ENSG00000168418. [Q8TDN1-1]
DR   Ensembl; ENST00000568181; ENSP00000457897; ENSG00000168418. [Q8TDN1-2]
DR   GeneID; 93107; -.
DR   KEGG; hsa:93107; -.
DR   UCSC; uc002fhu.1; human. [Q8TDN1-1]
DR   CTD; 93107; -.
DR   DisGeNET; 93107; -.
DR   EuPathDB; HostDB:ENSG00000168418.7; -.
DR   GeneCards; KCNG4; -.
DR   HGNC; HGNC:19697; KCNG4.
DR   HPA; HPA039161; -.
DR   MIM; 607603; gene.
DR   neXtProt; NX_Q8TDN1; -.
DR   OpenTargets; ENSG00000168418; -.
DR   PharmGKB; PA134989953; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231014; -.
DR   HOVERGEN; HBG100172; -.
DR   InParanoid; Q8TDN1; -.
DR   KO; K04903; -.
DR   OMA; NKCQFFQ; -.
DR   OrthoDB; EOG091G05DD; -.
DR   PhylomeDB; Q8TDN1; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNG4; -.
DR   GenomeRNAi; 93107; -.
DR   PRO; PR:Q8TDN1; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000168418; -.
DR   CleanEx; HS_KCNG3; -.
DR   CleanEx; HS_KCNG4; -.
DR   ExpressionAtlas; Q8TDN1; baseline and differential.
DR   Genevisible; Q8TDN1; HS.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    519       Potassium voltage-gated channel subfamily
FT                                G member 4.
FT                                /FTId=PRO_0000054080.
FT   TOPO_DOM      1    218       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    219    240       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    241    261       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    262    283       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    284    294       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    295    314       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    315    328       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    329    353       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    354    368       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    369    390       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    391    405       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    406    417       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    418    425       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    426    432       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    433    461       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    462    519       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       418    423       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   VAR_SEQ     253    256       GECS -> VSGL (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001029.
FT   VAR_SEQ     257    519       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001030.
FT   VARIANT       8      8       G -> W (in dbSNP:rs35379218).
FT                                /FTId=VAR_053861.
FT   VARIANT     206    206       R -> W (in dbSNP:rs11646443).
FT                                /FTId=VAR_053862.
FT   VARIANT     255    255       C -> Y (in dbSNP:rs17736370).
FT                                /FTId=VAR_053863.
FT   VARIANT     321    321       E -> K (in dbSNP:rs4782905).
FT                                /FTId=VAR_053864.
FT   VARIANT     325    325       G -> R (in dbSNP:rs7196482).
FT                                /FTId=VAR_053865.
FT   VARIANT     427    427       R -> H (in dbSNP:rs35649980).
FT                                /FTId=VAR_053866.
SQ   SEQUENCE   519 AA;  58979 MW;  E5BBA354931AB0A4 CRC64;
     MPMPSRDGGL HPRHHHYGSH SPWSQLLSSP METPSIKGLY YRRVRKVGAL DASPVDLKKE
     ILINVGGRRY LLPWSTLDRF PLSRLSKLRL CRSYEEIVQL CDDYDEDSQE FFFDRSPSAF
     GVIVSFLAAG KLVLLQEMCA LSFQEELAYW GIEEAHLERC CLRKLLRKLE ELEELAKLHR
     EDVLRQQRET RRPASHSSRW GLCMNRLREM VENPQSGLPG KVFACLSILF VATTAVSLCV
     STMPDLRAEE DQGECSRKCY YIFIVETICV AWFSLEFCLR FVQAQDKCQF FQGPLNIIDI
     LAISPYYVSL AVSEEPPEDG ERPSGSSYLE KVGLVLRVLR ALRILYVMRL ARHSLGLQTL
     GLTVRRCTRE FGLLLLFLAV AITLFSPLVY VAEKESGRVL EFTSIPASYW WAIISMTTVG
     YGDMVPRSVP GQMVALSSIL SGILIMAFPA TSIFHTFSHS YLELKKEQEQ LQARLRHLQN
     TGPASECELL DPHVASEHEL MNDVNDLILE GPALPIMHM
//
ID   KVS4_CAEEL              Reviewed;         503 AA.
AC   Q9XXD1; Q6EUU0;
DT   05-JUL-2017, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 3.
DT   22-NOV-2017, entry version 133.
DE   RecName: Full=Probable voltage-gated potassium channel subunit kvs-4 {ECO:0000305};
GN   Name=kvs-4 {ECO:0000312|WormBase:Y48A6B.6a};
GN   ORFNames=Y48A6B.6 {ECO:0000312|WormBase:Y48A6B.6a};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305}
RP   INTERACTION WITH UNC-101, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   DOMAIN, AND MUTAGENESIS OF 217-TRP--GLU-221; 217-TRP--ILE-219;
RP   ILE-219; 496-GLU--LEU-500 AND 497-GLN--MET-498.
RX   PubMed=26762178; DOI=10.1002/1873-3468.12043;
RA   Zhou X., Zeng J., Ouyang C., Luo Q., Yu M., Yang Z., Wang H., Shen K.,
RA   Shi A.;
RT   "A novel bipartite UNC-101/AP-1 mu1 binding signal mediates KVS-
RT   4/Kv2.1 somatodendritic distribution in Caenorhabditis elegans.";
RL   FEBS Lett. 590:76-92(2016).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer (Probable). Interacts with
CC       unc-101 (via N-terminus); which targets kvs-4 to dendrites
CC       (PubMed:26762178). {ECO:0000269|PubMed:26762178, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000255}. Perikaryon
CC       {ECO:0000269|PubMed:26762178}. Cell projection, axon
CC       {ECO:0000269|PubMed:26762178}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:26762178}. Note=Association with unc-101 is
CC       required for dendritic localization.
CC       {ECO:0000305|PubMed:26762178}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=a {ECO:0000312|WormBase:Y48A6B.6a};
CC         IsoId=Q9XXD1-1; Sequence=Displayed;
CC       Name=b {ECO:0000312|WormBase:Y48A6B.6b};
CC         IsoId=Q9XXD1-2; Sequence=VSP_059007, VSP_059008;
CC   -!- TISSUE SPECIFICITY: Expressed in the cholinergic motor neuron DA9,
CC       mechanosensory neurons ALM and PLM, and the interneuron PVPL.
CC       {ECO:0000269|PubMed:26762178}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- DOMAIN: The EQMIL and WNIIE motifs are required for dendritic
CC       localization. {ECO:0000269|PubMed:26762178}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. B (Shab) (TC
CC       1.A.1.2) subfamily. Kv2.2/KCNB2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284603; CAA19530.3; -; Genomic_DNA.
DR   EMBL; BX284603; CAH04760.1; -; Genomic_DNA.
DR   PIR; T26983; T26983.
DR   RefSeq; NP_001022888.1; NM_001027717.2. [Q9XXD1-1]
DR   RefSeq; NP_001022889.1; NM_001027718.3. [Q9XXD1-2]
DR   UniGene; Cel.9760; -.
DR   ProteinModelPortal; Q9XXD1; -.
DR   IntAct; Q9XXD1; 1.
DR   STRING; 6239.Y48A6B.6b; -.
DR   PaxDb; Q6EUU0; -.
DR   EnsemblMetazoa; Y48A6B.6a; Y48A6B.6a; WBGene00012967. [Q9XXD1-1]
DR   EnsemblMetazoa; Y48A6B.6b; Y48A6B.6b; WBGene00012967. [Q9XXD1-2]
DR   GeneID; 190011; -.
DR   KEGG; cel:CELE_Y48A6B.6; -.
DR   UCSC; Y48A6B.6b; c. elegans. [Q9XXD1-1]
DR   CTD; 190011; -.
DR   WormBase; Y48A6B.6a; CE36457; WBGene00012967; kvs-4. [Q9XXD1-1]
DR   WormBase; Y48A6B.6b; CE36458; WBGene00012967; kvs-4. [Q9XXD1-2]
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00890000139669; -.
DR   HOGENOM; HOG000272628; -.
DR   InParanoid; Q6EUU0; -.
DR   OMA; NHFHIPT; -.
DR   OrthoDB; EOG091G0FP3; -.
DR   PRO; PR:Q9XXD1; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00012967; -.
DR   ExpressionAtlas; Q9XXD1; baseline.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cell projection;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    503       Probable voltage-gated potassium channel
FT                                subunit kvs-4. {ECO:0000305}.
FT                                /FTId=PRO_0000440898.
FT   TOPO_DOM      1    231       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    232    252       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    253    275       Extracellular. {ECO:0000305}.
FT   TRANSMEM    276    296       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    297    313       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    314    334       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    335    346       Extracellular. {ECO:0000305}.
FT   TRANSMEM    347    366       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    367    383       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    384    404       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    405    417       Extracellular. {ECO:0000305}.
FT   INTRAMEM    418    429       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    430    434       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    435    445       Extracellular. {ECO:0000305}.
FT   TRANSMEM    446    466       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    467    503       Cytoplasmic. {ECO:0000305}.
FT   REGION      368    383       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       217    219       Required for dendritic localization.
FT                                {ECO:0000269|PubMed:26762178}.
FT   MOTIF       430    435       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       496    500       Required for dendritic localization.
FT                                {ECO:0000269|PubMed:26762178}.
FT   CARBOHYD    264    264       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   VAR_SEQ       1     47       MNSAIMQGAAMATSHGIARLNRHNAQRNHFHIPTANRLFYQ
FT                                LQTPCT -> MSHQASHFGVKKKWKANGSSGGGGLSAFARM
FT                                KPVLDPSADRIWTIGQIIYQRHQAFNRNSAIKSQDNGSFDY
FT                                IDMVSQSSLDR (in isoform b).
FT                                /FTId=VSP_059007.
FT   VAR_SEQ     452    478       Missing (in isoform b).
FT                                /FTId=VSP_059008.
FT   MUTAGEN     217    221       WNIIE->AAAAA: Disrupts dendritic
FT                                localization.
FT                                {ECO:0000269|PubMed:26762178}.
FT   MUTAGEN     217    219       WNI->ANA: Disrupts dendritic
FT                                localization.
FT                                {ECO:0000269|PubMed:26762178}.
FT   MUTAGEN     219    219       I->A: Disrupts dendritic localization.
FT                                {ECO:0000269|PubMed:26762178}.
FT   MUTAGEN     496    500       EQMIL->AAAAA: Disrupts dendritic
FT                                localization.
FT                                {ECO:0000269|PubMed:26762178}.
FT   MUTAGEN     497    498       QM->AA: Disrupts dendritic localization.
FT                                {ECO:0000269|PubMed:26762178}.
SQ   SEQUENCE   503 AA;  56966 MW;  1611A5E0417E016C CRC64;
     MNSAIMQGAA MATSHGIARL NRHNAQRNHF HIPTANRLFY QLQTPCTSTE EERRTVQTDD
     VAEIGMQRPD YQMYCGEEEI SEQFVKLNVG GQRFMLRKDT IRRRGVGRLL DLINKPVADS
     NADAFFSSTS EFYFERPPSL FHIVYQFYLN GVIHQPSNLC PVDIIEELEY WRIIPDQYLA
     SCCCAQQIDD DDEEVEEQDK PNLFKTLRFG EIRRCVWNII EEPASSGKAQ AFAVCSVVFV
     LISISGLVLG SLPELQVATK QRNNLTGEEF TEMEPMPILG YIEYVCIVWF TMEYGLKMLV
     SAERSKTFRQ LLNIIDLLAI LPFIIEMLLL IFGISTEQLR DLKGAFLVIR ILRVLRVIRV
     LKLGRYSSGL QMFGKTLKAS FRQLGMMAMV VMTGVIFFST LVYFLEKDEP ASKFHSIPAA
     CWWCIVTMTT VGYGDLTPVT VPGKLVATGA IACGVLVLAL PITIIVDNFM KVAETERPAG
     GNRYRTSQYP KATKSEQMIL KVT
//
ID   TM175_CHRP1             Reviewed;         192 AA.
AC   A0A086F3E3;
DT   11-NOV-2015, integrated into UniProtKB/Swiss-Prot.
DT   29-OCT-2014, sequence version 1.
DT   25-OCT-2017, entry version 9.
DE   RecName: Full=Potassium channel HX13_20290;
GN   ORFNames=HX13_20290 {ECO:0000312|EMBL:KFF73457.1};
OS   Chryseobacterium sp. (strain P1-3).
OC   Bacteria; Bacteroidetes; Flavobacteriia; Flavobacteriales;
OC   Flavobacteriaceae; Chryseobacterium.
OX   NCBI_TaxID=1517683;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=P1-3 {ECO:0000312|EMBL:KFF73457.1};
RA   Park G.-S., Hong S.-J., Kwak Y., Choi J.-B., Jung B.K., Lee C.H.,
RA   Shin J.-H.;
RT   "Chryseobacterium sp. P1-3 whole genome sequence.";
RL   Submitted (JUL-2014) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION.
RX   PubMed=26317472; DOI=10.1016/j.cell.2015.08.002;
RA   Cang C., Aranda K., Seo Y.J., Gasnier B., Ren D.;
RT   "TMEM175 is an organelle K(+) channel regulating lysosomal function.";
RL   Cell 162:1101-1112(2015).
RN   [3]
RP   SUBUNIT.
RX   PubMed=28723891; DOI=10.1038/nature23269;
RA   Lee C., Guo J., Zeng W., Kim S., She J., Cang C., Ren D., Jiang Y.;
RT   "The lysosomal potassium channel TMEM175 adopts a novel tetrameric
RT   architecture.";
RL   Nature 547:472-475(2017).
CC   -!- FUNCTION: Potassium channel. {ECO:0000305|PubMed:26317472}.
CC   -!- SUBUNIT: Homotetramer (PubMed:28723891).
CC       {ECO:0000269|PubMed:28723891}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane
CC       protein {ECO:0000255}.
CC   -!- DOMAIN: The six transmembrane regions are tightly packed within
CC       each subunit without undergoing domain swapping. Transmembranes
CC       TM1-TM3 are positioned on the inner circle of the channel tetramer
CC       and participate in inter-subunit interactions that are central to
CC       the assembly of the ion conduction pore. The RxxxFSD motif within
CC       transmembrane TM1 coordinates a network of specific inter- and
CC       intra-subunit interactions with other conserved residues on TM2
CC       and TM3 and plays a key role in the tetrameric assembly of the
CC       channel. Transmembrane TM4-TM6 are positioned on the periphery of
CC       the channel and do not contribute contacts with neighboring
CC       subunits. Transmembranes TM1 and TM2 are linked by an extended
CC       strand-like tail and two short helices (H1 and H2) which protrude
CC       outwards from the main body of the transmembrane domain and
CC       enclose the external open entrance of the ion conduction pore in
CC       the channel tetramer. Transmembrane TM1 forms the pore-lining
CC       inner helix at the center of the channel, creating an hourglass-
CC       shaped ion permeation pathway in the channel tetramer. Three
CC       hydrophobic residues on the C-terminal half of the TM1 helix form
CC       a bottleneck along the ion conduction pathway and serve as the
CC       selectivity filter of the channel. Ile-16 is probably responsible
CC       for channel selectivity. {ECO:0000250|UniProtKB:K9UJK2}.
CC   -!- SIMILARITY: Belongs to the TMEM175 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; JPEQ01000015; KFF73457.1; -; Genomic_DNA.
DR   EnsemblBacteria; KFF73457; KFF73457; HX13_20290.
DR   Proteomes; UP000028723; Unassembled WGS sequence.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0022841; F:potassium ion leak channel activity; TAS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; TAS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   InterPro; IPR010617; TMEM175.
DR   Pfam; PF06736; DUF1211; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    192       Potassium channel HX13_20290.
FT                                /FTId=PRO_0000434743.
FT   TRANSMEM      1     24       Helical; Name=TM1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM     25     25       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM     26     39       Extracellular.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TRANSMEM     40     65       Helical; Name=TM2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM     66     71       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TRANSMEM     72     93       Helical; Name=TM3.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM     94    101       Extracellular.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TRANSMEM    102    126       Helical; Name=TM4.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM    127    133       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TRANSMEM    134    162       Helical; Name=TM5.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM    163    164       Extracellular.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TRANSMEM    165    180       Helical; Name=TM6.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM    181    192       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   REGION       26     29       Short helix H1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   REGION       31     37       Short helix H2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   MOTIF         5     11       RxxxFSD motif.
FT                                {ECO:0000250|UniProtKB:Q9BSA9}.
FT   SITE         16     16       Hydrophobic filter residue 1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   SITE         20     20       Hydrophobic filter residue 2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   SITE         23     23       Hydrophobic filter residue 3.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
SQ   SEQUENCE   192 AA;  21996 MW;  5400703856099E2C CRC64;
     MTKGRLEAFS DGVLAIIITI MVLELKVPEG SSWASLQPIL PRFLAYIFSF IYVGIYWNNH
     HHLFQTVKKV NGSILWANLH LLFWLSLMPI ATEWIGTSHF AQNPVATYGI GLIMSAIAYT
     ILENVIIRCE GENSKLKEAI HSKFKEYISI IFYVLGIATS FFYPYIAIGF YYLVALIWLI
     PDKRIEKSLK EN
//
ID   KCNS1_OTOGA             Reviewed;         528 AA.
AC   A4K2Q6;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 1.
DT   22-NOV-2017, entry version 55.
DE   RecName: Full=Potassium voltage-gated channel subfamily S member 1;
DE   AltName: Full=Delayed-rectifier K(+) channel alpha subunit 1;
GN   Name=KCNS1;
OS   Otolemur garnettii (Small-eared galago) (Garnett's greater bushbaby).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Strepsirrhini;
OC   Lorisiformes; Galagidae; Otolemur.
OX   NCBI_TaxID=30611;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=17267810; DOI=10.1101/gr.6004607;
RG   NISC comparative sequencing program;
RA   Hurle B., Swanson W., Green E.D.;
RT   "Comparative sequence analyses reveal rapid and divergent evolutionary
RT   changes of the WFDC locus in the primate lineage.";
RL   Genome Res. 17:276-286(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RG   The Broad Institute Genome Sequencing Platform;
RA   Di Palma F., Johnson J., Lander E.S., Lindblad-Toh K., Jaffe D.B.,
RA   Gnerre S., MacCallum I., Przybylski D., Ribeiro F.J., Burton J.N.,
RA   Walker B.J., Sharpe T., Hall G.;
RT   "Version 3 of the genome sequence of Otolemur garnettii(Bushbaby).";
RL   Submitted (MAR-2011) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Can form functional heterotetrameric channels
CC       with KCNB1 and KCNB2; modulates the delayed rectifier voltage-
CC       gated potassium channel activation and deactivation rates of KCNB1
CC       and KCNB2. {ECO:0000250|UniProtKB:O35173}.
CC   -!- SUBUNIT: Heteromultimer with KCNB1 and KCNB2. Does not form
CC       homomultimers. {ECO:0000250|UniProtKB:O35173}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:O35173}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:O35173}. Note=May not reach the plasma
CC       membrane but remain in an intracellular compartment in the absence
CC       of KCNB1 or KCNB2. {ECO:0000250|UniProtKB:O35173}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. S (TC
CC       1.A.1.2) subfamily. Kv9.1/KCNS1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DP000040; ABO52941.1; -; Genomic_DNA.
DR   ProteinModelPortal; A4K2Q6; -.
DR   STRING; 30611.ENSOGAP00000018307; -.
DR   Ensembl; ENSOGAT00000033173; ENSOGAP00000018307; ENSOGAG00000025880.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; A4K2Q6; -.
DR   OMA; PCPDEIS; -.
DR   OrthoDB; EOG091G0FP3; -.
DR   TreeFam; TF313103; -.
DR   Proteomes; UP000005225; Unassembled WGS sequence.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:Ensembl.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IEA:Ensembl.
DR   GO; GO:0015459; F:potassium channel regulator activity; IEA:Ensembl.
DR   GO; GO:0006813; P:potassium ion transport; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    528       Potassium voltage-gated channel subfamily
FT                                S member 1.
FT                                /FTId=PRO_0000289619.
FT   TOPO_DOM      1    217       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    218    239       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    240    270       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    271    293       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    294    304       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    305    322       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    323    341       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    342    362       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    363    377       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    378    399       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    400    412       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    413    424       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    425    432       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    433    439       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    440    468       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    469    528       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       425    430       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
SQ   SEQUENCE   528 AA;  57969 MW;  01F437F5175ADBCC CRC64;
     MLMLLVRGTH FENNWSKLIP PATIDALGNE SPVPDSEVPN SGIPWRRSDE ALSVNVGGVR
     RRLSARALAR FPGTRLGRLQ AAASEEQARR LCDDYDAAAG EFYFDRHPGF FLSLLHFYRT
     GRLHVLDELC VFAFGQEADY WGLGENALAA CCRARYLERR VARPRAWDED SDTPSSVDPC
     TDEISDVQRE LARYGAARCG RLRRRLWLTM ENPGYSLPSK LFSCVSIGVV LASIAAMCIH
     SLPEYQAHEA AAAVATVVAG RGAEGVRDDP VLRRLEYFCI AWFSFEVSSR LLLAPSARNF
     FCHPLNLIDI VSVLPFYLTL LAGVALGGNQ NGTGGEELGH FGKVVQVFRL MRIFRVLKLA
     RHSTGLRSLG ATLKHSYREV GILLLYLAVG VSVFSGVAYT AEKEEDEGFA TIPACWWWGT
     VSMTTVGYGD VVPVTLAGKL AASGCILGGI LVVALPITII FNKFSHFYQR QKALEAAVRN
     SGHREFEDLL SSIDGVSEAS LGTSRETSQE GRSADLEAPS QSPKPQVY
//
ID   KCNU1_HUMAN             Reviewed;        1149 AA.
AC   A8MYU2;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   02-SEP-2008, sequence version 2.
DT   20-DEC-2017, entry version 97.
DE   RecName: Full=Potassium channel subfamily U member 1;
DE   AltName: Full=Calcium-activated potassium channel subunit alpha-3;
DE   AltName: Full=Calcium-activated potassium channel, subfamily M subunit alpha-3;
DE   AltName: Full=KCa5;
DE   AltName: Full=Slowpoke homolog 3;
GN   Name=KCNU1; Synonyms=KCNMA3, KCNMC1, SLO3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=9452476; DOI=10.1074/jbc.273.6.3509;
RA   Schreiber M., Wei A., Yuan A., Gaut J., Saito M., Salkoff L.;
RT   "Slo3, a novel pH-sensitive K+ channel from mammalian spermatocytes.";
RL   J. Biol. Chem. 273:3509-3516(1998).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 330-1063, FUNCTION, AND PH
RP   DEPENDENCE.
RX   PubMed=23129643; DOI=10.1073/pnas.1215078109;
RA   Leonetti M.D., Yuan P., Hsiung Y., Mackinnon R.;
RT   "Functional and structural analysis of the human SLO3 pH- and voltage-
RT   gated K+ channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:19274-19279(2012).
CC   -!- FUNCTION: Testis-specific potassium channel activated by both
CC       intracellular pH and membrane voltage that mediates export of
CC       K(+). May represent the primary spermatozoan K(+) current. In
CC       contrast to KCNMA1/SLO1, it is not activated by Ca(2+) or Mg(2+).
CC       Critical for fertility. May play an important role in sperm
CC       osmoregulation required for the acquisition of normal morphology
CC       and motility when faced with osmotic challenges, such as those
CC       experienced after mixing with seminal fluid and entry into the
CC       vagina. {ECO:0000269|PubMed:23129643}.
CC   -!- SUBUNIT: Homotetramer; which constitutes the calcium-activated
CC       potassium channel. May interact with LRRC52; this interaction may
CC       change channel gating properties, such as shifting gating to more
CC       negative potentials at a given pH. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:9452476}.
CC   -!- DOMAIN: The S4 segment, which is characterized by a series of
CC       positively charged amino acids at every third position, is part of
CC       the voltage-sensor. {ECO:0000250}.
CC   -!- DOMAIN: The pore-forming domain (also referred as P region) is
CC       imbedded into the membrane, and forms the selectivity filter of
CC       the pore. It contains the signature sequence of potassium channels
CC       that displays selectivity to potassium (By similarity).
CC       {ECO:0000250}.
CC   -!- DOMAIN: The RCK N-terminal domain mediates the
CC       homotetramerization, thereby promoting the assembly of monomers
CC       into functional potassium channel. {ECO:0000250}.
CC   -!- DOMAIN: The C-terminal cytosolic region confers the pH-dependence.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Calcium-
CC       activated (TC 1.A.1.3) subfamily. KCa5.1/KCNU1 sub-subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC124076; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS55220.1; -.
DR   RefSeq; NP_001027006.2; NM_001031836.2.
DR   UniGene; Hs.13861; -.
DR   PDB; 4HPF; X-ray; 3.40 A; A/B=330-1062.
DR   PDBsum; 4HPF; -.
DR   ProteinModelPortal; A8MYU2; -.
DR   SMR; A8MYU2; -.
DR   DIP; DIP-60091N; -.
DR   STRING; 9606.ENSP00000382770; -.
DR   GuidetoPHARMACOLOGY; 387; -.
DR   iPTMnet; A8MYU2; -.
DR   PhosphoSitePlus; A8MYU2; -.
DR   BioMuta; KCNU1; -.
DR   PaxDb; A8MYU2; -.
DR   PRIDE; A8MYU2; -.
DR   Ensembl; ENST00000399881; ENSP00000382770; ENSG00000215262.
DR   GeneID; 157855; -.
DR   KEGG; hsa:157855; -.
DR   UCSC; uc010lvw.5; human.
DR   CTD; 157855; -.
DR   DisGeNET; 157855; -.
DR   EuPathDB; HostDB:ENSG00000215262.7; -.
DR   GeneCards; KCNU1; -.
DR   H-InvDB; HIX0020845; -.
DR   HGNC; HGNC:18867; KCNU1.
DR   MIM; 615215; gene.
DR   neXtProt; NX_A8MYU2; -.
DR   OpenTargets; ENSG00000215262; -.
DR   PharmGKB; PA38727; -.
DR   eggNOG; KOG1420; Eukaryota.
DR   eggNOG; ENOG410YUX1; LUCA.
DR   GeneTree; ENSGT00530000063026; -.
DR   HOGENOM; HOG000019856; -.
DR   HOVERGEN; HBG052222; -.
DR   InParanoid; A8MYU2; -.
DR   KO; K05274; -.
DR   OMA; DSSGMFH; -.
DR   OrthoDB; EOG091G148D; -.
DR   PhylomeDB; A8MYU2; -.
DR   TreeFam; TF314283; -.
DR   Reactome; R-HSA-1300642; Sperm Motility And Taxes.
DR   GeneWiki; KCNU1; -.
DR   GenomeRNAi; 157855; -.
DR   PRO; PR:A8MYU2; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000215262; -.
DR   CleanEx; HS_KCNU1; -.
DR   ExpressionAtlas; A8MYU2; baseline and differential.
DR   Genevisible; A8MYU2; HS.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IBA:GO_Central.
DR   GO; GO:0060072; F:large conductance calcium-activated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005267; F:potassium channel activity; TAS:Reactome.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0035036; P:sperm-egg recognition; TAS:Reactome.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003929; K_chnl_BK_asu.
DR   Pfam; PF03493; BK_channel_a; 1.
DR   Pfam; PF00520; Ion_trans; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1149       Potassium channel subfamily U member 1.
FT                                /FTId=PRO_0000349186.
FT   TOPO_DOM      1     24       Extracellular. {ECO:0000255}.
FT   TRANSMEM     25     45       Helical; Name=Segment S0. {ECO:0000255}.
FT   TOPO_DOM     46    101       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    102    122       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    123    138       Extracellular. {ECO:0000255}.
FT   TRANSMEM    139    159       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    160    163       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    164    184       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    185    188       Extracellular. {ECO:0000255}.
FT   TRANSMEM    189    209       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    210    226       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    227    247       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    248    259       Extracellular. {ECO:0000255}.
FT   INTRAMEM    260    282       Pore-forming; Name=P region.
FT                                {ECO:0000255}.
FT   TOPO_DOM    283    291       Extracellular. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    313   1149       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      339    482       RCK N-terminal.
FT   REGION      480    500       Segment S7.
FT   REGION      537    557       Segment S8.
FT   REGION      711    731       Segment S9.
FT   REGION      895    915       Segment S10.
FT   MOTIF       276    279       Selectivity for potassium.
FT   VARIANT     175    175       D -> N (in dbSNP:rs1111125).
FT                                /FTId=VAR_060148.
FT   VARIANT     768    768       W -> R (in dbSNP:rs28608091).
FT                                /FTId=VAR_053868.
FT   VARIANT     916    916       N -> S (in dbSNP:rs16885577).
FT                                /FTId=VAR_053869.
FT   STRAND      300    305       {ECO:0000244|PDB:4HPF}.
FT   HELIX       312    315       {ECO:0000244|PDB:4HPF}.
FT   STRAND      334    338       {ECO:0000244|PDB:4HPF}.
FT   HELIX       354    357       {ECO:0000244|PDB:4HPF}.
FT   STRAND      367    369       {ECO:0000244|PDB:4HPF}.
FT   HELIX       372    377       {ECO:0000244|PDB:4HPF}.
FT   HELIX       378    380       {ECO:0000244|PDB:4HPF}.
FT   STRAND      386    391       {ECO:0000244|PDB:4HPF}.
FT   HELIX       397    403       {ECO:0000244|PDB:4HPF}.
FT   HELIX       405    407       {ECO:0000244|PDB:4HPF}.
FT   STRAND      409    413       {ECO:0000244|PDB:4HPF}.
FT   HELIX       422    439       {ECO:0000244|PDB:4HPF}.
FT   STRAND      445    448       {ECO:0000244|PDB:4HPF}.
FT   HELIX       452    456       {ECO:0000244|PDB:4HPF}.
FT   HELIX       457    460       {ECO:0000244|PDB:4HPF}.
FT   TURN        466    469       {ECO:0000244|PDB:4HPF}.
FT   STRAND      471    473       {ECO:0000244|PDB:4HPF}.
FT   HELIX       475    488       {ECO:0000244|PDB:4HPF}.
FT   HELIX       492    498       {ECO:0000244|PDB:4HPF}.
FT   HELIX       512    521       {ECO:0000244|PDB:4HPF}.
FT   STRAND      527    529       {ECO:0000244|PDB:4HPF}.
FT   HELIX       532    534       {ECO:0000244|PDB:4HPF}.
FT   HELIX       539    549       {ECO:0000244|PDB:4HPF}.
FT   STRAND      553    558       {ECO:0000244|PDB:4HPF}.
FT   STRAND      571    573       {ECO:0000244|PDB:4HPF}.
FT   STRAND      585    591       {ECO:0000244|PDB:4HPF}.
FT   HELIX       593    597       {ECO:0000244|PDB:4HPF}.
FT   HELIX       598    600       {ECO:0000244|PDB:4HPF}.
FT   HELIX       745    747       {ECO:0000244|PDB:4HPF}.
FT   STRAND      861    864       {ECO:0000244|PDB:4HPF}.
FT   HELIX       868    870       {ECO:0000244|PDB:4HPF}.
FT   HELIX       871    878       {ECO:0000244|PDB:4HPF}.
FT   TURN        882    884       {ECO:0000244|PDB:4HPF}.
FT   HELIX       889    891       {ECO:0000244|PDB:4HPF}.
FT   HELIX       893    897       {ECO:0000244|PDB:4HPF}.
FT   STRAND      899    901       {ECO:0000244|PDB:4HPF}.
FT   HELIX       903    908       {ECO:0000244|PDB:4HPF}.
FT   HELIX       909    915       {ECO:0000244|PDB:4HPF}.
FT   HELIX       917    928       {ECO:0000244|PDB:4HPF}.
FT   STRAND      962    966       {ECO:0000244|PDB:4HPF}.
FT   STRAND      968    971       {ECO:0000244|PDB:4HPF}.
FT   HELIX       972    975       {ECO:0000244|PDB:4HPF}.
FT   HELIX       982    993       {ECO:0000244|PDB:4HPF}.
FT   STRAND      996   1003       {ECO:0000244|PDB:4HPF}.
FT   STRAND     1015   1020       {ECO:0000244|PDB:4HPF}.
FT   STRAND     1032   1037       {ECO:0000244|PDB:4HPF}.
SQ   SEQUENCE   1149 AA;  129543 MW;  BA527F41498B6AA7 CRC64;
     MFQTKLRNET WEDLPKMSCT TEIQAAFILS SFVTFFSGLI ILLIFRLIWR SVKKWQIIKG
     TGIILELFTS GTIARSHVRS LHFQGQFRDH IEMLLSAQTF VGQVLVILVF VLSIGSLIIY
     FINSADPVGS CSSYEDKTIP IDLVFNAFFS FYFGLRFMAA DDKIKFWLEM NSIVDIFTIP
     PTFISYYLKS NWLGLRFLRA LRLLELPQIL QILRAIKTSN SVKFSKLLSI ILSTWFTAAG
     FIHLVENSGD PWLKGRNSQN ISYFESIYLV MATTSTVGFG DVVAKTSLGR TFIMFFTLGS
     LILFANYIPE MVELFANKRK YTSSYEALKG KKFIVVCGNI TVDSVTAFLR NFLRDKSGEI
     NTEIVFLGET PPSLELETIF KCYLAYTTFI SGSAMKWEDL RRVAVESAEA CLIIANPLCS
     DSHAEDISNI MRVLSIKNYD STTRIIIQIL QSHNKVYLPK IPSWNWDTGD NIICFAELKL
     GFIAQGCLVP GLCTFLTSLF VEQNKKVMPK QTWKKHFLNS MKNKILTQRL SDDFAGMSFP
     EVARLCFLKM HLLLIAIEYK SLFTDGFCGL ILNPPPQVRI RKNTLGFFIA ETPKDVRRAL
     FYCSVCHDDV FIPELITNCG CKSRSRQHIT VPSVKRMKKC LKGISSRISG QDSPPRVSAS
     TSSISNFTTR TLQHDVEQDS DQLDSSGMFH WCKPTSLDKV TLKRTGKSKY KFRNHIVACV
     FGDAHSAPMG LRNFVMPLRA SNYTRKELKD IVFIGSLDYL QREWRFLWNF PQIYILPGCA
     LYSGDLHAAN IEQCSMCAVL SPPPQPSSNQ TLVDTEAIMA TLTIGSLQID SSSDPSPSVS
     EETPGYTNGH NEKSNCRKVP ILTELKNPSN IHFIEQLGGL EGSLQETNLH LSTAFSTGTV
     FSGSFLDSLL ATAFYNYHVL ELLQMLVTGG VSSQLEQHLD KDKVYGVADS CTSLLSGRNR
     CKLGLLSLHE TILSDVNPRN TFGQLFCGSL DLFGILCVGL YRIIDEEELN PENKRFVITR
     PANEFKLLPS DLVFCAIPFS TACYKRNEEF SLQKSYEIVN KASQTTETHS DTNCPPTIDS
     VTETLYSPVY SYQPRTNSLS FPKQIAWNQS RTNSIISSQI PLGDNAKENE RKTSDEVYDE
     DPFAYSEPL
//
ID   UN103_CAEEL             Reviewed;         829 AA.
AC   G5EFJ9; G5ECG3; G5EDE3; G5EE47; G5EFT6; G5EG15; G5EG91; G5EGQ1;
AC   M1Z8A0; M1ZJW5;
DT   12-APR-2017, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 1.
DT   20-DEC-2017, entry version 56.
DE   RecName: Full=Potassium voltage-gated channel unc-103 {ECO:0000305};
DE   AltName: Full=Ether-a-go-go-related gene potassium channel homolog {ECO:0000250|UniProtKB:Q12809};
DE            Short=ERG homolog {ECO:0000250|UniProtKB:Q12809};
DE            Short=Eag-related protein homolog {ECO:0000250|UniProtKB:Q12809};
DE            Short=Ether-a-go-go-related protein homolog {ECO:0000250|UniProtKB:Q12809};
DE   AltName: Full=Uncoordinated protein 103 {ECO:0000303|PubMed:10647014};
GN   Name=unc-103 {ECO:0000303|PubMed:10647014,
GN   ECO:0000312|WormBase:C30D11.1a};
GN   ORFNames=C30D11.1 {ECO:0000312|WormBase:C30D11.1a};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F).
RX   PubMed=10647014; DOI=10.1038/46072;
RA   Reiner D.J., Newton E.M., Tian H., Thomas J.H.;
RT   "Diverse behavioural defects caused by mutations in Caenorhabditis
RT   elegans unc-43 CaM kinase II.";
RL   Nature 402:199-203(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, AND MUTAGENESIS OF HIS-203; TRP-282; GLY-344 AND PRO-464.
RX   PubMed=12684455;
RA   Garcia L.R., Sternberg P.W.;
RT   "Caenorhabditis elegans UNC-103 ERG-like potassium channel regulates
RT   contractile behaviors of sex muscles in males before and during
RT   mating.";
RL   J. Neurosci. 23:2696-2705(2003).
RN   [4]
RP   MUTAGENESIS OF ALA-369.
RX   PubMed=15280551; DOI=10.1073/pnas.0306005101;
RA   Petersen C.I., McFarland T.R., Stepanovic S.Z., Yang P., Reiner D.J.,
RA   Hayashi K., George A.L. Jr., Roden D.M., Thomas J.H., Balser J.R.;
RT   "In vivo identification of genes that modify ether-a-go-go-related
RT   gene activity in Caenorhabditis elegans may also affect human cardiac
RT   arrhythmia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:11773-11778(2004).
RN   [5]
RP   SUBUNIT, INTERACTION WITH DNJ-1, AND MUTAGENESIS OF ALA-369.
RX   PubMed=27916661; DOI=10.1016/j.molcel.2016.10.027;
RA   Li K., Jiang Q., Bai X., Yang Y.F., Ruan M.Y., Cai S.Q.;
RT   "Tetrameric assembly of K(+) channels requires ER-located chaperone
RT   proteins.";
RL   Mol. Cell 65:52-65(2017).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated inwardly
CC       rectifying potassium channel. Channel properties are modulated by
CC       cAMP and subunit assembly (By similarity). Regulates the movements
CC       of the male's copulatory spicules before and during male mating
CC       behavior (PubMed:12684455). {ECO:0000250|UniProtKB:Q12809,
CC       ECO:0000269|PubMed:12684455}.
CC   -!- SUBUNIT: The potassium channel is composed of a homo- or
CC       heterotetrameric complex (PubMed:27916661). Interacts with dnj-1;
CC       dnj-1 chaperone promotes tetramerization (PubMed:27916661).
CC       {ECO:0000269|PubMed:27916661}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q12809}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=10;
CC       Name=a;
CC         IsoId=G5EFJ9-1; Sequence=Displayed;
CC       Name=c;
CC         IsoId=G5EFJ9-2; Sequence=VSP_058897;
CC       Name=b;
CC         IsoId=G5EFJ9-3; Sequence=VSP_058896;
CC       Name=h;
CC         IsoId=G5EFJ9-4; Sequence=VSP_058900, VSP_058903, VSP_058904,
CC                                  VSP_058905;
CC       Name=e;
CC         IsoId=G5EFJ9-5; Sequence=VSP_058899;
CC       Name=d;
CC         IsoId=G5EFJ9-6; Sequence=VSP_058898;
CC       Name=g;
CC         IsoId=G5EFJ9-7; Sequence=VSP_058900, VSP_058903;
CC       Name=f;
CC         IsoId=G5EFJ9-8; Sequence=VSP_058900;
CC       Name=i;
CC         IsoId=G5EFJ9-9; Sequence=VSP_058901;
CC       Name=j;
CC         IsoId=G5EFJ9-10; Sequence=VSP_058902;
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag) (TC
CC       1.A.1.20) subfamily. Kv11.1/KCNH2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF257518; AAF68999.1; -; mRNA.
DR   EMBL; BX284603; CAA84644.2; -; Genomic_DNA.
DR   EMBL; BX284603; CAO78712.1; -; Genomic_DNA.
DR   EMBL; BX284603; CAO78713.1; -; Genomic_DNA.
DR   EMBL; BX284603; CAO78714.1; -; Genomic_DNA.
DR   EMBL; BX284603; CAO78715.1; -; Genomic_DNA.
DR   EMBL; BX284603; CAO78716.1; -; Genomic_DNA.
DR   EMBL; BX284603; CAO78717.1; -; Genomic_DNA.
DR   EMBL; BX284603; CAO78718.1; -; Genomic_DNA.
DR   EMBL; BX284603; CCU83367.1; -; Genomic_DNA.
DR   EMBL; BX284603; CCU83368.1; -; Genomic_DNA.
DR   PIR; T19579; T19579.
DR   RefSeq; NP_001122682.1; NM_001129210.2. [G5EFJ9-1]
DR   RefSeq; NP_001122683.1; NM_001129211.1. [G5EFJ9-3]
DR   RefSeq; NP_001122684.1; NM_001129212.1. [G5EFJ9-2]
DR   RefSeq; NP_001122685.1; NM_001129213.1. [G5EFJ9-6]
DR   RefSeq; NP_001122686.1; NM_001129214.1. [G5EFJ9-5]
DR   RefSeq; NP_001122687.1; NM_001129215.1. [G5EFJ9-7]
DR   RefSeq; NP_001122688.1; NM_001129216.1.
DR   RefSeq; NP_001293649.1; NM_001306720.1. [G5EFJ9-9]
DR   RefSeq; NP_001293650.1; NM_001306721.1. [G5EFJ9-10]
DR   RefSeq; NP_497824.1; NM_065423.5. [G5EFJ9-8]
DR   UniGene; Cel.19508; -.
DR   ProteinModelPortal; G5EFJ9; -.
DR   SMR; G5EFJ9; -.
DR   STRING; 6239.C30D11.1c; -.
DR   PaxDb; G5EFJ9; -.
DR   PeptideAtlas; G5ECG3; -.
DR   EnsemblMetazoa; C30D11.1a; C30D11.1a; WBGene00006830. [G5EFJ9-1]
DR   EnsemblMetazoa; C30D11.1b; C30D11.1b; WBGene00006830. [G5EFJ9-3]
DR   EnsemblMetazoa; C30D11.1c; C30D11.1c; WBGene00006830. [G5EFJ9-2]
DR   EnsemblMetazoa; C30D11.1d; C30D11.1d; WBGene00006830. [G5EFJ9-6]
DR   EnsemblMetazoa; C30D11.1e; C30D11.1e; WBGene00006830. [G5EFJ9-5]
DR   EnsemblMetazoa; C30D11.1f; C30D11.1f; WBGene00006830. [G5EFJ9-8]
DR   EnsemblMetazoa; C30D11.1g; C30D11.1g; WBGene00006830. [G5EFJ9-7]
DR   EnsemblMetazoa; C30D11.1h; C30D11.1h; WBGene00006830.
DR   EnsemblMetazoa; C30D11.1i; C30D11.1i; WBGene00006830. [G5EFJ9-9]
DR   EnsemblMetazoa; C30D11.1j; C30D11.1j; WBGene00006830. [G5EFJ9-10]
DR   GeneID; 175527; -.
DR   KEGG; cel:CELE_C30D11.1; -.
DR   CTD; 175527; -.
DR   WormBase; C30D11.1a; CE41297; WBGene00006830; unc-103. [G5EFJ9-1]
DR   WormBase; C30D11.1b; CE41298; WBGene00006830; unc-103. [G5EFJ9-3]
DR   WormBase; C30D11.1c; CE41299; WBGene00006830; unc-103. [G5EFJ9-2]
DR   WormBase; C30D11.1d; CE41300; WBGene00006830; unc-103. [G5EFJ9-6]
DR   WormBase; C30D11.1e; CE41301; WBGene00006830; unc-103. [G5EFJ9-5]
DR   WormBase; C30D11.1f; CE27805; WBGene00006830; unc-103. [G5EFJ9-8]
DR   WormBase; C30D11.1g; CE41302; WBGene00006830; unc-103. [G5EFJ9-7]
DR   WormBase; C30D11.1h; CE41303; WBGene00006830; unc-103.
DR   WormBase; C30D11.1i; CE48274; WBGene00006830; unc-103. [G5EFJ9-9]
DR   WormBase; C30D11.1j; CE48244; WBGene00006830; unc-103. [G5EFJ9-10]
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140833; -.
DR   InParanoid; M1Z8A0; -.
DR   KO; K04905; -.
DR   OMA; IERMQNK; -.
DR   OrthoDB; EOG091G024C; -.
DR   PRO; PR:G5EFJ9; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00006830; -.
DR   ExpressionAtlas; G5EFJ9; baseline.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   GO; GO:0007617; P:mating behavior; IMP:WormBase.
DR   GO; GO:0006937; P:regulation of muscle contraction; IMP:WormBase.
DR   GO; GO:0046662; P:regulation of oviposition; NAS:WormBase.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003967; K_chnl_volt-dep_ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01470; ERGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    829       Potassium voltage-gated channel unc-103.
FT                                /FTId=PRO_0000439645.
FT   TOPO_DOM      1    123       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    124    144       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    145    158       Extracellular. {ECO:0000305}.
FT   TRANSMEM    159    179       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    180    203       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    204    224       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    225    234       Extracellular. {ECO:0000305}.
FT   TRANSMEM    235    255       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    256    261       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    262    282       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    283    327       Extracellular. {ECO:0000305}.
FT   INTRAMEM    328    348       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    349    354       Extracellular. {ECO:0000305}.
FT   TRANSMEM    355    375       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    376    829       Cytoplasmic. {ECO:0000305}.
FT   NP_BIND     458    559       cNMP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00060}.
FT   CARBOHYD    313    313       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   VAR_SEQ       1     87       MKTAVFGRDSGEPGSPCGAPPSLTFTPPATLVPPTHHHSRS
FT                                TNRGGVSGTGGGGSGGLQGAPGAGGPRASHSSRRTSRLHNN
FT                                VSALG -> MDRTRPSVRNYSLDLTRHRKLTADAKAVSPSS
FT                                CSVKFMPEVLDNHGTTTSARKHSSLSQPALRCHSKQHHNIL
FT                                SPHALA (in isoform b).
FT                                /FTId=VSP_058896.
FT   VAR_SEQ       1     87       MKTAVFGRDSGEPGSPCGAPPSLTFTPPATLVPPTHHHSRS
FT                                TNRGGVSGTGGGGSGGLQGAPGAGGPRASHSSRRTSRLHNN
FT                                VSALG -> MDSSVPMIDLSSGDDEEVEVAMRRSYLLPPVP
FT                                ERPDGFPSLLFGNGNLSRSTLSINQEISMAPSPFSEITVSS
FT                                QRPLVARSGSNSSEHNLQIKEAVKKKPVADIAHVSGTFVCV
FT                                CVRGAQK (in isoform c).
FT                                /FTId=VSP_058897.
FT   VAR_SEQ       1     87       MKTAVFGRDSGEPGSPCGAPPSLTFTPPATLVPPTHHHSRS
FT                                TNRGGVSGTGGGGSGGLQGAPGAGGPRASHSSRRTSRLHNN
FT                                VSALG -> MPRRPPLLRLAPVPEDEEDDEVFFEPADKNDD
FT                                KQRFLPKQSRGSSRFVSEDVLNNSDDEEENK (in
FT                                isoform d).
FT                                /FTId=VSP_058898.
FT   VAR_SEQ       1     87       MKTAVFGRDSGEPGSPCGAPPSLTFTPPATLVPPTHHHSRS
FT                                TNRGGVSGTGGGGSGGLQGAPGAGGPRASHSSRRTSRLHNN
FT                                VSALG -> MVGGGGGGGAGGSSTRRNAAIASTSSTTSSAA
FT                                GRRASAFVRRMSMAIPTLSADPVPFSA (in isoform
FT                                e).
FT                                /FTId=VSP_058899.
FT   VAR_SEQ       1     87       MKTAVFGRDSGEPGSPCGAPPSLTFTPPATLVPPTHHHSRS
FT                                TNRGGVSGTGGGGSGGLQGAPGAGGPRASHSSRRTSRLHNN
FT                                VSALG -> MSSSTNHTGIIQHHPSQSQQQATTSSGAGNAV
FT                                ASQAKQLMVVLQSGSYK (in isoform h, isoform
FT                                g and isoform f).
FT                                /FTId=VSP_058900.
FT   VAR_SEQ       1     87       MKTAVFGRDSGEPGSPCGAPPSLTFTPPATLVPPTHHHSRS
FT                                TNRGGVSGTGGGGSGGLQGAPGAGGPRASHSSRRTSRLHNN
FT                                VSALG -> MRA (in isoform i).
FT                                /FTId=VSP_058901.
FT   VAR_SEQ       1     87       MKTAVFGRDSGEPGSPCGAPPSLTFTPPATLVPPTHHHSRS
FT                                TNRGGVSGTGGGGSGGLQGAPGAGGPRASHSSRRTSRLHNN
FT                                VSALG -> MPRRPPLLRLAPVPEDEEDDEVFFEPADKNDD
FT                                KQRFLPKQSRGSSRFVSEDVLNNSDDEEENKRCHLVSSSHA
FT                                SLRSLSPCPSLQSSSSIGGCGGGGMVGGGGGGGAGGSSTRR
FT                                NAAIASTSSTTSSAAGRRASAFVRRMSMAIPTLSADPVPFS
FT                                A (in isoform j).
FT                                /FTId=VSP_058902.
FT   VAR_SEQ     645    722       SSSRCSPPHAALTATRSEATPLLRRSTNHHEEDDALFDDIR
FT                                AFARGNTVTMSPTVAGNSVSPTTAIHNDGIHSQQLSD ->
FT                                N (in isoform h and isoform g).
FT                                /FTId=VSP_058903.
FT   VAR_SEQ     779    781       EPN -> RRR (in isoform h).
FT                                /FTId=VSP_058904.
FT   VAR_SEQ     782    829       Missing (in isoform h).
FT                                /FTId=VSP_058905.
FT   MUTAGEN     203    203       H->N: In sy557; causes spontaneous
FT                                contractions of the spicule muscles,
FT                                inducing spicule protraction in the
FT                                absence of mating cues; when associated
FT                                with R-282.
FT                                {ECO:0000269|PubMed:12684455}.
FT   MUTAGEN     282    282       W->R: In sy557; causes spontaneous
FT                                contractions of the spicule muscles,
FT                                inducing spicule protraction in the
FT                                absence of mating cues; when associated
FT                                with N-203.
FT                                {ECO:0000269|PubMed:12684455}.
FT   MUTAGEN     344    344       G->E: In sy670; causes spontaneous
FT                                contractions of the spicule muscles,
FT                                inducing spicule protraction in the
FT                                absence of mating cues.
FT                                {ECO:0000269|PubMed:12684455}.
FT   MUTAGEN     369    369       A->T: In n500 and e1597; gain-of-function
FT                                mutation which causes locomotive and egg-
FT                                laying defects as well as pharyngeal-
FT                                pumping defect.
FT                                {ECO:0000269|PubMed:15280551,
FT                                ECO:0000269|PubMed:27916661}.
FT   MUTAGEN     464    464       P->S: In sy674; causes mild contractions
FT                                of the spicule muscles, inducing spicule
FT                                protraction in the absence of mating
FT                                cues. {ECO:0000269|PubMed:12684455}.
SQ   SEQUENCE   829 AA;  91928 MW;  C35EBA4C27C94597 CRC64;
     MKTAVFGRDS GEPGSPCGAP PSLTFTPPAT LVPPTHHHSR STNRGGVSGT GGGGSGGLQG
     APGAGGPRAS HSSRRTSRLH NNVSALGVLS LGADVLPEYK LQPTRIHHCT IVHYSPFKAV
     WDWIILLLVI YTAVFTPYVA AFLLRELQDT AKKSRFTEPL EIVDLIVDIM FIVDIIINFR
     TTYVNENDEA CQVVSDPGKI ATHYFKGWFI IDMVAAVPFD LLLVSTNSDE TTTLIGLLKT
     ARLLRLVRVA RKLDRYSEYG AAVLLLLMAT FALIAHWLAC IWYAIGSAEL SHKEYTWLHQ
     LSKQLAQPYT STNGTIPTGG PTLKSRYVTS LYFTLSTITS IGFGNVSATT DSEKIFTIIM
     MILGSLMYAS VFGNVSAIIQ RLYSGTARYH TEMSRLREFI RFHQIPNPLR QRLEEYFQHA
     WSYTNGIDMN LVLKGFPDCL QADICLHLNR NLLSGCAAFA GSTPGCLRAL SMRFRTTHSP
     PGDTLVHRGD ILTGLYFIAR GSVEILNDDN TVMGILGKDD IFGENPLLYD EVGKSSCNVR
     ALTYCDLHKI LRDDLLDVLD MYPEFAETFC KNLTITYNLR DDAQSLRKKF DRHKLLRMSS
     SMNKDRYTTP PDGDHGNAAV RRSAESVSRC DSNPIDRRQS AGSRSSSRCS PPHAALTATR
     SEATPLLRRS TNHHEEDDAL FDDIRAFARG NTVTMSPTVA GNSVSPTTAI HNDGIHSQQL
     SDRSDDYEER RANMFGRRLE SIESQMERMQ NKFNSDMETL IKLVKEQSII RNNGSSNEEP
     NARYRPNNYI SSAIRLPNGG GGGVVDEMRV SRLSSHEPPT PTQETDTIL
//
ID   TM175_CHAP6             Reviewed;         203 AA.
AC   K9UJK2;
DT   25-OCT-2017, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2013, sequence version 1.
DT   20-DEC-2017, entry version 21.
DE   RecName: Full=Potassium channel Cha6605_3372 {ECO:0000305};
DE   AltName: Full=Transmembrane protein 175 {ECO:0000303|PubMed:28723891};
DE            Short=CmTMEM175 {ECO:0000303|PubMed:28723891};
GN   ORFNames=Cha6605_3372 {ECO:0000312|EMBL:AFY94374.1};
OS   Chamaesiphon minutus (strain ATCC 27169 / PCC 6605).
OC   Bacteria; Cyanobacteria; Synechococcales; Chamaesiphonaceae;
OC   Chamaesiphon.
OX   NCBI_TaxID=1173020;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 27169 / PCC 6605;
RG   US DOE Joint Genome Institute;
RA   Gugger M., Coursin T., Rippka R., Tandeau De Marsac N., Huntemann M.,
RA   Wei C.-L., Han J., Detter J.C., Han C., Tapia R., Chen A.,
RA   Kyrpides N., Mavromatis K., Markowitz V., Szeto E., Ivanova N.,
RA   Pagani I., Pati A., Goodwin L., Nordberg H.P., Cantor M.N., Hua S.X.,
RA   Woyke T., Kerfeld C.A.;
RT   "Finished chromosome of genome of Chamaesiphon sp. PCC 6605.";
RL   Submitted (MAY-2012) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 7-203, FUNCTION, TOPOLOGY,
RP   SUBUNIT, DOMAIN, AND MUTAGENESIS OF ILE-23.
RX   PubMed=28723891; DOI=10.1038/nature23269;
RA   Lee C., Guo J., Zeng W., Kim S., She J., Cang C., Ren D., Jiang Y.;
RT   "The lysosomal potassium channel TMEM175 adopts a novel tetrameric
RT   architecture.";
RL   Nature 547:472-475(2017).
CC   -!- FUNCTION: Potassium channel (PubMed:28723891). The channel is
CC       permeable for K(+), Rb(+) and Cs(+), while it is unable to conduct
CC       Na(+) (PubMed:28723891). {ECO:0000269|PubMed:28723891}.
CC   -!- SUBUNIT: Homotetramer (PubMed:28723891).
CC       {ECO:0000269|PubMed:28723891}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane
CC       protein {ECO:0000269|PubMed:28723891}.
CC   -!- DOMAIN: In contrast to canonical tetrameric potassium channels,
CC       lacks the TVGYG selectivity filter motif and presents a completely
CC       different structure. The six transmembrane regions are tightly
CC       packed within each subunit without undergoing domain swapping.
CC       Transmembranes TM1-TM3 are positioned on the inner circle of the
CC       channel tetramer and participate in inter-subunit interactions
CC       that are central to the assembly of the ion conduction pore. The
CC       RxxxFSD motif within transmembrane TM1 coordinates a network of
CC       specific inter- and intra-subunit interactions with other
CC       conserved residues on TM2 and TM3 and plays a key role in the
CC       tetrameric assembly of the channel. Transmembrane TM4-TM6 are
CC       positioned on the periphery of the channel and do not contribute
CC       contacts with neighboring subunits. Transmembranes TM1 and TM2 are
CC       linked by an extended strand-like tail and two short helices (H1
CC       and H2) which protrude outwards from the main body of the
CC       transmembrane domain and enclose the external open entrance of the
CC       ion conduction pore in the channel tetramer. Transmembrane TM3 is
CC       bent into two segments (TM3a and TM3b) due to the presence of a
CC       conserved proline (Pro-102). Transmembrane TM1 forms the pore-
CC       lining inner helix at the center of the channel, creating an
CC       hourglass-shaped ion permeation pathway in the channel tetramer.
CC       Three hydrophobic residues (Ile-23, Leu-27 and Leu-30) on the C-
CC       terminal half of the TM1 helix form a bottleneck along the ion
CC       conduction pathway and serve as the selectivity filter of the
CC       channel. Ile-23 is probably responsible for channel selectivity.
CC       {ECO:0000269|PubMed:28723891}.
CC   -!- SIMILARITY: Belongs to the TMEM175 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP003600; AFY94374.1; -; Genomic_DNA.
DR   RefSeq; WP_015160509.1; NC_019697.1.
DR   PDB; 5VRE; X-ray; 3.30 A; A/B/C/D=1-203.
DR   PDBsum; 5VRE; -.
DR   SMR; K9UJK2; -.
DR   EnsemblBacteria; AFY94374; AFY94374; Cha6605_3372.
DR   KEGG; cmp:Cha6605_3372; -.
DR   PATRIC; fig|1173020.3.peg.3871; -.
DR   OrthoDB; POG091H0CJC; -.
DR   Proteomes; UP000010366; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005267; F:potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   InterPro; IPR010617; TMEM175.
DR   Pfam; PF06736; DUF1211; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    203       Potassium channel Cha6605_3372.
FT                                /FTId=PRO_0000442004.
FT   TOPO_DOM      1      7       Cytoplasmic.
FT                                {ECO:0000305|PubMed:28723891}.
FT   TRANSMEM      8     31       Helical; Name=TM1.
FT                                {ECO:0000269|PubMed:28723891}.
FT   TOPO_DOM     32     52       Extracellular.
FT                                {ECO:0000305|PubMed:28723891}.
FT   TRANSMEM     53     78       Helical; Name=TM2.
FT                                {ECO:0000269|PubMed:28723891}.
FT   TOPO_DOM     79     84       Cytoplasmic.
FT                                {ECO:0000305|PubMed:28723891}.
FT   TRANSMEM     85    110       Helical; Name=TM3.
FT                                {ECO:0000269|PubMed:28723891}.
FT   TOPO_DOM    111    117       Extracellular.
FT                                {ECO:0000305|PubMed:28723891}.
FT   TRANSMEM    118    142       Helical; Name=TM4.
FT                                {ECO:0000269|PubMed:28723891}.
FT   TOPO_DOM    143    154       Cytoplasmic.
FT                                {ECO:0000305|PubMed:28723891}.
FT   TRANSMEM    155    181       Helical; Name=TM5.
FT                                {ECO:0000269|PubMed:28723891}.
FT   TOPO_DOM    182    183       Extracellular.
FT                                {ECO:0000305|PubMed:28723891}.
FT   TRANSMEM    184    199       Helical; Name=TM6.
FT                                {ECO:0000269|PubMed:28723891}.
FT   TOPO_DOM    200    203       Cytoplasmic.
FT                                {ECO:0000305|PubMed:28723891}.
FT   REGION       37     42       Short helix H1.
FT                                {ECO:0000269|PubMed:28723891}.
FT   REGION       44     50       Short helix H2.
FT                                {ECO:0000269|PubMed:28723891}.
FT   MOTIF         6     12       RxxxFSD motif.
FT                                {ECO:0000269|PubMed:28723891}.
FT   SITE         23     23       Hydrophobic filter residue 1.
FT                                {ECO:0000269|PubMed:28723891}.
FT   SITE         27     27       Hydrophobic filter residue 2.
FT                                {ECO:0000269|PubMed:28723891}.
FT   SITE         30     30       Hydrophobic filter residue 3.
FT                                {ECO:0000269|PubMed:28723891}.
FT   MUTAGEN      23     23       I->A,C,N: Impaired selectivity. Can
FT                                conduct both K(+) and Na(+).
FT                                {ECO:0000269|PubMed:28723891}.
SQ   SEQUENCE   203 AA;  22674 MW;  53D7E93F759FEBE4 CRC64;
     MVEAPEQSET GRIEAFSDGV FAIAITLLVL EIKVPQHKIV ETVGLVSSLL SLWPSYLAFL
     TSFASILVMW VNHHRIFSLV ARTDHAFFYW NGLLLMLVTF VPFPTALLAE YLIHPQARVA
     ASVYAGIFLA IAIVFNRLWK HAATADRLLA QKADRHEVDA ITKQYRFGPG LYLVAFALSF
     ISVWLSVGVC FVLAIYFALR SNA
//
ID   KCNK1_HUMAN             Reviewed;         336 AA.
AC   O00180; Q13307; Q5T5E8;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   25-OCT-2017, entry version 164.
DE   RecName: Full=Potassium channel subfamily K member 1;
DE   AltName: Full=Inward rectifying potassium channel protein TWIK-1 {ECO:0000303|PubMed:8605869};
DE   AltName: Full=Potassium channel K2P1 {ECO:0000303|PubMed:15820677};
DE   AltName: Full=Potassium channel KCNO1;
GN   Name=KCNK1; Synonyms=HOHO1 {ECO:0000303|PubMed:9462864}, KCNO1, TWIK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION,
RP   MUTAGENESIS OF THR-161, ENZYME REGULATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=8605869;
RA   Lesage F., Guillemare E., Fink M., Duprat F., Lazdunski M., Romey G.,
RA   Barhanin J.;
RT   "TWIK-1, a ubiquitous human weakly inward rectifying K+ channel with a
RT   novel structure.";
RL   EMBO J. 15:1004-1011(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND REVIEW.
RC   TISSUE=Brain;
RX   PubMed=9462864; DOI=10.1007/s109-1998-8100-0;
RA   Goldstein S.A.N., Wang K.-W., Ilan N., Pausch M.H.;
RT   "Sequence and function of the two P domain potassium channels:
RT   implications of an emerging superfamily.";
RL   J. Mol. Med. 76:13-20(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=9362344;
RA   Orias M., Velazquez H., Tung F., Lee G., Desir G.V.;
RT   "Cloning and localization of a double-pore K channel, KCNK1: exclusive
RT   expression in distal nephron segments.";
RL   Am. J. Physiol. 273:F663-F666(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, SUBUNIT, DISULFIDE BOND, GLYCOSYLATION AT ASN-95,
RP   MUTAGENESIS OF CYS-69 AND ASN-95, SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=8978667;
RA   Lesage F., Reyes R., Fink M., Duprat F., Guillemare E., Lazdunski M.;
RT   "Dimerization of TWIK-1 K+ channel subunits via a disulfide bridge.";
RL   EMBO J. 15:6400-6407(1996).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=11165377; DOI=10.1016/S0169-328X(00)00263-1;
RA   Medhurst A.D., Rennie G., Chapman C.G., Meadows H., Duckworth M.D.,
RA   Kelsell R.E., Gloger I.I., Pangalos M.N.;
RT   "Distribution analysis of human two pore domain potassium channels in
RT   tissues of the central nervous system and periphery.";
RL   Brain Res. Mol. Brain Res. 86:101-114(2001).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, SUMOYLATION AT LYS-274, MUTAGENESIS OF
RP   HIS-122 AND LYS-274, AND INTERACTION WITH UBE2I.
RX   PubMed=15820677; DOI=10.1016/j.cell.2005.01.019;
RA   Rajan S., Plant L.D., Rabin M.L., Butler M.H., Goldstein S.A.;
RT   "Sumoylation silences the plasma membrane leak K+ channel K2P1.";
RL   Cell 121:37-47(2005).
RN   [10]
RP   LACK OF SUMOYLATION AT LYS-274, MUTAGENESIS OF LYS-274, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=17693262; DOI=10.1016/j.cell.2007.06.012;
RA   Feliciangeli S., Bendahhou S., Sandoz G., Gounon P., Reichold M.,
RA   Warth R., Lazdunski M., Barhanin J., Lesage F.;
RT   "Does sumoylation control K2P1/TWIK1 background K+ channels?";
RL   Cell 130:563-569(2007).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=17478540; DOI=10.1113/jphysiol.2006.126714;
RA   Gaborit N., Le Bouter S., Szuts V., Varro A., Escande D., Nattel S.,
RA   Demolombe S.;
RT   "Regional and tissue specific transcript signatures of ion channel
RT   genes in the non-diseased human heart.";
RL   J. Physiol. (Lond.) 582:675-693(2007).
RN   [12]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF LYS-274; 293-ILE-ILE-294 AND 299-LEU--HIS-336.
RX   PubMed=19959478; DOI=10.1074/jbc.M109.078535;
RA   Feliciangeli S., Tardy M.P., Sandoz G., Chatelain F.C., Warth R.,
RA   Barhanin J., Bendahhou S., Lesage F.;
RT   "Potassium channel silencing by constitutive endocytosis and
RT   intracellular sequestration.";
RL   J. Biol. Chem. 285:4798-4805(2010).
RN   [13]
RP   SUMOYLATION AT LYS-274, MUTAGENESIS OF HIS-122 AND LYS-274, FUNCTION,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=20498050; DOI=10.1073/pnas.1004712107;
RA   Plant L.D., Dementieva I.S., Kollewe A., Olikara S., Marks J.D.,
RA   Goldstein S.A.;
RT   "One SUMO is sufficient to silence the dimeric potassium channel
RT   K2P1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:10743-10748(2010).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF THR-118 AND LYS-274,
RP   TISSUE SPECIFICITY, AND ENZYME REGULATION.
RX   PubMed=21653227; DOI=10.1126/scisignal.2001726;
RA   Ma L., Zhang X., Chen H.;
RT   "TWIK-1 two-pore domain potassium channels change ion selectivity and
RT   conduct inward leak sodium currents in hypokalemia.";
RL   Sci. Signal. 4:RA37-RA37(2011).
RN   [15]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=21964404; DOI=10.1152/ajplung.00102.2011;
RA   Zhao K.Q., Xiong G., Wilber M., Cohen N.A., Kreindler J.L.;
RT   "A role for two-pore K? channels in modulating Na? absorption and Cl?
RT   secretion in normal human bronchial epithelial cells.";
RL   Am. J. Physiol. 302:L4-L12(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF 108-LEU-PHE-109;
RP   THR-118; HIS-122; LEU-146; LEU-228; THR-250 AND LYS-274.
RX   PubMed=22431633; DOI=10.1073/pnas.1201132109;
RA   Chatelain F.C., Bichet D., Douguet D., Feliciangeli S., Bendahhou S.,
RA   Reichold M., Warth R., Barhanin J., Lesage F.;
RT   "TWIK1, a unique background channel with variable ion selectivity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:5499-5504(2012).
RN   [18]
RP   SUBCELLULAR LOCATION, FUNCTION, SUMOYLATION, INTERACTION WITH KCNK3
RP   AND KCNK9, AND MUTAGENESIS OF TYR-231.
RX   PubMed=23169818; DOI=10.1126/scisignal.2003431;
RA   Plant L.D., Zuniga L., Araki D., Marks J.D., Goldstein S.A.;
RT   "SUMOylation silences heterodimeric TASK potassium channels containing
RT   K2P1 subunits in cerebellar granule neurons.";
RL   Sci. Signal. 5:RA84-RA84(2012).
RN   [19]
RP   REVIEW.
RX   PubMed=25530075; DOI=10.1113/jphysiol.2014.287268;
RA   Feliciangeli S., Chatelain F.C., Bichet D., Lesage F.;
RT   "The family of K2P channels: salient structural and functional
RT   properties.";
RL   J. Physiol. (Lond.) 593:2587-2603(2015).
RN   [20]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF LEU-146 AND LEU-261,
RP   AND SITE.
RX   PubMed=25001086; DOI=10.1038/ncomms5377;
RA   Aryal P., Abd-Wahab F., Bucci G., Sansom M.S., Tucker S.J.;
RT   "A hydrophobic barrier deep within the inner pore of the TWIK-1 K2P
RT   potassium channel.";
RL   Nat. Commun. 5:4377-4377(2014).
RN   [21]
RP   REVIEW.
RX   PubMed=25339226; DOI=10.1007/s00424-014-1631-y;
RA   Bichet D., Blin S., Feliciangeli S., Chatelain F.C., Bobak N.,
RA   Lesage F.;
RT   "Silent but not dumb: how cellular trafficking and pore gating
RT   modulate expression of TWIK1 and THIK2.";
RL   Pflugers Arch. 467:1121-1131(2015).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 23-288 IN COMPLEX WITH
RP   POTASSIUM IONS, FUNCTION, SUBUNIT, DISULFIDE BOND, TOPOLOGY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=22282804; DOI=10.1126/science.1213274;
RA   Miller A.N., Long S.B.;
RT   "Crystal structure of the human two-pore domain potassium channel
RT   K2P1.";
RL   Science 335:432-436(2012).
CC   -!- FUNCTION: Ion channel that contributes to passive transmembrane
CC       potassium transport and to the regulation of the resting membrane
CC       potential in brain astrocytes, but also in kidney and in other
CC       tissues (PubMed:15820677, PubMed:21653227). Forms dimeric channels
CC       through which potassium ions pass in accordance with their
CC       electrochemical gradient. The channel is selective for K(+) ions
CC       at physiological potassium concentrations and at neutral pH, but
CC       becomes permeable to Na(+) at subphysiological K(+) levels and
CC       upon acidification of the extracellular medium (PubMed:21653227,
CC       PubMed:22431633). The homodimer has very low potassium channel
CC       activity, when expressed in heterologous systems, and can function
CC       as weakly inward rectifying potassium channel (PubMed:8605869,
CC       PubMed:8978667, PubMed:15820677, PubMed:21653227, PubMed:22431633,
CC       PubMed:23169818, PubMed:25001086). Channel activity is modulated
CC       by activation of serotonin receptors (By similarity).
CC       Heterodimeric channels containing KCNK1 and KCNK2 have much higher
CC       activity, and may represent the predominant form in astrocytes (By
CC       similarity). Heterodimeric channels containing KCNK1 and KCNK3 or
CC       KCNK9 have much higher activity (PubMed:23169818). Heterodimeric
CC       channels formed by KCNK1 and KCNK9 may contribute to halothane-
CC       sensitive currents (PubMed:23169818). Mediates outward rectifying
CC       potassium currents in dentate gyrus granule cells and contributes
CC       to the regulation of their resting membrane potential (By
CC       similarity). Contributes to the regulation of action potential
CC       firing in dentate gyrus granule cells and down-regulates their
CC       intrinsic excitability (By similarity). In astrocytes, the
CC       heterodimer formed by KCNK1 and KCNK2 is required for rapid
CC       glutamate release in response to activation of G-protein coupled
CC       receptors, such as F2R and CNR1 (By similarity). Required for
CC       normal ion and water transport in the kidney (By similarity).
CC       Contributes to the regulation of the resting membrane potential of
CC       pancreatic beta cells (By similarity). The low channel activity of
CC       homodimeric KCNK1 may be due to sumoylation (PubMed:15820677,
CC       PubMed:20498050, PubMed:23169818). The low channel activity may be
CC       due to rapid internalization from the cell membrane and retention
CC       in recycling endosomes (PubMed:19959478).
CC       {ECO:0000250|UniProtKB:O08581, ECO:0000250|UniProtKB:Q9Z2T2,
CC       ECO:0000269|PubMed:15820677, ECO:0000269|PubMed:17693262,
CC       ECO:0000269|PubMed:19959478, ECO:0000269|PubMed:20498050,
CC       ECO:0000269|PubMed:21653227, ECO:0000269|PubMed:22282804,
CC       ECO:0000269|PubMed:22431633, ECO:0000269|PubMed:23169818,
CC       ECO:0000269|PubMed:25001086, ECO:0000269|PubMed:8605869,
CC       ECO:0000269|PubMed:8978667}.
CC   -!- ENZYME REGULATION: Inhibited by Ba(2+) ions and quinidine
CC       (PubMed:8605869). Inhibited by quinine (PubMed:8605869,
CC       PubMed:21653227). Is slightly inhibited by 10 mM
CC       tetraethylammonium (TEA), and only marginally inhibited by 4-
CC       aminopyridine, charybdotoxin and dendrotoxin (PubMed:8605869).
CC       Lowering the extracellular pH to below 6.5 transiently activates
CC       the channel, and then inhibits channel activity (PubMed:15820677,
CC       PubMed:22431633). Inhibited when the intracellular pH is decreased
CC       down to pH 6.0, but this may be due to indirect effects
CC       (PubMed:8605869). {ECO:0000269|PubMed:15820677,
CC       ECO:0000269|PubMed:21653227, ECO:0000269|PubMed:22431633,
CC       ECO:0000269|PubMed:8605869}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Has a unit conductance of 34 pS. Both activation and
CC         channel closure are very rapid. Is not voltage-gated. The
CC         relationship between voltage and current is nearly linear. Has a
CC         mean open time of 0.3 msec at a membrane potential of -80 mV,
CC         and 1.9 msec at +80 mV (PubMed:8605869).
CC         {ECO:0000269|PubMed:19959478, ECO:0000269|PubMed:8605869};
CC   -!- SUBUNIT: Homodimer; disulfide-linked (PubMed:8978667,
CC       PubMed:22282804). Heterodimer with KCNK2; disulfide-linked (By
CC       similarity). In astrocytes, forms mostly heterodimeric potassium
CC       channels with KCNK2, with only a minor proportion of functional
CC       channels containing homodimeric KCNK1 (By similarity). Interacts
CC       with KCNK3 and KCNK9, forming functional heterodimeric channels
CC       (PubMed:23169818). Interacts with GNG4 (By similarity). Identified
CC       in a complex with PSD and ARF6; interacts only with PSD that is
CC       bound to ARF6 (By similarity). Interacts with UBE2I
CC       (PubMed:15820677). {ECO:0000250|UniProtKB:O08581,
CC       ECO:0000269|PubMed:15820677, ECO:0000269|PubMed:22282804,
CC       ECO:0000269|PubMed:23169818, ECO:0000269|PubMed:8978667}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-3914675, EBI-3914675;
CC       A8MQ03:CYSRT1; NbExp=4; IntAct=EBI-3914675, EBI-3867333;
CC       P63165:SUMO1; NbExp=3; IntAct=EBI-3914675, EBI-80140;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15820677,
CC       ECO:0000269|PubMed:17693262, ECO:0000269|PubMed:20498050,
CC       ECO:0000269|PubMed:21653227, ECO:0000269|PubMed:22282804,
CC       ECO:0000269|PubMed:22431633, ECO:0000269|PubMed:23169818,
CC       ECO:0000269|PubMed:25001086, ECO:0000269|PubMed:8605869,
CC       ECO:0000269|PubMed:8978667}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:22282804, ECO:0000269|PubMed:8978667,
CC       ECO:0000305}. Recycling endosome {ECO:0000269|PubMed:19959478}.
CC       Cell junction, synapse {ECO:0000250|UniProtKB:Q9Z2T2}. Cytoplasmic
CC       vesicle {ECO:0000250|UniProtKB:O08581}. Perikaryon
CC       {ECO:0000250|UniProtKB:O08581}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:O08581}. Cell projection
CC       {ECO:0000250|UniProtKB:O08581}. Apical cell membrane
CC       {ECO:0000269|PubMed:21964404}; Multi-pass membrane protein
CC       {ECO:0000305}. Note=The heterodimer with KCNK2 is detected at the
CC       astrocyte cell membrane. Not detected at the astrocyte cell
CC       membrane when KCNK2 is absent. Detected on neuronal cell bodies,
CC       and to a lesser degree on neuronal cell projections. Detected on
CC       hippocampus dentate gyrus granule cell bodies and to a lesser
CC       degree on proximal dendrites. Detected in synaptic membranes.
CC       Detected at the apical cell membrane in stria vascularis in the
CC       cochlea. Detected at the apical cell membrane of vestibular dark
CC       cells situated between the crista and the utricle in the inner
CC       ear. Detected at the apical cell membrane in kidney proximal
CC       tubule segment S1 and in subapical compartments in segments S1, S2
CC       and S3. Predominantly in cytoplasmic structures in kidney distal
CC       convoluted tubules and collecting ducts (By similarity). Detected
CC       at the apical cell membrane of bronchial epithelial cells
CC       (PubMed:21964404). {ECO:0000250|UniProtKB:O08581,
CC       ECO:0000250|UniProtKB:Q9Z2T2, ECO:0000269|PubMed:21964404}.
CC   -!- TISSUE SPECIFICITY: Detected in bronchial epithelial cells
CC       (PubMed:21964404). Detected in heart left atrium and left
CC       ventricle (PubMed:17478540). Detected in cardiac myocytes (at
CC       protein level) (PubMed:21653227). Widely expressed with high
CC       levels in heart, brain and kidney, and lower levels in colon,
CC       ovary, placenta, lung and liver (PubMed:8605869, PubMed:9362344).
CC       Highly expressed in cerebellum, and detected at lower levels in
CC       amygdala, caudate nucleus, brain cortex, hippocampus, putamen,
CC       substantia nigra, thalamus, dorsal root ganglion, spinal cord,
CC       pituitary, heart, kidney, lung, placenta, pancreas, stomach, small
CC       intestine, uterus and prostate (PubMed:11165377). Detected in
CC       right and left heart ventricle and atrium, and in heart Purkinje
CC       fibers (PubMed:17478540). Detected in bronchial epithelial cells
CC       (PubMed:21964404). {ECO:0000269|PubMed:11165377,
CC       ECO:0000269|PubMed:17478540, ECO:0000269|PubMed:21653227,
CC       ECO:0000269|PubMed:21964404, ECO:0000269|PubMed:8605869,
CC       ECO:0000269|PubMed:9362344}.
CC   -!- PTM: Sumoylation is controversial. Sumoylated by UBE2I
CC       (PubMed:15820677). Not sumoylated when expressed in xenopus
CC       oocytes or mammalian cells (PubMed:17693262). Sumoylation
CC       inactivates the channel, but does not interfere with expression at
CC       the cell membrane (PubMed:15820677). Sumoylation of a single
CC       subunit is sufficient to silence the dimeric channel
CC       (PubMed:20498050, PubMed:23169818). Sumoylation of KCNK1 is
CC       sufficient to silence heterodimeric channels formed by KCNK1 and
CC       KCNK3 or KCNK9 (PubMed:23169818). Desumoylated by SENP1; this
CC       activates the channel (PubMed:15820677, PubMed:20498050,
CC       PubMed:23169818). Desumoylated by SENP1; this strongly increases
CC       halothane-mediated activation of heterodimeric channels formed
CC       with KCNK9 (PubMed:23169818). SENP1 treatment has no effect
CC       (PubMed:17693262). {ECO:0000269|PubMed:15820677,
CC       ECO:0000269|PubMed:17693262, ECO:0000269|PubMed:20498050,
CC       ECO:0000269|PubMed:23169818}.
CC   -!- MISCELLANEOUS: When the external K(+) concentration is lowered to
CC       subphysiological levels, it takes several minutes till the channel
CC       has reached a new, stable state characterized by increased Na(+)
CC       permeability (PubMed:21653227). Likewise, when the external pH is
CC       lowered to values below 6.5, it takes several minutes till the
CC       channel has reached a new, stable state characterized by increased
CC       Na(+) permeability (PubMed:22431633). When raising the K(+)
CC       concentration back to 5 mM, it takes 40 to 70 minutes for the
CC       channel to regain its original selectivity for K(+)
CC       (PubMed:21653227). Likewise, it takes more that 25 minutes for the
CC       channel to regain its original K(+) selectivity when the pH is
CC       raised back to 7.4 (PubMed:22431633).
CC       {ECO:0000269|PubMed:21653227, ECO:0000269|PubMed:22431633}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U33632; AAB01688.1; -; mRNA.
DR   EMBL; U76996; AAB97878.1; -; mRNA.
DR   EMBL; U90065; AAB51147.1; -; mRNA.
DR   EMBL; AL356357; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471098; EAW69989.1; -; Genomic_DNA.
DR   EMBL; BC018051; AAH18051.1; -; mRNA.
DR   CCDS; CCDS1599.1; -.
DR   PIR; S65566; S65566.
DR   RefSeq; NP_002236.1; NM_002245.3.
DR   UniGene; Hs.208544; -.
DR   PDB; 3UKM; X-ray; 3.40 A; A/B/C/D=19-288.
DR   PDBsum; 3UKM; -.
DR   ProteinModelPortal; O00180; -.
DR   SMR; O00180; -.
DR   BioGrid; 109976; 5.
DR   DIP; DIP-59532N; -.
DR   IntAct; O00180; 5.
DR   STRING; 9606.ENSP00000355580; -.
DR   DrugBank; DB00308; Ibutilide.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB01346; Quinidine barbiturate.
DR   iPTMnet; O00180; -.
DR   PhosphoSitePlus; O00180; -.
DR   BioMuta; KCNK1; -.
DR   EPD; O00180; -.
DR   MaxQB; O00180; -.
DR   PaxDb; O00180; -.
DR   PeptideAtlas; O00180; -.
DR   PRIDE; O00180; -.
DR   DNASU; 3775; -.
DR   Ensembl; ENST00000366621; ENSP00000355580; ENSG00000135750.
DR   GeneID; 3775; -.
DR   KEGG; hsa:3775; -.
DR   UCSC; uc010pxo.1; human.
DR   CTD; 3775; -.
DR   DisGeNET; 3775; -.
DR   EuPathDB; HostDB:ENSG00000135750.14; -.
DR   GeneCards; KCNK1; -.
DR   HGNC; HGNC:6272; KCNK1.
DR   HPA; CAB022588; -.
DR   HPA; HPA016049; -.
DR   MIM; 601745; gene.
DR   neXtProt; NX_O00180; -.
DR   OpenTargets; ENSG00000135750; -.
DR   PharmGKB; PA219; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000286014; -.
DR   HOVERGEN; HBG052237; -.
DR   InParanoid; O00180; -.
DR   KO; K04912; -.
DR   OMA; VQRVTIH; -.
DR   OrthoDB; EOG091G0DIX; -.
DR   PhylomeDB; O00180; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-HSA-1299308; Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK).
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   ChiTaRS; KCNK1; human.
DR   GeneWiki; KCNK1; -.
DR   GenomeRNAi; 3775; -.
DR   PRO; PR:O00180; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000135750; -.
DR   CleanEx; HS_KCNK1; -.
DR   ExpressionAtlas; O00180; baseline and differential.
DR   Genevisible; O00180; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:1902937; C:inward rectifier potassium channel complex; IEA:Ensembl.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0034705; C:potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc.
DR   GO; GO:0005267; F:potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IDA:UniProtKB.
DR   GO; GO:0005272; F:sodium channel activity; IDA:UniProtKB.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0060075; P:regulation of resting membrane potential; IMP:UniProtKB.
DR   GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR005408; 2pore_dom_K_chnl_TWIK.
DR   InterPro; IPR001779; 2pore_dom_K_chnl_TWIK1.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01096; TWIK1CHANNEL.
DR   PRINTS; PR01586; TWIKCHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Cell projection;
KW   Complete proteome; Cytoplasmic vesicle; Disulfide bond; Endosome;
KW   Glycoprotein; Ion channel; Ion transport; Isopeptide bond; Membrane;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Synapse; Transmembrane; Transmembrane helix;
KW   Transport; Ubl conjugation.
FT   CHAIN         1    336       Potassium channel subfamily K member 1.
FT                                /FTId=PRO_0000101740.
FT   TOPO_DOM      1     20       Cytoplasmic.
FT                                {ECO:0000269|PubMed:22282804}.
FT   TRANSMEM     21     41       Helical. {ECO:0000269|PubMed:22282804}.
FT   TOPO_DOM     42    103       Extracellular.
FT                                {ECO:0000269|PubMed:22282804,
FT                                ECO:0000305|PubMed:8978667}.
FT   INTRAMEM    104    116       Helical; Name=Pore helix 1.
FT                                {ECO:0000269|PubMed:22282804}.
FT   INTRAMEM    117    122       {ECO:0000269|PubMed:22282804}.
FT   TOPO_DOM    123    132       Extracellular.
FT                                {ECO:0000269|PubMed:22282804}.
FT   TRANSMEM    133    156       Helical. {ECO:0000269|PubMed:22282804}.
FT   TOPO_DOM    157    181       Cytoplasmic.
FT                                {ECO:0000269|PubMed:22282804}.
FT   TRANSMEM    182    202       Helical. {ECO:0000269|PubMed:22282804}.
FT   TOPO_DOM    203    211       Extracellular.
FT                                {ECO:0000269|PubMed:22282804}.
FT   INTRAMEM    212    224       Helical; Name=Pore helix 2.
FT                                {ECO:0000269|PubMed:22282804}.
FT   INTRAMEM    225    231       {ECO:0000269|PubMed:22282804}.
FT   TOPO_DOM    232    243       Extracellular.
FT                                {ECO:0000269|PubMed:22282804}.
FT   TRANSMEM    244    267       Helical. {ECO:0000269|PubMed:22282804}.
FT   TOPO_DOM    268    336       Cytoplasmic.
FT                                {ECO:0000269|PubMed:22282804}.
FT   REGION      117    122       Selectivity filter 1.
FT                                {ECO:0000269|PubMed:22282804,
FT                                ECO:0000305|PubMed:21653227}.
FT   REGION      225    230       Selectivity filter 2.
FT                                {ECO:0000269|PubMed:22282804}.
FT   REGION      293    299       Important for intracellular retention in
FT                                recycling endosomes.
FT                                {ECO:0000269|PubMed:19959478}.
FT   SITE        118    118       Important for increased permeability to
FT                                Na(+) when K(+) levels are
FT                                subphysiological.
FT                                {ECO:0000269|PubMed:21653227}.
FT   SITE        146    146       Part of a hydrophobic barrier that is
FT                                stochastically dewetted and limits ion
FT                                permeability.
FT                                {ECO:0000269|PubMed:22431633,
FT                                ECO:0000269|PubMed:25001086}.
FT   SITE        261    261       Part of a hydrophobic barrier that is
FT                                stochastically dewetted and limits ion
FT                                permeability.
FT                                {ECO:0000269|PubMed:25001086}.
FT   MOD_RES     326    326       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z2T2}.
FT   CARBOHYD     95     95       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:8978667}.
FT   DISULFID     69     69       Interchain. {ECO:0000269|PubMed:22282804,
FT                                ECO:0000269|PubMed:8978667}.
FT   CROSSLNK    274    274       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:15820677,
FT                                ECO:0000269|PubMed:20498050}.
FT   MUTAGEN      69     69       C->A: Abolishes channel activity and
FT                                formation of disulfide-linked homodimers.
FT                                {ECO:0000269|PubMed:8978667}.
FT   MUTAGEN      95     95       N->A: Abolishes N-glycosylation.
FT                                {ECO:0000269|PubMed:8978667}.
FT   MUTAGEN     108    109       LF->FY: Impairs selectivity for K(+) ions
FT                                and increases permeability to Na(+) ions,
FT                                both at pH 7.4 and at pH 6.
FT                                {ECO:0000269|PubMed:22431633}.
FT   MUTAGEN     118    118       T->I: Abolishes change in ion selectivity
FT                                in the presence of subphysiological K(+)
FT                                levels. {ECO:0000269|PubMed:21653227}.
FT   MUTAGEN     122    122       H->K: Increases channel activity, and has
FT                                only a minor effect on the inhibition by
FT                                acidification of the extracellular
FT                                medium. {ECO:0000269|PubMed:22431633}.
FT   MUTAGEN     122    122       H->N: Decreases channel activity and
FT                                abolishes inhibition by acidification of
FT                                the extracellular medium.
FT                                {ECO:0000269|PubMed:15820677,
FT                                ECO:0000269|PubMed:20498050,
FT                                ECO:0000269|PubMed:22431633}.
FT   MUTAGEN     146    146       L->A,V: Does not increase the low
FT                                intrinsic channel activity.
FT                                {ECO:0000269|PubMed:25001086}.
FT   MUTAGEN     146    146       L->D: Increases channel activity.
FT                                {ECO:0000269|PubMed:22431633,
FT                                ECO:0000269|PubMed:25001086}.
FT   MUTAGEN     146    146       L->N,T: Increases channel activity.
FT                                {ECO:0000269|PubMed:25001086}.
FT   MUTAGEN     146    146       L->S: Increases channel activity.
FT                                Strongly increases channel activity; when
FT                                associated with S-261.
FT                                {ECO:0000269|PubMed:25001086}.
FT   MUTAGEN     161    161       T->A: No effect on channel activity.
FT                                {ECO:0000269|PubMed:8605869}.
FT   MUTAGEN     228    228       L->F: No effect on selectivity for K(+)
FT                                ions. {ECO:0000269|PubMed:22431633}.
FT   MUTAGEN     231    231       Y->F: Strongly decreases activity of
FT                                homodimeric channels and of heterodimeric
FT                                channels formed with KCNK3 and with
FT                                KCNK9. No effect on location at the cell
FT                                membrane. {ECO:0000269|PubMed:23169818}.
FT   MUTAGEN     250    250       T->L: Slighly decreases the increased
FT                                permeability to Na(+) ions at pH 6.
FT                                {ECO:0000269|PubMed:22431633}.
FT   MUTAGEN     261    261       L->D,N: Increases channel activity.
FT                                {ECO:0000269|PubMed:25001086}.
FT   MUTAGEN     261    261       L->S: Increases channel activity.
FT                                Strongly increases channel activity; when
FT                                associated with S-146.
FT                                {ECO:0000269|PubMed:25001086}.
FT   MUTAGEN     274    274       K->A,C,D,Q,R: Converts the electrically
FT                                silent channel that is present at the
FT                                cell membrane to an active channel.
FT                                {ECO:0000269|PubMed:20498050}.
FT   MUTAGEN     274    274       K->E: Converts the electrically silent
FT                                channel that is present at the cell
FT                                membrane to an active channel. No effect
FT                                on retention in recycling endosomes.
FT                                {ECO:0000269|PubMed:15820677,
FT                                ECO:0000269|PubMed:17693262,
FT                                ECO:0000269|PubMed:19959478,
FT                                ECO:0000269|PubMed:20498050,
FT                                ECO:0000269|PubMed:21653227,
FT                                ECO:0000269|PubMed:22431633}.
FT   MUTAGEN     293    294       II->AA: Strongly increases location at
FT                                the cell membrane.
FT                                {ECO:0000269|PubMed:19959478}.
FT   MUTAGEN     299    336       Missing: No effect on intracellular
FT                                retention in recycling endosomes.
FT                                {ECO:0000269|PubMed:19959478}.
FT   HELIX        19     66       {ECO:0000244|PDB:3UKM}.
FT   HELIX        72     86       {ECO:0000244|PDB:3UKM}.
FT   TURN         87     89       {ECO:0000244|PDB:3UKM}.
FT   HELIX       104    115       {ECO:0000244|PDB:3UKM}.
FT   HELIX       128    160       {ECO:0000244|PDB:3UKM}.
FT   TURN        163    167       {ECO:0000244|PDB:3UKM}.
FT   HELIX       177    195       {ECO:0000244|PDB:3UKM}.
FT   HELIX       197    206       {ECO:0000244|PDB:3UKM}.
FT   STRAND      207    209       {ECO:0000244|PDB:3UKM}.
FT   HELIX       212    223       {ECO:0000244|PDB:3UKM}.
FT   STRAND      236    238       {ECO:0000244|PDB:3UKM}.
FT   HELIX       242    268       {ECO:0000244|PDB:3UKM}.
FT   HELIX       271    278       {ECO:0000244|PDB:3UKM}.
SQ   SEQUENCE   336 AA;  38143 MW;  2A41D9501323215D CRC64;
     MLQSLAGSSC VRLVERHRSA WCFGFLVLGY LLYLVFGAVV FSSVELPYED LLRQELRKLK
     RRFLEEHECL SEQQLEQFLG RVLEASNYGV SVLSNASGNW NWDFTSALFF ASTVLSTTGY
     GHTVPLSDGG KAFCIIYSVI GIPFTLLFLT AVVQRITVHV TRRPVLYFHI RWGFSKQVVA
     IVHAVLLGFV TVSCFFFIPA AVFSVLEDDW NFLESFYFCF ISLSTIGLGD YVPGEGYNQK
     FRELYKIGIT CYLLLGLIAM LVVLETFCEL HELKKFRKMF YVKKDKDEDQ VHIIEHDQLS
     FSSITDQAAG MKEDQKQNEP FVATQSSACV DGPANH
//
ID   KCNK1_MOUSE             Reviewed;         336 AA.
AC   O08581; Q99L99;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   20-DEC-2017, entry version 150.
DE   RecName: Full=Potassium channel subfamily K member 1;
DE   AltName: Full=Inward rectifying potassium channel protein TWIK-1 {ECO:0000303|PubMed:9013852};
GN   Name=Kcnk1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9013852; DOI=10.1016/S0014-5793(96)01491-3;
RA   Lesage F., Lauritzen I., Duprat F., Reyes R., Fink M., Heurteaux C.,
RA   Lazdunski M.;
RT   "The structure, function and distribution of the mouse TWIK-1 K+
RT   channel.";
RL   FEBS Lett. 402:28-32(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RC   STRAIN=129/SvJ; TISSUE=Liver;
RX   PubMed=9559671; DOI=10.1016/S0014-5793(98)00260-9;
RA   Arrighi I., Lesage F., Scimeca J.-C., Carle G.F., Barhanin J.;
RT   "Structure, chromosome localization, and tissue distribution of the
RT   mouse twik K+ channel gene.";
RL   FEBS Lett. 425:310-316(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12855359; DOI=10.1016/S0378-5955(03)00162-X;
RA   Nicolas M.T., Barhanin J., Reyes R., Dememes D.;
RT   "Cellular localization of TWIK-1, a two-pore-domain potassium channel
RT   in the rodent inner ear.";
RL   Hear. Res. 181:20-26(2003).
RN   [6]
RP   IDENTIFICATION IN A COMPLEX WITH PSD AND ARF6, TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15540117; DOI=10.1038/sj.embor.7400292;
RA   Decressac S., Franco M., Bendahhou S., Warth R., Knauer S.,
RA   Barhanin J., Lazdunski M., Lesage F.;
RT   "ARF6-dependent interaction of the TWIK1 K+ channel with EFA6, a
RT   GDP/GTP exchange factor for ARF6.";
RL   EMBO Rep. 5:1171-1175(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16025300; DOI=10.1007/s00424-005-1480-9;
RA   Nie X., Arrighi I., Kaissling B., Pfaff I., Mann J., Barhanin J.,
RA   Vallon V.;
RT   "Expression and insights on function of potassium channel TWIK-1 in
RT   mouse kidney.";
RL   Pflugers Arch. 451:479-488(2005).
RN   [8]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=16847696; DOI=10.1007/s00424-006-0107-0;
RA   Millar I.D., Taylor H.C., Cooper G.J., Kibble J.D., Barhanin J.,
RA   Robson L.;
RT   "Adaptive downregulation of a quinidine-sensitive cation conductance
RT   in renal principal cells of TWIK-1 knockout mice.";
RL   Pflugers Arch. 453:107-116(2006).
RN   [9]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=17079103; DOI=10.1016/j.heares.2006.09.002;
RA   Chen W.C., Davis R.L.;
RT   "Voltage-gated and two-pore-domain potassium channels in murine spiral
RT   ganglion neurons.";
RL   Hear. Res. 222:89-99(2006).
RN   [10]
RP   DEVELOPMENTAL STAGE, AND TISSUE SPECIFICITY.
RX   PubMed=18222039; DOI=10.1016/j.neuroscience.2007.12.011;
RA   Aller M.I., Wisden W.;
RT   "Changes in expression of some two-pore domain potassium channel genes
RT   (KCNK) in selected brain regions of developing mice.";
RL   Neuroscience 151:1154-1172(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF 293-ILE-MET-294.
RX   PubMed=19959478; DOI=10.1074/jbc.M109.078535;
RA   Feliciangeli S., Tardy M.P., Sandoz G., Chatelain F.C., Warth R.,
RA   Barhanin J., Bendahhou S., Lesage F.;
RT   "Potassium channel silencing by constitutive endocytosis and
RT   intracellular sequestration.";
RL   J. Biol. Chem. 285:4798-4805(2010).
RN   [13]
RP   FUNCTION, TISSUE SPECIFICITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22431633; DOI=10.1073/pnas.1201132109;
RA   Chatelain F.C., Bichet D., Douguet D., Feliciangeli S., Bendahhou S.,
RA   Reichold M., Warth R., Barhanin J., Lesage F.;
RT   "TWIK1, a unique background channel with variable ion selectivity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:5499-5504(2012).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=24368895; DOI=10.3389/fncel.2013.00246;
RA   Wang W., Putra A., Schools G.P., Ma B., Chen H., Kaczmarek L.K.,
RA   Barhanin J., Lesage F., Zhou M.;
RT   "The contribution of TWIK-1 channels to astrocyte K(+) current is
RT   limited by retention in intracellular compartments.";
RL   Front. Cell. Neurosci. 7:246-246(2013).
RN   [15]
RP   REVIEW.
RX   PubMed=25530075; DOI=10.1113/jphysiol.2014.287268;
RA   Feliciangeli S., Chatelain F.C., Bichet D., Lesage F.;
RT   "The family of K2P channels: salient structural and functional
RT   properties.";
RL   J. Physiol. (Lond.) 593:2587-2603(2015).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=25406588; DOI=10.1186/s13041-014-0080-z;
RA   Yarishkin O., Lee D.Y., Kim E., Cho C.H., Choi J.H., Lee C.J.,
RA   Hwang E.M., Park J.Y.;
RT   "TWIK-1 contributes to the intrinsic excitability of dentate granule
RT   cells in mouse hippocampus.";
RL   Mol. Brain 7:80-80(2014).
RN   [17]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNK2 AND GNG4, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, MUTAGENESIS OF CYS-69 AND GLY-119, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=24496152; DOI=10.1038/ncomms4227;
RA   Hwang E.M., Kim E., Yarishkin O., Woo D.H., Han K.S., Park N., Bae Y.,
RA   Woo J., Kim D., Park M., Lee C.J., Park J.Y.;
RT   "A disulphide-linked heterodimer of TWIK-1 and TREK-1 mediates passive
RT   conductance in astrocytes.";
RL   Nat. Commun. 5:3227-3227(2014).
RN   [18]
RP   REVIEW.
RX   PubMed=25339226; DOI=10.1007/s00424-014-1631-y;
RA   Bichet D., Blin S., Feliciangeli S., Chatelain F.C., Bobak N.,
RA   Lesage F.;
RT   "Silent but not dumb: how cellular trafficking and pore gating
RT   modulate expression of TWIK1 and THIK2.";
RL   Pflugers Arch. 467:1121-1131(2015).
CC   -!- FUNCTION: Ion channel that contributes to passive transmembrane
CC       potassium transport and to the regulation of the resting membrane
CC       potential in brain astrocytes, but also in kidney and in other
CC       tissues (PubMed:16847696, PubMed:22431633, PubMed:24368895). Forms
CC       dimeric channels through which potassium ions pass in accordance
CC       with their electrochemical gradient. The channel is selective for
CC       K(+) ions at physiological potassium concentrations and at neutral
CC       pH, but becomes permeable to Na(+) at subphysiological K(+) levels
CC       and upon acidification of the extracellular medium. The homodimer
CC       has very low potassium channel activity, when expressed in
CC       heterologous systems, and can function as weakly inward rectifying
CC       potassium channel (PubMed:9013852, PubMed:24496152). Channel
CC       activity is modulated by activation of serotonin receptors
CC       (PubMed:24368895). Heterodimeric channels containing KCNK1 and
CC       KCNK2 have much higher activity, and may represent the predominant
CC       form in astrocytes (PubMed:24496152). Heterodimeric channels
CC       containing KCNK1 and KCNK3 or KCNK9 have much higher activity.
CC       Heterodimeric channels formed by KCNK1 and KCNK9 may contribute to
CC       halothane-sensitive currents (By similarity). Mediates outward
CC       rectifying potassium currents in dentate gyrus granule cells and
CC       contributes to the regulation of their resting membrane potential
CC       (PubMed:25406588). Contributes to the regulation of action
CC       potential firing in dentate gyrus granule cells and down-regulates
CC       their intrinsic excitability (PubMed:25406588). In astrocytes, the
CC       heterodimer formed by KCNK1 and KCNK2 is required for rapid
CC       glutamate release in response to activation of G-protein coupled
CC       receptors, such as F2R and CNR1 (PubMed:24496152). Required for
CC       normal ion and water transport in the kidney (PubMed:16025300).
CC       Contributes to the regulation of the resting membrane potential of
CC       pancreatic beta cells (PubMed:22431633). The low channel activity
CC       of homodimeric KCNK1 may be due to sumoylation. The low channel
CC       activity may be due to rapid internalization from the cell
CC       membrane and retention in recycling endosomes (PubMed:15540117).
CC       {ECO:0000250|UniProtKB:O00180, ECO:0000250|UniProtKB:Q9Z2T2,
CC       ECO:0000269|PubMed:15540117, ECO:0000269|PubMed:16025300,
CC       ECO:0000269|PubMed:16847696, ECO:0000269|PubMed:22431633,
CC       ECO:0000269|PubMed:24368895, ECO:0000269|PubMed:24496152,
CC       ECO:0000269|PubMed:9013852}.
CC   -!- ENZYME REGULATION: Inhibited by quinine, quinidine, barium, and
CC       internal acidification. {ECO:0000269|PubMed:9013852,
CC       ECO:0000305|PubMed:16847696}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Both activation and channel closure are very rapid. Is not
CC         voltage-gated (PubMed:22431633, PubMed:24496152). The
CC         relationship between voltage and current is nearly linear
CC         (PubMed:22431633, PubMed:24496152).
CC         {ECO:0000269|PubMed:22431633, ECO:0000269|PubMed:24496152,
CC         ECO:0000305};
CC   -!- SUBUNIT: Homodimer; disulfide-linked (PubMed:9013852). Heterodimer
CC       with KCNK2; disulfide-linked (PubMed:24496152). In astrocytes,
CC       forms mostly heterodimeric potassium channels with KCNK2, with
CC       only a minor proportion of functional channels containing
CC       homodimeric KCNK1 (By similarity). Interacts with KCNK3 and KCNK9,
CC       forming functional heterodimeric channels (By similarity).
CC       Interacts with GNG4 (PubMed:24496152). Identified in a complex
CC       with PSD and ARF6; interacts only with PSD that is bound to ARF6
CC       (PubMed:15540117). Interacts with UBE2I (By similarity).
CC       {ECO:0000250|UniProtKB:O00180, ECO:0000269|PubMed:15540117,
CC       ECO:0000269|PubMed:24496152, ECO:0000269|PubMed:9013852}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15540117,
CC       ECO:0000269|PubMed:19959478, ECO:0000269|PubMed:24368895,
CC       ECO:0000269|PubMed:24496152, ECO:0000269|PubMed:9013852}; Multi-
CC       pass membrane protein {ECO:0000305}. Recycling endosome
CC       {ECO:0000269|PubMed:15540117}. Apical cell membrane
CC       {ECO:0000269|PubMed:12855359, ECO:0000305|PubMed:16025300}.
CC       Cytoplasmic vesicle {ECO:0000269|PubMed:16025300,
CC       ECO:0000269|PubMed:24368895}. Perikaryon
CC       {ECO:0000269|PubMed:12855359, ECO:0000269|PubMed:17079103,
CC       ECO:0000269|PubMed:25406588}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:25406588}. Cell projection
CC       {ECO:0000269|PubMed:17079103}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q9Z2T2}. Note=The heterodimer with KCNK2 is
CC       detected at the astrocyte cell membrane (PubMed:24496152). Not
CC       detected at the astrocyte cell membrane when KCNK2 is absent
CC       (PubMed:24496152). Detected on neuronal cell bodies, and to a
CC       lesser degree on neuronal cell projections (PubMed:12855359,
CC       PubMed:17079103). Detected on hippocampus dentate gyrus granule
CC       cell bodies and to a lesser degree on proximal dendrites
CC       (PubMed:25406588). Detected in synaptic membranes. Detected at the
CC       apical cell membrane in stria vascularis in the cochlea (By
CC       similarity). Detected at the apical cell membrane of vestibular
CC       dark cells situated between the crista and the utricle in the
CC       inner ear (PubMed:12855359). Detected at the apical cell membrane
CC       in stria vascularis in the cochlea (PubMed:12855359). Detected at
CC       the apical cell membrane in kidney proximal tubule segment S1 and
CC       in subapical compartments in segments S1, S2 and S3
CC       (PubMed:16025300). Predominantly in cytoplasmic structures in
CC       kidney distal convoluted tubules and collecting ducts
CC       (PubMed:16025300). Predominantly in cytoplasmic structures in
CC       hippocampus astrocytes; only a minor proportion of the protein is
CC       present at the cell membrane (PubMed:24368895).
CC       {ECO:0000250|UniProtKB:Q9Z2T2, ECO:0000269|PubMed:16025300,
CC       ECO:0000269|PubMed:17079103, ECO:0000269|PubMed:24368895,
CC       ECO:0000269|PubMed:24496152, ECO:0000269|PubMed:25406588}.
CC   -!- TISSUE SPECIFICITY: Detected in spiral ganglion neurons
CC       (PubMed:17079103). Detected in hippocampus CA1 and CA1 regions and
CC       in the molecular layer of the dentate gyrus (PubMed:24368895,
CC       PubMed:25406588). Detected on hippocampus astrocytes
CC       (PubMed:24368895, PubMed:24496152). Highly expressed in the stria
CC       vascularis in the cochlea (PubMed:12855359). Detected in pancreas
CC       islet beta cells (PubMed:22431633). Detected in kidney, at brush
CC       border membranes in proximal tubules and in cytoplasmic structures
CC       in distal convoluted tubules, thick ascending limbs and collecting
CC       ducts (at protein level) (PubMed:15540117, PubMed:16025300).
CC       Widely expressed. Detected in spiral ganglion cells
CC       (PubMed:17079103). Highest expression in brain, kidney, thyroid,
CC       salivary gland, adrenal gland, prostate, epididymis, uterus,
CC       placenta, colon and jejunum. Moderate expression in eyes,
CC       pituitary, pancreas, smooth muscle, testis and ovary. Very low
CC       levels in lung, aorta, liver, heart, skeletal muscle, thymus and
CC       spleen. In the brain, highest expression in cerebellar granule
CC       cells, brainstem, hippocampus and cerebral cortex
CC       (PubMed:18222039). {ECO:0000269|PubMed:15540117,
CC       ECO:0000269|PubMed:16025300, ECO:0000269|PubMed:18222039,
CC       ECO:0000269|PubMed:22431633, ECO:0000269|PubMed:24368895,
CC       ECO:0000269|PubMed:25406588, ECO:0000269|PubMed:9013852,
CC       ECO:0000269|PubMed:9559671}.
CC   -!- DEVELOPMENTAL STAGE: Detected at very low levels in the embyonic
CC       central nervous system (PubMed:9559671, PubMed:18222039). Detected
CC       as early as 7 days post conception (PubMed:9559671). Detected in
CC       dorsal root ganglia, hippocampus, olfactory epithelia and
CC       intestine at 19 dpc (PubMed:18222039). Expression in the brain
CC       increases strongly 3-8 days after birth, a period of intense
CC       postnatal brain development (PubMed:9559671, PubMed:18222039).
CC       Detected in dentate granule cells; expression levels show no
CC       significant variability during postnatal development
CC       (PubMed:18222039). Expression is higher in adults than in neonates
CC       (PubMed:9559671, PubMed:18222039). {ECO:0000269|PubMed:18222039,
CC       ECO:0000269|PubMed:9559671}.
CC   -!- PTM: Sumoylation is controversial. Sumoylated by UBE2I. Not
CC       sumoylated when expressed in xenopus oocytes or mammalian cells.
CC       Sumoylation inactivates the channel, but does not interfere with
CC       expression at the cell membrane. Sumoylation of a single subunit
CC       is sufficient to silence the dimeric channel. Sumoylation of KCNK1
CC       is sufficient to silence heterodimeric channels formed by KCNK1
CC       and KCNK3 or KCNK9. Desumoylated by SENP1; this activates the
CC       channel. Desumoylated by SENP1; this strongly increases halothane-
CC       mediated activation of heterodimeric channels formed with KCNK9.
CC       SENP1 treatment has no effect. {ECO:0000250|UniProtKB:O00180}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype on standard chow,
CC       excepting a lower urinary flow rate (PubMed:16025300). Mice appear
CC       normal and are fertile (PubMed:24368895). When kept on a low
CC       phosphate diet, both wild-type and mutant mice show strongly
CC       reduced urinary phosphate secretion. Still, mutant mice display
CC       higher fractional urinary phosphate secretion relative to wild-
CC       type, leading to reduced inorganic phosphate levels in blood
CC       plasma. The impaired phosphate homeostasis seems to be due to
CC       indirect effects on the expression of other transporters, such as
CC       SLC34A1 and AQP2 (PubMed:16025300). Principal cells from kidney
CC       collecting duct are hyperpolarized, display reduced potassium
CC       conductance and strongly reduced quinidine-sensitive potassium
CC       channel activity (PubMed:16847696). Besides, collecting ducts from
CC       mutant mouse kidney display a larger diameter relative to wild-
CC       type (PubMed:16847696). {ECO:0000269|PubMed:16025300,
CC       ECO:0000269|PubMed:16847696, ECO:0000269|PubMed:24368895}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF033017; AAC16973.1; -; mRNA.
DR   EMBL; CH466525; EDL11808.1; -; Genomic_DNA.
DR   EMBL; BC003729; AAH03729.1; -; mRNA.
DR   CCDS; CCDS22783.1; -.
DR   RefSeq; NP_032456.2; NM_008430.2.
DR   UniGene; Mm.10800; -.
DR   ProteinModelPortal; O08581; -.
DR   BioGrid; 200907; 46.
DR   IntAct; O08581; 45.
DR   STRING; 10090.ENSMUSP00000046103; -.
DR   TCDB; 1.A.1.8.1; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O08581; -.
DR   PhosphoSitePlus; O08581; -.
DR   MaxQB; O08581; -.
DR   PaxDb; O08581; -.
DR   PeptideAtlas; O08581; -.
DR   PRIDE; O08581; -.
DR   Ensembl; ENSMUST00000046765; ENSMUSP00000046103; ENSMUSG00000033998.
DR   GeneID; 16525; -.
DR   KEGG; mmu:16525; -.
DR   UCSC; uc009nyr.3; mouse.
DR   CTD; 3775; -.
DR   MGI; MGI:109322; Kcnk1.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000286014; -.
DR   HOVERGEN; HBG052237; -.
DR   InParanoid; O08581; -.
DR   KO; K04912; -.
DR   OMA; VQRVTIH; -.
DR   OrthoDB; EOG091G0DIX; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-MMU-1299308; Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK).
DR   Reactome; R-MMU-5576886; Phase 4 - resting membrane potential.
DR   ChiTaRS; Kcnk1; mouse.
DR   PRO; PR:O08581; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   Bgee; ENSMUSG00000033998; -.
DR   CleanEx; MM_KCNK1; -.
DR   ExpressionAtlas; O08581; baseline and differential.
DR   Genevisible; O08581; MM.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; IDA:MGI.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:1902937; C:inward rectifier potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0034705; C:potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; IDA:MGI.
DR   GO; GO:0022841; F:potassium ion leak channel activity; ISS:UniProtKB.
DR   GO; GO:0005272; F:sodium channel activity; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; IC:MGI.
DR   GO; GO:0060075; P:regulation of resting membrane potential; ISS:UniProtKB.
DR   GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR005408; 2pore_dom_K_chnl_TWIK.
DR   InterPro; IPR001779; 2pore_dom_K_chnl_TWIK1.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01096; TWIK1CHANNEL.
DR   PRINTS; PR01586; TWIKCHANNEL.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Complete proteome;
KW   Cytoplasmic vesicle; Disulfide bond; Endosome; Glycoprotein;
KW   Ion channel; Ion transport; Isopeptide bond; Membrane; Phosphoprotein;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Synapse; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation.
FT   CHAIN         1    336       Potassium channel subfamily K member 1.
FT                                /FTId=PRO_0000101741.
FT   TOPO_DOM      1     20       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   TRANSMEM     21     41       Helical. {ECO:0000250|UniProtKB:O00180}.
FT   TOPO_DOM     42    103       Extracellular.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   INTRAMEM    104    116       Helical; Name=Pore helix 1.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   INTRAMEM    117    122       {ECO:0000250|UniProtKB:O00180}.
FT   TOPO_DOM    123    132       Extracellular.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   TRANSMEM    133    156       Helical. {ECO:0000250|UniProtKB:O00180}.
FT   TOPO_DOM    157    181       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   TRANSMEM    182    202       Helical. {ECO:0000250|UniProtKB:O00180}.
FT   TOPO_DOM    203    211       Extracellular.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   INTRAMEM    212    224       Helical; Name=Pore helix 2.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   INTRAMEM    225    231       {ECO:0000250|UniProtKB:O00180}.
FT   TOPO_DOM    232    243       Extracellular.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   TRANSMEM    244    267       Helical. {ECO:0000250|UniProtKB:O00180}.
FT   TOPO_DOM    268    336       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   REGION      117    122       Selectivity filter 1.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   REGION      225    230       Selectivity filter 2.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   REGION      293    299       Important for intracellular retention in
FT                                recycling endosomes.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   SITE        118    118       Important for increased permeability to
FT                                Na(+) when K(+) levels are
FT                                subphysiological.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   SITE        146    146       Part of a hydrophobic barrier that is
FT                                stochastically dewetted and limits ion
FT                                permeability.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   SITE        261    261       Part of a hydrophobic barrier that is
FT                                stochastically dewetted and limits ion
FT                                permeability.
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   MOD_RES     326    326       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z2T2}.
FT   CARBOHYD     95     95       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     69     69       Interchain.
FT                                {ECO:0000250|UniProtKB:O00180,
FT                                ECO:0000269|PubMed:24496152}.
FT   CROSSLNK    274    274       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000250|UniProtKB:O00180}.
FT   MUTAGEN      69     69       C->S: Abolishes formation of a disulfide-
FT                                linked heterodimer with KCNK2.
FT                                {ECO:0000269|PubMed:24496152}.
FT   MUTAGEN     119    119       G->E: Abolishes potassium channel
FT                                activity. {ECO:0000269|PubMed:24496152}.
FT   MUTAGEN     293    294       IM->AA: Increases channel expression at
FT                                the cell membrane, resulting in higher
FT                                channel activity.
FT                                {ECO:0000269|PubMed:19959478}.
FT   CONFLICT     44     44       V -> E (in Ref. 1; AAC16973).
FT                                {ECO:0000305}.
FT   CONFLICT    152    152       V -> L (in Ref. 1; AAC16973).
FT                                {ECO:0000305}.
FT   CONFLICT    259    259       A -> T (in Ref. 1; AAC16973).
FT                                {ECO:0000305}.
SQ   SEQUENCE   336 AA;  38201 MW;  76B7FD5361A6216C CRC64;
     MLQSLAGSSC VRLVERHRSA WCFGFLVLGY LLYLVFGAVV FSSVELPYED LLRQELRKLK
     RRFLEEHECL SEPQLEQFLG RVLEASNYGV SVLSNASGNW NWDFTSALFF ASTVLSTTGY
     GHTVPLSDGG KAFCIIYSVI GIPFTLLFLT AVVQRVTVHV TRRPVLYFHI RWGFSKQVVA
     IVHAVLLGFV TVSCFFFIPA AVFSVLEDDW NFLESFYFCF ISLSTIGLGD YVPGEGYNQK
     FRELYKIGIT CYLLLGLIAM LVVLETFCEL HELKKFRKMF YVKKDKDEDL VHIMEHDQLS
     FSSVTEQVAG LKEEQKQSEP FVASQSPPYE DGSADH
//
ID   KCNK3_HUMAN             Reviewed;         394 AA.
AC   O14649; Q53SU2;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   20-DEC-2017, entry version 157.
DE   RecName: Full=Potassium channel subfamily K member 3;
DE   AltName: Full=Acid-sensitive potassium channel protein TASK-1;
DE   AltName: Full=TWIK-related acid-sensitive K(+) channel 1;
DE   AltName: Full=Two pore potassium channel KT3.1;
DE            Short=Two pore K(+) channel KT3.1;
GN   Name=KCNK3; Synonyms=TASK, TASK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Kidney;
RX   PubMed=9312005; DOI=10.1093/emboj/16.17.5464;
RA   Duprat F., Lesage F., Fink M., Reyes R., Heurteaux C., Lazdunski M.;
RT   "TASK, a human background K+ channel to sense external pH variations
RT   near physiological pH.";
RL   EMBO J. 16:5464-5471(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RX   PubMed=10748056; DOI=10.1074/jbc.M001948200;
RA   Lopes C.M.B., Gallagher P.G., Buck M.E., Butler M.H.,
RA   Goldstein S.A.N.;
RT   "Proton block and voltage gating are potassium-dependent in the
RT   cardiac leak channel Kcnk3.";
RL   J. Biol. Chem. 275:16969-16978(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   ACTIVATION.
RX   PubMed=10321245; DOI=10.1038/8084;
RA   Patel A.J., Honore E., Lesage F., Fink M., Romey G., Lazdunski M.;
RT   "Inhalational anesthetics activate two-pore-domain background K+
RT   channels.";
RL   Nat. Neurosci. 2:422-426(1999).
RN   [6]
RP   MUTAGENESIS OF HIS-98.
RX   PubMed=11680614; DOI=10.1007/s004240100620;
RA   Ashmole I., Goodwin P.A., Stanfield P.R.;
RT   "TASK-5, a novel member of the tandem pore K+ channel family.";
RL   Pflugers Arch. 442:828-833(2001).
RN   [7]
RP   INTERACTION WITH KCNK1, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23169818; DOI=10.1126/scisignal.2003431;
RA   Plant L.D., Zuniga L., Araki D., Marks J.D., Goldstein S.A.;
RT   "SUMOylation silences heterodimeric TASK potassium channels containing
RT   K2P1 subunits in cerebellar granule neurons.";
RL   Sci. Signal. 5:RA84-RA84(2012).
RN   [8]
RP   VARIANTS PPH4 LYS-8; ARG-97; LYS-182; CYS-192; ASP-203 AND LEU-221,
RP   AND CHARACTERIZATION OF VARIANTS PPH4 LYS-8; ARG-97; LYS-182; CYS-192;
RP   ASP-203 AND LEU-221.
RX   PubMed=23883380; DOI=10.1056/NEJMoa1211097;
RA   Ma L., Roman-Campos D., Austin E.D., Eyries M., Sampson K.S.,
RA   Soubrier F., Germain M., Tregouet D.A., Borczuk A., Rosenzweig E.B.,
RA   Girerd B., Montani D., Humbert M., Loyd J.E., Kass R.S., Chung W.K.;
RT   "A novel channelopathy in pulmonary arterial hypertension.";
RL   N. Engl. J. Med. 369:351-361(2013).
CC   -!- FUNCTION: pH-dependent, voltage-insensitive, background potassium
CC       channel protein. Rectification direction results from potassium
CC       ion concentration on either side of the membrane. Acts as an
CC       outward rectifier when external potassium concentration is low.
CC       When external potassium concentration is high, current is inward.
CC       {ECO:0000269|PubMed:23169818, ECO:0000269|PubMed:9312005}.
CC   -!- SUBUNIT: Homodimer (Probable). Heterodimer with KCNK1.
CC       {ECO:0000269|PubMed:23169818, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23169818};
CC       Multi-pass membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Widespread expression in adult. Strongest
CC       expression in pancreas and placenta. Lower expression in brain,
CC       lung, prostate, heart, kidney, uterus, small intestine and colon.
CC   -!- DISEASE: Pulmonary hypertension, primary, 4 (PPH4) [MIM:615344]: A
CC       rare disorder characterized by plexiform lesions of proliferating
CC       endothelial cells in pulmonary arterioles. The lesions lead to
CC       elevated pulmonary arterial pression, right ventricular failure,
CC       and death. The disease can occur from infancy throughout life and
CC       it has a mean age at onset of 36 years. Penetrance is reduced.
CC       Although familial pulmonary hypertension is rare, cases secondary
CC       to known etiologies are more common and include those associated
CC       with the appetite-suppressant drugs.
CC       {ECO:0000269|PubMed:23883380}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Inhibited by external acidification. Activated by
CC       halothane and isoflurane.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF006823; AAC51777.1; -; mRNA.
DR   EMBL; AF065163; AAG29340.1; -; mRNA.
DR   EMBL; AC015977; AAY24312.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00678.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00679.1; -; Genomic_DNA.
DR   CCDS; CCDS1727.1; -.
DR   RefSeq; NP_002237.1; NM_002246.2.
DR   UniGene; Hs.24040; -.
DR   UniGene; Hs.645288; -.
DR   ProteinModelPortal; O14649; -.
DR   SMR; O14649; -.
DR   BioGrid; 109978; 3.
DR   IntAct; O14649; 1.
DR   MINT; MINT-1645466; -.
DR   STRING; 9606.ENSP00000306275; -.
DR   BindingDB; O14649; -.
DR   ChEMBL; CHEMBL2321613; -.
DR   DrugBank; DB00561; Doxapram.
DR   DrugBank; DB01159; Halothane.
DR   GuidetoPHARMACOLOGY; 515; -.
DR   TCDB; 1.A.1.9.2; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O14649; -.
DR   PhosphoSitePlus; O14649; -.
DR   BioMuta; KCNK3; -.
DR   PaxDb; O14649; -.
DR   PeptideAtlas; O14649; -.
DR   PRIDE; O14649; -.
DR   Ensembl; ENST00000302909; ENSP00000306275; ENSG00000171303.
DR   GeneID; 3777; -.
DR   KEGG; hsa:3777; -.
DR   UCSC; uc002rhn.3; human.
DR   CTD; 3777; -.
DR   DisGeNET; 3777; -.
DR   EuPathDB; HostDB:ENSG00000171303.6; -.
DR   GeneCards; KCNK3; -.
DR   HGNC; HGNC:6278; KCNK3.
DR   MalaCards; KCNK3; -.
DR   MIM; 603220; gene.
DR   MIM; 615344; phenotype.
DR   neXtProt; NX_O14649; -.
DR   OpenTargets; ENSG00000171303; -.
DR   Orphanet; 275777; Heritable pulmonary arterial hypertension.
DR   Orphanet; 275766; Idiopathic pulmonary arterial hypertension.
DR   PharmGKB; PA30060; -.
DR   eggNOG; KOG4404; Eukaryota.
DR   eggNOG; ENOG410XRZJ; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000231463; -.
DR   HOVERGEN; HBG052239; -.
DR   InParanoid; O14649; -.
DR   KO; K04914; -.
DR   OMA; CSGTQRS; -.
DR   OrthoDB; EOG091G08DH; -.
DR   PhylomeDB; O14649; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-HSA-1299316; TWIK-releated acid-sensitive K+ channel (TASK).
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   SIGNOR; O14649; -.
DR   GeneWiki; KCNK3; -.
DR   GenomeRNAi; 3777; -.
DR   PRO; PR:O14649; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000171303; -.
DR   CleanEx; HS_KCNK3; -.
DR   ExpressionAtlas; O14649; baseline and differential.
DR   Genevisible; O14649; HS.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IMP:UniProtKB.
DR   GO; GO:0008083; F:growth factor activity; IEA:InterPro.
DR   GO; GO:0005216; F:ion channel activity; IMP:UniProtKB.
DR   GO; GO:0005252; F:open rectifier potassium channel activity; IEA:Ensembl.
DR   GO; GO:0005267; F:potassium channel activity; TAS:Reactome.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IDA:UniProtKB.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0044548; F:S100 protein binding; IPI:UniProtKB.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:0071294; P:cellular response to zinc ion; IEA:Ensembl.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0090102; P:cochlea development; IEA:Ensembl.
DR   GO; GO:0034220; P:ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR022341; IGF-I.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR005406; KCNK3.
DR   PANTHER; PTHR11003:SF138; PTHR11003:SF138; 1.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01584; TASK1CHANNEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disease mutation; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    394       Potassium channel subfamily K member 3.
FT                                /FTId=PRO_0000101744.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      9     29       Helical. {ECO:0000255}.
FT   INTRAMEM     78    101       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    108    128       Helical. {ECO:0000255}.
FT   TOPO_DOM    129    158       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical. {ECO:0000255}.
FT   INTRAMEM    184    207       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    223    243       Helical. {ECO:0000255}.
FT   TOPO_DOM    244    394       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT       8      8       T -> K (in PPH4; loss of function;
FT                                channel activity can be rescued with the
FT                                use of the phospholipase A2 inhibitor
FT                                ONO-RS-082).
FT                                {ECO:0000269|PubMed:23883380}.
FT                                /FTId=VAR_070126.
FT   VARIANT      97     97       G -> R (in PPH4; loss of function;
FT                                dbSNP:rs398123040).
FT                                {ECO:0000269|PubMed:23883380}.
FT                                /FTId=VAR_070127.
FT   VARIANT     182    182       E -> K (in PPH4; loss of function;
FT                                channel activity can be rescued with the
FT                                use of the phospholipase A2 inhibitor
FT                                ONO-RS-082; dbSNP:rs398123042).
FT                                {ECO:0000269|PubMed:23883380}.
FT                                /FTId=VAR_070128.
FT   VARIANT     192    192       Y -> C (in PPH4; loss of function;
FT                                dbSNP:rs398123043).
FT                                {ECO:0000269|PubMed:23883380}.
FT                                /FTId=VAR_070129.
FT   VARIANT     203    203       G -> D (in PPH4; loss of function;
FT                                channel activity cannot be rescued with
FT                                the use of the phospholipase A2 inhibitor
FT                                ONO-RS-082; dbSNP:rs398123039).
FT                                {ECO:0000269|PubMed:23883380}.
FT                                /FTId=VAR_070130.
FT   VARIANT     221    221       V -> L (in PPH4; loss of function;
FT                                dbSNP:rs398123041).
FT                                {ECO:0000269|PubMed:23883380}.
FT                                /FTId=VAR_070131.
FT   MUTAGEN      98     98       H->N: Greatly reduces pH sensitivity.
FT                                {ECO:0000269|PubMed:11680614}.
SQ   SEQUENCE   394 AA;  43518 MW;  9FF4C8266F615FB7 CRC64;
     MKRQNVRTLA LIVCTFTYLL VGAAVFDALE SEPELIERQR LELRQQELRA RYNLSQGGYE
     ELERVVLRLK PHKAGVQWRF AGSFYFAITV ITTIGYGHAA PSTDGGKVFC MFYALLGIPL
     TLVMFQSLGE RINTLVRYLL HRAKKGLGMR RADVSMANMV LIGFFSCIST LCIGAAAFSH
     YEHWTFFQAY YYCFITLTTI GFGDYVALQK DQALQTQPQY VAFSFVYILT GLTVIGAFLN
     LVVLRFMTMN AEDEKRDAEH RALLTRNGQA GGGGGGGSAH TTDTASSTAA AGGGGFRNVY
     AEVLHFQSMC SCLWYKSREK LQYSIPMIIP RDLSTSDTCV EQSHSSPGGG GRYSDTPSRR
     CLCSGAPRSA ISSVSTGLHS LSTFRGLMKR RSSV
//
ID   SUP9_CAEEL              Reviewed;         329 AA.
AC   O17185; O76795;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 2.
DT   25-OCT-2017, entry version 121.
DE   RecName: Full=Two pore potassium channel protein sup-9;
DE   AltName: Full=Suppressor of unc-93 protein 9;
DE   AltName: Full=n2P38;
GN   Name=sup-9 {ECO:0000312|WormBase:F34D6.3}; ORFNames=F34D6.3;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAQ84518.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, DEVELOPMENTAL STAGE, AND MUTAGENESIS OF MET-1; GLY-22;
RP   ALA-23; VAL-41; VAL-44; ASP-58; ILE-61; ALA-74; ILE-94; GLY-95;
RP   PRO-101; THR-103; GLY-106; PHE-109; PRO-119; GLY-121; LEU-122;
RP   TRP-165; GLY-172; GLY-173; ALA-174; GLU-181; TYR-190; THR-195;
RP   GLY-200; GLY-202; ASP-203; PHE-226; GLY-230; SER-235; ALA-236 AND
RP   VAL-242.
RC   STRAIN=Bristol N2 {ECO:0000269|PubMed:14534247};
RX   PubMed=14534247;
RA   de la Cruz I.P., Levin J.Z., Cummins C., Anderson P., Horvitz H.R.;
RT   "sup-9, sup-10, and unc-93 may encode components of a two-pore K+
RT   channel that coordinates muscle contraction in Caenorhabditis
RT   elegans.";
RL   J. Neurosci. 23:9133-9145(2003).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAC32863.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Wang Z.-W., Salkoff L.;
RT   "Potassium channels in C. elegans.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [4] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=11301195; DOI=10.1016/S0306-4522(01)00079-3;
RA   Salkoff L., Butler A., Fawcett G., Kunkel M., McArdle C.,
RA   Paz-y-Mino G., Nonet M., Walton N., Wang Z.-W., Yuan A., Wei A.;
RT   "Evolution tunes the excitability of individual neurons.";
RL   Neuroscience 103:853-859(2001).
RN   [5]
RP   FUNCTION, REGION, AND MUTAGENESIS OF ASP-27; THR-100; LEU-122;
RP   ARG-244; SER-292; SER-294 AND LEU-303.
RX   PubMed=24586202; DOI=10.1371/journal.pgen.1004175;
RA   de la Cruz I.P., Ma L., Horvitz H.R.;
RT   "The Caenorhabditis elegans iodotyrosine deiodinase ortholog SUP-18
RT   functions through a conserved channel SC-box to regulate the muscle
RT   two-pore domain potassium channel SUP-9.";
RL   PLoS Genet. 10:E1004175-E1004175(2014).
CC   -!- FUNCTION: Potassium channel involved in coordination of muscle
CC       contraction (PubMed:14534247). Activity is regulated by sup-18
CC       (PubMed:24586202). {ECO:0000269|PubMed:14534247,
CC       ECO:0000269|PubMed:24586202}.
CC   -!- SUBUNIT: May form a complex with the regulatory subunits unc-93
CC       and sup-10. {ECO:0000303|PubMed:14534247}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}. Note=Associated with dense bodies.
CC       {ECO:0000269|PubMed:14534247}.
CC   -!- TISSUE SPECIFICITY: Low levels along surface of body-wall muscle
CC       cells, in vulval and intestinal muscles and, more weakly, in anal
CC       depressor and sphincter muscles. Also expressed in a subset of
CC       head neurons. {ECO:0000269|PubMed:11301195,
CC       ECO:0000269|PubMed:14534247}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in body wall muscles from 3.5-fold
CC       stage of embryogenesis with highest levels in late embryos and L1
CC       stage larvae. Lower levels persist to adulthood.
CC       {ECO:0000269|PubMed:14534247}.
CC   -!- MISCELLANEOUS: Uncoordinated rubber band response is phenocopied
CC       by exposure to the unc-49 agonist muscimol.
CC       {ECO:0000269|PubMed:14534247}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000255}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY357729; AAQ84518.1; -; mRNA.
DR   EMBL; AF083652; AAC32863.1; -; mRNA.
DR   EMBL; FO081204; CCD69862.1; -; Genomic_DNA.
DR   PIR; T32347; T32347.
DR   PIR; T43509; T43509.
DR   RefSeq; NP_494333.1; NM_061932.3.
DR   UniGene; Cel.14253; -.
DR   ProteinModelPortal; O17185; -.
DR   STRING; 6239.F34D6.3; -.
DR   TCDB; 1.A.1.9.7; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; O17185; -.
DR   EnsemblMetazoa; F34D6.3; F34D6.3; WBGene00006318.
DR   GeneID; 173613; -.
DR   KEGG; cel:CELE_F34D6.3; -.
DR   UCSC; F34D6.3; c. elegans.
DR   CTD; 173613; -.
DR   WormBase; F34D6.3; CE28297; WBGene00006318; sup-9.
DR   eggNOG; KOG4404; Eukaryota.
DR   eggNOG; ENOG410XRZJ; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000231463; -.
DR   InParanoid; O17185; -.
DR   KO; K04919; -.
DR   OMA; MTMNTED; -.
DR   OrthoDB; EOG091G08DH; -.
DR   PhylomeDB; O17185; -.
DR   Reactome; R-CEL-1299316; TWIK-releated acid-sensitive K+ channel (TASK).
DR   Reactome; R-CEL-5576886; Phase 4 - resting membrane potential.
DR   PRO; PR:O17185; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00006318; -.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:WormBase.
DR   GO; GO:0036195; C:muscle cell projection membrane; IDA:WormBase.
DR   GO; GO:0055120; C:striated muscle dense body; IDA:WormBase.
DR   GO; GO:0005267; F:potassium channel activity; TAS:UniProtKB.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; TAS:UniProtKB.
DR   GO; GO:0006937; P:regulation of muscle contraction; IMP:UniProtKB.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    329       Two pore potassium channel protein sup-9.
FT                                /FTId=PRO_0000101770.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      9     29       Helical. {ECO:0000255}.
FT   INTRAMEM     80    100       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    108    128       Helical. {ECO:0000255}.
FT   TOPO_DOM    129    157       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    158    178       Helical. {ECO:0000255}.
FT   INTRAMEM    186    206       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    220    240       Helical. {ECO:0000255}.
FT   TOPO_DOM    241    329       Cytoplasmic. {ECO:0000255}.
FT   REGION      289    296       May be important for regulation by and/or
FT                                interaction with sup-10.
FT                                {ECO:0000303|PubMed:24586202}.
FT   MOTIF        93     98       Selectivity filter. {ECO:0000255}.
FT   MOTIF       198    203       Selectivity filter. {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    182    182       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN       1      1       M->I: In n2282; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN      22     22       G->E: In n213; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN      23     23       A->V: In lr129; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN      27     27       D->N: In n4265 and n3975; loss of
FT                                function. Not required for sup-18
FT                                mediated regulation.
FT                                {ECO:0000269|PubMed:24586202}.
FT   MUTAGEN      41     41       V->A: In n1472; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN      44     44       V->E: In n233; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN      58     58       D->V: In n2291; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN      61     61       I->S: In lr35; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN      74     74       A->V: In n1025; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN      94     94       I->N: In n1016; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN      95     95       G->D: In n1020 and n2354; loss of
FT                                function. {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     100    100       T->I: In n3976; loss of function. Not
FT                                required for sup-18 mediated regulation.
FT                                {ECO:0000269|PubMed:24586202}.
FT   MUTAGEN     101    101       P->S: In n190, n598, n2353 and n2356;
FT                                loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     103    103       T->I: In n2347; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     106    106       G->E: In n1009; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     106    106       G->R: In n2351; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     109    109       F->S: In lr45; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     119    119       P->S: In n2281 and n2345; loss of
FT                                function. {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     121    121       G->R: In lr100; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     122    122       L->F: In n264 and n3977; loss of
FT                                function. Not required for sup-18
FT                                mediated regulation.
FT                                {ECO:0000269|PubMed:14534247,
FT                                ECO:0000269|PubMed:24586202}.
FT   MUTAGEN     165    165       W->R: In lr38; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     172    172       G->E: In n219; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     172    172       G->R: In n223 and n2355; loss of
FT                                function. {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     173    173       G->E: In n2288; partial loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     173    173       G->R: In n2294 and n2296; loss of
FT                                function. {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     174    174       A->T: In n2359; partial loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     181    181       E->K: In n2350; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     190    190       Y->F: In n2352; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     195    195       T->I: In n2278 and n2343; loss of
FT                                function. {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     200    200       G->E: In n191, n2283 and n2286; loss of
FT                                function. {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     202    202       G->D: In n2344; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     202    202       G->S: In n1469; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     203    203       D->A: In lr1; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     203    203       D->N: In n2346 and n2349; loss of
FT                                function. {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     226    226       F->S: In n1557; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     230    230       G->E: In n2176; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     230    230       G->R: In n2348; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     235    235       S->F: In n189 and n2358; loss of
FT                                function. {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     236    236       A->M: In n2360 and n2361; partial loss of
FT                                function. {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     236    236       A->T: In n1550, n3310, e2655 and 2661;
FT                                gain of function, uncoordinated rubber
FT                                band response in heterozygous mutants,
FT                                inviable in homozygous mutants.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     242    242       V->M: In lr142; loss of function.
FT                                {ECO:0000269|PubMed:14534247}.
FT   MUTAGEN     244    244       R->W: In n3935; loss of function.
FT                                {ECO:0000269|PubMed:24586202}.
FT   MUTAGEN     292    292       S->A: In n4259; loss of function.
FT                                {ECO:0000269|PubMed:24586202}.
FT   MUTAGEN     292    292       S->F: In n1435, n3942, n4253 and n4254;
FT                                loss of function.
FT                                {ECO:0000269|PubMed:24586202}.
FT   MUTAGEN     293    293       C->A: Loss of function.
FT                                {ECO:0000269|PubMed:24586202}.
FT   MUTAGEN     294    294       S->A: In n4262; loss of function.
FT                                {ECO:0000269|PubMed:24586202}.
FT   MUTAGEN     295    295       C->A: Loss of function.
FT                                {ECO:0000269|PubMed:24586202}.
FT   MUTAGEN     296    296       Y->A: Loss of function.
FT                                {ECO:0000269|PubMed:24586202}.
FT   MUTAGEN     303    303       L->P: In n4269; loss of function.
FT                                {ECO:0000269|PubMed:24586202}.
SQ   SEQUENCE   329 AA;  36992 MW;  338A6D9A577464CD CRC64;
     MKRQNIRTLS LIVCTLTYLL VGAAVFDALE TENEILQRKL VQRVREKLKT KYNMSNADYE
     ILEATIVKSV PHKAGYQWKF SGAFYFATTV ITTIGYGHST PMTDAGKVFC MLYALAGIPL
     GLIMFQSIGE RMNTFAAKLL RFIRRAAGKQ PIVTSSDLII FCTGWGGLLI FGGAFMFSSY
     ENWTYFDAVY YCFVTLTTIG FGDYVALQKR GSLQTQPEYV FFSLVFILFG LTVISAAMNL
     LVLRFLTMNT EDERRDEQEA ILAAQGLVRV GDPTADDDFG RLPLSDNVSL ASCSCYQLPD
     EKLRHRHRKH TEPHGGPPTF SGMTTRPKY
//
ID   KCNS1_MOUSE             Reviewed;         497 AA.
AC   O35173; A2A5M1;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   22-NOV-2017, entry version 137.
DE   RecName: Full=Potassium voltage-gated channel subfamily S member 1;
DE   AltName: Full=Delayed-rectifier K(+) channel alpha subunit 1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv9.1;
GN   Name=Kcns1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9305895; DOI=10.1074/jbc.272.39.24371;
RA   Salinas M., Duprat F., Heurteaux C., Hugnot J.-P., Lazdunski M.;
RT   "New modulatory alpha subunits for mammalian Shab K+ channels.";
RL   J. Biol. Chem. 272:24371-24379(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Can form functional heterotetrameric channels
CC       with KCNB1 and KCNB2; modulates the delayed rectifier voltage-
CC       gated potassium channel activation and deactivation rates of KCNB1
CC       and KCNB2 (PubMed:9305895). {ECO:0000269|PubMed:9305895}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1 and KCNB2 (PubMed:9305895).
CC       Does not form homomultimers (PubMed:9305895).
CC       {ECO:0000269|PubMed:9305895}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9305895};
CC       Multi-pass membrane protein {ECO:0000305}. Note=May not reach the
CC       plasma membrane but remain in an intracellular compartment in the
CC       absence of KCNB1 or KCNB2 (PubMed:9305895).
CC       {ECO:0000269|PubMed:9305895}.
CC   -!- TISSUE SPECIFICITY: Detected in brain, but not in the other
CC       tissues tested. The highest levels of expression are in olfactory
CC       bulb, cerebral cortex, hippocampus, habenula, basolateral
CC       amygdaloid nuclei and cerebellum (PubMed:9305895).
CC       {ECO:0000269|PubMed:9305895}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. S (TC
CC       1.A.1.2) subfamily. Kv9.1/KCNS1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF008573; AAB72050.1; -; mRNA.
DR   EMBL; AL591512; CAM21684.1; -; Genomic_DNA.
DR   EMBL; CH466551; EDL06364.1; -; Genomic_DNA.
DR   CCDS; CCDS17022.1; -.
DR   RefSeq; NP_032461.2; NM_008435.2.
DR   UniGene; Mm.6217; -.
DR   ProteinModelPortal; O35173; -.
DR   STRING; 10090.ENSMUSP00000038901; -.
DR   PhosphoSitePlus; O35173; -.
DR   PaxDb; O35173; -.
DR   PRIDE; O35173; -.
DR   DNASU; 16538; -.
DR   Ensembl; ENSMUST00000045196; ENSMUSP00000038901; ENSMUSG00000040164.
DR   GeneID; 16538; -.
DR   KEGG; mmu:16538; -.
DR   UCSC; uc008ntv.1; mouse.
DR   CTD; 3787; -.
DR   MGI; MGI:1197019; Kcns1.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; O35173; -.
DR   KO; K04931; -.
DR   OMA; PCPDEIS; -.
DR   OrthoDB; EOG091G0FP3; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-MMU-1296072; Voltage gated Potassium channels.
DR   PRO; PR:O35173; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   Bgee; ENSMUSG00000040164; -.
DR   CleanEx; MM_KCNS1; -.
DR   Genevisible; O35173; MM.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0015459; F:potassium channel regulator activity; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    497       Potassium voltage-gated channel subfamily
FT                                S member 1.
FT                                /FTId=PRO_0000054082.
FT   TOPO_DOM      1    186       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    187    208       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    209    239       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    240    262       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    263    273       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    274    291       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    292    309       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    310    330       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    331    345       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    346    367       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    368    379       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    380    391       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    392    399       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    400    406       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    407    435       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    436    497       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       392    397       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   COMPBIAS    219    228       Poly-Ala.
FT   CONFLICT    440    440       A -> G (in Ref. 1; AAB72050).
FT                                {ECO:0000305}.
SQ   SEQUENCE   497 AA;  54918 MW;  F734A3D4B093BEBE CRC64;
     MVSEFPGPGS RVPWRPRDEA LRVNVGGVRR LLSARALARF PGTRLGRLQA AASEEQARRL
     CDDYDAAAHE FYFDRHPGFF LGLLHFYRTG HLHVLDELCV FAFGQEADYW GLGENALATC
     CRARYLERRV ARPRAWDEDS DAPSSVDPCP DEISDVQREL ARYGAARCGR LRRRLWLTME
     NPGYSLPSKL FSCVSIGVVL ASIAAMCIHS LPEYQAREAA AAVAAVAAGR SAEEVRDDPV
     LRRLEYFCIA WFSFEVSSRL LLAPSTRNFF CHPLNLIDIV SVLPFYLTLL AGAALGDQRG
     ASGEELGDLG KVVQVFRLMR IFRVLKLARH STGLRSLGAT LKHSYREVGI LLLYLAVGVS
     VFSGVAYTAE EENEGFHTIP ACWWWGTVSM TTVGYGDVVP ETVGGKLAAS GCILGGILVV
     ALPITIIFNK FSHFYRRQKA LEAAVRSSGQ REFEDLLSSV DGVSDVSLET SRDTSQEGRS
     TDLETQAPRE PAKSHSY
//
ID   KCNQ2_HUMAN             Reviewed;         872 AA.
AC   O43526; O43796; O75580; O95845; Q4VXP4; Q4VXR6; Q5VYT8; Q96J59;
AC   Q99454;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   20-DEC-2017, entry version 190.
DE   RecName: Full=Potassium voltage-gated channel subfamily KQT member 2 {ECO:0000305};
DE   AltName: Full=KQT-like 2;
DE   AltName: Full=Neuroblastoma-specific potassium channel subunit alpha KvLQT2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv7.2;
GN   Name=KCNQ2 {ECO:0000312|HGNC:HGNC:6296};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6).
RC   TISSUE=Neuroblastoma;
RX   PubMed=9039501; DOI=10.1093/dnares/3.5.311;
RA   Yokoyama M., Nishi Y., Yoshii J., Okubo K., Matsubara K.;
RT   "Identification and cloning of neuroblastoma-specific and nerve
RT   tissue-specific genes through compiled expression profiles.";
RL   DNA Res. 3:311-320(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS BFNS1 CYS-284 AND
RP   THR-306.
RC   TISSUE=Brain, Fetal brain, and Temporal cortex;
RX   PubMed=9425895; DOI=10.1038/ng0198-25;
RA   Singh N.A., Charlier C., Stauffer D., DuPont B.R., Leach R.J.,
RA   Melis R., Ronen G.M., Bjerre I., Quattlebaum T., Murphy J.V.,
RA   McHarg M.L., Gagnon D., Rosales T.O., Peiffer A., Anderson V.E.,
RA   Leppert M.;
RT   "A novel potassium channel gene, KCNQ2, is mutated in an inherited
RT   epilepsy of newborns.";
RL   Nat. Genet. 18:25-29(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Fetal brain;
RX   PubMed=9430594; DOI=10.1126/science.279.5349.403;
RA   Biervert C., Schroeder B.C., Kubisch C., Berkovic S.F., Propping P.,
RA   Jentsch T.J., Steinlein O.K.;
RT   "A potassium channel mutation in neonatal human epilepsy.";
RL   Science 279:403-406(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), FUNCTION, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=9836639; DOI=10.1126/science.282.5395.1890;
RA   Wang H.-S., Pan Z., Shi W., Brown B.S., Wymore R.S., Cohen I.S.,
RA   Dixon J.E., McKinnon D.;
RT   "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of
RT   the M-channel.";
RL   Science 282:1890-1893(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 5).
RX   PubMed=9827540; DOI=10.1016/S0014-5793(98)01296-4;
RA   Tinel N., Lauritzen I., Chouabe C., Lazdunski M., Borsotto M.;
RT   "The KCNQ2 potassium channel: splice variants, functional and
RT   developmental expression. Brain localization and comparison with
RT   KCNQ3.";
RL   FEBS Lett. 438:171-176(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   TISSUE=Brain, and Fetal brain;
RX   PubMed=9677360; DOI=10.1074/jbc.273.31.19419;
RA   Yang W.-P., Levesque P.C., Little W.A., Conder M.L., Ramakrishnan P.,
RA   Neubauer M.G., Blanar M.A.;
RT   "Functional expression of two KvLQT1-related potassium channels
RT   responsible for an inherited idiopathic epilepsy.";
RL   J. Biol. Chem. 273:19419-19423(1998).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11160379;
RA   Smith J.S., Iannotti C.A., Dargis P.G., Christian E.P., Aiyar J.;
RT   "Differential expression of KCNQ2 splice variants: implications to M
RT   current function during neuronal development.";
RL   J. Neurosci. 21:1096-1103(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   MUTAGENESIS OF SER-52 AND GLY-279, PHOSPHORYLATION AT SER-52, AND
RP   CHARACTERIZATION OF VARIANTS CYS-284 AND THR-306.
RX   PubMed=9872318; DOI=10.1038/25367;
RA   Schroeder B.C., Kubisch C., Stein V., Jentsch T.J.;
RT   "Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+
RT   channels causes epilepsy.";
RL   Nature 396:687-690(1998).
RN   [11]
RP   INVOLVEMENT IN M-LIKE CURRENT.
RX   PubMed=10479678;
RA   Selyanko A.A., Hadley J.K., Wood I.C., Abogadie F.C., Delmas P.,
RA   Buckley N.J., London B., Brown D.A.;
RT   "Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to
RT   the M-like current in a mammalian neuronal cell.";
RL   J. Neurosci. 19:7742-7756(1999).
RN   [12]
RP   ASSOCIATION WITH KCNE2.
RX   PubMed=11034315; DOI=10.1016/S0014-5793(00)01918-9;
RA   Tinel N., Diochot S., Lauritzen I., Barhanin J., Lazdunski M.,
RA   Borsotto M.;
RT   "M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2
RT   subunit.";
RL   FEBS Lett. 480:137-141(2000).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10788442; DOI=10.1074/jbc.275.18.13343;
RA   Schwake M., Pusch M., Kharkovets T., Jentsch T.J.;
RT   "Surface expression and single channel properties of KCNQ2/KCNQ3, M-
RT   type K+ channels involved in epilepsy.";
RL   J. Biol. Chem. 275:13343-13348(2000).
RN   [14]
RP   FUNCTION, AND INHIBITION BY M1 MUSCARINIC RECEPTORS.
RX   PubMed=10684873;
RA   Shapiro M.S., Roche J.P., Kaftan E.J., Cruzblanca H., Mackie K.,
RA   Hille B.;
RT   "Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+)
RT   channels that underlie the neuronal M current.";
RL   J. Neurosci. 20:1710-1721(2000).
RN   [15]
RP   INHIBITION BY M1 MUSCARINIC RECEPTORS.
RX   PubMed=10713961; DOI=10.1111/j.1469-7793.2000.t01-2-00349.x;
RA   Selyanko A.A., Hadley J.K., Wood I.C., Abogadie F.C., Jentsch T.J.,
RA   Brown D.A.;
RT   "Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells
RT   via M1 muscarinic acetylcholine receptors.";
RL   J. Physiol. (Lond.) 522:349-355(2000).
RN   [16]
RP   ACTIVATION BY RETICABINE.
RX   PubMed=10908292;
RA   Main M.J., Cryan J.E., Dupere J.R., Cox B., Clare J.J., Burbidge S.A.;
RT   "Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant
RT   retigabine.";
RL   Mol. Pharmacol. 58:253-262(2000).
RN   [17]
RP   ACTIVATION BY RETICABINE.
RX   PubMed=10953053;
RA   Wickenden A.D., Yu W., Zou A., Jegla T., Wagoner P.K.;
RT   "Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3
RT   potassium channels.";
RL   Mol. Pharmacol. 58:591-600(2000).
RN   [18]
RP   ACTIVATION BY RETICABINE.
RX   PubMed=10713399; DOI=10.1016/S0304-3940(00)00866-1;
RA   Rundfeldt C., Netzer R.;
RT   "The novel anticonvulsant retigabine activates M-currents in Chinese
RT   hamster ovary-cells transfected with human KCNQ2/3 subunits.";
RL   Neurosci. Lett. 282:73-76(2000).
RN   [19]
RP   TISSUE SPECIFICITY, AND BIOCHEMICAL CHARACTERIZATION.
RX   PubMed=10781098; DOI=10.1073/pnas.090092797;
RA   Cooper E.C., Aldape K.D., Abosch A., Barbaro N.M., Berger M.S.,
RA   Peacock W.S., Jan Y.N., Jan L.Y.;
RT   "Colocalization and coassembly of two human brain M-type potassium
RT   channel subunits that are mutated in epilepsy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:4914-4919(2000).
RN   [20]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [21]
RP   PHOSPHORYLATION AT THR-217, AND MUTAGENESIS OF THR-217.
RX   PubMed=16319223; DOI=10.1073/pnas.0509122102;
RA   Surti T.S., Huang L., Jan Y.N., Jan L.Y., Cooper E.C.;
RT   "Identification by mass spectrometry and functional characterization
RT   of two phosphorylation sites of KCNQ2/KCNQ3 channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:17828-17833(2005).
RN   [22] {ECO:0000244|PDB:5J03}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 530-557 IN COMPLEX WITH
RP   CALMODULIN, SUBUNIT, INTERACTION WITH CALMODULIN, AND REGION.
RX   PubMed=27564677; DOI=10.1021/acs.biochem.6b00477;
RA   Strulovich R., Tobelaim W.S., Attali B., Hirsch J.A.;
RT   "Structural insights into the M-channel proximal C-terminus/calmodulin
RT   complex.";
RL   Biochemistry 55:5353-5365(2016).
RN   [23]
RP   VARIANT THR-780.
RX   PubMed=10323247; DOI=10.1007/s004390050941;
RA   Biervert C., Steinlein O.K.;
RT   "Structural and mutational analysis of KCNQ2, the major gene locus for
RT   benign familial neonatal convulsions.";
RL   Hum. Genet. 104:234-240(1999).
RN   [24]
RP   VARIANT BFNS1 TRP-214.
RX   PubMed=11175290; DOI=10.1038/sj.ejhg.5200570;
RA   Miraglia del Giudice E., Coppola G., Scuccimarra G., Cirillo G.,
RA   Bellini G., Pascotto A.;
RT   "Benign familial neonatal convulsions (BFNC) resulting from mutation
RT   of the KCNQ2 voltage sensor.";
RL   Eur. J. Hum. Genet. 8:994-997(2000).
RN   [25]
RP   VARIANT BFNS1 TRP-207, CHARACTERIZATION OF VARIANT BFNS1 TRP-207, AND
RP   FUNCTION.
RX   PubMed=11572947; DOI=10.1073/pnas.211431298;
RA   Dedek K., Kunath B., Kananura C., Reuner U., Jentsch T.J.,
RA   Steinlein O.K.;
RT   "Myokymia and neonatal epilepsy caused by a mutation in the voltage
RT   sensor of the KCNQ2 K+ channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:12272-12277(2001).
RN   [26]
RP   VARIANTS BFNS1 VAL-208; GLN-228; PHE-243; CYS-284; THR-306 AND
RP   GLN-333, CHARACTERIZATION OF VARIANTS BFNS1 VAL-208 AND GLN-333, AND
RP   FUNCTION.
RX   PubMed=14534157; DOI=10.1093/brain/awg286;
RG   The BFNC physician consortium;
RA   Singh N.A., Westenskow P., Charlier C., Pappas C., Leslie J.,
RA   Dillon J., Anderson V.E., Sanguinetti M.C., Leppert M.F.;
RT   "KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal
RT   convulsions: expansion of the functional and mutation spectrum.";
RL   Brain 126:2726-2737(2003).
RN   [27]
RP   VARIANT EIEE7 TRP-247, CHARACTERIZATION OF VARIANT EIEE7 TRP-247, AND
RP   FUNCTION.
RX   PubMed=12742592; DOI=10.1016/S0920-1211(03)00037-8;
RA   Dedek K., Fusco L., Teloy N., Steinlein O.K.;
RT   "Neonatal convulsions and epileptic encephalopathy in an Italian
RT   family with a missense mutation in the fifth transmembrane region of
RT   KCNQ2.";
RL   Epilepsy Res. 54:21-27(2003).
RN   [28]
RP   VARIANT BFNS1 ASN-554, VARIANT EIEE7 ASN-554, AND CHARACTERIZATION OF
RP   VARIANT BFNS1 ASN-554.
RX   PubMed=15249611; DOI=10.1212/01.WNL.0000132979.08394.6D;
RA   Borgatti R., Zucca C., Cavallini A., Ferrario M., Panzeri C.,
RA   Castaldo P., Soldovieri M.V., Baschirotto C., Bresolin N.,
RA   Dalla Bernardina B., Taglialatela M., Bassi M.T.;
RT   "A novel mutation in KCNQ2 associated with BFNC, drug resistant
RT   epilepsy, and mental retardation.";
RL   Neurology 63:57-65(2004).
RN   [29]
RP   VARIANT GLN-207, CHARACTERIZATION OF VARIANT GLN-207, AND FUNCTION.
RX   PubMed=17872363; DOI=10.1212/01.wnl.0000275523.95103.36;
RA   Wuttke T.V., Jurkat-Rott K., Paulus W., Garncarek M., Lehmann-Horn F.,
RA   Lerche H.;
RT   "Peripheral nerve hyperexcitability due to dominant-negative KCNQ2
RT   mutations.";
RL   Neurology 69:2045-2053(2007).
RN   [30]
RP   VARIANTS BFNS1 ASP-154; GLU-159; VAL-196; 448-ARG--LYS-872 DEL AND
RP   TRP-547, AND VARIANT ALA-217.
RX   PubMed=23360469; DOI=10.1111/epi.12089;
RA   Zara F., Specchio N., Striano P., Robbiano A., Gennaro E.,
RA   Paravidino R., Vanni N., Beccaria F., Capovilla G., Bianchi A.,
RA   Caffi L., Cardilli V., Darra F., Bernardina B.D., Fusco L.,
RA   Gaggero R., Giordano L., Guerrini R., Incorpora G., Mastrangelo M.,
RA   Spaccini L., Laverda A.M., Vecchi M., Vanadia F., Veggiotti P.,
RA   Viri M., Occhi G., Budetta M., Taglialatela M., Coviello D.A.,
RA   Vigevano F., Minetti C.;
RT   "Genetic testing in benign familial epilepsies of the first year of
RT   life: clinical and diagnostic significance.";
RL   Epilepsia 54:425-436(2013).
RN   [31]
RP   VARIANT EIEE7 ILE-276.
RX   PubMed=24463883; DOI=10.1093/hmg/ddu030;
RG   WGS500 Consortium;
RA   Martin H.C., Kim G.E., Pagnamenta A.T., Murakami Y., Carvill G.L.,
RA   Meyer E., Copley R.R., Rimmer A., Barcia G., Fleming M.R.,
RA   Kronengold J., Brown M.R., Hudspith K.A., Broxholme J., Kanapin A.,
RA   Cazier J.B., Kinoshita T., Nabbout R., Bentley D., McVean G.,
RA   Heavin S., Zaiwalla Z., McShane T., Mefford H.C., Shears D.,
RA   Stewart H., Kurian M.A., Scheffer I.E., Blair E., Donnelly P.,
RA   Kaczmarek L.K., Taylor J.C.;
RT   "Clinical whole-genome sequencing in severe early-onset epilepsy
RT   reveals new genes and improves molecular diagnosis.";
RL   Hum. Mol. Genet. 23:3200-3211(2014).
RN   [32]
RP   VARIANTS EIEE7 CYS-210; PRO-234 AND 578-MET-LEU-579 DELINS ILE-MET.
RX   PubMed=25818041; DOI=10.1111/epi.12954;
RA   Mercimek-Mahmutoglu S., Patel J., Cordeiro D., Hewson S., Callen D.,
RA   Donner E.J., Hahn C.D., Kannu P., Kobayashi J., Minassian B.A.,
RA   Moharir M., Siriwardena K., Weiss S.K., Weksberg R., Snead O.C. III;
RT   "Diagnostic yield of genetic testing in epileptic encephalopathy in
RT   childhood.";
RL   Epilepsia 56:707-716(2015).
RN   [33]
RP   VARIANTS BFNS1 ALA-114; ARG-159; 204-GLN--LYS-872 DEL; GLN-213;
RP   GLY-353; PHE-358; 448-ARG--LYS-872 DEL; VAL-578; 581-ARG--LYS-872 DEL;
RP   SER-588 AND ARG-637.
RX   PubMed=25982755; DOI=10.1111/epi.13020;
RA   Grinton B.E., Heron S.E., Pelekanos J.T., Zuberi S.M., Kivity S.,
RA   Afawi Z., Williams T.C., Casalaz D.M., Yendle S., Linder I., Lev D.,
RA   Lerman-Sagie T., Malone S., Bassan H., Goldberg-Stern H., Stanley T.,
RA   Hayman M., Calvert S., Korczyn A.D., Shevell M., Scheffer I.E.,
RA   Mulley J.C., Berkovic S.F.;
RT   "Familial neonatal seizures in 36 families: Clinical and genetic
RT   features correlate with outcome.";
RL   Epilepsia 56:1071-1080(2015).
RN   [34]
RP   VARIANT EIEE7 THR-306.
RX   PubMed=26138355; DOI=10.1111/cge.12636;
RA   Dimassi S., Labalme A., Ville D., Calender A., Mignot C.,
RA   Boutry-Kryza N., de Bellescize J., Rivier-Ringenbach C.,
RA   Bourel-Ponchel E., Cheillan D., Simonet T., Maincent K., Rossi M.,
RA   Till M., Mougou-Zerelli S., Edery P., Saad A., Heron D.,
RA   des Portes V., Sanlaville D., Lesca G.;
RT   "Whole-exome sequencing improves the diagnosis yield in sporadic
RT   infantile spasm syndrome.";
RL   Clin. Genet. 89:198-204(2016).
RN   [35]
RP   VARIANTS EIEE7 CYS-201; GLN-213 AND SER-561, AND VARIANTS BFNS1
RP   TRP-213 AND 581-ARG--LYS-872 DEL.
RX   PubMed=26993267; DOI=10.1136/jmedgenet-2015-103263;
RA   Trump N., McTague A., Brittain H., Papandreou A., Meyer E., Ngoh A.,
RA   Palmer R., Morrogh D., Boustred C., Hurst J.A., Jenkins L.,
RA   Kurian M.A., Scott R.H.;
RT   "Improving diagnosis and broadening the phenotypes in early-onset
RT   seizure and severe developmental delay disorders through gene panel
RT   analysis.";
RL   J. Med. Genet. 53:310-317(2016).
RN   [36]
RP   VARIANTS EIEE7 GLU-266; PHE-268; SER-291; VAL-294; SER-301 AND
RP   GLN-581, AND VARIANT SER-777.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Associates with KCNQ3 to form a potassium channel with
CC       essentially identical properties to the channel underlying the
CC       native M-current, a slowly activating and deactivating potassium
CC       conductance which plays a critical role in determining the
CC       subthreshold electrical excitability of neurons as well as the
CC       responsiveness to synaptic inputs. Therefore, it is important in
CC       the regulation of neuronal excitability. KCNQ2/KCNQ3 current is
CC       blocked by linopirdine and XE991, and activated by the
CC       anticonvulsant retigabine (PubMed:9836639, PubMed:11572947,
CC       PubMed:14534157, PubMed:12742592, PubMed:17872363). As the native
CC       M-channel, the potassium channel composed of KCNQ2 and KCNQ3 is
CC       also suppressed by activation of the muscarinic acetylcholine
CC       receptor CHRM1 (PubMed:10684873). {ECO:0000269|PubMed:10684873,
CC       ECO:0000269|PubMed:11572947, ECO:0000269|PubMed:12742592,
CC       ECO:0000269|PubMed:14534157, ECO:0000269|PubMed:17872363,
CC       ECO:0000269|PubMed:9836639}.
CC   -!- SUBUNIT: Heterotetramer with KCNQ3; form the heterotetrameric M
CC       potassium channel (PubMed:9836639, PubMed:27564677). Interacts
CC       with calmodulin; the interaction is calcium-independent,
CC       constitutive and participates to the proper assembly of a
CC       functional heterotetrameric M channel (PubMed:27564677). May
CC       associate with KCNE2 (PubMed:11034315). Interacts with IQCJ-SCHIP1
CC       (By similarity). {ECO:0000250|UniProtKB:Q9Z351,
CC       ECO:0000269|PubMed:11034315, ECO:0000269|PubMed:27564677,
CC       ECO:0000269|PubMed:9836639}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10788442,
CC       ECO:0000269|PubMed:9836639}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=O43526-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43526-2; Sequence=VSP_000988;
CC       Name=3;
CC         IsoId=O43526-3; Sequence=VSP_000985, VSP_000988;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=4;
CC         IsoId=O43526-4; Sequence=VSP_000989, VSP_000990;
CC       Name=5;
CC         IsoId=O43526-5; Sequence=VSP_000984, VSP_000988;
CC       Name=6; Synonyms=HNSPC;
CC         IsoId=O43526-6; Sequence=VSP_000986, VSP_000987;
CC   -!- TISSUE SPECIFICITY: In adult and fetal brain. Highly expressed in
CC       areas containing neuronal cell bodies, low in spinal chord and
CC       corpus callosum. Isoform 2 is preferentially expressed in
CC       differentiated neurons. Isoform 6 is prominent in fetal brain,
CC       undifferentiated neuroblastoma cells and brain tumors.
CC       {ECO:0000269|PubMed:10781098}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- PTM: KCNQ2/KCNQ3 heteromeric current can be increased by
CC       intracellular cyclic AMP, an effect that depends on
CC       phosphorylation of Ser-52 in the N-terminal region.
CC       {ECO:0000269|PubMed:16319223, ECO:0000269|PubMed:9872318}.
CC   -!- DISEASE: Seizures, benign familial neonatal 1 (BFNS1)
CC       [MIM:121200]: A disorder characterized by clusters of seizures
CC       occurring in the first days of life. Most patients have
CC       spontaneous remission by 12 months of age and show normal
CC       psychomotor development. Some rare cases manifest an atypical
CC       severe phenotype associated with epileptic encephalopathy and
CC       psychomotor retardation. The disorder is distinguished from benign
CC       familial infantile seizures by an earlier age at onset. In some
CC       patients, neonatal convulsions are followed later in life by
CC       myokymia, a benign condition characterized by spontaneous
CC       involuntary contractions of skeletal muscles fiber groups that can
CC       be observed as vermiform movement of the overlying skin.
CC       Electromyography typically shows continuous motor unit activity
CC       with spontaneous oligo- and multiplet-discharges of high
CC       intraburst frequency (myokymic discharges). Some patients may have
CC       isolated myokymia. {ECO:0000269|PubMed:11175290,
CC       ECO:0000269|PubMed:11572947, ECO:0000269|PubMed:14534157,
CC       ECO:0000269|PubMed:15249611, ECO:0000269|PubMed:23360469,
CC       ECO:0000269|PubMed:25982755, ECO:0000269|PubMed:26993267,
CC       ECO:0000269|PubMed:9425895}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 7 (EIEE7)
CC       [MIM:613720]: An autosomal dominant seizure disorder characterized
CC       by infantile onset of refractory seizures with resultant delayed
CC       neurologic development and persistent neurologic abnormalities.
CC       {ECO:0000269|PubMed:12742592, ECO:0000269|PubMed:15249611,
CC       ECO:0000269|PubMed:24463883, ECO:0000269|PubMed:25818041,
CC       ECO:0000269|PubMed:26138355, ECO:0000269|PubMed:26993267,
CC       ECO:0000269|PubMed:27864847}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Inclusion of isoform 6 in heteromultimers results
CC       in attenuation of potassium current. Prominent expression of
CC       isoform 6 in the developing brain may alter firing repertoires of
CC       immature neurons excitability to provide cues for proliferation
CC       rather than differentiation.
CC   -!- SIMILARITY: Belongs to the potassium channel family. KQT (TC
CC       1.A.1.15) subfamily. Kv7.2/KCNQ2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D82346; BAA11557.1; -; mRNA.
DR   EMBL; AF033348; AAB97315.1; -; mRNA.
DR   EMBL; Y15065; CAA75348.1; -; mRNA.
DR   EMBL; AF110020; AAD16988.1; -; mRNA.
DR   EMBL; AF074247; AAC25921.1; -; mRNA.
DR   EMBL; AL353658; CAH72958.1; -; Genomic_DNA.
DR   EMBL; AL121827; CAH72958.1; JOINED; Genomic_DNA.
DR   EMBL; AL121829; CAH72958.1; JOINED; Genomic_DNA.
DR   EMBL; AL353658; CAH72959.1; -; Genomic_DNA.
DR   EMBL; AL121827; CAH72959.1; JOINED; Genomic_DNA.
DR   EMBL; AL121829; CAH72959.1; JOINED; Genomic_DNA.
DR   EMBL; AL121827; CAI95054.1; -; Genomic_DNA.
DR   EMBL; AL121829; CAI95054.1; JOINED; Genomic_DNA.
DR   EMBL; AL353658; CAI95054.1; JOINED; Genomic_DNA.
DR   EMBL; AL121829; CAI95740.1; -; Genomic_DNA.
DR   EMBL; AL121827; CAI95740.1; JOINED; Genomic_DNA.
DR   EMBL; AL353658; CAI95740.1; JOINED; Genomic_DNA.
DR   EMBL; AL121829; CAI95744.1; -; Genomic_DNA.
DR   EMBL; AL121827; CAI95744.1; JOINED; Genomic_DNA.
DR   EMBL; AL353658; CAI95744.1; JOINED; Genomic_DNA.
DR   EMBL; BC000699; AAH00699.1; -; mRNA.
DR   CCDS; CCDS13518.1; -. [O43526-3]
DR   CCDS; CCDS13519.1; -. [O43526-2]
DR   CCDS; CCDS13520.1; -. [O43526-1]
DR   CCDS; CCDS13521.1; -. [O43526-6]
DR   CCDS; CCDS46629.1; -. [O43526-4]
DR   PIR; JC5275; JC5275.
DR   RefSeq; NP_004509.2; NM_004518.5. [O43526-3]
DR   RefSeq; NP_742104.1; NM_172106.2. [O43526-2]
DR   RefSeq; NP_742105.1; NM_172107.3. [O43526-1]
DR   RefSeq; NP_742106.1; NM_172108.4. [O43526-4]
DR   RefSeq; NP_742107.1; NM_172109.2. [O43526-6]
DR   UniGene; Hs.161851; -.
DR   UniGene; Hs.652468; -.
DR   PDB; 5J03; X-ray; 2.00 A; A=530-557.
DR   PDBsum; 5J03; -.
DR   ProteinModelPortal; O43526; -.
DR   SMR; O43526; -.
DR   BioGrid; 109986; 6.
DR   CORUM; O43526; -.
DR   IntAct; O43526; 1.
DR   MINT; MINT-8402812; -.
DR   STRING; 9606.ENSP00000352035; -.
DR   BindingDB; O43526; -.
DR   ChEMBL; CHEMBL2476; -.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB04953; Ezogabine.
DR   DrugBank; DB06089; ICA-105665.
DR   DrugBank; DB00939; Meclofenamic acid.
DR   GuidetoPHARMACOLOGY; 561; -.
DR   TCDB; 1.A.1.15.2; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O43526; -.
DR   PhosphoSitePlus; O43526; -.
DR   BioMuta; KCNQ2; -.
DR   PaxDb; O43526; -.
DR   PeptideAtlas; O43526; -.
DR   PRIDE; O43526; -.
DR   DNASU; 3785; -.
DR   Ensembl; ENST00000344425; ENSP00000345523; ENSG00000075043. [O43526-6]
DR   Ensembl; ENST00000344462; ENSP00000339611; ENSG00000075043. [O43526-4]
DR   Ensembl; ENST00000359125; ENSP00000352035; ENSG00000075043. [O43526-1]
DR   Ensembl; ENST00000360480; ENSP00000353668; ENSG00000075043. [O43526-3]
DR   Ensembl; ENST00000626839; ENSP00000486706; ENSG00000075043. [O43526-2]
DR   GeneID; 3785; -.
DR   KEGG; hsa:3785; -.
DR   UCSC; uc002yey.2; human. [O43526-1]
DR   CTD; 3785; -.
DR   DisGeNET; 3785; -.
DR   EuPathDB; HostDB:ENSG00000075043.17; -.
DR   GeneCards; KCNQ2; -.
DR   GeneReviews; KCNQ2; -.
DR   HGNC; HGNC:6296; KCNQ2.
DR   HPA; HPA016642; -.
DR   HPA; HPA057112; -.
DR   MalaCards; KCNQ2; -.
DR   MIM; 121200; phenotype.
DR   MIM; 602235; gene.
DR   MIM; 613720; phenotype.
DR   neXtProt; NX_O43526; -.
DR   OpenTargets; ENSG00000075043; -.
DR   Orphanet; 306; Benign familial infantile epilepsy.
DR   Orphanet; 1949; Benign familial neonatal seizures.
DR   Orphanet; 140927; Benign familial neonatal-infantile seizures.
DR   Orphanet; 1934; Early infantile epileptic encephalopathy.
DR   PharmGKB; PA30074; -.
DR   eggNOG; KOG1419; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00550000074513; -.
DR   HOVERGEN; HBG059014; -.
DR   InParanoid; O43526; -.
DR   KO; K04927; -.
DR   OMA; VTVPMYS; -.
DR   OrthoDB; EOG091G02ZT; -.
DR   PhylomeDB; O43526; -.
DR   TreeFam; TF315186; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-445095; Interaction between L1 and Ankyrins.
DR   SIGNOR; O43526; -.
DR   ChiTaRS; KCNQ2; human.
DR   GeneWiki; KvLQT2; -.
DR   GenomeRNAi; 3785; -.
DR   PRO; PR:O43526; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000075043; -.
DR   CleanEx; HS_KCNQ2; -.
DR   ExpressionAtlas; O43526; baseline and differential.
DR   Genevisible; O43526; HS.
DR   GO; GO:0043194; C:axon initial segment; ISS:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0033268; C:node of Ranvier; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0030506; F:ankyrin binding; IPI:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   InterPro; IPR020969; Ankyrin-G_BS.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003937; K_chnl_volt-dep_KCNQ.
DR   InterPro; IPR003947; K_chnl_volt-dep_KCNQ2.
DR   InterPro; IPR013821; K_chnl_volt-dep_KCNQ_C.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF6; PTHR11537:SF6; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03520; KCNQ_channel; 1.
DR   Pfam; PF11956; KCNQC3-Ank-G_bd; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01461; KCNQ2CHANNEL.
DR   PRINTS; PR01459; KCNQCHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Disease mutation; Epilepsy; Ion channel; Ion transport; Membrane;
KW   Mental retardation; Phosphoprotein; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    872       Potassium voltage-gated channel subfamily
FT                                KQT member 2.
FT                                /FTId=PRO_0000054030.
FT   TOPO_DOM      1     91       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     92    112       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    113    122       Extracellular. {ECO:0000255}.
FT   TRANSMEM    123    143       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    144    166       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    167    187       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    188    195       Extracellular. {ECO:0000255}.
FT   TRANSMEM    196    218       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    219    231       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    232    252       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    253    264       Extracellular. {ECO:0000255}.
FT   INTRAMEM    265    285       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    286    291       Extracellular. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    313    872       Cytoplasmic. {ECO:0000255}.
FT   REGION      317    539       Mediates interaction with calmodulin.
FT                                {ECO:0000269|PubMed:27564677}.
FT   MOTIF       277    282       Selectivity filter. {ECO:0000250}.
FT   MOD_RES      52     52       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:9872318}.
FT   MOD_RES     217    217       Phosphothreonine.
FT                                {ECO:0000269|PubMed:16319223}.
FT   MOD_RES     466    466       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z351}.
FT   MOD_RES     468    468       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z351}.
FT   MOD_RES     472    472       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z351}.
FT   MOD_RES     476    476       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z351}.
FT   MOD_RES     478    478       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z351}.
FT   MOD_RES     507    507       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88943}.
FT   MOD_RES     672    672       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88943}.
FT   MOD_RES     801    801       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88943}.
FT   MOD_RES     803    803       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88943}.
FT   VAR_SEQ     310    320       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:9827540}.
FT                                /FTId=VSP_000984.
FT   VAR_SEQ     373    393       SSQTQTYGASRLIPPLNQLEL -> RYRRRAPATKQLFHFL
FT                                FSICS (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9039501}.
FT                                /FTId=VSP_000986.
FT   VAR_SEQ     373    382       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9430594}.
FT                                /FTId=VSP_000985.
FT   VAR_SEQ     394    872       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9039501}.
FT                                /FTId=VSP_000987.
FT   VAR_SEQ     417    446       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:9836639}.
FT                                /FTId=VSP_000989.
FT   VAR_SEQ     417    434       Missing (in isoform 2, isoform 3 and
FT                                isoform 5). {ECO:0000303|PubMed:11160379,
FT                                ECO:0000303|PubMed:9430594,
FT                                ECO:0000303|PubMed:9827540}.
FT                                /FTId=VSP_000988.
FT   VAR_SEQ     509    509       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:9836639}.
FT                                /FTId=VSP_000990.
FT   VARIANT     114    114       T -> A (in BFNS1; dbSNP:rs1057516076).
FT                                {ECO:0000269|PubMed:25982755}.
FT                                /FTId=VAR_078658.
FT   VARIANT     154    154       Y -> D (in BFNS1; with infantile
FT                                seizures; dbSNP:rs1057516078).
FT                                {ECO:0000269|PubMed:23360469}.
FT                                /FTId=VAR_078659.
FT   VARIANT     159    159       G -> E (in BFNS1; dbSNP:rs1057516081).
FT                                {ECO:0000269|PubMed:23360469}.
FT                                /FTId=VAR_078660.
FT   VARIANT     159    159       G -> R (in BFNS1; dbSNP:rs1057516080).
FT                                {ECO:0000269|PubMed:25982755}.
FT                                /FTId=VAR_078661.
FT   VARIANT     196    196       A -> V (in BFNS1; with infantile
FT                                seizures; dbSNP:rs118192199).
FT                                {ECO:0000269|PubMed:23360469}.
FT                                /FTId=VAR_078662.
FT   VARIANT     201    201       R -> C (in EIEE7; unknown pathological
FT                                significance; dbSNP:rs796052623).
FT                                {ECO:0000269|PubMed:26993267}.
FT                                /FTId=VAR_078663.
FT   VARIANT     204    872       Missing (in BFNS1).
FT                                {ECO:0000269|PubMed:25982755}.
FT                                /FTId=VAR_078664.
FT   VARIANT     207    207       R -> Q (found in a patient with isolated
FT                                myokymia; leads to a shift of voltage-
FT                                dependent activation; dbSNP:rs118192200).
FT                                {ECO:0000269|PubMed:17872363}.
FT                                /FTId=VAR_043819.
FT   VARIANT     207    207       R -> W (in BFNS1; phenotype
FT                                manifestations include myokymia in some
FT                                patients; leads to a shift of voltage-
FT                                dependent activation of the channel and a
FT                                dramatic slowing of activation upon
FT                                depolarization; dbSNP:rs74315391).
FT                                {ECO:0000269|PubMed:11572947}.
FT                                /FTId=VAR_026987.
FT   VARIANT     208    208       M -> V (in BFNS1; minor effect on maximal
FT                                current but clearly exhibits a faster
FT                                rate of deactivation; dbSNP:rs118192201).
FT                                {ECO:0000269|PubMed:14534157}.
FT                                /FTId=VAR_026988.
FT   VARIANT     210    210       R -> C (in EIEE7; dbSNP:rs796052626).
FT                                {ECO:0000269|PubMed:25818041}.
FT                                /FTId=VAR_078665.
FT   VARIANT     213    213       R -> Q (in BFNS1 and EIEE7;
FT                                dbSNP:rs397514581).
FT                                {ECO:0000269|PubMed:25982755,
FT                                ECO:0000269|PubMed:26993267}.
FT                                /FTId=VAR_078666.
FT   VARIANT     213    213       R -> W (in BFNS1; unknown pathological
FT                                significance; dbSNP:rs118192203).
FT                                {ECO:0000269|PubMed:26993267}.
FT                                /FTId=VAR_078667.
FT   VARIANT     214    214       R -> W (in BFNS1; dbSNP:rs28939684).
FT                                {ECO:0000269|PubMed:11175290}.
FT                                /FTId=VAR_010929.
FT   VARIANT     217    217       T -> A (in BFNS1; also in patients with
FT                                infantile seizures; dbSNP:rs1057516089).
FT                                {ECO:0000269|PubMed:23360469}.
FT                                /FTId=VAR_078668.
FT   VARIANT     228    228       H -> Q (in BFNS1; dbSNP:rs118192204).
FT                                {ECO:0000269|PubMed:14534157}.
FT                                /FTId=VAR_026989.
FT   VARIANT     234    234       T -> P (in EIEE7; dbSNP:rs1057516091).
FT                                {ECO:0000269|PubMed:25818041}.
FT                                /FTId=VAR_078669.
FT   VARIANT     243    243       L -> F (in BFNS1; dbSNP:rs118192205).
FT                                {ECO:0000269|PubMed:14534157}.
FT                                /FTId=VAR_026990.
FT   VARIANT     247    247       S -> W (in EIEE7; reduces channel
FT                                currents by more than 50% in homomeric
FT                                channels; dbSNP:rs74315392).
FT                                {ECO:0000269|PubMed:12742592}.
FT                                /FTId=VAR_026991.
FT   VARIANT     266    266       D -> E (in EIEE7; patient also manifests
FT                                dyskinesia; dbSNP:rs1057519536).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078207.
FT   VARIANT     268    268       L -> F (in EIEE7; dbSNP:rs1057516094).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078208.
FT   VARIANT     276    276       T -> I (in EIEE7; dbSNP:rs1057516095).
FT                                {ECO:0000269|PubMed:24463883}.
FT                                /FTId=VAR_078670.
FT   VARIANT     284    284       Y -> C (in BFNS1; 30%-60% reduction of wt
FT                                current in heteromeric channels;
FT                                dbSNP:rs28939683).
FT                                {ECO:0000269|PubMed:14534157,
FT                                ECO:0000269|PubMed:9425895,
FT                                ECO:0000269|PubMed:9872318}.
FT                                /FTId=VAR_010930.
FT   VARIANT     291    291       R -> S (in EIEE7; dbSNP:rs1057519535).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078209.
FT   VARIANT     294    294       A -> V (in EIEE7; dbSNP:rs118192211).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078210.
FT   VARIANT     301    301       G -> S (in EIEE7; dbSNP:rs1057516099).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078211.
FT   VARIANT     306    306       A -> T (in BFNS1 and EIEE7; 20%-40%
FT                                reduction of wt current in heteromeric
FT                                channels; dbSNP:rs74315390).
FT                                {ECO:0000269|PubMed:14534157,
FT                                ECO:0000269|PubMed:26138355,
FT                                ECO:0000269|PubMed:9425895,
FT                                ECO:0000269|PubMed:9872318}.
FT                                /FTId=VAR_010931.
FT   VARIANT     333    333       R -> Q (in BFNS1; moderate effect; less
FT                                than 50% reduction in current compared
FT                                with wt heteromeric channels;
FT                                dbSNP:rs118192216).
FT                                {ECO:0000269|PubMed:14534157}.
FT                                /FTId=VAR_026992.
FT   VARIANT     353    353       R -> G (in BFNS1; dbSNP:rs118192218).
FT                                {ECO:0000269|PubMed:25982755}.
FT                                /FTId=VAR_078671.
FT   VARIANT     358    358       S -> F (in BFNS1; dbSNP:rs1057516110).
FT                                {ECO:0000269|PubMed:25982755}.
FT                                /FTId=VAR_078672.
FT   VARIANT     448    872       Missing (in BFNS1; with infantile
FT                                seizures). {ECO:0000269|PubMed:23360469,
FT                                ECO:0000269|PubMed:25982755}.
FT                                /FTId=VAR_078673.
FT   VARIANT     547    547       R -> W (in BFNS1; dbSNP:rs796052650).
FT                                {ECO:0000269|PubMed:23360469}.
FT                                /FTId=VAR_078674.
FT   VARIANT     554    554       K -> N (in BFNS1 and EIEE7; decreases the
FT                                voltage-dependence of the channel;
FT                                dbSNP:rs267607198).
FT                                {ECO:0000269|PubMed:15249611}.
FT                                /FTId=VAR_026993.
FT   VARIANT     561    561       P -> S (in EIEE7).
FT                                {ECO:0000269|PubMed:26993267}.
FT                                /FTId=VAR_078675.
FT   VARIANT     578    579       ML -> IM (in EIEE7; dbSNP:rs796052665).
FT                                {ECO:0000269|PubMed:25818041}.
FT                                /FTId=VAR_078676.
FT   VARIANT     578    578       M -> V (in BFNS1; dbSNP:rs1057516123).
FT                                {ECO:0000269|PubMed:25982755}.
FT                                /FTId=VAR_078677.
FT   VARIANT     581    872       Missing (in BFNS1).
FT                                {ECO:0000269|PubMed:25982755,
FT                                ECO:0000269|PubMed:26993267}.
FT                                /FTId=VAR_078678.
FT   VARIANT     581    581       R -> Q (in EIEE7; dbSNP:rs118192235).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078212.
FT   VARIANT     588    588       R -> S (in BFNS1; dbSNP:rs118192237).
FT                                {ECO:0000269|PubMed:25982755}.
FT                                /FTId=VAR_078679.
FT   VARIANT     637    637       L -> R (in BFNS1; dbSNP:rs118192240).
FT                                {ECO:0000269|PubMed:25982755}.
FT                                /FTId=VAR_078680.
FT   VARIANT     777    777       P -> S (found in a patient with
FT                                continuous spikes and waves during sleep;
FT                                unknown pathological significance;
FT                                dbSNP:rs748400155).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078213.
FT   VARIANT     780    780       N -> T (in dbSNP:rs1801475).
FT                                {ECO:0000269|PubMed:10323247}.
FT                                /FTId=VAR_010932.
FT   MUTAGEN      52     52       S->E: 40% increase in potassium current
FT                                amplitude. Ratio of 1:1.
FT                                {ECO:0000269|PubMed:9872318}.
FT   MUTAGEN      52     52       S->Q: Decrease of PKA stimulation. Ratio
FT                                of 1:1. {ECO:0000269|PubMed:9872318}.
FT   MUTAGEN     217    217       T->A: No effect on current or expression.
FT                                {ECO:0000269|PubMed:16319223}.
FT   MUTAGEN     217    217       T->D: Abolishes currents without reducing
FT                                channel protein expression.
FT                                {ECO:0000269|PubMed:16319223}.
FT   MUTAGEN     279    279       G->S: More than 50% reduction of wt
FT                                heteromeric current. Ratio of 1:1 and
FT                                1:1:2. {ECO:0000269|PubMed:9872318}.
FT   CONFLICT    699    699       K -> E (in Ref. 4; AAD16988).
FT                                {ECO:0000305}.
FT   CONFLICT    854    854       R -> C (in Ref. 4; AAD16988).
FT                                {ECO:0000305}.
FT   HELIX       535    556       {ECO:0000244|PDB:5J03}.
SQ   SEQUENCE   872 AA;  95848 MW;  22E8A0880A27B58C CRC64;
     MVQKSRNGGV YPGPSGEKKL KVGFVGLDPG APDSTRDGAL LIAGSEAPKR GSILSKPRAG
     GAGAGKPPKR NAFYRKLQNF LYNVLERPRG WAFIYHAYVF LLVFSCLVLS VFSTIKEYEK
     SSEGALYILE IVTIVVFGVE YFVRIWAAGC CCRYRGWRGR LKFARKPFCV IDIMVLIASI
     AVLAAGSQGN VFATSALRSL RFLQILRMIR MDRRGGTWKL LGSVVYAHSK ELVTAWYIGF
     LCLILASFLV YLAEKGENDH FDTYADALWW GLITLTTIGY GDKYPQTWNG RLLAATFTLI
     GVSFFALPAG ILGSGFALKV QEQHRQKHFE KRRNPAAGLI QSAWRFYATN LSRTDLHSTW
     QYYERTVTVP MYSSQTQTYG ASRLIPPLNQ LELLRNLKSK SGLAFRKDPP PEPSPSKGSP
     CRGPLCGCCP GRSSQKVSLK DRVFSSPRGV AAKGKGSPQA QTVRRSPSAD QSLEDSPSKV
     PKSWSFGDRS RARQAFRIKG AASRQNSEEA SLPGEDIVDD KSCPCEFVTE DLTPGLKVSI
     RAVCVMRFLV SKRKFKESLR PYDVMDVIEQ YSAGHLDMLS RIKSLQSRVD QIVGRGPAIT
     DKDRTKGPAE AELPEDPSMM GRLGKVEKQV LSMEKKLDFL VNIYMQRMGI PPTETEAYFG
     AKEPEPAPPY HSPEDSREHV DRHGCIVKIV RSSSSTGQKN FSAPPAAPPV QCPPSTSWQP
     QSHPRQGHGT SPVGDHGSLV RIPPPPAHER SLSAYGGGNR ASMEFLRQED TPGCRPPEGN
     LRDSDTSISI PSVDHEELER SFSGFSISQS KENLDALNSC YAAVAPCAKV RPYIAEGESD
     TDSDLCTPCG PPPRSATGEG PFGDVGWAGP RK
//
ID   KCNH7_RAT               Reviewed;        1195 AA.
AC   O54852;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   25-OCT-2017, entry version 145.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 7;
DE   AltName: Full=Ether-a-go-go-related gene potassium channel 3;
DE            Short=ERG-3;
DE            Short=Eag-related protein 3;
DE            Short=Ether-a-go-go-related protein 3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv11.3;
GN   Name=Kcnh7; Synonyms=Erg3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9390998;
RA   Shi W., Wymore R.S., Wang H.-S., Pan Z., Cohen I.S., McKinnon D.,
RA   Dixon J.E.;
RT   "Identification of two nervous system-specific members of the erg
RT   potassium channel gene family.";
RL   J. Neurosci. 17:9423-9432(1997).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=10718922; DOI=10.1046/j.1365-2826.2000.00447.x;
RA   Wulfsen I., Hauber H.-P., Schiemann D., Bauer C.K., Schwarz J.R.;
RT   "Expression of mRNA for voltage-dependent and inward-rectifying K
RT   channels in GH3/B6 cells and rat pituitary.";
RL   J. Neuroendocrinol. 12:263-272(2000).
RN   [3]
RP   INTERACTION WITH KCNH2 AND KCNH6.
RX   PubMed=11212207; DOI=10.1007/s004240000467;
RA   Wimmers S., Wulfsen I., Bauer C.K., Schwarz J.R.;
RT   "Erg1, erg2 and erg3 K channel subunits are able to form
RT   heteromultimers.";
RL   Pflugers Arch. 441:450-455(2001).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-174; SER-319; SER-891
RP   AND SER-894, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium
CC       channel. Channel properties may be modulated by cAMP and subunit
CC       assembly.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits. Heteromultimer with
CC       KCNH2/ERG1 and KCNH6/ERG2.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Detected in total brain, in superior cervical,
CC       mesenteric and celiac ganglia, and at very low levels in retina.
CC       Found in pituitary. {ECO:0000269|PubMed:10718922}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag) (TC
CC       1.A.1.20) subfamily. Kv11.3/KCNH7 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF016191; AAB94741.1; -; mRNA.
DR   RefSeq; NP_571987.1; NM_131912.1.
DR   UniGene; Rn.10874; -.
DR   ProteinModelPortal; O54852; -.
DR   SMR; O54852; -.
DR   BioGrid; 250984; 1.
DR   STRING; 10116.ENSRNOP00000009920; -.
DR   GuidetoPHARMACOLOGY; 574; -.
DR   TCDB; 1.A.1.20.3; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O54852; -.
DR   PhosphoSitePlus; O54852; -.
DR   PaxDb; O54852; -.
DR   GeneID; 170739; -.
DR   KEGG; rno:170739; -.
DR   UCSC; RGD:621112; rat.
DR   CTD; 90134; -.
DR   RGD; 621112; Kcnh7.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000230793; -.
DR   HOVERGEN; HBG052232; -.
DR   InParanoid; O54852; -.
DR   KO; K04910; -.
DR   OrthoDB; EOG091G024C; -.
DR   PhylomeDB; O54852; -.
DR   TreeFam; TF313130; -.
DR   PRO; PR:O54852; -.
DR   Proteomes; UP000002494; Unplaced.
DR   Genevisible; O54852; RN.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IDA:RGD.
DR   GO; GO:0005267; F:potassium channel activity; IDA:RGD.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:RGD.
DR   GO; GO:0007623; P:circadian rhythm; IEP:RGD.
DR   GO; GO:0006813; P:potassium ion transport; IDA:RGD.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003967; K_chnl_volt-dep_ERG.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01470; ERGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1   1195       Potassium voltage-gated channel subfamily
FT                                H member 7.
FT                                /FTId=PRO_0000054017.
FT   TOPO_DOM      1    412       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    413    433       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    434    449       Extracellular. {ECO:0000255}.
FT   TRANSMEM    450    470       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    471    494       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    495    515       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    516    521       Extracellular. {ECO:0000255}.
FT   TRANSMEM    522    542       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    543    549       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    550    570       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    571    614       Extracellular. {ECO:0000255}.
FT   INTRAMEM    615    635       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    636    641       Extracellular. {ECO:0000255}.
FT   TRANSMEM    642    662       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    663   1195       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       41     70       PAS.
FT   DOMAIN       92    144       PAC.
FT   NP_BIND     745    862       cNMP.
FT   MOTIF       627    632       Selectivity filter. {ECO:0000250}.
FT   MOD_RES     174    174       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     238    238       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ER47}.
FT   MOD_RES     319    319       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     891    891       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     894    894       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   CARBOHYD    600    600       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     480    480       E->S: Lower channel activity.
SQ   SEQUENCE   1195 AA;  134901 MW;  BA24C54BB86C59B7 CRC64;
     MPVRRGHVAP QNTFLGTIIR KFEGQNKKFI IANARVQNCA IIYCNDGFCE MTGFSRPDVM
     QKPCTCDFLH GPETKRHDIA QIAQALLGSE ERKVEVTYYH KNGSTFICNT HIIPVKNQEG
     VAMMFIINFE YVTDEDNAAS PERVNPILPV KSVNRKLFGF KFPGLRVLTY RKQSLPQEDP
     DVVVIDSSKH SDDSVAMKHF KSPTKESCSP SEADDTKALI QPSQCSPLVN ISGPLDHSSP
     KRQWDRLYPD MLQSSSQLTH SRSRESLCSI RRASSVHDIE GFNVHPKNIF RDRHASEDNG
     RNVKGPFNHI KSSLLGSTSD SNLNKYSTIN KIPQLTLNFS DVKTEKKNTS PPSSDKTIIA
     PKVKERTHNV TEKVTQVLSL GADVLPEYKL QTPRINKFTI LHYSPFKAVW DWLILLLVIY
     TAIFTPYSAA FLLNDREEQK RRECGYSCSP LNVVDLIVDI MFIIDILINF RTTYVNQNEE
     VVSDPAKIAV HYFKGWFLID MVAAIPFDLL IFGSGSDETT TLIGLLKTAR LLRLVRVARK
     LDRYSEYGAA VLMLLMCIFA LIAHWLACIW YAIGNVERPY LTDKIGWLDS LGTQIGKRYN
     DSDSSSGPSI KDKYVTALYF TFSSLTSVGF GNVSPNTNSE KIFSICVMLI GSLMYASIFG
     NVSAIIQRLY SGTARYHMQM LRVKEFIRFH QIPNPLRQRL EEYFQHAWTY TNGIDMNMVL
     KGFPECLQAD ICLHLNQTLL QNCKAFRGAS KGCLRALAMK FKTTHAPPGD TLVHCGDVLT
     ALYFLSRGSI EILKDDIVVA ILGKNDIFGE MVHLYAKPGK SNADVRALTY CDLHKIQRED
     LLEVLDMYPE FSDHFLTNLE LTFNLRHESA KSQSINDSEG DTCKLRRRRL SFESEGDKDF
     SKENSANDAD DSTDTIRRYQ SSKKHFEEKK SRSSSFISSI DDEQKPLFLG TVDSTPRMVK
     ASRHHGEEAA PPSGRIHTDK RSHSCKDITD THSWEREHAR AQPEECSPSG LQRAAWGISE
     TESDLTYGEV EQRLDLLQEQ LNRLESQMTT DIQAILQLLQ KQTTVVPPAY SMVTAGAEYQ
     RPILRLLRTS HPRASIKTDR SFSPSSQCPE FLDLEKSKLK SKESLSSGKR LNTASEDNLT
     SLLKQDSDAS SELDPRQRKS YLHPIRHPSL PDSSLSTVGI LGLHRHVSDP GLPGK
//
ID   KCNH6_RAT               Reviewed;         950 AA.
AC   O54853;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   25-OCT-2017, entry version 140.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 6;
DE   AltName: Full=Ether-a-go-go-related gene potassium channel 2;
DE            Short=ERG-2;
DE            Short=Eag-related protein 2;
DE            Short=Ether-a-go-go-related protein 2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv11.2;
GN   Name=Kcnh6; Synonyms=Erg2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cervical ganglion;
RX   PubMed=9390998;
RA   Shi W., Wymore R.S., Wang H.-S., Pan Z., Cohen I.S., McKinnon D.,
RA   Dixon J.E.;
RT   "Identification of two nervous system-specific members of the erg
RT   potassium channel gene family.";
RL   J. Neurosci. 17:9423-9432(1997).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=10718922; DOI=10.1046/j.1365-2826.2000.00447.x;
RA   Wulfsen I., Hauber H.-P., Schiemann D., Bauer C.K., Schwarz J.R.;
RT   "Expression of mRNA for voltage-dependent and inward-rectifying K
RT   channels in GH3/B6 cells and rat pituitary.";
RL   J. Neuroendocrinol. 12:263-272(2000).
RN   [3]
RP   INTERACTION WITH KCNH2 AND KCNH7, AND MUTAGENESIS OF GLY-480.
RX   PubMed=11212207; DOI=10.1007/s004240000467;
RA   Wimmers S., Wulfsen I., Bauer C.K., Schwarz J.R.;
RT   "Erg1, erg2 and erg3 K channel subunits are able to form
RT   heteromultimers.";
RL   Pflugers Arch. 441:450-455(2001).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=11425889;
RA   Saganich M.J., Machado E., Rudy B.;
RT   "Differential expression of genes encoding subthreshold-operating
RT   voltage-gated K+ channels in brain.";
RL   J. Neurosci. 21:4609-4624(2001).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium
CC       channel. Elicits a slowly activating, rectifying current. Channel
CC       properties may be modulated by cAMP and subunit assembly.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits. Heteromultimer with
CC       KCNH2/ERG1 and KCNH7/ERG3.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Highly expressed in celiac and superior
CC       mesenteric ganglia, but not detected in brain or in heart.
CC       Detected at low levels in retina. Also found in pituitary. Also
CC       found in the olfactory bulb (granular and mitral cell layers)
CC       (PubMed:11425889). {ECO:0000269|PubMed:10718922,
CC       ECO:0000269|PubMed:11425889}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag) (TC
CC       1.A.1.20) subfamily. Kv11.2/KCNH6 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF016192; AAB94742.1; -; mRNA.
DR   RefSeq; NP_446389.1; NM_053937.1.
DR   UniGene; Rn.10875; -.
DR   ProteinModelPortal; O54853; -.
DR   SMR; O54853; -.
DR   STRING; 10116.ENSRNOP00000010816; -.
DR   GuidetoPHARMACOLOGY; 573; -.
DR   TCDB; 1.A.1.20.2; the voltage-gated ion channel (vic) superfamily.
DR   PhosphoSitePlus; O54853; -.
DR   PaxDb; O54853; -.
DR   GeneID; 116745; -.
DR   KEGG; rno:116745; -.
DR   UCSC; RGD:620304; rat.
DR   CTD; 81033; -.
DR   RGD; 620304; Kcnh6.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000230793; -.
DR   HOVERGEN; HBG052232; -.
DR   InParanoid; O54853; -.
DR   KO; K04909; -.
DR   PhylomeDB; O54853; -.
DR   PRO; PR:O54853; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:RGD.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IDA:RGD.
DR   GO; GO:0005267; F:potassium channel activity; TAS:RGD.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:RGD.
DR   GO; GO:0006813; P:potassium ion transport; IDA:RGD.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:RGD.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003967; K_chnl_volt-dep_ERG.
DR   InterPro; IPR030172; KCNH6.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF468; PTHR10217:SF468; 2.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01470; ERGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    950       Potassium voltage-gated channel subfamily
FT                                H member 6.
FT                                /FTId=PRO_0000054014.
FT   TOPO_DOM      1    261       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    262    282       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    283    298       Extracellular. {ECO:0000255}.
FT   TRANSMEM    299    319       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    320    340       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    341    361       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    362    370       Extracellular. {ECO:0000255}.
FT   TRANSMEM    371    391       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    392    398       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    399    419       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    420    463       Extracellular. {ECO:0000255}.
FT   INTRAMEM    464    484       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    485    490       Extracellular. {ECO:0000255}.
FT   TRANSMEM    491    511       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    512    950       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       41     70       PAS.
FT   DOMAIN       92    144       PAC.
FT   NP_BIND     594    711       cNMP.
FT   MOTIF       476    481       Selectivity filter. {ECO:0000250}.
FT   MUTAGEN     480    480       G->S: Dominant negative mutant; abolishes
FT                                ERG current.
FT                                {ECO:0000269|PubMed:11212207}.
SQ   SEQUENCE   950 AA;  105706 MW;  AB5AE674B08776F0 CRC64;
     MPVRRGHVAP QNTYLDTIIR KFEGQSRKFL IANAQMENCA IIYCNDGFCE LFGYSRVEVM
     QRPCTCDFLT GPNTPSSAVS RLAQALLGAE ECKVDILYYR KDASSFRCLV DVVPVKNEDG
     AVIMFILNFE DLAQLLAKSS SRSLTQRLLS HSFLGSEGSH SRPSGQGPGP GRGKYRTVSQ
     IPQFTLNFVE FNLEKHRSGS TTEIEIIAPH KVVERTQNVT EKVTQVLSLG ADVLPEYKLQ
     APRIHRGTIL HYSPFKAVWD WLILLLVIYT AVFTPYSAAF LLSDQDESQR GTCGYTCSPL
     TVVDLIVDIM FVVDIVINFR TTYVNTNDEV VSHPRRIAVH YFKGWFLIDM VAAIPFDLLI
     FRTGSDETTT LIGLLKTARL LRLVRVARKL DRYSEYGAAV LFLLMCTFAL IAHWLACIWY
     AIGNVERPYL EPKIGWLDSL GAQLGKQYNG SDPASGPSVQ DKYVTALYFT FSSLTSVGFG
     NVSPNTNSEK VFSICVMLIG SLMYASIFGN VSAIIQRLYS GTARYHTQML RVKEFIRFHQ
     IPNPLRQRLE EYFQHAWSYT NGIDMNAVLK GFPECLQADI CLHLHRALLQ HCPAFRGASK
     GCLRALAVKF KTTHAPPGDT LVHLGDVLST LYFISRGSIE ILRDDVVVAI LGKNDIFGEP
     ASLHARPGKS SADVRALTYC DLHKIHRADL LEVLDMYPAF ADTFWNKLEV TFNLRDADGG
     LQSTPRQAPG HQDPQGFFLN DSQSGAAPSL SISDTSALWP ELLQQMPPSP PNPRQDLDCW
     HRELGFKLEQ LQAQMNRLES RVSSDLSRIL QLLQHPQGRP SYILGASASS DLASFPETSV
     TRSSESTLLV GHVPSAQTLS YGDLDDHIQT PRNFSPRTPH VAMAMDKTLV PSSEQEQPGG
     LLSPLASPLR PLEVPGLGGS RFPSLPEHLS SVPKQLEFQR HGSDPGFTRS
//
ID   KCNK3_RAT               Reviewed;         411 AA.
AC   O54912;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   22-NOV-2017, entry version 131.
DE   RecName: Full=Potassium channel subfamily K member 3;
DE   AltName: Full=Acid-sensitive potassium channel protein TASK-1;
DE   AltName: Full=TWIK-related acid-sensitive K(+) channel 1;
DE   AltName: Full=Two pore potassium channel KT3.1;
DE            Short=Two pore K(+) channel KT3.1;
GN   Name=Kcnk3; Synonyms=Task, Task1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=9437008;
RA   Leonoudakis D., Gray A.T., Winegar B.D., Kindler C.H., Harada M.,
RA   Taylor D.M., Chavez R.A., Forsayeth J.R., Yost C.S.;
RT   "An open rectifier potassium channel with two pore domains in tandem
RT   cloned from rat cerebellum.";
RL   J. Neurosci. 18:868-877(1998).
CC   -!- FUNCTION: pH-dependent, voltage-insensitive, background potassium
CC       channel protein. Rectification direction results from potassium
CC       ion concentration on either side of the membrane. Acts as an
CC       outward rectifier when external potassium concentration is low.
CC       When external potassium concentration is high, current is inward.
CC       {ECO:0000250|UniProtKB:O14649}.
CC   -!- SUBUNIT: Homodimer. Heterodimer with KCNK1.
CC       {ECO:0000250|UniProtKB:O14649}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:O14649}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:O14649}.
CC   -!- TISSUE SPECIFICITY: Strongest expression in heart. Moderate
CC       expression in lung and brain. Low levels in liver, kidney and
CC       skeletal muscle.
CC   -!- MISCELLANEOUS: Inhibited by extracellular acidification, zinc,
CC       bupivacaine and phenytoin. Activated by protein kinase A.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF031384; AAC39952.1; -; mRNA.
DR   RefSeq; NP_203694.1; NM_033376.1.
DR   UniGene; Rn.15536; -.
DR   ProteinModelPortal; O54912; -.
DR   DIP; DIP-61121N; -.
DR   IntAct; O54912; 2.
DR   STRING; 10116.ENSRNOP00000013107; -.
DR   ChEMBL; CHEMBL4294; -.
DR   PhosphoSitePlus; O54912; -.
DR   PaxDb; O54912; -.
DR   PRIDE; O54912; -.
DR   Ensembl; ENSRNOT00000013107; ENSRNOP00000013107; ENSRNOG00000009790.
DR   GeneID; 29553; -.
DR   KEGG; rno:29553; -.
DR   CTD; 3777; -.
DR   RGD; 61997; Kcnk3.
DR   eggNOG; KOG4404; Eukaryota.
DR   eggNOG; ENOG410XRZJ; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000231463; -.
DR   HOVERGEN; HBG052239; -.
DR   InParanoid; O54912; -.
DR   KO; K04914; -.
DR   OMA; CSGTQRS; -.
DR   OrthoDB; EOG091G08DH; -.
DR   PhylomeDB; O54912; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-RNO-1299316; TWIK-releated acid-sensitive K+ channel (TASK).
DR   Reactome; R-RNO-5576886; Phase 4 - resting membrane potential.
DR   PRO; PR:O54912; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000009790; -.
DR   ExpressionAtlas; O54912; baseline and differential.
DR   Genevisible; O54912; RN.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0008083; F:growth factor activity; IEA:InterPro.
DR   GO; GO:0005216; F:ion channel activity; ISO:RGD.
DR   GO; GO:0005252; F:open rectifier potassium channel activity; IDA:RGD.
DR   GO; GO:0022841; F:potassium ion leak channel activity; ISS:UniProtKB.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IMP:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; IMP:RGD.
DR   GO; GO:0044548; F:S100 protein binding; ISO:RGD.
DR   GO; GO:0007420; P:brain development; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IMP:RGD.
DR   GO; GO:0071294; P:cellular response to zinc ion; IEP:RGD.
DR   GO; GO:0090102; P:cochlea development; IEP:RGD.
DR   GO; GO:0034220; P:ion transmembrane transport; ISO:RGD.
DR   GO; GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:0042493; P:response to drug; IMP:RGD.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR022341; IGF-I.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR005406; KCNK3.
DR   PANTHER; PTHR11003:SF138; PTHR11003:SF138; 1.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01584; TASK1CHANNEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   2: Evidence at transcript level;
KW   Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    411       Potassium channel subfamily K member 3.
FT                                /FTId=PRO_0000101746.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      9     29       Helical. {ECO:0000255}.
FT   INTRAMEM     78    101       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    108    128       Helical. {ECO:0000255}.
FT   TOPO_DOM    129    158       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical. {ECO:0000255}.
FT   INTRAMEM    184    207       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    223    243       Helical. {ECO:0000255}.
FT   TOPO_DOM    244    411       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   411 AA;  45276 MW;  D2778016E09E2BF5 CRC64;
     MKRQNVRTLA LIVCTFTYLL VGAAVFDALE SEPEMIERQR LELRQLELRA RYNLSEGGYE
     ELERVVLRLK PHKAGVQWRF AGSFYFAITV ITTIGYGHAA PSTDGGKVFC MFYALLGIPL
     TLVMFQSLGE RINTFVRYLL HRAKRGLGMR HAEVSMANMV LIGFVSCIST LCIGAAAFSY
     YERWTFFQAY YYCFITLTTI GFGDYVALQK DQALQTQPQY VAFSFVYILT GLTVIGAFLN
     LVVLRFMTMN AEDEKRDAEH RALLTHNGQA GGLGGLSCLS GSLGDGVRPR DPVTCAAAAG
     GMGVGVGVGG SGFRNVYAEM LHFQSMCSCL WYKSREKLQY SIPMIIPRDL STSDTCVEHS
     HSSPGGGGRY SDTPSHPCLC SGTQRSAISS VSTGLHSLAT FRGLMKRRSS V
//
ID   KCNU1_MOUSE             Reviewed;        1121 AA.
AC   O54982;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   25-OCT-2017, entry version 128.
DE   RecName: Full=Potassium channel subfamily U member 1;
DE   AltName: Full=Calcium-activated potassium channel subunit alpha-3;
DE   AltName: Full=Calcium-activated potassium channel, subfamily M subunit alpha-3;
DE   AltName: Full=Pore-forming subunit of the sperm-specific alkalization activated K(+) current;
DE            Short=KSper;
DE   AltName: Full=Slowpoke homolog 3;
DE            Short=mSlo3;
DE   AltName: Full=pH-sensitive maxi potassium channel;
GN   Name=Kcnu1; Synonyms=Kcnma3, Ksper, Slo3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=9452476; DOI=10.1074/jbc.273.6.3509;
RA   Schreiber M., Wei A., Yuan A., Gaut J., Saito M., Salkoff L.;
RT   "Slo3, a novel pH-sensitive K+ channel from mammalian spermatocytes.";
RL   J. Biol. Chem. 273:3509-3516(1998).
RN   [2]
RP   FUNCTION.
RX   PubMed=11696614; DOI=10.1085/jgp.118.5.589;
RA   Shi J., Cui J.;
RT   "Intracellular Mg(2+) enhances the function of BK-type Ca(2+)-
RT   activated K(+) channels.";
RL   J. Gen. Physiol. 118:589-606(2001).
RN   [3]
RP   FUNCTION.
RX   PubMed=11723163; DOI=10.1085/jgp.118.6.711;
RA   Moss B.L., Magleby K.L.;
RT   "Gating and conductance properties of BK channels are modulated by the
RT   S9-S10 tail domain of the alpha subunit. A study of mSlo1 and mSlo3
RT   wild-type and chimeric channels.";
RL   J. Gen. Physiol. 118:711-734(2001).
RN   [4]
RP   FUNCTION.
RX   PubMed=15201331; DOI=10.1523/JNEUROSCI.1296-04.2004;
RA   Xia X.-M., Zhang X., Lingle C.J.;
RT   "Ligand-dependent activation of Slo family channels is defined by
RT   interchangeable cytosolic domains.";
RL   J. Neurosci. 24:5585-5591(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=16940555; DOI=10.1085/jgp.200609552;
RA   Zhang X., Zeng X., Lingle C.J.;
RT   "Slo3 K+ channels: voltage and pH dependence of macroscopic
RT   currents.";
RL   J. Gen. Physiol. 128:317-336(2006).
RN   [6]
RP   FUNCTION, AND MUTAGENESIS OF PHE-279.
RX   PubMed=16940554; DOI=10.1085/jgp.200609551;
RA   Zhang X., Zeng X., Xia X.-M., Lingle C.J.;
RT   "pH-regulated Slo3 K+ channels: properties of unitary currents.";
RL   J. Gen. Physiol. 128:301-315(2006).
RN   [7]
RP   FUNCTION, IDENTIFICATION AS KSPER, DISRUPTION PHENOTYPE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=21427226; DOI=10.1073/pnas.1100240108;
RA   Zeng X.H., Yang C., Kim S.T., Lingle C.J., Xia X.M.;
RT   "Deletion of the Slo3 gene abolishes alkalization-activated K+ current
RT   in mouse spermatozoa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:5879-5884(2011).
RN   [8]
RP   INTERACTION WITH LRRC52, SUBCELLULAR LOCATION, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=22084117; DOI=10.1073/pnas.1111104108;
RA   Yang C., Zeng X.H., Zhou Y., Xia X.M., Lingle C.J.;
RT   "LRRC52 (leucine-rich-repeat-containing protein 52), a testis-specific
RT   auxiliary subunit of the alkalization-activated Slo3 channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:19419-19424(2011).
RN   [9]
RP   FUNCTION, AND PH DEPENDENCE.
RX   PubMed=23129643; DOI=10.1073/pnas.1215078109;
RA   Leonetti M.D., Yuan P., Hsiung Y., Mackinnon R.;
RT   "Functional and structural analysis of the human SLO3 pH- and voltage-
RT   gated K+ channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:19274-19279(2012).
CC   -!- FUNCTION: Testis-specific potassium channel activated by both
CC       intracellular pH and membrane voltage that mediates export of
CC       K(+). Represents the primary spermatozoan K(+) current. In
CC       contrast to KCNMA1/SLO1, it is not activated by Ca(2+) or Mg(2+).
CC       Critical for fertility. May play an important role in sperm
CC       osmoregulation required for the acquisition of normal morphology
CC       and motility when faced with osmotic challenges, such as those
CC       experienced after mixing with seminal fluid and entry into the
CC       vagina. {ECO:0000269|PubMed:11696614, ECO:0000269|PubMed:11723163,
CC       ECO:0000269|PubMed:15201331, ECO:0000269|PubMed:16940554,
CC       ECO:0000269|PubMed:16940555, ECO:0000269|PubMed:21427226,
CC       ECO:0000269|PubMed:23129643, ECO:0000269|PubMed:9452476}.
CC   -!- SUBUNIT: Homotetramer; which constitutes the calcium-activated
CC       potassium channel. May interact with LRRC52; this interaction may
CC       change some channel gating properties, such as shifting gating to
CC       more negative potentials at a given pH.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22084117};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:22084117}.
CC   -!- TISSUE SPECIFICITY: Testis-specific. Mainly expressed in
CC       spermatocytes. {ECO:0000269|PubMed:21427226,
CC       ECO:0000269|PubMed:9452476}.
CC   -!- DEVELOPMENTAL STAGE: Very low expression levels in testis before
CC       postnatal day 25 (P25). Levels strongly increase between P25 and
CC       P30, and then remain high from P30 through P150.
CC       {ECO:0000269|PubMed:22084117}.
CC   -!- DOMAIN: The S4 segment, which is characterized by a series of
CC       positively charged amino acids at every third position, is part of
CC       the voltage-sensor. {ECO:0000250}.
CC   -!- DOMAIN: The pore-forming domain (also referred as P region) is
CC       imbedded into the membrane, and forms the selectivity filter of
CC       the pore. It contains the signature sequence of potassium channels
CC       that displays selectivity to potassium (By similarity).
CC       {ECO:0000250}.
CC   -!- DOMAIN: The RCK N-terminal domain mediates the
CC       homotetramerization, thereby promoting the assembly of monomers
CC       into functional potassium channel. {ECO:0000250}.
CC   -!- DOMAIN: The C-terminal cytosolic region confers the pH-dependence.
CC   -!- DISRUPTION PHENOTYPE: Mutant males are infertile, but their sperm
CC       retains some fertility within in vitro fertilization assays.
CC       Spermatozoa exhibit a higher incidence of morphological
CC       abnormalities as compared to wild-type, accentuated by hypotonic
CC       challenge and deficits in motility, in the absence of bicarbonate.
CC       {ECO:0000269|PubMed:21427226}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Calcium-
CC       activated (TC 1.A.1.3) subfamily. KCa5.1/KCNU1 sub-subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF039213; AAB99742.2; -; mRNA.
DR   CCDS; CCDS52530.1; -.
DR   PIR; T42383; T42383.
DR   RefSeq; NP_032458.3; NM_008432.3.
DR   UniGene; Mm.289679; -.
DR   ProteinModelPortal; O54982; -.
DR   STRING; 10090.ENSMUSP00000096457; -.
DR   GuidetoPHARMACOLOGY; 387; -.
DR   TCDB; 1.A.1.3.5; the voltage-gated ion channel (vic) superfamily.
DR   PhosphoSitePlus; O54982; -.
DR   PaxDb; O54982; -.
DR   PRIDE; O54982; -.
DR   DNASU; 16532; -.
DR   GeneID; 16532; -.
DR   KEGG; mmu:16532; -.
DR   CTD; 157855; -.
DR   MGI; MGI:1202300; Kcnu1.
DR   eggNOG; KOG1420; Eukaryota.
DR   eggNOG; ENOG410YUX1; LUCA.
DR   HOGENOM; HOG000019856; -.
DR   HOVERGEN; HBG052222; -.
DR   InParanoid; O54982; -.
DR   KO; K05274; -.
DR   PhylomeDB; O54982; -.
DR   PRO; PR:O54982; -.
DR   Proteomes; UP000000589; Unplaced.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IBA:GO_Central.
DR   GO; GO:0060072; F:large conductance calcium-activated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005267; F:potassium channel activity; IMP:MGI.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; IMP:MGI.
DR   GO; GO:0050821; P:protein stabilization; IMP:MGI.
DR   GO; GO:0022414; P:reproductive process; IMP:MGI.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003929; K_chnl_BK_asu.
DR   Pfam; PF03493; BK_channel_a; 1.
DR   Pfam; PF00520; Ion_trans; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1   1121       Potassium channel subfamily U member 1.
FT                                /FTId=PRO_0000349188.
FT   TOPO_DOM      1     24       Extracellular. {ECO:0000255}.
FT   TRANSMEM     25     45       Helical; Name=Segment S0. {ECO:0000255}.
FT   TOPO_DOM     46    101       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    102    122       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    123    137       Extracellular. {ECO:0000255}.
FT   TRANSMEM    138    158       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    159    165       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    166    186       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    187    188       Extracellular. {ECO:0000255}.
FT   TRANSMEM    189    209       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    210    226       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    227    247       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    248    259       Extracellular. {ECO:0000255}.
FT   INTRAMEM    260    282       Pore-forming; Name=P region.
FT                                {ECO:0000255}.
FT   TOPO_DOM    283    290       Extracellular. {ECO:0000255}.
FT   TRANSMEM    291    311       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    312   1121       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      339    482       RCK N-terminal.
FT   REGION      480    500       Segment S7.
FT   REGION      537    557       Segment S8.
FT   REGION      716    736       Segment S9.
FT   REGION      900    920       Segment S1.
FT   MOTIF       276    279       Selectivity for potassium.
FT   MUTAGEN     279    279       F->Y: Does not induce any change in
FT                                single channel conductance or variance in
FT                                open current levels.
FT                                {ECO:0000269|PubMed:16940554}.
SQ   SEQUENCE   1121 AA;  126870 MW;  4D7E0425B97B47A1 CRC64;
     MSQTLLDSLN QKELTETSCT IEIQAAFILS SLATFFGGLI ILFLFRIALK SSRSWKYVKG
     PRGLLELFSS RRIEANPLRK LYFHGVFRQR IEMLLSAQTV VGQVLVILVF VLSIGSLVIY
     FINSMDPVRR CSSYEDKIVH GDLSFNAFFS FYFGLRFWAA EDKIKFWLEM NSIVDIFTIP
     PTFISYYLKS NWLGLRFLRA LRLLELPKIL QILQVIKTSN SVKLSKLLSI VISTWFTAAG
     FLHLVENSGD PWLNGRNSQT MSYFESIYLV TATMSTVGFG DVVAKTSLGR IFIVFFTLGS
     LILFANYIPE MVELFSTRKK YTKPYEAVKG KKFIVVCGNI TVDSVTAFLR NFLHWKSGEI
     NIEIVFLGET LPCLELETLL KCHTSCTNFV CGTALKFEDL KRVAVENSEA CLILANHFCS
     DLHDEDNSNI MRVLSIKNYY PQTRVIIQIL QSQNKVFLSK IPNWDWSAGD NILCFAELKL
     GFIAQGCLVP GLCTFLTTLF IEQNQKVFPK HPWQKHFLNG LKNKILTQRL SNDFVGMTFP
     QVSRLCFVKL NLMLIAIQHK PFFHSCCTLI LNPSSQVRLN KDTLGFFIAD SSKAVKRAFF
     YCSNCHSDVC NPELIGKCNC KIKSRQQLIA PTIMVMKSSL TDFTTSSHIH ASMSTEIHTC
     FSREQPSLIT ITTNRPTTND TVDDTDMLDS SGMFHWCRAM PLDKVVLKRS EKAKHEFQNH
     IVVCVFGDAQ CTLVGLRNFV MPLRASNYTR QELKDIVFIG SLEYFQREWR FLRNFPKIHI
     MPGSALYMGD LIAVNVEQCS MCVILATPYK ALSSQILVDT EAIMATLNIQ SLRITSPTPG
     SSKSEVKPSS AFDSKERKQR YKQIPILTEL KNPSNIHFIE QMGGLDGMLK GTSLHLSTSF
     STGAVFSDTF LDSLLATSFY NYHVVELLQM LVTGGISSEM EHYLVKEKPY KTTDDYEAIK
     SGRTRCKLGL LSLDQTVLSG INPRKTFGQL FCGSLDNFGI LCVGLYRMID EEEPSQEHKR
     FVITRPSNEC HLLPSDLVFC AIPFNTTCGK SDSSPSIQAQ NNSTNATTPL AQGSNFFDSH
     HADESHDLYP VDDTGERWSQ HHHSRVYPLD TLDASDIVQE K
//
ID   HCN1_HUMAN              Reviewed;         890 AA.
AC   O60741;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 3.
DT   20-DEC-2017, entry version 147.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1;
DE   AltName: Full=Brain cyclic nucleotide-gated channel 1;
DE            Short=BCNG-1;
GN   Name=HCN1; Synonyms=BCNG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 122-862, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9630217; DOI=10.1016/S0092-8674(00)81434-8;
RA   Santoro B., Liu D.T., Yao H., Bartsch D., Kandel E.R.,
RA   Siegelbaum S.A., Tibbs G.R.;
RT   "Identification of a gene encoding a hyperpolarization-activated
RT   'pacemaker' channel of brain.";
RL   Cell 93:717-729(1998).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND ENZYME REGULATION.
RX   PubMed=15351778; DOI=10.1038/sj.bjp.0705945;
RA   Gill C.H., Randall A., Bates S.A., Hill K., Owen D., Larkman P.M.,
RA   Cairns W., Yusaf S.P., Murdock P.R., Strijbos P.J., Powell A.J.,
RA   Benham C.D., Davies C.H.;
RT   "Characterization of the human HCN1 channel and its inhibition by
RT   capsazepine.";
RL   Br. J. Pharmacol. 143:411-421(2004).
RN   [4] {ECO:0000244|PDB:5U6O, ECO:0000244|PDB:5U6P}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS) OF APOPROTEIN AND IN
RP   COMPLEX WITH CAMP, FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, SUBUNIT,
RP   AND ENZYME REGULATION.
RX   PubMed=28086084; DOI=10.1016/j.cell.2016.12.023;
RA   Lee C.H., MacKinnon R.;
RT   "Structures of the human HCN1 hyperpolarization-activated channel.";
RL   Cell 168:111-120(2017).
RN   [5]
RP   INVOLVEMENT IN EIEE24, VARIANTS EIEE24 VAL-47; PHE-100; PRO-272;
RP   TYR-279; THR-297 AND HIS-401, AND CHARACTERIZATION OF VARIANTS EIEE24
RP   PHE-100; PRO-272; TYR-279; THR-297 AND HIS-401.
RX   PubMed=24747641; DOI=10.1038/ng.2952;
RG   EuroEPINOMICS RES Consortium;
RA   Nava C., Dalle C., Rastetter A., Striano P., de Kovel C.G.,
RA   Nabbout R., Cances C., Ville D., Brilstra E.H., Gobbi G., Raffo E.,
RA   Bouteiller D., Marie Y., Trouillard O., Robbiano A., Keren B.,
RA   Agher D., Roze E., Lesage S., Nicolas A., Brice A., Baulac M.,
RA   Vogt C., El Hajj N., Schneider E., Suls A., Weckhuysen S., Gormley P.,
RA   Lehesjoki A.E., De Jonghe P., Helbig I., Baulac S., Zara F.,
RA   Koeleman B.P., Haaf T., LeGuern E., Depienne C.;
RT   "De novo mutations in HCN1 cause early infantile epileptic
RT   encephalopathy.";
RL   Nat. Genet. 46:640-645(2014).
RN   [6]
RP   VARIANTS EIEE24 ILE-153 AND ASP-391.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak
CC       selectivity for potassium over sodium ions (PubMed:28086084).
CC       Contributes to the native pacemaker currents in heart (If) and in
CC       neurons (Ih). May mediate responses to sour stimuli.
CC       {ECO:0000269|PubMed:15351778, ECO:0000269|PubMed:28086084}.
CC   -!- ENZYME REGULATION: Activated by cAMP, and at 10-100 times higher
CC       concentrations, also by cGMP. cAMP binding promotes
CC       tetramerization and formation of an active channel. Compared to
CC       other family members, cAMP has less stimulatory effect on HCN1
CC       because part of the molecules already contain bound cAMP and form
CC       homotetramers when cAMP levels are low. Inhibited by Cs(1+),
CC       zatebradine, capsazepine and ZD7288. {ECO:0000269|PubMed:15351778,
CC       ECO:0000269|PubMed:28086084}.
CC   -!- SUBUNIT: Homotetramer (PubMed:28086084). Heterotetramer with HCN2.
CC       The potassium channel is composed of a homo- or heterotetrameric
CC       complex of pore-forming subunits. Interacts with KCNE2. Interacts
CC       with the SH3 domain of CSK (By similarity).
CC       {ECO:0000250|UniProtKB:O88704, ECO:0000269|PubMed:28086084}.
CC   -!- INTERACTION:
CC       Q4ACU6-1:Shank3 (xeno); NbExp=4; IntAct=EBI-11173743, EBI-16201983;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15351778,
CC       ECO:0000269|PubMed:28086084}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15351778, ECO:0000269|PubMed:28086084}.
CC   -!- TISSUE SPECIFICITY: Detected in brain, in particular in amygdala
CC       and hippocampus, while expression in caudate nucleus, corpus
CC       callosum, substantia nigra, subthalamic nucleus and thalamus is
CC       very low or not detectable. Detected at very low levels in muscle
CC       and pancreas. {ECO:0000269|PubMed:9630217}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000305|PubMed:28086084}.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 24 (EIEE24)
CC       [MIM:615871]: A disease characterized by early-onset seizures,
CC       intellectual disability of varying degrees, and behavioral
CC       disturbances or autistic features in most individuals.
CC       {ECO:0000269|PubMed:24747641, ECO:0000269|PubMed:27864847}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC39759.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC099514; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC114975; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117529; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138520; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF064876; AAC39759.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS3952.1; -.
DR   RefSeq; NP_066550.2; NM_021072.3.
DR   UniGene; Hs.353176; -.
DR   PDB; 5U6O; EM; 3.50 A; A/B/C/D=1-890.
DR   PDB; 5U6P; EM; 3.51 A; A/B/C/D=1-890.
DR   PDBsum; 5U6O; -.
DR   PDBsum; 5U6P; -.
DR   ProteinModelPortal; O60741; -.
DR   SMR; O60741; -.
DR   BioGrid; 131543; 5.
DR   DIP; DIP-62038N; -.
DR   IntAct; O60741; 1.
DR   STRING; 9606.ENSP00000307342; -.
DR   BindingDB; O60741; -.
DR   ChEMBL; CHEMBL1795171; -.
DR   GuidetoPHARMACOLOGY; 400; -.
DR   iPTMnet; O60741; -.
DR   PhosphoSitePlus; O60741; -.
DR   BioMuta; HCN1; -.
DR   MaxQB; O60741; -.
DR   PaxDb; O60741; -.
DR   PeptideAtlas; O60741; -.
DR   PRIDE; O60741; -.
DR   Ensembl; ENST00000303230; ENSP00000307342; ENSG00000164588.
DR   GeneID; 348980; -.
DR   KEGG; hsa:348980; -.
DR   UCSC; uc003jok.4; human.
DR   CTD; 348980; -.
DR   DisGeNET; 348980; -.
DR   EuPathDB; HostDB:ENSG00000164588.5; -.
DR   GeneCards; HCN1; -.
DR   H-InvDB; HIX0004850; -.
DR   HGNC; HGNC:4845; HCN1.
DR   HPA; HPA019195; -.
DR   MalaCards; HCN1; -.
DR   MIM; 602780; gene.
DR   MIM; 615871; phenotype.
DR   neXtProt; NX_O60741; -.
DR   OpenTargets; ENSG00000164588; -.
DR   Orphanet; 1934; Early infantile epileptic encephalopathy.
DR   PharmGKB; PA77; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039489; -.
DR   InParanoid; O60741; -.
DR   KO; K04954; -.
DR   OMA; TRTFHYA; -.
DR   OrthoDB; EOG091G0JQU; -.
DR   PhylomeDB; O60741; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-HSA-1296061; HCN channels.
DR   ChiTaRS; HCN1; human.
DR   GeneWiki; HCN1; -.
DR   GenomeRNAi; 348980; -.
DR   PRO; PR:O60741; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000164588; -.
DR   CleanEx; HS_HCN1; -.
DR   ExpressionAtlas; O60741; baseline and differential.
DR   Genevisible; O60741; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0098855; C:HCN channel complex; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030552; F:cAMP binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; NAS:UniProtKB.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IMP:UniProtKB.
DR   GO; GO:0045176; P:apical protein localization; IEA:Ensembl.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:UniProtKB.
DR   GO; GO:0046549; P:retinal cone cell development; IEA:Ensembl.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IMP:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR030169; K/Na_HCN1.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF373; PTHR10217:SF373; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cAMP; cAMP-binding; Cell membrane; Complete proteome;
KW   Disease mutation; Epilepsy; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Nucleotide-binding; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Sodium; Sodium channel; Sodium transport; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    890       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                1.
FT                                /FTId=PRO_0000054107.
FT   TOPO_DOM      1    142       Cytoplasmic.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TRANSMEM    143    164       Helical; Name=Segment S1.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    165    173       Extracellular.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TRANSMEM    174    194       Helical; Name=Segment S2.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    195    215       Cytoplasmic.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TRANSMEM    216    236       Helical; Name=Segment S3.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    237    260       Extracellular.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TRANSMEM    261    281       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    282    295       Cytoplasmic.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TRANSMEM    296    318       Helical; Name=Segment S5.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    319    344       Extracellular.
FT                                {ECO:0000269|PubMed:28086084}.
FT   INTRAMEM    345    366       Pore-forming; Name=Segment H5.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    367    371       Extracellular.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TRANSMEM    372    392       Helical; Name=Segment S6.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    393    890       Cytoplasmic.
FT                                {ECO:0000269|PubMed:28086084}.
FT   NP_BIND     539    542       cAMP. {ECO:0000244|PDB:5U6P,
FT                                ECO:0000305|PubMed:28086084}.
FT   NP_BIND     549    550       cAMP. {ECO:0000244|PDB:5U6P,
FT                                ECO:0000305|PubMed:28086084}.
FT   NP_BIND     590    593       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   REGION        1     93       Intrinsically disordered.
FT                                {ECO:0000305|PubMed:28086084}.
FT   MOTIF       358    362       Selectivity filter.
FT                                {ECO:0000305|PubMed:28086084}.
FT   COMPBIAS      1     80       Gly-rich.
FT   COMPBIAS    726    756       Gln-rich.
FT   COMPBIAS    857    863       Poly-Pro.
FT   CARBOHYD    338    338       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      42     42       P -> S (in dbSNP:rs56164833).
FT                                /FTId=VAR_061105.
FT   VARIANT      47     47       G -> V (in EIEE24; unknown pathological
FT                                significance; dbSNP:rs544994462).
FT                                {ECO:0000269|PubMed:24747641}.
FT                                /FTId=VAR_071825.
FT   VARIANT     100    100       S -> F (in EIEE24; dominant-negative
FT                                mutation resulting in gain of channel
FT                                function; dbSNP:rs587777492).
FT                                {ECO:0000269|PubMed:24747641}.
FT                                /FTId=VAR_071826.
FT   VARIANT     153    153       M -> I (in EIEE24; dbSNP:rs1057519548).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078216.
FT   VARIANT     272    272       S -> P (in EIEE24; dominant-negative
FT                                mutation resulting in loss of channel
FT                                currents; dbSNP:rs587777493).
FT                                {ECO:0000269|PubMed:24747641}.
FT                                /FTId=VAR_071827.
FT   VARIANT     279    279       H -> Y (in EIEE24; results in a gain of
FT                                channel function; dbSNP:rs587777495).
FT                                {ECO:0000269|PubMed:24747641}.
FT                                /FTId=VAR_071828.
FT   VARIANT     297    297       R -> T (in EIEE24; dominant-negative
FT                                mutation resulting in loss of channel
FT                                currents; dbSNP:rs587777494).
FT                                {ECO:0000269|PubMed:24747641}.
FT                                /FTId=VAR_071829.
FT   VARIANT     391    391       G -> D (in EIEE24; dbSNP:rs1057519547).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078217.
FT   VARIANT     401    401       D -> H (in EIEE24; results in a gain of
FT                                channel function; dbSNP:rs587777491).
FT                                {ECO:0000269|PubMed:24747641}.
FT                                /FTId=VAR_071830.
FT   CONFLICT    786    786       L -> F (in Ref. 2; AAC39759).
FT                                {ECO:0000305}.
FT   CONFLICT    789    789       S -> W (in Ref. 2; AAC39759).
FT                                {ECO:0000305}.
FT   CONFLICT    841    841       L -> F (in Ref. 2; AAC39759).
FT                                {ECO:0000305}.
FT   CONFLICT    857    857       P -> L (in Ref. 2; AAC39759).
FT                                {ECO:0000305}.
FT   CONFLICT    861    861       P -> L (in Ref. 2; AAC39759).
FT                                {ECO:0000305}.
FT   HELIX        95    102       {ECO:0000244|PDB:5U6O}.
FT   HELIX       108    114       {ECO:0000244|PDB:5U6O}.
FT   HELIX       117    127       {ECO:0000244|PDB:5U6O}.
FT   STRAND      130    133       {ECO:0000244|PDB:5U6O}.
FT   HELIX       140    166       {ECO:0000244|PDB:5U6O}.
FT   HELIX       173    195       {ECO:0000244|PDB:5U6O}.
FT   TURN        209    211       {ECO:0000244|PDB:5U6O}.
FT   HELIX       212    218       {ECO:0000244|PDB:5U6O}.
FT   TURN        219    221       {ECO:0000244|PDB:5U6O}.
FT   HELIX       222    229       {ECO:0000244|PDB:5U6O}.
FT   HELIX       232    241       {ECO:0000244|PDB:5U6O}.
FT   HELIX       253    264       {ECO:0000244|PDB:5U6O}.
FT   HELIX       265    269       {ECO:0000244|PDB:5U6O}.
FT   HELIX       270    289       {ECO:0000244|PDB:5U6O}.
FT   HELIX       293    322       {ECO:0000244|PDB:5U6O}.
FT   HELIX       330    333       {ECO:0000244|PDB:5U6O}.
FT   STRAND      337    339       {ECO:0000244|PDB:5U6O}.
FT   HELIX       341    357       {ECO:0000244|PDB:5U6O}.
FT   STRAND      362    364       {ECO:0000244|PDB:5U6O}.
FT   HELIX       369    400       {ECO:0000244|PDB:5U6O}.
FT   HELIX       402    421       {ECO:0000244|PDB:5U6O}.
FT   HELIX       425    439       {ECO:0000244|PDB:5U6O}.
FT   HELIX       446    452       {ECO:0000244|PDB:5U6O}.
FT   HELIX       455    472       {ECO:0000244|PDB:5U6O}.
FT   TURN        474    477       {ECO:0000244|PDB:5U6O}.
FT   HELIX       481    490       {ECO:0000244|PDB:5U6O}.
FT   STRAND      492    496       {ECO:0000244|PDB:5U6O}.
FT   STRAND      501    503       {ECO:0000244|PDB:5U6O}.
FT   STRAND      505    507       {ECO:0000244|PDB:5U6O}.
FT   STRAND      511    523       {ECO:0000244|PDB:5U6O}.
FT   STRAND      525    527       {ECO:0000244|PDB:5U6O}.
FT   STRAND      541    545       {ECO:0000244|PDB:5U6O}.
FT   STRAND      551    565       {ECO:0000244|PDB:5U6O}.
FT   HELIX       566    575       {ECO:0000244|PDB:5U6O}.
FT   HELIX       577    584       {ECO:0000244|PDB:5U6O}.
SQ   SEQUENCE   890 AA;  98796 MW;  A62F5E79C01257A2 CRC64;
     MEGGGKPNSS SNSRDDGNSV FPAKASATGA GPAAAEKRLG TPPGGGGAGA KEHGNSVCFK
     VDGGGGGGGG GGGGEEPAGG FEDAEGPRRQ YGFMQRQFTS MLQPGVNKFS LRMFGSQKAV
     EKEQERVKTA GFWIIHPYSD FRFYWDLIML IMMVGNLVII PVGITFFTEQ TTTPWIIFNV
     ASDTVFLLDL IMNFRTGTVN EDSSEIILDP KVIKMNYLKS WFVVDFISSI PVDYIFLIVE
     KGMDSEVYKT ARALRIVRFT KILSLLRLLR LSRLIRYIHQ WEEIFHMTYD LASAVVRIFN
     LIGMMLLLCH WDGCLQFLVP LLQDFPPDCW VSLNEMVNDS WGKQYSYALF KAMSHMLCIG
     YGAQAPVSMS DLWITMLSMI VGATCYAMFV GHATALIQSL DSSRRQYQEK YKQVEQYMSF
     HKLPADMRQK IHDYYEHRYQ GKIFDEENIL NELNDPLREE IVNFNCRKLV ATMPLFANAD
     PNFVTAMLSK LRFEVFQPGD YIIREGAVGK KMYFIQHGVA GVITKSSKEM KLTDGSYFGE
     ICLLTKGRRT ASVRADTYCR LYSLSVDNFN EVLEEYPMMR RAFETVAIDR LDRIGKKNSI
     LLQKFQKDLN TGVFNNQENE ILKQIVKHDR EMVQAIAPIN YPQMTTLNST SSTTTPTSRM
     RTQSPPVYTA TSLSHSNLHS PSPSTQTPQP SAILSPCSYT TAVCSPPVQS PLAARTFHYA
     SPTASQLSLM QQQPQQQVQQ SQPPQTQPQQ PSPQPQTPGS STPKNEVHKS TQALHNTNLT
     REVRPLSASQ PSLPHEVSTL ISRPHPTVGE SLASIPQPVT AVPGTGLQAG GRSTVPQRVT
     LFRQMSSGAI PPNRGVPPAP PPPAAALPRE SSSVLNTDPD AEKPRFASNL
//
ID   KCNK4_MOUSE             Reviewed;         398 AA.
AC   O88454;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   20-DEC-2017, entry version 135.
DE   RecName: Full=Potassium channel subfamily K member 4;
DE   AltName: Full=TWIK-related arachidonic acid-stimulated potassium channel protein;
DE            Short=TRAAK;
GN   Name=Kcnk4; Synonyms=Traak;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9628867; DOI=10.1093/emboj/17.12.3297;
RA   Fink M., Lesage F., Duprat F., Heurteaux C., Reyes R., Fosset M.,
RA   Lazdunski M.;
RT   "A neuronal two P domain K+ channel stimulated by arachidonic acid and
RT   polyunsaturated fatty acids.";
RL   EMBO J. 17:3297-3308(1998).
RN   [2]
RP   ENZYME REGULATION.
RX   PubMed=10321245; DOI=10.1038/8084;
RA   Patel A.J., Honore E., Lesage F., Fink M., Romey G., Lazdunski M.;
RT   "Inhalational anesthetics activate two-pore-domain background K+
RT   channels.";
RL   Nat. Neurosci. 2:422-426(1999).
RN   [3]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19279663; DOI=10.1038/emboj.2009.57;
RA   Noel J., Zimmermann K., Busserolles J., Deval E., Alloui A.,
RA   Diochot S., Guy N., Borsotto M., Reeh P., Eschalier A., Lazdunski M.;
RT   "The mechano-activated K+ channels TRAAK and TREK-1 control both warm
RT   and cold perception.";
RL   EMBO J. 28:1308-1318(2009).
CC   -!- FUNCTION: Voltage-insensitive potassium channel (PubMed:9628867).
CC       Channel opening is triggered by mechanical forces that deform the
CC       membrane. Channel opening is triggered by raising the
CC       intracellular pH to basic levels (By similarity). The channel is
CC       inactive at 24 degrees Celsius (in vitro); raising the temperature
CC       to 37 degrees Celsius increases the frequency of channel opening,
CC       with a further increase in channel activity when the temperature
CC       is raised to 42 degrees Celsius (By similarity). Plays a role in
CC       the sensory perception of pain caused by pressure
CC       (PubMed:19279663). Plays a role in the perception of pain caused
CC       by heat (PubMed:19279663). {ECO:0000250|UniProtKB:G3V8V5,
CC       ECO:0000269|PubMed:19279663, ECO:0000269|PubMed:9628867}.
CC   -!- ENZYME REGULATION: Activated by arachidonic acid and other
CC       unsaturated fatty acids (PubMed:9628867). Not affected by volatile
CC       general anesthetics such as chloroform, diethyl ether, halothane
CC       and isoflurane (PubMed:10321245). {ECO:0000269|PubMed:10321245,
CC       ECO:0000269|PubMed:9628867}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked.
CC       {ECO:0000250|UniProtKB:Q9NYG8}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9628867};
CC       Multi-pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O88454-1; Sequence=Displayed;
CC       Name=2; Synonyms=TRAAKT, Truncated;
CC         IsoId=O88454-2; Sequence=VSP_006690, VSP_006691;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, spinal cord and eye. Not
CC       detected in heart, skeletal muscle, liver, lungs, kidney and
CC       testis. {ECO:0000269|PubMed:9628867}.
CC   -!- DOMAIN: Channel opening is brought about by a conformation change
CC       that involves buckling of the second transmembrane helix and
CC       affects the position and orientation of the fourth transmembrane
CC       helix. {ECO:0000250|UniProtKB:Q9NYG8}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q9NYG8}.
CC   -!- DISRUPTION PHENOTYPE: Mutant mice show increased sensitivity to
CC       pain caused by pressure, but also by heat.
CC       {ECO:0000269|PubMed:19279663}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF056492; AAC40181.1; -; mRNA.
DR   CCDS; CCDS29511.1; -. [O88454-1]
DR   RefSeq; NP_032457.1; NM_008431.3. [O88454-1]
DR   RefSeq; XP_006526783.1; XM_006526720.2. [O88454-1]
DR   UniGene; Mm.12894; -.
DR   ProteinModelPortal; O88454; -.
DR   SMR; O88454; -.
DR   STRING; 10090.ENSMUSP00000025908; -.
DR   TCDB; 1.A.1.9.3; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O88454; -.
DR   PhosphoSitePlus; O88454; -.
DR   PaxDb; O88454; -.
DR   PRIDE; O88454; -.
DR   Ensembl; ENSMUST00000025908; ENSMUSP00000025908; ENSMUSG00000024957. [O88454-1]
DR   GeneID; 16528; -.
DR   KEGG; mmu:16528; -.
DR   UCSC; uc008gjj.1; mouse. [O88454-1]
DR   CTD; 50801; -.
DR   MGI; MGI:1298234; Kcnk4.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000013106; -.
DR   HOVERGEN; HBG052234; -.
DR   InParanoid; O88454; -.
DR   KO; K04915; -.
DR   OMA; LDYPSEN; -.
DR   OrthoDB; EOG091G0E3R; -.
DR   PhylomeDB; O88454; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-MMU-1299503; TWIK related potassium channel (TREK).
DR   PRO; PR:O88454; -.
DR   Proteomes; UP000000589; Chromosome 19.
DR   Bgee; ENSMUSG00000024957; -.
DR   CleanEx; MM_KCNK4; -.
DR   ExpressionAtlas; O88454; baseline and differential.
DR   Genevisible; O88454; MM.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0034705; C:potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0098782; F:mechanically-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0097604; F:temperature-gated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0071469; P:cellular response to alkaline pH; ISS:UniProtKB.
DR   GO; GO:0071398; P:cellular response to fatty acid; ISS:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISO:MGI.
DR   GO; GO:0071502; P:cellular response to temperature stimulus; ISS:UniProtKB.
DR   GO; GO:0050976; P:detection of mechanical stimulus involved in sensory perception of touch; IMP:UniProtKB.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0019233; P:sensory perception of pain; IMP:UniProtKB.
DR   GO; GO:0050951; P:sensory perception of temperature stimulus; IMP:UniProtKB.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR008074; 2pore_dom_K_chnl_TRAAK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01691; TRAAKCHANNEL.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    398       Potassium channel subfamily K member 4.
FT                                /FTId=PRO_0000101748.
FT   TOPO_DOM      1      3       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9NYG8}.
FT   TRANSMEM      4     24       Helical. {ECO:0000250|UniProtKB:Q9NYG8}.
FT   TOPO_DOM     25     88       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q9NYG8}.
FT   INTRAMEM     89    103       Helical; Name=Pore helix 1.
FT                                {ECO:0000250|UniProtKB:Q9NYG8}.
FT   INTRAMEM    104    110       {ECO:0000250|UniProtKB:Q9NYG8}.
FT   TOPO_DOM    111    118       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q9NYG8}.
FT   TRANSMEM    119    151       Helical. {ECO:0000250|UniProtKB:Q9NYG8}.
FT   TOPO_DOM    152    173       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9NYG8}.
FT   TRANSMEM    174    195       Helical. {ECO:0000250|UniProtKB:Q9NYG8}.
FT   TOPO_DOM    196    200       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q9NYG8}.
FT   INTRAMEM    201    214       Helical; Name=Pore helix 2.
FT                                {ECO:0000250|UniProtKB:Q9NYG8}.
FT   INTRAMEM    215    220       {ECO:0000250|UniProtKB:Q9NYG8}.
FT   TOPO_DOM    221    234       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q9NYG8}.
FT   TRANSMEM    235    261       Helical. {ECO:0000250|UniProtKB:Q9NYG8}.
FT   TOPO_DOM    262    398       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9NYG8}.
FT   REGION      104    109       Selectivity filter 1.
FT                                {ECO:0000250|UniProtKB:Q9NYG8}.
FT   REGION      213    218       Selectivity filter 2.
FT                                {ECO:0000250|UniProtKB:Q9NYG8}.
FT   CARBOHYD     81     81       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     84     84       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     52     52       Interchain.
FT                                {ECO:0000250|UniProtKB:Q9NYG8}.
FT   VAR_SEQ      63     67       KLLVE -> KAMAI (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_006690.
FT   VAR_SEQ      68    398       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_006691.
SQ   SEQUENCE   398 AA;  43052 MW;  478A834B7B7AEC92 CRC64;
     MRSTTLLALL ALVLLYLVSG ALVFQALEQP HEQQAQKKMD HGRDQFLRDH PCVSQKSLED
     FIKLLVEALG GGANPETSWT NSSNHSSAWN LGSAFFFSGT IITTIGYGNI VLHTDAGRLF
     CIFYALVGIP LFGMLLAGVG DRLGSSLRRG IGHIEAIFLK WHVPPGLVRS LSAVLFLLIG
     CLLFVLTPTF VFSYMESWSK LEAIYFVIVT LTTVGFGDYV PGDGTGQNSP AYQPLVWFWI
     LFGLAYFASV LTTIGNWLRA VSRRTRAEMG GLTAQAASWT GTVTARVTQR TGPSAPPPEK
     EQPLLPSSLP APPAVVEPAG RPGSPAPAEK VETPSPPTAS ALDYPSENLA FIDESSDTQS
     ERGCALPRAP RGRRRPNPSK KPSRPRGPGR LRDKAVPV
//
ID   HCN2_MOUSE              Reviewed;         863 AA.
AC   O88703; O70506;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   20-DEC-2017, entry version 159.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2;
DE   AltName: Full=Brain cyclic nucleotide-gated channel 2;
DE            Short=BCNG-2;
DE   AltName: Full=Hyperpolarization-activated cation channel 1;
DE            Short=HAC-1;
GN   Name=Hcn2; Synonyms=Bcng2, Hac1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   STRAIN=BALB/cJ;
RX   PubMed=9634236; DOI=10.1038/31255;
RA   Ludwig A., Zong X., Jeglitsch M., Hofmann F., Biel M.;
RT   "A family of hyperpolarization-activated cation channels.";
RL   Nature 393:587-591(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 150-653, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9630217; DOI=10.1016/S0092-8674(00)81434-8;
RA   Santoro B., Liu D.T., Yao H., Bartsch D., Kandel E.R.,
RA   Siegelbaum S.A., Tibbs G.R.;
RT   "Identification of a gene encoding a hyperpolarization-activated
RT   'pacemaker' channel of brain.";
RL   Cell 93:717-729(1998).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-225; ASP-231;
RP   ASP-267; ASP-275; LYS-291; ARG-294; ARG-297; ARG-300; LYS-303;
RP   SER-306; ARG-309; ARG-312; ARG-315 AND ARG-318.
RX   PubMed=10962006; DOI=10.1074/jbc.M007034200;
RA   Chen J., Mitcheson J.S., Lin M., Sanguinetti M.C.;
RT   "Functional roles of charged residues in the putative voltage sensor
RT   of the HCN2 pacemaker channel.";
RL   J. Biol. Chem. 275:36465-36471(2000).
RN   [4]
RP   INTERACTION WITH KCNE2.
RX   PubMed=11420311; DOI=10.1161/hh1201.093511;
RA   Yu H., Wu J., Potapova I., Wymore R.T., Holmes B., Zuckerman J.,
RA   Pan Z., Wang H., Shi W., Robinson R.B., El-Maghrabi M.R., Benjamin W.,
RA   Dixon J.E., McKinnon D., Cohen I.S., Wymore R.;
RT   "MinK-related peptide 1: a beta subunit for the HCN ion channel
RT   subunit family enhances expression and speeds activation.";
RL   Circ. Res. 88:E84-E87(2001).
RN   [5]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   HIS-321.
RX   PubMed=11096117; DOI=10.1074/jbc.M010326200;
RA   Zong X., Stieber J., Ludwig A., Hofmann F., Biel M.;
RT   "A single histidine residue determines the pH sensitivity of the
RT   pacemaker channel HCN2.";
RL   J. Biol. Chem. 276:6313-6319(2001).
RN   [6]
RP   MUTAGENESIS OF ARG-318; GLU-324; TYR-331 AND ARG-339.
RX   PubMed=11553787; DOI=10.1073/pnas.201250598;
RA   Chen J., Mitcheson J.S., Tristani-Firouzi M., Lin M.,
RA   Sanguinetti M.C.;
RT   "The S4-S5 linker couples voltage sensing and activation of pacemaker
RT   channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:11277-11282(2001).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF SER-306.
RX   PubMed=11741901; DOI=10.1074/jbc.M106974200;
RA   Proenza C., Angoli D., Agranovich E., Macri V., Accili E.A.;
RT   "Pacemaker channels produce an instantaneous current.";
RL   J. Biol. Chem. 277:5101-5109(2002).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH HCN1.
RX   PubMed=12034718; DOI=10.1074/jbc.M200504200;
RA   Proenza C., Tran N., Angoli D., Zahynacz K., Balcar P., Accili E.A.;
RT   "Different roles for the cyclic nucleotide binding domain and amino
RT   terminus in assembly and expression of hyperpolarization-activated,
RT   cyclic nucleotide-gated channels.";
RL   J. Biol. Chem. 277:29634-29642(2002).
RN   [9]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=12193608; DOI=10.1074/jbc.M208477200;
RA   Tran N., Proenza C., Macri V., Petigara F., Sloan E., Samler S.,
RA   Accili E.A.;
RT   "A conserved domain in the NH2 terminus important for assembly and
RT   functional expression of pacemaker channels.";
RL   J. Biol. Chem. 277:43588-43592(2002).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119; SER-743; SER-750;
RP   SER-757; SER-840; SER-842 AND SER-847, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [11]
RP   PHOSPHORYLATION AT SER-641.
RX   PubMed=21347269; DOI=10.1371/journal.pone.0017078;
RA   Hammelmann V., Zong X., Hofmann F., Michalakis S., Biel M.;
RT   "The cGMP-dependent protein kinase II Is an inhibitory modulator of
RT   the hyperpolarization-activated HCN2 channel.";
RL   PLoS ONE 6:E17078-E17078(2011).
RN   [12]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   SER-594.
RX   PubMed=23103389; DOI=10.1016/j.str.2012.09.017;
RA   Xu X., Marni F., Wu S., Su Z., Musayev F., Shrestha S., Xie C.,
RA   Gao W., Liu Q., Zhou L.;
RT   "Local and global interpretations of a disease-causing mutation near
RT   the ligand entry path in hyperpolarization-activated cAMP-gated
RT   channel.";
RL   Structure 20:2116-2123(2012).
RN   [13]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-728, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 443-643 IN COMPLEXES WITH
RP   CAMP AND CGMP, FUNCTION, ENZYME REGULATION, NUCLEOTIDE-BINDING, AND
RP   SUBUNIT.
RX   PubMed=12968185; DOI=10.1038/nature01922;
RA   Zagotta W.N., Olivier N.B., Black K.D., Young E.C., Olson R.,
RA   Gouaux E.;
RT   "Structural basis for modulation and agonist specificity of HCN
RT   pacemaker channels.";
RL   Nature 425:200-205(2003).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 443-640, FUNCTION, ENZYME
RP   REGULATION, SUBUNIT, SUBCELLULAR LOCATION, AND NUCLEOTIDE-BINDING.
RX   PubMed=17562314; DOI=10.1016/j.str.2007.04.008;
RA   Flynn G.E., Black K.D., Islas L.D., Sankaran B., Zagotta W.N.;
RT   "Structure and rearrangements in the carboxy-terminal region of SpIH
RT   channels.";
RL   Structure 15:671-682(2007).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 443-640 IN COMPLEX WITH
RP   CAMP, SUBUNIT, AND NUCLEOTIDE-BINDING.
RX   PubMed=18367452; DOI=10.1074/jbc.M710463200;
RA   Craven K.B., Olivier N.B., Zagotta W.N.;
RT   "C-terminal movement during gating in cyclic nucleotide-modulated
RT   channels.";
RL   J. Biol. Chem. 283:14728-14738(2008).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 443-640 IN COMPLEX WITH
RP   CAMP, AND NUCLEOTIDE-BINDING.
RX   PubMed=19525958; DOI=10.1038/nmeth.1341;
RA   Taraska J.W., Puljung M.C., Olivier N.B., Flynn G.E., Zagotta W.N.;
RT   "Mapping the structure and conformational movements of proteins with
RT   transition metal ion FRET.";
RL   Nat. Methods 6:532-537(2009).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 857-863 IN COMPLEX WITH
RP   PEX5L, AND SUBUNIT.
RX   PubMed=22550182; DOI=10.1073/pnas.1201997109;
RA   Bankston J.R., Camp S.S., DiMaio F., Lewis A.S., Chetkovich D.M.,
RA   Zagotta W.N.;
RT   "Structure and stoichiometry of an accessory subunit TRIP8b
RT   interaction with hyperpolarization-activated cyclic nucleotide-gated
RT   channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:7899-7904(2012).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak
CC       selectivity for potassium over sodium ions. Contributes to the
CC       native pacemaker currents in heart (If) and in neurons (Ih). Can
CC       also transport ammonium in the distal nephron. Produces a large
CC       instantaneous current. {ECO:0000269|PubMed:10962006,
CC       ECO:0000269|PubMed:11096117, ECO:0000269|PubMed:11741901,
CC       ECO:0000269|PubMed:12034718, ECO:0000269|PubMed:12193608,
CC       ECO:0000269|PubMed:12968185, ECO:0000269|PubMed:17562314,
CC       ECO:0000269|PubMed:23103389}.
CC   -!- ENZYME REGULATION: Activated by cAMP, and at 10-100 times higher
CC       concentrations, also by cGMP. cAMP binding causes a conformation
CC       change that leads to the assembly of an active tetramer and
CC       channel opening. Channel activity is modulated by intracellular
CC       chloride ions and pH; acidic pH shifts the activation to more
CC       negative voltages. {ECO:0000269|PubMed:11096117,
CC       ECO:0000269|PubMed:12968185, ECO:0000269|PubMed:17562314,
CC       ECO:0000269|PubMed:23103389}.
CC   -!- SUBUNIT: Homotetramer. Heterotetramer with HCN1. The potassium
CC       channel is composed of a homo- or heterotetrameric complex of
CC       pore-forming subunits. Forms an obligate 4:4 complex with
CC       accessory subunit PEX5L. Interacts with KCNE2.
CC       {ECO:0000269|PubMed:11420311, ECO:0000269|PubMed:12034718,
CC       ECO:0000269|PubMed:12193608, ECO:0000269|PubMed:12968185,
CC       ECO:0000269|PubMed:17562314, ECO:0000269|PubMed:18367452,
CC       ECO:0000269|PubMed:19525958, ECO:0000269|PubMed:22550182}.
CC   -!- INTERACTION:
CC       Q8IYB4-6:PEX5L (xeno); NbExp=18; IntAct=EBI-771231, EBI-16150786;
CC       P00523:SRC (xeno); NbExp=5; IntAct=EBI-771231, EBI-848039;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10962006,
CC       ECO:0000269|PubMed:11096117, ECO:0000269|PubMed:12034718,
CC       ECO:0000269|PubMed:12193608, ECO:0000269|PubMed:17562314,
CC       ECO:0000269|PubMed:23103389}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10962006, ECO:0000269|PubMed:11096117,
CC       ECO:0000269|PubMed:12034718, ECO:0000269|PubMed:12193608,
CC       ECO:0000269|PubMed:17562314, ECO:0000269|PubMed:23103389}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain. Detected at low
CC       levels in heart, in ventricle, atrium and in sinoatrial node
CC       (SAN). {ECO:0000269|PubMed:9630217}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- PTM: Phosphorylation at Ser-641 by PRKG2 shifts the voltage-
CC       dependence to more negative voltages, hence counteracting the
CC       stimulatory effect of cGMP on gating.
CC       {ECO:0000269|PubMed:21347269}.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ225122; CAA12406.1; -; mRNA.
DR   EMBL; AF064873; AAC40125.1; -; mRNA.
DR   CCDS; CCDS23986.1; -.
DR   RefSeq; NP_032252.1; NM_008226.2.
DR   UniGene; Mm.12956; -.
DR   PDB; 1Q3E; X-ray; 1.90 A; A/B=443-645.
DR   PDB; 1Q43; X-ray; 2.00 A; A/B=443-645.
DR   PDB; 1Q5O; X-ray; 2.30 A; A=443-645.
DR   PDB; 2Q0A; X-ray; 2.25 A; A/B=443-640.
DR   PDB; 3BPZ; X-ray; 1.65 A; A/B/C/D=443-640.
DR   PDB; 3ETQ; X-ray; 1.90 A; A/B=443-640.
DR   PDB; 3FFQ; X-ray; 2.40 A; A/B=443-640.
DR   PDB; 4EQF; X-ray; 3.00 A; B=857-863.
DR   PDB; 5JON; X-ray; 2.04 A; A/B=494-640.
DR   PDB; 5KHG; X-ray; 2.24 A; A=443-643.
DR   PDB; 5KHH; X-ray; 1.77 A; A=443-643.
DR   PDB; 5KHI; X-ray; 2.10 A; A=443-643.
DR   PDB; 5KHJ; X-ray; 2.01 A; A/B=443-643.
DR   PDB; 5KHK; X-ray; 2.07 A; A=443-643.
DR   PDBsum; 1Q3E; -.
DR   PDBsum; 1Q43; -.
DR   PDBsum; 1Q5O; -.
DR   PDBsum; 2Q0A; -.
DR   PDBsum; 3BPZ; -.
DR   PDBsum; 3ETQ; -.
DR   PDBsum; 3FFQ; -.
DR   PDBsum; 4EQF; -.
DR   PDBsum; 5JON; -.
DR   PDBsum; 5KHG; -.
DR   PDBsum; 5KHH; -.
DR   PDBsum; 5KHI; -.
DR   PDBsum; 5KHJ; -.
DR   PDBsum; 5KHK; -.
DR   ProteinModelPortal; O88703; -.
DR   SMR; O88703; -.
DR   BioGrid; 200253; 3.
DR   DIP; DIP-29326N; -.
DR   IntAct; O88703; 4.
DR   MINT; MINT-155013; -.
DR   STRING; 10090.ENSMUSP00000020581; -.
DR   BindingDB; O88703; -.
DR   ChEMBL; CHEMBL1250408; -.
DR   GuidetoPHARMACOLOGY; 401; -.
DR   iPTMnet; O88703; -.
DR   PhosphoSitePlus; O88703; -.
DR   SwissPalm; O88703; -.
DR   MaxQB; O88703; -.
DR   PaxDb; O88703; -.
DR   PRIDE; O88703; -.
DR   Ensembl; ENSMUST00000020581; ENSMUSP00000020581; ENSMUSG00000020331.
DR   Ensembl; ENSMUST00000099513; ENSMUSP00000097113; ENSMUSG00000020331.
DR   GeneID; 15166; -.
DR   KEGG; mmu:15166; -.
DR   UCSC; uc007fzn.1; mouse.
DR   CTD; 610; -.
DR   MGI; MGI:1298210; Hcn2.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039489; -.
DR   InParanoid; O88703; -.
DR   KO; K04955; -.
DR   OMA; CPQVARP; -.
DR   OrthoDB; EOG091G0JQU; -.
DR   PhylomeDB; O88703; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-MMU-1296061; HCN channels.
DR   EvolutionaryTrace; O88703; -.
DR   PRO; PR:O88703; -.
DR   Proteomes; UP000000589; Chromosome 10.
DR   Bgee; ENSMUSG00000020331; -.
DR   Genevisible; O88703; MM.
DR   GO; GO:0098855; C:HCN channel complex; ISO:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; ISO:MGI.
DR   GO; GO:0071320; P:cellular response to cAMP; ISS:UniProtKB.
DR   GO; GO:0071321; P:cellular response to cGMP; ISO:MGI.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; ISO:MGI.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:MGI.
DR   GO; GO:0098719; P:sodium ion import across plasma membrane; ISO:MGI.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISO:MGI.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cAMP; cAMP-binding; Cell membrane; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Methylation; Nucleotide-binding; Phosphoprotein; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome; Sodium;
KW   Sodium channel; Sodium transport; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1    863       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                2.
FT                                /FTId=PRO_0000054112.
FT   TOPO_DOM      1    188       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    189    209       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    210    213       Extracellular. {ECO:0000255}.
FT   TRANSMEM    214    234       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    235    261       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    262    282       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    283    290       Extracellular. {ECO:0000255}.
FT   TRANSMEM    291    311       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    312    342       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    343    363       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    364    386       Extracellular. {ECO:0000255}.
FT   INTRAMEM    387    408       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    409    413       Extracellular. {ECO:0000255}.
FT   TRANSMEM    414    434       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    435    863       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     581    584       cAMP. {ECO:0000269|PubMed:18367452,
FT                                ECO:0000269|PubMed:19525958}.
FT   NP_BIND     591    592       cAMP. {ECO:0000269|PubMed:18367452,
FT                                ECO:0000269|PubMed:19525958}.
FT   NP_BIND     632    635       cAMP. {ECO:0000269|PubMed:18367452,
FT                                ECO:0000269|PubMed:19525958}.
FT   REGION      131    182       Involved in subunit assembly.
FT   COMPBIAS     10     58       Pro-rich.
FT   COMPBIAS    688    835       Pro-rich.
FT   MOD_RES     119    119       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     134    134       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JKA9}.
FT   MOD_RES     641    641       Phosphoserine; by PKG/PRKG2.
FT                                {ECO:0000269|PubMed:21347269}.
FT   MOD_RES     726    726       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JKA9}.
FT   MOD_RES     728    728       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     743    743       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     750    750       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     757    757       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     840    840       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     842    842       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     847    847       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   CARBOHYD    380    380       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     225    225       D->N: Abolishes surface expression and
FT                                channel activity.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     231    231       D->N: Reduces surface expression and
FT                                abolishes channel activity.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     267    267       D->N: Reduces surface expression and
FT                                abolishes channel activity.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     275    275       D->N: Reduces surface expression and
FT                                abolishes channel activity.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     291    291       K->Q: Shifts voltage dependence of
FT                                activation to more negative values.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     294    294       R->Q: Shifts voltage dependence of
FT                                activation to more negative values.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     297    297       R->Q: Shifts voltage dependence of
FT                                activation to more negative values.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     300    300       R->Q: Shifts voltage dependence of
FT                                activation to more negative values.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     303    303       K->Q: Decreases current amplitude.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     306    306       S->Q: Decreases current amplitude.
FT                                {ECO:0000269|PubMed:10962006,
FT                                ECO:0000269|PubMed:11741901}.
FT   MUTAGEN     309    309       R->Q: Abolishes surface expression and
FT                                channel activity.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     312    312       R->Q: Reduces surface expression and
FT                                decreases current amplitude.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     315    315       R->Q: Reduces surface expression and
FT                                abolishes channel activity.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     318    318       R->Q: Reduces surface expression and
FT                                disrupts channel closure.
FT                                {ECO:0000269|PubMed:10962006,
FT                                ECO:0000269|PubMed:11553787}.
FT   MUTAGEN     321    321       H->E: Shifts voltage dependence of
FT                                activation to more positive values and
FT                                abolishes pH-sensitivity.
FT                                {ECO:0000269|PubMed:11096117}.
FT   MUTAGEN     321    321       H->Q: Abolishes pH-sensitivity.
FT                                {ECO:0000269|PubMed:11096117}.
FT   MUTAGEN     321    321       H->R: Abolishes pH-sensitivity.
FT                                {ECO:0000269|PubMed:11096117}.
FT   MUTAGEN     324    324       E->Q: Disrupts channel closure.
FT                                {ECO:0000269|PubMed:11553787}.
FT   MUTAGEN     331    331       Y->A: Disrupts channel closure.
FT                                {ECO:0000269|PubMed:11553787}.
FT   MUTAGEN     331    331       Y->S: Disrupts channel closure.
FT                                {ECO:0000269|PubMed:11553787}.
FT   MUTAGEN     339    339       R->Q: Disrupts channel closure.
FT                                {ECO:0000269|PubMed:11553787}.
FT   MUTAGEN     594    594       S->R: Shifts channel activation to more
FT                                negative voltage, slows channel opening
FT                                and speeds up channel closure. Reduces
FT                                sensitivity to activation by cAMP.
FT                                {ECO:0000269|PubMed:23103389}.
FT   CONFLICT    486    486       F -> S (in Ref. 2; AAC40125).
FT                                {ECO:0000305}.
FT   CONFLICT    642    642       I -> T (in Ref. 2; AAC40125).
FT                                {ECO:0000305}.
FT   HELIX       444    462       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       467    481       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       488    494       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       497    507       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       509    513       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       516    519       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       523    532       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      534    538       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      543    545       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      553    559       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      561    565       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      567    569       {ECO:0000244|PDB:2Q0A}.
FT   STRAND      572    575       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      579    581       {ECO:0000244|PDB:5KHK}.
FT   HELIX       582    587       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      588    590       {ECO:0000244|PDB:5KHH}.
FT   STRAND      592    599       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      601    607       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       608    617       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       619    621       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       622    635       {ECO:0000244|PDB:3BPZ}.
SQ   SEQUENCE   863 AA;  94722 MW;  17CDC4DFF07AC039 CRC64;
     MDARGGGGRP GDSPGTTPAP GPPPPPPPPA PPQPQPPPAP PPNPTTPSHP ESADEPGPRA
     RLCSRDSACT PGAAKGGANG ECGRGEPQCS PEGPARGPKV SFSCRGAASG PSAAEEAGSE
     EAGPAGEPRG SQASFLQRQF GALLQPGVNK FSLRMFGSQK AVEREQERVK SAGAWIIHPY
     SDFRFYWDFT MLLFMVGNLI IIPVGITFFK DETTAPWIVF NVVSDTFFLM DLVLNFRTGI
     VIEDNTEIIL DPEKIKKKYL RTWFVVDFVS SIPVDYIFLI VEKGIDSEVY KTARALRIVR
     FTKILSLLRL LRLSRLIRYI HQWEEIFHMT YDLASAVMRI CNLISMMLLL CHWDGCLQFL
     VPMLQDFPSD CWVSINNMVN HSWSELYSFA LFKAMSHMLC IGYGRQAPES MTDIWLTMLS
     MIVGATCYAM FIGHATALIQ SLDSSRRQYQ EKYKQVEQYM SFHKLPADFR QKIHDYYEHR
     YQGKMFDEDS ILGELNGPLR EEIVNFNCRK LVASMPLFAN ADPNFVTAML TKLKFEVFQP
     GDYIIREGTI GKKMYFIQHG VVSVLTKGNK EMKLSDGSYF GEICLLTRGR RTASVRADTY
     CRLYSLSVDN FNEVLEEYPM MRRAFETVAI DRLDRIGKKN SILLHKVQHD LSSGVFNNQE
     NAIIQEIVKY DREMVQQAEL GQRVGLFPPP PPPQVTSAIA TLQQAVAMSF CPQVARPLVG
     PLALGSPRLV RRAPPGPLPP AASPGPPAAS PPAAPSSPRA PRTSPYGVPG SPATRVGPAL
     PARRLSRASR PLSASQPSLP HGVPAPSPAA SARPASSSTP RLGPAPTART AAPSPDRRDS
     ASPGAASGLD PLDSARSRLS SNL
//
ID   KCNQ3_RAT               Reviewed;         873 AA.
AC   O88944; Q9Z240;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   19-DEC-2001, sequence version 2.
DT   22-NOV-2017, entry version 142.
DE   RecName: Full=Potassium voltage-gated channel subfamily KQT member 3 {ECO:0000305};
DE   AltName: Full=KQT-like 3;
DE   AltName: Full=Potassium channel subunit alpha KvLQT3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv7.3;
GN   Name=Kcnq3 {ECO:0000312|RGD:69222};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Derst C., Preisig-Mueller R., Hennighausen A., Daut J.;
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Brain;
RX   PubMed=9836639; DOI=10.1126/science.282.5395.1890;
RA   Wang H.-S., Pan Z., Shi W., Brown B.S., Wymore R.S., Cohen I.S.,
RA   Dixon J.E., McKinnon D.;
RT   "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of
RT   the M-channel.";
RL   Science 282:1890-1893(1998).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-82, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   INTERACTION WITH IQCJ-SCHIP1.
RX   PubMed=27979964; DOI=10.1074/jbc.M116.758029;
RA   Martin P.M., Cifuentes-Diaz C., Devaux J., Garcia M., Bureau J.,
RA   Thomasseau S., Klingler E., Girault J.A., Goutebroze L.;
RT   "Schwannomin-interacting protein 1 isoform IQCJ-SCHIP1 is a
RT   multipartner ankyrin- and spectrin-binding protein involved in the
RT   organization of nodes of Ranvier.";
RL   J. Biol. Chem. 292:2441-2456(2017).
CC   -!- FUNCTION: Associates with KCNQ2 or KCNQ5 to form a potassium
CC       channel with essentially identical properties to the channel
CC       underlying the native M-current, a slowly activating and
CC       deactivating potassium conductance which plays a critical role in
CC       determining the subthreshold electrical excitability of neurons as
CC       well as the responsiveness to synaptic inputs. Therefore, it is
CC       important in the regulation of neuronal excitability.
CC       {ECO:0000269|PubMed:9836639}.
CC   -!- SUBUNIT: Heterotetramer with KCNQ2; form the heterotetrameric M
CC       potassium channel. Interacts with calmodulin; the interaction is
CC       calcium-independent, constitutive and participates to the proper
CC       assembly of a functional heterotetrameric M channel.
CC       Heteromultimer with KCNQ5. May associate with KCNE2. Interacts
CC       with IQCJ-SCHIP1 (PubMed:27979964). {ECO:0000250|UniProtKB:O43525,
CC       ECO:0000269|PubMed:27979964}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9836639};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O88944-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O88944-2; Sequence=VSP_001012;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in brain and sympathetic ganglia. In
CC       brain, expressed in cortex, hippocampus and at much lower levels
CC       in cerebellum. In sympathetic ganglia, expressed at approximately
CC       equal levels in both superior cervical ganglia and prevertebral
CC       ganglia.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. KQT (TC
CC       1.A.1.15) subfamily. Kv7.3/KCNQ3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF087454; AAC36723.2; -; mRNA.
DR   EMBL; AF091247; AAC79846.1; -; mRNA.
DR   UniGene; Rn.205060; -.
DR   ProteinModelPortal; O88944; -.
DR   CORUM; O88944; -.
DR   STRING; 10116.ENSRNOP00000065354; -.
DR   ChEMBL; CHEMBL5531; -.
DR   GuidetoPHARMACOLOGY; 562; -.
DR   iPTMnet; O88944; -.
DR   PhosphoSitePlus; O88944; -.
DR   PaxDb; O88944; -.
DR   PRIDE; O88944; -.
DR   UCSC; RGD:69222; rat. [O88944-1]
DR   RGD; 69222; Kcnq3.
DR   eggNOG; KOG1419; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000220839; -.
DR   HOVERGEN; HBG059014; -.
DR   InParanoid; O88944; -.
DR   OrthoDB; EOG091G02ZT; -.
DR   PhylomeDB; O88944; -.
DR   PRO; PR:O88944; -.
DR   Proteomes; UP000002494; Unplaced.
DR   Genevisible; O88944; RN.
DR   GO; GO:0043194; C:axon initial segment; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0033268; C:node of Ranvier; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0036477; C:somatodendritic compartment; IDA:RGD.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IDA:RGD.
DR   GO; GO:0044325; F:ion channel binding; IPI:RGD.
DR   GO; GO:0005267; F:potassium channel activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:RGD.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; ISO:RGD.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0071242; P:cellular response to ammonium ion; IMP:RGD.
DR   GO; GO:0061548; P:ganglion development; IEP:RGD.
DR   GO; GO:0034220; P:ion transmembrane transport; IMP:RGD.
DR   GO; GO:0060081; P:membrane hyperpolarization; ISO:RGD.
DR   GO; GO:0014003; P:oligodendrocyte development; IEP:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   InterPro; IPR020969; Ankyrin-G_BS.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003937; K_chnl_volt-dep_KCNQ.
DR   InterPro; IPR003948; K_chnl_volt-dep_KCNQ3.
DR   InterPro; IPR013821; K_chnl_volt-dep_KCNQ_C.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF5; PTHR11537:SF5; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03520; KCNQ_channel; 1.
DR   Pfam; PF11956; KCNQC3-Ank-G_bd; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01462; KCNQ3CHANNEL.
DR   PRINTS; PR01459; KCNQCHANNEL.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    873       Potassium voltage-gated channel subfamily
FT                                KQT member 3.
FT                                /FTId=PRO_0000054036.
FT   TOPO_DOM      1    122       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    123    143       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    144    153       Extracellular. {ECO:0000305}.
FT   TRANSMEM    154    174       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    175    197       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    198    218       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    219    226       Extracellular. {ECO:0000305}.
FT   TRANSMEM    227    248       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    249    262       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    263    283       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    284    304       Extracellular. {ECO:0000305}.
FT   INTRAMEM    305    325       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    326    331       Extracellular. {ECO:0000305}.
FT   TRANSMEM    332    352       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    353    873       Cytoplasmic. {ECO:0000305}.
FT   REGION      357    538       Mediates interaction with calmodulin.
FT                                {ECO:0000250|UniProtKB:O43525}.
FT   MOTIF       317    322       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS     13     25       Poly-Gly.
FT   MOD_RES      82     82       Phosphothreonine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   VAR_SEQ       1     83       MGLKARRAAGAAGGGGGEGGGGGGGAANPAGGDSAVAGDEE
FT                                RKVGLAPGDVEQVTLALGTGADKDGTLLLEGGGREEGQRRT
FT                                P -> MALEFPGLQPPPPPRPRTPSAPSSRSSSGEGEAPSG
FT                                GEADGAQGS (in isoform 2).
FT                                {ECO:0000303|PubMed:9836639}.
FT                                /FTId=VSP_001012.
FT   CONFLICT    654    654       H -> R (in Ref. 2; AAC79846).
FT                                {ECO:0000305}.
SQ   SEQUENCE   873 AA;  96898 MW;  D77AF88088051E15 CRC64;
     MGLKARRAAG AAGGGGGEGG GGGGGAANPA GGDSAVAGDE ERKVGLAPGD VEQVTLALGT
     GADKDGTLLL EGGGREEGQR RTPQGIGLLA KTPLSRPVKR NNAKYRRIQT LIYDALERPR
     GWALLYHALV FLIVLGCLIL AVLTTFKEYE TVSGDWLLLL ETFAIFIFGA EFALRIWAAG
     CCCRYKGWRG RLKFARKPLC MLDIFVLIAS VPVVAVGNQG NVLATSLRSL RFLQILRMLR
     MDRRGGTWKL LGSAICAHSK ELITAWYIGF LTLILSSFLV YLVEKDVPEM DAQGEEMKEE
     FETYADALWW GLITLATIGY GDKTPKTWEG RLIAATFSLI GVSFFALPAG ILGSGLALKV
     QEQHRQKHFE KRRKPAAELI QAAWRYYATN PNRLDLVATW RFYESVVSFP FFRKEQLEAA
     ASQKLGLLDR VRLSNPRGSN TKGKLFTPLN VDAIEESPSK EPKPVGLNNK ERFRTAFRMK
     AYAFWQSSED AGTGDPMTED RGYGNDFLIE DMIPTLKAAI RAVRILQFRL YKKKFKETLR
     PYDVKDVIEQ YSAGHLDMLS RIKYLQTRID MIFTPGPPST PKHKKSQKGS AFTYPSQQSP
     RNEPYVARAA TSETEDQSMM GKFVKVERQV HDMGKKLDFL VDMHMQHMER LQVHVTEYYP
     TKGASSPAEG EKKEDNRYSD LKTIICNYSE SGPPDPPYSF HQVPIDRVGP YGFFAHDPVK
     LTRGGPSSTK AQANLPSSGS TYAERPTVLP ILTLLDSCVS YHSQTELQGP YSDHISPRQR
     RSITRDSDTP LSLMSVNHEE LERSPSGFSI SQDRDDYVFG PSGGSSWMRE KRYLAEGETD
     TDTDPFTPSG SMPMSSTGDG ISDSIWTPSN KPT
//
ID   KCNH1_HUMAN             Reviewed;         989 AA.
AC   O95259; B1AQ26; O76035; Q14CL3;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   25-OCT-2017, entry version 174.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 1;
DE   AltName: Full=Ether-a-go-go potassium channel 1 {ECO:0000303|PubMed:27325704};
DE            Short=EAG channel 1 {ECO:0000303|PubMed:23881642, ECO:0000303|PubMed:27325704};
DE            Short=h-eag;
DE            Short=hEAG1 {ECO:0000303|PubMed:23881642, ECO:0000303|PubMed:27325704};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv10.1;
GN   Name=KCNH1;
GN   Synonyms=EAG {ECO:0000303|PubMed:10523298},
GN   EAG1 {ECO:0000303|PubMed:23881642, ECO:0000303|PubMed:27325704};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Myoblast;
RX   PubMed=9738473; DOI=10.1016/S0014-5793(98)00973-9;
RA   Occhiodoro T., Bernheim L., Liu J.-H., Bijlenga P., Sinnreich M.,
RA   Bader C.R., Fischer-Lougheed J.;
RT   "Cloning of a human ether-a-go-go potassium channel expressed in
RT   myoblasts at the onset of fusion.";
RL   FEBS Lett. 434:177-182(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=10523298; DOI=10.1093/emboj/18.20.5540;
RA   Pardo L.A., del Camino D., Sanchez A., Alves F., Brueggemann A.,
RA   Beckh S., Stuehmer W.;
RT   "Oncogenic potential of EAG K(+) channels.";
RL   EMBO J. 18:5540-5547(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, CALMODULIN-BINDING DOMAIN, AND ENZYME
RP   REGULATION.
RX   PubMed=10880439; DOI=10.1093/emboj/19.13.3263;
RA   Schoenherr R., Lober K., Heinemann S.H.;
RT   "Inhibition of human ether a go-go potassium channels by
RT   Ca(2+)/calmodulin.";
RL   EMBO J. 19:3263-3271(2000).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH KCNH5.
RX   PubMed=11943152; DOI=10.1016/S0014-5793(02)02365-7;
RA   Schoenherr R., Gessner G., Loeber K., Heinemann S.H.;
RT   "Functional distinction of human EAG1 and EAG2 potassium channels.";
RL   FEBS Lett. 514:204-208(2002).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21559285; DOI=10.1371/journal.pone.0019257;
RA   Chen Y., Sanchez A., Rubio M.E., Kohl T., Pardo L.A., Stuhmer W.;
RT   "Functional K(v)10.1 channels localize to the inner nuclear
RT   membrane.";
RL   PLoS ONE 6:E19257-E19257(2011).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22841712; DOI=10.1016/j.febslet.2012.07.055;
RA   Ninkovic M., Mitkovski M., Kohl T., Stuhmer W., Pardo L.A.;
RT   "Physical and functional interaction of KV10.1 with Rabaptin-5 impacts
RT   ion channel trafficking.";
RL   FEBS Lett. 586:3077-3084(2012).
RN   [10]
RP   INTERACTION WITH CTTN.
RX   PubMed=23144454; DOI=10.1074/jbc.M112.372540;
RA   Herrmann S., Ninkovic M., Kohl T., Lorinczi E., Pardo L.A.;
RT   "Cortactin controls surface expression of the voltage-gated potassium
RT   channel K(V)10.1.";
RL   J. Biol. Chem. 287:44151-44163(2012).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF 699-TYR--LEU-701.
RX   PubMed=22732247; DOI=10.1016/j.jmb.2012.06.025;
RA   Marques-Carvalho M.J., Sahoo N., Muskett F.W., Vieira-Pires R.S.,
RA   Gabant G., Cadene M., Schonherr R., Morais-Cabral J.H.;
RT   "Structural, biochemical, and functional characterization of the
RT   cyclic nucleotide binding homology domain from the mouse EAG1
RT   potassium channel.";
RL   J. Mol. Biol. 423:34-46(2012).
RN   [12]
RP   FUNCTION.
RX   PubMed=23881642; DOI=10.1002/jcp.24435;
RA   Zhang Y.Y., Yue J., Che H., Sun H.Y., Tse H.F., Li G.R.;
RT   "BKCa and hEag1 channels regulate cell proliferation and
RT   differentiation in human bone marrow-derived mesenchymal stem cells.";
RL   J. Cell. Physiol. 229:202-212(2014).
RN   [13]
RP   PHOSPHORYLATION.
RX   PubMed=24587194; DOI=10.1371/journal.pone.0090024;
RA   Schlichter L.C., Jiang J., Wang J., Newell E.W., Tsui F.W., Lam D.;
RT   "Regulation of hERG and hEAG channels by Src and by SHP-1 tyrosine
RT   phosphatase via an ITIM region in the cyclic nucleotide binding
RT   domain.";
RL   PLoS ONE 9:E90024-E90024(2014).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25556795; DOI=10.1113/jphysiol.2014.281600;
RA   Mortensen L.S., Schmidt H., Farsi Z., Barrantes-Freer A., Rubio M.E.,
RA   Ufartes R., Eilers J., Sakaba T., Stuehmer W., Pardo L.A.;
RT   "KV 10.1 opposes activity-dependent increase in Ca2+ influx into the
RT   presynaptic terminal of the parallel fibre-Purkinje cell synapse.";
RL   J. Physiol. (Lond.) 593:181-196(2015).
RN   [15]
RP   INVOLVEMENT IN TMBTS, VARIANTS TMBTS ASN-217; PHE-489; VAL-494 AND
RP   ARG-503, AND CHARACTERIZATION OF VARIANTS TMBTS ASN-217; PHE-489;
RP   VAL-494 AND ARG-503.
RX   PubMed=25420144; DOI=10.1038/ng.3153;
RA   Simons C., Rash L.D., Crawford J., Ma L., Cristofori-Armstrong B.,
RA   Miller D., Ru K., Baillie G.J., Alanay Y., Jacquinet A., Debray F.G.,
RA   Verloes A., Shen J., Yesil G., Guler S., Yuksel A., Cleary J.G.,
RA   Grimmond S.M., McGaughran J., King G.F., Gabbett M.T., Taft R.J.;
RT   "Mutations in the voltage-gated potassium channel gene KCNH1 cause
RT   Temple-Baraitser syndrome and epilepsy.";
RL   Nat. Genet. 47:73-77(2015).
RN   [16]
RP   INVOLVEMENT IN ZLS1, VARIANTS ZLS1 TYR-352; ARG-375; VAL-379; LEU-383;
RP   VAL-494 AND ARG-496, AND CHARACTERIZATION OF VARIANTS ZLS1 TYR-352;
RP   ARG-375; VAL-379; LEU-383; VAL-494 AND ARG-496.
RX   PubMed=25915598; DOI=10.1038/ng.3282;
RA   Kortuem F., Caputo V., Bauer C.K., Stella L., Ciolfi A., Alawi M.,
RA   Bocchinfuso G., Flex E., Paolacci S., Dentici M.L., Grammatico P.,
RA   Korenke G.C., Leuzzi V., Mowat D., Nair L.D., Nguyen T.T., Thierry P.,
RA   White S.M., Dallapiccola B., Pizzuti A., Campeau P.M., Tartaglia M.,
RA   Kutsche K.;
RT   "Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome.";
RL   Nat. Genet. 47:661-667(2015).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, ENZYME REGULATION, AND DOMAIN.
RX   PubMed=27325704; DOI=10.1074/jbc.M116.733576;
RA   Loerinczi E., Helliwell M., Finch A., Stansfeld P.J., Davies N.W.,
RA   Mahaut-Smith M., Muskett F.W., Mitcheson J.S.;
RT   "Calmodulin regulates human ether a go-go 1 (hEAG1) potassium channels
RT   through interactions of the Eag domain with the cyclic nucleotide
RT   binding homology domain.";
RL   J. Biol. Chem. 291:17907-17918(2016).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, AND ENZYME REGULATION.
RX   PubMed=27005320; DOI=10.1038/srep23417;
RA   Han B., He K., Cai C., Tang Y., Yang L., Heinemann S.H., Hoshi T.,
RA   Hou S.;
RT   "Human EAG channels are directly modulated by PIP2 as revealed by
RT   electrophysiological and optical interference investigations.";
RL   Sci. Rep. 6:23417-23417(2016).
RN   [19]
RP   FUNCTION, SUBCELLULAR LOCATION, ENZYME REGULATION, INTERACTION WITH
RP   CALM, AND MUTAGENESIS OF VAL-737 AND LEU-740.
RX   PubMed=27618660; DOI=10.1016/j.str.2016.07.020;
RA   Marques-Carvalho M.J., Oppermann J., Munoz E., Fernandes A.S.,
RA   Gabant G., Cadene M., Heinemann S.H., Schoenherr R.,
RA   Morais-Cabral J.H.;
RT   "Molecular insights into the mechanism of calmodulin inhibition of the
RT   EAG1 potassium channel.";
RL   Structure 24:1742-1754(2016).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 1-146.
RA   Xue T., Juan S., Xiaohong Q.;
RT   "Crystal structure of PAS domain from the hEAG potassium channel.";
RL   Submitted (APR-2016) to the PDB data bank.
CC   -!- FUNCTION: Pore-forming (alpha) subunit of a voltage-gated delayed
CC       rectifier potassium channel (PubMed:9738473, PubMed:11943152,
CC       PubMed:10880439, PubMed:22732247, PubMed:25556795,
CC       PubMed:27325704, PubMed:27005320, PubMed:27618660). Channel
CC       properties are modulated by subunit assembly (PubMed:11943152).
CC       Mediates IK(NI) current in myoblasts (PubMed:9738473). Involved in
CC       the regulation of cell proliferation and differentiation, in
CC       particular adipogenic and osteogenic differentiation in bone
CC       marrow-derived mesenchymal stem cells (MSCs) (PubMed:23881642).
CC       {ECO:0000269|PubMed:10880439, ECO:0000269|PubMed:11943152,
CC       ECO:0000269|PubMed:22732247, ECO:0000269|PubMed:23881642,
CC       ECO:0000269|PubMed:25556795, ECO:0000269|PubMed:27005320,
CC       ECO:0000269|PubMed:27325704, ECO:0000269|PubMed:27618660,
CC       ECO:0000269|PubMed:9738473}.
CC   -!- ENZYME REGULATION: Channel activity is inhibited by interaction
CC       with Ca(2+)-bound calmodulin (PubMed:10880439, PubMed:27325704,
CC       PubMed:27005320, PubMed:27618660). Interaction of a single pore-
CC       forming alpha subunit with a calmodulin chain is sufficient to
CC       promote channel closure (PubMed:10880439). Channel activity is not
CC       regulated by cyclic nucleotides (By similarity). Channel activity
CC       is inhibited by binding intracellular phosphatidylinositol-3,5-
CC       bisphosphate and phosphatidylinositol-4,5-bisphosphate (PIP2), but
CC       is not inhibited by phosphatidylinositol 4-phosphate
CC       (PubMed:27005320). {ECO:0000250|UniProtKB:Q60603,
CC       ECO:0000269|PubMed:10880439, ECO:0000269|PubMed:27005320,
CC       ECO:0000269|PubMed:27325704, ECO:0000269|PubMed:27618660}.
CC   -!- SUBUNIT: The potassium channel is composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits. Heteromultimer with
CC       KCNH5/EAG2 (PubMed:11943152). Interacts with ALG10B (By
CC       similarity). Interacts with RABEP1 (By similarity). Interacts (via
CC       C-terminus) with CTTN (PubMed:23144454). Interacts (via C-terminal
CC       cytoplasmic region) with Ca(2+)-bound calmodulin (PubMed:10880439,
CC       PubMed:27325704, PubMed:27618660). {ECO:0000250|UniProtKB:Q63472,
CC       ECO:0000269|PubMed:10880439, ECO:0000269|PubMed:11943152,
CC       ECO:0000269|PubMed:23144454, ECO:0000269|PubMed:27325704,
CC       ECO:0000269|PubMed:27618660}.
CC   -!- INTERACTION:
CC       P62158:CALM3; NbExp=8; IntAct=EBI-9836801, EBI-397435;
CC       Q7L8L6:FASTKD5; NbExp=3; IntAct=EBI-2909270, EBI-747570;
CC       P02638:S100B (xeno); NbExp=3; IntAct=EBI-2909270, EBI-458452;
CC       O00560:SDCBP; NbExp=3; IntAct=EBI-2909270, EBI-727004;
CC       Q96HA8:WDYHV1; NbExp=3; IntAct=EBI-2909270, EBI-741158;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10880439,
CC       ECO:0000269|PubMed:11943152, ECO:0000269|PubMed:21559285,
CC       ECO:0000269|PubMed:22732247, ECO:0000269|PubMed:22841712,
CC       ECO:0000269|PubMed:25556795, ECO:0000269|PubMed:27005320,
CC       ECO:0000269|PubMed:27325704, ECO:0000269|PubMed:27618660,
CC       ECO:0000269|PubMed:9738473}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:21559285}. Nucleus inner membrane
CC       {ECO:0000269|PubMed:21559285}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:21559285}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q63472}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q63472}. Cell junction, synapse,
CC       presynaptic cell membrane {ECO:0000250|UniProtKB:Q63472}.
CC       Perikaryon {ECO:0000250|UniProtKB:Q63472}. Cell junction, synapse,
CC       postsynaptic cell membrane, postsynaptic density
CC       {ECO:0000250|UniProtKB:Q63472}. Early endosome membrane
CC       {ECO:0000269|PubMed:22841712}. Note=Perinuclear KCNH1 is located
CC       to NPC-free islands.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2; Synonyms=hEAGB;
CC         IsoId=O95259-1; Sequence=Displayed;
CC       Name=1; Synonyms=hEAG;
CC         IsoId=O95259-2; Sequence=VSP_000964;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain and in myoblasts at
CC       the onset of fusion, but not in other tissues. Detected in HeLa
CC       (cervical carcinoma), SH-SY5Y (neuroblastoma) and MCF-7
CC       (epithelial tumor) cells, but not in normal epithelial cells.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250|UniProtKB:Q63472}.
CC   -!- DOMAIN: The C-terminal region interacts with the cyclic
CC       nucleotide-binding domain and contributes to regulate channel
CC       gating. {ECO:0000250|UniProtKB:Q60603}.
CC   -!- DOMAIN: The PAS and PAC domain interact with the cyclic
CC       nucleotide-binding domain and contribute to the regulation of
CC       channel gating (PubMed:27325704). Calmodulin binding clamps
CC       together the PAS and PAC domain with the cyclic nucleotide-binding
CC       domain from a neighboring subunit and causes a conformation change
CC       that leads to channel closure. {ECO:0000250|UniProtKB:Q63472,
CC       ECO:0000269|PubMed:27325704}.
CC   -!- DOMAIN: The cyclic nucleotide-binding domain lacks residues that
CC       are essential for nucleotide-binding and cannot bind cyclic
CC       nucleotides. Instead, residues from the C-terminal domain (the so-
CC       called intrinsic ligand) bind in the cavity that would be expected
CC       to bind cyclic nucleotides. Interaction with the C-terminal region
CC       hinders interaction with CALM and reduces the affinity for CALM.
CC       {ECO:0000250|UniProtKB:Q60603}.
CC   -!- PTM: Channel activity is regulated via tyrosine
CC       phosphorylation/dephosphorylation by SRC and PTPN6
CC       (PubMed:24587194). {ECO:0000269|PubMed:24587194}.
CC   -!- DISEASE: Temple-Baraitser syndrome (TMBTS) [MIM:611816]: A
CC       developmental disorder characterized by intellectual disability,
CC       epilepsy, hypoplasia or aplasia of the thumb and great toe nails,
CC       and broadening and/or elongation of the thumbs and halluces, which
CC       have a tubular aspect. Some patients show facial dysmorphism.
CC       {ECO:0000269|PubMed:25420144}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500]: A
CC       disorder characterized by gingival fibromatosis, dysplastic or
CC       absent nails, finger abnormalities, hepatosplenomegaly, and
CC       abnormalities of the cartilage of the nose and/or ears.
CC       {ECO:0000269|PubMed:25915598}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag) (TC
CC       1.A.1.20) subfamily. Kv10.1/KCNH1 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/KCNH1ID41048ch1q32.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ001366; CAA04700.1; -; mRNA.
DR   EMBL; AF078741; AAC68668.1; -; mRNA.
DR   EMBL; AF078742; AAC68669.1; -; mRNA.
DR   EMBL; AL590132; CAH71752.1; -; Genomic_DNA.
DR   EMBL; AC092017; CAH71752.1; JOINED; Genomic_DNA.
DR   EMBL; AC096636; CAH71752.1; JOINED; Genomic_DNA.
DR   EMBL; AC099755; CAH71752.1; JOINED; Genomic_DNA.
DR   EMBL; AL590132; CAH71753.1; -; Genomic_DNA.
DR   EMBL; AC092017; CAH71753.1; JOINED; Genomic_DNA.
DR   EMBL; AC096636; CAH71753.1; JOINED; Genomic_DNA.
DR   EMBL; AC099755; CAH71753.1; JOINED; Genomic_DNA.
DR   EMBL; CH471100; EAW93424.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93425.1; -; Genomic_DNA.
DR   EMBL; BC113709; AAI13710.1; -; mRNA.
DR   EMBL; BC143599; AAI43600.1; -; mRNA.
DR   CCDS; CCDS1496.1; -. [O95259-1]
DR   CCDS; CCDS31015.1; -. [O95259-2]
DR   RefSeq; NP_002229.1; NM_002238.3. [O95259-2]
DR   RefSeq; NP_758872.1; NM_172362.2. [O95259-1]
DR   UniGene; Hs.553187; -.
DR   PDB; 5J7E; X-ray; 1.90 A; A/B/C/D/E/F=1-146.
DR   PDBsum; 5J7E; -.
DR   ProteinModelPortal; O95259; -.
DR   SMR; O95259; -.
DR   BioGrid; 109958; 7.
DR   IntAct; O95259; 10.
DR   MINT; MINT-138319; -.
DR   STRING; 9606.ENSP00000271751; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   GuidetoPHARMACOLOGY; 570; -.
DR   TCDB; 1.I.1.1.3; the eukaryotic nuclear pore complex (e-npc) family.
DR   iPTMnet; O95259; -.
DR   PhosphoSitePlus; O95259; -.
DR   BioMuta; KCNH1; -.
DR   MaxQB; O95259; -.
DR   PaxDb; O95259; -.
DR   PeptideAtlas; O95259; -.
DR   PRIDE; O95259; -.
DR   Ensembl; ENST00000271751; ENSP00000271751; ENSG00000143473. [O95259-1]
DR   Ensembl; ENST00000638293; ENSP00000491986; ENSG00000283965. [O95259-2]
DR   Ensembl; ENST00000638907; ENSP00000492550; ENSG00000283965. [O95259-1]
DR   Ensembl; ENST00000638960; ENSP00000492302; ENSG00000143473. [O95259-2]
DR   Ensembl; ENST00000639355; ENSP00000491578; ENSG00000283965. [O95259-2]
DR   Ensembl; ENST00000639420; ENSP00000492350; ENSG00000283965. [O95259-2]
DR   Ensembl; ENST00000639952; ENSP00000492697; ENSG00000143473. [O95259-2]
DR   Ensembl; ENST00000640402; ENSP00000491804; ENSG00000283965. [O95259-2]
DR   Ensembl; ENST00000640528; ENSP00000491725; ENSG00000143473. [O95259-2]
DR   Ensembl; ENST00000640710; ENSP00000492513; ENSG00000143473. [O95259-2]
DR   GeneID; 3756; -.
DR   KEGG; hsa:3756; -.
DR   UCSC; uc001hib.3; human. [O95259-1]
DR   CTD; 3756; -.
DR   DisGeNET; 3756; -.
DR   EuPathDB; HostDB:ENSG00000143473.11; -.
DR   GeneCards; KCNH1; -.
DR   HGNC; HGNC:6250; KCNH1.
DR   HPA; HPA014551; -.
DR   HPA; HPA019445; -.
DR   MalaCards; KCNH1; -.
DR   MIM; 135500; phenotype.
DR   MIM; 603305; gene.
DR   MIM; 611816; phenotype.
DR   neXtProt; NX_O95259; -.
DR   OpenTargets; ENSG00000143473; -.
DR   PharmGKB; PA30037; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140833; -.
DR   HOGENOM; HOG000230794; -.
DR   HOVERGEN; HBG101348; -.
DR   InParanoid; O95259; -.
DR   KO; K04904; -.
DR   OMA; KGEDWNK; -.
DR   OrthoDB; EOG091G0OXR; -.
DR   PhylomeDB; O95259; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNH1; -.
DR   GenomeRNAi; 3756; -.
DR   PRO; PR:O95259; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143473; -.
DR   CleanEx; HS_KCNH1; -.
DR   ExpressionAtlas; O95259; baseline and differential.
DR   Genevisible; O95259; HS.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0031901; C:early endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005637; C:nuclear inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:1902936; F:phosphatidylinositol bisphosphate binding; IDA:UniProtKB.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0071277; P:cellular response to calcium ion; IMP:UniProtKB.
DR   GO; GO:0007520; P:myoblast fusion; TAS:ProtInc.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IMP:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0042127; P:regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR030170; EAG1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003949; K_chnl_volt-dep_EAG.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF530; PTHR10217:SF530; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01464; EAGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00086; PAC; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calmodulin-binding; Cell junction;
KW   Cell membrane; Cell projection; Complete proteome; Disease mutation;
KW   Endosome; Epilepsy; Glycoprotein; Ion channel; Ion transport;
KW   Lipid-binding; Membrane; Mental retardation; Nucleus; Phosphoprotein;
KW   Postsynaptic cell membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Synapse; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    989       Potassium voltage-gated channel subfamily
FT                                H member 1.
FT                                /FTId=PRO_0000053994.
FT   TOPO_DOM      1    220       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TRANSMEM    221    241       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    242    248       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TRANSMEM    249    269       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    270    290       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TRANSMEM    291    309       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    310    345       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TRANSMEM    346    368       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    369    377       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TRANSMEM    378    399       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    400    448       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   INTRAMEM    449    470       Pore-forming; Name=Segment H5.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    471    477       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TRANSMEM    478    498       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   TOPO_DOM    499    989       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   DOMAIN       14     94       PAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN       93    145       PAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00141}.
FT   REGION      151    162       Required for phosphatidylinositol
FT                                bisphosphate binding.
FT                                {ECO:0000269|PubMed:27005320}.
FT   REGION      673    770       Calmodulin-binding.
FT                                {ECO:0000269|PubMed:10880439}.
FT   REGION      699    701       Interaction with cyclic nucleotide-
FT                                binding pocket.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   REGION      924    964       CAD (involved in subunit assembly).
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   MOTIF       463    468       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:Q63472}.
FT   MOD_RES     899    899       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q920E3}.
FT   MOD_RES     974    974       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   MOD_RES     978    978       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   MOD_RES     981    981       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   CARBOHYD    415    415       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    433    433       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     318    344       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:10523298,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000964.
FT   VARIANT     217    217       K -> N (in TMBTS; gain-of-function
FT                                mutation resulting in a decreased
FT                                threshold of channel activation and
FT                                slower deactivation compared to wild-
FT                                type; dbSNP:rs727502822).
FT                                {ECO:0000269|PubMed:25420144}.
FT                                /FTId=VAR_072612.
FT   VARIANT     352    352       S -> Y (in ZLS1; gain-of-function effect;
FT                                accelerated channel activation and slower
FT                                deactivation; associated in cis with L-
FT                                383; dbSNP:rs730882172).
FT                                {ECO:0000269|PubMed:25915598}.
FT                                /FTId=VAR_073957.
FT   VARIANT     375    375       G -> R (in ZLS1; gain-of-function effect;
FT                                accelerated channel activation and slower
FT                                deactivation; dbSNP:rs730882174).
FT                                {ECO:0000269|PubMed:25915598}.
FT                                /FTId=VAR_073958.
FT   VARIANT     379    379       L -> V (in ZLS1; dbSNP:rs730882176).
FT                                {ECO:0000269|PubMed:25915598}.
FT                                /FTId=VAR_073959.
FT   VARIANT     383    383       V -> L (in ZLS1; gain-of-function effect;
FT                                accelerated channel activation and slower
FT                                deactivation; associated in cis with Y-
FT                                352; dbSNP:rs730882173).
FT                                {ECO:0000269|PubMed:25915598}.
FT                                /FTId=VAR_073960.
FT   VARIANT     489    489       L -> F (in TMBTS; gain-of-function
FT                                mutation resulting in a decreased
FT                                threshold of channel activation and
FT                                slower deactivation compared to wild-
FT                                type). {ECO:0000269|PubMed:25420144}.
FT                                /FTId=VAR_072613.
FT   VARIANT     494    494       I -> V (in TMBTS and ZLS1; gain-of-
FT                                function effect; resulting in a decreased
FT                                threshold of channel activation and
FT                                slower deactivation; dbSNP:rs727502819).
FT                                {ECO:0000269|PubMed:25420144,
FT                                ECO:0000269|PubMed:25915598}.
FT                                /FTId=VAR_072614.
FT   VARIANT     496    496       G -> R (in ZLS1; gain-of-function effect;
FT                                increased conductance at negative
FT                                potentials; dbSNP:rs730882175).
FT                                {ECO:0000269|PubMed:25915598}.
FT                                /FTId=VAR_073961.
FT   VARIANT     503    503       Q -> R (in TMBTS; gain-of-function
FT                                mutation resulting in a decreased
FT                                threshold of channel activation and
FT                                slower deactivation compared to wild-
FT                                type; dbSNP:rs727502821).
FT                                {ECO:0000269|PubMed:25420144}.
FT                                /FTId=VAR_072615.
FT   MUTAGEN     699    701       YNL->ANA: Shifts the voltage-dependence
FT                                of channel gating and decreases the rate
FT                                of channel opening.
FT                                {ECO:0000269|PubMed:22732247}.
FT   MUTAGEN     737    737       V->S: Abolishes inhibition of channel
FT                                activity by elevated cytoplasmic Ca(2+).
FT                                {ECO:0000269|PubMed:27618660}.
FT   MUTAGEN     740    740       L->S: Abolishes inhibition of channel
FT                                activity by elevated cytoplasmic Ca(2+).
FT                                {ECO:0000269|PubMed:27618660}.
FT   STRAND       29     34       {ECO:0000244|PDB:5J7E}.
FT   STRAND       41     45       {ECO:0000244|PDB:5J7E}.
FT   HELIX        47     53       {ECO:0000244|PDB:5J7E}.
FT   HELIX        57     59       {ECO:0000244|PDB:5J7E}.
FT   TURN         60     62       {ECO:0000244|PDB:5J7E}.
FT   HELIX        68     70       {ECO:0000244|PDB:5J7E}.
FT   HELIX        77     88       {ECO:0000244|PDB:5J7E}.
FT   STRAND       93    100       {ECO:0000244|PDB:5J7E}.
FT   STRAND      106    117       {ECO:0000244|PDB:5J7E}.
FT   STRAND      123    132       {ECO:0000244|PDB:5J7E}.
SQ   SEQUENCE   989 AA;  111423 MW;  CAA8CB251300C7E5 CRC64;
     MTMAGGRRGL VAPQNTFLEN IVRRSNDTNF VLGNAQIVDW PIVYSNDGFC KLSGYHRAEV
     MQKSSTCSFM YGELTDKDTI EKVRQTFENY EMNSFEILMY KKNRTPVWFF VKIAPIRNEQ
     DKVVLFLCTF SDITAFKQPI EDDSCKGWGK FARLTRALTS SRGVLQQLAP SVQKGENVHK
     HSRLAEVLQL GSDILPQYKQ EAPKTPPHII LHYCVFKTTW DWIILILTFY TAILVPYNVS
     FKTRQNNVAW LVVDSIVDVI FLVDIVLNFH TTFVGPAGEV ISDPKLIRMN YLKTWFVIDL
     LSCLPYDVIN AFENVDEVSA FMGDPGKIGF ADQIPPPLEG RESQGISSLF SSLKVVRLLR
     LGRVARKLDH YIEYGAAVLV LLVCVFGLAA HWMACIWYSI GDYEIFDEDT KTIRNNSWLY
     QLAMDIGTPY QFNGSGSGKW EGGPSKNSVY ISSLYFTMTS LTSVGFGNIA PSTDIEKIFA
     VAIMMIGSLL YATIFGNVTT IFQQMYANTN RYHEMLNSVR DFLKLYQVPK GLSERVMDYI
     VSTWSMSRGI DTEKVLQICP KDMRADICVH LNRKVFKEHP AFRLASDGCL RALAMEFQTV
     HCAPGDLIYH AGESVDSLCF VVSGSLEVIQ DDEVVAILGK GDVFGDVFWK EATLAQSCAN
     VRALTYCDLH VIKRDALQKV LEFYTAFSHS FSRNLILTYN LRKRIVFRKI SDVKREEEER
     MKRKNEAPLI LPPDHPVRRL FQRFRQQKEA RLAAERGGRD LDDLDVEKGN VLTEHASANH
     SLVKASVVTV RESPATPVSF QAASTSGVPD HAKLQAPGSE CLGPKGGGGD CAKRKSWARF
     KDACGKSEDW NKVSKAESME TLPERTKASG EATLKKTDSC DSGITKSDLR LDNVGEARSP
     QDRSPILAEV KHSFYPIPEQ TLQATVLEVR HELKEDIKAL NAKMTNIEKQ LSEILRILTS
     RRSSQSPQEL FEISRPQSPE SERDIFGAS
//
ID   KCNK5_HUMAN             Reviewed;         499 AA.
AC   O95279; B2RAQ6; B5TJL2; Q5VV76;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   27-SEP-2017, entry version 141.
DE   RecName: Full=Potassium channel subfamily K member 5;
DE   AltName: Full=Acid-sensitive potassium channel protein TASK-2;
DE   AltName: Full=TWIK-related acid-sensitive K(+) channel 2;
GN   Name=KCNK5; Synonyms=TASK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=9812978; DOI=10.1074/jbc.273.47.30863;
RA   Reyes R., Duprat F., Lesage F., Fink M., Salinas M., Farman N.,
RA   Lazdunski M.;
RT   "Cloning and expression of a novel pH-sensitive two pore domain K+
RT   channel from human kidney.";
RL   J. Biol. Chem. 273:30863-30869(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=18516069; DOI=10.1038/bjp.2008.213;
RA   Gierten J., Ficker E., Bloehs R., Schlomer K., Kathofer S., Scholz E.,
RA   Zitron E., Kiesecker C., Bauer A., Becker R., Katus H.A., Karle C.A.,
RA   Thomas D.;
RT   "Regulation of two-pore-domain (K2P) potassium leak channels by the
RT   tyrosine kinase inhibitor genistein.";
RL   Br. J. Pharmacol. 154:1680-1690(2008).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERCHAIN DISULFIDE BOND.
RX   PubMed=12851074; DOI=10.1080/0968768031000084181;
RA   Niemeyer M.I., Cid L.P., Valenzuela X., Paeile V., Sepulveda F.V.;
RT   "Extracellular conserved cysteine forms an intersubunit disulphide
RT   bridge in the KCNK5 (TASK-2) K+ channel without having an essential
RT   effect upon activity.";
RL   Mol. Membr. Biol. 20:185-191(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-371, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
CC   -!- FUNCTION: pH-dependent, voltage insensitive, outwardly rectifying
CC       potassium channel. Outward rectification is lost at high external
CC       K(+) concentrations.
CC   -!- SUBUNIT: Homodimer; disulfide-linked.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Abundant expression in kidney, also detected
CC       in liver, placenta and small intestine. In the kidney, expression
CC       is restricted to the distal tubules and collecting ducts. Not
CC       expressed in proximal tubules or glomeruli.
CC   -!- MISCELLANEOUS: Inhibited by quinine, quinidine and external
CC       acidification.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF084830; AAC79458.1; -; mRNA.
DR   EMBL; EU978936; ACH86095.1; -; mRNA.
DR   EMBL; AK314298; BAG36953.1; -; mRNA.
DR   EMBL; AL451185; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03979.1; -; Genomic_DNA.
DR   EMBL; BC060793; AAH60793.1; -; mRNA.
DR   EMBL; BC069573; AAH69573.1; -; mRNA.
DR   CCDS; CCDS4841.1; -.
DR   RefSeq; NP_003731.1; NM_003740.3.
DR   UniGene; Hs.444448; -.
DR   ProteinModelPortal; O95279; -.
DR   SMR; O95279; -.
DR   BioGrid; 114197; 2.
DR   IntAct; O95279; 1.
DR   STRING; 9606.ENSP00000352527; -.
DR   TCDB; 1.A.1.8.2; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O95279; -.
DR   PhosphoSitePlus; O95279; -.
DR   BioMuta; KCNK5; -.
DR   EPD; O95279; -.
DR   MaxQB; O95279; -.
DR   PaxDb; O95279; -.
DR   PeptideAtlas; O95279; -.
DR   PRIDE; O95279; -.
DR   Ensembl; ENST00000359534; ENSP00000352527; ENSG00000164626.
DR   GeneID; 8645; -.
DR   KEGG; hsa:8645; -.
DR   UCSC; uc003oon.4; human.
DR   CTD; 8645; -.
DR   DisGeNET; 8645; -.
DR   EuPathDB; HostDB:ENSG00000164626.8; -.
DR   GeneCards; KCNK5; -.
DR   HGNC; HGNC:6280; KCNK5.
DR   HPA; HPA059148; -.
DR   MIM; 603493; gene.
DR   neXtProt; NX_O95279; -.
DR   OpenTargets; ENSG00000164626; -.
DR   PharmGKB; PA30062; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000113211; -.
DR   HOVERGEN; HBG052236; -.
DR   InParanoid; O95279; -.
DR   KO; K04916; -.
DR   OMA; YFVELWI; -.
DR   OrthoDB; EOG091G058Z; -.
DR   PhylomeDB; O95279; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   ChiTaRS; KCNK5; human.
DR   GeneWiki; KCNK5; -.
DR   GenomeRNAi; 8645; -.
DR   PRO; PR:O95279; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000164626; -.
DR   CleanEx; HS_KCNK5; -.
DR   ExpressionAtlas; O95279; baseline and differential.
DR   Genevisible; O95279; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005267; F:potassium channel activity; TAS:ProtInc.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:Ensembl.
DR   GO; GO:0007588; P:excretion; TAS:ProtInc.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    499       Potassium channel subfamily K member 5.
FT                                /FTId=PRO_0000101749.
FT   TOPO_DOM      1      7       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      8     26       Helical. {ECO:0000255}.
FT   INTRAMEM     85    112       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    113    133       Helical. {ECO:0000255}.
FT   TOPO_DOM    134    157       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    158    180       Helical. {ECO:0000255}.
FT   INTRAMEM    190    215       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    230    250       Helical. {ECO:0000255}.
FT   TOPO_DOM    251    325       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     371    371       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   CARBOHYD     77     77       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     51     51       Interchain.
FT   VARIANT     465    465       P -> T (in dbSNP:rs9462487).
FT                                /FTId=VAR_052425.
FT   CONFLICT    423    423       V -> A (in Ref. 3; BAG36953).
FT                                {ECO:0000305}.
SQ   SEQUENCE   499 AA;  55130 MW;  E871A7A4823DDA00 CRC64;
     MVDRGPLLTS AIIFYLAIGA AIFEVLEEPH WKEAKKNYYT QKLHLLKEFP CLGQEGLDKI
     LEVVSDAAGQ GVAITGNQTF NNWNWPNAMI FAATVITTIG YGNVAPKTPA GRLFCVFYGL
     FGVPLCLTWI SALGKFFGGR AKRLGQFLTK RGVSLRKAQI TCTVIFIVWG VLVHLVIPPF
     VFMVTEGWNY IEGLYYSFIT ISTIGFGDFV AGVNPSANYH ALYRYFVELW IYLGLAWLSL
     FVNWKVSMFV EVHKAIKKRR RRRKESFESS PHSRKALQVK GSTASKDVNI FSFLSKKEET
     YNDLIKQIGK KAMKTSGGGE TGPGPGLGPQ GGGLPALPPS LVPLVVYSKN RVPTLEEVSQ
     TLRSKGHVSR SPDEEAVARA PEDSSPAPEV FMNQLDRISE ECEPWDAQDY HPLIFQDASI
     TFVNTEAGLS DEETSKSSLE DNLAGEESPQ QGAEAKAPLN MGEFPSSSES TFTSTESELS
     VPYEQLMNEY NKANSPKGT
//
ID   KCNQ1_FELCA             Reviewed;         582 AA.
AC   O97531; M3W6T1;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   20-JAN-2016, sequence version 2.
DT   25-OCT-2017, entry version 99.
DE   RecName: Full=Potassium voltage-gated channel subfamily KQT member 1 {ECO:0000250|UniProtKB:P51787};
DE   AltName: Full=IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1 {ECO:0000250|UniProtKB:P51787};
DE   AltName: Full=KQT-like 1 {ECO:0000250|UniProtKB:P51787};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv7.1 {ECO:0000250|UniProtKB:P51787};
DE   Flags: Fragment;
GN   Name=KCNQ1 {ECO:0000250|UniProtKB:P51787};
GN   Synonyms=KVLQT1 {ECO:0000250|UniProtKB:P51787};
OS   Felis catus (Cat) (Felis silvestris catus).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Carnivora; Feliformia; Felidae;
OC   Felinae; Felis.
OX   NCBI_TaxID=9685;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Abyssinian;
RX   PubMed=17975172; DOI=10.1101/gr.6380007;
RA   Pontius J.U., Mullikin J.C., Smith D.R., Lindblad-Toh K., Gnerre S.,
RA   Clamp M., Chang J., Stephens R., Neelam B., Volfovsky N.,
RA   Schaffer A.A., Agarwala R., Narfstrom K., Murphy W.J., Giger U.,
RA   Roca A.L., Antunes A., Menotti-Raymond M., Yuhki N.,
RA   Pecon-Slattery J., Johnson W.E., Bourque G., Tesler G., O'Brien S.J.;
RT   "Initial sequence and comparative analysis of the cat genome.";
RL   Genome Res. 17:1675-1689(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 104-275.
RC   TISSUE=Heart;
RA   Chen L.-S.K.;
RT   "Expression of minK and KvLQT1 mRNA in cat tissues: a genetic evidence
RT   for the cardiac IKs channel.";
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Potassium channel that plays an important role in a
CC       number of tissues, including heart, inner ear, stomach and colon
CC       (By similarity). Associates with KCNE beta subunits that modulates
CC       current kinetics (By similarity). Induces a voltage-dependent by
CC       rapidly activating and slowly deactivating potassium-selective
CC       outward current (By similarity). Promotes also a delayed voltage
CC       activated potassium current showing outward rectification
CC       characteristic (By similarity). During beta-adrenergic receptor
CC       stimulation participates in cardiac repolarization by associating
CC       with KCNE1 to form the I(Ks) cardiac potassium current that
CC       increases the amplitude and slows down the activation kinetics of
CC       outward potassium current I(Ks) (By similarity). Muscarinic
CC       agonist oxotremorine-M strongly suppresses KCNQ1/KCNE1 current (By
CC       similarity). When associated with KCNE3, forms the potassium
CC       channel that is important for cyclic AMP-stimulated intestinal
CC       secretion of chloride ions (By similarity). This interaction with
CC       KCNE3 is reduced by 17beta-estradiol, resulting in the reduction
CC       of currents (By similarity). During conditions of increased
CC       substrate load, maintains the driving force for proximal tubular
CC       and intestinal sodium ions absorption, gastric acid secretion, and
CC       cAMP-induced jejunal chloride ions secretion (By similarity).
CC       Allows the provision of potassium ions to the luminal membrane of
CC       the secretory canaliculus in the resting state as well as during
CC       stimulated acid secretion (By similarity). When associated with
CC       KCNE2, forms a heterooligomer complex leading to currents with an
CC       apparently instantaneous activation, a rapid deactivation process
CC       and a linear current-voltage relationship and decreases the
CC       amplitude of the outward current (By similarity). When associated
CC       with KCNE4, inhibits voltage-gated potassium channel activity (By
CC       similarity). When associated with KCNE5, this complex only
CC       conducts current upon strong and continued depolarization (By
CC       similarity). Also forms a heterotetramer with KCNQ5 that has a
CC       voltage-gated potassium channel activity (By similarity). Binds
CC       with phosphatidylinositol 4,5-bisphosphate (By similarity).
CC       {ECO:0000250|UniProtKB:P51787, ECO:0000250|UniProtKB:P97414,
CC       ECO:0000250|UniProtKB:Q9Z0N7}.
CC   -!- SUBUNIT: Tetramer. Heterotetramer with KCNE1; targets to the
CC       membrane raft. Interacts (via C-terminus) with CALM; forms an
CC       heterotetramer in a calcium-independent manner. Interacts with
CC       AKAP9; targets protein kinase A (PKA) catalytic and regulatory
CC       subunits and protein phosphatase 1 (PP1) to the KCNQ1-KCNE1
CC       complex, allowing PKA-mediated phosphorylation and increase of
CC       delayed rectifier potassium channel activity. Interacts with
CC       KCNE2; form a heterooligomer complex that targets to the membrane
CC       raft and leading to currents with an apparently instantaneous
CC       activation, a rapid deactivation process and a linear current-
CC       voltage relationship and decreases the amplitude of the outward
CC       current. Interacts with AP2M1; mediates estrogen-induced
CC       internalization via clathrin-coated vesicles. Interacts with
CC       NEDD4L; promotes internalization and decreases I(Ks) currents.
CC       Interacts with USP2; counteracts the NEDD4L-specific down-
CC       regulation of I(Ks) and restore plasma membrane localization.
CC       Heterotetramer with KCNQ5; has a voltage-gated potassium channel
CC       activity. Interacts with KCNE3; alters membrane raft localization.
CC       Interacts with KCNE4; impairs KCNQ1 localization in lipid rafts
CC       and inhibits voltage-gated potassium channel activity. Interacts
CC       with KCNE5; impairs KCNQ1 localization in lipid rafts and only
CC       conducts current upon strong and continued depolarization.
CC       {ECO:0000250|UniProtKB:P51787}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P51787}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P51787}. Cytoplasmic vesicle membrane
CC       {ECO:0000250|UniProtKB:P51787}. Early endosome
CC       {ECO:0000250|UniProtKB:P51787}. Membrane raft
CC       {ECO:0000250|UniProtKB:P51787}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P51787}. Basolateral cell membrane
CC       {ECO:0000250|UniProtKB:P51787}. Note=Colocalized with KCNE3 at the
CC       plasma membrane. Upon 17beta-oestradiol treatment, colocalizes
CC       with RAB5A at early endosome. Heterotetramer with KCNQ5 is highly
CC       retained at the endoplasmic reticulum and is localized outside of
CC       lipid raft microdomains. During the early stages of epithelial
CC       cell polarization induced by the calcium switch it removed from
CC       plasma membrane to the endoplasmic reticulum where it retained and
CC       it is redistributed to the basolateral cell surface in a PI3K-
CC       dependent manner at a later stage. {ECO:0000250|UniProtKB:P51787}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250|UniProtKB:P51787}.
CC   -!- DOMAIN: The coiled-coil domain mediates tetramerization.
CC       {ECO:0000250|UniProtKB:P51787}.
CC   -!- DOMAIN: The segment S6 is involved in the inhibition of voltage-
CC       gated potassium channel activity by KCNE4.
CC       {ECO:0000250|UniProtKB:P51787}.
CC   -!- DOMAIN: The C-terminal assembly domain promotes self-interactiona;
CC       allows functional channel. {ECO:0000250|UniProtKB:P51787}.
CC   -!- PTM: Phosphorylated by PKA; increases delayed rectifier potassium
CC       channel activity of the KCNQ1-KCNE1 complex through a
CC       macromolecular complex that includes PKA, PP1, and the targeting
CC       protein AKAP9. {ECO:0000250|UniProtKB:P51787}.
CC   -!- PTM: Ubiquitinated by NEDD4L; promotes internalization. The
CC       ubiquitinylated form is internalized through a clathrin-mediated
CC       endocytosis by interacting with AP2M1 and is recycled back to the
CC       cell membrane via RAB4A and RAB11A.
CC       {ECO:0000250|UniProtKB:P51787}.
CC   -!- PTM: Deubiquitinated by USP2; counteracts the NEDD4L-specific
CC       down-regulation of I(Ks) and restores the membrane localization.
CC       {ECO:0000250|UniProtKB:P51787}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. KQT (TC
CC       1.A.1.15) subfamily. Kv7.1/KCNQ1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AANG02067979; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG02067981; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG02067980; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336025; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336026; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336027; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336028; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336030; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336031; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336032; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336033; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336034; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336035; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336036; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336037; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336038; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336039; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336041; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336042; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336043; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336044; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336045; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AANG03336046; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF013961; AAC98890.1; -; mRNA.
DR   ProteinModelPortal; O97531; -.
DR   STRING; 9685.ENSFCAP00000006446; -.
DR   eggNOG; KOG1419; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOVERGEN; HBG059014; -.
DR   InParanoid; O97531; -.
DR   OrthoDB; EOG091G02ZT; -.
DR   Proteomes; UP000011712; Unplaced.
DR   Bgee; ENSFCAG00000006943; -.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0034702; C:ion channel complex; ISS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0048839; P:inner ear development; ISS:UniProtKB.
DR   GO; GO:0050892; P:intestinal absorption; ISS:UniProtKB.
DR   GO; GO:0086009; P:membrane repolarization; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0060453; P:regulation of gastric acid secretion; ISS:UniProtKB.
DR   GO; GO:0070293; P:renal absorption; ISS:UniProtKB.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003937; K_chnl_volt-dep_KCNQ.
DR   InterPro; IPR013821; K_chnl_volt-dep_KCNQ_C.
DR   InterPro; IPR005827; K_chnl_volt-dep_KCQN1.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF109; PTHR11537:SF109; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03520; KCNQ_channel; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01460; KCNQ1CHANNEL.
DR   PRINTS; PR01459; KCNQCHANNEL.
PE   2: Evidence at transcript level;
KW   Calmodulin-binding; Cell membrane; Coiled coil; Complete proteome;
KW   Cytoplasmic vesicle; Endoplasmic reticulum; Endosome; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Ubl conjugation;
KW   Voltage-gated channel.
FT   CHAIN        <1    582       Potassium voltage-gated channel subfamily
FT                                KQT member 1.
FT                                /FTId=PRO_0000054023.
FT   TRANSMEM     33     53       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     54     58       Extracellular. {ECO:0000255}.
FT   TRANSMEM     59     79       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM     80    107       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    108    128       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    129    136       Extracellular. {ECO:0000255}.
FT   TRANSMEM    137    159       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    160    172       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    173    193       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    194    210       Extracellular. {ECO:0000255}.
FT   INTRAMEM    211    231       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    232    238       Extracellular. {ECO:0000255}.
FT   TRANSMEM    239    259       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    260    582       Cytoplasmic. {ECO:0000255}.
FT   REGION      446    483       Interaction with KCNE1 C-terminus.
FT                                {ECO:0000250|UniProtKB:P51787}.
FT   REGION      499    527       Interaction with AKAP9.
FT                                {ECO:0000250|UniProtKB:P51787}.
FT   REGION      500    531       C-terminal assembly domain.
FT                                {ECO:0000250|UniProtKB:P51787}.
FT   COILED      496    532       {ECO:0000250|UniProtKB:P51787}.
FT   MOTIF       223    228       Selectivity filter. {ECO:0000250}.
FT   MOD_RES     318    318       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97414}.
FT   MOD_RES     320    320       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97414}.
FT   CARBOHYD    200    200       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   NON_TER       1      1
SQ   SEQUENCE   582 AA;  65419 MW;  69CF20E75842C6C9 CRC64;
     RVSIYSARRP LLARTHIQGR VYNFLERPTG WKCFVYHFAV FLIVLVCLIF SVLSTIEQYV
     ALATGTLFWM EIVLVVFFGT EYVVRLWSAG CRSKYVGVWG RLRFARKPIS IIDLIVVLAS
     MVVLCVGSKG QVFATSAIRG IRFLQILRML HVDRQGGTWR LLGSVVFIHR QELITTLYIG
     FLGLIFSSYF VYLAEKDAVN ESGQVEFGSY ADALWWGVVT VTTIGYGDKV PQTWVGKTIA
     SCFSVFAISF FALPAGILGS GFALKVQQKQ RQKHFNRQIP AAASLIQTAW RCYAAENPES
     STWNIYVRKP TRSHTLLSPS PKPKKSVMVK KKKFKLDKDN GVSPGEKTLT VPHITCEPVS
     EKRRPDHFSV DTCDSSVKSP MLLEVSTTHF LRTNSVAEDL DLEGETPLVP ITHVSQLREH
     HRATIKVIRR MQYFVAKKKF QQARKPYDVR DVIEQYSQGH LNLMVRIKEL QRRLDQSIGK
     PSLFISVSEK SKDRGSNTIG ARLNRVEDKV AQLDQRLVLI TDMLQQLLSL HHGGPPGSRP
     PSGGGAQVQP CGPTNPELFL PGNALPTYEQ LTVPRRGPEE GS
//
ID   KCNAS_DROME             Reviewed;         655 AA.
AC   P08510; A4V4Q2; B6IDJ2; M9MSC0; M9NEM4; M9PF21; P08511; P08512;
AC   P08513; Q24277; Q24521; Q7KUW5; Q8IQY9; Q8MT41; Q9VWZ5; Q9VWZ9;
AC   Q9VX00;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   04-APR-2006, sequence version 3.
DT   22-NOV-2017, entry version 204.
DE   RecName: Full=Potassium voltage-gated channel protein Shaker;
DE   AltName: Full=Protein minisleep;
GN   Name=Sh; Synonyms=mns; ORFNames=CG12348;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA), AND RNA EDITING OF
RP   POSITIONS 464; 489 AND 491.
RX   PubMed=2441471; DOI=10.1126/science.2441471;
RA   Tempel B.L., Papazian D.M., Schwarz T.L., Jan Y.N., Jan L.Y.;
RT   "Sequence of a probable potassium channel component encoded at Shaker
RT   locus of Drosophila.";
RL   Science 237:770-775(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM DELTA).
RC   STRAIN=Canton-S, and Oregon-R;
RX   PubMed=16453805;
RA   Baumann A., Krah-Jentgens I., Mueller R., Mueller-Holtkamp F.,
RA   Seidel R., Kecskemethy N., Casal J., Ferrus A., Pongs O.;
RT   "Molecular organization of the maternal effect region of the Shaker
RT   complex of Drosophila: characterization of an I(A) channel transcript
RT   with homology to vertebrate Na(+) channel.";
RL   EMBO J. 6:3419-3429(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA; BETA; DELTA AND EPSILON),
RP   AND RNA EDITING OF POSITIONS 464; 489 AND 491.
RC   STRAIN=Canton-S; TISSUE=Larva;
RX   PubMed=2456921;
RA   Pongs O., Kecskemethy N., Mueller R., Krah-Jentgens I., Baumann A.,
RA   Kiltz H.H., Canal I., Llamazares S., Ferrus A.;
RT   "Shaker encodes a family of putative potassium channel proteins in the
RT   nervous system of Drosophila.";
RL   EMBO J. 7:1087-1096(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA; BETA AND E).
RX   PubMed=2448635; DOI=10.1038/331137a0;
RA   Schwarz T.L., Tempel B.L., Papazian D.M., Jan Y.N., Jan L.Y.;
RT   "Multiple potassium-channel components are produced by alternative
RT   splicing at the Shaker locus in Drosophila.";
RL   Nature 331:137-142(1988).
RN   [5]
RP   ERRATUM.
RA   Schwarz T.L., Tempel B.L., Papazian D.M., Jan Y.N., Jan L.Y.;
RL   Nature 332:740-740(1988).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [7]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM D), AND RNA EDITING OF
RP   POSITION 360.
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM D).
RC   STRAIN=Berkeley;
RA   Carlson J., Booth B., Frise E., Park S., Wan K., Yu C., Celniker S.;
RL   Submitted (NOV-2008) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-257 (ISOFORM BETA).
RC   TISSUE=Larva;
RX   PubMed=2440582; DOI=10.1016/0092-8674(87)90494-6;
RA   Kamb A., Iverson L.E., Tanouye M.A.;
RT   "Molecular characterization of Shaker, a Drosophila gene that encodes
RT   a potassium channel.";
RL   Cell 50:405-413(1987).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 450-534.
RC   STRAIN=H4;
RX   PubMed=3272175; DOI=10.1016/0896-6273(88)90192-4;
RA   Kamb A., Tseng-Crank J., Tanouye M.A.;
RT   "Multiple products of the Drosophila Shaker gene may contribute to
RT   potassium channel diversity.";
RL   Neuron 1:421-430(1988).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=2448636; DOI=10.1038/331143a0;
RA   Timpe L.C., Schwarz T.L., Tempel B.L., Papazian D.M., Jan Y.N.,
RA   Jan L.Y.;
RT   "Expression of functional potassium channels from Shaker cDNA in
RT   Xenopus oocytes.";
RL   Nature 331:143-145(1988).
RN   [13]
RP   RNA EDITING.
RX   PubMed=12907802; DOI=10.1126/science.1086763;
RA   Hoopengardner B., Bhalla T., Staber C., Reenan R.;
RT   "Nervous system targets of RNA editing identified by comparative
RT   genomics.";
RL   Science 301:832-836(2003).
RN   [14]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF THR-248.
RX   PubMed=15858564; DOI=10.1038/nature03486;
RA   Cirelli C., Bushey D., Hill S., Huber R., Kreber R., Ganetzky B.,
RA   Tononi G.;
RT   "Reduced sleep in Drosophila Shaker mutants.";
RL   Nature 434:1087-1092(2005).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-259 AND ASN-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Oregon-R; TISSUE=Head;
RX   PubMed=17893096; DOI=10.1093/glycob/cwm097;
RA   Koles K., Lim J.-M., Aoki K., Porterfield M., Tiemeyer M., Wells L.,
RA   Panin V.;
RT   "Identification of N-glycosylated proteins from the central nervous
RT   system of Drosophila melanogaster.";
RL   Glycobiology 17:1388-1403(2007).
RN   [16]
RP   STRUCTURE BY NMR OF 378-397.
RX   PubMed=12023222; DOI=10.1016/S0006-3495(02)75640-3;
RA   Ohlenschlaeger O., Hojo H., Ramachandran R., Goerlach M., Haris P.I.;
RT   "Three-dimensional structure of the S4-S5 segment of the Shaker
RT   potassium channel.";
RL   Biophys. J. 82:2995-3002(2002).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes. The
CC       channel alternates between opened and closed conformations in
CC       response to the voltage difference across the membrane. Forms
CC       rapidly inactivating tetrameric potassium-selective channels
CC       through which potassium ions pass in accordance with their
CC       electrochemical gradient and may contribute to A-type currents
CC       (PubMed:2448636). Plays a role in the regulation of sleep need or
CC       efficiency (PubMed:15858564). {ECO:0000269|PubMed:15858564,
CC       ECO:0000269|PubMed:2448636}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer of potassium channel
CC       proteins. {ECO:0000305}.
CC   -!- INTERACTION:
CC       P31007:dlg1; NbExp=3; IntAct=EBI-85074, EBI-389374;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:2448636};
CC       Multi-pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=E;
CC         IsoId=P08510-1; Sequence=Displayed;
CC       Name=Alpha; Synonyms=B, Adult;
CC         IsoId=P08510-2; Sequence=VSP_017889, VSP_000959;
CC       Name=Beta; Synonyms=C, I, J, Late population;
CC         IsoId=P08510-3; Sequence=VSP_000954;
CC       Name=Delta; Synonyms=Larval, A, H;
CC         IsoId=P08510-5; Sequence=VSP_000956, VSP_000957, VSP_000958;
CC       Name=Epsilon; Synonyms=Larval, F;
CC         IsoId=P08510-6; Sequence=VSP_000957, VSP_000958;
CC       Name=D;
CC         IsoId=P08510-7; Sequence=VSP_000956, VSP_017889, VSP_000959;
CC         Note=No experimental confirmation available.;
CC       Name=N;
CC         IsoId=P08510-8; Sequence=VSP_054719;
CC         Note=No experimental confirmation available.;
CC       Name=L;
CC         IsoId=P08510-9; Sequence=VSP_000954, VSP_054720;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- RNA EDITING: Modified_positions=178 {ECO:0000269|PubMed:12907802},
CC       360 {ECO:0000269|PubMed:12537569, ECO:0000269|PubMed:12907802},
CC       464 {ECO:0000269|PubMed:12907802, ECO:0000269|PubMed:2441471,
CC       ECO:0000269|PubMed:2456921}, 489 {ECO:0000269|PubMed:12907802,
CC       ECO:0000269|PubMed:2441471, ECO:0000269|PubMed:2456921}, 491
CC       {ECO:0000269|PubMed:12907802, ECO:0000269|PubMed:2441471,
CC       ECO:0000269|PubMed:2456921}; Note=Partially edited.;
CC   -!- DISRUPTION PHENOTYPE: Reduced sleep. Flies sleep for one-third of
CC       the wild-type amount. They perform normally in a number of tasks,
CC       have preserved sleep homeostasis, but are not impaired by sleep
CC       deprivation. They also have a reduced lifespan.
CC       {ECO:0000269|PubMed:15858564}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Shaker sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA70217.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M17211; AAA28417.1; -; mRNA.
DR   EMBL; X06184; CAA29549.1; -; mRNA.
DR   EMBL; X07131; CAA30143.1; -; mRNA.
DR   EMBL; X07132; CAA30144.1; -; mRNA.
DR   EMBL; X07133; CAA30145.1; -; mRNA.
DR   EMBL; X07134; CAA30146.1; -; mRNA.
DR   EMBL; X06742; CAA29917.1; -; mRNA.
DR   EMBL; AE014298; AAF48785.3; -; Genomic_DNA.
DR   EMBL; AE014298; AAF48786.3; -; Genomic_DNA.
DR   EMBL; AE014298; AAF48790.2; -; Genomic_DNA.
DR   EMBL; AE014298; AAN09451.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAN09452.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAS65395.2; -; Genomic_DNA.
DR   EMBL; AE014298; AAS65396.1; -; Genomic_DNA.
DR   EMBL; AE014298; ADV37750.1; -; Genomic_DNA.
DR   EMBL; AE014298; AFH07440.1; -; Genomic_DNA.
DR   EMBL; AE014298; AGB95507.1; -; Genomic_DNA.
DR   EMBL; AY118398; AAM48427.1; -; mRNA.
DR   EMBL; BT050432; ACJ13139.1; -; mRNA.
DR   EMBL; M17155; AAA70217.1; ALT_FRAME; mRNA.
DR   EMBL; X78908; CAA55519.1; -; Genomic_DNA.
DR   PIR; A27159; A27159.
DR   PIR; JH0193; JH0193.
DR   PIR; S00480; S00480.
DR   PIR; S02284; S02284.
DR   RefSeq; NP_001162788.1; NM_001169317.1. [P08510-5]
DR   RefSeq; NP_001188668.1; NM_001201739.2. [P08510-3]
DR   RefSeq; NP_001245727.1; NM_001258798.2. [P08510-9]
DR   RefSeq; NP_001259665.2; NM_001272736.2. [P08510-2]
DR   RefSeq; NP_523393.3; NM_078669.5. [P08510-2]
DR   RefSeq; NP_728120.1; NM_167592.4. [P08510-7]
DR   RefSeq; NP_728122.1; NM_167594.4. [P08510-3]
DR   RefSeq; NP_728123.1; NM_167595.4. [P08510-1]
DR   RefSeq; NP_728124.1; NM_167596.5. [P08510-5]
DR   RefSeq; NP_996497.1; NM_206774.2. [P08510-6]
DR   RefSeq; NP_996498.2; NM_206775.5. [P08510-3]
DR   UniGene; Dm.7088; -.
DR   PDB; 1HO2; NMR; -; A=378-397.
DR   PDB; 1HO7; NMR; -; A=378-397.
DR   PDBsum; 1HO2; -.
DR   PDBsum; 1HO7; -.
DR   ProteinModelPortal; P08510; -.
DR   SMR; P08510; -.
DR   BioGrid; 59101; 16.
DR   DIP; DIP-41151N; -.
DR   IntAct; P08510; 5.
DR   MINT; MINT-317832; -.
DR   STRING; 7227.FBpp0088599; -.
DR   TCDB; 1.A.1.2.6; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P08510; -.
DR   PaxDb; P08510; -.
DR   PRIDE; P08510; -.
DR   EnsemblMetazoa; FBtr0089657; FBpp0088599; FBgn0003380. [P08510-1]
DR   EnsemblMetazoa; FBtr0089658; FBpp0088600; FBgn0003380. [P08510-2]
DR   EnsemblMetazoa; FBtr0089659; FBpp0088601; FBgn0003380. [P08510-5]
DR   EnsemblMetazoa; FBtr0089660; FBpp0088602; FBgn0003380. [P08510-7]
DR   EnsemblMetazoa; FBtr0089661; FBpp0088603; FBgn0003380. [P08510-3]
DR   EnsemblMetazoa; FBtr0089663; FBpp0088605; FBgn0003380. [P08510-6]
DR   EnsemblMetazoa; FBtr0301955; FBpp0291167; FBgn0003380. [P08510-5]
DR   EnsemblMetazoa; FBtr0302902; FBpp0292033; FBgn0003380. [P08510-3]
DR   EnsemblMetazoa; FBtr0302903; FBpp0292034; FBgn0003380. [P08510-3]
DR   EnsemblMetazoa; FBtr0308200; FBpp0300520; FBgn0003380. [P08510-9]
DR   EnsemblMetazoa; FBtr0346703; FBpp0312316; FBgn0003380. [P08510-2]
DR   EnsemblMetazoa; FBtr0346704; FBpp0312317; FBgn0003380. [P08510-2]
DR   GeneID; 32780; -.
DR   KEGG; dme:Dmel_CG12348; -.
DR   UCSC; CG12348-RG; d. melanogaster.
DR   CTD; 32780; -.
DR   FlyBase; FBgn0003380; Sh.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   InParanoid; P08510; -.
DR   KO; K04874; -.
DR   OMA; PEPDHEC; -.
DR   OrthoDB; EOG091G10NU; -.
DR   PhylomeDB; P08510; -.
DR   Reactome; R-DME-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; Sh; fly.
DR   EvolutionaryTrace; P08510; -.
DR   GenomeRNAi; 32780; -.
DR   PRO; PR:P08510; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0003380; -.
DR   ExpressionAtlas; P08510; differential.
DR   Genevisible; P08510; DM.
DR   GO; GO:0016021; C:integral component of membrane; IDA:FlyBase.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IPI:FlyBase.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; IDA:FlyBase.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:FlyBase.
DR   GO; GO:0001508; P:action potential; IMP:FlyBase.
DR   GO; GO:0048675; P:axon extension; IMP:FlyBase.
DR   GO; GO:0048150; P:behavioral response to ether; NAS:FlyBase.
DR   GO; GO:1903351; P:cellular response to dopamine; IMP:FlyBase.
DR   GO; GO:0007619; P:courtship behavior; TAS:FlyBase.
DR   GO; GO:0009584; P:detection of visible light; IMP:FlyBase.
DR   GO; GO:0007629; P:flight behavior; IMP:FlyBase.
DR   GO; GO:0008345; P:larval locomotory behavior; IMP:FlyBase.
DR   GO; GO:0007611; P:learning or memory; NAS:FlyBase.
DR   GO; GO:0048047; P:mating behavior, sex discrimination; IDA:FlyBase.
DR   GO; GO:0045938; P:positive regulation of circadian sleep/wake cycle, sleep; IMP:FlyBase.
DR   GO; GO:0045838; P:positive regulation of membrane potential; IMP:FlyBase.
DR   GO; GO:0006813; P:potassium ion transport; TAS:FlyBase.
DR   GO; GO:0007637; P:proboscis extension reflex; IMP:FlyBase.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0045187; P:regulation of circadian sleep/wake cycle, sleep; IMP:FlyBase.
DR   GO; GO:0060025; P:regulation of synaptic activity; IMP:FlyBase.
DR   GO; GO:0050909; P:sensory perception of taste; NAS:FlyBase.
DR   GO; GO:0030431; P:sleep; IMP:FlyBase.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   RNA editing; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    655       Potassium voltage-gated channel protein
FT                                Shaker.
FT                                /FTId=PRO_0000053963.
FT   TOPO_DOM      1    224       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    225    246       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    247    278       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    279    300       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    301    311       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    312    332       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    333    357       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    358    378       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    379    393       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    394    415       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    416    429       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    430    441       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    442    449       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    450    456       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    457    485       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    486    655       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION        1    188       Tetramerization domain.
FT                                {ECO:0000250|UniProtKB:P10499}.
FT   REGION      380    393       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       442    447       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   COMPBIAS     15     53       Gln-rich.
FT   COMPBIAS    558    619       Gln-rich.
FT   COMPBIAS    625    630       Poly-Ala.
FT   CARBOHYD    259    259       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17893096}.
FT   CARBOHYD    263    263       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17893096}.
FT   VAR_SEQ       1     61       MAAVAGLYGLGEDRQHRKKQQQQQQHQKEQLEQKEEQKKIA
FT                                ERKLQLREQQLQRNSLDGYG -> MTMWQSGGMGGHGSQNN
FT                                PWMKLMGIVHKERRHTENVQSQSGSNERNLNQ (in
FT                                isoform Beta and isoform L).
FT                                {ECO:0000303|PubMed:2440582,
FT                                ECO:0000303|PubMed:2448635,
FT                                ECO:0000303|PubMed:2456921}.
FT                                /FTId=VSP_000954.
FT   VAR_SEQ       1     61       MAAVAGLYGLGEDRQHRKKQQQQQQHQKEQLEQKEEQKKIA
FT                                ERKLQLREQQLQRNSLDGYG -> MAHITTTHGSLSQATR
FT                                (in isoform Delta and isoform D).
FT                                {ECO:0000303|PubMed:12537569,
FT                                ECO:0000303|PubMed:16453805,
FT                                ECO:0000303|PubMed:2456921,
FT                                ECO:0000303|Ref.9}.
FT                                /FTId=VSP_000956.
FT   VAR_SEQ     349    349       D -> V (in isoform Delta and isoform
FT                                Epsilon). {ECO:0000303|PubMed:16453805,
FT                                ECO:0000303|PubMed:2456921}.
FT                                /FTId=VSP_000957.
FT   VAR_SEQ     350    655       Missing (in isoform Delta and isoform
FT                                Epsilon). {ECO:0000303|PubMed:16453805,
FT                                ECO:0000303|PubMed:2456921}.
FT                                /FTId=VSP_000958.
FT   VAR_SEQ     407    655       VVLFSSAVYFAEAGSENSFFKSIPDAFWWAVVTMTTVGYGD
FT                                MTPVGVWGKIVGSLCAIAGVLTIALPVPVIVSNFNYFYHRE
FT                                TDQEEMQSQNFNHVTSCPYLPGTLGQHMKKSSLSESSSDMM
FT                                DLDDGVESTPGLTETHPGRSAVAPFLGAQQQQQQPVASSLS
FT                                MSIDKQLQHPLQQLTQTQLYQQQQQQQQQQQNGFKQQQQQT
FT                                QQQLQQQQSHTINASAAAATSGSGSSGLTMRHNNALAVSIE
FT                                TDV -> KFHTVNKKKKNNIPHLLIDLRVLFKQHQKQKRNT
FT                                AKRLRPSRQTYPRYPAPSKDIFSTTSHCPKVLIHILTVNRS
FT                                KTTYNYSGIVQRSRIKTTTKDTYI (in isoform N).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_054719.
FT   VAR_SEQ     453    463       VWGKIVGSLCA -> FWGKIVGSLCV (in isoform
FT                                Alpha and isoform D).
FT                                {ECO:0000303|PubMed:12537569,
FT                                ECO:0000303|PubMed:2441471,
FT                                ECO:0000303|PubMed:2448635,
FT                                ECO:0000303|PubMed:2456921,
FT                                ECO:0000303|Ref.9}.
FT                                /FTId=VSP_017889.
FT   VAR_SEQ     506    655       PYLPGTLGQHMKKSSLSESSSDMMDLDDGVESTPGLTETHP
FT                                GRSAVAPFLGAQQQQQQPVASSLSMSIDKQLQHPLQQLTQT
FT                                QLYQQQQQQQQQQQNGFKQQQQQTQQQLQQQQSHTINASAA
FT                                AATSGSGSSGLTMRHNNALAVSIETDV -> SYLPGALGQH
FT                                LKKSSLSESSSDIMDLDDGIDATTPGLTDHTGRHMVPFLRT
FT                                QQSFEKQQLQLQLQLQQQSQSPHGQQMTQQQQLGQNGLRST
FT                                NSLQLRHNNAMAVSIETDV (in isoform Alpha and
FT                                isoform D). {ECO:0000303|PubMed:12537569,
FT                                ECO:0000303|PubMed:2441471,
FT                                ECO:0000303|PubMed:2448635,
FT                                ECO:0000303|PubMed:2456921,
FT                                ECO:0000303|Ref.9}.
FT                                /FTId=VSP_000959.
FT   VAR_SEQ     512    512       L -> LV (in isoform L). {ECO:0000305}.
FT                                /FTId=VSP_054720.
FT   VARIANT     178    178       K -> E (in RNA edited version).
FT   VARIANT     178    178       K -> G (in RNA edited version).
FT   VARIANT     178    178       K -> R (in RNA edited version).
FT   VARIANT     360    360       I -> M (in RNA edited version).
FT   VARIANT     464    464       I -> V (in RNA edited version).
FT   VARIANT     489    489       T -> A (in RNA edited version).
FT   VARIANT     491    491       Q -> R (in RNA edited version).
FT   MUTAGEN     248    248       T->I: In mns; flies display reduced
FT                                sleep. {ECO:0000269|PubMed:15858564}.
FT   CONFLICT    563    563       Q -> QQ (in Ref. 4; CAA29917).
FT                                {ECO:0000305}.
FT   CONFLICT    583    584       QL -> HV (in Ref. 4; CAA29917).
FT                                {ECO:0000305}.
FT   HELIX       380    394       {ECO:0000244|PDB:1HO2}.
SQ   SEQUENCE   655 AA;  74193 MW;  5833E3052C9D19B3 CRC64;
     MAAVAGLYGL GEDRQHRKKQ QQQQQHQKEQ LEQKEEQKKI AERKLQLREQ QLQRNSLDGY
     GSLPKLSSQD EEGGAGHGFG GGPQHFEPIP HDHDFCERVV INVSGLRFET QLRTLNQFPD
     TLLGDPARRL RYFDPLRNEY FFDRSRPSFD AILYYYQSGG RLRRPVNVPL DVFSEEIKFY
     ELGDQAINKF REDEGFIKEE ERPLPDNEKQ RKVWLLFEYP ESSQAARVVA IISVFVILLS
     IVIFCLETLP EFKHYKVFNT TTNGTKIEED EVPDITDPFF LIETLCIIWF TFELTVRFLA
     CPNKLNFCRD VMNVIDIIAI IPYFITLATV VAEEEDTLNL PKAPVSPQDK SSNQAMSLAI
     LRVIRLVRVF RIFKLSRHSK GLQILGRTLK ASMRELGLLI FFLFIGVVLF SSAVYFAEAG
     SENSFFKSIP DAFWWAVVTM TTVGYGDMTP VGVWGKIVGS LCAIAGVLTI ALPVPVIVSN
     FNYFYHRETD QEEMQSQNFN HVTSCPYLPG TLGQHMKKSS LSESSSDMMD LDDGVESTPG
     LTETHPGRSA VAPFLGAQQQ QQQPVASSLS MSIDKQLQHP LQQLTQTQLY QQQQQQQQQQ
     QNGFKQQQQQ TQQQLQQQQS HTINASAAAA TSGSGSSGLT MRHNNALAVS IETDV
//
ID   KCNE1_HUMAN             Reviewed;         129 AA.
AC   P15382; A5H1P2; Q8N709; Q91Z94;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   22-NOV-2017, entry version 185.
DE   RecName: Full=Potassium voltage-gated channel subfamily E member 1;
DE   AltName: Full=Delayed rectifier potassium channel subunit IsK;
DE   AltName: Full=IKs producing slow voltage-gated potassium channel subunit beta Mink;
DE   AltName: Full=Minimal potassium channel;
GN   Name=KCNE1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2730656; DOI=10.1016/0006-291X(89)91577-5;
RA   Murai T., Kakizuka A., Takumi T., Ohkubo H., Nakanishi S.;
RT   "Molecular cloning and sequence analysis of human genomic DNA encoding
RT   a novel membrane protein which exhibits a slowly activating potassium
RT   channel activity.";
RL   Biochem. Biophys. Res. Commun. 161:176-181(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLY-38.
RC   TISSUE=Leukocyte;
RX   PubMed=7828904; DOI=10.1016/0378-1119(94)90685-8;
RA   Lai L.P., Deng C.L., Moss A.J., Kass R.S., Liang C.S.;
RT   "Polymorphism of the gene encoding a human minimal potassium ion
RT   channel (minK).";
RL   Gene 151:339-340(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cornea;
RA   Rae J.L.;
RT   "Delayed rectifier potassium channel subunit from human cornea
RT   epithelium.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS HIS-32 AND
RP   GLY-38.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=9312006; DOI=10.1093/emboj/16.17.5472;
RA   Chouabe C., Neyroud N., Guicheney P., Lazdunski M., Romey G.,
RA   Barhanin J.;
RT   "Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell
RT   and Lange-Nielsen inherited cardiac arrhythmias.";
RL   EMBO J. 16:5472-5479(1997).
RN   [7]
RP   INTERACTION WITH KCNH2.
RX   PubMed=9230439; DOI=10.1038/40882;
RA   McDonald T.V., Yu Z., Ming Z., Palma E., Meyers M.B., Wang K.-W.,
RA   Goldstein S.A.N., Fishman G.I.;
RT   "A minK-HERG complex regulates the cardiac potassium current I(Kr).";
RL   Nature 388:289-292(1997).
RN   [8]
RP   MUTAGENESIS OF LYS-69.
RX   PubMed=11874988; DOI=10.1096/fj.01-0520hyp;
RA   Abbott G.W., Goldstein S.A.N.;
RT   "Disease-associated mutations in KCNE potassium channel subunits
RT   (MiRPs) reveal promiscuous disruption of multiple currents and
RT   conservation of mechanism.";
RL   FASEB J. 16:390-400(2002).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19219384; DOI=10.1007/s00232-009-9154-8;
RA   McCrossan Z.A., Roepke T.K., Lewis A., Panaghie G., Abbott G.W.;
RT   "Regulation of the Kv2.1 potassium channel by MinK and MiRP1.";
RL   J. Membr. Biol. 228:1-14(2009).
RN   [10]
RP   INTERACTION WITH KCNQ1, AND SUBCELLULAR LOCATION.
RX   PubMed=20533308; DOI=10.1002/jcp.22265;
RA   Roura-Ferrer M., Sole L., Oliveras A., Dahan R., Bielanska J.,
RA   Villarroel A., Comes N., Felipe A.;
RT   "Impact of KCNE subunits on KCNQ1 (Kv7.1) channel membrane surface
RT   targeting.";
RL   J. Cell. Physiol. 225:692-700(2010).
RN   [11]
RP   GLYCOSYLATION AT ASN-5 AND ASN-26, AND CHARACTERIZATION OF VARIANT
RP   JLNS2 ILE-7.
RX   PubMed=21676880; DOI=10.1074/jbc.M111.235168;
RA   Bas T., Gao G.Y., Lvov A., Chandrasekhar K.D., Gilmore R.,
RA   Kobertz W.R.;
RT   "Post-translational N-glycosylation of type I transmembrane KCNE1
RT   peptides: implications for membrane protein biogenesis and disease.";
RL   J. Biol. Chem. 286:28150-28159(2011).
RN   [12]
RP   GLYCOSYLATION AT ASN-5 AND THR-7, AND MUTAGENESIS OF ASN-5; THR-6;
RP   THR-7 AND SER-28.
RX   PubMed=21669976; DOI=10.1113/jphysiol.2011.211284;
RA   Chandrasekhar K.D., Lvov A., Terrenoire C., Gao G.Y., Kass R.S.,
RA   Kobertz W.R.;
RT   "O-glycosylation of the cardiac I(Ks) complex.";
RL   J. Physiol. (Lond.) 589:3721-3730(2011).
RN   [13]
RP   STRUCTURE BY NMR.
RX   PubMed=18611041; DOI=10.1021/bi800875q;
RA   Kang C., Tian C., Soennichsen F.D., Smith J.A., Meiler J.,
RA   George A.L. Jr., Vanoye C.G., Kim H.J., Sanders C.R.;
RT   "Structure of KCNE1 and implications for how it modulates the KCNQ1
RT   potassium channel.";
RL   Biochemistry 47:7999-8006(2008).
RN   [14]
RP   VARIANT ASN-85.
RX   PubMed=8899564; DOI=10.1006/jmcc.1996.0198;
RA   Tesson F., Donger C., Denjoy I., Berthet M., Bennaceur M., Petit C.,
RA   Coumel P., Schwartz K., Guicheney P.;
RT   "Exclusion of KCNE1 (IsK) as a candidate gene for Jervell and Lange-
RT   Nielsen syndrome.";
RL   J. Mol. Cell. Cardiol. 28:2051-2055(1996).
RN   [15]
RP   VARIANT JLNS2 58-PRO-PRO-59.
RX   PubMed=9328483; DOI=10.1093/hmg/6.12.2179;
RA   Tyson J., Tranebjaerg L., Bellman S., Wren C., Taylor J.F.N.,
RA   Bathen J., Aslaksen B., Soerland S.J., Lund O., Malcolm S.,
RA   Pembrey M., Bhattacharya S., Bitner-Glindzicz M.;
RT   "IsK and KvLQT1: mutation in either of the two subunits of the slow
RT   component of the delayed rectifier potassium channel can cause Jervell
RT   and Lange-Nielsen syndrome.";
RL   Hum. Mol. Genet. 6:2179-2185(1997).
RN   [16]
RP   VARIANTS JLNS2 ILE-7 AND ASN-76.
RX   PubMed=9354783; DOI=10.1038/ng1197-267;
RA   Schulze-Bahr E., Wang Q., Wedekind H., Haverkamp W., Chen Q., Sun Y.,
RA   Rubie C., Hordt M., Towbin J.A., Borggrefe M., Assmann G., Qu X.,
RA   Somberg J.C., Breithardt G., Oberti C., Funke H.;
RT   "KCNE1 mutations cause Jervell and Lange-Nielsen syndrome.";
RL   Nat. Genet. 17:267-268(1997).
RN   [17]
RP   VARIANTS LQT5 LEU-74 AND ASN-76.
RX   PubMed=9354802; DOI=10.1038/ng1197-338;
RA   Splawski I., Tristani-Firouzi M., Lehmann M.H., Sanguinetti M.C.,
RA   Keating M.T.;
RT   "Mutations in the hminK gene cause long QT syndrome and suppress IKs
RT   function.";
RL   Nat. Genet. 17:338-340(1997).
RN   [18]
RP   VARIANT LQT5 ASN-76.
RX   PubMed=9445165; DOI=10.1161/01.CIR.97.2.142;
RA   Duggal P., Vesely M.R., Wattanasirichaigoon D., Villafane J.,
RA   Kaushik V., Beggs A.H.;
RT   "Mutation of the gene for IsK associated with both Jervell and Lange-
RT   Nielsen and Romano-Ward forms of Long-QT syndrome.";
RL   Circulation 97:142-146(1998).
RN   [19]
RP   VARIANTS JLNS2 PHE-47; HIS-51 AND ASN-76, AND VARIANT LQT5 ARG-87.
RX   PubMed=10400998; DOI=10.1093/hmg/8.8.1499;
RA   Bianchi L., Shen Z., Dennis A.T., Priori S.G., Napolitano C.,
RA   Ronchetti E., Bryskin R., Schwartz P.J., Brown A.M.;
RT   "Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr
RT   and trafficking in long QT syndrome.";
RL   Hum. Mol. Genet. 8:1499-1507(1999).
RN   [20]
RP   VARIANTS LQT5 HIS-32; TRP-98 AND THR-127.
RX   PubMed=10973849; DOI=10.1161/01.CIR.102.10.1178;
RA   Splawski I., Shen J., Timothy K.W., Lehmann M.H., Priori S.G.,
RA   Robinson J.L., Moss A.J., Schwartz P.J., Towbin J.A., Vincent G.M.,
RA   Keating M.T.;
RT   "Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A,
RT   KCNE1, and KCNE2.";
RL   Circulation 102:1178-1185(2000).
RN   [21]
RP   VARIANT LQT5 ILE-109.
RX   PubMed=11692163; DOI=10.1007/s001090100249;
RA   Schulze-Bahr E., Schwarz M., Hauenschild S., Wedekind H., Funke H.,
RA   Haverkamp W., Breithardt W., Pongs O., Isbrandt D., Breithardt G.;
RT   "A novel long-QT 5 gene mutation in the C-terminus (V109I) is
RT   associated with a mild phenotype.";
RL   J. Mol. Med. 79:504-509(2001).
RN   [22]
RP   VARIANT ASN-85.
RX   PubMed=15051636; DOI=10.1161/01.CIR.0000125524.34234.13;
RA   Westenskow P., Splawski I., Timothy K.W., Keating M.T.,
RA   Sanguinetti M.C.;
RT   "Compound mutations: a common cause of severe long-QT syndrome.";
RL   Circulation 109:1834-1841(2004).
RN   [23]
RP   VARIANTS LQT5 HIS-36 AND SER-53.
RX   PubMed=16414944; DOI=10.1001/jama.294.23.2975;
RA   Napolitano C., Priori S.G., Schwartz P.J., Bloise R., Ronchetti E.,
RA   Nastoli J., Bottelli G., Cerrone M., Leonardi S.;
RT   "Genetic testing in the long QT syndrome: development and validation
RT   of an efficient approach to genotyping in clinical practice.";
RL   JAMA 294:2975-2980(2005).
RN   [24]
RP   VARIANTS GLY-38 AND ASN-85, AND CHARACTERIZATION OF VARIANT ASN-85.
RX   PubMed=16823764; DOI=10.1002/humu.20360;
RA   Van Laer L., Carlsson P.-I., Ottschytsch N., Bondeson M.-L.,
RA   Konings A., Vandevelde A., Dieltjens N., Fransen E., Snyders D.,
RA   Borg E., Raes A., Van Camp G.;
RT   "The contribution of genes involved in potassium-recycling in the
RT   inner ear to noise-induced hearing loss.";
RL   Hum. Mutat. 27:786-795(2006).
RN   [25]
RP   VARIANTS LQT5 VAL-8; MET-10; LEU-28; HIS-32; SER-55; PRO-58; PRO-59;
RP   CYS-67; HIS-67; MET-70; ASN-76; LYS-83 AND MET-125.
RX   PubMed=19716085; DOI=10.1016/j.hrthm.2009.05.021;
RA   Kapplinger J.D., Tester D.J., Salisbury B.A., Carr J.L.,
RA   Harris-Kerr C., Pollevick G.D., Wilde A.A., Ackerman M.J.;
RT   "Spectrum and prevalence of mutations from the first 2,500 consecutive
RT   unrelated patients referred for the FAMILION long QT syndrome genetic
RT   test.";
RL   Heart Rhythm 6:1297-1303(2009).
RN   [26]
RP   CHARACTERIZATION OF VARIANTS LQT5 ILE-109 AND THR-127, AND MUTAGENESIS
RP   OF 109-VAL--PRO-129.
RX   PubMed=25037568; DOI=10.1242/jcs.147033;
RA   Dvir M., Strulovich R., Sachyani D., Ben-Tal Cohen I., Haitin Y.,
RA   Dessauer C., Pongs O., Kass R., Hirsch J.A., Attali B.;
RT   "Long QT mutations at the interface between KCNQ1 helix C and KCNE1
RT   disrupt I(KS) regulation by PKA and PIP(2).";
RL   J. Cell Sci. 127:3943-3955(2014).
CC   -!- FUNCTION: Ancillary protein that assembles as a beta subunit with
CC       a voltage-gated potassium channel complex of pore-forming alpha
CC       subunits. Modulates the gating kinetics and enhances stability of
CC       the channel complex. Assembled with KCNB1 modulates the gating
CC       characteristics of the delayed rectifier voltage-dependent
CC       potassium channel KCNB1 (PubMed:19219384). Assembled with
CC       KCNQ1/KVLQT1 is proposed to form the slowly activating delayed
CC       rectifier cardiac potassium (IKs) channel. The outward current
CC       reaches its steady state only after 50 seconds. Assembled with
CC       KCNH2/HERG may modulate the rapidly activating component of the
CC       delayed rectifying potassium current in heart (IKr).
CC       {ECO:0000269|PubMed:19219384}.
CC   -!- SUBUNIT: Interacts with KCNB1. Interacts with KCNC2 (By
CC       similarity). Associates with KCNH2/HERG (PubMed:9230439).
CC       Interacts with KNCQ1; targets the complex KNCQ1-KCNE1 to the
CC       membrane raft (PubMed:20533308). {ECO:0000250|UniProtKB:P15383,
CC       ECO:0000269|PubMed:20533308, ECO:0000269|PubMed:9230439}.
CC   -!- INTERACTION:
CC       P51787:KCNQ1; NbExp=4; IntAct=EBI-7043557, EBI-359667;
CC       A6HIS0:Tcap (xeno); NbExp=3; IntAct=EBI-7043557, EBI-8784724;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19219384};
CC       Single-pass type I membrane protein {ECO:0000305}. Apical cell
CC       membrane {ECO:0000250|UniProtKB:P15383}. Membrane raft
CC       {ECO:0000269|PubMed:20533308}. Note=Colocalizes with KCNB1 at the
CC       plasma membrane (By similarity). Targets to the membrane raft when
CC       associated with KNCQ1 (PubMed:20533308).
CC       {ECO:0000250|UniProtKB:P15383, ECO:0000269|PubMed:20533308}.
CC   -!- TISSUE SPECIFICITY: Expressed in lung, kidney, testis, ovaries,
CC       small intestine, peripheral blood leukocytes. Expressed in the
CC       heart (PubMed:19219384). Not detected in pancreas, spleen,
CC       prostate and colon. Restrictively localized in the apical membrane
CC       portion of epithelial cells. {ECO:0000269|PubMed:19219384,
CC       ECO:0000269|PubMed:9312006}.
CC   -!- PTM: Phosphorylation inhibits the potassium current.
CC       {ECO:0000250}.
CC   -!- PTM: N-glycosylation at Asn-26 occurs post-translationally, and
CC       requires prior cotranslational glycosylation at Asn-5.
CC       {ECO:0000269|PubMed:21669976, ECO:0000269|PubMed:21676880}.
CC   -!- DISEASE: Jervell and Lange-Nielsen syndrome 2 (JLNS2)
CC       [MIM:612347]: An autosomal recessive disorder characterized by
CC       congenital deafness, prolongation of the QT interval, syncopal
CC       attacks due to ventricular arrhythmias, and a high risk of sudden
CC       death. {ECO:0000269|PubMed:10400998, ECO:0000269|PubMed:21676880,
CC       ECO:0000269|PubMed:9328483, ECO:0000269|PubMed:9354783}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Long QT syndrome 5 (LQT5) [MIM:613695]: A heart disorder
CC       characterized by a prolonged QT interval on the ECG and
CC       polymorphic ventricular arrhythmias. They cause syncope and sudden
CC       death in response to exercise or emotional stress, and can present
CC       with a sentinel event of sudden cardiac death in infancy.
CC       {ECO:0000269|PubMed:10400998, ECO:0000269|PubMed:10973849,
CC       ECO:0000269|PubMed:11692163, ECO:0000269|PubMed:16414944,
CC       ECO:0000269|PubMed:19716085, ECO:0000269|PubMed:25037568,
CC       ECO:0000269|PubMed:9354802, ECO:0000269|PubMed:9445165}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel KCNE family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH36452.1; Type=Erroneous termination; Positions=106; Note=Translated as Cys.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M26685; AAA36129.1; -; Genomic_DNA.
DR   EMBL; L33815; AAA63905.1; -; Genomic_DNA.
DR   EMBL; L28168; AAA58418.1; -; mRNA.
DR   EMBL; AF135188; AAD25096.1; -; mRNA.
DR   EMBL; DQ784803; ABQ01238.1; -; Genomic_DNA.
DR   EMBL; BC036452; AAH36452.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS13636.1; -.
DR   PIR; A32447; A32447.
DR   RefSeq; NP_000210.2; NM_000219.5.
DR   RefSeq; NP_001121140.1; NM_001127668.3.
DR   RefSeq; NP_001121141.1; NM_001127669.3.
DR   RefSeq; NP_001121142.1; NM_001127670.3.
DR   RefSeq; NP_001257331.1; NM_001270402.2.
DR   RefSeq; NP_001257332.1; NM_001270403.2.
DR   RefSeq; NP_001257333.1; NM_001270404.2.
DR   RefSeq; NP_001257334.1; NM_001270405.2.
DR   UniGene; Hs.121495; -.
DR   UniGene; Hs.745384; -.
DR   PDB; 2K21; NMR; -; A=1-129.
DR   PDBsum; 2K21; -.
DR   DisProt; DP00796; -.
DR   ProteinModelPortal; P15382; -.
DR   SMR; P15382; -.
DR   BioGrid; 109955; 23.
DR   CORUM; P15382; -.
DR   IntAct; P15382; 4.
DR   MINT; MINT-7297782; -.
DR   STRING; 9606.ENSP00000337255; -.
DR   BindingDB; P15382; -.
DR   ChEMBL; CHEMBL4872; -.
DR   DrugBank; DB04957; Azimilide.
DR   DrugBank; DB00808; Indapamide.
DR   iPTMnet; P15382; -.
DR   PhosphoSitePlus; P15382; -.
DR   BioMuta; KCNE1; -.
DR   DMDM; 116416; -.
DR   PaxDb; P15382; -.
DR   PRIDE; P15382; -.
DR   DNASU; 3753; -.
DR   Ensembl; ENST00000337385; ENSP00000337255; ENSG00000180509.
DR   Ensembl; ENST00000399284; ENSP00000382225; ENSG00000180509.
DR   Ensembl; ENST00000399286; ENSP00000382226; ENSG00000180509.
DR   Ensembl; ENST00000399289; ENSP00000382228; ENSG00000180509.
DR   Ensembl; ENST00000416357; ENSP00000416258; ENSG00000180509.
DR   Ensembl; ENST00000432085; ENSP00000412498; ENSG00000180509.
DR   Ensembl; ENST00000611936; ENSP00000478215; ENSG00000180509.
DR   Ensembl; ENST00000621601; ENSP00000483895; ENSG00000180509.
DR   GeneID; 3753; -.
DR   KEGG; hsa:3753; -.
DR   UCSC; uc002ytz.5; human.
DR   CTD; 3753; -.
DR   DisGeNET; 3753; -.
DR   EuPathDB; HostDB:ENSG00000180509.11; -.
DR   GeneCards; KCNE1; -.
DR   GeneReviews; KCNE1; -.
DR   HGNC; HGNC:6240; KCNE1.
DR   MalaCards; KCNE1; -.
DR   MIM; 176261; gene.
DR   MIM; 612347; phenotype.
DR   MIM; 613695; phenotype.
DR   neXtProt; NX_P15382; -.
DR   OpenTargets; ENSG00000180509; -.
DR   Orphanet; 334; Familial atrial fibrillation.
DR   Orphanet; 90647; Jervell and Lange-Nielsen syndrome.
DR   Orphanet; 101016; Romano-Ward syndrome.
DR   PharmGKB; PA211; -.
DR   eggNOG; ENOG410IY71; Eukaryota.
DR   eggNOG; ENOG410Y1SF; LUCA.
DR   GeneTree; ENSGT00510000048994; -.
DR   HOGENOM; HOG000113207; -.
DR   HOVERGEN; HBG052226; -.
DR   InParanoid; P15382; -.
DR   KO; K04894; -.
DR   OMA; ALYILMV; -.
DR   OrthoDB; EOG091G0UDJ; -.
DR   PhylomeDB; P15382; -.
DR   TreeFam; TF335976; -.
DR   Reactome; R-HSA-5576890; Phase 3 - rapid repolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   SIGNOR; P15382; -.
DR   ChiTaRS; KCNE1; human.
DR   EvolutionaryTrace; P15382; -.
DR   GeneWiki; KCNE1; -.
DR   GenomeRNAi; 3753; -.
DR   PRO; PR:P15382; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000180509; -.
DR   CleanEx; HS_KCNE1; -.
DR   ExpressionAtlas; P15382; baseline and differential.
DR   Genevisible; P15382; HS.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0030018; C:Z disc; ISS:BHF-UCL.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:UniProtKB.
DR   GO; GO:0031433; F:telethonin binding; IPI:BHF-UCL.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:BHF-UCL.
DR   GO; GO:0086009; P:membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:0086011; P:membrane repolarization during action potential; IDA:BHF-UCL.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IDA:BHF-UCL.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:1902260; P:negative regulation of delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0090315; P:negative regulation of protein targeting to membrane; ISS:BHF-UCL.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0071435; P:potassium ion export; IDA:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0006487; P:protein N-linked glycosylation; IDA:UniProtKB.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0007605; P:sensory perception of sound; TAS:ProtInc.
DR   GO; GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   InterPro; IPR000369; K_chnl_KCNE.
DR   InterPro; IPR005424; K_chnl_volt-dep_bsu_KCNE1.
DR   PANTHER; PTHR15282; PTHR15282; 1.
DR   Pfam; PF02060; ISK_Channel; 1.
DR   PRINTS; PR01604; KCNE1CHANNEL.
DR   PRINTS; PR00168; KCNECHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Deafness;
KW   Disease mutation; Glycoprotein; Ion channel; Ion transport;
KW   Long QT syndrome; Membrane; Phosphoprotein; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    129       Potassium voltage-gated channel subfamily
FT                                E member 1.
FT                                /FTId=PRO_0000144278.
FT   TRANSMEM     44     66       Helical. {ECO:0000255}.
FT   TOPO_DOM     67    129       Cytoplasmic. {ECO:0000255}.
FT   REGION      109    129       interaction with KCNQ1 C-terminus.
FT                                {ECO:0000269|PubMed:25037568}.
FT   MOD_RES     102    102       Phosphoserine; by PKC. {ECO:0000250}.
FT   CARBOHYD      5      5       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21669976,
FT                                ECO:0000269|PubMed:21676880}.
FT   CARBOHYD      7      7       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:21669976}.
FT   CARBOHYD     26     26       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21676880}.
FT   VARIANT       7      7       T -> I (in JLNS2; impairs glycosylation
FT                                at N-5; dbSNP:rs28933384).
FT                                {ECO:0000269|PubMed:21676880,
FT                                ECO:0000269|PubMed:9354783}.
FT                                /FTId=VAR_008897.
FT   VARIANT       8      8       A -> V (in LQT5; unknown pathological
FT                                significance; dbSNP:rs199473348).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074908.
FT   VARIANT      10     10       T -> M (in LQT5; unknown pathological
FT                                significance; dbSNP:rs144917638).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074909.
FT   VARIANT      28     28       S -> L (in LQT5; unknown pathological
FT                                significance; dbSNP:rs199473350).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074910.
FT   VARIANT      32     32       R -> H (in LQT5; unknown pathological
FT                                significance; dbSNP:rs17857111).
FT                                {ECO:0000269|PubMed:10973849,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009906.
FT   VARIANT      36     36       R -> H (in LQT5; unknown pathological
FT                                significance; dbSNP:rs199473351).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074911.
FT   VARIANT      38     38       S -> G (in dbSNP:rs1805127).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16823764,
FT                                ECO:0000269|PubMed:7828904}.
FT                                /FTId=VAR_001558.
FT   VARIANT      47     47       V -> F (in JLNS2; dbSNP:rs199473353).
FT                                {ECO:0000269|PubMed:10400998}.
FT                                /FTId=VAR_008898.
FT   VARIANT      51     51       L -> H (in JLNS2).
FT                                {ECO:0000269|PubMed:10400998}.
FT                                /FTId=VAR_008899.
FT   VARIANT      52     52       G -> A (in dbSNP:rs17173509).
FT                                /FTId=VAR_048024.
FT   VARIANT      53     53       F -> S (in LQT5; unknown pathological
FT                                significance; dbSNP:rs199473355).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074912.
FT   VARIANT      55     55       G -> S (in LQT5; unknown pathological
FT                                significance; dbSNP:rs199473644).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074913.
FT   VARIANT      58     59       TL -> PP (in JLNS2; dbSNP:rs281865421).
FT                                /FTId=VAR_001559.
FT   VARIANT      58     58       T -> P (in LQT5; unknown pathological
FT                                significance; dbSNP:rs147187721).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074914.
FT   VARIANT      59     59       L -> P (in LQT5; unknown pathological
FT                                significance; dbSNP:rs141813529).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074915.
FT   VARIANT      67     67       R -> C (in LQT5; unknown pathological
FT                                significance; dbSNP:rs199473645).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074916.
FT   VARIANT      67     67       R -> H (in LQT5; unknown pathological
FT                                significance; dbSNP:rs79654911).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074917.
FT   VARIANT      70     70       K -> M (in LQT5; unknown pathological
FT                                significance; dbSNP:rs199473646).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074918.
FT   VARIANT      74     74       S -> L (in LQT5; dbSNP:rs74315446).
FT                                {ECO:0000269|PubMed:9354802}.
FT                                /FTId=VAR_008900.
FT   VARIANT      76     76       D -> N (in LQT5 and JLNS2; suppresses
FT                                KCNQ1 currents markedly;
FT                                dbSNP:rs74315445).
FT                                {ECO:0000269|PubMed:10400998,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9354783,
FT                                ECO:0000269|PubMed:9354802,
FT                                ECO:0000269|PubMed:9445165}.
FT                                /FTId=VAR_008901.
FT   VARIANT      83     83       E -> K (in LQT5; unknown pathological
FT                                significance; dbSNP:rs199473360).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074919.
FT   VARIANT      85     85       D -> N (predisposes to acquired LQT5
FT                                susceptibility; shows a significant
FT                                difference in current density and
FT                                midpoint potential compared to the wild-
FT                                type channel; dbSNP:rs1805128).
FT                                {ECO:0000269|PubMed:15051636,
FT                                ECO:0000269|PubMed:16823764,
FT                                ECO:0000269|PubMed:8899564}.
FT                                /FTId=VAR_008902.
FT   VARIANT      87     87       W -> R (in LQT5; dbSNP:rs199473361).
FT                                {ECO:0000269|PubMed:10400998}.
FT                                /FTId=VAR_008903.
FT   VARIANT      98     98       R -> W (in LQT5; dbSNP:rs199473362).
FT                                {ECO:0000269|PubMed:10973849}.
FT                                /FTId=VAR_009907.
FT   VARIANT     109    109       V -> I (in LQT5; mild phenotype; no
FT                                effect on KCNQ1 C-terminus interaction;
FT                                increases cAMP-mediated up-regulation of
FT                                the I(KS) current; no effect on
FT                                phosphorylation at S27;
FT                                dbSNP:rs77442996).
FT                                {ECO:0000269|PubMed:11692163,
FT                                ECO:0000269|PubMed:25037568}.
FT                                /FTId=VAR_012802.
FT   VARIANT     125    125       T -> M (in LQT5; unknown pathological
FT                                significance; dbSNP:rs142511345).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074920.
FT   VARIANT     127    127       P -> T (in LQT5; moderately reduces I(KS)
FT                                current density; no change of the voltage
FT                                dependence of channel activation;
FT                                markedly reduces interaction with KCNQ1
FT                                C-terminus; no effect on plasma membrane
FT                                localization; loss of cAMP-mediated up-
FT                                regulation of the I(KS) current; no
FT                                effect on interaction with AKAP9; impairs
FT                                phosphorylation at S-27 during cAMP-
FT                                dependent stimulation;
FT                                dbSNP:rs199473647).
FT                                {ECO:0000269|PubMed:10973849,
FT                                ECO:0000269|PubMed:25037568}.
FT                                /FTId=VAR_009908.
FT   MUTAGEN       5      5       N->Q: No measurable effect on assembly
FT                                with KCNQ1 or cell surface expression of
FT                                the KCNE1/KCNQ1 channel complex, and loss
FT                                of glycosylation at N-5; when associated
FT                                with T-28. {ECO:0000269|PubMed:21669976}.
FT   MUTAGEN       6      6       T->F: No measurable effect on assembly
FT                                with KCNQ1 or cell surface expression of
FT                                the KCNE1/KCNQ1 channel complex. Loss of
FT                                glycosylation at T-7.
FT                                {ECO:0000269|PubMed:21669976}.
FT   MUTAGEN       7      7       T->A: 50% reduction of cell surface
FT                                expression of the KCNE1/KCNQ1 channel
FT                                complex, and loss of glycosylation at N-5
FT                                and T-7; when associated with T-28.
FT                                {ECO:0000269|PubMed:21669976}.
FT   MUTAGEN      28     28       S->T: No measurable effect on assembly
FT                                with KCNQ1 or cell surface expression of
FT                                the KCNE1/KCNQ1 channel complex, and loss
FT                                of glycosylation at N-5; when associated
FT                                with Q-5. 50% reduction of cell surface
FT                                expression of the KCNE1/KCNQ1 channel
FT                                complex, and loss of glycosylation at N-5
FT                                and T-7; when associated with A-7.
FT                                {ECO:0000269|PubMed:21669976}.
FT   MUTAGEN      69     69       K->H: Lowers current 2-fold and leads to
FT                                faster deactivation of KCNQ1/KCNE1
FT                                channel. {ECO:0000269|PubMed:11874988}.
FT   MUTAGEN     109    129       Missing: Totally suppressed interaction
FT                                with KCNQ1 C-terminus.
FT                                {ECO:0000269|PubMed:25037568}.
FT   HELIX         4      9       {ECO:0000244|PDB:2K21}.
FT   HELIX        13     22       {ECO:0000244|PDB:2K21}.
FT   HELIX        30     32       {ECO:0000244|PDB:2K21}.
FT   HELIX        46     71       {ECO:0000244|PDB:2K21}.
FT   TURN         77     81       {ECO:0000244|PDB:2K21}.
FT   TURN         84     86       {ECO:0000244|PDB:2K21}.
FT   HELIX        92    105       {ECO:0000244|PDB:2K21}.
FT   STRAND      114    116       {ECO:0000244|PDB:2K21}.
SQ   SEQUENCE   129 AA;  14675 MW;  5442D70929D4E87E CRC64;
     MILSNTTAVT PFLTKLWQET VQQGGNMSGL ARRSPRSSDG KLEALYVLMV LGFFGFFTLG
     IMLSYIRSKK LEHSNDPFNV YIESDAWQEK DKAYVQARVL ESYRSCYVVE NHLAIEQPNT
     HLPETKPSP
//
ID   KCNE1_RAT               Reviewed;         130 AA.
AC   P15383;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   22-NOV-2017, entry version 131.
DE   RecName: Full=Potassium voltage-gated channel subfamily E member 1;
DE   AltName: Full=Delayed rectifier potassium channel subunit IsK;
DE   AltName: Full=IKs producing slow voltage-gated potassium channel subunit beta Mink;
DE   AltName: Full=Minimal potassium channel;
GN   Name=Kcne1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=3194754; DOI=10.1126/science.3194754;
RA   Takumi T., Ohkubo H., Nakanishi S.;
RT   "Cloning of a membrane protein that induces a slow voltage-gated
RT   potassium current.";
RL   Science 242:1042-1045(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=2183220; DOI=10.1073/pnas.87.8.2975;
RA   Folander K., Smith J.S., Antanavage J., Bennett C., Stein R.B.,
RA   Swanson R.;
RT   "Cloning and expression of the delayed-rectifier IsK channel from
RT   neonatal rat heart and diethylstilbestrol-primed rat uterus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2975-2979(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE, INDUCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Uterus;
RX   PubMed=2344412; DOI=10.1016/0896-6273(90)90207-V;
RA   Pragnell M., Snay K.J., Trimmer J.S., Maclusky N.J., Naftolin F.,
RA   Kaczmarek L.K., Boyle M.B.;
RT   "Estrogen induction of a small, putative K+ channel mRNA in rat
RT   uterus.";
RL   Neuron 4:807-812(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=2229022;
RA   Iwai M., Masu M., Tsuchida K., Mori T., Ohkubo H., Nakanishi S.;
RT   "Characterization of gene organization and generation of heterogeneous
RT   mRNA species of rat ISK protein.";
RL   J. Biochem. 108:200-206(1990).
RN   [5]
RP   MUTAGENESIS OF SER-103.
RX   PubMed=1553557; DOI=10.1126/science.1553557;
RA   Busch A.E., Varnum M.D., North R.A., Adelman J.P.;
RT   "An amino acid mutation in a potassium channel that prevents
RT   inhibition by protein kinase C.";
RL   Science 255:1705-1707(1992).
RN   [6]
RP   MUTAGENESIS OF ASP-77.
RX   PubMed=7605639; DOI=10.1016/0896-6273(95)90277-5;
RA   Wang K.-W., Goldstein S.A.N.;
RT   "Subunit composition of minK potassium channels.";
RL   Neuron 14:1303-1309(1995).
RN   [7]
RP   SUBUNIT, INTERACTION WITH KCNC2, AND SUBCELLULAR LOCATION.
RX   PubMed=14679187; DOI=10.1074/jbc.M310501200;
RA   Lewis A., McCrossan Z.A., Abbott G.W.;
RT   "MinK, MiRP1, and MiRP2 diversify Kv3.1 and Kv3.2 potassium channel
RT   gating.";
RL   J. Biol. Chem. 279:7884-7892(2004).
RN   [8]
RP   FUNCTION, INTERACTION WITH KCNB1, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=19219384; DOI=10.1007/s00232-009-9154-8;
RA   McCrossan Z.A., Roepke T.K., Lewis A., Panaghie G., Abbott G.W.;
RT   "Regulation of the Kv2.1 potassium channel by MinK and MiRP1.";
RL   J. Membr. Biol. 228:1-14(2009).
CC   -!- FUNCTION: Ancillary protein that assembles as a beta subunit with
CC       a voltage-gated potassium channel complex of pore-forming alpha
CC       subunits. Modulates the gating kinetics and enhances stability of
CC       the channel complex. Assembled with KCNB1 modulates the gating
CC       characteristics of the delayed rectifier voltage-dependent
CC       potassium channel KCNB1 (PubMed:19219384). Assembled with
CC       KCNQ1/KVLQT1 is proposed to form the slowly activating delayed
CC       rectifier cardiac potassium (IKs) channel. The outward current
CC       reaches its steady state only after 50 seconds. Assembled with
CC       KCNH2/HERG may modulate the rapidly activating component of the
CC       delayed rectifying potassium current in heart (IKr) (By
CC       similarity). {ECO:0000250|UniProtKB:P15382,
CC       ECO:0000269|PubMed:19219384}.
CC   -!- SUBUNIT: Interacts with KCNB1 (PubMed:19219384). Interacts with
CC       KCNC2 (PubMed:14679187). Associates with KCNH2/HERG (By
CC       similarity). Interacts with KNCQ1; targets the complex KNCQ1-KCNE1
CC       to the membrane raft (By similarity).
CC       {ECO:0000250|UniProtKB:P15382, ECO:0000250|UniProtKB:P23299,
CC       ECO:0000269|PubMed:14679187, ECO:0000269|PubMed:19219384}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14679187,
CC       ECO:0000269|PubMed:19219384}; Single-pass type I membrane protein
CC       {ECO:0000305}. Apical cell membrane {ECO:0000269|PubMed:19219384}.
CC       Membrane raft {ECO:0000250|UniProtKB:P15382}. Note=Colocalizes
CC       with KCNB1 at the plasma membrane. Restrictively localized in the
CC       apical membrane portion of epithelial cells. Targets to the
CC       membrane raft when associated with KNCQ1 (By similarity).
CC       {ECO:0000250|UniProtKB:P15382, ECO:0000269|PubMed:19219384}.
CC   -!- TISSUE SPECIFICITY: Expressed in the heart (PubMed:2183220,
CC       PubMed:19219384). Expressed in kidney (PubMed:2344412). Expressed
CC       in estrogen-induced uterus (PubMed:2344412).
CC       {ECO:0000269|PubMed:19219384, ECO:0000269|PubMed:2183220,
CC       ECO:0000269|PubMed:2344412}.
CC   -!- INDUCTION: By estrogen. {ECO:0000269|PubMed:2344412}.
CC   -!- PTM: Phosphorylation inhibits the potassium current.
CC   -!- PTM: N-glycosylation at Asn-26 occurs post-translationally, and
CC       requires prior cotranslational glycosylation at Asn-5.
CC       {ECO:0000250}.
CC   -!- MISCELLANEOUS: Mutagenesis experiments were carried out by
CC       expressing in Xenopus oocytes the mutant Asn-77 either
CC       individually (homomultimers) or in combination with wild-type
CC       KCNE1 (heteromultimers) in a 1:1 ratio (PubMed:7605639).
CC       {ECO:0000269|PubMed:7605639}.
CC   -!- SIMILARITY: Belongs to the potassium channel KCNE family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M22412; AAA41822.1; -; mRNA.
DR   EMBL; M36461; AAA41098.1; -; mRNA.
DR   EMBL; D10709; BAA01553.1; ALT_SEQ; Genomic_DNA.
DR   PIR; A35633; A35633.
DR   RefSeq; NP_037105.1; NM_012973.1.
DR   RefSeq; XP_006248096.1; XM_006248034.3.
DR   RefSeq; XP_006248097.1; XM_006248035.2.
DR   RefSeq; XP_008766788.1; XM_008768566.2.
DR   RefSeq; XP_017453375.1; XM_017597886.1.
DR   RefSeq; XP_017453376.1; XM_017597887.1.
DR   UniGene; Rn.9734; -.
DR   SMR; P15383; -.
DR   CORUM; P15383; -.
DR   STRING; 10116.ENSRNOP00000002717; -.
DR   TCDB; 8.A.10.1.1; the slow voltage-gated k+) channel accessory protein (mink) family.
DR   iPTMnet; P15383; -.
DR   PhosphoSitePlus; P15383; -.
DR   PaxDb; P15383; -.
DR   Ensembl; ENSRNOT00000002717; ENSRNOP00000002717; ENSRNOG00000001984.
DR   GeneID; 25471; -.
DR   KEGG; rno:25471; -.
DR   UCSC; RGD:2956; rat.
DR   CTD; 3753; -.
DR   RGD; 2956; Kcne1.
DR   eggNOG; ENOG410IY71; Eukaryota.
DR   eggNOG; ENOG410Y1SF; LUCA.
DR   GeneTree; ENSGT00510000048994; -.
DR   HOGENOM; HOG000113207; -.
DR   HOVERGEN; HBG052226; -.
DR   InParanoid; P15383; -.
DR   KO; K04894; -.
DR   OMA; ALYILMV; -.
DR   OrthoDB; EOG091G0UDJ; -.
DR   PhylomeDB; P15383; -.
DR   TreeFam; TF335976; -.
DR   Reactome; R-RNO-5576890; Phase 3 - rapid repolarisation.
DR   Reactome; R-RNO-5576893; Phase 2 - plateau phase.
DR   PRO; PR:P15383; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000001984; -.
DR   Genevisible; P15383; RN.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:RGD.
DR   GO; GO:0005764; C:lysosome; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:RGD.
DR   GO; GO:0030018; C:Z disc; IDA:BHF-UCL.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IMP:RGD.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:RGD.
DR   GO; GO:0031433; F:telethonin binding; ISO:RGD.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:RGD.
DR   GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; ISO:RGD.
DR   GO; GO:0071468; P:cellular response to acidic pH; IDA:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; ISO:RGD.
DR   GO; GO:0071482; P:cellular response to light stimulus; IEP:RGD.
DR   GO; GO:0002070; P:epithelial cell maturation; ISO:RGD.
DR   GO; GO:0060047; P:heart contraction; ISO:RGD.
DR   GO; GO:0008584; P:male gonad development; IEP:RGD.
DR   GO; GO:0086009; P:membrane repolarization; ISO:RGD.
DR   GO; GO:0086011; P:membrane repolarization during action potential; ISO:RGD.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; ISO:RGD.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; ISO:RGD.
DR   GO; GO:1902260; P:negative regulation of delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0090315; P:negative regulation of protein targeting to membrane; IDA:RGD.
DR   GO; GO:1903817; P:negative regulation of voltage-gated potassium channel activity; IDA:RGD.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:RGD.
DR   GO; GO:1901387; P:positive regulation of voltage-gated calcium channel activity; IDA:RGD.
DR   GO; GO:1903818; P:positive regulation of voltage-gated potassium channel activity; IMP:RGD.
DR   GO; GO:0071435; P:potassium ion export; ISO:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0006487; P:protein N-linked glycosylation; ISS:UniProtKB.
DR   GO; GO:0006493; P:protein O-linked glycosylation; ISS:UniProtKB.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; ISO:RGD.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; ISO:RGD.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; ISO:RGD.
DR   GO; GO:0086005; P:ventricular cardiac muscle cell action potential; ISO:RGD.
DR   InterPro; IPR000369; K_chnl_KCNE.
DR   InterPro; IPR005424; K_chnl_volt-dep_bsu_KCNE1.
DR   PANTHER; PTHR15282; PTHR15282; 1.
DR   Pfam; PF02060; ISK_Channel; 1.
DR   PRINTS; PR01604; KCNE1CHANNEL.
DR   PRINTS; PR00168; KCNECHANNEL.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    130       Potassium voltage-gated channel subfamily
FT                                E member 1.
FT                                /FTId=PRO_0000144283.
FT   TRANSMEM     45     67       Helical. {ECO:0000255}.
FT   TOPO_DOM     68    130       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     103    103       Phosphoserine; by PKC. {ECO:0000305}.
FT   CARBOHYD      5      5       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     26     26       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN      77     77       D->N: No current (homomultimers); one
FT                                fourth of the WT current
FT                                (heteromultimers).
FT                                {ECO:0000269|PubMed:7605639}.
FT   MUTAGEN     103    103       S->A: Abolishes inhibition by
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:1553557}.
SQ   SEQUENCE   130 AA;  14699 MW;  76717E7ED73C5E4D CRC64;
     MALSNSTTVL PFLASLWQET DEPGGNMSAD LARRSQLRDD SKLEALYILM VLGFFGFFTL
     GIMLSYIRSK KLEHSHDPFN VYIESDAWQE KGKALFQARV LESFRACYVI ENQAAVEQPA
     THLPELKPLS
//
ID   KCNA3_RAT               Reviewed;         525 AA.
AC   P15384;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 2.
DT   22-NOV-2017, entry version 151.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 3;
DE   AltName: Full=RCK3;
DE   AltName: Full=RGK5;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv3;
GN   Name=Kcna3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=2555158;
RA   Stuehmer W., Ruppersberg J.P., Schroerter K.H., Sakmann B.,
RA   Stocker M., Giese K.P., Perschke A., Baumann A., Pongs O.;
RT   "Molecular basis of functional diversity of voltage-gated potassium
RT   channels in mammalian brain.";
RL   EMBO J. 8:3235-3244(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=2361015; DOI=10.1016/0896-6273(90)90146-7;
RA   Swanson R., Marshall J., Smith J., Williams J., Boyle M.B.,
RA   Folander K., Luneau C.J., Antanavage J., Oliva C., Buhrow S.A.,
RA   Bennett C., Stein R.B., Kaczmarek L.M.;
RT   "Cloning and expression of cDNA and genomic clones encoding three
RT   delayed rectifier potassium channels in rat brain.";
RL   Neuron 4:929-939(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Lymphocyte;
RX   PubMed=2351830;
RA   Douglass J., Osborne P.B., Cai Y.C., Wilkinson M., Christie M.J.,
RA   Adelman J.P.;
RT   "Characterization and functional expression of a rat genomic DNA clone
RT   encoding a lymphocyte potassium channel.";
RL   J. Immunol. 144:4841-4850(1990).
RN   [4]
RP   INTERACTION WITH DLG1; DLG2 AND DLG4.
RX   PubMed=7477295; DOI=10.1038/378085a0;
RA   Kim E., Niethammer M., Rothschild A., Jan Y.N., Sheng M.;
RT   "Clustering of Shaker-type K+ channels by interaction with a family of
RT   membrane-associated guanylate kinases.";
RL   Nature 378:85-88(1995).
RN   [5]
RP   GLYCOSYLATION AT ASN-229, LACK OF GLYCOSYLATION AT ASN-228, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=22613618; DOI=10.1111/j.1742-4658.2012.08642.x;
RA   Zhu J., Yan J., Thornhill W.B.;
RT   "N-glycosylation promotes the cell surface expression of Kv1.3
RT   potassium channels.";
RL   FEBS J. 279:2632-2644(2012).
CC   -!- FUNCTION: Mediates the voltage-dependent potassium ion
CC       permeability of excitable membranes. Assuming opened or closed
CC       conformations in response to the voltage difference across the
CC       membrane, the protein forms a potassium-selective channel through
CC       which potassium ions may pass in accordance with their
CC       electrochemical gradient.
CC   -!- SUBUNIT: Heterotetramer of potassium channel proteins (By
CC       similarity). Binds PDZ domains of DLG1, DLG2 and DLG4.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       P78352:DLG4 (xeno); NbExp=2; IntAct=EBI-631478, EBI-80389;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22613618};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:22613618}.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- PTM: N-glycosylation promotes the cell surface expression.
CC       {ECO:0000269|PubMed:22613618}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.3/KCNA3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16001; CAA34132.1; -; mRNA.
DR   EMBL; M30312; AAA42035.1; -; Genomic_DNA.
DR   EMBL; M31744; AAA41500.1; -; Genomic_DNA.
DR   PIR; A43531; A43531.
DR   RefSeq; NP_062143.3; NM_019270.3.
DR   UniGene; Rn.44292; -.
DR   ProteinModelPortal; P15384; -.
DR   BioGrid; 248344; 1.
DR   IntAct; P15384; 1.
DR   STRING; 10116.ENSRNOP00000024372; -.
DR   ChEMBL; CHEMBL4248; -.
DR   GuidetoPHARMACOLOGY; 540; -.
DR   iPTMnet; P15384; -.
DR   PhosphoSitePlus; P15384; -.
DR   PaxDb; P15384; -.
DR   PRIDE; P15384; -.
DR   Ensembl; ENSRNOT00000092240; ENSRNOP00000075761; ENSRNOG00000062002.
DR   GeneID; 29731; -.
DR   KEGG; rno:29731; -.
DR   UCSC; RGD:2951; rat.
DR   CTD; 3738; -.
DR   RGD; 2951; Kcna3.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; P15384; -.
DR   KO; K04876; -.
DR   OMA; LPRRDFQ; -.
DR   PhylomeDB; P15384; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-RNO-1296072; Voltage gated Potassium channels.
DR   PRO; PR:P15384; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000062002; -.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IMP:RGD.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IMP:RGD.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004050; K_chnl_volt-dep_Kv1.3.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01510; KV13CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Lipoprotein; Membrane; Palmitate; Phosphoprotein;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    525       Potassium voltage-gated channel subfamily
FT                                A member 3.
FT                                /FTId=PRO_0000053979.
FT   TOPO_DOM      1    184       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    185    203       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    204    244       Extracellular. {ECO:0000255}.
FT   TRANSMEM    245    266       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    267    277       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    278    298       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    299    312       Extracellular. {ECO:0000255}.
FT   TRANSMEM    313    331       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    332    347       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    348    367       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    368    408       Extracellular. {ECO:0000255}.
FT   TRANSMEM    409    431       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    432    525       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       394    399       Selectivity filter. {ECO:0000250}.
FT   MOTIF       523    525       PDZ-binding.
FT   SITE        228    228       Not glycosylated.
FT                                {ECO:0000269|PubMed:22613618}.
FT   MOD_RES     470    470       Phosphoserine; by PKA. {ECO:0000255}.
FT   LIPID       267    267       S-palmitoyl cysteine. {ECO:0000255}.
FT   CARBOHYD    229    229       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22613618}.
FT   CONFLICT    106    106       F -> L (in Ref. 1; CAA34132).
FT                                {ECO:0000305}.
FT   CONFLICT    181    181       G -> R (in Ref. 3; AAA42035).
FT                                {ECO:0000305}.
FT   CONFLICT    430    430       V -> L (in Ref. 3; AAA42035).
FT                                {ECO:0000305}.
SQ   SEQUENCE   525 AA;  58425 MW;  6DA8869D5471C401 CRC64;
     MTVVPGDHLL EPEAAGGGGG DPPQGGCVSG GGCDRYEPLP PALPAAGEQD CCGERVVINI
     SGLRFETQLK TLCQFPETLL GDPKRRMRYF DPLRNEYFFD RNRPSFDAIL YYYQSGGRIR
     RPVNVPIDIF SEEIRFYQLG EEAMEKFRED EGFLREEERP LPRRDFQRQV WLLFEYPESS
     GPARGIAIVS VLVILISIVI FCLETLPEFR DEKDYPASPS QDVFEAANNS TSGASSGASS
     FSDPFFVVET LCIIWFSFEL LVRFFACPSK ATFSRNIMNL IDIVAIIPYF ITLGTELAER
     QGNGQQAMSL AILRVIRLVR VFRIFKLSRH SKGLQILGQT LKASMRELGL LIFFLFIGVI
     LFSSAVYFAE ADDPSSGFNS IPDAFWWAVV TMTTVGYGDM HPVTIGGKIV GSLCAIAGVL
     TIALPVPVIV SNFNYFYHRE TEGEEQAQYM HVGSCQHLSS SAEELRKARS NSTLSKSEYM
     VIEEGGMNHS AFPQTPFKTG NSTATCTTNN NPNSCVNIKK IFTDV
//
ID   KCNB1_RAT               Reviewed;         857 AA.
AC   P15387;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2002, sequence version 3.
DT   22-NOV-2017, entry version 154.
DE   RecName: Full=Potassium voltage-gated channel subfamily B member 1 {ECO:0000250|UniProtKB:Q14721};
DE   AltName: Full=Delayed rectifier potassium channel 1 {ECO:0000303|PubMed:2770868};
DE            Short=DRK1 {ECO:0000303|PubMed:2770868};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv2.1;
GN   Name=Kcnb1 {ECO:0000312|RGD:2954};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-857, FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND ENZYME REGULATION.
RC   TISSUE=Brain;
RX   PubMed=2770868; DOI=10.1038/340642a0;
RA   Frech G.C., Vandongen A.M.J., Schuster G., Brown A.M., Joho R.H.;
RT   "A novel potassium channel with delayed rectifier properties isolated
RT   from rat brain by expression cloning.";
RL   Nature 340:642-645(1989).
RN   [2]
RP   SEQUENCE REVISION.
RA   Frech G.C.;
RL   Submitted (FEB-1990) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-575, AND TISSUE SPECIFICITY.
RX   PubMed=1740690;
RA   Drewe J.A., Verma S., Frech G.C., Joho R.H.;
RT   "Distinct spatial and temporal expression patterns of K+ channel mRNAs
RT   from different subfamilies.";
RL   J. Neurosci. 12:538-548(1992).
RN   [4]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=2206531; DOI=10.1016/0896-6273(90)90082-Q;
RA   VanDongen A.M., Frech G.C., Drewe J.A., Joho R.H., Brown A.M.;
RT   "Alteration and restoration of K+ channel function by deletions at the
RT   N- and C-termini.";
RL   Neuron 5:433-443(1990).
RN   [5]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=1875913;
RA   Taglialatela M., Vandongen A.M., Drewe J.A., Joho R.H., Brown A.M.,
RA   Kirsch G.E.;
RT   "Patterns of internal and external tetraethylammonium block in four
RT   homologous K+ channels.";
RL   Mol. Pharmacol. 40:299-307(1991).
RN   [6]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=1961744; DOI=10.1073/pnas.88.23.10764;
RA   Trimmer J.S.;
RT   "Immunological identification and characterization of a delayed
RT   rectifier K+ channel polypeptide in rat brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:10764-10768(1991).
RN   [7]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=8508921; DOI=10.1016/0014-5793(93)81394-F;
RA   Trimmer J.S.;
RT   "Expression of Kv2.1 delayed rectifier K+ channel isoforms in the
RT   developing rat brain.";
RL   FEBS Lett. 324:205-210(1993).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=8463836;
RA   Hwang P.M., Fotuhi M., Bredt D.S., Cunningham A.M., Snyder S.H.;
RT   "Contrasting immunohistochemical localizations in rat brain of two
RT   novel K+ channels of the Shab subfamily.";
RL   J. Neurosci. 13:1569-1576(1993).
RN   [9]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, PHOSPHORYLATION, ENZYME
RP   REGULATION, SUBCELLULAR LOCATION, AND LACK OF GLYCOSYLATION.
RX   PubMed=8083226;
RA   Shi G., Kleinklaus A.K., Marrion N.V., Trimmer J.S.;
RT   "Properties of Kv2.1 K+ channels expressed in transfected mammalian
RT   cells.";
RL   J. Biol. Chem. 269:23204-23211(1994).
RN   [10]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND LACK OF INTERACTION WITH
RP   KCNAB1 AND KCNAB2.
RX   PubMed=7623158;
RA   Rhodes K.J., Keilbaugh S.A., Barrezueta N.X., Lopez K.L.,
RA   Trimmer J.S.;
RT   "Association and colocalization of K+ channel alpha- and beta-subunit
RT   polypeptides in rat brain.";
RL   J. Neurosci. 15:5360-5371(1995).
RN   [11]
RP   ENZYME REGULATION.
RX   PubMed=7576642; DOI=10.1016/0896-6273(95)90184-1;
RA   Swartz K.J., MacKinnon R.;
RT   "An inhibitor of the Kv2.1 potassium channel isolated from the venom
RT   of a Chilean tarantula.";
RL   Neuron 15:941-949(1995).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=8978827; DOI=10.1083/jcb.135.6.1619;
RA   Scannevin R.H., Murakoshi H., Rhodes K.J., Trimmer J.S.;
RT   "Identification of a cytoplasmic domain important in the polarized
RT   expression and clustering of the Kv2.1 K+ channel.";
RL   J. Cell Biol. 135:1619-1632(1996).
RN   [13]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNV1, AND SUBCELLULAR LOCATION.
RX   PubMed=8670833;
RA   Hugnot J.-P., Salinas M., Lesage F., Guillemare E., de Weille J.,
RA   Heurteaux C., Mattei M.-G., Lazdunski M.;
RT   "Kv8.1, a new neuronal potassium channel subunit with specific
RT   inhibitory properties towards Shab and Shaw channels.";
RL   EMBO J. 15:3322-3331(1996).
RN   [14]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNG1, AND SUBCELLULAR LOCATION.
RX   PubMed=8980147; DOI=10.1016/S0014-5793(96)01316-6;
RA   Post M.A., Kirsch G.E., Brown A.M.;
RT   "Kv2.1 and electrically silent Kv6.1 potassium channel subunits
RT   combine and express a novel current.";
RL   FEBS Lett. 399:177-182(1996).
RN   [15]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNS3, SUBCELLULAR LOCATION,
RP   ENZYME REGULATION, AND TISSUE SPECIFICITY.
RX   PubMed=9362476; DOI=10.1093/emboj/16.22.6615;
RA   Patel A.J., Lazdunski M., Honore E.;
RT   "Kv2.1/Kv9.3, a novel ATP-dependent delayed-rectifier K+ channel in
RT   oxygen-sensitive pulmonary artery myocytes.";
RL   EMBO J. 16:6615-6625(1997).
RN   [16]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=9079713; DOI=10.1074/jbc.272.13.8774;
RA   Salinas M., de Weille J., Guillemare E., Lazdunski M., Hugnot J.-P.;
RT   "Modes of regulation of shab K+ channel activity by the Kv8.1
RT   subunit.";
RL   J. Biol. Chem. 272:8774-8780(1997).
RN   [17]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=9305895; DOI=10.1074/jbc.272.39.24371;
RA   Salinas M., Duprat F., Heurteaux C., Hugnot J.-P., Lazdunski M.;
RT   "New modulatory alpha subunits for mammalian Shab K+ channels.";
RL   J. Biol. Chem. 272:24371-24379(1997).
RN   [18]
RP   PHOSPHORYLATION, FUNCTION, AND MUTAGENESIS OF SER-444 AND SER-496.
RX   PubMed=9351973; DOI=10.1124/mol.52.5.821;
RA   Murakoshi H., Shi G., Scannevin R.H., Trimmer J.S.;
RT   "Phosphorylation of the Kv2.1 K+ channel alters voltage-dependent
RT   activation.";
RL   Mol. Pharmacol. 52:821-828(1997).
RN   [19]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNF1 AND KCNG1, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=9696692;
RA   Kramer J.W., Post M.A., Brown A.M., Kirsch G.E.;
RT   "Modulation of potassium channel gating by coexpression of Kv2.1 with
RT   regulatory Kv5.1 or Kv6.1 alpha-subunits.";
RL   Am. J. Physiol. 274:C1501-C1510(1998).
RN   [20]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9616203; DOI=10.1172/JCI333;
RA   Archer S.L., Souil E., Dinh-Xuan A.T., Schremmer B., Mercier J.C.,
RA   El Yaagoubi A., Nguyen-Huu L., Reeve H.L., Hampl V.;
RT   "Molecular identification of the role of voltage-gated K+ channels,
RT   Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of
RT   resting membrane potential in rat pulmonary artery myocytes.";
RL   J. Clin. Invest. 101:2319-2330(1998).
RN   [21]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND INTERACTION WITH PIAS3.
RX   PubMed=9565597; DOI=10.1074/jbc.273.19.11745;
RA   Wible B.A., Yang Q., Kuryshev Y.A., Accili E.A., Brown A.M.;
RT   "Cloning and expression of a novel K+ channel regulatory protein,
RT   KChAP.";
RL   J. Biol. Chem. 273:11745-11751(1998).
RN   [22]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9522360; DOI=10.1016/S0306-4522(97)00519-8;
RA   Du J., Tao-Cheng J.H., Zerfas P., McBain C.J.;
RT   "The K+ channel, Kv2.1, is apposed to astrocytic processes and is
RT   associated with inhibitory postsynaptic membranes in hippocampal and
RT   cortical principal neurons and inhibitory interneurons.";
RL   Neuroscience 84:37-48(1998).
RN   [23]
RP   REVIEW.
RX   PubMed=10414301; DOI=10.1111/j.1749-6632.1999.tb11293.x;
RA   Coetzee W.A., Amarillo Y., Chiu J., Chow A., Lau D., McCormack T.,
RA   Moreno H., Nadal M.S., Ozaita A., Pountney D., Saganich M.,
RA   Vega-Saenz de Miera E., Rudy B.;
RT   "Molecular diversity of K+ channels.";
RL   Ann. N. Y. Acad. Sci. 868:233-285(1999).
RN   [24]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10024359;
RA   Murakoshi H., Trimmer J.S.;
RT   "Identification of the Kv2.1 K+ channel as a major component of the
RT   delayed rectifier K+ current in rat hippocampal neurons.";
RL   J. Neurosci. 19:1728-1735(1999).
RN   [25]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10414968;
RA   Baranauskas G., Tkatch T., Surmeier D.J.;
RT   "Delayed rectifier currents in rat globus pallidus neurons are
RT   attributable to Kv2.1 and Kv3.1/3.2 K(+) channels.";
RL   J. Neurosci. 19:6394-6404(1999).
RN   [26]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10618149; DOI=10.1111/j.1469-7793.2000.t01-2-00019.xm;
RA   Du J., Haak L.L., Phillips-Tansey E., Russell J.T., McBain C.J.;
RT   "Frequency-dependent regulation of rat hippocampal somato-dendritic
RT   excitability by the K+ channel subunit Kv2.1.";
RL   J. Physiol. (Lond.) 522:19-31(2000).
RN   [27]
RP   SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF SER-587; SER-590;
RP   PHE-591 AND SER-593.
RX   PubMed=10719893; DOI=10.1016/S0896-6273(00)80902-2;
RA   Lim S.T., Antonucci D.E., Scannevin R.H., Trimmer J.S.;
RT   "A novel targeting signal for proximal clustering of the Kv2.1 K+
RT   channel in hippocampal neurons.";
RL   Neuron 25:385-397(2000).
RN   [28]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11463864; DOI=10.1210/mend.15.8.0685;
RA   MacDonald P.E., Ha X.F., Wang J., Smukler S.R., Sun A.M.,
RA   Gaisano H.Y., Salapatek A.M., Backx P.H., Wheeler M.B.;
RT   "Members of the Kv1 and Kv2 voltage-dependent K(+) channel families
RT   regulate insulin secretion.";
RL   Mol. Endocrinol. 15:1423-1435(2001).
RN   [29]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   TRP-369 AND TYR-384.
RX   PubMed=12451110;
RA   Malin S.A., Nerbonne J.M.;
RT   "Delayed rectifier K+ currents, IK, are encoded by Kv2 alpha-subunits
RT   and regulate tonic firing in mammalian sympathetic neurons.";
RL   J. Neurosci. 22:10094-10105(2002).
RN   [30]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12127166; DOI=10.1016/S0024-3205(02)01922-7;
RA   Lu Y., Hanna S.T., Tang G., Wang R.;
RT   "Contributions of Kv1.2, Kv1.5 and Kv2.1 subunits to the native
RT   delayed rectifier K(+) current in rat mesenteric artery smooth muscle
RT   cells.";
RL   Life Sci. 71:1465-1473(2002).
RN   [31]
RP   FUNCTION, INTERACTION WITH SNAP25, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12403834; DOI=10.1210/me.2002-0058;
RA   MacDonald P.E., Wang G., Tsuk S., Dodo C., Kang Y., Tang L.,
RA   Wheeler M.B., Cattral M.S., Lakey J.R., Salapatek A.M., Lotan I.,
RA   Gaisano H.Y.;
RT   "Synaptosome-associated protein of 25 kilodaltons modulates Kv2.1
RT   voltage-dependent K(+) channels in neuroendocrine islet beta-cells
RT   through an interaction with the channel N terminus.";
RL   Mol. Endocrinol. 16:2452-2461(2002).
RN   [32]
RP   ENZYME REGULATION.
RX   PubMed=12065754; DOI=10.1124/mol.62.1.48;
RA   Escoubas P., Diochot S., Celerier M.-L., Nakajima T., Lazdunski M.;
RT   "Novel tarantula toxins for subtypes of voltage-dependent potassium
RT   channels in the Kv2 and Kv4 subfamilies.";
RL   Mol. Pharmacol. 62:48-57(2002).
RN   [33]
RP   FUNCTION, SELF-ASSOCIATION, DOMAIN, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF GLN-71 AND GLU-79.
RX   PubMed=12560340; DOI=10.1074/jbc.M212973200;
RA   Ju M., Stevens L., Leadbitter E., Wray D.;
RT   "The Roles of N- and C-terminal determinants in the activation of the
RT   Kv2.1 potassium channel.";
RL   J. Biol. Chem. 278:12769-12778(2003).
RN   [34]
RP   PHOSPHORYLATION AT TYR-128, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   TYR-128.
RX   PubMed=12615930; DOI=10.1074/jbc.M212766200;
RA   Tiran Z., Peretz A., Attali B., Elson A.;
RT   "Phosphorylation-dependent regulation of Kv2.1 Channel activity at
RT   tyrosine 124 by Src and by protein-tyrosine phosphatase epsilon.";
RL   J. Biol. Chem. 278:17509-17514(2003).
RN   [35]
RP   FUNCTION, INTERACTION WITH STX1A, AND SUBCELLULAR LOCATION.
RX   PubMed=12621036; DOI=10.1074/jbc.M213088200;
RA   Leung Y.M., Kang Y., Gao X., Xia F., Xie H., Sheu L., Tsuk S.,
RA   Lotan I., Tsushima R.G., Gaisano H.Y.;
RT   "Syntaxin 1A binds to the cytoplasmic C terminus of Kv2.1 to regulate
RT   channel gating and trafficking.";
RL   J. Biol. Chem. 278:17532-17538(2003).
RN   [36]
RP   FUNCTION, INTERACTION WITH SNP25 AND STX1A, AND SUBCELLULAR LOCATION.
RX   PubMed=12807875; DOI=10.1074/jbc.M304943200;
RA   Michaelevski I., Chikvashvili D., Tsuk S., Singer-Lahat D., Kang Y.,
RA   Linial M., Gaisano H.Y., Fili O., Lotan I.;
RT   "Direct interaction of target SNAREs with the Kv2.1 channel. Modal
RT   regulation of channel activation and inactivation gating.";
RL   J. Biol. Chem. 278:34320-34330(2003).
RN   [37]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   TRP-369 AND TYR-384.
RX   PubMed=12832499;
RA   Pal S., Hartnett K.A., Nerbonne J.M., Levitan E.S., Aizenman E.;
RT   "Mediation of neuronal apoptosis by Kv2.1-encoded potassium
RT   channels.";
RL   J. Neurosci. 23:4798-4802(2003).
RN   [38]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNE3, SUBCELLULAR LOCATION,
RP   DOMAIN, AND TISSUE SPECIFICITY.
RX   PubMed=12954870;
RA   McCrossan Z.A., Lewis A., Panaghie G., Jordan P.N., Christini D.J.,
RA   Lerner D.J., Abbott G.W.;
RT   "MinK-related peptide 2 modulates Kv2.1 and Kv3.1 potassium channels
RT   in mammalian brain.";
RL   J. Neurosci. 23:8077-8091(2003).
RN   [39]
RP   FUNCTION, SUBCELLULAR LOCATION, INDUCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15322114; DOI=10.1074/jbc.M408789200;
RA   Amberg G.C., Rossow C.F., Navedo M.F., Santana L.F.;
RT   "NFATc3 regulates Kv2.1 expression in arterial smooth muscle.";
RL   J. Biol. Chem. 279:47326-47334(2004).
RN   [40]
RP   FUNCTION, PHOSPHORYLATION, DEPHOSPHORYLATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15195093; DOI=10.1038/nn1260;
RA   Misonou H., Mohapatra D.P., Park E.W., Leung V., Zhen D., Misonou K.,
RA   Anderson A.E., Trimmer J.S.;
RT   "Regulation of ion channel localization and phosphorylation by
RT   neuronal activity.";
RL   Nat. Neurosci. 7:711-718(2004).
RN   [41]
RP   REVIEW.
RX   PubMed=15858231; DOI=10.1385/CBB:42:2:167;
RA   Cox R.H.;
RT   "Molecular determinants of voltage-gated potassium currents in
RT   vascular smooth muscle.";
RL   Cell Biochem. Biophys. 42:167-195(2005).
RN   [42]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15855232; DOI=10.1242/jcs.02348;
RA   O'Connell K.M., Tamkun M.M.;
RT   "Targeting of voltage-gated potassium channel isoforms to distinct
RT   cell surface microdomains.";
RL   J. Cell Sci. 118:2155-2166(2005).
RN   [43]
RP   FUNCTION, PHOSPHORYLATION, DEPHOSPHORYLATION, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=16319318; DOI=10.1523/JNEUROSCI.3370-05.2005;
RA   Misonou H., Mohapatra D.P., Menegola M., Trimmer J.S.;
RT   "Calcium- and metabolic state-dependent modulation of the voltage-
RT   dependent Kv2.1 channel regulates neuronal excitability in response to
RT   ischemia.";
RL   J. Neurosci. 25:11184-11193(2005).
RN   [44]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16273079; DOI=10.1038/sj.cdd.4401792;
RA   Pal S.K., Takimoto K., Aizenman E., Levitan E.S.;
RT   "Apoptotic surface delivery of K+ channels.";
RL   Cell Death Differ. 13:661-667(2006).
RN   [45]
RP   FUNCTION, PHOSPHORYLATION, DEPHOSPHORYLATION, DOMAIN, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=16407566; DOI=10.1523/JNEUROSCI.4620-05.2006;
RA   Mohapatra D.P., Trimmer J.S.;
RT   "The Kv2.1 C terminus can autonomously transfer Kv2.1-like
RT   phosphorylation-dependent localization, voltage-dependent gating, and
RT   muscarinic modulation to diverse Kv channels.";
RL   J. Neurosci. 26:685-695(2006).
RN   [46]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16988031; DOI=10.1523/JNEUROSCI.1825-06.2006;
RA   O'Connell K.M., Rolig A.S., Whitesell J.D., Tamkun M.M.;
RT   "Kv2.1 potassium channels are retained within dynamic cell surface
RT   microdomains that are defined by a perimeter fence.";
RL   J. Neurosci. 26:9609-9618(2006).
RN   [47]
RP   PHOSPHORYLATION AT SER-457; SER-567; SER-607 AND SER-719, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND FUNCTION.
RX   PubMed=17192433; DOI=10.1523/JNEUROSCI.3970-06.2006;
RA   Misonou H., Menegola M., Mohapatra D.P., Guy L.K., Park K.-S.,
RA   Trimmer J.S.;
RT   "Bidirectional activity-dependent regulation of neuronal ion channel
RT   phosphorylation.";
RL   J. Neurosci. 26:13505-13514(2006).
RN   [48]
RP   PHOSPHORYLATION AT SER-15; SER-457; SER-484; SER-496; SER-503;
RP   SER-520; SER-541; SER-567; SER-590; SER-607; SER-655; SER-719;
RP   SER-771; SER-799; SER-804 AND THR-836, FUNCTION, IDENTIFICATION BY
RP   MASS SPECTROMETRY, AND MUTAGENESIS OF SER-15; SER-457; SER-484;
RP   SER-541; SER-567; SER-607; SER-655; SER-719; SER-771 AND SER-804.
RX   PubMed=16917065; DOI=10.1126/science.1124254;
RA   Park K.-S., Mohapatra D.P., Misonou H., Trimmer J.S.;
RT   "Graded regulation of the Kv2.1 potassium channel by variable
RT   phosphorylation.";
RL   Science 313:976-979(2006).
RN   [49]
RP   PHOSPHORYLATION AT SER-15; SER-457; SER-541; SER-607; SER-655;
RP   SER-719; SER-799; SER-804 AND THR-836, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=18690023; DOI=10.4161/chan.4388;
RA   Park K.S., Mohapatra D.P., Trimmer J.S.;
RT   "Proteomic analyses of K(v)2.1 channel phosphorylation sites
RT   determining cell background specific differences in function.";
RL   Channels 1:59-61(2007).
RN   [50]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17606996; DOI=10.1242/jcs.007351;
RA   Tamkun M.M., O'connell K.M., Rolig A.S.;
RT   "A cytoskeletal-based perimeter fence selectively corrals a sub-
RT   population of cell surface Kv2.1 channels.";
RL   J. Cell Sci. 120:2413-2423(2007).
RN   [51]
RP   FUNCTION, INTERACTION WITH STX1A, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF TRP-369 AND TYR-384.
RX   PubMed=17301173; DOI=10.1523/JNEUROSCI.4006-06.2007;
RA   Singer-Lahat D., Sheinin A., Chikvashvili D., Tsuk S., Greitzer D.,
RA   Friedrich R., Feinshreiber L., Ashery U., Benveniste M., Levitan E.S.,
RA   Lotan I.;
RT   "K+ channel facilitation of exocytosis by dynamic interaction with
RT   syntaxin.";
RL   J. Neurosci. 27:1651-1658(2007).
RN   [52]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17379638; DOI=10.1113/jphysiol.2007.128454;
RA   Guan D., Tkatch T., Surmeier D.J., Armstrong W.E., Foehring R.C.;
RT   "Kv2 subunits underlie slowly inactivating potassium current in rat
RT   neocortical pyramidal neurons.";
RL   J. Physiol. (Lond.) 581:941-960(2007).
RN   [53]
RP   PHOSPHORYLATION AT SER-804, MUTAGENESIS OF TRP-369; TYR-384 AND
RP   SER-804, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17360683; DOI=10.1073/pnas.0610159104;
RA   Redman P.T., He K., Hartnett K.A., Jefferson B.S., Hu L.,
RA   Rosenberg P.A., Levitan E.S., Aizenman E.;
RT   "Apoptotic surge of potassium currents is mediated by p38
RT   phosphorylation of Kv2.1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:3568-3573(2007).
RN   [54]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17965280; DOI=10.1152/ajpheart.01038.2007;
RA   O'Connell K.M., Whitesell J.D., Tamkun M.M.;
RT   "Localization and mobility of the delayed-rectifer K+ channel Kv2.1 in
RT   adult cardiomyocytes.";
RL   Am. J. Physiol. 294:H229-H237(2008).
RN   [55]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19014551; DOI=10.1186/1471-2202-9-112;
RA   Sarmiere P.D., Weigle C.M., Tamkun M.M.;
RT   "The Kv2.1 K+ channel targets to the axon initial segment of
RT   hippocampal and cortical neurons in culture and in situ.";
RL   BMC Neurosci. 9:112-112(2008).
RN   [56]
RP   FUNCTION, SELF-ASSOCIATION, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND
RP   DOMAIN.
RX   PubMed=18463252; DOI=10.1523/JNEUROSCI.0186-08.2008;
RA   Mohapatra D.P., Siino D.F., Trimmer J.S.;
RT   "Interdomain cytoplasmic interactions govern the intracellular
RT   trafficking, gating, and modulation of the Kv2.1 channel.";
RL   J. Neurosci. 28:4982-4994(2008).
RN   [57]
RP   INTERACTION WITH VAMP2, AND SUBCELLULAR LOCATION.
RX   PubMed=18542995; DOI=10.1007/s00424-008-0468-7;
RA   Lvov A., Chikvashvili D., Michaelevski I., Lotan I.;
RT   "VAMP2 interacts directly with the N terminus of Kv2.1 to enhance
RT   channel inactivation.";
RL   Pflugers Arch. 456:1121-1136(2008).
RN   [58]
RP   FUNCTION, INTERACTION WITH STX1A, AND SUBCELLULAR LOCATION.
RX   PubMed=18167541; DOI=10.1371/journal.pone.0001381;
RA   Singer-Lahat D., Chikvashvili D., Lotan I.;
RT   "Direct interaction of endogenous Kv channels with syntaxin enhances
RT   exocytosis by neuroendocrine cells.";
RL   PLoS ONE 3:E1381-E1381(2008).
RN   [59]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19276663; DOI=10.4161/chan.3.1.7655;
RA   Mohapatra D.P., Misonou H., Pan S.J., Held J.E., Surmeier D.J.,
RA   Trimmer J.S.;
RT   "Regulation of intrinsic excitability in hippocampal neurons by
RT   activity-dependent modulation of the KV2.1 potassium channel.";
RL   Channels 3:46-56(2009).
RN   [60]
RP   TISSUE SPECIFICITY.
RX   PubMed=19074135; DOI=10.1074/jbc.M808786200;
RA   Mederos y Schnitzler M., Rinne S., Skrobek L., Renigunta V.,
RA   Schlichthorl G., Derst C., Gudermann T., Daut J., Preisig-Muller R.;
RT   "Mutation of histidine 105 in the T1 domain of the potassium channel
RT   Kv2.1 disrupts heteromerization with Kv6.3 and Kv6.4.";
RL   J. Biol. Chem. 284:4695-4704(2009).
RN   [61]
RP   INTERACTION WITH VAMP2, SELF-ASSOCIATION, DOMAIN, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=19690160; DOI=10.1074/jbc.M109.028761;
RA   Lvov A., Greitzer D., Berlin S., Chikvashvili D., Tsuk S., Lotan I.,
RA   Michaelevski I.;
RT   "Rearrangements in the relative orientation of cytoplasmic domains
RT   induced by a membrane-anchored protein mediate modulations in Kv
RT   channel gating.";
RL   J. Biol. Chem. 284:28276-28291(2009).
RN   [62]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNE1 AND KCNE2, SUBCELLULAR
RP   LOCATION, DOMAIN, AND TISSUE SPECIFICITY.
RX   PubMed=19219384; DOI=10.1007/s00232-009-9154-8;
RA   McCrossan Z.A., Roepke T.K., Lewis A., Panaghie G., Abbott G.W.;
RT   "Regulation of the Kv2.1 potassium channel by MinK and MiRP1.";
RL   J. Membr. Biol. 228:1-14(2009).
RN   [63]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH SNAP25; STX1A AND
RP   VAMP2.
RX   PubMed=19077057; DOI=10.1111/j.1471-4159.2008.05834.x;
RA   Yao H., Zhou K., Yan D., Li M., Wang Y.;
RT   "The Kv2.1 channels mediate neuronal apoptosis induced by
RT   excitotoxicity.";
RL   J. Neurochem. 108:909-919(2009).
RN   [64]
RP   FUNCTION, PHOSPHORYLATION AT TYR-128, DEPHOSPHORYLATION, AND
RP   MUTAGENESIS OF TYR-128 AND SER-804.
RX   PubMed=19622611; DOI=10.1113/jphysiol.2009.176321;
RA   Redman P.T., Hartnett K.A., Aras M.A., Levitan E.S., Aizenman E.;
RT   "Regulation of apoptotic potassium currents by coordinated zinc-
RT   dependent signalling.";
RL   J. Physiol. (Lond.) 587:4393-4404(2009).
RN   [65]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNB2, SUBCELLULAR LOCATION,
RP   MUTAGENESIS OF TRP-369 AND TYR-384, TISSUE SPECIFICITY, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=20202934; DOI=10.1074/jbc.M109.074260;
RA   Kihira Y., Hermanstyne T.O., Misonou H.;
RT   "Formation of heteromeric Kv2 channels in mammalian brain neurons.";
RL   J. Biol. Chem. 285:15048-15055(2010).
RN   [66]
RP   FUNCTION, INTERACTION WITH STX1A, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF TRP-369 AND TYR-384.
RX   PubMed=20484665; DOI=10.1242/jcs.063719;
RA   Feinshreiber L., Singer-Lahat D., Friedrich R., Matti U., Sheinin A.,
RA   Yizhar O., Nachman R., Chikvashvili D., Rettig J., Ashery U.,
RA   Lotan I.;
RT   "Non-conducting function of the Kv2.1 channel enables it to recruit
RT   vesicles for release in neuroendocrine and nerve cells.";
RL   J. Cell Sci. 123:1940-1947(2010).
RN   [67]
RP   PHOSPHORYLATION AT SER-520; SER-655; SER-607 AND SER-804,
RP   DEPHOSPHORYLATION AT SER-607, AND SUBCELLULAR LOCATION.
RX   PubMed=21712386; DOI=10.1074/jbc.M111.251942;
RA   Cerda O., Trimmer J.S.;
RT   "Activity-dependent phosphorylation of neuronal Kv2.1 potassium
RT   channels by CDK5.";
RL   J. Biol. Chem. 286:28738-28748(2011).
RN   [68]
RP   FUNCTION, SUMOYLATION AT LYS-474, DESUMOYLATION, SUBCELLULAR LOCATION,
RP   MUTAGENESIS OF LYS-149; LYS-259 AND LYS-474, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=21518833; DOI=10.1085/jgp.201110604;
RA   Plant L.D., Dowdell E.J., Dementieva I.S., Marks J.D., Goldstein S.A.;
RT   "SUMO modification of cell surface Kv2.1 potassium channels regulates
RT   the activity of rat hippocampal neurons.";
RL   J. Gen. Physiol. 137:441-454(2011).
RN   [69]
RP   PHOSPHORYLATION, ACETYLATION, AND INTERACTION WITH CREB1.
RX   PubMed=21818121; DOI=10.1038/cdd.2011.102;
RA   Kim S.J., Widenmaier S.B., Choi W.S., Nian C., Ao Z., Warnock G.,
RA   McIntosh C.H.;
RT   "Pancreatic beta-cell prosurvival effects of the incretin hormones
RT   involve post-translational modification of Kv2.1 delayed rectifier
RT   channels.";
RL   Cell Death Differ. 19:333-344(2012).
RN   [70]
RP   FUNCTION, INTERACTION WITH STX1A, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF TRP-369 AND TYR-384.
RX   PubMed=22411134; DOI=10.1007/s00125-012-2512-6;
RA   Dai X.Q., Manning Fox J.E., Chikvashvili D., Casimir M., Plummer G.,
RA   Hajmrle C., Spigelman A.F., Kin T., Singer-Lahat D., Kang Y.,
RA   Shapiro A.M., Gaisano H.Y., Lotan I., Macdonald P.E.;
RT   "The voltage-dependent potassium channel subunit Kv2.1 regulates
RT   insulin secretion from rodent and human islets independently of its
RT   electrical function.";
RL   Diabetologia 55:1709-1720(2012).
RN   [71]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22648171; DOI=10.1091/mbc.E12-01-0047;
RA   Deutsch E., Weigel A.V., Akin E.J., Fox P., Hansen G., Haberkorn C.J.,
RA   Loftus R., Krapf D., Tamkun M.M.;
RT   "Kv2.1 cell surface clusters are insertion platforms for ion channel
RT   delivery to the plasma membrane.";
RL   Mol. Biol. Cell 23:2917-2929(2012).
RN   [72]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484; SER-519; SER-520
RP   AND SER-655, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [73]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23878373; DOI=10.1113/jphysiol.2013.257253;
RA   Guan D., Armstrong W.E., Foehring R.C.;
RT   "Kv2 channels regulate firing rate in pyramidal neurons from rat
RT   sensorimotor cortex.";
RL   J. Physiol. (Lond.) 591:4807-4825(2013).
RN   [74]
RP   INTERACTION WITH MYL12B, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   SER-590.
RX   PubMed=24569993; DOI=10.1074/jbc.M113.534495;
RA   Jensen C.S., Watanabe S., Rasmussen H.B., Schmitt N., Olesen S.P.,
RA   Frost N.A., Blanpied T.A., Misonou H.;
RT   "Specific sorting and post-Golgi trafficking of dendritic potassium
RT   channels in living neurons.";
RL   J. Biol. Chem. 289:10566-10581(2014).
RN   [75]
RP   PHOSPHORYLATION AT SER-607, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=24477962; DOI=10.1002/cne.23551;
RA   King A.N., Manning C.F., Trimmer J.S.;
RT   "A unique ion channel clustering domain on the axon initial segment of
RT   mammalian neurons.";
RL   J. Comp. Neurol. 522:2594-2608(2014).
RN   [76]
RP   FUNCTION, INTERACTION WITH STX1A, AND SUBCELLULAR LOCATION.
RX   PubMed=24928958; DOI=10.1113/jphysiol.2014.276964;
RA   McCord M.C., Kullmann P.H., He K., Hartnett K.A., Horn J.P., Lotan I.,
RA   Aizenman E.;
RT   "Syntaxin-binding domain of Kv2.1 is essential for the expression of
RT   apoptotic K+ currents.";
RL   J. Physiol. (Lond.) 592:3511-3521(2014).
RN   [77]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 272-304.
RX   PubMed=18004376; DOI=10.1038/nature06265;
RA   Long S.B., Tao X., Campbell E.B., MacKinnon R.;
RT   "Atomic structure of a voltage-dependent K+ channel in a lipid
RT   membrane-like environment.";
RL   Nature 450:376-382(2007).
RN   [78]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 272-304.
RX   PubMed=20360102; DOI=10.1126/science.1185954;
RA   Tao X., Lee A., Limapichat W., Dougherty D.A., MacKinnon R.;
RT   "A gating charge transfer center in voltage sensors.";
RL   Science 328:67-73(2010).
RN   [79]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 272-304.
RX   PubMed=23705070; DOI=10.7554/eLife.00594;
RA   Banerjee A., Lee A., Campbell E., Mackinnon R.;
RT   "Structure of a pore-blocking toxin in complex with a eukaryotic
RT   voltage-dependent K(+) channel.";
RL   Elife 2:E00594-E00594(2013).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes,
CC       primarily in the brain, but also in the pancreas and
CC       cardiovascular system. Contributes to the regulation of the action
CC       potential (AP) repolarization, duration and frequency of
CC       repetitive AP firing in neurons, muscle cells and endocrine cells
CC       and plays a role in homeostatic attenuation of electrical
CC       excitability throughout the brain (PubMed:10024359,
CC       PubMed:10618149, PubMed:12451110, PubMed:17379638,
CC       PubMed:19276663, PubMed:23878373). Plays also a role in the
CC       regulation of exocytosis independently of its electrical function
CC       (PubMed:20484665). Forms tetrameric potassium-selective channels
CC       through which potassium ions pass in accordance with their
CC       electrochemical gradient. The channel alternates between opened
CC       and closed conformations in response to the voltage difference
CC       across the membrane. Homotetrameric channels mediate a delayed-
CC       rectifier voltage-dependent outward potassium current that display
CC       rapid activation and slow inactivation in response to membrane
CC       depolarization (PubMed:2770868, PubMed:2206531, PubMed:1875913,
CC       PubMed:8083226, PubMed:8978827, PubMed:9351973, PubMed:9565597,
CC       PubMed:12560340). Can form functional homotetrameric and
CC       heterotetrameric channels that contain variable proportions of
CC       KCNB2; channel properties depend on the type of alpha subunits
CC       that are part of the channel (PubMed:20202934). Can also form
CC       functional heterotetrameric channels with other alpha subunits
CC       that are non-conducting when expressed alone, such as KCNF1,
CC       KCNG1, KCNG3, KCNG4, KCNH1, KCNH2, KCNS1, KCNS2, KCNS3 and KCNV1,
CC       creating a functionally diverse range of channel complexes
CC       (PubMed:8670833, PubMed:8980147, PubMed:9362476, PubMed:9079713,
CC       PubMed:9305895, PubMed:9696692). Heterotetrameric channel activity
CC       formed with KCNS3 show increased current amplitude with the
CC       threshold for action potential activation shifted towards more
CC       negative values in hypoxic-treated pulmonary artery smooth muscle
CC       cells (PubMed:9362476). Channel properties are also modulated by
CC       cytoplasmic ancillary beta subunits such as AMIGO1, KCNE1, KCNE2
CC       and KCNE3, slowing activation and inactivation rate of the delayed
CC       rectifier potassium channels (PubMed:12954870, PubMed:19219384).
CC       In vivo, membranes probably contain a mixture of heteromeric
CC       potassium channel complexes, making it difficult to assign
CC       currents observed in intact tissues to any particular potassium
CC       channel family member. Major contributor to the slowly
CC       inactivating delayed-rectifier voltage-gated potassium current in
CC       neurons of the central nervous system, sympathetic ganglion
CC       neurons, neuroendocrine cells, pancreatic beta cells,
CC       cardiomyocytes and smooth muscle cells (PubMed:9362476,
CC       PubMed:9616203, PubMed:10024359, PubMed:10414968, PubMed:10618149,
CC       PubMed:11463864, PubMed:12451110, PubMed:12127166,
CC       PubMed:12403834, PubMed:12621036, PubMed:12807875,
CC       PubMed:12832499, PubMed:12954870, PubMed:15322114,
CC       PubMed:15195093, PubMed:16407566, PubMed:17301173,
CC       PubMed:17379638, PubMed:18463252, PubMed:18167541,
CC       PubMed:19276663, PubMed:20484665, PubMed:21518833,
CC       PubMed:22411134, PubMed:23878373). Mediates the major part of the
CC       somatodendritic delayed-rectifier potassium current in hippocampal
CC       and cortical pyramidal neurons and sympathetic superior cervical
CC       ganglion (CGC) neurons that acts to slow down periods of firing,
CC       especially during high frequency stimulation (PubMed:10618149,
CC       PubMed:12451110, PubMed:16319318, PubMed:17379638,
CC       PubMed:19276663, PubMed:23878373, PubMed:16917065). Plays a role
CC       in the induction of long-term potentiation (LTP) of neuron
CC       excitability in the CA3 layer of the hippocampus (By similarity).
CC       Contributes to the regulation of glucose-induced action potential
CC       amplitude and duration in pancreatic beta cells, hence limiting
CC       calcium influx and insulin secretion (PubMed:11463864). Plays a
CC       role in the regulation of resting membrane potential and
CC       contraction in hypoxia-treated pulmonary artery smooth muscle
CC       cells (PubMed:9616203). May contribute to the regulation of the
CC       duration of both the action potential of cardiomyocytes and the
CC       heart ventricular repolarization QT interval (By similarity).
CC       Contributes to the pronounced pro-apoptotic potassium current
CC       surge during neuronal apoptotic cell death in response to
CC       oxidative injury (PubMed:12832499, PubMed:16273079,
CC       PubMed:17360683, PubMed:19077057, PubMed:19622611,
CC       PubMed:24928958). May confer neuroprotection in response to
CC       hypoxia/ischemic insults by suppressing pyramidal neurons
CC       hyperexcitability in hippocampal and cortical regions
CC       (PubMed:16319318). Promotes trafficking of KCNG3, KCNH1 and KCNH2
CC       to the cell surface membrane, presumably by forming
CC       heterotetrameric channels with these subunits (By similarity).
CC       Plays a role in the calcium-dependent recruitment and release of
CC       fusion-competent vesicles from the soma of neurons, neuroendocrine
CC       and glucose-induced pancreatic beta cells by binding key
CC       components of the fusion machinery in a pore-independent manner
CC       (PubMed:11463864, PubMed:17301173, PubMed:18167541,
CC       PubMed:20484665, PubMed:22411134). {ECO:0000250|UniProtKB:Q03717,
CC       ECO:0000269|PubMed:10024359, ECO:0000269|PubMed:10414968,
CC       ECO:0000269|PubMed:10618149, ECO:0000269|PubMed:11463864,
CC       ECO:0000269|PubMed:12127166, ECO:0000269|PubMed:12403834,
CC       ECO:0000269|PubMed:12451110, ECO:0000269|PubMed:12560340,
CC       ECO:0000269|PubMed:12621036, ECO:0000269|PubMed:12807875,
CC       ECO:0000269|PubMed:12832499, ECO:0000269|PubMed:12954870,
CC       ECO:0000269|PubMed:15195093, ECO:0000269|PubMed:15322114,
CC       ECO:0000269|PubMed:16273079, ECO:0000269|PubMed:16319318,
CC       ECO:0000269|PubMed:16407566, ECO:0000269|PubMed:16917065,
CC       ECO:0000269|PubMed:17301173, ECO:0000269|PubMed:17360683,
CC       ECO:0000269|PubMed:17379638, ECO:0000269|PubMed:18167541,
CC       ECO:0000269|PubMed:18463252, ECO:0000269|PubMed:1875913,
CC       ECO:0000269|PubMed:19077057, ECO:0000269|PubMed:19219384,
CC       ECO:0000269|PubMed:19276663, ECO:0000269|PubMed:19622611,
CC       ECO:0000269|PubMed:20202934, ECO:0000269|PubMed:20484665,
CC       ECO:0000269|PubMed:21518833, ECO:0000269|PubMed:2206531,
CC       ECO:0000269|PubMed:22411134, ECO:0000269|PubMed:23878373,
CC       ECO:0000269|PubMed:24928958, ECO:0000269|PubMed:2770868,
CC       ECO:0000269|PubMed:8083226, ECO:0000269|PubMed:8670833,
CC       ECO:0000269|PubMed:8978827, ECO:0000269|PubMed:8980147,
CC       ECO:0000269|PubMed:9079713, ECO:0000269|PubMed:9305895,
CC       ECO:0000269|PubMed:9351973, ECO:0000269|PubMed:9362476,
CC       ECO:0000269|PubMed:9565597, ECO:0000269|PubMed:9616203,
CC       ECO:0000269|PubMed:9696692}.
CC   -!- ENZYME REGULATION: Inhibited by 42 nM hanatoxin 1 (HaTx1), a
CC       spider venom toxin of the tarantula G. spatulata (PubMed:7576642).
CC       Inhibited by 100 nM stromatoxin 1 (ScTx1), a spider venom toxin of
CC       the tarantula S. calceata (PubMed:12065754). Modestly sensitive to
CC       millimolar levels of tetraethylammonium (TEA) and 4-aminopyridine
CC       (4-AP) (PubMed:2770868, PubMed:1875913, PubMed:8083226,
CC       PubMed:9362476). Completely insensitive to toxins such as
CC       dendrotoxin (DTX) and charybdotoxin (CTX) (PubMed:9362476).
CC       {ECO:0000269|PubMed:12065754, ECO:0000269|PubMed:1875913,
CC       ECO:0000269|PubMed:2770868, ECO:0000269|PubMed:7576642,
CC       ECO:0000269|PubMed:8083226, ECO:0000269|PubMed:9362476,
CC       ECO:0000305|PubMed:10414301, ECO:0000305|PubMed:15858231}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Homotetrameric channels expressed in xenopus oocytes or in
CC         mammalian non-neuronal cells display delayed-rectifier voltage-
CC         dependent potassium currents which are activated during membrane
CC         depolarization, i.e within a risetime of about 20 msec
CC         (PubMed:2770868). After that, inactivate very slowly, i.e within
CC         more than 5 sec (PubMed:2206531, PubMed:8083226). Their
CC         activation requires low threshold potentials of about -20 to -30
CC         mV, with a midpoint activation at about 10 mV (PubMed:2770868,
CC         PubMed:2206531, PubMed:8083226). For inactivation, the voltage
CC         at half-maximal amplitude is about -20 mV (PubMed:2206531,
CC         PubMed:8083226). The time constant for recovery after
CC         inactivation is about 1.6 sec. Channels have an unitary
CC         conductance of about 8 pS (PubMed:10414301, PubMed:15858231).
CC         The voltage-dependence of activation and inactivation and other
CC         channel characteristics vary depending on the experimental
CC         conditions, the expression system, the presence or absence of
CC         ancillary subunits and post-translational modifications.
CC         {ECO:0000269|PubMed:2206531, ECO:0000269|PubMed:2770868,
CC         ECO:0000269|PubMed:8083226, ECO:0000305|PubMed:10414301,
CC         ECO:0000305|PubMed:15858231};
CC   -!- SUBUNIT: Homotetramer or heterotetramer with KCNB2
CC       (PubMed:20202934). Heterotetramer with non-conducting channel-
CC       forming alpha subunits such as KCNF1, KCNG1, KCNG3, KCNG4, KCNH1,
CC       KCNH2, KCNS1, KCNS2, KCNS3 and KCNV1 (PubMed:8670833,
CC       PubMed:8980147, PubMed:9362476, PubMed:9079713, PubMed:9305895,
CC       PubMed:9696692). Channel activity is regulated by association with
CC       ancillary beta subunits such as AMIGO1, KCNE1, KCNE2 and KCNE3
CC       (PubMed:12954870, PubMed:19219384). Self-associates (via N-
CC       terminus and C-terminus); self-association is required to regulate
CC       trafficking, gating and C-terminal phosphorylation-dependent
CC       modulation of the channel (PubMed:12560340, PubMed:18463252,
CC       PubMed:19690160). Interacts (via C-terminus) with STX1A (via C-
CC       terminus); this decreases the rate of channel activation and
CC       increases the rate of channel inactivation in pancreatic beta
CC       cells, induces also neuronal apoptosis in response to oxidative
CC       injury as well as pore-independent enhancement of exocytosis in
CC       neuroendocrine cells, chromaffin cells, pancreatic beta cells and
CC       from the soma of dorsal root ganglia (DRG) neurons
CC       (PubMed:12621036, PubMed:12807875, PubMed:17301173,
CC       PubMed:18167541, PubMed:19077057, PubMed:20484665,
CC       PubMed:22411134, PubMed:24928958). Interacts (via N-terminus) with
CC       SNAP25; this decreases the rate of channel inactivation in
CC       pancreatic beta cells and also increases interaction during
CC       neuronal apoptosis in a N-methyl-D-aspartate receptor (NMDAR)-
CC       dependent manner (PubMed:12403834, PubMed:12807875,
CC       PubMed:19077057). Interacts (via N-terminus and C-terminus) with
CC       VAMP2 (via N-terminus); stimulates channel inactivation rate
CC       (PubMed:18542995, PubMed:19690160, PubMed:19077057). Interacts
CC       with CREB1; this promotes channel acetylation in response to
CC       stimulation by incretin hormones (PubMed:21818121). Interacts (via
CC       N-terminus and C-terminus) with MYL12B (PubMed:24569993).
CC       Interacts (via N-terminus) with PIAS3; this increases the number
CC       of functional channels at the cell surface (PubMed:9565597).
CC       Interacts with SUMO1. Interacts (via phosphorylated form) with
CC       PTPRE; this reduces phosphorylation and channel activity in
CC       heterologous cells (By similarity). {ECO:0000250|UniProtKB:Q03717,
CC       ECO:0000250|UniProtKB:Q14721, ECO:0000269|PubMed:12403834,
CC       ECO:0000269|PubMed:12560340, ECO:0000269|PubMed:12621036,
CC       ECO:0000269|PubMed:12807875, ECO:0000269|PubMed:12954870,
CC       ECO:0000269|PubMed:17301173, ECO:0000269|PubMed:18167541,
CC       ECO:0000269|PubMed:18463252, ECO:0000269|PubMed:18542995,
CC       ECO:0000269|PubMed:19077057, ECO:0000269|PubMed:19219384,
CC       ECO:0000269|PubMed:19690160, ECO:0000269|PubMed:20202934,
CC       ECO:0000269|PubMed:20484665, ECO:0000269|PubMed:21818121,
CC       ECO:0000269|PubMed:22411134, ECO:0000269|PubMed:24569993,
CC       ECO:0000269|PubMed:24928958, ECO:0000269|PubMed:8670833,
CC       ECO:0000269|PubMed:8980147, ECO:0000269|PubMed:9079713,
CC       ECO:0000269|PubMed:9305895, ECO:0000269|PubMed:9362476,
CC       ECO:0000269|PubMed:9565597, ECO:0000269|PubMed:9696692}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10024359,
CC       ECO:0000269|PubMed:10414968, ECO:0000269|PubMed:10618149,
CC       ECO:0000269|PubMed:10719893, ECO:0000269|PubMed:12127166,
CC       ECO:0000269|PubMed:12403834, ECO:0000269|PubMed:12451110,
CC       ECO:0000269|PubMed:12560340, ECO:0000269|PubMed:12615930,
CC       ECO:0000269|PubMed:12621036, ECO:0000269|PubMed:12807875,
CC       ECO:0000269|PubMed:12832499, ECO:0000269|PubMed:12954870,
CC       ECO:0000269|PubMed:15195093, ECO:0000269|PubMed:15322114,
CC       ECO:0000269|PubMed:15855232, ECO:0000269|PubMed:16273079,
CC       ECO:0000269|PubMed:16319318, ECO:0000269|PubMed:16407566,
CC       ECO:0000269|PubMed:16988031, ECO:0000269|PubMed:17192433,
CC       ECO:0000269|PubMed:17301173, ECO:0000269|PubMed:17360683,
CC       ECO:0000269|PubMed:17379638, ECO:0000269|PubMed:17606996,
CC       ECO:0000269|PubMed:17965280, ECO:0000269|PubMed:18167541,
CC       ECO:0000269|PubMed:18463252, ECO:0000269|PubMed:18542995,
CC       ECO:0000269|PubMed:19014551, ECO:0000269|PubMed:19077057,
CC       ECO:0000269|PubMed:19219384, ECO:0000269|PubMed:19276663,
CC       ECO:0000269|PubMed:19690160, ECO:0000269|PubMed:20202934,
CC       ECO:0000269|PubMed:20484665, ECO:0000269|PubMed:21518833,
CC       ECO:0000269|PubMed:21712386, ECO:0000269|PubMed:22411134,
CC       ECO:0000269|PubMed:23878373, ECO:0000269|PubMed:24477962,
CC       ECO:0000269|PubMed:24569993, ECO:0000269|PubMed:24928958,
CC       ECO:0000269|PubMed:7623158, ECO:0000269|PubMed:8083226,
CC       ECO:0000269|PubMed:8463836, ECO:0000269|PubMed:8508921,
CC       ECO:0000269|PubMed:8670833, ECO:0000269|PubMed:8978827,
CC       ECO:0000269|PubMed:8980147, ECO:0000269|PubMed:9079713,
CC       ECO:0000269|PubMed:9305895, ECO:0000269|PubMed:9362476,
CC       ECO:0000269|PubMed:9522360, ECO:0000269|PubMed:9565597,
CC       ECO:0000269|PubMed:9616203, ECO:0000269|PubMed:9696692}.
CC       Perikaryon {ECO:0000269|PubMed:10024359,
CC       ECO:0000269|PubMed:10618149, ECO:0000269|PubMed:10719893,
CC       ECO:0000269|PubMed:12954870, ECO:0000269|PubMed:15195093,
CC       ECO:0000269|PubMed:16319318, ECO:0000269|PubMed:16407566,
CC       ECO:0000269|PubMed:16988031, ECO:0000269|PubMed:17379638,
CC       ECO:0000269|PubMed:17965280, ECO:0000269|PubMed:18463252,
CC       ECO:0000269|PubMed:19014551, ECO:0000269|PubMed:19077057,
CC       ECO:0000269|PubMed:1961744, ECO:0000269|PubMed:20202934,
CC       ECO:0000269|PubMed:21518833, ECO:0000269|PubMed:21712386,
CC       ECO:0000269|PubMed:22648171, ECO:0000269|PubMed:23878373,
CC       ECO:0000269|PubMed:24477962, ECO:0000269|PubMed:24569993,
CC       ECO:0000269|PubMed:7623158, ECO:0000269|PubMed:8463836,
CC       ECO:0000269|PubMed:8978827, ECO:0000269|PubMed:9522360}. Cell
CC       projection, dendrite {ECO:0000269|PubMed:10024359,
CC       ECO:0000269|PubMed:10618149, ECO:0000269|PubMed:10719893,
CC       ECO:0000269|PubMed:12954870, ECO:0000269|PubMed:15195093,
CC       ECO:0000269|PubMed:16319318, ECO:0000269|PubMed:16407566,
CC       ECO:0000269|PubMed:17379638, ECO:0000269|PubMed:17965280,
CC       ECO:0000269|PubMed:18463252, ECO:0000269|PubMed:19014551,
CC       ECO:0000269|PubMed:19077057, ECO:0000269|PubMed:20202934,
CC       ECO:0000269|PubMed:21518833, ECO:0000269|PubMed:21712386,
CC       ECO:0000269|PubMed:22648171, ECO:0000269|PubMed:23878373,
CC       ECO:0000269|PubMed:24477962, ECO:0000269|PubMed:24569993,
CC       ECO:0000269|PubMed:7623158, ECO:0000269|PubMed:8463836,
CC       ECO:0000269|PubMed:9522360}. Cell projection, axon
CC       {ECO:0000269|PubMed:19014551, ECO:0000269|PubMed:22648171,
CC       ECO:0000269|PubMed:24477962}. Cell junction, synapse, postsynaptic
CC       cell membrane {ECO:0000269|PubMed:9522360}. Cell junction, synapse
CC       {ECO:0000269|PubMed:9522360}. Cell junction, synapse, synaptosome
CC       {ECO:0000269|PubMed:8508921}. Membrane
CC       {ECO:0000269|PubMed:8508921}; Multi-pass membrane protein. Lateral
CC       cell membrane {ECO:0000269|PubMed:8978827}. Cell membrane,
CC       sarcolemma {ECO:0000269|PubMed:17965280}. Note=Localizes to high-
CC       density somatodendritic clusters and non-clustered sites on the
CC       surface of neocortical and hippocampal pyramidal neurons in a
CC       cortical actin cytoskeleton-dependent manner (PubMed:1961744,
CC       PubMed:8978827, PubMed:9522360, PubMed:10024359, PubMed:10719893,
CC       PubMed:15195093, PubMed:16319318, PubMed:16407566,
CC       PubMed:16988031, PubMed:17606996, PubMed:17379638,
CC       PubMed:19014551, PubMed:18463252, PubMed:22648171,
CC       PubMed:23878373, PubMed:24569993, PubMed:24477962). Localizes also
CC       to high-density clusters in the axon initial segment (AIS), at
CC       ankyrin-G-deficient sites, on the surface of neocortical and
CC       hippocampal pyramidal neurons (PubMed:17379638, PubMed:19014551,
CC       PubMed:22648171, PubMed:24477962). KCNB1-containing AIS clusters
CC       localize either in close apposition to smooth endoplasmic
CC       reticulum cisternal organelles or with GABA-A receptor-containing
CC       synapses of hippocampal and cortical pyramidal neurons,
CC       respectively (PubMed:24477962). Localizes to high-density clusters
CC       on the cell surface of atrial and ventricular myocytes and at the
CC       lateral plasma membrane in epithelial cells (PubMed:8978827,
CC       PubMed:17965280). Localizes both to the axial and transverse
CC       tubules (T tubule) and sarcolemma in ventricular myocytes
CC       (PubMed:17965280). Associated with lipid raft domains
CC       (PubMed:15855232). In cortical neurons, apoptotic injuries induce
CC       de novo plasma membrane insertion in a SNARE-dependent manner
CC       causing an apoptotic potassium current surge (PubMed:16273079,
CC       PubMed:19077057). {ECO:0000250|UniProtKB:Q03717,
CC       ECO:0000250|UniProtKB:Q14721, ECO:0000269|PubMed:10024359,
CC       ECO:0000269|PubMed:10719893, ECO:0000269|PubMed:12615930,
CC       ECO:0000269|PubMed:12807875, ECO:0000269|PubMed:12954870,
CC       ECO:0000269|PubMed:15195093, ECO:0000269|PubMed:15855232,
CC       ECO:0000269|PubMed:16273079, ECO:0000269|PubMed:16319318,
CC       ECO:0000269|PubMed:16407566, ECO:0000269|PubMed:16988031,
CC       ECO:0000269|PubMed:17301173, ECO:0000269|PubMed:17379638,
CC       ECO:0000269|PubMed:17606996, ECO:0000269|PubMed:17965280,
CC       ECO:0000269|PubMed:18463252, ECO:0000269|PubMed:19014551,
CC       ECO:0000269|PubMed:19077057, ECO:0000269|PubMed:19219384,
CC       ECO:0000269|PubMed:1961744, ECO:0000269|PubMed:20202934,
CC       ECO:0000269|PubMed:21518833, ECO:0000269|PubMed:22648171,
CC       ECO:0000269|PubMed:23878373, ECO:0000269|PubMed:24477962,
CC       ECO:0000269|PubMed:24569993, ECO:0000269|PubMed:8508921,
CC       ECO:0000269|PubMed:8978827, ECO:0000269|PubMed:9522360}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain (PubMed:1740690,
CC       PubMed:1961744, PubMed:8508921, PubMed:7623158, PubMed:12954870).
CC       Expressed in the hippocampus, cerebral cortex, cerebellum,
CC       thalamus, hypothalamus, olfactory bulb, corpus striatum and medial
CC       hebenula (PubMed:8463836, PubMed:10414301, PubMed:16319318).
CC       Expressed in pancreatic islets (PubMed:12403834). Expressed in
CC       heart and skeletal muscle (PubMed:1740690, PubMed:19219384,
CC       PubMed:10414301). Levels remain constant throughout postnatal
CC       development (PubMed:17192433). Expressed in neocortical pyramidal
CC       neurons and inhibitory interneurons (PubMed:1961744,
CC       PubMed:9522360, PubMed:10618149, PubMed:12832499, PubMed:17192433,
CC       PubMed:17379638, PubMed:19014551, PubMed:20202934,
CC       PubMed:24477962). Expressed in the superior cervical ganglion
CC       (SCG) neurons (PubMed:12451110). Expressed in globus pallidus
CC       neurons (PubMed:10414968). Expressed in pancreatic beta cells
CC       (PubMed:11463864, PubMed:22411134). Expressed in cardiomyocytes
CC       (PubMed:17965280). Expressed in arterial smooth muscle, alveolar
CC       epithelium and parenchyma (at protein level) (PubMed:9362476,
CC       PubMed:9616203, PubMed:15322114). Expressed in brain, heart, lung,
CC       liver, colon, kidney and adrenal gland (PubMed:8508921,
CC       PubMed:9362476, PubMed:19074135). Expressed in pyramidal cells of
CC       the cerebral cortex, in Purkinje and granule cells of the
CC       cerebellum (PubMed:8463836). Expressed in CA1-CA3 pyramidal cells,
CC       dentate granule cells and interneurons of the hippocampus
CC       (PubMed:7623158, PubMed:10024359). Expressed in pulmonary artery
CC       (PA) smooth muscle cells (PubMed:9362476).
CC       {ECO:0000269|PubMed:10024359, ECO:0000269|PubMed:10414968,
CC       ECO:0000269|PubMed:10618149, ECO:0000269|PubMed:11463864,
CC       ECO:0000269|PubMed:12403834, ECO:0000269|PubMed:12451110,
CC       ECO:0000269|PubMed:12832499, ECO:0000269|PubMed:12954870,
CC       ECO:0000269|PubMed:15322114, ECO:0000269|PubMed:16319318,
CC       ECO:0000269|PubMed:17192433, ECO:0000269|PubMed:17379638,
CC       ECO:0000269|PubMed:1740690, ECO:0000269|PubMed:17965280,
CC       ECO:0000269|PubMed:19014551, ECO:0000269|PubMed:19074135,
CC       ECO:0000269|PubMed:19219384, ECO:0000269|PubMed:1961744,
CC       ECO:0000269|PubMed:20202934, ECO:0000269|PubMed:22411134,
CC       ECO:0000269|PubMed:24477962, ECO:0000269|PubMed:7623158,
CC       ECO:0000269|PubMed:8463836, ECO:0000269|PubMed:8508921,
CC       ECO:0000269|PubMed:9362476, ECO:0000269|PubMed:9522360,
CC       ECO:0000269|PubMed:9616203}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in embryonic brain at 14 dpc, and
CC       thereafter (at protein level) (PubMed:8508921). Expressed in
CC       embryonic brain at 14 dpc, and thereafter (PubMed:8508921).
CC       {ECO:0000269|PubMed:8508921}.
CC   -!- INDUCTION: Down-regulated by angiotensin II in a NFATC3-dependent
CC       manner (PubMed:15322114). {ECO:0000269|PubMed:15322114}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- DOMAIN: The N-terminal and C-terminal cytoplasmic regions mediate
CC       homooligomerization; self-association is required to regulate
CC       trafficking, gating and C-terminal phosphorylation-dependent
CC       modulation of the channel (PubMed:12560340, PubMed:18463252,
CC       PubMed:19690160). The N-terminal cytoplasmic region is important
CC       for interaction with other channel-forming alpha subunits and with
CC       ancillary beta subunits (PubMed:12954870, PubMed:19219384). The C-
CC       terminus is necessary and sufficient for the restricted
CC       localization to, and clustering within, both in soma and proximal
CC       portions of dendrite of neurons and in lateral membrane of non-
CC       neuronal polarized cells (PubMed:8978827, PubMed:10719893). The C-
CC       terminus is both necessary and sufficient as a mediator of
CC       cholinergic and calcium-stimulated modulation of channel cell
CC       membrane clustering localization and activity in hippocampal
CC       neurons (PubMed:16407566). {ECO:0000250|UniProtKB:Q14721,
CC       ECO:0000269|PubMed:10719893, ECO:0000269|PubMed:12560340,
CC       ECO:0000269|PubMed:12954870, ECO:0000269|PubMed:16407566,
CC       ECO:0000269|PubMed:18463252, ECO:0000269|PubMed:19219384,
CC       ECO:0000269|PubMed:19690160, ECO:0000269|PubMed:8978827}.
CC   -!- PTM: Phosphorylated (PubMed:8083226, PubMed:15195093,
CC       PubMed:16319318, PubMed:16407566, PubMed:18463252). Differential
CC       C-terminal phosphorylation on a subset of serines allows graded
CC       activity-dependent regulation of channel gating in hippocampal
CC       neurons (PubMed:9351973, PubMed:17192433, PubMed:16917065). Ser-
CC       607 and Tyr-128 are significant sites of voltage-gated regulation
CC       through phosphorylation/dephosphorylation activities
CC       (PubMed:12615930, PubMed:17192433). Tyr-128 can be phosphorylated
CC       by Src and dephosphorylated by cytoplasmic form of the phosphatase
CC       PTPRE isoform 2 (PubMed:12615930). CDK5-induced Ser-607
CC       phosphorylation increases in response to acute blockade of
CC       neuronal activity (PubMed:21712386). Phosphorylated on Tyr-128 by
CC       Src and on Ser-804 by MAPK14/P38MAPK; phosphorylations are
CC       necessary and sufficient for an increase in plasma membrane
CC       insertion, apoptotic potassium current surge and completion of the
CC       neuronal cell death program (PubMed:17360683, PubMed:19622611).
CC       Phosphorylated on Ser-520, Ser-607, Ser-655 and Ser-804 by CDK5;
CC       phosphorylation is necessary for KCNB1 channel clustering
CC       formation (PubMed:21712386). The Ser-607 phosphorylation state
CC       differs between KCNB1-containing clusters on the proximal and
CC       distal portions of the axon initial segment (AIS)
CC       (PubMed:24477962). Highly phosphorylated on serine residues in the
CC       C-terminal cytoplasmic tail in resting neurons (PubMed:9351973,
CC       PubMed:16917065). Phosphorylated in pancreatic beta cells in
CC       response to incretin hormones stimulation in a PKA- and
CC       RPS6KA5/MSK1-dependent signaling pathway, promoting beta cell
CC       survival (PubMed:21818121). Phosphorylation on Ser-567 is reduced
CC       during postnatal development with low levels at P2 and P5; levels
CC       then increase to reach adult levels by P14 (PubMed:17192433).
CC       Phosphorylation on Ser-457, Ser-541, Ser-567, Ser-607, Ser-655 and
CC       Ser-719 as well as the N-terminal Ser-15 are sensitive to
CC       calcineurin-mediated dephosphorylation contributing to the
CC       modulation of the voltage-dependent gating properties
CC       (PubMed:17192433, PubMed:16917065). Dephosphorylation by
CC       phosphatase PTPRE isoform 2 confers neuroprotection by its
CC       inhibitory influence on the neuronal apoptotic potassium current
CC       surge in a Zn(2+)-dependent manner (PubMed:19622611).
CC       Dephosphorylated at Ser-607 by protein phosphatase PPP1CA
CC       (PubMed:21712386). Hypoxia-, seizure- or glutamate-induced
CC       neuronal activities promote calcium/calcineurin-dependent
CC       dephosphorylation resulting in a loss of KCNB1-containing
CC       clustering and enhanced channel activity (PubMed:15195093,
CC       PubMed:16319318, PubMed:16407566, PubMed:17192433,
CC       PubMed:16917065). In response to brain ischemia, Ser-567 and Ser-
CC       607 are strongly dephosphorylated while Ser-457 and Ser-719 are
CC       less dephosphorylated (PubMed:17192433). In response to brain
CC       seizures, phosphorylation levels on Ser-567 and Ser-607 are
CC       greatly reduced (PubMed:17192433). Phosphorylated/dephosphorylated
CC       by Src or FYN tyrosine-protein kinases and tyrosine phosphatase
CC       PTPRE in primary Schwann cells and sciatic nerve tissue (By
CC       similarity). {ECO:0000250|UniProtKB:Q03717,
CC       ECO:0000269|PubMed:12615930, ECO:0000269|PubMed:15195093,
CC       ECO:0000269|PubMed:16319318, ECO:0000269|PubMed:16407566,
CC       ECO:0000269|PubMed:16917065, ECO:0000269|PubMed:17192433,
CC       ECO:0000269|PubMed:17360683, ECO:0000269|PubMed:18463252,
CC       ECO:0000269|PubMed:18690023, ECO:0000269|PubMed:19622611,
CC       ECO:0000269|PubMed:21712386, ECO:0000269|PubMed:21818121,
CC       ECO:0000269|PubMed:24477962, ECO:0000269|PubMed:8083226,
CC       ECO:0000269|PubMed:9351973}.
CC   -!- PTM: Acetylated. Acetylation occurs in pancreatic beta cells in
CC       response to stimulation by incretin hormones in a histone
CC       acetyltransferase (HAT)/histone deacetylase (HDAC)-dependent
CC       signaling pathway, promoting beta cell survival (PubMed:21818121).
CC       {ECO:0000269|PubMed:21818121}.
CC   -!- PTM: Sumoylated on Lys-474, preferentially with SUMO1; sumoylation
CC       induces a positive shift in the voltage-dependence of activation
CC       and inhibits channel activity (PubMed:21518833). Sumoylation
CC       increases the frequency of repetitive action potential firing at
CC       the cell surface of hippocampal neurons and decreases its
CC       frequency in pancreatic beta cells (PubMed:21518833). Desumoylated
CC       by SENP1 (PubMed:21518833). {ECO:0000269|PubMed:21518833}.
CC   -!- PTM: Not glycosylated (PubMed:8083226).
CC       {ECO:0000269|PubMed:8083226}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. B (Shab) (TC
CC       1.A.1.2) subfamily. Kv2.1/KCNB1 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA34497.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16476; CAA34497.1; ALT_INIT; mRNA.
DR   PIR; S05448; CHRTD1.
DR   RefSeq; NP_037318.1; NM_013186.1.
DR   UniGene; Rn.26724; -.
DR   PDB; 2R9R; X-ray; 2.40 A; B/H=272-304.
DR   PDB; 3LNM; X-ray; 2.90 A; B/D=272-304.
DR   PDB; 4JTA; X-ray; 2.50 A; B/Q=274-306.
DR   PDB; 4JTC; X-ray; 2.56 A; B/H=274-306.
DR   PDB; 4JTD; X-ray; 2.54 A; B/H=274-306.
DR   PDBsum; 2R9R; -.
DR   PDBsum; 3LNM; -.
DR   PDBsum; 4JTA; -.
DR   PDBsum; 4JTC; -.
DR   PDBsum; 4JTD; -.
DR   ProteinModelPortal; P15387; -.
DR   SMR; P15387; -.
DR   BioGrid; 247764; 5.
DR   IntAct; P15387; 4.
DR   MINT; MINT-8283237; -.
DR   STRING; 10116.ENSRNOP00000065961; -.
DR   BindingDB; P15387; -.
DR   ChEMBL; CHEMBL1075226; -.
DR   GuidetoPHARMACOLOGY; 546; -.
DR   iPTMnet; P15387; -.
DR   PhosphoSitePlus; P15387; -.
DR   PaxDb; P15387; -.
DR   PRIDE; P15387; -.
DR   GeneID; 25736; -.
DR   KEGG; rno:25736; -.
DR   UCSC; RGD:2954; rat.
DR   CTD; 3745; -.
DR   RGD; 2954; Kcnb1.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOVERGEN; HBG052225; -.
DR   InParanoid; P15387; -.
DR   KO; K04885; -.
DR   OrthoDB; EOG091G0FP3; -.
DR   PhylomeDB; P15387; -.
DR   EvolutionaryTrace; P15387; -.
DR   PRO; PR:P15387; -.
DR   Proteomes; UP000002494; Unplaced.
DR   Genevisible; P15387; RN.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0032590; C:dendrite membrane; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:RGD.
DR   GO; GO:0016328; C:lateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:RGD.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IMP:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:RGD.
DR   GO; GO:0000149; F:SNARE binding; IPI:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:MGI.
DR   GO; GO:0001508; P:action potential; IDA:UniProtKB.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0031669; P:cellular response to nutrient levels; IDA:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0007215; P:glutamate receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; ISS:UniProtKB.
DR   GO; GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IDA:UniProtKB.
DR   GO; GO:0033605; P:positive regulation of catecholamine secretion; IDA:UniProtKB.
DR   GO; GO:1900454; P:positive regulation of long term synaptic depression; ISS:UniProtKB.
DR   GO; GO:0010701; P:positive regulation of norepinephrine secretion; IDA:UniProtKB.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; IDA:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB.
DR   GO; GO:0051259; P:protein oligomerization; IMP:RGD.
DR   GO; GO:0098900; P:regulation of action potential; ISS:UniProtKB.
DR   GO; GO:2000671; P:regulation of motor neuron apoptotic process; IDA:UniProtKB.
DR   GO; GO:0006904; P:vesicle docking involved in exocytosis; IDA:UniProtKB.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003973; K_chnl_volt-dep_Kv2.
DR   InterPro; IPR004350; K_chnl_volt-dep_Kv2.1.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03521; Kv2channel; 2.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01514; KV21CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01495; SHABCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Cell projection;
KW   Complete proteome; Exocytosis; Ion channel; Ion transport;
KW   Isopeptide bond; Membrane; Phosphoprotein; Postsynaptic cell membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Synapse; Synaptosome; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation; Voltage-gated channel.
FT   CHAIN         1    857       Potassium voltage-gated channel subfamily
FT                                B member 1.
FT                                /FTId=PRO_0000054046.
FT   TOPO_DOM      1    186       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    187    208       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    209    228       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    229    250       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    251    259       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    260    280       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    281    294       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    295    316       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    317    330       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    331    351       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    352    364       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    365    376       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    377    384       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    385    391       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    392    420       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    421    857       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION       59     75       Self-association.
FT                                {ECO:0000269|PubMed:18463252,
FT                                ECO:0000269|PubMed:19690160}.
FT   REGION      448    481       Self-association.
FT                                {ECO:0000269|PubMed:18463252,
FT                                ECO:0000269|PubMed:19690160}.
FT   MOTIF       377    382       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   COMPBIAS    517    520       Poly-Ser.
FT   COMPBIAS    700    705       Poly-Ala.
FT   MOD_RES      15     15       Phosphoserine.
FT                                {ECO:0000269|PubMed:16917065,
FT                                ECO:0000269|PubMed:18690023}.
FT   MOD_RES     128    128       Phosphotyrosine; by Src.
FT                                {ECO:0000269|PubMed:12615930,
FT                                ECO:0000269|PubMed:19622611}.
FT   MOD_RES     444    444       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03717}.
FT   MOD_RES     457    457       Phosphoserine.
FT                                {ECO:0000269|PubMed:16917065,
FT                                ECO:0000269|PubMed:17192433,
FT                                ECO:0000269|PubMed:18690023}.
FT   MOD_RES     484    484       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903,
FT                                ECO:0000269|PubMed:16917065}.
FT   MOD_RES     496    496       Phosphoserine.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MOD_RES     503    503       Phosphoserine.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MOD_RES     519    519       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     520    520       Phosphoserine; by CDK5; in vitro.
FT                                {ECO:0000244|PubMed:22673903,
FT                                ECO:0000269|PubMed:16917065,
FT                                ECO:0000269|PubMed:21712386}.
FT   MOD_RES     541    541       Phosphoserine.
FT                                {ECO:0000269|PubMed:16917065,
FT                                ECO:0000269|PubMed:18690023}.
FT   MOD_RES     567    567       Phosphoserine.
FT                                {ECO:0000269|PubMed:16917065,
FT                                ECO:0000269|PubMed:17192433}.
FT   MOD_RES     590    590       Phosphoserine.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MOD_RES     607    607       Phosphoserine; by CDK5.
FT                                {ECO:0000269|PubMed:16917065,
FT                                ECO:0000269|PubMed:17192433,
FT                                ECO:0000269|PubMed:18690023,
FT                                ECO:0000269|PubMed:21712386,
FT                                ECO:0000269|PubMed:24477962}.
FT   MOD_RES     655    655       Phosphoserine; by CDK5; in vitro.
FT                                {ECO:0000244|PubMed:22673903,
FT                                ECO:0000269|PubMed:16917065,
FT                                ECO:0000269|PubMed:18690023,
FT                                ECO:0000269|PubMed:21712386}.
FT   MOD_RES     719    719       Phosphoserine.
FT                                {ECO:0000269|PubMed:16917065,
FT                                ECO:0000269|PubMed:17192433,
FT                                ECO:0000269|PubMed:18690023}.
FT   MOD_RES     771    771       Phosphoserine.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MOD_RES     799    799       Phosphoserine.
FT                                {ECO:0000269|PubMed:16917065,
FT                                ECO:0000269|PubMed:18690023}.
FT   MOD_RES     804    804       Phosphoserine; by CDK5, MAPK14; in vitro.
FT                                {ECO:0000269|PubMed:16917065,
FT                                ECO:0000269|PubMed:17360683,
FT                                ECO:0000269|PubMed:18690023,
FT                                ECO:0000269|PubMed:21712386}.
FT   MOD_RES     836    836       Phosphothreonine.
FT                                {ECO:0000269|PubMed:16917065,
FT                                ECO:0000269|PubMed:18690023}.
FT   CROSSLNK    474    474       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:21518833}.
FT   MUTAGEN      15     15       S->A: Shift in voltage-dependent gating
FT                                on calcineurin-dependent activation and
FT                                steady-state inactivation. Additive
FT                                effect on activation and steady-state
FT                                inactivation; when associated with A-457.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN      15     15       S->D: Resists voltage-dependent gating on
FT                                calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN      71     71       Q->E: Reduces channel activity.
FT                                {ECO:0000269|PubMed:12560340}.
FT   MUTAGEN      79     79       E->D: No effect on channel activity.
FT                                {ECO:0000269|PubMed:12560340}.
FT   MUTAGEN     128    128       Y->F: Reduces the increase of plasma
FT                                membrane insertion and apoptotic
FT                                enhancement of potassium current during
FT                                cell death program. Significant loss of
FT                                Src-mediated phosphorylation and channel
FT                                activity. Reduces interaction with PTPRE.
FT                                Increases cell viability against
FT                                apoptotic insults. Abolishes the increase
FT                                of plasma membrane insertion and
FT                                apoptotic enhancement of potassium
FT                                current during cell death program; when
FT                                associated with D-804.
FT                                {ECO:0000269|PubMed:12615930,
FT                                ECO:0000269|PubMed:19622611}.
FT   MUTAGEN     149    149       K->Q: No loss of SUMO-dependent channel
FT                                activity modulation in hippocampal
FT                                neurons. {ECO:0000269|PubMed:21518833}.
FT   MUTAGEN     259    259       K->Q: No loss of SUMO-dependent channel
FT                                activity modulation in hippocampal
FT                                neurons. {ECO:0000269|PubMed:21518833}.
FT   MUTAGEN     369    369       W->C: Reduces channel activity. Does not
FT                                inhibit membrane plasma subcellular
FT                                localization, interaction with STX1A,
FT                                pore-independent exocytosis activity and
FT                                apoptotic enhancement of potassium
FT                                current during cell death program; when
FT                                associated with T-384.
FT                                {ECO:0000269|PubMed:12451110,
FT                                ECO:0000269|PubMed:12832499,
FT                                ECO:0000269|PubMed:17301173,
FT                                ECO:0000269|PubMed:17360683,
FT                                ECO:0000269|PubMed:20202934,
FT                                ECO:0000269|PubMed:20484665,
FT                                ECO:0000269|PubMed:22411134}.
FT   MUTAGEN     384    384       Y->T: Reduces channel activity. Does not
FT                                inhibit membrane plasma subcellular
FT                                localization, interaction with STX1A,
FT                                pore-independent exocytosis activity and
FT                                apoptotic enhancement of potassium
FT                                current during cell death program; when
FT                                associated with C-369.
FT                                {ECO:0000269|PubMed:12451110,
FT                                ECO:0000269|PubMed:12832499,
FT                                ECO:0000269|PubMed:17301173,
FT                                ECO:0000269|PubMed:20202934,
FT                                ECO:0000269|PubMed:20484665,
FT                                ECO:0000269|PubMed:22411134}.
FT   MUTAGEN     444    444       S->A: No effect on Src-mediated
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:9351973}.
FT   MUTAGEN     457    457       S->A: Shift in voltage-dependent gating
FT                                on calcineurin-dependent activation and
FT                                steady-state inactivation. Additive
FT                                effect on activation and steady-state
FT                                inactivation; when associated with A-15.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     457    457       S->D: Resists voltage-dependent gating on
FT                                calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     474    474       K->Q: Loss of SUMO-dependent channel
FT                                activity modulation in hippocampal
FT                                neurons. {ECO:0000269|PubMed:21518833}.
FT   MUTAGEN     484    484       S->A: Shift in voltage-dependent gating
FT                                on calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     484    484       S->D: Resists voltage-dependent gating on
FT                                calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     496    496       S->A: No effect on Src-mediated
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:9351973}.
FT   MUTAGEN     541    541       S->A: Shift in voltage-dependent gating
FT                                on calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     541    541       S->D: Resists voltage-dependent gating on
FT                                calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     567    567       S->A: Shift in voltage-dependent gating
FT                                on calcineurin-dependent activation and
FT                                steady-state inactivation. Larger effect
FT                                on activation and steady-state
FT                                inactivation; when associated with A-607.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     567    567       S->D: Resists voltage-dependent gating on
FT                                calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     587    587       S->A: Abolishes clustered subcellular
FT                                distribution in neurons.
FT                                {ECO:0000269|PubMed:10719893}.
FT   MUTAGEN     590    590       S->A: Abolishes clustered subcellular
FT                                distribution in neurons. Does not affect
FT                                KCNB1-containing vesicles motility.
FT                                {ECO:0000269|PubMed:10719893,
FT                                ECO:0000269|PubMed:24569993}.
FT   MUTAGEN     591    591       F->A: Abolishes clustered subcellular
FT                                distribution in neurons.
FT                                {ECO:0000269|PubMed:10719893}.
FT   MUTAGEN     593    593       S->A: Abolishes clustered subcellular
FT                                distribution in neurons.
FT                                {ECO:0000269|PubMed:10719893}.
FT   MUTAGEN     607    607       S->A: Shift in voltage-dependent gating
FT                                on calcineurin-dependent activation and
FT                                steady-state inactivation. Larger effect
FT                                on activation and steady-state
FT                                inactivation; when associated with A-567.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     607    607       S->D: Resists voltage-dependent gating on
FT                                calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     655    655       S->A: Shift in voltage-dependent gating
FT                                on calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     655    655       S->D: Resists voltage-dependent gating on
FT                                calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     719    719       S->A: Shift in voltage-dependent gating
FT                                on calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     719    719       S->D: Resists voltage-dependent gating on
FT                                calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     771    771       S->A: Shift in voltage-dependent gating
FT                                on calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     771    771       S->D: Resists voltage-dependent gating on
FT                                calcineurin-dependent activation and
FT                                steady-state inactivation.
FT                                {ECO:0000269|PubMed:16917065}.
FT   MUTAGEN     804    804       S->A: Reduces the increase of plasma
FT                                membrane insertion and apoptotic
FT                                enhancement of potassium current during
FT                                cell death program. No change in
FT                                calcineurin-dependent regulation of
FT                                voltage-dependent gating. Abolishes the
FT                                increase of plasma membrane insertion and
FT                                apoptotic enhancement of potassium
FT                                current during cell death program; when
FT                                associated with F-128.
FT                                {ECO:0000269|PubMed:16917065,
FT                                ECO:0000269|PubMed:17360683,
FT                                ECO:0000269|PubMed:19622611}.
FT   MUTAGEN     804    804       S->D: Does not reduce apoptotic
FT                                enhancement of potassium current during
FT                                the cell death program.
FT                                {ECO:0000269|PubMed:17360683}.
FT   HELIX       274    281       {ECO:0000244|PDB:4JTA}.
FT   HELIX       286    302       {ECO:0000244|PDB:4JTA}.
FT   HELIX       303    307       {ECO:0000244|PDB:4JTA}.
SQ   SEQUENCE   857 AA;  95637 MW;  B3C5B0839AB15FD0 CRC64;
     MPAGMTKHGS RSTSSLPPEP MEIVRSKACS RRVRLNVGGL AHEVLWRTLD RLPRTRLGKL
     RDCNTHDSLL QVCDDYSLED NEYFFDRHPG AFTSILNFYR TGRLHMMEEM CALSFSQELD
     YWGIDEIYLE SCCQARYHQK KEQMNEELKR EAETLREREG EEFDNTCCAE KRKKLWDLLE
     KPNSSVAAKI LAIISIMFIV LSTIALSLNT LPELQSLDEF GQSTDNPQLA HVEAVCIAWF
     TMEYLLRFLS SPKKWKFFKG PLNAIDLLAI LPYYVTIFLT ESNKSVLQFQ NVRRVVQIFR
     IMRILRILKL ARHSTGLQSL GFTLRRSYNE LGLLILFLAM GIMIFSSLVF FAEKDEDDTK
     FKSIPASFWW ATITMTTVGY GDIYPKTLLG KIVGGLCCIA GVLVIALPIP IIVNNFSEFY
     KEQKRQEKAI KRREALERAK RNGSIVSMNM KDAFARSIEM MDIVVEKNGE SIAKKDKVQD
     NHLSPNKWKW TKRALSETSS SKSFETKEQG SPEKARSSSS PQHLNVQQLE DMYSKMAKTQ
     SQPILNTKEM APQSKPPEEL EMSSMPSPVA PLPARTEGVI DMRSMSSIDS FISCATDFPE
     ATRFSHSPLA SLSSKAGSST APEVGWRGAL GASGGRLTET NPIPETSRSG FFVESPRSSM
     KTNNPLKLRA LKVNFVEGDP TPLLPSLGLY HDPLRNRGGA AAAVAGLECA SLLDKPVLSP
     ESSIYTTASA RTPPRSPEKH TAIAFNFEAG VHHYIDTDTD DEGQLLYSVD SSPPKSLHGS
     TSPKFSTGAR TEKNHFESSP LPTSPKFLRP NCVYSSEGLT GKGPGAQEKC KLENHTPPDV
     HMLPGGGAHG STRDQSI
//
ID   KCNA6_HUMAN             Reviewed;         529 AA.
AC   P17658;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 1.
DT   22-NOV-2017, entry version 163.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 6;
DE   AltName: Full=Voltage-gated potassium channel HBK2 {ECO:0000303|PubMed:2347305};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.6;
GN   Name=KCNA6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=2347305;
RA   Grupe A., Schroeter K.H., Ruppersberg J.P., Stocker M., Drewes T.,
RA   Beckh S., Pongs O.;
RT   "Cloning and expression of a human voltage-gated potassium channel. A
RT   novel member of the RCK potassium channel family.";
RL   EMBO J. 9:1749-1756(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=14575698; DOI=10.1016/j.bbrc.2003.09.167;
RA   Guihard G., Bellocq C., Grelet E., Escande D.;
RT   "Human Kv1.6 current displays a C-type-like inactivation when re-
RT   expressed in cos-7 cells.";
RL   Biochem. Biophys. Res. Commun. 311:83-89(2003).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes. Forms
CC       tetrameric potassium-selective channels through which potassium
CC       ions pass in accordance with their electrochemical gradient
CC       (PubMed:2347305, PubMed:14575698). The channel alternates between
CC       opened and closed conformations in response to the voltage
CC       difference across the membrane (PubMed:2347305, PubMed:14575698).
CC       Can form functional homotetrameric channels and heterotetrameric
CC       channels that contain variable proportions of KCNA1, KCNA2, KCNA4,
CC       KCNA6, and possibly other family members as well; channel
CC       properties depend on the type of alpha subunits that are part of
CC       the channel (By similarity). Channel properties are modulated by
CC       cytoplasmic beta subunits that regulate the subcellular location
CC       of the alpha subunits and promote rapid inactivation (By
CC       similarity). Homotetrameric channels display rapid activation and
CC       slow inactivation (PubMed:2347305). {ECO:0000250|UniProtKB:P17659,
CC       ECO:0000269|PubMed:14575698, ECO:0000269|PubMed:2347305}.
CC   -!- SUBUNIT: Homotetramer and heterotetramer of potassium channel
CC       proteins (By similarity). Interacts with KCNAB1 and KCNAB2 (By
CC       similarity). {ECO:0000250|UniProtKB:P17659, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14575698,
CC       ECO:0000269|PubMed:2347305}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.6/KCNA6 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X17622; CAA35623.1; -; mRNA.
DR   EMBL; BC069355; AAH69355.1; -; mRNA.
DR   CCDS; CCDS8534.1; -.
DR   PIR; S12787; S12787.
DR   RefSeq; NP_002226.1; NM_002235.3.
DR   RefSeq; XP_005253743.1; XM_005253686.3.
DR   RefSeq; XP_011519257.1; XM_011520955.2.
DR   RefSeq; XP_016874759.1; XM_017019270.1.
DR   RefSeq; XP_016874760.1; XM_017019271.1.
DR   RefSeq; XP_016874761.1; XM_017019272.1.
DR   UniGene; Hs.306190; -.
DR   ProteinModelPortal; P17658; -.
DR   BioGrid; 109944; 13.
DR   IntAct; P17658; 2.
DR   STRING; 9606.ENSP00000280684; -.
DR   BindingDB; P17658; -.
DR   ChEMBL; CHEMBL5279; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 543; -.
DR   iPTMnet; P17658; -.
DR   PhosphoSitePlus; P17658; -.
DR   BioMuta; KCNA6; -.
DR   DMDM; 116434; -.
DR   PaxDb; P17658; -.
DR   PeptideAtlas; P17658; -.
DR   PRIDE; P17658; -.
DR   DNASU; 3742; -.
DR   GeneID; 3742; -.
DR   KEGG; hsa:3742; -.
DR   UCSC; uc001qng.4; human.
DR   CTD; 3742; -.
DR   DisGeNET; 3742; -.
DR   EuPathDB; HostDB:ENSG00000151079.7; -.
DR   GeneCards; KCNA6; -.
DR   HGNC; HGNC:6225; KCNA6.
DR   HPA; CAB011539; -.
DR   HPA; HPA014418; -.
DR   MIM; 176257; gene.
DR   neXtProt; NX_P17658; -.
DR   OpenTargets; ENSG00000130035; -.
DR   OpenTargets; ENSG00000151079; -.
DR   PharmGKB; PA30022; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   GeneTree; ENSGT00900000140827; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; P17658; -.
DR   KO; K04879; -.
DR   OMA; GKPEFSE; -.
DR   OrthoDB; EOG091G10NU; -.
DR   PhylomeDB; P17658; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNA6; human.
DR   GeneWiki; KCNA6; -.
DR   GenomeRNAi; 3742; -.
DR   PRO; PR:P17658; -.
DR   Proteomes; UP000005640; Unplaced.
DR   Bgee; ENSG00000151079; -.
DR   CleanEx; HS_KCNA6; -.
DR   Genevisible; P17658; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0043679; C:axon terminus; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0034705; C:potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004053; K_chnl_volt-dep_Kv1.6.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF104; PTHR11537:SF104; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01513; KV16CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    529       Potassium voltage-gated channel subfamily
FT                                A member 6.
FT                                /FTId=PRO_0000053990.
FT   TOPO_DOM      1    171       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    172    193       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    194    262       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    263    284       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    285    295       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    296    316       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    317    337       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    338    358       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    359    373       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    374    395       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    396    409       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    410    421       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    422    429       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    430    436       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    437    465       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    466    529       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION      360    373       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       422    427       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       527    529       PDZ-binding. {ECO:0000255}.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61923}.
FT   MOD_RES     511    511       Phosphoserine; by PKA. {ECO:0000305}.
FT   LIPID       285    285       S-palmitoyl cysteine. {ECO:0000255}.
SQ   SEQUENCE   529 AA;  58729 MW;  CFF0710A1F9CD69F CRC64;
     MRSEKSLTLA APGEVRGPEG EQQDAGDFPE AGGGGGCCSS ERLVINISGL RFETQLRTLS
     LFPDTLLGDP GRRVRFFDPL RNEYFFDRNR PSFDAILYYY QSGGRLRRPV NVPLDIFLEE
     IRFYQLGDEA LAAFREDEGC LPEGGEDEKP LPSQPFQRQV WLLFEYPESS GPARGIAIVS
     VLVILISIVI FCLETLPQFR VDGRGGNNGG VSRVSPVSRG SQEEEEDEDD SYTFHHGITP
     GEMGTGGSSS LSTLGGSFFT DPFFLVETLC IVWFTFELLV RFSACPSKPA FFRNIMNIID
     LVAIFPYFIT LGTELVQQQE QQPASGGGGQ NGQQAMSLAI LRVIRLVRVF RIFKLSRHSK
     GLQILGKTLQ ASMRELGLLI FFLFIGVILF SSAVYFAEAD DDDSLFPSIP DAFWWAVVTM
     TTVGYGDMYP MTVGGKIVGS LCAIAGVLTI ALPVPVIVSN FNYFYHRETE QEEQGQYTHV
     TCGQPAPDLR ATDNGLGKPD FPEANRERRP SYLPTPHRAY AEKRMLTEV
//
ID   KCNAB_DROME             Reviewed;         985 AA.
AC   P17970; O76805; Q9I7T9; Q9I7U0;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2001, sequence version 2.
DT   22-NOV-2017, entry version 161.
DE   RecName: Full=Potassium voltage-gated channel protein Shab;
GN   Name=Shab; ORFNames=CG43128;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ISOFORMS A AND B).
RC   STRAIN=Oregon-R;
RX   PubMed=2493160; DOI=10.1126/science.2493160;
RA   Butler A., Wei A.G., Baker K., Salkoff L.;
RT   "A family of putative potassium channel genes in Drosophila.";
RL   Science 243:943-947(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RX   PubMed=2333511; DOI=10.1126/science.2333511;
RA   Wei A.G., Covarrubias M., Butler A., Baker K., Pak M., Salkoff L.;
RT   "K+ current diversity is produced by an extended gene family conserved
RT   in Drosophila and mouse.";
RL   Science 248:599-603(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RX   PubMed=2336395; DOI=10.1093/nar/18.8.2173;
RA   Butler A., Wei A., Baker K., Salkoff L.;
RT   "Shal, Shab, and Shaw: three genes encoding potassium channels in
RT   Drosophila.";
RL   Nucleic Acids Res. 18:2173-2174(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), AND MUTAGENESIS.
RC   STRAIN=Canton-S;
RX   PubMed=10419540; DOI=10.1074/jbc.274.31.22109;
RA   Hegde P., Gu G.G., Chen D., Free S.J., Singh S.;
RT   "Mutational analysis of the Shab-encoded delayed rectifier K(+)
RT   channels in Drosophila.";
RL   J. Biol. Chem. 274:22109-22113(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [6]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
CC   -!- FUNCTION: Mediates the voltage-dependent potassium ion
CC       permeability of excitable membranes. Assuming opened or closed
CC       conformations in response to the voltage difference across the
CC       membrane, the protein forms a potassium-selective channel through
CC       which potassium ions may pass in accordance with their
CC       electrochemical gradient.
CC   -!- SUBUNIT: Heterotetramer of potassium channel proteins.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=B;
CC         IsoId=P17970-1; Sequence=Displayed;
CC       Name=A;
CC         IsoId=P17970-2; Sequence=VSP_000960;
CC   -!- DEVELOPMENTAL STAGE: Expressed in late embryos and pupae.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments.
CC   -!- MISCELLANEOUS: The segment S4 is probably the voltage-sensor and
CC       is characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. B (Shab) (TC
CC       1.A.1.2) subfamily. Shab sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG22232.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAG22233.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M32659; AAA28896.1; -; mRNA.
DR   EMBL; AF084525; AAC33365.1; -; mRNA.
DR   EMBL; AE014296; AAG22232.2; ALT_INIT; Genomic_DNA.
DR   EMBL; AE014296; AAG22233.1; ALT_INIT; Genomic_DNA.
DR   PIR; S12746; S12746.
DR   RefSeq; NP_523894.2; NM_079170.6.
DR   RefSeq; NP_728783.1; NM_167967.4.
DR   UniGene; Dm.2563; -.
DR   ProteinModelPortal; P17970; -.
DR   SMR; P17970; -.
DR   BioGrid; 63854; 3.
DR   STRING; 7227.FBpp0306030; -.
DR   TCDB; 1.A.1.2.1; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; P17970; -.
DR   PRIDE; P17970; -.
DR   GeneID; 38352; -.
DR   KEGG; dme:Dmel_CG43128; -.
DR   CTD; 38352; -.
DR   FlyBase; FBgn0262593; Shab.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   InParanoid; P17970; -.
DR   KO; K04885; -.
DR   OrthoDB; EOG091G0FP3; -.
DR   PhylomeDB; P17970; -.
DR   Reactome; R-DME-1296072; Voltage gated Potassium channels.
DR   Reactome; R-DME-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   ChiTaRS; Shab; fly.
DR   GenomeRNAi; 38352; -.
DR   PRO; PR:P17970; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0262593; -.
DR   ExpressionAtlas; P17970; differential.
DR   Genevisible; P17970; DM.
DR   GO; GO:0005886; C:plasma membrane; ISS:FlyBase.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:FlyBase.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:FlyBase.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:FlyBase.
DR   GO; GO:0001508; P:action potential; IMP:FlyBase.
DR   GO; GO:0007268; P:chemical synaptic transmission; IMP:FlyBase.
DR   GO; GO:0008345; P:larval locomotory behavior; IMP:FlyBase.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IMP:FlyBase.
DR   GO; GO:0045938; P:positive regulation of circadian sleep/wake cycle, sleep; IMP:FlyBase.
DR   GO; GO:0006813; P:potassium ion transport; TAS:FlyBase.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0008016; P:regulation of heart contraction; IMP:FlyBase.
DR   GO; GO:0060025; P:regulation of synaptic activity; IMP:FlyBase.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 2.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    985       Potassium voltage-gated channel protein
FT                                Shab.
FT                                /FTId=PRO_0000053965.
FT   TRANSMEM    436    454       Helical; Name=Segment S1.
FT   TRANSMEM    474    495       Helical; Name=Segment S2.
FT   TRANSMEM    506    527       Helical; Name=Segment S3.
FT   TRANSMEM    536    561       Helical; Name=Segment S4.
FT   TRANSMEM    577    598       Helical; Name=Segment S5.
FT   TRANSMEM    638    659       Helical; Name=Segment S6.
FT   MOTIF       623    628       Selectivity filter. {ECO:0000250}.
FT   MOD_RES     690    690       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES     731    731       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES     796    796       Phosphoserine; by PKA. {ECO:0000255}.
FT   CARBOHYD    245    245       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    429    429       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    530    530       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    749    749       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    756    756       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    885    885       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    888    888       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    914    914       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     717    746       Missing (in isoform A).
FT                                {ECO:0000303|PubMed:10419540}.
FT                                /FTId=VSP_000960.
FT   MUTAGEN     435    435       R->Q: In allele Shab-1; temperature-
FT                                sensitive paralytic.
FT                                {ECO:0000269|PubMed:10419540}.
FT   MUTAGEN     608    608       V->D: In allele Shab-1; temperature-
FT                                sensitive paralytic.
FT                                {ECO:0000269|PubMed:10419540}.
FT   CONFLICT     31     31       Q -> L (in Ref. 1, 2 and 3).
FT                                {ECO:0000305}.
FT   CONFLICT    220    220       S -> G (in Ref. 1, 2 and 3).
FT                                {ECO:0000305}.
FT   CONFLICT    307    307       R -> G (in Ref. 1, 2 and 3).
FT                                {ECO:0000305}.
FT   CONFLICT    362    362       S -> G (in Ref. 1, 2 and 3).
FT                                {ECO:0000305}.
FT   CONFLICT    414    415       FS -> CA (in Ref. 5; AAG22232/AAG22233).
FT                                {ECO:0000305}.
FT   CONFLICT    495    495       A -> S (in Ref. 1, 2 and 3).
FT                                {ECO:0000305}.
FT   CONFLICT    553    553       V -> I (in Ref. 5; AAG22232/AAG22233).
FT                                {ECO:0000305}.
FT   CONFLICT    613    613       A -> T (in Ref. 5; AAG22232/AAG22233).
FT                                {ECO:0000305}.
FT   CONFLICT    630    630       C -> Y (in Ref. 5; AAG22232/AAG22233).
FT                                {ECO:0000305}.
FT   CONFLICT    651    651       V -> I (in Ref. 5; AAG22232/AAG22233).
FT                                {ECO:0000305}.
FT   CONFLICT    827    828       EQ -> DE (in Ref. 1, 2 and 3).
FT                                {ECO:0000305}.
FT   CONFLICT    877    877       A -> G (in Ref. 1, 2 and 3).
FT                                {ECO:0000305}.
FT   CONFLICT    903    985       GDGDGGGVDDDNLSQAKGLPIQMMITPGEVAELRRQVALEN
FT                                LQNQRMDNLEQDVPVEFECCFCTTKGLPGCHGECIPLRANS
FT                                V -> VMEMGAVSMTTTFPRPRDCPSR (in Ref. 1, 2
FT                                and 3). {ECO:0000305}.
FT   CONFLICT    911    913       DDD -> NDN (in Ref. 4; AAC33365).
FT                                {ECO:0000305}.
SQ   SEQUENCE   985 AA;  106359 MW;  59E38AD35F064AC8 CRC64;
     MVGQLQGGQA AGQQQQQQQA TQQQQHSKQQ QQQQQQQQQQ LQLKQHQQQQ QDILYQQHNE
     AIAIARGLQA ATPADIGDNQ PYYDTSGNVD WERAMGAGGA GAYGGIGIGS LPAAGGAAYH
     LGPANPAGLV SRHLDYGDGG HLAGPSAGLP AGAVGSGAGA GAGAGASVTG SGSGAGTGTG
     TGAGSGSGSG AAGKEVRYAP FPVASPTHSI PTTSQQIVGS VGGVGVGGAS SQSISGGVPT
     HSQSNTTGAL QRTHSRSMSS IPPPEPFMIA QSKAVNSRVS INVGGVRHEV LWRTLERLPH
     TRLGRLRECT THEAIVELCD DYSLADNEYF FDRHPKSFSS ILNFYRTGKL HIVDEMCVLA
     FSDDLEYWGV DELYLESCCQ HKYHQRKENV HEEMRKEAES LRQRDEEEFG EGKFSEYQKY
     LWELLEKPNT SFAARVIAVI SILFIVLSTI ALTLNTLPQL QHIDNGTPQD NPQLAMVEAV
     CITWFTLEYI LRFSASPDKW KFFKGGLNII DLLAILPYFV SLFLLETNKN ATDQFQDVRR
     VVQVFRIMRI LRVLKLARHS TGLQSLGFTL RNSYKELGLL MLFLAMGVLI FSSLAYFAEK
     DEKDTKFVSI PEAFWWAGIT MTTVGYGDIC PTTALGKVIG TVCCICGVLV VALPIPIIVN
     NFAEFYKNQM RREKALKRRE ALDRAKREGS IVSFHHINLK DAFAKSMDLI DVIVDTGKQT
     NVVHPKGKRQ STPNIGRQTL DVQSAPGHNL SQTDGNSTEG ESTSGRNPAT TGTGCYKNYD
     HVANLRNSNL HNRRGSSSEQ DAVPPYSFDN PNARQTSMMA MESYRREQQA LLQQQQQQQQ
     QMLQMQQIQQ KAPNGNGGAT GGGVANNLAM VAASSAATAV ATATNASNAS NTAPGSEGAE
     GGGDGDGGGV DDDNLSQAKG LPIQMMITPG EVAELRRQVA LENLQNQRMD NLEQDVPVEF
     ECCFCTTKGL PGCHGECIPL RANSV
//
ID   KCNAW_DROME             Reviewed;         498 AA.
AC   P17972; Q9VQU5;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   22-NOV-2017, entry version 158.
DE   RecName: Full=Potassium voltage-gated channel protein Shaw;
DE   AltName: Full=Shaw2;
GN   Name=Shaw; Synonyms=SHAW2; ORFNames=CG2822;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2333511; DOI=10.1126/science.2333511;
RA   Wei A.G., Covarrubias M., Butler A., Baker K., Pak M., Salkoff L.;
RT   "K+ current diversity is produced by an extended gene family conserved
RT   in Drosophila and mouse.";
RL   Science 248:599-603(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2336395; DOI=10.1093/nar/18.8.2173;
RA   Butler A., Wei A., Baker K., Salkoff L.;
RT   "Shal, Shab, and Shaw: three genes encoding potassium channels in
RT   Drosophila.";
RL   Nucleic Acids Res. 18:2173-2174(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
CC   -!- FUNCTION: Mediates the voltage-dependent potassium ion
CC       permeability of excitable membranes. Assuming opened or closed
CC       conformations in response to the voltage difference across the
CC       membrane, the protein forms a potassium-selective channel through
CC       which potassium ions may pass in accordance with their
CC       electrochemical gradient.
CC   -!- SUBUNIT: Heterotetramer of potassium channel proteins.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- MISCELLANEOUS: The segment S4 is probably the voltage-sensor and
CC       is characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- MISCELLANEOUS: This channel protein belongs to the delayed
CC       rectifier class.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw) (TC
CC       1.A.1.2) subfamily. Shaw sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M32661; AAA28897.1; -; mRNA.
DR   EMBL; AE014134; AAF51069.1; -; Genomic_DNA.
DR   PIR; A41359; A41359.
DR   RefSeq; NP_476721.1; NM_057373.3.
DR   UniGene; Dm.4566; -.
DR   ProteinModelPortal; P17972; -.
DR   BioGrid; 59803; 1.
DR   STRING; 7227.FBpp0288427; -.
DR   TCDB; 1.A.1.2.2; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; P17972; -.
DR   PRIDE; P17972; -.
DR   EnsemblMetazoa; FBtr0089274; FBpp0088331; FBgn0003386.
DR   GeneID; 33599; -.
DR   KEGG; dme:Dmel_CG2822; -.
DR   CTD; 33599; -.
DR   FlyBase; FBgn0003386; Shaw.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000238082; -.
DR   InParanoid; P17972; -.
DR   KO; K04887; -.
DR   OrthoDB; EOG091G0EJL; -.
DR   PhylomeDB; P17972; -.
DR   Reactome; R-DME-1296072; Voltage gated Potassium channels.
DR   Reactome; R-DME-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   GenomeRNAi; 33599; -.
DR   PRO; PR:P17972; -.
DR   Proteomes; UP000000803; Chromosome 2L.
DR   Bgee; FBgn0003386; -.
DR   ExpressionAtlas; P17972; differential.
DR   Genevisible; P17972; DM.
DR   GO; GO:0005886; C:plasma membrane; ISS:FlyBase.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISS:FlyBase.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; ISS:FlyBase.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:FlyBase.
DR   GO; GO:0006813; P:potassium ion transport; ISS:FlyBase.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0030431; P:sleep; IMP:FlyBase.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR015572; Shaw_inv.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF237; PTHR11537:SF237; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    498       Potassium voltage-gated channel protein
FT                                Shaw.
FT                                /FTId=PRO_0000053967.
FT   TRANSMEM    175    193       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    230    252       Helical; Name=Segment S2. {ECO:0000255}.
FT   TRANSMEM    263    284       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    292    313       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TRANSMEM    329    350       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    392    413       Helical; Name=Segment S6. {ECO:0000255}.
FT   MOTIF       377    382       Selectivity filter. {ECO:0000250}.
FT   CARBOHYD    206    206       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    213    213       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    481    481       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   498 AA;  56509 MW;  977E3B7F22F098E2 CRC64;
     MNLINMDSEN RVVLNVGGIR HETYKATLKK IPATRLSRLT EALANYDPIL NEYFFDRHPG
     VFAQVLNYYR TGKLHYPTDV CGPLFEEELE FWGLDSNQVE PCCWMTYTQH RDTQETLAVL
     DRLDLDTEKP SEEELARKFG FEEDYYKGTI SWWQEMKPRI WSLFDEPYSS NAAKTIGVVS
     VFFICISILS FCLKTHPDMR VPIVRNITVK TANGSNGWFL DKTQTNAHIA FFYIECVCNA
     WFTFEILVRF ISSPNKWEFI KSSVNIIDYI ATLSFYIDLV LQRFASHLEN ADILEFFSII
     RIMRLFKLTR HSSGLKILIQ TFRASAKELT LLVFFLVLGI VIFASLVYYA ERIQPNPHND
     FNSIPLGLWW ALVTMTTVGY GDMAPKTYIG MFVGALCALA GVLTIALPVP VIVSNFAMYY
     SHTQARAKLP KKRRRVLPVE QPRQPRLPGA PGGVSGCGTP GSGPHSGPMG SGGTGPRRMN
     NKTKDLVSPK SDMAFSFD
//
ID   KCNA3_HUMAN             Reviewed;         575 AA.
AC   P22001; Q5VWN2;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   22-NOV-2017, entry version 181.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 3;
DE   AltName: Full=HGK5;
DE   AltName: Full=HLK3;
DE   AltName: Full=HPCN3;
DE   AltName: Full=Voltage-gated K(+) channel HuKIII;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.3;
GN   Name=KCNA3; Synonyms=HGK5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   PubMed=7829094; DOI=10.1006/geno.1994.1500;
RA   Folander K., Douglass J., Swanson R.;
RT   "Confirmation of the assignment of the gene encoding Kv1.3, a voltage-
RT   gated potassium channel (KCNA3) to the proximal short arm of human
RT   chromosome 1.";
RL   Genomics 23:295-296(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 12-575.
RC   TISSUE=Skeletal muscle;
RX   PubMed=1986382; DOI=10.1073/pnas.88.1.53;
RA   Philipson L.H., Hice R.E., Schaefer K., Lamendola J., Bell G.I.,
RA   Nelson D.J., Steiner D.F.;
RT   "Sequence and functional expression in Xenopus oocytes of a human
RT   insulinoma and islet potassium channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:53-57(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-575.
RX   PubMed=1373731;
RA   Attali B., Romey G., Honore E., Schmid-Alliana A., Mattei M.-G.,
RA   Lesage F., Ricard P., Barhanin J., Lazdunski M.;
RT   "Cloning, functional expression, and regulation of two K+ channels in
RT   human T lymphocytes.";
RL   J. Biol. Chem. 267:8650-8657(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 47-575.
RC   TISSUE=Lymphocyte;
RX   PubMed=1547020; DOI=10.1089/dna.1992.11.163;
RA   Cai Y.-C., Osborne P.B., North R.A., Dooley D.C., Douglass J.;
RT   "Characterization and functional expression of genomic DNA encoding
RT   the human lymphocyte type n potassium channel.";
RL   DNA Cell Biol. 11:163-172(1992).
CC   -!- FUNCTION: Mediates the voltage-dependent potassium ion
CC       permeability of excitable membranes. Assuming opened or closed
CC       conformations in response to the voltage difference across the
CC       membrane, the protein forms a potassium-selective channel through
CC       which potassium ions may pass in accordance with their
CC       electrochemical gradient.
CC   -!- SUBUNIT: Heterotetramer of potassium channel proteins. Binds PDZ
CC       domains of DLG1, DLG2 and DLG4 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q07812:BAX; NbExp=2; IntAct=EBI-8627664, EBI-516580;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- PTM: N-glycosylation promotes the cell surface expression.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.3/KCNA3 sub-subfamily. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-53 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA36425.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA36425.1; Type=Frameshift; Positions=42; Evidence={ECO:0000305};
CC       Sequence=AAA59457.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA59457.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC       Sequence=AAB88073.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAC31761.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAC31761.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L23499; AAC31761.1; ALT_SEQ; mRNA.
DR   EMBL; AL365361; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471122; EAW56457.1; -; Genomic_DNA.
DR   EMBL; BC035059; AAH35059.2; -; mRNA.
DR   EMBL; M55515; AAA36425.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M85217; AAA59457.1; ALT_SEQ; mRNA.
DR   EMBL; M38217; AAB88073.1; ALT_INIT; Genomic_DNA.
DR   CCDS; CCDS828.2; -.
DR   PIR; A38101; A38101.
DR   RefSeq; NP_002223.3; NM_002232.4.
DR   UniGene; Hs.169948; -.
DR   UniGene; Hs.619197; -.
DR   UniGene; Hs.628223; -.
DR   PDB; 4BGC; X-ray; 1.20 A; A=104-204.
DR   PDBsum; 4BGC; -.
DR   ProteinModelPortal; P22001; -.
DR   SMR; P22001; -.
DR   BioGrid; 109941; 16.
DR   DIP; DIP-44822N; -.
DR   IntAct; P22001; 3.
DR   MINT; MINT-1528422; -.
DR   STRING; 9606.ENSP00000358784; -.
DR   BindingDB; P22001; -.
DR   ChEMBL; CHEMBL4633; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 540; -.
DR   TCDB; 1.A.1.2.4; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P22001; -.
DR   PhosphoSitePlus; P22001; -.
DR   DMDM; 215274135; -.
DR   MaxQB; P22001; -.
DR   PaxDb; P22001; -.
DR   PeptideAtlas; P22001; -.
DR   PRIDE; P22001; -.
DR   DNASU; 3738; -.
DR   Ensembl; ENST00000369769; ENSP00000358784; ENSG00000177272.
DR   GeneID; 3738; -.
DR   KEGG; hsa:3738; -.
DR   UCSC; uc001dzv.3; human.
DR   CTD; 3738; -.
DR   DisGeNET; 3738; -.
DR   EuPathDB; HostDB:ENSG00000177272.8; -.
DR   GeneCards; KCNA3; -.
DR   HGNC; HGNC:6221; KCNA3.
DR   HPA; HPA016625; -.
DR   MIM; 176263; gene.
DR   neXtProt; NX_P22001; -.
DR   OpenTargets; ENSG00000177272; -.
DR   PharmGKB; PA30021; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; P22001; -.
DR   KO; K04876; -.
DR   OMA; LPRRDFQ; -.
DR   OrthoDB; EOG091G10NU; -.
DR   PhylomeDB; P22001; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   SIGNOR; P22001; -.
DR   GeneWiki; KCNA3; -.
DR   GenomeRNAi; 3738; -.
DR   PRO; PR:P22001; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000177272; -.
DR   CleanEx; HS_KCNA3; -.
DR   Genevisible; P22001; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IEA:Ensembl.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IEA:Ensembl.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004050; K_chnl_volt-dep_Kv1.3.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01510; KV13CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    575       Potassium voltage-gated channel subfamily
FT                                A member 3.
FT                                /FTId=PRO_0000053977.
FT   TOPO_DOM      1    234       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    235    253       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    254    294       Extracellular. {ECO:0000255}.
FT   TRANSMEM    295    316       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    317    327       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    328    348       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    349    362       Extracellular. {ECO:0000255}.
FT   TRANSMEM    363    381       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    382    397       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    398    417       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    418    458       Extracellular. {ECO:0000255}.
FT   TRANSMEM    459    481       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    482    575       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       444    449       Selectivity filter. {ECO:0000250}.
FT   MOTIF       573    575       PDZ-binding. {ECO:0000250}.
FT   MOD_RES     520    520       Phosphoserine; by PKA. {ECO:0000255}.
FT   LIPID       317    317       S-palmitoyl cysteine. {ECO:0000255}.
FT   CARBOHYD    279    279       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT     72     72       A -> G (in Ref. 5; AAA36425).
FT                                {ECO:0000305}.
FT   CONFLICT     89     89       L -> V (in Ref. 5; AAA36425).
FT                                {ECO:0000305}.
FT   CONFLICT    113    113       L -> V (in Ref. 6; AAA59457).
FT                                {ECO:0000305}.
FT   CONFLICT    143    143       L -> V (in Ref. 5; AAA36425).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       E -> K (in Ref. 1; AAC31761).
FT                                {ECO:0000305}.
FT   CONFLICT    390    390       T -> S (in Ref. 5; AAA36425).
FT                                {ECO:0000305}.
FT   CONFLICT    471    471       T -> S (in Ref. 5; AAA36425).
FT                                {ECO:0000305}.
FT   CONFLICT    540    540       S -> T (in Ref. 5; AAA36425).
FT                                {ECO:0000305}.
FT   STRAND      105    110       {ECO:0000244|PDB:4BGC}.
FT   STRAND      113    118       {ECO:0000244|PDB:4BGC}.
FT   HELIX       119    122       {ECO:0000244|PDB:4BGC}.
FT   TURN        129    131       {ECO:0000244|PDB:4BGC}.
FT   HELIX       133    136       {ECO:0000244|PDB:4BGC}.
FT   HELIX       137    139       {ECO:0000244|PDB:4BGC}.
FT   TURN        142    145       {ECO:0000244|PDB:4BGC}.
FT   STRAND      146    149       {ECO:0000244|PDB:4BGC}.
FT   HELIX       153    164       {ECO:0000244|PDB:4BGC}.
FT   HELIX       177    186       {ECO:0000244|PDB:4BGC}.
FT   HELIX       191    201       {ECO:0000244|PDB:4BGC}.
SQ   SEQUENCE   575 AA;  63842 MW;  0E98905187A85F48 CRC64;
     MDERLSLLRS PPPPSARHRA HPPQRPASSG GAHTLVNHGY AEPAAGRELP PDMTVVPGDH
     LLEPEVADGG GAPPQGGCGG GGCDRYEPLP PSLPAAGEQD CCGERVVINI SGLRFETQLK
     TLCQFPETLL GDPKRRMRYF DPLRNEYFFD RNRPSFDAIL YYYQSGGRIR RPVNVPIDIF
     SEEIRFYQLG EEAMEKFRED EGFLREEERP LPRRDFQRQV WLLFEYPESS GPARGIAIVS
     VLVILISIVI FCLETLPEFR DEKDYPASTS QDSFEAAGNS TSGSRAGASS FSDPFFVVET
     LCIIWFSFEL LVRFFACPSK ATFSRNIMNL IDIVAIIPYF ITLGTELAER QGNGQQAMSL
     AILRVIRLVR VFRIFKLSRH SKGLQILGQT LKASMRELGL LIFFLFIGVI LFSSAVYFAE
     ADDPTSGFSS IPDAFWWAVV TMTTVGYGDM HPVTIGGKIV GSLCAIAGVL TIALPVPVIV
     SNFNYFYHRE TEGEEQSQYM HVGSCQHLSS SAEELRKARS NSTLSKSEYM VIEEGGMNHS
     AFPQTPFKTG NSTATCTTNN NPNSCVNIKK IFTDV
//
ID   KCNC2_RAT               Reviewed;         638 AA.
AC   P22462; P22461; P22463; Q63735;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   22-NOV-2017, entry version 154.
DE   RecName: Full=Potassium voltage-gated channel subfamily C member 2 {ECO:0000312|RGD:628829};
DE   AltName: Full=Potassium channel voltage-gated Shaw-related subfamily C member 2 {ECO:0000312|RGD:628829};
DE   AltName: Full=Shaw-like potassium channel {ECO:0000303|PubMed:1879548};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv3.2 {ECO:0000303|PubMed:1879548};
GN   Name=Kcnc2 {ECO:0000312|RGD:628829};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, ENZYME REGULATION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=2367536; DOI=10.1073/pnas.87.13.5227;
RA   McCormack T., de Miera E.C.V.-S., Rudy B.;
RT   "Molecular cloning of a member of a third class of Shaker-family K+
RT   channel genes in mammals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:5227-5231(1990).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=2023956; DOI=10.1073/pnas.88.9.4060-b;
RA   McCormack T., de Miera E.C.V.-S., Rudy B.;
RT   "Molecular cloning of a member of a third class of Shaker-family K+
RT   channel genes in mammals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:4060-4060(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=1879548; DOI=10.1016/0014-5793(91)81026-5;
RA   Luneau C.J., Wiedmann R., Smith J.S., Williams J.B.;
RT   "Shaw-like rat brain potassium channel cDNA's with divergent 3'
RT   ends.";
RL   FEBS Lett. 288:163-167(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=1378392;
RA   Rettig J., Wunder F., Stocker M., Lichtinghagen R., Mastiaux F.,
RA   Beckh S., Kues W., Pedarzani P., Schroeter K.H., Ruppersberg J.P.,
RA   Veh R., Pongs O.;
RT   "Characterization of a Shaw-related potassium channel family in rat
RT   brain.";
RL   EMBO J. 11:2473-2486(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=1374908; DOI=10.1073/pnas.89.10.4603;
RA   Baker H., Pollock J., Ellisman M., Kentros C., Miera E., Serodio P.,
RA   Weiser M., Rudy B., Fruhling D.;
RT   "Region-specific expression of a K+ channel gene in brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:4603-4607(1992).
RN   [6]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=8120636;
RA   Weiser M., Vega-Saenz de Miera E., Kentros C., Moreno H., Franzen L.,
RA   Hillman D., Baker H., Rudy B.;
RT   "Differential expression of Shaw-related K+ channels in the rat
RT   central nervous system.";
RL   J. Neurosci. 14:949-972(1994).
RN   [7]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION,
RP   PHOSPHORYLATION, MUTAGENESIS OF SER-563 AND SER-564, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=7643197;
RA   Moreno H., Kentros C., Bueno E., Weiser M., Hernandez A.,
RA   Vega-Saenz de Miera E., Ponce A., Thornhill W., Rudy B.;
RT   "Thalamocortical projections have a K+ channel that is phosphorylated
RT   and modulated by cAMP-dependent protein kinase.";
RL   J. Neurosci. 15:5486-5501(1995).
RN   [8]
RP   SUBCELLULAR LOCATION (ISOFORMS 1; 2 AND 3).
RX   PubMed=9307441; DOI=10.1007/s002329900278;
RA   Ponce A., Vega-Saenz de Miera E., Kentros C., Moreno H., Thornhill B.,
RA   Rudy B.;
RT   "K+ channel subunit isoforms with divergent carboxy-terminal sequences
RT   carry distinct membrane targeting signals.";
RL   J. Membr. Biol. 159:149-159(1997).
RN   [9]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, SUBUNIT,
RP   INTERACTION WITH KCNC1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10482766;
RA   Hernandez-Pineda R., Chow A., Amarillo Y., Moreno H., Saganich M.,
RA   Vega-Saenz de Miera E.C., Hernandez-Cruz A., Rudy B.;
RT   "Kv3.1-Kv3.2 channels underlie a high-voltage-activating component of
RT   the delayed rectifier K+ current in projecting neurons from the globus
RT   pallidus.";
RL   J. Neurophysiol. 82:1512-1528(1999).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10414968;
RA   Baranauskas G., Tkatch T., Surmeier D.J.;
RT   "Delayed rectifier currents in rat globus pallidus neurons are
RT   attributable to Kv2.1 and Kv3.1/3.2 K(+) channels.";
RL   J. Neurosci. 19:6394-6404(1999).
RN   [11]
RP   REVIEW.
RX   PubMed=10414303; DOI=10.1111/j.1749-6632.1999.tb11295.x;
RA   Rudy B., Chow A., Lau D., Amarillo Y., Ozaita A., Saganich M.,
RA   Moreno H., Nadal M.S., Hernandez-Pineda R., Hernandez-Cruz A.,
RA   Erisir A., Leonard C., Vega-Saenz de Miera E.;
RT   "Contributions of Kv3 channels to neuronal excitability.";
RL   Ann. N. Y. Acad. Sci. 868:304-343(1999).
RN   [12]
RP   REVIEW.
RX   PubMed=11506885; DOI=10.1016/S0166-2236(00)01892-0;
RA   Rudy B., McBain C.J.;
RT   "Kv3 channels: voltage-gated K+ channels designed for high-frequency
RT   repetitive firing.";
RL   Trends Neurosci. 24:517-526(2001).
RN   [13]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF SER-563 AND SER-564.
RX   PubMed=11281123; DOI=10.1111/j.1469-7793.2001.0345k.x;
RA   Moreno H., Vega-Saenz de Miera E., Nadal M.S., Amarillo Y., Rudy B.;
RT   "Modulation of Kv3 potassium channels expressed in CHO cells by a
RT   nitric oxide-activated phosphatase.";
RL   J. Physiol. (Lond.) 530:345-358(2001).
RN   [14]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, INTERACTION WITH
RP   KCNC1; KCNE1; KCNE2 AND KCNE3, AND SUBCELLULAR LOCATION.
RX   PubMed=14679187; DOI=10.1074/jbc.M310501200;
RA   Lewis A., McCrossan Z.A., Abbott G.W.;
RT   "MinK, MiRP1, and MiRP2 diversify Kv3.1 and Kv3.2 potassium channel
RT   gating.";
RL   J. Biol. Chem. 279:7884-7892(2004).
RN   [15]
RP   TISSUE SPECIFICITY.
RX   PubMed=16413129; DOI=10.1016/j.neuroscience.2005.11.047;
RA   McDonald A.J., Mascagni F.;
RT   "Differential expression of Kv3.1b and Kv3.2 potassium channel
RT   subunits in interneurons of the basolateral amygdala.";
RL   Neuroscience 138:537-547(2006).
RN   [16]
RP   INDUCTION.
RX   PubMed=18775767; DOI=10.1016/j.neuroscience.2008.08.008;
RA   Grabert J., Wahle P.;
RT   "Neuronal activity and TrkB ligands influence Kv3.1b and Kv3.2
RT   expression in developing cortical interneurons.";
RL   Neuroscience 156:618-629(2008).
RN   [17]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=18708127; DOI=10.1016/j.neuroscience.2008.07.035;
RA   Grabert J., Wahle P.;
RT   "Visual experience regulates Kv3.1b and Kv3.2 expression in developing
RT   rat visual cortex.";
RL   Neuroscience 158:654-664(2009).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=22831914; DOI=10.1016/j.ceca.2012.06.007;
RA   Kuznetsov K.I., Grygorov O.O., Maslov V.Y., Veselovsky N.S.,
RA   Fedulova S.A.;
RT   "Kv3 channels modulate calcium signals induced by fast firing patterns
RT   in the rat retinal ganglion cells.";
RL   Cell Calcium 52:405-411(2012).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes,
CC       primarily in the brain. Contributes to the regulation of the fast
CC       action potential repolarization and in sustained high-frequency
CC       firing in neurons of the central nervous system (PubMed:10482766,
CC       PubMed:10414968, PubMed:11506885, PubMed:22831914). Homotetramer
CC       channels mediate delayed-rectifier voltage-dependent potassium
CC       currents that activate rapidly at high-threshold voltages and
CC       inactivate slowly (PubMed:2367536, PubMed:1879548, PubMed:8120636,
CC       PubMed:7643197, PubMed:10414303). Forms tetrameric channels
CC       through which potassium ions pass in accordance with their
CC       electrochemical gradient. The channel alternates between opened
CC       and closed conformations in response to the voltage difference
CC       across the membrane (PubMed:2367536, PubMed:1879548,
CC       PubMed:8120636, PubMed:7643197). Can form functional
CC       homotetrameric channels and heterotetrameric channels that contain
CC       variable proportions of KCNC1, and possibly other family members
CC       as well; channel properties depend on the type of alpha subunits
CC       that are part of the channel (PubMed:10482766, PubMed:14679187).
CC       Channel properties may be modulated either by the association with
CC       ancillary subunits, such as KCNE1, KCNE2 and KCNE3 or indirectly
CC       by nitric oxide (NO) through a cGMP- and PKG-mediated signaling
CC       cascade, slowing channel activation and deactivation of delayed
CC       rectifier potassium channels (PubMed:11281123, PubMed:14679187).
CC       Contributes to fire sustained trains of very brief action
CC       potentials at high frequency in retinal ganglion cells,
CC       thalamocortical and suprachiasmatic nucleus (SCN) neurons and in
CC       hippocampal and neocortical interneurons (PubMed:10482766,
CC       PubMed:10414968, PubMed:11506885, PubMed:22831914). Sustained
CC       maximal action potential firing frequency in inhibitory
CC       hippocampal interneurons is negatively modulated by histamine H2
CC       receptor activation in a cAMP- and protein kinase (PKA)
CC       phosphorylation-dependent manner. Plays a role in maintaining the
CC       fidelity of synaptic transmission in neocortical GABAergic
CC       interneurons by generating action potential (AP) repolarization at
CC       nerve terminals, thus reducing spike-evoked calcium influx and
CC       GABA neurotransmitter release. Required for long-range
CC       synchronization of gamma oscillations over distance in the
CC       neocortex. Contributes to the modulation of the circadian rhythm
CC       of spontaneous action potential firing in suprachiasmatic nucleus
CC       (SCN) neurons in a light-dependent manner (By similarity).
CC       {ECO:0000250|UniProtKB:Q14B80, ECO:0000269|PubMed:10414968,
CC       ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:11281123,
CC       ECO:0000269|PubMed:11506885, ECO:0000269|PubMed:14679187,
CC       ECO:0000269|PubMed:1879548, ECO:0000269|PubMed:22831914,
CC       ECO:0000269|PubMed:2367536, ECO:0000269|PubMed:7643197,
CC       ECO:0000269|PubMed:8120636, ECO:0000305|PubMed:10414303,
CC       ECO:0000305|PubMed:11506885}.
CC   -!- ENZYME REGULATION: Inhibited by Stichodactyla helianthus peptide
CC       ShK (By similarity). Inhibited by millimolar levels of
CC       tetraethylammonium (TEA). Contrary to other channels, inhibited
CC       only by millimolar levels of 4-aminopyridine (4-AP)
CC       (PubMed:2367536, PubMed:1879548, PubMed:7643197, PubMed:10482766,
CC       PubMed:10414303). {ECO:0000250|UniProtKB:Q96PR1,
CC       ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:1879548,
CC       ECO:0000269|PubMed:2367536, ECO:0000269|PubMed:7643197,
CC       ECO:0000305|PubMed:10414303}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Homotetrameric channels expressed in xenopus oocytes or in
CC         mammalian non-neuronal cells display delayed-rectifier voltage-
CC         dependent potassium currents, that are rapidly activated during
CC         membrane depolarization, i.e within a risetime of a few msec.
CC         After that, inactivates very slowly, i.e within about >800 msec.
CC         Their activation requires a threshold potential at about -10 mV,
CC         with a midpoint activation at about 12.1 mV and a steepness
CC         parameter of about 8.4 mV (PubMed:2367536, PubMed:1879548,
CC         PubMed:8120636, PubMed:7643197, PubMed:10414303,
CC         PubMed:11281123, PubMed:14679187). The voltage-dependence of
CC         activation and inactivation and other channel characteristics
CC         vary depending on the experimental conditions, the expression
CC         system, the presence or absence of ancillary subunits and post-
CC         translational modifications (PubMed:7643197, PubMed:10414303,
CC         PubMed:11281123, PubMed:14679187). {ECO:0000269|PubMed:11281123,
CC         ECO:0000269|PubMed:14679187, ECO:0000269|PubMed:1879548,
CC         ECO:0000269|PubMed:2367536, ECO:0000269|PubMed:7643197,
CC         ECO:0000269|PubMed:8120636, ECO:0000305|PubMed:10414303};
CC   -!- SUBUNIT: Homotetramer and heterotetramer with other channel-
CC       forming alpha subunits, such as KCNC1. Interacts with KCNC1
CC       (PubMed:10482766, PubMed:14679187). Homotetramer or heterotetramer
CC       channel activity is regulated by association with modulating
CC       ancillary subunits such as KCNE1, KCNE2 and KCNE3, creating a
CC       functionally diverse range of channel complexes. Interacts with
CC       KCNE1, KCNE2 and KCNE3 (PubMed:14679187).
CC       {ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:14679187}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10414968,
CC       ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:14679187,
CC       ECO:0000269|PubMed:1879548, ECO:0000269|PubMed:22831914,
CC       ECO:0000269|PubMed:2367536, ECO:0000269|PubMed:7643197,
CC       ECO:0000269|PubMed:8120636}; Multi-pass membrane protein
CC       {ECO:0000255}. Membrane {ECO:0000269|PubMed:11281123}; Multi-pass
CC       membrane protein {ECO:0000255}. Perikaryon
CC       {ECO:0000269|PubMed:10482766}. Cell projection, axon
CC       {ECO:0000269|PubMed:7643197}. Cell junction, synapse
CC       {ECO:0000269|PubMed:7643197}. Cell junction, synapse, synaptosome
CC       {ECO:0000269|PubMed:7643197}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q14B80}. Cell junction, synapse,
CC       postsynaptic cell membrane {ECO:0000250|UniProtKB:Q14B80}. Cell
CC       junction, synapse, presynaptic cell membrane
CC       {ECO:0000250|UniProtKB:Q14B80}. Note=Localizes on the surface of
CC       cell somata, proximal dendrites and axonal membranes. Also
CC       detected throughout the neuropil. Localized in starburst cell
CC       somata and proximal dendrite processes. Colocalized with GABA in
CC       presynaptic terminals. Clustered in patches in somatic and
CC       proximal dendritic membrane as well as in axons and presnypatic
CC       terminals of GABAergic interneurons; some of these patches are
CC       found near postsynaptic sites (By similarity). Colocalizes with
CC       parvalbumin in globus pallidus neurons (PubMed:10482766).
CC       Localizes in thalamocortical axons and synapses (PubMed:7643197).
CC       {ECO:0000250|UniProtKB:Q14B80, ECO:0000269|PubMed:10482766,
CC       ECO:0000269|PubMed:7643197}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Apical cell membrane
CC       {ECO:0000269|PubMed:9307441}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Apical cell membrane
CC       {ECO:0000269|PubMed:9307441}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Basolateral cell membrane
CC       {ECO:0000269|PubMed:9307441}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=KV3.2B {ECO:0000303|PubMed:1879548};
CC         IsoId=P22462-1; Sequence=Displayed;
CC       Name=2; Synonyms=KV3.2C {ECO:0000303|PubMed:1879548};
CC         IsoId=P22462-2; Sequence=VSP_001018;
CC       Name=3; Synonyms=KV3.2A, KShIIIA.1 {ECO:0000303|PubMed:2367536};
CC         IsoId=P22462-3; Sequence=VSP_001019;
CC       Name=4;
CC         IsoId=P22462-4; Sequence=VSP_001020;
CC   -!- TISSUE SPECIFICITY: Expressed in neurons of the visual cortex
CC       during postnatal development (PubMed:18708127). Expressed in
CC       neurons of the globus pallidus at postnatal age day 7 (P7), onward
CC       (PubMed:10482766). Expressed in thalamic relay neurons. Expressed
CC       in neurons in layer IV and deeper cortical layers of the
CC       neocortex. Expressed in hippocampal interneurons (PubMed:7643197).
CC       Expressed in nonpyramidal interneurons in the basolateral amygdala
CC       (PubMed:16413129). Expressed in retinal ganglion cells (at protein
CC       level) (PubMed:22831914). Widely expressed in the brain
CC       (PubMed:1879548, PubMed:8120636). Expressed in numerous thalamic
CC       relay neurons throughout the dorsal thalamus. Expressed in
CC       interneurons of the deep layers V-VI of the cerebral cortex, the
CC       CA1 and CA3 pyramidal and dentate gyrus (DG) granule cells of the
CC       hippocampus, in neurons of the caudate-putamen, globus pallidus
CC       and subthalamic nucleus. Also expressed in the optic layer of
CC       interior colliculus, the inferior colliculus, the red nucleus, the
CC       medial geniculate, the ventral lateral lemiscus, the
CC       reticulotegmental nucleus and in the deep cerebellar nuclei
CC       (PubMed:1374908, PubMed:8120636, PubMed:7643197, PubMed:18708127).
CC       Expressed in globus pallidus (GP) neurons (PubMed:10414968).
CC       {ECO:0000269|PubMed:10414968, ECO:0000269|PubMed:10482766,
CC       ECO:0000269|PubMed:1374908, ECO:0000269|PubMed:16413129,
CC       ECO:0000269|PubMed:18708127, ECO:0000269|PubMed:1879548,
CC       ECO:0000269|PubMed:22831914, ECO:0000269|PubMed:7643197,
CC       ECO:0000269|PubMed:8120636}.
CC   -!- INDUCTION: Up-regulated in visual cortex during the second
CC       postnatal week from dark-reared animals (at protein level). Down-
CC       regulated in visual cortex by active visual experience until
CC       postnatal day P40 of dark-reared animals (PubMed:18708127). Down-
CC       regulated by chronic action potential activity deprivation in
CC       organotypic culture of the visual cortex (PubMed:18775767).
CC       {ECO:0000269|PubMed:18708127, ECO:0000269|PubMed:18775767}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: Phosphorylated by PKA in cortical synaptosomes
CC       (PubMed:7643197). cAMP-dependent phosphorylation inhibits channel
CC       activity (PubMed:7643197). Histamine H2 receptor- and PKA-induced
CC       phosphorylation extends action potential spike duration, reduces
CC       action potential spike amplitude, sustains maximum firing
CC       frequency in hippocampal interneurons; also reduces the incidence
CC       of high-frequency oscillations in hippocampal CA3 pyramidal cell
CC       layers (By similarity). {ECO:0000250|UniProtKB:P63142,
CC       ECO:0000269|PubMed:7643197}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw) (TC
CC       1.A.1.2) subfamily. Kv3.2/KCNC2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M34052; AAA42142.1; -; mRNA.
DR   EMBL; M59211; AAA41819.1; -; mRNA.
DR   EMBL; M59313; AAA41820.1; ALT_SEQ; mRNA.
DR   EMBL; X62839; CAA44643.1; -; mRNA.
DR   EMBL; M84203; AAA42143.1; -; mRNA.
DR   PIR; A39402; A39402.
DR   PIR; B45292; B45292.
DR   PIR; S22703; S22703.
DR   RefSeq; NP_631962.1; NM_139216.1. [P22462-3]
DR   RefSeq; NP_631963.1; NM_139217.1. [P22462-1]
DR   RefSeq; XP_006241389.1; XM_006241327.3. [P22462-1]
DR   RefSeq; XP_017450149.1; XM_017594660.1. [P22462-1]
DR   RefSeq; XP_017450150.1; XM_017594661.1. [P22462-2]
DR   RefSeq; XP_017450151.1; XM_017594662.1. [P22462-4]
DR   RefSeq; XP_017450152.1; XM_017594663.1. [P22462-3]
DR   UniGene; Rn.9733; -.
DR   ProteinModelPortal; P22462; -.
DR   BioGrid; 251521; 1.
DR   STRING; 10116.ENSRNOP00000005773; -.
DR   GuidetoPHARMACOLOGY; 549; -.
DR   PhosphoSitePlus; P22462; -.
DR   PaxDb; P22462; -.
DR   Ensembl; ENSRNOT00000005690; ENSRNOP00000005690; ENSRNOG00000004077. [P22462-3]
DR   Ensembl; ENSRNOT00000005773; ENSRNOP00000005773; ENSRNOG00000004077. [P22462-1]
DR   GeneID; 246153; -.
DR   KEGG; rno:246153; -.
DR   UCSC; RGD:628829; rat. [P22462-1]
DR   CTD; 3747; -.
DR   RGD; 628829; Kcnc2.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231012; -.
DR   HOVERGEN; HBG105862; -.
DR   InParanoid; P22462; -.
DR   KO; K04888; -.
DR   OMA; HYAHAAM; -.
DR   OrthoDB; EOG091G0EJL; -.
DR   PhylomeDB; P22462; -.
DR   TreeFam; TF352511; -.
DR   Reactome; R-RNO-1296072; Voltage gated Potassium channels.
DR   Reactome; R-RNO-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   PRO; PR:P22462; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000004077; -.
DR   Genevisible; P22462; RN.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030673; C:axolemma; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; IDA:UniProtKB.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0031982; C:vesicle; IDA:RGD.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0001508; P:action potential; ISO:RGD.
DR   GO; GO:0071242; P:cellular response to ammonium ion; IEP:RGD.
DR   GO; GO:0071732; P:cellular response to nitric oxide; IDA:UniProtKB.
DR   GO; GO:0097237; P:cellular response to toxic substance; IMP:RGD.
DR   GO; GO:0021759; P:globus pallidus development; IEP:RGD.
DR   GO; GO:0034220; P:ion transmembrane transport; IDA:RGD.
DR   GO; GO:0038060; P:nitric oxide-cGMP-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:RGD.
DR   GO; GO:1903818; P:positive regulation of voltage-gated potassium channel activity; IDA:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0009642; P:response to light intensity; IEP:RGD.
DR   GO; GO:0032026; P:response to magnesium ion; IEP:RGD.
DR   GO; GO:1990089; P:response to nerve growth factor; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Cell projection;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Postsynaptic cell membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome; Synapse;
KW   Synaptosome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    638       Potassium voltage-gated channel subfamily
FT                                C member 2.
FT                                /FTId=PRO_0000054054.
FT   TOPO_DOM      1    229       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    230    248       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    284    303       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    304    314       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    315    337       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    346    368       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    369    381       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    382    401       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    451    473       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    474    638       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       437    442       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS     56     99       Gly/Pro-rich (insert).
FT   MOD_RES     564    564       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES     600    600       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q14B80}.
FT   CARBOHYD    259    259       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    266    266       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     594    638       GYEKSRSLNNIAGLAGNALRLSPVTSPYNSPCPLRRSRSPI
FT                                PSIL -> ASTLEPMESTSQTKGDTRPEAHWNCAHLLNFGC
FT                                PTGSSFPTL (in isoform 2).
FT                                {ECO:0000303|PubMed:1879548}.
FT                                /FTId=VSP_001018.
FT   VAR_SEQ     594    638       GYEKSRSLNNIAGLAGNALRLSPVTSPYNSPCPLRRSRSPI
FT                                PSIL -> DNCKDVVITGYTQAEARSLT (in isoform
FT                                3). {ECO:0000303|PubMed:2367536}.
FT                                /FTId=VSP_001019.
FT   VAR_SEQ     594    638       GYEKSRSLNNIAGLAGNALRLSPVTSPYNSPCPLRRSRSPI
FT                                PSIL -> VLYRIYHGFLPAENGTLRFSHSKDCTGNFCY
FT                                (in isoform 4).
FT                                {ECO:0000303|PubMed:1378392}.
FT                                /FTId=VSP_001020.
FT   MUTAGEN     563    563       S->A: Does not abolish channel activity
FT                                inhibition in presence of nitric oxide
FT                                (NO); when associated with A-564. Absence
FT                                of channel activity inhibition in
FT                                presence of cAMP; when associated with A-
FT                                564. {ECO:0000269|PubMed:11281123,
FT                                ECO:0000269|PubMed:7643197}.
FT   MUTAGEN     564    564       S->A: Does not abolish channel activity
FT                                inhibition in presence of nitric oxide
FT                                (NO); when associated with A-564. Absence
FT                                of channel activity inhibition in
FT                                presence of cAMP; when associated with A-
FT                                563. {ECO:0000269|PubMed:11281123,
FT                                ECO:0000269|PubMed:7643197}.
FT   CONFLICT      2      2       G -> S (in Ref. 4; CAA44643).
FT                                {ECO:0000305}.
SQ   SEQUENCE   638 AA;  70191 MW;  25C102B4CCE53BF4 CRC64;
     MGKIENNERV ILNVGGTRHE TYRSTLKTLP GTRLALLASS EPQGDCLTAA GDKLQPLPPP
     LSPPPRPPPL SPVPSGCFEG GAGNCSSHGG NGSDHPGGGR EFFFDRHPGV FAYVLNYYRT
     GKLHCPADVC GPLFEEELAF WGIDETDVEP CCWMTYRQHR DAEEALDIFE TPDLIGGDPG
     DDEDLGGKRL GIEDAAGLGG PDGKSGRWRK LQPRMWALFE DPYSSRAARF IAFASLFFIL
     VSITTFCLET HEAFNIVKNK TEPVINGTSA VLQYEIETDP ALTYVEGVCV VWFTFEFLVR
     IVFSPNKLEF IKNLLNIIDF VAILPFYLEV GLSGLSSKAA KDVLGFLRVV RFVRILRIFK
     LTRHFVGLRV LGHTLRASTN EFLLLIIFLA LGVLIFATMI YYAERVGAQP NDPSASEHTQ
     FKNIPIGFWW AVVTMTTLGY GDMYPQTWSG MLVGALCALA GVLTIAMPVP VIVNNFGMYY
     SLAMAKQKLP RKRKKHIPPA PLASSPTFCK TELNMACNST QSDTCLGKEN RLLEHNRSVL
     SGDDSTGSEP PLSPPERLPI RRSSTRDKNR RGETCFLLTT GDYTCASDGG IRKGYEKSRS
     LNNIAGLAGN ALRLSPVTSP YNSPCPLRRS RSPIPSIL
//
ID   KCNC1_HUMAN             Reviewed;         511 AA.
AC   P48547; K4DI87;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   20-DEC-2017, entry version 162.
DE   RecName: Full=Potassium voltage-gated channel subfamily C member 1;
DE   AltName: Full=NGK2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv3.1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv4;
GN   Name=KCNC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8449507; DOI=10.1006/geno.1993.1075;
RA   Ried T., Rudy B., de Miera E., Lau D., Ward D.C., Sen K.;
RT   "Localization of a highly conserved human potassium channel gene
RT   (NGK2-KV4; KCNC1) to chromosome 11p15.";
RL   Genomics 15:405-411(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 244-475 (ISOFORM 1).
RX   PubMed=1400413;
RA   Grissmer S., Ghanshani S., Dethlefs B., McPherson J.D., Wasmuth J.J.,
RA   Gutman G.A., Cahalan M.D., Chandy K.G.;
RT   "The Shaw-related potassium channel gene, Kv3.1, on human chromosome
RT   11, encodes the type l K+ channel in T cells.";
RL   J. Biol. Chem. 267:20971-20979(1992).
RN   [5]
RP   INTERACTION WITH KCNC3.
RX   PubMed=23734863; DOI=10.1042/BJ20130034;
RA   Zhao J., Zhu J., Thornhill W.B.;
RT   "Spinocerebellar ataxia-13 Kv3.3 potassium channels: arginine-to-
RT   histidine mutations affect both functional and protein expression on
RT   the cell surface.";
RL   Biochem. J. 454:259-265(2013).
RN   [6]
RP   INVOLVEMENT IN EPM7, VARIANT EPM7 HIS-320, CHARACTERIZATION OF VARIANT
RP   EPM7 HIS-320, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25401298; DOI=10.1038/ng.3144;
RA   Muona M., Berkovic S.F., Dibbens L.M., Oliver K.L., Maljevic S.,
RA   Bayly M.A., Joensuu T., Canafoglia L., Franceschetti S.,
RA   Michelucci R., Markkinen S., Heron S.E., Hildebrand M.S.,
RA   Andermann E., Andermann F., Gambardella A., Tinuper P., Licchetta L.,
RA   Scheffer I.E., Criscuolo C., Filla A., Ferlazzo E., Ahmad J.,
RA   Ahmad A., Baykan B., Said E., Topcu M., Riguzzi P., King M.D.,
RA   Ozkara C., Andrade D.M., Engelsen B.A., Crespel A., Lindenau M.,
RA   Lohmann E., Saletti V., Massano J., Privitera M., Espay A.J.,
RA   Kauffmann B., Duchowny M., Moeller R.S., Straussberg R., Afawi Z.,
RA   Ben-Zeev B., Samocha K.E., Daly M.J., Petrou S., Lerche H.,
RA   Palotie A., Lehesjoki A.E.;
RT   "A recurrent de novo mutation in KCNC1 causes progressive myoclonus
RT   epilepsy.";
RL   Nat. Genet. 47:39-46(2015).
CC   -!- FUNCTION: Voltage-gated potassium channel that plays an important
CC       role in the rapid repolarization of fast-firing brain neurons. The
CC       channel opens in response to the voltage difference across the
CC       membrane, forming a potassium-selective channel through which
CC       potassium ions pass in accordance with their electrochemical
CC       gradient (PubMed:25401298). Can form functional homotetrameric
CC       channels and heterotetrameric channels that contain variable
CC       proportions of KCNC2, and possibly other family members as well.
CC       Contributes to fire sustained trains of very brief action
CC       potentials at high frequency in pallidal neurons.
CC       {ECO:0000250|UniProtKB:P25122, ECO:0000269|PubMed:25401298}.
CC   -!- SUBUNIT: Heteromultimer with KCNG3, KCNG4 and KCNV2 (By
CC       similarity). Heteromultimer with KCNC2 (By similarity).
CC       Heterotetramer with KCNC3 (PubMed:23734863). Interacts with the
CC       ancillary subunits KCNE1 and KCNE2; the interaction modulates
CC       channel activity (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P25122, ECO:0000269|PubMed:23734863}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:25401298};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P48547-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P48547-2; Sequence=VSP_055129;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000305}.
CC   -!- DOMAIN: The tail may be important in modulation of channel
CC       activity and/or targeting of the channel to specific subcellular
CC       compartments. {ECO:0000305}.
CC   -!- PTM: N-glycosylated; contains sialylated glycans.
CC       {ECO:0000250|UniProtKB:P25122}.
CC   -!- DISEASE: Epilepsy, progressive myoclonic 7 (EPM7) [MIM:616187]: A
CC       neurologic disorder characterized by progressive myoclonic
CC       epilepsy, manifesting in the first or second decades of life.
CC       Cognitive function may decline in some patients. Myoclonus is a
CC       brief, involuntary twitching of a muscle or a group of muscles.
CC       {ECO:0000269|PubMed:25401298}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw) (TC
CC       1.A.1.2) subfamily. Kv3.1/KCNC1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S56770; AAB25764.1; -; mRNA.
DR   EMBL; AC124056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124078; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124301; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68425.1; -; Genomic_DNA.
DR   EMBL; M96747; AAA59458.1; -; mRNA.
DR   CCDS; CCDS44547.1; -. [P48547-2]
DR   CCDS; CCDS7827.1; -. [P48547-1]
DR   PIR; A46020; A46020.
DR   RefSeq; NP_001106212.1; NM_001112741.1. [P48547-2]
DR   RefSeq; NP_004967.1; NM_004976.4. [P48547-1]
DR   UniGene; Hs.552896; -.
DR   ProteinModelPortal; P48547; -.
DR   SMR; P48547; -.
DR   BioGrid; 109948; 8.
DR   IntAct; P48547; 3.
DR   STRING; 9606.ENSP00000265969; -.
DR   BindingDB; P48547; -.
DR   ChEMBL; CHEMBL5529; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   iPTMnet; P48547; -.
DR   PhosphoSitePlus; P48547; -.
DR   BioMuta; KCNC1; -.
DR   DMDM; 1352085; -.
DR   EPD; P48547; -.
DR   PaxDb; P48547; -.
DR   PeptideAtlas; P48547; -.
DR   PRIDE; P48547; -.
DR   Ensembl; ENST00000265969; ENSP00000265969; ENSG00000129159. [P48547-2]
DR   Ensembl; ENST00000379472; ENSP00000368785; ENSG00000129159. [P48547-1]
DR   GeneID; 3746; -.
DR   KEGG; hsa:3746; -.
DR   UCSC; uc001mnk.5; human. [P48547-1]
DR   CTD; 3746; -.
DR   DisGeNET; 3746; -.
DR   EuPathDB; HostDB:ENSG00000129159.6; -.
DR   GeneCards; KCNC1; -.
DR   HGNC; HGNC:6233; KCNC1.
DR   HPA; HPA047634; -.
DR   HPA; HPA048249; -.
DR   MalaCards; KCNC1; -.
DR   MIM; 176258; gene.
DR   MIM; 616187; phenotype.
DR   neXtProt; NX_P48547; -.
DR   OpenTargets; ENSG00000129159; -.
DR   PharmGKB; PA30026; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231012; -.
DR   HOVERGEN; HBG105862; -.
DR   InParanoid; P48547; -.
DR   KO; K04887; -.
DR   OMA; SGGFWRR; -.
DR   OrthoDB; EOG091G0EJL; -.
DR   PhylomeDB; P48547; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GenomeRNAi; 3746; -.
DR   PRO; PR:P48547; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000129159; -.
DR   CleanEx; HS_KCNC1; -.
DR   ExpressionAtlas; P48547; baseline and differential.
DR   Genevisible; P48547; HS.
DR   GO; GO:0030673; C:axolemma; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0032590; C:dendrite membrane; IEA:Ensembl.
DR   GO; GO:0032809; C:neuronal cell body membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IEA:Ensembl.
DR   GO; GO:0019894; F:kinesin binding; IEA:Ensembl.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0021759; P:globus pallidus development; IEA:Ensembl.
DR   GO; GO:1903818; P:positive regulation of voltage-gated potassium channel activity; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0051262; P:protein tetramerization; IDA:UniProtKB.
DR   GO; GO:0014075; P:response to amine; IEA:Ensembl.
DR   GO; GO:0010996; P:response to auditory stimulus; IEA:Ensembl.
DR   GO; GO:0071774; P:response to fibroblast growth factor; IEA:Ensembl.
DR   GO; GO:0009642; P:response to light intensity; IEA:Ensembl.
DR   GO; GO:1990089; P:response to nerve growth factor; IEA:Ensembl.
DR   GO; GO:0035864; P:response to potassium ion; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; IEA:Ensembl.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR005403; K_chnl_volt-dep_Kv3.1.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01581; KV31CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disease mutation; Epilepsy; Glycoprotein; Ion channel; Ion transport;
KW   Membrane; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    511       Potassium voltage-gated channel subfamily
FT                                C member 1.
FT                                /FTId=PRO_0000054051.
FT   TOPO_DOM      1    190       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    191    209       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    248    267       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    268    276       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    277    295       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    309    331       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    332    344       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    345    366       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    415    436       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    437    511       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       400    405       Selectivity filter. {ECO:0000250}.
FT   MOD_RES      44     44       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P25122}.
FT   MOD_RES     130    130       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P25122}.
FT   MOD_RES     142    142       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P25122}.
FT   MOD_RES     158    158       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P25122}.
FT   MOD_RES     160    160       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15388}.
FT   MOD_RES     474    474       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15388}.
FT   MOD_RES     483    483       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P15388}.
FT   CARBOHYD    220    220       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    229    229       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     502    511       GRKPLRGMSI -> DSKLNGEVAKAALANEDCPHIDQALTP
FT                                DEGLPFTRSGTRERYGPCFLLSTGEYACPPGGGMRKDLCKE
FT                                SPVIAKYMPTEAVRVT (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_055129.
FT   VARIANT     320    320       R -> H (in EPM7; causes a dominant-
FT                                negative loss of current upon membrane
FT                                depolarization; dbSNP:rs727502818).
FT                                {ECO:0000269|PubMed:25401298}.
FT                                /FTId=VAR_072705.
SQ   SEQUENCE   511 AA;  57942 MW;  10A93478F7120ABB CRC64;
     MGQGDESERI VINVGGTRHQ TYRSTLRTLP GTRLAWLAEP DAHSHFDYDP RADEFFFDRH
     PGVFAHILNY YRTGKLHCPA DVCGPLYEEE LAFWGIDETD VEPCCWMTYR QHRDAEEALD
     SFGGAPLDNS ADDADADGPG DSGDGEDELE MTKRLALSDS PDGRPGGFWR RWQPRIWALF
     EDPYSSRYAR YVAFASLFFI LVSITTFCLE THERFNPIVN KTEIENVRNG TQVRYYREAE
     TEAFLTYIEG VCVVWFTFEF LMRVIFCPNK VEFIKNSLNI IDFVAILPFY LEVGLSGLSS
     KAAKDVLGFL RVVRFVRILR IFKLTRHFVG LRVLGHTLRA STNEFLLLII FLALGVLIFA
     TMIYYAERIG AQPNDPSASE HTHFKNIPIG FWWAVVTMTT LGYGDMYPQT WSGMLVGALC
     ALAGVLTIAM PVPVIVNNFG MYYSLAMAKQ KLPKKKKKHI PRPPQLGSPN YCKSVVNSPH
     HSTQSDTCPL AQEEILEINR AGRKPLRGMS I
//
ID   KCNQ1_HUMAN             Reviewed;         676 AA.
AC   P51787; O00347; O60607; O94787; Q14D14; Q7Z6G9; Q92960; Q9UMN8;
AC   Q9UMN9;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 3.
DT   25-OCT-2017, entry version 196.
DE   RecName: Full=Potassium voltage-gated channel subfamily KQT member 1 {ECO:0000305};
DE   AltName: Full=IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1 {ECO:0000305|PubMed:9312006};
DE   AltName: Full=KQT-like 1 {ECO:0000305};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv7.1 {ECO:0000305|PubMed:20533308};
GN   Name=KCNQ1 {ECO:0000312|HGNC:HGNC:6294};
GN   Synonyms=KCNA8 {ECO:0000312|HGNC:HGNC:6294},
GN   KCNA9 {ECO:0000312|HGNC:HGNC:6294},
GN   KVLQT1 {ECO:0000303|PubMed:9312006};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND CHARACTERIZATION
RP   OF VARIANT LQT1 CYS-555.
RC   TISSUE=Kidney;
RX   PubMed=9312006; DOI=10.1093/emboj/16.17.5472;
RA   Chouabe C., Neyroud N., Guicheney P., Lazdunski M., Romey G.,
RA   Barhanin J.;
RT   "Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell
RT   and Lange-Nielsen inherited cardiac arrhythmias.";
RL   EMBO J. 16:5472-5479(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=9305853; DOI=10.1074/jbc.272.39.24109;
RA   Jiang M., Tseng-Crank J., Tseng G.-N.;
RT   "Suppression of slow delayed rectifier current by a truncated isoform
RT   of KvLQT1 cloned from normal human heart.";
RL   J. Biol. Chem. 272:24109-24112(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2), VARIANTS LQT1
RP   ASN-242; HIS-250; SER-314 AND MET-587, AND VARIANT SER-643.
RX   PubMed=9799083; DOI=10.1007/s004390050819;
RA   Itoh T., Tanaka T., Nagai R., Kikuchi K., Ogawa S., Okada S.,
RA   Yamagata S., Yano K., Yazaki Y., Nakamura Y.;
RT   "Genomic organization and mutational analysis of KVLQT1, a gene
RT   responsible for familial long QT syndrome.";
RL   Hum. Genet. 103:290-294(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2), AND VARIANTS
RP   LQT1 MET-587 AND HIS-591.
RX   PubMed=10024302; DOI=10.1161/01.RES.84.3.290;
RA   Neyroud N., Richard P., Vignier N., Donger C., Denjoy I., Demay L.,
RA   Shkolnikova M., Pesce R., Chevalier P., Hainque B., Coumel P.,
RA   Schwartz K., Guicheney P.;
RT   "Genomic organization of the KCNQ1 K+ channel gene and identification
RT   of C-terminal mutations in the long-QT syndrome.";
RL   Circ. Res. 84:290-297(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RA   Seebohm G.;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-129, AND FUNCTION.
RX   PubMed=9108097; DOI=10.1073/pnas.94.8.4017;
RA   Yang W.-P., Levesque P.C., Little W.A., Conder M.L., Shalaby F.Y.,
RA   Blanar M.A.;
RT   "KvLQT1, a voltage-gated potassium channel responsible for human
RT   cardiac arrhythmias.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:4017-4021(1997).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 107-676, AND FUNCTION.
RC   TISSUE=Pancreas;
RX   PubMed=8900283; DOI=10.1038/384080a0;
RA   Sanguinetti M.C., Curran M.E., Zou A., Shen J., Spector P.S.,
RA   Atkinson D.L., Keating M.T.;
RT   "Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks)
RT   potassium channel.";
RL   Nature 384:80-83(1996).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 130-676, AND VARIANTS LQT1.
RX   PubMed=8528244; DOI=10.1038/ng0196-17;
RA   Wang Q., Curran M.E., Splawski I., Burn T.C., Millholland J.M.,
RA   Vanraay T.J., Shen J., Timothy K.W., Vincent G.M., de Jager T.,
RA   Schwartz P.J., Towbin J.A., Moss A.J., Atkinson D.L., Landes G.M.,
RA   Connors T.D., Keating M.T.;
RT   "Positional cloning of a novel potassium channel gene: KVLQT1
RT   mutations cause cardiac arrhythmias.";
RL   Nat. Genet. 12:17-23(1996).
RN   [13]
RP   IDENTIFICATION OF C-TERMINAL ASSEMBLY DOMAIN.
RX   PubMed=10654932; DOI=10.1093/emboj/19.3.332;
RA   Schmitt N., Schwarz M., Peretz A., Abitbol I., Attali B., Pongs O.;
RT   "A recessive C-terminal Jervell and Lange-Nielsen mutation of the
RT   KCNQ1 channel impairs subunit assembly.";
RL   EMBO J. 19:332-340(2000).
RN   [14]
RP   INTERACTION WITH KCNE2, AND FUNCTION.
RX   PubMed=11101505; DOI=10.1093/emboj/19.23.6326;
RA   Tinel N., Diochot S., Borsotto M., Lazdunski M., Barhanin J.;
RT   "KCNE2 confers background current characteristics to the cardiac KCNQ1
RT   potassium channel.";
RL   EMBO J. 19:6326-6330(2000).
RN   [15]
RP   FUNCTION.
RX   PubMed=10713961; DOI=10.1111/j.1469-7793.2000.t01-2-00349.x;
RA   Selyanko A.A., Hadley J.K., Wood I.C., Abogadie F.C., Jentsch T.J.,
RA   Brown D.A.;
RT   "Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells
RT   via M1 muscarinic acetylcholine receptors.";
RL   J. Physiol. (Lond.) 522:349-355(2000).
RN   [16]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10646604; DOI=10.1038/35003200;
RA   Schroeder B.C., Waldegger S., Fehr S., Bleich M., Warth R., Greger R.,
RA   Jentsch T.J.;
RT   "A constitutively open potassium channel formed by KCNQ1 and KCNE3.";
RL   Nature 403:196-199(2000).
RN   [17]
RP   FUNCTION.
RX   PubMed=12324418; DOI=10.1016/S0006-3495(02)73961-1;
RA   Angelo K., Jespersen T., Grunnet M., Nielsen M.S., Klaerke D.A.,
RA   Olesen S.P.;
RT   "KCNE5 induces time- and voltage-dependent modulation of the KCNQ1
RT   current.";
RL   Biophys. J. 83:1997-2006(2002).
RN   [18]
RP   INTERACTION WITH AKAP9, PHOSPHORYLATION AT SER-27, CHARACTERIZATION OF
RP   VARIANT LQT1 ASP-589, AND MUTAGENESIS OF SER-27; LEU-602 AND ILE-609.
RX   PubMed=11799244; DOI=10.1126/science.1066843;
RA   Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J.,
RA   Marks A.R., Kass R.S.;
RT   "Requirement of a macromolecular signaling complex for beta adrenergic
RT   receptor modulation of the KCNQ1-KCNE1 potassium channel.";
RL   Science 295:496-499(2002).
RN   [19]
RP   FUNCTION, DOMAIN, INTERACTION WITH KCNE4, AND MUTAGENESIS OF VAL-324;
RP   LYS-326; THR-327; ILE-328; SER-338 AND PHE-340.
RX   PubMed=19687231; DOI=10.1085/jgp.200910234;
RA   Vanoye C.G., Welch R.C., Daniels M.A., Manderfield L.J., Tapper A.R.,
RA   Sanders C.R., George A.L. Jr.;
RT   "Distinct subdomains of the KCNQ1 S6 segment determine channel
RT   modulation by different KCNE subunits.";
RL   J. Gen. Physiol. 134:207-217(2009).
RN   [20]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH KCNE1; KCNE2; KCNE3; KCNE4
RP   AND KCNE5.
RX   PubMed=20533308; DOI=10.1002/jcp.22265;
RA   Roura-Ferrer M., Sole L., Oliveras A., Dahan R., Bielanska J.,
RA   Villarroel A., Comes N., Felipe A.;
RT   "Impact of KCNE subunits on KCNQ1 (Kv7.1) channel membrane surface
RT   targeting.";
RL   J. Cell. Physiol. 225:692-700(2010).
RN   [21]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21228319; DOI=10.1152/ajpcell.00390.2010;
RA   Andersen M.N., Olesen S.P., Rasmussen H.B.;
RT   "Kv7.1 surface expression is regulated by epithelial cell
RT   polarization.";
RL   Am. J. Physiol. 300:C814-C824(2011).
RN   [22]
RP   INTERACTION WITH NEDD4L AND USP2, UBIQUITINATED, DEUBIQUITINATED, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=22024150; DOI=10.1016/j.hrthm.2011.10.026;
RA   Krzystanek K., Rasmussen H.B., Grunnet M., Staub O., Olesen S.P.,
RA   Abriel H., Jespersen T.;
RT   "Deubiquitylating enzyme USP2 counteracts Nedd4-2-mediated
RT   downregulation of KCNQ1 potassium channels.";
RL   Heart Rhythm 9:440-448(2012).
RN   [23]
RP   INTERACTION WITH AP2M1 AND NEDD4L, AND SUBCELLULAR LOCATION.
RX   PubMed=23529131; DOI=10.1113/jphysiol.2013.251678;
RA   Rapetti-Mauss R., O'Mahony F., Sepulveda F.V., Urbach V., Harvey B.J.;
RT   "Oestrogen promotes KCNQ1 potassium channel endocytosis and
RT   postendocytic trafficking in colonic epithelium.";
RL   J. Physiol. (Lond.) 591:2813-2831(2013).
RN   [24]
RP   INTERACTION WITH KCNQ5, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=24855057; DOI=10.1161/ATVBAHA.114.303801;
RA   Oliveras A., Roura-Ferrer M., Sole L., de la Cruz A., Prieto A.,
RA   Etxebarria A., Manils J., Morales-Cano D., Condom E., Soler C.,
RA   Cogolludo A., Valenzuela C., Villarroel A., Comes N., Felipe A.;
RT   "Functional assembly of Kv7.1/Kv7.5 channels with emerging properties
RT   on vascular muscle physiology.";
RL   Arterioscler. Thromb. Vasc. Biol. 34:1522-1530(2014).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 574-622, INTERACTION WITH
RP   CALM, SUBCELLULAR LOCATION, MUTAGENESIS OF GLY-589; ALA-590 AND
RP   ASN-593, CHARACTERIZATION OF VARIANT LQT1 ASP-589, AND
RP   TETRAMERIZATION.
RX   PubMed=18165683; DOI=10.1074/jbc.M707541200;
RA   Wiener R., Haitin Y., Shamgar L., Fernandez-Alonso M.C., Martos A.,
RA   Chomsky-Hecht O., Rivas G., Attali B., Hirsch J.A.;
RT   "The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit
RT   assembly and protein interaction.";
RL   J. Biol. Chem. 283:5815-5830(2008).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 583-611, SUBUNIT, AND
RP   COILED-COIL.
RX   PubMed=19693805; DOI=10.1002/pro.224;
RA   Xu Q., Minor D.L. Jr.;
RT   "Crystal structure of a trimeric form of the K(V)7.1 (KCNQ1) A-domain
RT   tail coiled-coil reveals structural plasticity and context dependent
RT   changes in a putative coiled-coil trimerization motif.";
RL   Protein Sci. 18:2100-2114(2009).
RN   [27]
RP   CHARACTERIZATION OF VARIANTS LQT1 PRO-178; PHE-273 AND ILE-312.
RX   PubMed=9323054; DOI=10.1161/01.CIR.96.6.1733;
RA   Shalaby F.Y., Levesque P.C., Yang W.-P., Little W.A., Conder M.L.,
RA   Jenkins-West T., Blanar M.A.;
RT   "Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT
RT   syndrome.";
RL   Circulation 96:1733-1736(1997).
RN   [28]
RP   REVIEW ON VARIANTS.
RX   PubMed=10704188;
RX   DOI=10.1002/(SICI)1096-8628(19990924)89:3<137::AID-AJMG4>3.3.CO;2-3;
RA   Tranebjaerg L., Bathen J., Tyson J., Bitner-Glindzicz M.;
RT   "Jervell and Lange-Nielsen syndrome: a Norwegian perspective.";
RL   Am. J. Med. Genet. 89:137-146(1999).
RN   [29]
RP   VARIANTS LQT1 SER-314 AND VAL-341.
RX   PubMed=8872472; DOI=10.1093/hmg/5.9.1319;
RA   Russell M.W., Dick M. II, Collins F.S., Brody L.C.;
RT   "KVLQT1 mutations in three families with familial or sporadic long QT
RT   syndrome.";
RL   Hum. Mol. Genet. 5:1319-1324(1996).
RN   [30]
RP   VARIANT LQT1 VAL-341.
RX   PubMed=8818942; DOI=10.1136/jmg.33.7.567;
RA   de Jager T., Corbett C.H., Badenhorst J.C., Brink P.A., Corfield V.A.;
RT   "Evidence of a long QT founder gene with varying phenotypic expression
RT   in South African families.";
RL   J. Med. Genet. 33:567-573(1996).
RN   [31]
RP   VARIANTS LQT1 MET-254 AND MET-417.
RA   Wedekind H., Schulze-Bahr E., Lange S., Rubie C., Haverkamp W.,
RA   Hoerdt M., Borggrefe M., Assmann G., Breithardt G., Funke H.;
RT   "A severe form of long-QT syndrome caused by KVLQT1 mutations located
RT   in cis (Abstract #2051).";
RL   Am. J. Hum. Genet. Suppl. 61:A350-A350(1997).
RN   [32]
RP   VARIANTS LQT1 THR-178; MET-313; ARG-325 AND PRO-366.
RX   PubMed=9024139; DOI=10.1161/01.CIR.95.3.565;
RA   Tanaka T., Nagai R., Tomoike H., Takata S., Yano K., Yabuta K.,
RA   Haneda N., Nakano O., Shibata A., Sawayama T., Kasai H., Yazaki Y.,
RA   Nakamura Y.;
RT   "Four novel KVLQT1 and four novel HERG mutations in familial long-QT
RT   syndrome.";
RL   Circulation 95:565-567(1997).
RN   [33]
RP   VARIANTS LQT1.
RX   PubMed=9386136; DOI=10.1161/01.CIR.96.9.2778;
RA   Donger C., Denjoy I., Berthet M., Neyroud N., Cruaud C., Bennaceur M.,
RA   Chivoret G., Schwartz K., Coumel P., Guicheney P.;
RT   "KVLQT1 C-terminal missense mutation causes a forme fruste long-QT
RT   syndrome.";
RL   Circulation 96:2778-2781(1997).
RN   [34]
RP   VARIANT LQT1 ARG-216.
RX   PubMed=9272155; DOI=10.1007/s004390050516;
RA   van den Berg M.H., Wilde A.A.M., Robles de Medina E.O., Meyer H.,
RA   Geelen J.L.M.C., Jongbloed R.J.E., Wellens H.J., Geraedts J.P.M.;
RT   "The long QT syndrome: a novel missense mutation in the S6 region of
RT   the KVLQT1 gene.";
RL   Hum. Genet. 100:356-361(1997).
RN   [35]
RP   VARIANT LQT1 ASN-317.
RX   PubMed=9302275; DOI=10.1093/hmg/6.11.1943;
RA   Wollnik B., Schroeder B.C., Kubisch C., Esperer H.D., Wieacker P.,
RA   Jentsch T.J.;
RT   "Pathophysiological mechanisms of dominant and recessive KVLQT1 K+
RT   channel mutations found in inherited cardiac arrhythmias.";
RL   Hum. Mol. Genet. 6:1943-1949(1997).
RN   [36]
RP   VARIANT LQT1 VAL-341.
RX   PubMed=9570196; DOI=10.1161/01.CIR.97.13.1264;
RA   Li H., Chen Q., Moss A.J., Robinson J.L., Goytia V., Perry J.C.,
RA   Vincent G.M., Priori S.G., Lehmann M.H., Denfield S.W., Duff D.,
RA   Kaine S., Shimizu W., Schwartz P.J., Wang Q., Towbin J.A.;
RT   "New mutations in the KVLQT1 potassium channel that cause long-QT
RT   syndrome.";
RL   Circulation 97:1264-1269(1998).
RN   [37]
RP   VARIANT LQT1 THR-300.
RX   PubMed=9641694; DOI=10.1161/01.CIR.97.24.2420;
RA   Priori S.G., Schwartz P.J., Napolitano C., Bianchi L., Dennis A.T.,
RA   de Fusco M., Brown A.M., Casari G.;
RT   "A recessive variant of the Romano-Ward Long-QT syndrome?";
RL   Circulation 97:2420-2425(1998).
RN   [38]
RP   VARIANT JLNS1 SER-305.
RX   PubMed=9781056; DOI=10.1038/sj.ejhg.5200165;
RA   Neyroud N., Denjoy I., Donger C., Gary F., Villain E., Leenhardt A.,
RA   Benali K., Schwartz K., Coumel P., Guicheney P.;
RT   "Heterozygous mutation in the pore of potassium channel gene KvLQT1
RT   causes an apparently normal phenotype in long QT syndrome.";
RL   Eur. J. Hum. Genet. 6:129-133(1998).
RN   [39]
RP   VARIANTS LQT1 ARG-168; SER-314; CYS-315; ASN-318; PRO-353 AND TRP-366.
RX   PubMed=9693036; DOI=10.1006/geno.1998.5361;
RA   Splawski I., Shen J., Timothy K.W., Vincent G.M., Lehmann M.H.,
RA   Keating M.T.;
RT   "Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and
RT   KCNE1.";
RL   Genomics 51:86-97(1998).
RN   [40]
RP   VARIANTS LQT1 ILE-311 AND ASN-317.
RX   PubMed=9482580;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:2<158::AID-HUMU9>3.0.CO;2-F;
RA   Saarinen K., Swan H., Kainulainen K., Toivonen L., Viitasalo M.,
RA   Kontula K.;
RT   "Molecular genetics of the long QT syndrome: two novel mutations of
RT   the KVLQT1 gene and phenotypic expression of the mutant gene in a
RT   large kindred.";
RL   Hum. Mutat. 11:158-165(1998).
RN   [41]
RP   VARIANT LQT1 PHE-339 DEL.
RX   PubMed=9702906; DOI=10.1203/00006450-199808000-00002;
RA   Ackerman M.J., Schroeder J.J., Berry R., Schaid D.J., Porter C.-B.J.,
RA   Michels V.V., Thibodeau S.N.;
RT   "A novel mutation in KVLQT1 is the molecular basis of inherited long
RT   QT syndrome in a near-drowning patient's family.";
RL   Pediatr. Res. 44:148-153(1998).
RN   [42]
RP   VARIANT JLNS1 HIS-243.
RX   PubMed=10090886; DOI=10.1086/302346;
RA   Mohammad-Panah R., Demolombe S., Neyroud N., Guicheney P., Kyndt F.,
RA   van den Hoff M., Baro I., Escande D.;
RT   "Mutations in a dominant-negative isoform correlate with phenotype in
RT   inherited cardiac arrhythmias.";
RL   Am. J. Hum. Genet. 64:1015-1023(1999).
RN   [43]
RP   VARIANT LQT1 HIS-174.
RX   PubMed=10367071;
RA   Denjoy I., Lupoglazoff J.M., Donger C., Berthet M., Richard P.,
RA   Neyroud N., Villain E., Lucet V., Coumel P., Guicheney P.;
RT   "Congenital long QT syndrome. The value of genetics in prognostic
RT   evaluation.";
RL   Arch. Mal. Coeur Vaiss. 92:557-563(1999).
RN   [44]
RP   VARIANTS LQT1 LEU-225; CYS-281 AND CYS-315.
RX   PubMed=9927399; DOI=10.1161/01.CIR.99.4.529;
RA   Priori S.G., Napolitano C., Schwartz P.J.;
RT   "Low penetrance in the long-QT syndrome: clinical impact.";
RL   Circulation 99:529-533(1999).
RN   [45]
RP   VARIANT LQT1 THR-525.
RX   PubMed=10482963; DOI=10.1038/sj.ejhg.5200323;
RA   Larsen L.A., Fosdal I., Andersen P.S., Kanters J.K., Vuust J.,
RA   Wettrell G., Christiansen M.;
RT   "Recessive Romano-Ward syndrome associated with compound
RT   heterozygosity for two mutations in the KVLQT1 gene.";
RL   Eur. J. Hum. Genet. 7:724-728(1999).
RN   [46]
RP   VARIANTS LQT1 SER-184; ARG-189; SER-314; SER-315; ARG-345; PRO-373 AND
RP   ARG-392.
RX   PubMed=10220144;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:4<301::AID-HUMU7>3.0.CO;2-V;
RA   Jongbloed R.J.E., Wilde A.A.M., Geelen J.L.M.C., Doevendans P.,
RA   Schaap C., van Langen I., van Tintelen J.P., Cobben J.M.,
RA   Beaufort-Krol G.C.M., Geraedts J.P.M., Smeets H.J.M.;
RT   "Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.";
RL   Hum. Mutat. 13:301-310(1999).
RN   [47]
RP   VARIANT LQT1 CYS-157.
RX   PubMed=10220146;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:4<318::AID-HUMU9>3.0.CO;2-F;
RA   Larsen L.A., Christiansen M., Vuust J., Andersen P.S.;
RT   "High-throughput single-strand conformation polymorphism analysis by
RT   automated capillary electrophoresis: robust multiplex analysis and
RT   pattern-based identification of allelic variants.";
RL   Hum. Mutat. 13:318-327(1999).
RN   [48]
RP   CHARACTERIZATION OF VARIANTS LQT1 CYS-243; ARG-248 AND LYS-261.
RX   PubMed=10409658; DOI=10.1074/jbc.274.30.21063;
RA   Franqueza L., Lin M., Shen J., Keating M.T., Sanguinetti M.C.;
RT   "Long QT syndrome-associated mutations in the S4-S5 linker of KvLQT1
RT   potassium channels modify gating and interaction with minK subunits.";
RL   J. Biol. Chem. 274:21063-21070(1999).
RN   [49]
RP   ERRATUM.
RA   Franqueza L., Lin M., Shen J., Keating M.T., Sanguinetti M.C.;
RL   J. Biol. Chem. 274:25188-25188(1999).
RN   [50]
RP   VARIANTS LQT1 GLN-190; TRP-533 AND TRP-539, VARIANT JLNS1 HIS-243,
RP   CHARACTERIZATION OF VARIANTS LQT1 GLN-190; TRP-533 AND TRP-539, AND
RP   CHARACTERIZATION OF VARIANT JLNS1 HIS-243.
RX   PubMed=10728423; DOI=10.1016/S0008-6363(99)00411-3;
RA   Chouabe C., Neyroud N., Richard P., Denjoy I., Hainque B., Romey G.,
RA   Drici M.-D., Guicheney P., Barhanin J.;
RT   "Novel mutations in KvLQT1 that affect Iks activation through
RT   interactions with Isk.";
RL   Cardiovasc. Res. 45:971-980(2000).
RN   [51]
RP   VARIANTS LQT1.
RX   PubMed=10973849; DOI=10.1161/01.CIR.102.10.1178;
RA   Splawski I., Shen J., Timothy K.W., Lehmann M.H., Priori S.G.,
RA   Robinson J.L., Moss A.J., Schwartz P.J., Towbin J.A., Vincent G.M.,
RA   Keating M.T.;
RT   "Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A,
RT   KCNE1, and KCNE2.";
RL   Circulation 102:1178-1185(2000).
RN   [52]
RP   VARIANTS LQT1 PRO-191; SER-275; LEU-277 AND VAL-306.
RX   PubMed=12442276; DOI=10.1002/humu.9085;
RA   Liu W., Yang J., Hu D., Kang C., Li C., Zhang S., Li P., Chen Z.,
RA   Qin X., Ying K., Li Y., Li Y., Li Z., Cheng X., Li L., Qi Y., Chen S.,
RA   Wang Q.;
RT   "KCNQ1 and KCNH2 mutations associated with long QT syndrome in a
RT   Chinese population.";
RL   Hum. Mutat. 20:475-476(2002).
RN   [53]
RP   VARIANT ATFB3 GLY-140.
RX   PubMed=12522251; DOI=10.1126/science.1077771;
RA   Chen Y.-H., Xu S.-J., Bendahhou S., Wang X.-L., Wang Y., Xu W.-Y.,
RA   Jin H.-W., Sun H., Su X.-Y., Zhuang Q.-N., Yang Y.-Q., Li Y.-B.,
RA   Liu Y., Xu H.-J., Li X.-F., Ma N., Mou C.-P., Chen Z., Barhanin J.,
RA   Huang W.;
RT   "KCNQ1 gain-of-function mutation in familial atrial fibrillation.";
RL   Science 299:251-254(2003).
RN   [54]
RP   VARIANT SQT2 LEU-307, AND CHARACTERIZATION OF VARIANT SQT2 LEU-307.
RX   PubMed=15159330; DOI=10.1161/01.CIR.0000130409.72142.FE;
RA   Bellocq C., van Ginneken A.C.G., Bezzina C.R., Alders M., Escande D.,
RA   Mannens M.M.A.M., Baro I., Wilde A.A.M.;
RT   "Mutation in the KCNQ1 gene leading to the short QT-interval
RT   syndrome.";
RL   Circulation 109:2394-2397(2004).
RN   [55]
RP   VARIANTS LQT1 71-ALA--PRO-73 DEL; THR-73; GLY-115; TYR-122; ILE-133;
RP   PHE-136; LYS-160; ARG-168; CYS-174; GLN-190; PHE-204; LEU-225;
RP   ASN-235; ASN-242; CYS-243; MET-254; 254-VAL--PHE-256 DEL; CYS-259;
RP   LEU-259; ASP-261; PRO-266; SER-269; ASP-269; PHE-273; ARG-273; SER-276
RP   DEL; LEU-277; HIS-278; LYS-290; ASP-292; CYS-293; VAL-302; ARG-304;
RP   SER-305; ILE-312; SER-314; ARG-314; ASP-314; CYS-315; ARG-316;
RP   ALA-322; PHE-339 DEL; VAL-341; SER-343; GLU-344; VAL-344; GLU-345;
RP   TRP-349; PRO-353; ARG-362; TRP-366; HIS-374; SER-380; TYR-389;
RP   TRP-452; GLY-524; GLU-526; TRP-539; LEU-546; CYS-555; HIS-555;
RP   TYR-566; SER-567; ARG-568; MET-587; THR-590; HIS-591; GLN-594; MET-619
RP   AND SER-626.
RX   PubMed=15840476; DOI=10.1016/j.hrthm.2005.01.020;
RA   Tester D.J., Will M.L., Haglund C.M., Ackerman M.J.;
RT   "Compendium of cardiac channel mutations in 541 consecutive unrelated
RT   patients referred for long QT syndrome genetic testing.";
RL   Heart Rhythm 2:507-517(2005).
RN   [56]
RP   VARIANTS LQT1 THR-46; PHE-137; LYS-146; ASP-173; PRO-174; TRP-190;
RP   PRO-192; HIS-202; MET-204; PHE-209; MET-215; HIS-231; PRO-239;
RP   LEU-254; ARG-258; ASN-258; VAL-262; ASP-272; TRP-277; GLU-280;
RP   GLU-287; THR-302; ASP-308; GLU-316; MET-322; ARG-343; LEU-343;
RP   PRO-349; ARG-350; SER-351; THR-360; ASP-372; MET-393; GLY-518;
RP   PRO-518; ASP-548; ALA-554; THR-567; LEU-573; HIS-583 AND ASP-586.
RX   PubMed=16414944; DOI=10.1001/jama.294.23.2975;
RA   Napolitano C., Priori S.G., Schwartz P.J., Bloise R., Ronchetti E.,
RA   Nastoli J., Bottelli G., Cerrone M., Leonardi S.;
RT   "Genetic testing in the long QT syndrome: development and validation
RT   of an efficient approach to genotyping in clinical practice.";
RL   JAMA 294:2975-2980(2005).
RN   [57]
RP   VARIANTS LQT1 CYS-231; PRO-243; CYS-259; HIS-259; PHE-273; SER-314;
RP   GLU-316; VAL-341; VAL-344 AND SER-626.
RX   PubMed=16922724; DOI=10.1111/j.1399-0004.2006.00671.x;
RA   Millat G., Chevalier P., Restier-Miron L., Da Costa A., Bouvagnet P.,
RA   Kugener B., Fayol L., Gonzalez Armengod C., Oddou B., Chanavat V.,
RA   Froidefond E., Perraudin R., Rousson R., Rodriguez-Lafrasse C.;
RT   "Spectrum of pathogenic mutations and associated polymorphisms in a
RT   cohort of 44 unrelated patients with long QT syndrome.";
RL   Clin. Genet. 70:214-227(2006).
RN   [58]
RP   VARIANT JLNS1 MET-322, AND VARIANT LQT1 MET-322.
RX   PubMed=18400097; DOI=10.1186/1471-2350-9-24;
RA   Zhang S., Yin K., Ren X., Wang P., Zhang S., Cheng L., Yang J.,
RA   Liu J.Y., Liu M., Wang Q.K.;
RT   "Identification of a novel KCNQ1 mutation associated with both Jervell
RT   and Lange-Nielsen and Romano-Ward forms of long QT syndrome in a
RT   Chinese family.";
RL   BMC Med. Genet. 9:24-24(2008).
RN   [59]
RP   VARIANT JLNS1 PHE-248, AND CHARACTERIZATION OF VARIANT JLNS1 PHE-248.
RX   PubMed=18441444; DOI=10.1253/circj.72.687;
RA   Ohno S., Kubota T., Yoshida H., Tsuji K., Makiyama T., Yamada S.,
RA   Kuga K., Yamaguchi I., Kita T., Horie M.;
RT   "A novel mutation associated with Jervell and Lange-Nielsen syndrome
RT   in a Japanese family.";
RL   Circ. J. 72:687-693(2008).
RN   [60]
RP   INVOLVEMENT IN NIDDM.
RX   PubMed=18711367; DOI=10.1038/ng.207;
RA   Yasuda K., Miyake K., Horikawa Y., Hara K., Osawa H., Furuta H.,
RA   Hirota Y., Mori H., Jonsson A., Sato Y., Yamagata K., Hinokio Y.,
RA   Wang H.Y., Tanahashi T., Nakamura N., Oka Y., Iwasaki N., Iwamoto Y.,
RA   Yamada Y., Seino Y., Maegawa H., Kashiwagi A., Takeda J., Maeda E.,
RA   Shin H.D., Cho Y.M., Park K.S., Lee H.K., Ng M.C., Ma R.C., So W.Y.,
RA   Chan J.C., Lyssenko V., Tuomi T., Nilsson P., Groop L., Kamatani N.,
RA   Sekine A., Nakamura Y., Yamamoto K., Yoshida T., Tokunaga K.,
RA   Itakura M., Makino H., Nanjo K., Kadowaki T., Kasuga M.;
RT   "Variants in KCNQ1 are associated with susceptibility to type 2
RT   diabetes mellitus.";
RL   Nat. Genet. 40:1092-1097(2008).
RN   [61]
RP   INVOLVEMENT IN NIDDM.
RX   PubMed=18711366; DOI=10.1038/ng.208;
RA   Unoki H., Takahashi A., Kawaguchi T., Hara K., Horikoshi M.,
RA   Andersen G., Ng D.P., Holmkvist J., Borch-Johnsen K., Jorgensen T.,
RA   Sandbaek A., Lauritzen T., Hansen T., Nurbaya S., Tsunoda T., Kubo M.,
RA   Babazono T., Hirose H., Hayashi M., Iwamoto Y., Kashiwagi A., Kaku K.,
RA   Kawamori R., Tai E.S., Pedersen O., Kamatani N., Kadowaki T.,
RA   Kikkawa R., Nakamura Y., Maeda S.;
RT   "SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes
RT   in East Asian and European populations.";
RL   Nat. Genet. 40:1098-1102(2008).
RN   [62]
RP   INVOLVEMENT IN NIDDM.
RX   PubMed=24390345; DOI=10.1038/nature12828;
RG   The SIGMA Type 2 Diabetes Consortium;
RT   "Sequence variants in SLC16A11 are a common risk factor for type 2
RT   diabetes in Mexico.";
RL   Nature 506:97-101(2014).
RN   [63]
RP   VARIANTS LQT1 VAL-2; SER-7; THR-46; 64-PRO--PRO-70 DEL; PHE-66;
RP   THR-73; CYS-111; LEU-117; LEU-127; ILE-133; PRO-134; ALA-144; MET-153;
RP   MET-162; ARG-168; MET-172; CYS-174; HIS-174; THR-178; SER-179;
RP   HIS-184; ARG-186; GLN-190; LEU-190; TRP-195; VAL-198; ALA-199;
RP   MET-204; MET-215; MET-224; LEU-225; CYS-231; HIS-231; ASN-235;
RP   GLY-241; ASN-242; CYS-243; PRO-250; MET-254; CYS-259; LEU-259;
RP   VAL-262; PRO-266; SER-268; ASP-269; SER-269; ASP-272; PHE-273;
RP   VAL-274; LEU-277; PRO-277; GLU-280; CYS-281; PRO-282; GLY-283;
RP   ASP-292; CYS-293; GLU-302; VAL-302; PRO-303; ARG-305; SER-305;
RP   ARG-306; ILE-312; CYS-314; SER-314; CYS-315; VAL-316; SER-320;
RP   ALA-322; MET-322; ARG-325; TYR-339; GLU-341; GLY-341; VAL-341;
RP   PHE-342; LEU-343; ARG-350; SER-351; ARG-354; MET-360; ARG-362;
RP   HIS-365; GLN-366; TRP-366; HIS-374; GLY-379; LYS-385; PRO-389; THR-391
RP   INS; TRP-397; ARG-398; GLU-446; LEU-448; TRP-451; SER-460; LEU-477;
RP   TRP-511; GLN-518; ARG-520; SER-522; GLY-524; THR-525; VAL-525;
RP   TRP-533; GLN-539; TRP-539; ILE-541; LYS-543; LEU-546; ARG-547;
RP   CYS-555; HIS-555; SER-555; GLU-557; PHE-566; PRO-566; TYR-566;
RP   THR-567; ARG-568; GLU-569; LEU-571; MET-587; ASP-589; CYS-591;
RP   HIS-591; GLN-594; PRO-594; GLU-596 DEL; LYS-596; MET-600; ASN-611;
RP   HIS-614 DEL; SER-626 AND ARG-635.
RX   PubMed=19716085; DOI=10.1016/j.hrthm.2009.05.021;
RA   Kapplinger J.D., Tester D.J., Salisbury B.A., Carr J.L.,
RA   Harris-Kerr C., Pollevick G.D., Wilde A.A., Ackerman M.J.;
RT   "Spectrum and prevalence of mutations from the first 2,500 consecutive
RT   unrelated patients referred for the FAMILION long QT syndrome genetic
RT   test.";
RL   Heart Rhythm 6:1297-1303(2009).
RN   [64]
RP   VARIANT LQT1 HIS-320, AND CHARACTERIZATION OF VARIANTS LQT1 ALA-320
RP   AND HIS-320.
RX   PubMed=19540844; DOI=10.1016/j.yjmcc.2009.06.009;
RA   Thomas D., Khalil M., Alter M., Schweizer P.A., Karle C.A.,
RA   Wimmer A.B., Licka M., Katus H.A., Koenen M., Ulmer H.E., Zehelein J.;
RT   "Biophysical characterization of KCNQ1 P320 mutations linked to long
RT   QT syndrome 1.";
RL   J. Mol. Cell. Cardiol. 48:230-237(2010).
RN   [65]
RP   VARIANT LQT1 LEU-277, AND CHARACTERIZATION OF VARIANT LQT1 LEU-277.
RX   PubMed=21241800; DOI=10.1016/j.bbadis.2011.01.008;
RA   Aidery P., Kisselbach J., Schweizer P.A., Becker R., Katus H.A.,
RA   Thomas D.;
RT   "Biophysical properties of mutant KCNQ1 S277L channels linked to
RT   hereditary long QT syndrome with phenotypic variability.";
RL   Biochim. Biophys. Acta 1812:488-494(2011).
RN   [66]
RP   VARIANT LQT1 GLU-557, AND CHARACTERIZATION OF VARIANT LQT1 GLU-557.
RX   PubMed=25139741; DOI=10.1093/cvr/cvu191;
RA   Spaetjens R.L., Bebarova M., Seyen S.R., Lentink V., Jongbloed R.J.,
RA   Arens Y.H., Heijman J., Volders P.G.;
RT   "Long-QT mutation p.K557E-Kv7.1: dominant-negative suppression of IKs,
RT   but preserved cAMP-dependent up-regulation.";
RL   Cardiovasc. Res. 104:216-225(2014).
RN   [67]
RP   VARIANTS LQT1 ASN-235; CYS-315 AND ALA-322, AND CHARACTERIZATION OF
RP   VARIANT LQT1 ASN-235.
RX   PubMed=24269949; DOI=10.1016/j.hrthm.2013.11.021;
RA   Bartos D.C., Giudicessi J.R., Tester D.J., Ackerman M.J., Ohno S.,
RA   Horie M., Gollob M.H., Burgess D.E., Delisle B.P.;
RT   "A KCNQ1 mutation contributes to the concealed type 1 long QT
RT   phenotype by limiting the Kv7.1 channel conformational changes
RT   associated with protein kinase A phosphorylation.";
RL   Heart Rhythm 11:459-468(2014).
RN   [68]
RP   VARIANT LQT1 SER-269, AND CHARACTERIZATION OF VARIANT LQT1 SER-269.
RX   PubMed=24184248; DOI=10.1016/j.jacc.2013.08.1648;
RA   Wu J., Naiki N., Ding W.G., Ohno S., Kato K., Zang W.J., Delisle B.P.,
RA   Matsuura H., Horie M.;
RT   "A molecular mechanism for adrenergic-induced long QT syndrome.";
RL   J. Am. Coll. Cardiol. 63:819-827(2014).
RN   [69]
RP   CHARACTERIZATION OF VARIANTS LQT1 LEU-546; CYS-555; HIS-555; GLU-557
RP   AND ASP-589, INTERACTION WITH KCNE1 AND AKAP9, SUBCELLULAR LOCATION,
RP   AND FUNCTION.
RX   PubMed=25037568; DOI=10.1242/jcs.147033;
RA   Dvir M., Strulovich R., Sachyani D., Ben-Tal Cohen I., Haitin Y.,
RA   Dessauer C., Pongs O., Kass R., Hirsch J.A., Attali B.;
RT   "Long QT mutations at the interface between KCNQ1 helix C and KCNE1
RT   disrupt I(KS) regulation by PKA and PIP(2).";
RL   J. Cell Sci. 127:3943-3955(2014).
RN   [70]
RP   VARIANT LQT1 THR-590, AND CHARACTERIZATION OF VARIANT LQT1 THR-590.
RX   PubMed=24713462; DOI=10.1016/j.yjmcc.2014.03.019;
RA   Kinoshita K., Komatsu T., Nishide K., Hata Y., Hisajima N.,
RA   Takahashi H., Kimoto K., Aonuma K., Tsushima E., Tabata T.,
RA   Yoshida T., Mori H., Nishida K., Yamaguchi Y., Ichida F.,
RA   Fukurotani K., Inoue H., Nishida N.;
RT   "A590T mutation in KCNQ1 C-terminal helix D decreases IKs channel
RT   trafficking and function but not Yotiao interaction.";
RL   J. Mol. Cell. Cardiol. 72:273-280(2014).
RN   [71]
RP   CHARACTERIZATION OF VARIANTS LQT1 ASN-242; PRO-243; HIS-250; VAL-306;
RP   ASN-317; ASP-586 AND MET-619, AND CHARACTERIZATION OF VARIANTS JLNS1
RP   PHE-248; ILE-311; MET-322 AND ASP-589.
RX   PubMed=25705178; DOI=10.3389/fncel.2015.00032;
RA   Mousavi Nik A., Gharaie S., Jeong Kim H.;
RT   "Cellular mechanisms of mutations in Kv7.1: auditory functions in
RT   Jervell and Lange-Nielsen syndrome vs. Romano-Ward syndrome.";
RL   Front. Cell. Neurosci. 9:32-32(2015).
CC   -!- FUNCTION: Potassium channel that plays an important role in a
CC       number of tissues, including heart, inner ear, stomach and colon
CC       (By similarity) (PubMed:10646604). Associates with KCNE beta
CC       subunits that modulates current kinetics (By similarity)
CC       (PubMed:9312006, PubMed:9108097, PubMed:8900283, PubMed:10646604,
CC       PubMed:11101505, PubMed:19687231). Induces a voltage-dependent by
CC       rapidly activating and slowly deactivating potassium-selective
CC       outward current (By similarity) (PubMed:9312006, PubMed:9108097,
CC       PubMed:8900283, PubMed:10646604, PubMed:11101505). Promotes also a
CC       delayed voltage activated potassium current showing outward
CC       rectification characteristic (By similarity). During beta-
CC       adrenergic receptor stimulation participates in cardiac
CC       repolarization by associating with KCNE1 to form the I(Ks) cardiac
CC       potassium current that increases the amplitude and slows down the
CC       activation kinetics of outward potassium current I(Ks) (By
CC       similarity) (PubMed:9312006, PubMed:9108097, PubMed:8900283,
CC       PubMed:10646604, PubMed:11101505). Muscarinic agonist
CC       oxotremorine-M strongly suppresses KCNQ1/KCNE1 current
CC       (PubMed:10713961). When associated with KCNE3, forms the potassium
CC       channel that is important for cyclic AMP-stimulated intestinal
CC       secretion of chloride ions (PubMed:10646604). This interaction
CC       with KCNE3 is reduced by 17beta-estradiol, resulting in the
CC       reduction of currents (By similarity). During conditions of
CC       increased substrate load, maintains the driving force for proximal
CC       tubular and intestinal sodium ions absorption, gastric acid
CC       secretion, and cAMP-induced jejunal chloride ions secretion (By
CC       similarity). Allows the provision of potassium ions to the luminal
CC       membrane of the secretory canaliculus in the resting state as well
CC       as during stimulated acid secretion (By similarity). When
CC       associated with KCNE2, forms a heterooligomer complex leading to
CC       currents with an apparently instantaneous activation, a rapid
CC       deactivation process and a linear current-voltage relationship and
CC       decreases the amplitude of the outward current (PubMed:11101505).
CC       When associated with KCNE4, inhibits voltage-gated potassium
CC       channel activity (PubMed:19687231). When associated with KCNE5,
CC       this complex only conducts current upon strong and continued
CC       depolarization (PubMed:12324418). Also forms a heterotetramer with
CC       KCNQ5; has a voltage-gated potassium channel activity
CC       (PubMed:24855057). Binds with phosphatidylinositol 4,5-
CC       bisphosphate (PubMed:25037568). {ECO:0000250|UniProtKB:P97414,
CC       ECO:0000250|UniProtKB:Q9Z0N7, ECO:0000269|PubMed:10646604,
CC       ECO:0000269|PubMed:10713961, ECO:0000269|PubMed:11101505,
CC       ECO:0000269|PubMed:12324418, ECO:0000269|PubMed:19687231,
CC       ECO:0000269|PubMed:24855057, ECO:0000269|PubMed:25037568,
CC       ECO:0000269|PubMed:8900283, ECO:0000269|PubMed:9108097,
CC       ECO:0000269|PubMed:9312006}.
CC   -!- FUNCTION: Isoform 2: Non-functional alone but modulatory when
CC       coexpressed with the full-length isoform 1.
CC       {ECO:0000269|PubMed:9305853}.
CC   -!- SUBUNIT: Tetramer (PubMed:18165683, PubMed:19693805).
CC       Heterotetramer with KCNE1; targets to the membrane raft
CC       (PubMed:25037568, PubMed:19693805, PubMed:20533308). Interacts
CC       (via C-terminus) with CALM; forms a heterotetramer in a calcium-
CC       independent manner (PubMed:18165683). Interacts with AKAP9;
CC       targets protein kinase A (PKA) catalytic and regulatory subunits
CC       and protein phosphatase 1 (PP1) to the KCNQ1-KCNE1 complex,
CC       allowing PKA-mediated phosphorylation and increase of delayed
CC       rectifier potassium channel activity (PubMed:11799244,
CC       PubMed:25037568). Interacts with KCNE2; forms a heterooligomer
CC       complex that targets to the membrane raft and leading to currents
CC       with an apparently instantaneous activation, a rapid deactivation
CC       process and a linear current-voltage relationship and decreases
CC       the amplitude of the outward current (PubMed:11101505,
CC       PubMed:20533308). Interacts with AP2M1; mediates estrogen-induced
CC       internalization via clathrin-coated vesicles (PubMed:23529131).
CC       Interacts with NEDD4L; promotes internalization and decreases
CC       I(Ks) currents (PubMed:23529131, PubMed:22024150). Interacts with
CC       USP2; counteracts the NEDD4L-specific down-regulation of I(Ks) and
CC       restore plasma membrane localization (PubMed:22024150).
CC       Heterotetramer with KCNQ5; has a voltage-gated potassium channel
CC       activity (PubMed:24855057). Interacts with KCNE3; alters membrane
CC       raft localization (PubMed:20533308). Interacts with KCNE4; impairs
CC       KCNQ1 localization in lipid rafts and inhibits voltage-gated
CC       potassium channel activity (PubMed:19687231, PubMed:20533308).
CC       Interacts with KCNE5; impairs KCNQ1 localization in lipid rafts
CC       and only conducts current upon strong and continued depolarization
CC       (PubMed:20533308, PubMed:12324418). {ECO:0000269|PubMed:11101505,
CC       ECO:0000269|PubMed:11799244, ECO:0000269|PubMed:12324418,
CC       ECO:0000269|PubMed:18165683, ECO:0000269|PubMed:19687231,
CC       ECO:0000269|PubMed:19693805, ECO:0000269|PubMed:20533308,
CC       ECO:0000269|PubMed:22024150, ECO:0000269|PubMed:23529131,
CC       ECO:0000269|PubMed:24855057, ECO:0000269|PubMed:25037568}.
CC   -!- INTERACTION:
CC       P62158:CALM3; NbExp=6; IntAct=EBI-15885881, EBI-397435;
CC       P15382:KCNE1; NbExp=4; IntAct=EBI-359667, EBI-7043557;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10646604,
CC       ECO:0000269|PubMed:18165683, ECO:0000269|PubMed:21228319,
CC       ECO:0000269|PubMed:22024150, ECO:0000269|PubMed:25037568}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:18165683}. Cytoplasmic
CC       vesicle membrane {ECO:0000269|PubMed:18165683,
CC       ECO:0000269|PubMed:23529131}. Early endosome
CC       {ECO:0000269|PubMed:23529131}. Membrane raft
CC       {ECO:0000269|PubMed:20533308, ECO:0000269|PubMed:24855057}.
CC       Endoplasmic reticulum {ECO:0000269|PubMed:21228319,
CC       ECO:0000269|PubMed:24855057}. Basolateral cell membrane
CC       {ECO:0000269|PubMed:21228319}. Note=Colocalized with KCNE3 at the
CC       plasma membrane (PubMed:10646604). Upon 17beta-oestradiol
CC       treatment, colocalizes with RAB5A at early endosome
CC       (PubMed:23529131). Heterotetramer with KCNQ5 is highly retained at
CC       the endoplasmic reticulum and is localized outside of lipid raft
CC       microdomains (PubMed:24855057). During the early stages of
CC       epithelial cell polarization induced by the calcium switch it
CC       removed from plasma membrane to the endoplasmic reticulum where it
CC       retained and it is redistributed to the basolateral cell surface
CC       in a PI3K-dependent manner at a later stage (PubMed:21228319).
CC       {ECO:0000269|PubMed:10646604, ECO:0000269|PubMed:21228319,
CC       ECO:0000269|PubMed:23529131, ECO:0000269|PubMed:24855057}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P51787-1; Sequence=Displayed;
CC       Name=2; Synonyms=TKvLQT1;
CC         IsoId=P51787-2; Sequence=VSP_000981, VSP_000982;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in heart, pancreas,
CC       prostate, kidney, small intestine and peripheral blood leukocytes.
CC       Less abundant in placenta, lung, spleen, colon, thymus, testis and
CC       ovaries.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- DOMAIN: The coiled-coil domain mediates tetramerization.
CC       {ECO:0000269|PubMed:18165683, ECO:0000269|PubMed:19693805}.
CC   -!- DOMAIN: The segment S6 is involved in the inhibition of voltage-
CC       gated potassium channel activity by KCNE4.
CC       {ECO:0000269|PubMed:19687231}.
CC   -!- DOMAIN: The C-terminal assembly domain promotes self-interactiona;
CC       allows functional channel. {ECO:0000269|PubMed:10654932}.
CC   -!- PTM: Phosphorylation at Ser-27 by PKA; increases delayed rectifier
CC       potassium channel activity of the KCNQ1-KCNE1 complex through a
CC       macromolecular complex that includes PKA, PP1, and the targeting
CC       protein AKAP9. {ECO:0000269|PubMed:11799244,
CC       ECO:0000269|PubMed:25037568}.
CC   -!- PTM: Ubiquitinated by NEDD4L; promotes internalization
CC       (PubMed:22024150). The ubiquitinylated form is internalized
CC       through a clathrin-mediated endocytosis by interacting with AP2M1
CC       and is recycled back to the cell membrane via RAB4A and RAB11A
CC       (PubMed:23529131). {ECO:0000269|PubMed:22024150,
CC       ECO:0000269|PubMed:23529131}.
CC   -!- PTM: Deubiquitinated by USP2; counteracts the NEDD4L-specific
CC       down-regulation of I(Ks) and restores the membrane localization.
CC       {ECO:0000269|PubMed:22024150}.
CC   -!- DISEASE: Long QT syndrome 1 (LQT1) [MIM:192500]: A heart disorder
CC       characterized by a prolonged QT interval on the ECG and
CC       polymorphic ventricular arrhythmias. They cause syncope and sudden
CC       death in response to exercise or emotional stress, and can present
CC       with a sentinel event of sudden cardiac death in infancy.
CC       {ECO:0000269|PubMed:10024302, ECO:0000269|PubMed:10220144,
CC       ECO:0000269|PubMed:10220146, ECO:0000269|PubMed:10367071,
CC       ECO:0000269|PubMed:10409658, ECO:0000269|PubMed:10482963,
CC       ECO:0000269|PubMed:10728423, ECO:0000269|PubMed:10973849,
CC       ECO:0000269|PubMed:11799244, ECO:0000269|PubMed:12442276,
CC       ECO:0000269|PubMed:15840476, ECO:0000269|PubMed:16414944,
CC       ECO:0000269|PubMed:16922724, ECO:0000269|PubMed:18165683,
CC       ECO:0000269|PubMed:18400097, ECO:0000269|PubMed:19540844,
CC       ECO:0000269|PubMed:19716085, ECO:0000269|PubMed:21241800,
CC       ECO:0000269|PubMed:24184248, ECO:0000269|PubMed:24269949,
CC       ECO:0000269|PubMed:24713462, ECO:0000269|PubMed:25037568,
CC       ECO:0000269|PubMed:25139741, ECO:0000269|PubMed:25705178,
CC       ECO:0000269|PubMed:8528244, ECO:0000269|PubMed:8818942,
CC       ECO:0000269|PubMed:8872472, ECO:0000269|PubMed:9024139,
CC       ECO:0000269|PubMed:9272155, ECO:0000269|PubMed:9302275,
CC       ECO:0000269|PubMed:9312006, ECO:0000269|PubMed:9323054,
CC       ECO:0000269|PubMed:9386136, ECO:0000269|PubMed:9482580,
CC       ECO:0000269|PubMed:9570196, ECO:0000269|PubMed:9641694,
CC       ECO:0000269|PubMed:9693036, ECO:0000269|PubMed:9702906,
CC       ECO:0000269|PubMed:9799083, ECO:0000269|PubMed:9927399,
CC       ECO:0000269|Ref.31}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Jervell and Lange-Nielsen syndrome 1 (JLNS1)
CC       [MIM:220400]: An autosomal recessive disorder characterized by
CC       congenital deafness, prolongation of the QT interval, syncopal
CC       attacks due to ventricular arrhythmias, and a high risk of sudden
CC       death. {ECO:0000269|PubMed:10090886, ECO:0000269|PubMed:10728423,
CC       ECO:0000269|PubMed:18400097, ECO:0000269|PubMed:18441444,
CC       ECO:0000269|PubMed:25705178, ECO:0000269|PubMed:9781056}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Atrial fibrillation, familial, 3 (ATFB3) [MIM:607554]: An
CC       autosomal dominant form of atrial fibrillation, a common sustained
CC       cardiac rhythm disturbance. Atrial fibrillation is characterized
CC       by disorganized atrial electrical activity and ineffective atrial
CC       contraction promoting blood stasis in the atria and reduces
CC       ventricular filling. It can result in palpitations, syncope,
CC       thromboembolic stroke, and congestive heart failure.
CC       {ECO:0000269|PubMed:12522251}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Short QT syndrome 2 (SQT2) [MIM:609621]: A heart disorder
CC       characterized by idiopathic persistently and uniformly short QT
CC       interval on ECG in the absence of structural heart disease in
CC       affected individuals. It causes syncope and sudden death.
CC       {ECO:0000269|PubMed:15159330}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM)
CC       [MIM:125853]: A multifactorial disorder of glucose homeostasis
CC       caused by a lack of sensitivity to the body's own insulin.
CC       Affected individuals usually have an obese body habitus and
CC       manifestations of a metabolic syndrome characterized by diabetes,
CC       insulin resistance, hypertension and hypertriglyceridemia. The
CC       disease results in long-term complications that affect the eyes,
CC       kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:18711366,
CC       ECO:0000269|PubMed:18711367, ECO:0000269|PubMed:24390345}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Mutagenesis experiments were carried out by
CC       expressing in Xenopus oocytes or COS-7 cells KCNQ1 mutants either
CC       individually (homomultimers) or in combination with both wild-type
CC       KCNQ1 (mut/wt homomultimers) and minK (heteromultimers).
CC   -!- SIMILARITY: Belongs to the potassium channel family. KQT (TC
CC       1.A.1.15) subfamily. Kv7.1/KCNQ1 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC51781.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=BAA34739.1; Type=Frameshift; Positions=129, 159; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=KvLQT1 entry;
CC       URL="https://en.wikipedia.org/wiki/KvLQT1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF000571; AAC51776.1; -; mRNA.
DR   EMBL; AF051426; AAC05705.1; -; mRNA.
DR   EMBL; AB015163; BAA34738.1; -; Genomic_DNA.
DR   EMBL; AB015163; BAA34739.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AJ006345; CAB44649.1; -; Genomic_DNA.
DR   EMBL; AJ006345; CAB44650.1; -; Genomic_DNA.
DR   EMBL; AY114213; AAM94040.1; -; mRNA.
DR   EMBL; AK290618; BAF83307.1; -; mRNA.
DR   EMBL; AC013791; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC021424; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124055; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP006463; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455303; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455304; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455305; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455306; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF459741; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471158; EAX02517.1; -; Genomic_DNA.
DR   EMBL; BC113545; AAI13546.1; -; mRNA.
DR   EMBL; U86146; AAB53974.1; -; mRNA.
DR   EMBL; U89364; AAC51781.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS7736.1; -. [P51787-1]
DR   RefSeq; NP_000209.2; NM_000218.2. [P51787-1]
DR   RefSeq; NP_861463.1; NM_181798.1. [P51787-2]
DR   UniGene; Hs.95162; -.
DR   PDB; 3BJ4; X-ray; 2.00 A; A/B=574-622.
DR   PDB; 3HFC; X-ray; 2.45 A; A/B/C=583-611.
DR   PDB; 3HFE; X-ray; 1.70 A; A/B/C=583-611.
DR   PDB; 4UMO; X-ray; 3.00 A; A/B=352-539.
DR   PDB; 4V0C; X-ray; 2.86 A; A/B=352-539.
DR   PDBsum; 3BJ4; -.
DR   PDBsum; 3HFC; -.
DR   PDBsum; 3HFE; -.
DR   PDBsum; 4UMO; -.
DR   PDBsum; 4V0C; -.
DR   ProteinModelPortal; P51787; -.
DR   SMR; P51787; -.
DR   BioGrid; 109985; 16.
DR   CORUM; P51787; -.
DR   DIP; DIP-27591N; -.
DR   DIP; DIP-29941N; -.
DR   IntAct; P51787; 5.
DR   MINT; MINT-1145466; -.
DR   STRING; 9606.ENSP00000155840; -.
DR   BindingDB; P51787; -.
DR   ChEMBL; CHEMBL1866; -.
DR   DrugBank; DB04957; Azimilide.
DR   DrugBank; DB01244; Bepridil.
DR   DrugBank; DB06089; ICA-105665.
DR   DrugBank; DB00808; Indapamide.
DR   GuidetoPHARMACOLOGY; 560; -.
DR   TCDB; 1.A.1.15.6; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P51787; -.
DR   PhosphoSitePlus; P51787; -.
DR   BioMuta; KCNQ1; -.
DR   DMDM; 6166005; -.
DR   PaxDb; P51787; -.
DR   PeptideAtlas; P51787; -.
DR   PRIDE; P51787; -.
DR   DNASU; 3784; -.
DR   Ensembl; ENST00000155840; ENSP00000155840; ENSG00000053918. [P51787-1]
DR   Ensembl; ENST00000335475; ENSP00000334497; ENSG00000053918. [P51787-2]
DR   GeneID; 3784; -.
DR   KEGG; hsa:3784; -.
DR   UCSC; uc001lwn.4; human. [P51787-1]
DR   CTD; 3784; -.
DR   DisGeNET; 3784; -.
DR   EuPathDB; HostDB:ENSG00000053918.15; -.
DR   GeneCards; KCNQ1; -.
DR   GeneReviews; KCNQ1; -.
DR   HGNC; HGNC:6294; KCNQ1.
DR   HPA; CAB018656; -.
DR   HPA; HPA048553; -.
DR   MalaCards; KCNQ1; -.
DR   MIM; 125853; phenotype.
DR   MIM; 192500; phenotype.
DR   MIM; 220400; phenotype.
DR   MIM; 607542; gene.
DR   MIM; 607554; phenotype.
DR   MIM; 609621; phenotype.
DR   neXtProt; NX_P51787; -.
DR   OpenTargets; ENSG00000053918; -.
DR   Orphanet; 334; Familial atrial fibrillation.
DR   Orphanet; 51083; Familial short QT syndrome.
DR   Orphanet; 90647; Jervell and Lange-Nielsen syndrome.
DR   Orphanet; 101016; Romano-Ward syndrome.
DR   PharmGKB; PA223; -.
DR   eggNOG; KOG1419; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00550000074513; -.
DR   HOGENOM; HOG000220839; -.
DR   HOVERGEN; HBG059014; -.
DR   InParanoid; P51787; -.
DR   KO; K04926; -.
DR   OMA; ERKRWGW; -.
DR   OrthoDB; EOG091G02ZT; -.
DR   PhylomeDB; P51787; -.
DR   TreeFam; TF315186; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-5576890; Phase 3 - rapid repolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   SignaLink; P51787; -.
DR   ChiTaRS; KCNQ1; human.
DR   EvolutionaryTrace; P51787; -.
DR   GeneWiki; KvLQT1; -.
DR   GenomeRNAi; 3784; -.
DR   PRO; PR:P51787; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000053918; -.
DR   CleanEx; HS_KCNQ1; -.
DR   ExpressionAtlas; P51787; baseline and differential.
DR   Genevisible; P51787; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005769; C:early endosome; IDA:BHF-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0034702; C:ion channel complex; IPI:UniProtKB.
DR   GO; GO:0005770; C:late endosome; IDA:BHF-UCL.
DR   GO; GO:0005764; C:lysosome; IDA:BHF-UCL.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; IDA:BHF-UCL.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB.
DR   GO; GO:0034236; F:protein kinase A catalytic subunit binding; IDA:BHF-UCL.
DR   GO; GO:0034237; F:protein kinase A regulatory subunit binding; IDA:BHF-UCL.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IDA:BHF-UCL.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:BHF-UCL.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0086089; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0086008; F:voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:1902282; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0086014; P:atrial cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0072358; P:cardiovascular system development; IEA:Ensembl.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:BHF-UCL.
DR   GO; GO:0035690; P:cellular response to drug; IDA:BHF-UCL.
DR   GO; GO:0071872; P:cellular response to epinephrine stimulus; TAS:BHF-UCL.
DR   GO; GO:0016458; P:gene silencing; IEA:Ensembl.
DR   GO; GO:0048839; P:inner ear development; ISS:UniProtKB.
DR   GO; GO:0050892; P:intestinal absorption; ISS:UniProtKB.
DR   GO; GO:0086011; P:membrane repolarization during action potential; IDA:BHF-UCL.
DR   GO; GO:0098914; P:membrane repolarization during atrial cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:1902260; P:negative regulation of delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:1903817; P:negative regulation of voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0060452; P:positive regulation of cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0010460; P:positive regulation of heart rate; IMP:BHF-UCL.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0071435; P:potassium ion export; IDA:BHF-UCL.
DR   GO; GO:0097623; P:potassium ion export across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0060453; P:regulation of gastric acid secretion; ISS:UniProtKB.
DR   GO; GO:0006349; P:regulation of gene expression by genetic imprinting; IEA:Ensembl.
DR   GO; GO:0008016; P:regulation of heart contraction; IC:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0070293; P:renal absorption; ISS:UniProtKB.
DR   GO; GO:0007605; P:sensory perception of sound; TAS:ProtInc.
DR   GO; GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003937; K_chnl_volt-dep_KCNQ.
DR   InterPro; IPR013821; K_chnl_volt-dep_KCNQ_C.
DR   InterPro; IPR005827; K_chnl_volt-dep_KCQN1.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF109; PTHR11537:SF109; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03520; KCNQ_channel; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01460; KCNQ1CHANNEL.
DR   PRINTS; PR01459; KCNQCHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Atrial fibrillation;
KW   Calmodulin-binding; Cell membrane; Coiled coil; Complete proteome;
KW   Cytoplasmic vesicle; Deafness; Diabetes mellitus; Disease mutation;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Ion channel;
KW   Ion transport; Long QT syndrome; Membrane; Phosphoprotein;
KW   Polymorphism; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Short QT syndrome; Transmembrane;
KW   Transmembrane helix; Transport; Ubl conjugation;
KW   Voltage-gated channel.
FT   CHAIN         1    676       Potassium voltage-gated channel subfamily
FT                                KQT member 1.
FT                                /FTId=PRO_0000054022.
FT   TOPO_DOM      1    121       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    122    142       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    143    147       Extracellular. {ECO:0000255}.
FT   TRANSMEM    148    168       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    169    196       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    197    217       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    218    225       Extracellular. {ECO:0000255}.
FT   TRANSMEM    226    248       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    249    261       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    262    282       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    283    299       Extracellular. {ECO:0000255}.
FT   INTRAMEM    300    320       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    321    327       Extracellular. {ECO:0000255}.
FT   TRANSMEM    328    348       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    349    676       Cytoplasmic. {ECO:0000255}.
FT   REGION      535    572       Interaction with KCNE1 C-terminus.
FT                                {ECO:0000269|PubMed:25037568}.
FT   REGION      588    616       Interaction with AKAP9.
FT                                {ECO:0000269|PubMed:11799244}.
FT   REGION      589    620       C-terminal assembly domain.
FT                                {ECO:0000269|PubMed:10654932}.
FT   COILED      585    621       {ECO:0000269|PubMed:19693805}.
FT   MOTIF       312    317       Selectivity filter. {ECO:0000250}.
FT   MOD_RES      27     27       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:11799244}.
FT   MOD_RES     407    407       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97414}.
FT   MOD_RES     409    409       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97414}.
FT   CARBOHYD    289    289       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    127       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9305853}.
FT                                /FTId=VSP_000981.
FT   VAR_SEQ     128    129       AV -> MD (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9305853}.
FT                                /FTId=VSP_000982.
FT   VARIANT       2      2       A -> V (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473442).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074927.
FT   VARIANT       7      7       P -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473443).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074928.
FT   VARIANT      46     46       A -> T (in LQT1; dbSNP:rs199473671).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074929.
FT   VARIANT      64     70       Missing (in LQT1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074930.
FT   VARIANT      66     66       S -> F (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473446).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074931.
FT   VARIANT      71     73       Missing (in LQT1).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_009917.
FT   VARIANT      73     73       P -> T (in LQT1; dbSNP:rs199472676).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068287.
FT   VARIANT     111    111       Y -> C (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472678).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009918.
FT   VARIANT     115    115       E -> G (in LQT1; dbSNP:rs199472679).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068288.
FT   VARIANT     117    117       P -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs120074191).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074932.
FT   VARIANT     122    122       C -> Y (in LQT1; dbSNP:rs199472681).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068289.
FT   VARIANT     127    127       F -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472682).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074933.
FT   VARIANT     133    133       V -> I (in LQT1; dbSNP:rs199473449).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068290.
FT   VARIANT     134    134       L -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472685).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074934.
FT   VARIANT     136    136       C -> F (in LQT1; dbSNP:rs199472686).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068291.
FT   VARIANT     137    137       L -> F (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473450).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074935.
FT   VARIANT     140    140       S -> G (in ATFB3; gain of function;
FT                                dbSNP:rs120074192).
FT                                {ECO:0000269|PubMed:12522251}.
FT                                /FTId=VAR_015742.
FT   VARIANT     144    144       T -> A (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473451).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074936.
FT   VARIANT     146    146       E -> K (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472688).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074937.
FT   VARIANT     153    153       T -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs143709408).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074938.
FT   VARIANT     157    157       F -> C (in LQT1; dbSNP:rs199472690).
FT                                {ECO:0000269|PubMed:10220146}.
FT                                /FTId=VAR_008124.
FT   VARIANT     160    160       E -> K (in LQT1; dbSNP:rs199473453).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_009919.
FT   VARIANT     162    162       V -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472692).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074939.
FT   VARIANT     167    168       FG -> W (in LQT1).
FT                                /FTId=VAR_001515.
FT   VARIANT     168    168       G -> R (in LQT1; dbSNP:rs179489).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_001516.
FT   VARIANT     172    172       V -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472694).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074940.
FT   VARIANT     173    173       V -> D (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472695).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074941.
FT   VARIANT     174    174       R -> C (in LQT1; dbSNP:rs199472696).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_001517.
FT   VARIANT     174    174       R -> H (in LQT1; dbSNP:rs199472697).
FT                                {ECO:0000269|PubMed:10367071,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008939.
FT   VARIANT     174    174       R -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472697).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074942.
FT   VARIANT     178    178       A -> P (in LQT1; loss of channel
FT                                activity; dbSNP:rs120074177).
FT                                {ECO:0000269|PubMed:9323054}.
FT                                /FTId=VAR_001518.
FT   VARIANT     178    178       A -> T (in LQT1; dbSNP:rs120074177).
FT                                {ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_009920.
FT   VARIANT     179    179       G -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473394).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009921.
FT   VARIANT     184    184       Y -> H (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473661).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074943.
FT   VARIANT     184    184       Y -> S (in LQT1; dbSNP:rs199473397).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_008125.
FT   VARIANT     186    186       G -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473398).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074944.
FT   VARIANT     189    189       G -> R (in LQT1; familial sudden death;
FT                                dbSNP:rs104894252).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_001519.
FT   VARIANT     190    190       R -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs120074178).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074945.
FT   VARIANT     190    190       R -> Q (in LQT1; loss of channel
FT                                activity; dbSNP:rs120074178).
FT                                {ECO:0000269|PubMed:10728423,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_001520.
FT   VARIANT     190    190       R -> W (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473662).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074946.
FT   VARIANT     191    191       L -> P (in LQT1; dbSNP:rs199473401).
FT                                {ECO:0000269|PubMed:12442276}.
FT                                /FTId=VAR_074687.
FT   VARIANT     192    192       R -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472698).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074947.
FT   VARIANT     194    194       A -> P (in LQT1; dbSNP:rs199472699).
FT                                /FTId=VAR_009922.
FT   VARIANT     195    195       R -> W (in LQT1; unknown pathological
FT                                significance; dbSNP:rs150172393).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074948.
FT   VARIANT     198    198       I -> V (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472700).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074949.
FT   VARIANT     199    199       S -> A (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472701).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074950.
FT   VARIANT     202    202       D -> H (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472702).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074951.
FT   VARIANT     204    204       I -> F (in LQT1; dbSNP:rs199472703).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068292.
FT   VARIANT     204    204       I -> M (in LQT1; dbSNP:rs199473455).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074952.
FT   VARIANT     209    209       S -> F (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472704).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074953.
FT   VARIANT     215    215       V -> M (in LQT1; dbSNP:rs17215479).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074954.
FT   VARIANT     216    216       G -> R (in LQT1).
FT                                {ECO:0000269|PubMed:9272155}.
FT                                /FTId=VAR_001521.
FT   VARIANT     224    224       T -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472706).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074955.
FT   VARIANT     225    225       S -> L (in LQT1; dbSNP:rs199473456).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9927399}.
FT                                /FTId=VAR_009923.
FT   VARIANT     231    231       R -> C (in LQT1; dbSNP:rs199473457).
FT                                {ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074956.
FT   VARIANT     231    231       R -> H (in LQT1; dbSNP:rs199472709).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074957.
FT   VARIANT     235    235       I -> N (in LQT1; decreases delayed
FT                                rectifier potassium current Iks; prevents
FT                                the up-regulation of Iks through PKA
FT                                activation; dbSNP:rs199472710).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:24269949}.
FT                                /FTId=VAR_068293.
FT   VARIANT     239    239       L -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473458).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074958.
FT   VARIANT     241    241       V -> G (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472711).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074959.
FT   VARIANT     242    242       D -> N (in LQT1; decreases outward
FT                                potassium current; decreases plasma
FT                                membrane localization;
FT                                dbSNP:rs199472712).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:25705178,
FT                                ECO:0000269|PubMed:9799083}.
FT                                /FTId=VAR_008940.
FT   VARIANT     243    243       R -> C (in LQT1; slower rate of
FT                                activation and voltage dependence of
FT                                activation-inactivation shifted to more
FT                                positive potentials (homomultimers);
FT                                channels non-functional
FT                                (heteromultimers); dbSNP:rs199472713).
FT                                {ECO:0000269|PubMed:10409658,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_010933.
FT   VARIANT     243    243       R -> H (in JLNS1; minor changes of wt
FT                                current (homomultimers); positive voltage
FT                                shift of the channel activation
FT                                (heteromultimers); dbSNP:rs120074196).
FT                                {ECO:0000269|PubMed:10090886,
FT                                ECO:0000269|PubMed:10728423}.
FT                                /FTId=VAR_008941.
FT   VARIANT     243    243       R -> P (in LQT1; complete loss of outward
FT                                potassium current; enhances outward
FT                                potassium current when co-transfected
FT                                with wild type; decreases plasma membrane
FT                                localization; dbSNP:rs120074196).
FT                                {ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_074688.
FT   VARIANT     248    248       W -> F (in JLNS1; requires 2 nucleotide
FT                                substitutions; does not affect plasma
FT                                membrane localization; complete loss of
FT                                outward currents; enhances outward
FT                                currents when coexpressed with wild type
FT                                at equimolar ratio; dbSNP:rs397508123).
FT                                {ECO:0000269|PubMed:18441444,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_074689.
FT   VARIANT     248    248       W -> R (in LQT1; slower rate of
FT                                activation and voltage dependence of
FT                                activation-inactivation shifted to more
FT                                positive potentials (homomultimers);
FT                                channels non-functional
FT                                (heteromultimers); dbSNP:rs199473459).
FT                                {ECO:0000269|PubMed:10409658}.
FT                                /FTId=VAR_008942.
FT   VARIANT     250    250       L -> H (in LQT1; complete loss of outward
FT                                potassium current; enhances outward
FT                                potassium current when co-transfected
FT                                with wild type; decreases plasma membrane
FT                                localization; dbSNP:rs199472715).
FT                                {ECO:0000269|PubMed:25705178,
FT                                ECO:0000269|PubMed:9799083}.
FT                                /FTId=VAR_008943.
FT   VARIANT     250    250       L -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472715).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074960.
FT   VARIANT     254    256       Missing (in LQT1).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068294.
FT   VARIANT     254    254       V -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs120074179).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074961.
FT   VARIANT     254    254       V -> M (in LQT1; associated with M-417 in
FT                                a patient; dbSNP:rs120074179).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|Ref.31}.
FT                                /FTId=VAR_001522.
FT   VARIANT     258    258       H -> N (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472717).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074962.
FT   VARIANT     258    258       H -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472718).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074963.
FT   VARIANT     259    259       R -> C (in LQT1; dbSNP:rs199472719).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068295.
FT   VARIANT     259    259       R -> H (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472720).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_074964.
FT   VARIANT     259    259       R -> L (in LQT1; dbSNP:rs199472720).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068296.
FT   VARIANT     261    261       E -> D (in JLNS1; dbSNP:rs199472721).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_008944.
FT   VARIANT     261    261       E -> K (in LQT1; loss of channel activity
FT                                and no interaction with wt KVLQT1 or MINK
FT                                subunits; dbSNP:rs199472722).
FT                                {ECO:0000269|PubMed:10409658}.
FT                                /FTId=VAR_001523.
FT   VARIANT     262    262       L -> V (in LQT1; dbSNP:rs199472723).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074965.
FT   VARIANT     266    266       L -> P (in LQT1; dbSNP:rs199473460).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009924.
FT   VARIANT     268    268       I -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472725).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074966.
FT   VARIANT     269    269       G -> D (in LQT1; dbSNP:rs120074194).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_001524.
FT   VARIANT     269    269       G -> S (in LQT1; decreases IKs amplitude;
FT                                accelerates the IKs deactivation; effect
FT                                on plasma membrane localization; reduces
FT                                up-regulation of Iks through PKA
FT                                activation; dbSNP:rs120074193).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:24184248}.
FT                                /FTId=VAR_009925.
FT   VARIANT     272    272       G -> D (in LQT1; dbSNP:rs199472726).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074967.
FT   VARIANT     273    273       L -> F (in LQT1; functional channel with
FT                                reduced macroscopic conductance
FT                                (homomultimers); alteration of normal
FT                                KVLQT1 function (mut/wt homomultimers);
FT                                dbSNP:rs120074180).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9323054}.
FT                                /FTId=VAR_001525.
FT   VARIANT     273    273       L -> R (in LQT1; dbSNP:rs199472727).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068297.
FT   VARIANT     274    274       I -> V (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472728).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074968.
FT   VARIANT     275    275       F -> S (in LQT1; dbSNP:rs199472729).
FT                                {ECO:0000269|PubMed:12442276}.
FT                                /FTId=VAR_074690.
FT   VARIANT     276    276       Missing (in LQT1).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068298.
FT   VARIANT     277    277       S -> L (in LQT1; loss of function
FT                                mutation acting in a dominant-negative
FT                                manner; dbSNP:rs199472730).
FT                                {ECO:0000269|PubMed:12442276,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:21241800}.
FT                                /FTId=VAR_065777.
FT   VARIANT     277    277       S -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473461).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074969.
FT   VARIANT     277    277       S -> W (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472730).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074970.
FT   VARIANT     278    278       Y -> H (in LQT1; dbSNP:rs199472731).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068299.
FT   VARIANT     280    280       V -> E (in LQT1; dbSNP:rs199473462).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074971.
FT   VARIANT     281    281       Y -> C (in LQT1; dbSNP:rs199472732).
FT                                {ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9927399}.
FT                                /FTId=VAR_008945.
FT   VARIANT     282    282       L -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472733).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074972.
FT   VARIANT     283    283       A -> G (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473463).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074973.
FT   VARIANT     287    287       A -> E (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472735).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074974.
FT   VARIANT     290    290       E -> K (in LQT1; dbSNP:rs199473464).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068300.
FT   VARIANT     292    292       G -> D (in LQT1; dbSNP:rs199472736).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068301.
FT   VARIANT     293    293       R -> C (in LQT1; dbSNP:rs199472737).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068302.
FT   VARIANT     300    300       A -> T (in LQT1; dbSNP:rs120074187).
FT                                {ECO:0000269|PubMed:9641694}.
FT                                /FTId=VAR_001526.
FT   VARIANT     302    302       A -> E (in LQT1; unknown pathological
FT                                significance; dbSNP:rs193922365).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074975.
FT   VARIANT     302    302       A -> T (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472739).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074976.
FT   VARIANT     302    302       A -> V (in LQT1; dbSNP:rs193922365).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068303.
FT   VARIANT     303    303       L -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472740).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074977.
FT   VARIANT     304    304       W -> R (in LQT1; dbSNP:rs199473466).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068304.
FT   VARIANT     305    305       W -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472741).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074978.
FT   VARIANT     305    305       W -> S (in JLNS1; dbSNP:rs120074186).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9781056}.
FT                                /FTId=VAR_001527.
FT   VARIANT     306    306       G -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs120074181).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_001528.
FT   VARIANT     306    306       G -> V (in LQT1; complete loss of outward
FT                                potassium current; enhances outward
FT                                potassium current when co-transfected
FT                                with wild type; decreases plasma membrane
FT                                localization; dbSNP:rs199472742).
FT                                {ECO:0000269|PubMed:12442276,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_074691.
FT   VARIANT     307    307       V -> L (in SQT2; gain of function;
FT                                dbSNP:rs120074195).
FT                                {ECO:0000269|PubMed:15159330}.
FT                                /FTId=VAR_023841.
FT   VARIANT     308    308       V -> D (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473467).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074979.
FT   VARIANT     309    309       T -> R (in LQT1; dbSNP:rs199472743).
FT                                /FTId=VAR_001529.
FT   VARIANT     310    310       V -> I (in LQT1; dbSNP:rs199472745).
FT                                /FTId=VAR_009926.
FT   VARIANT     311    311       T -> I (in LQT1 and JLNS1; impairs
FT                                outward potassium current; affects plasma
FT                                membrane localization;
FT                                dbSNP:rs199472746).
FT                                {ECO:0000269|PubMed:25705178,
FT                                ECO:0000269|PubMed:9482580}.
FT                                /FTId=VAR_009927.
FT   VARIANT     312    312       T -> I (in LQT1; loss of channel
FT                                activity; dbSNP:rs120074182).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9323054}.
FT                                /FTId=VAR_001530.
FT   VARIANT     313    313       I -> M (in LQT1; dbSNP:rs199472747).
FT                                {ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_001531.
FT   VARIANT     314    314       G -> C (in LQT1; unknown pathological
FT                                significance; dbSNP:rs120074184).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074980.
FT   VARIANT     314    314       G -> D (in LQT1; dbSNP:rs199472748).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068305.
FT   VARIANT     314    314       G -> R (in LQT1; dbSNP:rs120074184).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068306.
FT   VARIANT     314    314       G -> S (in LQT1; dbSNP:rs120074184).
FT                                {ECO:0000269|PubMed:10220144,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:8872472,
FT                                ECO:0000269|PubMed:9693036,
FT                                ECO:0000269|PubMed:9799083}.
FT                                /FTId=VAR_001532.
FT   VARIANT     315    315       Y -> C (in LQT1; dbSNP:rs74462309).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:24269949,
FT                                ECO:0000269|PubMed:9693036,
FT                                ECO:0000269|PubMed:9927399}.
FT                                /FTId=VAR_008946.
FT   VARIANT     315    315       Y -> S (in LQT1; dbSNP:rs74462309).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_001533.
FT   VARIANT     316    316       G -> E (in LQT1; dbSNP:rs199472749).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_074981.
FT   VARIANT     316    316       G -> R (in LQT1; dbSNP:rs104894255).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068307.
FT   VARIANT     316    316       G -> V (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472749).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074982.
FT   VARIANT     317    317       D -> N (in LQT1; complete loss of outward
FT                                potassium current when expressed alone
FT                                and even in the presence of the wild type
FT                                at variable ratios; decreases plasma
FT                                membrane localization;
FT                                dbSNP:rs199472751).
FT                                {ECO:0000269|PubMed:25705178,
FT                                ECO:0000269|PubMed:9302275,
FT                                ECO:0000269|PubMed:9482580}.
FT                                /FTId=VAR_001534.
FT   VARIANT     318    318       K -> N (in LQT1; dbSNP:rs199472752).
FT                                {ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_008947.
FT   VARIANT     320    320       P -> A (in LQT1; loss of function
FT                                mutation acting in a dominant-negative
FT                                manner; dbSNP:rs199472753).
FT                                {ECO:0000269|PubMed:19540844}.
FT                                /FTId=VAR_001535.
FT   VARIANT     320    320       P -> H (in LQT1; loss of function
FT                                mutation acting in a dominant-negative
FT                                manner; dbSNP:rs199473470).
FT                                {ECO:0000269|PubMed:19540844}.
FT                                /FTId=VAR_065778.
FT   VARIANT     320    320       P -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472753).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074983.
FT   VARIANT     322    322       T -> A (in LQT1; dbSNP:rs199472754).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:24269949}.
FT                                /FTId=VAR_068308.
FT   VARIANT     322    322       T -> M (in JLNS1 and LQT1; impairs
FT                                outward potassium current; affects plasma
FT                                membrane localization;
FT                                dbSNP:rs199472755).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:18400097,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_074692.
FT   VARIANT     325    325       G -> R (in LQT1; dbSNP:rs199472756).
FT                                {ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_001536.
FT   VARIANT     339    339       F -> Y (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472759).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074984.
FT   VARIANT     339    339       Missing (in LQT1).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:9702906}.
FT                                /FTId=VAR_001537.
FT   VARIANT     341    341       A -> E (in LQT1; dbSNP:rs12720459).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_001538.
FT   VARIANT     341    341       A -> G (in LQT1; unknown pathological
FT                                significance; dbSNP:rs12720459).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074985.
FT   VARIANT     341    341       A -> V (in LQT1; dbSNP:rs12720459).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:8818942,
FT                                ECO:0000269|PubMed:8872472,
FT                                ECO:0000269|PubMed:9570196}.
FT                                /FTId=VAR_001539.
FT   VARIANT     342    342       L -> F (in LQT1; dbSNP:rs199472760).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_001540.
FT   VARIANT     343    343       P -> L (in LQT1; dbSNP:rs199472761).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074986.
FT   VARIANT     343    343       P -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472761).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074987.
FT   VARIANT     343    343       P -> S (in LQT1; dbSNP:rs199472762).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068309.
FT   VARIANT     344    344       A -> E (in LQT1; dbSNP:rs199472763).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068310.
FT   VARIANT     344    344       A -> V (in LQT1; dbSNP:rs199472763).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_001541.
FT   VARIANT     345    345       G -> E (in LQT1; dbSNP:rs120074183).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_001542.
FT   VARIANT     345    345       G -> R (in LQT1; familial sudden death;
FT                                dbSNP:rs199473471).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_008126.
FT   VARIANT     349    349       S -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472764).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074988.
FT   VARIANT     349    349       S -> W (in LQT1; dbSNP:rs199472765).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_009928.
FT   VARIANT     350    350       G -> R (in LQT1; dbSNP:rs199472824).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074989.
FT   VARIANT     351    351       F -> S (in LQT1; dbSNP:rs199473402).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074990.
FT   VARIANT     353    353       L -> P (in LQT1; dbSNP:rs199473403).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_009180.
FT   VARIANT     354    354       K -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473404).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074991.
FT   VARIANT     360    360       R -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473407).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074992.
FT   VARIANT     360    360       R -> T (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473407).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074993.
FT   VARIANT     362    362       K -> R (in LQT1; dbSNP:rs12720458).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_048025.
FT   VARIANT     365    365       N -> H (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473409).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074994.
FT   VARIANT     366    366       R -> P (in LQT1; dbSNP:rs199473410).
FT                                {ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_001543.
FT   VARIANT     366    366       R -> Q (in LQT1; dbSNP:rs199473410).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009929.
FT   VARIANT     366    366       R -> W (in LQT1; dbSNP:rs199473411).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_008948.
FT   VARIANT     371    371       A -> T (in LQT1; dbSNP:rs199473412).
FT                                /FTId=VAR_001544.
FT   VARIANT     372    372       A -> D (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473472).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074995.
FT   VARIANT     373    373       S -> P (in LQT1; dbSNP:rs199472766).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_008127.
FT   VARIANT     374    374       L -> H (in LQT1; dbSNP:rs199472767).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068311.
FT   VARIANT     379    379       W -> G (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472768).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074996.
FT   VARIANT     380    380       R -> S (in LQT1; dbSNP:rs199472771).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068312.
FT   VARIANT     385    385       E -> K (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473473).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074997.
FT   VARIANT     389    389       S -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472772).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074998.
FT   VARIANT     389    389       S -> Y (in LQT1; dbSNP:rs199472773).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068313.
FT   VARIANT     391    391       T -> I (in LQT1; dbSNP:rs199473474).
FT                                /FTId=VAR_009930.
FT   VARIANT     391    391       T -> TT (in LQT1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074999.
FT   VARIANT     392    392       W -> R (in LQT1; dbSNP:rs199472774).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_008128.
FT   VARIANT     393    393       K -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472775).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075000.
FT   VARIANT     393    393       K -> N (in dbSNP:rs12720457).
FT                                /FTId=VAR_048026.
FT   VARIANT     397    397       R -> W (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472776).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075001.
FT   VARIANT     398    398       K -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472777).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075002.
FT   VARIANT     417    417       V -> M (in LQT1; associated with M-254 in
FT                                a patient; dbSNP:rs267607197).
FT                                {ECO:0000269|Ref.31}.
FT                                /FTId=VAR_010934.
FT   VARIANT     446    446       D -> E (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472780).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075003.
FT   VARIANT     448    448       P -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs12720449).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075004.
FT   VARIANT     448    448       P -> R (in LQT1; dbSNP:rs12720449).
FT                                /FTId=VAR_009931.
FT   VARIANT     451    451       R -> W (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472782).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075005.
FT   VARIANT     452    452       R -> W (in LQT1; dbSNP:rs140452381).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068314.
FT   VARIANT     460    460       G -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472783).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075006.
FT   VARIANT     477    477       P -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472784).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075007.
FT   VARIANT     511    511       R -> W (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472785).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075008.
FT   VARIANT     518    518       R -> G (in LQT1; unknown pathological
FT                                significance; dbSNP:rs17215500).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075009.
FT   VARIANT     518    518       R -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs145974930).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075010.
FT   VARIANT     518    518       R -> Q (in LQT1; unknown pathological
FT                                significance; dbSNP:rs145974930).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075011.
FT   VARIANT     520    520       M -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473479).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075012.
FT   VARIANT     522    522       Y -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472789).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075013.
FT   VARIANT     524    524       V -> G (in LQT1; dbSNP:rs199472790).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068315.
FT   VARIANT     525    525       A -> T (in LQT1; dbSNP:rs120074188).
FT                                {ECO:0000269|PubMed:10482963,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009181.
FT   VARIANT     525    525       A -> V (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472791).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075014.
FT   VARIANT     526    526       K -> E (in LQT1; dbSNP:rs199472792).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068316.
FT   VARIANT     533    533       R -> W (in LQT1; minor changes of wt
FT                                current (homomultimers); positive voltage
FT                                shift of the channel activation
FT                                (heteromultimers); dbSNP:rs199472793).
FT                                {ECO:0000269|PubMed:10728423,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008949.
FT   VARIANT     539    539       R -> Q (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472794).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075015.
FT   VARIANT     539    539       R -> W (in LQT1; minor changes of wt
FT                                current (homomultimers); positive voltage
FT                                shift of the channel activation
FT                                (heteromultimers); dbSNP:rs199472795).
FT                                {ECO:0000269|PubMed:10728423,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008950.
FT   VARIANT     541    541       V -> I (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472796).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075016.
FT   VARIANT     543    543       E -> K (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472797).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075017.
FT   VARIANT     546    546       S -> L (in LQT1; decreases interaction
FT                                with KCNE1 C-terminus; does not affect
FT                                plasma membrane localization; reduces IKS
FT                                current density; impairs binding with
FT                                Phosphatidylinositol 4,5-bisphosphate;
FT                                dbSNP:rs199473480).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:25037568}.
FT                                /FTId=VAR_068317.
FT   VARIANT     547    547       Q -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472798).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075018.
FT   VARIANT     548    548       G -> D (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472799).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075019.
FT   VARIANT     554    554       V -> A (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473481).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075020.
FT   VARIANT     555    555       R -> C (in LQT1; associated with a fruste
FT                                phenotype; decreases interaction with
FT                                KCNE1 C-terminus; does not affect plasma
FT                                membrane localization; reduces IKS
FT                                current density; shifts activation of the
FT                                voltage dependence; deactivates more
FT                                rapidly; impairs binding with
FT                                phosphatidylinositol 4,5-bisphosphate;
FT                                dbSNP:rs120074185).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:25037568,
FT                                ECO:0000269|PubMed:9312006}.
FT                                /FTId=VAR_001545.
FT   VARIANT     555    555       R -> H (in LQT1; decreases interaction
FT                                with KCNE1 C-terminus; does not affect
FT                                plasma membrane localization; reduces IKS
FT                                current density; impairs binding with
FT                                Phosphatidylinositol 4,5-bisphosphate;
FT                                dbSNP:rs199472800).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:25037568}.
FT                                /FTId=VAR_068318.
FT   VARIANT     555    555       R -> S (in LQT1; unknown pathological
FT                                significance; dbSNP:rs120074185).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075021.
FT   VARIANT     557    557       K -> E (in LQT1; no effect on cell
FT                                membrane localization; slows activation
FT                                kinetics; accelerates deactivation
FT                                kinetics; rightshifts the voltage-
FT                                dependent activation; does not affect
FT                                cAMP-dependent up-regulation; decreases
FT                                interaction with KCNE1 C-terminus; does
FT                                not affect plasma membrane localization;
FT                                does not affect phosphorylation at S-27
FT                                during cAMP-dependent stimulation;
FT                                reduces IKS current density; impairs
FT                                binding with Phosphatidylinositol 4,5-
FT                                bisphosphate; dbSNP:rs199472801).
FT                                {ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:25037568,
FT                                ECO:0000269|PubMed:25139741}.
FT                                /FTId=VAR_074693.
FT   VARIANT     566    566       S -> F (in LQT1; dbSNP:rs199472804).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009932.
FT   VARIANT     566    566       S -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472803).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075022.
FT   VARIANT     566    566       S -> Y (in LQT1; dbSNP:rs199472804).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068319.
FT   VARIANT     567    567       I -> S (in LQT1; dbSNP:rs199472805).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068320.
FT   VARIANT     567    567       I -> T (in LQT1; dbSNP:rs199472805).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075023.
FT   VARIANT     568    568       G -> R (in LQT1; dbSNP:rs199472807).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068321.
FT   VARIANT     569    569       K -> E (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472808).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075024.
FT   VARIANT     571    571       S -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472809).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075025.
FT   VARIANT     573    573       F -> L (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472810).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075026.
FT   VARIANT     583    583       R -> C (in LQT1; dbSNP:rs17221854).
FT                                /FTId=VAR_009933.
FT   VARIANT     583    583       R -> H (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473482).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_075027.
FT   VARIANT     586    586       N -> D (in LQT1; decreases outward
FT                                potassium current; decreases plasma
FT                                membrane localization;
FT                                dbSNP:rs199472812).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_074694.
FT   VARIANT     587    587       T -> M (in LQT1; dbSNP:rs120074189).
FT                                {ECO:0000269|PubMed:10024302,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9799083}.
FT                                /FTId=VAR_008951.
FT   VARIANT     589    589       G -> D (in LQT1 and JLNS1; affects plasma
FT                                membrane localization; strongly reduces
FT                                potassium current; impairs binding to
FT                                AKAP9 and the targeting protein kinase A
FT                                (PKA) catalytic subunit and protein
FT                                phosphatase 1 (PP1); dbSNP:rs120074190).
FT                                {ECO:0000269|PubMed:11799244,
FT                                ECO:0000269|PubMed:18165683,
FT                                ECO:0000269|PubMed:25037568,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_008952.
FT   VARIANT     590    590       A -> T (in LQT1; reduces IKs density and
FT                                causes a right-shift of the
FT                                current?voltage relation of channel
FT                                activation; reduces cell surface
FT                                expression; no effect on interaction with
FT                                AKAP9; does not affect the cAMP-dependent
FT                                IKs up-regulation; dbSNP:rs199472813).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:24713462}.
FT                                /FTId=VAR_068322.
FT   VARIANT     591    591       R -> C (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473483).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075028.
FT   VARIANT     591    591       R -> H (in LQT1; dbSNP:rs199472814).
FT                                {ECO:0000269|PubMed:10024302,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008953.
FT   VARIANT     594    594       R -> P (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472815).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075029.
FT   VARIANT     594    594       R -> Q (in LQT1; dbSNP:rs199472815).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009934.
FT   VARIANT     596    596       E -> K (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199472816).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075030.
FT   VARIANT     596    596       Missing (in LQT1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075031.
FT   VARIANT     600    600       T -> M (in LQT1; unknown pathological
FT                                significance; dbSNP:rs34516117).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075032.
FT   VARIANT     611    611       D -> N (in LQT1; unknown pathological
FT                                significance; dbSNP:rs147445322).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075033.
FT   VARIANT     614    614       Missing (in LQT1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075034.
FT   VARIANT     619    619       L -> M (in LQT1; decreases outward
FT                                potassium current; decreases plasma
FT                                membrane localization;
FT                                dbSNP:rs199472819).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:25705178}.
FT                                /FTId=VAR_068323.
FT   VARIANT     626    626       G -> S (in LQT1; dbSNP:rs199472821).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068324.
FT   VARIANT     635    635       G -> R (in LQT1; unknown pathological
FT                                significance; dbSNP:rs199473484).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_075035.
FT   VARIANT     643    643       G -> S (in dbSNP:rs1800172).
FT                                {ECO:0000269|PubMed:9799083}.
FT                                /FTId=VAR_008954.
FT   MUTAGEN      27     27       S->A: No phosphorylation by PKA.
FT                                Decreases delayed rectifier potassium
FT                                channel activity.
FT                                {ECO:0000269|PubMed:11799244}.
FT   MUTAGEN     324    324       V->L: Has a voltage-gated potassium
FT                                channel activity. Inhibition of voltage-
FT                                gated potassium channel activity by
FT                                KCNE4. {ECO:0000269|PubMed:19687231}.
FT   MUTAGEN     326    326       K->R: Has a voltage-gated potassium
FT                                channel activity. Disrupts KCNE4-mediated
FT                                voltage-gated potassium channel activity
FT                                inhibition.
FT                                {ECO:0000269|PubMed:19687231}.
FT   MUTAGEN     327    327       T->V: Has a voltage-gated potassium
FT                                channel activity. Disrupts KCNE4-mediated
FT                                voltage-gated potassium channel activity
FT                                inhibition.
FT                                {ECO:0000269|PubMed:19687231}.
FT   MUTAGEN     328    328       I->L: Has a voltage-gated potassium
FT                                channel activity. Inhibition of voltage-
FT                                gated potassium channel activity by
FT                                KCNE4. {ECO:0000269|PubMed:19687231}.
FT   MUTAGEN     338    338       S->C: Inhibits voltage-gated potassium
FT                                channel activity.
FT                                {ECO:0000269|PubMed:19687231}.
FT   MUTAGEN     340    340       F->C: Inhibits voltage-gated potassium
FT                                channel activity.
FT                                {ECO:0000269|PubMed:19687231}.
FT   MUTAGEN     589    589       G->M: No effect.
FT                                {ECO:0000269|PubMed:18165683}.
FT   MUTAGEN     590    590       A->W: Reduced cell surface expression and
FT                                strongly reduced potassium current.
FT                                {ECO:0000269|PubMed:18165683}.
FT   MUTAGEN     593    593       N->G: Reduced cell surface expression and
FT                                moderately reduced potassium current.
FT                                {ECO:0000269|PubMed:18165683}.
FT   MUTAGEN     602    602       L->A: Does not interact with AKAP9 and
FT                                the targeting protein kinase A (PKA)
FT                                catalytic subunit and protein phosphatase
FT                                1 (PP1); when associated with I-609.
FT                                {ECO:0000269|PubMed:11799244}.
FT   MUTAGEN     609    609       I->A: Does not interact with AKAP9 and
FT                                the kinase A (PKA) catalytic subunit and
FT                                protein phosphatase 1 (PP1); when
FT                                associated with L-602.
FT                                {ECO:0000269|PubMed:11799244}.
FT   CONFLICT     64     65       PA -> HV (in Ref. 4; CAB44649).
FT                                {ECO:0000305}.
FT   CONFLICT    370    370       Missing (in Ref. 2; AAC05705).
FT                                {ECO:0000305}.
FT   CONFLICT    607    608       AL -> VI (in Ref. 5; AAM94040).
FT                                {ECO:0000305}.
FT   CONFLICT    619    644       LHGGSTPGSGGPPREGGAHITQPCGS -> MQQGGPTCNSR
FT                                SQVVASNE (in Ref. 5; AAM94040).
FT                                {ECO:0000305}.
FT   CONFLICT    648    649       VD -> IN (in Ref. 5; AAM94040).
FT                                {ECO:0000305}.
FT   CONFLICT    658    658       T -> S (in Ref. 5; AAM94040).
FT                                {ECO:0000305}.
FT   CONFLICT    669    670       RR -> QT (in Ref. 5; AAM94040).
FT                                {ECO:0000305}.
FT   HELIX       359    384       {ECO:0000244|PDB:4V0C}.
FT   STRAND      386    391       {ECO:0000244|PDB:4V0C}.
FT   HELIX       392    394       {ECO:0000244|PDB:4V0C}.
FT   HELIX       502    533       {ECO:0000244|PDB:4V0C}.
FT   HELIX       588    609       {ECO:0000244|PDB:3HFE}.
SQ   SEQUENCE   676 AA;  74699 MW;  ADFCA9E2B9763B21 CRC64;
     MAAASSPPRA ERKRWGWGRL PGARRGSAGL AKKCPFSLEL AEGGPAGGAL YAPIAPGAPG
     PAPPASPAAP AAPPVASDLG PRPPVSLDPR VSIYSTRRPV LARTHVQGRV YNFLERPTGW
     KCFVYHFAVF LIVLVCLIFS VLSTIEQYAA LATGTLFWME IVLVVFFGTE YVVRLWSAGC
     RSKYVGLWGR LRFARKPISI IDLIVVVASM VVLCVGSKGQ VFATSAIRGI RFLQILRMLH
     VDRQGGTWRL LGSVVFIHRQ ELITTLYIGF LGLIFSSYFV YLAEKDAVNE SGRVEFGSYA
     DALWWGVVTV TTIGYGDKVP QTWVGKTIAS CFSVFAISFF ALPAGILGSG FALKVQQKQR
     QKHFNRQIPA AASLIQTAWR CYAAENPDSS TWKIYIRKAP RSHTLLSPSP KPKKSVVVKK
     KKFKLDKDNG VTPGEKMLTV PHITCDPPEE RRLDHFSVDG YDSSVRKSPT LLEVSMPHFM
     RTNSFAEDLD LEGETLLTPI THISQLREHH RATIKVIRRM QYFVAKKKFQ QARKPYDVRD
     VIEQYSQGHL NLMVRIKELQ RRLDQSIGKP SLFISVSEKS KDRGSNTIGA RLNRVEDKVT
     QLDQRLALIT DMLHQLLSLH GGSTPGSGGP PREGGAHITQ PCGSGGSVDP ELFLPSNTLP
     TYEQLTVPRR GPDEGS
//
ID   KCNKA_HUMAN             Reviewed;         538 AA.
AC   P57789; B2R8T4; B2RCT3; B5TJL4; Q6B014; Q8TDK7; Q8TDK8; Q9HB59;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 1.
DT   27-SEP-2017, entry version 146.
DE   RecName: Full=Potassium channel subfamily K member 10;
DE   AltName: Full=Outward rectifying potassium channel protein TREK-2;
DE   AltName: Full=TREK-2 K(+) channel subunit;
GN   Name=KCNK10; Synonyms=TREK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RX   PubMed=10880510; DOI=10.1074/jbc.M002822200;
RA   Lesage F., Terrenoire C., Romey G., Lazdunski M.;
RT   "Human TREK2, a 2P domain mechano-sensitive K+ channel with multiple
RT   regulations by polyunsaturated fatty acids, lysophospholipids and Gs,
RT   Gi, and Gq protein-coupled receptors.";
RL   J. Biol. Chem. 275:28398-28405(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS B AND C).
RX   PubMed=11897838; DOI=10.1113/jphysiol.2001.013432;
RA   Gu W., Schlichthorl G., Hirsch J.R., Engels H., Karschin C.,
RA   Karschin A., Derst C., Steinlein O.K., Daut J.;
RT   "Expression pattern and functional characteristics of two novel splice
RT   variants of the two-pore-domain potassium channel TREK-2.";
RL   J. Physiol. (Lond.) 539:657-668(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND C).
RC   TISSUE=Brain, Kidney, and Pancreas;
RX   PubMed=18516069; DOI=10.1038/bjp.2008.213;
RA   Gierten J., Ficker E., Bloehs R., Schlomer K., Kathofer S., Scholz E.,
RA   Zitron E., Kiesecker C., Bauer A., Becker R., Katus H.A., Karle C.A.,
RA   Thomas D.;
RT   "Regulation of two-pore-domain (K2P) potassium leak channels by the
RT   tyrosine kinase inhibitor genistein.";
RL   Br. J. Pharmacol. 154:1680-1690(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND C), AND VARIANT
RP   THR-512.
RC   TISSUE=Brain, and Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Outward rectifying potassium channel. Produces rapidly
CC       activating and non-inactivating outward rectifier K(+) currents.
CC       Activated by arachidonic acid and other naturally occurring
CC       unsaturated free fatty acids.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=A; Synonyms=TREK-2a;
CC         IsoId=P57789-1; Sequence=Displayed;
CC       Name=B; Synonyms=TREK-2b;
CC         IsoId=P57789-4; Sequence=VSP_006697;
CC       Name=C; Synonyms=TREK-2c;
CC         IsoId=P57789-3; Sequence=VSP_006698;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in pancreas and kidney
CC       and to a lower level in brain, testis, colon, and small intestine.
CC       Isoform b is strongly expressed in kidney (primarily in the
CC       proximal tubule) and pancreas, whereas isoform c is abundantly
CC       expressed in brain.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF279890; AAG15191.1; -; mRNA.
DR   EMBL; AF385399; AAL95705.1; -; mRNA.
DR   EMBL; AF385400; AAL95706.1; -; mRNA.
DR   EMBL; EU978938; ACH86097.1; -; mRNA.
DR   EMBL; EU978939; ACH86098.1; -; mRNA.
DR   EMBL; EU978940; ACH86099.1; -; mRNA.
DR   EMBL; EU978941; ACH86100.1; -; mRNA.
DR   EMBL; AK313499; BAG36281.1; -; mRNA.
DR   EMBL; AK315263; BAG37680.1; -; mRNA.
DR   EMBL; AL049834; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133279; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81373.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW81374.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW81375.1; -; Genomic_DNA.
DR   EMBL; BC075021; AAH75021.1; -; mRNA.
DR   EMBL; BC075022; AAH75022.1; -; mRNA.
DR   CCDS; CCDS9880.1; -. [P57789-1]
DR   CCDS; CCDS9881.1; -. [P57789-3]
DR   CCDS; CCDS9882.1; -. [P57789-4]
DR   RefSeq; NP_066984.1; NM_021161.4. [P57789-1]
DR   RefSeq; NP_612190.1; NM_138317.2. [P57789-3]
DR   RefSeq; NP_612191.1; NM_138318.2. [P57789-4]
DR   UniGene; Hs.560255; -.
DR   PDB; 4BW5; X-ray; 3.20 A; A/B/C/D=62-335.
DR   PDB; 4XDJ; X-ray; 3.80 A; A/B/C/D=62-335.
DR   PDB; 4XDK; X-ray; 3.60 A; A/B/C/D=62-335.
DR   PDB; 4XDL; X-ray; 3.50 A; A/B/C/D=62-335.
DR   PDBsum; 4BW5; -.
DR   PDBsum; 4XDJ; -.
DR   PDBsum; 4XDK; -.
DR   PDBsum; 4XDL; -.
DR   ProteinModelPortal; P57789; -.
DR   SMR; P57789; -.
DR   BioGrid; 119924; 1.
DR   DIP; DIP-44050N; -.
DR   IntAct; P57789; 1.
DR   MINT; MINT-4050532; -.
DR   STRING; 9606.ENSP00000310568; -.
DR   ChEMBL; CHEMBL2331041; -.
DR   GuidetoPHARMACOLOGY; 521; -.
DR   iPTMnet; P57789; -.
DR   PhosphoSitePlus; P57789; -.
DR   BioMuta; KCNK10; -.
DR   DMDM; 13431412; -.
DR   PaxDb; P57789; -.
DR   PeptideAtlas; P57789; -.
DR   PRIDE; P57789; -.
DR   Ensembl; ENST00000312350; ENSP00000310568; ENSG00000100433. [P57789-4]
DR   Ensembl; ENST00000319231; ENSP00000312811; ENSG00000100433. [P57789-3]
DR   Ensembl; ENST00000340700; ENSP00000343104; ENSG00000100433. [P57789-1]
DR   GeneID; 54207; -.
DR   KEGG; hsa:54207; -.
DR   UCSC; uc001xwm.4; human. [P57789-1]
DR   CTD; 54207; -.
DR   DisGeNET; 54207; -.
DR   EuPathDB; HostDB:ENSG00000100433.15; -.
DR   GeneCards; KCNK10; -.
DR   HGNC; HGNC:6273; KCNK10.
DR   HPA; HPA030462; -.
DR   MIM; 605873; gene.
DR   neXtProt; NX_P57789; -.
DR   OpenTargets; ENSG00000100433; -.
DR   PharmGKB; PA30053; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000013106; -.
DR   HOVERGEN; HBG052234; -.
DR   InParanoid; P57789; -.
DR   KO; K04920; -.
DR   OMA; KQVNWDP; -.
DR   OrthoDB; EOG091G0E3R; -.
DR   PhylomeDB; P57789; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-HSA-1299503; TWIK related potassium channel (TREK).
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   ChiTaRS; KCNK10; human.
DR   GeneWiki; KCNK10; -.
DR   GenomeRNAi; 54207; -.
DR   PRO; PR:P57789; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100433; -.
DR   CleanEx; HS_KCNK10; -.
DR   ExpressionAtlas; P57789; baseline and differential.
DR   Genevisible; P57789; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005267; F:potassium channel activity; TAS:ProtInc.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003976; 2pore_dom_K_chnl_TREK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01499; TREKCHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    538       Potassium channel subfamily K member 10.
FT                                /FTId=PRO_0000101758.
FT   TOPO_DOM      1     71       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     72     92       Helical. {ECO:0000255}.
FT   INTRAMEM    154    180       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    182    202       Helical. {ECO:0000255}.
FT   TOPO_DOM    203    233       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    234    254       Helical. {ECO:0000255}.
FT   INTRAMEM    263    294       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    299    319       Helical. {ECO:0000255}.
FT   TOPO_DOM    320    538       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    144    144       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    147    147       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    148    148       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     12       MFFLYTDFFLSL -> MEDGFKGDRTEGCRSDS (in
FT                                isoform B). {ECO:0000303|PubMed:11897838,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:18516069}.
FT                                /FTId=VSP_006697.
FT   VAR_SEQ       1     12       MFFLYTDFFLSL -> MKFPIETPRKQVNWDPK (in
FT                                isoform C). {ECO:0000303|PubMed:11897838,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:18516069}.
FT                                /FTId=VSP_006698.
FT   VARIANT      70     70       K -> Q (in dbSNP:rs398263).
FT                                /FTId=VAR_060216.
FT   VARIANT     512    512       A -> T (in dbSNP:rs17762463).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_052428.
FT   CONFLICT    529    529       E -> G (in Ref. 2; AAL95705/AAL95706).
FT                                {ECO:0000305}.
FT   HELIX        69    115       {ECO:0000244|PDB:4BW5}.
FT   HELIX       121    136       {ECO:0000244|PDB:4BW5}.
FT   TURN        145    148       {ECO:0000244|PDB:4XDL}.
FT   STRAND      151    153       {ECO:0000244|PDB:4BW5}.
FT   HELIX       154    165       {ECO:0000244|PDB:4BW5}.
FT   HELIX       178    222       {ECO:0000244|PDB:4BW5}.
FT   TURN        223    225       {ECO:0000244|PDB:4XDL}.
FT   HELIX       232    247       {ECO:0000244|PDB:4BW5}.
FT   HELIX       249    258       {ECO:0000244|PDB:4BW5}.
FT   HELIX       263    274       {ECO:0000244|PDB:4BW5}.
FT   STRAND      280    282       {ECO:0000244|PDB:4BW5}.
FT   STRAND      288    290       {ECO:0000244|PDB:4XDL}.
FT   HELIX       296    325       {ECO:0000244|PDB:4BW5}.
SQ   SEQUENCE   538 AA;  59765 MW;  8EA615B08D147FBC CRC64;
     MFFLYTDFFL SLVAVPAAAP VCQPKSATNG QPPAPAPTPT PRLSISSRAT VVARMEGTSQ
     GGLQTVMKWK TVVAIFVVVV VYLVTGGLVF RALEQPFESS QKNTIALEKA EFLRDHVCVS
     PQELETLIQH ALDADNAGVS PIGNSSNNSS HWDLGSAFFF AGTVITTIGY GNIAPSTEGG
     KIFCILYAIF GIPLFGFLLA GIGDQLGTIF GKSIARVEKV FRKKQVSQTK IRVISTILFI
     LAGCIVFVTI PAVIFKYIEG WTALESIYFV VVTLTTVGFG DFVAGGNAGI NYREWYKPLV
     WFWILVGLAY FAAVLSMIGD WLRVLSKKTK EEVGEIKAHA AEWKANVTAE FRETRRRLSV
     EIHDKLQRAA TIRSMERRRL GLDQRAHSLD MLSPEKRSVF AALDTGRFKA SSQESINNRP
     NNLRLKGPEQ LNKHGQGASE DNIINKFGST SRLTKRKNKD LKKTLPEDVQ KIYKTFRNYS
     LDEEKKEEET EKMCNSDNSS TAMLTDCIQQ HAELENGMIP TDTKDREPEN NSLLEDRN
//
ID   KCNQ1_MOUSE             Reviewed;         668 AA.
AC   P97414; O88702; Q3U4H1; Q7TNZ1; Q7TPL7; Q80VR7;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   25-OCT-2017, entry version 164.
DE   RecName: Full=Potassium voltage-gated channel subfamily KQT member 1;
DE   AltName: Full=IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1 {ECO:0000305|PubMed:11120752};
DE   AltName: Full=KQT-like 1 {ECO:0000250|UniProtKB:P51787};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv7.1 {ECO:0000250|UniProtKB:P51787};
GN   Name=Kcnq1 {ECO:0000312|MGI:MGI:108083};
GN   Synonyms=Kcna9 {ECO:0000312|MGI:MGI:108083},
GN   Kvlqt1 {ECO:0000303|PubMed:11120752};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM I), FUNCTION, AND DISRUPTION
RP   PHENOTYPE.
RC   STRAIN=129/SvJ; TISSUE=Heart;
RX   PubMed=15004216; DOI=10.1124/jpet.103.063743;
RA   Knollmann B.C., Casimiro M.C., Katchman A.N., Sirenko S.G.,
RA   Schober T., Rong Q., Pfeifer K., Ebert S.N.;
RT   "Isoproterenol exacerbates a long QT phenotype in Kcnq1-deficient
RT   neonatal mice: possible roles for human-like Kcnq1 isoform 1 and slow
RT   delayed rectifier K+ current.";
RL   J. Pharmacol. Exp. Ther. 310:311-318(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM I).
RC   STRAIN=NOD;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM I).
RC   STRAIN=FVB/N; TISSUE=Colon, and Olfactory epithelium;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 31-668 (ISOFORM I), FUNCTION, AND
RP   INTERACTION WITH KCNE1.
RC   TISSUE=Heart;
RX   PubMed=8900282; DOI=10.1038/384078a0;
RA   Barhanin J., Lesage F., Guillemare E., Fink M., Lazdunski M.,
RA   Romey G.;
RT   "K(V)LQT1 and IsK (minK) proteins associate to form the I(Ks) cardiac
RT   potassium current.";
RL   Nature 384:78-80(1996).
RN   [5]
RP   PARTIAL NUCLEOTIDE SEQUENCE (ISOFORM II), AND TISSUE SPECIFICITY.
RC   STRAIN=C57BL/6J;
RX   PubMed=9618174; DOI=10.1093/hmg/7.7.1149;
RA   Paulsen M., Davies K.R., Bowden L.M., Villar A.J., Franck O.,
RA   Fuermann M., Dean W.L., Moore T.F., Rodrigues N., Davies K.E.,
RA   Hu R.-J., Feinberg A.P., Maher E.R., Reik W., Walter J.;
RT   "Syntenic organization of the mouse distal chromosome 7 imprinting
RT   cluster and the Beckwith-Wiedemann syndrome region in chromosome
RT   11p15.5.";
RL   Hum. Mol. Genet. 7:1149-1159(1998).
RN   [6]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=11120752; DOI=10.1172/JCI10897;
RA   Lee M.P., Ravenel J.D., Hu R.J., Lustig L.R., Tomaselli G.,
RA   Berger R.D., Brandenburg S.A., Litzi T.J., Bunton T.E., Limb C.,
RA   Francis H., Gorelikow M., Gu H., Washington K., Argani P.,
RA   Goldenring J.R., Coffey R.J., Feinberg A.P.;
RT   "Targeted disruption of the Kvlqt1 gene causes deafness and gastric
RT   hyperplasia in mice.";
RL   J. Clin. Invest. 106:1447-1455(2000).
RN   [7]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=16314573; DOI=10.1073/pnas.0505860102;
RA   Vallon V., Grahammer F., Volkl H., Sandu C.D., Richter K.,
RA   Rexhepaj R., Gerlach U., Rong Q., Pfeifer K., Lang F.;
RT   "KCNQ1-dependent transport in renal and gastrointestinal epithelia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:17864-17869(2005).
RN   [8]
RP   FUNCTION.
RX   PubMed=17597584; DOI=10.1016/j.bbrc.2007.06.038;
RA   Knollmann B.C., Sirenko S., Rong Q., Katchman A.N., Casimiro M.,
RA   Pfeifer K., Ebert S.N.;
RT   "Kcnq1 contributes to an adrenergic-sensitive steady-state K+ current
RT   in mouse heart.";
RL   Biochem. Biophys. Res. Commun. 360:212-218(2007).
RN   [9]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=19491250; DOI=10.1113/jphysiol.2009.173302;
RA   Song P., Groos S., Riederer B., Feng Z., Krabbenhoeft A., Smolka A.,
RA   Seidler U.;
RT   "KCNQ1 is the luminal K+ recycling channel during stimulation of
RT   gastric acid secretion.";
RL   J. Physiol. (Lond.) 587:3955-3965(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406 AND SER-408, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Heart, Kidney, and Pancreas;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Potassium channel that plays an important role in a
CC       number of tissues, including heart, inner ear, stomach and colon
CC       (By similarity) (PubMed:16314573, PubMed:11120752,
CC       PubMed:15004216). Associates with KCNE beta subunits that
CC       modulates current kinetics (By similarity) (PubMed:17597584,
CC       PubMed:15004216). Induces a voltage-dependent by rapidly
CC       activating and slowly deactivating potassium-selective outward
CC       current (By similarity) (PubMed:8900282). Promotes also a delayed
CC       voltage activated potassium current showing outward rectification
CC       characteristic (By similarity). During beta-adrenergic receptor
CC       stimulation participates in cardiac repolarization by associating
CC       with KCNE1 to form the I(Ks) cardiac potassium current that
CC       increases the amplitude and slows down the activation kinetics of
CC       outward potassium current I(Ks) (By similarity) (PubMed:15004216,
CC       PubMed:17597584). Muscarinic agonist oxotremorine-M strongly
CC       suppresses KCNQ1/KCNE1 current (By similarity). When associated
CC       with KCNE3, forms the potassium channel that is important for
CC       cyclic AMP-stimulated intestinal secretion of chloride ions (By
CC       similarity). This interaction with KCNE3 is reduced by 17beta-
CC       estradiol, resulting in the reduction of currents (By similarity).
CC       During conditions of increased substrate load, maintains the
CC       driving force for proximal tubular and intestinal sodium ions
CC       absorption, gastric acid secretion, and cAMP-induced jejunal
CC       chloride ions secretion (PubMed:16314573). Allows the provision of
CC       potassium ions to the luminal membrane of the secretory
CC       canaliculus in the resting state as well as during stimulated acid
CC       secretion (PubMed:19491250). When associated with KCNE2, forms an
CC       heterooligomer complex leading to currents with an apparently
CC       instantaneous activation, a rapid deactivation process and a
CC       linear current-voltage relationship and decreases the amplitude of
CC       the outward current (By similarity). When associated with KCNE4,
CC       inhibits voltage-gated potassium channel activity (By similarity).
CC       When associated with KCNE5, this complex only conducts current
CC       upon strong and continued depolarization (By similarity). Also
CC       forms a heterotetramer with KCNQ5; has a voltage-gated potassium
CC       channel activity (By similarity). Binds with phosphatidylinositol
CC       4,5-bisphosphate (By similarity). {ECO:0000250|UniProtKB:P51787,
CC       ECO:0000250|UniProtKB:Q9Z0N7, ECO:0000269|PubMed:11120752,
CC       ECO:0000269|PubMed:15004216, ECO:0000269|PubMed:16314573,
CC       ECO:0000269|PubMed:17597584, ECO:0000269|PubMed:19491250,
CC       ECO:0000269|PubMed:8900282}.
CC   -!- SUBUNIT: Tetramer (By similarity). Heterotetramer with KCNE1; form
CC       the native cardiac channel I(Ks) which increases the amplitude and
CC       slows down the activation kinetics of outward potassium current
CC       and targets to the membrane raft (By similarity) (PubMed:8900282).
CC       Interacts (via C-terminus) with CALM; forms a heterotetramer in a
CC       calcium-independent manner. Interacts with AKAP9; targets protein
CC       kinase A (PKA) catalytic and regulatory subunits and protein
CC       phosphatase 1 (PP1) to the KCNQ1-KCNE1 complex, allowing PKA-
CC       mediated phosphorylation and increase of delayed rectifier
CC       potassium channel activity. Interacts with KCNE2; form an
CC       heterooligomer complex that targets to the membrane raft and
CC       leading to currents with an apparently instantaneous activation, a
CC       rapid deactivation process and a linear current-voltage
CC       relationship and decreases the amplitude of the outward current.
CC       Interacts with AP2M1; mediates estrogen-induced internalization
CC       via clathrin-coated vesicles. Interacts with NEDD4L; promotes
CC       internalization and decreases I(Ks) currents. Interacts with USP2;
CC       counteracts the NEDD4L-specific down-regulation of I(Ks) and
CC       restore plasma membrane localization. Heterotetramer with KCNQ5;
CC       has a voltage-gated potassium channel activity. Interacts with
CC       KCNE3; alters membrane raft localization. Interacts with KCNE4;
CC       impairs KCNQ1 localization in lipid rafts and inhibits voltage-
CC       gated potassium channel activity. Interacts with KCNE5; impairs
CC       KCNQ1 localization in lipid rafts and only conducts current upon
CC       strong and continued depolarization (By similarity).
CC       {ECO:0000250|UniProtKB:P51787, ECO:0000269|PubMed:8900282}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P51787}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P51787}. Cytoplasmic vesicle membrane
CC       {ECO:0000250|UniProtKB:P51787}. Early endosome
CC       {ECO:0000250|UniProtKB:P51787}. Membrane raft
CC       {ECO:0000250|UniProtKB:P51787}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P51787}. Basolateral cell membrane
CC       {ECO:0000250|UniProtKB:P51787}. Note=Colocalized with KCNE3 at the
CC       plasma membrane. Upon 17beta-oestradiol treatment, colocalizes
CC       with RAB5A at early endosome. Heterotetramer with KCNQ5 is highly
CC       retained at the endoplasmic reticulum and is localized outside of
CC       lipid raft microdomains. During the early stages of epithelial
CC       cell polarization induced by the calcium switch it removed from
CC       plasma membrane to the endoplasmic reticulum where it retained and
CC       it is redistributed to the basolateral cell surface in a PI3K-
CC       dependent manner at a later stage. {ECO:0000250|UniProtKB:P51787}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=I;
CC         IsoId=P97414-1; Sequence=Displayed;
CC       Name=II;
CC         IsoId=P97414-2; Sequence=VSP_011748, VSP_000983;
CC   -!- TISSUE SPECIFICITY: Expressed in heart, kidney and salivary
CC       glands. Detected in the cochlea. Almost undetectable in brain,
CC       skeletal muscle and liver. Widely expressed in embryonic and
CC       neonatal tissues. {ECO:0000269|PubMed:9618174}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250|UniProtKB:P51787}.
CC   -!- DOMAIN: The coiled-coil domain mediates tetramerization.
CC       {ECO:0000250|UniProtKB:P51787}.
CC   -!- DOMAIN: The segment S6 is involved in the inhibition of voltage-
CC       gated potassium channel activity by KCNE4.
CC       {ECO:0000250|UniProtKB:P51787}.
CC   -!- DOMAIN: The C-terminal assembly domain promotes self-interactiona;
CC       allows functional channel. {ECO:0000250|UniProtKB:P51787}.
CC   -!- PTM: Phosphorylation at Ser-27 by PKA; increases delayed rectifier
CC       potassium channel activity of the KCNQ1-KCNE1 complex through a
CC       macromolecular complex that includes PKA, PP1, and the targeting
CC       protein AKAP9. {ECO:0000250|UniProtKB:P51787}.
CC   -!- PTM: Ubiquitinated by NEDD4L; promotes internalization. The
CC       ubiquitinylated form is internalized through a clathrin-mediated
CC       endocytosis by interacting with AP2M1 and is recycled back to the
CC       cell membrane via RAB4A and RAB11A.
CC       {ECO:0000250|UniProtKB:P51787}.
CC   -!- PTM: Deubiquitinated by USP2; counteracts the NEDD4L-specific
CC       down-regulation of I(Ks) and restores the membrane localization.
CC       {ECO:0000250|UniProtKB:P51787}.
CC   -!- DISRUPTION PHENOTYPE: Mice lacking Kcnq1 show an intestinal
CC       absorption impairment which is associated with reduced serum
CC       vitamin B12 concentrations, mild macrocytic anemia, and fecal loss
CC       of sodium and potassium ions (PubMed:16314573). Mice lacking Kcnq1
CC       show microvillar secretory membranes intact, but basal acid
CC       secretion is absent and forskolin-stimulated acid output is
CC       reduced by approximately 90% in gastric mucosa (PubMed:19491250).
CC       Homozygous Kcnq1 mice develop normally and are viable, demonstrate
CC       hyperactivity, circling, and nodding behaviors; exhibit no
CC       electrocardiographic abnormalities but present a complete
CC       deafness, as well as circular movement and repetitive falling;
CC       show severe anatomic disruption of the cochlear and vestibular end
CC       organs; also display threefold enlargement by weight of the
CC       stomach resulting from mucous neck cell hyperplasia
CC       (PubMed:11120752). Mice neonates lacking Kcnq1 display
CC       significantly prolonged QT intervals during baseline ECG
CC       assessments which significantly increased following isoproterenol
CC       challenge; furthermore, the slow delayed rectifier potassium
CC       current (IKs) is absent (PubMed:15004216).
CC       {ECO:0000269|PubMed:11120752, ECO:0000269|PubMed:15004216,
CC       ECO:0000269|PubMed:16314573, ECO:0000269|PubMed:19491250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. KQT (TC
CC       1.A.1.15) subfamily. Kv7.1/KCNQ1 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB36518.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY331142; AAP93874.1; -; mRNA.
DR   EMBL; AK154244; BAE32460.1; -; mRNA.
DR   EMBL; BC045142; AAH45142.2; -; mRNA.
DR   EMBL; BC055304; AAH55304.1; -; mRNA.
DR   EMBL; U70068; AAB36518.1; ALT_INIT; mRNA.
DR   EMBL; AJ002201; CAA05246.1; -; mRNA.
DR   CCDS; CCDS22039.1; -. [P97414-1]
DR   RefSeq; NP_032460.2; NM_008434.2. [P97414-1]
DR   UniGene; Mm.439769; -.
DR   UniGene; Mm.453036; -.
DR   UniGene; Mm.453037; -.
DR   ProteinModelPortal; P97414; -.
DR   SMR; P97414; -.
DR   IntAct; P97414; 1.
DR   STRING; 10090.ENSMUSP00000009689; -.
DR   GuidetoPHARMACOLOGY; 560; -.
DR   TCDB; 1.A.1.15.1; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P97414; -.
DR   PhosphoSitePlus; P97414; -.
DR   MaxQB; P97414; -.
DR   PaxDb; P97414; -.
DR   PeptideAtlas; P97414; -.
DR   PRIDE; P97414; -.
DR   Ensembl; ENSMUST00000009689; ENSMUSP00000009689; ENSMUSG00000009545. [P97414-1]
DR   GeneID; 16535; -.
DR   KEGG; mmu:16535; -.
DR   UCSC; uc009kpb.1; mouse. [P97414-1]
DR   CTD; 3784; -.
DR   MGI; MGI:108083; Kcnq1.
DR   eggNOG; KOG1419; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00550000074513; -.
DR   HOGENOM; HOG000220839; -.
DR   HOVERGEN; HBG059014; -.
DR   InParanoid; P97414; -.
DR   KO; K04926; -.
DR   OMA; ERKRWGW; -.
DR   OrthoDB; EOG091G02ZT; -.
DR   TreeFam; TF315186; -.
DR   Reactome; R-MMU-1296072; Voltage gated Potassium channels.
DR   Reactome; R-MMU-5576890; Phase 3 - rapid repolarisation.
DR   Reactome; R-MMU-5576893; Phase 2 - plateau phase.
DR   ChiTaRS; Kcnq1; mouse.
DR   PRO; PR:P97414; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   Bgee; ENSMUSG00000009545; -.
DR   ExpressionAtlas; P97414; baseline and differential.
DR   Genevisible; P97414; MM.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005769; C:early endosome; ISO:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0034702; C:ion channel complex; ISS:UniProtKB.
DR   GO; GO:0005770; C:late endosome; ISO:MGI.
DR   GO; GO:0005764; C:lysosome; ISO:MGI.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISO:MGI.
DR   GO; GO:0005516; F:calmodulin binding; ISO:MGI.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; ISO:MGI.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0034236; F:protein kinase A catalytic subunit binding; ISO:MGI.
DR   GO; GO:0034237; F:protein kinase A regulatory subunit binding; ISO:MGI.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; ISO:MGI.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:MGI.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0086089; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; ISO:MGI.
DR   GO; GO:0086008; F:voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization; ISO:MGI.
DR   GO; GO:1902282; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; ISO:MGI.
DR   GO; GO:0086014; P:atrial cardiac muscle cell action potential; ISO:MGI.
DR   GO; GO:0060048; P:cardiac muscle contraction; ISO:MGI.
DR   GO; GO:0072358; P:cardiovascular system development; IMP:MGI.
DR   GO; GO:0071320; P:cellular response to cAMP; ISO:MGI.
DR   GO; GO:0035690; P:cellular response to drug; ISO:MGI.
DR   GO; GO:0016458; P:gene silencing; IMP:MGI.
DR   GO; GO:0048839; P:inner ear development; IMP:UniProtKB.
DR   GO; GO:0050892; P:intestinal absorption; ISS:UniProtKB.
DR   GO; GO:0086009; P:membrane repolarization; IMP:UniProtKB.
DR   GO; GO:0086011; P:membrane repolarization during action potential; ISO:MGI.
DR   GO; GO:0098914; P:membrane repolarization during atrial cardiac muscle cell action potential; ISO:MGI.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; ISO:MGI.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; ISO:MGI.
DR   GO; GO:1902260; P:negative regulation of delayed rectifier potassium channel activity; ISO:MGI.
DR   GO; GO:1903817; P:negative regulation of voltage-gated potassium channel activity; ISO:MGI.
DR   GO; GO:0060452; P:positive regulation of cardiac muscle contraction; ISO:MGI.
DR   GO; GO:0010460; P:positive regulation of heart rate; ISO:MGI.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; ISO:MGI.
DR   GO; GO:0071435; P:potassium ion export; ISO:MGI.
DR   GO; GO:0097623; P:potassium ion export across plasma membrane; ISO:MGI.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISO:MGI.
DR   GO; GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; ISO:MGI.
DR   GO; GO:0060453; P:regulation of gastric acid secretion; IMP:UniProtKB.
DR   GO; GO:0006349; P:regulation of gene expression by genetic imprinting; IMP:MGI.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; ISO:MGI.
DR   GO; GO:0060306; P:regulation of membrane repolarization; ISO:MGI.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; ISO:MGI.
DR   GO; GO:0070293; P:renal absorption; IMP:UniProtKB.
DR   GO; GO:0086005; P:ventricular cardiac muscle cell action potential; ISO:MGI.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003937; K_chnl_volt-dep_KCNQ.
DR   InterPro; IPR013821; K_chnl_volt-dep_KCNQ_C.
DR   InterPro; IPR005827; K_chnl_volt-dep_KCQN1.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF109; PTHR11537:SF109; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03520; KCNQ_channel; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01460; KCNQ1CHANNEL.
DR   PRINTS; PR01459; KCNQCHANNEL.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calmodulin-binding; Cell membrane; Coiled coil;
KW   Complete proteome; Cytoplasmic vesicle; Endoplasmic reticulum;
KW   Endosome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation; Voltage-gated channel.
FT   CHAIN         1    668       Potassium voltage-gated channel subfamily
FT                                KQT member 1.
FT                                /FTId=PRO_0000054024.
FT   TOPO_DOM      1    120       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    121    141       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    142    146       Extracellular. {ECO:0000255}.
FT   TRANSMEM    147    167       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    168    195       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    196    216       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    217    224       Extracellular. {ECO:0000255}.
FT   TRANSMEM    225    247       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    248    260       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    261    281       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    282    298       Extracellular. {ECO:0000255}.
FT   INTRAMEM    299    319       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    320    330       Extracellular. {ECO:0000255}.
FT   TRANSMEM    331    351       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    352    668       Cytoplasmic. {ECO:0000255}.
FT   REGION      534    571       Interaction with KCNE1 C-terminus.
FT                                {ECO:0000250|UniProtKB:P51787}.
FT   REGION      587    615       Interaction with AKAP9.
FT                                {ECO:0000250|UniProtKB:P51787}.
FT   REGION      588    619       C-terminal assembly domain.
FT                                {ECO:0000250|UniProtKB:P51787}.
FT   COILED      584    620       {ECO:0000250|UniProtKB:P51787}.
FT   MOTIF       311    316       Selectivity filter. {ECO:0000250}.
FT   MOD_RES      27     27       Phosphoserine; by PKA.
FT                                {ECO:0000250|UniProtKB:P51787}.
FT   MOD_RES     406    406       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     408    408       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   CARBOHYD    288    288       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    111       Missing (in isoform II). {ECO:0000305}.
FT                                /FTId=VSP_011748.
FT   VAR_SEQ     112    128       FLERPTGWKCFVYHFTV -> MHQLPTSILIPKNMPGG
FT                                (in isoform II). {ECO:0000305}.
FT                                /FTId=VSP_000983.
FT   CONFLICT    473    473       V -> L (in Ref. 1; AAP93874 and 4;
FT                                AAB36518). {ECO:0000305}.
SQ   SEQUENCE   668 AA;  74514 MW;  8CE35CBA3102B85B CRC64;
     MDTASSPPSA ERKRAGWSRL LGARRGSAVV KKCPFSLELA EGGPEGSTVY APIAPTGAPG
     LAPPMSTPVS PAPAPADLGP RPRVSLDPRV SIYSARRPLL ARTHIQGRVY NFLERPTGWK
     CFVYHFTVFL IVLVCLIFSV LSTIEQYAAL ATGTLFWMEI VLVVFFGTEY VVRLWSAGCR
     SKYVGIWGRL RFARKPISII DLIVVVASMV VLCVGSKGQV FATSAIRGIR FLQILRMLHV
     DRQGGTWRLL GSVVFIHRQE LITTLYIGFL GLIFSSYFVY LAEKDAVNES GRIEFGSYAD
     ALWWGVVTVT TIGYGDKVPQ TWVGKTIASC FSVFAISFFA LPAGILGSGF ALKVQQKQRQ
     KHFNRQIPAA ASLIQTAWRC YAAENPDSAT WKIYVRKPAR SHTLLSPSPK PKKSVMVKKK
     KFKLDKDNGM SPGEKMFNVP HITYDPPEDR RPDHFSIDGY DSSVRKSPTL LEVSTPHFLR
     TNSFAEDLDL EGETLLTPIT HVSQLRDHHR ATIKVIRRMQ YFVAKKKFQQ ARKPYDVRDV
     IEQYSQGHLN LMVRIKELQR RLDQSIGKPS LFIPISEKSK DRGSNTIGAR LNRVEDKVTQ
     LDQRLVIITD MLHQLLSMQQ GGPTCNSRSQ VVASNEGGSI NPELFLPSNS LPTYEQLTVP
     QTGPDEGS
//
ID   Y4233_RHOPA             Reviewed;         412 AA.
AC   Q02006;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   16-FEB-2004, sequence version 2.
DT   25-OCT-2017, entry version 103.
DE   RecName: Full=Putative potassium channel protein RPA4233;
GN   OrderedLocusNames=RPA4233;
OS   Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rhizobiales;
OC   Bradyrhizobiaceae; Rhodopseudomonas.
OX   NCBI_TaxID=258594;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC BAA-98 / CGA009;
RX   PubMed=14704707; DOI=10.1038/nbt923;
RA   Larimer F.W., Chain P., Hauser L., Lamerdin J.E., Malfatti S., Do L.,
RA   Land M.L., Pelletier D.A., Beatty J.T., Lang A.S., Tabita F.R.,
RA   Gibson J.L., Hanson T.E., Bobst C., Torres y Torres J.L., Peres C.,
RA   Harrison F.H., Gibson J., Harwood C.S.;
RT   "Complete genome sequence of the metabolically versatile
RT   photosynthetic bacterium Rhodopseudomonas palustris.";
RL   Nat. Biotechnol. 22:55-61(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-15.
RC   STRAIN=ATCC BAA-98 / CGA009;
RX   PubMed=1522059; DOI=10.1128/jb.174.18.5803-5813.1992;
RA   Dispensa M., Thomas C.T., Kim M.-K., Perrotta J.A., Gibson J.,
RA   Harwood C.S.;
RT   "Anaerobic growth of Rhodopseudomonas palustris on 4-hydroxybenzoate
RT   is dependent on AadR, a member of the cyclic AMP receptor protein
RT   family of transcriptional regulators.";
RL   J. Bacteriol. 174:5803-5813(1992).
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the potassium channel family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX572606; CAE29674.1; -; Genomic_DNA.
DR   EMBL; M92426; AAA26091.1; -; Genomic_DNA.
DR   PIR; C43334; C43334.
DR   RefSeq; WP_011159768.1; NC_005296.1.
DR   ProteinModelPortal; Q02006; -.
DR   SMR; Q02006; -.
DR   STRING; 258594.RPA4233; -.
DR   TCDB; 1.A.1.24.1; the voltage-gated ion channel (vic) superfamily.
DR   EnsemblBacteria; CAE29674; CAE29674; RPA4233.
DR   KEGG; rpa:RPA4233; -.
DR   eggNOG; ENOG4105EYW; Bacteria.
DR   eggNOG; COG0664; LUCA.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000271293; -.
DR   KO; K10716; -.
DR   OMA; MYFIAEG; -.
DR   OrthoDB; POG091H04JJ; -.
DR   PhylomeDB; Q02006; -.
DR   BioCyc; RPAL258594:G13CN-4263-MONOMER; -.
DR   Proteomes; UP000001426; Chromosome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00889; CNMP_BINDING_2; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    412       Putative potassium channel protein
FT                                RPA4233.
FT                                /FTId=PRO_0000054103.
FT   TRANSMEM     35     55       Helical. {ECO:0000255}.
FT   TRANSMEM     65     85       Helical. {ECO:0000255}.
FT   TRANSMEM    164    184       Helical. {ECO:0000255}.
FT   TRANSMEM    202    222       Helical. {ECO:0000255}.
FT   TRANSMEM    225    245       Helical. {ECO:0000255}.
FT   NP_BIND     270    388       cNMP.
FT   MOTIF       210    215       Selectivity filter. {ECO:0000250}.
SQ   SEQUENCE   412 AA;  46121 MW;  6CAD64DFA5E776B6 CRC64;
     MRDETPAYLR ARHYFYEILE SQAQTSRMGV IVNRFIVFFI VLSVGITVME SVPAMREDYG
     RLFQALELLC LVMFSIEYYI RIWIAPEHLP YHHMSPLRAA WAYMISPQGI VDCISVMPLW
     IALFGPDDLR VLIILRMLRL LKFARYSSGM RSLLEVLESE RRALMACLVI LACATLVSAT
     AMHIAEGHVQ PEKFGTIPDA MWWAIVTLST IGYGDVVPAT GIGRMVASAT IICGLIMIAL
     PVGIVANAFS EVIHRRDFIV NWSMVARVPL FSHLTAGDIA HIMQLLQARQ IERGEVVFRR
     GEPATAMYFI AEGDVEIELG PEDKGRRIRL GTGHFFGEIA VLKRVERSAT VKAVSRTRLL
     VLDGADLRAL IAREPSIARK INQIVEGRTG RNLNLEIADL EGQADVSVEE NA
//
ID   KCNAE_DROME             Reviewed;        1174 AA.
AC   Q02280; Q9VXZ6;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 2.
DT   25-OCT-2017, entry version 160.
DE   RecName: Full=Potassium voltage-gated channel protein eag;
DE   AltName: Full=Ether-a-go-go protein;
GN   Name=eag; ORFNames=CG10952;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND DISRUPTION PHENOTYPE.
RC   TISSUE=Head;
RX   PubMed=1840699; DOI=10.1126/science.1840699;
RA   Warmke J., Drysdale R.A., Ganetzky B.;
RT   "A distinct potassium channel polypeptide encoded by the Drosophila
RT   eag locus.";
RL   Science 252:1560-1562(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   FUNCTION.
RX   PubMed=11517334; DOI=10.1073/pnas.191107698;
RA   Yager J., Richards S., Hekmat-Scafe D.S., Hurd D.D., Sundaresan V.,
RA   Caprette D.R., Saxton W.M., Carlson J.R., Stern M.;
RT   "Control of Drosophila perineurial glial growth by interacting
RT   neurotransmitter-mediated signaling pathways.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:10445-10450(2001).
RN   [5]
RP   FUNCTION, PHOSPHORYLATION AT THR-787, MUTAGENESIS OF THR-787, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11980904; DOI=10.1074/jbc.M201949200;
RA   Wang Z., Wilson G.F., Griffith L.C.;
RT   "Calcium/calmodulin-dependent protein kinase II phosphorylates and
RT   regulates the Drosophila eag potassium channel.";
RL   J. Biol. Chem. 277:24022-24029(2002).
RN   [6]
RP   FUNCTION, INTERACTION WITH CASK, AND SUBCELLULAR LOCATION.
RX   PubMed=15901771; DOI=10.1523/JNEUROSCI.4566-04.2005;
RA   Marble D.D., Hegle A.P., Snyder E.D. II, Dimitratos S., Bryant P.J.,
RA   Wilson G.F.;
RT   "Camguk/CASK enhances Ether-a-go-go potassium current by a
RT   phosphorylation-dependent mechanism.";
RL   J. Neurosci. 25:4898-4907(2005).
CC   -!- FUNCTION: Structural component of a potassium channel. Mediates
CC       the potassium permeability of membranes; potassium current is
CC       regulated by CaMKII and CASK. Has a role in growth of the
CC       perineurial glial layer of the larval peripheral nerve.
CC       {ECO:0000269|PubMed:11517334, ECO:0000269|PubMed:11980904,
CC       ECO:0000269|PubMed:15901771, ECO:0000269|PubMed:1840699}.
CC   -!- SUBUNIT: The voltage-dependent potassium channel is a
CC       heterotetramer of potassium channel proteins (By similarity).
CC       Interaction with CASK. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q24210:CASK; NbExp=10; IntAct=EBI-85304, EBI-214423;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:15901771};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:15901771}.
CC       Note=Eag recruits CASK to the plasma membrane.
CC   -!- TISSUE SPECIFICITY: Expressed in the axon and the terminal boutons
CC       of motor neurons. {ECO:0000269|PubMed:11980904}.
CC   -!- PTM: When in complex with CASK, the efficiency of Thr-787
CC       phosphorylation is increased. {ECO:0000269|PubMed:11980904}.
CC   -!- DISRUPTION PHENOTYPE: Increased growth of the perineurial glial
CC       layer of the larval peripheral nerve. Hyperexcitability at the
CC       larval neuromuscular junction (NMJ) and memory formation defects
CC       in the adult. {ECO:0000269|PubMed:1840699}.
CC   -!- MISCELLANEOUS: The segment S4 is probably the voltage-sensor and
CC       is characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- MISCELLANEOUS: The segment H5 is thought to line the channel pore.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag) (TC
CC       1.A.1.20) subfamily. Eag sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M61157; AAA28495.1; -; mRNA.
DR   EMBL; AE014298; AAF48410.1; -; Genomic_DNA.
DR   PIR; A40853; A40853.
DR   RefSeq; NP_511158.2; NM_078603.4.
DR   UniGene; Dm.2914; -.
DR   PDB; 5FG8; X-ray; 1.96 A; B=768-820.
DR   PDB; 5H9B; X-ray; 2.25 A; B=770-820.
DR   PDB; 5HU3; X-ray; 1.89 A; B=768-820.
DR   PDBsum; 5FG8; -.
DR   PDBsum; 5H9B; -.
DR   PDBsum; 5HU3; -.
DR   ProteinModelPortal; Q02280; -.
DR   SMR; Q02280; -.
DR   BioGrid; 58786; 6.
DR   IntAct; Q02280; 3.
DR   STRING; 7227.FBpp0110308; -.
DR   TCDB; 1.A.1.20.6; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q02280; -.
DR   PaxDb; Q02280; -.
DR   PRIDE; Q02280; -.
DR   EnsemblMetazoa; FBtr0073955; FBpp0073772; FBgn0000535.
DR   GeneID; 32428; -.
DR   KEGG; dme:Dmel_CG10952; -.
DR   CTD; 32428; -.
DR   FlyBase; FBgn0000535; eag.
DR   eggNOG; KOG0501; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140833; -.
DR   InParanoid; Q02280; -.
DR   KO; K04908; -.
DR   OrthoDB; EOG091G0OXR; -.
DR   PhylomeDB; Q02280; -.
DR   Reactome; R-DME-1296072; Voltage gated Potassium channels.
DR   GenomeRNAi; 32428; -.
DR   PRO; PR:Q02280; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0000535; -.
DR   Genevisible; Q02280; DM.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IPI:FlyBase.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; IDA:FlyBase.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:FlyBase.
DR   GO; GO:0048150; P:behavioral response to ether; NAS:FlyBase.
DR   GO; GO:0007619; P:courtship behavior; TAS:FlyBase.
DR   GO; GO:0007629; P:flight behavior; IMP:FlyBase.
DR   GO; GO:0007612; P:learning; IMP:FlyBase.
DR   GO; GO:0007611; P:learning or memory; NAS:FlyBase.
DR   GO; GO:0042066; P:perineurial glial growth; IGI:FlyBase.
DR   GO; GO:0006813; P:potassium ion transport; IDA:FlyBase.
DR   GO; GO:0051259; P:protein oligomerization; IPI:FlyBase.
DR   GO; GO:0008016; P:regulation of heart contraction; NAS:FlyBase.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0007608; P:sensory perception of smell; NAS:FlyBase.
DR   CDD; cd00038; CAP_ED; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003949; K_chnl_volt-dep_EAG.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01464; EAGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Developmental protein;
KW   Differentiation; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Neurogenesis; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1174       Potassium voltage-gated channel protein
FT                                eag.
FT                                /FTId=PRO_0000053964.
FT   TOPO_DOM      1    226       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    227    246       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    247    268       Extracellular. {ECO:0000255}.
FT   TRANSMEM    269    291       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    292    313       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    314    335       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    336    342       Extracellular. {ECO:0000255}.
FT   TRANSMEM    343    369       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    370    371       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    372    393       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    394    441       Extracellular. {ECO:0000255}.
FT   INTRAMEM    442    467       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    468    470       Extracellular. {ECO:0000255}.
FT   TRANSMEM    471    493       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    494   1174       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       43     97       PAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN      113    165       PAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00141}.
FT   NP_BIND     571    688       cNMP.
FT   MOTIF       453    458       Selectivity filter. {ECO:0000250}.
FT   MOD_RES     787    787       Phosphothreonine; by CaMK2.
FT                                {ECO:0000269|PubMed:11980904}.
FT   CARBOHYD    262    262       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    412    412       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    424    424       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     787    787       T->A: Reduced eag channel amplitude and
FT                                accelerated inactivation. Does not affect
FT                                binding with CASK.
FT                                {ECO:0000269|PubMed:11980904}.
FT   CONFLICT    548    548       Y -> C (in Ref. 1; AAA28495).
FT                                {ECO:0000305}.
FT   CONFLICT    567    567       N -> D (in Ref. 1; AAA28495).
FT                                {ECO:0000305}.
FT   CONFLICT    571    571       A -> T (in Ref. 1; AAA28495).
FT                                {ECO:0000305}.
FT   CONFLICT    699    699       K -> R (in Ref. 1; AAA28495).
FT                                {ECO:0000305}.
FT   CONFLICT    769    769       F -> L (in Ref. 1; AAA28495).
FT                                {ECO:0000305}.
FT   CONFLICT    894    894       I -> V (in Ref. 1; AAA28495).
FT                                {ECO:0000305}.
FT   CONFLICT    934    934       G -> S (in Ref. 1; AAA28495).
FT                                {ECO:0000305}.
FT   CONFLICT   1015   1015       N -> D (in Ref. 1; AAA28495).
FT                                {ECO:0000305}.
FT   CONFLICT   1042   1042       R -> G (in Ref. 1; AAA28495).
FT                                {ECO:0000305}.
FT   CONFLICT   1049   1049       K -> E (in Ref. 1; AAA28495).
FT                                {ECO:0000305}.
FT   CONFLICT   1088   1088       T -> A (in Ref. 1; AAA28495).
FT                                {ECO:0000305}.
FT   CONFLICT   1142   1142       T -> I (in Ref. 1; AAA28495).
FT                                {ECO:0000305}.
FT   STRAND      788    791       {ECO:0000244|PDB:5FG8}.
SQ   SEQUENCE   1174 AA;  126371 MW;  B8F86ACBB5627FD3 CRC64;
     MPGGRRGLVA PQNTFLENII RRSNSQPDSS FLLANAQIVD FPIVYCNESF CKISGYNRAE
     VMQKSCRYVC GFMYGELTDK ETVGRLEYTL ENQQQDQFEI LLYKKNNLQC GCALSQFGKA
     QTQETPLWLL LQVAPIRNER DLVVLFLLTF RDITALKQPI DSEDTKGVLG LSKFAKLARS
     VTRSRQFSAH LPTLKDPTKQ SNLAHMMSLS ADIMPQYRQE APKTPPHILL HYCAFKAIWD
     WVILCLTFYT AIMVPYNVAF KNKTSEDVSL LVVDSIVDVI FFIDIVLNFH TTFVGPGGEV
     VSDPKVIRMN YLKSWFIIDL LSCLPYDVFN AFDRDEDGIG SLFSALKVVR LLRLGRVVRK
     LDRYLEYGAA MLILLLCFYM LVAHWLACIW YSIGRSDADN GIQYSWLWKL ANVTQSPYSY
     IWSNDTGPEL VNGPSRKSMY VTALYFTMTC MTSVGFGNVA AETDNEKVFT ICMMIIAALL
     YATIFGHVTT IIQQMTSATA KYHDMLNNVR EFMKLHEVPK ALSERVMDYV VSTWAMTKGL
     DTEKVLNYCP KDMKADICVH LNRKVFNEHP AFRLASDGCL RALAMHFMMS HSAPGDLLYH
     TGESIDSLCF IVTGSLEVIQ DDEVVAILGK GDVFGDQFWK DSAVGQSAAN VRALTYCDLH
     AIKRDKLLEV LDFYSAFANS FARNLVLTYN LRHRLIFRKV ADVKREKELA ERRKNEPQLP
     QNQDHLVRKI FSKFRRTPQV QAGSKELVGG SGQSDVEKGD GEVERTKVFP KAPKLQASQA
     TLARQDTIDE GGEVDSSPPS RDSRVVIEGA AVSSATVGPS PPVATTSSAA AGAGVSGGPG
     SGGTVVAIVT KADRNLALER ERQIEMASSR ATTSDTYDTG LRETPPTLAQ RDLIATVLDM
     KVDVRLELQR MQQRIGRIED LLGELVKRLA PGAGSGGNAP DNSSGQTTPG DEICAGCGAG
     GGGTPTTQAP PTSAVTSPVD TVITISSPGA SGSGSGTGAG AGSAVAGAGG AGLLNPGATV
     VSSAGGNGLG PLMLKKRRSK SRKAPAPPKQ TLASTAGTAT AAPAGVAGSG MTSSAPASAD
     QQQQHQSTAD QSPTTPGAEL LHLRLLEEDF TAAQLPSTSS GGAGGGGGSG SGATPTTPPP
     TTAGGSGSGT PTSTTATTTP TGSGTATRGK LDFL
//
ID   SLO_DROME               Reviewed;        1200 AA.
AC   Q03720; A4V3D4; Q24369; Q24384; Q24385; Q59DU0; Q59DU1; Q59DU2;
AC   Q59DU3; Q59DU4; Q59DU5; Q59DU6; Q59DU7; Q59DU8; Q59DU9; Q59DV0;
AC   Q59DV1; Q59DV2; Q7JP74; Q7KS13; Q86NK5; Q8IMV9; Q9TWA1; Q9VC51;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2006, sequence version 3.
DT   25-OCT-2017, entry version 163.
DE   RecName: Full=Calcium-activated potassium channel slowpoke;
DE            Short=dSlo;
DE   AltName: Full=BK channel;
DE   AltName: Full=Maxi K channel;
DE            Short=MaxiK;
GN   Name=slo; ORFNames=CG10693;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   17-1200 (ISOFORMS 2 AND 3), AND FUNCTION.
RC   TISSUE=Head;
RX   PubMed=1857984; DOI=10.1126/science.1857984;
RA   Atkinson N.S., Robertson G.A., Ganetzky B.;
RT   "A component of calcium-activated potassium channels encoded by the
RT   Drosophila slo locus.";
RL   Science 253:551-555(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5; A; D; E; H; I; J; L; N; P AND
RP   Q), AND FUNCTION.
RC   STRAIN=Canton-S; TISSUE=Head;
RX   PubMed=1497890; DOI=10.1016/0896-6273(92)90160-F;
RA   Adelman J.P., Shen K.-Z., Kavanaugh M.P., Warren R.A., Wu Y.-N.,
RA   Lagrutta A., Bond C.T., North R.A.;
RT   "Calcium-activated potassium channels expressed from cloned
RT   complementary DNAs.";
RL   Neuron 9:209-216(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-82, AND TISSUE SPECIFICITY.
RC   STRAIN=Iso-1;
RX   PubMed=8774450;
RA   Brenner R., Thomas T.O., Becker M.N., Atkinson N.S.;
RT   "Tissue-specific expression of a Ca(2+)-activated K+ channel is
RT   controlled by multiple upstream regulatory elements.";
RL   J. Neurosci. 16:1827-1835(1996).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=7666207;
RA   Becker M.N., Brenner R., Atkinson N.S.;
RT   "Tissue-specific expression of a Drosophila calcium-activated
RT   potassium channel.";
RL   J. Neurosci. 15:6250-6259(1995).
RN   [8]
RP   INTERACTION WITH SLIP1.
RX   PubMed=9502797;
RA   Xia X.-M., Hirschberg B., Smolik S., Forte M., Adelman J.P.;
RT   "dSLo interacting protein 1, a novel protein that interacts with
RT   large-conductance calcium-activated potassium channels.";
RL   J. Neurosci. 18:2360-2369(1998).
RN   [9]
RP   INTERACTION WITH SLOB.
RX   PubMed=9539129; DOI=10.1016/S0896-6273(00)80995-2;
RA   Schopperle W.M., Holmqvist M.H., Zhou Y., Wang J., Wang Z.,
RA   Griffith L.C., Keselman I., Kusinitz F., Dagan D., Levitan I.B.;
RT   "Slob, a novel protein that interacts with the Slowpoke calcium-
RT   dependent potassium channel.";
RL   Neuron 20:565-573(1998).
RN   [10]
RP   INTERACTION WITH PKA AND SRC, PHOSPHORYLATION AT SER-978, AND
RP   MUTAGENESIS OF TYR-552; SER-978 AND TYR-1012.
RX   PubMed=10234050;
RA   Wang J., Zhou Y., Wen H., Levitan I.B.;
RT   "Simultaneous binding of two protein kinases to a calcium-dependent
RT   potassium channel.";
RL   J. Neurosci. 19:RC4-RC4(1999).
RN   [11]
RP   INDIRECT INTERACTION WITH 14-3-3-ZETA.
RX   PubMed=10230800; DOI=10.1016/S0896-6273(00)80739-4;
RA   Zhou Y., Schopperle W.M., Murrey H., Jaramillo A., Dagan D.,
RA   Griffith L.C., Levitan I.B.;
RT   "A dynamically regulated 14-3-3, Slob, and Slowpoke potassium channel
RT   complex in Drosophila presynaptic nerve terminals.";
RL   Neuron 22:809-818(1999).
RN   [12]
RP   DOMAIN CALCIUM BOWL, AND MUTAGENESIS OF 1002-ASP--ASP-1006.
RX   PubMed=11274367; DOI=10.1073/pnas.081072398;
RA   Bian S., Favre I., Moczydlowski E.;
RT   "Ca2+-binding activity of a COOH-terminal fragment of the Drosophila
RT   BK channel involved in Ca2+-dependent activation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:4776-4781(2001).
RN   [13]
RP   PHOSPHORYLATION.
RX   PubMed=12019304;
RA   Zhou Y., Wang J., Wen H., Kucherovsky O., Levitan I.B.;
RT   "Modulation of Drosophila slowpoke calcium-dependent potassium channel
RT   activity by bound protein kinase a catalytic subunit.";
RL   J. Neurosci. 22:3855-3863(2002).
CC   -!- FUNCTION: Potassium channel activated by both membrane
CC       depolarization or increase in cytosolic Ca(2+) that mediates
CC       export of K(+). Its activation dampens the excitatory events that
CC       elevate the cytosolic Ca(2+) concentration and/or depolarize the
CC       cell membrane. It therefore contributes to repolarization of the
CC       membrane potential. Kinetics are determined by alternative
CC       splicing, phosphorylation status and its combination interaction
CC       with Slob and 14-3-3-zeta. While the interaction with Slob1 alone
CC       increases its activity, its interaction with both Slob1 and 14-3-
CC       3-zeta decreases its activity. {ECO:0000269|PubMed:1497890,
CC       ECO:0000269|PubMed:1857984}.
CC   -!- SUBUNIT: Homotetramer; which constitutes the calcium-activated
CC       potassium channel (By similarity). Interacts with Slip1. Interacts
CC       with Slob, and, indirectly with 14-3-3-zeta via its interaction
CC       with Slob. Interacts with Pka-C1 and Src kinases, which can bind
CC       simultaneously to it. {ECO:0000250, ECO:0000269|PubMed:10234050,
CC       ECO:0000269|PubMed:9502797, ECO:0000269|PubMed:9539129}.
CC   -!- INTERACTION:
CC       P12370:Pka-C1; NbExp=5; IntAct=EBI-426805, EBI-82224;
CC       Q8MR31:Slip1; NbExp=5; IntAct=EBI-426805, EBI-123875;
CC       Q8IPH9-1:Slob; NbExp=2; IntAct=EBI-426805, EBI-424896;
CC       P00528:Src64B; NbExp=3; IntAct=EBI-426805, EBI-87092;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=20;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=N;
CC         IsoId=Q03720-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q03720-2; Sequence=VSP_050267, VSP_050268;
CC       Name=3;
CC         IsoId=Q03720-4; Sequence=VSP_050268;
CC       Name=5;
CC         IsoId=Q03720-6; Sequence=VSP_010001, VSP_010002, VSP_050267,
CC                                  VSP_050268;
CC       Name=6;
CC         IsoId=Q03720-3; Sequence=VSP_009999, VSP_010000, VSP_010001,
CC                                  VSP_010003, VSP_050268;
CC       Name=A; Synonyms=G;
CC         IsoId=Q03720-5; Sequence=VSP_010004;
CC       Name=B;
CC         IsoId=Q03720-7; Sequence=VSP_009999;
CC       Name=C;
CC         IsoId=Q03720-8; Sequence=VSP_009999, VSP_010002;
CC         Note=No experimental confirmation available.;
CC       Name=D;
CC         IsoId=Q03720-9; Sequence=VSP_020625, VSP_010004;
CC       Name=E;
CC         IsoId=Q03720-10; Sequence=VSP_010000, VSP_010004;
CC       Name=F;
CC         IsoId=Q03720-11; Sequence=VSP_010001, VSP_010004;
CC         Note=No experimental confirmation available.;
CC       Name=H;
CC         IsoId=Q03720-12; Sequence=VSP_010002, VSP_010004;
CC       Name=I;
CC         IsoId=Q03720-13; Sequence=VSP_050267;
CC       Name=J;
CC         IsoId=Q03720-14; Sequence=VSP_020627;
CC       Name=K;
CC         IsoId=Q03720-15; Sequence=VSP_020628;
CC         Note=No experimental confirmation available.;
CC       Name=L;
CC         IsoId=Q03720-16; Sequence=VSP_020626;
CC       Name=M;
CC         IsoId=Q03720-17; Sequence=VSP_010004, VSP_050268;
CC         Note=No experimental confirmation available.;
CC       Name=O;
CC         IsoId=Q03720-18; Sequence=VSP_010002, VSP_020628;
CC         Note=No experimental confirmation available.;
CC       Name=P;
CC         IsoId=Q03720-19; Sequence=VSP_010000, VSP_010002, VSP_020628;
CC       Name=Q;
CC         IsoId=Q03720-20; Sequence=VSP_010000, VSP_010002, VSP_010004;
CC   -!- TISSUE SPECIFICITY: Expressed in muscle cells, neurons of the CNS
CC       and PNS, mushroom bodies, a limited number of cells in embryonic
CC       and larval midgut and in epithelial-derived tracheal cells. During
CC       pupariation and embryogenesis, it is expressed in muscles many
CC       hours prior to the appearance of functional channels.
CC       {ECO:0000269|PubMed:7666207, ECO:0000269|PubMed:8774450}.
CC   -!- DOMAIN: The S4 segment, which is characterized by a series of
CC       positively charged amino acids at every third position, is part of
CC       the voltage-sensor. {ECO:0000250}.
CC   -!- DOMAIN: The pore-forming domain (also referred as P region) is
CC       imbedded into the membrane, and forms the selectivity filter of
CC       the pore. It contains the signature sequence of potassium channels
CC       that displays selectivity to potassium (By similarity).
CC       {ECO:0000250}.
CC   -!- DOMAIN: The RCK N-terminal domain mediates the
CC       homotetramerization, thereby promoting the assembly of monomers
CC       into functional potassium channel. It includes binding sites for
CC       Ca(2+) and Mg(2+) (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The calcium bowl constitutes one of the Ca(2+) sensors and
CC       probably acts as a Ca(2+)-binding site.
CC       {ECO:0000269|PubMed:11274367}.
CC   -!- PTM: Phosphorylated. Phosphorylation may be mediated by both PKA
CC       and SRC kinases, which activate the channel activity.
CC       Phosphorylation by PKA is however unclear. Indeed, although
CC       modulation of channel activity requires Pka-C1, it does not
CC       interacts with the whole PKA holoenzyme. Moreover, modulation of
CC       activity does not depend upon phosphorylation of Ser-978.
CC       {ECO:0000269|PubMed:10234050, ECO:0000269|PubMed:12019304}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Calcium-
CC       activated (TC 1.A.1.3) subfamily. Slo sub-subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA28902.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAO45232.1; Type=Frameshift; Positions=192; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M69053; AAA28902.1; ALT_INIT; mRNA.
DR   EMBL; M96840; AAA28651.1; -; mRNA.
DR   EMBL; AE014297; AAF56324.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAN14013.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAS65211.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52977.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52978.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52979.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52980.2; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52981.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52982.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52983.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52984.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52985.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52986.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52987.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52988.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52989.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52990.1; -; Genomic_DNA.
DR   EMBL; BT004876; AAO45232.1; ALT_FRAME; mRNA.
DR   EMBL; U40315; AAC47020.1; -; Genomic_DNA.
DR   EMBL; U40315; AAC47021.1; -; Genomic_DNA.
DR   PIR; A39800; A39800.
DR   PIR; C39800; C39800.
DR   PIR; JH0697; JH0697.
DR   PIR; PS0438; PS0438.
DR   PIR; PS0439; PS0439.
DR   PIR; PS0440; PS0440.
DR   PIR; PS0441; PS0441.
DR   PIR; PS0446; PS0446.
DR   RefSeq; NP_001014651.1; NM_001014651.3. [Q03720-20]
DR   RefSeq; NP_001014652.1; NM_001014652.3. [Q03720-19]
DR   RefSeq; NP_001014653.1; NM_001014653.3. [Q03720-18]
DR   RefSeq; NP_001014654.1; NM_001014654.3. [Q03720-1]
DR   RefSeq; NP_001014655.1; NM_001014655.3. [Q03720-17]
DR   RefSeq; NP_001014656.1; NM_001014656.3. [Q03720-16]
DR   RefSeq; NP_001014657.1; NM_001014657.3. [Q03720-15]
DR   RefSeq; NP_001014658.1; NM_001014658.3. [Q03720-14]
DR   RefSeq; NP_001014659.1; NM_001014659.3. [Q03720-13]
DR   RefSeq; NP_001014660.1; NM_001014660.3. [Q03720-12]
DR   RefSeq; NP_001014661.2; NM_001014661.4. [Q03720-3]
DR   RefSeq; NP_001014662.1; NM_001014662.3. [Q03720-11]
DR   RefSeq; NP_001014663.1; NM_001014663.3. [Q03720-10]
DR   RefSeq; NP_001014664.1; NM_001014664.3. [Q03720-9]
DR   RefSeq; NP_524486.2; NM_079762.4. [Q03720-5]
DR   RefSeq; NP_733029.1; NM_170164.4. [Q03720-7]
DR   RefSeq; NP_996289.1; NM_206566.4. [Q03720-8]
DR   UniGene; Dm.19520; -.
DR   ProteinModelPortal; Q03720; -.
DR   SMR; Q03720; -.
DR   BioGrid; 67865; 11.
DR   IntAct; Q03720; 9.
DR   TCDB; 1.A.1.3.1; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q03720; -.
DR   PRIDE; Q03720; -.
DR   EnsemblMetazoa; FBtr0084683; FBpp0084063; FBgn0003429. [Q03720-7]
DR   EnsemblMetazoa; FBtr0084684; FBpp0084064; FBgn0003429. [Q03720-5]
DR   EnsemblMetazoa; FBtr0084685; FBpp0089227; FBgn0003429. [Q03720-8]
DR   EnsemblMetazoa; FBtr0100622; FBpp0100082; FBgn0003429. [Q03720-9]
DR   EnsemblMetazoa; FBtr0100623; FBpp0100083; FBgn0003429. [Q03720-10]
DR   EnsemblMetazoa; FBtr0100624; FBpp0100084; FBgn0003429. [Q03720-11]
DR   EnsemblMetazoa; FBtr0100627; FBpp0100086; FBgn0003429. [Q03720-12]
DR   EnsemblMetazoa; FBtr0100629; FBpp0100089; FBgn0003429. [Q03720-13]
DR   EnsemblMetazoa; FBtr0100631; FBpp0100091; FBgn0003429. [Q03720-14]
DR   EnsemblMetazoa; FBtr0100632; FBpp0100092; FBgn0003429. [Q03720-15]
DR   EnsemblMetazoa; FBtr0100633; FBpp0100093; FBgn0003429. [Q03720-16]
DR   EnsemblMetazoa; FBtr0100634; FBpp0100094; FBgn0003429. [Q03720-17]
DR   EnsemblMetazoa; FBtr0100635; FBpp0100095; FBgn0003429. [Q03720-1]
DR   EnsemblMetazoa; FBtr0100636; FBpp0100096; FBgn0003429. [Q03720-18]
DR   EnsemblMetazoa; FBtr0100637; FBpp0100097; FBgn0003429. [Q03720-19]
DR   EnsemblMetazoa; FBtr0100638; FBpp0100098; FBgn0003429. [Q03720-20]
DR   EnsemblMetazoa; FBtr0301581; FBpp0290796; FBgn0003429. [Q03720-3]
DR   GeneID; 42940; -.
DR   KEGG; dme:Dmel_CG10693; -.
DR   UCSC; CG10693-RA; d. melanogaster.
DR   UCSC; CG10693-RG; d. melanogaster.
DR   CTD; 42940; -.
DR   FlyBase; FBgn0003429; slo.
DR   GeneTree; ENSGT00530000063026; -.
DR   InParanoid; Q03720; -.
DR   KO; K04936; -.
DR   OMA; NRMGQEK; -.
DR   OrthoDB; EOG091G148D; -.
DR   PhylomeDB; Q03720; -.
DR   ChiTaRS; slo; fly.
DR   GenomeRNAi; 42940; -.
DR   PRO; PR:Q03720; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0003429; -.
DR   ExpressionAtlas; Q03720; differential.
DR   Genevisible; Q03720; DM.
DR   GO; GO:0016020; C:membrane; IDA:FlyBase.
DR   GO; GO:0043005; C:neuron projection; IDA:FlyBase.
DR   GO; GO:0043025; C:neuronal cell body; IDA:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; NAS:FlyBase.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IBA:GO_Central.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0060072; F:large conductance calcium-activated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0048512; P:circadian behavior; IMP:FlyBase.
DR   GO; GO:0007623; P:circadian rhythm; IMP:FlyBase.
DR   GO; GO:0045433; P:male courtship behavior, veined wing generated song production; IMP:FlyBase.
DR   GO; GO:1900074; P:negative regulation of neuromuscular synaptic transmission; IMP:FlyBase.
DR   GO; GO:0006813; P:potassium ion transport; IDA:UniProtKB.
DR   GO; GO:0008582; P:regulation of synaptic growth at neuromuscular junction; IMP:FlyBase.
DR   GO; GO:0042493; P:response to drug; IMP:FlyBase.
DR   InterPro; IPR024939; Ca-act_K_channel_Slo-1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003929; K_chnl_BK_asu.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR10027:SF33; PTHR10027:SF33; 1.
DR   Pfam; PF03493; BK_channel_a; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1200       Calcium-activated potassium channel
FT                                slowpoke.
FT                                /FTId=PRO_0000054141.
FT   TOPO_DOM      1     48       Extracellular. {ECO:0000255}.
FT   TRANSMEM     49     69       Helical; Name=Segment S0. {ECO:0000255}.
FT   TOPO_DOM     70    127       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    128    149       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    150    164       Extracellular. {ECO:0000255}.
FT   TRANSMEM    165    185       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    186    189       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    190    210       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    211    214       Extracellular. {ECO:0000255}.
FT   TRANSMEM    215    235       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    236    250       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    251    271       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    272    284       Extracellular. {ECO:0000255}.
FT   INTRAMEM    285    307       Pore-forming; Name=P region.
FT                                {ECO:0000255}.
FT   TOPO_DOM    308    316       Extracellular. {ECO:0000255}.
FT   TRANSMEM    317    337       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    338   1200       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      364    507       RCK N-terminal.
FT   REGION      505    525       Segment S7.
FT   REGION      563    583       Segment S8.
FT   REGION      828    848       Segment S9.
FT   REGION     1017   1037       Segment S10.
FT   MOTIF       301    304       Selectivity for potassium.
FT   MOTIF       988   1010       Calcium bowl.
FT   MOD_RES     978    978       Phosphoserine.
FT                                {ECO:0000269|PubMed:10234050}.
FT   VAR_SEQ       1     17       Missing (in isoform 6, isoform B and
FT                                isoform C). {ECO:0000303|PubMed:12537569,
FT                                ECO:0000303|PubMed:1857984}.
FT                                /FTId=VSP_009999.
FT   VAR_SEQ     328    356       MFASSIPEIIELVGSGNKYGGELKREHGK -> IFASCIPE
FT                                IIDLIGTRAKYGGTLKNEKGR (in isoform 6,
FT                                isoform E, isoform P and isoform Q).
FT                                {ECO:0000303|PubMed:12537569,
FT                                ECO:0000303|PubMed:1497890}.
FT                                /FTId=VSP_010000.
FT   VAR_SEQ     328    355       MFASSIPEIIELVGSGNKYGGELKREHG -> VFASWIPEI
FT                                TELAAQRSKYGGTYSKDPR (in isoform D).
FT                                {ECO:0000303|PubMed:1497890}.
FT                                /FTId=VSP_020625.
FT   VAR_SEQ     396    426       PPDLELEGLFKRHFTTVEFFQGTIMNPIDLQ -> EPDLEL
FT                                EGLLKRHYTTVAFFQGTMMNAVDLE (in isoform 5,
FT                                isoform 6 and isoform F).
FT                                {ECO:0000303|PubMed:12537569,
FT                                ECO:0000303|PubMed:1497890}.
FT                                /FTId=VSP_010001.
FT   VAR_SEQ     536    569       MQSWTNDYLRGTGMEMYTETLSPTFIGIPFAQAT -> TQA
FT                                WQNDYLQGTGCEMYTETLSPSFTGMTFPQAS (in
FT                                isoform 5, isoform C, isoform H, isoform
FT                                O, isoform P and isoform Q).
FT                                {ECO:0000303|PubMed:1497890}.
FT                                /FTId=VSP_010002.
FT   VAR_SEQ     649    685       LTVQPRSKFDDLDEHHPAPTFTPPELPKRVHVRGSVS ->
FT                                YVGMIMMQTGMVNQGITSVMNTME (in isoform L).
FT                                {ECO:0000303|PubMed:1497890}.
FT                                /FTId=VSP_020626.
FT   VAR_SEQ     650    686       TVQPRSKFDDLDEHHPAPTFTPPELPKRVHVRGSVSG ->
FT                                ATFRKGVRAVQMVGRAS (in isoform J).
FT                                {ECO:0000303|PubMed:1497890}.
FT                                /FTId=VSP_020627.
FT   VAR_SEQ     650    661       TVQPRSKFDDLD -> ATFRKGVRAVQMVGRAKDDEYSLSN
FT                                (in isoform 2, isoform 5 and isoform I).
FT                                {ECO:0000303|PubMed:1497890,
FT                                ECO:0000303|PubMed:1857984}.
FT                                /FTId=VSP_050267.
FT   VAR_SEQ     650    661       TVQPRSKFDDLD -> ATFRKGVRAVQMVGRAN (in
FT                                isoform 6).
FT                                {ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_010003.
FT   VAR_SEQ     661    697       DEHHPAPTFTPPELPKRVHVRGSVSGDITRDREDTNL ->
FT                                V (in isoform K, isoform O and isoform
FT                                P). {ECO:0000303|PubMed:1497890}.
FT                                /FTId=VSP_020628.
FT   VAR_SEQ     661    685       Missing (in isoform A, isoform D, isoform
FT                                E, isoform F, isoform H, isoform M and
FT                                isoform Q). {ECO:0000303|PubMed:1497890}.
FT                                /FTId=VSP_010004.
FT   VAR_SEQ     761    761       P -> PPENDANPYAGYQLAYEVKKLMP (in isoform
FT                                2, isoform 3, isoform 5, isoform 6 and
FT                                isoform M). {ECO:0000303|PubMed:12537569,
FT                                ECO:0000303|PubMed:1497890,
FT                                ECO:0000303|PubMed:1857984}.
FT                                /FTId=VSP_050268.
FT   MUTAGEN     552    552       Y->F: Affects the interaction with SRC.
FT                                {ECO:0000269|PubMed:10234050}.
FT   MUTAGEN     978    978       S->A: Does not affect activation of
FT                                channel. {ECO:0000269|PubMed:10234050}.
FT   MUTAGEN    1002   1006       DDDDD->NNNNN: Alters calcium binding.
FT                                {ECO:0000269|PubMed:11274367}.
FT   MUTAGEN    1012   1012       Y->F: Affects the interaction with SRC.
FT                                {ECO:0000269|PubMed:10234050}.
FT   CONFLICT     81     81       E -> R (in Ref. 6; AAC47020/AAC47021).
FT                                {ECO:0000305}.
FT   CONFLICT    281    281       N -> D (in Ref. 1; AAA28902, 2; AAA28651
FT                                and 5; AAO45232). {ECO:0000305}.
FT   CONFLICT    994    994       S -> G (in Ref. 1; AAA28902, 2; AAA28651
FT                                and 5; AAO45232). {ECO:0000305}.
SQ   SEQUENCE   1200 AA;  133102 MW;  306A12234C63AD0D CRC64;
     MASGLIDTNF SSTLANGMSG CDQSTVESLA DDPTDSPFDA DDCLKVRKYW CFLLSSIFTF
     LAGLLVVLLW RAFAFVCCRK EPDLGPNDPK QKEQKASRNK QEFEGTFMTE AKDWAGELIS
     GQTTTGRILV VLVFILSIAS LIIYFVDASS EEVERCQKWS NNITQQIDLA FNIFFMVYFF
     IRFIAASDKL WFMLEMYSFV DYFTIPPSFV SIYLDRTWIG LRFLRALRLM TVPDILQYLN
     VLKTSSSIRL AQLVSIFISV WLTAAGIIHL LENSGDPLDF NNAHRLSYWT CVYFLIVTMS
     TVGYGDVYCE TVLGRTFLVF FLLVGLAMFA SSIPEIIELV GSGNKYGGEL KREHGKRHIV
     VCGHITYESV SHFLKDFLHE DREDVDVEVV FLHRKPPDLE LEGLFKRHFT TVEFFQGTIM
     NPIDLQRVKV HEADACLVLA NKYCQDPDAE DAANIMRVIS IKNYSDDIRV IIQLMQYHNK
     AYLLNIPSWD WKQGDDVICL AELKLGFIAQ SCLAPGFSTM MANLFAMRSF KTSPDMQSWT
     NDYLRGTGME MYTETLSPTF IGIPFAQATE LCFSKLKLLL LAIEIKGAEE GADSKISINP
     RGAKIQANTQ GFFIAQSADE VKRAWFYCKA CHEDIKDETL IKKCKCKNLT VQPRSKFDDL
     DEHHPAPTFT PPELPKRVHV RGSVSGDITR DREDTNLLNR NVRRPNGTGN GTGGMHHMNN
     TAAAAAAAAA AGKQVNKVKP TVNVSRQVEG QVISPSQYNR PTSRSSGTGT QNQNGGVSLP
     AGIADDQSKD FDFEKTEMKY DSTGMFHWSP AKSLEDCILD RNQAAMTVLN GHVVVCLFAD
     PDSPLIGLRN LVMPLRASNF HYHELKHVVI VGSVDYIRRE WKMLQNLPKI SVLNGSPLSR
     ADLRAVNVNL CDMCCILSAK VPSNDDPTLA DKEAILASLN IKAMTFDDTI GVLSQRGPEF
     DNLSATAGSP IVLQRRGSVY GANVPMITEL VNDSNVQFLD QDDDDDPDTE LYLTQPFACG
     TAFAVSVLDS LMSTTYFNQN ALTLIRSLIT GGATPELELI LAEGAGLRGG YSTVESLSNR
     DRCRVGQISL YDGPLAQFGE CGKYGDLFVA ALKSYGMLCI GLYRFRDTSS SCDASSKRYV
     ITNPPDDFSL LPTDQVFVLM QFDPGLEYKP PAVRAPAGGR GTNTQGSGVG GGGSNKDDNS
//
ID   KCMA1_MOUSE             Reviewed;        1209 AA.
AC   Q08460; Q64703; Q8VHF1; Q9R196;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-APR-2004, sequence version 2.
DT   20-DEC-2017, entry version 175.
DE   RecName: Full=Calcium-activated potassium channel subunit alpha-1;
DE   AltName: Full=BK channel;
DE   AltName: Full=BKCA alpha;
DE   AltName: Full=Calcium-activated potassium channel, subfamily M subunit alpha-1;
DE   AltName: Full=K(VCA)alpha;
DE   AltName: Full=KCa1.1;
DE   AltName: Full=Maxi K channel;
DE            Short=MaxiK;
DE   AltName: Full=Slo-alpha;
DE   AltName: Full=Slo1;
DE            Short=mSlo1;
DE   AltName: Full=Slowpoke homolog;
DE            Short=Slo homolog;
DE            Short=mSlo;
GN   Name=Kcnma1; Synonyms=Kcnma;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=7987297; DOI=10.1093/hmg/3.8.1239;
RA   Pallanck L., Ganetzky B.;
RT   "Cloning and characterization of human and mouse homologs of the
RT   Drosophila calcium-activated potassium channel gene, slowpoke.";
RL   Hum. Mol. Genet. 3:1239-1243(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 26-1209 (ISOFORMS 2 AND 5), AND
RP   FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=7687074; DOI=10.1126/science.7687074;
RA   Butler A., Tsunoda S., McCobb D.P., Wei A., Salkoff L.;
RT   "mSlo, a complex mouse gene encoding 'maxi' calcium-activated
RT   potassium channels.";
RL   Science 261:221-224(1993).
RN   [3]
RP   MUTAGENESIS OF VAL-151.
RX   PubMed=16341213; DOI=10.1038/nn1602;
RA   Liu J., Asuncion-Chin M., Liu P., Dopico A.M.;
RT   "CaM kinase II phosphorylation of slo Thr107 regulates activity and
RT   ethanol responses of BK channels.";
RL   Nat. Neurosci. 9:41-49(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 66-1209 (ISOFORM 4).
RC   TISSUE=Pituitary anterior lobe;
RX   PubMed=10517674; DOI=10.1210/mend.13.10.0355;
RA   Shipston M.J., Duncan R.R., Clark A.G., Antoni F.A., Tian L.;
RT   "Molecular components of large conductance calcium-activated potassium
RT   (BK) channels in mouse pituitary corticotropes.";
RL   Mol. Endocrinol. 13:1728-1737(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 66-1209 (ISOFORM 3).
RC   STRAIN=NIH Swiss; TISSUE=Parotid gland;
RX   PubMed=12388098; DOI=10.1152/ajpcell.00044.2002;
RA   Nehrke K., Quinn C.C., Begenisich T.;
RT   "Molecular identification of Ca2+-activated K+ channels in parotid
RT   acinar cells.";
RL   Am. J. Physiol. 284:C535-C546(2003).
RN   [6]
RP   INTERACTION WITH KCNMB3.
RX   PubMed=10804197;
RA   Weiger T.M., Holmqvist M.H., Levitan I.B., Clark F.T., Sprague S.,
RA   Huang W.-J., Ge P., Wang C., Lawson D., Jurman M.E., Glucksmann M.A.,
RA   Silos-Santiago I., DiStefano P.S., Curtis R.;
RT   "A novel nervous system beta subunit that downregulates human large
RT   conductance calcium-dependent potassium channels.";
RL   J. Neurosci. 20:3563-3570(2000).
RN   [7]
RP   MUTAGENESIS OF ARG-272; ARG-278; GLU-284 AND GLN-287.
RX   PubMed=11112549; DOI=10.1021/bi001509+;
RA   Cui J., Aldrich R.W.;
RT   "Allosteric linkage between voltage and Ca(2+)-dependent activation of
RT   BK-type mslo1 K(+) channels.";
RL   Biochemistry 39:15612-15619(2000).
RN   [8]
RP   CALCIUM-BINDING, AND MUTAGENESIS OF 992-ASP--ASP-996.
RX   PubMed=12149279; DOI=10.1085/jgp.20028627;
RA   Bao L., Rapin A.M., Holmstrand E.C., Cox D.H.;
RT   "Elimination of the BK(Ca) channel's high-affinity Ca(2+)
RT   sensitivity.";
RL   J. Gen. Physiol. 120:173-189(2002).
RN   [9]
RP   MAGNESIUM-BINDING, AND MUTAGENESIS OF GLU-439; HIS-444; THR-461;
RP   GLN-462 AND GLU-464.
RX   PubMed=12192410; DOI=10.1038/nature00941;
RA   Shi J., Krishnamoorthy G., Yang Y., Hu L., Chaturvedi N., Harilal D.,
RA   Qin J., Cui J.;
RT   "Mechanism of magnesium activation of calcium-activated potassium
RT   channels.";
RL   Nature 418:876-880(2002).
RN   [10]
RP   CALCIUM-BINDING, MAGNESIUM-BINDING, AND MUTAGENESIS OF ASP-427;
RP   ASP-432; ASP-434 AND GLU-464.
RX   PubMed=12192411; DOI=10.1038/nature00956;
RA   Xia X.-M., Zeng X., Lingle C.J.;
RT   "Multiple regulatory sites in large-conductance calcium-activated
RT   potassium channels.";
RL   Nature 418:880-884(2002).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-709; SER-711; SER-724;
RP   SER-728; THR-916; SER-924 AND SER-928, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT THR-670 AND SER-672 (ISOFORM 2), AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [12]
RP   INTERACTION WITH RAB11B.
RX   PubMed=22935415; DOI=10.1016/j.bbrc.2012.08.067;
RA   Sokolowski S., Harvey M., Sakai Y., Jordan A., Sokolowski B.;
RT   "The large conductance calcium-activated K(+) channel interacts with
RT   the small GTPase Rab11b.";
RL   Biochem. Biophys. Res. Commun. 426:221-225(2012).
CC   -!- FUNCTION: Potassium channel activated by both membrane
CC       depolarization or increase in cytosolic Ca(2+) that mediates
CC       export of K(+). It is also activated by the concentration of
CC       cytosolic Mg(2+). Its activation dampens the excitatory events
CC       that elevate the cytosolic Ca(2+) concentration and/or depolarize
CC       the cell membrane. It therefore contributes to repolarization of
CC       the membrane potential. Plays a key role in controlling
CC       excitability in a number of systems, such as regulation of the
CC       contraction of smooth muscle, the tuning of hair cells in the
CC       cochlea, regulation of transmitter release, and innate immunity.
CC       In smooth muscles, its activation by high level of Ca(2+), caused
CC       by ryanodine receptors in the sarcoplasmic reticulum, regulates
CC       the membrane potential. In cochlea cells, its number and kinetic
CC       properties partly determine the characteristic frequency of each
CC       hair cell and thereby helps to establish a tonotopic map. Kinetics
CC       of KCNMA1 channels are determined by alternative splicing,
CC       phosphorylation status and its combination with modulating beta
CC       subunits. Highly sensitive to both iberiotoxin (IbTx) and
CC       charybdotoxin (CTX). {ECO:0000269|PubMed:7687074}.
CC   -!- ENZYME REGULATION: Ethanol and carbon monoxide-bound heme increase
CC       channel activation. Heme inhibits channel activation (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homotetramer; which constitutes the calcium-activated
CC       potassium channel. Interacts with beta subunits KCNMB1, KCNMB2,
CC       KCNMB3 and KCNMB4. Interacts with gamma subunits LRRC26, LRRC38,
CC       LRRC52 and LRRC55. Beta and gamma subunits are accessory, and
CC       modulate its activity (By similarity). Interacts with RAB11B.
CC       {ECO:0000250, ECO:0000269|PubMed:10804197,
CC       ECO:0000269|PubMed:22935415}.
CC   -!- INTERACTION:
CC       P63260:Actg1; NbExp=4; IntAct=EBI-1633915, EBI-351301;
CC       P48036:Anxa5; NbExp=4; IntAct=EBI-1633915, EBI-1184119;
CC       Q00623:Apoa1; NbExp=4; IntAct=EBI-1633915, EBI-1634106;
CC       P08251:ATP1B1 (xeno); NbExp=5; IntAct=EBI-1633915, EBI-7206371;
CC       P62204:Calm3; NbExp=4; IntAct=EBI-1633915, EBI-397460;
CC       P46109:CRKL (xeno); NbExp=5; IntAct=EBI-1633915, EBI-910;
CC       Q14247:CTTN (xeno); NbExp=3; IntAct=EBI-1633915, EBI-351886;
CC       Q60598:Cttn; NbExp=2; IntAct=EBI-1633915, EBI-397955;
CC       P16858:Gapdh; NbExp=3; IntAct=EBI-1633915, EBI-444871;
CC       O75791:GRAP2 (xeno); NbExp=3; IntAct=EBI-1633915, EBI-740418;
CC       P84075:Hpca; NbExp=3; IntAct=EBI-1633915, EBI-2128343;
CC       Q8CAE3:Kcnmb1; NbExp=2; IntAct=EBI-15575817, EBI-15575793;
CC       O88952:Lin7c; NbExp=4; IntAct=EBI-1633915, EBI-821316;
CC       P27573:Mpz; NbExp=4; IntAct=EBI-1633915, EBI-1634589;
CC       P61982:Ywhag; NbExp=4; IntAct=EBI-1633915, EBI-359843;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=May be partially controlled by hormonal stress.
CC         Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q08460-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q08460-2; Sequence=VSP_009960, VSP_009961, VSP_009962,
CC                                  VSP_009964, VSP_009965;
CC         Note=Contains a phosphothreonine at position 670. Contains a
CC         phosphoserine at position 672. {ECO:0000244|PubMed:21183079};
CC       Name=3;
CC         IsoId=Q08460-3; Sequence=VSP_009961, VSP_009964;
CC       Name=4; Synonyms=STREX-1;
CC         IsoId=Q08460-4; Sequence=VSP_009961, VSP_009963, VSP_009964;
CC       Name=5;
CC         IsoId=Q08460-5; Sequence=VSP_009959;
CC   -!- DOMAIN: The S0 segment is essential for the modulation by the
CC       accessory beta subunits KCNMB1, KCNMB2, KCNMB3 and KCNMB4.
CC   -!- DOMAIN: The S4 segment, which is characterized by a series of
CC       positively charged amino acids at every third position, is part of
CC       the voltage-sensor.
CC   -!- DOMAIN: The pore-forming domain (also referred as P region) is
CC       imbedded into the membrane, and forms the selectivity filter of
CC       the pore. It contains the signature sequence of potassium channels
CC       that displays selectivity to potassium.
CC   -!- DOMAIN: The RCK N-terminal domain mediates the
CC       homotetramerization, thereby promoting the assembly of monomers
CC       into functional potassium channel. It includes binding sites for
CC       Ca(2+) and Mg(2+).
CC   -!- DOMAIN: The calcium bowl constitutes one of the Ca(2+) sensors and
CC       probably acts as a Ca(2+)-binding site. There are however other
CC       Ca(2+) sensors regions required for activation of the channel.
CC   -!- DOMAIN: The heme-binding motif mediates inhibition of channel
CC       activation by heme. Carbon monoxide-bound heme leads to increased
CC       channel activation (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated (Probable). Phosphorylation by kinases such as
CC       PKA and/or PKG. In smooth muscles, phosphorylation affects its
CC       activity. {ECO:0000305}.
CC   -!- PTM: Palmitoylation by ZDHHC22 and ZDHHC23 within the
CC       intracellular linker between the S0 and S1 transmembrane domains
CC       regulates localization to the plasma membrane. Depalmitoylated by
CC       LYPLA1 and LYPLAL1, leading to retard exit from the trans-Golgi
CC       network (By similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: The protein was initially thought to contain two
CC       functionally distinct parts: The core channel (from the N-terminus
CC       to the S9 segment) that mediates the channel activity, and the
CC       cytoplasmic tail (from the S9 segment to the C-terminus) that
CC       mediates the calcium sensing. The situation is however more
CC       complex, since the core channel contains binding sites for Ca(2+)
CC       and Mg(2+).
CC   -!- SIMILARITY: Belongs to the potassium channel family. Calcium-
CC       activated (TC 1.A.1.3) subfamily. KCa1.1/KCNMA1 sub-subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA50215.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U09383; AAA50215.1; ALT_INIT; mRNA.
DR   EMBL; L16912; AAA39746.1; -; mRNA.
DR   EMBL; AF156674; AAD49225.1; -; mRNA.
DR   EMBL; AF465244; AAL69971.1; -; mRNA.
DR   CCDS; CCDS79275.1; -. [Q08460-3]
DR   CCDS; CCDS79276.1; -. [Q08460-4]
DR   CCDS; CCDS79277.1; -. [Q08460-1]
DR   PIR; A48206; A48206.
DR   PIR; I49017; I49017.
DR   RefSeq; NP_001240294.1; NM_001253365.1.
DR   RefSeq; NP_001240298.1; NM_001253369.1.
DR   RefSeq; NP_034740.2; NM_010610.3.
DR   UniGene; Mm.343607; -.
DR   UniGene; Mm.486347; -.
DR   ProteinModelPortal; Q08460; -.
DR   SMR; Q08460; -.
DR   BioGrid; 200913; 182.
DR   DIP; DIP-42413N; -.
DR   IntAct; Q08460; 194.
DR   MINT; MINT-1203219; -.
DR   STRING; 10090.ENSMUSP00000136447; -.
DR   ChEMBL; CHEMBL2800; -.
DR   DrugBank; DB08837; Tetraethylammonium.
DR   GuidetoPHARMACOLOGY; 380; -.
DR   iPTMnet; Q08460; -.
DR   PhosphoSitePlus; Q08460; -.
DR   SwissPalm; Q08460; -.
DR   MaxQB; Q08460; -.
DR   PaxDb; Q08460; -.
DR   PeptideAtlas; Q08460; -.
DR   PRIDE; Q08460; -.
DR   GeneID; 16531; -.
DR   KEGG; mmu:16531; -.
DR   UCSC; uc029sfy.1; mouse. [Q08460-2]
DR   CTD; 3778; -.
DR   MGI; MGI:99923; Kcnma1.
DR   eggNOG; KOG1420; Eukaryota.
DR   eggNOG; ENOG410YUX1; LUCA.
DR   HOGENOM; HOG000019856; -.
DR   HOVERGEN; HBG052222; -.
DR   InParanoid; Q08460; -.
DR   KO; K04936; -.
DR   PhylomeDB; Q08460; -.
DR   ChiTaRS; Kcnma1; mouse.
DR   PRO; PR:Q08460; -.
DR   Proteomes; UP000000589; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:MGI.
DR   GO; GO:0005901; C:caveola; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:MGI.
DR   GO; GO:0043195; C:terminal bouton; IDA:MGI.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IGI:MGI.
DR   GO; GO:0003779; F:actin binding; ISO:MGI.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0060072; F:large conductance calcium-activated potassium channel activity; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005267; F:potassium channel activity; IMP:MGI.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:MGI.
DR   GO; GO:0007628; P:adult walking behavior; IMP:MGI.
DR   GO; GO:0042491; P:auditory receptor cell differentiation; IMP:MGI.
DR   GO; GO:0048469; P:cell maturation; IMP:MGI.
DR   GO; GO:0030007; P:cellular potassium ion homeostasis; ISO:MGI.
DR   GO; GO:0007268; P:chemical synaptic transmission; IMP:MGI.
DR   GO; GO:0007623; P:circadian rhythm; IMP:MGI.
DR   GO; GO:0060082; P:eye blink reflex; IMP:MGI.
DR   GO; GO:0045475; P:locomotor rhythm; IMP:MGI.
DR   GO; GO:0060073; P:micturition; IMP:MGI.
DR   GO; GO:0045794; P:negative regulation of cell volume; IMP:MGI.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IMP:MGI.
DR   GO; GO:0019228; P:neuronal action potential; IMP:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:MGI.
DR   GO; GO:0006813; P:potassium ion transport; IDA:MGI.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:MGI.
DR   GO; GO:0032344; P:regulation of aldosterone metabolic process; IMP:MGI.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:MGI.
DR   GO; GO:0060087; P:relaxation of vascular smooth muscle; IMP:MGI.
DR   GO; GO:0051592; P:response to calcium ion; ISO:MGI.
DR   GO; GO:0034465; P:response to carbon monoxide; ISO:MGI.
DR   GO; GO:0001666; P:response to hypoxia; IDA:MGI.
DR   GO; GO:0006970; P:response to osmotic stress; ISO:MGI.
DR   GO; GO:0046541; P:saliva secretion; IGI:MGI.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:MGI.
DR   GO; GO:0060083; P:smooth muscle contraction involved in micturition; IMP:MGI.
DR   GO; GO:0042311; P:vasodilation; IMP:MGI.
DR   InterPro; IPR024939; Ca-act_K_channel_Slo-1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003929; K_chnl_BK_asu.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR10027:SF28; PTHR10027:SF28; 2.
DR   Pfam; PF03493; BK_channel_a; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell membrane; Complete proteome;
KW   Ion channel; Ion transport; Lipoprotein; Magnesium; Membrane;
KW   Metal-binding; Palmitate; Phosphoprotein; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1209       Calcium-activated potassium channel
FT                                subunit alpha-1.
FT                                /FTId=PRO_0000054134.
FT   TOPO_DOM      1     86       Extracellular. {ECO:0000255}.
FT   TRANSMEM     87    107       Helical; Name=Segment S0. {ECO:0000255}.
FT   TOPO_DOM    108    178       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    200    214       Extracellular. {ECO:0000255}.
FT   TRANSMEM    215    235       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    236    239       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    240    260       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    261    264       Extracellular. {ECO:0000255}.
FT   TRANSMEM    265    285       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    286    300       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    301    321       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    322    335       Extracellular. {ECO:0000255}.
FT   INTRAMEM    336    358       Pore-forming; Name=P region.
FT                                {ECO:0000255}.
FT   TOPO_DOM    359    367       Extracellular. {ECO:0000255}.
FT   TRANSMEM    368    388       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    389   1209       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      415    558       RCK N-terminal.
FT   REGION      556    576       Segment S7.
FT   REGION      613    633       Segment S8.
FT   REGION      681    685       Heme-binding motif.
FT   REGION      783    803       Segment S9.
FT   REGION     1005   1025       Segment S10.
FT   MOTIF       352    355       Selectivity for potassium.
FT   MOTIF       976    998       Calcium bowl.
FT   COMPBIAS      4     10       Poly-Gly.
FT   COMPBIAS     13     23       Poly-Gly.
FT   COMPBIAS     40     60       Poly-Ser.
FT   METAL       439    439       Magnesium. {ECO:0000305}.
FT   METAL       462    462       Magnesium. {ECO:0000305}.
FT   METAL       464    464       Magnesium. {ECO:0000305}.
FT   METAL       985    985       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       988    988       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       991    991       Calcium. {ECO:0000250}.
FT   METAL       993    993       Calcium. {ECO:0000250}.
FT   MOD_RES     709    709       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     711    711       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     724    724       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     728    728       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     916    916       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     924    924       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     928    928       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   LIPID       118    118       S-palmitoyl cysteine. {ECO:0000250}.
FT   LIPID       119    119       S-palmitoyl cysteine. {ECO:0000250}.
FT   LIPID       121    121       S-palmitoyl cysteine. {ECO:0000250}.
FT   VAR_SEQ       1     65       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:7687074}.
FT                                /FTId=VSP_009959.
FT   VAR_SEQ       1     50       MANGGGGGGGSSGGGGGGGGGSGLRMSSNIHANNLSLDASS
FT                                SSSSSSSSS -> MELEHPKSPPYP (in isoform 2).
FT                                {ECO:0000303|PubMed:7687074}.
FT                                /FTId=VSP_009960.
FT   VAR_SEQ     643    646       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:10517674,
FT                                ECO:0000303|PubMed:12388098,
FT                                ECO:0000303|PubMed:7687074}.
FT                                /FTId=VSP_009961.
FT   VAR_SEQ     702    702       L -> LIYF (in isoform 2).
FT                                {ECO:0000303|PubMed:7687074}.
FT                                /FTId=VSP_009962.
FT   VAR_SEQ     702    702       L -> PKMSIYKRMRRACCFDCGRSERDCSCMSGRVRGNVD
FT                                TLERTFPLSSVSVNDCSTSFRAF (in isoform 4).
FT                                {ECO:0000303|PubMed:10517674}.
FT                                /FTId=VSP_009963.
FT   VAR_SEQ     948    974       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:10517674,
FT                                ECO:0000303|PubMed:12388098,
FT                                ECO:0000303|PubMed:7687074}.
FT                                /FTId=VSP_009964.
FT   VAR_SEQ    1203   1209       RKEMVYR -> ATRMTRMGQAEKKWFTDEPDNAYPRNIQIK
FT                                PMSTHMANQINQYKSTSSLIPPIREVEDEC (in
FT                                isoform 2). {ECO:0000303|PubMed:7687074}.
FT                                /FTId=VSP_009965.
FT   MUTAGEN     151    151       V->T: Loss of phosphorylation-independent
FT                                activation of channel activity by
FT                                ethanol. CaMK2-dependent phosphorylation
FT                                leads to populations of partially
FT                                phosphorylated tetramers with a range of
FT                                responses to ethanol from activation to
FT                                inhibition.
FT                                {ECO:0000269|PubMed:16341213}.
FT   MUTAGEN     272    272       R->Q: Alters the voltage-dependent
FT                                gating. {ECO:0000269|PubMed:11112549}.
FT   MUTAGEN     278    278       R->Q: Alters the voltage-dependent
FT                                gating. {ECO:0000269|PubMed:11112549}.
FT   MUTAGEN     284    284       E->R: Alters the voltage-dependent
FT                                gating; when associated with R-287.
FT                                {ECO:0000269|PubMed:11112549}.
FT   MUTAGEN     287    287       Q->R: Alters the voltage-dependent
FT                                gating; when associated with K-284.
FT                                {ECO:0000269|PubMed:11112549}.
FT   MUTAGEN     427    427       D->A: Does not affect sensitivity to
FT                                Ca(2+). {ECO:0000269|PubMed:12192411}.
FT   MUTAGEN     432    432       D->A: Reduced sensitivity to Ca(2+).
FT                                {ECO:0000269|PubMed:12192411}.
FT   MUTAGEN     434    434       D->A: Does not affect sensitivity to
FT                                Ca(2+). {ECO:0000269|PubMed:12192411}.
FT   MUTAGEN     439    439       E->A: Abolishes sensitivity to Mg(2+),
FT                                but not sensitivity to Ca(2+).
FT                                {ECO:0000269|PubMed:12192410}.
FT   MUTAGEN     444    444       H->G: Reduces sensitivity to Mg(2+), but
FT                                not sensitivity to Ca(2+).
FT                                {ECO:0000269|PubMed:12192410}.
FT   MUTAGEN     461    461       T->A: Reduces sensitivity to Mg(2+), but
FT                                not sensitivity to Ca(2+).
FT                                {ECO:0000269|PubMed:12192410}.
FT   MUTAGEN     462    462       Q->C: Reduces sensitivity to Mg(2+), but
FT                                not sensitivity to Ca(2+).
FT                                {ECO:0000269|PubMed:12192410}.
FT   MUTAGEN     464    464       E->D,A: Remains sensitive to Mg(2+).
FT                                {ECO:0000269|PubMed:12192410,
FT                                ECO:0000269|PubMed:12192411}.
FT   MUTAGEN     464    464       E->N: Abolishes sensitivity to Mg(2+),
FT                                but not sensitivity to Ca(2+).
FT                                {ECO:0000269|PubMed:12192410,
FT                                ECO:0000269|PubMed:12192411}.
FT   MUTAGEN     992    996       DDDPD->AAAAA: Alters calcium binding.
FT                                {ECO:0000269|PubMed:12149279}.
SQ   SEQUENCE   1209 AA;  134396 MW;  9E07ABF5DCFA62DF CRC64;
     MANGGGGGGG SSGGGGGGGG GSGLRMSSNI HANNLSLDAS SSSSSSSSSS SSSSSSSSSS
     VHEPKMDALI IPVTMEVPCD SRGQRMWWAF LASSMVTFFG GLFIILLWRT LKYLWTVCCH
     CGGKTKEAQK INNGSSQADG TLKPVDEKEE VVAAEVGWMT SVKDWAGVMI SAQTLTGRVL
     VVLVFALSIG ALVIYFIDSS NPIESCQNFY KDFTLQIDMA FNVFFLLYFG LRFIAANDKL
     WFWLEVNSVV DFFTVPPVFV SVYLNRSWLG LRFLRALRLI QFSEILQFLN ILKTSNSIKL
     VNLLSIFIST WLTAAGFIHL VENSGDPWEN FQNNQALTYW ECVYLLMVTM STVGYGDVYA
     KTTLGRLFMV FFILGGLAMF ASYVPEIIEL IGNRKKYGGS YSAVSGRKHI VVCGHITLES
     VSNFLKDFLH KDRDDVNVEI VFLHNISPNL ELEALFKRHF TQVEFYQGSV LNPHDLARVK
     IESADACLIL ANKYCADPDA EDASNIMRVI SIKNYHPKIR IITQMLQYHN KAHLLNIPSW
     NWKEGDDAIC LAELKLGFIA QSCLAQGLST MLANLFSMRS FIKIEEDTWQ KYYLEGVSNE
     MYTEYLSSAF VGLSFPTVCE LCFVKLKLLM IAIEYKSANR ESRSRKRILI NPGNHLKIQE
     GTLGFFIASD AKEVKRAFFY CKACHDDVTD PKRIKKCGCR RLEDEQPPTL SPKKKQRNGG
     MRNSPNTSPK LMRHDPLLIP GNDQIDNMDS NVKKYDSTGM FHWCAPKEIE KVILTRSEAA
     MTVLSGHVVV CIFGDVSSAL IGLRNLVMPL RASNFHYHEL KHIVFVGSIE YLKREWETLH
     NFPKVSILPG TPLSRADLRA VNINLCDMCV ILSANQNNID DTSLQDKECI LASLNIKSMQ
     FDDSIGVLQA NSQGFTPPGM DRSSPDNSPV HGMLRQPSIT TGVNIPIITE LAKPGKLPLV
     SVNQEKNSGT HILMITELVN DTNVQFLDQD DDDDPDTELY LTQPFACGTA FAVSVLDSLM
     SATYFNDNIL TLIRTLVTGG ATPELEALIA EENALRGGYS TPQTLANRDR CRVAQLALLD
     GPFADLGDGG CYGDLFCKAL KTYNMLCFGI YRLRDAHLST PSQCTKRYVI TNPPYEFELV
     PTDLIFCLMQ FDHNAGQSRA SLSHSSHSSQ SSSKKSSSVH SIPSTANRPN RPKSRESRDK
     QNRKEMVYR
//
ID   AKT1_ORYSJ              Reviewed;         935 AA.
AC   Q0JKV1; A0A0P0V5X9; Q8VYX2;
DT   10-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 1.
DT   20-DEC-2017, entry version 85.
DE   RecName: Full=Potassium channel AKT1;
DE            Short=OsAKT1;
GN   Name=AKT1; OrderedLocusNames=Os01g0648000, LOC_Os01g45990;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   "The rice annotation project database (RAP-DB): 2008 update.";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12869764; DOI=10.1126/science.1081288;
RG   The rice full-length cDNA consortium;
RT   "Collection, mapping, and annotation of over 28,000 cDNA clones from
RT   japonica rice.";
RL   Science 301:376-379(2003).
RN   [5]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=15599592; DOI=10.1007/s00425-004-1437-9;
RA   Fuchs I., Stoelzle S., Ivashikina N., Hedrich R.;
RT   "Rice K+ uptake channel OsAKT1 is sensitive to salt stress.";
RL   Planta 221:212-221(2005).
CC   -!- FUNCTION: Highly selective inward-rectifying potassium channel
CC       that mediates potassium uptake by plant roots. Assuming opened or
CC       closed conformations in response to the voltage difference across
CC       the membrane, the channel is activated by hyperpolarization. May
CC       be a major salt-sensitive potassium channel in roots.
CC       {ECO:0000269|PubMed:15599592}.
CC   -!- SUBUNIT: The potassium channel is probably a homo- or
CC       heterotetrameric complex of pore-forming subunits. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in roots and coleoptile of young
CC       seedlings. {ECO:0000269|PubMed:15599592}.
CC   -!- INDUCTION: Down-regulated by salt stress.
CC       {ECO:0000269|PubMed:15599592}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AK120308; Type=Frameshift; Positions=769; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP008207; BAF05627.1; -; Genomic_DNA.
DR   EMBL; AP014957; BAS73421.1; -; Genomic_DNA.
DR   EMBL; AK120308; -; NOT_ANNOTATED_CDS; mRNA.
DR   RefSeq; XP_015621694.1; XM_015766208.1.
DR   UniGene; Os.50245; -.
DR   ProteinModelPortal; Q0JKV1; -.
DR   SMR; Q0JKV1; -.
DR   STRING; 39947.LOC_Os01g45990.1; -.
DR   PaxDb; Q0JKV1; -.
DR   PRIDE; Q0JKV1; -.
DR   EnsemblPlants; OS01T0648000-01; OS01T0648000-01; OS01G0648000.
DR   GeneID; 4326245; -.
DR   Gramene; OS01T0648000-01; OS01T0648000-01; OS01G0648000.
DR   KEGG; osa:4326245; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   InParanoid; Q0JKV1; -.
DR   KO; K21867; -.
DR   OMA; TGLYACI; -.
DR   OrthoDB; EOG093601WX; -.
DR   Proteomes; UP000059680; Chromosome 1.
DR   ExpressionAtlas; Q0JKV1; baseline and differential.
DR   Genevisible; Q0JKV1; OS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00204; ANK; 1.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.25.40.20; -; 2.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00248; ANK; 5.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   2: Evidence at transcript level;
KW   ANK repeat; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    935       Potassium channel AKT1.
FT                                /FTId=PRO_0000054095.
FT   TOPO_DOM      1    106       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    107    127       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    128    136       Extracellular. {ECO:0000255}.
FT   TRANSMEM    137    157       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    158    178       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    200    205       Extracellular. {ECO:0000255}.
FT   TRANSMEM    206    226       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    227    240       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    241    261       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    262    288       Extracellular. {ECO:0000255}.
FT   INTRAMEM    289    308       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    309    312       Extracellular. {ECO:0000255}.
FT   TRANSMEM    313    333       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    334    935       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      565    594       ANK 1.
FT   REPEAT      598    627       ANK 2.
FT   REPEAT      631    660       ANK 3.
FT   REPEAT      662    691       ANK 4.
FT   REPEAT      695    724       ANK 5.
FT   REPEAT      728    757       ANK 6.
FT   DOMAIN      859    935       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     419    538       cNMP.
SQ   SEQUENCE   935 AA;  104464 MW;  F606E3563EA69B23 CRC64;
     MARWGAARMA ACGPWGRNRR VGAGDAFEAS EVRRDGRSRM MPACGPWGAG HGGGDPALER
     ELSRDGSHYS ISSAILPSLG ARSNRRIKLR RFIISPYDRR YRIWETFLIV LVVYSAWVSP
     FEFGFIPKPT GALATADNVV NAFFAVDIIL TFFVAYLDKM SYMLEDDPKK IAWRYSTTWL
     VLDVASTIPS EFARRILPSK LRSYGFFNML RLWRLRRVSS LFSRLEKDRH FNYFWVRCAK
     LICVTLFAVH CAACFYYLLA DRYPVPTSTW IGNYMADFHE RSLWIRYVTS VYWSITTLTT
     VGYGDLHAEN TREMIFNIFY MLFNLGLTAY LIGNMTNLVV HGTSRTRNYR DTIQAATSFG
     VRNQLPPRLQ DQMISHISLK YRTDSEGLQQ QEILDSLPKA IKSSISQYLF FHLVQNVYLF
     QGVSNDLIFQ LVSEMKAEYF PPREDVILQN EAPTDFYILV SGSVELVEQQ NGADQVIQVA
     TSGEVVGEIG VLCYRPQLFT VRTRSLCQLL RLNRTAFLSI VQSNVGDGTI IMNNLIQFLK
     EQKENSVMAG VVKEIESMLA RGNLDLPITL CFAVTRGDDF LLHQLLKRGM DPNESDNDGH
     TALHIAASKG NEQCVRLLLE YGADPNARDS EGKVPLWEAL CEKHAAVVQL LVEGGADLSS
     GDTGLYACIA VEESDTELLN DIIHYGGDVN RARRDGTTAL HRAVCDGNVQ MAELLLEHGA
     DIDKQDGNGW TPRALAEQQG HDDIQLLFRS RKAATASGHH HVPSSTTTRV APAAAAASLI
     GRFNSEPMMK NMIHEDADLP SRVLPEKLRR KRVTFQNSLF GVISSSQAQR ETDHPLSRGG
     LAATGSPNPS SGSRNAVIRV TISCPEKGNT AGKLVLLPQT LDMLLELGAK KFDFAPTKVL
     TVEGAEVDEV ELIRDGDHLV LVSNEWDAEK MKGKS
//
ID   KCNH2_HUMAN             Reviewed;        1159 AA.
AC   Q12809; A5H1P7; C4PFH9; D3DX04; O75418; O75680; Q708S9; Q9BT72;
AC   Q9BUT7; Q9H3P0;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   20-DEC-2017, entry version 202.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 2;
DE   AltName: Full=Eag homolog;
DE   AltName: Full=Ether-a-go-go-related gene potassium channel 1;
DE            Short=ERG-1;
DE            Short=Eag-related protein 1;
DE            Short=Ether-a-go-go-related protein 1;
DE            Short=H-ERG;
DE            Short=hERG-1;
DE            Short=hERG1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv11.1;
GN   Name=KCNH2; Synonyms=ERG, ERG1, HERG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RC   TISSUE=Hippocampus;
RX   PubMed=8159766; DOI=10.1073/pnas.91.8.3438;
RA   Warmke J.W., Ganetzky B.;
RT   "A family of potassium channel genes related to eag in Drosophila and
RT   mammals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3438-3442(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM A), AND VARIANT LQT2
RP   CYS-534.
RX   PubMed=9600240; DOI=10.1007/s004390050717;
RA   Itoh T., Tanaka T., Nagai R., Kamiya T., Sawayama T., Nakayama T.,
RA   Tomoike H., Sakurada H., Yazaki Y., Nakamura Y.;
RT   "Genomic organization and mutational analysis of HERG, a gene
RT   responsible for familial long QT syndrome.";
RL   Hum. Genet. 102:435-439(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A-USO).
RC   TISSUE=Heart;
RX   PubMed=11374908; DOI=10.1006/geno.2001.6527;
RA   Soejima H., Kawamoto S., Akai J., Miyoshi O., Arai Y., Morohka T.,
RA   Matsuo S., Niikawa N., Kimura A., Okubo K., Mukai T.;
RT   "Isolation of novel heart-specific genes using the BodyMap database.";
RL   Genomics 74:115-120(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RA   Downie D., Chapman C.G., Punia P., Rice S., Bahmani F., Murdock P.,
RA   Pearson N., Randall A.D., Meadows H.J.;
RT   "Potent inhibition of HERG K+ channels by the neuroprotective agent
RT   Sipatrigine.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RX   PubMed=12431979; DOI=10.1074/jbc.M210789200;
RA   Crociani O., Guasti L., Balzi M., Becchetti A., Wanke E., Olivotto M.,
RA   Wymore R.S., Arcangeli A.;
RT   "Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor
RT   cells.";
RL   J. Biol. Chem. 278:2947-2955(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B-USO), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=18559421; DOI=10.1128/MCB.00304-08;
RA   Guasti L., Crociani O., Redaelli E., Pillozzi S., Polvani S.,
RA   Masselli M., Mello T., Galli A., Amedei A., Wymore R.S., Wanke E.,
RA   Arcangeli A.;
RT   "Identification of a posttranslational mechanism for the regulation of
RT   hERG1 K+ channel expression and hERG1 current density in tumor
RT   cells.";
RL   Mol. Cell. Biol. 28:5043-5060(2008).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3.1), AND SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=19412172; DOI=10.1038/nm.1962;
RA   Huffaker S.J., Chen J., Nicodemus K.K., Sambataro F., Yang F.,
RA   Mattay V., Lipska B.K., Hyde T.M., Song J., Rujescu D., Giegling I.,
RA   Mayilyan K., Proust M.J., Soghoyan A., Caforio G., Callicott J.H.,
RA   Bertolino A., Meyer-Lindenberg A., Chang J., Ji Y., Egan M.F.,
RA   Goldberg T.E., Kleinman J.E., Lu B., Weinberger D.R.;
RT   "A primate-specific, brain isoform of KCNH2 affects cortical
RT   physiology, cognition, neuronal repolarization and risk of
RT   schizophrenia.";
RL   Nat. Medicines 15:509-518(2009).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-376 (ISOFORM B).
RC   TISSUE=Heart;
RX   PubMed=9351462; DOI=10.1161/01.RES.81.5.870;
RA   London B., Trudeau M.C., Newton K.P., Beyer A.K., Copeland N.G.,
RA   Gilbert D.J., Jenkins N.A., Satler C.A., Robertson G.A.;
RT   "Two isoforms of the mouse ether-a-go-go-related gene coassemble to
RT   form channels with properties similar to the rapidly activating
RT   component of the cardiac delayed rectifier K+ current.";
RL   Circ. Res. 81:870-878(1997).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-376 (ISOFORM B).
RC   TISSUE=Heart atrium;
RX   PubMed=9351446; DOI=10.1161/01.RES.81.5.719;
RA   Lees-Miller J.P., Kondo C., Wang L., Duff H.J.;
RT   "Electrophysiological characterization of an alternatively processed
RT   ERG K+ channel in mouse and human hearts.";
RL   Circ. Res. 81:719-726(1997).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 27-1159 (ISOFORM A), AND VARIANT
RP   GLY-ALA-GLY-189 INS.
RX   PubMed=10790218;
RX   DOI=10.1002/(SICI)1098-1004(200005)15:5<483::AID-HUMU18>3.3.CO;2-K;
RA   Paulussen A., Yang P., Pangalos M., Verhasselt P., Marrannes R.,
RA   Verfaille C., Vandenberk I., Crabbe R., Konings F., Luyten W.,
RA   Armstrong M.;
RT   "Analysis of the human KCNH2(HERG) gene: identification and
RT   characterization of a novel mutation Y667X associated with long QT
RT   syndrome and a non-pathological 9 bp insertion.";
RL   Hum. Mutat. 15:483-483(2000).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 59-800 (ISOFORM 4), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 716-1159 (ISOFORMS A/B).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 795-888 (ISOFORM A-USO).
RC   TISSUE=Heart ventricle;
RX   PubMed=9765245; DOI=10.1074/jbc.273.42.27231;
RA   Kupershmidt S., Snyders D.J., Raes A., Roden D.M.;
RT   "A K+ channel splice variant common in human heart lacks a C-terminal
RT   domain required for expression of rapidly activating delayed rectifier
RT   current.";
RL   J. Biol. Chem. 273:27231-27235(1998).
RN   [16]
RP   MUTAGENESIS OF ASN-598; ASN-629 AND SER-631, AND GLYCOSYLATION AT
RP   ASN-598.
RX   PubMed=12063277; DOI=10.1152/ajpheart.00008.2002;
RA   Gong Q., Anderson C.L., January C.T., Zhou Z.;
RT   "Role of glycosylation in cell surface expression and stability of
RT   HERG potassium channels.";
RL   Am. J. Physiol. 283:H77-H84(2002).
RN   [17]
RP   MUTAGENESIS OF SER-283; SER-890; THR-895 AND SER-1137, AND
RP   PHOSPHORYLATION.
RX   PubMed=10837251; DOI=10.1016/S0960-9822(00)00516-9;
RA   Cui J., Melman Y., Palma E., Fishman G.I., McDonald T.V.;
RT   "Cyclic AMP regulates the HERG K(+) channel by dual pathways.";
RL   Curr. Biol. 10:671-674(2000).
RN   [18]
RP   INTERACTION WITH KCNE1.
RX   PubMed=9230439; DOI=10.1038/40882;
RA   McDonald T.V., Yu Z., Ming Z., Palma E., Meyers M.B., Wang K.-W.,
RA   Goldstein S.A.N., Fishman G.I.;
RT   "A minK-HERG complex regulates the cardiac potassium current I(Kr).";
RL   Nature 388:289-292(1997).
RN   [19]
RP   INTERACTION WITH KCNE2.
RX   PubMed=10219239; DOI=10.1016/S0092-8674(00)80728-X;
RA   Abbott G.W., Sesti F., Splawski I., Buck M.E., Lehmann M.H.,
RA   Timothy K.W., Keating M.T., Goldstein S.A.N.;
RT   "MiRP1 forms IKr potassium channels with HERG and is associated with
RT   cardiac arrhythmia.";
RL   Cell 97:175-187(1999).
RN   [20]
RP   INTERACTION WITH CANX, AND CHARACTERIZATION OF VARIANT LQT2 ASP-470.
RX   PubMed=16361248; DOI=10.1074/jbc.M511765200;
RA   Gong Q., Jones M.A., Zhou Z.;
RT   "Mechanisms of pharmacological rescue of trafficking-defective hERG
RT   mutant channels in human long QT syndrome.";
RL   J. Biol. Chem. 281:4069-4074(2006).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239; SER-320; SER-871
RP   AND SER-1137, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   INTERACTION WITH RNF207, AND INDUCTION BY RNF207.
RX   PubMed=25281747; DOI=10.1074/jbc.M114.592295;
RA   Roder K., Werdich A.A., Li W., Liu M., Kim T.Y., Organ-Darling L.E.,
RA   Moshal K.S., Hwang J.M., Lu Y., Choi B.R., MacRae C.A., Koren G.;
RT   "RING finger protein RNF207, a novel regulator of cardiac
RT   excitation.";
RL   J. Biol. Chem. 289:33730-33740(2014).
RN   [24]
RP   FUNCTION, INTERACTION WITH NDFIP1 AND NDFIP2, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=26363003; DOI=10.1042/BJ20141282;
RA   Kang Y., Guo J., Yang T., Li W., Zhang S.;
RT   "Regulation of the human ether-a-go-go-related gene (hERG) potassium
RT   channel by Nedd4 family interacting proteins (Ndfips).";
RL   Biochem. J. 472:71-82(2015).
RN   [25]
RP   FUNCTION, SUBUNIT, INTERACTION WITH DNAJB12 AND DNAJB14, VARIANT LQT2
RP   TYR-64, AND CHARACTERIZATION OF VARIANTS LQT2 TYR-64 AND PRO-65.
RX   PubMed=27916661; DOI=10.1016/j.molcel.2016.10.027;
RA   Li K., Jiang Q., Bai X., Yang Y.F., Ruan M.Y., Cai S.Q.;
RT   "Tetrameric assembly of K(+) channels requires ER-located chaperone
RT   proteins.";
RL   Mol. Cell 65:52-65(2017).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1-135, AND MUTAGENESIS OF
RP   PHE-29 AND TYR-43.
RX   PubMed=9845367; DOI=10.1016/S0092-8674(00)81635-9;
RA   Morais Cabral J.H., Lee A., Cohen S.L., Chait B.T., Li M.,
RA   Mackinnon R.;
RT   "Crystal structure and functional analysis of the HERG potassium
RT   channel N-terminus: a eukaryotic PAS domain.";
RL   Cell 95:649-655(1998).
RN   [27]
RP   VARIANTS LQT2 ASP-470; VAL-561 AND SER-628.
RX   PubMed=7889573; DOI=10.1016/0092-8674(95)90358-5;
RA   Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D.,
RA   Keating M.T.;
RT   "A molecular basis for cardiac arrhythmia: HERG mutations cause long
RT   QT syndrome.";
RL   Cell 80:795-803(1995).
RN   [28]
RP   VARIANT LQT2 MET-822.
RX   PubMed=8914737;
RX   DOI=10.1002/(SICI)1096-8628(19961002)65:1<27::AID-AJMG4>3.3.CO;2-J;
RA   Satler C.A., Walsh E.P., Vesely M.R., Plummer M.H., Ginsburg G.S.,
RA   Jacob H.J.;
RT   "Novel missense mutation in the cyclic nucleotide-binding domain of
RT   HERG causes long QT syndrome.";
RL   Am. J. Med. Genet. 65:27-35(1996).
RN   [29]
RP   VARIANT LQT2 ARG-593.
RX   PubMed=8635257; DOI=10.1161/01.CIR.93.10.1791;
RA   Benson D.W., MacRae C.A., Vesely M.R., Walsh E.P., Seidman J.G.,
RA   Seidman C.E., Satler C.A.;
RT   "Missense mutation in the pore region of HERG causes familial long QT
RT   syndrome.";
RL   Circulation 93:1791-1795(1996).
RN   [30]
RP   VARIANT LQT2 THR-561.
RX   PubMed=8877771; DOI=10.1006/jmcc.1996.0151;
RA   Dausse E., Berthet M., Denjoy I., Andre-Fouet X., Cruaud C.,
RA   Bennaceur M., Faure S., Coumel P., Schwartz K., Guicheney P.;
RT   "A mutation in HERG associated with notched T waves in long QT
RT   syndrome.";
RL   J. Mol. Cell. Cardiol. 28:1609-1615(1996).
RN   [31]
RP   VARIANTS LQT2 ILE-474; HIS-611; VAL-614 AND LEU-630.
RX   PubMed=9024139; DOI=10.1161/01.CIR.95.3.565;
RA   Tanaka T., Nagai R., Tomoike H., Takata S., Yano K., Yabuta K.,
RA   Haneda N., Nakano O., Shibata A., Sawayama T., Kasai H., Yazaki Y.,
RA   Nakamura Y.;
RT   "Four novel KVLQT1 and four novel HERG mutations in familial long-QT
RT   syndrome.";
RL   Circulation 95:565-567(1997).
RN   [32]
RP   VARIANTS LQT2 CYS-572; ASP-588; VAL-614 AND ALA-630.
RX   PubMed=9693036; DOI=10.1006/geno.1998.5361;
RA   Splawski I., Shen J., Timothy K.W., Vincent G.M., Lehmann M.H.,
RA   Keating M.T.;
RT   "Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and
RT   KCNE1.";
RL   Genomics 51:86-97(1998).
RN   [33]
RP   VARIANTS LQT2 LEU-612; VAL-614; ASP-629; SER-629 AND SER-633.
RX   PubMed=9544837; DOI=10.1007/s004390050690;
RA   Satler C.A., Vesely M.R., Duggal P., Ginsburg G.S., Beggs A.H.;
RT   "Multiple different missense mutations in the pore region of HERG in
RT   patients with long QT syndrome.";
RL   Hum. Genet. 102:265-272(1998).
RN   [34]
RP   VARIANT LQT2 SER-601.
RX   PubMed=9452080;
RA   Akimoto K., Furutani M., Imamura S., Furutani Y., Kasanuki H.,
RA   Takao A., Momma K., Matsuoka R.;
RT   "Novel missense mutation (G601S) of HERG in a Japanese long QT
RT   syndrome family.";
RL   Hum. Mutat. Suppl. 1:S184-S186(1998).
RN   [35]
RP   VARIANT LQT2 LEU-818.
RX   PubMed=10086971; DOI=10.1161/01.CIR.99.11.1464;
RA   Berthet M., Denjoy I., Donger C., Demay L., Hammoude H., Klug D.,
RA   Schulze-Bahr E., Richard P., Funke H., Schwartz K., Coumel P.,
RA   Hainque B., Guicheney P.;
RT   "C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-
RT   associated mutation in cardiac event occurrence.";
RL   Circulation 99:1464-1470(1999).
RN   [36]
RP   VARIANTS LQT2 PRO-558; CYS-582; SER-604; MET-613 AND LEU-640.
RX   PubMed=10220144;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:4<301::AID-HUMU7>3.0.CO;2-V;
RA   Jongbloed R.J.E., Wilde A.A.M., Geelen J.L.M.C., Doevendans P.,
RA   Schaap C., van Langen I., van Tintelen J.P., Cobben J.M.,
RA   Beaufort-Krol G.C.M., Geraedts J.P.M., Smeets H.J.M.;
RT   "Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.";
RL   Hum. Mutat. 13:301-310(1999).
RN   [37]
RP   VARIANTS LQT2 LEU-29; THR-33; ARG-53; GLN-56; GLY-66; ARG-70; PRO-78
RP   AND ARG-86.
RX   PubMed=10187793; DOI=10.1074/jbc.274.15.10113;
RA   Chen J., Zou A., Splawski I., Keating M.T., Sanguinetti M.C.;
RT   "Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS)
RT   domain of HERG potassium channels accelerate channel deactivation.";
RL   J. Biol. Chem. 274:10113-10118(1999).
RN   [38]
RP   VARIANT LQT2 LYS-629.
RX   PubMed=10517660; DOI=10.1111/j.1540-8167.1999.tb00304.x;
RA   Yoshida H., Horie M., Otani H., Takano M., Tsuji K., Kubota T.,
RA   Fukunami M., Sasayama S.;
RT   "Characterization of a novel missense mutation in the pore of HERG in
RT   a patient with long QT syndrome.";
RL   J. Cardiovasc. Electrophysiol. 10:1262-1270(1999).
RN   [39]
RP   VARIANT LQT2 ARG-572.
RX   PubMed=10735633; DOI=10.1034/j.1399-0004.2000.570206.x;
RA   Larsen L.A., Svendsen I.H., Jensen A.M., Kanters J.K., Andersen P.S.,
RA   Moeller M., Soerensen S.A., Sandoee E., Jacobsen J.R., Vuust J.,
RA   Christiansen M.;
RT   "Long QT syndrome with a high mortality rate caused by a novel G572R
RT   missense mutation in KCNH2.";
RL   Clin. Genet. 57:125-130(2000).
RN   [40]
RP   VARIANTS LQT2, AND REVIEW ON VARIANTS.
RX   PubMed=10973849; DOI=10.1161/01.CIR.102.10.1178;
RA   Splawski I., Shen J., Timothy K.W., Lehmann M.H., Priori S.G.,
RA   Robinson J.L., Moss A.J., Schwartz P.J., Towbin J.A., Vincent G.M.,
RA   Keating M.T.;
RT   "Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A,
RT   KCNE1, and KCNE2.";
RL   Circulation 102:1178-1185(2000).
RN   [41]
RP   VARIANTS LQT2 TRP-176; LEU-451; HIS-569; SER-584; SER-601 AND MET-613,
RP   AND VARIANT THR-897.
RX   PubMed=10862094;
RX   DOI=10.1002/1098-1004(200006)15:6<580::AID-HUMU16>3.3.CO;2-S;
RA   Laitinen P., Fodstad H., Piippo K., Swan H., Toivonen L.,
RA   Viitasalo M., Kaprio J., Kontula K.;
RT   "Survey of the coding region of the HERG gene in long QT syndrome
RT   reveals six novel mutations and an amino acid polymorphism with
RT   possible phenotypic effects.";
RL   Hum. Mutat. 15:580-581(2000).
RN   [42]
RP   CHARACTERIZATION OF VARIANT LQT2 VAL-561.
RX   PubMed=10753933; DOI=10.1074/jbc.275.15.11241;
RA   Kagan A., Yu Z., Fishman G.I., McDonald T.V.;
RT   "The dominant negative LQT2 mutation A561V reduces wild-type HERG
RT   expression.";
RL   J. Biol. Chem. 275:11241-11248(2000).
RN   [43]
RP   VARIANT LQT2 THR-490.
RX   PubMed=11170080;
RX   DOI=10.1002/1096-8628(20010201)98:4<348::AID-AJMG1109>3.0.CO;2-A;
RA   Yoshida H., Horie M., Otani H., Kawashima T., Onishi Y., Sasayama S.;
RT   "Bradycardia-induced long QT syndrome caused by a de novo missense
RT   mutation in the S2-S3 inner loop of HERG.";
RL   Am. J. Med. Genet. 98:348-352(2001).
RN   [44]
RP   VARIANT LQT2 LYS-637.
RX   PubMed=12062363; DOI=10.1016/S0008-6363(02)00240-7;
RA   Hayashi K., Shimizu M., Ino H., Yamaguchi M., Mabuchi H., Hoshi N.,
RA   Higashida H.;
RT   "Characterization of a novel missense mutation E637K in the pore-S6
RT   loop of HERG in a patient with long QT syndrome.";
RL   Cardiovasc. Res. 54:67-76(2002).
RN   [45]
RP   VARIANTS TRP-784 AND THR-897, AND CHARACTERIZATION OF VARIANT TRP-784.
RX   PubMed=11997281; DOI=10.1161/01.CIR.0000014448.19052.4C;
RA   Yang P., Kanki H., Drolet B., Yang T., Wei J., Viswanathan P.C.,
RA   Hohnloser S.H., Shimizu W., Schwartz P.J., Stanton M., Murray K.T.,
RA   Norris K., George A.L. Jr., Roden D.M.;
RT   "Allelic variants in long-QT disease genes in patients with drug-
RT   associated torsades de pointes.";
RL   Circulation 105:1943-1948(2002).
RN   [46]
RP   VARIANTS LQT2 PRO-413; ASP-444 AND HIS-559.
RX   PubMed=12442276; DOI=10.1002/humu.9085;
RA   Liu W., Yang J., Hu D., Kang C., Li C., Zhang S., Li P., Chen Z.,
RA   Qin X., Ying K., Li Y., Li Y., Li Z., Cheng X., Li L., Qi Y., Chen S.,
RA   Wang Q.;
RT   "KCNQ1 and KCNH2 mutations associated with long QT syndrome in a
RT   Chinese population.";
RL   Hum. Mutat. 20:475-476(2002).
RN   [47]
RP   VARIANT LQT2 PRO-65.
RX   PubMed=12354768; DOI=10.1074/jbc.M206569200;
RA   Paulussen A., Raes A., Matthijs G., Snyders D.J., Cohen N.,
RA   Aerssens J.;
RT   "A novel mutation (T65P) in the PAS domain of the human potassium
RT   channel HERG results in the long QT syndrome by trafficking
RT   deficiency.";
RL   J. Biol. Chem. 277:48610-48616(2002).
RN   [48]
RP   VARIANT LQT2 GLN-752.
RX   PubMed=12621127; DOI=10.1203/01.PDR.0000059750.17002.B6;
RA   Johnson W.H. Jr., Yang P., Yang T., Lau Y.R., Mostella B.A.,
RA   Wolff D.J., Roden D.M., Benson D.W.;
RT   "Clinical, genetic, and biophysical characterization of a homozygous
RT   HERG mutation causing severe neonatal long QT syndrome.";
RL   Pediatr. Res. 53:744-748(2003).
RN   [49]
RP   VARIANT SQT1 LYS-588.
RX   PubMed=14676148; DOI=10.1161/01.CIR.0000109482.92774.3A;
RA   Brugada R., Hong K., Dumaine R., Cordeiro J., Gaita F., Borggrefe M.,
RA   Menendez T.M., Brugada J., Pollevick G.D., Wolpert C., Burashnikov E.,
RA   Matsuo K., Wu Y.S., Guerchicoff A., Bianchi F., Giustetto C.,
RA   Schimpf R., Brugada P., Antzelevitch C.;
RT   "Sudden death associated with short-QT syndrome linked to mutations in
RT   HERG.";
RL   Circulation 109:30-35(2004).
RN   [50]
RP   VARIANT LQT2 ILE-861.
RX   PubMed=15051636; DOI=10.1161/01.CIR.0000125524.34234.13;
RA   Westenskow P., Splawski I., Timothy K.W., Keating M.T.,
RA   Sanguinetti M.C.;
RT   "Compound mutations: a common cause of severe long-QT syndrome.";
RL   Circulation 109:1834-1841(2004).
RN   [51]
RP   VARIANTS LQT2 ILE-26; LEU-29; SER-31; ARG-53; LEU-55; PRO-65; ARG-70;
RP   PRO-78; VAL-85; GLN-100; SER-238; TRP-306; LEU-320; CYS-328; CYS-420;
RP   MET-421; THR-422; SER-427; TYR-456; TYR-475 DEL; CYS-534; SER-552;
RP   THR-561; VAL-561; PRO-562; LEU-571; SER-572; CYS-582; SER-584;
RP   ASP-588; ARG-596; SER-604; MET-613; VAL-614; PHE-622; ILE-623;
RP   SER-628; VAL-628; ALA-630; SER-633; ILE-635; VAL-640; PHE-641;
RP   671-ALA--THR-675 DEL; LEU-721; TYR-774; TRP-784; ASP-788; CYS-805;
RP   ARG-820; MET-822; GLY-837; HIS-887; VAL-913; ARG-925; ILE-983; ILE-996
RP   AND ASP-1036.
RX   PubMed=15840476; DOI=10.1016/j.hrthm.2005.01.020;
RA   Tester D.J., Will M.L., Haglund C.M., Ackerman M.J.;
RT   "Compendium of cardiac channel mutations in 541 consecutive unrelated
RT   patients referred for long QT syndrome genetic testing.";
RL   Heart Rhythm 2:507-517(2005).
RN   [52]
RP   VARIANTS LQT2 CYS-43; TYR-49; ALA-58; ASP-58; GLY-58; LEU-68; ARG-71;
RP   MET-74; SER-251; SER-410; HIS-426; HIS-427; LEU-428; TYR-460; HIS-501;
RP   LEU-534; SER-566; ARG-568; VAL-571; ASP-572; LEU-582; HIS-609;
RP   PHE-615; ARG-621; ALA-626; ASP-637; PHE-644; CYS-656; LEU-660;
RP   PRO-696; TRP-800; PRO-818; HIS-861; LEU-968 AND TYR-1153.
RX   PubMed=16414944; DOI=10.1001/jama.294.23.2975;
RA   Napolitano C., Priori S.G., Schwartz P.J., Bloise R., Ronchetti E.,
RA   Nastoli J., Bottelli G., Cerrone M., Leonardi S.;
RT   "Genetic testing in the long QT syndrome: development and validation
RT   of an efficient approach to genotyping in clinical practice.";
RL   JAMA 294:2975-2980(2005).
RN   [53]
RP   VARIANT SQT1 LYS-588.
RX   PubMed=15828882; DOI=10.1046/j.1540-8167.2005.40621.x;
RA   Hong K., Bjerregaard P., Gussak I., Brugada R.;
RT   "Short QT syndrome and atrial fibrillation caused by mutation in
RT   KCNH2.";
RL   J. Cardiovasc. Electrophysiol. 16:394-396(2005).
RN   [54]
RP   VARIANTS LQT2 GLY-100; HIS-427; ASN-525; PRO-528; CYS-696 AND CYS-948.
RX   PubMed=16922724; DOI=10.1111/j.1399-0004.2006.00671.x;
RA   Millat G., Chevalier P., Restier-Miron L., Da Costa A., Bouvagnet P.,
RA   Kugener B., Fayol L., Gonzalez Armengod C., Oddou B., Chanavat V.,
RA   Froidefond E., Perraudin R., Rousson R., Rodriguez-Lafrasse C.;
RT   "Spectrum of pathogenic mutations and associated polymorphisms in a
RT   cohort of 44 unrelated patients with long QT syndrome.";
RL   Clin. Genet. 70:214-227(2006).
RN   [55]
RP   VARIANTS LQT2 ALA-16; GLY-20; LEU-29; THR-30; THR-32; PHE-41; TYR-45;
RP   ASP-53; HIS-54; PRO-57; TRP-64; ARG-70; ASN-70; 72-PRO--ALA-80 DELINS
RP   ARG-PRO-VAL; GLN-72; LEU-72; ARG-74; MET-74; PRO-74; VAL-85; PRO-86;
RP   GLY-94; GLN-100; TRP-100; ALA-102; TYR-106; ARG-108; SER-114; CYS-125;
RP   LEU-141; ALA-149; HIS-164; VAL-218; GLY-242; ASN-259; ASP-277;
RP   THR-291; LEU-301; CYS-312; SER-314; ASN-323; CYS-328; ARG-402;
RP   MET-421; CYS-427; LEU-431; LEU-440; LEU-451; TYR-466; ASN-473;
RP   CYS-475; ILE-476; THR-490; CYS-493; SER-493; ASN-501; TRP-531;
RP   CYS-534; LEU-534; SER-552; GLU-558; THR-561; VAL-561; ARG-562;
RP   THR-565; ASP-572; SER-572; VAL-572; CYS-582; ARG-584; SER-584;
RP   CYS-585; LYS-593; ASP-594; HIS-596; LEU-596; CYS-597; ARG-599;
RP   CYS-601; SER-601; SER-604; LEU-605; SER-605; GLY-609; MET-613;
RP   VAL-614; CYS-616; ASP-626; SER-628; ILE-629; SER-629; ILE-634;
RP   ASP-635; LYS-635; ASP-637; ASN-638; LYS-638 DEL; LEU-644; PHE-644;
RP   ILE-645; SER-648; ARG-657; LEU-660; THR-662; PRO-678; TYR-687;
RP   PRO-693; VAL-711; PHE-728; VAL-749; ASN-757; TYR-767; ALA-770;
RP   TYR-774; LYS-788; 791-ARG--LEU-799 DEL; TRP-791; GLU-806; MET-822;
RP   TRP-823; TYR-837; SER-846; CYS-885; CYS-894; LEU-894; ARG-903;
RP   LEU-906; VAL-913; GLN-920; TRP-920; GLN-922; ALA-924; GLU-924;
RP   ASN-937; GLN-1005; HIS-1007; TRP-1033; MET-1038; PRO-1049; VAL-1066;
RP   CYS-1078; LEU-1093 AND VAL-1115.
RX   PubMed=19716085; DOI=10.1016/j.hrthm.2009.05.021;
RA   Kapplinger J.D., Tester D.J., Salisbury B.A., Carr J.L.,
RA   Harris-Kerr C., Pollevick G.D., Wilde A.A., Ackerman M.J.;
RT   "Spectrum and prevalence of mutations from the first 2,500 consecutive
RT   unrelated patients referred for the FAMILION long QT syndrome genetic
RT   test.";
RL   Heart Rhythm 6:1297-1303(2009).
RN   [56]
RP   VARIANT LQT2 PRO-744, AND CHARACTERIZATION OF VARIANT LQT2 PRO-744.
RX   PubMed=22314138; DOI=10.1016/j.bbrc.2012.01.118;
RA   Aidery P., Kisselbach J., Gaspar H., Baldea I., Schweizer P.A.,
RA   Becker R., Katus H.A., Thomas D.;
RT   "Identification and functional characterization of the novel human
RT   ether-a-go-go-related gene (hERG) R744P mutant associated with
RT   hereditary long QT syndrome 2.";
RL   Biochem. Biophys. Res. Commun. 418:830-835(2012).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated inwardly
CC       rectifying potassium channel. Channel properties are modulated by
CC       cAMP and subunit assembly. Mediates the rapidly activating
CC       component of the delayed rectifying potassium current in heart
CC       (IKr) (PubMed:18559421, PubMed:26363003, PubMed:27916661).
CC       {ECO:0000269|PubMed:18559421, ECO:0000269|PubMed:26363003,
CC       ECO:0000269|PubMed:27916661}.
CC   -!- FUNCTION: Isoform A-USO: Has no channel activity by itself, but
CC       modulates channel characteristics by forming heterotetramers with
CC       other isoforms which are retained intracellularly and undergo
CC       ubiquitin-dependent degradation. {ECO:0000269|PubMed:18559421}.
CC   -!- FUNCTION: Isoform B-USO: Has no channel activity by itself, but
CC       modulates channel characteristics by forming heterotetramers with
CC       other isoforms which are retained intracellularly and undergo
CC       ubiquitin-dependent degradation. {ECO:0000269|PubMed:18559421}.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits (PubMed:27916661).
CC       Interacts with DNAJB12 and DNAJB14; chaperones DNAJB12 and DNAJB14
CC       promote tetramerization (PubMed:27916661). Heteromultimer with
CC       KCNH6/ERG2 and KCNH7/ERG3 (By similarity). Interacts with ALG10B
CC       (By similarity). Heteromultimer with KCNE1 and KCNE2
CC       (PubMed:9230439, PubMed:10219239). Interacts with CANX
CC       (PubMed:16361248). The core-glycosylated, but not the fully
CC       glycosylated form interacts with RNF207 (PubMed:25281747).
CC       Interacts with NDFIP1 and NDFIP2 (PubMed:26363003).
CC       {ECO:0000250|UniProtKB:O08962, ECO:0000269|PubMed:10219239,
CC       ECO:0000269|PubMed:16361248, ECO:0000269|PubMed:25281747,
CC       ECO:0000269|PubMed:26363003, ECO:0000269|PubMed:27916661,
CC       ECO:0000269|PubMed:9230439}.
CC   -!- INTERACTION:
CC       Self; NbExp=6; IntAct=EBI-720643, EBI-720643;
CC       Q03135:CAV1; NbExp=5; IntAct=EBI-720643, EBI-603614;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18559421,
CC       ECO:0000269|PubMed:19412172, ECO:0000269|PubMed:26363003}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:18559421,
CC       ECO:0000269|PubMed:19412172}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=A;
CC         IsoId=Q12809-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q12809-2; Sequence=VSP_000965;
CC       Name=4;
CC         IsoId=Q12809-4; Sequence=VSP_000966;
CC         Note=No experimental confirmation available.;
CC       Name=A-USO;
CC         IsoId=Q12809-5; Sequence=VSP_047880, VSP_047881;
CC         Note=Twice more abundant than isoform 1 in heart.;
CC       Name=B-USO;
CC         IsoId=Q12809-6; Sequence=VSP_047878, VSP_047879, VSP_047880,
CC                                  VSP_047881;
CC       Name=3.1;
CC         IsoId=Q12809-7; Sequence=VSP_047877;
CC         Note=Primate-specific. Lacks a domain that is crucial for slow
CC         channel deactivation.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart and brain. Isoforms
CC       USO are frequently overexpressed in cancer cells.
CC       {ECO:0000269|PubMed:18559421}.
CC   -!- INDUCTION: Up-regulated by RNF207 (at protein level).
CC       {ECO:0000269|PubMed:25281747}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- PTM: Phosphorylated on serine and threonine residues.
CC       Phosphorylation by PKA inhibits ion conduction.
CC       {ECO:0000269|PubMed:10837251}.
CC   -!- DISEASE: Long QT syndrome 2 (LQT2) [MIM:613688]: A heart disorder
CC       characterized by a prolonged QT interval on the ECG and
CC       polymorphic ventricular arrhythmias. They cause syncope and sudden
CC       death in response to exercise or emotional stress, and can present
CC       with a sentinel event of sudden cardiac death in infancy. Deafness
CC       is often associated with long QT syndrome type 2.
CC       {ECO:0000269|PubMed:10086971, ECO:0000269|PubMed:10187793,
CC       ECO:0000269|PubMed:10220144, ECO:0000269|PubMed:10517660,
CC       ECO:0000269|PubMed:10735633, ECO:0000269|PubMed:10753933,
CC       ECO:0000269|PubMed:10862094, ECO:0000269|PubMed:10973849,
CC       ECO:0000269|PubMed:11170080, ECO:0000269|PubMed:12062363,
CC       ECO:0000269|PubMed:12354768, ECO:0000269|PubMed:12442276,
CC       ECO:0000269|PubMed:12621127, ECO:0000269|PubMed:15051636,
CC       ECO:0000269|PubMed:15840476, ECO:0000269|PubMed:16361248,
CC       ECO:0000269|PubMed:16414944, ECO:0000269|PubMed:16922724,
CC       ECO:0000269|PubMed:19716085, ECO:0000269|PubMed:22314138,
CC       ECO:0000269|PubMed:27916661, ECO:0000269|PubMed:7889573,
CC       ECO:0000269|PubMed:8635257, ECO:0000269|PubMed:8877771,
CC       ECO:0000269|PubMed:8914737, ECO:0000269|PubMed:9024139,
CC       ECO:0000269|PubMed:9452080, ECO:0000269|PubMed:9544837,
CC       ECO:0000269|PubMed:9600240, ECO:0000269|PubMed:9693036}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Short QT syndrome 1 (SQT1) [MIM:609620]: A heart disorder
CC       characterized by idiopathic persistently and uniformly short QT
CC       interval on ECG in the absence of structural heart disease in
CC       affected individuals. It causes syncope and sudden death.
CC       {ECO:0000269|PubMed:14676148, ECO:0000269|PubMed:15828882}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag) (TC
CC       1.A.1.20) subfamily. Kv11.1/KCNH2 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA09232.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ether-a-go-go potassium
CC       channels entry;
CC       URL="https://en.wikipedia.org/wiki/Ether-a-go-go_potassium_channels";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U04270; AAA62473.1; -; mRNA.
DR   EMBL; AB009071; BAA37096.1; -; Genomic_DNA.
DR   EMBL; AB044806; BAB19682.1; -; mRNA.
DR   EMBL; AF363636; AAL37559.1; -; mRNA.
DR   EMBL; AJ512214; CAD54447.1; -; mRNA.
DR   EMBL; AJ609614; CAE82156.1; -; mRNA.
DR   EMBL; FJ938021; ACR24650.1; -; mRNA.
DR   EMBL; DQ784808; ABQ01243.1; -; Genomic_DNA.
DR   EMBL; AC006343; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011234; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471173; EAW54072.1; -; Genomic_DNA.
DR   EMBL; AJ010538; CAA09232.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AJ010539; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010540; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010541; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010542; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010543; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010544; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010545; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010546; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010547; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010548; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010549; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010550; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010551; CAA09232.1; JOINED; Genomic_DNA.
DR   EMBL; CH471173; EAW54075.1; -; Genomic_DNA.
DR   EMBL; BC001914; AAH01914.2; -; mRNA.
DR   EMBL; BC004311; AAH04311.2; -; mRNA.
DR   EMBL; AF052728; AAC69709.1; -; mRNA.
DR   CCDS; CCDS5910.1; -. [Q12809-1]
DR   CCDS; CCDS5911.1; -. [Q12809-2]
DR   PIR; I38465; I38465.
DR   RefSeq; NP_000229.1; NM_000238.3. [Q12809-1]
DR   RefSeq; NP_001191727.1; NM_001204798.1. [Q12809-6]
DR   RefSeq; NP_742053.1; NM_172056.2. [Q12809-5]
DR   RefSeq; NP_742054.1; NM_172057.2. [Q12809-2]
DR   UniGene; Hs.647099; -.
DR   PDB; 1BYW; X-ray; 2.60 A; A=26-135.
DR   PDB; 1UJL; NMR; -; A=570-611.
DR   PDB; 2L0W; NMR; -; A=1-135.
DR   PDB; 2L1M; NMR; -; A=1-135.
DR   PDB; 2L4R; NMR; -; A=1-135.
DR   PDB; 2LE7; NMR; -; A=532-551.
DR   PDB; 2N7G; NMR; -; A=734-864.
DR   PDB; 4HP9; X-ray; 2.12 A; A=10-135.
DR   PDB; 4HQA; X-ray; 1.96 A; A=1-135.
DR   PDB; 5VA1; EM; 3.70 A; A=1-1159.
DR   PDB; 5VA2; EM; 3.80 A; A=1-1159.
DR   PDB; 5VA3; EM; 4.00 A; A=1-1159.
DR   PDBsum; 1BYW; -.
DR   PDBsum; 1UJL; -.
DR   PDBsum; 2L0W; -.
DR   PDBsum; 2L1M; -.
DR   PDBsum; 2L4R; -.
DR   PDBsum; 2LE7; -.
DR   PDBsum; 2N7G; -.
DR   PDBsum; 4HP9; -.
DR   PDBsum; 4HQA; -.
DR   PDBsum; 5VA1; -.
DR   PDBsum; 5VA2; -.
DR   PDBsum; 5VA3; -.
DR   ProteinModelPortal; Q12809; -.
DR   SMR; Q12809; -.
DR   BioGrid; 109959; 23.
DR   CORUM; Q12809; -.
DR   DIP; DIP-48929N; -.
DR   IntAct; Q12809; 8.
DR   MINT; MINT-1427435; -.
DR   STRING; 9606.ENSP00000262186; -.
DR   BindingDB; Q12809; -.
DR   ChEMBL; CHEMBL240; -.
DR   DrugBank; DB00346; Alfuzosin.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB00276; Amsacrine.
DR   DrugBank; DB00637; Astemizole.
DR   DrugBank; DB04957; Azimilide.
DR   DrugBank; DB01136; Carvedilol.
DR   DrugBank; DB00477; Chlorpromazine.
DR   DrugBank; DB00537; Ciprofloxacin.
DR   DrugBank; DB00604; Cisapride.
DR   DrugBank; DB01211; Clarithromycin.
DR   DrugBank; DB00204; Dofetilide.
DR   DrugBank; DB00590; Doxazosin.
DR   DrugBank; DB01142; Doxepin.
DR   DrugBank; DB04855; Dronedarone.
DR   DrugBank; DB00199; Erythromycin.
DR   DrugBank; DB01218; Halofantrine.
DR   DrugBank; DB00308; Ibutilide.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB01100; Pimozide.
DR   DrugBank; DB00457; Prazosin.
DR   DrugBank; DB01182; Propafenone.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB06144; Sertindole.
DR   DrugBank; DB00489; Sotalol.
DR   DrugBank; DB01162; Terazosin.
DR   DrugBank; DB00342; Terfenadine.
DR   DrugBank; DB00679; Thioridazine.
DR   DrugBank; DB00661; Verapamil.
DR   GuidetoPHARMACOLOGY; 572; -.
DR   TCDB; 1.A.1.20.1; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q12809; -.
DR   PhosphoSitePlus; Q12809; -.
DR   BioMuta; KCNH2; -.
DR   DMDM; 7531135; -.
DR   PaxDb; Q12809; -.
DR   PeptideAtlas; Q12809; -.
DR   PRIDE; Q12809; -.
DR   DNASU; 3757; -.
DR   Ensembl; ENST00000262186; ENSP00000262186; ENSG00000055118. [Q12809-1]
DR   Ensembl; ENST00000330883; ENSP00000328531; ENSG00000055118. [Q12809-2]
DR   GeneID; 3757; -.
DR   KEGG; hsa:3757; -.
DR   UCSC; uc003wib.4; human. [Q12809-1]
DR   CTD; 3757; -.
DR   DisGeNET; 3757; -.
DR   EuPathDB; HostDB:ENSG00000055118.14; -.
DR   GeneCards; KCNH2; -.
DR   GeneReviews; KCNH2; -.
DR   HGNC; HGNC:6251; KCNH2.
DR   MalaCards; KCNH2; -.
DR   MIM; 152427; gene.
DR   MIM; 609620; phenotype.
DR   MIM; 613688; phenotype.
DR   neXtProt; NX_Q12809; -.
DR   OpenTargets; ENSG00000055118; -.
DR   Orphanet; 51083; Familial short QT syndrome.
DR   Orphanet; 101016; Romano-Ward syndrome.
DR   PharmGKB; PA212; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140833; -.
DR   HOGENOM; HOG000207541; -.
DR   HOVERGEN; HBG052232; -.
DR   InParanoid; Q12809; -.
DR   KO; K04905; -.
DR   OMA; GPWGESP; -.
DR   OrthoDB; EOG091G024C; -.
DR   PhylomeDB; Q12809; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-5576890; Phase 3 - rapid repolarisation.
DR   SignaLink; Q12809; -.
DR   SIGNOR; Q12809; -.
DR   ChiTaRS; KCNH2; human.
DR   EvolutionaryTrace; Q12809; -.
DR   GeneWiki; HERG; -.
DR   GenomeRNAi; 3757; -.
DR   PRO; PR:Q12809; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000055118; -.
DR   CleanEx; HS_ERG; -.
DR   CleanEx; HS_KCNH2; -.
DR   ExpressionAtlas; Q12809; baseline and differential.
DR   Genevisible; Q12809; HS.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:1902937; C:inward rectifier potassium channel complex; IMP:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IMP:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0055131; F:C3HC4-type RING finger domain binding; IPI:BHF-UCL.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:BHF-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0086008; F:voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization; IC:BHF-UCL.
DR   GO; GO:1902282; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0035690; P:cellular response to drug; IDA:BHF-UCL.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IDA:BHF-UCL.
DR   GO; GO:0086009; P:membrane repolarization; IMP:UniProtKB.
DR   GO; GO:0086011; P:membrane repolarization during action potential; IDA:BHF-UCL.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:1902303; P:negative regulation of potassium ion export; IDA:BHF-UCL.
DR   GO; GO:1901380; P:negative regulation of potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0071435; P:potassium ion export; IDA:BHF-UCL.
DR   GO; GO:0097623; P:potassium ion export across plasma membrane; IGI:BHF-UCL.
DR   GO; GO:0055075; P:potassium ion homeostasis; IDA:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0003064; P:regulation of heart rate by hormone; TAS:BHF-UCL.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL.
DR   GO; GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   CDD; cd00038; CAP_ED; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003967; K_chnl_volt-dep_ERG.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01470; ERGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00086; PAC; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Deafness; Disease mutation; Glycoprotein; Ion channel; Ion transport;
KW   Long QT syndrome; Membrane; Methylation; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Short QT syndrome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1   1159       Potassium voltage-gated channel subfamily
FT                                H member 2.
FT                                /FTId=PRO_0000053999.
FT   TOPO_DOM      1    403       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    404    424       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    425    450       Extracellular. {ECO:0000255}.
FT   TRANSMEM    451    471       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    472    495       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    496    516       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    517    520       Extracellular. {ECO:0000255}.
FT   TRANSMEM    521    541       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    542    547       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    548    568       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    569    611       Extracellular. {ECO:0000255}.
FT   INTRAMEM    612    632       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    633    638       Extracellular. {ECO:0000255}.
FT   TRANSMEM    639    659       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    660   1159       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       41     70       PAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN       92    144       PAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00141}.
FT   NP_BIND     742    842       cNMP.
FT   MOTIF       624    629       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS    297    300       Poly-Pro.
FT   MOD_RES     239    239       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     243    243       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES     283    283       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES     284    284       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES     320    320       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     351    351       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O08962}.
FT   MOD_RES     871    871       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     874    874       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES    1014   1014       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:O35219}.
FT   MOD_RES    1137   1137       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    598    598       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12063277}.
FT   VAR_SEQ       1    376       MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAV
FT                                IYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQI
FT                                AQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVI
FT                                MFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFR
FT                                LKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAP
FT                                SSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPG
FT                                QLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADD
FT                                IEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYR
FT                                TISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHN
FT                                VTEKVTQ -> MAAPAGKASRTGALRPRAQKGRVRRAVRIS
FT                                SLVAQE (in isoform B).
FT                                {ECO:0000303|PubMed:12431979,
FT                                ECO:0000303|PubMed:9351446,
FT                                ECO:0000303|PubMed:9351462}.
FT                                /FTId=VSP_000965.
FT   VAR_SEQ       1    102       MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAV
FT                                IYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQI
FT                                AQALLGAEERKVEIAFYRKD -> MSSHSA (in
FT                                isoform 3.1).
FT                                {ECO:0000303|PubMed:19412172}.
FT                                /FTId=VSP_047877.
FT   VAR_SEQ       1     36       MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARV -> M
FT                                AAPAGKASRTGALRPRAQKGRVRRAVRISSLVAQE (in
FT                                isoform B-USO).
FT                                {ECO:0000303|PubMed:18559421}.
FT                                /FTId=VSP_047878.
FT   VAR_SEQ      37    376       Missing (in isoform B-USO).
FT                                {ECO:0000303|PubMed:18559421}.
FT                                /FTId=VSP_047879.
FT   VAR_SEQ     139    195       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000966.
FT   VAR_SEQ     801    888       KNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEV
FT                                LDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFS
FT                                RQRKRK -> MGWGAGTGLEMPSAASRGASLLNMQSLGLWT
FT                                WDCLQGHWAPLIHLNSGPPSGAMERSPTWGEAAELWGSHIL
FT                                LPFRIRHKQTLFASLK (in isoform A-USO and
FT                                isoform B-USO).
FT                                {ECO:0000303|PubMed:11374908,
FT                                ECO:0000303|PubMed:18559421,
FT                                ECO:0000303|PubMed:9765245}.
FT                                /FTId=VSP_047880.
FT   VAR_SEQ     889   1159       Missing (in isoform A-USO and isoform B-
FT                                USO). {ECO:0000303|PubMed:11374908,
FT                                ECO:0000303|PubMed:18559421,
FT                                ECO:0000303|PubMed:9765245}.
FT                                /FTId=VSP_047881.
FT   VARIANT      16     16       D -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472825).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074765.
FT   VARIANT      20     20       R -> G (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473486).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074766.
FT   VARIANT      26     26       S -> I (in LQT2; dbSNP:rs199472827).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068249.
FT   VARIANT      29     29       F -> L (in LQT2; dbSNP:rs199472830).
FT                                {ECO:0000269|PubMed:10187793,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008907.
FT   VARIANT      30     30       I -> T (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472832).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074767.
FT   VARIANT      31     31       I -> S (in LQT2; dbSNP:rs199472833).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068250.
FT   VARIANT      32     32       A -> T (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472834).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074768.
FT   VARIANT      33     33       N -> T (in LQT2; dbSNP:rs199473487).
FT                                {ECO:0000269|PubMed:10187793}.
FT                                /FTId=VAR_008908.
FT   VARIANT      41     41       V -> F (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472835).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074769.
FT   VARIANT      43     43       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472836).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074770.
FT   VARIANT      45     45       N -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472839).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074771.
FT   VARIANT      47     47       G -> V (in LQT2; dbSNP:rs199473490).
FT                                /FTId=VAR_009909.
FT   VARIANT      49     49       C -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472840).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074772.
FT   VARIANT      53     53       G -> D (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473491).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074773.
FT   VARIANT      53     53       G -> R (in LQT2; dbSNP:rs199472842).
FT                                {ECO:0000269|PubMed:10187793,
FT                                ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_008909.
FT   VARIANT      54     54       Y -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472843).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074774.
FT   VARIANT      55     55       S -> L (in LQT2; dbSNP:rs199472844).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068251.
FT   VARIANT      56     56       R -> Q (in LQT2; dbSNP:rs199472845).
FT                                {ECO:0000269|PubMed:10187793}.
FT                                /FTId=VAR_008910.
FT   VARIANT      57     57       A -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472846).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074775.
FT   VARIANT      58     58       E -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472847).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074776.
FT   VARIANT      58     58       E -> D (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473492).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074777.
FT   VARIANT      58     58       E -> G (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472847).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074778.
FT   VARIANT      64     64       C -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473414).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074779.
FT   VARIANT      64     64       C -> Y (in LQT2; decreased protein
FT                                stability; dbSNP:rs199473415).
FT                                {ECO:0000269|PubMed:27916661}.
FT                                /FTId=VAR_077953.
FT   VARIANT      65     65       T -> P (in LQT2; decreased protein
FT                                stability; dbSNP:rs121912511).
FT                                {ECO:0000269|PubMed:12354768,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:27916661}.
FT                                /FTId=VAR_014371.
FT   VARIANT      66     66       C -> G (in LQT2; dbSNP:rs199473416).
FT                                {ECO:0000269|PubMed:10187793}.
FT                                /FTId=VAR_008911.
FT   VARIANT      68     68       F -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473417).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074780.
FT   VARIANT      70     70       H -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473418).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074781.
FT   VARIANT      70     70       H -> R (in LQT2; dbSNP:rs199473419).
FT                                {ECO:0000269|PubMed:10187793,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008912.
FT   VARIANT      71     71       G -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473420).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074782.
FT   VARIANT      72     80       PRTQRRAAA -> RPV (in LQT2; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074783.
FT   VARIANT      72     72       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473421).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074784.
FT   VARIANT      72     72       P -> Q (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473421).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009910.
FT   VARIANT      74     74       T -> M (in LQT2; dbSNP:rs199473422).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074785.
FT   VARIANT      74     74       T -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473666).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074786.
FT   VARIANT      74     74       T -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473422).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074787.
FT   VARIANT      78     78       A -> P (in LQT2; dbSNP:rs199472848).
FT                                {ECO:0000269|PubMed:10187793,
FT                                ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_008913.
FT   VARIANT      85     85       A -> V (in LQT2; dbSNP:rs199473494).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068252.
FT   VARIANT      86     86       L -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472851).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074788.
FT   VARIANT      86     86       L -> R (in LQT2; dbSNP:rs199472851).
FT                                {ECO:0000269|PubMed:10187793}.
FT                                /FTId=VAR_008914.
FT   VARIANT      94     94       V -> G (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472852).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074789.
FT   VARIANT     100    100       R -> G (in LQT2; digenic; the patient
FT                                also carries mutation N-1819 on SCN5A;
FT                                dbSNP:rs121912515).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_036669.
FT   VARIANT     100    100       R -> Q (in LQT2; dbSNP:rs199472855).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068253.
FT   VARIANT     100    100       R -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs121912515).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074790.
FT   VARIANT     102    102       D -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472857).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074791.
FT   VARIANT     106    106       F -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472858).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074792.
FT   VARIANT     108    108       C -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472859).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074793.
FT   VARIANT     114    114       P -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472861).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074794.
FT   VARIANT     125    125       F -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473499).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074795.
FT   VARIANT     141    141       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472864).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074796.
FT   VARIANT     149    149       G -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472865).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074797.
FT   VARIANT     164    164       R -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472866).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074798.
FT   VARIANT     176    176       R -> W (in LQT2; dbSNP:rs36210422).
FT                                {ECO:0000269|PubMed:10862094}.
FT                                /FTId=VAR_008915.
FT   VARIANT     181    181       R -> Q (in dbSNP:rs41308954).
FT                                /FTId=VAR_036670.
FT   VARIANT     189    189       G -> GGAG. {ECO:0000269|PubMed:10790218}.
FT                                /FTId=VAR_014372.
FT   VARIANT     218    218       M -> V (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472869).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074799.
FT   VARIANT     238    238       G -> S (in LQT2; dbSNP:rs199473501).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068254.
FT   VARIANT     242    242       R -> G (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472872).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074800.
FT   VARIANT     251    251       P -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472873).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074801.
FT   VARIANT     259    259       D -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472876).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074802.
FT   VARIANT     277    277       A -> D (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472878).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074803.
FT   VARIANT     291    291       M -> T (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472881).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074804.
FT   VARIANT     301    301       R -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472883).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074805.
FT   VARIANT     306    306       G -> W (in LQT2; dbSNP:rs199472884).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068255.
FT   VARIANT     312    312       R -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472885).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009911.
FT   VARIANT     314    314       G -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473504).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074806.
FT   VARIANT     320    320       S -> L (in LQT2; dbSNP:rs199472886).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068256.
FT   VARIANT     323    323       D -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472887).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074807.
FT   VARIANT     328    328       R -> C (in LQT2; dbSNP:rs199473505).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068257.
FT   VARIANT     347    347       P -> S (in LQT2; dbSNP:rs138776684).
FT                                /FTId=VAR_009912.
FT   VARIANT     402    402       H -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473506).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074808.
FT   VARIANT     410    410       W -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472892).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074809.
FT   VARIANT     413    413       L -> P (in LQT2; dbSNP:rs199472893).
FT                                {ECO:0000269|PubMed:12442276}.
FT                                /FTId=VAR_074684.
FT   VARIANT     420    420       Y -> C (in LQT2; dbSNP:rs199473507).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068258.
FT   VARIANT     421    421       T -> M (in LQT2; dbSNP:rs199472894).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068259.
FT   VARIANT     422    422       A -> T (in LQT2; dbSNP:rs199472895).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068260.
FT   VARIANT     426    426       P -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472896).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074810.
FT   VARIANT     427    427       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472897).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074811.
FT   VARIANT     427    427       Y -> H (in LQT2; dbSNP:rs199472898).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_074812.
FT   VARIANT     427    427       Y -> S (in LQT2; dbSNP:rs199472897).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068261.
FT   VARIANT     428    428       S -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472899).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074813.
FT   VARIANT     431    431       F -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472900).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074814.
FT   VARIANT     436    436       T -> M (in LQT2; dbSNP:rs199472901).
FT                                /FTId=VAR_008916.
FT   VARIANT     440    440       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473509).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074815.
FT   VARIANT     444    444       E -> D (in LQT2; dbSNP:rs9770044).
FT                                {ECO:0000269|PubMed:12442276}.
FT                                /FTId=VAR_074685.
FT   VARIANT     451    451       P -> L (in LQT2; dbSNP:rs199472902).
FT                                {ECO:0000269|PubMed:10862094,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_014373.
FT   VARIANT     456    456       D -> Y (in LQT2; dbSNP:rs199473510).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068262.
FT   VARIANT     460    460       D -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472903).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074816.
FT   VARIANT     466    466       D -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473511).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074817.
FT   VARIANT     470    470       N -> D (in LQT2; aberrant protein folding
FT                                increases the association of mutant KCNH2
FT                                with CANX and results in defective
FT                                protein trafficking; dbSNP:rs121912505).
FT                                {ECO:0000269|PubMed:16361248,
FT                                ECO:0000269|PubMed:7889573}.
FT                                /FTId=VAR_008578.
FT   VARIANT     473    473       T -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472905).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074818.
FT   VARIANT     474    474       T -> I (in LQT2; dbSNP:rs199472906).
FT                                {ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_008917.
FT   VARIANT     475    475       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472907).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074819.
FT   VARIANT     475    475       Missing (in LQT2).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068263.
FT   VARIANT     476    476       V -> I (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472908).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074820.
FT   VARIANT     490    490       A -> T (in LQT2; bradycardia-induced;
FT                                dbSNP:rs28928905).
FT                                {ECO:0000269|PubMed:11170080,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_036671.
FT   VARIANT     493    493       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472911).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074821.
FT   VARIANT     493    493       Y -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472911).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074822.
FT   VARIANT     500    508       Missing (in LQT2).
FT                                /FTId=VAR_009178.
FT   VARIANT     501    501       D -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472912).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074823.
FT   VARIANT     501    501       D -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472912).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074824.
FT   VARIANT     525    525       K -> N (in LQT2; located on the same
FT                                allele as Pro-528; dbSNP:rs199472913).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_036672.
FT   VARIANT     528    528       R -> P (in LQT2; located on the same
FT                                allele as Asn-525; dbSNP:rs199472914).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_036673.
FT   VARIANT     531    531       R -> Q (in LQT2; dbSNP:rs199473515).
FT                                /FTId=VAR_009913.
FT   VARIANT     531    531       R -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472915).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074825.
FT   VARIANT     534    534       R -> C (in LQT2; dbSNP:rs199472916).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9600240}.
FT                                /FTId=VAR_008579.
FT   VARIANT     534    534       R -> L (in LQT2; dbSNP:rs199473516).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074826.
FT   VARIANT     552    552       L -> S (in LQT2; dbSNP:rs199472918).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008918.
FT   VARIANT     558    558       A -> E (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472919).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074827.
FT   VARIANT     558    558       A -> P (in LQT2; dbSNP:rs121912516).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_008919.
FT   VARIANT     559    559       L -> H (in LQT2; dbSNP:rs199472920).
FT                                {ECO:0000269|PubMed:12442276}.
FT                                /FTId=VAR_074686.
FT   VARIANT     561    561       A -> T (in LQT2; dbSNP:rs199472921).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:8877771}.
FT                                /FTId=VAR_014374.
FT   VARIANT     561    561       A -> V (in LQT2; the mutation reduces
FT                                wild-type channel expression;
FT                                dbSNP:rs121912504).
FT                                {ECO:0000269|PubMed:10753933,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:7889573}.
FT                                /FTId=VAR_008580.
FT   VARIANT     562    562       H -> P (in LQT2; dbSNP:rs199472922).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068264.
FT   VARIANT     562    562       H -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472922).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074828.
FT   VARIANT     564    564       L -> P (in LQT2; dbSNP:rs199472924).
FT                                /FTId=VAR_008920.
FT   VARIANT     565    565       A -> T (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473518).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074829.
FT   VARIANT     566    566       C -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472925).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074830.
FT   VARIANT     568    568       W -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472927).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074831.
FT   VARIANT     569    569       Y -> H (in LQT2; dbSNP:rs199473520).
FT                                {ECO:0000269|PubMed:10862094}.
FT                                /FTId=VAR_008921.
FT   VARIANT     571    571       I -> L (in LQT2; dbSNP:rs199472928).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068265.
FT   VARIANT     571    571       I -> V (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472928).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074832.
FT   VARIANT     572    572       G -> C (in LQT2; dbSNP:rs9333649).
FT                                {ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_008923.
FT   VARIANT     572    572       G -> D (in LQT2; dbSNP:rs199473423).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074833.
FT   VARIANT     572    572       G -> R (in LQT2; severe form;
FT                                dbSNP:rs9333649).
FT                                {ECO:0000269|PubMed:10735633}.
FT                                /FTId=VAR_008922.
FT   VARIANT     572    572       G -> S (in LQT2; dbSNP:rs9333649).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068266.
FT   VARIANT     572    572       G -> V (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473423).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074834.
FT   VARIANT     582    582       R -> C (in LQT2; dbSNP:rs121912508).
FT                                {ECO:0000269|PubMed:10220144,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008581.
FT   VARIANT     582    582       R -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473426).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074835.
FT   VARIANT     584    584       G -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473428).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074836.
FT   VARIANT     584    584       G -> S (in LQT2; dbSNP:rs199473428).
FT                                {ECO:0000269|PubMed:10862094,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008924.
FT   VARIANT     585    585       W -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473430).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_009914.
FT   VARIANT     588    588       N -> D (in LQT2; dbSNP:rs199473431).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_008925.
FT   VARIANT     588    588       N -> K (in SQT1; dbSNP:rs104894021).
FT                                {ECO:0000269|PubMed:14676148,
FT                                ECO:0000269|PubMed:15828882}.
FT                                /FTId=VAR_023840.
FT   VARIANT     593    593       I -> K (in LQT2; unknown pathological
FT                                significance; dbSNP:rs28928904).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074837.
FT   VARIANT     593    593       I -> R (in LQT2; dbSNP:rs28928904).
FT                                {ECO:0000269|PubMed:8635257}.
FT                                /FTId=VAR_008582.
FT   VARIANT     593    593       I -> T (in LQT2; dbSNP:rs28928904).
FT                                /FTId=VAR_009915.
FT   VARIANT     594    594       G -> D (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472931).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074838.
FT   VARIANT     596    596       P -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472933).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074839.
FT   VARIANT     596    596       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472933).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074840.
FT   VARIANT     596    596       P -> R (in LQT2; dbSNP:rs199472933).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068267.
FT   VARIANT     597    597       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472934).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074841.
FT   VARIANT     599    599       S -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472935).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074842.
FT   VARIANT     601    601       G -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472936).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074843.
FT   VARIANT     601    601       G -> S (in LQT2; dbSNP:rs199472936).
FT                                {ECO:0000269|PubMed:10862094,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9452080}.
FT                                /FTId=VAR_008926.
FT   VARIANT     604    604       G -> S (in LQT2; dbSNP:rs199473522).
FT                                {ECO:0000269|PubMed:10220144,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008927.
FT   VARIANT     605    605       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472938).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074844.
FT   VARIANT     605    605       P -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472939).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074845.
FT   VARIANT     609    609       D -> G (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472940).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074846.
FT   VARIANT     609    609       D -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472941).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074847.
FT   VARIANT     609    609       D -> N (in LQT2; dbSNP:rs199472941).
FT                                /FTId=VAR_009916.
FT   VARIANT     611    611       Y -> H (in LQT2; dbSNP:rs199472942).
FT                                {ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_008928.
FT   VARIANT     612    612       V -> L (in LQT2; dbSNP:rs199472943).
FT                                {ECO:0000269|PubMed:9544837}.
FT                                /FTId=VAR_008929.
FT   VARIANT     613    613       T -> M (in LQT2; dbSNP:rs199473524).
FT                                {ECO:0000269|PubMed:10220144,
FT                                ECO:0000269|PubMed:10862094,
FT                                ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008930.
FT   VARIANT     614    614       A -> V (in LQT2; dbSNP:rs199472944).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9024139,
FT                                ECO:0000269|PubMed:9544837,
FT                                ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_008931.
FT   VARIANT     615    615       L -> F (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472945).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074848.
FT   VARIANT     615    615       L -> V (in LQT2; dbSNP:rs199472945).
FT                                /FTId=VAR_014375.
FT   VARIANT     616    616       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472946).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074849.
FT   VARIANT     621    621       S -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472949).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074850.
FT   VARIANT     622    622       L -> F (in LQT2; dbSNP:rs199473525).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068268.
FT   VARIANT     623    623       T -> I (in LQT2; dbSNP:rs199472950).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068269.
FT   VARIANT     626    626       G -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472952).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074851.
FT   VARIANT     626    626       G -> D (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472952).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074852.
FT   VARIANT     626    626       G -> S (in LQT2; dbSNP:rs199472953).
FT                                /FTId=VAR_014376.
FT   VARIANT     627    627       F -> L (in LQT2; dbSNP:rs199473039).
FT                                /FTId=VAR_014377.
FT   VARIANT     628    628       G -> S (in LQT2; dbSNP:rs121912507).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:7889573}.
FT                                /FTId=VAR_008583.
FT   VARIANT     628    628       G -> V (in LQT2; dbSNP:rs199472955).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068270.
FT   VARIANT     629    629       N -> D (in LQT2; dbSNP:rs199472956).
FT                                {ECO:0000269|PubMed:9544837}.
FT                                /FTId=VAR_008932.
FT   VARIANT     629    629       N -> I (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472957).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074853.
FT   VARIANT     629    629       N -> K (in LQT2; dbSNP:rs41307295).
FT                                {ECO:0000269|PubMed:10517660}.
FT                                /FTId=VAR_008933.
FT   VARIANT     629    629       N -> S (in LQT2; dbSNP:rs199472957).
FT                                {ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:9544837}.
FT                                /FTId=VAR_009179.
FT   VARIANT     630    630       V -> A (in LQT2; dbSNP:rs199473526).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:9693036}.
FT                                /FTId=VAR_008935.
FT   VARIANT     630    630       V -> L (in LQT2; dbSNP:rs199472958).
FT                                {ECO:0000269|PubMed:9024139}.
FT                                /FTId=VAR_008934.
FT   VARIANT     632    632       P -> S (in LQT2; dbSNP:rs199473527).
FT                                /FTId=VAR_014378.
FT   VARIANT     633    633       N -> S (in LQT2; dbSNP:rs199472961).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:9544837}.
FT                                /FTId=VAR_008936.
FT   VARIANT     634    634       T -> I (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472962).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074854.
FT   VARIANT     635    635       N -> D (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472963).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074855.
FT   VARIANT     635    635       N -> I (in LQT2; dbSNP:rs199472964).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068271.
FT   VARIANT     635    635       N -> K (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472965).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074856.
FT   VARIANT     637    637       E -> D (in LQT2; dbSNP:rs199472966).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074857.
FT   VARIANT     637    637       E -> K (in LQT2; dbSNP:rs199472968).
FT                                {ECO:0000269|PubMed:12062363}.
FT                                /FTId=VAR_014379.
FT   VARIANT     638    638       K -> E (in LQT2; dbSNP:rs199473528).
FT                                /FTId=VAR_014380.
FT   VARIANT     638    638       K -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472969).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074858.
FT   VARIANT     638    638       Missing (in LQT2; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_014381.
FT   VARIANT     640    640       F -> L (in LQT2; dbSNP:rs199472970).
FT                                {ECO:0000269|PubMed:10220144}.
FT                                /FTId=VAR_008937.
FT   VARIANT     640    640       F -> V (in LQT2; dbSNP:rs199473529).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068272.
FT   VARIANT     641    641       S -> F (in LQT2; dbSNP:rs199472971).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068273.
FT   VARIANT     644    644       V -> F (in LQT2; dbSNP:rs199472972).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074859.
FT   VARIANT     644    644       V -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472972).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074860.
FT   VARIANT     645    645       M -> I (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472973).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074861.
FT   VARIANT     645    645       M -> L (in LQT2; dbSNP:rs199472974).
FT                                /FTId=VAR_014382.
FT   VARIANT     648    648       G -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472975).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074862.
FT   VARIANT     656    656       F -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472977).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074863.
FT   VARIANT     657    657       G -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472978).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074864.
FT   VARIANT     660    660       S -> L (in LQT2; dbSNP:rs199472979).
FT                                {ECO:0000269|PubMed:16414944,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074865.
FT   VARIANT     662    662       I -> T (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472980).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074866.
FT   VARIANT     671    675       Missing (in LQT2).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068274.
FT   VARIANT     678    678       L -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472981).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074867.
FT   VARIANT     687    687       H -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472982).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074868.
FT   VARIANT     693    693       L -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472983).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074869.
FT   VARIANT     696    696       R -> C (in LQT2; dbSNP:rs199472984).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_036674.
FT   VARIANT     696    696       R -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473531).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074870.
FT   VARIANT     711    711       I -> V (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473532).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074871.
FT   VARIANT     721    721       P -> L (in LQT2; dbSNP:rs199472986).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068275.
FT   VARIANT     728    728       I -> F (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473533).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074872.
FT   VARIANT     744    744       R -> P (in LQT2; impairs channel
FT                                function; exhibits reduced activating
FT                                currents compared to wild-type; cell
FT                                surface trafficking is not impaired; does
FT                                not exert dominant-negative effects on
FT                                wild-type channel; the half-maximal
FT                                activation voltage is not significantly
FT                                affected by the mutation).
FT                                {ECO:0000269|PubMed:22314138}.
FT                                /FTId=VAR_068276.
FT   VARIANT     749    749       G -> V (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472989).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074873.
FT   VARIANT     752    752       R -> Q (in LQT2; dbSNP:rs121912512).
FT                                {ECO:0000269|PubMed:12621127}.
FT                                /FTId=VAR_036675.
FT   VARIANT     752    752       R -> W (in LQT2; dbSNP:rs199472990).
FT                                /FTId=VAR_014383.
FT   VARIANT     757    757       K -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472992).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074874.
FT   VARIANT     767    767       D -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472993).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074875.
FT   VARIANT     770    770       V -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472994).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074876.
FT   VARIANT     774    774       D -> Y (in LQT2; dbSNP:rs199472995).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068277.
FT   VARIANT     784    784       R -> W (predisposes to LQT2 and torsades
FT                                de pointes while taking the drug
FT                                amiodarone; in vitro studies confirmed a
FT                                significant reduction in potassium
FT                                currents; the ECG abnormalities reversed
FT                                on drug withdrawal; dbSNP:rs12720441).
FT                                {ECO:0000269|PubMed:11997281,
FT                                ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_036676.
FT   VARIANT     788    788       E -> D (in LQT2; dbSNP:rs199473535).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068278.
FT   VARIANT     788    788       E -> K (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472997).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074877.
FT   VARIANT     791    799       Missing (in LQT2; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074878.
FT   VARIANT     791    791       R -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs138498207).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074879.
FT   VARIANT     800    800       G -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199472998).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074880.
FT   VARIANT     805    805       F -> C (in LQT2; dbSNP:rs199472999).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_014384.
FT   VARIANT     805    805       F -> S (in LQT2; dbSNP:rs199472999).
FT                                /FTId=VAR_014385.
FT   VARIANT     806    806       G -> E (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473000).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074881.
FT   VARIANT     818    818       S -> L (in LQT2; dbSNP:rs121912510).
FT                                {ECO:0000269|PubMed:10086971}.
FT                                /FTId=VAR_008938.
FT   VARIANT     818    818       S -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473537).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074882.
FT   VARIANT     820    820       G -> R (in LQT2; dbSNP:rs199473001).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068279.
FT   VARIANT     822    822       V -> M (in LQT2; dbSNP:rs121912506).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085,
FT                                ECO:0000269|PubMed:8914737}.
FT                                /FTId=VAR_008584.
FT   VARIANT     823    823       R -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473538).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_014386.
FT   VARIANT     837    837       D -> G (in LQT2; dbSNP:rs199473004).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068280.
FT   VARIANT     837    837       D -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473005).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074883.
FT   VARIANT     846    846       P -> S (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473006).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074884.
FT   VARIANT     861    861       N -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473007).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074885.
FT   VARIANT     861    861       N -> I (in LQT2; dbSNP:rs121912513).
FT                                {ECO:0000269|PubMed:15051636}.
FT                                /FTId=VAR_014387.
FT   VARIANT     885    885       R -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs143512106).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074886.
FT   VARIANT     887    887       R -> H (in LQT2; dbSNP:rs199473432).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068281.
FT   VARIANT     894    894       R -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473433).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074887.
FT   VARIANT     894    894       R -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473668).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074888.
FT   VARIANT     897    897       K -> T (in dbSNP:rs1805123).
FT                                {ECO:0000269|PubMed:10862094,
FT                                ECO:0000269|PubMed:11997281}.
FT                                /FTId=VAR_014388.
FT   VARIANT     903    903       G -> R (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473669).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074889.
FT   VARIANT     906    906       S -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473435).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074890.
FT   VARIANT     913    913       A -> V (in LQT2; dbSNP:rs77331749).
FT                                {ECO:0000269|PubMed:15840476,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_068282.
FT   VARIANT     917    917       P -> L (in LQT2; dbSNP:rs76420733).
FT                                /FTId=VAR_014389.
FT   VARIANT     920    920       R -> Q (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473670).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074891.
FT   VARIANT     920    920       R -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473438).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074892.
FT   VARIANT     922    922       R -> Q (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473439).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074893.
FT   VARIANT     922    922       R -> W (in LQT2; dbSNP:rs199473440).
FT                                /FTId=VAR_014390.
FT   VARIANT     924    924       G -> A (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473009).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074894.
FT   VARIANT     924    924       G -> E (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473009).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074895.
FT   VARIANT     925    925       G -> R (in LQT2; dbSNP:rs199473010).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068283.
FT   VARIANT     937    937       S -> N (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473540).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074896.
FT   VARIANT     948    948       R -> C (in LQT2; dbSNP:rs121912514).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_036677.
FT   VARIANT     968    968       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473017).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074897.
FT   VARIANT     983    983       T -> I (in LQT2; dbSNP:rs149955375).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068284.
FT   VARIANT     996    996       N -> I (in LQT2; dbSNP:rs199473018).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068285.
FT   VARIANT    1005   1005       R -> Q (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473019).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074898.
FT   VARIANT    1007   1007       R -> H (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473542).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074899.
FT   VARIANT    1016   1016       P -> L (in dbSNP:rs41313074).
FT                                /FTId=VAR_036679.
FT   VARIANT    1016   1016       P -> S (in dbSNP:rs41307280).
FT                                /FTId=VAR_036678.
FT   VARIANT    1020   1020       P -> S (in dbSNP:rs41307274).
FT                                /FTId=VAR_036680.
FT   VARIANT    1026   1026       P -> L (in dbSNP:rs41307271).
FT                                /FTId=VAR_036681.
FT   VARIANT    1033   1033       R -> W (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473021).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074900.
FT   VARIANT    1036   1036       G -> D (in LQT2; dbSNP:rs199473022).
FT                                {ECO:0000269|PubMed:15840476}.
FT                                /FTId=VAR_068286.
FT   VARIANT    1038   1038       V -> M (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473544).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074901.
FT   VARIANT    1049   1049       L -> P (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473026).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074902.
FT   VARIANT    1055   1055       R -> Q (in dbSNP:rs41307270).
FT                                /FTId=VAR_036682.
FT   VARIANT    1066   1066       L -> V (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473027).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074903.
FT   VARIANT    1078   1078       Y -> C (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473029).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074904.
FT   VARIANT    1093   1093       P -> L (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473545).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074905.
FT   VARIANT    1115   1115       M -> V (in LQT2; dbSNP:rs199473546).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074906.
FT   VARIANT    1153   1153       H -> Y (in LQT2; unknown pathological
FT                                significance; dbSNP:rs199473035).
FT                                {ECO:0000269|PubMed:16414944}.
FT                                /FTId=VAR_074907.
FT   MUTAGEN      29     29       F->A: Slows down deactivation.
FT                                {ECO:0000269|PubMed:9845367}.
FT   MUTAGEN      43     43       Y->A: Slows down deactivation.
FT                                {ECO:0000269|PubMed:9845367}.
FT   MUTAGEN     283    283       S->A: Abolishes phosphorylation; when
FT                                associated with A-890; A-895 and A-1137.
FT                                {ECO:0000269|PubMed:10837251}.
FT   MUTAGEN     598    598       N->Q: No effect on cell surface
FT                                expression, but changes inactivation
FT                                kinetics; when associated with A-631.
FT                                {ECO:0000269|PubMed:12063277}.
FT   MUTAGEN     629    629       N->Q: Abolishes cell surface expression;
FT                                has no effect on N-glycosylation.
FT                                {ECO:0000269|PubMed:12063277}.
FT   MUTAGEN     631    631       S->A: No effect on cell surface
FT                                expression, but changes inactivation
FT                                kinetics; when associated with Q-598.
FT                                {ECO:0000269|PubMed:12063277}.
FT   MUTAGEN     890    890       S->A: Abolishes phosphorylation; when
FT                                associated with A-283; A-895 and A-1137.
FT                                {ECO:0000269|PubMed:10837251}.
FT   MUTAGEN     895    895       T->A: Abolishes phosphorylation; when
FT                                associated with A-283; A-890 and A-1137.
FT                                {ECO:0000269|PubMed:10837251}.
FT   MUTAGEN    1137   1137       S->A: Abolishes phosphorylation; when
FT                                associated with A-283; A-890 and A-895.
FT                                {ECO:0000269|PubMed:10837251}.
FT   HELIX        15     19       {ECO:0000244|PDB:4HP9}.
FT   TURN         23     26       {ECO:0000244|PDB:2L0W}.
FT   STRAND       29     33       {ECO:0000244|PDB:4HQA}.
FT   STRAND       36     38       {ECO:0000244|PDB:1BYW}.
FT   STRAND       40     44       {ECO:0000244|PDB:4HQA}.
FT   HELIX        46     52       {ECO:0000244|PDB:4HQA}.
FT   HELIX        56     59       {ECO:0000244|PDB:4HQA}.
FT   HELIX        67     69       {ECO:0000244|PDB:4HQA}.
FT   HELIX        76     87       {ECO:0000244|PDB:4HQA}.
FT   STRAND       88     90       {ECO:0000244|PDB:4HP9}.
FT   STRAND       92     99       {ECO:0000244|PDB:4HQA}.
FT   STRAND      105    116       {ECO:0000244|PDB:4HQA}.
FT   STRAND      118    120       {ECO:0000244|PDB:4HQA}.
FT   STRAND      122    134       {ECO:0000244|PDB:4HQA}.
FT   TURN        538    540       {ECO:0000244|PDB:2LE7}.
FT   HELIX       542    549       {ECO:0000244|PDB:2LE7}.
FT   STRAND      577    580       {ECO:0000244|PDB:1UJL}.
FT   HELIX       586    593       {ECO:0000244|PDB:1UJL}.
FT   HELIX       605    610       {ECO:0000244|PDB:1UJL}.
FT   HELIX       735    739       {ECO:0000244|PDB:2N7G}.
FT   STRAND      743    745       {ECO:0000244|PDB:2N7G}.
FT   TURN        748    750       {ECO:0000244|PDB:2N7G}.
FT   HELIX       751    757       {ECO:0000244|PDB:2N7G}.
FT   STRAND      759    763       {ECO:0000244|PDB:2N7G}.
FT   STRAND      768    770       {ECO:0000244|PDB:2N7G}.
FT   STRAND      778    785       {ECO:0000244|PDB:2N7G}.
FT   STRAND      787    795       {ECO:0000244|PDB:2N7G}.
FT   TURN        809    811       {ECO:0000244|PDB:2N7G}.
FT   STRAND      819    824       {ECO:0000244|PDB:2N7G}.
FT   STRAND      826    834       {ECO:0000244|PDB:2N7G}.
FT   HELIX       835    844       {ECO:0000244|PDB:2N7G}.
FT   HELIX       846    855       {ECO:0000244|PDB:2N7G}.
FT   STRAND      859    861       {ECO:0000244|PDB:2N7G}.
SQ   SEQUENCE   1159 AA;  126655 MW;  D03BD4F657641FBA CRC64;
     MPVRRGHVAP QNTFLDTIIR KFEGQSRKFI IANARVENCA VIYCNDGFCE LCGYSRAEVM
     QRPCTCDFLH GPRTQRRAAA QIAQALLGAE ERKVEIAFYR KDGSCFLCLV DVVPVKNEDG
     AVIMFILNFE VVMEKDMVGS PAHDTNHRGP PTSWLAPGRA KTFRLKLPAL LALTARESSV
     RSGGAGGAGA PGAVVVDVDL TPAAPSSESL ALDEVTAMDN HVAGLGPAEE RRALVGPGSP
     PRSAPGQLPS PRAHSLNPDA SGSSCSLART RSRESCASVR RASSADDIEA MRAGVLPPPP
     RHASTGAMHP LRSGLLNSTS DSDLVRYRTI SKIPQITLNF VDLKGDPFLA SPTSDREIIA
     PKIKERTHNV TEKVTQVLSL GADVLPEYKL QAPRIHRWTI LHYSPFKAVW DWLILLLVIY
     TAVFTPYSAA FLLKETEEGP PATECGYACQ PLAVVDLIVD IMFIVDILIN FRTTYVNANE
     EVVSHPGRIA VHYFKGWFLI DMVAAIPFDL LIFGSGSEEL IGLLKTARLL RLVRVARKLD
     RYSEYGAAVL FLLMCTFALI AHWLACIWYA IGNMEQPHMD SRIGWLHNLG DQIGKPYNSS
     GLGGPSIKDK YVTALYFTFS SLTSVGFGNV SPNTNSEKIF SICVMLIGSL MYASIFGNVS
     AIIQRLYSGT ARYHTQMLRV REFIRFHQIP NPLRQRLEEY FQHAWSYTNG IDMNAVLKGF
     PECLQADICL HLNRSLLQHC KPFRGATKGC LRALAMKFKT THAPPGDTLV HAGDLLTALY
     FISRGSIEIL RGDVVVAILG KNDIFGEPLN LYARPGKSNG DVRALTYCDL HKIHRDDLLE
     VLDMYPEFSD HFWSSLEITF NLRDTNMIPG SPGSTELEGG FSRQRKRKLS FRRRTDKDTE
     QPGEVSALGP GRAGAGPSSR GRPGGPWGES PSSGPSSPES SEDEGPGRSS SPLRLVPFSS
     PRPPGEPPGG EPLMEDCEKS SDTCNPLSGA FSGVSNIFSF WGDSRGRQYQ ELPRCPAPTP
     SLLNIPLSSP GRRPRGDVES RLDALQRQLN RLETRLSADM ATVLQLLQRQ MTLVPPAYSA
     VTTPGPGPTS TSPLLPVSPL PTLTLDSLSQ VSQFMACEEL PPGAPELPQE GPTRRLSLPG
     QLGALTSQPL HRHGSDPGS
//
ID   PKD2_HUMAN              Reviewed;         968 AA.
AC   Q13563; O60441; Q15764; Q2M1Q3; Q2M1Q5;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   20-DEC-2017, entry version 184.
DE   RecName: Full=Polycystin-2;
DE            Short=PC2 {ECO:0000303|PubMed:27991905};
DE   AltName: Full=Autosomal dominant polycystic kidney disease type II protein;
DE   AltName: Full=Polycystic kidney disease 2 protein;
DE   AltName: Full=Polycystwin {ECO:0000303|PubMed:8954772};
DE   AltName: Full=R48321;
DE   AltName: Full=Transient receptor potential cation channel subfamily P member 2 {ECO:0000303|PubMed:19556541, ECO:0000312|HGNC:HGNC:9009};
GN   Name=PKD2 {ECO:0000312|HGNC:HGNC:9009};
GN   Synonyms=TRPP2 {ECO:0000303|PubMed:19556541,
GN   ECO:0000312|HGNC:HGNC:9009};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=8650545; DOI=10.1126/science.272.5266.1339;
RA   Mochizuki T., Wu G., Hayashi T., Xenophontos S.L., Veldhuisen B.,
RA   Saris J.J., Reynolds D.M., Cai Y., Gabow P.A., Pierides A.,
RA   Kimberling W.J., Breuning M.H., Deltas C.C., Peters D.J.M., Somlo S.;
RT   "PKD2, a gene for polycystic kidney disease that encodes an integral
RT   membrane protein.";
RL   Science 272:1339-1342(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9286709; DOI=10.1006/geno.1997.4851;
RA   Hayashi T., Mochizuki T., Reynolds D.M., Wu G., Cai Y., Somlo S.;
RT   "Characterization of the exon structure of the polycystic kidney
RT   disease 2 gene (PKD2).";
RL   Genomics 44:131-136(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   PRO-28.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 361-968 (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=8954772; DOI=10.1006/geno.1996.0584;
RA   Schneider M.C., Rodriguez A., Nomura H., Zhou J., Morton C.C.,
RA   Reeders S.T., Weremowicz S.;
RT   "A gene similar to PKD1 maps to chromosome 4q22: a candidate gene for
RT   PKD2.";
RL   Genomics 38:1-4(1996).
RN   [5]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=10770959;
RA   Foggensteiner L., Bevan A.P., Thomas R., Coleman N., Boulter C.,
RA   Bradley J., Ibraghimov-Beskrovnaya O., Klinger K., Sandford R.;
RT   "Cellular and subcellular distribution of polycystin-2, the protein
RT   product of the PKD2 gene.";
RL   J. Am. Soc. Nephrol. 11:814-827(2000).
RN   [6]
RP   INTERACTION WITH CD2AP, AND SUBCELLULAR LOCATION.
RX   PubMed=10913159; DOI=10.1074/jbc.M006624200;
RA   Lehtonen S., Ora A., Olkkonen V.M., Geng L., Zerial M., Somlo S.,
RA   Lehtonen E.;
RT   "In vivo interaction of the adapter protein CD2-associated protein
RT   with the type 2 polycystic kidney disease protein, polycystin-2.";
RL   J. Biol. Chem. 275:32888-32893(2000).
RN   [7]
RP   INTERACTION WITH HAX1, AND SUBCELLULAR LOCATION.
RX   PubMed=10760273; DOI=10.1073/pnas.97.8.4017;
RA   Gallagher A.R., Cedzich A., Gretz N., Somlo S., Witzgall R.;
RT   "The polycystic kidney disease protein PKD2 interacts with Hax-1, a
RT   protein associated with the actin cytoskeleton.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:4017-4022(2000).
RN   [8]
RP   REVIEW.
RX   PubMed=11698076; DOI=10.1016/S0165-6147(00)01832-0;
RA   Stayner C., Zhou J.;
RT   "Polycystin channels and kidney disease.";
RL   Trends Pharmacol. Sci. 22:543-546(2001).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND CHARACTERIZATION OF VARIANT PKD2
RP   VAL-511.
RX   PubMed=11854751; DOI=10.1038/ncb754;
RA   Koulen P., Cai Y., Geng L., Maeda Y., Nishimura S., Witzgall R.,
RA   Ehrlich B.E., Somlo S.;
RT   "Polycystin-2 is an intracellular calcium release channel.";
RL   Nat. Cell Biol. 4:191-197(2002).
RN   [10]
RP   ALTERNATIVE SPLICING (ISOFORMS 2; 3; 4 AND 5).
RX   PubMed=16192288; DOI=10.1093/hmg/ddi356;
RA   Hackmann K., Markoff A., Qian F., Bogdanova N., Germino G.G.,
RA   Pennekamp P., Dworniczak B., Horst J., Gerke V.;
RT   "A splice form of polycystin-2, lacking exon 7, does not interact with
RT   polycystin-1.";
RL   Hum. Mol. Genet. 14:3249-3262(2005).
RN   [11]
RP   FUNCTION, INTERACTION WITH PACS1 AND PACS2, SUBCELLULAR LOCATION,
RP   PHOSPHORYLATION AT SER-812, AND MUTAGENESIS OF SER-812 AND
RP   815-ASP--ASP-817.
RX   PubMed=15692563; DOI=10.1038/sj.emboj.7600566;
RA   Koettgen M., Benzing T., Simmen T., Tauber R., Buchholz B.,
RA   Feliciangeli S., Huber T.B., Schermer B., Kramer-Zucker A.,
RA   Hoepker K., Simmen K.C., Tschucke C.C., Sandford R., Kim E.,
RA   Thomas G., Walz G.;
RT   "Trafficking of TRPP2 by PACS proteins represents a novel mechanism of
RT   ion channel regulation.";
RL   EMBO J. 24:705-716(2005).
RN   [12]
RP   FUNCTION, ENZYME REGULATION, PHOSPHORYLATION AT SER-76; SER-80 AND
RP   SER-812, AND MUTAGENESIS OF SER-76; SER-80; THR-721; SER-801; SER-812;
RP   SER-831 AND SER-943.
RX   PubMed=16551655; DOI=10.1093/hmg/ddl070;
RA   Streets A.J., Moon D.J., Kane M.E., Obara T., Ong A.C.;
RT   "Identification of an N-terminal glycogen synthase kinase 3
RT   phosphorylation site which regulates the functional localization of
RT   polycystin-2 in vivo and in vitro.";
RL   Hum. Mol. Genet. 15:1465-1473(2006).
RN   [13]
RP   FUNCTION, INTERACTION WITH TRPV4, AND SUBCELLULAR LOCATION.
RX   PubMed=18695040; DOI=10.1083/jcb.200805124;
RA   Kottgen M., Buchholz B., Garcia-Gonzalez M.A., Kotsis F., Fu X.,
RA   Doerken M., Boehlke C., Steffl D., Tauber R., Wegierski T.,
RA   Nitschke R., Suzuki M., Kramer-Zucker A., Germino G.G., Watnick T.,
RA   Prenen J., Nilius B., Kuehn E.W., Walz G.;
RT   "TRPP2 and TRPV4 form a polymodal sensory channel complex.";
RL   J. Cell Biol. 182:437-447(2008).
RN   [14]
RP   GLYCOSYLATION AT ASN-328.
RX   PubMed=19139490; DOI=10.1074/mcp.M800504-MCP200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F.,
RA   Zheng Z.B., Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y.,
RA   Zhang Y.K., Deng Y.L., Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core
RT   fucosylated glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [15]
RP   FUNCTION, ENZYME REGULATION, PHOSPHORYLATION AT SER-801, MUTAGENESIS
RP   OF SER-801 AND SER-804, SUBCELLULAR LOCATION, SUBUNIT, AND INTERACTION
RP   WITH PKD1.
RX   PubMed=20881056; DOI=10.1091/mbc.E10-04-0377;
RA   Streets A.J., Needham A.J., Gill S.K., Ong A.C.;
RT   "Protein kinase D-mediated phosphorylation of polycystin-2 (TRPP2) is
RT   essential for its effects on cell growth and calcium channel
RT   activity.";
RL   Mol. Biol. Cell 21:3853-3865(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-812, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-812, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT
RP   SER-829, TISSUE SPECIFICITY, AND MUTAGENESIS OF SER-829.
RX   PubMed=26269590; DOI=10.1074/jbc.M115.661082;
RA   del Rocio Cantero M., Velazquez I.F., Streets A.J., Ong A.C.M.,
RA   Cantiello H.F.;
RT   "The cAMP Signaling Pathway and Direct Protein Kinase A
RT   Phosphorylation Regulate Polycystin-2 (TRPP2) Channel Function.";
RL   J. Biol. Chem. 290:23888-23896(2015).
RN   [19]
RP   SUBCELLULAR LOCATION.
RX   PubMed=27259053; DOI=10.1016/j.ajhg.2016.05.004;
RG   Genkyst Study Group, HALT Progression of Polycystic Kidney Disease Group;
RG   Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease;
RA   Porath B., Gainullin V.G., Cornec-Le Gall E., Dillinger E.K.,
RA   Heyer C.M., Hopp K., Edwards M.E., Madsen C.D., Mauritz S.R.,
RA   Banks C.J., Baheti S., Reddy B., Herrero J.I., Banales J.M.,
RA   Hogan M.C., Tasic V., Watnick T.J., Chapman A.B., Vigneau C.,
RA   Lavainne F., Audrezet M.P., Ferec C., Le Meur Y., Torres V.E.,
RA   Harris P.C.;
RT   "Mutations in GANAB, encoding the glucosidase IIalpha subunit, cause
RT   autosomal-dominant polycystic kidney and liver disease.";
RL   Am. J. Hum. Genet. 98:1193-1207(2016).
RN   [20]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF PHE-604; PHE-605 AND
RP   736-LEU-ASN-737, AND CHARACTERIZATION OF VARIANTS PKD2 GLY-414;
RP   GLY-420 AND VAL-511.
RX   PubMed=27071085; DOI=10.1073/pnas.1517066113;
RA   Arif Pavel M., Lv C., Ng C., Yang L., Kashyap P., Lam C.,
RA   Valentino V., Fung H.Y., Campbell T., Moeller S.G., Zenisek D.,
RA   Holtzman N.G., Yu Y.;
RT   "Function and regulation of TRPP2 ion channel revealed by a gain-of-
RT   function mutant.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:E2363-E2372(2016).
RN   [21]
RP   3D-STRUCTURE MODELING, PROTEIN SEQUENCE OF 711-715; 720-724; 804-808
RP   AND 823-827, IDENTIFICATION BY MASS SPECTROMETRY, DOMAIN,
RP   CALCIUM-BINDING, CIRCULAR DICHROISM, SUBUNIT, AND MUTAGENESIS OF
RP   THR-771; GLU-774; LEU-842; VAL-846; MET-849; ILE-853; ILE-856 AND
RP   VAL-863.
RX   PubMed=18694932; DOI=10.1074/jbc.M802743200;
RA   Celic A., Petri E.T., Demeler B., Ehrlich B.E., Boggon T.J.;
RT   "Domain mapping of the polycystin-2 C-terminal tail using de novo
RT   molecular modeling and biophysical analysis.";
RL   J. Biol. Chem. 283:28305-28312(2008).
RN   [22] {ECO:0000244|PDB:3HRN, ECO:0000244|PDB:3HRO}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 833-872, COILED COIL,
RP   SUBCELLULAR LOCATION, SUBUNIT, AND MUTAGENESIS OF LEU-842; VAL-846;
RP   MET-849; ILE-860; VAL-863 AND LEU-867.
RX   PubMed=19556541; DOI=10.1073/pnas.0903684106;
RA   Yu Y., Ulbrich M.H., Li M.H., Buraei Z., Chen X.Z., Ong A.C., Tong L.,
RA   Isacoff E.Y., Yang J.;
RT   "Structural and molecular basis of the assembly of the TRPP2/PKD1
RT   complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:11558-11563(2009).
RN   [23] {ECO:0000244|PDB:2KQ6}
RP   STRUCTURE BY NMR OF 720-797.
RX   PubMed=20439752; DOI=10.1073/pnas.0912295107;
RA   Petri E.T., Celic A., Kennedy S.D., Ehrlich B.E., Boggon T.J.,
RA   Hodsdon M.E.;
RT   "Structure of the EF-hand domain of polycystin-2 suggests a mechanism
RT   for Ca2+-dependent regulation of polycystin-2 channel activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:9176-9181(2010).
RN   [24] {ECO:0000244|PDB:2Y4Q}
RP   STRUCTURE BY NMR OF 717-792 IN COMPLEX WITH CALCIUM, DOMAIN, AND
RP   MUTAGENESIS OF GLN-768 AND GLU-774.
RX   PubMed=24990821; DOI=10.1002/PRO.2513;
RA   Allen M.D., Qamar S., Vadivelu M.K., Sandford R.N., Bycroft M.;
RT   "A high-resolution structure of the EF-hand domain of human
RT   polycystin-2.";
RL   Protein Sci. 23:1301-1308(2014).
RN   [25] {ECO:0000244|PDB:5T4D}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.00 ANGSTROMS) OF 198-702, SUBUNIT,
RP   SUBCELLULAR LOCATION, TOPOLOGY, GLYCOSYLATION AT ASN-328; ASN-362 AND
RP   ASN-375, AND DISULFIDE BONDS.
RX   PubMed=27768895; DOI=10.1016/j.cell.2016.09.048;
RA   Shen P.S., Yang X., DeCaen P.G., Liu X., Bulkley D., Clapham D.E.,
RA   Cao E.;
RT   "The structure of the polycystic kidney disease channel PKD2 in lipid
RT   nanodiscs.";
RL   Cell 167:763-773(2016).
RN   [26] {ECO:0000244|PDB:5K47}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.20 ANGSTROMS) OF 185-723,
RP   FUNCTION, SUBUNIT, TOPOLOGY, AND GLYCOSYLATION AT ASN-328; ASN-362 AND
RP   ASN-375.
RX   PubMed=27991905; DOI=10.1038/nsmb.3343;
RA   Grieben M., Pike A.C., Shintre C.A., Venturi E., El-Ajouz S.,
RA   Tessitore A., Shrestha L., Mukhopadhyay S., Mahajan P., Chalk R.,
RA   Burgess-Brown N.A., Sitsapesan R., Huiskonen J.T., Carpenter E.P.;
RT   "Structure of the polycystic kidney disease TRP channel polycystin-2
RT   (PC2).";
RL   Nat. Struct. Mol. Biol. 24:114-122(2017).
RN   [27] {ECO:0000244|PDB:5MKE, ECO:0000244|PDB:5MKF}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.20 ANGSTROMS) IN COMPLEX WITH
RP   CALCIUM AND LIPIDS, SUBUNIT, SUBCELLULAR LOCATION, TOPOLOGY,
RP   GLYCOSYLATION AT ASN-299; ASN-305; ASN-328; ASN-362 AND ASN-375, AND
RP   DISULFIDE BONDS.
RX   PubMed=28092368; DOI=10.1038/nsmb.3357;
RA   Wilkes M., Madej M.G., Kreuter L., Rhinow D., Heinz V., De Sanctis S.,
RA   Ruppel S., Richter R.M., Joos F., Grieben M., Pike A.C.,
RA   Huiskonen J.T., Carpenter E.P., Kuhlbrandt W., Witzgall R.,
RA   Ziegler C.;
RT   "Molecular insights into lipid-assisted Ca2+ regulation of the TRP
RT   channel polycystin-2.";
RL   Nat. Struct. Mol. Biol. 24:123-130(2017).
RN   [28]
RP   VARIANT PKD2 GLY-414.
RX   PubMed=9326320; DOI=10.1086/515497;
RA   Veldhuisen B., Saris J.J., de Haij S., Hayashi T., Reynolds D.M.,
RA   Mochizuki T., Elles R., Fossdal R., Bogdanova N., van Dijk M.A.,
RA   Coto E., Ravine D., Noerby S., Verellen-Dumoulin C., Breuning M.H.,
RA   Somlo S., Peters D.J.M.;
RT   "A spectrum of mutations in the second gene for autosomal dominant
RT   polycystic kidney disease (PKD2).";
RL   Am. J. Hum. Genet. 61:547-555(1997).
RN   [29]
RP   VARIANT PKD2 VAL-511.
RX   PubMed=10541293;
RA   Reynolds D.M., Hayashi T., Cai Y., Veldhuisen B., Watnick T.J.,
RA   Lens X.M., Mochizuki T., Qian F., Maeda Y., Li L., Fossdal R.,
RA   Coto E., Wu G., Breuning M.H., Germino G.G., Peters D.J.M., Somlo S.;
RT   "Aberrant splicing in the PKD2 gene as a cause of polycystic kidney
RT   disease.";
RL   J. Am. Soc. Nephrol. 10:2342-2351(1999).
RN   [30]
RP   VARIANT PKD2 PRO-356, AND VARIANT PRO-28.
RX   PubMed=10411676; DOI=10.1046/j.1523-1755.1999.00534.x;
RA   Torra R., Viribay M., Telleria D., Badenas C., Watson M., Harris P.C.,
RA   Darnell A., San Millan J.L.;
RT   "Seven novel mutations of the PKD2 gene in families with autosomal
RT   dominant polycystic kidney disease.";
RL   Kidney Int. 56:28-33(1999).
RN   [31]
RP   VARIANTS PKD2 ILE-479 DEL; 504-ARG--VAL-512 DEL AND TYR-684 DEL.
RX   PubMed=10835625; DOI=10.1038/75981;
RA   Watnick T.J., He N., Wang K., Liang Y., Parfrey P., Hefferton D.,
RA   St George-Hyslop P.H., Germino G.G., Pei Y.;
RT   "Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of
RT   trans-heterozygous mutations.";
RL   Nat. Genet. 25:143-144(2000).
RN   [32]
RP   VARIANT PKD2 TRP-322, AND VARIANTS LEU-24; PRO-28 AND LEU-800.
RX   PubMed=11968093; DOI=10.1002/humu.9035;
RA   Reiterova J., Stekrova J., Peters D.J.M., Kapras J., Kohoutova M.,
RA   Merta M., Zidovska J.;
RT   "Four novel mutations of the PKD2 gene in Czech families with
RT   autosomal dominant polycystic kidney disease.";
RL   Hum. Mutat. 19:573-573(2002).
RN   [33]
RP   VARIANTS PKD2 PRO-356; GLY-414; ARG-632 AND GLN-807.
RX   PubMed=12707387; DOI=10.1097/01.ASN.0000061774.90975.25;
RA   Magistroni R., He N., Wang K., Andrew R., Johnson A., Gabow P.,
RA   Dicks E., Parfrey P., Torra R., San-Millan J.L., Coto E., Van Dijk M.,
RA   Breuning M., Peters D., Bogdanova N., Ligabue G., Albertazzi A.,
RA   Hateboer N., Demetriou K., Pierides A., Deltas C.,
RA   St George-Hyslop P., Ravine D., Pei Y.;
RT   "Genotype-renal function correlation in type 2 autosomal dominant
RT   polycystic kidney disease.";
RL   J. Am. Soc. Nephrol. 14:1164-1174(2003).
RN   [34]
RP   VARIANTS PKD2 GLN-306 AND GLY-420, AND VARIANT PRO-28.
RX   PubMed=14993477; DOI=10.1093/ndt/gfh083;
RA   Stekrova J., Reiterova J., Merta M., Damborsky J., Zidovska J.,
RA   Kebrdlova V., Kohoutova M.;
RT   "PKD2 mutations in a Czech population with autosomal dominant
RT   polycystic kidney disease.";
RL   Nephrol. Dial. Transplant. 19:1116-1122(2004).
RN   [35]
RP   VARIANT PKD2 GLN-322.
RX   PubMed=15772804; DOI=10.1007/s00109-005-0644-6;
RA   Peltola P., Lumiaho A., Miettinen R., Pihlajamaeki J., Sandford R.,
RA   Laakso M.;
RT   "Genetics and phenotypic characteristics of autosomal dominant
RT   polycystic kidney disease in Finns.";
RL   J. Mol. Med. 83:638-646(2005).
RN   [36]
RP   VARIANTS PRO-28; THR-190 AND CYS-482.
RX   PubMed=18837007; DOI=10.1002/humu.20842;
RA   Tan Y.-C., Blumenfeld J.D., Anghel R., Donahue S., Belenkaya R.,
RA   Balina M., Parker T., Levine D., Leonard D.G.B., Rennert H.;
RT   "Novel method for genomic analysis of PKD1 and PKD2 mutations in
RT   autosomal dominant polycystic kidney disease.";
RL   Hum. Mutat. 30:264-273(2009).
RN   [37]
RP   VARIANT PKD2 PRO-384.
RX   PubMed=21115670; DOI=10.1093/ndt/gfq720;
RA   Hoefele J., Mayer K., Scholz M., Klein H.G.;
RT   "Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney
RT   disease (ADPKD).";
RL   Nephrol. Dial. Transplant. 26:2181-2188(2011).
CC   -!- FUNCTION: Functions as a cation channel involved in fluid-flow
CC       mechanosensation by the primary cilium in renal epithelium
CC       (PubMed:18695040). Functions as outward-rectifying K(+) channel,
CC       but is also permeable to Ca(2+), and to a much lesser degree also
CC       to Na(+) (PubMed:11854751, PubMed:15692563, PubMed:27071085,
CC       PubMed:27991905). May contribute to the release of Ca(2+) stores
CC       from the endoplasmic reticulum (PubMed:11854751, PubMed:20881056).
CC       Together with TRPV4, forms mechano- and thermosensitive channels
CC       in cilium (PubMed:18695040). PKD1 and PKD2 may function through a
CC       common signaling pathway that is necessary to maintain the normal,
CC       differentiated state of renal tubule cells. Acts as a regulator of
CC       cilium length, together with PKD1. The dynamic control of cilium
CC       length is essential in the regulation of mechanotransductive
CC       signaling. The cilium length response creates a negative feedback
CC       loop whereby fluid shear-mediated deflection of the primary
CC       cilium, which decreases intracellular cAMP, leads to cilium
CC       shortening and thus decreases flow-induced signaling. Also
CC       involved in left-right axis specification via its role in sensing
CC       nodal flow; forms a complex with PKD1L1 in cilia to facilitate
CC       flow detection in left-right patterning. Detection of asymmetric
CC       nodal flow gives rise to a Ca(2+) signal that is required for
CC       normal, asymmetric expression of genes involved in the
CC       specification of body left-right laterality (By similarity).
CC       {ECO:0000250|UniProtKB:O35245, ECO:0000269|PubMed:11854751,
CC       ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:16551655,
CC       ECO:0000269|PubMed:18695040, ECO:0000269|PubMed:20881056,
CC       ECO:0000269|PubMed:27991905, ECO:0000305}.
CC   -!- ENZYME REGULATION: Channnel activity is regulated by
CC       phosphorylation (PubMed:16551655, PubMed:20881056,
CC       PubMed:26269590). Channnel activity is regulated by intracellular
CC       Ca(2+) (PubMed:11854751). {ECO:0000269|PubMed:11854751,
CC       ECO:0000269|PubMed:16551655, ECO:0000269|PubMed:20881056,
CC       ECO:0000269|PubMed:26269590}.
CC   -!- SUBUNIT: Homotetramer (PubMed:20881056, PubMed:27768895,
CC       PubMed:27991905, PubMed:28092368). Interacts with PKD1, giving
CC       rise to a complex formed by one PKD1 chain and a PKD2 homooligomer
CC       (PubMed:20881056, PubMed:19556541). In vitro results suggest
CC       assembly of a complex composed of one PKD1 chain and a PKD2
CC       trimer; the physiological significance of this is uncertain
CC       (PubMed:19556541). Isoform 1 interacts with PKD1 while isoform 3
CC       does not (By similarity). Interacts with PKD1L1. PKD1 requires the
CC       presence of PKD2 for stable expression (By similarity). Interacts
CC       with CD2AP (PubMed:10913159). Interacts with HAX1
CC       (PubMed:10760273). Interacts with NEK8 (By similarity). Part of a
CC       complex containing AKAP5, ADCY5, ADCY6 and PDE4C (By similarity).
CC       Interacts (via C-terminus) with TRPV4 (via C-terminus)
CC       (PubMed:18695040). Interacts (via C-terminal acidic region) with
CC       PACS1 and PACS2; these interactions retain the protein in the
CC       endoplasmic reticulum and prevent trafficking to the cell membrane
CC       (PubMed:15692563). {ECO:0000250|UniProtKB:O35245,
CC       ECO:0000269|PubMed:10760273, ECO:0000269|PubMed:10913159,
CC       ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:18695040,
CC       ECO:0000269|PubMed:19556541, ECO:0000269|PubMed:20881056,
CC       ECO:0000269|PubMed:27768895, ECO:0000269|PubMed:27991905,
CC       ECO:0000269|PubMed:28092368}.
CC   -!- INTERACTION:
CC       Self; NbExp=8; IntAct=EBI-7813714, EBI-7813714;
CC       O35387:Hax1 (xeno); NbExp=3; IntAct=EBI-7813714, EBI-642449;
CC       Q02363:ID2; NbExp=7; IntAct=EBI-7813714, EBI-713450;
CC       Q91908:itpr1 (xeno); NbExp=2; IntAct=EBI-7813714, EBI-9633447;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-7813714, EBI-10171697;
CC       P60410:KRTAP10-8; NbExp=3; IntAct=EBI-7813714, EBI-10171774;
CC       P43361:MAGEA8; NbExp=3; IntAct=EBI-7813714, EBI-10182930;
CC       P98161:PKD1; NbExp=8; IntAct=EBI-7813714, EBI-1752013;
CC       P98161-3:PKD1; NbExp=4; IntAct=EBI-9837017, EBI-15930070;
CC       O08852:Pkd1 (xeno); NbExp=2; IntAct=EBI-9837017, EBI-6666305;
CC       O15162:PLSCR1; NbExp=3; IntAct=EBI-7813714, EBI-740019;
CC       J9P3Y7:RYR2 (xeno); NbExp=2; IntAct=EBI-9837017, EBI-15630134;
CC       P48995:TRPC1; NbExp=3; IntAct=EBI-7813714, EBI-929665;
CC       P48995-2:TRPC1; NbExp=4; IntAct=EBI-7813714, EBI-9830970;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium membrane
CC       {ECO:0000269|PubMed:18695040, ECO:0000269|PubMed:20881056,
CC       ECO:0000269|PubMed:27259053}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:27768895, ECO:0000269|PubMed:27991905,
CC       ECO:0000269|PubMed:28092368}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10760273, ECO:0000269|PubMed:11854751,
CC       ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:20881056,
CC       ECO:0000269|PubMed:28092368, ECO:0000305|PubMed:10913159}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:27768895,
CC       ECO:0000269|PubMed:27991905, ECO:0000269|PubMed:28092368}. Cell
CC       membrane {ECO:0000269|PubMed:15692563,
CC       ECO:0000269|PubMed:19556541, ECO:0000269|PubMed:26269590,
CC       ECO:0000269|PubMed:27071085, ECO:0000269|PubMed:27259053,
CC       ECO:0000269|PubMed:28092368}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:27768895, ECO:0000269|PubMed:27991905,
CC       ECO:0000269|PubMed:28092368}. Basolateral cell membrane
CC       {ECO:0000269|PubMed:10770959}. Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:10770959}. Note=Retained in the endoplasmic
CC       reticulum by interaction with PACS1 and PACS2 (PubMed:15692563).
CC       Detected on kidney tubule basolateral membranes and basal
CC       cytoplasmic vesicles (PubMed:10770959). Cell surface and cilium
CC       localization requires GANAB (PubMed:27259053).
CC       {ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:27259053}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q13563-1; Sequence=Displayed;
CC       Name=2; Synonyms=delta6;
CC         IsoId=Q13563-2; Sequence=VSP_042479, VSP_042480;
CC       Name=3; Synonyms=delta7;
CC         IsoId=Q13563-3; Sequence=VSP_042481;
CC       Name=4; Synonyms=delta9;
CC         IsoId=Q13563-4; Sequence=VSP_042482, VSP_042483;
CC       Name=5; Synonyms=delta12/13;
CC         IsoId=Q13563-5; Sequence=VSP_042484;
CC         Note=Minor isoform.;
CC   -!- TISSUE SPECIFICITY: Detected in fetal and adult kidney
CC       (PubMed:10770959). Detected at the thick ascending limb of the
CC       loop of Henle, at distal tubules, including the distal convoluted
CC       tubule and cortical collecting tubules, with weak staining of the
CC       collecting duct (PubMed:10770959). Detected on placenta
CC       syncytiotrophoblasts (at protein level) (PubMed:26269590).
CC       Strongly expressed in ovary, fetal and adult kidney, testis, and
CC       small intestine. Not detected in peripheral leukocytes.
CC       {ECO:0000269|PubMed:10770959, ECO:0000269|PubMed:26269590,
CC       ECO:0000269|PubMed:8650545}.
CC   -!- DOMAIN: The C-terminal coiled-coil domain is involved in
CC       oligomerization and the interaction with PKD1 (PubMed:18694932,
CC       PubMed:19556541). The isolated coiled-coil domain forms a
CC       homotrimer in vitro; the homotrimer interacts with a single PKD1
CC       chain (PubMed:19556541). The coiled-coil domain binds calcium and
CC       undergoes a calcium-induced conformation change (in vitro)
CC       (PubMed:18694932). {ECO:0000269|PubMed:18694932,
CC       ECO:0000269|PubMed:19556541}.
CC   -!- PTM: Phosphorylated. Phosphorylation is important for protein
CC       function; a mutant that lacks the N-terminal phosphorylation sites
CC       cannot complement a zebrafish pkd2-deficient mutant
CC       (PubMed:16551655). PKD-mediated phosphorylation at the C-terminus
CC       regulates its function in the release of Ca(2+) stores from the
CC       endoplasmic reticulum (PubMed:20881056). PKA-mediated
CC       phosphorylation at a C-terminal site strongly increases the open
CC       probability of the channel, but does not increase single channel
CC       conductance (PubMed:26269590). {ECO:0000269|PubMed:16551655,
CC       ECO:0000269|PubMed:20881056, ECO:0000269|PubMed:26269590}.
CC   -!- PTM: N-glycosylated. The four subunits in a tetramer probably
CC       differ in the extent of glycosylation; simultaneous glycosylation
CC       of all experimentally validated sites would probably create steric
CC       hindrance. Thus, glycosylation at Asn-305 is not compatible with
CC       glycosylation at Asn-328; only one of these two residues is
CC       glycosylated at a given time. {ECO:0000269|PubMed:28092368}.
CC   -!- DISEASE: Polycystic kidney disease 2 (PKD2) [MIM:613095]: A
CC       disorder characterized by progressive formation and enlargement of
CC       cysts in both kidneys, typically leading to end-stage renal
CC       disease in adult life. Cysts also occurs in the liver and other
CC       organs. It represents approximately 15% of the cases of autosomal
CC       dominant polycystic kidney disease. PKD2 is clinically milder than
CC       PKD1 but it has a deleterious impact on overall life expectancy.
CC       {ECO:0000269|PubMed:10411676, ECO:0000269|PubMed:10541293,
CC       ECO:0000269|PubMed:10835625, ECO:0000269|PubMed:11854751,
CC       ECO:0000269|PubMed:11968093, ECO:0000269|PubMed:12707387,
CC       ECO:0000269|PubMed:14993477, ECO:0000269|PubMed:15772804,
CC       ECO:0000269|PubMed:21115670, ECO:0000269|PubMed:27071085,
CC       ECO:0000269|PubMed:9326320}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The mechanisms that govern channel opening are
CC       complex and still under debate; heterologous expression of PKD2 by
CC       itself or together with PKD1 gives rise to very low or
CC       undetectable spontaneous ion channel activity, in spite of its
CC       presence at the cell membrane. {ECO:0000269|PubMed:19556541,
CC       ECO:0000269|PubMed:27768895}.
CC   -!- SIMILARITY: Belongs to the polycystin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Polycystin 2 - Not a C-type lectin;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_205";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U50928; AAC50520.1; -; mRNA.
DR   EMBL; AF004873; AAC16004.1; -; Genomic_DNA.
DR   EMBL; AF004859; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004860; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004861; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004862; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004863; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004864; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004865; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004866; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004867; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004868; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004869; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004870; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004871; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; AF004872; AAC16004.1; JOINED; Genomic_DNA.
DR   EMBL; BC112261; AAI12262.1; -; mRNA.
DR   EMBL; BC112263; AAI12264.1; -; mRNA.
DR   EMBL; U56813; AAC50933.1; -; mRNA.
DR   CCDS; CCDS3627.1; -. [Q13563-1]
DR   PIR; G02640; G02640.
DR   RefSeq; NP_000288.1; NM_000297.3. [Q13563-1]
DR   UniGene; Hs.181272; -.
DR   PDB; 2KLD; NMR; -; A=680-796.
DR   PDB; 2KLE; NMR; -; A=680-796.
DR   PDB; 2KQ6; NMR; -; A=720-797.
DR   PDB; 2Y4Q; NMR; -; A=717-792.
DR   PDB; 3HRN; X-ray; 1.90 A; A=833-895.
DR   PDB; 3HRO; X-ray; 1.90 A; A=833-872.
DR   PDB; 5K47; EM; 4.20 A; A/B/C/D=185-723.
DR   PDB; 5MKE; EM; 4.30 A; A/B/C/D=1-968.
DR   PDB; 5MKF; EM; 4.20 A; A/B/C/D=1-968.
DR   PDB; 5T4D; EM; 3.00 A; A/B/C/D=198-702.
DR   PDBsum; 2KLD; -.
DR   PDBsum; 2KLE; -.
DR   PDBsum; 2KQ6; -.
DR   PDBsum; 2Y4Q; -.
DR   PDBsum; 3HRN; -.
DR   PDBsum; 3HRO; -.
DR   PDBsum; 5K47; -.
DR   PDBsum; 5MKE; -.
DR   PDBsum; 5MKF; -.
DR   PDBsum; 5T4D; -.
DR   ProteinModelPortal; Q13563; -.
DR   SMR; Q13563; -.
DR   BioGrid; 111328; 44.
DR   CORUM; Q13563; -.
DR   DIP; DIP-47455N; -.
DR   ELM; Q13563; -.
DR   IntAct; Q13563; 25.
DR   MINT; MINT-6618167; -.
DR   STRING; 9606.ENSP00000237596; -.
DR   BindingDB; Q13563; -.
DR   GuidetoPHARMACOLOGY; 504; -.
DR   TCDB; 1.A.5.2.1; the polycystin cation channel (pcc) family.
DR   iPTMnet; Q13563; -.
DR   PhosphoSitePlus; Q13563; -.
DR   BioMuta; PKD2; -.
DR   DMDM; 116242717; -.
DR   MaxQB; Q13563; -.
DR   PaxDb; Q13563; -.
DR   PeptideAtlas; Q13563; -.
DR   PRIDE; Q13563; -.
DR   DNASU; 5311; -.
DR   Ensembl; ENST00000237596; ENSP00000237596; ENSG00000118762. [Q13563-1]
DR   GeneID; 5311; -.
DR   KEGG; hsa:5311; -.
DR   UCSC; uc003hre.4; human. [Q13563-1]
DR   CTD; 5311; -.
DR   DisGeNET; 5311; -.
DR   EuPathDB; HostDB:ENSG00000118762.7; -.
DR   GeneCards; PKD2; -.
DR   GeneReviews; PKD2; -.
DR   HGNC; HGNC:9009; PKD2.
DR   HPA; CAB004544; -.
DR   HPA; HPA015794; -.
DR   MalaCards; PKD2; -.
DR   MIM; 173910; gene.
DR   MIM; 613095; phenotype.
DR   neXtProt; NX_Q13563; -.
DR   OpenTargets; ENSG00000118762; -.
DR   Orphanet; 730; Autosomal dominant polycystic kidney disease.
DR   PharmGKB; PA33343; -.
DR   eggNOG; KOG3599; Eukaryota.
DR   eggNOG; ENOG410XTGE; LUCA.
DR   GeneTree; ENSGT00700000104221; -.
DR   HOGENOM; HOG000230858; -.
DR   HOVERGEN; HBG014945; -.
DR   InParanoid; Q13563; -.
DR   KO; K04986; -.
DR   OMA; QAWSRDN; -.
DR   OrthoDB; EOG091G034F; -.
DR   PhylomeDB; Q13563; -.
DR   TreeFam; TF316484; -.
DR   Reactome; R-HSA-5620916; VxPx cargo-targeting to cilium.
DR   SIGNOR; Q13563; -.
DR   ChiTaRS; PKD2; human.
DR   EvolutionaryTrace; Q13563; -.
DR   GeneWiki; Polycystic_kidney_disease_2; -.
DR   GenomeRNAi; 5311; -.
DR   PRO; PR:Q13563; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000118762; -.
DR   CleanEx; HS_PKD2; -.
DR   ExpressionAtlas; Q13563; baseline and differential.
DR   Genevisible; Q13563; HS.
DR   GO; GO:0045180; C:basal cortex; IDA:BHF-UCL.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0036064; C:ciliary basal body; IDA:MGI.
DR   GO; GO:0060170; C:ciliary membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005929; C:cilium; ISS:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0071458; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; IDA:BHF-UCL.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IDA:BHF-UCL.
DR   GO; GO:0072686; C:mitotic spindle; IDA:BHF-UCL.
DR   GO; GO:0031514; C:motile cilium; ISS:BHF-UCL.
DR   GO; GO:0097730; C:non-motile cilium; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0002133; C:polycystin complex; ISS:BHF-UCL.
DR   GO; GO:0042805; F:actinin binding; IDA:BHF-UCL.
DR   GO; GO:0051117; F:ATPase binding; ISS:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0048763; F:calcium-induced calcium release activity; IDA:BHF-UCL.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IDA:BHF-UCL.
DR   GO; GO:0043398; F:HLH domain binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0051371; F:muscle alpha-actinin binding; IEA:Ensembl.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0005102; F:receptor binding; IPI:BHF-UCL.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:BHF-UCL.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; IDA:BHF-UCL.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IDA:BHF-UCL.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IDA:BHF-UCL.
DR   GO; GO:0035904; P:aorta development; IEP:UniProtKB.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEP:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0006816; P:calcium ion transport; IDA:BHF-UCL.
DR   GO; GO:0007050; P:cell cycle arrest; ISS:BHF-UCL.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; IMP:UniProtKB.
DR   GO; GO:0071498; P:cellular response to fluid shear stress; IMP:BHF-UCL.
DR   GO; GO:0071464; P:cellular response to hydrostatic pressure; IDA:BHF-UCL.
DR   GO; GO:0071470; P:cellular response to osmotic stress; IDA:BHF-UCL.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; NAS:BHF-UCL.
DR   GO; GO:0051298; P:centrosome duplication; NAS:BHF-UCL.
DR   GO; GO:0042994; P:cytoplasmic sequestering of transcription factor; IMP:BHF-UCL.
DR   GO; GO:0050982; P:detection of mechanical stimulus; ISS:BHF-UCL.
DR   GO; GO:0003127; P:detection of nodal flow; ISS:BHF-UCL.
DR   GO; GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL.
DR   GO; GO:0071910; P:determination of liver left/right asymmetry; IMP:BHF-UCL.
DR   GO; GO:0001892; P:embryonic placenta development; ISS:BHF-UCL.
DR   GO; GO:0007507; P:heart development; IEP:UniProtKB.
DR   GO; GO:0001947; P:heart looping; IMP:BHF-UCL.
DR   GO; GO:0007259; P:JAK-STAT cascade; ISS:BHF-UCL.
DR   GO; GO:0001889; P:liver development; IEP:UniProtKB.
DR   GO; GO:0072177; P:mesonephric duct development; IEP:UniProtKB.
DR   GO; GO:0072164; P:mesonephric tubule development; IEP:UniProtKB.
DR   GO; GO:0072218; P:metanephric ascending thin limb development; IEP:UniProtKB.
DR   GO; GO:0072214; P:metanephric cortex development; IEP:UniProtKB.
DR   GO; GO:0072219; P:metanephric cortical collecting duct development; IEP:UniProtKB.
DR   GO; GO:0072235; P:metanephric distal tubule development; IEP:UniProtKB.
DR   GO; GO:0072075; P:metanephric mesenchyme development; IEP:UniProtKB.
DR   GO; GO:0035502; P:metanephric part of ureteric bud development; IEP:UniProtKB.
DR   GO; GO:0072284; P:metanephric S-shaped body morphogenesis; IEP:UniProtKB.
DR   GO; GO:0072208; P:metanephric smooth muscle tissue development; IEP:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; NAS:BHF-UCL.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IMP:BHF-UCL.
DR   GO; GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; ISS:BHF-UCL.
DR   GO; GO:0021915; P:neural tube development; IEP:UniProtKB.
DR   GO; GO:0060674; P:placenta blood vessel development; ISS:BHF-UCL.
DR   GO; GO:0071158; P:positive regulation of cell cycle arrest; IMP:BHF-UCL.
DR   GO; GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL.
DR   GO; GO:0031587; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IMP:BHF-UCL.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0090279; P:regulation of calcium ion import; IDA:BHF-UCL.
DR   GO; GO:0030814; P:regulation of cAMP metabolic process; ISS:BHF-UCL.
DR   GO; GO:0042127; P:regulation of cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:BHF-UCL.
DR   GO; GO:0061441; P:renal artery morphogenesis; IEP:UniProtKB.
DR   GO; GO:0061333; P:renal tubule morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0021510; P:spinal cord development; IEP:UniProtKB.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   InterPro; IPR003915; PKD_2.
DR   Pfam; PF08016; PKD_channel; 1.
DR   PRINTS; PR01433; POLYCYSTIN2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Cell membrane; Cell projection; Ciliopathy; Cilium;
KW   Coiled coil; Complete proteome; Cytoplasmic vesicle;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Ion channel; Ion transport;
KW   Membrane; Metal-binding; Methylation; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    968       Polycystin-2.
FT                                /FTId=PRO_0000164356.
FT   TOPO_DOM      1    219       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TRANSMEM    220    241       Helical; Name=S1.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    242    468       Extracellular.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TRANSMEM    469    489       Helical; Name=S2.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    490    505       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TRANSMEM    506    526       Helical; Name=S3.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    527    552       Extracellular.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TRANSMEM    553    573       Helical; Name=S4.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    574    597       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TRANSMEM    598    619       Helical; Name=5.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    620    631       Extracellular.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   INTRAMEM    632    646       Pore-forming.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    647    654       Extracellular.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TRANSMEM    655    675       Helical; Name=S6.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   TOPO_DOM    676    968       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   DOMAIN      750    785       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448,
FT                                ECO:0000269|PubMed:18694932,
FT                                ECO:0000269|PubMed:24990821}.
FT   CA_BIND     763    774       {ECO:0000244|PDB:2Y4Q,
FT                                ECO:0000255|PROSITE-ProRule:PRU00448,
FT                                ECO:0000269|PubMed:18694932,
FT                                ECO:0000269|PubMed:24990821}.
FT   REGION      803    822       Linker. {ECO:0000305|PubMed:18694932}.
FT   REGION      810    821       Important for interaction with PACS1 and
FT                                PACS2. {ECO:0000269|PubMed:15692563}.
FT   COILED      833    872       {ECO:0000269|PubMed:19556541,
FT                                ECO:0000305|PubMed:18694932}.
FT   MOTIF       641    643       Selectivity filter.
FT                                {ECO:0000305|PubMed:28092368}.
FT   COMPBIAS     95    107       Poly-Glu.
FT   COMPBIAS    153    157       Poly-Arg.
FT   METAL       763    763       Calcium. {ECO:0000244|PDB:2Y4Q,
FT                                ECO:0000269|PubMed:24990821}.
FT   METAL       765    765       Calcium. {ECO:0000244|PDB:2Y4Q,
FT                                ECO:0000269|PubMed:24990821}.
FT   METAL       767    767       Calcium. {ECO:0000244|PDB:2Y4Q,
FT                                ECO:0000269|PubMed:24990821}.
FT   METAL       769    769       Calcium; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:2Y4Q,
FT                                ECO:0000269|PubMed:24990821}.
FT   METAL       774    774       Calcium. {ECO:0000244|PDB:2Y4Q,
FT                                ECO:0000269|PubMed:24990821}.
FT   MOD_RES      76     76       Phosphoserine.
FT                                {ECO:0000269|PubMed:16551655}.
FT   MOD_RES      80     80       Phosphoserine.
FT                                {ECO:0000305|PubMed:16551655}.
FT   MOD_RES     137    137       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:O35245}.
FT   MOD_RES     801    801       Phosphoserine.
FT                                {ECO:0000269|PubMed:20881056,
FT                                ECO:0000305|PubMed:16551655}.
FT   MOD_RES     808    808       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35245}.
FT   MOD_RES     812    812       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000305|PubMed:15692563,
FT                                ECO:0000305|PubMed:16551655}.
FT   MOD_RES     829    829       Phosphoserine.
FT                                {ECO:0000305|PubMed:26269590}.
FT   CARBOHYD    299    299       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:28092368}.
FT   CARBOHYD    305    305       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:28092368}.
FT   CARBOHYD    328    328       N-linked (GlcNAc...) (complex)
FT                                asparagine. {ECO:0000269|PubMed:19139490,
FT                                ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   CARBOHYD    362    362       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   CARBOHYD    375    375       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:27991905,
FT                                ECO:0000269|PubMed:28092368}.
FT   DISULFID    331    344       {ECO:0000244|PDB:5MKF,
FT                                ECO:0000244|PDB:5T4D,
FT                                ECO:0000269|PubMed:27768895,
FT                                ECO:0000269|PubMed:28092368}.
FT   VAR_SEQ     476    483       CEIIFCFF -> FICSSYGD (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_042479.
FT   VAR_SEQ     484    968       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_042480.
FT   VAR_SEQ     517    572       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_042481.
FT   VAR_SEQ     633    646       IFTQFRIILGDINF -> IICSWRSSMIRTLK (in
FT                                isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_042482.
FT   VAR_SEQ     647    968       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_042483.
FT   VAR_SEQ     748    841       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_042484.
FT   VARIANT      24     24       P -> L (in dbSNP:rs1004860210).
FT                                {ECO:0000269|PubMed:11968093}.
FT                                /FTId=VAR_058820.
FT   VARIANT      28     28       R -> P (common polymorphism;
FT                                dbSNP:rs1805044).
FT                                {ECO:0000269|PubMed:10411676,
FT                                ECO:0000269|PubMed:11968093,
FT                                ECO:0000269|PubMed:14993477,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_011072.
FT   VARIANT     190    190       A -> T (in dbSNP:rs117078377).
FT                                {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058821.
FT   VARIANT     306    306       R -> Q (in PKD2; dbSNP:rs990932947).
FT                                {ECO:0000269|PubMed:14993477}.
FT                                /FTId=VAR_058822.
FT   VARIANT     322    322       R -> Q (in PKD2; dbSNP:rs145877597).
FT                                {ECO:0000269|PubMed:15772804}.
FT                                /FTId=VAR_058823.
FT   VARIANT     322    322       R -> W (in PKD2).
FT                                {ECO:0000269|PubMed:11968093}.
FT                                /FTId=VAR_058824.
FT   VARIANT     356    356       A -> P (in PKD2).
FT                                {ECO:0000269|PubMed:10411676,
FT                                ECO:0000269|PubMed:12707387}.
FT                                /FTId=VAR_011073.
FT   VARIANT     384    384       A -> P (in PKD2).
FT                                {ECO:0000269|PubMed:21115670}.
FT                                /FTId=VAR_064394.
FT   VARIANT     414    414       W -> G (in PKD2; affects channel activity
FT                                as it is able to abolish channel currents
FT                                induced by the gain-of-function
FT                                artificial mutant P-604).
FT                                {ECO:0000269|PubMed:12707387,
FT                                ECO:0000269|PubMed:27071085,
FT                                ECO:0000269|PubMed:9326320}.
FT                                /FTId=VAR_009195.
FT   VARIANT     420    420       R -> G (in PKD2; affects channel activity
FT                                as it is able to abolish channel currents
FT                                induced by the gain-of-function
FT                                artificial mutant P-604).
FT                                {ECO:0000269|PubMed:14993477,
FT                                ECO:0000269|PubMed:27071085}.
FT                                /FTId=VAR_058825.
FT   VARIANT     452    452       I -> V (in dbSNP:rs1801612).
FT                                /FTId=VAR_014919.
FT   VARIANT     479    479       Missing (in PKD2; somatic mutation).
FT                                {ECO:0000269|PubMed:10835625}.
FT                                /FTId=VAR_011074.
FT   VARIANT     482    482       F -> C (in dbSNP:rs75762896).
FT                                {ECO:0000269|PubMed:18837007}.
FT                                /FTId=VAR_058826.
FT   VARIANT     504    512       Missing (in PKD2; somatic mutation).
FT                                {ECO:0000269|PubMed:10835625}.
FT                                /FTId=VAR_011075.
FT   VARIANT     511    511       D -> V (in PKD2; loss of function in the
FT                                release of Ca(2+) stores from the
FT                                endoplasmic reticulum; no effect on
FT                                location at the endoplasmic reticulum;
FT                                affects channel activity as it is able to
FT                                abolish channel currents induced by the
FT                                gain-of-function artificial mutant P-604;
FT                                dbSNP:rs121918043).
FT                                {ECO:0000269|PubMed:10541293,
FT                                ECO:0000269|PubMed:11854751,
FT                                ECO:0000269|PubMed:27071085}.
FT                                /FTId=VAR_058827.
FT   VARIANT     632    632       C -> R (in PKD2).
FT                                {ECO:0000269|PubMed:12707387}.
FT                                /FTId=VAR_058828.
FT   VARIANT     684    684       Missing (in PKD2; somatic mutation).
FT                                {ECO:0000269|PubMed:10835625}.
FT                                /FTId=VAR_011076.
FT   VARIANT     800    800       M -> L (in dbSNP:rs2234917).
FT                                {ECO:0000269|PubMed:11968093}.
FT                                /FTId=VAR_058829.
FT   VARIANT     807    807       R -> Q (in PKD2; dbSNP:rs147654263).
FT                                {ECO:0000269|PubMed:12707387}.
FT                                /FTId=VAR_058830.
FT   MUTAGEN      76     76       S->A: Abolishes phosphorylation of the N-
FT                                terminal domain. Abolishes the ability to
FT                                complement a pkd2-deficient zebrafish
FT                                mutant; when associated with A-80.
FT                                {ECO:0000269|PubMed:16551655}.
FT   MUTAGEN      80     80       S->A: Decreases phosphorylation of the N-
FT                                terminal domain. Abolishes the ability to
FT                                complement a pkd2-deficient zebrafish
FT                                mutant; when associated with A-76.
FT                                {ECO:0000269|PubMed:16551655}.
FT   MUTAGEN     604    604       F->A,I: No effect on channel activation.
FT                                {ECO:0000269|PubMed:27071085}.
FT   MUTAGEN     604    604       F->P: Gain-of-function mutation resulting
FT                                in increased channel activity. Absence of
FT                                gain of function; when associated with F-
FT                                605 DEL; when associated with V-511; when
FT                                associated with G-414; when associated
FT                                with G-420. Increased channel activity;
FT                                when associated with 736-L-N-737 DEL.
FT                                {ECO:0000269|PubMed:27071085}.
FT   MUTAGEN     605    605       Missing: Abolishes increased channel
FT                                activity due to a gain of function
FT                                mutation; when associated with P-604.
FT                                {ECO:0000269|PubMed:27071085}.
FT   MUTAGEN     721    721       T->A: Decreases phosphorylation; when
FT                                associated with A-801; A-812; A-831 and
FT                                A-943. {ECO:0000269|PubMed:16551655}.
FT   MUTAGEN     736    737       Missing: Increased channel activity; when
FT                                associated with P-604.
FT                                {ECO:0000269|PubMed:27071085}.
FT   MUTAGEN     768    768       Q->G: Strongly increases calcium binding
FT                                affinity. {ECO:0000269|PubMed:24990821}.
FT   MUTAGEN     771    771       T->A: Loss of calcium-binding site; when
FT                                associated with A-774.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     774    774       E->A: Loss of calcium-binding site; when
FT                                associated with A-771.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     774    774       E->Q: Abolishes calcium binding via the
FT                                EF-hand. {ECO:0000269|PubMed:24990821}.
FT   MUTAGEN     801    801       S->A: Decreases phosphorylation; when
FT                                associated with A-721; A-812; A-831 and
FT                                A-943. {ECO:0000269|PubMed:16551655}.
FT   MUTAGEN     801    801       S->D: Phosphomimetic mutant. No effect on
FT                                release of Ca(2+) stores from the
FT                                endoplasmic reticulum.
FT                                {ECO:0000269|PubMed:20881056}.
FT   MUTAGEN     801    801       S->G: Loss of phosphorylation at this
FT                                site. Impairs release of Ca(2+) stores
FT                                from the endoplasmic reticulum.
FT                                {ECO:0000269|PubMed:20881056}.
FT   MUTAGEN     804    804       S->N: Loss of phosphorylation at Ser-801.
FT                                {ECO:0000269|PubMed:20881056}.
FT   MUTAGEN     812    812       S->A: Decreases interaction with PACS1
FT                                and enhances expression at the cell
FT                                membrane. Decreases phosphorylation; when
FT                                associated with A-721; A-801; A-831 and
FT                                A-943. {ECO:0000269|PubMed:15692563,
FT                                ECO:0000269|PubMed:16551655}.
FT   MUTAGEN     812    812       S->D: No effect on interaction with
FT                                PACS1. {ECO:0000269|PubMed:15692563}.
FT   MUTAGEN     815    817       DDD->AAA: Strongly decreases interaction
FT                                with PACS1 and enhances expression at the
FT                                cell membrane.
FT                                {ECO:0000269|PubMed:15692563}.
FT   MUTAGEN     829    829       S->A: Abolishes increased channel opening
FT                                in response to cAMP and phosphorylation
FT                                by PKA. {ECO:0000269|PubMed:26269590}.
FT   MUTAGEN     831    831       S->A: Decreases phosphorylation; when
FT                                associated with A-721; A-801; A-812 and
FT                                A-943. {ECO:0000269|PubMed:16551655}.
FT   MUTAGEN     842    842       L->A: Abolishes oligomerization and
FT                                interaction with PKD1; when associated
FT                                with A-846; A-849; A-860; A-863 and A-
FT                                867. {ECO:0000269|PubMed:19556541}.
FT   MUTAGEN     842    842       L->P: Loss of protein solubility.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     846    846       V->A: Abolishes oligomerization and
FT                                interaction with PKD1; when associated
FT                                with A-842; A-849; A-860; A-863 and A-
FT                                867. {ECO:0000269|PubMed:19556541}.
FT   MUTAGEN     846    846       V->E: Loss of protein solubility.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     849    849       M->A: Abolishes oligomerization and
FT                                interaction with PKD1; when associated
FT                                with A-842; A-846; A-860; A-863 and A-
FT                                867. {ECO:0000269|PubMed:19556541}.
FT   MUTAGEN     849    849       M->K: Loss of protein solubility.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     853    853       I->P: Loss of protein solubility.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     856    856       I->K: Loss of protein solubility.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     860    860       I->A: Abolishes oligomerization and
FT                                interaction with PKD1; when associated
FT                                with A-842; A-846; A-849; A-863 and A-
FT                                867. {ECO:0000269|PubMed:19556541}.
FT   MUTAGEN     863    863       V->A: Abolishes oligomerization and
FT                                interaction with PKD1; when associated
FT                                with A-842; A-846; A-849; A-860 and A-
FT                                867. {ECO:0000269|PubMed:19556541}.
FT   MUTAGEN     863    863       V->E: Loss of protein solubility; when
FT                                associated with K-849.
FT                                {ECO:0000269|PubMed:18694932}.
FT   MUTAGEN     867    867       L->A: Abolishes oligomerization and
FT                                interaction with PKD1; when associated
FT                                with A-842; A-846; A-849; A-860 and A-
FT                                863. {ECO:0000269|PubMed:19556541}.
FT   MUTAGEN     943    943       S->A: Decreases phosphorylation; when
FT                                associated with A-721; A-801; A-812 and
FT                                A-831. {ECO:0000269|PubMed:16551655}.
FT   CONFLICT     45     45       G -> R (in Ref. 2; AAC16004).
FT                                {ECO:0000305}.
FT   CONFLICT    449    449       G -> V (in Ref. 4; AAC50933).
FT                                {ECO:0000305}.
FT   HELIX       217    241       {ECO:0000244|PDB:5T4D}.
FT   HELIX       246    257       {ECO:0000244|PDB:5T4D}.
FT   HELIX       276    283       {ECO:0000244|PDB:5T4D}.
FT   HELIX       286    291       {ECO:0000244|PDB:5T4D}.
FT   STRAND      304    306       {ECO:0000244|PDB:5T4D}.
FT   TURN        310    312       {ECO:0000244|PDB:5T4D}.
FT   STRAND      313    326       {ECO:0000244|PDB:5T4D}.
FT   HELIX       328    330       {ECO:0000244|PDB:5T4D}.
FT   HELIX       335    337       {ECO:0000244|PDB:5T4D}.
FT   TURN        338    340       {ECO:0000244|PDB:5T4D}.
FT   TURN        350    352       {ECO:0000244|PDB:5T4D}.
FT   TURN        364    366       {ECO:0000244|PDB:5T4D}.
FT   TURN        371    373       {ECO:0000244|PDB:5T4D}.
FT   STRAND      390    394       {ECO:0000244|PDB:5T4D}.
FT   HELIX       399    411       {ECO:0000244|PDB:5T4D}.
FT   STRAND      419    430       {ECO:0000244|PDB:5T4D}.
FT   TURN        431    434       {ECO:0000244|PDB:5T4D}.
FT   STRAND      435    444       {ECO:0000244|PDB:5T4D}.
FT   STRAND      452    460       {ECO:0000244|PDB:5T4D}.
FT   HELIX       468    491       {ECO:0000244|PDB:5T4D}.
FT   HELIX       506    527       {ECO:0000244|PDB:5T4D}.
FT   TURN        528    530       {ECO:0000244|PDB:5T4D}.
FT   HELIX       533    540       {ECO:0000244|PDB:5T4D}.
FT   HELIX       549    571       {ECO:0000244|PDB:5T4D}.
FT   HELIX       572    579       {ECO:0000244|PDB:5T4D}.
FT   HELIX       581    618       {ECO:0000244|PDB:5T4D}.
FT   STRAND      619    622       {ECO:0000244|PDB:5T4D}.
FT   HELIX       624    626       {ECO:0000244|PDB:5T4D}.
FT   HELIX       629    641       {ECO:0000244|PDB:5T4D}.
FT   HELIX       647    652       {ECO:0000244|PDB:5T4D}.
FT   HELIX       656    669       {ECO:0000244|PDB:5T4D}.
FT   TURN        670    672       {ECO:0000244|PDB:5T4D}.
FT   HELIX       673    692       {ECO:0000244|PDB:5T4D}.
FT   TURN        730    734       {ECO:0000244|PDB:2KLD}.
FT   HELIX       738    744       {ECO:0000244|PDB:2KLD}.
FT   TURN        745    747       {ECO:0000244|PDB:2KLD}.
FT   HELIX       752    762       {ECO:0000244|PDB:2KLD}.
FT   STRAND      763    766       {ECO:0000244|PDB:2KLD}.
FT   STRAND      767    771       {ECO:0000244|PDB:2Y4Q}.
FT   HELIX       773    777       {ECO:0000244|PDB:2KLD}.
FT   TURN        781    783       {ECO:0000244|PDB:2KLD}.
FT   STRAND      793    795       {ECO:0000244|PDB:2KQ6}.
FT   HELIX       836    894       {ECO:0000244|PDB:3HRN}.
SQ   SEQUENCE   968 AA;  109691 MW;  F8D2E760EBEA8B47 CRC64;
     MVNSSRVQPQ QPGDAKRPPA PRAPDPGRLM AGCAAVGASL AAPGGLCEQR GLEIEMQRIR
     QAAARDPPAG AAASPSPPLS SCSRQAWSRD NPGFEAEEEE EEVEGEEGGM VVEMDVEWRP
     GSRRSAASSA VSSVGARSRG LGGYHGAGHP SGRRRRREDQ GPPCPSPVGG GDPLHRHLPL
     EGQPPRVAWA ERLVRGLRGL WGTRLMEESS TNREKYLKSV LRELVTYLLF LIVLCILTYG
     MMSSNVYYYT RMMSQLFLDT PVSKTEKTNF KTLSSMEDFW KFTEGSLLDG LYWKMQPSNQ
     TEADNRSFIF YENLLLGVPR IRQLRVRNGS CSIPQDLRDE IKECYDVYSV SSEDRAPFGP
     RNGTAWIYTS EKDLNGSSHW GIIATYSGAG YYLDLSRTRE ETAAQVASLK KNVWLDRGTR
     ATFIDFSVYN ANINLFCVVR LLVEFPATGG VIPSWQFQPL KLIRYVTTFD FFLAACEIIF
     CFFIFYYVVE EILEIRIHKL HYFRSFWNCL DVVIVVLSVV AIGINIYRTS NVEVLLQFLE
     DQNTFPNFEH LAYWQIQFNN IAAVTVFFVW IKLFKFINFN RTMSQLSTTM SRCAKDLFGF
     AIMFFIIFLA YAQLAYLVFG TQVDDFSTFQ ECIFTQFRII LGDINFAEIE EANRVLGPIY
     FTTFVFFMFF ILLNMFLAII NDTYSEVKSD LAQQKAEMEL SDLIRKGYHK ALVKLKLKKN
     TVDDISESLR QGGGKLNFDE LRQDLKGKGH TDAEIEAIFT KYDQDGDQEL TEHEHQQMRD
     DLEKEREDLD LDHSSLPRPM SSRSFPRSLD DSEEDDDEDS GHSSRRRGSI SSGVSYEEFQ
     VLVRRVDRME HSIGSIVSKI DAVIVKLEIM ERAKLKRREV LGRLLDGVAE DERLGRDSEI
     HREQMERLVR EELERWESDD AASQISHGLG TPVGLNGQPR PRSSRPSSSQ STEGMEGAGG
     NGSSNVHV
//
ID   KCNC3_HUMAN             Reviewed;         757 AA.
AC   Q14003;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   04-NOV-2008, sequence version 3.
DT   20-DEC-2017, entry version 164.
DE   RecName: Full=Potassium voltage-gated channel subfamily C member 3;
DE   AltName: Full=KSHIIID;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv3.3;
GN   Name=KCNC3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT GLY-63, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Lens epithelium;
RX   PubMed=10712820; DOI=10.1006/exer.1999.0796;
RA   Rae J.L., Shepard A.R.;
RT   "Kv3.3 potassium channels in lens epithelium and corneal
RT   endothelium.";
RL   Exp. Eye Res. 70:339-348(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 291-651.
RA   Lee J.E., Garbutt J.H., Phillips K.L., Roses A.D.;
RT   "A human chromosome 19 Shaw type potassium channel gene.";
RL   Submitted (JAN-1992) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH HAX1 AND ARP3, AND
RP   DOMAIN.
RX   PubMed=26997484; DOI=10.1016/j.cell.2016.02.009;
RA   Zhang Y., Zhang X.F., Fleming M.R., Amiri A., El-Hassar L.,
RA   Surguchev A.A., Hyland C., Jenkins D.P., Desai R., Brown M.R.,
RA   Gazula V.R., Waters M.F., Large C.H., Horvath T.L., Navaratnam D.,
RA   Vaccarino F.M., Forscher P., Kaczmarek L.K.;
RT   "Kv3.3 channels bind Hax-1 and Arp2/3 to assemble a stable local actin
RT   network that regulates channel gating.";
RL   Cell 165:434-448(2016).
RN   [5]
RP   CHARACTERIZATION OF VARIANTS SCA13 HIS-420; HIS-423 AND LEU-448,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22289912; DOI=10.1113/jphysiol.2012.228205;
RA   Minassian N.A., Lin M.C., Papazian D.M.;
RT   "Altered Kv3.3 channel gating in early-onset spinocerebellar ataxia
RT   type 13.";
RL   J. Physiol. (Lond.) 590:1599-1614(2012).
RN   [6]
RP   CHARACTERIZATION OF VARIANTS SCA13 HIS-366; HIS-420; HIS-423 AND
RP   LEU-448, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, INTERACTION WITH
RP   KCNC1, AND MUTAGENESIS OF ARG-366; ARG-420 AND ARG-423.
RX   PubMed=23734863; DOI=10.1042/BJ20130034;
RA   Zhao J., Zhu J., Thornhill W.B.;
RT   "Spinocerebellar ataxia-13 Kv3.3 potassium channels: arginine-to-
RT   histidine mutations affect both functional and protein expression on
RT   the cell surface.";
RL   Biochem. J. 454:259-265(2013).
RN   [7]
RP   CHARACTERIZATION OF VARIANTS SCA13 HIS-420 AND LEU-448, SUBCELLULAR
RP   LOCATION, AND GLYCOSYLATION.
RX   PubMed=25152487; DOI=10.1016/j.nbd.2014.08.020;
RA   Gallego-Iradi C., Bickford J.S., Khare S., Hall A., Nick J.A.,
RA   Salmasinia D., Wawrowsky K., Bannykh S., Huynh D.P.,
RA   Rincon-Limas D.E., Pulst S.M., Nick H.S., Fernandez-Funez P.,
RA   Waters M.F.;
RT   "KCNC3(R420H), a K(+) channel mutation causative in spinocerebellar
RT   ataxia 13 displays aberrant intracellular trafficking.";
RL   Neurobiol. Dis. 71:270-279(2014).
RN   [8]
RP   VARIANTS SCA13 HIS-420 AND LEU-448, CHARACTERIZATION OF VARIANTS SCA13
RP   HIS-420 AND LEU-448, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16501573; DOI=10.1038/ng1758;
RA   Waters M.F., Minassian N.A., Stevanin G., Figueroa K.P.,
RA   Bannister J.P.A., Nolte D., Mock A.F., Evidente V.G.H., Fee D.B.,
RA   Mueller U., Duerr A., Brice A., Papazian D.M., Pulst S.M.;
RT   "Mutations in voltage-gated potassium channel KCNC3 cause degenerative
RT   and developmental nervous system phenotypes.";
RL   Nat. Genet. 38:447-451(2006).
RN   [9]
RP   VARIANTS SCA13 HIS-366; HIS-420 AND HIS-423, CHARACTERIZATION OF
RP   VARIANTS SCA13 HIS-366 AND HIS-423, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=19953606; DOI=10.1002/humu.21165;
RA   Figueroa K.P., Minassian N.A., Stevanin G., Waters M., Garibyan V.,
RA   Forlani S., Strzelczyk A., Buerk K., Brice A., Duerr A.,
RA   Papazian D.M., Pulst S.M.;
RT   "KCNC3: phenotype, mutations, channel biophysics-a study of 260
RT   familial ataxia patients.";
RL   Hum. Mutat. 31:191-196(2010).
RN   [10]
RP   VARIANT SCA13 HIS-423, VARIANT ASP-263, CHARACTERIZATION OF VARIANT
RP   ASP-263, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21479265; DOI=10.1371/journal.pone.0017811;
RA   Figueroa K.P., Waters M.F., Garibyan V., Bird T.D., Gomez C.M.,
RA   Ranum L.P., Minassian N.A., Papazian D.M., Pulst S.M.;
RT   "Frequency of KCNC3 DNA variants as causes of spinocerebellar ataxia
RT   13 (SCA13).";
RL   PLoS ONE 6:E17811-E17811(2011).
RN   [11]
RP   VARIANTS SCA13 ASN-129; HIS-420; HIS-423; ASN-477; MET-535; GLY-591;
RP   SER-643; ARG-645 AND ASN-746, VARIANTS HIS-41 AND GLY-63,
RP   CHARACTERIZATION OF VARIANTS SCA13 ASN-129; HIS-420; HIS-423; ASN-477;
RP   MET-535; GLY-591; SER-643; ARG-645 AND ASN-746, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=25756792; DOI=10.1371/journal.pone.0116599;
RA   Duarri A., Nibbeling E.A., Fokkens M.R., Meijer M., Boerrigter M.,
RA   Verschuuren-Bemelmans C.C., Kremer B.P., van de Warrenburg B.P.,
RA   Dooijes D., Boddeke E., Sinke R.J., Verbeek D.S.;
RT   "Functional analysis helps to define KCNC3 mutational spectrum in
RT   dutch ataxia cases.";
RL   PLoS ONE 10:E0116599-E0116599(2015).
CC   -!- FUNCTION: Voltage-gated potassium channel that plays an important
CC       role in the rapid repolarization of fast-firing brain neurons. The
CC       channel opens in response to the voltage difference across the
CC       membrane, forming a potassium-selective channel through which
CC       potassium ions pass in accordance with their electrochemical
CC       gradient. The channel displays rapid activation and inactivation
CC       kinetics (PubMed:10712820, PubMed:26997484, PubMed:22289912,
CC       PubMed:23734863, PubMed:16501573, PubMed:19953606,
CC       PubMed:21479265, PubMed:25756792). It plays a role in the
CC       regulation of the frequency, shape and duration of action
CC       potentials in Purkinje cells. Required for normal survival of
CC       cerebellar neurons, probably via its role in regulating the
CC       duration and frequency of action potentials that in turn regulate
CC       the activity of voltage-gated Ca(2+) channels and cellular Ca(2+)
CC       homeostasis (By similarity). Required for normal motor function
CC       (PubMed:23734863, PubMed:16501573, PubMed:19953606,
CC       PubMed:21479265, PubMed:25756792). Plays a role in the
CC       reorganization of the cortical actin cytoskeleton and the
CC       formation of actin veil structures in neuronal growth cones via
CC       its interaction with HAX1 and the Arp2/3 complex
CC       (PubMed:26997484). {ECO:0000250|UniProtKB:Q63959,
CC       ECO:0000269|PubMed:10712820, ECO:0000269|PubMed:16501573,
CC       ECO:0000269|PubMed:19953606, ECO:0000269|PubMed:21479265,
CC       ECO:0000269|PubMed:22289912, ECO:0000269|PubMed:23734863,
CC       ECO:0000269|PubMed:25756792, ECO:0000269|PubMed:26997484}.
CC   -!- SUBUNIT: Homotetramer. Heterotetramer with KCNC1
CC       (PubMed:23734863). Interacts (via C-terminus) with HAX1
CC       (PubMed:26997484). Identified in a complex with ACTR3, a subunit
CC       of the Arp2/3 complex; this interaction is indirect and depends on
CC       the presence of HAX1 (PubMed:26997484). Interaction with HAX1
CC       modulates channel gating (PubMed:26997484).
CC       {ECO:0000269|PubMed:23734863, ECO:0000269|PubMed:26997484}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10712820,
CC       ECO:0000269|PubMed:16501573, ECO:0000269|PubMed:19953606,
CC       ECO:0000269|PubMed:21479265, ECO:0000269|PubMed:22289912,
CC       ECO:0000269|PubMed:23734863, ECO:0000269|PubMed:25152487,
CC       ECO:0000269|PubMed:25756792, ECO:0000269|PubMed:26997484}; Multi-
CC       pass membrane protein {ECO:0000255}. Cell junction, synapse,
CC       presynaptic cell membrane {ECO:0000250|UniProtKB:Q63959}; Multi-
CC       pass membrane protein {ECO:0000255}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q63959}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q63959}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q63959}. Cell projection, dendritic spine
CC       membrane {ECO:0000250|UniProtKB:Q01956}; Multi-pass membrane
CC       protein {ECO:0000255}. Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:26997484}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:26997484}. Note=Detected on Purkinje cell
CC       dendritic spines (By similarity). Detected at presynaptic calices
CC       of Held (By similarity). Colocalizes with the cortical actin
CC       cytoskeleton and the Arp2/3 complex (PubMed:26997484).
CC       {ECO:0000250|UniProtKB:Q01956, ECO:0000250|UniProtKB:Q63959,
CC       ECO:0000269|PubMed:26997484}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000305}.
CC   -!- DOMAIN: The cytoplasmic N-terminus mediates N-type inactivation.
CC       {ECO:0000269|PubMed:26997484}.
CC   -!- DOMAIN: The C-terminal cytoplasmic tail contributes to the
CC       regulation of channel inactivation and to the interaction with
CC       HAX1 and the Arp2/3 complex. {ECO:0000269|PubMed:26997484}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:25152487}.
CC   -!- DISEASE: Spinocerebellar ataxia 13 (SCA13) [MIM:605259]:
CC       Spinocerebellar ataxia is a clinically and genetically
CC       heterogeneous group of cerebellar disorders. Patients show
CC       progressive incoordination of gait and often poor coordination of
CC       hands, speech and eye movements, due to degeneration of the
CC       cerebellum with variable involvement of the brainstem and spinal
CC       cord. SCA13 is an autosomal dominant cerebellar ataxia (ADCA)
CC       characterized by slow progression and variable age at onset,
CC       ranging from childhood to late adulthood. Mental retardation can
CC       be present in some patients. {ECO:0000269|PubMed:16501573,
CC       ECO:0000269|PubMed:19953606, ECO:0000269|PubMed:21479265,
CC       ECO:0000269|PubMed:22289912, ECO:0000269|PubMed:23734863,
CC       ECO:0000269|PubMed:25152487, ECO:0000269|PubMed:25756792}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw) (TC
CC       1.A.1.2) subfamily. Kv3.3/KCNC3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF055989; AAC24118.1; -; mRNA.
DR   EMBL; AC008655; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z11585; CAA77671.1; -; Genomic_DNA.
DR   CCDS; CCDS12793.1; -.
DR   PIR; S19552; S19552.
DR   RefSeq; NP_004968.2; NM_004977.2.
DR   RefSeq; XP_006723266.1; XM_006723203.2.
DR   RefSeq; XP_011525228.1; XM_011526926.1.
DR   UniGene; Hs.467146; -.
DR   ProteinModelPortal; Q14003; -.
DR   BioGrid; 109950; 1.
DR   STRING; 9606.ENSP00000434241; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   TCDB; 1.A.1.2.13; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q14003; -.
DR   PhosphoSitePlus; Q14003; -.
DR   BioMuta; KCNC3; -.
DR   DMDM; 212276500; -.
DR   EPD; Q14003; -.
DR   MaxQB; Q14003; -.
DR   PaxDb; Q14003; -.
DR   PeptideAtlas; Q14003; -.
DR   PRIDE; Q14003; -.
DR   DNASU; 3748; -.
DR   Ensembl; ENST00000477616; ENSP00000434241; ENSG00000131398.
DR   GeneID; 3748; -.
DR   KEGG; hsa:3748; -.
DR   UCSC; uc002pru.1; human.
DR   CTD; 3748; -.
DR   DisGeNET; 3748; -.
DR   EuPathDB; HostDB:ENSG00000131398.13; -.
DR   GeneCards; KCNC3; -.
DR   GeneReviews; KCNC3; -.
DR   H-InvDB; HIX0202872; -.
DR   HGNC; HGNC:6235; KCNC3.
DR   HPA; HPA018041; -.
DR   MalaCards; KCNC3; -.
DR   MIM; 176264; gene.
DR   MIM; 605259; phenotype.
DR   neXtProt; NX_Q14003; -.
DR   OpenTargets; ENSG00000131398; -.
DR   Orphanet; 98768; Spinocerebellar ataxia type 13.
DR   PharmGKB; PA30027; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231012; -.
DR   HOVERGEN; HBG105862; -.
DR   InParanoid; Q14003; -.
DR   KO; K04889; -.
DR   OMA; GFWGIDE; -.
DR   OrthoDB; EOG091G0EJL; -.
DR   PhylomeDB; Q14003; -.
DR   TreeFam; TF352511; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNC3; human.
DR   GeneWiki; KCNC3; -.
DR   GenomeRNAi; 3748; -.
DR   PRO; PR:Q14003; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000131398; -.
DR   CleanEx; HS_KCNC3; -.
DR   ExpressionAtlas; Q14003; baseline and differential.
DR   Genevisible; Q14003; HS.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0032591; C:dendritic spine membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0051262; P:protein tetramerization; IDA:UniProtKB.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR005404; K_chnl_volt-dep_Kv3.3.
DR   InterPro; IPR021105; K_chnl_volt-dep_Kv3_ID.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11404; Potassium_chann; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01582; KV33CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Disease mutation; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Methylation; Neurodegeneration;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Spinocerebellar ataxia; Synapse; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    757       Potassium voltage-gated channel subfamily
FT                                C member 3.
FT                                /FTId=PRO_0000054055.
FT   TOPO_DOM      1    290       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    291    309       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    351    370       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    371    379       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    380    398       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    412    434       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    435    447       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    448    469       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    518    539       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    540    757       Cytoplasmic. {ECO:0000305}.
FT   REGION        1     78       Important for normal N-type inactivation.
FT                                {ECO:0000269|PubMed:26997484}.
FT   MOTIF       503    508       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS     31     38       Poly-Pro.
FT   COMPBIAS     39     42       Poly-Gln.
FT   COMPBIAS     81     85       Poly-Gly.
FT   COMPBIAS    229    234       Poly-Gly.
FT   COMPBIAS    577    587       Poly-Pro.
FT   COMPBIAS    596    599       Poly-Pro.
FT   COMPBIAS    668    673       Poly-Ala.
FT   MOD_RES     625    625       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q63959}.
FT   MOD_RES     686    686       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63959}.
FT   MOD_RES     691    691       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63959}.
FT   CARBOHYD    320    320       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    336    336       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    483    483       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      41     41       Q -> H (rare polymorphism;
FT                                dbSNP:rs185017345).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074192.
FT   VARIANT      63     63       D -> G (rare polymorphism;
FT                                dbSNP:rs375912738).
FT                                {ECO:0000269|PubMed:10712820,
FT                                ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074193.
FT   VARIANT     129    129       D -> N (in SCA13; unknown pathological
FT                                significance; changes channel activity;
FT                                shifts the voltage dependence of
FT                                activation).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074194.
FT   VARIANT     263    263       G -> D (rare polymorphism; changes
FT                                channel activity; activates more quickly
FT                                and deactivates more slowly).
FT                                {ECO:0000269|PubMed:21479265}.
FT                                /FTId=VAR_074195.
FT   VARIANT     366    366       R -> H (in SCA13; unknown pathological
FT                                significance; dominant negative that
FT                                decreases channel activity; decreases
FT                                protein abundance; decreases protein
FT                                stability; decreases localization to the
FT                                plasma membrane; no effect on
FT                                tetramerization; dbSNP:rs769502387).
FT                                {ECO:0000269|PubMed:19953606,
FT                                ECO:0000269|PubMed:23734863}.
FT                                /FTId=VAR_074196.
FT   VARIANT     420    420       R -> H (in SCA13; dominant negative that
FT                                induces loss of channel activity;
FT                                decreases protein abundance; decreases
FT                                protein stability; decreases localization
FT                                to the plasma membrane and alters the
FT                                localization of the wild-type protein;
FT                                impairs N-glycosylation; no effect on
FT                                tetramerization; dbSNP:rs104894699).
FT                                {ECO:0000269|PubMed:16501573,
FT                                ECO:0000269|PubMed:19953606,
FT                                ECO:0000269|PubMed:22289912,
FT                                ECO:0000269|PubMed:23734863,
FT                                ECO:0000269|PubMed:25152487,
FT                                ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_029530.
FT   VARIANT     423    423       R -> H (in SCA13; dominant negative that
FT                                reduces channel activity; alters gating;
FT                                decreases protein abundance; decreases
FT                                localization to the plasma membrane; no
FT                                effect on tetramerization;
FT                                dbSNP:rs797044872).
FT                                {ECO:0000269|PubMed:19953606,
FT                                ECO:0000269|PubMed:21479265,
FT                                ECO:0000269|PubMed:22289912,
FT                                ECO:0000269|PubMed:23734863,
FT                                ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074197.
FT   VARIANT     448    448       F -> L (in SCA13; alters gating; slows
FT                                channel closing; decreases protein
FT                                abundance; no effect on localization to
FT                                the plasma membrane; no effect on N-
FT                                glycosylation; no effect on
FT                                tetramerization; dbSNP:rs104894700).
FT                                {ECO:0000269|PubMed:16501573,
FT                                ECO:0000269|PubMed:22289912,
FT                                ECO:0000269|PubMed:23734863,
FT                                ECO:0000269|PubMed:25152487}.
FT                                /FTId=VAR_029531.
FT   VARIANT     477    477       D -> N (in SCA13; unknown pathological
FT                                significance; no effect on channel
FT                                activity; dbSNP:rs148033381).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074198.
FT   VARIANT     535    535       V -> M (in SCA13; changes channel
FT                                activity; shifts the voltage dependence
FT                                of activation).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074199.
FT   VARIANT     591    591       S -> G (in SCA13; unknown pathological
FT                                significance; reduces channel activity;
FT                                shifts the voltage dependence of
FT                                activation; dbSNP:rs549394447).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074200.
FT   VARIANT     643    643       G -> S (in SCA13; unknown pathological
FT                                significance; no effect on channel
FT                                activity; dbSNP:rs778523009).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074201.
FT   VARIANT     645    645       P -> R (in SCA13; unknown pathological
FT                                significance; no effect on channel
FT                                activity). {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074202.
FT   VARIANT     746    746       D -> N (in SCA13; unknown pathological
FT                                significance; no effect on channel
FT                                activity; dbSNP:rs958323371).
FT                                {ECO:0000269|PubMed:25756792}.
FT                                /FTId=VAR_074203.
FT   MUTAGEN       1     78       Missing: Loss of N-type inactivation.
FT                                {ECO:0000269|PubMed:26997484}.
FT   MUTAGEN     366    366       R->K,A: Decreases protein abundance.
FT                                {ECO:0000269|PubMed:23734863}.
FT   MUTAGEN     420    420       R->K,A: Decreases protein abundance.
FT                                {ECO:0000269|PubMed:23734863}.
FT   MUTAGEN     423    423       R->K,A: Decreases protein abundance.
FT                                {ECO:0000269|PubMed:23734863}.
FT   MUTAGEN     592    592       G->R: Loss of interaction with ACTR3. No
FT                                effect on voltage-dependent channel
FT                                opening or current amplitude, but
FT                                decreased rate of inactivation during
FT                                prolonged depolarization.
FT                                {ECO:0000269|PubMed:26997484}.
SQ   SEQUENCE   757 AA;  80578 MW;  B44306B850DFD797 CRC64;
     MLSSVCVSSF RGRQGASKQQ PAPPPQPPES PPPPPLPPQQ QQPAQPGPAA SPAGPPAPRG
     PGDRRAEPCP GLPAAAMGRH GGGGGDSGKI VINVGGVRHE TYRSTLRTLP GTRLAGLTEP
     EAAARFDYDP GADEFFFDRH PGVFAYVLNY YRTGKLHCPA DVCGPLFEEE LGFWGIDETD
     VEACCWMTYR QHRDAEEALD SFEAPDPAGA ANAANAAGAH DGGLDDEAGA GGGGLDGAGG
     ELKRLCFQDA GGGAGGPPGG AGGAGGTWWR RWQPRVWALF EDPYSSRAAR YVAFASLFFI
     LISITTFCLE THEGFIHISN KTVTQASPIP GAPPENITNV EVETEPFLTY VEGVCVVWFT
     FEFLMRITFC PDKVEFLKSS LNIIDCVAIL PFYLEVGLSG LSSKAAKDVL GFLRVVRFVR
     ILRIFKLTRH FVGLRVLGHT LRASTNEFLL LIIFLALGVL IFATMIYYAE RIGADPDDIL
     GSNHTYFKNI PIGFWWAVVT MTTLGYGDMY PKTWSGMLVG ALCALAGVLT IAMPVPVIVN
     NFGMYYSLAM AKQKLPKKKN KHIPRPPQPG SPNYCKPDPP PPPPPHPHHG SGGISPPPPI
     TPPSMGVTVA GAYPAGPHTH PGLLRGGAGG LGIMGLPPLP APGEPCPLAQ EEVIEINRAD
     PRPNGDPAAA ALAHEDCPAI DQPAMSPEDK SPITPGSRGR YSRDRACFLL TDYAPSPDGS
     IRKATGAPPL PPQDWRKPGP PSFLPDLNAN AAAWISP
//
ID   TWK18_CAEEL             Reviewed;         461 AA.
AC   Q18120; Q9TZP8;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 2.
DT   27-SEP-2017, entry version 125.
DE   RecName: Full=TWiK family of potassium channels protein 18;
GN   Name=twk-18; ORFNames=C24A3.6;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC32861.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, MUTAGENESIS
RP   OF GLY-140; GLY-165 AND MET-280, AND DISRUPTION PHENOTYPE.
RX   PubMed=11027209;
RA   Kunkel M.T., Johnstone D.B., Thomas J.H., Salkoff L.;
RT   "Mutants of a temperature-sensitive two-P domain potassium channel.";
RL   J. Neurosci. 20:7517-7524(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-88, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- FUNCTION: Outwardly rectifying potassium channel protein; activity
CC       is sharply augmented by increase in temperature.
CC       {ECO:0000269|PubMed:11027209}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in body wall muscle.
CC       {ECO:0000269|PubMed:11027209}.
CC   -!- DISRUPTION PHENOTYPE: Worms display uncoordinated movement and
CC       paralysis. {ECO:0000269|PubMed:11027209}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000255}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF083650; AAC32861.1; -; mRNA.
DR   EMBL; FO080639; CCD65384.1; -; Genomic_DNA.
DR   PIR; T15585; T15585.
DR   PIR; T43394; T43394.
DR   RefSeq; NP_509516.1; NM_077115.5.
DR   UniGene; Cel.7698; -.
DR   ProteinModelPortal; Q18120; -.
DR   STRING; 6239.C24A3.6.2; -.
DR   TCDB; 1.A.1.9.5; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q18120; -.
DR   EPD; Q18120; -.
DR   PaxDb; Q18120; -.
DR   PeptideAtlas; Q18120; -.
DR   PRIDE; Q18120; -.
DR   EnsemblMetazoa; C24A3.6.1; C24A3.6.1; WBGene00006672.
DR   EnsemblMetazoa; C24A3.6.2; C24A3.6.2; WBGene00006672.
DR   GeneID; 181139; -.
DR   KEGG; cel:CELE_C24A3.6; -.
DR   UCSC; C24A3.6.2; c. elegans.
DR   CTD; 181139; -.
DR   WormBase; C24A3.6; CE24811; WBGene00006672; twk-18.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00700000104522; -.
DR   HOGENOM; HOG000015943; -.
DR   InParanoid; Q18120; -.
DR   KO; K05323; -.
DR   OMA; NIDQEYA; -.
DR   OrthoDB; EOG091G07IS; -.
DR   PhylomeDB; Q18120; -.
DR   Reactome; R-CEL-1299344; TWIK-related spinal cord K+ channel (TRESK).
DR   PRO; PR:Q18120; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00006672; -.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IC:WormBase.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IDA:WormBase.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0040011; P:locomotion; IMP:WormBase.
DR   GO; GO:0006936; P:muscle contraction; IMP:WormBase.
DR   GO; GO:0006813; P:potassium ion transport; IDA:WormBase.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    461       TWiK family of potassium channels protein
FT                                18.
FT                                /FTId=PRO_0000101773.
FT   TOPO_DOM      1     21       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     22     42       Helical. {ECO:0000255}.
FT   INTRAMEM    116    136       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    144    164       Helical. {ECO:0000255}.
FT   TOPO_DOM    165    224       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    225    245       Helical. {ECO:0000255}.
FT   INTRAMEM    253    273       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    281    301       Helical. {ECO:0000255}.
FT   TOPO_DOM    302    461       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     88     88       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   MUTAGEN     140    140       G->E: In sa589; defects in locomotion.
FT                                {ECO:0000269|PubMed:11027209}.
FT   MUTAGEN     165    165       G->D: In e1913; homozygotes are embryonic
FT                                lethal, heterozygotes exhibit defects in
FT                                locomotion.
FT                                {ECO:0000269|PubMed:11027209}.
FT   MUTAGEN     280    280       M->I: In cn110; temperature sensitive
FT                                defects in locomotion.
FT                                {ECO:0000269|PubMed:11027209}.
SQ   SEQUENCE   461 AA;  52746 MW;  D436B3654AB9C5DF CRC64;
     MAIVAQGVST ILTTFQKTFK GLLPLIILVA YTLLGAWIFW MIEGENEREM LIEQQKERDE
     LIRRTVYKIN QLQIKRQRRL MTAEEEYNRT AKVLTTFQET LGIVPADMDK DIHWTFLGSI
     FYCMTVYTTI GYGNIVPGTG WGRFATILYA FIGIPLTVLS LYCLGSLFAK GCKMLWRFFL
     KSTRVVSKDL SNKISEAADN IEEGTTAITP SAEKTENNDD DLLSFPISGL LLITVIWVIF
     CAVLFTFLEE WDFGTSLYFT LISFTTIGFG DILPSDYDFM PIVGVLLLIG LSLVSTVMTL
     IQQQIEALAS GMKDNIDQEY ARALNEARED GEVDEHVDPE EDPENNKKSF DAVISRMNWS
     KRGLYYLLPD SQKKELAKQS EKKMGRKSIK IQTDNDLLET LIREEILKAE LNNEMHKYTA
     PRSSHQPKLV YSDVREKEVP IEVVRVEHFN HGNEDYLEHD I
//
ID   TWK9_CAEEL              Reviewed;         568 AA.
AC   Q23435;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 2.
DT   27-SEP-2017, entry version 120.
DE   RecName: Full=TWiK family of potassium channels protein 9;
GN   Name=twk-9; ORFNames=ZK1251.8;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=15183729; DOI=10.1016/j.ydbio.2004.02.020;
RA   Portman D.S., Emmons S.W.;
RT   "Identification of C. elegans sensory ray genes using whole-genome
RT   expression profiling.";
RL   Dev. Biol. 270:499-512(2004).
CC   -!- FUNCTION: Potassium channel protein that may be component of
CC       regulatory network that controls ray development and function.
CC       {ECO:0000303|PubMed:15183729}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in ray A-type neurons and cell
CC       bodies. Also seen in head, pharyngeal and phasmid neurons, and in
CC       coelomocytes. {ECO:0000269|PubMed:15183729}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000255}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z68222; CAA92504.2; -; Genomic_DNA.
DR   PIR; T27725; T27725.
DR   RefSeq; NP_501724.2; NM_069323.2.
DR   UniGene; Cel.12254; -.
DR   ProteinModelPortal; Q23435; -.
DR   STRING; 6239.ZK1251.8; -.
DR   TCDB; 1.A.1.9.8; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q23435; -.
DR   EnsemblMetazoa; ZK1251.8a; ZK1251.8a; WBGene00006664.
DR   GeneID; 177803; -.
DR   KEGG; cel:CELE_ZK1251.8; -.
DR   UCSC; ZK1251.8; c. elegans.
DR   CTD; 177803; -.
DR   WormBase; ZK1251.8a; CE40540; WBGene00006664; twk-9.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00700000104522; -.
DR   HOGENOM; HOG000022314; -.
DR   InParanoid; Q23435; -.
DR   KO; K05323; -.
DR   OMA; CLERTIL; -.
DR   PhylomeDB; Q23435; -.
DR   Reactome; R-CEL-1299344; TWIK-related spinal cord K+ channel (TRESK).
DR   PRO; PR:Q23435; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00006664; -.
DR   ExpressionAtlas; Q23435; baseline.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
PE   2: Evidence at transcript level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    568       TWiK family of potassium channels protein
FT                                9.
FT                                /FTId=PRO_0000101772.
FT   TOPO_DOM      1     15       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     16     36       Helical. {ECO:0000255}.
FT   INTRAMEM    163    183       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    191    211       Helical. {ECO:0000255}.
FT   TOPO_DOM    212    316       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    317    337       Helical. {ECO:0000255}.
FT   INTRAMEM    343    363       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    370    390       Helical. {ECO:0000255}.
FT   TOPO_DOM    391    568       Cytoplasmic. {ECO:0000255}.
SQ   SEQUENCE   568 AA;  64533 MW;  6C47ED7AC4EEADA3 CRC64;
     MKCSFHIPEK YQWASTLFVH VALIAGVAVY TVFGALSMQW LESPDRVRAL LKRELKPVES
     LPPPPSISGL PDRITRVYLG EELAILDPGV HECLERTILT LFHDTKCDPY SFEHLNIELI
     DRCYAEANVP IPEGYGGQPR KKIKNKEEEK DVIDETPAEK WSIGNSVIFA FTVITTIGYG
     HVAPETFEGR LFLIFYGVIG VPFTLLTIAD LGMFLTRFLK NLLTMARRFA HYLVKLYQKA
     KKQRNKSQKT SPVMPDSERS EVWNTGKEMK EMSMRTAREP GEGDEIEVIE NGNDENGKEE
     DEEEPENNEP RKTEESIALG ITFTCYLVAG AKILSVYEPE MDFFKALYFN FVTLTTIGLG
     DFVPKSFDYL LITLIYIGIG LALTTMAIEI AADLLKKLHY IGRKMENVGQ AVVWFGGKKM
     TMKSLVKHLG DQFNIPEEEL ANFDMSAFVD NAIKVEKGEI ATLRKPPTPP VVFRERAFSF
     SNVRNSSESA LKYVDDNRFS KTTQPTIYTV IIHETTRTID TLHNLADAIR RDPSIPRLDL
     DVHYLTDMSA PTSFDENYLR TYTNARRK
//
ID   TM38B_XENTR             Reviewed;         284 AA.
AC   Q28FA9;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   04-APR-2006, sequence version 1.
DT   07-JUN-2017, entry version 59.
DE   RecName: Full=Trimeric intracellular cation channel type B;
DE            Short=TRIC-B;
DE            Short=TRICB;
DE   AltName: Full=Transmembrane protein 38B;
GN   Name=tmem38b; ORFNames=TEgg035c21.1;
OS   Xenopus tropicalis (Western clawed frog) (Silurana tropicalis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Silurana.
OX   NCBI_TaxID=8364;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Egg;
RG   Sanger Xenopus tropicalis EST/cDNA project;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Monovalent cation channel required for maintenance of
CC       rapid intracellular calcium release. May act as a potassium
CC       counter-ion channel that functions in synchronization with calcium
CC       release from intracellular stores. {ECO:0000250|UniProtKB:Q9DAV9}.
CC   -!- SUBUNIT: Homotrimer; trimerization probably requires binding to
CC       phosphatidylinositol 4,5-bisphosphate (PIP2).
CC       {ECO:0000250|UniProtKB:A5A6S6, ECO:0000250|UniProtKB:Q9NA73}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9DAV9}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9DAV9}.
CC   -!- SIMILARITY: Belongs to the TMEM38 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CR762060; CAJ81929.1; -; mRNA.
DR   EMBL; BC135582; AAI35583.1; -; mRNA.
DR   RefSeq; NP_001016127.1; NM_001016127.3.
DR   UniGene; Str.26823; -.
DR   ProteinModelPortal; Q28FA9; -.
DR   STRING; 8364.ENSXETP00000001972; -.
DR   PaxDb; Q28FA9; -.
DR   Ensembl; ENSXETT00000001972; ENSXETP00000001972; ENSXETG00000000907.
DR   GeneID; 548881; -.
DR   KEGG; xtr:548881; -.
DR   CTD; 55151; -.
DR   Xenbase; XB-GENE-5849692; tmem38b.
DR   eggNOG; KOG3944; Eukaryota.
DR   eggNOG; ENOG410XQ0P; LUCA.
DR   GeneTree; ENSGT00390000018845; -.
DR   HOGENOM; HOG000037929; -.
DR   HOVERGEN; HBG059853; -.
DR   InParanoid; Q28FA9; -.
DR   OMA; KMSYPSK; -.
DR   OrthoDB; EOG091G0GQP; -.
DR   TreeFam; TF313483; -.
DR   Proteomes; UP000008143; Unassembled WGS sequence.
DR   Bgee; ENSXETG00000000907; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IBA:GO_Central.
DR   InterPro; IPR007866; TRIC_channel.
DR   PANTHER; PTHR12454; PTHR12454; 1.
DR   Pfam; PF05197; TRIC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Endoplasmic reticulum; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    284       Trimeric intracellular cation channel
FT                                type B.
FT                                /FTId=PRO_0000291530.
FT   TOPO_DOM      1     15       Lumenal. {ECO:0000305}.
FT   TRANSMEM     16     32       Helical;Name=1. {ECO:0000255}.
FT   TOPO_DOM     33     44       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     45     68       Helical;Name=2. {ECO:0000255}.
FT   TOPO_DOM     69     79       Lumenal. {ECO:0000305}.
FT   TRANSMEM     80     99       Helical;Name=3. {ECO:0000255}.
FT   TOPO_DOM    100    102       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    103    121       Helical;Name=4. {ECO:0000255}.
FT   TOPO_DOM    122    139       Lumenal. {ECO:0000305}.
FT   TRANSMEM    140    157       Helical;Name=5. {ECO:0000255}.
FT   TOPO_DOM    158    178       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    179    196       Helical;Name=6. {ECO:0000255}.
FT   TOPO_DOM    197    204       Lumenal. {ECO:0000305}.
FT   TRANSMEM    205    225       Helical;Name=7. {ECO:0000255}.
FT   TOPO_DOM    226    284       Cytoplasmic. {ECO:0000305}.
FT   BINDING     117    117       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000250|UniProtKB:Q9NA73}.
FT   BINDING     121    121       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000250|UniProtKB:Q9NA73}.
SQ   SEQUENCE   284 AA;  31843 MW;  29F41C90D3E6DD38 CRC64;
     MESFSELSLQ FSQLSMFPFF ETAHYLTSVM SAREQAGAVD VASRSPLASW FSSMLYCFGG
     GILSSILLAE PPVGILSNTT SIILASAVWY MVYYFPYDLF YNCFFFLPIR LILAGMKEVT
     RTWKILSGVA HAHSHYKDAM LVMITIGWAR GAGGGLISNF EQLVRGVWKP ESNEFLKMSY
     PVKVTLIGAV LFTLQHGQYL PISRHNLMFI YTLFLILIKV TMMLTRSTAS PFLPLETSLQ
     HILFSRQQIP AEVRESPSSS GDKGKPSKKT LDKDSGEQDN KKDN
//
ID   AKT2_ARATH              Reviewed;         802 AA.
AC   Q38898; Q0WMS8; Q42408; Q9M0L6;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-OCT-2017, entry version 150.
DE   RecName: Full=Potassium channel AKT2/3;
GN   Name=AKT2; Synonyms=AKT3; OrderedLocusNames=At4g22200;
GN   ORFNames=T10I14.30;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=cv. Columbia;
RX   PubMed=8552711; DOI=10.1104/pp.109.3.1093;
RA   Cao Y., Ward J.M., Kelly W.B., Ichida A.M., Gaber R.F., Anderson J.A.,
RA   Uozumi N., Schroeder J.I., Crawford N.M.;
RT   "Multiple genes, tissue specificity, and expression-dependent
RT   modulation contribute to the functional diversity of potassium
RT   channels in Arabidopsis thaliana.";
RL   Plant Physiol. 109:1093-1106(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=8549795; DOI=10.1016/0014-5793(95)01417-9;
RA   Ketchum K.A., Slayman C.W.;
RT   "Isolation of an ion channel gene from Arabidopsis thaliana using the
RT   H5 signature sequence from voltage-dependent K+ channels.";
RL   FEBS Lett. 378:19-26(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G.,
RA   Pohl T., Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N.,
RA   Harris B., Ansorge W., Brandt P., Grivell L.A., Rieger M.,
RA   Weichselgartner M., de Simone V., Obermaier B., Mache R., Mueller M.,
RA   Kreis M., Delseny M., Puigdomenech P., Watson M., Schmidtheini T.,
RA   Reichert B., Portetelle D., Perez-Alonso M., Boutry M., Bancroft I.,
RA   Vos P., Hoheisel J., Zimmermann W., Wedler H., Ridley P.,
RA   Langham S.-A., McCullagh B., Bilham L., Robben J.,
RA   van der Schueren J., Grymonprez B., Chuang Y.-J., Vandenbussche F.,
RA   Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R., Defoor E.,
RA   Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W.,
RA   Mooijman P., Klein Lankhorst R., Rose M., Hauf J., Koetter P.,
RA   Berneiser S., Hempel S., Feldpausch M., Lamberth S., Van den Daele H.,
RA   De Keyser A., Buysshaert C., Gielen J., Villarroel R., De Clercq R.,
RA   van Montagu M., Rogers J., Cronin A., Quail M.A., Bray-Allen S.,
RA   Clark L., Doggett J., Hall S., Kay M., Lennard N., McLay K., Mayes R.,
RA   Pettett A., Rajandream M.A., Lyne M., Benes V., Rechmann S.,
RA   Borkova D., Bloecker H., Scharfe M., Grimm M., Loehnert T.-H.,
RA   Dose S., de Haan M., Maarse A.C., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D., Herzl A.,
RA   Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R.,
RA   Schnabl S., Hiller R., Schmidt W., Lecharny A., Aubourg S.,
RA   Chefdor F., Cooke R., Berger C., Monfort A., Casacuberta E.,
RA   Gibbons T., Weber N., Vandenbol M., Bargues M., Terol J., Torres A.,
RA   Perez-Perez A., Purnelle B., Bent E., Johnson S., Tacon D., Jesse T.,
RA   Heijnen L., Schwarz S., Scholler P., Heber S., Francs P., Bielke C.,
RA   Frishman D., Haase D., Lemcke K., Mewes H.-W., Stocker S.,
RA   Zaccaria P., Bevan M., Wilson R.K., de la Bastide M., Habermann K.,
RA   Parnell L., Dedhia N., Gnoj L., Schutz K., Huang E., Spiegel L.,
RA   Sekhon M., Murray J., Sheet P., Cordes M., Abu-Threideh J.,
RA   Stoneking T., Kalicki J., Graves T., Harmon G., Edwards J.,
RA   Latreille P., Courtney L., Cloud J., Abbott A., Scott K., Johnson D.,
RA   Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D.,
RA   Du H., Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C.,
RA   Antonoiu B., Zidanic M., Strong C., Sun H., Lamar B., Yordan C.,
RA   Ma P., Zhong J., Preston R., Vil D., Shekher M., Matero A., Shah R.,
RA   Swaby I.K., O'Shaughnessy A., Rodriguez M., Hoffman J., Till S.,
RA   Granat S., Shohdy N., Hasegawa A., Hameed A., Lodhi M., Johnson A.,
RA   Chen E., Marra M.A., Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:769-777(1999).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RA   Totoki Y., Seki M., Ishida J., Nakajima M., Enju A., Kamiya A.,
RA   Narusaka M., Shin-i T., Nakagawa M., Sakamoto N., Oishi K., Kohara Y.,
RA   Kobayashi M., Toyoda A., Sakaki Y., Sakurai T., Iida K., Akiyama K.,
RA   Satou M., Toyoda T., Konagaya A., Carninci P., Kawai J.,
RA   Hayashizaki Y., Shinozaki K.;
RT   "Large-scale analysis of RIKEN Arabidopsis full-length (RAFL) cDNAs.";
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   CHARACTERIZATION, AND TISSUE SPECIFICITY.
RX   PubMed=10377458; DOI=10.1073/pnas.96.13.7581;
RA   Marten I., Hoth S., Deeken R., Ache P., Ketchum K.A., Hoshi T.,
RA   Hedrich R.;
RT   "AKT3, a phloem-localized K+ channel, is blocked by protons.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:7581-7586(1999).
RN   [7]
RP   INTERACTION WITH KAT1.
RX   PubMed=9916143; DOI=10.1007/s002329900476;
RA   Baizabal-Aguirre V.M., Clemens S., Uozumi N., Schroeder J.I.;
RT   "Suppression of inward-rectifying K+ channels KAT1 and AKT2 by
RT   dominant negative point mutations in the KAT1 alpha-subunit.";
RL   J. Membr. Biol. 167:119-125(1999).
RN   [8]
RP   CHARACTERIZATION, AND TISSUE SPECIFICITY.
RX   PubMed=10852932; DOI=10.1105/tpc.12.6.837;
RA   Lacombe B., Pilot G., Michard E., Gaymard F., Sentenac H.,
RA   Thibaud J.-B.;
RT   "A shaker-like K(+) channel with weak rectification is expressed in
RT   both source and sink phloem tissues of Arabidopsis.";
RL   Plant Cell 12:837-851(2000).
RN   [9]
RP   INTERACTION WITH PP2CA.
RX   PubMed=11181729; DOI=10.1093/jexbot/52.354.181;
RA   Vranova E., Taehtiharju S., Sriprang R., Willekens H., Heino P.,
RA   Palva E.T., Inze D., Van Camp W.;
RT   "The AKT3 potassium channel protein interacts with the AtPP2CA protein
RT   phosphatase 2C.";
RL   J. Exp. Bot. 52:181-182(2001).
RN   [10]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [11]
RP   FUNCTION.
RX   PubMed=12447548; DOI=10.1007/s00425-002-0895-1;
RA   Deeken R., Geiger D., Fromm J., Koroleva O., Ache P.,
RA   Langenfeld-Heyser R., Sauer N., May S.T., Hedrich R.;
RT   "Loss of the AKT2/3 potassium channel affects sugar loading into the
RT   phloem of Arabidopsis.";
RL   Planta 216:334-344(2002).
RN   [12]
RP   INTERACTION WITH PP2CA, DEPHOSPHORYLATION BY PP2CA, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12034902; DOI=10.1105/tpc.000943;
RA   Cherel I., Michard E., Platet N., Mouline K., Alcon C., Sentenac H.,
RA   Thibaud J.-B.;
RT   "Physical and functional interaction of the Arabidopsis K(+) channel
RT   AKT2 and phosphatase AtPP2CA.";
RL   Plant Cell 14:1133-1146(2002).
RN   [13]
RP   MUTAGENESIS OF HIS-243; SER-286 AND ILE-289.
RX   PubMed=12172027; DOI=10.1105/tpc.003244;
RA   Geiger D., Becker D., Lacombe B., Hedrich R.;
RT   "Outer pore residues control the H(+) and K(+) sensitivity of the
RT   Arabidopsis potassium channel AKT3.";
RL   Plant Cell 14:1859-1868(2002).
RN   [14]
RP   FUNCTION, INTERACTION WITH AKT1 AND KAT3, AND INDUCTION.
RX   PubMed=12678562; DOI=10.1023/A:1022597102282;
RA   Pilot G., Gaymard F., Mouline K., Cherel I., Sentenac H.;
RT   "Regulated expression of Arabidopsis shaker K(+) channel genes
RT   involved in K(+) uptake and distribution in the plant.";
RL   Plant Mol. Biol. 51:773-787(2003).
RN   [15]
RP   SUBCELLULAR LOCATION, INTERACTION WITH CIPK6, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=21445098; DOI=10.1038/cr.2011.50;
RA   Held K., Pascaud F., Eckert C., Gajdanowicz P., Hashimoto K.,
RA   Corratge-Faillie C., Offenborn J.N., Lacombe B., Dreyer I.,
RA   Thibaud J.B., Kudla J.;
RT   "Calcium-dependent modulation and plasma membrane targeting of the
RT   AKT2 potassium channel by the CBL4/CIPK6 calcium sensor/protein kinase
RT   complex.";
RL   Cell Res. 21:1116-1130(2011).
RN   [16]
RP   INTERACTION WITH SLAC1.
RX   PubMed=27002025; DOI=10.1105/tpc.16.01050;
RA   Zhang A., Ren H.M., Tan Y.Q., Qi G.N., Yao F.Y., Wu G.L., Yang L.W.,
RA   Hussain J., Sun S.J., Wang Y.F.;
RT   "S-type anion channels SLAC1 and SLAH3 function as essential negative
RT   regulators of inward K+ channels and stomatal opening in
RT   Arabidopsis.";
RL   Plant Cell 0:0-0(2016).
CC   -!- FUNCTION: Highly selective and weak inward-rectifying potassium
CC       channel. Plays a role in both loading and unloading potassium
CC       into/from the phloem sap. Seems to control sugar loading into
CC       phloem via a voltage-dependent process. Blocked by physiological
CC       concentrations of external calcium and by external acidification.
CC       May interact with the cytoskeleton or with regulatory proteins.
CC       Dephosphorylation by PP2CA not only leads to the inhibition of
CC       potassium currents but also to an increase of the voltage-
CC       dependence of the channel. Regulated by the CBL4/CIPK6 calcium
CC       sensor/protein kinase complex via a kinase interaction-dependent
CC       but phosphorylation-independent translocation of the channel to
CC       the plasma membrane. {ECO:0000269|PubMed:12447548,
CC       ECO:0000269|PubMed:12678562}.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming subunits. Interacts with
CC       the phosphatase PPC2A and the kinase CIPK6. May interact with
CC       AKT1, KAT1 and KAT3. Interacts with SLAC1 (PubMed:27002025).
CC       {ECO:0000269|PubMed:11181729, ECO:0000269|PubMed:12034902,
CC       ECO:0000269|PubMed:12678562, ECO:0000269|PubMed:21445098,
CC       ECO:0000269|PubMed:27002025, ECO:0000269|PubMed:9916143}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-1552774, EBI-1552774;
CC       Q38998:AKT1; NbExp=3; IntAct=EBI-1552774, EBI-974289;
CC       Q39128:KAT1; NbExp=4; IntAct=EBI-1552774, EBI-1552490;
CC       Q38849:KAT2; NbExp=3; IntAct=EBI-1552774, EBI-2117720;
CC       P49598:PP2CA; NbExp=5; IntAct=EBI-1552774, EBI-1764934;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:21445098}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:21445098}. Note=Targeted to the cell membrane
CC       when interacting with CIPK6 and CBL4.
CC   -!- TISSUE SPECIFICITY: Expressed mainly in the phloem tissues
CC       throughout the plant but also, at a lower level, in leaf epiderm,
CC       mesophyll and guard cells. {ECO:0000269|PubMed:10377458,
CC       ECO:0000269|PubMed:10852932, ECO:0000269|PubMed:12034902,
CC       ECO:0000269|PubMed:8552711}.
CC   -!- INDUCTION: In shoots, strongly induced by abscisic acid (ABA)
CC       treatment and reduced after NaCl treatment or potassium
CC       starvation. {ECO:0000269|PubMed:12678562}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization.
CC   -!- PTM: Dephosphorylated by PP2CA.
CC   -!- DISRUPTION PHENOTYPE: Delayed development and flowering.
CC       {ECO:0000269|PubMed:21445098}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA96153.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA96154.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA16770.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAB79175.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U40154; AAA97865.1; -; mRNA.
DR   EMBL; U44744; AAA96153.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U44745; AAA96154.1; ALT_INIT; mRNA.
DR   EMBL; AL021712; CAA16770.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL161556; CAB79175.1; ALT_INIT; Genomic_DNA.
DR   EMBL; CP002687; AEE84571.1; -; Genomic_DNA.
DR   EMBL; AK229735; BAF01572.1; -; mRNA.
DR   PIR; S68699; S68699.
DR   RefSeq; NP_567651.1; NM_118342.3.
DR   UniGene; At.1970; -.
DR   ProteinModelPortal; Q38898; -.
DR   SMR; Q38898; -.
DR   BioGrid; 13600; 14.
DR   IntAct; Q38898; 5.
DR   MINT; MINT-8066047; -.
DR   STRING; 3702.AT4G22200.1; -.
DR   TCDB; 1.A.1.4.6; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q38898; -.
DR   EnsemblPlants; AT4G22200.1; AT4G22200.1; AT4G22200.
DR   GeneID; 828311; -.
DR   Gramene; AT4G22200.1; AT4G22200.1; AT4G22200.
DR   KEGG; ath:AT4G22200; -.
DR   Araport; AT4G22200; -.
DR   TAIR; locus:2132065; AT4G22200.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238230; -.
DR   InParanoid; Q38898; -.
DR   KO; K21867; -.
DR   OMA; QMDMVNL; -.
DR   OrthoDB; EOG0936023D; -.
DR   PhylomeDB; Q38898; -.
DR   PRO; PR:Q38898; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; Q38898; baseline and differential.
DR   Genevisible; Q38898; AT.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0009506; C:plasmodesma; IDA:TAIR.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:TAIR.
DR   GO; GO:0009737; P:response to abscisic acid; IEP:TAIR.
DR   CDD; cd00204; ANK; 1.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.25.40.20; -; 2.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00248; ANK; 5.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Complete proteome; Endoplasmic reticulum; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    802       Potassium channel AKT2/3.
FT                                /FTId=PRO_0000054122.
FT   TOPO_DOM      1     79       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     80    100       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    101    109       Extracellular. {ECO:0000255}.
FT   TRANSMEM    110    130       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    131    153       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    154    174       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    175    183       Extracellular. {ECO:0000255}.
FT   TRANSMEM    184    204       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    205    218       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    219    239       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    240    265       Extracellular. {ECO:0000255}.
FT   INTRAMEM    266    285       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    286    288       Extracellular. {ECO:0000255}.
FT   TRANSMEM    289    309       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    310    802       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      540    569       ANK 1.
FT   REPEAT      573    602       ANK 2.
FT   REPEAT      606    636       ANK 3.
FT   REPEAT      637    666       ANK 4.
FT   REPEAT      670    699       ANK 5.
FT   DOMAIN      725    802       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     394    513       cNMP.
FT   CARBOHYD    179    179       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    254    254       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     243    243       H->D: Abolishes the proton sensitivity;
FT                                lack of susceptibility to extracellular
FT                                potassium; when associated with E-286.
FT                                {ECO:0000269|PubMed:12172027}.
FT   MUTAGEN     286    286       S->E: Abolishes the proton and the
FT                                potassium sensitivity; lack of
FT                                susceptibility to extracellular
FT                                potassium; when associated with D-243.
FT                                {ECO:0000269|PubMed:12172027}.
FT   MUTAGEN     289    289       I->R: No change in proton sensitivity.
FT                                {ECO:0000269|PubMed:12172027}.
SQ   SEQUENCE   802 AA;  91308 MW;  6F138F9149ED3CD7 CRC64;
     MDLKYSASHC NLSSDMKLRR FHQHRGKGRE EEYDASSLSL NNLSKLILPP LGVASYNQNH
     IRSSGWIISP MDSRYRCWEF YMVLLVAYSA WVYPFEVAFL NSSPKRNLCI ADNIVDLFFA
     VDIVLTFFVA YIDERTQLLV REPKQIAVRY LSTWFLMDVA STIPFDAIGY LITGTSTLNI
     TCNLLGLLRF WRLRRVKHLF TRLEKDIRYS YFWIRCFRLL SVTLFLVHCA GCSYYLIADR
     YPHQGKTWTD AIPNFTETSL SIRYIAAIYW SITTMTTVGY GDLHASNTIE MVFITVYMLF
     NLGLTAYLIG NMTNLVVEGT RRTMEFRNSI EAASNFVNRN RLPPRLKDQI LAYMCLRFKA
     ESLNQQHLID QLPKSIYKSI CQHLFLPSVE KVYLFKGVSR EILLLLVSKM KAEYIPPRED
     VIMQNEAPDD VYIIVSGEVE IIDSEMERES VLGTLRCGDI FGEVGALCCR PQSYTFQTKS
     LSQLLRLKTS FLIETMQIKQ QDNATMLKNF LQHHKKLSNL DIGDLKAQQN GENTDVVPPN
     IASNLIAVVT TGNAALLDEL LKAKLSPDIT DSKGKTPLHV AASRGYEDCV LVLLKHGCNI
     HIRDVNGNSA LWEAIISKHY EIFRILYHFA AISDPHIAGD LLCEAAKQNN VEVMKALLKQ
     GLNVDTEDHH GVTALQVAMA EDQMDMVNLL ATNGADVVCV NTHNEFTPLE KLRVVEEEEE
     EERGRVSIYR GHPLERRERS CNEAGKLILL PPSLDDLKKI AGEKFGFDGS ETMVTNEDGA
     EIDSIEVIRD NDKLYFVVNK II
//
ID   AKT1_ARATH              Reviewed;         857 AA.
AC   Q38998; B9DI19; Q0WTF6; Q38797; Q84MA7;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 2.
DT   25-OCT-2017, entry version 148.
DE   RecName: Full=Potassium channel AKT1;
GN   Name=AKT1; OrderedLocusNames=At2g26650; ORFNames=F18A8.2;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Landsberg erecta;
RX   PubMed=1585180; DOI=10.1126/science.1585180;
RA   Sentenac H., Bonneaud N., Minet M., Lacroute F., Salmon J.-M.,
RA   Gaymard F., Grignon C.;
RT   "Cloning and expression in yeast of a plant potassium ion transport
RT   system.";
RL   Science 256:663-665(1992).
RN   [2]
RP   SEQUENCE REVISION.
RA   Sentenac H.;
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   STRAIN=cv. Landsberg erecta;
RX   PubMed=8555458; DOI=10.1007/BF00014968;
RA   Basset M., Conejero G., Lepetit M., Fourcroy P., Sentenac H.;
RT   "Organization and expression of the gene coding for the potassium
RT   transport system AKT1 of Arabidopsis thaliana.";
RL   Plant Mol. Biol. 29:947-958(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617197; DOI=10.1038/45471;
RA   Lin X., Kaul S., Rounsley S.D., Shea T.P., Benito M.-I., Town C.D.,
RA   Fujii C.Y., Mason T.M., Bowman C.L., Barnstead M.E., Feldblyum T.V.,
RA   Buell C.R., Ketchum K.A., Lee J.J., Ronning C.M., Koo H.L.,
RA   Moffat K.S., Cronin L.A., Shen M., Pai G., Van Aken S., Umayam L.,
RA   Tallon L.J., Gill J.E., Adams M.D., Carrera A.J., Creasy T.H.,
RA   Goodman H.M., Somerville C.R., Copenhaver G.P., Preuss D.,
RA   Nierman W.C., White O., Eisen J.A., Salzberg S.L., Fraser C.M.,
RA   Venter J.C.;
RT   "Sequence and analysis of chromosome 2 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:761-768(1999).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RC   TISSUE=Rosette leaf {ECO:0000312|EMBL:BAH20386.1};
RX   PubMed=19423640; DOI=10.1093/dnares/dsp009;
RA   Iida K., Fukami-Kobayashi K., Toyoda A., Sakaki Y., Kobayashi M.,
RA   Seki M., Shinozaki K.;
RT   "Analysis of multiple occurrences of alternative splicing events in
RT   Arabidopsis thaliana using novel sequenced full-length cDNAs.";
RL   DNA Res. 16:155-164(2009).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 79-857.
RC   STRAIN=cv. Columbia;
RA   Totoki Y., Seki M., Ishida J., Nakajima M., Enju A., Kamiya A.,
RA   Narusaka M., Shin-i T., Nakagawa M., Sakamoto N., Oishi K., Kohara Y.,
RA   Kobayashi M., Toyoda A., Sakaki Y., Sakurai T., Iida K., Akiyama K.,
RA   Satou M., Toyoda T., Konagaya A., Carninci P., Kawai J.,
RA   Hayashizaki Y., Shinozaki K.;
RT   "Large-scale analysis of RIKEN Arabidopsis full-length (RAFL) cDNAs.";
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 106-857.
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=8820606; DOI=10.1046/j.1365-313X.1996.09020195.x;
RA   Lagarde D., Basset M., Lepetit M., Conejero G., Gaymard F., Astruc S.,
RA   Grignon C.;
RT   "Tissue-specific expression of Arabidopsis AKT1 gene is consistent
RT   with a role in K+ nutrition.";
RL   Plant J. 9:195-203(1996).
RN   [10]
RP   SUBUNIT.
RX   PubMed=9218788; DOI=10.1093/emboj/16.12.3455;
RA   Daram P., Urbach S., Gaymard F., Sentenac H., Cherel I.;
RT   "Tetramerization of the AKT1 plant potassium channel involves its C-
RT   terminal cytoplasmic domain.";
RL   EMBO J. 16:3455-3463(1997).
RN   [11]
RP   FUNCTION.
RX   PubMed=9572739; DOI=10.1126/science.280.5365.918;
RA   Hirsch R.E., Lewis B.D., Spalding E.P., Sussman M.R.;
RT   "A role for the AKT1 potassium channel in plant nutrition.";
RL   Science 280:918-921(1998).
RN   [12]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [13]
RP   FUNCTION, INTERACTION WITH AKT2 AND KAT3, AND INDUCTION.
RX   PubMed=12678562; DOI=10.1023/A:1022597102282;
RA   Pilot G., Gaymard F., Mouline K., Cherel I., Sentenac H.;
RT   "Regulated expression of Arabidopsis shaker K(+) channel genes
RT   involved in K(+) uptake and distribution in the plant.";
RL   Plant Mol. Biol. 51:773-787(2003).
RN   [14]
RP   FUNCTION, INTERACTION WITH CIPK23, PHOSPHORYLATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=16814720; DOI=10.1016/j.cell.2006.06.011;
RA   Xu J., Li H.-D., Chen L.-Q., Wang Y., Liu L.-L., He L., Wu W.-H.;
RT   "A protein kinase, interacting with two calcineurin B-like proteins,
RT   regulates K+ transporter AKT1 in Arabidopsis.";
RL   Cell 125:1347-1360(2006).
RN   [15]
RP   FUNCTION, INTERACTION WITH CIPK23, AND PHOSPHORYLATION.
RX   PubMed=16895985; DOI=10.1073/pnas.0605129103;
RA   Li L., Kim B.-G., Cheong Y.H., Pandey G.K., Luan S.;
RT   "A Ca(2)+ signaling pathway regulates a K(+) channel for low-K
RT   response in Arabidopsis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:12625-12630(2006).
RN   [16]
RP   FUNCTION, PHOSPHORYLATION, AND INTERACTION WITH AIP1; CIPK6; CIPK16
RP   AND CIPK23.
RX   PubMed=17898163; DOI=10.1073/pnas.0707912104;
RA   Lee S.-C., Lan W.-Z., Kim B.-G., Li L., Cheong Y.H., Pandey G.K.,
RA   Lu G., Buchanan B.B., Luan S.;
RT   "A protein phosphorylation/dephosphorylation network regulates a plant
RT   potassium channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:15959-15964(2007).
RN   [17]
RP   FUNCTION.
RX   PubMed=20413648; DOI=10.1104/pp.110.154369;
RA   Pyo Y.J., Gierth M., Schroeder J.I., Cho M.H.;
RT   "High-affinity K(+) transport in Arabidopsis: AtHAK5 and AKT1 are
RT   vital for seedling establishment and postgermination growth under low-
RT   potassium conditions.";
RL   Plant Physiol. 153:863-875(2010).
RN   [18]
RP   INTERACTION WITH CBL10.
RX   PubMed=23331977; DOI=10.1111/tpj.12123;
RA   Ren X.L., Qi G.N., Feng H.Q., Zhao S., Zhao S.S., Wang Y., Wu W.H.;
RT   "Calcineurin B-like protein CBL10 directly interacts with AKT1 and
RT   modulates K+ homeostasis in Arabidopsis.";
RL   Plant J. 74:258-266(2013).
RN   [19]
RP   CRYSTALLIZATION OF THE ANKYRIN-REPEAT DOMAIN.
RX   PubMed=24699751; DOI=10.1107/S2053230X14005093;
RA   Chaves-Sanjuan A., Sanchez-Barrena M.J., Gonzalez-Rubio J.M.,
RA   Albert A.;
RT   "Preliminary crystallographic analysis of the ankyrin-repeat domain of
RT   Arabidopsis thaliana AKT1: identification of the domain boundaries for
RT   protein crystallization.";
RL   Acta Crystallogr. F Struct. Biol. Commun. 70:509-512(2014).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.87 ANGSTROMS) OF 518-702.
RA   Chaves-Sanjuan A., Gonzalez-Rubio J.M., Sanchez-Barrena M.J.,
RA   Albert A.;
RT   "Structure of the Ankyrin Domain of Akt1.";
RL   Submitted (JUL-2015) to the PDB data bank.
CC   -!- FUNCTION: Highly selective inward-rectifying potassium channel
CC       that mediate potassium uptake by plant roots in response to low
CC       K(+) conditions, by a calcium-, CBL-, and CIPK-dependent pathway.
CC       Positively regulated by phosphorylation by CIPK23. Negatively
CC       regulated by a kinase-independent regulatory mechanism involving a
CC       competing direct binding of CBL10. Involved in the stomatal
CC       regulation by monitoring the turgor pressure in guard cells.
CC       Assuming opened or closed conformations in response to the voltage
CC       difference across the membrane, the channel is activated by
CC       hyperpolarization. May interact with the cytoskeleton or with
CC       regulatory proteins (PubMed:12678562, PubMed:16814720,
CC       PubMed:16895985, PubMed:17898163, PubMed:9572739). Is essential
CC       with POT5/HAK5 for high-affinity potassium uptake in roots during
CC       seedling establishment and postgermination growth under low
CC       potassium conditions (PubMed:20413648).
CC       {ECO:0000269|PubMed:12678562, ECO:0000269|PubMed:16814720,
CC       ECO:0000269|PubMed:16895985, ECO:0000269|PubMed:17898163,
CC       ECO:0000269|PubMed:20413648, ECO:0000269|PubMed:9572739}.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming subunits. Possible
CC       heteromultimer with AKT2 or KAT3. Part of a K(+)-channel calcium-
CC       sensing kinase/phosphatase complex composed by a calcium sensor
CC       CBL (CBL1, CBL2, CBL3 or CBL9), a kinase CIPK (CIPK6, CIPK16 or
CC       CIPK23), a phosphatase PP2C (AIP1) and a K(+)-channel (AKT1).
CC       Interacts directly with AIP1, CBL10, CIPK6, CIPK16 and CIPK23.
CC       {ECO:0000269|PubMed:12678562, ECO:0000269|PubMed:16814720,
CC       ECO:0000269|PubMed:16895985, ECO:0000269|PubMed:17898163,
CC       ECO:0000269|PubMed:23331977, ECO:0000269|PubMed:9218788}.
CC   -!- INTERACTION:
CC       Self; NbExp=7; IntAct=EBI-974289, EBI-974289;
CC       Q38898:AKT2; NbExp=3; IntAct=EBI-974289, EBI-1552774;
CC       Q93VD3:CIPK23; NbExp=6; IntAct=EBI-974289, EBI-974277;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16814720};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:16814720}.
CC   -!- TISSUE SPECIFICITY: Preferentially expressed in the peripheral
CC       cell layers of root mature including root cortex and root hairs.
CC       Detected also, at a lower level, in the mesophyll of the leaves
CC       and at restricted sites corresponding to hydathodes and guard
CC       cells. {ECO:0000269|PubMed:8555458, ECO:0000269|PubMed:8820606}.
CC   -!- INDUCTION: In roots, strongly reduced after 2,4-
CC       dichlorophenoxyacetic acid (2,4-D) treatment and weakly reduced
CC       after benzyladenine (BA) treatment. In shoots, strongly reduced
CC       after abscisic acid (ABA) treatment and induced after
CC       benzyladenine (BA) treatment. {ECO:0000269|PubMed:12678562}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization.
CC   -!- PTM: Phosphorylated by CIPK proteins CIPK6, CIPK16 and CIPK23. The
CC       activation by phosphorylation is induced by low K(+) conditions
CC       and stimulates K(+) uptake and relocation. Dephosphorylation by
CC       AIP1 repressed the transport activity.
CC       {ECO:0000269|PubMed:16814720, ECO:0000269|PubMed:16895985,
CC       ECO:0000269|PubMed:17898163}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X62907; CAA44693.1; -; mRNA.
DR   EMBL; U06745; AAA96810.1; -; Genomic_DNA.
DR   EMBL; AC003105; AAB95299.1; -; Genomic_DNA.
DR   EMBL; CP002685; AEC07870.1; -; Genomic_DNA.
DR   EMBL; AK317729; BAH20386.1; -; mRNA.
DR   EMBL; AK227601; BAE99592.1; -; mRNA.
DR   EMBL; BT006442; AAP21250.1; -; mRNA.
DR   PIR; S23606; S23606.
DR   PIR; S62694; S62694.
DR   RefSeq; NP_001324538.1; NM_001336078.1.
DR   RefSeq; NP_180233.1; NM_128222.6.
DR   UniGene; At.48521; -.
DR   UniGene; At.68413; -.
DR   PDB; 5AAR; X-ray; 1.87 A; A=518-702.
DR   PDBsum; 5AAR; -.
DR   ProteinModelPortal; Q38998; -.
DR   SMR; Q38998; -.
DR   BioGrid; 2558; 16.
DR   DIP; DIP-36762N; -.
DR   IntAct; Q38998; 7.
DR   STRING; 3702.AT2G26650.1; -.
DR   TCDB; 1.A.1.4.1; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q38998; -.
DR   PaxDb; Q38998; -.
DR   EnsemblPlants; AT2G26650.1; AT2G26650.1; AT2G26650.
DR   GeneID; 817206; -.
DR   Gramene; AT2G26650.1; AT2G26650.1; AT2G26650.
DR   KEGG; ath:AT2G26650; -.
DR   Araport; AT2G26650; -.
DR   TAIR; locus:2043839; AT2G26650.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238230; -.
DR   InParanoid; Q38998; -.
DR   KO; K21867; -.
DR   OMA; TGLYACI; -.
DR   OrthoDB; EOG093601WX; -.
DR   PhylomeDB; Q38998; -.
DR   BioCyc; ARA:AT2G26550-MONOMER; -.
DR   BioCyc; MetaCyc:MONOMER-14552; -.
DR   PRO; PR:Q38998; -.
DR   Proteomes; UP000006548; Chromosome 2.
DR   ExpressionAtlas; Q38998; baseline and differential.
DR   Genevisible; Q38998; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IDA:TAIR.
DR   GO; GO:0010107; P:potassium ion import; IDA:TAIR.
DR   GO; GO:0006813; P:potassium ion transport; IMP:TAIR.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0090333; P:regulation of stomatal closure; IMP:TAIR.
DR   GO; GO:0009651; P:response to salt stress; IMP:TAIR.
DR   GO; GO:0009414; P:response to water deprivation; IMP:TAIR.
DR   GO; GO:0048767; P:root hair elongation; IMP:TAIR.
DR   CDD; cd00204; ANK; 1.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.25.40.20; -; 2.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00248; ANK; 5.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ANK repeat; Cell membrane; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    857       Potassium channel AKT1.
FT                                /FTId=PRO_0000054121.
FT   TOPO_DOM      1     61       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     62     82       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     83     90       Extracellular. {ECO:0000255}.
FT   TRANSMEM     91    111       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    112    134       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    135    155       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    156    158       Extracellular. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    180    193       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    194    214       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    215    241       Extracellular. {ECO:0000255}.
FT   INTRAMEM    242    261       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    262    265       Extracellular. {ECO:0000255}.
FT   TRANSMEM    266    286       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    287    857       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      515    546       ANK 1. {ECO:0000255}.
FT   REPEAT      550    579       ANK 2. {ECO:0000255}.
FT   REPEAT      583    612       ANK 3. {ECO:0000255}.
FT   REPEAT      614    643       ANK 4. {ECO:0000255}.
FT   REPEAT      647    676       ANK 5. {ECO:0000255}.
FT   REPEAT      680    709       ANK 6. {ECO:0000255}.
FT   DOMAIN      790    857       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     372    493       cNMP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00060}.
FT   HELIX       522    527       {ECO:0000244|PDB:5AAR}.
FT   HELIX       531    539       {ECO:0000244|PDB:5AAR}.
FT   HELIX       554    561       {ECO:0000244|PDB:5AAR}.
FT   HELIX       564    572       {ECO:0000244|PDB:5AAR}.
FT   HELIX       587    593       {ECO:0000244|PDB:5AAR}.
FT   HELIX       597    605       {ECO:0000244|PDB:5AAR}.
FT   HELIX       610    612       {ECO:0000244|PDB:5AAR}.
FT   HELIX       615    624       {ECO:0000244|PDB:5AAR}.
FT   HELIX       628    636       {ECO:0000244|PDB:5AAR}.
FT   HELIX       651    657       {ECO:0000244|PDB:5AAR}.
FT   HELIX       661    669       {ECO:0000244|PDB:5AAR}.
FT   HELIX       684    690       {ECO:0000244|PDB:5AAR}.
FT   HELIX       694    701       {ECO:0000244|PDB:5AAR}.
SQ   SEQUENCE   857 AA;  96990 MW;  28E1622BA3505F4C CRC64;
     MRGGALLCGQ VQDEIEQLSR ESSHFSLSTG ILPSLGARSN RRVKLRRFVV SPYDHKYRIW
     EAFLVVLVVY TAWVSPFEFG FLRKPRPPLS ITDNIVNAFF AIDIIMTFFV GYLDKSTYLI
     VDDRKQIAFK YLRSWFLLDL VSTIPSEAAM RISSQSYGLF NMLRLWRLRR VGALFARLEK
     DRNFNYFWVR CAKLVCVTLF AVHCAACFYY LIAARNSNPA KTWIGANVAN FLEESLWMRY
     VTSMYWSITT LTTVGYGDLH PVNTKEMIFD IFYMLFNLGL TAYLIGNMTN LVVHGTSRTR
     NFRDTIQAAS NFAHRNHLPP RLQDQMLAHL CLKYRTDSEG LQQQETLDAL PKAIRSSISH
     FLFYSLMDKV YLFRGVSNDL LFQLVSEMKA EYFPPKEDVI LQNEAPTDFY ILVNGTADLV
     DVDTGTESIV REVKAGDIIG EIGVLCYRPQ LFTVRTKRLC QLLRMNRTTF LNIIQANVGD
     GTIIMNNLLQ HLKEMNDPVM TNVLLEIENM LARGKMDLPL NLCFAAIRED DLLLHQLLKR
     GLDPNESDNN GRTPLHIAAS KGTLNCVLLL LEYHADPNCR DAEGSVPLWE AMVEGHEKVV
     KVLLEHGSTI DAGDVGHFAC TAAEQGNLKL LKEIVLHGGD VTRPRATGTS ALHTAVCEEN
     IEMVKYLLEQ GADVNKQDMH GWTPRDLAEQ QGHEDIKALF REKLHERRVH IETSSSVPIL
     KTGIRFLGRF TSEPNIRPAS REVSFRIRET RARRKTNNFD NSLFGILANQ SVPKNGLATV
     DEGRTGNPVR VTISCAEKDD IAGKLVLLPG SFKELLELGS NKFGIVATKV MNKDNNAEID
     DVDVIRDGDH LIFATDS
//
ID   TM38A_MOUSE             Reviewed;         298 AA.
AC   Q3TMP8; A5A6S4; A7LBB7; Q3TZB9; Q91WL2;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 2.
DT   05-JUL-2017, entry version 91.
DE   RecName: Full=Trimeric intracellular cation channel type A;
DE            Short=TRIC-A;
DE            Short=TRICA;
DE   AltName: Full=27 kDa sarcoplasmic reticulum protein;
DE   AltName: Full=Mitsugumin-33A;
DE   AltName: Full=SPR-27;
DE   AltName: Full=Transmembrane protein 38A;
GN   Name=Tmem38a;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TOPOLOGY, TISSUE SPECIFICITY,
RP   AND DISRUPTION PHENOTYPE.
RX   PubMed=17611541; DOI=10.1038/nature05928;
RA   Yazawa M., Ferrante C., Feng J., Mio K., Ogura T., Zhang M.,
RA   Lin P.-H., Pan Z., Komazaki S., Kato K., Nishi M., Zhao X.,
RA   Weisleder N., Sato C., Ma J., Takeshima H.;
RT   "TRIC channels are essential for Ca2+ handling in intracellular
RT   stores.";
RL   Nature 448:78-82(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J;
RA   Bleunven C., Treves S., Leo E., Ronjat M., De Waard M., Kern G.,
RA   Flucher B.E., Zorzato F.;
RT   "SPR-27 is a novel component of the supramolecular signaling complex
RT   involved in skeletal muscle excitation-contraction coupling.";
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Cerebellum, and Inner ear;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Heart;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Monovalent cation channel required for maintenance of
CC       rapid intracellular calcium release. May act as a potassium
CC       counter-ion channel that functions in synchronization with calcium
CC       release from intracellular stores. {ECO:0000269|PubMed:17611541}.
CC   -!- SUBUNIT: Homotrimer; trimerization probably requires binding to
CC       phosphatidylinositol 4,5-bisphosphate (PIP2).
CC       {ECO:0000250|UniProtKB:A5A6S6, ECO:0000250|UniProtKB:Q9NA73}.
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:A5A6S6}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:A5A6S6}. Nucleus membrane
CC       {ECO:0000250|UniProtKB:A5A6S6}.
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in heart and striated
CC       muscle. Also detected in brain, lung and kidney.
CC       {ECO:0000269|PubMed:17611541}.
CC   -!- DISRUPTION PHENOTYPE: Mice are viable. Mice lacking Tmem38a and
CC       Tmem38b show a weak heartbeat at E9.5 followed by loss of
CC       cardiomyocyte viability and embryonic lethality around E10.5.
CC       {ECO:0000269|PubMed:17611541}.
CC   -!- SIMILARITY: Belongs to the TMEM38 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB261158; BAF62541.1; -; mRNA.
DR   EMBL; EF988666; ABS17665.1; -; mRNA.
DR   EMBL; AK157969; BAE34290.1; -; mRNA.
DR   EMBL; AK165818; BAE38393.1; -; mRNA.
DR   EMBL; BC014728; AAH14728.1; -; mRNA.
DR   EMBL; BC024788; AAH24788.1; -; mRNA.
DR   CCDS; CCDS22417.1; -.
DR   RefSeq; NP_653117.1; NM_144534.1.
DR   UniGene; Mm.212927; -.
DR   STRING; 10090.ENSMUSP00000034244; -.
DR   TCDB; 1.A.62.1.1; the homotrimeric cation channel (tric) family.
DR   iPTMnet; Q3TMP8; -.
DR   PhosphoSitePlus; Q3TMP8; -.
DR   EPD; Q3TMP8; -.
DR   MaxQB; Q3TMP8; -.
DR   PaxDb; Q3TMP8; -.
DR   PeptideAtlas; Q3TMP8; -.
DR   PRIDE; Q3TMP8; -.
DR   Ensembl; ENSMUST00000034244; ENSMUSP00000034244; ENSMUSG00000031791.
DR   GeneID; 74166; -.
DR   KEGG; mmu:74166; -.
DR   UCSC; uc009mgi.2; mouse.
DR   CTD; 79041; -.
DR   MGI; MGI:1921416; Tmem38a.
DR   eggNOG; KOG3944; Eukaryota.
DR   eggNOG; ENOG410XQ0P; LUCA.
DR   GeneTree; ENSGT00390000018845; -.
DR   HOGENOM; HOG000037929; -.
DR   HOVERGEN; HBG059853; -.
DR   InParanoid; Q3TMP8; -.
DR   OMA; KYEPGAV; -.
DR   OrthoDB; EOG091G0GQP; -.
DR   PhylomeDB; Q3TMP8; -.
DR   TreeFam; TF313483; -.
DR   PRO; PR:Q3TMP8; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   Bgee; ENSMUSG00000031791; -.
DR   CleanEx; MM_TMEM38A; -.
DR   ExpressionAtlas; Q3TMP8; baseline and differential.
DR   Genevisible; Q3TMP8; MM.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; TAS:BHF-UCL.
DR   InterPro; IPR007866; TRIC_channel.
DR   PANTHER; PTHR12454; PTHR12454; 1.
DR   Pfam; PF05197; TRIC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Nucleus;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Sarcoplasmic reticulum; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    298       Trimeric intracellular cation channel
FT                                type A.
FT                                /FTId=PRO_0000271069.
FT   TOPO_DOM      1     18       Lumenal. {ECO:0000305}.
FT   TRANSMEM     19     39       Helical;Name=1. {ECO:0000255}.
FT   TOPO_DOM     40     51       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     52     72       Helical;Name=2. {ECO:0000255}.
FT   TOPO_DOM     73     85       Lumenal. {ECO:0000305}.
FT   TRANSMEM     86    106       Helical;Name=3. {ECO:0000255}.
FT   TOPO_DOM    107    144       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    145    165       Helical;Name=4. {ECO:0000255}.
FT   TOPO_DOM    166    178       Lumenal. {ECO:0000305}.
FT   TRANSMEM    179    199       Helical;Name=5. {ECO:0000255}.
FT   TOPO_DOM    200    209       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    210    230       Helical;Name=6. {ECO:0000255}.
FT   TOPO_DOM    231    234       Lumenal. {ECO:0000305}.
FT   TRANSMEM    235    255       Helical;Name=7. {ECO:0000255}.
FT   TOPO_DOM    256    298       Cytoplasmic. {ECO:0000305}.
FT   COMPBIAS    135    143       His-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00009}.
FT   BINDING     122    122       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000250|UniProtKB:Q9NA73}.
FT   BINDING     126    126       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000250|UniProtKB:Q9NA73}.
FT   CONFLICT     73     73       L -> P (in Ref. 3; BAE38393).
FT                                {ECO:0000305}.
FT   CONFLICT    276    276       G -> S (in Ref. 2; ABS17665 and 3;
FT                                BAE34290). {ECO:0000305}.
SQ   SEQUENCE   298 AA;  33309 MW;  F35559581DA80BD7 CRC64;
     MDLMSALSLG ELALSFSRVP LFPVFDLSYF IVSIIYLKYE PGAVELSRRH PVASWLCAML
     HCFGSYILAD LLLGEPIIDY FSNSSSILLA SGVWYLIFFC PLDLFYKCVC FLPVKLIFVA
     MKEVVRVRKI AVGIHHAHHH YHHGWFIMIA TGWVKGSGVA LLSNVEQLLR GVWKPETNEI
     LHMSFPTKAS LYGAILFTLQ QTRWLPVSKA SLIFVFTMFM VSCKVFLTAT HSHSSPFDIL
     EGYICPVLFG ATWGGDHHHD NHGAPHGMGL GTQHSGLPAK AKEELGEGSR KKKTKKAD
//
ID   MVP_METJA               Reviewed;         209 AA.
AC   Q57603;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   07-JUN-2017, entry version 99.
DE   RecName: Full=Hyperpolarization-activated voltage-gated potassium channel;
DE   AltName: Full=MVP;
GN   Name=mvp; OrderedLocusNames=MJ0139;
OS   Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 /
OS   JCM 10045 / NBRC 100440) (Methanococcus jannaschii).
OC   Archaea; Euryarchaeota; Methanococci; Methanococcales;
OC   Methanocaldococcaceae; Methanocaldococcus.
OX   NCBI_TaxID=243232;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHARACTERIZATION.
RX   PubMed=12640457; DOI=10.1038/nn1028;
RA   Sesti F., Rajan S., Gonzalez-Colaso R., Nikolaeva N.,
RA   Goldstein S.A.N.;
RT   "Hyperpolarization moves S4 sensors inward to open MVP, a
RT   methanococcal voltage-gated potassium channel.";
RL   Nat. Neurosci. 6:353-361(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440;
RX   PubMed=8688087; DOI=10.1126/science.273.5278.1058;
RA   Bult C.J., White O., Olsen G.J., Zhou L., Fleischmann R.D.,
RA   Sutton G.G., Blake J.A., FitzGerald L.M., Clayton R.A., Gocayne J.D.,
RA   Kerlavage A.R., Dougherty B.A., Tomb J.-F., Adams M.D., Reich C.I.,
RA   Overbeek R., Kirkness E.F., Weinstock K.G., Merrick J.M., Glodek A.,
RA   Scott J.L., Geoghagen N.S.M., Weidman J.F., Fuhrmann J.L., Nguyen D.,
RA   Utterback T.R., Kelley J.M., Peterson J.D., Sadow P.W., Hanna M.C.,
RA   Cotton M.D., Roberts K.M., Hurst M.A., Kaine B.P., Borodovsky M.,
RA   Klenk H.-P., Fraser C.M., Smith H.O., Woese C.R., Venter J.C.;
RT   "Complete genome sequence of the methanogenic archaeon, Methanococcus
RT   jannaschii.";
RL   Science 273:1058-1073(1996).
RN   [3]
RP   FUNCTION.
RC   STRAIN=ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440;
RX   PubMed=12860407; DOI=10.1016/S0014-5793(03)00706-3;
RA   Hellmer J., Zeilinger C.;
RT   "MjK1, a K+ channel from M. jannaschii, mediates K+ uptake and K+
RT   sensitivity in E. coli.";
RL   FEBS Lett. 547:165-169(2003).
CC   -!- FUNCTION: Voltage-gated potassium-selective channel opened by
CC       hyperpolarization. {ECO:0000269|PubMed:12860407}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids.
CC   -!- MISCELLANEOUS: Inhibited by barium.
CC   -!- SIMILARITY: Belongs to the potassium channel family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY268105; AAP31055.1; -; mRNA.
DR   EMBL; L77117; AAB98122.1; -; Genomic_DNA.
DR   PIR; C64317; C64317.
DR   RefSeq; WP_010869632.1; NC_000909.1.
DR   ProteinModelPortal; Q57603; -.
DR   STRING; 243232.MJ_0139; -.
DR   TCDB; 1.A.1.6.1; the voltage-gated ion channel (vic) superfamily.
DR   PRIDE; Q57603; -.
DR   EnsemblBacteria; AAB98122; AAB98122; MJ_0139.
DR   GeneID; 1450980; -.
DR   KEGG; mja:MJ_0139; -.
DR   eggNOG; arCOG01964; Archaea.
DR   eggNOG; COG1226; LUCA.
DR   InParanoid; Q57603; -.
DR   KO; K10716; -.
DR   OMA; LSTYNPP; -.
DR   OrthoDB; POG093Z0DUI; -.
DR   Proteomes; UP000000805; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    209       Hyperpolarization-activated voltage-gated
FT                                potassium channel.
FT                                /FTId=PRO_0000054098.
FT   TOPO_DOM      1     10       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     11     31       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     32     38       Extracellular. {ECO:0000255}.
FT   TRANSMEM     39     59       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM     60     71       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     72     92       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM     93     96       Extracellular. {ECO:0000255}.
FT   TRANSMEM     97    117       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    118    125       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    126    146       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    147    181       Extracellular. {ECO:0000255}.
FT   TRANSMEM    182    202       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    203    209       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       170    175       Selectivity filter. {ECO:0000250}.
SQ   SEQUENCE   209 AA;  24183 MW;  FC91E7320F34D90F CRC64;
     MNLKDRRLKK IMEVLSLIFT FEIVASFILS TYNPPYQDLL IKLDYISIMF FTFEFIYNFY
     YVEDKAKFFK DIYNIVDAIV VIAFLLYSLQ VFYSKAFLGL RVINLLRILV LLRIIKLRKL
     EENQALINFL TLLTICFIAS CLIWIVESGV NPAINNFFDA FYFTTISITT VGYGDITPKT
     DAGKLIIIFS VLFFISGLIT SLQKALKGD
//
ID   MJK1_METJA              Reviewed;         333 AA.
AC   Q57604;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   25-OCT-2017, entry version 114.
DE   RecName: Full=Potassium channel protein 1;
DE   AltName: Full=MjK1;
GN   OrderedLocusNames=MJ0138.1;
OS   Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 /
OS   JCM 10045 / NBRC 100440) (Methanococcus jannaschii).
OC   Archaea; Euryarchaeota; Methanococci; Methanococcales;
OC   Methanocaldococcaceae; Methanocaldococcus.
OX   NCBI_TaxID=243232;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440;
RX   PubMed=8688087; DOI=10.1126/science.273.5278.1058;
RA   Bult C.J., White O., Olsen G.J., Zhou L., Fleischmann R.D.,
RA   Sutton G.G., Blake J.A., FitzGerald L.M., Clayton R.A., Gocayne J.D.,
RA   Kerlavage A.R., Dougherty B.A., Tomb J.-F., Adams M.D., Reich C.I.,
RA   Overbeek R., Kirkness E.F., Weinstock K.G., Merrick J.M., Glodek A.,
RA   Scott J.L., Geoghagen N.S.M., Weidman J.F., Fuhrmann J.L., Nguyen D.,
RA   Utterback T.R., Kelley J.M., Peterson J.D., Sadow P.W., Hanna M.C.,
RA   Cotton M.D., Roberts K.M., Hurst M.A., Kaine B.P., Borodovsky M.,
RA   Klenk H.-P., Fraser C.M., Smith H.O., Woese C.R., Venter J.C.;
RT   "Complete genome sequence of the methanogenic archaeon, Methanococcus
RT   jannaschii.";
RL   Science 273:1058-1073(1996).
RN   [2]
RP   FUNCTION.
RC   STRAIN=ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440;
RX   PubMed=12860407; DOI=10.1016/S0014-5793(03)00706-3;
RA   Hellmer J., Zeilinger C.;
RT   "MjK1, a K+ channel from M. jannaschii, mediates K+ uptake and K+
RT   sensitivity in E. coli.";
RL   FEBS Lett. 547:165-169(2003).
CC   -!- FUNCTION: Potassium channel protein. Seems to conduct potassium at
CC       low membrane potentials. {ECO:0000269|PubMed:12860407}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- MISCELLANEOUS: Inhibited by barium and cesium.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L77117; AAB98130.1; -; Genomic_DNA.
DR   PIR; D64317; D64317.
DR   RefSeq; WP_010869633.1; NC_000909.1.
DR   ProteinModelPortal; Q57604; -.
DR   SMR; Q57604; -.
DR   STRING; 243232.MJ_0138.1; -.
DR   TCDB; 1.A.1.13.8; the voltage-gated ion channel (vic) superfamily.
DR   EnsemblBacteria; AAB98130; AAB98130; MJ_0138.1.
DR   GeneID; 1450981; -.
DR   KEGG; mja:MJ_0138.1; -.
DR   eggNOG; arCOG01960; Archaea.
DR   eggNOG; COG1226; LUCA.
DR   InParanoid; Q57604; -.
DR   KO; K10716; -.
DR   OMA; VFEGIWW; -.
DR   OrthoDB; POG093Z055I; -.
DR   PhylomeDB; Q57604; -.
DR   Proteomes; UP000000805; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.70.1450; -; 1.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR006037; RCK_C.
DR   InterPro; IPR036721; RCK_C_sf.
DR   InterPro; IPR003148; RCK_N.
DR   Pfam; PF07885; Ion_trans_2; 1.
DR   Pfam; PF02080; TrkA_C; 1.
DR   Pfam; PF02254; TrkA_N; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   SUPFAM; SSF116726; SSF116726; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS51202; RCK_C; 1.
DR   PROSITE; PS51201; RCK_N; 1.
PE   4: Predicted;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    333       Potassium channel protein 1.
FT                                /FTId=PRO_0000054099.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     27       Helical. {ECO:0000255}.
FT   TOPO_DOM     28     60       Extracellular. {ECO:0000255}.
FT   TRANSMEM     61     81       Helical. {ECO:0000255}.
FT   TOPO_DOM     82    333       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      109    233       RCK N-terminal. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00543}.
FT   DOMAIN      246    331       RCK C-terminal. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00544}.
FT   MOTIF        46     51       Selectivity filter. {ECO:0000250}.
SQ   SEQUENCE   333 AA;  37150 MW;  7CC082675F96B06A CRC64;
     METYEKIELG IIVIILLILI ESVILMTVEG WDFFTAFYTA VVTISTVGYG DYTPQTFLGK
     LSVIIYIFAG VGAVAYTMGN IASFFIEGHF RKYFRLRKMM DRIKKLNNHY IICGYGRLGK
     VIAEEFKKCN IPFVIIDSDE KLLEEALEKD PNLICIVGDA TSDDILKKAK IEKAKGLISV
     VSSDAENVFI TLSAKKLNPN IYIVAKAEKP STLDKLIKAG ADRAVCPYIV GGMEIARIAI
     NPDIVEFIHS LVATEEDMEV RRYIVKNKEL DNKLLKDSGI REKTGATILA VKKGDKTITS
     PPPDTVINIG DIIYAFGTKE QLEKLKRYVE GVE
//
ID   MJK2_METJA              Reviewed;         343 AA.
AC   Q58752;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   25-OCT-2017, entry version 105.
DE   RecName: Full=Probable potassium channel protein 2;
DE   AltName: Full=MjK2;
GN   OrderedLocusNames=MJ1357;
OS   Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 /
OS   JCM 10045 / NBRC 100440) (Methanococcus jannaschii).
OC   Archaea; Euryarchaeota; Methanococci; Methanococcales;
OC   Methanocaldococcaceae; Methanocaldococcus.
OX   NCBI_TaxID=243232;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440;
RX   PubMed=8688087; DOI=10.1126/science.273.5278.1058;
RA   Bult C.J., White O., Olsen G.J., Zhou L., Fleischmann R.D.,
RA   Sutton G.G., Blake J.A., FitzGerald L.M., Clayton R.A., Gocayne J.D.,
RA   Kerlavage A.R., Dougherty B.A., Tomb J.-F., Adams M.D., Reich C.I.,
RA   Overbeek R., Kirkness E.F., Weinstock K.G., Merrick J.M., Glodek A.,
RA   Scott J.L., Geoghagen N.S.M., Weidman J.F., Fuhrmann J.L., Nguyen D.,
RA   Utterback T.R., Kelley J.M., Peterson J.D., Sadow P.W., Hanna M.C.,
RA   Cotton M.D., Roberts K.M., Hurst M.A., Kaine B.P., Borodovsky M.,
RA   Klenk H.-P., Fraser C.M., Smith H.O., Woese C.R., Venter J.C.;
RT   "Complete genome sequence of the methanogenic archaeon, Methanococcus
RT   jannaschii.";
RL   Science 273:1058-1073(1996).
RN   [2]
RP   FUNCTION.
RC   STRAIN=ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440;
RX   PubMed=12860407; DOI=10.1016/S0014-5793(03)00706-3;
RA   Hellmer J., Zeilinger C.;
RT   "MjK1, a K+ channel from M. jannaschii, mediates K+ uptake and K+
RT   sensitivity in E. coli.";
RL   FEBS Lett. 547:165-169(2003).
CC   -!- FUNCTION: Probable potassium channel protein.
CC       {ECO:0000269|PubMed:12860407}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L77117; AAB99365.1; -; Genomic_DNA.
DR   PIR; D64469; D64469.
DR   RefSeq; WP_010870874.1; NC_000909.1.
DR   ProteinModelPortal; Q58752; -.
DR   SMR; Q58752; -.
DR   STRING; 243232.MJ_1357; -.
DR   EnsemblBacteria; AAB99365; AAB99365; MJ_1357.
DR   GeneID; 1452259; -.
DR   KEGG; mja:MJ_1357; -.
DR   eggNOG; arCOG01958; Archaea.
DR   eggNOG; COG1226; LUCA.
DR   InParanoid; Q58752; -.
DR   KO; K10716; -.
DR   OMA; AMIIEGN; -.
DR   OrthoDB; POG093Z055I; -.
DR   PhylomeDB; Q58752; -.
DR   Proteomes; UP000000805; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.70.1450; -; 1.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR006037; RCK_C.
DR   InterPro; IPR036721; RCK_C_sf.
DR   InterPro; IPR003148; RCK_N.
DR   Pfam; PF07885; Ion_trans_2; 1.
DR   Pfam; PF02080; TrkA_C; 1.
DR   Pfam; PF02254; TrkA_N; 1.
DR   SUPFAM; SSF116726; SSF116726; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS51202; RCK_C; 1.
DR   PROSITE; PS51201; RCK_N; 1.
PE   4: Predicted;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    343       Probable potassium channel protein 2.
FT                                /FTId=PRO_0000054100.
FT   TOPO_DOM      1      7       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      8     28       Helical. {ECO:0000255}.
FT   TOPO_DOM     29     61       Extracellular. {ECO:0000255}.
FT   TRANSMEM     62     82       Helical. {ECO:0000255}.
FT   TOPO_DOM     83    343       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      109    234       RCK N-terminal. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00543}.
FT   DOMAIN      253    338       RCK C-terminal. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00544}.
FT   MOTIF        46     51       Selectivity filter. {ECO:0000250}.
SQ   SEQUENCE   343 AA;  38884 MW;  61231B0C001B54C4 CRC64;
     METSKKLVIV AVLSITLILT YAYLISIIEG VDYFTALYFS VITITTTGYG DFTPKTFLGR
     TLTVVYLCVG VGIVMYLFSL IAEFIVEGKF EEFVRLKKMK NKIKTLKDHY IICGYGRLGK
     VVGEKFIEEN IPFIAIDINE DVLKEEYEKY PDKFLYIVGD AKKEEVLKKA KIDKAKGLIA
     TLPSDADNVF LTLTARELNP NILITAKADE KEAIRKLKIA GANRVVSPYL IGGLRMAEVS
     VRPGILDFLS TFIKIAKDEY EEDIELRKFV IEKDSELAYK SLKDANIRGK TGATILGIRR
     EKEFCINPYP EFILKPGDVI YAFGTEENLK YLENLVKKKK KKL
//
ID   KAT3_ORYSJ              Reviewed;         502 AA.
AC   Q5JM04; A0A0P0V8B7;
DT   28-JUN-2011, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   20-DEC-2017, entry version 94.
DE   RecName: Full=Potassium channel KAT3;
GN   OrderedLocusNames=Os01g0756700, LOC_Os01g55200; ORFNames=OJ1414_E05.9;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12447438; DOI=10.1038/nature01184;
RA   Sasaki T., Matsumoto T., Yamamoto K., Sakata K., Baba T., Katayose Y.,
RA   Wu J., Niimura Y., Cheng Z., Nagamura Y., Antonio B.A., Kanamori H.,
RA   Hosokawa S., Masukawa M., Arikawa K., Chiden Y., Hayashi M.,
RA   Okamoto M., Ando T., Aoki H., Arita K., Hamada M., Harada C.,
RA   Hijishita S., Honda M., Ichikawa Y., Idonuma A., Iijima M., Ikeda M.,
RA   Ikeno M., Ito S., Ito T., Ito Y., Ito Y., Iwabuchi A., Kamiya K.,
RA   Karasawa W., Katagiri S., Kikuta A., Kobayashi N., Kono I.,
RA   Machita K., Maehara T., Mizuno H., Mizubayashi T., Mukai Y.,
RA   Nagasaki H., Nakashima M., Nakama Y., Nakamichi Y., Nakamura M.,
RA   Namiki N., Negishi M., Ohta I., Ono N., Saji S., Sakai K., Shibata M.,
RA   Shimokawa T., Shomura A., Song J., Takazaki Y., Terasawa K., Tsuji K.,
RA   Waki K., Yamagata H., Yamane H., Yoshiki S., Yoshihara R., Yukawa K.,
RA   Zhong H., Iwama H., Endo T., Ito H., Hahn J.H., Kim H.-I., Eun M.-Y.,
RA   Yano M., Jiang J., Gojobori T.;
RT   "The genome sequence and structure of rice chromosome 1.";
RL   Nature 420:312-316(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   "The rice annotation project database (RAP-DB): 2008 update.";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12869764; DOI=10.1126/science.1081288;
RG   The rice full-length cDNA consortium;
RT   "Collection, mapping, and annotation of over 28,000 cDNA clones from
RT   japonica rice.";
RL   Science 301:376-379(2003).
CC   -!- FUNCTION: Probable inward-rectifying potassium channel. Assuming
CC       opened or closed conformations in response to the voltage
CC       difference across the membrane, the channel is activated by
CC       hyperpolarization (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP003375; BAD87503.1; -; Genomic_DNA.
DR   EMBL; AP008207; BAF06204.1; -; Genomic_DNA.
DR   EMBL; AP014957; BAS74411.1; -; Genomic_DNA.
DR   EMBL; AK100739; -; NOT_ANNOTATED_CDS; mRNA.
DR   RefSeq; XP_015632943.1; XM_015777457.1.
DR   UniGene; Os.33391; -.
DR   ProteinModelPortal; Q5JM04; -.
DR   SMR; Q5JM04; -.
DR   STRING; 39947.LOC_Os01g55200.1; -.
DR   PaxDb; Q5JM04; -.
DR   PRIDE; Q5JM04; -.
DR   EnsemblPlants; OS01T0756700-01; OS01T0756700-01; OS01G0756700.
DR   GeneID; 4325143; -.
DR   Gramene; OS01T0756700-01; OS01T0756700-01; OS01G0756700.
DR   KEGG; osa:4325143; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   InParanoid; Q5JM04; -.
DR   KO; K21867; -.
DR   OMA; CMYFAIS; -.
DR   OrthoDB; EOG093607E4; -.
DR   Proteomes; UP000059680; Chromosome 1.
DR   ExpressionAtlas; Q5JM04; baseline and differential.
DR   Genevisible; Q5JM04; OS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    502       Potassium channel KAT3.
FT                                /FTId=PRO_0000410879.
FT   TOPO_DOM      1     67       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     68     88       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     89     95       Extracellular. {ECO:0000255}.
FT   TRANSMEM     96    116       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    117    138       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    139    159       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    160    169       Extracellular. {ECO:0000255}.
FT   TRANSMEM    170    190       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    191    204       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    205    225       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    226    252       Extracellular. {ECO:0000255}.
FT   INTRAMEM    253    272       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    273    276       Extracellular. {ECO:0000255}.
FT   TRANSMEM    277    297       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    298    502       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     381    500       cNMP.
FT   CONFLICT    467    467       K -> E (in Ref. 5; AK100739).
FT                                {ECO:0000305}.
SQ   SEQUENCE   502 AA;  58008 MW;  7D4742FCDC8FC41F CRC64;
     MPRSSRMNLW PHCFPCFDDG DRSGNRFSTV CNFPDDLLPS LGATAHQPPK LRKYLVSPYD
     PRYKVWETFL IILVVYSAWI CPLEFAFLRY LPSAPFVVDD VVNGFFAVDI MLTFFVPFVD
     KKSYLLVNDP KKIAVRYLSS WFVFDVCSTV PFHSISLLFN EHGHDLGFKF LNVLRLWRLR
     RVSSMFARLE KDIRFNYAVI RCTKLISVTL FAIHCAGCIN YLIADRYPDP RRTWIGAVMP
     NFREDGLWIR YVTAMYWSIT TLTTTGYGDL HAENAREMLF GICYMLFNLW LTAYLIGNMT
     NLVVHSTSRT RDFRDVVQAA SEFAARNQLP QQIEEQMLNH ICLRYKTDGL KQQETLDVLP
     KAMRSSISHY LFFRVVQGAY LFKGVSSRFI QQLVTEMQAE YFAPKEDIIL QNDSPSDLYL
     LVSGAVDILV FLDGTEQVYR RAAEGELLGE IGVLCNKPQS FTFRTTKLSQ ILRISRTKLL
     GIIQENREDG DIIRSNLQQV NV
//
ID   KCNT1_HUMAN             Reviewed;        1230 AA.
AC   Q5JUK3; B3KXF7; B7ZVY4; B9EGP2; G5E9V0; Q9P2C5;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 2.
DT   20-DEC-2017, entry version 133.
DE   RecName: Full=Potassium channel subfamily T member 1;
DE   AltName: Full=KCa4.1;
GN   Name=KCNT1; Synonyms=KIAA1422;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1103 (ISOFORM 2), AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [6]
RP   INTERACTION WITH FMR1.
RX   PubMed=20512134; DOI=10.1038/nn.2563;
RA   Brown M.R., Kronengold J., Gazula V.R., Chen Y., Strumbos J.G.,
RA   Sigworth F.J., Navaratnam D., Kaczmarek L.K.;
RT   "Fragile X mental retardation protein controls gating of the sodium-
RT   activated potassium channel Slack.";
RL   Nat. Neurosci. 13:819-821(2010).
RN   [7]
RP   VARIANTS ENFL5 GLN-379; HIS-777; ILE-877 AND CYS-909.
RX   PubMed=23086396; DOI=10.1038/ng.2440;
RA   Heron S.E., Smith K.R., Bahlo M., Nobili L., Kahana E., Licchetta L.,
RA   Oliver K.L., Mazarib A., Afawi Z., Korczyn A., Plazzi G., Petrou S.,
RA   Berkovic S.F., Scheffer I.E., Dibbens L.M.;
RT   "Missense mutations in the sodium-gated potassium channel gene KCNT1
RT   cause severe autosomal dominant nocturnal frontal lobe epilepsy.";
RL   Nat. Genet. 44:1188-1190(2012).
RN   [8]
RP   VARIANTS EIEE14 GLN-409; HIS-455; MET-741 AND THR-915, AND
RP   CHARACTERIZATION OF VARIANTS EIEE14 GLN-409 AND THR-915.
RX   PubMed=23086397; DOI=10.1038/ng.2441;
RA   Barcia G., Fleming M.R., Deligniere A., Gazula V.R., Brown M.R.,
RA   Langouet M., Chen H., Kronengold J., Abhyankar A., Cilio R.,
RA   Nitschke P., Kaminska A., Boddaert N., Casanova J.L., Desguerre I.,
RA   Munnich A., Dulac O., Kaczmarek L.K., Colleaux L., Nabbout R.;
RT   "De novo gain-of-function KCNT1 channel mutations cause malignant
RT   migrating partial seizures of infancy.";
RL   Nat. Genet. 44:1255-1259(2012).
RN   [9]
RP   VARIANT EIEE14 SER-269.
RX   PubMed=24029078; DOI=10.1016/j.gene.2013.08.096;
RA   Ishii A., Shioda M., Okumura A., Kidokoro H., Sakauchi M., Shimada S.,
RA   Shimizu T., Osawa M., Hirose S., Yamamoto T.;
RT   "A recurrent KCNT1 mutation in two sporadic cases with malignant
RT   migrating partial seizures in infancy.";
RL   Gene 531:467-471(2013).
RN   [10]
RP   VARIANTS EIEE14 ILE-562 AND GLN-1088.
RX   PubMed=23708187; DOI=10.1038/ng.2646;
RA   Carvill G.L., Heavin S.B., Yendle S.C., McMahon J.M., O'Roak B.J.,
RA   Cook J., Khan A., Dorschner M.O., Weaver M., Calvert S., Malone S.,
RA   Wallace G., Stanley T., Bye A.M., Bleasel A., Howell K.B., Kivity S.,
RA   Mackay M.T., Rodriguez-Casero V., Webster R., Korczyn A., Afawi Z.,
RA   Zelnick N., Lerman-Sagie T., Lev D., Moeller R.S., Gill D.,
RA   Andrade D.M., Freeman J.L., Sadleir L.G., Shendure J., Berkovic S.F.,
RA   Scheffer I.E., Mefford H.C.;
RT   "Targeted resequencing in epileptic encephalopathies identifies de
RT   novo mutations in CHD2 and SYNGAP1.";
RL   Nat. Genet. 45:825-830(2013).
RN   [11]
RP   VARIANT EIEE14 THR-947, AND CHARACTERIZATION OF VARIANT EIEE14
RP   THR-947.
RX   PubMed=24463883; DOI=10.1093/hmg/ddu030;
RG   WGS500 Consortium;
RA   Martin H.C., Kim G.E., Pagnamenta A.T., Murakami Y., Carvill G.L.,
RA   Meyer E., Copley R.R., Rimmer A., Barcia G., Fleming M.R.,
RA   Kronengold J., Brown M.R., Hudspith K.A., Broxholme J., Kanapin A.,
RA   Cazier J.B., Kinoshita T., Nabbout R., Bentley D., McVean G.,
RA   Heavin S., Zaiwalla Z., McShane T., Mefford H.C., Shears D.,
RA   Stewart H., Kurian M.A., Scheffer I.E., Blair E., Donnelly P.,
RA   Kaczmarek L.K., Taylor J.C.;
RT   "Clinical whole-genome sequencing in severe early-onset epilepsy
RT   reveals new genes and improves molecular diagnosis.";
RL   Hum. Mol. Genet. 23:3200-3211(2014).
RN   [12]
RP   VARIANTS EIEE14 SER-269; LYS-877 AND THR-915.
RX   PubMed=26993267; DOI=10.1136/jmedgenet-2015-103263;
RA   Trump N., McTague A., Brittain H., Papandreou A., Meyer E., Ngoh A.,
RA   Palmer R., Morrogh D., Boustred C., Hurst J.A., Jenkins L.,
RA   Kurian M.A., Scott R.H.;
RT   "Improving diagnosis and broadening the phenotypes in early-onset
RT   seizure and severe developmental delay disorders through gene panel
RT   analysis.";
RL   J. Med. Genet. 53:310-317(2016).
RN   [13]
RP   VARIANTS EIEE14 VAL-497 AND GLU-928.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Outwardly rectifying potassium channel subunit that may
CC       coassemble with other Slo-type channel subunits. Activated by high
CC       intracellular sodium or chloride levels. Activated upon
CC       stimulation of G-protein coupled receptors, such as CHRM1 and
CC       GRIA1. May be regulated by calcium in the absence of sodium ions
CC       (in vitro) (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with FMR1; this interaction
CC       alters gating properties of KCNT1 (PubMed:20512134). Interacts
CC       with CRBN via its cytoplasmic C-terminus (By similarity).
CC       {ECO:0000250|UniProtKB:Q9Z258, ECO:0000269|PubMed:20512134}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q5JUK3-1; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=2;
CC         IsoId=Q5JUK3-2; Sequence=VSP_015470, VSP_015471;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q5JUK3-3; Sequence=VSP_015470, VSP_015471, VSP_044476;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q5JUK3-4; Sequence=VSP_055700, VSP_055701, VSP_015471;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highest expression in liver, brain and spinal
CC       cord. Lowest expression in skeletal muscle.
CC       {ECO:0000269|PubMed:10718198}.
CC   -!- PTM: Phosphorylated by protein kinase C. Phosphorylation of the C-
CC       terminal domain increases channel activity (By similarity).
CC       {ECO:0000250}.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 14 (EIEE14)
CC       [MIM:614959]: A rare epileptic encephalopathy of infancy that
CC       combines pharmacoresistant seizures with developmental delay. This
CC       severe neurologic disorder is characterized by onset in the first
CC       6 months of life of refractory focal seizures and arrest of
CC       psychomotor development. Ictal EEG shows discharges that arise
CC       randomly from various areas of both hemispheres and migrate from
CC       one brain region to another. {ECO:0000269|PubMed:23086397,
CC       ECO:0000269|PubMed:23708187, ECO:0000269|PubMed:24029078,
CC       ECO:0000269|PubMed:24463883, ECO:0000269|PubMed:26993267,
CC       ECO:0000269|PubMed:27864847}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Epilepsy, nocturnal frontal lobe, 5 (ENFL5) [MIM:615005]:
CC       An autosomal dominant focal epilepsy syndrome characterized by
CC       childhood onset of clusters of motor seizures during sleep. Some
CC       patients may develop behavioral or psychiatric manifestations
CC       and/or intellectual disability. The phenotype is more severe than
CC       observed in other genetic forms of nocturnal frontal lobe
CC       epilepsy. {ECO:0000269|PubMed:23086396}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Calcium-
CC       activated (TC 1.A.1.3) subfamily. KCa4.1/KCNT1 sub-subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92660.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK127272; BAG54469.1; -; mRNA.
DR   EMBL; AL158822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471090; EAW88180.1; -; Genomic_DNA.
DR   EMBL; BC136618; AAI36619.1; -; mRNA.
DR   EMBL; BC171770; AAI71770.1; -; mRNA.
DR   EMBL; AB037843; BAA92660.1; ALT_INIT; mRNA.
DR   CCDS; CCDS35175.2; -. [Q5JUK3-3]
DR   CCDS; CCDS65188.1; -. [Q5JUK3-4]
DR   RefSeq; NP_001258932.1; NM_001272003.1. [Q5JUK3-4]
DR   RefSeq; NP_065873.2; NM_020822.2. [Q5JUK3-3]
DR   UniGene; Hs.104950; -.
DR   ProteinModelPortal; Q5JUK3; -.
DR   SMR; Q5JUK3; -.
DR   STRING; 9606.ENSP00000360822; -.
DR   GuidetoPHARMACOLOGY; 385; -.
DR   iPTMnet; Q5JUK3; -.
DR   PhosphoSitePlus; Q5JUK3; -.
DR   BioMuta; KCNT1; -.
DR   DMDM; 73920089; -.
DR   PaxDb; Q5JUK3; -.
DR   PeptideAtlas; Q5JUK3; -.
DR   PRIDE; Q5JUK3; -.
DR   Ensembl; ENST00000371757; ENSP00000360822; ENSG00000107147. [Q5JUK3-3]
DR   Ensembl; ENST00000487664; ENSP00000417851; ENSG00000107147. [Q5JUK3-2]
DR   Ensembl; ENST00000488444; ENSP00000419007; ENSG00000107147. [Q5JUK3-1]
DR   Ensembl; ENST00000628528; ENSP00000486374; ENSG00000107147. [Q5JUK3-4]
DR   GeneID; 57582; -.
DR   KEGG; hsa:57582; -.
DR   UCSC; uc011mdq.3; human. [Q5JUK3-1]
DR   CTD; 57582; -.
DR   DisGeNET; 57582; -.
DR   EuPathDB; HostDB:ENSG00000107147.11; -.
DR   GeneCards; KCNT1; -.
DR   HGNC; HGNC:18865; KCNT1.
DR   HPA; HPA059880; -.
DR   MalaCards; KCNT1; -.
DR   MIM; 608167; gene.
DR   MIM; 614959; phenotype.
DR   MIM; 615005; phenotype.
DR   neXtProt; NX_Q5JUK3; -.
DR   OpenTargets; ENSG00000107147; -.
DR   Orphanet; 98784; Autosomal dominant nocturnal frontal lobe epilepsy.
DR   Orphanet; 293181; Malignant migrating partial seizures of infancy.
DR   PharmGKB; PA38725; -.
DR   eggNOG; KOG3193; Eukaryota.
DR   eggNOG; ENOG410XSMA; LUCA.
DR   GeneTree; ENSGT00530000063026; -.
DR   HOGENOM; HOG000231460; -.
DR   HOVERGEN; HBG055190; -.
DR   InParanoid; Q5JUK3; -.
DR   KO; K04946; -.
DR   OMA; WGPFSAF; -.
DR   OrthoDB; EOG091G011O; -.
DR   PhylomeDB; Q5JUK3; -.
DR   TreeFam; TF314283; -.
DR   ChiTaRS; KCNT1; human.
DR   GeneWiki; KCNT1; -.
DR   GenomeRNAi; 57582; -.
DR   PRO; PR:Q5JUK3; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000107147; -.
DR   CleanEx; HS_KCNT1; -.
DR   ExpressionAtlas; Q5JUK3; baseline and differential.
DR   Genevisible; Q5JUK3; HS.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IBA:GO_Central.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   InterPro; IPR003929; K_chnl_BK_asu.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF03493; BK_channel_a; 1.
DR   Pfam; PF07885; Ion_trans_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell membrane; Complete proteome;
KW   Disease mutation; Epilepsy; Glycoprotein; Ion channel; Ion transport;
KW   Membrane; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   1230       Potassium channel subfamily T member 1.
FT                                /FTId=PRO_0000054090.
FT   TOPO_DOM      1     97       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     98    118       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    119    155       Extracellular. {ECO:0000255}.
FT   TRANSMEM    156    176       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    177    187       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    188    208       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    209    213       Extracellular. {ECO:0000255}.
FT   TRANSMEM    214    226       Helical; Name=Segment S4. {ECO:0000255}.
FT   TOPO_DOM    227    251       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    252    272       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    273    281       Extracellular. {ECO:0000255}.
FT   INTRAMEM    282    302       Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    303    304       Extracellular. {ECO:0000255}.
FT   TRANSMEM    305    325       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    326   1230       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      475    596       RCK N-terminal.
FT   CARBOHYD    133    133       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    137    137       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     66       MARAKLPRSPSEGKAGPGGAPAGAAAPEEPHGLSPLLPARG
FT                                GGSVGSDVGQRLPVEDFSLDSSLSQ -> MPLPDGARTPGG
FT                                VCREARGGGYTNRTFEFDDGQCAPRRPCAGDGALLDTAGFK
FT                                MSDLDSEVLPLPPRYRFRDLLLGDPSFQNDDR (in
FT                                isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:10718198,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_015470.
FT   VAR_SEQ       1     66       MARAKLPRSPSEGKAGPGGAPAGAAAPEEPHGLSPLLPARG
FT                                GGSVGSDVGQRLPVEDFSLDSSLSQ -> MPLPDGARTPGG
FT                                VCREARGGGYTNRTFEFDDGQCAPR (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055700.
FT   VAR_SEQ     266    266       G -> GGCR (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055701.
FT   VAR_SEQ    1033   1033       E -> EPHDLRAQ (in isoform 2, isoform 3
FT                                and isoform 4).
FT                                {ECO:0000303|PubMed:10718198,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_015471.
FT   VAR_SEQ    1142   1162       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044476.
FT   VARIANT     269    269       G -> S (in EIEE14; dbSNP:rs587777264).
FT                                {ECO:0000269|PubMed:24029078,
FT                                ECO:0000269|PubMed:26993267}.
FT                                /FTId=VAR_078683.
FT   VARIANT     379    379       R -> Q (in ENFL5; dbSNP:rs397515407).
FT                                {ECO:0000269|PubMed:23086396}.
FT                                /FTId=VAR_069311.
FT   VARIANT     409    409       R -> Q (in EIEE14; gain-of-function
FT                                mutation; dbSNP:rs397515402).
FT                                {ECO:0000269|PubMed:23086397}.
FT                                /FTId=VAR_069312.
FT   VARIANT     455    455       R -> H (in EIEE14; dbSNP:rs397515404).
FT                                {ECO:0000269|PubMed:23086397}.
FT                                /FTId=VAR_069313.
FT   VARIANT     497    497       M -> V (in EIEE14; dbSNP:rs886041691).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078214.
FT   VARIANT     562    562       T -> I (in EIEE14; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23708187}.
FT                                /FTId=VAR_078641.
FT   VARIANT     741    741       I -> M (in EIEE14; dbSNP:rs370521183).
FT                                {ECO:0000269|PubMed:23086397}.
FT                                /FTId=VAR_069314.
FT   VARIANT     777    777       Y -> H (in ENFL5; dbSNP:rs397515406).
FT                                {ECO:0000269|PubMed:23086396}.
FT                                /FTId=VAR_069315.
FT   VARIANT     877    877       M -> I (in ENFL5; dbSNP:rs797044544).
FT                                {ECO:0000269|PubMed:23086396}.
FT                                /FTId=VAR_069316.
FT   VARIANT     877    877       M -> K (in EIEE14; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:26993267}.
FT                                /FTId=VAR_078684.
FT   VARIANT     909    909       R -> C (in ENFL5; dbSNP:rs397515405).
FT                                {ECO:0000269|PubMed:23086396}.
FT                                /FTId=VAR_069317.
FT   VARIANT     915    915       A -> T (in EIEE14; gain-of-function
FT                                mutation; dbSNP:rs397515403).
FT                                {ECO:0000269|PubMed:23086397,
FT                                ECO:0000269|PubMed:26993267}.
FT                                /FTId=VAR_069318.
FT   VARIANT     928    928       K -> E (in EIEE14; dbSNP:rs1057519544).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078215.
FT   VARIANT     947    947       A -> T (in EIEE14; variant homologue in
FT                                rat has increased channel activity upon
FT                                positive potentials).
FT                                {ECO:0000269|PubMed:24463883}.
FT                                /FTId=VAR_078685.
FT   VARIANT    1088   1088       R -> Q (in EIEE14; unknown pathological
FT                                significance; dbSNP:rs758311066).
FT                                {ECO:0000269|PubMed:23708187}.
FT                                /FTId=VAR_078642.
FT   CONFLICT    107    107       T -> I (in Ref. 1; BAG54469).
FT                                {ECO:0000305}.
FT   CONFLICT    498    498       L -> P (in Ref. 1; BAG54469).
FT                                {ECO:0000305}.
FT   CONFLICT    615    615       A -> V (in Ref. 4; AAI71770).
FT                                {ECO:0000305}.
FT   CONFLICT    822    822       K -> E (in Ref. 1; BAG54469).
FT                                {ECO:0000305}.
FT   CONFLICT    969    969       M -> K (in Ref. 1; BAG54469).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1230 AA;  138343 MW;  482D70015434493E CRC64;
     MARAKLPRSP SEGKAGPGGA PAGAAAPEEP HGLSPLLPAR GGGSVGSDVG QRLPVEDFSL
     DSSLSQVQVE FYVNENTFKE RLKLFFIKNQ RSSLRIRLFN FSLKLLTCLL YIVRVLLDDP
     ALGIGCWGCP KQNYSFNDSS SEINWAPILW VERKMTLWAI QVIVAIISFL ETMLLIYLSY
     KGNIWEQIFR VSFVLEMINT LPFIITIFWP PLRNLFIPVF LNCWLAKHAL ENMINDFHRA
     ILRTQSAMFN QVLILFCTLL CLVFTGTCGI QHLERAGENL SLLTSFYFCI VTFSTVGYGD
     VTPKIWPSQL LVVIMICVAL VVLPLQFEEL VYLWMERQKS GGNYSRHRAQ TEKHVVLCVS
     SLKIDLLMDF LNEFYAHPRL QDYYVVILCP TEMDVQVRRV LQIPLWSQRV IYLQGSALKD
     QDLMRAKMDN GEACFILSSR NEVDRTAADH QTILRAWAVK DFAPNCPLYV QILKPENKFH
     VKFADHVVCE EECKYAMLAL NCICPATSTL ITLLVHTSRG QEGQESPEQW QRMYGRCSGN
     EVYHIRMGDS KFFREYEGKS FTYAAFHAHK KYGVCLIGLK REDNKSILLN PGPRHILAAS
     DTCFYINITK EENSAFIFKQ EEKRKKRAFS GQGLHEGPAR LPVHSIIASM GTVAMDLQGT
     EHRPTQSGGG GGGSKLALPT ENGSGSRRPS IAPVLELADS SALLPCDLLS DQSEDEVTPS
     DDEGLSVVEY VKGYPPNSPY IGSSPTLCHL LPVKAPFCCL RLDKGCKHNS YEDAKAYGFK
     NKLIIVSAET AGNGLYNFIV PLRAYYRSRK ELNPIVLLLD NKPDHHFLEA ICCFPMVYYM
     EGSVDNLDSL LQCGIIYADN LVVVDKESTM SAEEDYMADA KTIVNVQTMF RLFPSLSITT
     ELTHPSNMRF MQFRAKDSYS LALSKLEKRE RENGSNLAFM FRLPFAAGRV FSISMLDTLL
     YQSFVKDYMI TITRLLLGLD TTPGSGYLCA MKITEGDLWI RTYGRLFQKL CSSSAEIPIG
     IYRTESHVFS TSESQISVNV EDCEDTREVK GPWGSRAGTG GSSQGRHTGG GDPAEHPLLR
     RKSLQWARRL SRKAPKQAGR AAAAEWISQQ RLSLYRRSER QELSELVKNR MKHLGLPTTG
     YEDVANLTAS DVMNRVNLGY LQDEMNDHQN TLSYVLINPP PDTRLEPSDI VYLIRSDPLA
     HVASSSQSRK SSCSHKLSSC NPETRDETQL
//
ID   KCNH1_RAT               Reviewed;         962 AA.
AC   Q63472;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-NOV-2017, entry version 150.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 1;
DE   AltName: Full=Ether-a-go-go potassium channel 1;
DE            Short=EAG channel 1;
DE            Short=EAG1;
DE            Short=r-eag {ECO:0000303|PubMed:9400421};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv10.1;
GN   Name=Kcnh1; Synonyms=Eag {ECO:0000303|PubMed:7925287};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Cerebellum;
RX   PubMed=7925287;
RA   Ludwig J., Terlau H., Wunder F., Brueggemann A., Pardo L.A.,
RA   Marquardt A., Stuehmer W., Pongs O.;
RT   "Functional expression of a rat homologue of the voltage gated ether a
RT   go-go potassium channel reveals differences in selectivity and
RT   activation kinetics between the Drosophila channel and its mammalian
RT   counterpart.";
RL   EMBO J. 13:4451-4458(1994).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN CAD, AND SUBUNIT.
RX   PubMed=9400421; DOI=10.1093/emboj/16.21.6337;
RA   Ludwig J., Owen D., Pongs O.;
RT   "Carboxy-terminal domain mediates assembly of the voltage-gated rat
RT   ether-a-go-go potassium channel.";
RL   EMBO J. 16:6337-6345(1997).
RN   [3]
RP   INTERACTION WITH ALG10B.
RC   STRAIN=Wistar; TISSUE=Cerebellum;
RX   PubMed=9722534; DOI=10.1074/jbc.273.36.23080;
RA   Hoshi N., Takahashi H., Shahidullah M., Yokoyama S., Higashida H.;
RT   "KCR1, a membrane protein that facilitates functional expression of
RT   non-inactivating K+ currents associates with rat EAG voltage-dependent
RT   K+ channels.";
RL   J. Biol. Chem. 273:23080-23085(1998).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=10718922; DOI=10.1046/j.1365-2826.2000.00447.x;
RA   Wulfsen I., Hauber H.-P., Schiemann D., Bauer C.K., Schwarz J.R.;
RT   "Expression of mRNA for voltage-dependent and inward-rectifying K
RT   channels in GH3/B6 cells and rat pituitary.";
RL   J. Neuroendocrinol. 12:263-272(2000).
RN   [5]
RP   INTERACTION WITH RABEP1.
RX   PubMed=22841712; DOI=10.1016/j.febslet.2012.07.055;
RA   Ninkovic M., Mitkovski M., Kohl T., Stuhmer W., Pardo L.A.;
RT   "Physical and functional interaction of KV10.1 with Rabaptin-5 impacts
RT   ion channel trafficking.";
RL   FEBS Lett. 586:3077-3084(2012).
RN   [6]
RP   INTERACTION WITH CTTN.
RX   PubMed=23144454; DOI=10.1074/jbc.M112.372540;
RA   Herrmann S., Ninkovic M., Kohl T., Lorinczi E., Pardo L.A.;
RT   "Cortactin controls surface expression of the voltage-gated potassium
RT   channel K(V)10.1.";
RL   J. Biol. Chem. 287:44151-44163(2012).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=24495567; DOI=10.1186/1471-2202-15-23;
RA   Chuang C.C., Jow G.M., Lin H.M., Weng Y.H., Hu J.H., Peng Y.J.,
RA   Chiu Y.C., Chiu M.M., Jeng C.J.;
RT   "The punctate localization of rat Eag1 K+ channels is conferred by the
RT   proximal post-CNBHD region.";
RL   BMC Neurosci. 15:23-23(2014).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=25556795; DOI=10.1113/jphysiol.2014.281600;
RA   Mortensen L.S., Schmidt H., Farsi Z., Barrantes-Freer A., Rubio M.E.,
RA   Ufartes R., Eilers J., Sakaba T., Stuehmer W., Pardo L.A.;
RT   "KV 10.1 opposes activity-dependent increase in Ca2+ influx into the
RT   presynaptic terminal of the parallel fibre-Purkinje cell synapse.";
RL   J. Physiol. (Lond.) 593:181-196(2015).
RN   [9]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.78 ANGSTROMS) OF 1-962 IN COMPLEX
RP   WITH CALM, FUNCTION, ENZYME REGULATION, SUBUNIT, SUBCELLULAR LOCATION,
RP   TOPOLOGY, AND GLYCOSYLATION AT ASN-388.
RX   PubMed=27516594; DOI=10.1126/science.aaf8070;
RA   Whicher J.R., MacKinnon R.;
RT   "Structure of the voltage-gated K(+) channel Eag1 reveals an
RT   alternative voltage sensing mechanism.";
RL   Science 353:664-669(2016).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of a voltage-gated delayed
CC       rectifier potassium channel (PubMed:7925287, PubMed:9400421,
CC       PubMed:24495567, PubMed:27516594). Channel properties are
CC       modulated by subunit assembly. Mediates IK(NI) current in
CC       myoblasts. Involved in the regulation of cell proliferation and
CC       differentiation, in particular adipogenic and osteogenic
CC       differentiation in bone marrow-derived mesenchymal stem cells
CC       (MSCs) (By similarity). {ECO:0000250|UniProtKB:O95259,
CC       ECO:0000269|PubMed:24495567, ECO:0000269|PubMed:27516594,
CC       ECO:0000269|PubMed:7925287, ECO:0000269|PubMed:9400421}.
CC   -!- ENZYME REGULATION: Channel activity is inhibited by interaction
CC       with Ca(2+)-bound calmodulin (PubMed:27516594). Interaction of a
CC       single pore-forming alpha subunit with a calmodulin chain is
CC       sufficient to promote channel closure. Channel activity is not
CC       regulated by cyclic nucleotides. Channel activity is inhibited by
CC       binding intracellular phosphatidylinositol-3,5-bisphosphate and
CC       phosphatidylinositol-4,5-bisphosphate (PIP2), but is not inhibited
CC       by phosphatidylinositol 4-phosphate (By similarity).
CC       {ECO:0000250|UniProtKB:O95259, ECO:0000250|UniProtKB:Q60603,
CC       ECO:0000269|PubMed:27516594}.
CC   -!- SUBUNIT: The potassium channel is composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits (PubMed:9400421,
CC       PubMed:27516594). Heteromultimer with KCNH5/EAG2 (By similarity).
CC       Interacts with ALG10B (PubMed:9722534). Interacts with RABEP1
CC       (PubMed:22841712). Interacts (via C-terminus) with CTTN
CC       (PubMed:23144454). Interacts (via cytoplasmic region) with Ca(2+)-
CC       bound calmodulin (PubMed:27516594). {ECO:0000250|UniProtKB:O95259,
CC       ECO:0000269|PubMed:22841712, ECO:0000269|PubMed:23144454,
CC       ECO:0000269|PubMed:27516594, ECO:0000269|PubMed:9400421,
CC       ECO:0000269|PubMed:9722534}.
CC   -!- INTERACTION:
CC       O35550:Rabep1; NbExp=2; IntAct=EBI-7991592, EBI-7991542;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:24495567,
CC       ECO:0000269|PubMed:27516594, ECO:0000269|PubMed:7925287,
CC       ECO:0000269|PubMed:9400421}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:27516594}. Nucleus inner membrane
CC       {ECO:0000250|UniProtKB:O95259}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:O95259}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:24495567}. Cell projection, axon
CC       {ECO:0000269|PubMed:24495567}. Cell junction, synapse, presynaptic
CC       cell membrane {ECO:0000269|PubMed:25556795}. Perikaryon
CC       {ECO:0000269|PubMed:24495567}. Cell junction, synapse,
CC       postsynaptic cell membrane, postsynaptic density
CC       {ECO:0000269|PubMed:24495567}. Early endosome membrane
CC       {ECO:0000250|UniProtKB:O95259}. Note=Perinuclear KCNH1 is located
CC       to NPC-free islands. {ECO:0000250|UniProtKB:O95259}.
CC   -!- TISSUE SPECIFICITY: Detected in cerebellum, at parallel fiber
CC       synapses on Purkinje cell spines (PubMed:25556795). Detected in
CC       hippocampus neurons (at protein level) (PubMed:24495567). Detected
CC       in brain, but not in the other tissues tested; expression is
CC       highest in granular cells of the dentate gyrus, in hippocampus CA3
CC       pyramidal cells, and in cerebellar granule cells (PubMed:7925287).
CC       Detected in pituitary (PubMed:10718922).
CC       {ECO:0000269|PubMed:10718922, ECO:0000269|PubMed:24495567,
CC       ECO:0000269|PubMed:25556795, ECO:0000269|PubMed:7925287}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000269|PubMed:9400421}.
CC   -!- DOMAIN: The C-terminal region interacts with the cyclic
CC       nucleotide-binding domain and contributes to regulate channel
CC       gating. {ECO:0000250|UniProtKB:Q60603}.
CC   -!- DOMAIN: The PAS and PAC domain interact with the cyclic
CC       nucleotide-binding domain and contribute to the regulation of
CC       channel gating. Calmodulin binding clamps together the PAS and PAC
CC       domain with the cyclic nucleotide-binding domain from a
CC       neighboring subunit and causes a conformation change that leads to
CC       channel closure. {ECO:0000269|PubMed:27516594}.
CC   -!- DOMAIN: The cyclic nucleotide-binding domain lacks residues that
CC       are essential for nucleotide-binding and cannot bind cyclic
CC       nucleotides. Instead, residues from the C-terminal domain (the so-
CC       called intrinsic ligand) bind in the cavity that would be expected
CC       to bind cyclic nucleotides. Interaction with the C-terminal region
CC       hinders interaction with CALM and reduces the affinity for CALM.
CC       {ECO:0000250|UniProtKB:Q60603}.
CC   -!- PTM: Channel activity is regulated via tyrosine
CC       phosphorylation/dephosphorylation by SRC and PTPN6.
CC       {ECO:0000250|UniProtKB:O95259}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag) (TC
CC       1.A.1.20) subfamily. Kv10.1/KCNH1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z34264; CAA84018.1; -; mRNA.
DR   PIR; I53197; I53197.
DR   RefSeq; NP_113930.1; NM_031742.1.
DR   RefSeq; XP_006250553.1; XM_006250491.3.
DR   UniGene; Rn.11071; -.
DR   PDB; 5K7L; EM; 3.78 A; A=1-962.
DR   PDBsum; 5K7L; -.
DR   ProteinModelPortal; Q63472; -.
DR   SMR; Q63472; -.
DR   IntAct; Q63472; 2.
DR   MINT; MINT-8386100; -.
DR   STRING; 10116.ENSRNOP00000005209; -.
DR   GuidetoPHARMACOLOGY; 570; -.
DR   TCDB; 1.A.1.20.4; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q63472; -.
DR   PhosphoSitePlus; Q63472; -.
DR   PaxDb; Q63472; -.
DR   PRIDE; Q63472; -.
DR   Ensembl; ENSRNOT00000005209; ENSRNOP00000005209; ENSRNOG00000003841.
DR   Ensembl; ENSRNOT00000077014; ENSRNOP00000068394; ENSRNOG00000003841.
DR   GeneID; 65198; -.
DR   KEGG; rno:65198; -.
DR   CTD; 3756; -.
DR   RGD; 68398; Kcnh1.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140833; -.
DR   HOVERGEN; HBG101348; -.
DR   InParanoid; Q63472; -.
DR   KO; K04904; -.
DR   PhylomeDB; Q63472; -.
DR   PRO; PR:Q63472; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000003841; -.
DR   ExpressionAtlas; Q63472; baseline and differential.
DR   Genevisible; Q63472; RN.
DR   GO; GO:0030673; C:axolemma; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0031901; C:early endosome membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005637; C:nuclear inner membrane; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0034705; C:potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:RGD.
DR   GO; GO:0045202; C:synapse; IDA:RGD.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0071889; F:14-3-3 protein binding; IPI:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:RGD.
DR   GO; GO:0044325; F:ion channel binding; IPI:RGD.
DR   GO; GO:1902936; F:phosphatidylinositol bisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; IDA:RGD.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:RGD.
DR   GO; GO:0042127; P:regulation of cell proliferation; ISS:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0001964; P:startle response; IMP:RGD.
DR   CDD; cd00038; CAP_ED; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR030170; EAG1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003949; K_chnl_volt-dep_EAG.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF530; PTHR10217:SF530; 2.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01464; EAGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00086; PAC; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calmodulin-binding; Cell junction; Cell membrane;
KW   Cell projection; Complete proteome; Endosome; Glycoprotein;
KW   Ion channel; Ion transport; Lipid-binding; Membrane; Nucleus;
KW   Phosphoprotein; Postsynaptic cell membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome; Synapse;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    962       Potassium voltage-gated channel subfamily
FT                                H member 1.
FT                                /FTId=PRO_0000053996.
FT   TOPO_DOM      1    220       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TRANSMEM    221    241       Helical; Name=Segment S1.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TOPO_DOM    242    248       Extracellular.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TRANSMEM    249    269       Helical; Name=Segment S2.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TOPO_DOM    270    290       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TRANSMEM    291    309       Helical; Name=Segment S3.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TOPO_DOM    310    318       Extracellular.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TRANSMEM    319    341       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TOPO_DOM    342    350       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TRANSMEM    351    372       Helical; Name=Segment S5.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TOPO_DOM    373    421       Extracellular.
FT                                {ECO:0000269|PubMed:27516594}.
FT   INTRAMEM    422    443       Pore-forming; Name=Segment H5.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TOPO_DOM    444    450       Extracellular.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TRANSMEM    451    471       Helical; Name=Segment S6.
FT                                {ECO:0000269|PubMed:27516594}.
FT   TOPO_DOM    472    962       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27516594}.
FT   DOMAIN       14     94       PAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN       93    145       PAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00141}.
FT   REGION      151    162       Required for phosphatidylinositol
FT                                bisphosphate binding.
FT                                {ECO:0000250|UniProtKB:O95259}.
FT   REGION      646    743       Calmodulin-binding.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   REGION      672    674       Interaction with cyclic nucleotide-
FT                                binding pocket.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   REGION      897    937       CAD (involved in subunit assembly).
FT                                {ECO:0000269|PubMed:9400421}.
FT   MOTIF       436    441       Selectivity filter.
FT                                {ECO:0000269|PubMed:27516594}.
FT   MOD_RES     872    872       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q920E3}.
FT   MOD_RES     947    947       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   MOD_RES     951    951       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   MOD_RES     954    954       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60603}.
FT   CARBOHYD    388    388       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:27516594}.
FT   CARBOHYD    406    406       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   962 AA;  108291 MW;  69DF4CE2DC435608 CRC64;
     MTMAGGRRGL VAPQNTFLEN IVRRSNDTNF VLGNAQIVDW PIVYSNDGFC KLSGYHRAEV
     MQKSSACSFM YGELTDKDTV EKVRQTFENY EMNSFEILMY KKNRTPVWFF VKIAPIRNEQ
     DKVVLFLCTF SDITAFKQPI EDDSCKGWGK FARLTRALTS SRGVLQQLAP SVQKGENVHK
     HSRLAEVLQL GSDILPQYKQ EAPKTPPHII LHYCVFKTTW DWIILILTFY TAILVPYNVS
     FKTRQNNVAW LVVDSIVDVI FLVDIVLNFH TTFVGPAGEV ISDPKLIRMN YLKTWFVIDL
     LSCLPYDVIN AFENVDEGIS SLFSSLKVVR LLRLGRVARK LDHYIEYGAA VLVLLVCVFG
     LAAHWMACIW YSIGDYEIFD EDTKTIRNNS WLYQLALDIG TPYQFNGSGS GKWEGGPSKN
     SVYISSLYFT MTSLTSVGFG NIAPSTDIEK IFAVAIMMIG SLLYATIFGN VTTIFQQMYA
     NTNRYHEMLN SVRDFLKLYQ VPKGLSERVM DYIVSTWSMS RGIDTEKVLQ ICPKDMRADI
     CVHLNRKVFK EHPAFRLASD GCLRALAMEF QTVHCAPGDL IYHAGESVDS LCFVVSGSLE
     VIQDDEVVAI LGKGDVFGDV FWKEATLAQS CANVRALTYC DLHVIKRDAL QKVLEFYTAF
     SHSFSRNLIL TYNLRKRIVF RKISDVKREE EERMKRKNEA PLILPPDHPV RRLFQRFRQQ
     KEARLAAERG GRDLDDLDVE KGNALTDHTS ANHSLVKASV VTVRESPATP VSFQAASTST
     VSDHAKLHAP GSECLGPKAG GGDPAKRKGW ARFKDACGKG EDWNKVSKAE SMETLPERTK
     ASGEATLKKT DSCDSGITKS DLRLDNVGEA RSPQDRSPIL AEVKHSFYPI PEQTLQATVL
     EVKHELKEDI KALNAKMTSI EKQLSEILRI LMSRGSSQSP QDTCEVSRPQ SPESDRDIFG
     AS
//
ID   KCNK9_XENLA             Reviewed;         374 AA.
AC   Q63ZI0;
DT   10-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2004, sequence version 1.
DT   25-OCT-2017, entry version 66.
DE   RecName: Full=Potassium channel subfamily K member 9;
GN   Name=kcnk9;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: pH-dependent, voltage-insensitive, background potassium
CC       channel protein. {ECO:0000250|UniProtKB:Q9NPC2}.
CC   -!- SUBUNIT: Homodimer. May form heterodimers with other family
CC       members. {ECO:0000250|UniProtKB:Q9NPC2}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q9NPC2}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NPC2}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC082937; AAH82937.1; -; mRNA.
DR   RefSeq; NP_001088104.1; NM_001094635.1.
DR   UniGene; Xl.49723; -.
DR   ProteinModelPortal; Q63ZI0; -.
DR   GeneID; 494803; -.
DR   KEGG; xla:494803; -.
DR   CTD; 494803; -.
DR   Xenbase; XB-GENE-6255084; kcnk9.
DR   HOVERGEN; HBG052239; -.
DR   KO; K04919; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR005407; KCNK9.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01585; TASK3CHANNEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   2: Evidence at transcript level;
KW   Cell membrane; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    374       Potassium channel subfamily K member 9.
FT                                /FTId=PRO_0000101757.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      9     29       Helical. {ECO:0000255}.
FT   TOPO_DOM     30     88       Extracellular. {ECO:0000255}.
FT   INTRAMEM     89    101       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TOPO_DOM    102    107       Extracellular. {ECO:0000255}.
FT   TRANSMEM    108    128       Helical. {ECO:0000255}.
FT   TOPO_DOM    129    158       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical. {ECO:0000255}.
FT   TOPO_DOM    180    194       Extracellular. {ECO:0000255}.
FT   INTRAMEM    195    207       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TOPO_DOM    208    218       Extracellular. {ECO:0000255}.
FT   TRANSMEM    219    239       Helical. {ECO:0000255}.
FT   TOPO_DOM    240    374       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   374 AA;  42718 MW;  8F37D8FF1F689F63 CRC64;
     MKRQNVRTLS LIICTFTYLL VGAAVFDALE SDYEMREEEK LKAEEIRLKG KYNISSEDYR
     QLELVIMQSE PHRAGVQWKF AGSFYFAITV ITTIGYGHAA PGTDAGKAFC MFYAVLGIPL
     TLVMFQSLGE RMNTFVKYLL KRIKKCCGMH STDVSMENMV TVGFFSCMGT LCIGAAAFSH
     YEEWSFFQAY YYCFITLTTI GFGDYVALQK NRALQKKPLY VAFSFMYILV GLTVIGAFLN
     LVVLRFLTMN SEDERRDAEE RASLAGNRNS MIIHIQEDTP HGRQRYKAEV TDLQSVCSCM
     CYRSHEYTSR MVSHQNSFSS KLNPQYFHSI SYKIEEISPS TLKNSLFPSP VSSVSPGLHS
     FTDKHRLMKR RKSI
//
ID   KCO3_ORYSJ              Reviewed;         456 AA.
AC   Q69TN4; A0A0P0XKR3; Q0J2T7;
DT   28-JUN-2011, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 1.
DT   20-DEC-2017, entry version 103.
DE   RecName: Full=Two pore potassium channel c;
DE            Short=Two K(+) channel c;
DE   AltName: Full=Calcium-activated outward-rectifying potassium channel 3;
DE            Short=OsKCO3;
GN   Name=TPKC; Synonyms=KCO3;
GN   OrderedLocusNames=Os09g0299400, LOC_Os09g12790;
GN   ORFNames=OsJ_28764, OSJNBa0062A09.6;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   "The rice annotation project database (RAP-DB): 2008 update.";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=15685292; DOI=10.1371/journal.pbio.0030038;
RA   Yu J., Wang J., Lin W., Li S., Li H., Zhou J., Ni P., Dong W., Hu S.,
RA   Zeng C., Zhang J., Zhang Y., Li R., Xu Z., Li S., Li X., Zheng H.,
RA   Cong L., Lin L., Yin J., Geng J., Li G., Shi J., Liu J., Lv H., Li J.,
RA   Wang J., Deng Y., Ran L., Shi X., Wang X., Wu Q., Li C., Ren X.,
RA   Wang J., Wang X., Li D., Liu D., Zhang X., Ji Z., Zhao W., Sun Y.,
RA   Zhang Z., Bao J., Han Y., Dong L., Ji J., Chen P., Wu S., Liu J.,
RA   Xiao Y., Bu D., Tan J., Yang L., Ye C., Zhang J., Xu J., Zhou Y.,
RA   Yu Y., Zhang B., Zhuang S., Wei H., Liu B., Lei M., Yu H., Li Y.,
RA   Xu H., Wei S., He X., Fang L., Zhang Z., Zhang Y., Huang X., Su Z.,
RA   Tong W., Li J., Tong Z., Li S., Ye J., Wang L., Fang L., Lei T.,
RA   Chen C.-S., Chen H.-C., Xu Z., Li H., Huang H., Zhang F., Xu H.,
RA   Li N., Zhao C., Li S., Dong L., Huang Y., Li L., Xi Y., Qi Q., Li W.,
RA   Zhang B., Hu W., Zhang Y., Tian X., Jiao Y., Liang X., Jin J., Gao L.,
RA   Zheng W., Hao B., Liu S.-M., Wang W., Yuan L., Cao M., McDermott J.,
RA   Samudrala R., Wang J., Wong G.K.-S., Yang H.;
RT   "The genomes of Oryza sativa: a history of duplications.";
RL   PLoS Biol. 3:266-281(2005).
CC   -!- FUNCTION: Inward-rectifying potassium channel. {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- DOMAIN: Each of the two pore-forming region (also called P-domain
CC       or P-loop) is enclosed by two transmembrane segments (2P/4TM) and
CC       contains the GYGD signature motif which seems to be involved in
CC       potassium selectivity.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.7) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAF24728.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP004736; BAD33183.1; -; Genomic_DNA.
DR   EMBL; AP008215; BAF24728.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AP014965; BAT07337.1; -; Genomic_DNA.
DR   EMBL; CM000146; EAZ44138.1; -; Genomic_DNA.
DR   RefSeq; XP_015651429.1; XM_015795943.1.
DR   ProteinModelPortal; Q69TN4; -.
DR   SMR; Q69TN4; -.
DR   STRING; 39947.LOC_Os09g12790.1; -.
DR   PaxDb; Q69TN4; -.
DR   PRIDE; Q69TN4; -.
DR   EnsemblPlants; OS09T0299400-00; OS09T0299400-00; OS09G0299400.
DR   GeneID; 4346662; -.
DR   Gramene; OS09T0299400-00; OS09T0299400-00; OS09G0299400.
DR   KEGG; osa:4346662; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000238193; -.
DR   InParanoid; Q69TN4; -.
DR   KO; K05389; -.
DR   OMA; HETHPIV; -.
DR   OrthoDB; EOG09360JKS; -.
DR   Proteomes; UP000059680; Chromosome 9.
DR   ExpressionAtlas; Q69TN4; baseline and differential.
DR   Genevisible; Q69TN4; OS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0009705; C:plant-type vacuole membrane; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
PE   3: Inferred from homology;
KW   Calcium; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    456       Two pore potassium channel c.
FT                                /FTId=PRO_0000410874.
FT   TOPO_DOM      1    152       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    153    173       Helical. {ECO:0000255}.
FT   INTRAMEM    192    211       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    223    243       Helical. {ECO:0000255}.
FT   TOPO_DOM    244    279       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    280    300       Helical. {ECO:0000255}.
FT   INTRAMEM    310    329       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    336    356       Helical. {ECO:0000255}.
FT   TOPO_DOM    357    456       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      373    408       EF-hand 1.
FT   DOMAIN      412    447       EF-hand 2.
FT   CA_BIND     386    397       {ECO:0000255}.
FT   CA_BIND     425    436       {ECO:0000255}.
FT   COMPBIAS     53     67       Poly-Pro.
FT   COMPBIAS    130    138       Poly-Ala.
SQ   SEQUENCE   456 AA;  49658 MW;  2CCC952FCB72542F CRC64;
     MDTEPLLSPL SPSPHLLHPL PEHAEVSTFS PPLSPCPSPA SSYKERIIFG AHPPPPPPPP
     PPPPPPPRGR RYYRRVSGDD LDVPSCSSSP SPPSDEENPP PNPPSLFDFI GGRTNLHRSR
     TAPAMAPLNA AAIAAAAASG DSRNPPPPPR RPAIVLHAFL FLLAYLAMGV TFYAALPGNF
     TSSAGPTHPV ADALYFCIVT LCTIGYGDIT PATPAAKLFS ISFVLIGFGF VDILLSGMVS
     YVLDLQEHLL ITALKNPRSV RKHRHNYIFD LKKGRMRVRM KVALALTVVA ICVGVGAAVL
     KRVENLGWLD AVYLAVMSVT TVGYGDHAFR TLAGRLFASA WLLVSTLAVA RAFLYLAEMR
     IDKRHRAMAN WVLSRDMTVS EFLAADIDNN GYVTKSEFVV YKLKEMGKIS EKDIMMICDQ
     FQRMDSGNCG KITLSDLLES HQLVTDLNEK KKGKKS
//
ID   PKD2_DANRE              Reviewed;         904 AA.
AC   Q6IVV8; Q2VF27;
DT   10-MAY-2017, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   25-OCT-2017, entry version 106.
DE   RecName: Full=Polycystin-2 {ECO:0000303|PubMed:16216239};
DE   AltName: Full=Curly up {ECO:0000303|PubMed:17360770};
DE            Short=Cup {ECO:0000303|PubMed:17360770};
DE   AltName: Full=Polycystic kidney disease 2 protein homolog;
DE   AltName: Full=Transient receptor potential cation channel subfamily P member 2;
GN   Name=pkd2 {ECO:0000312|ZFIN:ZDB-GENE-040827-4};
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1] {ECO:0000312|EMBL:AAT39122.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15269167; DOI=10.1242/dev.01240;
RA   Sun Z., Amsterdam A., Pazour G.J., Cole D.G., Miller M.S., Hopkins N.;
RT   "A genetic screen in zebrafish identifies cilia genes as a principal
RT   cause of cystic kidney.";
RL   Development 131:4085-4093(2004).
RN   [2] {ECO:0000312|EMBL:ABA60692.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, DISRUPTION PHENOTYPE, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=16216239; DOI=10.1016/j.ydbio.2005.08.047;
RA   Bisgrove B.W., Snarr B.S., Emrazian A., Yost H.J.;
RT   "Polaris and polycystin-2 in dorsal forerunner cells and Kupffer's
RT   vesicle are required for specification of the zebrafish left-right
RT   axis.";
RL   Dev. Biol. 287:274-288(2005).
RN   [3] {ECO:0000312|Ensembl:ENSDARP00000027024, ECO:0000312|Proteomes:UP000000437}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Tuebingen {ECO:0000312|Ensembl:ENSDARP00000027024,
RC   ECO:0000312|Proteomes:UP000000437};
RX   PubMed=23594743; DOI=10.1038/nature12111;
RA   Howe K., Clark M.D., Torroja C.F., Torrance J., Berthelot C.,
RA   Muffato M., Collins J.E., Humphray S., McLaren K., Matthews L.,
RA   McLaren S., Sealy I., Caccamo M., Churcher C., Scott C., Barrett J.C.,
RA   Koch R., Rauch G.J., White S., Chow W., Kilian B., Quintais L.T.,
RA   Guerra-Assuncao J.A., Zhou Y., Gu Y., Yen J., Vogel J.H., Eyre T.,
RA   Redmond S., Banerjee R., Chi J., Fu B., Langley E., Maguire S.F.,
RA   Laird G.K., Lloyd D., Kenyon E., Donaldson S., Sehra H.,
RA   Almeida-King J., Loveland J., Trevanion S., Jones M., Quail M.,
RA   Willey D., Hunt A., Burton J., Sims S., McLay K., Plumb B., Davis J.,
RA   Clee C., Oliver K., Clark R., Riddle C., Eliott D., Threadgold G.,
RA   Harden G., Ware D., Mortimer B., Kerry G., Heath P., Phillimore B.,
RA   Tracey A., Corby N., Dunn M., Johnson C., Wood J., Clark S., Pelan S.,
RA   Griffiths G., Smith M., Glithero R., Howden P., Barker N., Stevens C.,
RA   Harley J., Holt K., Panagiotidis G., Lovell J., Beasley H.,
RA   Henderson C., Gordon D., Auger K., Wright D., Collins J., Raisen C.,
RA   Dyer L., Leung K., Robertson L., Ambridge K., Leongamornlert D.,
RA   McGuire S., Gilderthorp R., Griffiths C., Manthravadi D., Nichol S.,
RA   Barker G., Whitehead S., Kay M., Brown J., Murnane C., Gray E.,
RA   Humphries M., Sycamore N., Barker D., Saunders D., Wallis J.,
RA   Babbage A., Hammond S., Mashreghi-Mohammadi M., Barr L., Martin S.,
RA   Wray P., Ellington A., Matthews N., Ellwood M., Woodmansey R.,
RA   Clark G., Cooper J., Tromans A., Grafham D., Skuce C., Pandian R.,
RA   Andrews R., Harrison E., Kimberley A., Garnett J., Fosker N., Hall R.,
RA   Garner P., Kelly D., Bird C., Palmer S., Gehring I., Berger A.,
RA   Dooley C.M., Ersan-Urun Z., Eser C., Geiger H., Geisler M.,
RA   Karotki L., Kirn A., Konantz J., Konantz M., Oberlander M.,
RA   Rudolph-Geiger S., Teucke M., Osoegawa K., Zhu B., Rapp A., Widaa S.,
RA   Langford C., Yang F., Carter N.P., Harrow J., Ning Z., Herrero J.,
RA   Searle S.M., Enright A., Geisler R., Plasterk R.H., Lee C.,
RA   Westerfield M., de Jong P.J., Zon L.I., Postlethwait J.H.,
RA   Nusslein-Volhard C., Hubbard T.J., Roest Crollius H., Rogers J.,
RA   Stemple D.L.;
RT   "The zebrafish reference genome sequence and its relationship to the
RT   human genome.";
RL   Nature 496:498-503(2013).
RN   [4]
RP   DISRUPTION PHENOTYPE, FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=16943304; DOI=10.1681/ASN.2006040412;
RA   Obara T., Mangos S., Liu Y., Zhao J., Wiessner S., Kramer-Zucker A.G.,
RA   Olale F., Schier A.F., Drummond I.A.;
RT   "Polycystin-2 immunolocalization and function in zebrafish.";
RL   J. Am. Soc. Nephrol. 17:2706-2718(2006).
RN   [5]
RP   DISRUPTION PHENOTYPE, AND PHOSPHORYLATION.
RX   PubMed=16551655; DOI=10.1093/hmg/ddl070;
RA   Streets A.J., Moon D.J., Kane M.E., Obara T., Ong A.C.;
RT   "Identification of an N-terminal glycogen synthase kinase 3
RT   phosphorylation site which regulates the functional localization of
RT   polycystin-2 in vivo and in vitro.";
RL   Hum. Mol. Genet. 15:1465-1473(2006).
RN   [6]
RP   FUNCTION, DISRUPTION PHENOTYPE, DEVELOPMENTAL STAGE, AND MUTAGENESIS
RP   OF LEU-351.
RX   PubMed=17360770; DOI=10.1242/dev.02827;
RA   Schottenfeld J., Sullivan-Brown J., Burdine R.D.;
RT   "Zebrafish curly up encodes a Pkd2 ortholog that restricts left-side-
RT   specific expression of southpaw.";
RL   Development 134:1605-1615(2007).
RN   [7]
RP   DISRUPTION PHENOTYPE, FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=23376035; DOI=10.1016/j.yjmcc.2013.01.015;
RA   Paavola J., Schliffke S., Rossetti S., Kuo I.Y., Yuan S., Sun Z.,
RA   Harris P.C., Torres V.E., Ehrlich B.E.;
RT   "Polycystin-2 mutations lead to impaired calcium cycling in the heart
RT   and predispose to dilated cardiomyopathy.";
RL   J. Mol. Cell. Cardiol. 58:199-208(2013).
RN   [8]
RP   DISRUPTION PHENOTYPE, DEVELOPMENTAL STAGE, TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=26432887; DOI=10.1242/bio.014076;
RA   Roxo-Rosa M., Jacinto R., Sampaio P., Lopes S.S.;
RT   "The zebrafish Kupffer's vesicle as a model system for the molecular
RT   mechanisms by which the lack of Polycystin-2 leads to stimulation of
RT   CFTR.";
RL   Biol. Open 4:1356-1366(2015).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=25660539; DOI=10.1016/j.cub.2014.12.051;
RA   Yuan S., Zhao L., Brueckner M., Sun Z.;
RT   "Intraciliary calcium oscillations initiate vertebrate left-right
RT   asymmetry.";
RL   Curr. Biol. 25:556-567(2015).
CC   -!- FUNCTION: Functions as non-selective cation channel (By
CC       similarity). Required for normal oscillation of Ca(2+) levels
CC       within cilia; these oscillations of the intraciliary Ca(2+) levels
CC       can trigger cytoplasmic Ca(2+) signaling cascades
CC       (PubMed:25660539). May contribute to the release of Ca(2+) stores
CC       from the endoplasmic reticulum (By similarity). Required for
CC       normal temporal variation of the intracellular Ca(2+) levels in
CC       the heart (PubMed:23376035). Plays a role in fluid-flow
CC       mechanosensation (By similarity). Required for normal
CC       specification of the body left-right axis during embryogenesis,
CC       most likely via its role in ciliary Ca(2+) oscillations in
CC       Kupffer's vesicle (PubMed:15269167, PubMed:16216239,
CC       PubMed:16943304, PubMed:17360770, PubMed:23376035,
CC       PubMed:25660539). {ECO:0000250|UniProtKB:O35245,
CC       ECO:0000250|UniProtKB:Q13563, ECO:0000269|PubMed:15269167,
CC       ECO:0000269|PubMed:16216239, ECO:0000269|PubMed:16943304,
CC       ECO:0000269|PubMed:17360770, ECO:0000269|PubMed:23376035,
CC       ECO:0000269|PubMed:25660539}.
CC   -!- ENZYME REGULATION: Channnel activity is regulated by
CC       phosphorylation. Channnel activity is regulated by intracellular
CC       Ca(2+). {ECO:0000250|UniProtKB:Q13563}.
CC   -!- SUBUNIT: Homotetramer (By similarity). Interacts with pkd1l1 (By
CC       similarity). {ECO:0000250|UniProtKB:H2LRU7,
CC       ECO:0000250|UniProtKB:Q13563}.
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:16943304}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q13563}. Cell membrane, sarcolemma
CC       {ECO:0000269|PubMed:16943304}. Cytoplasm, myofibril, sarcomere
CC       {ECO:0000269|PubMed:16943304}. Sarcoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:23376035}. Apical cell membrane
CC       {ECO:0000269|PubMed:16943304}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q13563}. Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:26432887}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q13563}. Cell projection, cilium
CC       {ECO:0000269|PubMed:16943304, ECO:0000269|PubMed:26432887}.
CC       Cytoplasm, cytoskeleton, cilium basal body
CC       {ECO:0000269|PubMed:26432887}. Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:16943304}. Note=Detected at the basolateral
CC       cell membrane and on apical, lumenal cilia in anterior, proximal
CC       pronephric ducts, and in intracellular vesicles in the posterior
CC       part of the pronephric duct. Detected on apical cell membranes on
CC       epithelial cells in the ear. {ECO:0000269|PubMed:16943304}.
CC   -!- TISSUE SPECIFICITY: Detected along cilia and at the cilium basal
CC       body in Kupffer's vesicle at the 10 somite stage
CC       (PubMed:26432887). Detected in heart at 48hpf (PubMed:23376035).
CC       Detected in muscle and pronephric kidney at 48 hpf
CC       (PubMed:16943304). Detected on trunk muscle sarcolemma and
CC       sarcomere, on ependymal cell cilia in brain, at the apical cell
CC       membrane in epithelial cells in the ear, at the lateral line organ
CC       and olfactory placode at 56 hpf (PubMed:16943304). Detected in
CC       adult kidney (at protein level) (PubMed:16943304).
CC       {ECO:0000269|PubMed:16943304, ECO:0000269|PubMed:26432887}.
CC   -!- DEVELOPMENTAL STAGE: First detected at the onset of gastrulation
CC       in a band at the blastoderm margin (PubMed:16216239,
CC       PubMed:17360770). Ubiquitous during gastrulation, somatogenesis
CC       and at 48 hpf (PubMed:16943304). During gastrulation, detected at
CC       the hypoblast of the dorsal midline and in dorsal forerunner cells
CC       that form a ciliated Kupffer's vesicle later on (PubMed:16216239,
CC       PubMed:17360770, PubMed:26432887). Ubiquitous during early somite
CC       stages, with high levels of expression in Kupffer's vesicle
CC       (PubMed:16216239, PubMed:17360770). At subsequent stages, detected
CC       in pronephric duct primordia and neural floorplate
CC       (PubMed:16216239, PubMed:16943304, PubMed:17360770,
CC       PubMed:26432887). Highly expressed in brain at 24 hpf
CC       (PubMed:16216239). At 3 dpf, detected at pharyngeal arches and the
CC       pectoral fin bud (PubMed:16216239). {ECO:0000269|PubMed:16216239,
CC       ECO:0000269|PubMed:16943304, ECO:0000269|PubMed:17360770,
CC       ECO:0000269|PubMed:26432887}.
CC   -!- DOMAIN: The C-terminal coiled-coil domain is involved in
CC       oligomerization. The coiled-coil domain binds calcium and
CC       undergoes a calcium-induced conformation change (in vitro).
CC       {ECO:0000250|UniProtKB:Q13563}.
CC   -!- PTM: Phosphorylated. Phosphorylation is important for protein
CC       function; a mutant human construct that lacks the N-terminal
CC       phosphorylation sites cannot complement a zebrafish pkd2-deficient
CC       mutant. {ECO:0000269|PubMed:16551655}.
CC   -!- PTM: N-glycosylated. The four subunits in a tetramer probably
CC       differ in the extent of glycosylation; simultaneous glycosylation
CC       of all experimentally validated sites would probably create steric
CC       hindrance. {ECO:0000250|UniProtKB:Q13563}.
CC   -!- DISRUPTION PHENOTYPE: Morpholino knockdown of the protein impairs
CC       specification of the left-right axis during embryonic development
CC       and randomization of heart and gut looping, plus misexpression of
CC       left-side specific genes (PubMed:16216239, PubMed:16943304,
CC       PubMed:17360770, PubMed:26432887, PubMed:25660539). Morpholino
CC       knockdown of the protein causes body curvature, tail curling,
CC       hydrocephalus and kidney cysts (PubMed:15269167, PubMed:16216239,
CC       PubMed:16943304, PubMed:16551655, PubMed:17360770,
CC       PubMed:23376035, PubMed:26432887). Morpholino knockdown has no
CC       effect on number, length or motility of pronephric cilia, but the
CC       fluid flow through the pronephric ducts seems to be impaired due
CC       to physical obstruction of the ducts (PubMed:16943304). Likewise,
CC       morpholino knockdown of the protein has no effect on the motility
CC       of cilia in Kupffer's vesicle (PubMed:25660539). Morpholino
CC       knockdown of the protein leads to an increase of the volume of
CC       Kupffer's vesicle, without any change in the proliferation of the
CC       cells that line the vesicle (PubMed:26432887). Morpholino
CC       knockdown of the protein leads to impaired heart function,
CC       characterized by arrhytmia and frequently associated with
CC       pericardial and abdominal edema and atrioventricular block
CC       (PubMed:23376035). {ECO:0000269|PubMed:15269167,
CC       ECO:0000269|PubMed:16216239, ECO:0000269|PubMed:16551655,
CC       ECO:0000269|PubMed:16943304, ECO:0000269|PubMed:17360770,
CC       ECO:0000269|PubMed:23376035, ECO:0000269|PubMed:26432887}.
CC   -!- SIMILARITY: Belongs to the polycystin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY618926; AAT39122.1; -; mRNA.
DR   EMBL; DQ175629; ABA60692.1; -; mRNA.
DR   EMBL; CR788312; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001002310.1; NM_001002310.1.
DR   RefSeq; XP_009292468.1; XM_009294193.2.
DR   UniGene; Dr.92211; -.
DR   SMR; Q6IVV8; -.
DR   STRING; 7955.ENSDARP00000027024; -.
DR   PaxDb; Q2VF27; -.
DR   Ensembl; ENSDART00000020412; ENSDARP00000027024; ENSDARG00000014098.
DR   GeneID; 432387; -.
DR   KEGG; dre:432387; -.
DR   CTD; 5311; -.
DR   ZFIN; ZDB-GENE-040827-4; pkd2.
DR   eggNOG; KOG3599; Eukaryota.
DR   eggNOG; ENOG410XTGE; LUCA.
DR   GeneTree; ENSGT00700000104221; -.
DR   HOGENOM; HOG000230858; -.
DR   HOVERGEN; HBG014945; -.
DR   KO; K04986; -.
DR   OMA; QAWSRDN; -.
DR   OrthoDB; EOG091G034F; -.
DR   TreeFam; TF316484; -.
DR   PRO; PR:Q6IVV8; -.
DR   Proteomes; UP000000437; Chromosome 1.
DR   Bgee; ENSDARG00000014098; -.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:ZFIN.
DR   GO; GO:0005929; C:cilium; IDA:ZFIN.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-KW.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ZFIN.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016328; C:lateral plasma membrane; ISS:ZFIN.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0030017; C:sarcomere; IEA:UniProtKB-SubCell.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0050982; P:detection of mechanical stimulus; IBA:GO_Central.
DR   GO; GO:0061371; P:determination of heart left/right asymmetry; IMP:ZFIN.
DR   GO; GO:0007368; P:determination of left/right symmetry; IMP:ZFIN.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IMP:ZFIN.
DR   GO; GO:0003143; P:embryonic heart tube morphogenesis; IMP:ZFIN.
DR   GO; GO:0007507; P:heart development; IMP:CACAO.
DR   GO; GO:0003146; P:heart jogging; IMP:ZFIN.
DR   GO; GO:0001947; P:heart looping; IMP:ZFIN.
DR   GO; GO:0001822; P:kidney development; IMP:ZFIN.
DR   GO; GO:0070121; P:Kupffer's vesicle development; IMP:ZFIN.
DR   GO; GO:0001946; P:lymphangiogenesis; IMP:ZFIN.
DR   GO; GO:0051284; P:positive regulation of sequestering of calcium ion; IMP:CACAO.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0048793; P:pronephros development; IMP:ZFIN.
DR   GO; GO:0072114; P:pronephros morphogenesis; IMP:ZFIN.
DR   GO; GO:0072019; P:proximal convoluted tubule development; IMP:ZFIN.
DR   GO; GO:0010882; P:regulation of cardiac muscle contraction by calcium ion signaling; IMP:ZFIN.
DR   GO; GO:0032965; P:regulation of collagen biosynthetic process; IMP:ZFIN.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   InterPro; IPR003915; PKD_2.
DR   Pfam; PF08016; PKD_channel; 1.
DR   PRINTS; PR01433; POLYCYSTIN2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Cell projection; Cilium; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Cytoskeleton; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Ion channel; Ion transport;
KW   Membrane; Metal-binding; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Sarcoplasmic reticulum;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    904       Polycystin-2.
FT                                /FTId=PRO_0000439854.
FT   TOPO_DOM      1    155       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TRANSMEM    156    177       Helical; Name=S1.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    178    404       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TRANSMEM    405    425       Helical; Name=S2.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    426    441       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TRANSMEM    442    462       Helical; Name=S3.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    463    489       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TRANSMEM    490    510       Helical; Name=S4.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    511    534       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TRANSMEM    535    556       Helical; Name=5.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    557    568       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   INTRAMEM    569    583       Pore-forming.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    584    591       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TRANSMEM    592    612       Helical; Name=S6.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   TOPO_DOM    613    904       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   DOMAIN      687    722       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     700    711       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   REGION      740    759       Linker. {ECO:0000250|UniProtKB:Q13563}.
FT   COILED      770    809       {ECO:0000250|UniProtKB:Q13563}.
FT   MOTIF       578    580       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   METAL       700    700       Calcium. {ECO:0000250|UniProtKB:Q13563}.
FT   METAL       702    702       Calcium. {ECO:0000250|UniProtKB:Q13563}.
FT   METAL       704    704       Calcium. {ECO:0000250|UniProtKB:Q13563}.
FT   METAL       706    706       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q13563}.
FT   METAL       711    711       Calcium. {ECO:0000250|UniProtKB:Q13563}.
FT   CARBOHYD    235    235       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    241    241       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    264    264       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    298    298       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    478    478       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    267    280       {ECO:0000250|UniProtKB:Q13563}.
FT   MUTAGEN     351    351       L->P: In ty30b; curly tail phenotype and
FT                                impaired left-right patterning.
FT                                {ECO:0000269|PubMed:17360770}.
FT   CONFLICT     15     15       A -> V (in Ref. 2; ABA60692).
FT                                {ECO:0000305}.
FT   CONFLICT    130    130       L -> P (in Ref. 2; ABA60692).
FT                                {ECO:0000305}.
FT   CONFLICT    325    325       G -> R (in Ref. 2; ABA60692).
FT                                {ECO:0000305}.
FT   CONFLICT    334    334       T -> A (in Ref. 2; ABA60692).
FT                                {ECO:0000305}.
FT   CONFLICT    604    608       FIFMI -> LIFMV (in Ref. 2; ABA60692).
FT                                {ECO:0000305}.
SQ   SEQUENCE   904 AA;  103269 MW;  53B45F174BB50E5E CRC64;
     MSSSRVRPQA PQSPAASASA SPPPHEGIEM EKMHHEEVGL GVPDETPSSP PTSSSRQAWS
     RDNPGFEPEE GMMEADWPPE SQGRRSVSTT SSSSSGGVPG NFSGISARIN RGLYPTPPAQ
     EHRSCGKRIL EKMRVLWDTR LLGESNSNRE MYLKTVLREM ITYILFLLTL CIITYGMVST
     NMYYYTKVMS QLFLDTPLSS GEPTNFKSLS TMEDFWKFTE GPFLNGMYWE LWYNNKSLPE
     NQSLIYYENL LLGVPRLRQL RVRNESCSVH EDLRDEVYDC YNVYSPANED KAPFGPKNGT
     AWRFKDESSL GESSYWGQVS TYGGGGYYQD LSRTREKSAN QLQELKNNLW LDRGTRAVFL
     DFSIYNGNVN LFCIVRLLVE FPATGGAVPS WQFQTVRLLR YVSSWDYFVG MCEVSFCLFV
     LYYLVEEALE IRLHRLRYFK SLWNCLDVLI VALSVPAIIM NICRTSAVSH RLHFLLENHS
     TYPNFEPLAR LQVHFNNLAA IIVFLSWVKL FKFINFNKTM NQLSTTMSRC AKDLMGFAIM
     FFIVFLAYAQ LAYLVFGTQV NDFSTFQACI FTQFRIILGD FDFSEIEEAD SVLGPIYFTT
     FVFFIFMILL NMFLAIINDT YSEVKADMAQ QRSEMEITDL IKKSYNRAMV KLKLKKSSIN
     DIPDSLQQAA GKLSFDELRQ DLRGKGHSDA EIEAIFAKYD LDGDQELTEH EHQQMRDDLE
     KEREDLDLEH SSLPRPASGR SFSRSQDDSE EDDDEDSGHS SRRRGSSSGG VSYEEFQVLV
     RRVDRMEHSI GSIVSKIDAV IVKLEAMERA KMKRRDVLGR ILDGVMEDER MGRDPELQRE
     QMDRLVRDEL ERWESDDTMS QVSHHHHQAT PIISSAQLRP RSSRPPSSLS NEGPDAAASG
     PAHL
//
ID   TM38A_DANRE             Reviewed;         295 AA.
AC   Q6P2T0;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   05-JUL-2017, entry version 70.
DE   RecName: Full=Trimeric intracellular cation channel type A;
DE            Short=TRIC-A;
DE            Short=TRICA;
DE   AltName: Full=Transmembrane protein 38A;
GN   Name=tmem38a; ORFNames=zgc:77831;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Monovalent cation channel required for maintenance of
CC       rapid intracellular calcium release. May act as a potassium
CC       counter-ion channel that functions in synchronization with calcium
CC       release from intracellular stores. {ECO:0000250|UniProtKB:Q3TMP8}.
CC   -!- SUBUNIT: Homotrimer; trimerization probably requires binding to
CC       phosphatidylinositol 4,5-bisphosphate (PIP2).
CC       {ECO:0000250|UniProtKB:A5A6S6, ECO:0000250|UniProtKB:Q9NA73}.
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:A5A6S6}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:A5A6S6}. Nucleus membrane
CC       {ECO:0000250|UniProtKB:A5A6S6}.
CC   -!- SIMILARITY: Belongs to the TMEM38 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC064309; AAH64309.1; -; mRNA.
DR   RefSeq; NP_957194.1; NM_200900.1.
DR   UniGene; Dr.78107; -.
DR   STRING; 7955.ENSDARP00000037150; -.
DR   PaxDb; Q6P2T0; -.
DR   Ensembl; ENSDART00000035560; ENSDARP00000037150; ENSDARG00000024047.
DR   GeneID; 393874; -.
DR   KEGG; dre:393874; -.
DR   CTD; 79041; -.
DR   ZFIN; ZDB-GENE-040426-1888; tmem38a.
DR   eggNOG; KOG3944; Eukaryota.
DR   eggNOG; ENOG410XQ0P; LUCA.
DR   GeneTree; ENSGT00390000018845; -.
DR   HOGENOM; HOG000037929; -.
DR   HOVERGEN; HBG059853; -.
DR   InParanoid; Q6P2T0; -.
DR   OMA; KYEPGAV; -.
DR   OrthoDB; EOG091G0GQP; -.
DR   PhylomeDB; Q6P2T0; -.
DR   TreeFam; TF313483; -.
DR   PRO; PR:Q6P2T0; -.
DR   Proteomes; UP000000437; Chromosome 11.
DR   Bgee; ENSDARG00000024047; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IBA:GO_Central.
DR   InterPro; IPR007866; TRIC_channel.
DR   PANTHER; PTHR12454; PTHR12454; 1.
DR   Pfam; PF05197; TRIC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Nucleus;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Sarcoplasmic reticulum; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    295       Trimeric intracellular cation channel
FT                                type A.
FT                                /FTId=PRO_0000291520.
FT   TOPO_DOM      1     18       Lumenal. {ECO:0000305}.
FT   TRANSMEM     19     37       Helical;Name=1. {ECO:0000255}.
FT   TOPO_DOM     38     51       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     52     75       Helical;Name=2. {ECO:0000255}.
FT   TOPO_DOM     76     86       Lumenal. {ECO:0000305}.
FT   TRANSMEM     87    106       Helical;Name=3. {ECO:0000255}.
FT   TOPO_DOM    107    144       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    145    162       Helical;Name=4. {ECO:0000255}.
FT   TOPO_DOM    163    182       Lumenal. {ECO:0000305}.
FT   TRANSMEM    183    199       Helical;Name=5. {ECO:0000255}.
FT   TOPO_DOM    200    210       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    211    227       Helical;Name=6. {ECO:0000255}.
FT   TOPO_DOM    228    236       Lumenal. {ECO:0000305}.
FT   TRANSMEM    237    255       Helical;Name=7. {ECO:0000255}.
FT   TOPO_DOM    256    295       Cytoplasmic. {ECO:0000305}.
FT   COMPBIAS    135    143       His-rich.
FT   BINDING     122    122       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000250|UniProtKB:Q9NA73}.
FT   BINDING     126    126       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000250|UniProtKB:Q9NA73}.
SQ   SEQUENCE   295 AA;  32951 MW;  938E391A3D68EFAE CRC64;
     MEVLDVLNLG EIAQYFSKMA MFPVFDVAYY IVSILYLKYE PGAVEVSRRS PVASWLCAML
     YCFGSYILAD IMLGVCPIDY FHNNSHILLA SAVWYLIFFC PLNLFYKCVA FMPVKLVLVA
     LKEVVRTRKI AAGVHHAHHA YHHGWLIMVI TGYVKGSGVA LMSNFEQLLR GVWKPETNEV
     LNMSFPTKAS LYGAILFTLQ EAHVLPVSKS TLICLFTLFM VSSKVFMTAR HSHGSPFALI
     ESWVCHVLFG SPLGTEDAHD HHHAAPAAAP APLSPAKNKE ELSEGTRKRK SKKAE
//
ID   TM38A_XENTR             Reviewed;         295 AA.
AC   Q6P8F8;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   05-JUL-2017, entry version 72.
DE   RecName: Full=Trimeric intracellular cation channel type A;
DE            Short=TRIC-A;
DE            Short=TRICA;
DE   AltName: Full=Transmembrane protein 38A;
GN   Name=tmem38a;
OS   Xenopus tropicalis (Western clawed frog) (Silurana tropicalis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Silurana.
OX   NCBI_TaxID=8364;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=N6; TISSUE=Skeletal muscle, and Tadpole;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Monovalent cation channel required for maintenance of
CC       rapid intracellular calcium release. May act as a potassium
CC       counter-ion channel that functions in synchronization with calcium
CC       release from intracellular stores. {ECO:0000250|UniProtKB:Q3TMP8}.
CC   -!- SUBUNIT: Homotrimer; trimerization probably requires binding to
CC       phosphatidylinositol 4,5-bisphosphate (PIP2).
CC       {ECO:0000250|UniProtKB:A5A6S6, ECO:0000250|UniProtKB:Q9NA73}.
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:A5A6S6}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:A5A6S6}. Nucleus membrane
CC       {ECO:0000250|UniProtKB:A5A6S6}.
CC   -!- SIMILARITY: Belongs to the TMEM38 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC061269; AAH61269.1; -; mRNA.
DR   EMBL; BC122046; AAI22047.1; -; mRNA.
DR   RefSeq; NP_988996.1; NM_203665.1.
DR   UniGene; Str.9956; -.
DR   STRING; 8364.ENSXETP00000046386; -.
DR   PaxDb; Q6P8F8; -.
DR   Ensembl; ENSXETT00000046386; ENSXETP00000046386; ENSXETG00000021455.
DR   GeneID; 394592; -.
DR   KEGG; xtr:394592; -.
DR   CTD; 79041; -.
DR   Xenbase; XB-GENE-5802848; tmem38a.
DR   eggNOG; KOG3944; Eukaryota.
DR   eggNOG; ENOG410XQ0P; LUCA.
DR   GeneTree; ENSGT00390000018845; -.
DR   HOGENOM; HOG000037929; -.
DR   HOVERGEN; HBG059853; -.
DR   InParanoid; Q6P8F8; -.
DR   OMA; KYEPGAV; -.
DR   OrthoDB; EOG091G0GQP; -.
DR   TreeFam; TF313483; -.
DR   Proteomes; UP000008143; Unassembled WGS sequence.
DR   Bgee; ENSXETG00000021455; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IBA:GO_Central.
DR   InterPro; IPR007866; TRIC_channel.
DR   PANTHER; PTHR12454; PTHR12454; 1.
DR   Pfam; PF05197; TRIC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Nucleus;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Sarcoplasmic reticulum; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    295       Trimeric intracellular cation channel
FT                                type A.
FT                                /FTId=PRO_0000291522.
FT   TOPO_DOM      1     11       Lumenal. {ECO:0000305}.
FT   TRANSMEM     12     32       Helical;Name=1. {ECO:0000255}.
FT   TOPO_DOM     33     51       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     52     72       Helical;Name=2. {ECO:0000255}.
FT   TOPO_DOM     73     84       Lumenal. {ECO:0000305}.
FT   TRANSMEM     85    105       Helical;Name=3. {ECO:0000255}.
FT   TOPO_DOM    106    144       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    145    165       Helical;Name=4. {ECO:0000255}.
FT   TOPO_DOM    166    178       Lumenal. {ECO:0000305}.
FT   TRANSMEM    179    199       Helical;Name=5. {ECO:0000255}.
FT   TOPO_DOM    200    201       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    202    222       Helical;Name=6. {ECO:0000255}.
FT   TOPO_DOM    223    233       Lumenal. {ECO:0000305}.
FT   TRANSMEM    234    254       Helical;Name=7. {ECO:0000255}.
FT   TOPO_DOM    255    295       Cytoplasmic. {ECO:0000305}.
FT   COMPBIAS    135    143       His-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00009}.
FT   COMPBIAS    256    273       His-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00009}.
FT   BINDING     122    122       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000250|UniProtKB:Q9NA73}.
FT   BINDING     126    126       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000250|UniProtKB:Q9NA73}.
SQ   SEQUENCE   295 AA;  33347 MW;  EA7E17495DECDA74 CRC64;
     MELLSALSLD DLAVAFSKLP VFPLFDVAYY IISILYLKYE PGAVDLSKRS PVASWLCAML
     YCFGSYILAD VLLGESPIHY FSNNANILLA SAVWYLTFFC PLNIFYKIVS FLPLKLVLVG
     MKEVVRVRKI AMGIHHAHHH YHHGWVIMVL IGWVKGSGVA LMSNLEQLLR GVWKPETNEI
     LHMSFPTKAS LYGAILFTLQ QAHWLPISKA YLIFFFTLFM AICKIYMTAT HSHGSPFAIF
     ESGICCVLFG AANGDHDDHG DHHHHHDDHD VSHSTVKSKE ELNEGTRKRK TKKAE
//
ID   KCNV1_HUMAN             Reviewed;         500 AA.
AC   Q6PIU1; Q9UHJ4;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   22-NOV-2017, entry version 125.
DE   RecName: Full=Potassium voltage-gated channel subfamily V member 1;
DE   AltName: Full=Neuronal potassium channel alpha subunit HNKA;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv8.1;
GN   Name=KCNV1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH KCNB1; KCNB2; KCNC4 AND KCND1.
RX   PubMed=8670833;
RA   Hugnot J.-P., Salinas M., Lesage F., Guillemare E., de Weille J.,
RA   Heurteaux C., Mattei M.-G., Lazdunski M.;
RT   "Kv8.1, a new neuronal potassium channel subunit with specific
RT   inhibitory properties towards Shab and Shaw channels.";
RL   EMBO J. 15:3322-3331(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=12383276; DOI=10.1046/j.1528-1157.43.s.9.7.x;
RA   Sano A., Mikami M., Nakamura M., Ueno S., Tanabe H., Kaneko S.;
RT   "Positional candidate approach for the gene responsible for benign
RT   adult familial myoclonic epilepsy.";
RL   Epilepsia 43:26-31(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RA   Xia J.-H., Zheng D., Tang X.-X., Yu K.-P., Tan S.;
RT   "Molecular cloning of human neuronal potassium channel alpha subunit
RT   (HNKA).";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-22.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH KCNB1 AND KCNB2.
RX   PubMed=9079713; DOI=10.1074/jbc.272.13.8774;
RA   Salinas M., de Weille J., Guillemare E., Lazdunski M., Hugnot J.-P.;
RT   "Modes of regulation of shab K+ channel activity by the Kv8.1
RT   subunit.";
RL   J. Biol. Chem. 272:8774-8780(1997).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Modulates KCNB1 and KCNB2 channel activity by
CC       shifting the threshold for inactivation to more negative values
CC       and by slowing the rate of inactivation. Can down-regulate the
CC       channel activity of KCNB1, KCNB2, KCNC4 and KCND1, possibly by
CC       trapping them in intracellular membranes.
CC       {ECO:0000269|PubMed:8670833, ECO:0000269|PubMed:9079713}.
CC   -!- SUBUNIT: Heteromultimer with KCNB1 and KCNB2. Interacts with KCNC4
CC       and KCND1. {ECO:0000269|PubMed:8670833,
CC       ECO:0000269|PubMed:9079713}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8670833,
CC       ECO:0000269|PubMed:9079713}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:8670833, ECO:0000269|PubMed:9079713}. Note=Has
CC       to be associated with another potassium channel subunit to get
CC       inserted in the plasma membrane. Remains intracellular in the
CC       absence of KCNB2.
CC   -!- TISSUE SPECIFICITY: Detected in brain.
CC       {ECO:0000269|PubMed:12383276}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. V (TC
CC       1.A.1.2) subfamily. Kv8.1/KCNV1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB032013; BAA92316.1; -; Genomic_DNA.
DR   EMBL; AF167082; AAD48031.2; -; mRNA.
DR   EMBL; BC028739; AAH28739.1; -; mRNA.
DR   CCDS; CCDS6314.1; -.
DR   RefSeq; NP_055194.1; NM_014379.3.
DR   UniGene; Hs.13285; -.
DR   ProteinModelPortal; Q6PIU1; -.
DR   BioGrid; 117954; 2.
DR   IntAct; Q6PIU1; 1.
DR   STRING; 9606.ENSP00000297404; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   PhosphoSitePlus; Q6PIU1; -.
DR   BioMuta; KCNV1; -.
DR   DMDM; 160013825; -.
DR   PaxDb; Q6PIU1; -.
DR   PeptideAtlas; Q6PIU1; -.
DR   PRIDE; Q6PIU1; -.
DR   DNASU; 27012; -.
DR   Ensembl; ENST00000297404; ENSP00000297404; ENSG00000164794.
DR   Ensembl; ENST00000524391; ENSP00000435954; ENSG00000164794.
DR   GeneID; 27012; -.
DR   KEGG; hsa:27012; -.
DR   UCSC; uc003ynr.5; human.
DR   CTD; 27012; -.
DR   EuPathDB; HostDB:ENSG00000164794.8; -.
DR   GeneCards; KCNV1; -.
DR   HGNC; HGNC:18861; KCNV1.
DR   MIM; 608164; gene.
DR   neXtProt; NX_Q6PIU1; -.
DR   OpenTargets; ENSG00000164794; -.
DR   PharmGKB; PA38721; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q6PIU1; -.
DR   KO; K04934; -.
DR   OMA; TIAQCYE; -.
DR   OrthoDB; EOG091G0FP3; -.
DR   PhylomeDB; Q6PIU1; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNV1; -.
DR   GenomeRNAi; 27012; -.
DR   PRO; PR:Q6PIU1; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000164794; -.
DR   CleanEx; HS_KCNV1; -.
DR   Genevisible; Q6PIU1; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0008200; F:ion channel inhibitor activity; TAS:ProtInc.
DR   GO; GO:0015459; F:potassium channel regulator activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003970; K_chnl_volt-dep_Kv8.1.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF38; PTHR11537:SF38; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01493; KV8CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    500       Potassium voltage-gated channel subfamily
FT                                V member 1.
FT                                /FTId=PRO_0000308350.
FT   TOPO_DOM      1    210       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    211    231       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    232    238       Extracellular. {ECO:0000255}.
FT   TRANSMEM    239    259       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    260    276       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    277    297       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    298    309       Extracellular. {ECO:0000255}.
FT   TRANSMEM    310    331       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    332    345       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    346    366       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    407    427       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    428    500       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       392    397       Selectivity filter. {ECO:0000250}.
FT   VARIANT      22     22       D -> G (in dbSNP:rs17852611).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_036804.
SQ   SEQUENCE   500 AA;  56304 MW;  C229E21ABC869C73 CRC64;
     MPSSGRALLD SPLDSGSLTS LDSSVFCSEG EGEPLALGDC FTVNVGGSRF VLSQQALSCF
     PHTRLGKLAV VVASYRRPGA LAAVPSPLEL CDDANPVDNE YFFDRSSQAF RYVLHYYRTG
     RLHVMEQLCA LSFLQEIQYW GIDELSIDSC CRDRYFRRKE LSETLDFKKD TEDQESQHES
     EQDFSQGPCP TVRQKLWNIL EKPGSSTAAR IFGVISIIFV VVSIINMALM SAELSWLDLQ
     LLEILEYVCI SWFTGEFVLR FLCVRDRCRF LRKVPNIIDL LAILPFYITL LVESLSGSQT
     TQELENVGRI VQVLRLLRAL RMLKLGRHST GLRSLGMTIT QCYEEVGLLL LFLSVGISIF
     STVEYFAEQS IPDTTFTSVP CAWWWATTSM TTVGYGDIRP DTTTGKIVAF MCILSGILVL
     ALPIAIINDR FSACYFTLKL KEAAVRQREA LKKLTKNIAT DSYISVNLRD VYARSIMEML
     RLKGRERAST RSSGGDDFWF
//
ID   KCNT2_HUMAN             Reviewed;        1135 AA.
AC   Q6UVM3; Q3SY59; Q5VTN1; Q6ZMT3;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   25-OCT-2017, entry version 130.
DE   RecName: Full=Potassium channel subfamily T member 2;
DE   AltName: Full=Sequence like an intermediate conductance potassium channel subunit;
DE   AltName: Full=Sodium and chloride-activated ATP-sensitive potassium channel Slo2.1;
GN   Name=KCNT2; Synonyms=SLICK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=14684870;
RA   Bhattacharjee A., Joiner W.J., Wu M., Yang Y., Sigworth F.J.,
RA   Kaczmarek L.K.;
RT   "Slick (Slo2.1), a rapidly-gating sodium-activated potassium channel
RT   inhibited by ATP.";
RL   J. Neurosci. 23:11681-11691(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Adipose tissue;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND PHOSPHORYLATION.
RX   PubMed=16687497; DOI=10.1523/JNEUROSCI.3372-05.2006;
RA   Santi C.M., Ferreira G., Yang B., Gazula V.R., Butler A., Wei A.,
RA   Kaczmarek L.K., Salkoff L.;
RT   "Opposite regulation of Slick and Slack K+ channels by
RT   neuromodulators.";
RL   J. Neurosci. 26:5059-5068(2006).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-33.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Outward rectifying potassium channel. Produces rapidly
CC       activating outward rectifier K(+) currents. Activated by high
CC       intracellular sodium and chloride levels. Channel activity is
CC       inhibited by ATP and by inhalation anesthetics, such as isoflurane
CC       (By similarity). Inhibited upon stimulation of G-protein coupled
CC       receptors, such as CHRM1 and GRIA1. {ECO:0000250,
CC       ECO:0000269|PubMed:14684870, ECO:0000269|PubMed:16687497}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q6UVM3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6UVM3-2; Sequence=VSP_029855;
CC       Name=3;
CC         IsoId=Q6UVM3-3; Sequence=VSP_029854, VSP_029855, VSP_029856;
CC       Name=4;
CC         IsoId=Q6UVM3-4; Sequence=VSP_029852, VSP_029853, VSP_029855,
CC                                  VSP_029856, VSP_029857;
CC   -!- PTM: Phosphorylated by protein kinase C. Phosphorylation of the C-
CC       terminal domain inhibits channel activity.
CC       {ECO:0000269|PubMed:16687497}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Calcium-
CC       activated (TC 1.A.1.3) subfamily. KCa4.2/KCNT2 sub-subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY359444; AAR06170.1; -; mRNA.
DR   EMBL; AK131498; BAD18642.1; -; mRNA.
DR   EMBL; BX647852; CAI46099.1; -; mRNA.
DR   EMBL; AL358853; CAH71957.1; -; Genomic_DNA.
DR   EMBL; AL138931; CAH71957.1; JOINED; Genomic_DNA.
DR   EMBL; AL139137; CAH71957.1; JOINED; Genomic_DNA.
DR   EMBL; AL591604; CAH71957.1; JOINED; Genomic_DNA.
DR   EMBL; AL358853; CAH71958.1; -; Genomic_DNA.
DR   EMBL; AL138931; CAH71958.1; JOINED; Genomic_DNA.
DR   EMBL; AL139137; CAH71958.1; JOINED; Genomic_DNA.
DR   EMBL; AL591604; CAH71958.1; JOINED; Genomic_DNA.
DR   EMBL; AL591604; CAH72932.1; -; Genomic_DNA.
DR   EMBL; AL138931; CAH72932.1; JOINED; Genomic_DNA.
DR   EMBL; AL139137; CAH72932.1; JOINED; Genomic_DNA.
DR   EMBL; AL358853; CAH72932.1; JOINED; Genomic_DNA.
DR   EMBL; AL591604; CAH72933.1; -; Genomic_DNA.
DR   EMBL; AL138931; CAH72933.1; JOINED; Genomic_DNA.
DR   EMBL; AL139137; CAH72933.1; JOINED; Genomic_DNA.
DR   EMBL; AL358853; CAH72933.1; JOINED; Genomic_DNA.
DR   EMBL; AL138931; CAI15623.1; -; Genomic_DNA.
DR   EMBL; AL139137; CAI15623.1; JOINED; Genomic_DNA.
DR   EMBL; AL358853; CAI15623.1; JOINED; Genomic_DNA.
DR   EMBL; AL591604; CAI15623.1; JOINED; Genomic_DNA.
DR   EMBL; AL138931; CAI15624.1; -; Genomic_DNA.
DR   EMBL; AL139137; CAI15624.1; JOINED; Genomic_DNA.
DR   EMBL; AL358853; CAI15624.1; JOINED; Genomic_DNA.
DR   EMBL; AL591604; CAI15624.1; JOINED; Genomic_DNA.
DR   EMBL; AL139137; CAI16091.1; -; Genomic_DNA.
DR   EMBL; AL138931; CAI16091.1; JOINED; Genomic_DNA.
DR   EMBL; AL358853; CAI16091.1; JOINED; Genomic_DNA.
DR   EMBL; AL591604; CAI16091.1; JOINED; Genomic_DNA.
DR   EMBL; AL139137; CAI16092.1; -; Genomic_DNA.
DR   EMBL; AL138931; CAI16092.1; JOINED; Genomic_DNA.
DR   EMBL; AL358853; CAI16092.1; JOINED; Genomic_DNA.
DR   EMBL; AL591604; CAI16092.1; JOINED; Genomic_DNA.
DR   EMBL; BC103948; AAI03949.1; -; mRNA.
DR   EMBL; BC103949; AAI03950.1; -; mRNA.
DR   EMBL; BC103950; AAI03951.1; -; mRNA.
DR   CCDS; CCDS1384.1; -. [Q6UVM3-1]
DR   CCDS; CCDS72994.1; -. [Q6UVM3-3]
DR   CCDS; CCDS72995.1; -. [Q6UVM3-2]
DR   RefSeq; NP_001274748.1; NM_001287819.1. [Q6UVM3-2]
DR   RefSeq; NP_001274749.1; NM_001287820.1. [Q6UVM3-3]
DR   RefSeq; NP_940905.2; NM_198503.3. [Q6UVM3-1]
DR   UniGene; Hs.657046; -.
DR   ProteinModelPortal; Q6UVM3; -.
DR   SMR; Q6UVM3; -.
DR   BioGrid; 131252; 11.
DR   GuidetoPHARMACOLOGY; 386; -.
DR   TCDB; 1.A.1.3.6; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q6UVM3; -.
DR   PhosphoSitePlus; Q6UVM3; -.
DR   DMDM; 74749370; -.
DR   PaxDb; Q6UVM3; -.
DR   PeptideAtlas; Q6UVM3; -.
DR   PRIDE; Q6UVM3; -.
DR   Ensembl; ENST00000294725; ENSP00000294725; ENSG00000162687. [Q6UVM3-1]
DR   Ensembl; ENST00000367433; ENSP00000356403; ENSG00000162687. [Q6UVM3-2]
DR   Ensembl; ENST00000609185; ENSP00000476657; ENSG00000162687. [Q6UVM3-3]
DR   GeneID; 343450; -.
DR   KEGG; hsa:343450; -.
DR   UCSC; uc001gtd.3; human. [Q6UVM3-1]
DR   CTD; 343450; -.
DR   EuPathDB; HostDB:ENSG00000162687.16; -.
DR   GeneCards; KCNT2; -.
DR   HGNC; HGNC:18866; KCNT2.
DR   HPA; HPA051218; -.
DR   MIM; 610044; gene.
DR   neXtProt; NX_Q6UVM3; -.
DR   OpenTargets; ENSG00000162687; -.
DR   PharmGKB; PA38726; -.
DR   eggNOG; KOG3193; Eukaryota.
DR   eggNOG; ENOG410XSMA; LUCA.
DR   GeneTree; ENSGT00530000063026; -.
DR   HOGENOM; HOG000231460; -.
DR   HOVERGEN; HBG055190; -.
DR   InParanoid; Q6UVM3; -.
DR   KO; K04947; -.
DR   OMA; GPRYIMS; -.
DR   OrthoDB; EOG091G011O; -.
DR   PhylomeDB; Q6UVM3; -.
DR   TreeFam; TF314283; -.
DR   ChiTaRS; KCNT2; human.
DR   GeneWiki; KCNT2; -.
DR   GenomeRNAi; 343450; -.
DR   PRO; PR:Q6UVM3; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162687; -.
DR   CleanEx; HS_KCNT2; -.
DR   ExpressionAtlas; Q6UVM3; baseline and differential.
DR   Genevisible; Q6UVM3; HS.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   InterPro; IPR003929; K_chnl_BK_asu.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   Pfam; PF03493; BK_channel_a; 1.
DR   Pfam; PF07885; Ion_trans_2; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   1135       Potassium channel subfamily T member 2.
FT                                /FTId=PRO_0000312503.
FT   TOPO_DOM      1     63       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     64     84       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     85    101       Extracellular. {ECO:0000255}.
FT   TRANSMEM    102    122       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    123    137       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    138    158       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    159    164       Extracellular. {ECO:0000255}.
FT   TRANSMEM    165    185       Helical; Name=Segment S4. {ECO:0000255}.
FT   TOPO_DOM    186    198       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    199    219       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    220    228       Extracellular. {ECO:0000255}.
FT   INTRAMEM    229    249       Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    250    256       Extracellular. {ECO:0000255}.
FT   TRANSMEM    257    277       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    278   1135       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      422    543       RCK N-terminal.
FT   NP_BIND    1025   1032       ATP. {ECO:0000255}.
FT   CARBOHYD     99     99       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     129    153       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029852.
FT   VAR_SEQ     468    468       Q -> QCVCLCCR (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029853.
FT   VAR_SEQ     469    518       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_029854.
FT   VAR_SEQ     760    783       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_029855.
FT   VAR_SEQ     970    970       E -> ESRKIASQ (in isoform 3 and isoform
FT                                4). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029856.
FT   VAR_SEQ    1071   1135       DEMNDHQSTLSYILINPSPDTRIELNDVVYLIRPDPLAYLP
FT                                NSEPSRRNSICNVTGQDSREETQL -> GMLFKNYCIYGLV
FT                                ISCH (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029857.
FT   VARIANT      33     33       V -> I (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_037527.
FT   VARIANT     413    413       C -> W (in dbSNP:rs12738104).
FT                                /FTId=VAR_037528.
FT   VARIANT     429    429       K -> N (in dbSNP:rs12742082).
FT                                /FTId=VAR_037529.
SQ   SEQUENCE   1135 AA;  130501 MW;  4957C6DAB1E030CF CRC64;
     MVDLESEVPP LPPRYRFRDL LLGDQGWQND DRVQVEFYMN ENTFKERLKL FFIKNQRSSL
     RIRLFNFSLK LLSCLLYIIR VLLENPSQGN EWSHIFWVNR SLPLWGLQVS VALISLFETI
     LLGYLSYKGN IWEQILRIPF ILEIINAVPF IISIFWPSLR NLFVPVFLNC WLAKHALENM
     INDLHRAIQR TQSAMFNQVL ILISTLLCLI FTCICGIQHL ERIGKKLNLF DSLYFCIVTF
     STVGFGDVTP ETWSSKLFVV AMICVALVVL PIQFEQLAYL WMERQKSGGN YSRHRAQTEK
     HVVLCVSSLK IDLLMDFLNE FYAHPRLQDY YVVILCPTEM DVQVRRVLQI PMWSQRVIYL
     QGSALKDQDL LRAKMDDAEA CFILSSRCEV DRTSSDHQTI LRAWAVKDFA PNCPLYVQIL
     KPENKFHIKF ADHVVCEEEF KYAMLALNCI CPATSTLITL LVHTSRGQEG QQSPEQWQKM
     YGRCSGNEVY HIVLEESTFF AEYEGKSFTY ASFHAHKKFG VCLIGVRRED NKNILLNPGP
     RYIMNSTDIC FYINITKEEN SAFKNQDQQR KSNVSRSFYH GPSRLPVHSI IASMGTVAID
     LQDTSCRSAS GPTLSLPTEG SKEIRRPSIA PVLEVADTSS IQTCDLLSDQ SEDETTPDEE
     MSSNLEYAKG YPPYSPYIGS SPTFCHLLHE KVPFCCLRLD KSCQHNYYED AKAYGFKNKL
     IIVAAETAGN GLYNFIVPLR AYYRPKKELN PIVLLLDNPP DMHFLDAICW FPMVYYMVGS
     IDNLDDLLRC GVTFAANMVV VDKESTMSAE EDYMADAKTI VNVQTLFRLF SSLSIITELT
     HPANMRFMQF RAKDCYSLAL SKLEKKERER GSNLAFMFRL PFAAGRVFSI SMLDTLLYQS
     FVKDYMISIT RLLLGLDTTP GSGFLCSMKI TADDLWIRTY ARLYQKLCSS TGDVPIGIYR
     TESQKLTTSE SQISISVEEW EDTKDSKEQG HHRSNHRNST SSDQSDHPLL RRKSMQWARR
     LSRKGPKHSG KTAEKITQQR LNLYRRSERQ ELAELVKNRM KHLGLSTVGY DEMNDHQSTL
     SYILINPSPD TRIELNDVVY LIRPDPLAYL PNSEPSRRNS ICNVTGQDSR EETQL
//
ID   KCNKI_MOUSE             Reviewed;         394 AA.
AC   Q6VV64; Q1LZJ5; Q1LZM8; Q3MI50; Q3MI51;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   22-NOV-2017, entry version 118.
DE   RecName: Full=Potassium channel subfamily K member 18;
DE   AltName: Full=Two-pore-domain potassium channel TRESK;
GN   Name=Kcnk18; Synonyms=Tresk-2, Tresk2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, MUTAGENESIS OF SER-276,
RP   PHOSPHORYLATION AT SER-276, AND TISSUE SPECIFICITY.
RC   STRAIN=NMRI; TISSUE=Cerebellum;
RX   PubMed=14981085; DOI=10.1074/jbc.M312229200;
RA   Czirjak G., Toth Z.E., Enyedi P.;
RT   "The two-pore domain K+ channel, TRESK, is activated by the
RT   cytoplasmic calcium signal through calcineurin.";
RL   J. Biol. Chem. 279:18550-18558(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND FUNCTION.
RC   STRAIN=BALB/cJ; TISSUE=Spinal cord;
RX   PubMed=16192517; DOI=10.1213/01.ane.0000168447.87557.5a;
RA   Keshavaprasad B., Liu C., Au J.D., Kindler C.H., Cotten J.F.,
RA   Yost C.S.;
RT   "Species-specific differences in response to anesthetics and other
RT   modulators by the K2P channel TRESK.";
RL   Anesth. Analg. 101:1042-1049(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Egg;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH CALCINEURIN.
RX   PubMed=16569637; DOI=10.1074/jbc.M602495200;
RA   Czirjak G., Enyedi P.;
RT   "Targeting of calcineurin to an NFAT-like docking site is required for
RT   the calcium-dependent activation of the background K+ channel,
RT   TRESK.";
RL   J. Biol. Chem. 281:14677-14682(2006).
RN   [6]
RP   TISSUE SPECIFICITY, AND MUTAGENESIS OF HIS-132.
RX   PubMed=17962323; DOI=10.1113/jphysiol.2007.145649;
RA   Dobler T., Springauf A., Tovornik S., Weber M., Schmitt A.,
RA   Sedlmeier R., Wischmeyer E., Doring F.;
RT   "TRESK two-pore-domain K+ channels constitute a significant component
RT   of background potassium currents in murine dorsal root ganglion
RT   neurones.";
RL   J. Physiol. (Lond.) 585:867-879(2007).
RN   [7]
RP   INTERACTION WITH YWHAH, MUTAGENESIS OF SER-264, AND PHOSPHORYLATION AT
RP   SER-264.
RX   PubMed=18397886; DOI=10.1074/jbc.M800712200;
RA   Czirjak G., Vuity D., Enyedi P.;
RT   "Phosphorylation-dependent binding of 14-3-3 proteins controls TRESK
RT   regulation.";
RL   J. Biol. Chem. 283:15672-15680(2008).
RN   [8]
RP   FUNCTION.
RX   PubMed=18568022; DOI=10.1038/nn.2143;
RA   Bautista D.M., Sigal Y.M., Milstein A.D., Garrison J.L., Zorn J.A.,
RA   Tsuruda P.R., Nicoll R.A., Julius D.;
RT   "Pungent agents from Szechuan peppers excite sensory neurons by
RT   inhibiting two-pore potassium channels.";
RL   Nat. Neurosci. 11:772-779(2008).
RN   [9]
RP   SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-83, AND MUTAGENESIS OF
RP   ASN-83.
RX   PubMed=20006580; DOI=10.1016/j.bbrc.2009.12.056;
RA   Egenberger B., Polleichtner G., Wischmeyer E., Doring F.;
RT   "N-linked glycosylation determines cell surface expression of two-
RT   pore-domain K+ channel TRESK.";
RL   Biochem. Biophys. Res. Commun. 391:1262-1267(2010).
RN   [10]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=20871611; DOI=10.1038/nm.2216;
RA   Lafreniere R.G., Cader M.Z., Poulin J.F., Andres-Enguix I.,
RA   Simoneau M., Gupta N., Boisvert K., Lafreniere F., McLaughlan S.,
RA   Dube M.P., Marcinkiewicz M.M., Ramagopalan S., Ansorge O., Brais B.,
RA   Sequeiros J., Pereira-Monteiro J.M., Griffiths L.R., Tucker S.J.,
RA   Ebers G., Rouleau G.A.;
RT   "A dominant-negative mutation in the TRESK potassium channel is linked
RT   to familial migraine with aura.";
RL   Nat. Med. 16:1157-1160(2010).
CC   -!- FUNCTION: Outward rectifying potassium channel. Produces rapidly
CC       activating outward rectifier K(+) currents. May function as
CC       background potassium channel that sets the resting membrane
CC       potential. Channel activity is directly activated by calcium
CC       signal. Activated by the G(q)-protein coupled receptor pathway.
CC       The calcium signal robustly activates the channel via calcineurin,
CC       whereas the anchoring of 14-3-3/YWHAH interferes with the return
CC       of the current to the resting state after activation. Inhibited
CC       also by arachidonic acid and other naturally occurring unsaturated
CC       free fatty acids. Channel activity is also enhanced by volatile
CC       anesthetics, such as isoflurane. Appears to be the primary target
CC       of hydroxy-alpha-sanshool, an ingredient of Schezuan pepper. May
CC       be involved in the somatosensory function with special respect to
CC       pain sensation. {ECO:0000269|PubMed:14981085,
CC       ECO:0000269|PubMed:16192517, ECO:0000269|PubMed:18568022}.
CC   -!- SUBUNIT: Interacts with calcineurin. Interacts with YWHAH, in a
CC       phosphorylation-dependent manner. {ECO:0000269|PubMed:16569637,
CC       ECO:0000269|PubMed:18397886}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20006580};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:20006580}.
CC   -!- TISSUE SPECIFICITY: Detected in brain cortex, cerebellum, dorsal
CC       root ganglion, spinal cord and testis. High expression in
CC       trigeminal ganglion, also expressed in autonomic nervous system
CC       ganglia such as the stellate ganglion and paravertebral
CC       sympathetic ganglia. Expressed in all adult spinal cord and brain
CC       regions, with slightly higher expression in thalamus,
CC       hypothalamus, hippocampus and posterior corte (at protein level).
CC       In non-neuronal tissues, substantial expression found in lung and
CC       heart and weal expression in liver, testis, kidney, small
CC       intestine and spleen. {ECO:0000269|PubMed:14981085,
CC       ECO:0000269|PubMed:16192517, ECO:0000269|PubMed:17962323,
CC       ECO:0000269|PubMed:20871611}.
CC   -!- DEVELOPMENTAL STAGE: Expression appears in trigeminal ganglion and
CC       dorsal root ganglia from E15.5 and increased through E18 to reach
CC       a peak in newborn mouse postnatal day 1.
CC       {ECO:0000269|PubMed:20871611}.
CC   -!- PTM: Phosphorylation of Ser-264 is required for the binding of 14-
CC       3-3eta/YWHAH. Calcineurin-mediated dephosphorylation of Ser-276
CC       enhances channel activity. {ECO:0000269|PubMed:14981085,
CC       ECO:0000269|PubMed:18397886}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:20006580}.
CC   -!- MISCELLANEOUS: Regulated by extracellular protons whereas human
CC       ortholog is not. His-132 is responsible for proton-dependent
CC       specific activity.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Throb - Issue 124 of
CC       December 2010;
CC       URL="https://web.expasy.org/spotlight/back_issues/124";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY325301; AAQ91836.1; -; mRNA.
DR   EMBL; AY542902; AAS48426.1; -; mRNA.
DR   EMBL; AK139600; BAE24080.1; -; mRNA.
DR   EMBL; AK162136; BAE36746.1; -; mRNA.
DR   EMBL; BC104132; AAI04133.1; -; mRNA.
DR   EMBL; BC104133; AAI04134.1; -; mRNA.
DR   EMBL; BC115705; AAI15706.1; -; mRNA.
DR   EMBL; BC115887; AAI15888.1; -; mRNA.
DR   EMBL; BC127136; AAI27137.1; -; mRNA.
DR   EMBL; BC127137; AAI27138.1; -; mRNA.
DR   CCDS; CCDS29934.1; -.
DR   RefSeq; NP_997144.1; NM_207261.3.
DR   UniGene; Mm.329947; -.
DR   ProteinModelPortal; Q6VV64; -.
DR   ELM; Q6VV64; -.
DR   IntAct; Q6VV64; 1.
DR   MINT; MINT-7997383; -.
DR   STRING; 10090.ENSMUSP00000065713; -.
DR   TCDB; 1.A.1.18.1; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q6VV64; -.
DR   PhosphoSitePlus; Q6VV64; -.
DR   PaxDb; Q6VV64; -.
DR   PRIDE; Q6VV64; -.
DR   Ensembl; ENSMUST00000065204; ENSMUSP00000065713; ENSMUSG00000040901.
DR   GeneID; 332396; -.
DR   KEGG; mmu:332396; -.
DR   UCSC; uc008ibh.1; mouse.
DR   CTD; 338567; -.
DR   MGI; MGI:2685627; Kcnk18.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00700000104522; -.
DR   HOGENOM; HOG000074045; -.
DR   HOVERGEN; HBG104673; -.
DR   InParanoid; Q6VV64; -.
DR   KO; K20007; -.
DR   OMA; FKLVQNR; -.
DR   OrthoDB; EOG091G0B4G; -.
DR   PhylomeDB; Q6VV64; -.
DR   TreeFam; TF316115; -.
DR   Reactome; R-MMU-1299344; TWIK-related spinal cord K+ channel (TRESK).
DR   PRO; PR:Q6VV64; -.
DR   Proteomes; UP000000589; Chromosome 19.
DR   Bgee; ENSMUSG00000040901; -.
DR   CleanEx; MM_KCNK18; -.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; ISO:MGI.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0071467; P:cellular response to pH; ISO:MGI.
DR   GO; GO:0071435; P:potassium ion export; ISO:MGI.
DR   GO; GO:0006813; P:potassium ion transport; IDA:UniProtKB.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    394       Potassium channel subfamily K member 18.
FT                                /FTId=PRO_0000312501.
FT   TOPO_DOM      1     31       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     32     52       Helical. {ECO:0000255}.
FT   INTRAMEM    114    140       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    142    162       Helical. {ECO:0000255}.
FT   TOPO_DOM    163    292       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    293    313       Helical. {ECO:0000255}.
FT   INTRAMEM    326    340       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    347    367       Helical. {ECO:0000255}.
FT   TOPO_DOM    368    394       Cytoplasmic. {ECO:0000255}.
FT   REGION      210    215       Interaction with calcineurin.
FT   REGION      261    266       Interaction with YWHAH.
FT                                {ECO:0000269|PubMed:18397886}.
FT   MOD_RES     264    264       Phosphoserine.
FT                                {ECO:0000269|PubMed:18397886}.
FT   MOD_RES     276    276       Phosphoserine.
FT                                {ECO:0000305|PubMed:14981085}.
FT   CARBOHYD     83     83       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20006580}.
FT   MUTAGEN      83     83       N->Q: Strongly reduced current amplitude
FT                                and localization to cell membrane.
FT                                {ECO:0000269|PubMed:20006580}.
FT   MUTAGEN     132    132       H->N: Insensitive to extracellular
FT                                protons. {ECO:0000269|PubMed:17962323}.
FT   MUTAGEN     212    212       I->A: Loss of interaction with
FT                                calcineurin and activation by elevated
FT                                intracellular calcium; when associated
FT                                with A-214.
FT   MUTAGEN     214    214       I->A: Strongly reduced activation by
FT                                elevated intracellular calcium. Loss of
FT                                interaction with calcineurin and
FT                                activation by elevated intracellular
FT                                calcium; when associated with A-212.
FT   MUTAGEN     264    264       S->A: Loss of interaction with YWHAH.
FT                                {ECO:0000269|PubMed:18397886}.
FT   MUTAGEN     276    276       S->A: Enhances basal channel activity and
FT                                abolishes stimulation by calcineurin.
FT                                {ECO:0000269|PubMed:14981085}.
FT   CONFLICT    228    228       K -> R (in Ref. 4; AAI15706/AAI04133).
FT                                {ECO:0000305}.
FT   CONFLICT    251    251       K -> E (in Ref. 4; AAI15706/AAI04133).
FT                                {ECO:0000305}.
SQ   SEQUENCE   394 AA;  44403 MW;  82D03F7D7F0D5591 CRC64;
     MEAEEPPEAR RCCPEALGKA RGCCPEALGK LLPGLCFLCC LVTYALVGAA LFSAVEGRPD
     PEAEENPELK KFLDDLCNIL KCNLTVVEGS RKNLCEHLQH LKPQWLKAPQ DWSFLSALFF
     CCTVFSTVGY GHMYPVTRLG KFLCMLYALF GIPLMFLVLT DIGDILATIL SRAYSRFQAL
     LCLPHDIFKW RSLPLCRKQP DSKPVEEAIP QIVIDAGVDE LLNPQPSKDP PSPSCNVELF
     ERLVAREKKN KLQPPTRPVE RSNSCPELVL GRLSCSILSN LDEVGQQVER LDIPLPVIAL
     VVFAYISCAA AILPFWETEL GFEDAFYFCF VTLTTIGFGD IVLVHPHFFL FFSIYIIVGM
     EILFIAFKLM QNRLLHTYKT LMLFVCQREV SLPW
//
ID   AKT2_ORYSJ              Reviewed;         855 AA.
AC   Q75HP9; Q0DHZ5; Q5TKJ4;
DT   28-JUN-2011, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   20-DEC-2017, entry version 99.
DE   RecName: Full=Potassium channel AKT2;
GN   OrderedLocusNames=Os05g0428700, LOC_Os05g35410;
GN   ORFNames=OsJ_18626, OSJNBb0048I21.3, P0636F09.19;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16261349; DOI=10.1007/s00438-005-0039-y;
RA   Cheng C.-H., Chung M.C., Liu S.-M., Chen S.-K., Kao F.Y., Lin S.-J.,
RA   Hsiao S.-H., Tseng I.C., Hsing Y.-I.C., Wu H.-P., Chen C.-S.,
RA   Shaw J.-F., Wu J., Matsumoto T., Sasaki T., Chen H.-C., Chow T.-Y.;
RT   "A fine physical map of the rice chromosome 5.";
RL   Mol. Genet. Genomics 274:337-345(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   "The rice annotation project database (RAP-DB): 2008 update.";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=15685292; DOI=10.1371/journal.pbio.0030038;
RA   Yu J., Wang J., Lin W., Li S., Li H., Zhou J., Ni P., Dong W., Hu S.,
RA   Zeng C., Zhang J., Zhang Y., Li R., Xu Z., Li S., Li X., Zheng H.,
RA   Cong L., Lin L., Yin J., Geng J., Li G., Shi J., Liu J., Lv H., Li J.,
RA   Wang J., Deng Y., Ran L., Shi X., Wang X., Wu Q., Li C., Ren X.,
RA   Wang J., Wang X., Li D., Liu D., Zhang X., Ji Z., Zhao W., Sun Y.,
RA   Zhang Z., Bao J., Han Y., Dong L., Ji J., Chen P., Wu S., Liu J.,
RA   Xiao Y., Bu D., Tan J., Yang L., Ye C., Zhang J., Xu J., Zhou Y.,
RA   Yu Y., Zhang B., Zhuang S., Wei H., Liu B., Lei M., Yu H., Li Y.,
RA   Xu H., Wei S., He X., Fang L., Zhang Z., Zhang Y., Huang X., Su Z.,
RA   Tong W., Li J., Tong Z., Li S., Ye J., Wang L., Fang L., Lei T.,
RA   Chen C.-S., Chen H.-C., Xu Z., Li H., Huang H., Zhang F., Xu H.,
RA   Li N., Zhao C., Li S., Dong L., Huang Y., Li L., Xi Y., Qi Q., Li W.,
RA   Zhang B., Hu W., Zhang Y., Tian X., Jiao Y., Liang X., Jin J., Gao L.,
RA   Zheng W., Hao B., Liu S.-M., Wang W., Yuan L., Cao M., McDermott J.,
RA   Samudrala R., Wang J., Wong G.K.-S., Yang H.;
RT   "The genomes of Oryza sativa: a history of duplications.";
RL   PLoS Biol. 3:266-281(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 290-855.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12869764; DOI=10.1126/science.1081288;
RG   The rice full-length cDNA consortium;
RT   "Collection, mapping, and annotation of over 28,000 cDNA clones from
RT   japonica rice.";
RL   Science 301:376-379(2003).
CC   -!- FUNCTION: Probable inward-rectifying potassium channel. Assuming
CC       opened or closed conformations in response to the voltage
CC       difference across the membrane, the channel is activated by
CC       hyperpolarization (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: The potassium channel is probably a homo- or
CC       heterotetrameric complex of pore-forming subunits. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAV59417.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAF17528.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC130600; AAV59417.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC135429; AAS90668.1; -; Genomic_DNA.
DR   EMBL; AP008211; BAF17528.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AP014961; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CM000142; EEE63802.1; -; Genomic_DNA.
DR   EMBL; AK061594; -; NOT_ANNOTATED_CDS; mRNA.
DR   RefSeq; XP_015637942.1; XM_015782456.1.
DR   UniGene; Os.13562; -.
DR   ProteinModelPortal; Q75HP9; -.
DR   SMR; Q75HP9; -.
DR   STRING; 39947.LOC_Os05g35410.1; -.
DR   PaxDb; Q75HP9; -.
DR   PRIDE; Q75HP9; -.
DR   EnsemblPlants; OS05T0428700-01; OS05T0428700-01; OS05G0428700.
DR   GeneID; 4338867; -.
DR   Gramene; OS05T0428700-01; OS05T0428700-01; OS05G0428700.
DR   KEGG; osa:4338867; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   InParanoid; Q75HP9; -.
DR   KO; K21867; -.
DR   OrthoDB; EOG0936023D; -.
DR   Proteomes; UP000059680; Chromosome 5.
DR   ExpressionAtlas; Q75HP9; baseline and differential.
DR   Genevisible; Q75HP9; OS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00204; ANK; 1.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.25.40.20; -; 2.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00248; ANK; 5.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   2: Evidence at transcript level;
KW   ANK repeat; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    855       Potassium channel AKT2.
FT                                /FTId=PRO_0000410875.
FT   TOPO_DOM      1     75       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     76     96       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     97    105       Extracellular. {ECO:0000255}.
FT   TRANSMEM    106    126       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    127    149       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    150    170       Helical. {ECO:0000255}.
FT   TOPO_DOM    171    179       Extracellular. {ECO:0000255}.
FT   TRANSMEM    180    200       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    201    214       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    215    235       Helical. {ECO:0000250}.
FT   TOPO_DOM    236    262       Extracellular. {ECO:0000255}.
FT   INTRAMEM    263    282       Pore-forming; Name=Segment H5.
FT                                {ECO:0000250}.
FT   TOPO_DOM    283    285       Extracellular. {ECO:0000255}.
FT   TRANSMEM    286    306       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    307    855       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      536    565       ANK 1.
FT   REPEAT      569    598       ANK 2.
FT   REPEAT      602    631       ANK 3.
FT   REPEAT      634    663       ANK 4.
FT   REPEAT      667    696       ANK 5.
FT   DOMAIN      768    855       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     391    511       cNMP.
FT   COMPBIAS     13     28       Poly-Gly.
SQ   SEQUENCE   855 AA;  94784 MW;  F37C097D3EEA7F2F CRC64;
     MKTSSFESAS SSGGSGGGGG GGGGEGSGSF NLRNLSKLIL PPLGVPAGGH AQSGHAGPND
     RRVISPLDSR YRCWDTFMVV LVAYSAWVYP FEVAFMNASP KGGLEVADIV VDLFFAVDIV
     LTFFVAYIDS RTQLLVRDRR RIATRYLSTF FIMDVASTIP FQGLAYIVTG EVRESPAFSL
     LGILRLWRLR KVKQFFTRLE KDIRFNYFWI RCARLIAVTL FLVHCAGCLY YLIADRYPHR
     EKTWIGAVIP DFQEASLWIR YTSSVYWSIT TMTTVGYGDM HAQNTVEMIF NIFYMLFNLG
     LTAYLIGNMT NLVVEGTRRT MEFRNSIRAA SNFVGRNHLP PRLKQQILAY MCLKFRAESL
     NQQQLMDQLP KSICKGICEY LFLPVVKDVY LFKGVSREVL LLMVTKMKPE YIPPKEDVIV
     QNEAPDDVYI VVSGEVEVIY SDGEAEERVV ATLGTRGVFG EVSALSDRPQ SFTLRTRTLC
     QLLRLRQAAL KEAMQSKPED SVVIIKNFLK HQIEMHDMKV EDLLGEDAAG EYDHGNIPCN
     LLTVAATGNS SFLEDLLKVG MDPDVGDSKG RTALHIAASK GYEDCVLVLL KQACNVNIKD
     AQGNTALWNA IAARHHKIFN ILYHFARVSS PHHAAGDLLC LAARRGDLDT LRELLKHGLA
     VDSEDRDGAT ALRVALAEGH ADVARLLVLN GASVDRAASH NEQQAAAAVS VDELRELMKT
     RELAHPVTIV VDSPSPAAAA VIREVGSSGD SRNGRRQSAR SDGAHWPRVS IYRGHPFVRN
     RSSEAGKLIN LPGTMEEFRI IIEEKLKVDA RKTLIMNDEG AEIDSIDVIR DNDKLFIVTE
     EHMTAVASMD SVSGS
//
ID   YUGO_BACSU              Reviewed;         328 AA.
AC   Q795M8; O05247;
DT   19-JAN-2010, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   25-OCT-2017, entry version 86.
DE   RecName: Full=Putative potassium channel protein YugO;
GN   Name=yugO; OrderedLocusNames=BSU31322; ORFNames=BSU31320;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9274030; DOI=10.1099/00221287-143-8-2769;
RA   Oudega B., Koningstein G., Rodrigues L., de Sales Ramon M.,
RA   Hilbert H., Duesterhoeft A., Pohl T.M., Weitzenegger T.;
RT   "Analysis of the Bacillus subtilis genome: cloning and nucleotide
RT   sequence of a 62 kb region between 275 degrees (rrnB) and 284 degrees
RT   (pai).";
RL   Microbiology 143:2769-2774(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G.,
RA   Azevedo V., Bertero M.G., Bessieres P., Bolotin A., Borchert S.,
RA   Borriss R., Boursier L., Brans A., Braun M., Brignell S.C., Bron S.,
RA   Brouillet S., Bruschi C.V., Caldwell B., Capuano V., Carter N.M.,
RA   Choi S.-K., Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A.,
RA   Denizot F., Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T.,
RA   Entian K.-D., Errington J., Fabret C., Ferrari E., Foulger D.,
RA   Fritz C., Fujita M., Fujita Y., Fuma S., Galizzi A., Galleron N.,
RA   Ghim S.-Y., Glaser P., Goffeau A., Golightly E.J., Grandi G.,
RA   Guiseppi G., Guy B.J., Haga K., Haiech J., Harwood C.R., Henaut A.,
RA   Hilbert H., Holsappel S., Hosono S., Hullo M.-F., Itaya M.,
RA   Jones L.-M., Joris B., Karamata D., Kasahara Y., Klaerr-Blanchard M.,
RA   Klein C., Kobayashi Y., Koetter P., Koningstein G., Krogh S.,
RA   Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G.,
RA   Rey M., Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B.,
RA   Rose M., Sadaie Y., Sato T., Scanlan E., Schleich S., Schroeter R.,
RA   Scoffone F., Sekiguchi J., Sekowska A., Seror S.J., Serror P.,
RA   Shin B.-S., Soldo B., Sorokin A., Tacconi E., Takagi T., Takahashi H.,
RA   Takemaru K., Takeuchi M., Tamakoshi A., Tanaka T., Terpstra P.,
RA   Tognoni A., Tosato V., Uchiyama S., Vandenbol M., Vannier F.,
RA   Vassarotti A., Viari A., Wambutt R., Wedler E., Wedler H.,
RA   Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB07933.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAB07933.1; Type=Frameshift; Positions=257; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z93936; CAB07933.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL009126; CAB15121.3; -; Genomic_DNA.
DR   RefSeq; NP_391010.3; NC_000964.3.
DR   RefSeq; WP_003242502.1; NZ_JNCM01000033.1.
DR   ProteinModelPortal; Q795M8; -.
DR   STRING; 224308.Bsubs1_010100017026; -.
DR   TCDB; 1.A.1.13.4; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q795M8; -.
DR   EnsemblBacteria; CAB15121; CAB15121; BSU31322.
DR   GeneID; 938842; -.
DR   KEGG; bsu:BSU31322; -.
DR   PATRIC; fig|224308.179.peg.3396; -.
DR   eggNOG; ENOG4107PBV; Bacteria.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000098412; -.
DR   InParanoid; Q795M8; -.
DR   KO; K10716; -.
DR   OMA; VFEGIWW; -.
DR   PhylomeDB; Q795M8; -.
DR   BioCyc; BSUB:BSU31322-MONOMER; -.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR003148; RCK_N.
DR   InterPro; IPR028325; VG_K_chnl.
DR   Pfam; PF07885; Ion_trans_2; 1.
DR   Pfam; PF02254; TrkA_N; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS51201; RCK_N; 1.
PE   4: Predicted;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    328       Putative potassium channel protein YugO.
FT                                /FTId=PRO_0000390882.
FT   TRANSMEM     19     39       Helical. {ECO:0000255}.
FT   TRANSMEM     42     62       Helical. {ECO:0000255}.
FT   TRANSMEM     73     93       Helical. {ECO:0000255}.
FT   DOMAIN      116    245       RCK N-terminal. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00543}.
SQ   SEQUENCE   328 AA;  36579 MW;  1C7CFEDC4D4C8E31 CRC64;
     MKSNRIFISW LRWPLFIRIG VIILCLILLF GQIIYILEPK QFTSVFEGIW WAVVTVSTVG
     YGDYVPHTPL GQAAGILLIL SGASFVTAYF ATLSAAAFSR QHRYIEGKVA YKGRDHIILI
     GWNEKTNRLL KDLQLAAPSK TVVLIDESLT EGPLIENVHF IRGHAADDGT LKRANITEAE
     SVMITADQYK SETDADMLSV LTLLSVKGLN PLAYCIVEIL TDRFVTNAER AGANQIIGTS
     EFISRAMLQH YQVKLRPSKQ QNGIKLTLDQ HVELLAVPDE LKGAAYKTCV LYFLDHNTTI
     IGIQKKEGPM LSPPLTYKVL ETDQFLAI
//
ID   GLIC_GLOVI              Reviewed;         359 AA.
AC   Q7NDN8;
DT   21-SEP-2011, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2003, sequence version 1.
DT   20-DEC-2017, entry version 94.
DE   RecName: Full=Proton-gated ion channel;
DE   AltName: Full=GLIC;
DE   AltName: Full=Ligand-gated ion channel;
DE            Short=LGIC;
DE   Flags: Precursor;
GN   Name=glvI; OrderedLocusNames=glr4197;
OS   Gloeobacter violaceus (strain PCC 7421).
OC   Bacteria; Cyanobacteria; Gloeobacteria; Gloeobacterales;
OC   Gloeobacteraceae; Gloeobacter.
OX   NCBI_TaxID=251221;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=PCC 7421;
RX   PubMed=14621292; DOI=10.1093/dnares/10.4.137;
RA   Nakamura Y., Kaneko T., Sato S., Mimuro M., Miyashita H., Tsuchiya T.,
RA   Sasamoto S., Watanabe A., Kawashima K., Kishida Y., Kiyokawa C.,
RA   Kohara M., Matsumoto M., Matsuno A., Nakazaki N., Shimpo S.,
RA   Takeuchi C., Yamada M., Tabata S.;
RT   "Complete genome structure of Gloeobacter violaceus PCC 7421, a
RT   cyanobacterium that lacks thylakoids.";
RL   DNA Res. 10:137-145(2003).
RN   [2]
RP   FUNCTION AS A PROTON-GATED ION CHANNEL, ION SELECTIVITY, ENZYME
RP   REGULATION, AND SUBUNIT.
RC   STRAIN=PCC 7421;
RX   PubMed=17167423; DOI=10.1038/nature05371;
RA   Bocquet N., Prado de Carvalho L., Cartaud J., Neyton J., Le Poupon C.,
RA   Taly A., Grutter T., Changeux J.P., Corringer P.J.;
RT   "A prokaryotic proton-gated ion channel from the nicotinic
RT   acetylcholine receptor family.";
RL   Nature 445:116-119(2007).
RN   [3]
RP   MODULATION BY ANESTHETICS, AND ENZYME REGULATION.
RC   STRAIN=PCC 7421;
RX   PubMed=19933531; DOI=10.1213/ANE.0b013e3181c4bc69;
RA   Weng Y., Yang L., Corringer P.J., Sonner J.M.;
RT   "Anesthetic sensitivity of the Gloeobacter violaceus proton-gated ion
RT   channel.";
RL   Anesth. Analg. 110:59-63(2010).
RN   [4]
RP   ANESTHETIC-BINDING, MUTAGENESIS STUDIES, AND FLUORESCENCE QUENCHING
RP   EXPERIMENTS.
RC   STRAIN=PCC 7421;
RX   PubMed=20858424; DOI=10.1016/j.bpj.2010.07.023;
RA   Chen Q., Cheng M.H., Xu Y., Tang P.;
RT   "Anesthetic binding in a pentameric ligand-gated ion channel: GLIC.";
RL   Biophys. J. 99:1801-1809(2010).
RN   [5]
RP   REVIEW.
RX   PubMed=19995852; DOI=10.1113/jphysiol.2009.183160;
RA   Corringer P.J., Baaden M., Bocquet N., Delarue M., Dufresne V.,
RA   Nury H., Prevost M., Van Renterghem C.;
RT   "Atomic structure and dynamics of pentameric ligand-gated ion
RT   channels: new insight from bacterial homologues.";
RL   J. Physiol. (Lond.) 588:565-572(2010).
RN   [6]
RP   GATING MECHANISM.
RX   PubMed=21041674; DOI=10.1073/pnas.1009313107;
RA   Zhu F., Hummer G.;
RT   "Pore opening and closing of a pentameric ligand-gated ion channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:19814-19819(2010).
RN   [7]
RP   ION SELECTIVITY MECHANISM.
RX   PubMed=21244835; DOI=10.1016/j.bpj.2010.11.077;
RA   Fritsch S., Ivanov I., Wang H., Cheng X.;
RT   "Ion selectivity mechanism in a bacterial pentameric ligand-gated ion
RT   channel.";
RL   Biophys. J. 100:390-398(2011).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 44-359, AND SUBUNIT.
RC   STRAIN=PCC 7421;
RX   PubMed=18987633; DOI=10.1038/nature07462;
RA   Bocquet N., Nury H., Baaden M., Le Poupon C., Changeux J.P.,
RA   Delarue M., Corringer P.J.;
RT   "X-ray structure of a pentameric ligand-gated ion channel in an
RT   apparently open conformation.";
RL   Nature 457:111-114(2009).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 43-359 OF WILD-TYPE AND
RP   MUTANT ALA-264, SUBUNIT, AND MUTAGENESIS OF GLU-264.
RC   STRAIN=PCC 7421;
RX   PubMed=18987630; DOI=10.1038/nature07461;
RA   Hilf R.J., Dutzler R.;
RT   "Structure of a potentially open state of a proton-activated
RT   pentameric ligand-gated ion channel.";
RL   Nature 457:115-118(2009).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 44-235, AND GATING
RP   MECHANISM.
RC   STRAIN=PCC 7421;
RX   PubMed=19917292; DOI=10.1016/j.jmb.2009.11.024;
RA   Nury H., Bocquet N., Le Poupon C., Raynal B., Haouz A.,
RA   Corringer P.J., Delarue M.;
RT   "Crystal structure of the extracellular domain of a bacterial ligand-
RT   gated ion channel.";
RL   J. Mol. Biol. 395:1114-1127(2010).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.20 ANGSTROMS) OF 43-359 OF WILD-TYPE AND
RP   MUTANT ASP-264 IN COMPLEXES WITH POSITIVELY CHARGED INHIBITORS, ENZYME
RP   REGULATION, MUTAGENESIS OF GLU-264; THR-268 AND SER-272, AND
RP   MECHANISMS OF OPEN CHANNEL BLOCK.
RC   STRAIN=PCC 7421;
RX   PubMed=21037567; DOI=10.1038/nsmb.1933;
RA   Hilf R.J., Bertozzi C., Zimmermann I., Reiter A., Trauner D.,
RA   Dutzler R.;
RT   "Structural basis of open channel block in a prokaryotic pentameric
RT   ligand-gated ion channel.";
RL   Nat. Struct. Mol. Biol. 17:1330-1336(2010).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.15 ANGSTROMS) OF 44-359 OF MUTANT PHE-279.
RC   STRAIN=PCC 7421;
RX   PubMed=20308576; DOI=10.1073/pnas.1001832107;
RA   Nury H., Poitevin F., Van Renterghem C., Changeux J.P.,
RA   Corringer P.J., Delarue M., Baaden M.;
RT   "One-microsecond molecular dynamics simulation of channel gating in a
RT   nicotinic receptor homologue.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:6275-6280(2010).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 44-359 IN COMPLEXES WITH
RP   PROPOFOL AND DESFLURANE ANESTHETICS, AND MUTAGENESIS OF ILE-244;
RP   VAL-284 AND THR-297.
RC   STRAIN=PCC 7421;
RX   PubMed=21248852; DOI=10.1038/nature09647;
RA   Nury H., Van Renterghem C., Weng Y., Tran A., Baaden M., Dusfresne V.,
RA   Changeux J.P., Sonner J.M., Delarue M., Corringer P.J.;
RT   "X-ray structures of general anaesthetics bound to a pentameric
RT   ligand-gated ion channel.";
RL   Nature 469:428-431(2011).
CC   -!- FUNCTION: Cationic channel with similar permeabilities for Na(+)
CC       and K(+), that is activated by an increase of the proton
CC       concentration on the extracellular side. Displays no permeability
CC       for chloride ions. Shows slow kinetics of activation, no
CC       desensitization and a single channel conductance of 8 pS. Might
CC       contribute to adaptation to external pH change.
CC       {ECO:0000269|PubMed:17167423}.
CC   -!- ENZYME REGULATION: Tetraethylammonium (TEA) and tetrabutylammonium
CC       (TBA) inhibit the proton-activated currents in a dose- and
CC       voltage-dependent manner in vitro, whereas the blocker of acid
CC       sensing ion channels, amiloride, has no effect. Channel current of
CC       GLIC can be inhibited by inhaled and intravenous general
CC       anesthetics at and below concentrations used clinically. Ion
CC       conduction is also inhibited by lidocaine and by divalent
CC       transition metal ions such as cadmium ions.
CC       {ECO:0000269|PubMed:17167423, ECO:0000269|PubMed:19933531,
CC       ECO:0000269|PubMed:21037567}.
CC   -!- SUBUNIT: Homopentamer. {ECO:0000269|PubMed:17167423,
CC       ECO:0000269|PubMed:18987630, ECO:0000269|PubMed:18987633}.
CC   -!- INTERACTION:
CC       Self; NbExp=26; IntAct=EBI-8423601, EBI-8423601;
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000305}; Multi-
CC       pass membrane protein {ECO:0000305}.
CC   -!- DOMAIN: Consists of an N-terminal ligand-binding domain that
CC       encloses a wide aqueous vestibule and a transmembrane domain that
CC       forms a narrow channel.
CC   -!- MISCELLANEOUS: The homologous nature of GLIC to eukaryotic
CC       nicotinic acetylcholine receptors and other eukaryotic pentameric
CC       ligand-gated ion channels, and its sensitivity to general
CC       anesthetics, define GLIC as a structural and functional model of
CC       signal transduction in the nervous system, also relevant for
CC       exploring the molecular basis of anesthetic action.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000045; BAC92138.1; -; Genomic_DNA.
DR   RefSeq; NP_927143.1; NC_005125.1.
DR   RefSeq; WP_011144181.1; NC_005125.1.
DR   PDB; 2XQ3; X-ray; 3.50 A; A/B/C/D/E=43-359.
DR   PDB; 2XQ4; X-ray; 3.60 A; A/B/C/D/E=43-359.
DR   PDB; 2XQ5; X-ray; 3.50 A; A/B/C/D/E=43-359.
DR   PDB; 2XQ6; X-ray; 3.70 A; A/B/C/D/E=43-359.
DR   PDB; 2XQ7; X-ray; 3.40 A; A/B/C/D/E=43-359.
DR   PDB; 2XQ8; X-ray; 3.60 A; A/B/C/D/E=43-359.
DR   PDB; 2XQ9; X-ray; 3.20 A; A/B/C/D/E=43-359.
DR   PDB; 2XQA; X-ray; 3.70 A; A/B/C/D/E=43-359.
DR   PDB; 3EAM; X-ray; 2.90 A; A/B/C/D/E=44-359.
DR   PDB; 3EHZ; X-ray; 3.10 A; A/B/C/D/E=50-359.
DR   PDB; 3EI0; X-ray; 3.50 A; A/B/C/D/E=50-359.
DR   PDB; 3IGQ; X-ray; 2.30 A; A/B/C/D/E/F=44-235.
DR   PDB; 3LSV; X-ray; 3.15 A; A/B/C/D/E=44-359.
DR   PDB; 3P4W; X-ray; 3.20 A; A/B/C/D/E=44-359.
DR   PDB; 3P50; X-ray; 3.30 A; A/B/C/D/E=44-359.
DR   PDB; 3TLS; X-ray; 3.20 A; A/B/C/D/E=44-359.
DR   PDB; 3TLT; X-ray; 3.30 A; A/B/C/D/E=44-359.
DR   PDB; 3TLU; X-ray; 2.85 A; A/B/C/D/E=44-359.
DR   PDB; 3TLV; X-ray; 2.90 A; A/B/C/D/E=44-359.
DR   PDB; 3TLW; X-ray; 2.60 A; A/B/C/D/E=44-359.
DR   PDB; 3UU3; X-ray; 3.15 A; A/B/C/D/E=44-359.
DR   PDB; 3UU4; X-ray; 3.05 A; A/B/C/D/E=44-359.
DR   PDB; 3UU5; X-ray; 2.90 A; A/B/C/D/E=44-359.
DR   PDB; 3UU6; X-ray; 2.98 A; A/B/C/D/E=44-359.
DR   PDB; 3UU8; X-ray; 3.25 A; A/B/C/D/E=44-359.
DR   PDB; 3UUB; X-ray; 2.90 A; A/B/C/D/E/F/G/H/I/J=44-359.
DR   PDB; 4F8H; X-ray; 2.99 A; A/B/C/D/E=43-359.
DR   PDB; 4HFB; X-ray; 2.75 A; A/B/C/D/E=44-359.
DR   PDB; 4HFC; X-ray; 3.05 A; A/B/C/D/E=44-359.
DR   PDB; 4HFD; X-ray; 3.10 A; A/B/C/D/E=44-359.
DR   PDB; 4HFE; X-ray; 2.80 A; A/B/C/D/E=44-359.
DR   PDB; 4HFH; X-ray; 2.65 A; A/B/C/D/E=44-359.
DR   PDB; 4HFI; X-ray; 2.40 A; A/B/C/D/E=44-359.
DR   PDB; 4IL4; X-ray; 3.30 A; A/B/C/D/E=44-359.
DR   PDB; 4IL9; X-ray; 2.83 A; A/B/C/D/E=44-358.
DR   PDB; 4ILA; X-ray; 3.50 A; A/B/C/D/E=44-358.
DR   PDB; 4ILB; X-ray; 3.15 A; A/B/C/D/E=44-358.
DR   PDB; 4ILC; X-ray; 2.99 A; A/B/C/D/E=44-358.
DR   PDB; 4IRE; X-ray; 3.19 A; A/B/C/D/E=43-359.
DR   PDB; 4LMJ; X-ray; 3.44 A; A/B/C/D/E=44-359.
DR   PDB; 4LMK; X-ray; 3.22 A; A/B/C/D/E=44-359.
DR   PDB; 4LML; X-ray; 3.80 A; A/B/C/D/E=44-359.
DR   PDB; 4NPP; X-ray; 3.35 A; A/B/C/D/E=44-359.
DR   PDB; 4NPQ; X-ray; 4.35 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T=44-359.
DR   PDB; 4QH1; X-ray; 3.40 A; A/B/C/D/E=44-359.
DR   PDB; 4QH4; X-ray; 3.20 A; A/B/C/D/E=44-359.
DR   PDB; 4QH5; X-ray; 3.00 A; A/B/C/D/E=44-359.
DR   PDB; 4X5T; X-ray; 3.50 A; A/B/C/D/E=44-235.
DR   PDB; 4YEU; X-ray; 4.60 A; A/B/C/D/E=236-357.
DR   PDB; 4ZZB; X-ray; 3.40 A; A/B/C/D/E=44-359.
DR   PDB; 4ZZC; X-ray; 3.10 A; A/B/C/D/E=43-359.
DR   PDB; 5HCJ; X-ray; 2.95 A; A/B/C/D/E=44-359.
DR   PDB; 5HCM; X-ray; 3.15 A; A/B/C/D/E=44-359.
DR   PDB; 5HEG; X-ray; 3.21 A; A/B/C/D/E=44-359.
DR   PDB; 5HEH; X-ray; 3.30 A; A/B/C/D/E=44-359.
DR   PDB; 5IUX; X-ray; 2.60 A; A/B/C/D/E=43-359.
DR   PDB; 5J0Z; X-ray; 3.25 A; A/B/C/D/E=47-357.
DR   PDB; 5L47; X-ray; 3.30 A; A/B/C/D/E=43-359.
DR   PDB; 5L4E; X-ray; 3.50 A; A/B/C/D/E=43-359.
DR   PDB; 5L4H; X-ray; 3.30 A; A/B/C/D/E=43-359.
DR   PDB; 5V6N; X-ray; 3.35 A; A/B/C/D/E=50-359.
DR   PDB; 5V6O; X-ray; 3.12 A; A/B/C/D/E=50-359.
DR   PDBsum; 2XQ3; -.
DR   PDBsum; 2XQ4; -.
DR   PDBsum; 2XQ5; -.
DR   PDBsum; 2XQ6; -.
DR   PDBsum; 2XQ7; -.
DR   PDBsum; 2XQ8; -.
DR   PDBsum; 2XQ9; -.
DR   PDBsum; 2XQA; -.
DR   PDBsum; 3EAM; -.
DR   PDBsum; 3EHZ; -.
DR   PDBsum; 3EI0; -.
DR   PDBsum; 3IGQ; -.
DR   PDBsum; 3LSV; -.
DR   PDBsum; 3P4W; -.
DR   PDBsum; 3P50; -.
DR   PDBsum; 3TLS; -.
DR   PDBsum; 3TLT; -.
DR   PDBsum; 3TLU; -.
DR   PDBsum; 3TLV; -.
DR   PDBsum; 3TLW; -.
DR   PDBsum; 3UU3; -.
DR   PDBsum; 3UU4; -.
DR   PDBsum; 3UU5; -.
DR   PDBsum; 3UU6; -.
DR   PDBsum; 3UU8; -.
DR   PDBsum; 3UUB; -.
DR   PDBsum; 4F8H; -.
DR   PDBsum; 4HFB; -.
DR   PDBsum; 4HFC; -.
DR   PDBsum; 4HFD; -.
DR   PDBsum; 4HFE; -.
DR   PDBsum; 4HFH; -.
DR   PDBsum; 4HFI; -.
DR   PDBsum; 4IL4; -.
DR   PDBsum; 4IL9; -.
DR   PDBsum; 4ILA; -.
DR   PDBsum; 4ILB; -.
DR   PDBsum; 4ILC; -.
DR   PDBsum; 4IRE; -.
DR   PDBsum; 4LMJ; -.
DR   PDBsum; 4LMK; -.
DR   PDBsum; 4LML; -.
DR   PDBsum; 4NPP; -.
DR   PDBsum; 4NPQ; -.
DR   PDBsum; 4QH1; -.
DR   PDBsum; 4QH4; -.
DR   PDBsum; 4QH5; -.
DR   PDBsum; 4X5T; -.
DR   PDBsum; 4YEU; -.
DR   PDBsum; 4ZZB; -.
DR   PDBsum; 4ZZC; -.
DR   PDBsum; 5HCJ; -.
DR   PDBsum; 5HCM; -.
DR   PDBsum; 5HEG; -.
DR   PDBsum; 5HEH; -.
DR   PDBsum; 5IUX; -.
DR   PDBsum; 5J0Z; -.
DR   PDBsum; 5L47; -.
DR   PDBsum; 5L4E; -.
DR   PDBsum; 5L4H; -.
DR   PDBsum; 5V6N; -.
DR   PDBsum; 5V6O; -.
DR   ProteinModelPortal; Q7NDN8; -.
DR   SMR; Q7NDN8; -.
DR   DIP; DIP-59040N; -.
DR   MINT; MINT-8425450; -.
DR   STRING; 251221.glr4197; -.
DR   TCDB; 1.A.9.8.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   EnsemblBacteria; BAC92138; BAC92138; BAC92138.
DR   GeneID; 2602600; -.
DR   KEGG; gvi:glr4197; -.
DR   eggNOG; ENOG4105TA1; Bacteria.
DR   eggNOG; ENOG4111U8M; LUCA.
DR   InParanoid; Q7NDN8; -.
DR   OMA; FRTTFCK; -.
DR   OrthoDB; POG091H13WE; -.
DR   PhylomeDB; Q7NDN8; -.
DR   EvolutionaryTrace; Q7NDN8; -.
DR   Proteomes; UP000000557; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005272; F:sodium channel activity; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   PANTHER; PTHR18945; PTHR18945; 2.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell inner membrane; Cell membrane; Complete proteome;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Receptor;
KW   Reference proteome; Signal; Sodium; Sodium channel; Sodium transport;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     43       {ECO:0000255}.
FT   CHAIN        44    359       Proton-gated ion channel.
FT                                /FTId=PRO_0000412722.
FT   TOPO_DOM     44    235       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    236    258       Helical.
FT   TOPO_DOM    259    261       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    262    286       Helical.
FT   TOPO_DOM    287    294       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    295    323       Helical.
FT   TOPO_DOM    324    326       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    327    359       Helical.
FT   MUTAGEN     244    244       I->Y: Marked gain of function, with a
FT                                ten-fold shift of the proton dose-
FT                                response curve towards lower
FT                                concentrations.
FT                                {ECO:0000269|PubMed:21248852}.
FT   MUTAGEN     264    264       E->A: Decreases cation selectivity.
FT                                Decreases the binding affinity of TEA and
FT                                TBA. Nearly abolishes block by Cd(2+).
FT                                {ECO:0000269|PubMed:18987630,
FT                                ECO:0000269|PubMed:21037567}.
FT   MUTAGEN     264    264       E->Q,D: Decreases binding affinity of
FT                                TBA. {ECO:0000269|PubMed:18987630,
FT                                ECO:0000269|PubMed:21037567}.
FT   MUTAGEN     268    268       T->A: Increases the binding affinity of
FT                                TBA. Weakens block by Cd(2+).
FT                                {ECO:0000269|PubMed:21037567}.
FT   MUTAGEN     272    272       S->A: Increases the binding affinity of
FT                                TBA. {ECO:0000269|PubMed:21037567}.
FT   MUTAGEN     284    284       V->M: Displays an increased sensitivity
FT                                to propofol but not to desflurane.
FT                                {ECO:0000269|PubMed:21248852}.
FT   MUTAGEN     297    297       T->A: Marked gain of function, with a
FT                                ten-fold shift of the proton dose-
FT                                response curve towards lower
FT                                concentrations. Shows also slower
FT                                apparent rate constants for activation
FT                                and deactivation. Displays an increased
FT                                sensitivity to propofol but a decreased
FT                                sensitivity to desflurane.
FT                                {ECO:0000269|PubMed:21248852}.
FT   STRAND       53     55       {ECO:0000244|PDB:4HFI}.
FT   STRAND       58     70       {ECO:0000244|PDB:3IGQ}.
FT   STRAND       76     90       {ECO:0000244|PDB:3IGQ}.
FT   HELIX        92     94       {ECO:0000244|PDB:3IGQ}.
FT   HELIX        98    101       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      104    107       {ECO:0000244|PDB:3TLW}.
FT   HELIX       110    112       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      118    126       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      128    136       {ECO:0000244|PDB:3IGQ}.
FT   TURN        138    140       {ECO:0000244|PDB:4F8H}.
FT   STRAND      141    153       {ECO:0000244|PDB:3IGQ}.
FT   TURN        159    162       {ECO:0000244|PDB:4HFI}.
FT   STRAND      165    174       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      178    180       {ECO:0000244|PDB:4QH5}.
FT   STRAND      182    186       {ECO:0000244|PDB:3IGQ}.
FT   HELIX       188    190       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      192    194       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      196    199       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      202    212       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      219    221       {ECO:0000244|PDB:3EI0}.
FT   STRAND      225    234       {ECO:0000244|PDB:3IGQ}.
FT   HELIX       236    238       {ECO:0000244|PDB:5IUX}.
FT   HELIX       239    242       {ECO:0000244|PDB:4HFI}.
FT   HELIX       244    254       {ECO:0000244|PDB:4HFI}.
FT   HELIX       255    259       {ECO:0000244|PDB:4HFI}.
FT   HELIX       263    286       {ECO:0000244|PDB:4HFI}.
FT   HELIX       296    323       {ECO:0000244|PDB:4HFI}.
FT   HELIX       327    356       {ECO:0000244|PDB:4HFI}.
SQ   SEQUENCE   359 AA;  40986 MW;  6F9009F96172C025 CRC64;
     MFPTGWRPKL SESIAASRML WQPMAAVAVV QIGLLWFSPP VWGQDMVSPP PPIADEPLTV
     NTGIYLIECY SLDDKAETFK VNAFLSLSWK DRRLAFDPVR SGVRVKTYEP EAIWIPEIRF
     VNVENARDAD VVDISVSPDG TVQYLERFSA RVLSPLDFRR YPFDSQTLHI YLIVRSVDTR
     NIVLAVDLEK VGKNDDVFLT GWDIESFTAV VKPANFALED RLESKLDYQL RISRQYFSYI
     PNIILPMLFI LFISWTAFWS TSYEANVTLV VSTLIAHIAF NILVETNLPK TPYMTYTGAI
     IFMIYLFYFV AVIEVTVQHY LKVESQPARA ASITRASRIA FPVVFLLANI ILAFLFFGF
//
ID   KAT5_ORYSJ              Reviewed;         368 AA.
AC   Q7XT08;
DT   28-JUN-2011, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   20-DEC-2017, entry version 80.
DE   RecName: Full=Putative potassium channel KAT5;
GN   OrderedLocusNames=Os04g0117500, LOC_Os04g02720;
GN   ORFNames=OsJ_13587, OSJNBb0050O03.14;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12447439; DOI=10.1038/nature01183;
RA   Feng Q., Zhang Y., Hao P., Wang S., Fu G., Huang Y., Li Y., Zhu J.,
RA   Liu Y., Hu X., Jia P., Zhang Y., Zhao Q., Ying K., Yu S., Tang Y.,
RA   Weng Q., Zhang L., Lu Y., Mu J., Lu Y., Zhang L.S., Yu Z., Fan D.,
RA   Liu X., Lu T., Li C., Wu Y., Sun T., Lei H., Li T., Hu H., Guan J.,
RA   Wu M., Zhang R., Zhou B., Chen Z., Chen L., Jin Z., Wang R., Yin H.,
RA   Cai Z., Ren S., Lv G., Gu W., Zhu G., Tu Y., Jia J., Zhang Y.,
RA   Chen J., Kang H., Chen X., Shao C., Sun Y., Hu Q., Zhang X., Zhang W.,
RA   Wang L., Ding C., Sheng H., Gu J., Chen S., Ni L., Zhu F., Chen W.,
RA   Lan L., Lai Y., Cheng Z., Gu M., Jiang J., Li J., Hong G., Xue Y.,
RA   Han B.;
RT   "Sequence and analysis of rice chromosome 4.";
RL   Nature 420:316-320(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=15685292; DOI=10.1371/journal.pbio.0030038;
RA   Yu J., Wang J., Lin W., Li S., Li H., Zhou J., Ni P., Dong W., Hu S.,
RA   Zeng C., Zhang J., Zhang Y., Li R., Xu Z., Li S., Li X., Zheng H.,
RA   Cong L., Lin L., Yin J., Geng J., Li G., Shi J., Liu J., Lv H., Li J.,
RA   Wang J., Deng Y., Ran L., Shi X., Wang X., Wu Q., Li C., Ren X.,
RA   Wang J., Wang X., Li D., Liu D., Zhang X., Ji Z., Zhao W., Sun Y.,
RA   Zhang Z., Bao J., Han Y., Dong L., Ji J., Chen P., Wu S., Liu J.,
RA   Xiao Y., Bu D., Tan J., Yang L., Ye C., Zhang J., Xu J., Zhou Y.,
RA   Yu Y., Zhang B., Zhuang S., Wei H., Liu B., Lei M., Yu H., Li Y.,
RA   Xu H., Wei S., He X., Fang L., Zhang Z., Zhang Y., Huang X., Su Z.,
RA   Tong W., Li J., Tong Z., Li S., Ye J., Wang L., Fang L., Lei T.,
RA   Chen C.-S., Chen H.-C., Xu Z., Li H., Huang H., Zhang F., Xu H.,
RA   Li N., Zhao C., Li S., Dong L., Huang Y., Li L., Xi Y., Qi Q., Li W.,
RA   Zhang B., Hu W., Zhang Y., Tian X., Jiao Y., Liang X., Jin J., Gao L.,
RA   Zheng W., Hao B., Liu S.-M., Wang W., Yuan L., Cao M., McDermott J.,
RA   Samudrala R., Wang J., Wong G.K.-S., Yang H.;
RT   "The genomes of Oryza sativa: a history of duplications.";
RL   PLoS Biol. 3:266-281(2005).
CC   -!- FUNCTION: Putative inward-rectifying potassium channel.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL606631; CAE01724.2; -; Genomic_DNA.
DR   EMBL; AP014960; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CM000141; EAZ29513.1; -; Genomic_DNA.
DR   ProteinModelPortal; Q7XT08; -.
DR   STRING; 39947.LOC_Os04g02720.1; -.
DR   PaxDb; Q7XT08; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238230; -.
DR   InParanoid; Q7XT08; -.
DR   Proteomes; UP000059680; Chromosome 4.
DR   ExpressionAtlas; Q7XT08; differential.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    368       Putative potassium channel KAT5.
FT                                /FTId=PRO_0000410881.
FT   TRANSMEM     33     53       Helical. {ECO:0000255}.
FT   TRANSMEM     97    117       Helical. {ECO:0000255}.
FT   TRANSMEM    132    152       Helical. {ECO:0000255}.
FT   INTRAMEM    180    199       Pore-forming. {ECO:0000255}.
FT   TRANSMEM    206    226       Helical. {ECO:0000255}.
FT   NP_BIND     225    344       cNMP.
SQ   SEQUENCE   368 AA;  42795 MW;  CBB0FBEB269D728C CRC64;
     MAARSELLRS AFGKASPSLG WFIVNPHRYS YRWWHMFLIM LVLYSAWASP FELSMEKAAS
     IALVVIRPSG RCLLRHRHCH ILLRHLVTGK RQGLWGLLNL LRLWRLRCAS KLFARVEKDV
     RFSYLWTRLI KLLCVTLFAL HFAACIYLWM VFNYKIKELT WIGSQIHSFE DRSVWFCYTC
     AVYWSITTLA TVGYGDLHAT NIGEMLFSIA FMLFNMGLTS YIIGNITNLV VRETSNTFKM
     RDMVQWVSEF GSMNRLPEVM REQMLANGQL RFRTKEQLQH EHVKRIGPRG MVGEIGVMFS
     IPQPFTIRSR RLTQVVRISH IHLLQAVRPN TADGCIVFSN FILVSDFVEY LESLKVQTKE
     VAFVSGHL
//
ID   KOR2_ORYSJ              Reviewed;         719 AA.
AC   Q7XUW4; B7EY26; Q0JCX5;
DT   28-JUN-2011, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   20-DEC-2017, entry version 93.
DE   RecName: Full=Potassium channel KOR2;
DE   AltName: Full=K(+) outward-rectifying channel 2;
GN   OrderedLocusNames=Os04g0445000, LOC_Os04g36740;
GN   ORFNames=OSJNBa0027P08.8;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12447439; DOI=10.1038/nature01183;
RA   Feng Q., Zhang Y., Hao P., Wang S., Fu G., Huang Y., Li Y., Zhu J.,
RA   Liu Y., Hu X., Jia P., Zhang Y., Zhao Q., Ying K., Yu S., Tang Y.,
RA   Weng Q., Zhang L., Lu Y., Mu J., Lu Y., Zhang L.S., Yu Z., Fan D.,
RA   Liu X., Lu T., Li C., Wu Y., Sun T., Lei H., Li T., Hu H., Guan J.,
RA   Wu M., Zhang R., Zhou B., Chen Z., Chen L., Jin Z., Wang R., Yin H.,
RA   Cai Z., Ren S., Lv G., Gu W., Zhu G., Tu Y., Jia J., Zhang Y.,
RA   Chen J., Kang H., Chen X., Shao C., Sun Y., Hu Q., Zhang X., Zhang W.,
RA   Wang L., Ding C., Sheng H., Gu J., Chen S., Ni L., Zhu F., Chen W.,
RA   Lan L., Lai Y., Cheng Z., Gu M., Jiang J., Li J., Hong G., Xue Y.,
RA   Han B.;
RT   "Sequence and analysis of rice chromosome 4.";
RL   Nature 420:316-320(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   "The rice annotation project database (RAP-DB): 2008 update.";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12869764; DOI=10.1126/science.1081288;
RG   The rice full-length cDNA consortium;
RT   "Collection, mapping, and annotation of over 28,000 cDNA clones from
RT   japonica rice.";
RL   Science 301:376-379(2003).
CC   -!- FUNCTION: Probable outward-rectifying potassium channel.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7XUW4-1; Sequence=Displayed;
CC         Note=Derived from EST data. No experimental confirmation
CC         available.;
CC       Name=2;
CC         IsoId=Q7XUW4-2; Sequence=VSP_041554;
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAF14812.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL731593; CAD40970.2; -; Genomic_DNA.
DR   EMBL; AP008210; BAF14812.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AP014960; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK105506; BAG97273.1; -; mRNA.
DR   RefSeq; XP_015636107.1; XM_015780621.1. [Q7XUW4-1]
DR   UniGene; Os.54520; -.
DR   ProteinModelPortal; Q7XUW4; -.
DR   SMR; Q7XUW4; -.
DR   STRING; 39947.LOC_Os04g36740.1; -.
DR   PaxDb; Q7XUW4; -.
DR   EnsemblPlants; OS04T0445000-01; OS04T0445000-01; OS04G0445000.
DR   GeneID; 4335955; -.
DR   Gramene; OS04T0445000-01; OS04T0445000-01; OS04G0445000.
DR   KEGG; osa:4335955; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000240830; -.
DR   InParanoid; Q7XUW4; -.
DR   KO; K21867; -.
DR   OrthoDB; EOG093606YB; -.
DR   Proteomes; UP000059680; Chromosome 4.
DR   ExpressionAtlas; Q7XUW4; baseline and differential.
DR   Genevisible; Q7XUW4; OS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00204; ANK; 1.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.25.40.20; -; 2.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00248; ANK; 4.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ANK repeat; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    719       Potassium channel KOR2.
FT                                /FTId=PRO_0000410884.
FT   TOPO_DOM      1     63       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     64     84       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     85     93       Extracellular. {ECO:0000255}.
FT   TRANSMEM     94    114       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    115    137       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    138    158       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    159    164       Extracellular. {ECO:0000255}.
FT   TRANSMEM    165    185       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    186    199       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    200    220       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    221    255       Extracellular. {ECO:0000255}.
FT   INTRAMEM    256    275       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    276    285       Extracellular. {ECO:0000255}.
FT   TRANSMEM    286    306       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    307    719       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      523    556       ANK 1.
FT   REPEAT      560    589       ANK 2.
FT   REPEAT      593    622       ANK 3.
FT   REPEAT      624    653       ANK 4.
FT   REPEAT      657    686       ANK 5.
FT   NP_BIND     383    503       cNMP.
FT   VAR_SEQ       1    280       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12869764}.
FT                                /FTId=VSP_041554.
SQ   SEQUENCE   719 AA;  81621 MW;  306CC09C30CE33A7 CRC64;
     MAEEYELNEI DDTLHGSVGS RLSLFARELK SRRSSSWHGG TALRLPKDLY ESLVIHPNGR
     WYRIWANMMF LWSIYSTFFT PFEFSFFRGL PDQLLDLECV QLVFLADVAV HFFLAYRDPH
     TYRMVHDKRH IALRYIKGSF ALDVLGCFPW DAIYKVTGRV EAVRWLVWVR LYRGRKVMAF
     FKRVEKDIRV SYLLTRIVKL ITVELYCTHT AACGFYYLAT TLPPAREGGT WIGSLSLGDA
     RYINFREVDL LTRYVTSLYL AIVTMATVGY GDIHAVNTRE MAFTVVYISF SIVLSAYLIG
     NMTALIVKGS RTERFRDRMT DLIRYMNRNR LGSAIRSQVK DHLMLQYESS YTRDRVIVDD
     IPVAVRSKMS QTLYLDMVSR VGLFRGCSDD FLSQIVLKLH EEFFLPGEVI LEQGTVVDQI
     YIVAHGCLEE VANGEDGSEE IISELRPYGI VGDVAVICNI PQPYTVRVCE LCSLLRIDKQ
     SLTSILQIYF KDNSQILSNL LKGKETESKR KQLESDITYL LAKQESELVL GVNNAAYHGD
     IFRLKSLISA GADPSKSDYD GRTALHIAAL RGYENIVRFL IQRGANVNSI DRFGNSPLLQ
     AVKSGHDRIT SLLVEHGAIL NLEDAGGYLC RVVRGGRIDL LKKLLRFGIS PNCRNYDQRT
     PLHIAAAEGL HLVASTLIES GADIQAKDRW GNTPLDEGRR CSSKPLVRIL EQARTVATN
//
ID   KCNKI_HUMAN             Reviewed;         384 AA.
AC   Q7Z418; Q5SQQ8;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   22-NOV-2017, entry version 122.
DE   RecName: Full=Potassium channel subfamily K member 18;
DE   AltName: Full=TWIK-related individual potassium channel;
DE   AltName: Full=TWIK-related spinal cord potassium channel;
GN   Name=KCNK18; Synonyms=TRESK, TRIK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Spinal cord;
RX   PubMed=12754259; DOI=10.1074/jbc.M206810200;
RA   Sano Y., Inamura K., Miyake A., Mochizuki S., Kitada C., Yokoi H.,
RA   Nozawa K., Okada H., Matsushime H., Furuichi K.;
RT   "A novel two-pore domain K+ channel, TRESK, is localized in the spinal
RT   cord.";
RL   J. Biol. Chem. 278:27406-27412(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15562060; DOI=10.1213/01.ANE.0000136849.07384.44;
RA   Liu C., Au J.D., Zou H.L., Cotten J.F., Yost C.S.;
RT   "Potent activation of the human tandem pore domain K channel TRESK
RT   with clinical concentrations of volatile anesthetics.";
RL   Anesth. Analg. 99:1715-1722(2004).
RN   [4]
RP   MUTAGENESIS OF TYR-121.
RX   PubMed=17962323; DOI=10.1113/jphysiol.2007.145649;
RA   Dobler T., Springauf A., Tovornik S., Weber M., Schmitt A.,
RA   Sedlmeier R., Wischmeyer E., Doring F.;
RT   "TRESK two-pore-domain K+ channels constitute a significant component
RT   of background potassium currents in murine dorsal root ganglion
RT   neurones.";
RL   J. Physiol. (Lond.) 585:867-879(2007).
RN   [5]
RP   SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-70, AND MUTAGENESIS OF
RP   ASN-70 AND ASN-96.
RX   PubMed=20006580; DOI=10.1016/j.bbrc.2009.12.056;
RA   Egenberger B., Polleichtner G., Wischmeyer E., Doring F.;
RT   "N-linked glycosylation determines cell surface expression of two-
RT   pore-domain K+ channel TRESK.";
RL   Biochem. Biophys. Res. Commun. 391:1262-1267(2010).
RN   [6]
RP   TISSUE SPECIFICITY, INVOLVEMENT IN MGR13, AND VARIANTS VAL-34 AND
RP   VAL-233.
RX   PubMed=20871611; DOI=10.1038/nm.2216;
RA   Lafreniere R.G., Cader M.Z., Poulin J.F., Andres-Enguix I.,
RA   Simoneau M., Gupta N., Boisvert K., Lafreniere F., McLaughlan S.,
RA   Dube M.P., Marcinkiewicz M.M., Ramagopalan S., Ansorge O., Brais B.,
RA   Sequeiros J., Pereira-Monteiro J.M., Griffiths L.R., Tucker S.J.,
RA   Ebers G., Rouleau G.A.;
RT   "A dominant-negative mutation in the TRESK potassium channel is linked
RT   to familial migraine with aura.";
RL   Nat. Med. 16:1157-1160(2010).
CC   -!- FUNCTION: Outward rectifying potassium channel. Produces rapidly
CC       activating outward rectifier K(+) currents. May function as
CC       background potassium channel that sets the resting membrane
CC       potential. Channel activity is directly activated by calcium
CC       signal. Activated by the G(q)-protein coupled receptor pathway.
CC       The calcium signal robustly activates the channel via calcineurin,
CC       whereas the anchoring of 14-3-3/YWHAH interferes with the return
CC       of the current to the resting state after activation. Inhibited
CC       also by arachidonic acid and other naturally occurring unsaturated
CC       free fatty acids. Channel activity is also enhanced by volatile
CC       anesthetics, such as isoflurane. Appears to be the primary target
CC       of hydroxy-alpha-sanshool, an ingredient of Schezuan pepper. May
CC       be involved in the somatosensory function with special respect to
CC       pain sensation (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:12754259, ECO:0000269|PubMed:15562060}.
CC   -!- SUBUNIT: Interacts with calcineurin. Interacts with YWHAH, in a
CC       phosphorylation-dependent manner. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20006580};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:20006580}.
CC   -!- TISSUE SPECIFICITY: Expressed specifically in dorsal root ganglion
CC       and trigeminal ganglion neurons. Detected at low levels in spinal
CC       cord. {ECO:0000269|PubMed:12754259, ECO:0000269|PubMed:15562060,
CC       ECO:0000269|PubMed:20871611}.
CC   -!- PTM: Phosphorylation of Ser-252 is required for the binding of 14-
CC       3-3eta/YWHAH. Calcineurin-mediated dephosphorylation of Ser-264
CC       enhances channel activity (By similarity). {ECO:0000250}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:20006580}.
CC   -!- DISEASE: Migraine with or without aura 13 (MGR13) [MIM:613656]: A
CC       form of migraine transmitted in an autosomal dominant pattern.
CC       Migraine is a disabling symptom complex of periodic headaches,
CC       usually temporal and unilateral. Headaches are often accompanied
CC       by irritability, nausea, vomiting and photophobia, preceded by
CC       constriction of the cranial arteries. The two major subtypes are
CC       common migraine (migraine without aura) and classic migraine
CC       (migraine with aura). Classic migraine is characterized by
CC       recurrent attacks of reversible neurological symptoms (aura) that
CC       precede or accompany the headache. Aura may include a combination
CC       of sensory disturbances, such as blurred vision, hallucinations,
CC       vertigo, numbness and difficulty in concentrating and speaking.
CC       {ECO:0000269|PubMed:20871611}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC       Susceptibility to migraine has been shown to be conferred by a
CC       frameshift mutation that segregates with the disorder in a large
CC       multigenerational family. Migraine was associated with sensitivity
CC       to lights, sounds, and smells, as well as nausea and occasional
CC       vomiting. Triggers included fatigue, alcohol and bright lights.
CC       Mutations in KCNK18 are a rare cause of migraine.
CC   -!- MISCELLANEOUS: In contrast to its mouse ortholog, it is not
CC       regulated by extracellular protons.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Throb - Issue 124 of
CC       December 2010;
CC       URL="https://web.expasy.org/spotlight/back_issues/124";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB087138; BAC78527.1; -; mRNA.
DR   EMBL; AL731557; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS7598.1; -.
DR   RefSeq; NP_862823.1; NM_181840.1.
DR   UniGene; Hs.449650; -.
DR   ProteinModelPortal; Q7Z418; -.
DR   BioGrid; 130759; 2.
DR   STRING; 9606.ENSP00000334650; -.
DR   ChEMBL; CHEMBL2331042; -.
DR   iPTMnet; Q7Z418; -.
DR   PhosphoSitePlus; Q7Z418; -.
DR   BioMuta; KCNK18; -.
DR   DMDM; 74750072; -.
DR   PaxDb; Q7Z418; -.
DR   PeptideAtlas; Q7Z418; -.
DR   PRIDE; Q7Z418; -.
DR   DNASU; 338567; -.
DR   Ensembl; ENST00000334549; ENSP00000334650; ENSG00000186795.
DR   GeneID; 338567; -.
DR   KEGG; hsa:338567; -.
DR   UCSC; uc010qsr.2; human.
DR   CTD; 338567; -.
DR   DisGeNET; 338567; -.
DR   EuPathDB; HostDB:ENSG00000186795.1; -.
DR   GeneCards; KCNK18; -.
DR   HGNC; HGNC:19439; KCNK18.
DR   HPA; HPA044739; -.
DR   MalaCards; KCNK18; -.
DR   MIM; 613655; gene.
DR   MIM; 613656; phenotype.
DR   neXtProt; NX_Q7Z418; -.
DR   OpenTargets; ENSG00000186795; -.
DR   PharmGKB; PA134985465; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00700000104522; -.
DR   HOGENOM; HOG000074045; -.
DR   HOVERGEN; HBG104673; -.
DR   InParanoid; Q7Z418; -.
DR   KO; K20007; -.
DR   OMA; FKLVQNR; -.
DR   OrthoDB; EOG091G0B4G; -.
DR   PhylomeDB; Q7Z418; -.
DR   TreeFam; TF316115; -.
DR   Reactome; R-HSA-1299344; TWIK-related spinal cord K+ channel (TRESK).
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   GeneWiki; KCNK18; -.
DR   GenomeRNAi; 338567; -.
DR   PRO; PR:Q7Z418; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000186795; -.
DR   CleanEx; HS_KCNK18; -.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IEA:Ensembl.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0005267; F:potassium channel activity; TAS:Reactome.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0071467; P:cellular response to pH; IDA:BHF-UCL.
DR   GO; GO:0071435; P:potassium ion export; IDA:BHF-UCL.
DR   GO; GO:0006813; P:potassium ion transport; IDA:UniProtKB.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    384       Potassium channel subfamily K member 18.
FT                                /FTId=PRO_0000312500.
FT   TOPO_DOM      1     23       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     24     44       Helical. {ECO:0000255}.
FT   INTRAMEM    103    129       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    130    148       Helical. {ECO:0000255}.
FT   TOPO_DOM    149    280       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    281    301       Helical. {ECO:0000255}.
FT   INTRAMEM    314    328       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    335    355       Helical. {ECO:0000255}.
FT   TOPO_DOM    356    384       Cytoplasmic. {ECO:0000255}.
FT   REGION      200    205       Interaction with calcineurin.
FT                                {ECO:0000250}.
FT   REGION      249    254       Interaction with YWHAH. {ECO:0000250}.
FT   SITE         96     96       Not glycosylated.
FT   MOD_RES     252    252       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6VV64}.
FT   CARBOHYD     70     70       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20006580}.
FT   VARIANT      34     34       A -> V. {ECO:0000269|PubMed:20871611}.
FT                                /FTId=VAR_064027.
FT   VARIANT      58     58       F -> Y (in dbSNP:rs3909165).
FT                                /FTId=VAR_037521.
FT   VARIANT     198    198       A -> G (in dbSNP:rs363359).
FT                                /FTId=VAR_037522.
FT   VARIANT     231    231       S -> P (in dbSNP:rs363315).
FT                                /FTId=VAR_037523.
FT   VARIANT     233    233       A -> V (in dbSNP:rs363360).
FT                                {ECO:0000269|PubMed:20871611}.
FT                                /FTId=VAR_037524.
FT   VARIANT     255    255       E -> K (in dbSNP:rs3026042).
FT                                /FTId=VAR_037525.
FT   VARIANT     346    346       V -> I (in dbSNP:rs12247136).
FT                                /FTId=VAR_037526.
FT   MUTAGEN      70     70       N->Q: Strongly reduced current amplitude
FT                                and localization to cell membrane.
FT                                Strongly reduced current amplitude and
FT                                localization to cell membrane; when
FT                                associated with Q-96.
FT                                {ECO:0000269|PubMed:20006580}.
FT   MUTAGEN      96     96       N->Q: Strongly reduced current amplitude
FT                                and localization to cell membrane.
FT                                Strongly reduced current amplitude and
FT                                localization to cell membrane; when
FT                                associated with Q-70.
FT                                {ECO:0000269|PubMed:20006580}.
FT   MUTAGEN     121    121       Y->H: Restores sensitivity to
FT                                extracellular protons.
FT                                {ECO:0000269|PubMed:17962323}.
SQ   SEQUENCE   384 AA;  43671 MW;  5D0B544F815ACB1C CRC64;
     MEVSGHPQAR RCCPEALGKL FPGLCFLCFL VTYALVGAVV FSAIEDGQVL VAADDGEFEK
     FLEELCRILN CSETVVEDRK QDLQGHLQKV KPQWFNRTTH WSFLSSLFFC CTVFSTVGYG
     YIYPVTRLGK YLCMLYALFG IPLMFLVLTD TGDILATILS TSYNRFRKFP FFTRPLLSKW
     CPKSLFKKKP DPKPADEAVP QIIISAEELP GPKLGTCPSR PSCSMELFER SHALEKQNTL
     QLPPQAMERS NSCPELVLGR LSYSIISNLD EVGQQVERLD IPLPIIALIV FAYISCAAAI
     LPFWETQLDF ENAFYFCFVT LTTIGFGDTV LEHPNFFLFF SIYIIVGMEI VFIAFKLVQN
     RLIDIYKNVM LFFAKGKFYH LVKK
//
ID   TM38B_DANRE             Reviewed;         289 AA.
AC   Q7ZVP8;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   07-JUN-2017, entry version 59.
DE   RecName: Full=Trimeric intracellular cation channel type B;
DE            Short=TRIC-B;
DE            Short=TRICB;
DE   AltName: Full=Transmembrane protein 38B;
GN   Name=tmem38b; ORFNames=zgc:55815;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=AB;
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Monovalent cation channel required for maintenance of
CC       rapid intracellular calcium release. May act as a potassium
CC       counter-ion channel that functions in synchronization with calcium
CC       release from intracellular stores. {ECO:0000250|UniProtKB:Q9DAV9}.
CC   -!- SUBUNIT: Homotrimer; trimerization probably requires binding to
CC       phosphatidylinositol 4,5-bisphosphate (PIP2).
CC       {ECO:0000250|UniProtKB:A5A6S6, ECO:0000250|UniProtKB:Q9NA73}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9DAV9}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9DAV9}.
CC   -!- SIMILARITY: Belongs to the TMEM38 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC045460; AAH45460.1; -; mRNA.
DR   RefSeq; NP_956470.1; NM_200176.1.
DR   UniGene; Dr.82370; -.
DR   SMR; Q7ZVP8; -.
DR   GeneID; 393145; -.
DR   KEGG; dre:393145; -.
DR   CTD; 55151; -.
DR   ZFIN; ZDB-GENE-040426-807; tmem38b.
DR   HOVERGEN; HBG059853; -.
DR   InParanoid; Q7ZVP8; -.
DR   PhylomeDB; Q7ZVP8; -.
DR   PRO; PR:Q7ZVP8; -.
DR   Proteomes; UP000000437; Unplaced.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IBA:GO_Central.
DR   InterPro; IPR007866; TRIC_channel.
DR   PANTHER; PTHR12454; PTHR12454; 1.
DR   Pfam; PF05197; TRIC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Endoplasmic reticulum; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    289       Trimeric intracellular cation channel
FT                                type B.
FT                                /FTId=PRO_0000291527.
FT   TOPO_DOM      1     18       Lumenal. {ECO:0000305}.
FT   TRANSMEM     19     36       Helical;Name=1. {ECO:0000255}.
FT   TOPO_DOM     37     49       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     50     73       Helical;Name=2. {ECO:0000255}.
FT   TOPO_DOM     74     85       Lumenal. {ECO:0000305}.
FT   TRANSMEM     86    103       Helical;Name=3. {ECO:0000255}.
FT   TOPO_DOM    104    107       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    108    125       Helical;Name=4. {ECO:0000255}.
FT   TOPO_DOM    126    144       Lumenal. {ECO:0000305}.
FT   TRANSMEM    145    162       Helical;Name=5. {ECO:0000255}.
FT   TOPO_DOM    163    183       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    184    201       Helical;Name=6. {ECO:0000255}.
FT   TOPO_DOM    202    210       Lumenal. {ECO:0000305}.
FT   TRANSMEM    211    230       Helical;Name=7. {ECO:0000255}.
FT   TOPO_DOM    231    289       Cytoplasmic. {ECO:0000305}.
FT   BINDING     122    122       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000250|UniProtKB:Q9NA73}.
FT   BINDING     126    126       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000250|UniProtKB:Q9NA73}.
SQ   SEQUENCE   289 AA;  32029 MW;  EA0CB9B8A1DE4BD8 CRC64;
     MDVFAFFNLN ELAFGLSKLP MFPYFDMAHY IISVMSLREQ PGALCVSQRS PLACWFSSML
     YCFGGAVLSA LMLADAPVAP LSNTTNLLLA TLMWYLVFYC PLDVVYSLAS LLPLRLVLTA
     MKEVTRTWKV LSGVSQAGSK YSDALFVMVA VGWAKGAGGG LISNFEQLVR GVWKPETNEL
     LKMSYPTKVT LLGAVVFSLQ QCRYLPIQTH HLTFIYTLFT VTNKTRMMLL GSSSHPLSSL
     ESFLYKTLFV RPLTDLSAEH THSKHNGSVP EPTTAQTHTK EAEASKKTN
//
ID   KCNG4_MOUSE             Reviewed;         506 AA.
AC   Q80XM3;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   22-NOV-2017, entry version 118.
DE   RecName: Full=Potassium voltage-gated channel subfamily G member 4;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv6.4;
GN   Name=Kcng4;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Preisig-Mueller R., Derst C., Schnitzler M.M., Daut J.;
RT   "Cloning and characterization of two novel gamma Kv subunits.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Can form functional heterotetrameric channels
CC       with KCNB1; modulates the delayed rectifier voltage-gated
CC       potassium channel activation and deactivation rates of KCNB1.
CC       {ECO:0000250|UniProtKB:Q8TDN1}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1.
CC       {ECO:0000250|UniProtKB:Q8TDN1}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q8TDN1}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q8TDN1}. Note=Has to be associated with
CC       KCNB1 or possibly another partner to get inserted in the plasma
CC       membrane. Colocalizes with KCNB1 at the plasma membrane. Remains
CC       intracellular in the absence of KCNB1.
CC       {ECO:0000250|UniProtKB:Q8TDN1}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. G (TC
CC       1.A.1.2) subfamily. Kv6.4/KCNG4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC043936; AAH43936.1; -; mRNA.
DR   EMBL; AF450109; AAP46290.1; -; mRNA.
DR   CCDS; CCDS22710.1; -.
DR   RefSeq; NP_080010.2; NM_025734.2.
DR   RefSeq; XP_006531352.1; XM_006531289.3.
DR   UniGene; Mm.358699; -.
DR   ProteinModelPortal; Q80XM3; -.
DR   STRING; 10090.ENSMUSP00000056552; -.
DR   iPTMnet; Q80XM3; -.
DR   PhosphoSitePlus; Q80XM3; -.
DR   PaxDb; Q80XM3; -.
DR   PRIDE; Q80XM3; -.
DR   Ensembl; ENSMUST00000061828; ENSMUSP00000056552; ENSMUSG00000045246.
DR   Ensembl; ENSMUST00000164382; ENSMUSP00000129687; ENSMUSG00000045246.
DR   GeneID; 66733; -.
DR   KEGG; mmu:66733; -.
DR   UCSC; uc009nqb.1; mouse.
DR   CTD; 93107; -.
DR   MGI; MGI:1913983; Kcng4.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231014; -.
DR   HOVERGEN; HBG100172; -.
DR   InParanoid; Q80XM3; -.
DR   KO; K04903; -.
DR   OMA; NKCQFFQ; -.
DR   OrthoDB; EOG091G05DD; -.
DR   PhylomeDB; Q80XM3; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-MMU-1296072; Voltage gated Potassium channels.
DR   PRO; PR:Q80XM3; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   Bgee; ENSMUSG00000045246; -.
DR   Genevisible; Q80XM3; MM.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:Ensembl.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; ISO:MGI.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    506       Potassium voltage-gated channel subfamily
FT                                G member 4.
FT                                /FTId=PRO_0000320142.
FT   TOPO_DOM      1    216       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    217    238       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    239    259       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    260    281       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    282    292       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    293    312       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    313    326       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    327    351       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    352    366       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    367    388       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    389    403       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    404    415       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    416    423       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    424    430       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    431    459       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    460    506       Cytoplasmic. {ECO:0000305}.
FT   MOTIF       416    421       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
SQ   SEQUENCE   506 AA;  57177 MW;  7CA48F0F71D58213 CRC64;
     MPMSSRDRDL HPGHHHFGSC SPLSQLWPGP EPKSVKGLYY SRARKVGNQD ASPEANLKEI
     LVNVGGQRYL LPWSTLDAFP LSRLSRLRLC RSHEEITQLC DDYDEDSQEF FFDRNPSAFG
     VIVSFLAAGK LVLLREMCAL SFREELSYWG IEETNLERCC LRKLLKKLEE AAELRREEAA
     QRQQQRQACH SEVQASRWAR SMNQLREMVE DPQSGLPGKV FACLSVLFVA TTAVSLCVST
     MPDFRAEEGK GECTRKCYYI FVVESICVAW FSLEFCLRFV QAPNKCQFFR GPLNVIDILA
     ISPYYVSLAV SDESPEAGER PSSSSYLEKV GLVLRVLRAL RILYVMRLAR HSLGLQTLGL
     TVRRCAREFG LLMLFLAVAV TLFSPLVYVA ENESGRVLEF TSIPASYWWA IISMTTVGYG
     DMVPRSVPGQ MVALSSILSG ILIMAFPATS IFHTFSHSYL ELKREQEQVQ ARLRRLQNTN
     SASERELLSD VDDLVPEGLT SPGRYM
//
ID   AKT6_ARATH              Reviewed;         888 AA.
AC   Q8GXE6; Q9SLA3;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   20-DEC-2017, entry version 122.
DE   RecName: Full=Potassium channel AKT6;
DE   AltName: Full=Potassium channel SPIK;
DE   AltName: Full=Shaker pollen inward rectifier K(+) channel;
GN   Name=AKT6; Synonyms=SPIK; OrderedLocusNames=At2g25600;
GN   ORFNames=F3N11.5;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], CHARACTERIZATION, TISSUE
RP   SPECIFICITY, AND FUNCTION.
RC   STRAIN=cv. Columbia;
RX   PubMed=11825875; DOI=10.1101/gad.213902;
RA   Mouline K., Very A.-A., Gaymard F., Boucherez J., Pilot G., Devic M.,
RA   Bouchez D., Thibaud J.-B., Sentenac H.;
RT   "Pollen tube development and competitive ability are impaired by
RT   disruption of a Shaker K(+) channel in Arabidopsis.";
RL   Genes Dev. 16:339-350(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617197; DOI=10.1038/45471;
RA   Lin X., Kaul S., Rounsley S.D., Shea T.P., Benito M.-I., Town C.D.,
RA   Fujii C.Y., Mason T.M., Bowman C.L., Barnstead M.E., Feldblyum T.V.,
RA   Buell C.R., Ketchum K.A., Lee J.J., Ronning C.M., Koo H.L.,
RA   Moffat K.S., Cronin L.A., Shen M., Pai G., Van Aken S., Umayam L.,
RA   Tallon L.J., Gill J.E., Adams M.D., Carrera A.J., Creasy T.H.,
RA   Goodman H.M., Somerville C.R., Copenhaver G.P., Preuss D.,
RA   Nierman W.C., White O., Eisen J.A., Salzberg S.L., Fraser C.M.,
RA   Venter J.C.;
RT   "Sequence and analysis of chromosome 2 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:761-768(1999).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 407-888.
RC   STRAIN=cv. Columbia;
RX   PubMed=11910074; DOI=10.1126/science.1071006;
RA   Seki M., Narusaka M., Kamiya A., Ishida J., Satou M., Sakurai T.,
RA   Nakajima M., Enju A., Akiyama K., Oono Y., Muramatsu M.,
RA   Hayashizaki Y., Kawai J., Carninci P., Itoh M., Ishii Y., Arakawa T.,
RA   Shibata K., Shinagawa A., Shinozaki K.;
RT   "Functional annotation of a full-length Arabidopsis cDNA collection.";
RL   Science 296:141-145(2002).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=10852932; DOI=10.1105/tpc.12.6.837;
RA   Lacombe B., Pilot G., Michard E., Gaymard F., Sentenac H.,
RA   Thibaud J.-B.;
RT   "A shaker-like K(+) channel with weak rectification is expressed in
RT   both source and sink phloem tissues of Arabidopsis.";
RL   Plant Cell 12:837-851(2000).
RN   [6]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
CC   -!- FUNCTION: Highly selective inward-rectifying potassium channel
CC       that could mediate potassium uptake in the pollen membrane. Plays
CC       an important role in pollen tube development. Assuming opened or
CC       closed conformations in response to the voltage difference across
CC       the membrane, the channel is activated by hyperpolarization. May
CC       interact with the cytoskeleton or with regulatory proteins.
CC       {ECO:0000269|PubMed:11825875}.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming subunits. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in flowers; especially
CC       in pollen. {ECO:0000269|PubMed:10852932,
CC       ECO:0000269|PubMed:11825875}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -!- CAUTION: Was originally erroneously termed AKT5.
CC       {ECO:0000305|PubMed:10852932}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ309323; CAC85283.1; -; Genomic_DNA.
DR   EMBL; AC006053; AAD31377.1; -; Genomic_DNA.
DR   EMBL; CP002685; AEC07722.1; -; Genomic_DNA.
DR   EMBL; AK118279; BAC42897.1; -; mRNA.
DR   PIR; D84650; D84650.
DR   RefSeq; NP_180131.3; NM_128118.5.
DR   UniGene; At.39001; -.
DR   ProteinModelPortal; Q8GXE6; -.
DR   SMR; Q8GXE6; -.
DR   BioGrid; 2451; 7.
DR   STRING; 3702.AT2G25600.1; -.
DR   TCDB; 1.A.1.4.8; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q8GXE6; -.
DR   PRIDE; Q8GXE6; -.
DR   EnsemblPlants; AT2G25600.1; AT2G25600.1; AT2G25600.
DR   GeneID; 817099; -.
DR   Gramene; AT2G25600.1; AT2G25600.1; AT2G25600.
DR   KEGG; ath:AT2G25600; -.
DR   Araport; AT2G25600; -.
DR   TAIR; locus:2050276; AT2G25600.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238230; -.
DR   InParanoid; Q8GXE6; -.
DR   KO; K21867; -.
DR   OMA; HFAGCIF; -.
DR   OrthoDB; EOG093601WX; -.
DR   PhylomeDB; Q8GXE6; -.
DR   PRO; PR:Q8GXE6; -.
DR   Proteomes; UP000006548; Chromosome 2.
DR   ExpressionAtlas; Q8GXE6; baseline and differential.
DR   Genevisible; Q8GXE6; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00204; ANK; 1.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.25.40.20; -; 2.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00248; ANK; 4.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    888       Potassium channel AKT6.
FT                                /FTId=PRO_0000054124.
FT   TOPO_DOM      1     84       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     85    105       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    106    113       Extracellular. {ECO:0000255}.
FT   TRANSMEM    114    134       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    135    155       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    156    176       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    177    184       Extracellular. {ECO:0000255}.
FT   TRANSMEM    185    205       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    206    219       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    220    240       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    241    267       Extracellular. {ECO:0000255}.
FT   INTRAMEM    268    287       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    288    291       Extracellular. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    313    888       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      543    572       ANK 1.
FT   REPEAT      576    605       ANK 2.
FT   REPEAT      609    638       ANK 3.
FT   REPEAT      640    669       ANK 4.
FT   REPEAT      673    702       ANK 5.
FT   DOMAIN      822    888       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     398    519       cNMP.
FT   COMPBIAS     15     24       Poly-Gly.
SQ   SEQUENCE   888 AA;  99215 MW;  60479CE59404505E CRC64;
     MEKKKVWFWG VKDDGEGGGG RGGGRTKDAE DDVADHLSRD GTMSQYSLSK GLLPSLGANN
     RSSRDVILPR FIVSPFDPRY RAWETFLVFL VLYTAWASPF EFGFLQKPRP PLSILDNIVN
     GFFAVDIVLT FFVAFLDKVT YLLVDDPKRI AWRYASTWLI FDVVSTFPYE IFGSLLHESI
     QGYGIFSMLR LWRLRRVSNC FARLEKDRKY SYFWVRCSKL LLVTLFVIHC GACFLYSIAA
     HYPDPSKTFM ALTDENWKES PIAVRYNTAM YWSITTFSTT GYGDIHGVNS REMTFILFYM
     VFNLGLSAYI IGNMTNLVVH VTGRTRKFRD TIQAASGFGQ RNNLPVRLQD QMVAHLCLRY
     RTDSEGLQQQ EIIDSLPKAI RSSISHYLFY EVVDKIYLFH GISNDLLFQL VTEMKAEYFP
     PKEDVILQNE APTDFYILVT GAVDIIARVN GVEQVVSEAQ RGHVFGEVGV LCYRPQLFTV
     RTKRLSQLLR LNRTVLLNLV QANVGDGAII MNNLLQHLKD SEDPVMKGVL ADTEHMLAQG
     KMDLPLSLCF AAARGDDLLL HQLLRRGSSP NEMDKDGRTA LHIAASKGSH YCVVLLLEHG
     ADPNIRDSEG NVPLWEAIIG RHREIAKLLA ENGAKLSLDS VSYFSGLAVE KNCLDALKDI
     IKYGGDVTLP DGNGTTALHR AVSEGHLEIV KFLLDQGADL DWPDSYGWTP RGLADHQGNE
     EIKTLFHNHR PVEKKPKPIP GIPQSPVTGK PLMKYSSEPT MHSGELVLDG GQVVVSQKRK
     LNNFRNSLFG IISAANSADD GGEVPRSPAV PGGGGSMIYP ERVTISSPEN GETGGKVVLL
     PNSMEELLKI GENKMGFVPT KVLTREGAEI DDITLIRDGD FLLLSRDP
//
ID   AKT3_ORYSJ              Reviewed;         907 AA.
AC   Q8H569; C7J4T3;
DT   28-JUN-2011, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   20-DEC-2017, entry version 81.
DE   RecName: Full=Potassium channel AKT3;
GN   OrderedLocusNames=Os07g0175400, LOC_Os07g07910;
GN   ORFNames=OJ1656_E11.135;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   "The rice annotation project database (RAP-DB): 2008 update.";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
CC   -!- FUNCTION: Probable inward-rectifying potassium channel. Assuming
CC       opened or closed conformations in response to the voltage
CC       difference across the membrane, the channel is activated by
CC       hyperpolarization (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAH93802.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP003843; BAC24865.1; -; Genomic_DNA.
DR   EMBL; AP008213; BAH93802.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AP014963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; Q8H569; -.
DR   SMR; Q8H569; -.
DR   STRING; 39947.LOC_Os07g07910.1; -.
DR   PaxDb; Q8H569; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238230; -.
DR   InParanoid; Q8H569; -.
DR   Proteomes; UP000059680; Chromosome 7.
DR   ExpressionAtlas; Q8H569; baseline and differential.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00204; ANK; 1.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.25.40.20; -; 2.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00248; ANK; 4.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   3: Inferred from homology;
KW   ANK repeat; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    907       Potassium channel AKT3.
FT                                /FTId=PRO_0000410876.
FT   TOPO_DOM      1     75       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     76     96       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     97    102       Extracellular. {ECO:0000255}.
FT   TRANSMEM    103    123       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    124    146       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    147    167       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    168    174       Extracellular. {ECO:0000255}.
FT   TRANSMEM    175    195       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    196    209       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    210    230       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    231    257       Extracellular. {ECO:0000255}.
FT   INTRAMEM    258    277       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    278    288       Extracellular. {ECO:0000255}.
FT   TRANSMEM    289    309       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    310    907       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      539    568       ANK 1.
FT   REPEAT      572    601       ANK 2.
FT   REPEAT      605    634       ANK 3.
FT   REPEAT      636    665       ANK 4.
FT   REPEAT      670    699       ANK 5.
FT   DOMAIN      827    907       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     388    512       cNMP.
SQ   SEQUENCE   907 AA;  99462 MW;  A0D9BAB721BD6E6E CRC64;
     MPTTKCAVPL VSGAAGGGGS AELTRQLSST QASPRFSFSS GVLPSLGSRG GGERHARLRR
     FIVSPYDRRY ELWNNYLILL VVYSAWVTPF EFGFVPEPAG ALAAADNAVN AFFAVDIVLT
     FFVAYTDPKT FLLQDDPRKI ALRYITTWFV LDVVATIPTE LARRILPPDL RSYGFFGILR
     LWRLHRVGIL FARLEKDRKF SYFWVRCVKL VCVTLFAVHC SACFYYLLAD RYPDPTNTWI
     SAYMPNFHKA SIWSRYVASM YWSITTLSTV GYGDMHAENT GEMVFTTTYM LFNLGLTAYI
     IGNMTNLVVH GTSRTRKFRD MIQAATSFAQ RHQLPARLQE QMVSHLSLKF RTNSEGLHQQ
     ETFEALPKAI KSSISHHLFF GLVQNVYLFE GVSNDLIFQL VSEMNAEYFA PREDIILQNE
     APADFYIIVS GSMELIELHN GIEQASVLTL AGMAKSGDVV GEIGVLCYRP QLFTARTRSL
     CQLLRLDRAA FLRIIQSNIA DGTIVMNNLI QYLREKKEIA SIVAVAKEID DMLARGQMDF
     PITLCFAASK GDSFLLHQLL KRGLDPNESD HYGRTALHIA ASNGNEQCVR LLLENGADSN
     SRDPEGRVPL WEALCRRHQT VVQLLVDAGA DLSGGDAAPY ARVAVEQNDA ALLGEIVRHG
     GDVSGACSGD GTTALHRAVL DGNVQMARLL LEHGADADAE DVNGLTPRAV AEQGGHADMQ
     LAFASATRHE PRKARPPPPA SAIVPVPLRD GVDSSPSSSS RRGRTSSTSA ASARSTPQRM
     ANFRNSLFGV ISSSHAFHHE GGYRGGGGGG GAAAERERSS SSPPLVRVAI SCPESRGGKD
     HSSKLVFMPE TLRGLLELGA ARFGVSPTRV VTSGGADVDD ARLVRDGDHL LLVTDKWVPP
     ENRSRNQ
//
ID   KCNSK_CAEEL             Reviewed;         536 AA.
AC   Q8I4B0; E3W725; Q09658; Q14V33; Q6BEV2; Q8I4A9; Q8I4B1;
DT   09-JAN-2013, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   22-NOV-2017, entry version 120.
DE   RecName: Full=Potassium voltage-gated channel protein shk-1;
GN   Name=shk-1 {ECO:0000312|EMBL:CAA88477.2}; ORFNames=ZK1321.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAA88477.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE
RP   SPLICING.
RC   STRAIN=Bristol N2 {ECO:0000312|EMBL:CAA88477.2};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305}
RP   ALTERNATIVE SPLICING, FUNCTION, AND TISSUE SPECIFICITY (ISOFORMS A; C
RP   AND D).
RX   PubMed=16899454; DOI=10.1074/jbc.M605814200;
RA   Fawcett G.L., Santi C.M., Butler A., Harris T., Covarrubias M.,
RA   Salkoff L.;
RT   "Mutant analysis of the Shal (Kv4) voltage-gated fast transient K+
RT   channel in Caenorhabditis elegans.";
RL   J. Biol. Chem. 281:30725-30735(2006).
RN   [3] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=21059759; DOI=10.1113/jphysiol.2010.200683;
RA   Liu P., Ge Q., Chen B., Salkoff L., Kotlikoff M.I., Wang Z.W.;
RT   "Genetic dissection of ion currents underlying all-or-none action
RT   potentials in C. elegans body-wall muscle cells.";
RL   J. Physiol. (Lond.) 589:101-117(2011).
CC   -!- FUNCTION: Mediates the voltage-dependent potassium ion
CC       permeability of excitable membranes. Has an important role in
CC       repolarization and in regulating the pattern of action potential
CC       firing. Isoform a expresses currents in a more depolarized voltage
CC       range than isoform d. {ECO:0000269|PubMed:16899454,
CC       ECO:0000269|PubMed:21059759}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P08510};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P08510}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=c {ECO:0000269|PubMed:9851916};
CC         IsoId=Q8I4B0-1; Sequence=Displayed;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=b {ECO:0000269|PubMed:9851916};
CC         IsoId=Q8I4B0-2; Sequence=VSP_044575;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=d {ECO:0000269|PubMed:9851916};
CC         IsoId=Q8I4B0-3; Sequence=VSP_044572;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=a {ECO:0000269|PubMed:9851916};
CC         IsoId=Q8I4B0-4; Sequence=VSP_044573, VSP_044575;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=e {ECO:0000269|PubMed:9851916};
CC         IsoId=Q8I4B0-5; Sequence=VSP_044571, VSP_044575;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=f {ECO:0000269|PubMed:9851916};
CC         IsoId=Q8I4B0-6; Sequence=VSP_044570, VSP_044575;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=g {ECO:0000269|PubMed:9851916};
CC         IsoId=Q8I4B0-7; Sequence=VSP_044574;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Expressed in a variety of interneurons and
CC       sensory neurons, as well as body wall muscle.
CC       {ECO:0000269|PubMed:16899454, ECO:0000269|PubMed:21059759}.
CC   -!- DISRUPTION PHENOTYPE: Delayed spike repolarization.
CC       {ECO:0000269|PubMed:21059759}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Shaker sub-subfamily. {ECO:0000255}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z48584; CAA88477.2; -; Genomic_DNA.
DR   EMBL; Z48584; CAD57715.1; -; Genomic_DNA.
DR   EMBL; Z48584; CAD57716.1; -; Genomic_DNA.
DR   EMBL; Z48584; CAD57717.1; -; Genomic_DNA.
DR   EMBL; Z48584; CAH04712.1; -; Genomic_DNA.
DR   EMBL; Z48584; CAK55179.1; -; Genomic_DNA.
DR   EMBL; Z48584; CBX53352.1; -; Genomic_DNA.
DR   RefSeq; NP_001022516.1; NM_001027345.2. [Q8I4B0-5]
DR   RefSeq; NP_001040829.1; NM_001047364.2. [Q8I4B0-6]
DR   RefSeq; NP_001254226.1; NM_001267297.1. [Q8I4B0-7]
DR   RefSeq; NP_496104.2; NM_063703.4. [Q8I4B0-4]
DR   RefSeq; NP_871934.1; NM_182134.3. [Q8I4B0-2]
DR   RefSeq; NP_871935.1; NM_182135.4. [Q8I4B0-1]
DR   RefSeq; NP_871936.1; NM_182136.4. [Q8I4B0-3]
DR   UniGene; Cel.7785; -.
DR   ProteinModelPortal; Q8I4B0; -.
DR   STRING; 6239.ZK1321.2c; -.
DR   TCDB; 1.A.1.2.20; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q8I4B0; -.
DR   PeptideAtlas; Q8I4B0; -.
DR   EnsemblMetazoa; ZK1321.2c; ZK1321.2c; WBGene00014261. [Q8I4B0-1]
DR   GeneID; 174536; -.
DR   KEGG; cel:CELE_ZK1321.2; -.
DR   UCSC; ZK1321.2a; c. elegans.
DR   CTD; 174536; -.
DR   WormBase; ZK1321.2a; CE32769; WBGene00014261; shk-1. [Q8I4B0-4]
DR   WormBase; ZK1321.2b; CE32770; WBGene00014261; shk-1. [Q8I4B0-2]
DR   WormBase; ZK1321.2c; CE32771; WBGene00014261; shk-1. [Q8I4B0-1]
DR   WormBase; ZK1321.2d; CE32772; WBGene00014261; shk-1. [Q8I4B0-3]
DR   WormBase; ZK1321.2e; CE36966; WBGene00014261; shk-1. [Q8I4B0-5]
DR   WormBase; ZK1321.2f; CE40295; WBGene00014261; shk-1. [Q8I4B0-6]
DR   WormBase; ZK1321.2g; CE45447; WBGene00014261; shk-1. [Q8I4B0-7]
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   InParanoid; Q8I4B0; -.
DR   KO; K04874; -.
DR   OMA; AHYRQAN; -.
DR   OrthoDB; EOG091G10NU; -.
DR   PhylomeDB; Q8I4B0; -.
DR   PRO; PR:Q8I4B0; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00014261; -.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:WormBase.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:WormBase.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:WormBase.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    536       Potassium voltage-gated channel protein
FT                                shk-1.
FT                                /FTId=PRO_0000420623.
FT   TOPO_DOM      1    275       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    276    296       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    297    322       Extracellular. {ECO:0000255}.
FT   TRANSMEM    323    343       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    344    356       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    357    377       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    378    425       Extracellular. {ECO:0000255}.
FT   TRANSMEM    426    446       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    447    458       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    459    479       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    480    486       Extracellular. {ECO:0000255}.
FT   TRANSMEM    487    507       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    508    536       Cytoplasmic. {ECO:0000255}.
FT   VAR_SEQ       1     89       Missing (in isoform f).
FT                                {ECO:0000303|PubMed:9851916}.
FT                                /FTId=VSP_044570.
FT   VAR_SEQ       1     85       MRFGGQRRCIESSDDNDSIDSMSIQQKNKEKEEWKWAQSLA
FT                                RRLEQVLNVHPEKYQNGCSSQRPSRQPSPVEQLAPIRSHSA
FT                                DFG -> MWRFNRIKS (in isoform e).
FT                                {ECO:0000303|PubMed:9851916}.
FT                                /FTId=VSP_044571.
FT   VAR_SEQ       1     41       MRFGGQRRCIESSDDNDSIDSMSIQQKNKEKEEWKWAQSLA
FT                                -> MIDSLI (in isoform d).
FT                                {ECO:0000303|PubMed:9851916}.
FT                                /FTId=VSP_044572.
FT   VAR_SEQ      42     85       RRLEQVLNVHPEKYQNGCSSQRPSRQPSPVEQLAPIRSHSA
FT                                DFG -> S (in isoform a).
FT                                {ECO:0000303|PubMed:9851916}.
FT                                /FTId=VSP_044573.
FT   VAR_SEQ     126    536       Missing (in isoform g).
FT                                {ECO:0000303|PubMed:9851916}.
FT                                /FTId=VSP_044574.
FT   VAR_SEQ     185    196       Missing (in isoform b, isoform a, isoform
FT                                e and isoform f).
FT                                {ECO:0000303|PubMed:9851916}.
FT                                /FTId=VSP_044575.
SQ   SEQUENCE   536 AA;  61234 MW;  9662A84009CF0632 CRC64;
     MRFGGQRRCI ESSDDNDSID SMSIQQKNKE KEEWKWAQSL ARRLEQVLNV HPEKYQNGCS
     SQRPSRQPSP VEQLAPIRSH SADFGRAAEM ASGNSEEGKG MLLRNGDDRI RLPSPQRGTP
     DTSSTQGHPY TDQIVTINVS GMRFQTFEST LSRYPNSLLG DRNKRQHFFV SDTNEFFFDR
     HRTTSSSFTF EIRNYLFESI LYIYQSGGRV KRPEIVPIDI FLKEMRFFQM GDDLLEEFWI
     AEGYEKPKEV MMPNNKTQRK IWELMEYPDS SLSARIIAFI SIAVIALSII SFCWETVPSD
     IEEKPINNSA TAELLDEMDE KHYSPFFWIE LMCILWFTIE LILRFISCPC KVTFATSVLN
     IIDFVAIAPF FVNFFFADTS KSNSSMSFAV LRVLRLVRVF RVFKLSRHSV GLQILGKTFR
     SSVQEFCLLI FFMAIALVLF ASGMYFAEQG EPNSKFTSIP ASFWFVLVTM TTVGYGDLVP
     LSPFGKVVGG MCAMIGVLTL ALPVPIIVAN FKHFYRQENR LASMKSKGDD ADDDIA
//
ID   KCO1_ARATH              Reviewed;         363 AA.
AC   Q8LBL1; O04718; Q0WNY4; Q9FM75;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2003, sequence version 2.
DT   27-SEP-2017, entry version 133.
DE   RecName: Full=Two-pore potassium channel 1;
DE            Short=AtTPK1;
DE   AltName: Full=Calcium-activated outward-rectifying potassium channel 1;
DE            Short=AtKCO1;
GN   Name=TPK1; Synonyms=KCO1; OrderedLocusNames=At5g55630;
GN   ORFNames=MDF20.7;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND CHARACTERIZATION.
RC   STRAIN=cv. C24;
RX   PubMed=9184204; DOI=10.1093/emboj/16.10.2565;
RA   Czempinski K., Zimmermann S., Ehrhardt T., Mueller-Roeber B.;
RT   "New structure and function in plant K+ channels: KCO1, an outward
RT   rectifier with a steep Ca2+ dependency.";
RL   EMBO J. 16:2565-2575(1997).
RN   [2]
RP   ERRATUM.
RA   Czempinski K., Zimmermann S., Ehrhardt T., Mueller-Roeber B.;
RL   EMBO J. 16:6896-6896(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=cv. C24;
RX   PubMed=12148538; DOI=10.1046/j.1365-313X.2002.01260.x;
RA   Czempinski K., Frachisse J.-M., Maurel C., Barbier-Brygoo H.,
RA   Mueller-Roeber B.;
RT   "Vacuolar membrane localization of the Arabidopsis 'two-pore' K+
RT   channel KCO1.";
RL   Plant J. 29:809-820(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=9628582; DOI=10.1093/dnares/5.1.41;
RA   Sato S., Kaneko T., Kotani H., Nakamura Y., Asamizu E., Miyajima N.,
RA   Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 5. IV.
RT   Sequence features of the regions of 1,456,315 bp covered by nineteen
RT   physically assigned P1 and TAC clones.";
RL   DNA Res. 5:41-54(1998).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RA   Totoki Y., Seki M., Ishida J., Nakajima M., Enju A., Kamiya A.,
RA   Narusaka M., Shin-i T., Nakagawa M., Sakamoto N., Oishi K., Kohara Y.,
RA   Kobayashi M., Toyoda A., Sakaki Y., Sakurai T., Iida K., Akiyama K.,
RA   Satou M., Toyoda T., Konagaya A., Carninci P., Kawai J.,
RA   Hayashizaki Y., Shinozaki K.;
RT   "Large-scale analysis of RIKEN Arabidopsis full-length (RAFL) cDNAs.";
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Brover V.V., Troukhan M.E., Alexandrov N.A., Lu Y.-P., Flavell R.B.,
RA   Feldmann K.A.;
RT   "Full-length cDNA from Arabidopsis thaliana.";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [9]
RP   CHARACTERIZATION, AND NULL MUTANT KCO1-7.
RX   PubMed=11821043; DOI=10.1016/S0014-5793(01)03273-2;
RA   Schoenknecht G., Spoormaker P., Steinmeyer R., Brueggeman L., Ache P.,
RA   Dutta R., Reintanz B., Godde M., Hedrich R., Palme K.;
RT   "KCO1 is a component of the slow-vacuolar (SV) ion channel.";
RL   FEBS Lett. 511:28-32(2002).
RN   [10]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=15505206; DOI=10.1073/pnas.0401502101;
RA   Becker D., Geiger D., Dunkel M., Roller A., Bertl A., Latz A.,
RA   Carpaneto A., Dietrich P., Roelfsema M.R., Voelker C., Schmidt D.,
RA   Mueller-Roeber B., Czempinski K., Hedrich R.;
RT   "AtTPK4, an Arabidopsis tandem-pore K+ channel, poised to control the
RT   pollen membrane voltage in a pH- and Ca2+-dependent manner.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15621-15626(2004).
RN   [11]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=16113216; DOI=10.1104/pp.105.065599;
RA   Bihler H., Eing C., Hebeisen S., Roller A., Czempinski K., Bertl A.;
RT   "TPK1 is a vacuolar ion channel different from the slow-vacuolar
RT   cation channel.";
RL   Plant Physiol. 139:417-424(2005).
RN   [12]
RP   TISSUE SPECIFICITY, AND SUBUNIT.
RX   PubMed=16984403; DOI=10.1111/j.1365-313X.2006.02868.x;
RA   Voelker C., Schmidt D., Mueller-Roeber B., Czempinski K.;
RT   "Members of the Arabidopsis AtTPK/KCO family form homomeric vacuolar
RT   channels in planta.";
RL   Plant J. 48:296-306(2006).
RN   [13]
RP   FUNCTION, INTERACTION WITH GRF1 AND GRF6, MUTAGENESIS OF SER-42,
RP   PHOSPHORYLATION, AND 3D-STRUCTURE MODELING.
RX   PubMed=17764516; DOI=10.1111/j.1365-313X.2007.03255.x;
RA   Latz A., Becker D., Hekman M., Mueller T., Beyhl D., Marten I.,
RA   Eing C., Fischer A., Dunkel M., Bertl A., Rapp U.R., Hedrich R.;
RT   "TPK1, a Ca(2+)-regulated Arabidopsis vacuole two-pore K(+) channel is
RT   activated by 14-3-3 proteins.";
RL   Plant J. 52:449-459(2007).
RN   [14]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND ENZYME REGULATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=17563365; DOI=10.1073/pnas.0702595104;
RA   Gobert A., Isayenkov S., Voelker C., Czempinski K., Maathuis F.J.;
RT   "The two-pore channel TPK1 gene encodes the vacuolar K+ conductance
RT   and plays a role in K+ homeostasis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:10726-10731(2007).
RN   [15]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF 296-ASP--GLU-298 AND
RP   301-ASP--ASP-303.
RX   PubMed=19825594; DOI=10.1093/mp/ssn064;
RA   Dunkel M., Latz A., Schumacher K., Mueller T., Becker D., Hedrich R.;
RT   "Targeting of vacuolar membrane localized members of the TPK channel
RT   family.";
RL   Mol. Plant 1:938-949(2008).
RN   [16]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND GLYCOSYLATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=21697507; DOI=10.1104/pp.111.177816;
RA   Maitrejean M., Wudick M.M., Voelker C., Prinsi B., Mueller-Roeber B.,
RA   Czempinski K., Pedrazzini E., Vitale A.;
RT   "Assembly and sorting of the tonoplast potassium channel AtTPK1 and
RT   its turnover by internalization into the vacuole.";
RL   Plant Physiol. 156:1783-1796(2011).
CC   -!- FUNCTION: Voltage-independent, large conductance and potassium-
CC       selective tonoplast ion channel. Regulated by cytoplasmic calcium
CC       and pH. Does not mediate slow-vacuolar (SV) ionic currents, but
CC       essential to establish VK currents. Has some permeability for
CC       Rb(+) and NH(4)(+), but none for Na(+), Cs(+) or Li(+). Involved
CC       in intracellular K(+) redistribution and/or K(+) retranslocation
CC       between different tissues. {ECO:0000269|PubMed:16113216,
CC       ECO:0000269|PubMed:17563365, ECO:0000269|PubMed:17764516,
CC       ECO:0000269|PubMed:21697507}.
CC   -!- ENZYME REGULATION: Could be activated by protein kinase C (By
CC       similarity). Strongly induced by calcium. Blocked by barium,
CC       tetraethylammonium (TEA), quinine and quinidine. {ECO:0000250,
CC       ECO:0000269|PubMed:16113216, ECO:0000269|PubMed:17563365}.
CC   -!- SUBUNIT: Homodimer. Interacts with GRF1 and GRF6, but only GRF6
CC       modulates the channel activity. {ECO:0000269|PubMed:16984403,
CC       ECO:0000269|PubMed:17764516, ECO:0000269|PubMed:21697507}.
CC   -!- SUBCELLULAR LOCATION: Vacuole membrane
CC       {ECO:0000269|PubMed:12148538, ECO:0000269|PubMed:19825594,
CC       ECO:0000269|PubMed:21697507}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12148538, ECO:0000269|PubMed:19825594,
CC       ECO:0000269|PubMed:21697507}. Note=Tonoplast.
CC   -!- TISSUE SPECIFICITY: Detected in mesophyll cells, guard cells and
CC       vascular tissues of the leaves. Expressed in the hilum, where the
CC       funiculus is attached during fruit maturation and in the embryo.
CC       Also expressed at a lower level in seedlings, root tips and
CC       elongation zones, and flowers. Could be detected in mitotically
CC       active tissues. {ECO:0000269|PubMed:12148538,
CC       ECO:0000269|PubMed:16984403}.
CC   -!- DOMAIN: Each of the two pore-forming region (also called P-domain
CC       or P-loop) is enclosed by two transmembrane segments (2P/4TM) and
CC       contains the GYGD signature motif which seems to be involved in
CC       potassium selectivity. The C-terminus (328-363) is required for
CC       vacuolar targeting.
CC   -!- PTM: Phosphorylation at Ser-42 increases and stabilizes the
CC       interaction with 14-3-3 proteins. {ECO:0000269|PubMed:17764516}.
CC   -!- DISRUPTION PHENOTYPE: Reduced growth in both high and low K(+)
CC       conditions. Slower germination and increased sensitivity to
CC       abscisic acid. Reduction of the total tonoplast current density.
CC       {ECO:0000269|PubMed:17563365}.
CC   -!- MISCELLANEOUS: 14-3-3 protein binding is not involved in
CC       endoplasmic reticulum export and tonoplast targeting.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.7) family. {ECO:0000305}.
CC   -!- CAUTION: Was initially described as an outward slow-vacuolar (SV)
CC       ion channel (PubMed:9184204 and PubMed:11821043). {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X97323; CAA65988.1; -; mRNA.
DR   EMBL; Y07825; CAA69158.1; -; Genomic_DNA.
DR   EMBL; AB009050; BAB09230.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED96660.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED96661.1; -; Genomic_DNA.
DR   EMBL; AK229302; BAF01165.1; -; mRNA.
DR   EMBL; AY087147; AAM64705.1; -; mRNA.
DR   RefSeq; NP_200374.1; NM_124945.4.
DR   RefSeq; NP_851196.1; NM_180865.1.
DR   UniGene; At.20254; -.
DR   ProteinModelPortal; Q8LBL1; -.
DR   SMR; Q8LBL1; -.
DR   BioGrid; 20901; 27.
DR   STRING; 3702.AT5G55630.1; -.
DR   TCDB; 1.A.1.7.3; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q8LBL1; -.
DR   PaxDb; Q8LBL1; -.
DR   EnsemblPlants; AT5G55630.1; AT5G55630.1; AT5G55630.
DR   EnsemblPlants; AT5G55630.2; AT5G55630.2; AT5G55630.
DR   GeneID; 835657; -.
DR   Gramene; AT5G55630.1; AT5G55630.1; AT5G55630.
DR   Gramene; AT5G55630.2; AT5G55630.2; AT5G55630.
DR   KEGG; ath:AT5G55630; -.
DR   Araport; AT5G55630; -.
DR   TAIR; locus:2162162; AT5G55630.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000238193; -.
DR   InParanoid; Q8LBL1; -.
DR   KO; K05389; -.
DR   OMA; HPSKIPM; -.
DR   OrthoDB; EOG09360EZI; -.
DR   PhylomeDB; Q8LBL1; -.
DR   BioCyc; ARA:AT5G55630-MONOMER; -.
DR   BioCyc; MetaCyc:MONOMER-14554; -.
DR   PRO; PR:Q8LBL1; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; Q8LBL1; baseline and differential.
DR   Genevisible; Q8LBL1; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0009705; C:plant-type vacuole membrane; IBA:GO_Central.
DR   GO; GO:0005774; C:vacuolar membrane; IDA:TAIR.
DR   GO; GO:0005216; F:ion channel activity; IDA:TAIR.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0030007; P:cellular potassium ion homeostasis; IMP:TAIR.
DR   GO; GO:0051260; P:protein homooligomerization; IPI:TAIR.
DR   GO; GO:0010029; P:regulation of seed germination; IMP:TAIR.
DR   GO; GO:0010119; P:regulation of stomatal movement; IMP:TAIR.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Vacuole.
FT   CHAIN         1    363       Two-pore potassium channel 1.
FT                                /FTId=PRO_0000101775.
FT   TOPO_DOM      1     78       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     79     99       Helical. {ECO:0000255}.
FT   INTRAMEM    111    130       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    137    157       Helical. {ECO:0000255}.
FT   TOPO_DOM    158    197       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    198    218       Helical. {ECO:0000255}.
FT   INTRAMEM    225    244       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    251    271       Helical. {ECO:0000255}.
FT   TOPO_DOM    272    363       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      288    323       EF-hand 1.
FT   DOMAIN      327    362       EF-hand 2.
FT   CA_BIND     301    312       1. {ECO:0000255}.
FT   CA_BIND     340    351       2. {ECO:0000255}.
FT   MOTIF       296    298       Endoplasmic reticulum release signal.
FT   COMPBIAS     33     39       Arg/Lys-rich (basic).
FT   SITE        131    131       Not glycosylated.
FT   MUTAGEN      42     42       S->A: Loss of interaction with GRF6, but
FT                                no effect on vacuolar targeting.
FT                                {ECO:0000269|PubMed:17764516}.
FT   MUTAGEN     296    298       DLE->GLG: Retention in the endoplasmic
FT                                reticulum. {ECO:0000269|PubMed:19825594}.
FT   MUTAGEN     301    303       DLD->GLG: No effect on vacuolar
FT                                targeting. {ECO:0000269|PubMed:19825594}.
FT   CONFLICT    227    227       F -> V (in Ref. 7; AAM64705).
FT                                {ECO:0000305}.
FT   CONFLICT    261    261       S -> T (in Ref. 1; CAA65988 and 3;
FT                                CAA69158). {ECO:0000305}.
SQ   SEQUENCE   363 AA;  40727 MW;  149B00AABBE40EFC CRC64;
     MSSDAARTPL LPTEKIDTMA QDFNLNSRTS SSRKRRLRRS RSAPRGDCMY NDDVKIDEPP
     PHPSKIPMFS DLNPNLRRVI MFLALYLTIG TLCFYLVRDQ ISGHKTSGVV DALYFCIVTM
     TTVGYGDLVP NSSASRLLAC AFVFSGMVLV GHLLSRAADY LVEKQEALLV RAFHLRQSFG
     PTDILKELHT NKLRYKCYAT CLVLVVLFIV GTIFLVMVEK MPVISAFYCV CSTVTTLGYG
     DKSFNSEAGR LFAVFWILTS SICLAQFFLY VAELNTENKQ RALVKWVLTR RITNNDLEAA
     DLDEDGVVGA AEFIVYKLKE MGKIDEKDIS GIMDEFEQLD YDESGTLTTS DIVLAQTTSQ
     IQR
//
ID   KCO2_ORYSJ              Reviewed;         349 AA.
AC   Q8LIN5; A0A0P0X1G6;
DT   28-JUN-2011, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   20-DEC-2017, entry version 127.
DE   RecName: Full=Two pore potassium channel b;
DE            Short=Two K(+) channel b;
DE   AltName: Full=Calcium-activated outward-rectifying potassium channel 2;
DE            Short=OsKCO2;
GN   Name=TPKB; Synonyms=KCO2;
GN   OrderedLocusNames=Os07g0108800, LOC_Os07g01810;
GN   ORFNames=OJ1567_G09.108, OsJ_22819, P0585H11.123;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   "The rice annotation project database (RAP-DB): 2008 update.";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=15685292; DOI=10.1371/journal.pbio.0030038;
RA   Yu J., Wang J., Lin W., Li S., Li H., Zhou J., Ni P., Dong W., Hu S.,
RA   Zeng C., Zhang J., Zhang Y., Li R., Xu Z., Li S., Li X., Zheng H.,
RA   Cong L., Lin L., Yin J., Geng J., Li G., Shi J., Liu J., Lv H., Li J.,
RA   Wang J., Deng Y., Ran L., Shi X., Wang X., Wu Q., Li C., Ren X.,
RA   Wang J., Wang X., Li D., Liu D., Zhang X., Ji Z., Zhao W., Sun Y.,
RA   Zhang Z., Bao J., Han Y., Dong L., Ji J., Chen P., Wu S., Liu J.,
RA   Xiao Y., Bu D., Tan J., Yang L., Ye C., Zhang J., Xu J., Zhou Y.,
RA   Yu Y., Zhang B., Zhuang S., Wei H., Liu B., Lei M., Yu H., Li Y.,
RA   Xu H., Wei S., He X., Fang L., Zhang Z., Zhang Y., Huang X., Su Z.,
RA   Tong W., Li J., Tong Z., Li S., Ye J., Wang L., Fang L., Lei T.,
RA   Chen C.-S., Chen H.-C., Xu Z., Li H., Huang H., Zhang F., Xu H.,
RA   Li N., Zhao C., Li S., Dong L., Huang Y., Li L., Xi Y., Qi Q., Li W.,
RA   Zhang B., Hu W., Zhang Y., Tian X., Jiao Y., Liang X., Jin J., Gao L.,
RA   Zheng W., Hao B., Liu S.-M., Wang W., Yuan L., Cao M., McDermott J.,
RA   Samudrala R., Wang J., Wong G.K.-S., Yang H.;
RT   "The genomes of Oryza sativa: a history of duplications.";
RL   PLoS Biol. 3:266-281(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12869764; DOI=10.1126/science.1081288;
RG   The rice full-length cDNA consortium;
RT   "Collection, mapping, and annotation of over 28,000 cDNA clones from
RT   japonica rice.";
RL   Science 301:376-379(2003).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-295.
RX   PubMed=21224427; DOI=10.1105/tpc.110.081463;
RA   Isayenkov S., Isner J.C., Maathuis F.J.;
RT   "Rice two-pore K+ channels are expressed in different types of
RT   vacuoles.";
RL   Plant Cell 23:756-768(2011).
CC   -!- FUNCTION: Highly selective inward-rectifying potassium channel
CC       that is specifically located in the tonoplast of protein storage
CC       vacuoles. Functions independently of the voltage difference across
CC       the membrane. {ECO:0000269|PubMed:21224427}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Vacuole membrane
CC       {ECO:0000269|PubMed:21224427}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:21224427}. Note=Tonoplast of protein storage
CC       vacuoles.
CC   -!- DOMAIN: Each of the two pore-forming region (also called P-domain
CC       or P-loop) is enclosed by two transmembrane segments (2P/4TM) and
CC       contains the GYGD signature motif which seems to be involved in
CC       potassium selectivity.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.7) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP003759; BAC06932.1; -; Genomic_DNA.
DR   EMBL; AP004342; BAD30634.1; -; Genomic_DNA.
DR   EMBL; AP008213; BAF20633.1; -; Genomic_DNA.
DR   EMBL; AP014963; BAS99736.1; -; Genomic_DNA.
DR   EMBL; CM000144; EAZ38441.1; -; Genomic_DNA.
DR   EMBL; AK109604; BAG98817.1; -; mRNA.
DR   UniGene; Os.29959; -.
DR   ProteinModelPortal; Q8LIN5; -.
DR   SMR; Q8LIN5; -.
DR   STRING; 39947.LOC_Os07g01810.1; -.
DR   PaxDb; Q8LIN5; -.
DR   PRIDE; Q8LIN5; -.
DR   EnsemblPlants; OS07T0108800-01; OS07T0108800-01; OS07G0108800.
DR   Gramene; OS07T0108800-01; OS07T0108800-01; OS07G0108800.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   InParanoid; Q8LIN5; -.
DR   OMA; NTKSRTT; -.
DR   OrthoDB; EOG09360EZI; -.
DR   Proteomes; UP000059680; Chromosome 7.
DR   ExpressionAtlas; Q8LIN5; baseline and differential.
DR   Genevisible; Q8LIN5; OS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0009705; C:plant-type vacuole membrane; IDA:UniProtKB.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0030007; P:cellular potassium ion homeostasis; IC:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR031144; TPK_plant.
DR   PANTHER; PTHR11003:SF137; PTHR11003:SF137; 1.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Vacuole.
FT   CHAIN         1    349       Two pore potassium channel b.
FT                                /FTId=PRO_0000410873.
FT   TOPO_DOM      1     66       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     67     87       Helical. {ECO:0000255}.
FT   INTRAMEM    100    119       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    123    143       Helical. {ECO:0000255}.
FT   TOPO_DOM    144    180       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    181    201       Helical. {ECO:0000255}.
FT   INTRAMEM    208    227       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    234    254       Helical. {ECO:0000255}.
FT   TOPO_DOM    255    349       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      271    306       EF-hand 1.
FT   DOMAIN      310    345       EF-hand 2.
FT   CA_BIND     284    295       {ECO:0000255}.
FT   CA_BIND     323    334       {ECO:0000255}.
FT   MUTAGEN     295    295       D->E: No effect on targeting to protein
FT                                storage vacuole.
FT                                {ECO:0000269|PubMed:21224427}.
SQ   SEQUENCE   349 AA;  37914 MW;  1B0BC09D2F17A357 CRC64;
     MAALDQQPLL HDGGDQKPPP EGAARRFRRC RTAPSSEPPP TDKDNSSAAD APPKTLFTGG
     GRPSFRLVGL LLVAYLLLGT IAFYLAMDHM SGTRTTRALD ALYFCVVTMT TVGYGDLVPA
     SDAAKLLACA FVFAGVAVVG TFLSKAADYL VEKQEALLFR ALHSHTMVRA MEMNKVRYKL
     YTAGLLLVAA VASGTVVLWK VEGMRAVDAF YCVCATVTTL GYGDRSFSSE GGRAFAVAWI
     TVSTVVVALF FLYAAELYTE RRQRELARWV LRRRTTNMDL EAADLDGDHR VGAADFVLYK
     LKELGKISQE DISEFLDEFD NLDADHSGTL SPADLAAAQP TPDPPPSLR
//
ID   KCNG3_HUMAN             Reviewed;         436 AA.
AC   Q8TAE7; Q53SC1;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   22-NOV-2017, entry version 137.
DE   RecName: Full=Potassium voltage-gated channel subfamily G member 3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv10.1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv6.3;
GN   Name=KCNG3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBUNIT, INTERACTION
RP   WITH KCNB1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11852086; DOI=10.1016/S0014-5793(02)02267-6;
RA   Sano Y., Mochizuki S., Miyake A., Kitada C., Inamura K., Yokoi H.,
RA   Nozawa K., Matsushime H., Furuichi K.;
RT   "Molecular cloning and characterization of Kv6.3, a novel modulatory
RT   subunit for voltage-gated K(+) channel Kv2.1.";
RL   FEBS Lett. 512:230-234(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBUNIT, INTERACTION
RP   WITH KCNB1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12060745; DOI=10.1073/pnas.122617999;
RA   Ottschytsch N., Raes A., Van Hoorick D., Snyders D.J.;
RT   "Obligatory heterotetramerization of three previously uncharacterized
RT   Kv channel alpha-subunits identified in the human genome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7986-7991(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Vega-Saenz de Miera E.C., Rudy B.;
RT   "Kv10.1a and Kv10.1b: two novel alternatively spliced potassium
RT   channel subunits.";
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=19074135; DOI=10.1074/jbc.M808786200;
RA   Mederos y Schnitzler M., Rinne S., Skrobek L., Renigunta V.,
RA   Schlichthorl G., Derst C., Gudermann T., Daut J., Preisig-Muller R.;
RT   "Mutation of histidine 105 in the T1 domain of the potassium channel
RT   Kv2.1 disrupts heteromerization with Kv6.3 and Kv6.4.";
RL   J. Biol. Chem. 284:4695-4704(2009).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself (PubMed:11852086). Can form functional
CC       heterotetrameric channels with KCNB1; this promotes a reduction in
CC       the rate of activation and inactivation of the delayed rectifier
CC       voltage-gated potassium channel KCNB1 (PubMed:11852086,
CC       PubMed:19074135). {ECO:0000269|PubMed:11852086,
CC       ECO:0000269|PubMed:19074135}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1 (PubMed:11852086,
CC       PubMed:12060745, PubMed:19074135). Does not form homomultimers
CC       (PubMed:12060745). {ECO:0000269|PubMed:11852086,
CC       ECO:0000269|PubMed:12060745, ECO:0000269|PubMed:19074135}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11852086,
CC       ECO:0000269|PubMed:12060745, ECO:0000269|PubMed:19074135}; Multi-
CC       pass membrane protein {ECO:0000305}. Cytoplasm
CC       {ECO:0000269|PubMed:12060745}. Note=Has to be associated with
CC       KCNB1 or possibly another partner to get inserted in the plasma
CC       membrane (PubMed:12060745). Colocalizes with KCNB1 at the plasma
CC       membrane (PubMed:12060745, PubMed:19074135). Remains intracellular
CC       in the absence of KCNB1 (PubMed:12060745).
CC       {ECO:0000269|PubMed:12060745, ECO:0000269|PubMed:19074135}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Kv10.1b;
CC         IsoId=Q8TAE7-1; Sequence=Displayed;
CC       Name=2; Synonyms=Kv10.1a;
CC         IsoId=Q8TAE7-2; Sequence=VSP_001026;
CC   -!- TISSUE SPECIFICITY: Expressed in the brain, liver, testis, small
CC       intestine, colon, thymus and adrenal gland (PubMed:11852086,
CC       PubMed:12060745). {ECO:0000269|PubMed:11852086,
CC       ECO:0000269|PubMed:12060745}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. G (TC
CC       1.A.1.2) subfamily. Kv6.3/KCNG3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB070604; BAB85520.1; -; mRNA.
DR   EMBL; AF348982; AAL83909.1; -; mRNA.
DR   EMBL; AF454547; AAM93548.1; -; mRNA.
DR   EMBL; AF454548; AAM93549.1; -; mRNA.
DR   EMBL; AC025750; AAY24039.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00319.1; -; Genomic_DNA.
DR   EMBL; BC071558; AAH71558.1; -; mRNA.
DR   CCDS; CCDS1809.1; -. [Q8TAE7-1]
DR   CCDS; CCDS42674.1; -. [Q8TAE7-2]
DR   RefSeq; NP_579875.1; NM_133329.5. [Q8TAE7-1]
DR   RefSeq; NP_758847.1; NM_172344.2. [Q8TAE7-2]
DR   UniGene; Hs.352633; -.
DR   ProteinModelPortal; Q8TAE7; -.
DR   BioGrid; 128090; 4.
DR   IntAct; Q8TAE7; 1.
DR   STRING; 9606.ENSP00000304127; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   iPTMnet; Q8TAE7; -.
DR   PhosphoSitePlus; Q8TAE7; -.
DR   BioMuta; KCNG3; -.
DR   DMDM; 24418472; -.
DR   PaxDb; Q8TAE7; -.
DR   PeptideAtlas; Q8TAE7; -.
DR   PRIDE; Q8TAE7; -.
DR   DNASU; 170850; -.
DR   Ensembl; ENST00000306078; ENSP00000304127; ENSG00000171126. [Q8TAE7-1]
DR   Ensembl; ENST00000394973; ENSP00000378424; ENSG00000171126. [Q8TAE7-2]
DR   GeneID; 170850; -.
DR   KEGG; hsa:170850; -.
DR   UCSC; uc002rsm.4; human. [Q8TAE7-1]
DR   CTD; 170850; -.
DR   DisGeNET; 170850; -.
DR   EuPathDB; HostDB:ENSG00000171126.7; -.
DR   GeneCards; KCNG3; -.
DR   HGNC; HGNC:18306; KCNG3.
DR   HPA; HPA041625; -.
DR   MIM; 606767; gene.
DR   neXtProt; NX_Q8TAE7; -.
DR   OpenTargets; ENSG00000171126; -.
DR   PharmGKB; PA30036; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231014; -.
DR   HOVERGEN; HBG100172; -.
DR   InParanoid; Q8TAE7; -.
DR   KO; K04902; -.
DR   OMA; HMCELSF; -.
DR   OrthoDB; EOG091G09VX; -.
DR   PhylomeDB; Q8TAE7; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNG3; -.
DR   GenomeRNAi; 170850; -.
DR   PRO; PR:Q8TAE7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000171126; -.
DR   CleanEx; HS_KCNG3; -.
DR   Genevisible; Q8TAE7; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Cytoplasm;
KW   Ion channel; Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    436       Potassium voltage-gated channel subfamily
FT                                G member 3.
FT                                /FTId=PRO_0000054077.
FT   TOPO_DOM      1    168       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    169    190       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    191    220       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    221    242       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    243    253       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    254    274       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    275    284       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    285    305       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    306    320       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    321    342       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    343    360       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    361    372       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    373    380       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    381    387       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    388    416       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    417    436       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       373    378       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   VAR_SEQ     212    222       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_001026.
SQ   SEQUENCE   436 AA;  49593 MW;  3C289CFF0B462513 CRC64;
     MTFGRSGAAS VVLNVGGARY SLSRELLKDF PLRRVSRLHG CRSERDVLEV CDDYDRERNE
     YFFDRHSEAF GFILLYVRGH GKLRFAPRMC ELSFYNEMIY WGLEGAHLEY CCQRRLDDRM
     SDTYTFYSAD EPGVLGRDEA RPGGAEAAPS RRWLERMRRT FEEPTSSLAA QILASVSVVF
     VIVSMVVLCA STLPDWRNAA ADNRSLDDRS RYSAGPGREP SGIIEAICIG WFTAECIVRF
     IVSKNKCEFV KRPLNIIDLL AITPYYISVL MTVFTGENSQ LQRAGVTLRV LRMMRIFWVI
     KLARHFIGLQ TLGLTLKRCY REMVMLLVFI CVAMAIFSAL SQLLEHGLDL ETSNKDFTSI
     PAACWWVIIS MTTVGYGDMY PITVPGRILG GVCVVSGIVL LALPITFIYH SFVQCYHELK
     FRSARYSRSL STEFLN
//
ID   KCNE4_HUMAN             Reviewed;         221 AA.
AC   Q8WWG9; B7Z275; Q53SM4; Q96CC4;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   03-SEP-2014, sequence version 4.
DT   22-NOV-2017, entry version 128.
DE   RecName: Full=Potassium voltage-gated channel subfamily E member 4;
DE   AltName: Full=MinK-related peptide 3;
DE   AltName: Full=Minimum potassium ion channel-related peptide 3;
DE   AltName: Full=Potassium channel subunit beta MiRP3;
GN   Name=KCNE4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 23-221, AND VARIANT GLU-196.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 25-221, AND VARIANT GLU-196.
RC   TISSUE=Heart, and Kidney;
RA   Hui R., Teng S., Lin C., Ma L., Zhen Y.;
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   ASSOCIATION WITH KCNQ1, AND TISSUE SPECIFICITY.
RX   PubMed=12096056; DOI=10.1113/jphysiol.2002.017301;
RA   Grunnet M., Jespersen T., Rasmussen H.B., Ljungstroem T.,
RA   Jorgensen N.K., Olesen S.-P., Klaerke D.A.;
RT   "KCNE4 is an inhibitory subunit to the KCNQ1 channel.";
RL   J. Physiol. (Lond.) 542:119-130(2002).
RN   [6]
RP   INTERACTION WITH KCNQ1.
RX   PubMed=19687231; DOI=10.1085/jgp.200910234;
RA   Vanoye C.G., Welch R.C., Daniels M.A., Manderfield L.J., Tapper A.R.,
RA   Sanders C.R., George A.L. Jr.;
RT   "Distinct subdomains of the KCNQ1 S6 segment determine channel
RT   modulation by different KCNE subunits.";
RL   J. Gen. Physiol. 134:207-217(2009).
RN   [7]
RP   INTERACTION WITH KCNQ1.
RX   PubMed=20533308; DOI=10.1002/jcp.22265;
RA   Roura-Ferrer M., Sole L., Oliveras A., Dahan R., Bielanska J.,
RA   Villarroel A., Comes N., Felipe A.;
RT   "Impact of KCNE subunits on KCNQ1 (Kv7.1) channel membrane surface
RT   targeting.";
RL   J. Cell. Physiol. 225:692-700(2010).
CC   -!- FUNCTION: Ancillary protein that assembles as a beta subunit with
CC       a voltage-gated potassium channel complex of pore-forming alpha
CC       subunits. Modulates the gating kinetics and enhances stability of
CC       the channel complex. May associate with KCNQ1/KVLTQ1 and inhibit
CC       potassium current.
CC   -!- SUBUNIT: Interacts with KCNQ1; impairs KCNQ1 localization in lipid
CC       rafts and inhibits voltage-gated potassium channel activity.
CC       {ECO:0000269|PubMed:12096056, ECO:0000269|PubMed:19687231,
CC       ECO:0000269|PubMed:20533308}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in embryo and adult
CC       uterus. Low expression found in kidney, small intestine, lung and
CC       heart. {ECO:0000269|PubMed:12096056}.
CC   -!- SIMILARITY: Belongs to the potassium channel KCNE family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH14429.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAL49979.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294423; BAH11761.1; -; mRNA.
DR   EMBL; AC017014; AAX93228.1; -; Genomic_DNA.
DR   EMBL; BC014429; AAH14429.1; ALT_INIT; mRNA.
DR   EMBL; AY065987; AAL49979.1; ALT_INIT; mRNA.
DR   CCDS; CCDS2456.2; -.
DR   RefSeq; NP_542402.3; NM_080671.3.
DR   UniGene; Hs.348522; -.
DR   ProteinModelPortal; Q8WWG9; -.
DR   SMR; Q8WWG9; -.
DR   BioGrid; 117217; 5.
DR   CORUM; Q8WWG9; -.
DR   IntAct; Q8WWG9; 2.
DR   STRING; 9606.ENSP00000281830; -.
DR   iPTMnet; Q8WWG9; -.
DR   PhosphoSitePlus; Q8WWG9; -.
DR   DMDM; 311033433; -.
DR   PaxDb; Q8WWG9; -.
DR   PeptideAtlas; Q8WWG9; -.
DR   PRIDE; Q8WWG9; -.
DR   DNASU; 23704; -.
DR   Ensembl; ENST00000281830; ENSP00000281830; ENSG00000152049.
DR   GeneID; 23704; -.
DR   KEGG; hsa:23704; -.
DR   UCSC; uc002vnl.7; human.
DR   CTD; 23704; -.
DR   DisGeNET; 23704; -.
DR   EuPathDB; HostDB:ENSG00000152049.6; -.
DR   GeneCards; KCNE4; -.
DR   HGNC; HGNC:6244; KCNE4.
DR   HPA; HPA011420; -.
DR   MIM; 607775; gene.
DR   neXtProt; NX_Q8WWG9; -.
DR   OpenTargets; ENSG00000152049; -.
DR   PharmGKB; PA30032; -.
DR   eggNOG; ENOG410IWSX; Eukaryota.
DR   eggNOG; ENOG41129VY; LUCA.
DR   GeneTree; ENSGT00390000013776; -.
DR   HOGENOM; HOG000237340; -.
DR   HOVERGEN; HBG052229; -.
DR   InParanoid; Q8WWG9; -.
DR   KO; K04898; -.
DR   OMA; LWGEAMK; -.
DR   OrthoDB; EOG091G0QZW; -.
DR   TreeFam; TF333025; -.
DR   Reactome; R-HSA-5576890; Phase 3 - rapid repolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   GeneWiki; KCNE4; -.
DR   GenomeRNAi; 23704; -.
DR   PRO; PR:Q8WWG9; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000152049; -.
DR   CleanEx; HS_KCNE4; -.
DR   Genevisible; Q8WWG9; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   InterPro; IPR000369; K_chnl_KCNE.
DR   PANTHER; PTHR15282; PTHR15282; 1.
DR   Pfam; PF02060; ISK_Channel; 1.
DR   PRINTS; PR00168; KCNECHANNEL.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Polymorphism; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    221       Potassium voltage-gated channel subfamily
FT                                E member 4.
FT                                /FTId=PRO_0000144292.
FT   TOPO_DOM      1     86       Extracellular. {ECO:0000255}.
FT   TRANSMEM     87    107       Helical. {ECO:0000255}.
FT   TOPO_DOM    108    221       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    120    123       Poly-Leu.
FT   CARBOHYD      9      9       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      98     98       G -> S (in dbSNP:rs13409084).
FT                                /FTId=VAR_030620.
FT   VARIANT     196    196       D -> E (in dbSNP:rs12621643).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_024411.
FT   CONFLICT     47     47       V -> A (in Ref. 1; BAH11761).
FT                                {ECO:0000305}.
FT   CONFLICT    105    105       M -> V (in Ref. 4; AAL49979).
FT                                {ECO:0000305}.
FT   CONFLICT    137    137       P -> S (in Ref. 4; AAL49979).
FT                                {ECO:0000305}.
SQ   SEQUENCE   221 AA;  23806 MW;  F601434C18E82CFE CRC64;
     MHFLTIYPNC SSGVVRAQSR TEQKNPLGLD DLGIQNLGQT VSLAPAVEAA SMLKMEPLNS
     THPGTAASSS PLESRAAGGG SGNGNEYFYI LVVMSFYGIF LIGIMLGYMK SKRREKKSSL
     LLLYKDEERL WGEAMKPLPV VSGLRSVQVP LMLNMLQESV APALSCTLCS MEGDSVSSES
     SSPDVHLTIQ EEGADDELEE TSETPLNESS EGSSENIHQN S
//
ID   KCNK2_RAT               Reviewed;         426 AA.
AC   Q920B6; A3QR52; Q3MMY3; Q5DNW4; Q5DNW5;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-NOV-2017, entry version 111.
DE   RecName: Full=Potassium channel subfamily K member 2 {ECO:0000250|UniProtKB:O95069};
DE   AltName: Full=Outward rectifying potassium channel protein TREK-1 {ECO:0000250|UniProtKB:O95069};
DE   AltName: Full=Stretch-activated potassium channel TREK-1 {ECO:0000303|PubMed:16248991};
DE   AltName: Full=TREK-1 K(+) channel subunit {ECO:0000250|UniProtKB:O95069};
DE   AltName: Full=Two pore domain potassium channel TREK-1 {ECO:0000303|PubMed:24196565};
DE   AltName: Full=Two pore potassium channel TPKC1 {ECO:0000250|UniProtKB:O95069};
GN   Name=Kcnk2 {ECO:0000312|EMBL:AAU06141.1,
GN   ECO:0000312|Ensembl:ENSRNOP00000003684, ECO:0000312|RGD:621448};
GN   Synonyms=Trek {ECO:0000312|EMBL:ABD64605.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAL01159.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Brain {ECO:0000312|EMBL:AAL01159.1};
RX   PubMed=11319556;
RA   Bockenhauer D., Zilberberg N., Goldstein S.A.;
RT   "KCNK2: reversible conversion of a hippocampal potassium leak into a
RT   voltage-dependent channel.";
RL   Nat. Neurosci. 4:486-491(2001).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAL95708.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar {ECO:0000312|EMBL:AAL95708.1};
RX   PubMed=11897838; DOI=10.1113/jphysiol.2001.013432;
RA   Gu W., Schlichthorl G., Hirsch J.R., Engels H., Karschin C.,
RA   Karschin A., Derst C., Steinlein O.K., Daut J.;
RT   "Expression pattern and functional characteristics of two novel splice
RT   variants of the two-pore-domain potassium channel TREK-2.";
RL   J. Physiol. (Lond.) 539:657-668(2002).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAU25945.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND
RP   ACTIVATION.
RX   PubMed=16248991; DOI=10.1016/j.cardiores.2005.08.018;
RA   Tao Li X., Dyachenko V., Zuzarte M., Putzke C., Preisig-Muller R.,
RA   Isenberg G., Daut J.;
RT   "The stretch-activated potassium channel TREK-1 in rat cardiac
RT   ventricular muscle.";
RL   Cardiovasc. Res. 69:86-97(2006).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:ABD64605.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 4 AND 5), FUNCTION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DOMAIN.
RX   PubMed=24196565; DOI=10.1007/s00424-013-1384-z;
RA   Rinne S., Renigunta V., Schlichthorl G., Zuzarte M., Bittner S.,
RA   Meuth S.G., Decher N., Daut J., Preisig-Muller R.;
RT   "A splice variant of the two-pore domain potassium channel TREK-1 with
RT   only one pore domain reduces the surface expression of full-length
RT   TREK-1 channels.";
RL   Pflugers Arch. 466:1559-1570(2014).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAU06141.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Wistar {ECO:0000312|EMBL:AAU06141.1};
RA   Li Z.B., Wang X.L.;
RT   "Possible role of TREK-1 in temperature regulation.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000312|Ensembl:ENSRNOP00000003684}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway {ECO:0000312|Ensembl:ENSRNOP00000003684};
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T.,
RA   Smith D., Lee H.-M., Gustafson E., Cahill P., Kana A.,
RA   Doucette-Stamm L., Weinstock K., Fechtel K., Weiss R.B., Dunn D.M.,
RA   Green E.D., Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K.,
RA   Zhu B., Marra M., Schein J., Bosdet I., Fjell C., Jones S.,
RA   Krzywinski M., Mathewson C., Siddiqui A., Wye N., McPherson J.,
RA   Zhao S., Fraser C.M., Shetty J., Shatsman S., Geer K., Chen Y.,
RA   Abramzon S., Nierman W.C., Havlak P.H., Chen R., Durbin K.J., Egan A.,
RA   Ren Y., Song X.-Z., Li B., Liu Y., Qin X., Cawley S., Cooney A.J.,
RA   D'Souza L.M., Martin K., Wu J.Q., Gonzalez-Garay M.L., Jackson A.R.,
RA   Kalafus K.J., McLeod M.P., Milosavljevic A., Virk D., Volkov A.,
RA   Wheeler D.A., Zhang Z., Bailey J.A., Eichler E.E., Tuzun E.,
RA   Birney E., Mongin E., Ureta-Vidal A., Woodwark C., Zdobnov E.,
RA   Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D.,
RA   Schmidt J., Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M.,
RA   Abril J.F., Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O.,
RA   Poliakov A., Huebner N., Ganten D., Goesele C., Hummel O.,
RA   Kreitler T., Lee Y.-A., Monti J., Schulz H., Zimdahl H.,
RA   Himmelbauer H., Lehrach H., Jacob H.J., Bromberg S.,
RA   Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E., Lazar J.,
RA   Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E.,
RA   Webber C., Brandt P., Nyakatura G., Adetobi M., Chiaromonte F.,
RA   Elnitski L., Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K.,
RA   Miller W., Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S.,
RA   Zhang Y., Lindpaintner K., Andrews T.D., Caccamo M., Clamp M.,
RA   Clarke L., Curwen V., Durbin R.M., Eyras E., Searle S.M., Cooper G.M.,
RA   Batzoglou S., Brudno M., Sidow A., Stone E.A., Payseur B.A.,
RA   Bourque G., Lopez-Otin C., Puente X.S., Chakrabarti K., Chatterji S.,
RA   Dewey C., Pachter L., Bray N., Yap V.B., Caspi A., Tesler G.,
RA   Pevzner P.A., Haussler D., Roskin K.M., Baertsch R., Clawson H.,
RA   Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J., Rosenbloom K.R.,
RA   Trumbower H., Weirauch M., Cooper D.N., Stenson P.D., Ma B., Brent M.,
RA   Arumugam M., Shteynberg D., Copley R.R., Taylor M.S., Riethman H.,
RA   Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S., Mockrin S.,
RA   Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into
RT   mammalian evolution.";
RL   Nature 428:493-521(2004).
RN   [7] {ECO:0000305, ECO:0000312|EMBL:AAU06141.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Ion channel that contributes to passive transmembrane
CC       potassium transport. Reversibly converts between a voltage-
CC       insensitive potassium leak channel and a voltage-dependent outward
CC       rectifying potassium channel in a phosphorylation-dependent manner
CC       (PubMed:11319556). In astrocytes, forms mostly heterodimeric
CC       potassium channels with KCNK1, with only a minor proportion of
CC       functional channels containing homodimeric KCNK2. In astrocytes,
CC       the heterodimer formed by KCNK1 and KCNK2 is required for rapid
CC       glutamate release in response to activation of G-protein coupled
CC       receptors, such as F2R and CNR1 (By similarity).
CC       {ECO:0000250|UniProtKB:P97438, ECO:0000269|PubMed:11319556}.
CC   -!- FUNCTION: Isoform 5: Does not display channel activity but reduces
CC       the channel activity of isoform 1, isoform 2 and isoform 4 and
CC       reduces cell surface expression of isoform 2.
CC       {ECO:0000269|PubMed:24196565}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked (By similarity). Heterodimer
CC       with KCNK1; disulfide-linked (By similarity). Interacts with BVES;
CC       the interaction enhances KCNK2 surface expression and is inhibited
CC       by cAMP (By similarity). {ECO:0000250|UniProtKB:O95069,
CC       ECO:0000250|UniProtKB:P97438}.
CC   -!- INTERACTION:
CC       P50150:GNG4 (xeno); NbExp=3; IntAct=EBI-6530063, EBI-6395970;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane
CC       {ECO:0000269|PubMed:24196565}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24196565}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cell membrane
CC       {ECO:0000269|PubMed:24196565}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24196565}.
CC   -!- SUBCELLULAR LOCATION: Isoform 5: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:24196565}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24196565}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1 {ECO:0000269|PubMed:11319556, ECO:0000269|PubMed:11897838};
CC       Synonyms=TREK-1b {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:16248991}; Synonyms=TREK-1a
CC       {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-2; Sequence=VSP_053954;
CC       Name=3 {ECO:0000269|PubMed:24196565}; Synonyms=TREK-1c
CC       {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-3; Sequence=VSP_053952;
CC       Name=4 {ECO:0000269|PubMed:24196565}; Synonyms=TREK-1d
CC       {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-4; Sequence=VSP_053953;
CC       Name=5 {ECO:0000269|PubMed:24196565}; Synonyms=TREK-1e
CC       {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-5; Sequence=VSP_053954, VSP_053955, VSP_053956;
CC   -!- TISSUE SPECIFICITY: Expressed in cardiomyocytes (at protein
CC       level). Expressed in various brain regions including the lateral
CC       olfactory tract, piriform cortex of the forebrain, paraventricular
CC       and anteromedial thalamic nuclei, brainstem, caudate putamen,
CC       nucleus accumbens, neocortex and interpeduncular nucleus. Isoform
CC       5 is expressed in brain and kidney. {ECO:0000269|PubMed:11897838,
CC       ECO:0000269|PubMed:16248991, ECO:0000269|PubMed:24196565}.
CC   -!- DOMAIN: The C-terminal region of isoform 5 mediates its
CC       intracellular retention. {ECO:0000269|PubMed:24196565}.
CC   -!- PTM: Phosphorylation at Ser-348 controls the reversible conversion
CC       from a leak channel to a voltage-dependent channel.
CC       {ECO:0000250|UniProtKB:O95069}.
CC   -!- MISCELLANEOUS: Activated by arachadonic acid, mechanical
CC       stretching and intracellular acidification.
CC       {ECO:0000269|PubMed:16248991}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000255}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF325671; AAL01159.1; -; mRNA.
DR   EMBL; AF385402; AAL95708.1; -; mRNA.
DR   EMBL; AY727922; AAU25945.1; -; mRNA.
DR   EMBL; AY555072; AAT64134.1; -; mRNA.
DR   EMBL; AY555073; AAT64135.1; -; mRNA.
DR   EMBL; DQ403851; ABD64605.1; -; mRNA.
DR   EMBL; AY695826; AAU06141.1; -; mRNA.
DR   EMBL; AABR06076806; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06076807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06076808; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06076809; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473985; EDL94961.1; -; Genomic_DNA.
DR   EMBL; CH473985; EDL94962.1; -; Genomic_DNA.
DR   RefSeq; NP_742038.2; NM_172041.2.
DR   RefSeq; NP_742039.1; NM_172042.1. [Q920B6-1]
DR   RefSeq; XP_006250495.1; XM_006250433.3. [Q920B6-4]
DR   RefSeq; XP_006250496.1; XM_006250434.3. [Q920B6-2]
DR   UniGene; Rn.21984; -.
DR   ProteinModelPortal; Q920B6; -.
DR   SMR; Q920B6; -.
DR   IntAct; Q920B6; 9.
DR   STRING; 10116.ENSRNOP00000003684; -.
DR   ChEMBL; CHEMBL3817718; -.
DR   PaxDb; Q920B6; -.
DR   PRIDE; Q920B6; -.
DR   Ensembl; ENSRNOT00000003684; ENSRNOP00000003684; ENSRNOG00000002653. [Q920B6-1]
DR   Ensembl; ENSRNOT00000077282; ENSRNOP00000068842; ENSRNOG00000002653. [Q920B6-3]
DR   GeneID; 170899; -.
DR   KEGG; rno:170899; -.
DR   UCSC; RGD:621448; rat. [Q920B6-1]
DR   CTD; 3776; -.
DR   RGD; 621448; Kcnk2.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000013106; -.
DR   HOVERGEN; HBG052234; -.
DR   InParanoid; Q920B6; -.
DR   KO; K04913; -.
DR   OMA; AINVMKW; -.
DR   OrthoDB; EOG091G0E3R; -.
DR   PhylomeDB; Q920B6; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-RNO-1299503; TWIK related potassium channel (TREK).
DR   PRO; PR:Q920B6; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000002653; -.
DR   Genevisible; Q920B6; RN.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0097449; C:astrocyte projection; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0044305; C:calyx of Held; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISO:RGD.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0019870; F:potassium channel inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISO:RGD.
DR   GO; GO:0003231; P:cardiac ventricle development; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0090102; P:cochlea development; IEP:RGD.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007613; P:memory; IEP:RGD.
DR   GO; GO:0060044; P:negative regulation of cardiac muscle cell proliferation; IMP:RGD.
DR   GO; GO:2000279; P:negative regulation of DNA biosynthetic process; IMP:RGD.
DR   GO; GO:0010942; P:positive regulation of cell death; IMP:RGD.
DR   GO; GO:1900039; P:positive regulation of cellular response to hypoxia; IMP:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003976; 2pore_dom_K_chnl_TREK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01499; TREKCHANNEL.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Endoplasmic reticulum; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    426       Potassium channel subfamily K member 2.
FT                                /FTId=PRO_0000426718.
FT   TOPO_DOM      1     61       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     62     82       Helical. {ECO:0000255}.
FT   INTRAMEM    144    170       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    172    192       Helical. {ECO:0000255}.
FT   TOPO_DOM    193    222       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    223    243       Helical. {ECO:0000255}.
FT   INTRAMEM    253    283       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    288    308       Helical. {ECO:0000255}.
FT   TOPO_DOM    309    426       Cytoplasmic. {ECO:0000255}.
FT   REGION      354    426       Required for basal channel activity.
FT                                {ECO:0000250|UniProtKB:P97438}.
FT   REGION      378    426       Essential for chloroform and halothane
FT                                sensitivity.
FT                                {ECO:0000250|UniProtKB:P97438}.
FT   MOD_RES     348    348       Phosphoserine; by PKA.
FT                                {ECO:0000250|UniProtKB:O95069}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    134    134       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    108    108       Interchain.
FT                                {ECO:0000250|UniProtKB:P97438}.
FT   VAR_SEQ       1     16       MLASASRERPGYTAGV -> MMNPRAKRSVYL (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:24196565}.
FT                                /FTId=VSP_053952.
FT   VAR_SEQ       1     15       MLASASRERPGYTAG -> MGA (in isoform 4).
FT                                {ECO:0000303|PubMed:24196565}.
FT                                /FTId=VSP_053953.
FT   VAR_SEQ       2     16       Missing (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:16248991,
FT                                ECO:0000303|PubMed:24196565}.
FT                                /FTId=VSP_053954.
FT   VAR_SEQ     213    241       KWNVSQTKIRIISTIIFILFGCVLFVALP -> VGRTLNIW
FT                                TSTSSSCGSGSSLGWPTLRLF (in isoform 5).
FT                                {ECO:0000303|PubMed:24196565}.
FT                                /FTId=VSP_053955.
FT   VAR_SEQ     242    426       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:24196565}.
FT                                /FTId=VSP_053956.
FT   CONFLICT    416    416       A -> R (in Ref. 4; ABD64605).
FT                                {ECO:0000305}.
SQ   SEQUENCE   426 AA;  46912 MW;  CACDA05BBE95FDBC CRC64;
     MLASASRERP GYTAGVAAPD LLDPKSAAQN SKPRLSFSAK PTVLASRVES DSAINVMKWK
     TVSTIFLVVV LYLIIGATVF KALEQPQEIS QRTTIVIQKQ NFIAQHACVN STELDELIQQ
     IVTAINAGII PLGNNSNQVS HWDLGSSFFF AGTVITTIGF GNISPRTEGG KIFCIIYALL
     GIPLFGFLLA GVGDQLGTIF GKGIAKVEDT FIKWNVSQTK IRIISTIIFI LFGCVLFVAL
     PAVIFKHIEG WSALDAIYFV VITLTTIGFG DYVAGGSDIE YLDFYKPVVW FWILVGLAYF
     AAVLSMIGDW LRVISKKTKE EVGEFRAHAA EWTANVTAEF KETRRRLSVE IYDKFQRATS
     VKRKLSAELA GNHNQELTPC RRTLSVNHLT SEREVLPPLL KAESIYLNGL TPHCAAEDIA
     VIENMK
//
ID   GORK_ARATH              Reviewed;         820 AA.
AC   Q94A76; Q9FNY5;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   25-OCT-2017, entry version 126.
DE   RecName: Full=Potassium channel GORK;
DE   AltName: Full=Guard cell outward rectifying K(+) channel;
DE            Short=AtGORK;
GN   Name=GORK; OrderedLocusNames=At5g37500; ORFNames=MPA22.4;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND CHARACTERIZATION.
RC   STRAIN=cv. Wassilewskija;
RX   PubMed=11113445; DOI=10.1016/S0014-5793(00)02248-1;
RA   Ache P., Becker D., Ivashikina N., Dietrich P., Roelfsema M.R.G.,
RA   Hedrich R.;
RT   "GORK, a delayed outward rectifier expressed in guard cells of
RT   Arabidopsis thaliana, is a K(+)-selective, K(+)-sensing ion channel.";
RL   FEBS Lett. 486:93-98(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RA   Kaneko T., Katoh T., Asamizu E., Sato S., Nakamura Y., Kotani H.,
RA   Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 5. XI.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 489-820.
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=11728473; DOI=10.1016/S0014-5793(01)03114-3;
RA   Ivashikina N., Becker D., Ache P., Meyerhoff O., Felle H.H.,
RA   Hedrich R.;
RT   "K(+) channel profile and electrical properties of Arabidopsis root
RT   hairs.";
RL   FEBS Lett. 508:463-469(2001).
RN   [6]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [7]
RP   CHARACTERIZATION, AND FUNCTION.
RX   PubMed=12671068; DOI=10.1073/pnas.0733970100;
RA   Hosy E., Vavasseur A., Mouline K., Dreyer I., Gaymard F., Poree F.,
RA   Boucherez J., Lebaudy A., Bouchez D., Very A.-A., Simonneau T.,
RA   Thibaud J.-B., Sentenac H.;
RT   "The Arabidopsis outward K(+) channel GORK is involved in regulation
RT   of stomatal movements and plant transpiration.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:5549-5554(2003).
RN   [8]
RP   INDUCTION.
RX   PubMed=14596925; DOI=10.1016/S0014-5793(03)01118-9;
RA   Becker D., Hoth S., Ache P., Wenkel S., Roelfsema M.R.G.,
RA   Meyerhoff O., Hartung W., Hedrich R.;
RT   "Regulation of the ABA-sensitive Arabidopsis potassium channel gene
RT   GORK in response to water stress.";
RL   FEBS Lett. 554:119-126(2003).
CC   -!- FUNCTION: Major selective outward-rectifying potassium channel of
CC       the guard cell membrane. Involved in regulation of stomatal
CC       movements according to the water status. Assuming opened or closed
CC       conformations in response to the voltage difference across the
CC       membrane, the channel is activated by depolarization. Conductance
CC       of the channel is modulated in a potassium-dependent fashion. May
CC       interact with the cytoskeleton or with regulatory proteins.
CC       {ECO:0000269|PubMed:12671068}.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming subunits. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in guard cell-containing tissues, in
CC       root epidermal cells and in root hairs. Detected in vascular cells
CC       of the root and shoot. {ECO:0000269|PubMed:11113445,
CC       ECO:0000269|PubMed:11728473}.
CC   -!- INDUCTION: Up-regulated under drought, salt stress and cold
CC       conditions. Induced by abscisic acid (ABA) treatment in roots and
CC       shoots but not in guard cells. {ECO:0000269|PubMed:14596925}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK83636.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ279009; CAC17380.1; -; mRNA.
DR   EMBL; AB025630; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CP002688; AED94198.1; -; Genomic_DNA.
DR   EMBL; AY049294; AAK83636.1; ALT_INIT; mRNA.
DR   EMBL; AY143848; AAN28787.1; -; mRNA.
DR   RefSeq; NP_198566.2; NM_123109.5.
DR   UniGene; At.10193; -.
DR   ProteinModelPortal; Q94A76; -.
DR   SMR; Q94A76; -.
DR   BioGrid; 18979; 3.
DR   IntAct; Q94A76; 2.
DR   STRING; 3702.AT5G37500.1; -.
DR   TCDB; 1.A.1.4.4; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q94A76; -.
DR   PaxDb; Q94A76; -.
DR   EnsemblPlants; AT5G37500.1; AT5G37500.1; AT5G37500.
DR   GeneID; 833728; -.
DR   Gramene; AT5G37500.1; AT5G37500.1; AT5G37500.
DR   KEGG; ath:AT5G37500; -.
DR   Araport; AT5G37500; -.
DR   TAIR; locus:2169866; AT5G37500.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000240830; -.
DR   InParanoid; Q94A76; -.
DR   KO; K21867; -.
DR   OMA; THIAHRY; -.
DR   OrthoDB; EOG093602RR; -.
DR   PhylomeDB; Q94A76; -.
DR   PRO; PR:Q94A76; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; Q94A76; baseline and differential.
DR   Genevisible; Q94A76; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:TAIR.
DR   GO; GO:0015075; F:ion transmembrane transporter activity; IMP:TAIR.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IMP:TAIR.
DR   GO; GO:0006811; P:ion transport; IMP:TAIR.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0009737; P:response to abscisic acid; IEP:TAIR.
DR   GO; GO:0009409; P:response to cold; IEP:TAIR.
DR   GO; GO:0009753; P:response to jasmonic acid; IMP:TAIR.
DR   GO; GO:0009414; P:response to water deprivation; IEP:TAIR.
DR   CDD; cd00204; ANK; 1.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.25.40.20; -; 2.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00248; ANK; 5.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    820       Potassium channel GORK.
FT                                /FTId=PRO_0000054129.
FT   TOPO_DOM      1     69       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     70     90       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM     91     97       Extracellular. {ECO:0000255}.
FT   TRANSMEM     98    118       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    119    141       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    142    162       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    163    168       Extracellular. {ECO:0000255}.
FT   TRANSMEM    169    189       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    190    203       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    204    224       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    225    259       Extracellular. {ECO:0000255}.
FT   INTRAMEM    260    279       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    280    285       Extracellular. {ECO:0000255}.
FT   TRANSMEM    286    306       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    307    820       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      528    559       ANK 1.
FT   REPEAT      563    592       ANK 2.
FT   REPEAT      596    625       ANK 3.
FT   REPEAT      627    656       ANK 4.
FT   REPEAT      660    689       ANK 5.
FT   REPEAT      693    722       ANK 6.
FT   DOMAIN      740    820       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     386    508       cNMP.
FT   CONFLICT    125    125       T -> S (in Ref. 1; CAC17380).
FT                                {ECO:0000305}.
FT   CONFLICT    230    230       N -> Q (in Ref. 1; CAC17380).
FT                                {ECO:0000305}.
FT   CONFLICT    306    306       I -> V (in Ref. 1; CAC17380).
FT                                {ECO:0000305}.
FT   CONFLICT    765    765       I -> V (in Ref. 1; CAC17380).
FT                                {ECO:0000305}.
SQ   SEQUENCE   820 AA;  94461 MW;  65F57190056A9AE4 CRC64;
     MGRLRRRQEI IDHEEEESND DVSSRRGKLS LAETFRWLDS SEHRRIETDG HNDYKYIIHP
     KNRWYKAWEM FILVWAIYSS LFTPMEFGFF RGLPERLFVL DIVGQIAFLV DIVLQFFVAY
     RDTQTYRTVY KPTRIAFRYL KSHFLMDFIG CFPWDLIYKA SGKHELVRYL LWIRLFRVRK
     VVEFFQRLEK DTRINYLFTR ILKLLFVEVY CTHTAACIFY YLATTLPPEN EGYTWIGSLK
     LGDYSYENFR EIDLWKRYTT ALYFAIVTMA TVGYGDIHAV NLREMIFVMI YVSFDMVLGA
     YLIGNITALI VKGSNTERFR DKMNDLISFM NRKKLGRDLR SQITGHVRLQ YDSHYTDTVM
     LQDIPASIRA KIAQLLYLPY IKKVPLFKGC STEFINQIVI RLHEEYFLPG EVITEQGNVV
     DHLYFVCEGL LEALVTKTDG SEESVTLLGP HTSFGDISII CNISQPFTVR VCELCHLLRL
     DKQSFSNILE IYFHDGRTIL NNIMEEKESN DRIKKLESDI VIHIGKQEAE LALKVNSAAF
     QGDFYQLKSL IRSGADPNKT DYDGRSPLHL AACRGYEDIT LFLIQEGVDV NLKDKFGHTP
     LFEAVKAGQE GVIGLLVKEG ASFNLEDSGN FLCTTVAKGD SDFLKRLLSS GMNPNSEDYD
     HRTPLHVAAS EGLFLMAKML VEAGASVISK DRWGNSPLDE ARLCGNKKLI KLLEDVKNAQ
     SSIYPSSLRE LQEERIERRK CTVFPFHPQE AKEERSRKHG VVVWIPSNLE KLIVTAAKEL
     GLSDGASFVL LSEDQGRITD IDMISDGHKL YMISDTTDQT
//
ID   SLO1_CAEEL              Reviewed;        1140 AA.
AC   Q95V25; Q95V26; Q95V27; Q9U268;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-APR-2004, sequence version 2.
DT   25-OCT-2017, entry version 136.
DE   RecName: Full=Calcium-activated potassium channel slo-1;
DE   AltName: Full=BK channel;
DE   AltName: Full=Maxi K channel;
DE            Short=MaxiK;
DE   AltName: Full=Slo homolog;
DE   AltName: Full=Slowpoke protein 1;
GN   Name=slo-1 {ECO:0000312|WormBase:Y51A2D.19a};
GN   ORFNames=Y51A2D.19 {ECO:0000312|WormBase:Y51A2D.19a};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND C), FUNCTION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF GLY-289.
RX   PubMed=11738032; DOI=10.1016/S0896-6273(01)00522-0;
RA   Wang Z.-W., Saifee O., Nonet M.L., Salkoff L.;
RT   "SLO-1 potassium channels control quantal content of neurotransmitter
RT   release at the C. elegans neuromuscular junction.";
RL   Neuron 32:867-881(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE
RP   SPLICING.
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   RESPONSE TO ETHANOL.
RX   PubMed=14675531; DOI=10.1016/S0092-8674(03)00979-6;
RA   Davies A.G., Pierce-Shimomura J.T., Kim H., VanHoven M.K.,
RA   Thiele T.R., Bonci A., Bargmann C.I., McIntire S.L.;
RT   "A central role of the BK potassium channel in behavioral responses to
RT   ethanol in C. elegans.";
RL   Cell 115:655-666(2003).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   GLU-350.
RX   PubMed=28168949; DOI=10.7554/eLife.24733;
RA   Oh K.H., Haney J.J., Wang X., Chuang C.F., Richmond J.E., Kim H.;
RT   "ERG-28 controls BK channel trafficking in the ER to regulate synaptic
RT   function and alcohol response in C. elegans.";
RL   Elife 6:0-0(2017).
CC   -!- FUNCTION: Potassium channel activated by both membrane
CC       depolarization or increase in cytosolic Ca(2+) that mediates
CC       export of K(+) (PubMed:11738032). Its activation dampens the
CC       excitatory events that elevate the cytosolic Ca(2+) concentration
CC       and/or depolarize the cell membrane (PubMed:11738032). It
CC       therefore contributes to repolarization of the membrane potential
CC       (PubMed:11738032). Essential for the regulation of
CC       neurotransmitter release at synapses (PubMed:11738032,
CC       PubMed:28168949). {ECO:0000269|PubMed:11738032,
CC       ECO:0000269|PubMed:28168949}.
CC   -!- SUBUNIT: Homotetramer; which constitutes the calcium-activated
CC       potassium channel. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305|PubMed:28168949};
CC       Multi-pass membrane protein {ECO:0000305}. Cell junction, synapse
CC       {ECO:0000269|PubMed:28168949}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=a;
CC         IsoId=Q95V25-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=Q95V25-2; Sequence=VSP_009998;
CC       Name=c;
CC         IsoId=Q95V25-3; Sequence=VSP_009996, VSP_009997, VSP_009998;
CC   -!- TISSUE SPECIFICITY: Expressed in synaptic regions of the nervous
CC       system including in both the nerve ring and nerve cords, as well
CC       as in the body-wall and vulval muscle.
CC       {ECO:0000269|PubMed:11738032, ECO:0000269|PubMed:28168949}.
CC   -!- DOMAIN: The S4 segment, which is characterized by a series of
CC       positively charged amino acids at every third position, is part of
CC       the voltage-sensor. {ECO:0000250}.
CC   -!- DOMAIN: The pore-forming domain (also referred as P region) is
CC       imbedded into the membrane, and forms the selectivity filter of
CC       the pore. It contains the signature sequence of potassium channels
CC       that displays selectivity to potassium (By similarity).
CC       {ECO:0000250}.
CC   -!- DOMAIN: The RCK N-terminal domain mediates the
CC       homotetramerization, thereby promoting the assembly of monomers
CC       into functional potassium channel. It includes binding sites for
CC       Ca(2+) and Mg(2+) (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The calcium bowl constitutes one of the Ca(2+) sensors and
CC       probably acts as a Ca(2+)-binding site. {ECO:0000250}.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Its activity is activated by ethanol, leading to
CC       the inhibition of neuronal activity.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Calcium-
CC       activated (TC 1.A.1.3) subfamily. Slo sub-subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF431891; AAL28102.1; -; mRNA.
DR   EMBL; AF431892; AAL28103.1; -; mRNA.
DR   EMBL; AF431893; AAL28104.1; -; mRNA.
DR   EMBL; AL021497; CAB54459.2; -; Genomic_DNA.
DR   EMBL; AL021497; CAD27617.1; -; Genomic_DNA.
DR   EMBL; AL021497; CAD27618.1; -; Genomic_DNA.
DR   PIR; T27083; T27083.
DR   RefSeq; NP_001024259.1; NM_001029088.1. [Q95V25-1]
DR   RefSeq; NP_001024260.1; NM_001029089.1.
DR   RefSeq; NP_001024261.1; NM_001029090.2. [Q95V25-3]
DR   UniGene; Cel.7073; -.
DR   ProteinModelPortal; Q95V25; -.
DR   SMR; Q95V25; -.
DR   MINT; MINT-8045859; -.
DR   STRING; 6239.Y51A2D.19a; -.
DR   ChEMBL; CHEMBL3085614; -.
DR   TCDB; 1.A.1.3.3; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q95V25; -.
DR   PaxDb; Q95V25; -.
DR   EnsemblMetazoa; Y51A2D.19a; Y51A2D.19a; WBGene00004830. [Q95V25-1]
DR   GeneID; 180203; -.
DR   UCSC; Y51A2D.19a; c. elegans. [Q95V25-1]
DR   CTD; 180203; -.
DR   WormBase; Y51A2D.19a; CE30364; WBGene00004830; slo-1. [Q95V25-1]
DR   WormBase; Y51A2D.19b; CE30365; WBGene00004830; slo-1. [Q95V25-2]
DR   WormBase; Y51A2D.19c; CE30366; WBGene00004830; slo-1. [Q95V25-3]
DR   eggNOG; KOG1420; Eukaryota.
DR   eggNOG; ENOG410YUX1; LUCA.
DR   GeneTree; ENSGT00530000063026; -.
DR   HOGENOM; HOG000019856; -.
DR   InParanoid; Q95V25; -.
DR   PhylomeDB; Q95V25; -.
DR   PRO; PR:Q95V25; -.
DR   Proteomes; UP000001940; Chromosome V.
DR   Bgee; WBGene00004830; -.
DR   ExpressionAtlas; Q95V25; baseline and differential.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0031430; C:M band; IDA:WormBase.
DR   GO; GO:0055120; C:striated muscle dense body; IDA:WormBase.
DR   GO; GO:0045202; C:synapse; IDA:WormBase.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IBA:GO_Central.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IDA:WormBase.
DR   GO; GO:0060072; F:large conductance calcium-activated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:WormBase.
DR   GO; GO:0048149; P:behavioral response to ethanol; IMP:WormBase.
DR   GO; GO:0040011; P:locomotion; IGI:WormBase.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IGI:WormBase.
DR   GO; GO:0043050; P:pharyngeal pumping; IMP:WormBase.
DR   GO; GO:0006813; P:potassium ion transport; IDA:WormBase.
DR   GO; GO:0046928; P:regulation of neurotransmitter secretion; IMP:WormBase.
DR   GO; GO:0042493; P:response to drug; IMP:WormBase.
DR   GO; GO:0045214; P:sarcomere organization; IGI:WormBase.
DR   InterPro; IPR024939; Ca-act_K_channel_Slo-1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003929; K_chnl_BK_asu.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR10027:SF33; PTHR10027:SF33; 1.
DR   Pfam; PF03493; BK_channel_a; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell junction; Cell membrane;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Synapse; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1   1140       Calcium-activated potassium channel slo-
FT                                1.
FT                                /FTId=PRO_0000054140.
FT   TOPO_DOM      1     44       Extracellular. {ECO:0000255}.
FT   TRANSMEM     45     65       Helical; Name=Segment S0. {ECO:0000255}.
FT   TOPO_DOM     66    139       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    140    161       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    162    178       Extracellular. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    200    203       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    204    224       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    225    228       Extracellular. {ECO:0000255}.
FT   TRANSMEM    229    249       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    250    264       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    265    285       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    286    299       Extracellular. {ECO:0000255}.
FT   INTRAMEM    300    322       Pore-forming; Name=P region.
FT                                {ECO:0000255}.
FT   TOPO_DOM    323    331       Extracellular. {ECO:0000255}.
FT   TRANSMEM    332    352       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    353   1140       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      353    519       RCK N-terminal.
FT   REGION      520    540       Segment S7.
FT   REGION      578    598       Segment S8.
FT   REGION      797    817       Segment S9.
FT   REGION      984   1004       Segment S10.
FT   MOTIF       316    319       Selectivity for potassium.
FT   MOTIF       955    977       Calcium bowl.
FT   VAR_SEQ     549    585       QTTPDWLNLYLCGAGMEMYTDTLSHSFVGMTFPEAVD ->
FT                                PHTPLWLNDYLRGAGMEMYTESLSPSFANMSFPEAAN (in
FT                                isoform c).
FT                                {ECO:0000303|PubMed:11738032}.
FT                                /FTId=VSP_009996.
FT   VAR_SEQ     678    678       R -> RDYSDFDALFYQND (in isoform c).
FT                                {ECO:0000303|PubMed:11738032}.
FT                                /FTId=VSP_009997.
FT   VAR_SEQ     713    735       SSTSDTHLNTKSLRFAYEIKKLM -> R (in isoform
FT                                b and isoform c).
FT                                {ECO:0000303|PubMed:11738032}.
FT                                /FTId=VSP_009998.
FT   MUTAGEN     289    289       G->E: In md1715; induces prolonged
FT                                synaptic release.
FT                                {ECO:0000269|PubMed:11738032}.
FT   MUTAGEN     350    350       E->K: In ky399gf; gain of function.
FT                                Insensitive to the acetylcholinesterase
FT                                inhibitor aldicarb, and locomotory speed
FT                                defects. In an erg-28 mutant background,
FT                                these defects are suppressed.
FT                                {ECO:0000269|PubMed:28168949}.
SQ   SEQUENCE   1140 AA;  129530 MW;  15670CB2CEA0F412 CRC64;
     MGEIYSPSQS KGFNQPYGYP MNCNLSRVFM EMTEEDRKCL EERKYWCFLL SSITTFCASM
     ILVVIWRVVT HLCCQRREKE FVEPIPAPEA VQINMNGSKH APSETDPFLK QQEEKHLGWM
     TEAKDWAGEL ISGQSLTGRF LVLLVFILSI GSLIIYFYDA SFQNFQVETC IPWQDSPSQQ
     IDLGFNIFFL VYFFIRFIAA SDKVWFLLEM YSWIDFFTIP PSFVAIYLQR NWLGFRFLRA
     LRLMTVPDIL QYLNILKTSS SIRLTQLVTI FVAVCLTGAG LVHLLENSGD FFKGFINPHR
     ITYADSVYFV LVTMSTVGYG DIYCTTLCGR LFMIFFILFG LAMFASYVPE IADLIGNRQK
     YGGEYKGEHG KKHIVVCGHI TYDSVSHFLQ DFLHEDRDDV DVEVVFLHRV VPDLELEGLF
     KRHFTKVEFF TGTVMDSLDL SRVKIGDADA CLVLANKYST NPDAEDAANI MRVISIKNYS
     SDIRVIVQLM QYHNKAYLLN IPSWDWKRGD DVICLAELKL GFIAQSCLAP GFSTMMANLF
     AMRSFKTSQT TPDWLNLYLC GAGMEMYTDT LSHSFVGMTF PEAVDLLFNR LGLLLLAIEL
     KDEENKECNI AINPGPHIVI QPQTQGFFIA QSADEVKRAF FWCKQCHDDI KDVSLIKKCK
     CKNLALFRRN TKHSTAARAR ATDVLQQFQP QAPAGPMGHL GQQVQLRMIN QQSSTSDTHL
     NTKSLRFAYE IKKLMPSSGG RRNSMSIPPD GRGVDFSKDF EQQFQDMKYD STGMFHWCPS
     RNLEDCVLER HQAAMTVLNG HVVVCLFADQ DSPLIGLRNF IMPLRSSNFH YHELKHVVIV
     GDLEYLRKEW KTLYNLPKIS ILNGSPLSRA DLRAVNINLC DMCVIISARV PNTEDTTLAD
     KEAILASLNI KAMQFDDTLG FFPMRHQTGD RSPLGSPISM QKKGAKFGTN VPMITELVND
     SNVQFLDQDD DDDPDTELYL TQPFACGTAF AISVLDSLMS TTYFNDSALT LIRTLVTGGA
     TPELELILAE GAGLRGGYST PETLSNRDRC RIAQISLQDN PYDGVVHNTT YGAMFTIALR
     RYGQLCIGLY RLHDQDNPDS MKRYVITNPP AELRIKNTDY VYVLEQFDPG LEYEPGKRHF
//
ID   KCNS1_HUMAN             Reviewed;         526 AA.
AC   Q96KK3; A2RUL9; B7ZM31; O43652; Q6DJU6;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 2.
DT   22-NOV-2017, entry version 136.
DE   RecName: Full=Potassium voltage-gated channel subfamily S member 1;
DE   AltName: Full=Delayed-rectifier K(+) channel alpha subunit 1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv9.1;
GN   Name=KCNS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Brain, and Lens epithelium;
RX   PubMed=10484328;
RA   Shepard A.R., Rae J.L.;
RT   "Electrically silent potassium channel subunits from human lens
RT   epithelium.";
RL   Am. J. Physiol. 277:C412-C424(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-489.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Can form functional heterotetrameric channels
CC       with KCNB1 and KCNB2; modulates the delayed rectifier voltage-
CC       gated potassium channel activation and deactivation rates of KCNB1
CC       and KCNB2 (PubMed:10484328). {ECO:0000269|PubMed:10484328}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1 (PubMed:10484328).
CC       Heterotetramer with KCNB2 (By similarity). Does not form
CC       homomultimers (PubMed:10484328). {ECO:0000250|UniProtKB:O35173,
CC       ECO:0000269|PubMed:10484328}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10484328};
CC       Multi-pass membrane protein {ECO:0000305}. Note=May not reach the
CC       plasma membrane but remain in an intracellular compartment in the
CC       absence of KCNB1 or KCNB2 (PubMed:10484328).
CC       {ECO:0000269|PubMed:10484328}.
CC   -!- TISSUE SPECIFICITY: Detected in all tissues tested with the
CC       exception of skeletal muscle. Highly expressed in adult and fetal
CC       brain, fetal kidney and lung, and adult prostate and testis
CC       (PubMed:10484328). {ECO:0000269|PubMed:10484328}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. S (TC
CC       1.A.1.2) subfamily. Kv9.1/KCNS1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF043473; AAC13165.2; -; mRNA.
DR   EMBL; Z93016; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC075033; AAH75033.2; -; mRNA.
DR   EMBL; BC075034; AAH75034.2; -; mRNA.
DR   EMBL; BC132959; AAI32960.1; -; mRNA.
DR   EMBL; BC144234; AAI44235.1; -; mRNA.
DR   CCDS; CCDS13342.1; -.
DR   RefSeq; NP_001309728.1; NM_001322799.1.
DR   RefSeq; NP_002242.2; NM_002251.4.
DR   UniGene; Hs.117780; -.
DR   UniGene; Hs.563002; -.
DR   ProteinModelPortal; Q96KK3; -.
DR   STRING; 9606.ENSP00000307694; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   TCDB; 1.A.1.2.7; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q96KK3; -.
DR   PhosphoSitePlus; Q96KK3; -.
DR   BioMuta; KCNS1; -.
DR   DMDM; 24418474; -.
DR   PaxDb; Q96KK3; -.
DR   PRIDE; Q96KK3; -.
DR   Ensembl; ENST00000306117; ENSP00000307694; ENSG00000124134.
DR   Ensembl; ENST00000537075; ENSP00000445595; ENSG00000124134.
DR   GeneID; 3787; -.
DR   KEGG; hsa:3787; -.
DR   UCSC; uc002xnc.4; human.
DR   CTD; 3787; -.
DR   DisGeNET; 3787; -.
DR   EuPathDB; HostDB:ENSG00000124134.8; -.
DR   GeneCards; KCNS1; -.
DR   HGNC; HGNC:6300; KCNS1.
DR   MIM; 602905; gene.
DR   neXtProt; NX_Q96KK3; -.
DR   OpenTargets; ENSG00000124134; -.
DR   PharmGKB; PA30078; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q96KK3; -.
DR   KO; K04931; -.
DR   OMA; PCPDEIS; -.
DR   OrthoDB; EOG091G0FP3; -.
DR   PhylomeDB; Q96KK3; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNS1; -.
DR   GenomeRNAi; 3787; -.
DR   PRO; PR:Q96KK3; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000124134; -.
DR   CleanEx; HS_KCNS1; -.
DR   ExpressionAtlas; Q96KK3; baseline and differential.
DR   Genevisible; Q96KK3; HS.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    526       Potassium voltage-gated channel subfamily
FT                                S member 1.
FT                                /FTId=PRO_0000054081.
FT   TOPO_DOM      1    217       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    218    239       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    240    270       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    271    293       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    294    304       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    305    322       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    323    337       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    338    358       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    359    373       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    374    395       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    396    408       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    409    420       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    421    428       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    429    435       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    436    464       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    465    526       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       421    426       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   COMPBIAS    250    259       Poly-Ala.
FT   VARIANT     489    489       I -> V (in dbSNP:rs734784).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_020052.
FT   VARIANT     508    508       Q -> R (in dbSNP:rs7264544).
FT                                /FTId=VAR_053867.
SQ   SEQUENCE   526 AA;  58372 MW;  00F0E415E3A68C91 CRC64;
     MLMLLVRGTH YENLRSKVVL PTPLGGRSTE TFVSEFPGPD TGIRWRRSDE ALRVNVGGVR
     RQLSARALAR FPGTRLGRLQ AAASEEQARR LCDDYDEAAR EFYFDRHPGF FLSLLHFYRT
     GHLHVLDELC VFAFGQEADY WGLGENALAA CCRARYLERR LTQPHAWDED SDTPSSVDPC
     PDEISDVQRE LARYGAARCG RLRRRLWLTM ENPGYSLPSK LFSCVSISVV LASIAAMCIH
     SLPEYQAREA AAAVAAVAAG RSPEGVRDDP VLRRLEYFCI AWFSFEVSSR LLLAPSTRNF
     FCHPLNLIDI VSVLPFYLTL LAGVALGDQG GKEFGHLGKV VQVFRLMRIF RVLKLARHST
     GLRSLGATLK HSYREVGILL LYLAVGVSVF SGVAYTAEKE EDVGFNTIPA CWWWGTVSMT
     TVGYGDVVPV TVAGKLAASG CILGGILVVA LPITIIFNKF SHFYRRQKAL EAAVRNSNHQ
     EFEDLLSSID GVSEASLETS RETSQEGQSA DLESQAPSEP PHPQMY
//
ID   KCNH8_HUMAN             Reviewed;        1107 AA.
AC   Q96L42; B7Z2I7; Q59GQ6;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   25-OCT-2017, entry version 150.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 8;
DE   AltName: Full=ELK1;
DE            Short=hElk1;
DE   AltName: Full=Ether-a-go-go-like potassium channel 3;
DE            Short=ELK channel 3;
DE            Short=ELK3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv12.1;
GN   Name=KCNH8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-893.
RC   TISSUE=Brain;
RX   PubMed=11897058; DOI=10.1177/108705710200700110;
RA   Baxter D.F., Kirk M., Garcia A.F., Raimondi A., Holmqvist M.H.,
RA   Flint K.K., Bojanic D., DiStefano P.S., Curtis R., Xie Y.;
RT   "A novel membrane potential-sensitive fluorescent dye improves cell-
RT   based assays for ion channels.";
RL   J. Biomol. Screen. 7:79-85(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 525-1107 (ISOFORM 1).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=12890647; DOI=10.1152/ajpcell.00179.2003;
RA   Zou A., Lin Z., Humble M., Creech C.D., Wagoner P.K., Krafte D.,
RA   Jegla T.J., Wickenden A.D.;
RT   "Distribution and functional properties of human KCNH8 (Elk1)
RT   potassium channels.";
RL   Am. J. Physiol. 285:C1356-C1366(2003).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium
CC       channel. Elicits a slowly activating, outward rectifying current.
CC       Channel properties may be modulated by cAMP and subunit assembly.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96L42-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96L42-2; Sequence=VSP_057036, VSP_057037, VSP_057038,
CC                                  VSP_057039;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Primarily expressed in the nervous system.
CC       {ECO:0000269|PubMed:12890647}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag) (TC
CC       1.A.1.20) subfamily. Kv12.1/KCNH8 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY053503; AAL15429.1; -; mRNA.
DR   EMBL; AK294759; BAH11873.1; -; mRNA.
DR   EMBL; AC015542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC061958; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC099538; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC116098; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135452; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138315; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB209053; BAD92290.1; -; mRNA.
DR   CCDS; CCDS2632.1; -. [Q96L42-1]
DR   RefSeq; NP_653234.2; NM_144633.2. [Q96L42-1]
DR   UniGene; Hs.475656; -.
DR   ProteinModelPortal; Q96L42; -.
DR   SMR; Q96L42; -.
DR   ELM; Q96L42; -.
DR   STRING; 9606.ENSP00000328813; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   GuidetoPHARMACOLOGY; 575; -.
DR   iPTMnet; Q96L42; -.
DR   PhosphoSitePlus; Q96L42; -.
DR   BioMuta; KCNH8; -.
DR   DMDM; 229462927; -.
DR   EPD; Q96L42; -.
DR   PaxDb; Q96L42; -.
DR   PeptideAtlas; Q96L42; -.
DR   PRIDE; Q96L42; -.
DR   DNASU; 131096; -.
DR   Ensembl; ENST00000328405; ENSP00000328813; ENSG00000183960. [Q96L42-1]
DR   GeneID; 131096; -.
DR   KEGG; hsa:131096; -.
DR   UCSC; uc003cbk.2; human. [Q96L42-1]
DR   CTD; 131096; -.
DR   DisGeNET; 131096; -.
DR   EuPathDB; HostDB:ENSG00000183960.8; -.
DR   GeneCards; KCNH8; -.
DR   H-InvDB; HIX0030767; -.
DR   HGNC; HGNC:18864; KCNH8.
DR   MIM; 608260; gene.
DR   neXtProt; NX_Q96L42; -.
DR   OpenTargets; ENSG00000183960; -.
DR   PharmGKB; PA38724; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140833; -.
DR   HOGENOM; HOG000230794; -.
DR   HOVERGEN; HBG052232; -.
DR   InParanoid; Q96L42; -.
DR   KO; K04911; -.
DR   OMA; NGSSFWC; -.
DR   OrthoDB; EOG091G0OXR; -.
DR   PhylomeDB; Q96L42; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNH8; human.
DR   GeneWiki; KCNH8; -.
DR   GenomeRNAi; 131096; -.
DR   PRO; PR:Q96L42; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000183960; -.
DR   CleanEx; HS_KCNH8; -.
DR   ExpressionAtlas; Q96L42; baseline and differential.
DR   Genevisible; Q96L42; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003950; K_chnl_volt-dep_ELK.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01465; ELKCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00086; PAC; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1107       Potassium voltage-gated channel subfamily
FT                                H member 8.
FT                                /FTId=PRO_0000054018.
FT   TOPO_DOM      1    225       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    226    246       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    247    255       Extracellular. {ECO:0000255}.
FT   TRANSMEM    256    276       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    277    298       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    299    319       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    320    327       Extracellular. {ECO:0000255}.
FT   TRANSMEM    328    348       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    349    357       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    358    378       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    379    419       Extracellular. {ECO:0000255}.
FT   INTRAMEM    420    440       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    441    448       Extracellular. {ECO:0000255}.
FT   TRANSMEM    449    469       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    470   1107       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       18     90       PAS.
FT   DOMAIN       93    145       PAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00141}.
FT   NP_BIND     551    668       cNMP.
FT   MOTIF       434    439       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS    711    723       Poly-Glu.
FT   COMPBIAS    951   1064       Ser-rich.
FT   CARBOHYD    320    320       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    409    409       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    359       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057036.
FT   VAR_SEQ     459    459       A -> VSQFQVCPRPSWIICWFRNHFGFILLMTT (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057037.
FT   VAR_SEQ     515    516       WS -> CF (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057038.
FT   VAR_SEQ     517   1107       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057039.
FT   VARIANT     893    893       Q -> R (in dbSNP:rs33915638).
FT                                {ECO:0000269|PubMed:11897058}.
FT                                /FTId=VAR_055098.
FT   VARIANT     984    984       E -> Q (in dbSNP:rs35160416).
FT                                /FTId=VAR_055099.
FT   CONFLICT    525    525       E -> Q (in Ref. 4; BAD92290).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1107 AA;  123804 MW;  F0E5DEC9A7877869 CRC64;
     MPVMKGLLAP QNTFLDTIAT RFDGTHSNFI LANAQVAKGF PIVYCSDGFC ELAGFARTEV
     MQKSCSCKFL FGVETNEQLM LQIEKSLEEK TEFKGEIMFY KKNGSPFWCL LDIVPIKNEK
     GDVVLFLASF KDITDTKVKI TPEDKKEDKV KGRSRAGTHF DSARRRSRAV LYHISGHLQR
     REKNKLKINN NVFVDKPAFP EYKVSDAKKS KFILLHFSTF KAGWDWLILL ATFYVAVTVP
     YNVCFIGNDD LSTTRSTTVS DIAVEILFII DIILNFRTTY VSKSGQVIFE ARSICIHYVT
     TWFIIDLIAA LPFDLLYAFN VTVVSLVHLL KTVRLLRLLR LLQKLDRYSQ HSTIVLTLLM
     SMFALLAHWM ACIWYVIGKM EREDNSLLKW EVGWLHELGK RLESPYYGNN TLGGPSIRSA
     YIAALYFTLS SLTSVGFGNV SANTDAEKIF SICTMLIGAL MHALVFGNVT AIIQRMYSRW
     SLYHTRTKDL KDFIRVHHLP QQLKQRMLEY FQTTWSVNNG IDSNELLKDF PDELRSDITM
     HLNKEILQLS LFECASRGCL RSLSLHIKTS FCAPGEYLLR QGDALQAIYF VCSGSMEVLK
     DSMVLAILGK GDLIGANLSI KDQVIKTNAD VKALTYCDLQ CIILKGLFEV LDLYPEYAHK
     FVEDIQHDLT YNLREGHESD VISRLSNKSM VSQSEPKGNG NINKRLPSIV EDEEEEEEGE
     EEEAVSLSPI CTRGSSSRNK KVGSNKAYLG LSLKQLASGT VPFHSPIRVS RSNSPKTKQE
     IDPPNHNKRK EKNLKLQLST LNNAGPPDLS PRIVDGIEDG NSSEESQTFD FGSERIRSEP
     RISPPLGDPE IGAAVLFIKA EETKQQINKL NSEVTTLTQE VSQLGKDMRN VIQLLENVLS
     PQQPSRFCSL HSTSVCPSRE SLQTRTSWSA HQPCLHLQTG GAAYTQAQLC SSNITSDIWS
     VDPSSVGSSP QRTGAHEQNP ADSELYHSPS LDYSPSHYQV VQEGHLQFLR CISPHSDSTL
     TPLQSISATL SSSVCSSSET SLHLVLPSRS EEGSFSQGTV SSFSLENLPG SWNQEGMASA
     STKPLENLPL EVVTSTAEVK DNKAINV
//
ID   KCNA7_HUMAN             Reviewed;         456 AA.
AC   Q96RP8; A1KYX7; Q9BYS4;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-NOV-2017, entry version 118.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 7;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.7;
GN   Name=KCNA7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT THR-418, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=11368907; DOI=10.1016/S0378-1119(01)00423-1;
RA   Kashuba V.I., Kvasha S.M., Protopopov A.I., Gizatullin R.Z.,
RA   Rynditch A.V., Wahlestedt C., Wasserman W.W., Zabarovsky E.R.;
RT   "Initial isolation and analysis of the human Kv1.7 (KCNA7) gene, a
RT   member of the voltage-gated potassium channel gene family.";
RL   Gene 268:115-122(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS ARG-189 AND THR-418, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=11896454; DOI=10.1038/sj.ejhg.5200739;
RA   Bardien-Kruger S., Wulff H., Arieff Z., Brink P., Chandy K.G.,
RA   Corfield V.;
RT   "Characterisation of the human voltage-gated potassium channel gene,
RT   KCNA7, a candidate gene for inherited cardiac disorders, and its
RT   exclusion as cause of progressive familial heart block I (PFHBI).";
RL   Eur. J. Hum. Genet. 10:36-43(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ARG-189.
RC   TISSUE=Heart muscle;
RA   Finol-Urdaneta R.K., Struever N., Terlau H.;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Mediates the voltage-dependent potassium ion
CC       permeability of excitable membranes. Assuming opened or closed
CC       conformations in response to the voltage difference across the
CC       membrane, the protein forms a potassium-selective channel through
CC       which potassium ions may pass in accordance with their
CC       electrochemical gradient (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterotetramer of potassium channel proteins.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in skeletal muscle, heart and
CC       kidney. {ECO:0000269|PubMed:11368907,
CC       ECO:0000269|PubMed:11896454}.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments. {ECO:0000250}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.7/KCNA7 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ310479; CAC29065.1; -; mRNA.
DR   EMBL; AF315818; AAK63002.1; -; mRNA.
DR   EMBL; AY779768; AAX11186.1; -; mRNA.
DR   CCDS; CCDS12755.1; -.
DR   RefSeq; NP_114092.2; NM_031886.2.
DR   UniGene; Hs.306973; -.
DR   ProteinModelPortal; Q96RP8; -.
DR   SMR; Q96RP8; -.
DR   STRING; 9606.ENSP00000221444; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   GuidetoPHARMACOLOGY; 544; -.
DR   iPTMnet; Q96RP8; -.
DR   PhosphoSitePlus; Q96RP8; -.
DR   BioMuta; KCNA7; -.
DR   DMDM; 74752109; -.
DR   EPD; Q96RP8; -.
DR   PaxDb; Q96RP8; -.
DR   PeptideAtlas; Q96RP8; -.
DR   PRIDE; Q96RP8; -.
DR   Ensembl; ENST00000221444; ENSP00000221444; ENSG00000104848.
DR   GeneID; 3743; -.
DR   KEGG; hsa:3743; -.
DR   UCSC; uc002pmg.3; human.
DR   CTD; 3743; -.
DR   DisGeNET; 3743; -.
DR   EuPathDB; HostDB:ENSG00000104848.1; -.
DR   GeneCards; KCNA7; -.
DR   HGNC; HGNC:6226; KCNA7.
DR   MIM; 176268; gene.
DR   neXtProt; NX_Q96RP8; -.
DR   OpenTargets; ENSG00000104848; -.
DR   PharmGKB; PA30023; -.
DR   eggNOG; KOG1545; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118846; -.
DR   HOGENOM; HOG000231015; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q96RP8; -.
DR   KO; K04880; -.
DR   OMA; PCGCCER; -.
DR   OrthoDB; EOG091G10NU; -.
DR   PhylomeDB; Q96RP8; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNA7; -.
DR   GenomeRNAi; 3743; -.
DR   PRO; PR:Q96RP8; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000104848; -.
DR   CleanEx; HS_KCNA7; -.
DR   Genevisible; Q96RP8; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Lipoprotein; Membrane; Palmitate; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    456       Potassium voltage-gated channel subfamily
FT                                A member 7.
FT                                /FTId=PRO_0000308273.
FT   TRANSMEM    144    164       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    209    229       Helical; Name=Segment S2. {ECO:0000255}.
FT   TRANSMEM    241    261       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    276    295       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TRANSMEM    312    332       Helical; Name=Segment S5. {ECO:0000255}.
FT   TRANSMEM    373    393       Helical; Name=Segment S6. {ECO:0000255}.
FT   MOTIF       358    363       Selectivity filter. {ECO:0000250}.
FT   LIPID       231    231       S-palmitoyl cysteine. {ECO:0000255}.
FT   CARBOHYD    191    191       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     189    189       P -> R (in dbSNP:rs1611775).
FT                                {ECO:0000269|PubMed:11896454,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_036776.
FT   VARIANT     418    418       M -> T (in dbSNP:rs1017219).
FT                                {ECO:0000269|PubMed:11368907,
FT                                ECO:0000269|PubMed:11896454}.
FT                                /FTId=VAR_036777.
FT   CONFLICT     71     71       Y -> H (in Ref. 3; AAX11186).
FT                                {ECO:0000305}.
FT   CONFLICT    180    180       A -> V (in Ref. 3; AAX11186).
FT                                {ECO:0000305}.
SQ   SEQUENCE   456 AA;  50559 MW;  EF9980CF54D52FB8 CRC64;
     MEPRCPPPCG CCERLVLNVA GLRFETRART LGRFPDTLLG DPARRGRFYD DARREYFFDR
     HRPSFDAVLY YYQSGGRLRR PAHVPLDVFL EEVAFYGLGA AALARLREDE GCPVPPERPL
     PRRAFARQLW LLFEFPESSQ AARVLAVVSV LVILVSIVVF CLETLPDFRD DRDGTGLAAA
     AAAGPFPAPL NGSSQMPGNP PRLPFNDPFF VVETLCICWF SFELLVRLLV CPSKAIFFKN
     VMNLIDFVAI LPYFVALGTE LARQRGVGQQ AMSLAILRVI RLVRVFRIFK LSRHSKGLQI
     LGQTLRASMR ELGLLIFFLF IGVVLFSSAV YFAEVDRVDS HFTSIPESFW WAVVTMTTVG
     YGDMAPVTVG GKIVGSLCAI AGVLTISLPV PVIVSNFSYF YHRETEGEEA GMFSHVDMQP
     CGPLEGKANG GLVDGEVPEL PPPLWAPPGK HLVTEV
//
ID   KCNKH_HUMAN             Reviewed;         332 AA.
AC   Q96T54; E9PB46; Q5TCF4; Q8TAW4; Q9BXD1; Q9H592;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   25-OCT-2017, entry version 143.
DE   RecName: Full=Potassium channel subfamily K member 17;
DE   AltName: Full=2P domain potassium channel Talk-2;
DE   AltName: Full=Acid-sensitive potassium channel protein TASK-4;
DE   AltName: Full=TWIK-related acid-sensitive K(+) channel 4;
DE   AltName: Full=TWIK-related alkaline pH-activated K(+) channel 2;
DE            Short=TALK-2;
GN   Name=KCNK17; Synonyms=TALK2, TASK4; ORFNames=UNQ5816/PRO19634;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=11263999; DOI=10.1006/bbrc.2001.4562;
RA   Girard C., Duprat F., Terrenoire C., Tinel N., Fosset M., Romey G.,
RA   Lazdunski M., Lesage F.;
RT   "Genomic and functional characteristics of novel human pancreatic 2P
RT   domain K(+) channels.";
RL   Biochem. Biophys. Res. Commun. 282:249-256(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLY-21.
RC   TISSUE=Adrenal gland;
RX   PubMed=11248242; DOI=10.1016/S0014-5793(01)02222-0;
RA   Decher N., Maier M., Dittrich W., Gassenhuber J., Brueggemann A.,
RA   Busch A.E., Steinmeyer K.;
RT   "Characterization of TASK-4, a novel member of the pH-sensitive, two-
RT   pore domain potassium channel family.";
RL   FEBS Lett. 492:84-89(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-21.
RC   TISSUE=Lung, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Outward rectifying potassium channel. Produces rapidly
CC       activating and non-inactivating outward rectifier K(+) currents.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96T54-3; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96T54-4; Sequence=VSP_047354;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- MISCELLANEOUS: Inhibited by Ba(2+), quinidine, chloroform and
CC       halothane. Activated at alkaline pH. Activated by quinine and
CC       isoflurane.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK28551.1; Type=Frameshift; Positions=260; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF358910; AAK49533.1; -; mRNA.
DR   EMBL; AF339912; AAK28551.1; ALT_FRAME; mRNA.
DR   EMBL; AY358853; AAQ89212.1; -; mRNA.
DR   EMBL; AL136087; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC025726; AAH25726.1; -; mRNA.
DR   CCDS; CCDS47419.1; -. [Q96T54-4]
DR   CCDS; CCDS4842.1; -. [Q96T54-3]
DR   RefSeq; NP_001128583.1; NM_001135111.1. [Q96T54-4]
DR   RefSeq; NP_113648.2; NM_031460.3. [Q96T54-3]
DR   UniGene; Hs.162282; -.
DR   ProteinModelPortal; Q96T54; -.
DR   BioGrid; 124608; 1.
DR   STRING; 9606.ENSP00000362328; -.
DR   TCDB; 1.A.1.9.6; the voltage-gated ion channel (vic) superfamily.
DR   BioMuta; KCNK17; -.
DR   DMDM; 24636280; -.
DR   PaxDb; Q96T54; -.
DR   PeptideAtlas; Q96T54; -.
DR   PRIDE; Q96T54; -.
DR   DNASU; 89822; -.
DR   Ensembl; ENST00000373231; ENSP00000362328; ENSG00000124780. [Q96T54-3]
DR   Ensembl; ENST00000453413; ENSP00000401271; ENSG00000124780. [Q96T54-4]
DR   GeneID; 89822; -.
DR   KEGG; hsa:89822; -.
DR   UCSC; uc003ooo.4; human. [Q96T54-3]
DR   CTD; 89822; -.
DR   DisGeNET; 89822; -.
DR   EuPathDB; HostDB:ENSG00000124780.13; -.
DR   GeneCards; KCNK17; -.
DR   HGNC; HGNC:14465; KCNK17.
DR   HPA; HPA043892; -.
DR   MIM; 607370; gene.
DR   neXtProt; NX_Q96T54; -.
DR   OpenTargets; ENSG00000124780; -.
DR   PharmGKB; PA30058; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000074161; -.
DR   HOVERGEN; HBG052240; -.
DR   InParanoid; Q96T54; -.
DR   KO; K04925; -.
DR   OMA; SMGRWEF; -.
DR   OrthoDB; EOG091G08DF; -.
DR   PhylomeDB; Q96T54; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-HSA-1299361; TWIK-related alkaline pH activated K+ channel (TALK).
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   GeneWiki; KCNK17; -.
DR   GenomeRNAi; 89822; -.
DR   PRO; PR:Q96T54; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000124780; -.
DR   CleanEx; HS_KCNK17; -.
DR   Genevisible; Q96T54; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005267; F:potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0006813; P:potassium ion transport; IDA:UniProtKB.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    332       Potassium channel subfamily K member 17.
FT                                /FTId=PRO_0000101768.
FT   TOPO_DOM      1     20       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     21     43       Helical. {ECO:0000255}.
FT   INTRAMEM    106    124       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    128    148       Helical. {ECO:0000255}.
FT   TOPO_DOM    149    179       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    180    200       Helical. {ECO:0000255}.
FT   INTRAMEM    211    230       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    244    264       Helical. {ECO:0000255}.
FT   TOPO_DOM    265    332       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     65     65       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     94     94       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     230    332       GMNPSQRYPLWYKNMVSLWILFGMAWLALIIKLILSQLETP
FT                                GRVCSCCHHSSKEDFKSQSWRQGPDREPESHSPQQGCYPEG
FT                                PMGIIQHLEPSAHAAGCGKDS -> ASCLISDTRKPNRDWQ
FT                                TLERTSKSSGGLLKYRFLAGHGGSHL (in isoform
FT                                2). {ECO:0000305}.
FT                                /FTId=VSP_047354.
FT   VARIANT      21     21       S -> G (in dbSNP:rs10947804).
FT                                {ECO:0000269|PubMed:11248242,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_032362.
FT   VARIANT     253    253       M -> L (in dbSNP:rs35677794).
FT                                /FTId=VAR_032363.
FT   VARIANT     296    296       R -> Q (in dbSNP:rs2758910).
FT                                /FTId=VAR_024683.
SQ   SEQUENCE   332 AA;  36895 MW;  1848DBC06E078158 CRC64;
     MYRPRARAAP EGRVRGCAVP STVLLLLAYL AYLALGTGVF WTLEGRAAQD SSRSFQRDKW
     ELLQNFTCLD RPALDSLIRD VVQAYKNGAS LLSNTTSMGR WELVGSFFFS VSTITTIGYG
     NLSPNTMAAR LFCIFFALVG IPLNLVVLNR LGHLMQQGVN HWASRLGGTW QDPDKARWLA
     GSGALLSGLL LFLLLPPLLF SHMEGWSYTE GFYFAFITLS TVGFGDYVIG MNPSQRYPLW
     YKNMVSLWIL FGMAWLALII KLILSQLETP GRVCSCCHHS SKEDFKSQSW RQGPDREPES
     HSPQQGCYPE GPMGIIQHLE PSAHAAGCGK DS
//
ID   KCNKG_HUMAN             Reviewed;         309 AA.
AC   Q96T55; B5TJL9; Q2M2N9; Q5TCF3; Q6X6Z3; Q6X6Z4; Q6X6Z5; Q9H591;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-NOV-2017, entry version 129.
DE   RecName: Full=Potassium channel subfamily K member 16;
DE   AltName: Full=2P domain potassium channel Talk-1;
DE   AltName: Full=TWIK-related alkaline pH-activated K(+) channel 1;
DE            Short=TALK-1;
GN   Name=KCNK16; Synonyms=TALK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RC   TISSUE=Pancreas;
RX   PubMed=11263999; DOI=10.1006/bbrc.2001.4562;
RA   Girard C., Duprat F., Terrenoire C., Tinel N., Fosset M., Romey G.,
RA   Lazdunski M., Lesage F.;
RT   "Genomic and functional characteristics of novel human pancreatic 2P
RT   domain K(+) channels.";
RL   Biochem. Biophys. Res. Commun. 282:249-256(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS B; C AND D), TISSUE SPECIFICITY,
RP   ALTERNATIVE SPLICING, AND VARIANT HIS-301.
RX   PubMed=12724142; DOI=10.1152/ajpcell.00601.2002;
RA   Han J., Kang D., Kim D.;
RT   "Functional properties of four splice variants of a human pancreatic
RT   tandem-pore K+ channel, TALK-1.";
RL   Am. J. Physiol. 285:C529-C538(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RC   TISSUE=Pancreas;
RX   PubMed=18516069; DOI=10.1038/bjp.2008.213;
RA   Gierten J., Ficker E., Bloehs R., Schlomer K., Kathofer S., Scholz E.,
RA   Zitron E., Kiesecker C., Bauer A., Becker R., Katus H.A., Karle C.A.,
RA   Thomas D.;
RT   "Regulation of two-pore-domain (K2P) potassium leak channels by the
RT   tyrosine kinase inhibitor genistein.";
RL   Br. J. Pharmacol. 154:1680-1690(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT HIS-301.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM C).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Outward rectifying potassium channel. Produces rapidly
CC       activating and non-inactivating outward rectifier K(+) currents.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- INTERACTION:
CC       P32242:OTX1; NbExp=3; IntAct=EBI-10294109, EBI-740446;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=a;
CC         IsoId=Q96T55-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=Q96T55-3; Sequence=VSP_039865;
CC       Name=c;
CC         IsoId=Q96T55-4; Sequence=VSP_039863;
CC       Name=d;
CC         IsoId=Q96T55-5; Sequence=VSP_039864;
CC   -!- TISSUE SPECIFICITY: Highly expressed in pancreas. Not detectable
CC       in the other tissues tested. {ECO:0000269|PubMed:12724142}.
CC   -!- MISCELLANEOUS: Inhibited by Ba(2+), quinine, quinidine, chloroform
CC       and halothane. Activated at alkaline pH.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF358909; AAK49532.1; -; mRNA.
DR   EMBL; AY253145; AAP82866.1; -; mRNA.
DR   EMBL; AY253146; AAP82867.1; -; mRNA.
DR   EMBL; AY253147; AAP82868.1; -; mRNA.
DR   EMBL; EU978943; ACH86102.1; -; mRNA.
DR   EMBL; AL136087; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03982.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03984.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03985.1; -; Genomic_DNA.
DR   EMBL; BC111860; AAI11861.1; -; mRNA.
DR   CCDS; CCDS47420.1; -. [Q96T55-5]
DR   CCDS; CCDS47421.1; -. [Q96T55-4]
DR   CCDS; CCDS47422.1; -. [Q96T55-3]
DR   CCDS; CCDS4843.1; -. [Q96T55-1]
DR   RefSeq; NP_001128577.1; NM_001135105.1. [Q96T55-4]
DR   RefSeq; NP_001128578.1; NM_001135106.1. [Q96T55-3]
DR   RefSeq; NP_001128579.1; NM_001135107.1. [Q96T55-5]
DR   RefSeq; NP_115491.1; NM_032115.3. [Q96T55-1]
DR   RefSeq; XP_016866835.1; XM_017011346.1. [Q96T55-5]
DR   UniGene; Hs.287765; -.
DR   ProteinModelPortal; Q96T55; -.
DR   BioGrid; 123763; 24.
DR   IntAct; Q96T55; 2.
DR   STRING; 9606.ENSP00000391498; -.
DR   TCDB; 1.A.1.9.10; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q96T55; -.
DR   PhosphoSitePlus; Q96T55; -.
DR   BioMuta; KCNK16; -.
DR   DMDM; 24636281; -.
DR   PaxDb; Q96T55; -.
DR   PRIDE; Q96T55; -.
DR   Ensembl; ENST00000373227; ENSP00000362324; ENSG00000095981. [Q96T55-5]
DR   Ensembl; ENST00000373229; ENSP00000362326; ENSG00000095981. [Q96T55-1]
DR   Ensembl; ENST00000425054; ENSP00000391498; ENSG00000095981. [Q96T55-4]
DR   Ensembl; ENST00000437525; ENSP00000415375; ENSG00000095981. [Q96T55-3]
DR   GeneID; 83795; -.
DR   KEGG; hsa:83795; -.
DR   UCSC; uc003ooq.3; human. [Q96T55-1]
DR   CTD; 83795; -.
DR   DisGeNET; 83795; -.
DR   EuPathDB; HostDB:ENSG00000095981.10; -.
DR   GeneCards; KCNK16; -.
DR   HGNC; HGNC:14464; KCNK16.
DR   MIM; 607369; gene.
DR   neXtProt; NX_Q96T55; -.
DR   OpenTargets; ENSG00000095981; -.
DR   PharmGKB; PA30057; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOVERGEN; HBG104884; -.
DR   InParanoid; Q96T55; -.
DR   KO; K04924; -.
DR   OMA; GWSYGEG; -.
DR   OrthoDB; EOG091G0E3R; -.
DR   PhylomeDB; Q96T55; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-HSA-1299361; TWIK-related alkaline pH activated K+ channel (TALK).
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   GeneWiki; KCNK16; -.
DR   GenomeRNAi; 83795; -.
DR   PRO; PR:Q96T55; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000095981; -.
DR   CleanEx; HS_KCNK16; -.
DR   ExpressionAtlas; Q96T55; baseline and differential.
DR   Genevisible; Q96T55; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005267; F:potassium channel activity; IDA:MGI.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0006813; P:potassium ion transport; IDA:MGI.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    309       Potassium channel subfamily K member 16.
FT                                /FTId=PRO_0000101767.
FT   TOPO_DOM      1     13       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     14     34       Helical. {ECO:0000255}.
FT   INTRAMEM     98    116       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    120    140       Helical. {ECO:0000255}.
FT   TOPO_DOM    141    165       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    166    186       Helical. {ECO:0000255}.
FT   INTRAMEM    202    221       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    238    258       Helical. {ECO:0000255}.
FT   TOPO_DOM    259    309       Cytoplasmic. {ECO:0000255}.
FT   VAR_SEQ     222    309       TDPSKHYISVYRSLAAIWILLGLAWLALILPLGPLLLHRCC
FT                                QLWLLSLRQGCGAKAAPGRRPRRGSTAARGVQVTPQDFPIS
FT                                KKGLGS -> HPLNFITPSGLLPSQEPFQTPHGKPESQQIP
FT                                GSFQKVSSMNVWPLSGMHSPGLAFPLPDCNIPDQERFRPLH
FT                                PGAWKFWPLPLPSSNSKWAPMWLGSSAQV (in isoform
FT                                c). {ECO:0000303|PubMed:12724142,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039863.
FT   VAR_SEQ     222    268       Missing (in isoform d).
FT                                {ECO:0000303|PubMed:12724142}.
FT                                /FTId=VSP_039864.
FT   VAR_SEQ     269    309       LRQGCGAKAAPGRRPRRGSTAARGVQVTPQDFPISKKGLGS
FT                                -> RGLGVKDGAASDPSGLPRPQKIPISA (in isoform
FT                                b). {ECO:0000303|PubMed:12724142,
FT                                ECO:0000303|PubMed:18516069}.
FT                                /FTId=VSP_039865.
FT   VARIANT     215    215       F -> L (in dbSNP:rs9462527).
FT                                /FTId=VAR_063636.
FT   VARIANT     275    275       A -> G (in dbSNP:rs1535500).
FT                                /FTId=VAR_063637.
FT   VARIANT     301    301       P -> H (in dbSNP:rs11756091).
FT                                {ECO:0000269|PubMed:12724142,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_052430.
FT   CONFLICT     49     49       L -> S (in Ref. 2; AAP82866).
FT                                {ECO:0000305}.
FT   CONFLICT    149    149       A -> V (in Ref. 2; AAP82867).
FT                                {ECO:0000305}.
FT   CONFLICT    200    200       S -> G (in Ref. 2; AAP82866).
FT                                {ECO:0000305}.
FT   CONFLICT    205    207       FAF -> LLS (in Ref. 2; AAP82867).
FT                                {ECO:0000305}.
SQ   SEQUENCE   309 AA;  34153 MW;  99C4B11EB26B0764 CRC64;
     MPSAGLCSCW GGRVLPLLLA YVCYLLLGAT IFQLLERQAE AQSRDQFQLE KLRFLENYTC
     LDQWAMEQFV QVIMEAWVKG VNPKGNSTNP SNWDFGSSFF FAGTVVTTIG YGNLAPSTEA
     GQVFCVFYAL LGIPLNVIFL NHLGTGLRAH LAAIERWEDR PRRSQVLQVL GLALFLTLGT
     LVILIFPPMV FSHVEGWSFS EGFYFAFITL STIGFGDYVV GTDPSKHYIS VYRSLAAIWI
     LLGLAWLALI LPLGPLLLHR CCQLWLLSLR QGCGAKAAPG RRPRRGSTAA RGVQVTPQDF
     PISKKGLGS
//
ID   TVOK_THEVO              Reviewed;         348 AA.
AC   Q979Z2;
DT   15-MAR-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 1.
DT   20-DEC-2017, entry version 95.
DE   RecName: Full=Calcium-gated potassium channel TvoK {ECO:0000305};
GN   Name=tvoK {ECO:0000303|PubMed:17588939};
GN   ORFNames=TVG1041141 {ECO:0000312|EMBL:BAB60160.1};
OS   Thermoplasma volcanium (strain ATCC 51530 / DSM 4299 / JCM 9571 / NBRC
OS   15438 / GSS1).
OC   Archaea; Euryarchaeota; Thermoplasmata; Thermoplasmatales;
OC   Thermoplasmataceae; Thermoplasma.
OX   NCBI_TaxID=273116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 51530 / DSM 4299 / JCM 9571 / NBRC 15438 / GSS1;
RX   PubMed=11121031; DOI=10.1073/pnas.97.26.14257;
RA   Kawashima T., Amano N., Koike H., Makino S., Higuchi S.,
RA   Kawashima-Ohya Y., Watanabe K., Yamazaki M., Kanehori K., Kawamoto T.,
RA   Nunoshiba T., Yamamoto Y., Aramaki H., Makino K., Suzuki M.;
RT   "Archaeal adaptation to higher temperatures revealed by genomic
RT   sequence of Thermoplasma volcanium.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14257-14262(2000).
RN   [2]
RP   FUNCTION, SUBUNIT, ALTERNATIVE INITIATION, AND MUTAGENESIS OF ARG-111;
RP   LYS-114; LEU-115 AND LYS-117.
RX   PubMed=17588939; DOI=10.1074/jbc.M703650200;
RA   Parfenova L.V., Abarca-Heidemann K., Crane B.M., Rothberg B.S.;
RT   "Molecular architecture and divalent cation activation of TvoK, a
RT   prokaryotic potassium channel.";
RL   J. Biol. Chem. 282:24302-24309(2007).
CC   -!- FUNCTION: Calcium-gated potassium channel. Can also be activated
CC       by Mg(2+), Mn(2+) and Ni(2+). {ECO:0000269|PubMed:17588939}.
CC   -!- SUBUNIT: Heterooctamer composed of four full-length subunits and
CC       four soluble RCK domains. {ECO:0000269|PubMed:17588939}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=1 {ECO:0000305}; Synonyms=Calcium-gated potassium channel
CC       {ECO:0000305};
CC         IsoId=Q979Z2-1; Sequence=Displayed;
CC       Name=2 {ECO:0000305}; Synonyms=Soluble RCK domain {ECO:0000305};
CC         IsoId=Q979Z2-2; Sequence=VSP_059160, VSP_059161;
CC         Note=Starts at UUG codon. {ECO:0000269|PubMed:17588939};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000011; BAB60160.1; -; Genomic_DNA.
DR   RefSeq; WP_010917246.1; NC_002689.2.
DR   ProteinModelPortal; Q979Z2; -.
DR   SMR; Q979Z2; -.
DR   STRING; 273116.TVN0988; -.
DR   TCDB; 1.A.1.13.3; the voltage-gated ion channel (vic) superfamily.
DR   EnsemblBacteria; BAB60160; BAB60160; BAB60160.
DR   GeneID; 1441128; -.
DR   KEGG; tvo:TVG1041141; -.
DR   eggNOG; arCOG01958; Archaea.
DR   eggNOG; COG1226; LUCA.
DR   KO; K10716; -.
DR   OMA; AMIIEGN; -.
DR   OrthoDB; POG093Z055I; -.
DR   Proteomes; UP000001017; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR006037; RCK_C.
DR   InterPro; IPR003148; RCK_N.
DR   Pfam; PF07885; Ion_trans_2; 1.
DR   Pfam; PF02254; TrkA_N; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS51202; RCK_C; 1.
DR   PROSITE; PS51201; RCK_N; 1.
PE   1: Evidence at protein level;
KW   Alternative initiation; Calcium; Cell membrane; Complete proteome;
KW   Ion channel; Ion transport; Magnesium; Manganese; Membrane;
KW   Metal-binding; Nickel; Potassium; Potassium channel;
KW   Potassium transport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    348       Calcium-gated potassium channel TvoK.
FT                                /FTId=PRO_0000439237.
FT   TRANSMEM     19     39       Helical. {ECO:0000255}.
FT   TRANSMEM     52     72       Helical. {ECO:0000255}.
FT   TRANSMEM     80    100       Helical. {ECO:0000255}.
FT   DOMAIN      122    253       RCK N-terminal. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00543}.
FT   DOMAIN      266    348       RCK C-terminal. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00544}.
FT   VAR_SEQ       1    114       Missing (in isoform 2).
FT                                {ECO:0000269|PubMed:17588939}.
FT                                /FTId=VSP_059160.
FT   VAR_SEQ     115    115       L -> M (in isoform 2).
FT                                /FTId=VSP_059161.
FT   MUTAGEN     111    111       R->N: Reduces levels of the soluble RCK
FT                                domain. {ECO:0000269|PubMed:17588939}.
FT   MUTAGEN     114    114       K->N: Does not affect levels of the
FT                                soluble RCK domain.
FT                                {ECO:0000269|PubMed:17588939}.
FT   MUTAGEN     115    115       L->N: Abolishes expression of the soluble
FT                                RCK domain.
FT                                {ECO:0000269|PubMed:17588939}.
FT   MUTAGEN     117    117       K->N: Does not affect levels of the
FT                                soluble RCK domain.
FT                                {ECO:0000269|PubMed:17588939}.
SQ   SEQUENCE   348 AA;  38605 MW;  706E08967EABA376 CRC64;
     MRPFRTLVKV LQKIESSPLT KVFMAFIIVV LIGSYLEFLT QRNVKYSEIK NYFTAIWFTM
     ETVTTVGYGD VVPVSNLGRV VAMLIMVSGI GLLGTLTATI SAYLFQIRIE RRGKLEKRLK
     NHTIICNWNA YTRNIIEGNR DEEAAPIVIL SENTDNSEKY QNVFFVKGDC TSEDDLKNAA
     IEDAARVVIM SDIENNAIPE DLLDAKTLLS IFTVRKLNNA VEIIAEVRDE KNKKHAVSAG
     ATEVLSVGEL SSRLISRSIS NPGLTDFILK SLSETEDFKI FSIEACGILP GMTVKDAASN
     LAEVCVIISV ISKGKIEYPP DRSYKIGAGD YVVFLAKNKK EVEEAIKG
//
ID   CNGK1_RHILO             Reviewed;         355 AA.
AC   Q98GN8;
DT   14-OCT-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 1.
DT   25-OCT-2017, entry version 102.
DE   RecName: Full=Cyclic nucleotide-gated potassium channel mll3241;
DE   AltName: Full=MlotiK1 channel;
GN   OrderedLocusNames=mll3241;
OS   Rhizobium loti (strain MAFF303099) (Mesorhizobium loti).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rhizobiales;
OC   Phyllobacteriaceae; Mesorhizobium.
OX   NCBI_TaxID=266835;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=MAFF303099;
RX   PubMed=11214968; DOI=10.1093/dnares/7.6.331;
RA   Kaneko T., Nakamura Y., Sato S., Asamizu E., Kato T., Sasamoto S.,
RA   Watanabe A., Idesawa K., Ishikawa A., Kawashima K., Kimura T.,
RA   Kishida Y., Kiyokawa C., Kohara M., Matsumoto M., Matsuno A.,
RA   Mochizuki Y., Nakayama S., Nakazaki N., Shimpo S., Sugimoto M.,
RA   Takeuchi C., Yamada M., Tabata S.;
RT   "Complete genome structure of the nitrogen-fixing symbiotic bacterium
RT   Mesorhizobium loti.";
RL   DNA Res. 7:331-338(2000).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 218-355 IN COMPLEXES WITH
RP   CAMP, FUNCTION, SUBUNIT, AND MUTAGENESIS OF TRP-227 AND ARG-348.
RX   PubMed=15550244; DOI=10.1016/j.cell.2004.10.030;
RA   Clayton G.M., Silverman W.R., Heginbotham L., Morais-Cabral J.H.;
RT   "Structural basis of ligand activation in a cyclic nucleotide
RT   regulated potassium channel.";
RL   Cell 119:615-627(2004).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS), MEMBRANE TOPOLOGY, AND
RP   MUTAGENESIS OF PHE-203 AND TYR-215.
RX   PubMed=18216238; DOI=10.1073/pnas.0711533105;
RA   Clayton G.M., Altieri S., Heginbotham L., Unger V.M.,
RA   Morais-Cabral J.H.;
RT   "Structure of the transmembrane regions of a bacterial cyclic
RT   nucleotide-regulated channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:1511-1515(2008).
CC   -!- FUNCTION: Cyclic nucleotide-regulated potassium channel activated
CC       by cAMP. {ECO:0000269|PubMed:15550244}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15550244}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-15658025, EBI-15658025;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the potassium channel family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000012; BAB50178.1; -; Genomic_DNA.
DR   RefSeq; WP_010911524.1; NC_002678.2.
DR   PDB; 1U12; X-ray; 2.70 A; A/B=218-355.
DR   PDB; 1VP6; X-ray; 1.70 A; A/C=218-355.
DR   PDB; 2K0G; NMR; -; A=216-355.
DR   PDB; 2KXL; NMR; -; A=216-355.
DR   PDB; 2ZD9; X-ray; 4.00 A; A/B/C/D=1-355.
DR   PDB; 3BEH; X-ray; 3.10 A; A/B/C/D=1-355.
DR   PDB; 3CL1; X-ray; 2.40 A; A/B=216-355.
DR   PDB; 3CLP; X-ray; 2.00 A; A/C=216-355.
DR   PDB; 3CO2; X-ray; 2.90 A; A/B/C/D=216-355.
DR   PDB; 4CHV; EM; 7.00 A; A/B/C/D=1-355.
DR   PDB; 4CHW; EM; 7.00 A; A/B/C/D=1-355.
DR   PDB; 4MUV; X-ray; 1.25 A; A/B=216-355.
DR   PDBsum; 1U12; -.
DR   PDBsum; 1VP6; -.
DR   PDBsum; 2K0G; -.
DR   PDBsum; 2KXL; -.
DR   PDBsum; 2ZD9; -.
DR   PDBsum; 3BEH; -.
DR   PDBsum; 3CL1; -.
DR   PDBsum; 3CLP; -.
DR   PDBsum; 3CO2; -.
DR   PDBsum; 4CHV; -.
DR   PDBsum; 4CHW; -.
DR   PDBsum; 4MUV; -.
DR   ProteinModelPortal; Q98GN8; -.
DR   SMR; Q98GN8; -.
DR   DIP; DIP-29507N; -.
DR   STRING; 266835.mll3241; -.
DR   DrugBank; DB02527; Cyclic Adenosine Monophosphate.
DR   DrugBank; DB04147; Lauryl Dimethylamine-N-Oxide.
DR   TCDB; 1.A.1.25.1; the voltage-gated ion channel (vic) superfamily.
DR   EnsemblBacteria; BAB50178; BAB50178; BAB50178.
DR   KEGG; mlo:mll3241; -.
DR   PATRIC; fig|266835.9.peg.2584; -.
DR   eggNOG; ENOG4105EYW; Bacteria.
DR   eggNOG; COG0664; LUCA.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000271293; -.
DR   KO; K10716; -.
DR   OMA; MYFIAEG; -.
DR   OrthoDB; POG091H04JJ; -.
DR   EvolutionaryTrace; Q98GN8; -.
DR   Proteomes; UP000000552; Chromosome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR028325; VG_K_chnl.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF07885; Ion_trans_2; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS00889; CNMP_BINDING_2; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cAMP; cAMP-binding; Cell membrane; Complete proteome;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Nucleotide-binding; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    355       Cyclic nucleotide-gated potassium channel
FT                                mll3241.
FT                                /FTId=PRO_0000351501.
FT   TOPO_DOM      1     12       Cytoplasmic.
FT   TRANSMEM     13     30       Helical; Name=Segment S1.
FT   TOPO_DOM     31     38       Periplasmic.
FT   TRANSMEM     39     61       Helical; Name=Segment S2.
FT   TOPO_DOM     62     74       Cytoplasmic.
FT   TRANSMEM     75     94       Helical; Name=Segment S3.
FT   TRANSMEM     95    112       Helical; Name=Segment S4.
FT   TOPO_DOM    113    129       Cytoplasmic.
FT   TRANSMEM    130    150       Helical; Name=Segment S5.
FT   TOPO_DOM    151    161       Periplasmic.
FT   INTRAMEM    162    180       Pore-forming.
FT   TOPO_DOM    181    185       Periplasmic.
FT   TRANSMEM    186    210       Helical; Name=Segment S6.
FT   TOPO_DOM    211    355       Cytoplasmic.
FT   NP_BIND     297    298       cAMP.
FT   NP_BIND     307    308       cAMP.
FT   MOTIF       175    180       Selectivity filter. {ECO:0000305}.
FT   BINDING     348    348       cAMP.
FT   MUTAGEN     203    203       F->A: Increased channel conductance.
FT                                {ECO:0000269|PubMed:18216238}.
FT   MUTAGEN     215    215       Y->A: Increased channel conductance.
FT                                {ECO:0000269|PubMed:18216238}.
FT   MUTAGEN     227    227       W->A: Loss of channel activity.
FT                                {ECO:0000269|PubMed:15550244}.
FT   MUTAGEN     348    348       R->A: Loss of cAMP binding. Loss of
FT                                channel activity.
FT                                {ECO:0000269|PubMed:15550244}.
FT   STRAND        9     12       {ECO:0000244|PDB:3BEH}.
FT   HELIX        13     28       {ECO:0000244|PDB:3BEH}.
FT   STRAND       30     32       {ECO:0000244|PDB:3BEH}.
FT   HELIX        35     61       {ECO:0000244|PDB:3BEH}.
FT   HELIX        72     90       {ECO:0000244|PDB:3BEH}.
FT   HELIX        95    105       {ECO:0000244|PDB:3BEH}.
FT   HELIX       107    110       {ECO:0000244|PDB:3BEH}.
FT   HELIX       115    124       {ECO:0000244|PDB:3BEH}.
FT   HELIX       126    151       {ECO:0000244|PDB:3BEH}.
FT   TURN        152    154       {ECO:0000244|PDB:3BEH}.
FT   HELIX       156    159       {ECO:0000244|PDB:3BEH}.
FT   HELIX       162    173       {ECO:0000244|PDB:3BEH}.
FT   STRAND      179    181       {ECO:0000244|PDB:3BEH}.
FT   HELIX       216    223       {ECO:0000244|PDB:4MUV}.
FT   HELIX       226    230       {ECO:0000244|PDB:4MUV}.
FT   HELIX       234    238       {ECO:0000244|PDB:4MUV}.
FT   HELIX       241    250       {ECO:0000244|PDB:4MUV}.
FT   STRAND      252    256       {ECO:0000244|PDB:4MUV}.
FT   STRAND      261    263       {ECO:0000244|PDB:4MUV}.
FT   STRAND      271    278       {ECO:0000244|PDB:4MUV}.
FT   STRAND      280    286       {ECO:0000244|PDB:4MUV}.
FT   STRAND      288    290       {ECO:0000244|PDB:4MUV}.
FT   STRAND      295    297       {ECO:0000244|PDB:3CLP}.
FT   HELIX       298    303       {ECO:0000244|PDB:4MUV}.
FT   STRAND      308    323       {ECO:0000244|PDB:4MUV}.
FT   HELIX       324    333       {ECO:0000244|PDB:4MUV}.
FT   HELIX       335    352       {ECO:0000244|PDB:4MUV}.
SQ   SEQUENCE   355 AA;  37735 MW;  35EE06373D563933 CRC64;
     MSVLPFLRIY APLNAVLAAP GLLAVAALTI PDMSGRSRLA LAALLAVIWG AYLLQLAATL
     LKRRAGVVRD RTPKIAIDVL AVLVPLAAFL LDGSPDWSLY CAVWLLKPLR DSTFFPVLGR
     VLANEARNLI GVTTLFGVVL FAVALAAYVI ERDIQPEKFG SIPQAMWWAV VTLSTTGYGD
     TIPQSFAGRV LAGAVMMSGI GIFGLWAGIL ATGFYQEVRR GDFVRNWQLV AAVPLFQKLG
     PAVLVEIVRA LRARTVPAGA VICRIGEPGD RMFFVVEGSV SVATPNPVEL GPGAFFGEMA
     LISGEPRSAT VSAATTVSLL SLHSADFQML CSSSPEIAEI FRKTALERRG AAASA
//
ID   KCNS3_HUMAN             Reviewed;         491 AA.
AC   Q9BQ31; D6W520; O43651; Q4ZFY1; Q96B56;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   22-NOV-2017, entry version 142.
DE   RecName: Full=Potassium voltage-gated channel subfamily S member 3;
DE   AltName: Full=Delayed-rectifier K(+) channel alpha subunit 3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv9.3;
GN   Name=KCNS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   AND VARIANT ALA-450.
RC   TISSUE=Lens epithelium;
RX   PubMed=10484328;
RA   Shepard A.R., Rae J.L.;
RT   "Electrically silent potassium channel subunits from human lens
RT   epithelium.";
RL   Am. J. Physiol. 277:C412-C424(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-450.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LEU-225 AND
RP   ALA-450.
RC   TISSUE=Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=22943705; DOI=10.3109/01443615.2012.709288;
RA   Fyfe G.K., Panicker S., Jones R.L., Wareing M.;
RT   "Expression of an electrically silent voltage-gated potassium channel
RT   in the human placenta.";
RL   J. Obstet. Gynaecol. 32:624-629(2012).
CC   -!- FUNCTION: Potassium channel subunit that does not form functional
CC       channels by itself. Can form functional heterotetrameric channels
CC       with KCNB1; modulates the delayed rectifier voltage-gated
CC       potassium channel activation and deactivation rates of KCNB1
CC       (PubMed:10484328). Heterotetrameric channel activity formed with
CC       KCNB1 show increased current amplitude with the threshold for
CC       action potential activation shifted towards more negative values
CC       in hypoxic-treated pulmonary artery smooth muscle cells (By
CC       similarity). {ECO:0000250|UniProtKB:O88759,
CC       ECO:0000269|PubMed:10484328}.
CC   -!- SUBUNIT: Heterotetramer with KCNB1 (PubMed:10484328). Does not
CC       form homomultimers (PubMed:10484328).
CC       {ECO:0000269|PubMed:10484328}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10484328};
CC       Multi-pass membrane protein {ECO:0000305}. Note=May not reach the
CC       plasma membrane but remain in an intracellular compartment in the
CC       absence of KCNB1 (PubMed:10484328). {ECO:0000269|PubMed:10484328}.
CC   -!- TISSUE SPECIFICITY: Detected in whole normal term placental and
CC       placental chorionic plate arteries and veins. Detected in
CC       syncytiotrophoblast and in blood vessel endothelium within
CC       intermediate villi and chorionic plate (at protein level)
CC       (PubMed:22943705). Detected in most tissues, but not in peripheral
CC       blood lymphocytes. The highest levels of expression are in lung
CC       (PubMed:10484328). {ECO:0000269|PubMed:10484328,
CC       ECO:0000269|PubMed:22943705}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. S (TC
CC       1.A.1.2) subfamily. Kv9.3/KCNS3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF043472; AAC13164.1; -; mRNA.
DR   EMBL; AK314451; BAG37059.1; -; mRNA.
DR   EMBL; AC093731; AAX88969.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00861.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00862.1; -; Genomic_DNA.
DR   EMBL; BC004148; AAH04148.1; -; mRNA.
DR   EMBL; BC004987; AAH04987.1; -; mRNA.
DR   EMBL; BC015947; AAH15947.1; -; mRNA.
DR   CCDS; CCDS1692.1; -.
DR   RefSeq; NP_001269357.1; NM_001282428.1.
DR   RefSeq; NP_002243.3; NM_002252.4.
DR   RefSeq; XP_011531127.1; XM_011532825.1.
DR   RefSeq; XP_016859548.1; XM_017004059.1.
DR   UniGene; Hs.414489; -.
DR   ProteinModelPortal; Q9BQ31; -.
DR   SMR; Q9BQ31; -.
DR   BioGrid; 109991; 36.
DR   IntAct; Q9BQ31; 1.
DR   STRING; 9606.ENSP00000305824; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   TCDB; 1.A.1.2.15; the voltage-gated ion channel (vic) superfamily.
DR   BioMuta; KCNS3; -.
DR   DMDM; 311033434; -.
DR   PaxDb; Q9BQ31; -.
DR   PeptideAtlas; Q9BQ31; -.
DR   PRIDE; Q9BQ31; -.
DR   DNASU; 3790; -.
DR   Ensembl; ENST00000304101; ENSP00000305824; ENSG00000170745.
DR   Ensembl; ENST00000403915; ENSP00000385968; ENSG00000170745.
DR   GeneID; 3790; -.
DR   KEGG; hsa:3790; -.
DR   UCSC; uc002rcv.4; human.
DR   CTD; 3790; -.
DR   DisGeNET; 3790; -.
DR   EuPathDB; HostDB:ENSG00000170745.11; -.
DR   GeneCards; KCNS3; -.
DR   H-InvDB; HIX0001848; -.
DR   HGNC; HGNC:6302; KCNS3.
DR   HPA; HPA014864; -.
DR   MIM; 603888; gene.
DR   neXtProt; NX_Q9BQ31; -.
DR   OpenTargets; ENSG00000170745; -.
DR   PharmGKB; PA30080; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q9BQ31; -.
DR   KO; K04933; -.
DR   OMA; WDQKSND; -.
DR   OrthoDB; EOG091G0FP3; -.
DR   PhylomeDB; Q9BQ31; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   GeneWiki; KCNS3; -.
DR   GenomeRNAi; 3790; -.
DR   PRO; PR:Q9BQ31; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000170745; -.
DR   CleanEx; HS_KCNS3; -.
DR   ExpressionAtlas; Q9BQ31; baseline and differential.
DR   Genevisible; Q9BQ31; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; TAS:ProtInc.
DR   GO; GO:0015459; F:potassium channel regulator activity; TAS:ProtInc.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    491       Potassium voltage-gated channel subfamily
FT                                S member 3.
FT                                /FTId=PRO_0000054087.
FT   TOPO_DOM      1    182       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    183    204       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    205    220       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    221    243       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    244    254       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    255    275       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    276    285       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    286    306       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    307    321       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    322    343       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    344    357       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    358    369       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    370    377       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    378    384       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    385    413       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    414    491       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       370    375       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   VARIANT     225    225       V -> L (in dbSNP:rs17856097).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_036986.
FT   VARIANT     450    450       T -> A (in dbSNP:rs4832524).
FT                                {ECO:0000269|PubMed:10484328,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014200.
FT   CONFLICT     27     27       S -> Y (in Ref. 3; AAH15947).
FT                                {ECO:0000305}.
SQ   SEQUENCE   491 AA;  56001 MW;  FFE02CA3DCA50185 CRC64;
     MVFGEFFHRP GQDEELVNLN VGGFKQSVDQ STLLRFPHTR LGKLLTCHSE EAILELCDDY
     SVADKEYYFD RNPSLFRYVL NFYYTGKLHV MEELCVFSFC QEIEYWGINE LFIDSCCSNR
     YQERKEENHE KDWDQKSHDV STDSSFEESS LFEKELEKFD TLRFGQLRKK IWIRMENPAY
     CLSAKLIAIS SLSVVLASIV AMCVHSMSEF QNEDGEVDDP VLEGVEIACI AWFTGELAVR
     LAAAPCQKKF WKNPLNIIDF VSIIPFYATL AVDTKEEESE DIENMGKVVQ ILRLMRIFRI
     LKLARHSVGL RSLGATLRHS YHEVGLLLLF LSVGISIFSV LIYSVEKDDH TSSLTSIPIC
     WWWATISMTT VGYGDTHPVT LAGKLIASTC IICGILVVAL PITIIFNKFS KYYQKQKDID
     VDQCSEDAPE KCHELPYFNI RDIYAQRMHT FITSLSSVGI VVSDPDSTDA SSIEDNEDIC
     NTTSLENCTA K
//
ID   TM175_HUMAN             Reviewed;         504 AA.
AC   Q9BSA9; D3DVN4; Q8ND13;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   25-OCT-2017, entry version 106.
DE   RecName: Full=Endosomal/lysosomal potassium channel TMEM175 {ECO:0000305};
DE   AltName: Full=Transmembrane protein 175 {ECO:0000312|HGNC:HGNC:28709};
DE            Short=hTMEM175 {ECO:0000303|PubMed:26317472, ECO:0000303|PubMed:28723891};
GN   Name=TMEM175 {ECO:0000312|HGNC:HGNC:28709};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-6, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5]
RP   FUNCTION, DOMAIN, SUBCELLULAR LOCATION, TOPOLOGY, TISSUE SPECIFICITY,
RP   AND MUTAGENESIS OF ARG-35; PHE-39; SER-40 AND ASP-41.
RX   PubMed=26317472; DOI=10.1016/j.cell.2015.08.002;
RA   Cang C., Aranda K., Seo Y.J., Gasnier B., Ren D.;
RT   "TMEM175 is an organelle K(+) channel regulating lysosomal function.";
RL   Cell 162:1101-1112(2015).
RN   [6]
RP   FUNCTION, SUBUNIT, DOMAIN, AND MUTAGENESIS OF ILE-46; VAL-50; LEU-53;
RP   ILE-271; LEU-275 AND LEU-278.
RX   PubMed=28723891; DOI=10.1038/nature23269;
RA   Lee C., Guo J., Zeng W., Kim S., She J., Cang C., Ren D., Jiang Y.;
RT   "The lysosomal potassium channel TMEM175 adopts a novel tetrameric
RT   architecture.";
RL   Nature 547:472-475(2017).
RN   [7]
RP   POSSIBLE INVOLVEMENT IN PARK.
RX   PubMed=28193887; DOI=10.1073/pnas.1616332114;
RA   Jinn S., Drolet R.E., Cramer P.E., Wong A.H., Toolan D.M.,
RA   Gretzula C.A., Voleti B., Vassileva G., Disa J., Tadin-Strapps M.,
RA   Stone D.J.;
RT   "TMEM175 deficiency impairs lysosomal and mitochondrial function and
RT   increases alpha-synuclein aggregation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:2389-2394(2017).
CC   -!- FUNCTION: Organelle-specific potassium channel specifically
CC       responsible for potassium conductance in endosomes and lysosomes.
CC       Forms a potassium-permeable leak-like channel, which regulates
CC       lumenal pH stability and is required for autophagosome-lysosome
CC       fusion. Constitutes the major lysosomal potassium channel.
CC       {ECO:0000269|PubMed:26317472, ECO:0000269|PubMed:28723891}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305|PubMed:28723891}.
CC   -!- SUBCELLULAR LOCATION: Endosome membrane
CC       {ECO:0000269|PubMed:26317472}; Multi-pass membrane protein
CC       {ECO:0000255}. Lysosome membrane {ECO:0000269|PubMed:26317472};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BSA9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BSA9-2; Sequence=VSP_024213;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:26317472}.
CC   -!- DOMAIN: Composed of two modules of six transmembranes, forming a
CC       homodimer with a tetrameric architecture (PubMed:28723891). The
CC       six transmembrane regions of each module are tightly packed within
CC       each subunit without undergoing domain swapping (By similarity).
CC       Transmembranes TM1-TM3 of each module are positioned on the inner
CC       circle of the channel tetramer and participate in inter-subunit
CC       interactions that are central to the assembly of the ion
CC       conduction pore (By similarity). The RxxxFSD motifs within
CC       transmembranes TM1 coordinate a network of specific inter- and
CC       intra-subunit interactions with other conserved residues on TM2
CC       and TM3 and play a key role in the tetrameric assembly of the
CC       channel (By similarity). Transmembranes TM4-TM6 are positioned on
CC       the periphery of the channel and do not contribute contacts with
CC       neighboring subunits (By similarity). Transmembranes TM1 and TM2
CC       are linked by an extended strand-like tail and two short helices
CC       (H1 and H2) which protrude outwards from the main body of the
CC       transmembrane domain and enclose the external open entrance of the
CC       ion conduction pore in the channel tetramer (By similarity).
CC       Transmembranes TM1 form the pore-lining inner helix at the center
CC       of the channel, creating an hourglass-shaped ion permeation
CC       pathway in the channel tetramer (By similarity). Three hydrophobic
CC       residues on the C-terminal half of the TM1 helices form a
CC       bottleneck along the ion conduction pathway and serve as the
CC       selectivity filter of the channel (By similarity). Ile-46 (and
CC       Ile-271) are probably responsible for channel selectivity
CC       (PubMed:28723891). {ECO:0000250|UniProtKB:K9UJK2,
CC       ECO:0000269|PubMed:28723891}.
CC   -!- DISEASE: Parkinson disease (PARK) [MIM:168600]: A complex
CC       neurodegenerative disorder characterized by bradykinesia, resting
CC       tremor, muscular rigidity and postural instability. Additional
CC       features are characteristic postural abnormalities, dysautonomia,
CC       dystonic cramps, and dementia. The pathology of Parkinson disease
CC       involves the loss of dopaminergic neurons in the substantia nigra
CC       and the presence of Lewy bodies (intraneuronal accumulations of
CC       aggregated proteins), in surviving neurons in various areas of the
CC       brain. The disease is progressive and usually manifests after the
CC       age of 50 years, although early-onset cases (before 50 years) are
CC       known. The majority of the cases are sporadic suggesting a
CC       multifactorial etiology based on environmental and genetic
CC       factors. However, some patients present with a positive family
CC       history for the disease. Familial forms of the disease usually
CC       begin at earlier ages and are associated with atypical clinical
CC       features. {ECO:0000269|PubMed:28193887}. Note=Disease
CC       susceptibility may be associated with variations affecting the
CC       gene represented in this entry. TMEM175 defects result in unstable
CC       lysosomal pH, leading to decreased lysosomal catalytic activity,
CC       decreased glucocerebrosidase activity, impaired autophagosome
CC       clearance by the lysosome and decreased mitochondrial respiration
CC       (PubMed:28193887). {ECO:0000269|PubMed:28193887}.
CC   -!- SIMILARITY: Belongs to the TMEM175 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL834199; CAD38888.1; -; mRNA.
DR   EMBL; CH471131; EAW82633.1; -; Genomic_DNA.
DR   EMBL; CH471131; EAW82638.1; -; Genomic_DNA.
DR   EMBL; BC005158; AAH05158.1; -; mRNA.
DR   CCDS; CCDS3341.1; -. [Q9BSA9-1]
DR   CCDS; CCDS75088.1; -. [Q9BSA9-2]
DR   RefSeq; NP_001284355.1; NM_001297426.1. [Q9BSA9-2]
DR   RefSeq; NP_001284356.1; NM_001297427.1. [Q9BSA9-2]
DR   RefSeq; NP_001284357.1; NM_001297428.1. [Q9BSA9-2]
DR   RefSeq; NP_115702.1; NM_032326.3. [Q9BSA9-1]
DR   RefSeq; XP_005272361.1; XM_005272304.1. [Q9BSA9-2]
DR   RefSeq; XP_016864190.1; XM_017008701.1. [Q9BSA9-1]
DR   RefSeq; XP_016864194.1; XM_017008705.1. [Q9BSA9-2]
DR   UniGene; Hs.478936; -.
DR   ProteinModelPortal; Q9BSA9; -.
DR   BioGrid; 124013; 3.
DR   IntAct; Q9BSA9; 4.
DR   TCDB; 1.A.78.1.1; the k+-selective channel in endosomes and lysosomes (kel) family.
DR   iPTMnet; Q9BSA9; -.
DR   PhosphoSitePlus; Q9BSA9; -.
DR   BioMuta; TMEM175; -.
DR   DMDM; 74732981; -.
DR   MaxQB; Q9BSA9; -.
DR   PaxDb; Q9BSA9; -.
DR   PeptideAtlas; Q9BSA9; -.
DR   PRIDE; Q9BSA9; -.
DR   DNASU; 84286; -.
DR   Ensembl; ENST00000264771; ENSP00000264771; ENSG00000127419. [Q9BSA9-1]
DR   Ensembl; ENST00000515740; ENSP00000427039; ENSG00000127419. [Q9BSA9-2]
DR   Ensembl; ENST00000622959; ENSP00000485461; ENSG00000127419. [Q9BSA9-2]
DR   GeneID; 84286; -.
DR   KEGG; hsa:84286; -.
DR   UCSC; uc003gbq.4; human. [Q9BSA9-1]
DR   CTD; 84286; -.
DR   DisGeNET; 84286; -.
DR   EuPathDB; HostDB:ENSG00000127419.16; -.
DR   GeneCards; TMEM175; -.
DR   H-InvDB; HIX0004008; -.
DR   HGNC; HGNC:28709; TMEM175.
DR   HPA; HPA057160; -.
DR   MIM; 168600; phenotype.
DR   MIM; 616660; gene.
DR   neXtProt; NX_Q9BSA9; -.
DR   OpenTargets; ENSG00000127419; -.
DR   PharmGKB; PA162405946; -.
DR   eggNOG; ENOG410IIWE; Eukaryota.
DR   eggNOG; ENOG410ZP3B; LUCA.
DR   GeneTree; ENSGT00390000015667; -.
DR   HOGENOM; HOG000154616; -.
DR   HOVERGEN; HBG059914; -.
DR   InParanoid; Q9BSA9; -.
DR   OMA; ACMMLIT; -.
DR   OrthoDB; EOG091G05QO; -.
DR   PhylomeDB; Q9BSA9; -.
DR   TreeFam; TF328838; -.
DR   ChiTaRS; TMEM175; human.
DR   GenomeRNAi; 84286; -.
DR   PRO; PR:Q9BSA9; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000127419; -.
DR   CleanEx; HS_TMEM175; -.
DR   ExpressionAtlas; Q9BSA9; baseline and differential.
DR   Genevisible; Q9BSA9; HS.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IDA:UniProtKB.
DR   GO; GO:0090385; P:phagosome-lysosome fusion; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0035751; P:regulation of lysosomal lumen pH; IEA:Ensembl.
DR   InterPro; IPR010617; TMEM175.
DR   Pfam; PF06736; DUF1211; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endosome; Ion channel;
KW   Ion transport; Lysosome; Membrane; Neurodegeneration;
KW   Parkinson disease; Parkinsonism; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    504       Endosomal/lysosomal potassium channel
FT                                TMEM175.
FT                                /FTId=PRO_0000282588.
FT   TOPO_DOM      1     35       Cytoplasmic.
FT                                {ECO:0000305|PubMed:26317472}.
FT   TRANSMEM     36     56       Helical; Name=TM1-1. {ECO:0000255}.
FT   TOPO_DOM     57     72       Lumenal. {ECO:0000305}.
FT   TRANSMEM     73     93       Helical; Name=TM2-1. {ECO:0000255}.
FT   TOPO_DOM     94    110       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    111    131       Helical; Name=TM3-1. {ECO:0000255}.
FT   TOPO_DOM    132    137       Lumenal. {ECO:0000305}.
FT   TRANSMEM    138    158       Helical; Name=TM4-1. {ECO:0000255}.
FT   TOPO_DOM    159    184       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    185    205       Helical; Name=TM5-1. {ECO:0000255}.
FT   TOPO_DOM    206    210       Lumenal. {ECO:0000305}.
FT   TRANSMEM    211    230       Helical; Name=TM6-1. {ECO:0000255}.
FT   TOPO_DOM    231    260       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    261    281       Helical; Name=TM1-2. {ECO:0000255}.
FT   TOPO_DOM    282    309       Lumenal. {ECO:0000305}.
FT   TRANSMEM    310    330       Helical; Name=TM2-2. {ECO:0000255}.
FT   TOPO_DOM    331    339       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    340    360       Helical; Name=TM3-2. {ECO:0000255}.
FT   TOPO_DOM    361    377       Lumenal. {ECO:0000305}.
FT   TRANSMEM    378    398       Helical; Name=TM4-2. {ECO:0000255}.
FT   TOPO_DOM    399    416       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    417    437       Helical; Name=TM5-2. {ECO:0000255}.
FT   TOPO_DOM    438    452       Lumenal. {ECO:0000305}.
FT   TRANSMEM    453    473       Helical; Name=TM6-2. {ECO:0000255}.
FT   TOPO_DOM    474    504       Cytoplasmic.
FT                                {ECO:0000305|PubMed:26317472}.
FT   REGION       58     63       Short helix H1-1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   REGION       65     71       Short helix H2-1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   REGION      288    296       Short helix H1-2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   REGION      298    304       Short helix H2-2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   MOTIF        35     41       RxxxFSD motif 1.
FT                                {ECO:0000269|PubMed:26317472}.
FT   MOTIF       260    266       RxxxFSD motif 2.
FT                                {ECO:0000305|PubMed:26317472}.
FT   SITE         46     46       Hydrophobic filter residue 1-1.
FT                                {ECO:0000269|PubMed:28723891}.
FT   SITE         50     50       Hydrophobic filter residue 2-1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   SITE         53     53       Hydrophobic filter residue 3-1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   SITE        271    271       Hydrophobic filter residue 1-2.
FT                                {ECO:0000269|PubMed:28723891}.
FT   SITE        275    275       Hydrophobic filter residue 2-2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   SITE        278    278       Hydrophobic filter residue 3-2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   MOD_RES       6      6       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   VAR_SEQ       1    116       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_024213.
FT   VARIANT      65     65       Q -> P (in dbSNP:rs34884217).
FT                                /FTId=VAR_053873.
FT   VARIANT     393    393       M -> T (in dbSNP:rs34311866).
FT                                /FTId=VAR_053874.
FT   MUTAGEN      35     35       R->A: Impaired potassium channel
FT                                activity. {ECO:0000305}.
FT   MUTAGEN      39     39       F->V: Impaired potassium channel
FT                                activity. {ECO:0000305}.
FT   MUTAGEN      40     40       S->A: Impaired potassium channel
FT                                activity. {ECO:0000305}.
FT   MUTAGEN      41     41       D->A,E,N: Impaired potassium channel
FT                                activity. {ECO:0000305}.
FT   MUTAGEN      46     46       I->N: Impaired selectivity; can conduct
FT                                both K(+) and Na(+); when associated with
FT                                N-271. {ECO:0000269|PubMed:28723891}.
FT   MUTAGEN      50     50       V->A: Does not affect selectivity; when
FT                                associated with A-275.
FT                                {ECO:0000269|PubMed:28723891}.
FT   MUTAGEN      53     53       L->A: Does not affect selectivity; when
FT                                associated with A-278.
FT                                {ECO:0000269|PubMed:28723891}.
FT   MUTAGEN     271    271       I->N: Impaired selectivity; can conduct
FT                                both K(+) and Na(+); when associated with
FT                                N-46. {ECO:0000269|PubMed:28723891}.
FT   MUTAGEN     275    275       L->A: Does not affect selectivity; when
FT                                associated with A-50.
FT                                {ECO:0000269|PubMed:28723891}.
FT   MUTAGEN     278    278       L->A: Does not affect selectivity; when
FT                                associated with A-53.
FT                                {ECO:0000269|PubMed:28723891}.
SQ   SEQUENCE   504 AA;  55615 MW;  7FEE4C22CA248094 CRC64;
     MSQPRTPEQA LDTPGDCPPG RRDEDAGEGI QCSQRMLSFS DALLSIIATV MILPVTHTEI
     SPEQQFDRSV QRLLATRIAV YLMTFLIVTV AWAAHTRLFQ VVGKTDDTLA LLNLACMMTI
     TFLPYTFSLM VTFPDVPLGI FLFCVCVIAI GVVQALIVGY AFHFPHLLSP QIQRSAHRAL
     YRRHVLGIVL QGPALCFAAA IFSLFFVPLS YLLMVTVILL PYVSKVTGWC RDRLLGHREP
     SAHPVEVFSF DLHEPLSKER VEAFSDGVYA IVATLLILDI CEDNVPDPKD VKERFSGSLV
     AALSATGPRF LAYFGSFATV GLLWFAHHSL FLHVRKATRA MGLLNTLSLA FVGGLPLAYQ
     QTSAFARQPR DELERVRVSC TIIFLASIFQ LAMWTTALLH QAETLQPSVW FGGREHVLMF
     AKLALYPCAS LLAFASTCLL SRFSVGIFHL MQIAVPCAFL LLRLLVGLAL ATLRVLRGLA
     RPEHPPPAPT GQDDPQSQLL PAPC
//
ID   TM175_MOUSE             Reviewed;         499 AA.
AC   Q9CXY1; Q3TDC4; Q99K00;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   25-OCT-2017, entry version 96.
DE   RecName: Full=Endosomal/lysosomal potassium channel TMEM175 {ECO:0000250|UniProtKB:Q9BSA9};
DE   AltName: Full=Transmembrane protein 175;
DE            Short=mTMEM175 {ECO:0000303|PubMed:26317472};
GN   Name=Tmem175 {ECO:0000312|MGI:MGI:1919642};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Dendritic cell, and Head;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Czech II; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [4]
RP   FUNCTION.
RX   PubMed=26317472; DOI=10.1016/j.cell.2015.08.002;
RA   Cang C., Aranda K., Seo Y.J., Gasnier B., Ren D.;
RT   "TMEM175 is an organelle K(+) channel regulating lysosomal function.";
RL   Cell 162:1101-1112(2015).
CC   -!- FUNCTION: Organelle-specific potassium channel specifically
CC       responsible for potassium conductance in endosomes and lysosomes.
CC       Forms a potassium-permeable leak-like channel, which regulates
CC       lumenal pH stability and is required for autophagosome-lysosome
CC       fusion. Constitutes the major lysosomal potassium channel.
CC       {ECO:0000269|PubMed:26317472}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:Q9BSA9}.
CC   -!- SUBCELLULAR LOCATION: Endosome membrane
CC       {ECO:0000250|UniProtKB:Q9BSA9}; Multi-pass membrane protein
CC       {ECO:0000255}. Lysosome membrane {ECO:0000250|UniProtKB:Q9BSA9};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- DOMAIN: Composed of two modules of six transmembranes, forming a
CC       homodimer with a tetrameric architecture (By similarity). The six
CC       transmembrane regions of each module are tightly packed within
CC       each subunit without undergoing domain swapping (By similarity).
CC       Transmembranes TM1-TM3 of each module are positioned on the inner
CC       circle of the channel tetramer and participate in inter-subunit
CC       interactions that are central to the assembly of the ion
CC       conduction pore (By similarity). The RxxxFSD motifs within
CC       transmembranes TM1 coordinate a network of specific inter- and
CC       intra-subunit interactions with other conserved residues on TM2
CC       and TM3 and play a key role in the tetrameric assembly of the
CC       channel (By similarity). Transmembranes TM4-TM6 are positioned on
CC       the periphery of the channel and do not contribute contacts with
CC       neighboring subunits (By similarity). Transmembranes TM1 and TM2
CC       are linked by an extended strand-like tail and two short helices
CC       (H1 and H2) which protrude outwards from the main body of the
CC       transmembrane domain and enclose the external open entrance of the
CC       ion conduction pore in the channel tetramer (By similarity).
CC       Transmembranes TM1 form the pore-lining inner helix at the center
CC       of the channel, creating an hourglass-shaped ion permeation
CC       pathway in the channel tetramer (By similarity). Three hydrophobic
CC       residues on the C-terminal half of the TM1 helices form a
CC       bottleneck along the ion conduction pathway and serve as the
CC       selectivity filter of the channel (By similarity). Ile-43 (and
CC       Ile-268) are probably responsible for channel selectivity (By
CC       similarity). {ECO:0000250|UniProtKB:K9UJK2,
CC       ECO:0000250|UniProtKB:Q9BSA9}.
CC   -!- SIMILARITY: Belongs to the TMEM175 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK013879; BAB29031.1; -; mRNA.
DR   EMBL; AK170273; BAE41678.1; -; mRNA.
DR   EMBL; BC005542; AAH05542.1; -; mRNA.
DR   CCDS; CCDS19514.1; -.
DR   RefSeq; NP_001157004.1; NM_001163532.1.
DR   RefSeq; NP_082499.3; NM_028223.3.
DR   RefSeq; XP_006535292.1; XM_006535229.2.
DR   RefSeq; XP_006535293.1; XM_006535230.3.
DR   UniGene; Mm.258324; -.
DR   ProteinModelPortal; Q9CXY1; -.
DR   SMR; Q9CXY1; -.
DR   iPTMnet; Q9CXY1; -.
DR   PhosphoSitePlus; Q9CXY1; -.
DR   EPD; Q9CXY1; -.
DR   MaxQB; Q9CXY1; -.
DR   PaxDb; Q9CXY1; -.
DR   PRIDE; Q9CXY1; -.
DR   Ensembl; ENSMUST00000063272; ENSMUSP00000068607; ENSMUSG00000013495.
DR   Ensembl; ENSMUST00000078323; ENSMUSP00000077437; ENSMUSG00000013495.
DR   Ensembl; ENSMUST00000120327; ENSMUSP00000112780; ENSMUSG00000013495.
DR   GeneID; 72392; -.
DR   KEGG; mmu:72392; -.
DR   UCSC; uc008yoq.2; mouse.
DR   CTD; 84286; -.
DR   MGI; MGI:1919642; Tmem175.
DR   eggNOG; ENOG410IIWE; Eukaryota.
DR   eggNOG; ENOG410ZP3B; LUCA.
DR   GeneTree; ENSGT00390000015667; -.
DR   HOGENOM; HOG000154616; -.
DR   HOVERGEN; HBG059914; -.
DR   InParanoid; Q9CXY1; -.
DR   OMA; ACMMLIT; -.
DR   OrthoDB; EOG091G05QO; -.
DR   PhylomeDB; Q9CXY1; -.
DR   TreeFam; TF328838; -.
DR   PRO; PR:Q9CXY1; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   Bgee; ENSMUSG00000013495; -.
DR   CleanEx; MM_TMEM175; -.
DR   ExpressionAtlas; Q9CXY1; baseline and differential.
DR   Genevisible; Q9CXY1; MM.
DR   GO; GO:0005768; C:endosome; ISS:UniProtKB.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005765; C:lysosomal membrane; ISO:MGI.
DR   GO; GO:0005764; C:lysosome; ISS:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IMP:UniProtKB.
DR   GO; GO:0090385; P:phagosome-lysosome fusion; IMP:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0035751; P:regulation of lysosomal lumen pH; IMP:UniProtKB.
DR   InterPro; IPR010617; TMEM175.
DR   Pfam; PF06736; DUF1211; 2.
PE   1: Evidence at protein level;
KW   Complete proteome; Endosome; Ion channel; Ion transport; Lysosome;
KW   Membrane; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    499       Endosomal/lysosomal potassium channel
FT                                TMEM175.
FT                                /FTId=PRO_0000282589.
FT   TOPO_DOM      1     32       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     33     53       Helical; Name=TM1-1. {ECO:0000255}.
FT   TOPO_DOM     54     69       Lumenal. {ECO:0000305}.
FT   TRANSMEM     70     90       Helical; Name=TM2-1. {ECO:0000255}.
FT   TOPO_DOM     91    107       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    108    128       Helical; Name=TM3-1. {ECO:0000255}.
FT   TOPO_DOM    129    134       Lumenal. {ECO:0000305}.
FT   TRANSMEM    135    155       Helical; Name=TM4-1. {ECO:0000255}.
FT   TOPO_DOM    156    181       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    182    202       Helical; Name=TM5-1. {ECO:0000255}.
FT   TOPO_DOM    203    207       Lumenal. {ECO:0000305}.
FT   TRANSMEM    208    227       Helical; Name=TM6-1. {ECO:0000255}.
FT   TOPO_DOM    228    257       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    258    278       Helical; Name=TM1-2. {ECO:0000255}.
FT   TOPO_DOM    279    306       Lumenal. {ECO:0000305}.
FT   TRANSMEM    307    327       Helical; Name=TM2-2. {ECO:0000255}.
FT   TOPO_DOM    328    336       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    337    357       Helical; Name=TM3-2. {ECO:0000255}.
FT   TOPO_DOM    358    374       Lumenal. {ECO:0000305}.
FT   TRANSMEM    375    395       Helical; Name=TM4-2. {ECO:0000255}.
FT   TOPO_DOM    396    413       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    414    434       Helical; Name=TM5-2. {ECO:0000255}.
FT   TOPO_DOM    435    449       Lumenal. {ECO:0000305}.
FT   TRANSMEM    450    470       Helical; Name=TM6-2. {ECO:0000255}.
FT   TOPO_DOM    471    499       Cytoplasmic. {ECO:0000305}.
FT   REGION       55     60       Short helix H1-1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   REGION       62     68       Short helix H2-1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   REGION      285    293       Short helix H1-2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   REGION      295    301       Short helix H2-2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   MOTIF        32     38       RxxxFSD motif 1.
FT                                {ECO:0000250|UniProtKB:Q9BSA9}.
FT   MOTIF       257    263       RxxxFSD motif 2.
FT                                {ECO:0000250|UniProtKB:Q9BSA9}.
FT   SITE         43     43       Hydrophobic filter residue 1-1.
FT                                {ECO:0000250|UniProtKB:Q9BSA9}.
FT   SITE         47     47       Hydrophobic filter residue 2-1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   SITE         50     50       Hydrophobic filter residue 3-1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   SITE        268    268       Hydrophobic filter residue 1-2.
FT                                {ECO:0000250|UniProtKB:Q9BSA9}.
FT   SITE        272    272       Hydrophobic filter residue 2-2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   SITE        275    275       Hydrophobic filter residue 3-2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   MOD_RES       6      6       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9BSA9}.
FT   CONFLICT    174    174       H -> R (in Ref. 2; AAH05542).
FT                                {ECO:0000305}.
FT   CONFLICT    197    197       A -> S (in Ref. 1; BAE41678).
FT                                {ECO:0000305}.
FT   CONFLICT    324    324       H -> R (in Ref. 1; BAE41678).
FT                                {ECO:0000305}.
FT   CONFLICT    475    475       G -> R (in Ref. 1; BAB29031).
FT                                {ECO:0000305}.
SQ   SEQUENCE   499 AA;  55578 MW;  BDED3561EF10EB92 CRC64;
     MSRLQTEEQA VDSEGDSSLH RRNEEGTQSS HRMLGFSDAL LSIIATVMIL PVTHTEISPE
     QQFDKSIQKL LATRIAVYLM TFLIVTVAWT AHTRLFQVVG KIDDTLALLN LACMMTITLL
     PYTFSLMVTF PDVPLGIFLF CVCVIAIGSV QAMIVGYAFH FPHLLNPQIQ CSTHRDLSRR
     HILHLVLRGP ALCFVAAVFS LFFFPLSYLL MVTVIFLPHI SKATTWCKDK LMGQRESPAH
     DMEPFSIDLH APLSKERVEA FSDGVYAIVA TLLILDICED NVPDPKDVQE KFSGSLVAAL
     GAYGPQFLAY FGSFATVGLL WFAHHSLFLH VRKATQTMGL LNILSLAFVG GLPLAYQQTS
     AFARQPHDEL ERVRVSCAII FFASIFQFAI WTTALLHQTE TLQPAVQFGG QEHAFMFAKL
     ALYPCASLLA FAATCLLSRF STAIFHLMQI SVPFAFLLLR LLVRLALAGL QVLRGLWPHH
     PQQDQSEPEA QSQLLPDPC
//
ID   KCNE2_MOUSE             Reviewed;         123 AA.
AC   Q9D808; Q8R1Z7;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2002, sequence version 2.
DT   22-NOV-2017, entry version 121.
DE   RecName: Full=Potassium voltage-gated channel subfamily E member 2;
DE   AltName: Full=MinK-related peptide 1;
DE   AltName: Full=Minimum potassium ion channel-related peptide 1;
DE   AltName: Full=Potassium channel subunit beta MiRP1;
GN   Name=Kcne2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Stomach;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Ancillary protein that assembles as a beta subunit with
CC       a voltage-gated potassium channel complex of pore-forming alpha
CC       subunits. Modulates the gating kinetics and enhances stability of
CC       the channel complex. Assembled with KCNB1 modulates the gating
CC       characteristics of the delayed rectifier voltage-dependent
CC       potassium channel KCNB1. Associated with KCNH2/HERG is proposed to
CC       form the rapidly activating component of the delayed rectifying
CC       potassium current in heart (IKr). May associate with KCNQ2 and/or
CC       KCNQ3 and modulate the native M-type current. May associate with
CC       HCN1 and HCN2 and increase potassium current (By similarity).
CC       Interacts with KCNQ1; forms a heterooligomer complex leading to
CC       currents with an apparently instantaneous activation, a rapid
CC       deactivation process and a linear current-voltage relationship and
CC       decreases the amplitude of the outward current (By similarity).
CC       {ECO:0000250|UniProtKB:P63161, ECO:0000250|UniProtKB:Q9Y6J6}.
CC   -!- SUBUNIT: Interacts with KCNB1. Associates with KCNH2/ERG1. May
CC       associate with KCNQ2 and KCNQ3. Associates with HCN1 and probably
CC       HCN2. Heteromultimer with KCNC2. Interacts with KCNC2 (By
CC       similarity). Interacts with KCNQ1; forms a heterooligomer complex
CC       that targets to the membrane raft and leading to currents with an
CC       apparently instantaneous activation, a rapid deactivation process
CC       and a linear current-voltage relationship and decreases the
CC       amplitude of the outward current (By similarity).
CC       {ECO:0000250|UniProtKB:P63161, ECO:0000250|UniProtKB:Q9Y6J6}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P63161,
CC       ECO:0000250|UniProtKB:Q9Y6J6}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:P63161}. Note=Colocalizes with KCNB1 at the
CC       plasma membrane. {ECO:0000250|UniProtKB:P63161}.
CC   -!- SIMILARITY: Belongs to the potassium channel KCNE family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK008619; BAB25781.1; -; mRNA.
DR   EMBL; BC022699; AAH22699.1; -; mRNA.
DR   CCDS; CCDS28333.1; -.
DR   RefSeq; NP_598871.1; NM_134110.3.
DR   RefSeq; XP_006523096.1; XM_006523033.3.
DR   UniGene; Mm.156736; -.
DR   ProteinModelPortal; Q9D808; -.
DR   SMR; Q9D808; -.
DR   STRING; 10090.ENSMUSP00000048849; -.
DR   TCDB; 8.A.10.2.1; the slow voltage-gated k+) channel accessory protein (mink) family.
DR   iPTMnet; Q9D808; -.
DR   PhosphoSitePlus; Q9D808; -.
DR   PaxDb; Q9D808; -.
DR   PRIDE; Q9D808; -.
DR   GeneID; 246133; -.
DR   KEGG; mmu:246133; -.
DR   UCSC; uc007zyw.2; mouse.
DR   CTD; 9992; -.
DR   MGI; MGI:1891123; Kcne2.
DR   eggNOG; ENOG410IX4Y; Eukaryota.
DR   eggNOG; ENOG411297Y; LUCA.
DR   HOGENOM; HOG000113208; -.
DR   HOVERGEN; HBG052227; -.
DR   InParanoid; Q9D808; -.
DR   KO; K04896; -.
DR   PhylomeDB; Q9D808; -.
DR   TreeFam; TF336058; -.
DR   PRO; PR:Q9D808; -.
DR   Proteomes; UP000000589; Unplaced.
DR   GO; GO:0009986; C:cell surface; ISO:MGI.
DR   GO; GO:0005764; C:lysosome; ISO:MGI.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISO:MGI.
DR   GO; GO:0044325; F:ion channel binding; ISO:MGI.
DR   GO; GO:0015459; F:potassium channel regulator activity; ISS:UniProtKB.
DR   GO; GO:1902282; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; ISO:MGI.
DR   GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; ISO:MGI.
DR   GO; GO:0034613; P:cellular protein localization; IMP:MGI.
DR   GO; GO:0035690; P:cellular response to drug; ISO:MGI.
DR   GO; GO:0086009; P:membrane repolarization; ISO:MGI.
DR   GO; GO:0086011; P:membrane repolarization during action potential; ISO:MGI.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; ISO:MGI.
DR   GO; GO:1902260; P:negative regulation of delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:1901800; P:positive regulation of proteasomal protein catabolic process; ISO:MGI.
DR   GO; GO:0071435; P:potassium ion export; ISO:MGI.
DR   GO; GO:0010107; P:potassium ion import; ISO:MGI.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:MGI.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; ISO:MGI.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; ISO:MGI.
DR   GO; GO:1901979; P:regulation of inward rectifier potassium channel activity; ISO:MGI.
DR   GO; GO:0060306; P:regulation of membrane repolarization; ISO:MGI.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; ISO:MGI.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:MGI.
DR   GO; GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:MGI.
DR   InterPro; IPR000369; K_chnl_KCNE.
DR   InterPro; IPR005425; K_chnl_volt-dep_bsu_KCNE2.
DR   PANTHER; PTHR15282; PTHR15282; 1.
DR   Pfam; PF02060; ISK_Channel; 1.
DR   PRINTS; PR01605; KCNE2CHANNEL.
PE   2: Evidence at transcript level;
KW   Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    123       Potassium voltage-gated channel subfamily
FT                                E member 2.
FT                                /FTId=PRO_0000144286.
FT   TRANSMEM     49     69       Helical. {ECO:0000255}.
FT   TOPO_DOM     70    123       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD      6      6       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     29     29       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT     82     82       H -> D (in Ref. 1; BAB25781).
FT                                {ECO:0000305}.
SQ   SEQUENCE   123 AA;  14370 MW;  0A52784967FD741C CRC64;
     MATLANLTQT LEDAFKKIFI TYMDSWRRNT TAEEQALQAR VDAENFYYVI LYLMVMIGMF
     SFIVVAILVS TVKSKRREHS QHPYHQYIVE DWQEKYKSQI LHLEDSKATI HENMGATGFT
     VSP
//
ID   KCNKD_RAT               Reviewed;         405 AA.
AC   Q9ERS0;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   27-SEP-2017, entry version 86.
DE   RecName: Full=Potassium channel subfamily K member 13;
DE   AltName: Full=Tandem pore domain halothane-inhibited potassium channel 1;
DE            Short=THIK-1;
GN   Name=Kcnk13;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   STRAIN=Wistar; TISSUE=Brain, and Heart;
RX   PubMed=11060316; DOI=10.1074/jbc.M008985200;
RA   Rajan S., Wischmeyer E., Karschin C., Preisig-Mueller R.,
RA   Grzeschik K.-H., Daut J., Karschin A., Derst C.;
RT   "THIK-1 and THIK-2, a novel subfamily of tandem pore domain K+
RT   channels.";
RL   J. Biol. Chem. 276:7302-7311(2001).
CC   -!- FUNCTION: Potassium channel displaying weak inward rectification
CC       in symmetrical K(+) solution.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. In brain expression is rather low
CC       and restricted to the olfactory bulb and tubercle, to the
CC       ventromedial hypothalamic nucleus, lateral septal nucleus dorsal,
CC       lateral mammillary nucleus, lateral parabrachial nuclei, reticular
CC       nucleus and reunions nuclei.
CC   -!- MISCELLANEOUS: Weakly sensitive to low extracellular pH. Activated
CC       by arachidonic acid; inhibited by halothane and Ba++.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF287301; AAG32312.1; -; mRNA.
DR   RefSeq; NP_071629.1; NM_022293.1.
DR   UniGene; Rn.53793; -.
DR   ProteinModelPortal; Q9ERS0; -.
DR   SMR; Q9ERS0; -.
DR   STRING; 10116.ENSRNOP00000067310; -.
DR   PaxDb; Q9ERS0; -.
DR   PRIDE; Q9ERS0; -.
DR   GeneID; 64120; -.
DR   KEGG; rno:64120; -.
DR   UCSC; RGD:68941; rat.
DR   CTD; 56659; -.
DR   RGD; 68941; Kcnk13.
DR   eggNOG; KOG4404; Eukaryota.
DR   eggNOG; ENOG410XRZJ; LUCA.
DR   HOVERGEN; HBG052238; -.
DR   InParanoid; Q9ERS0; -.
DR   KO; K04922; -.
DR   PhylomeDB; Q9ERS0; -.
DR   PRO; PR:Q9ERS0; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR005410; 2pore_dom_K_chnl_THIK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01588; THIKCHANNEL.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    405       Potassium channel subfamily K member 13.
FT                                /FTId=PRO_0000101764.
FT   TOPO_DOM      1     19       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     20     40       Helical. {ECO:0000255}.
FT   INTRAMEM     95    115       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    125    145       Helical. {ECO:0000255}.
FT   TOPO_DOM    146    193       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    194    214       Helical. {ECO:0000255}.
FT   INTRAMEM    224    244       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    263    283       Helical. {ECO:0000255}.
FT   TOPO_DOM    284    405       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     59     59       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     65     65       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   405 AA;  45081 MW;  441EB3EB2EC28C62 CRC64;
     MAGRGCSCSP GHLNEDNARF LLLAGLILLY LLGGAAVFSA LELAQELQAK QRWEERLANF
     SRGHNLSREE LRGFLRHYEE ATKAGIRMDS VRPRWDFTGA FYFVGTVVTT IGFGMTTPAT
     TGGKVFLIFY GLIGCASTIL FFNLFLERLI TVIAYVMRTC HHQQLRRRGT VARDNRKAPR
     KGEADSLAGW KPSVYYVMLI LCLASVAISC GASALYTTME GWSYFDSVYF CFVASSTIGF
     GDLVSSQNAQ YENEGLYRFV NFFFILMGVC CIYSMFNVIS ILIKQTVNWI LRKLDSGCFP
     QCQRGLLRSR RNVVMPGNIR NRCNISIETD GVMESDTDGR RLSGEMISMK DTNKVSLAIL
     QKQLSEMANG GPHQTSTSSR DDEFSGGVGA FAVMNNRLAE TSGDR
//
ID   KCNKC_RAT               Reviewed;         430 AA.
AC   Q9ERS1;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   25-OCT-2017, entry version 108.
DE   RecName: Full=Potassium channel subfamily K member 12;
DE   AltName: Full=Tandem pore domain halothane-inhibited potassium channel 2;
DE            Short=THIK-2;
GN   Name=Kcnk12;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=11060316; DOI=10.1074/jbc.M008985200;
RA   Rajan S., Wischmeyer E., Karschin C., Preisig-Mueller R.,
RA   Grzeschik K.-H., Daut J., Karschin A., Derst C.;
RT   "THIK-1 and THIK-2, a novel subfamily of tandem pore domain K+
RT   channels.";
RL   J. Biol. Chem. 276:7302-7311(2001).
CC   -!- FUNCTION: Probable potassium channel subunit. No channel activity
CC       observed in heterologous systems. May need to associate with
CC       another protein to form a functional channel.
CC   -!- SUBUNIT: Heterodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in most brain regions. Also
CC       expressed in other tissues such as lung, kidney, liver, stomach
CC       and spleen. {ECO:0000269|PubMed:11060316}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF287300; AAG32311.1; -; mRNA.
DR   RefSeq; NP_071628.1; NM_022292.1.
DR   UniGene; Rn.64577; -.
DR   ProteinModelPortal; Q9ERS1; -.
DR   STRING; 10116.ENSRNOP00000021570; -.
DR   PaxDb; Q9ERS1; -.
DR   Ensembl; ENSRNOT00000021570; ENSRNOP00000021570; ENSRNOG00000016110.
DR   GeneID; 64119; -.
DR   KEGG; rno:64119; -.
DR   UCSC; RGD:68940; rat.
DR   CTD; 56660; -.
DR   RGD; 68940; Kcnk12.
DR   eggNOG; KOG4404; Eukaryota.
DR   eggNOG; ENOG410XRZJ; LUCA.
DR   GeneTree; ENSGT00860000133807; -.
DR   HOGENOM; HOG000013227; -.
DR   HOVERGEN; HBG052238; -.
DR   InParanoid; Q9ERS1; -.
DR   KO; K04921; -.
DR   OMA; NGYPRTV; -.
DR   OrthoDB; EOG091G06SB; -.
DR   PhylomeDB; Q9ERS1; -.
DR   TreeFam; TF313947; -.
DR   PRO; PR:Q9ERS1; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000016110; -.
DR   Genevisible; Q9ERS1; RN.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR005410; 2pore_dom_K_chnl_THIK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01588; THIKCHANNEL.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    430       Potassium channel subfamily K member 12.
FT                                /FTId=PRO_0000101761.
FT   TOPO_DOM      1     38       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     39     59       Helical. {ECO:0000255}.
FT   INTRAMEM    114    134       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    145    165       Helical. {ECO:0000255}.
FT   TOPO_DOM    166    212       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    213    233       Helical. {ECO:0000255}.
FT   INTRAMEM    243    263       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    282    302       Helical. {ECO:0000255}.
FT   TOPO_DOM    303    430       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS     22     27       Poly-Cys.
FT   CARBOHYD     78     78       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   430 AA;  46965 MW;  69F1D16C6BFE7180 CRC64;
     MSSRSPRPPP RRCRRRLPRP SCCCCCCRRS HLNEDTGRFV LLAALIGLYL VAGATVFSAL
     ESPGEAEARA RWGATLRNFS AAHGVAEPEL RAFLRHYEAA LAAGVRADAL RPRWDFPGAF
     YFVGTVVSTI GFGMTTPATV GGKAFLIAYG LFGCAGTILF FNLFLERIIS LLAFIMRACR
     ERQLRRSGLL PATFRRGSAL SEADSLAGWK PSVYHVLLIL GLFAVLLACC ASAMYTSVEG
     WDYVDSLYFC FVTFSTIGFG DLVSSQHAAY RNQGLYRLGN FLFILLGVCC IYSLFNVISI
     LIKQVLNWML RKLSCRCCTR CCPAPGAPLS RRNAITPGSR LRRRLAALGT DPAARDSDAE
     GRRLSGELIS MRDLTASNKV SLALLQKQLS ETANGYPRSV CVNTRQNGFS GGVGALGIMN
     NRLAETSASR
//
ID   KCNK9_RAT               Reviewed;         396 AA.
AC   Q9ES08; Q923V6; Q9JLD4;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   10-JAN-2006, sequence version 2.
DT   22-NOV-2017, entry version 124.
DE   RecName: Full=Potassium channel subfamily K member 9;
DE   AltName: Full=Acid-sensitive potassium channel protein TASK-3;
DE   AltName: Full=TWIK-related acid-sensitive K(+) channel 3;
DE   AltName: Full=Two pore potassium channel KT3.2;
DE            Short=Two pore K(+) channel KT3.2;
GN   Name=Kcnk9; Synonyms=Task3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF HIS-98.
RC   STRAIN=Sprague-Dawley; TISSUE=Cerebellum;
RX   PubMed=10734076; DOI=10.1074/jbc.275.13.9340;
RA   Kim Y., Bang H., Kim D.;
RT   "TASK-3, a new member of the tandem pore K+ channel family.";
RL   J. Biol. Chem. 275:9340-9347(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar;
RX   PubMed=11875121; DOI=10.1210/mend.16.3.0788;
RA   Czirjak G., Enyedi P.;
RT   "TASK-3 dominates the background potassium conductance in rat adrenal
RT   glomerulosa cells.";
RL   Mol. Endocrinol. 16:621-629(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-237, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11431495;
RA   Vega-Saenz de Miera E., Lau D.H.P., Zhadina M., Pountney D.,
RA   Coetzee W.A., Rudy B.;
RT   "KT3.2 and KT3.3, two novel human two-pore K(+) channels closely
RT   related to TASK-1.";
RL   J. Neurophysiol. 86:130-142(2001).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=11749039; DOI=10.1006/mcne.2001.1045;
RA   Karschin C., Wischmeyer E., Preisig-Mueller R., Rajan S., Derst C.,
RA   Grzeschik K.-H., Daut J., Karschin A.;
RT   "Expression pattern in brain of TASK-1, TASK-3, and a tandem pore
RT   domain K(+) channel subunit, TASK-5, associated with the central
RT   auditory nervous system.";
RL   Mol. Cell. Neurosci. 18:632-648(2001).
CC   -!- FUNCTION: pH-dependent, voltage-insensitive, background potassium
CC       channel protein. {ECO:0000269|PubMed:10734076,
CC       ECO:0000269|PubMed:11875121}.
CC   -!- SUBUNIT: Homodimer. Heterodimer with KCNK1.
CC       {ECO:0000250|UniProtKB:Q9NPC2}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q9NPC2}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NPC2}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in the CNS and at lower
CC       levels in the colon, kidney, liver, lung, spleen, stomach and
CC       skeletal muscle. The highest expression was found in the olfactory
CC       nuclei, piriform cortex, cerebellum, antedorsal thalmic nucleus,
CC       pontine nucleus, dorsal raphe and several nuclei in the medulla.
CC       Shows a non-homogeneous distribution in the hippocampus. Expressed
CC       at highest levels in the lateral posterior and inferior portions
CC       and at medium levels in neocortex. {ECO:0000269|PubMed:10734076,
CC       ECO:0000269|PubMed:11431495, ECO:0000269|PubMed:11749039,
CC       ECO:0000269|PubMed:11875121}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF60229.1; Type=Frameshift; Positions=170, 171, 175; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF192366; AAF60229.1; ALT_FRAME; mRNA.
DR   EMBL; AF391084; AAK69764.1; -; mRNA.
DR   EMBL; AF257082; AAG33128.1; -; mRNA.
DR   RefSeq; NP_445857.2; NM_053405.2.
DR   RefSeq; XP_017450625.1; XM_017595136.1.
DR   UniGene; Rn.48796; -.
DR   ProteinModelPortal; Q9ES08; -.
DR   DIP; DIP-61122N; -.
DR   IntAct; Q9ES08; 1.
DR   STRING; 10116.ENSRNOP00000012408; -.
DR   PaxDb; Q9ES08; -.
DR   Ensembl; ENSRNOT00000012408; ENSRNOP00000012408; ENSRNOG00000009265.
DR   GeneID; 84429; -.
DR   KEGG; rno:84429; -.
DR   UCSC; RGD:621451; rat.
DR   CTD; 51305; -.
DR   RGD; 621451; Kcnk9.
DR   eggNOG; KOG4404; Eukaryota.
DR   eggNOG; ENOG410XRZJ; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000231463; -.
DR   HOVERGEN; HBG052239; -.
DR   InParanoid; Q9ES08; -.
DR   KO; K04919; -.
DR   OMA; DDYREIE; -.
DR   OrthoDB; EOG091G08DH; -.
DR   PhylomeDB; Q9ES08; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-RNO-1299316; TWIK-releated acid-sensitive K+ channel (TASK).
DR   PRO; PR:Q9ES08; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000009265; -.
DR   Genevisible; Q9ES08; RN.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IMP:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; IMP:RGD.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISO:RGD.
DR   GO; GO:0071804; P:cellular potassium ion transport; ISO:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR005407; KCNK9.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01585; TASK3CHANNEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    396       Potassium channel subfamily K member 9.
FT                                /FTId=PRO_0000101756.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      9     29       Helical. {ECO:0000255}.
FT   TOPO_DOM     30     88       Extracellular. {ECO:0000255}.
FT   INTRAMEM     89    101       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TOPO_DOM    102    107       Extracellular. {ECO:0000255}.
FT   TRANSMEM    108    128       Helical. {ECO:0000255}.
FT   TOPO_DOM    129    158       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical. {ECO:0000255}.
FT   TOPO_DOM    180    194       Extracellular. {ECO:0000255}.
FT   INTRAMEM    195    207       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TOPO_DOM    208    218       Extracellular. {ECO:0000255}.
FT   TRANSMEM    219    239       Helical. {ECO:0000255}.
FT   TOPO_DOM    240    396       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN      98     98       H->D: Reduces sensitivity to alterations
FT                                in external pH.
FT                                {ECO:0000269|PubMed:10734076}.
SQ   SEQUENCE   396 AA;  44357 MW;  734EB0EEA1ED1828 CRC64;
     MKRQNVRTLS LIACTFTYLL VGAAVFDALE SDHEMREEEK LKAEEVRLRG KYNISSDDYQ
     QLELVILQSE PHRAGVQWKF AGSFYFAITV ITTIGYGHAA PGTDAGKAFC MFYAVLGIPL
     TLVMFQSLGE RMNTFVRYLL KRIKKCCGMR NTEVSMENMV TVGFFSCMGT LCLGAAAFSQ
     CEDWSFFHAY YYCFITLTTI GFGDFVALQS KGALQRKPFY VAFSFMYILV GLTVIGAFLN
     LVVLRFLTMN TDEDLLEGEV AQILAGNPRR VVVRVPQSRK RHHPMYFLRK YGRTLCYLCF
     PGANWGDDDD DDDDAVENVV VTTPVPPAVA AAAAAATPGP STRNVRATVH SVSCRVEEIP
     PDVLRNTYFR SPFGAIPPGM HTCGENHRLH IRRKSI
//
ID   KCO4_ARATH              Reviewed;         284 AA.
AC   Q9FWX6; Q6X308;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   27-SEP-2017, entry version 101.
DE   RecName: Full=Two-pore potassium channel 4;
DE            Short=AtTPK4;
DE   AltName: Full=Outward-rectifying potassium channel 4;
DE            Short=AtKCO4;
GN   Name=TPK4; Synonyms=KCO4; OrderedLocusNames=At1g02510;
GN   ORFNames=T14P4.16;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, SUBCELLULAR LOCATION,
RP   DISRUPTION PHENOTYPE, GENE FAMILY, AND NOMENCLATURE.
RC   STRAIN=cv. Columbia;
RX   PubMed=15505206; DOI=10.1073/pnas.0401502101;
RA   Becker D., Geiger D., Dunkel M., Roller A., Bertl A., Latz A.,
RA   Carpaneto A., Dietrich P., Roelfsema M.R., Voelker C., Schmidt D.,
RA   Mueller-Roeber B., Czempinski K., Hedrich R.;
RT   "AtTPK4, an Arabidopsis tandem-pore K+ channel, poised to control the
RT   pollen membrane voltage in a pH- and Ca2+-dependent manner.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15621-15626(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130712; DOI=10.1038/35048500;
RA   Theologis A., Ecker J.R., Palm C.J., Federspiel N.A., Kaul S.,
RA   White O., Alonso J., Altafi H., Araujo R., Bowman C.L., Brooks S.Y.,
RA   Buehler E., Chan A., Chao Q., Chen H., Cheuk R.F., Chin C.W.,
RA   Chung M.K., Conn L., Conway A.B., Conway A.R., Creasy T.H., Dewar K.,
RA   Dunn P., Etgu P., Feldblyum T.V., Feng J.-D., Fong B., Fujii C.Y.,
RA   Gill J.E., Goldsmith A.D., Haas B., Hansen N.F., Hughes B., Huizar L.,
RA   Hunter J.L., Jenkins J., Johnson-Hopson C., Khan S., Khaykin E.,
RA   Kim C.J., Koo H.L., Kremenetskaia I., Kurtz D.B., Kwan A., Lam B.,
RA   Langin-Hooper S., Lee A., Lee J.M., Lenz C.A., Li J.H., Li Y.-P.,
RA   Lin X., Liu S.X., Liu Z.A., Luros J.S., Maiti R., Marziali A.,
RA   Militscher J., Miranda M., Nguyen M., Nierman W.C., Osborne B.I.,
RA   Pai G., Peterson J., Pham P.K., Rizzo M., Rooney T., Rowley D.,
RA   Sakano H., Salzberg S.L., Schwartz J.R., Shinn P., Southwick A.M.,
RA   Sun H., Tallon L.J., Tambunga G., Toriumi M.J., Town C.D.,
RA   Utterback T., Van Aken S., Vaysberg M., Vysotskaia V.S., Walker M.,
RA   Wu D., Yu G., Fraser C.M., Venter J.C., Davis R.W.;
RT   "Sequence and analysis of chromosome 1 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:816-820(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [5]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=16984403; DOI=10.1111/j.1365-313X.2006.02868.x;
RA   Voelker C., Schmidt D., Mueller-Roeber B., Czempinski K.;
RT   "Members of the Arabidopsis AtTPK/KCO family form homomeric vacuolar
RT   channels in planta.";
RL   Plant J. 48:296-306(2006).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19825594; DOI=10.1093/mp/ssn064;
RA   Dunkel M., Latz A., Schumacher K., Mueller T., Becker D., Hedrich R.;
RT   "Targeting of vacuolar membrane localized members of the TPK channel
RT   family.";
RL   Mol. Plant 1:938-949(2008).
CC   -!- FUNCTION: Voltage-independent, instantaneously activating,
CC       potassium-selective plasma membrane ion channel. Open rectifier.
CC       Regulated by cytoplasmic pH and extra-cellular calcium. Has some
CC       permeability for Rb(+) and NH(4)(+), but none for Na(+) or Li(+).
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15505206,
CC       ECO:0000269|PubMed:19825594}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15505206, ECO:0000269|PubMed:19825594}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in pollen.
CC       {ECO:0000269|PubMed:15505206, ECO:0000269|PubMed:16984403}.
CC   -!- DEVELOPMENTAL STAGE: Not expressed during very early stages of
CC       flower development, but detected when buds are still closed.
CC       {ECO:0000269|PubMed:16984403}.
CC   -!- DOMAIN: Each of the two pore-forming region (also called P-domain
CC       or P-loop) is enclosed by two transmembrane segments (2P/4TM) and
CC       contains the GYGD signature motif which seems to be involved in
CC       potassium selectivity.
CC   -!- DISRUPTION PHENOTYPE: No effect on pollen germination rate and
CC       growth. {ECO:0000269|PubMed:15505206}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.7) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY258073; AAP82009.1; -; mRNA.
DR   EMBL; AC022521; AAG10638.1; -; Genomic_DNA.
DR   EMBL; CP002684; AEE27439.1; -; Genomic_DNA.
DR   PIR; D86155; D86155.
DR   RefSeq; NP_171752.1; NM_100132.2.
DR   UniGene; At.42597; -.
DR   ProteinModelPortal; Q9FWX6; -.
DR   BioGrid; 23086; 2.
DR   STRING; 3702.AT1G02510.1; -.
DR   TCDB; 1.A.1.7.2; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q9FWX6; -.
DR   EnsemblPlants; AT1G02510.1; AT1G02510.1; AT1G02510.
DR   GeneID; 837846; -.
DR   Gramene; AT1G02510.1; AT1G02510.1; AT1G02510.
DR   KEGG; ath:AT1G02510; -.
DR   Araport; AT1G02510; -.
DR   TAIR; locus:2196155; AT1G02510.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000238193; -.
DR   InParanoid; Q9FWX6; -.
DR   KO; K05389; -.
DR   OMA; FLHVFER; -.
DR   OrthoDB; EOG09360JKS; -.
DR   PhylomeDB; Q9FWX6; -.
DR   PRO; PR:Q9FWX6; -.
DR   Proteomes; UP000006548; Chromosome 1.
DR   ExpressionAtlas; Q9FWX6; baseline and differential.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0009705; C:plant-type vacuole membrane; IBA:GO_Central.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
PE   2: Evidence at transcript level;
KW   Cell membrane; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    284       Two-pore potassium channel 4.
FT                                /FTId=PRO_0000101778.
FT   TOPO_DOM      1     31       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     32     52       Helical. {ECO:0000255}.
FT   INTRAMEM     70     89       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM     93    113       Helical. {ECO:0000255}.
FT   TOPO_DOM    114    156       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    157    177       Helical. {ECO:0000255}.
FT   INTRAMEM    184    203       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    211    231       Helical. {ECO:0000255}.
FT   TOPO_DOM    232    284       Cytoplasmic. {ECO:0000255}.
SQ   SEQUENCE   284 AA;  32061 MW;  AF54B529AE1BBB91 CRC64;
     MEEENLLNEN LLHPNESSPE ETQVTTVSKS KWTILVLAMI LLLVYLTFGV CTYSFFRDQF
     SGTETNLFVD AFYFSIVTFS TVGYGDIVPS TSTTKILTIV LVSTGVVFLD YLLNRVVSHV
     LSLQENAILD RINKTRNRAI RDHIAEDGKI RLKWKLCLAF CAVGLCVGSG ALFLHVFERL
     DWLDSVYLSV ISVTTVGYGD KTFKTVEGRG FAVFWLLLST IAMATLFLYL AEMRIDRTTV
     MKLPPSESEF IVFKLRESGR ISEDDIKQIV REFENLEEVP SSGS
//
ID   KCNH6_HUMAN             Reviewed;         994 AA.
AC   Q9H252; Q9BRD7;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   25-OCT-2017, entry version 159.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 6;
DE   AltName: Full=Ether-a-go-go-related gene potassium channel 2;
DE            Short=ERG-2;
DE            Short=Eag-related protein 2;
DE            Short=Ether-a-go-go-related protein 2;
DE            Short=hERG-2;
DE            Short=hERG2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv11.2;
GN   Name=KCNH6; Synonyms=ERG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Titus S.A., Ganetzky B.S.;
RT   "Human Eag-related gene member 2 (Herg2) potassium channel.";
RL   Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   MET-925.
RC   TISSUE=Amygdala, and Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12634931; DOI=10.1007/s00424-002-0980-0;
RA   Bauer C.K., Wulfsen I., Schaefer R., Glassmeier G., Wimmers S.,
RA   Flitsch J., Luedecke D.K., Schwarz J.R.;
RT   "HERG K(+) currents in human prolactin-secreting adenoma cells.";
RL   Pflugers Arch. 445:589-600(2003).
RN   [5]
RP   GLYCOSYLATION AT ASN-449.
RX   PubMed=19139490; DOI=10.1074/mcp.M800504-MCP200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F.,
RA   Zheng Z.B., Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y.,
RA   Zhang Y.K., Deng Y.L., Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core
RT   fucosylated glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium
CC       channel. Elicits a slowly activating, rectifying current (By
CC       similarity). Channel properties may be modulated by cAMP and
CC       subunit assembly. {ECO:0000250}.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits. Heteromultimers with
CC       KCNH2/ERG1 and KCNH7/ERG3 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=1;
CC         IsoId=Q9H252-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H252-2; Sequence=VSP_000977, VSP_000978;
CC       Name=3;
CC         IsoId=Q9H252-3; Sequence=VSP_000979, VSP_000980;
CC   -!- TISSUE SPECIFICITY: Expressed in prolactin-secreting adenomas.
CC       {ECO:0000269|PubMed:12634931}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag) (TC
CC       1.A.1.20) subfamily. Kv11.2/KCNH6 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF311913; AAG40871.1; -; mRNA.
DR   EMBL; AK090969; BAC03559.1; -; mRNA.
DR   EMBL; AK091877; BAC03764.1; -; mRNA.
DR   EMBL; BC006334; AAH06334.1; -; mRNA.
DR   CCDS; CCDS11638.1; -. [Q9H252-1]
DR   CCDS; CCDS11639.1; -. [Q9H252-2]
DR   RefSeq; NP_001265848.1; NM_001278919.1.
DR   RefSeq; NP_001265849.1; NM_001278920.1.
DR   RefSeq; NP_110406.1; NM_030779.3. [Q9H252-1]
DR   RefSeq; NP_775115.1; NM_173092.2. [Q9H252-2]
DR   RefSeq; XP_011523612.1; XM_011525310.2. [Q9H252-2]
DR   RefSeq; XP_016880664.1; XM_017025175.1. [Q9H252-1]
DR   UniGene; Hs.591177; -.
DR   ProteinModelPortal; Q9H252; -.
DR   SMR; Q9H252; -.
DR   STRING; 9606.ENSP00000463533; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   DrugBank; DB00590; Doxazosin.
DR   DrugBank; DB00308; Ibutilide.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB00457; Prazosin.
DR   DrugBank; DB01162; Terazosin.
DR   GuidetoPHARMACOLOGY; 573; -.
DR   iPTMnet; Q9H252; -.
DR   PhosphoSitePlus; Q9H252; -.
DR   BioMuta; KCNH6; -.
DR   DMDM; 26006810; -.
DR   PaxDb; Q9H252; -.
DR   PeptideAtlas; Q9H252; -.
DR   PRIDE; Q9H252; -.
DR   DNASU; 81033; -.
DR   Ensembl; ENST00000456941; ENSP00000396900; ENSG00000173826. [Q9H252-2]
DR   Ensembl; ENST00000580652; ENSP00000464672; ENSG00000173826. [Q9H252-3]
DR   Ensembl; ENST00000581784; ENSP00000463830; ENSG00000173826. [Q9H252-2]
DR   Ensembl; ENST00000583023; ENSP00000463533; ENSG00000173826. [Q9H252-1]
DR   GeneID; 81033; -.
DR   KEGG; hsa:81033; -.
DR   UCSC; uc002jax.2; human. [Q9H252-1]
DR   CTD; 81033; -.
DR   DisGeNET; 81033; -.
DR   EuPathDB; HostDB:ENSG00000173826.14; -.
DR   GeneCards; KCNH6; -.
DR   HGNC; HGNC:18862; KCNH6.
DR   MIM; 608168; gene.
DR   neXtProt; NX_Q9H252; -.
DR   OpenTargets; ENSG00000173826; -.
DR   PharmGKB; PA38722; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140833; -.
DR   HOGENOM; HOG000230793; -.
DR   HOVERGEN; HBG052232; -.
DR   InParanoid; Q9H252; -.
DR   KO; K04909; -.
DR   OMA; MFVVDIV; -.
DR   OrthoDB; EOG091G024C; -.
DR   PhylomeDB; Q9H252; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNH6; -.
DR   GenomeRNAi; 81033; -.
DR   PRO; PR:Q9H252; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000173826; -.
DR   CleanEx; HS_KCNH6; -.
DR   ExpressionAtlas; Q9H252; baseline and differential.
DR   Genevisible; Q9H252; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003967; K_chnl_volt-dep_ERG.
DR   InterPro; IPR030172; KCNH6.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF468; PTHR10217:SF468; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01470; ERGCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    994       Potassium voltage-gated channel subfamily
FT                                H member 6.
FT                                /FTId=PRO_0000054013.
FT   TOPO_DOM      1    261       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    262    282       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    283    298       Extracellular. {ECO:0000255}.
FT   TRANSMEM    299    319       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    320    340       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    341    361       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    362    370       Extracellular. {ECO:0000255}.
FT   TRANSMEM    371    391       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    392    398       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    399    419       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    420    463       Extracellular. {ECO:0000255}.
FT   INTRAMEM    464    484       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    485    490       Extracellular. {ECO:0000255}.
FT   TRANSMEM    491    511       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    512    994       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       41     70       PAS.
FT   DOMAIN       92    144       PAC.
FT   NP_BIND     594    711       cNMP.
FT   MOTIF       476    481       Selectivity filter. {ECO:0000250}.
FT   CARBOHYD    449    449       N-linked (GlcNAc...) (complex)
FT                                asparagine.
FT                                {ECO:0000269|PubMed:19139490}.
FT   VAR_SEQ     419    472       WYAIGNVERPYLEHKIGWLDSLGVQLGKRYNGSDPASGPSV
FT                                QDKYVTALYFTFS -> C (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_000977.
FT   VAR_SEQ     501    502       SL -> CE (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000979.
FT   VAR_SEQ     503    994       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000980.
FT   VAR_SEQ     745    780       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_000978.
FT   VARIANT     165    165       G -> R (in dbSNP:rs35399062).
FT                                /FTId=VAR_053857.
FT   VARIANT     925    925       T -> M (in dbSNP:rs35819807).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_053858.
FT   CONFLICT    963    963       F -> L (in Ref. 2; BAC03764).
FT                                {ECO:0000305}.
SQ   SEQUENCE   994 AA;  109925 MW;  BE9ECB349A798576 CRC64;
     MPVRRGHVAP QNTYLDTIIR KFEGQSRKFL IANAQMENCA IIYCNDGFCE LFGYSRVEVM
     QQPCTCDFLT GPNTPSSAVS RLAQALLGAE ECKVDILYYR KDASSFRCLV DVVPVKNEDG
     AVIMFILNFE DLAQLLAKCS SRSLSQRLLS QSFLGSEGSH GRPGGPGPGT GRGKYRTISQ
     IPQFTLNFVE FNLEKHRSSS TTEIEIIAPH KVVERTQNVT EKVTQVLSLG ADVLPEYKLQ
     APRIHRWTIL HYSPFKAVWD WLILLLVIYT AVFTPYSAAF LLSDQDESRR GACSYTCSPL
     TVVDLIVDIM FVVDIVINFR TTYVNTNDEV VSHPRRIAVH YFKGWFLIDM VAAIPFDLLI
     FRTGSDETTT LIGLLKTARL LRLVRVARKL DRYSEYGAAV LFLLMCTFAL IAHWLACIWY
     AIGNVERPYL EHKIGWLDSL GVQLGKRYNG SDPASGPSVQ DKYVTALYFT FSSLTSVGFG
     NVSPNTNSEK VFSICVMLIG SLMYASIFGN VSAIIQRLYS GTARYHTQML RVKEFIRFHQ
     IPNPLRQRLE EYFQHAWSYT NGIDMNAVLK GFPECLQADI CLHLHRALLQ HCPAFSGAGK
     GCLRALAVKF KTTHAPPGDT LVHLGDVLST LYFISRGSIE ILRDDVVVAI LGKNDIFGEP
     VSLHAQPGKS SADVRALTYC DLHKIQRADL LEVLDMYPAF AESFWSKLEV TFNLRDAAGG
     LHSSPRQAPG SQDHQGFFLS DNQSGSPHEL GPQFPSKGYS LLGPGSQNSM GAGPCAPGHP
     DAAPPLSISD ASGLWPELLQ EMPPRHSPQS PQEDPDCWPL KLGSRLEQLQ AQMNRLESRV
     SSDLSRILQL LQKPMPQGHA SYILEAPASN DLALVPIASE TTSPGPRLPQ GFLPPAQTPS
     YGDLDDCSPK HRNSSPRMPH LAVATDKTLA PSSEQEQPEG LWPPLASPLH PLEVQGLICG
     PCFSSLPEHL GSVPKQLDFQ RHGSDPGFAG SWGH
//
ID   KCNF1_HUMAN             Reviewed;         494 AA.
AC   Q9H3M0; O43527; Q585L3;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-NOV-2017, entry version 138.
DE   RecName: Full=Potassium voltage-gated channel subfamily F member 1;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv5.1;
DE   AltName: Full=kH1;
GN   Name=KCNF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   PubMed=9434767; DOI=10.1006/bbrc.1997.7830;
RA   Su K., Kyaw H., Fan P., Zeng Z., Shell B.K., Carter K.C., Li Y.;
RT   "Isolation, characterization, and mapping of two human potassium
RT   channels.";
RL   Biochem. Biophys. Res. Commun. 241:675-681(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Chen J., Ptacek J.L.;
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hypothalamus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH DLG1.
RX   PubMed=12445884; DOI=10.1016/S0008-6363(02)00602-8;
RA   Godreau D., Vranckx R., Maguy A., Rucker-Martin C., Goyenvalle C.,
RA   Abdelshafy S., Tessier S., Couetil J.P., Hatem S.N.;
RT   "Expression, regulation and role of the MAGUK protein SAP-97 in human
RT   atrial myocardium.";
RL   Cardiovasc. Res. 56:433-442(2002).
CC   -!- FUNCTION: Putative voltage-gated potassium channel.
CC   -!- SUBUNIT: Heteromultimer with KCNG3, KCNG4 and KCNV2. Interacts
CC       with DLG1. {ECO:0000269|PubMed:12445884}.
CC   -!- INTERACTION:
CC       O95363:FARS2; NbExp=4; IntAct=EBI-6918743, EBI-2513774;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Detected in heart, brain, liver, skeletal
CC       muscle, kidney and pancreas.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. F (TC
CC       1.A.1.2) subfamily. Kv5.1/KCNF1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF033382; AAC05597.1; -; mRNA.
DR   EMBL; AF029780; AAG43055.1; -; mRNA.
DR   EMBL; AC019041; AAX81991.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00946.1; -; Genomic_DNA.
DR   EMBL; BC026110; AAH26110.1; -; mRNA.
DR   CCDS; CCDS1676.1; -.
DR   PIR; JC5919; JC5919.
DR   RefSeq; NP_002227.2; NM_002236.4.
DR   UniGene; Hs.23735; -.
DR   ProteinModelPortal; Q9H3M0; -.
DR   BioGrid; 109956; 4.
DR   IntAct; Q9H3M0; 9.
DR   STRING; 9606.ENSP00000295082; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   TCDB; 1.A.1.2.18; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9H3M0; -.
DR   PhosphoSitePlus; Q9H3M0; -.
DR   BioMuta; KCNF1; -.
DR   DMDM; 24418476; -.
DR   PaxDb; Q9H3M0; -.
DR   PeptideAtlas; Q9H3M0; -.
DR   PRIDE; Q9H3M0; -.
DR   DNASU; 3754; -.
DR   Ensembl; ENST00000295082; ENSP00000295082; ENSG00000162975.
DR   GeneID; 3754; -.
DR   KEGG; hsa:3754; -.
DR   UCSC; uc002rax.3; human.
DR   CTD; 3754; -.
DR   EuPathDB; HostDB:ENSG00000162975.4; -.
DR   GeneCards; KCNF1; -.
DR   HGNC; HGNC:6246; KCNF1.
DR   HPA; CAB004678; -.
DR   HPA; HPA014738; -.
DR   MIM; 603787; gene.
DR   neXtProt; NX_Q9H3M0; -.
DR   OpenTargets; ENSG00000162975; -.
DR   PharmGKB; PA30033; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231016; -.
DR   HOVERGEN; HBG052230; -.
DR   InParanoid; Q9H3M0; -.
DR   KO; K04899; -.
DR   OMA; NEMEFWK; -.
DR   OrthoDB; EOG091G0FP3; -.
DR   PhylomeDB; Q9H3M0; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNF1; -.
DR   GenomeRNAi; 3754; -.
DR   PRO; PR:Q9H3M0; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000162975; -.
DR   CleanEx; HS_KCNF1; -.
DR   Genevisible; Q9H3M0; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005267; F:potassium channel activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003971; K_chnl_volt-dep_Kv9.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01494; KV9CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    494       Potassium voltage-gated channel subfamily
FT                                F member 1.
FT                                /FTId=PRO_0000054072.
FT   TOPO_DOM      1    183       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    184    204       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    224    244       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    245    249       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    250    270       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    290    310       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    311    324       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    325    345       Helical; Name=Segment S5. {ECO:0000255}.
FT   INTRAMEM    358    378       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TRANSMEM    386    406       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    407    494       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       370    375       Selectivity filter. {ECO:0000250}.
FT   CONFLICT    186    186       V -> E (in Ref. 1; AAC05597).
FT                                {ECO:0000305}.
FT   CONFLICT    202    202       G -> D (in Ref. 1; AAC05597).
FT                                {ECO:0000305}.
FT   CONFLICT    356    356       S -> N (in Ref. 1; AAC05597).
FT                                {ECO:0000305}.
FT   CONFLICT    383    383       G -> S (in Ref. 1; AAC05597).
FT                                {ECO:0000305}.
SQ   SEQUENCE   494 AA;  55584 MW;  87E2FB117F927F60 CRC64;
     MDGSGERSLP EPGSQSSAAS DDIEIVVNVG GVRQVLYGDL LSQYPETRLA ELINCLAGGY
     DTIFSLCDDY DPGKREFYFD RDPDAFKCVI EVYYFGEVHM KKGICPICFK NEMDFWKVDL
     KFLDDCCKSH LSEKREELEE IARRVQLILD DLGVDAAEGR WRRCQKCVWK FLEKPESSCP
     ARVVAVLSFL LILVSSVVMC MGTIPELQVL DAEGNRVEHP TLENVETACI GWFTLEYLLR
     LFSSPNKLHF ALSFMNIVDV LAILPFYVSL TLTHLGARMM ELTNVQQAVQ ALRIMRIARI
     FKLARHSSGL QTLTYALKRS FKELGLLLMY LAVGIFVFSA LGYTMEQSHP ETLFKSIPQS
     FWWAIITMTT VGYGDIYPKT TLGKLNAAIS FLCGVIAIAL PIHPIINNFV RYYNKQRVLE
     TAAKHELELM ELNSSSGGEG KTGGSRSDLD NLPPEPAGKE APSCSSRLKL SHSDTFIPLL
     TEEKHHRTRL QSCK
//
ID   KCNKF_HUMAN             Reviewed;         330 AA.
AC   Q9H427; Q52LL3; Q9HBC8;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-2002, sequence version 2.
DT   25-OCT-2017, entry version 128.
DE   RecName: Full=Potassium channel subfamily K member 15;
DE   AltName: Full=Acid-sensitive potassium channel protein TASK-5;
DE   AltName: Full=TWIK-related acid-sensitive K(+) channel 5;
DE   AltName: Full=Two pore potassium channel KT3.3;
DE            Short=Two pore K(+) channel KT3.3;
GN   Name=KCNK15; Synonyms=TASK5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT GLU-95.
RX   PubMed=11409881; DOI=10.1006/bbrc.2001.5064;
RA   Kim D., Gnatenco C.;
RT   "TASK-5, a new member of the tandem-pore K(+) channel family.";
RL   Biochem. Biophys. Res. Commun. 284:923-930(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=11431495;
RA   Vega-Saenz de Miera E., Lau D.H.P., Zhadina M., Pountney D.,
RA   Coetzee W.A., Rudy B.;
RT   "KT3.2 and KT3.3, two novel human two-pore K(+) channels closely
RT   related to TASK-1.";
RL   J. Neurophysiol. 86:130-142(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], POLYMORPHISM, VARIANTS
RP   GLU-95; THR-260; HIS-261 AND LEU-323, AND MUTAGENESIS OF ARG-138;
RP   141-LEU--CYS-145; TRP-151 AND CYS-153.
RC   TISSUE=Brain, Colon, and Ovarian carcinoma;
RX   PubMed=11749039; DOI=10.1006/mcne.2001.1045;
RA   Karschin C., Wischmeyer E., Preisig-Mueller R., Rajan S., Derst C.,
RA   Grzeschik K.-H., Daut J., Karschin A.;
RT   "Expression pattern in brain of TASK-1, TASK-3, and a tandem pore
RT   domain K(+) channel subunit, TASK-5, associated with the central
RT   auditory nervous system.";
RL   Mol. Cell. Neurosci. 18:632-648(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=11680614; DOI=10.1007/s004240100620;
RA   Ashmole I., Goodwin P.A., Stanfield P.R.;
RT   "TASK-5, a novel member of the tandem pore K+ channel family.";
RL   Pflugers Arch. 442:828-833(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS GLU-95;
RP   THR-260 AND LEU-323.
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-95; THR-260
RP   AND HIS-261.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Probable potassium channel subunit. No channel activity
CC       observed in heterologous systems. May need to associate with
CC       another protein to form a functional channel.
CC   -!- SUBUNIT: Heterodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Detected in pancreas, heart, placenta, lung,
CC       liver, kidney, ovary, testis, skeletal muscle and adrenal gland,
CC       and at lower levels in prostate, spleen and thyroid gland.
CC       {ECO:0000269|PubMed:11409881, ECO:0000269|PubMed:11680614}.
CC   -!- POLYMORPHISM: Three variant polypeptides are known: TASK-5A, TASK-
CC       5B and TASK-5C. The sequence shown is that of TASK-5C.
CC       {ECO:0000269|PubMed:11409881, ECO:0000269|PubMed:11749039,
CC       ECO:0000269|PubMed:11780052, ECO:0000269|PubMed:15489334}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF257081; AAG33127.1; -; mRNA.
DR   EMBL; AF294350; AAK97091.1; -; mRNA.
DR   EMBL; AF294351; AAK97092.1; -; mRNA.
DR   EMBL; AF294352; AAK97093.1; -; Genomic_DNA.
DR   EMBL; AF336342; AAK37518.1; -; mRNA.
DR   EMBL; AL118522; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC093874; AAH93874.1; -; mRNA.
DR   EMBL; BC143282; AAI43283.1; -; mRNA.
DR   CCDS; CCDS13337.1; -.
DR   PIR; JC7703; JC7703.
DR   RefSeq; NP_071753.2; NM_022358.3.
DR   UniGene; Hs.528664; -.
DR   ProteinModelPortal; Q9H427; -.
DR   STRING; 9606.ENSP00000361952; -.
DR   TCDB; 1.A.1.9.12; the voltage-gated ion channel (vic) superfamily.
DR   PhosphoSitePlus; Q9H427; -.
DR   BioMuta; KCNK15; -.
DR   DMDM; 24636282; -.
DR   MaxQB; Q9H427; -.
DR   PaxDb; Q9H427; -.
DR   PeptideAtlas; Q9H427; -.
DR   PRIDE; Q9H427; -.
DR   Ensembl; ENST00000372861; ENSP00000361952; ENSG00000124249.
DR   GeneID; 60598; -.
DR   KEGG; hsa:60598; -.
DR   UCSC; uc002xmr.4; human.
DR   CTD; 60598; -.
DR   EuPathDB; HostDB:ENSG00000124249.6; -.
DR   GeneCards; KCNK15; -.
DR   H-InvDB; HIX0040517; -.
DR   HGNC; HGNC:13814; KCNK15.
DR   HPA; HPA064861; -.
DR   MIM; 607368; gene.
DR   neXtProt; NX_Q9H427; -.
DR   PharmGKB; PA30056; -.
DR   eggNOG; KOG4404; Eukaryota.
DR   eggNOG; ENOG410XRZJ; LUCA.
DR   HOGENOM; HOG000231463; -.
DR   HOVERGEN; HBG052239; -.
DR   InParanoid; Q9H427; -.
DR   KO; K04923; -.
DR   OrthoDB; EOG091G08DH; -.
DR   PhylomeDB; Q9H427; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   SignaLink; Q9H427; -.
DR   ChiTaRS; KCNK15; human.
DR   GeneWiki; KCNK15; -.
DR   GenomeRNAi; 60598; -.
DR   PRO; PR:Q9H427; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000124249; -.
DR   CleanEx; HS_KCNK15; -.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005267; F:potassium channel activity; TAS:Reactome.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR008073; TASK5.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01690; TASK5CHANNEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    330       Potassium channel subfamily K member 15.
FT                                /FTId=PRO_0000101765.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      9     29       Helical. {ECO:0000255}.
FT   INTRAMEM     80    101       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    108    128       Helical. {ECO:0000255}.
FT   TOPO_DOM    129    158       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical. {ECO:0000255}.
FT   INTRAMEM    189    209       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    223    243       Helical. {ECO:0000255}.
FT   TOPO_DOM    244    330       Cytoplasmic. {ECO:0000255}.
FT   VARIANT      95     95       G -> E (in TASK-5B; dbSNP:rs1111032).
FT                                {ECO:0000269|PubMed:11409881,
FT                                ECO:0000269|PubMed:11749039,
FT                                ECO:0000269|PubMed:11780052,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_014211.
FT   VARIANT     260    260       P -> T (in TASK-5B; dbSNP:rs6073538).
FT                                {ECO:0000269|PubMed:11749039,
FT                                ECO:0000269|PubMed:11780052,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_014212.
FT   VARIANT     261    261       P -> H (in TASK-5A; dbSNP:rs13037900).
FT                                {ECO:0000269|PubMed:11749039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_014213.
FT   VARIANT     323    323       P -> L (in TASK-5B; dbSNP:rs13042905).
FT                                {ECO:0000269|PubMed:11749039,
FT                                ECO:0000269|PubMed:11780052}.
FT                                /FTId=VAR_014214.
FT   MUTAGEN     138    138       R->Y: No effect on lack of functional
FT                                expression.
FT                                {ECO:0000269|PubMed:11749039}.
FT   MUTAGEN     141    145       LAAKC->HRAKK: No effect on lack of
FT                                functional expression.
FT                                {ECO:0000269|PubMed:11749039}.
FT   MUTAGEN     151    151       W->R: No effect on lack of functional
FT                                expression.
FT                                {ECO:0000269|PubMed:11749039}.
FT   MUTAGEN     153    153       C->D: No effect on lack of functional
FT                                expression.
FT                                {ECO:0000269|PubMed:11749039}.
SQ   SEQUENCE   330 AA;  36130 MW;  AA2A54D0615BC53C CRC64;
     MRRPSVRAAG LVLCTLCYLL VGAAVFDALE SEAESGRQRL LVQKRGALRR KFGFSAEDYR
     ELERLALQAE PHRAGRQWKF PGSFYFAITV ITTIGYGHAA PGTDSGKVFC MFYALLGIPL
     TLVTFQSLGE RLNAVVRRLL LAAKCCLGLR WTCVSTENLV VAGLLACAAT LALGAVAFSH
     FEGWTFFHAY YYCFITLTTI GFGDFVALQS GEALQRKLPY VAFSFLYILL GLTVIGAFLN
     LVVLRFLVAS ADWPERAARP PSPRPPGAPE SRGLWLPRRP ARSVGSASVF CHVHKLERCA
     RDNLGFSPPS SPGVVRGGQA PRPGARWKSI
//
ID   KCNKD_HUMAN             Reviewed;         408 AA.
AC   Q9HB14; B5TJL8; Q96E79;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-2002, sequence version 2.
DT   20-DEC-2017, entry version 142.
DE   RecName: Full=Potassium channel subfamily K member 13;
DE   AltName: Full=Tandem pore domain halothane-inhibited potassium channel 1;
DE            Short=THIK-1;
GN   Name=KCNK13;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11060316; DOI=10.1074/jbc.M008985200;
RA   Rajan S., Wischmeyer E., Karschin C., Preisig-Mueller R.,
RA   Grzeschik K.-H., Daut J., Karschin A., Derst C.;
RT   "THIK-1 and THIK-2, a novel subfamily of tandem pore domain K+
RT   channels.";
RL   J. Biol. Chem. 276:7302-7311(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=18516069; DOI=10.1038/bjp.2008.213;
RA   Gierten J., Ficker E., Bloehs R., Schlomer K., Kathofer S., Scholz E.,
RA   Zitron E., Kiesecker C., Bauer A., Becker R., Katus H.A., Karle C.A.,
RA   Thomas D.;
RT   "Regulation of two-pore-domain (K2P) potassium leak channels by the
RT   tyrosine kinase inhibitor genistein.";
RL   Br. J. Pharmacol. 154:1680-1690(2008).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Potassium channel displaying weak inward rectification
CC       in symmetrical K(+) solution. {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- MISCELLANEOUS: The current is enhanced by arachidonic acid and
CC       inhibited by halothane. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF287303; AAG32314.1; -; mRNA.
DR   EMBL; EU978942; ACH86101.1; -; mRNA.
DR   EMBL; CH471061; EAW81417.1; -; Genomic_DNA.
DR   EMBL; BC012779; AAH12779.1; -; mRNA.
DR   CCDS; CCDS9889.1; -.
DR   RefSeq; NP_071337.2; NM_022054.3.
DR   UniGene; Hs.510191; -.
DR   ProteinModelPortal; Q9HB14; -.
DR   SMR; Q9HB14; -.
DR   STRING; 9606.ENSP00000282146; -.
DR   iPTMnet; Q9HB14; -.
DR   PhosphoSitePlus; Q9HB14; -.
DR   BioMuta; KCNK13; -.
DR   DMDM; 24636284; -.
DR   EPD; Q9HB14; -.
DR   MaxQB; Q9HB14; -.
DR   PaxDb; Q9HB14; -.
DR   PeptideAtlas; Q9HB14; -.
DR   PRIDE; Q9HB14; -.
DR   DNASU; 56659; -.
DR   Ensembl; ENST00000282146; ENSP00000282146; ENSG00000152315.
DR   GeneID; 56659; -.
DR   KEGG; hsa:56659; -.
DR   UCSC; uc001xye.2; human.
DR   CTD; 56659; -.
DR   DisGeNET; 56659; -.
DR   EuPathDB; HostDB:ENSG00000152315.4; -.
DR   GeneCards; KCNK13; -.
DR   HGNC; HGNC:6275; KCNK13.
DR   HPA; HPA003514; -.
DR   MIM; 607367; gene.
DR   neXtProt; NX_Q9HB14; -.
DR   OpenTargets; ENSG00000152315; -.
DR   PharmGKB; PA30055; -.
DR   eggNOG; KOG4404; Eukaryota.
DR   eggNOG; ENOG410XRZJ; LUCA.
DR   GeneTree; ENSGT00860000133807; -.
DR   HOGENOM; HOG000013227; -.
DR   HOVERGEN; HBG052238; -.
DR   InParanoid; Q9HB14; -.
DR   KO; K04922; -.
DR   OMA; VNWILRK; -.
DR   OrthoDB; EOG091G06SB; -.
DR   PhylomeDB; Q9HB14; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-HSA-1299287; Tandem pore domain halothane-inhibited K+ channel (THIK).
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   GeneWiki; KCNK13; -.
DR   GenomeRNAi; 56659; -.
DR   PRO; PR:Q9HB14; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000152315; -.
DR   CleanEx; HS_KCNK13; -.
DR   Genevisible; Q9HB14; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005267; F:potassium channel activity; TAS:Reactome.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR005410; 2pore_dom_K_chnl_THIK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01588; THIKCHANNEL.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Polymorphism; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    408       Potassium channel subfamily K member 13.
FT                                /FTId=PRO_0000101762.
FT   TOPO_DOM      1     19       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     20     40       Helical. {ECO:0000255}.
FT   INTRAMEM     95    115       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    125    145       Helical. {ECO:0000255}.
FT   TOPO_DOM    146    193       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    194    214       Helical. {ECO:0000255}.
FT   INTRAMEM    224    244       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    263    283       Helical. {ECO:0000255}.
FT   TOPO_DOM    284    408       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     59     59       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     65     65       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     305    305       G -> R (in dbSNP:rs3814848).
FT                                /FTId=VAR_052429.
FT   VARIANT     389    389       G -> A (in dbSNP:rs35909577).
FT                                /FTId=VAR_034052.
FT   CONFLICT    288    288       N -> D (in Ref. 1; AAG32314).
FT                                {ECO:0000305}.
SQ   SEQUENCE   408 AA;  45391 MW;  B303C01AFD59EE19 CRC64;
     MAGRGFSWGP GHLNEDNARF LLLAALIVLY LLGGAAVFSA LELAHERQAK QRWEERLANF
     SRGHNLSRDE LRGFLRHYEE ATRAGIRVDN VRPRWDFTGA FYFVGTVVST IGFGMTTPAT
     VGGKIFLIFY GLVGCSSTIL FFNLFLERLI TIIAYIMKSC HQRQLRRRGA LPQESLKDAG
     QCEVDSLAGW KPSVYYVMLI LCTASILISC CASAMYTPIE GWSYFDSLYF CFVAFSTIGF
     GDLVSSQNAH YESQGLYRFA NFVFILMGVC CIYSLFNVIS ILIKQSLNWI LRKMDSGCCP
     QCQRGLLRSR RNVVMPGSVR NRCNISIETD GVAESDTDGR RLSGEMISMK DLLAANKASL
     AILQKQLSEM ANGCPHQTST LARDNEFSGG VGAFAIMNNR LAETSGDR
//
ID   KCNA1_ONCMY             Reviewed;         483 AA.
AC   Q9I829;
DT   13-JUL-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-NOV-2017, entry version 70.
DE   RecName: Full=Shaker-related potassium channel tsha2;
DE   AltName: Full=Trout shaker 2;
OS   Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Protacanthopterygii;
OC   Salmoniformes; Salmonidae; Salmoninae; Oncorhynchus.
OX   NCBI_TaxID=8022;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9486764;
RX   DOI=10.1002/(SICI)1097-4547(19980201)51:3<284::AID-JNR2>3.0.CO;2-C;
RA   Nguyen T.-D., Jeserich G.;
RT   "Molecular structure and expression of shaker type potassium channels
RT   in glial cells of trout CNS.";
RL   J. Neurosci. Res. 51:284-292(1998).
CC   -!- FUNCTION: Mediates the voltage-dependent potassium ion
CC       permeability of excitable membranes. Assuming opened or closed
CC       conformations in response to the voltage difference across the
CC       membrane, the protein forms a potassium-selective channel through
CC       which potassium ions may pass in accordance with their
CC       electrochemical gradient (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterotetramer of potassium channel proteins. Binds PDZ
CC       domains of dlg1, dlg2 and dlg4 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in oligodendrocytes and astrocytes.
CC       {ECO:0000269|PubMed:9486764}.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments. {ECO:0000250}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF252302; AAF70088.1; -; Genomic_DNA.
DR   ProteinModelPortal; Q9I829; -.
DR   PRIDE; Q9I829; -.
DR   HOVERGEN; HBG052230; -.
DR   GO; GO:0044224; C:juxtaparanode region of axon; ISS:UniProtKB.
DR   GO; GO:0033270; C:paranode region of axon; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0010960; P:magnesium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0042391; P:regulation of membrane potential; ISS:UniProtKB.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   2: Evidence at transcript level;
KW   Ion channel; Ion transport; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    483       Shaker-related potassium channel tsha2.
FT                                /FTId=PRO_0000395617.
FT   TOPO_DOM      1    165       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    166    186       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    187    220       Extracellular. {ECO:0000255}.
FT   TRANSMEM    221    241       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    242    252       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    253    273       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    274    324       Extracellular. {ECO:0000255}.
FT   TRANSMEM    325    345       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    346    353       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    354    374       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    375    385       Extracellular. {ECO:0000255}.
FT   TRANSMEM    386    406       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    407    483       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       371    376       Selectivity filter. {ECO:0000250}.
FT   MOTIF       481    483       PDZ-binding. {ECO:0000250}.
FT   MOD_RES     426    426       Phosphotyrosine. {ECO:0000250}.
FT   MOD_RES     430    430       Phosphothreonine. {ECO:0000250}.
FT   LIPID       243    243       S-palmitoyl cysteine. {ECO:0000255}.
SQ   SEQUENCE   483 AA;  54956 MW;  68A78AECA4424956 CRC64;
     MTVVSCEIQD ETVVVSPLYQ DDCDEERGDQ ECSERVVINI SGLRFETQLR TLSRFPTTLL
     GDPRKRMRFF DPLRNEYFFD RNRPSFDAIL YYYQSGGKLR RPVNVTMDIF MEEMTFYEIE
     EEAIDMFKED EGMIIEVERA MPDNEFQRQL WLLFEYPESS GPARMIAVVS VSVIVISIVI
     FCLETLPQFR EDTSANLPLS NHHTTNGTTL HKKPNLFTDP FFMVETLCIV WFSFEFLVRF
     LSCPSKPAFF KNAMNSIDIL AIAPYFITLG LELAEQQEAG SEQAMSLAIL RVIRLVRVFR
     IFKLSRHSKG LQILGQTLHA SISELGLLIF FLLIGVILFS SAVYFAEADD PESGFSSIPA
     AFWWAVVSMT TVGYGDMCPV TIGGKIVGSM CAIAGVLTIA LPVPVIVSNF NYFYHRERND
     EETAVYTHVT CGQQNASFGE FKSTSDSRQS LTKSEDTEED SCETIRLTHF NPFEHYTGKL
     TDV
//
ID   KCNA2_ONCMY             Reviewed;         494 AA.
AC   Q9I830;
DT   13-JUL-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-NOV-2017, entry version 70.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 2;
DE   AltName: Full=Shaker-related potassium channel tsha1 {ECO:0000303|PubMed:9486764};
DE   AltName: Full=Trout shaker 1 {ECO:0000303|PubMed:9486764};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.2;
GN   Name=kcna2;
OS   Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Protacanthopterygii;
OC   Salmoniformes; Salmonidae; Salmoninae; Oncorhynchus.
OX   NCBI_TaxID=8022;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9486764;
RX   DOI=10.1002/(SICI)1097-4547(19980201)51:3<284::AID-JNR2>3.0.CO;2-C;
RA   Nguyen T.-D., Jeserich G.;
RT   "Molecular structure and expression of shaker type potassium channels
RT   in glial cells of trout CNS.";
RL   J. Neurosci. Res. 51:284-292(1998).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates
CC       transmembrane potassium transport in excitable membranes,
CC       primarily in the brain and central nervous system. Prevents
CC       aberrant action potential firing and regulates neuronal output.
CC       Forms tetrameric potassium-selective channels through which
CC       potassium ions pass in accordance with their electrochemical
CC       gradient. The channel alternates between opened and closed
CC       conformations in response to the voltage difference across the
CC       membrane (By similarity). Can form functional homotetrameric
CC       channels and heterotetrameric channels with other family members;
CC       the channels characteristics depend critically on the types of
CC       channel-forming alpha subunits that are present (By similarity).
CC       Channel properties are modulated by cytoplasmic beta subunits that
CC       regulate the subcellular location of the alpha subunits (By
CC       similarity). In vivo, membranes probably contain a mixture of
CC       heteromeric potassium channel complexes, making it difficult to
CC       assign currents observed in intact tissues to any particular
CC       potassium channel family member. Homotetrameric KCNA2 forms a
CC       delayed-rectifier potassium channel that opens in response to
CC       membrane depolarization, followed by slow spontaneous channel
CC       closure (By similarity). Regulates neuronal excitability and plays
CC       a role as pacemaker in the regulation of neuronal action
CC       potentials (By similarity). KCNA2-containing channels play a
CC       presynaptic role and prevent hyperexcitability and aberrant action
CC       potential firing (By similarity). Response to toxins that are
CC       selective for KCNA2-containing potassium channels suggests that in
CC       Purkinje cells, dendritic subthreshold KCNA2-containing potassium
CC       channels prevent random spontaneous calcium spikes, suppressing
CC       dendritic hyperexcitability without hindering the generation of
CC       somatic action potentials, and thereby play an important role in
CC       motor coordination (By similarity). Plays a role in the induction
CC       of long-term potentiation of neuron excitability in the CA3 layer
CC       of the hippocampus (By similarity). {ECO:0000250|UniProtKB:P63141,
CC       ECO:0000250|UniProtKB:P63142}.
CC   -!- SUBUNIT: Homotetramer and heterotetramer with other family
CC       members. {ECO:0000250|UniProtKB:P63142}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P63142}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- TISSUE SPECIFICITY: Expressed in oligodendrocytes.
CC       {ECO:0000269|PubMed:9486764}.
CC   -!- DOMAIN: The cytoplasmic N-terminus is important for
CC       tetramerization. Interactions between the different subunits
CC       modulate the gating characteristics (By similarity).
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as voltage-sensor
CC       and is characterized by a series of positively charged amino acids
CC       at every third position. Channel opening and closing is effected
CC       by a conformation change that affects the position and orientation
CC       of the voltage-sensor paddle formed by S3 and S4 within the
CC       membrane. A transmembrane electric field that is positive inside
CC       would push the positively charged S4 segment outwards, thereby
CC       opening the pore, while a field that is negative inside would pull
CC       the S4 segment inwards and close the pore. Changes in the position
CC       and orientation of S4 are then transmitted to the activation gate
CC       formed by the inner helix bundle via the S4-S5 linker region.
CC       {ECO:0000250|UniProtKB:P63142}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker)
CC       (TC 1.A.1.2) subfamily. Kv1.2/KCNA2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF252301; AAF70087.1; -; Genomic_DNA.
DR   ProteinModelPortal; Q9I830; -.
DR   HOVERGEN; HBG052230; -.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0044224; C:juxtaparanode region of axon; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0019228; P:neuronal action potential; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004049; K_chnl_volt-dep_Kv1.2.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   PANTHER; PTHR11537:SF23; PTHR11537:SF23; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01509; KV12CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Glycoprotein; Ion channel; Ion transport; Lipoprotein;
KW   Membrane; Palmitate; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    494       Potassium voltage-gated channel subfamily
FT                                A member 2.
FT                                /FTId=PRO_0000395616.
FT   TOPO_DOM      1    159       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    160    181       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    182    216       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    217    238       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    239    249       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    250    270       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    271    284       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    285    305       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    306    320       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    321    342       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    343    356       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    357    368       Helical; Name=Pore helix.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   INTRAMEM    369    376       {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    377    383       Extracellular.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TRANSMEM    384    412       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   TOPO_DOM    413    494       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION        1    124       Tetramerization domain.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   REGION      307    320       S4-S5 linker.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       369    374       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   MOTIF       492    494       PDZ-binding.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   SITE        376    376       Important for binding with the scorpion
FT                                mesomartoxin; when the scorpion
FT                                mesomartoxin-rKv1.2/KCNA2 interaction is
FT                                modeled, this residue is close to the 'Y-
FT                                57' residue of the toxin.
FT                                {ECO:0000250|UniProtKB:P63142}.
FT   LIPID       239    239       S-palmitoyl cysteine. {ECO:0000255}.
FT   CARBOHYD    203    203       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   494 AA;  55900 MW;  AF66998F97F22CD4 CRC64;
     MTVATGDPSD EAAAHPGNPA EYDPDADHEC CERVVINISG LRFETQLKTL SQFPDTLLGD
     PKKRMRYFDP LRNEYFFDRS RTSFDAILYF YQSGGRLRRP ANVTLDIFSE EIRFYELGDE
     AIELFREDEG FVKEEERPLP DNEFQRQVWL LFEYPESSGP ARIIAIISVM VILISIVSFC
     LETLPIFRND DDEPHSVFDT NTNTTIYFTS TYFTDPFFIL ETLCIIWFSF EFLVRLFACP
     SKSGFFGNVM NIIDVVAIIP YFITLATELA EKPEDGQAGQ QAMSLAILRV IRLVRVFRIF
     KLSRHSKGLQ ILGQTLKASM RELGLLIFFL FIGVILFSSA VYFAEADEPE SQFESIPDAF
     WWAVVSMTTV GYGDMVPTTI GGKIVGSLCA IAGVLTIALP VPVIVSNFNY FYHRETEGEE
     QAQCLGPVTK EDSNEELKKS RSGSTISKSD YMEIQEGVNN TIEDIPEENL KTQANCTTLA
     NTNYVNITKM LTDV
//
ID   HCN1_RAT                Reviewed;         910 AA.
AC   Q9JKB0;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-NOV-2017, entry version 118.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1;
GN   Name=Hcn1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=11000485; DOI=10.1016/S0169-328X(00)00155-8;
RA   Monteggia L.M., Eisch A.J., Tang M.D., Kaczmarek L.K., Nestler E.J.;
RT   "Cloning and localization of the hyperpolarization-activated cyclic
RT   nucleotide-gated channel family in rat brain.";
RL   Brain Res. Mol. Brain Res. 81:129-139(2000).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11675786; DOI=10.1038/35098087;
RA   Stevens D.R., Seifert R., Bufe B., Mueller F., Kremmer E., Gauss R.,
RA   Meyerhof W., Kaupp U.B., Lindemann B.;
RT   "Hyperpolarization-activated channels HCN1 and HCN4 mediate responses
RT   to sour stimuli.";
RL   Nature 413:631-635(2001).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak
CC       selectivity for potassium over sodium ions. Contributes to the
CC       native pacemaker currents in heart (If) and in neurons (Ih). May
CC       mediate responses to sour stimuli. {ECO:0000269|PubMed:11675786}.
CC   -!- ENZYME REGULATION: Activated by cAMP, and at 10-100 times higher
CC       concentrations, also by cGMP. cAMP binding promotes
CC       tetramerization and formation of an active channel. Compared to
CC       other family members, cAMP has less stimulatory effect on HCN1
CC       because part of the molecules already contain bound cAMP and form
CC       homotetramers when cAMP levels are low (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homotetramer. Heterotetramer with HCN2. The potassium
CC       channel is composed of a homo- or heterotetrameric complex of
CC       pore-forming subunits. Interacts with KCNE2. Interacts with the
CC       SH3 domain of CSK. {ECO:0000250|UniProtKB:O88704}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11675786};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:11675786}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in cerebral cortex,
CC       cerebellum, throughout the hippocampus, in medial habenula,
CC       anterior dorsal nucleus in the thalamus, tenia tecta, several
CC       nuclei of the general motor system and in optic nerve layer.
CC       Detected in a subset of elongated cells in taste buds.
CC       {ECO:0000269|PubMed:11000485, ECO:0000269|PubMed:11675786}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250|UniProtKB:O60741}.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF247450; AAF62173.1; -; mRNA.
DR   RefSeq; NP_445827.1; NM_053375.1.
DR   UniGene; Rn.21408; -.
DR   ProteinModelPortal; Q9JKB0; -.
DR   SMR; Q9JKB0; -.
DR   BioGrid; 249933; 2.
DR   STRING; 10116.ENSRNOP00000016142; -.
DR   iPTMnet; Q9JKB0; -.
DR   PhosphoSitePlus; Q9JKB0; -.
DR   PaxDb; Q9JKB0; -.
DR   PRIDE; Q9JKB0; -.
DR   GeneID; 84390; -.
DR   KEGG; rno:84390; -.
DR   CTD; 348980; -.
DR   RGD; 620688; Hcn1.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039489; -.
DR   InParanoid; Q9JKB0; -.
DR   KO; K04954; -.
DR   PhylomeDB; Q9JKB0; -.
DR   PRO; PR:Q9JKB0; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0097440; C:apical dendrite; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0032590; C:dendrite membrane; IDA:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0098855; C:HCN channel complex; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0036477; C:somatodendritic compartment; IDA:RGD.
DR   GO; GO:0045202; C:synapse; IDA:RGD.
DR   GO; GO:0030552; F:cAMP binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:RGD.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:RGD.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:RGD.
DR   GO; GO:0008022; F:protein C-terminus binding; IMP:RGD.
DR   GO; GO:0032403; F:protein complex binding; IPI:RGD.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; ISO:RGD.
DR   GO; GO:0007568; P:aging; IEP:RGD.
DR   GO; GO:0045176; P:apical protein localization; ISO:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; ISS:UniProtKB.
DR   GO; GO:0035458; P:cellular response to interferon-beta; IEP:RGD.
DR   GO; GO:0006954; P:inflammatory response; IEP:RGD.
DR   GO; GO:0042711; P:maternal behavior; IEP:RGD.
DR   GO; GO:0045759; P:negative regulation of action potential; IMP:RGD.
DR   GO; GO:2001259; P:positive regulation of cation channel activity; IDA:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB.
DR   GO; GO:0003254; P:regulation of membrane depolarization; IDA:RGD.
DR   GO; GO:1902630; P:regulation of membrane hyperpolarization; IMP:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IDA:RGD.
DR   GO; GO:0072718; P:response to cisplatin; IEP:RGD.
DR   GO; GO:1902065; P:response to L-glutamate; IEP:RGD.
DR   GO; GO:0046549; P:retinal cone cell development; ISO:RGD.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISO:RGD.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR030169; K/Na_HCN1.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   PANTHER; PTHR10217:SF373; PTHR10217:SF373; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   2: Evidence at transcript level;
KW   cAMP; cAMP-binding; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Nucleotide-binding; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Sodium; Sodium channel; Sodium transport;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    910       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                1.
FT                                /FTId=PRO_0000054110.
FT   TOPO_DOM      1    131       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    132    153       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    154    162       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    163    183       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    184    204       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    205    225       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    226    249       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    250    270       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    271    284       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    285    307       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    308    333       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   INTRAMEM    334    355       Pore-forming; Name=Segment H5.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    356    360       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    361    381       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    382    910       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   NP_BIND     528    531       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   NP_BIND     538    539       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   NP_BIND     579    582       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   REGION        1     82       Intrinsically disordered. {ECO:0000305}.
FT   MOTIF       347    351       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   COMPBIAS    715    777       Gln-rich.
FT   COMPBIAS    878    884       Poly-Pro.
FT   CARBOHYD    327    327       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   910 AA;  102422 MW;  11E32D2BE73F4528 CRC64;
     MEGGGKPNSA SNSRDDGNSV YPSKAPATGP AAADKRLGTP PGGGAAGKEH GNSVCFKVDG
     GGGEEPAGSF EDAEGPRRQY GFMQRQFTSM LQPGVNKFSL RMFGSQKAVE KEQERVKTAG
     FWIIHPYSDF RFYWDLIMLI MMVGNLVIIP VGITFFTEQT TTPWIIFNVA SDTVFLLDLI
     MNFRTGTVNE DSSEIILDPK VIKMNYLKSW FVVDFISSIP VDYIFLIVEK GMDSEVYKTA
     RALRIVRFTK ILSLLRLLRL SRLIRYIHQW EEIFHMTYDL ASAVVRIFNL IGMMLLLCHW
     DGCLQFLVPL LQDFPPDCWV SLNEMVNDSW GKQYSYALFK AMSHMLCIGY GAQAPVSMSD
     LWITMLSMIV GATCYAMFVG HATALIQSLD SSRRQYQEKY KQVEQYMSFH KLPADMRQKI
     HDYYEHRYQG KIFDEENILS ELNDPLREEI VNFNCRKLVA TMPLFANADP NFVTAMLSKL
     RFEVFQPGDY IIREGAVGKK MYFIQHGVAG VITKSSKEMK LTDGSYFGEI CLLTKGRRTA
     SVRADTYCRL YSLSVDNFNE VLEEYPMMRR AFETVAIDRL DRIGKKNSIL LQKFQKDLNT
     GVFNNQENEI LKQIVKHDRE MVQAIPPINY PQMTALNCTS STTTPTSRMR TQSPPVYTAT
     SLSHSNLHSP SPSTQTPQPS AILSPCSYTT AVCSPPIQSP LATRTFHYAS PTASQLSLMQ
     QPQPQLQQSQ VQQTQTQTQQ QQQQQQPQPQ PQQPQQQQQQ QQQQQQQQQQ QQQQQPQTPG
     SSTPKNEVHK STQALHNTHL TREVRPLSAS QPSLPHEVST MISRPHPTVG ESLASIPQPV
     ATVHSTGLQA GSRSTVPQRV TLFRQMSSGA IPPNRGVPPA PPPPAAVQRE SPSVLNKDPD
     AEKPRFASNL
//
ID   KCNK9_CAVPO             Reviewed;         365 AA.
AC   Q9JL58;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   27-SEP-2017, entry version 83.
DE   RecName: Full=Potassium channel subfamily K member 9;
DE   AltName: Full=Acid-sensitive potassium channel protein TASK-3;
DE   AltName: Full=TWIK-related acid-sensitive K(+) channel 3;
GN   Name=KCNK9; Synonyms=TASK3;
OS   Cavia porcellus (Guinea pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia;
OC   Hystricomorpha; Caviidae; Cavia.
OX   NCBI_TaxID=10141;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF HIS-98.
RC   TISSUE=Brain;
RX   PubMed=10747866; DOI=10.1074/jbc.M000030200;
RA   Rajan S., Wischmeyer E., Liu G.X., Preisig-Mueller R., Daut J.,
RA   Karschin A., Derst C.;
RT   "TASK-3, a novel tandem pore domain acid-sensitive K+ channel. An
RT   extracellular histidine as pH sensor.";
RL   J. Biol. Chem. 275:16650-16657(2000).
CC   -!- FUNCTION: pH-dependent, voltage-insensitive, background potassium
CC       channel protein. {ECO:0000269|PubMed:10747866}.
CC   -!- SUBUNIT: Homodimer. Heterodimer with KCNK1.
CC       {ECO:0000250|UniProtKB:Q9NPC2}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q9NPC2}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NPC2}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in the brain.
CC       {ECO:0000269|PubMed:10747866}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF212827; AAF63706.1; -; mRNA.
DR   RefSeq; NP_001166448.1; NM_001172977.1.
DR   ProteinModelPortal; Q9JL58; -.
DR   SMR; Q9JL58; -.
DR   STRING; 10141.ENSCPOP00000017207; -.
DR   GeneID; 100135568; -.
DR   CTD; 51305; -.
DR   eggNOG; KOG4404; Eukaryota.
DR   eggNOG; ENOG410XRZJ; LUCA.
DR   HOGENOM; HOG000231463; -.
DR   HOVERGEN; HBG052239; -.
DR   InParanoid; Q9JL58; -.
DR   Proteomes; UP000005447; Unassembled WGS sequence.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR005407; KCNK9.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01585; TASK3CHANNEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    365       Potassium channel subfamily K member 9.
FT                                /FTId=PRO_0000101753.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      9     29       Helical. {ECO:0000255}.
FT   TOPO_DOM     30     88       Extracellular. {ECO:0000255}.
FT   INTRAMEM     89    101       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TOPO_DOM    102    107       Extracellular. {ECO:0000255}.
FT   TRANSMEM    108    128       Helical. {ECO:0000255}.
FT   TOPO_DOM    129    158       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical. {ECO:0000255}.
FT   TOPO_DOM    180    194       Extracellular. {ECO:0000255}.
FT   INTRAMEM    195    207       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TOPO_DOM    208    218       Extracellular. {ECO:0000255}.
FT   TRANSMEM    219    239       Helical. {ECO:0000255}.
FT   TOPO_DOM    240    365       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN      98     98       H->N,Y: Reduces sensitivity to
FT                                alterations in external pH.
FT                                {ECO:0000269|PubMed:10747866}.
SQ   SEQUENCE   365 AA;  40769 MW;  261DC973FF53AF91 CRC64;
     MKKQNVRTLS LIACTFTYLL VGAAVFDALE SDHEMREEEK LKAEEIRIRG KYNISTEDYR
     QLELVILQSE PHRAGVQWKF AGSFYFAITV ITTIGYGHAA PGTDAGKAFC MFYAVLGIPL
     TLVMFQSLGE RMNTFVRYLL KRIKKCCGMR NTEVSMENMV TVGFFSCMGT LCIGAAAFSQ
     CEEWSFFHAY YYCFITLTTI GFGDYVALQS KGALQRKPFY VAFSFMYILV GLTVIGAFLN
     LVVLRFLTMN SDEERGEGEE GAALPGNPSS VVTHISEEAR QVRQRYRGEG GDLQSVCSCA
     CYRSQPQNFG ATLAPQPLHS ISCRIEEISP STLKNSLFPS PISSVSPGLH SFGDNHRLML
     RRKSV
//
ID   SKOR_ARATH              Reviewed;         828 AA.
AC   Q9M8S6; O82630; Q9SB86;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   25-OCT-2017, entry version 136.
DE   RecName: Full=Potassium channel SKOR;
DE   AltName: Full=Stelar K(+) outward rectifying channel;
GN   Name=SKOR; OrderedLocusNames=At3g02850; ORFNames=F13E7.21;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], TISSUE SPECIFICITY,
RP   CHARACTERIZATION, AND FUNCTION.
RC   STRAIN=cv. Landsberg erecta;
RX   PubMed=9741629; DOI=10.1016/S0092-8674(00)81606-2;
RA   Gaymard F., Pilot G., Lacombe B., Bouchez D., Bruneau D.,
RA   Boucherez J., Michaux-Ferriere N., Thibaud J.-B., Sentenac H.;
RT   "Identification and disruption of a plant shaker-like outward channel
RT   involved in K+ release into the xylem sap.";
RL   Cell 94:647-655(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130713; DOI=10.1038/35048706;
RA   Salanoubat M., Lemcke K., Rieger M., Ansorge W., Unseld M.,
RA   Fartmann B., Valle G., Bloecker H., Perez-Alonso M., Obermaier B.,
RA   Delseny M., Boutry M., Grivell L.A., Mache R., Puigdomenech P.,
RA   De Simone V., Choisne N., Artiguenave F., Robert C., Brottier P.,
RA   Wincker P., Cattolico L., Weissenbach J., Saurin W., Quetier F.,
RA   Schaefer M., Mueller-Auer S., Gabel C., Fuchs M., Benes V.,
RA   Wurmbach E., Drzonek H., Erfle H., Jordan N., Bangert S.,
RA   Wiedelmann R., Kranz H., Voss H., Holland R., Brandt P., Nyakatura G.,
RA   Vezzi A., D'Angelo M., Pallavicini A., Toppo S., Simionati B.,
RA   Conrad A., Hornischer K., Kauer G., Loehnert T.-H., Nordsiek G.,
RA   Reichelt J., Scharfe M., Schoen O., Bargues M., Terol J., Climent J.,
RA   Navarro P., Collado C., Perez-Perez A., Ottenwaelder B., Duchemin D.,
RA   Cooke R., Laudie M., Berger-Llauro C., Purnelle B., Masuy D.,
RA   de Haan M., Maarse A.C., Alcaraz J.-P., Cottet A., Casacuberta E.,
RA   Monfort A., Argiriou A., Flores M., Liguori R., Vitale D.,
RA   Mannhaupt G., Haase D., Schoof H., Rudd S., Zaccaria P., Mewes H.-W.,
RA   Mayer K.F.X., Kaul S., Town C.D., Koo H.L., Tallon L.J., Jenkins J.,
RA   Rooney T., Rizzo M., Walts A., Utterback T., Fujii C.Y., Shea T.P.,
RA   Creasy T.H., Haas B., Maiti R., Wu D., Peterson J., Van Aken S.,
RA   Pai G., Militscher J., Sellers P., Gill J.E., Feldblyum T.V.,
RA   Preuss D., Lin X., Nierman W.C., Salzberg S.L., White O., Venter J.C.,
RA   Fraser C.M., Kaneko T., Nakamura Y., Sato S., Kato T., Asamizu E.,
RA   Sasamoto S., Kimura T., Idesawa K., Kawashima K., Kishida Y.,
RA   Kiyokawa C., Kohara M., Matsumoto M., Matsuno A., Muraki A.,
RA   Nakayama S., Nakazaki N., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Tabata S.;
RT   "Sequence and analysis of chromosome 3 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:820-822(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PROTON SENSITIVITY.
RX   PubMed=10682858; DOI=10.1016/S0014-5793(00)01093-0;
RA   Lacombe B., Pilot G., Gaymard F., Sentenac H., Thibaud J.-B.;
RT   "pH control of the plant outwardly-rectifying potassium channel
RT   SKOR.";
RL   FEBS Lett. 466:351-354(2000).
RN   [5]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [6]
RP   INDUCTION.
RX   PubMed=12678562; DOI=10.1023/A:1022597102282;
RA   Pilot G., Gaymard F., Mouline K., Cherel I., Sentenac H.;
RT   "Regulated expression of Arabidopsis shaker K(+) channel genes
RT   involved in K(+) uptake and distribution in the plant.";
RL   Plant Mol. Biol. 51:773-787(2003).
CC   -!- FUNCTION: Highly selective outward-rectifying potassium channel.
CC       Involved in potassium release into the xylem sap toward the
CC       shoots. Assuming opened or closed conformations in response to the
CC       voltage difference across the membrane, the channel is activated
CC       by depolarization. The voltage-dependence of the channel is
CC       abolished by internal or external acidification. May interact with
CC       the cytoskeleton or with regulatory proteins.
CC       {ECO:0000269|PubMed:9741629}.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming subunits. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in root pericycle and xylem
CC       parenchyma, and in flower at a lower level.
CC       {ECO:0000269|PubMed:9741629}.
CC   -!- INDUCTION: In roots, strongly inhibited by 2,4-
CC       dichlorophenoxyacetic acid (2,4-D), abscisic acid (ABA) and
CC       benzyladenine (BA) treatment or by potassium starvation.
CC       {ECO:0000269|PubMed:12678562}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization.
CC   -!- MISCELLANEOUS: Loss-of-function mutation skor-1 leads to a reduced
CC       shoot potassium content.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ223357; CAA11280.1; -; Genomic_DNA.
DR   EMBL; AJ223358; CAA11281.1; -; mRNA.
DR   EMBL; AC018363; AAF26975.1; -; Genomic_DNA.
DR   EMBL; CP002686; AEE73866.1; -; Genomic_DNA.
DR   PIR; T52046; T52046.
DR   RefSeq; NP_186934.1; NM_111153.4.
DR   UniGene; At.41071; -.
DR   UniGene; At.48613; -.
DR   ProteinModelPortal; Q9M8S6; -.
DR   SMR; Q9M8S6; -.
DR   BioGrid; 6385; 2.
DR   IntAct; Q9M8S6; 1.
DR   STRING; 3702.AT3G02850.1; -.
DR   TCDB; 1.A.1.4.5; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q9M8S6; -.
DR   PRIDE; Q9M8S6; -.
DR   EnsemblPlants; AT3G02850.1; AT3G02850.1; AT3G02850.
DR   GeneID; 821052; -.
DR   Gramene; AT3G02850.1; AT3G02850.1; AT3G02850.
DR   KEGG; ath:AT3G02850; -.
DR   Araport; AT3G02850; -.
DR   TAIR; locus:2075442; AT3G02850.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000240830; -.
DR   InParanoid; Q9M8S6; -.
DR   KO; K21867; -.
DR   OMA; RDKMHPR; -.
DR   OrthoDB; EOG093602RR; -.
DR   PhylomeDB; Q9M8S6; -.
DR   BioCyc; ARA:AT3G02850-MONOMER; -.
DR   BioCyc; MetaCyc:MONOMER-14560; -.
DR   PRO; PR:Q9M8S6; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; Q9M8S6; baseline and differential.
DR   Genevisible; Q9M8S6; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IDA:TAIR.
DR   GO; GO:0055075; P:potassium ion homeostasis; IMP:TAIR.
DR   GO; GO:0006813; P:potassium ion transport; IDA:TAIR.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00204; ANK; 1.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00248; ANK; 5.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    828       Potassium channel SKOR.
FT                                /FTId=PRO_0000054128.
FT   TOPO_DOM      1     86       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     87    107       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    108    114       Extracellular. {ECO:0000255}.
FT   TRANSMEM    115    135       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    136    158       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    180    185       Extracellular. {ECO:0000255}.
FT   TRANSMEM    186    206       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    207    220       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    221    241       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    242    276       Extracellular. {ECO:0000255}.
FT   INTRAMEM    277    296       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    297    300       Extracellular. {ECO:0000255}.
FT   TRANSMEM    301    321       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    322    828       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      545    576       ANK 1.
FT   REPEAT      580    609       ANK 2.
FT   REPEAT      613    642       ANK 3.
FT   REPEAT      644    673       ANK 4.
FT   REPEAT      677    706       ANK 5.
FT   REPEAT      710    740       ANK 6.
FT   DOMAIN      756    828       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     403    523       cNMP.
FT   CONFLICT     16     16       E -> R (in Ref. 1; CAA11281).
FT                                {ECO:0000305}.
FT   CONFLICT    547    548       EL -> DV (in Ref. 1; CAA11280/CAA11281).
FT                                {ECO:0000305}.
SQ   SEQUENCE   828 AA;  93899 MW;  C6C7B161C8904D03 CRC64;
     MGGSSGGGVS YRSGGESDVE LEDYEVDDFR DGIVESRGNR FNPLTNFLGL DFAGGSGGKF
     TVINGIRDIS RGSIVHPDNR WYKAWTMFIL IWALYSSFFT PLEFGFFRGL PENLFILDIA
     GQIAFLVDIV LTFFVAYRDS RTYRMIYKRS SIALRYLKST FIIDLLACMP WDIIYKAAGE
     KEEVRYLLLI RLYRVHRVIL FFHKMEKDIR INYLFTRIVK LIFVELYCTH TAACIFYYLA
     TTLPASQEGY TWIGSLKLGD YSYSKFREID LWTRYTTSMY FAVVTMATVG YGDIHAVNMR
     EMIFAMVYIS FDMILGAYLI GNMTALIVKG SKTERFRDKM ADIMRYMNRN KLGRNIRGQI
     TGHLRLQYES SYTEAAVLQD IPVSIRAKIA QTLYLPYIEK VPLFRGCSSE FINQIVIRLH
     EEFFLPGEVI MEQGSVVDQL YFVCHGVLEE IGITKDGSEE IVAVLQPDHS FGEISILCNI
     PQPYTVRVAE LCRILRLDKQ SFMNILEIFF HDGRRILNNL LEGKESNVRI KQLESDITFH
     ISKQEAELAL KLNSAAFYGD LYQLKSLIRA GGDPNKTDYD GRSPLHLAAS RGYEDITLYL
     IQESVDVNIK DKLGSTPLLE AIKNGNDRVA ALLVKEGATL NIENAGTFLC TVVAKGDSDF
     LKRLLSNGID PNSKDYDHRT PLHVAASEGF YVLAIQLVEA SANVLAKDRW GNTPLDEALG
     CGNKMLIKLL EDAKNSQISS FPSGSKEPKD KVYKKKCTVY FSHPGDSKEK RRRGIVLWVP
     RSIEELIRTA KEQLNVPEAS CVLSEDEAKI IDVDLISDGQ KLYLAVET
//
ID   HCN1_RABIT              Reviewed;         822 AA.
AC   Q9MZS1; Q9TU38; Q9TUE2; Q9TUE3;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   25-OCT-2017, entry version 95.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1;
DE   AltName: Full=rbHCN1;
GN   Name=HCN1;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae;
OC   Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, ENZYME
RP   REGULATION, AND TISSUE SPECIFICITY.
RC   STRAIN=New Zealand white; TISSUE=Heart;
RX   PubMed=11328811; DOI=10.1074/jbc.M100830200;
RA   Moroni A., Gorza L., Beltrame M., Gravante B., Vaccari T.,
RA   Bianchi M.E., Altomare C., Longhi R., Heurteaux C., Vitadello M.,
RA   Malgaroli A., DiFrancesco D.;
RT   "Hyperpolarization-activated cyclic nucleotide-gated channel 1 is a
RT   molecular determinant of the cardiac pacemaker current If.";
RL   J. Biol. Chem. 276:29233-29241(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 95-236, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=10400919; DOI=10.1161/01.RES.85.1.e1;
RA   Shi W., Wymore R., Yu H., Wu J., Wymore R.T., Pan Z., Robinson R.B.,
RA   Dixon J.E., McKinnon D., Cohen I.S.;
RT   "Distribution and prevalence of hyperpolarization-activated cation
RT   channel (HCN) mRNA expression in cardiac tissues.";
RL   Circ. Res. 85:1-6(1999).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak
CC       selectivity for potassium over sodium ions. Contributes to the
CC       native pacemaker currents in heart (If) and in neurons (Ih). May
CC       mediate responses to sour stimuli. {ECO:0000269|PubMed:11328811}.
CC   -!- ENZYME REGULATION: Activated by cAMP, and at 10-100 times higher
CC       concentrations, also by cGMP. cAMP binding promotes
CC       tetramerization and formation of an active channel. Compared to
CC       other family members, cAMP has less stimulatory effect on HCN1
CC       because part of the molecules already contain bound cAMP and form
CC       homotetramers when cAMP levels are low.
CC       {ECO:0000269|PubMed:11328811}.
CC   -!- SUBUNIT: Homotetramer. Heterotetramer with HCN2. The potassium
CC       channel is composed of a homo- or heterotetrameric complex of
CC       pore-forming subunits. Interacts with KCNE2. Interacts with the
CC       SH3 domain of CSK. {ECO:0000250|UniProtKB:O88704}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11328811};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:11328811}.
CC   -!- TISSUE SPECIFICITY: Detected in myocytes in heart sinoatrial node
CC       (SAN) and in brain, in particular in the granule cell layer and in
CC       Purkinje neuron bodies in the cerebellum.
CC       {ECO:0000269|PubMed:10400919, ECO:0000269|PubMed:11328811}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250|UniProtKB:O60741}.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-30 is the initiator.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF168122; AAF89636.2; -; mRNA.
DR   EMBL; AF155167; AAF01494.1; -; mRNA.
DR   RefSeq; NP_001075532.1; NM_001082063.1.
DR   UniGene; Ocu.2387; -.
DR   ProteinModelPortal; Q9MZS1; -.
DR   SMR; Q9MZS1; -.
DR   STRING; 9986.ENSOCUP00000014684; -.
DR   GeneID; 100008732; -.
DR   KEGG; ocu:100008732; -.
DR   CTD; 348980; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039489; -.
DR   InParanoid; Q9MZS1; -.
DR   KO; K04954; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0098855; C:HCN channel complex; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0030552; F:cAMP binding; ISS:UniProtKB.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005272; F:sodium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR030169; K/Na_HCN1.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF373; PTHR10217:SF373; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   2: Evidence at transcript level;
KW   cAMP; cAMP-binding; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Nucleotide-binding; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Sodium; Sodium channel; Sodium transport;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    822       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                1.
FT                                /FTId=PRO_0000054109.
FT   TOPO_DOM      1     78       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM     79    100       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    101    109       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    110    130       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    131    151       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    152    172       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    173    196       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    197    217       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    218    231       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    232    254       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    255    280       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   INTRAMEM    281    302       Pore-forming; Name=Segment H5.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    303    307       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    308    328       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    329    822       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   NP_BIND     475    478       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   NP_BIND     485    486       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   NP_BIND     526    529       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   MOTIF       294    298       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   COMPBIAS    662    688       Gln-rich.
FT   COMPBIAS    789    795       Poly-Pro.
FT   CARBOHYD    274    274       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   822 AA;  92897 MW;  1BC67F5B35D46BD6 CRC64;
     MATASSPPRR PRRARGLEDA EGPRRQYGFM QRQFTSMLQP GVNKFSLRMF GSQKAVEKEQ
     ERVKTAGFWI IHPYSDFRFY WDLIMLIMMV GNLVIIPVGI TFFTEQTTTP WIIFNVASDT
     VFLLDLIMNF RTGTVNEDSS EIILDPKVIK MNYLKSWFVV DFISSIPVDY IFLIVEKGMD
     SEVYKTARAL RIVRFTKILS LLRLLRLSRL IRYIHQWEEI FHMTYDLASA VVRIFNLIGM
     MLLLCHWDGC LQFLVPLLQD FPPDCWVSLN EMVNDSWGKQ YSYALFKAMS HMLCIGYGAQ
     APVSMSDLWI TMLSMIVGAT CYAMFVGHAT ALIQSLDSSR RQYQEKYKQV EQYMSFHKLP
     ADMRQKIHDY YEHRYQGKIF DEENILNELN DPLREEIVNF NCRKLVATMP LFANADPNFV
     TAMLSKLRFE VFQPGDYIIR EGAVGKKMYF IQHGVAGVIT KSSKEMKLTD GSYFGEICLL
     TKGRRTASVR ADTYCRLYSL SVDNFNEVLE EYPMMRRAFE TVAIDRLDRI GKKNSILLQK
     FQKDLNTGVF NNQENEILKQ IVKHDREMVQ AIAPISYPQM TALNSTSSTA TPTSRMRTQS
     PPVYTATSLS HSNLHSPSPS TQTPQPSAIL SPCSYTTAVC SPPVQSPLAT RTFHYASPTA
     SQLSLMPQQQ QQPQAPQTQP QQPPQQPQTP GSATPKNEVH RSTQALPNTS LTREVRPLSA
     SQPSLPHEVS TLISRPHPTV GESLASIPQP VAAVHSAGLQ AAGRSTVPQR VTLFRQMSSG
     AIPPNRGVPP APPPPAAPLQ REASSVLNTD PEAEKPRFAS NL
//
ID   T38B1_CAEEL             Reviewed;         295 AA.
AC   Q9NA75;
DT   07-JUN-2017, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 2.
DT   25-OCT-2017, entry version 93.
DE   RecName: Full=Trimeric intracellular cation channel type 1B.1 {ECO:0000305};
DE            Short=TRIC-1B.1 {ECO:0000305};
DE   AltName: Full=TRIC-B1;
GN   ORFNames=Y57A10A.10 {ECO:0000312|WormBase:Y57A10A.10};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000244|PDB:5EGI}
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 1-251 IN COMPLEX WITH PIP2,
RP   FUNCTION, ENZYME REGULATION, SUBUNIT, TOPOLOGY, AND MUTAGENESIS OF
RP   LYS-129; ARG-133 AND TRP-180.
RX   PubMed=27698420; DOI=10.1038/nature19767;
RA   Yang H., Hu M., Guo J., Ou X., Cai T., Liu Z.;
RT   "Pore architecture of TRIC channels and insights into their gating
RT   mechanism.";
RL   Nature 538:537-541(2016).
CC   -!- FUNCTION: Potassium channel that mediates transmembrane potassium
CC       transport (PubMed:27698420). Might be required for maintenance of
CC       rapid intracellular calcium release (By similarity). May act as a
CC       counter-ion channel that functions in synchronization with calcium
CC       release from intracellular stores (By similarity). Binds
CC       phosphatidylinositol 4,5-bisphosphate (PIP2) (PubMed:27698420).
CC       {ECO:0000250|UniProtKB:Q9DAV9, ECO:0000269|PubMed:27698420}.
CC   -!- SUBUNIT: Homotrimer; trimerization probably requires binding to
CC       phosphatidylinositol 4,5-bisphosphate (PIP2).
CC       {ECO:0000269|PubMed:27698420}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9DAV9}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9DAV9}.
CC   -!- SIMILARITY: Belongs to the TMEM38 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284602; CAB55030.2; -; Genomic_DNA.
DR   RefSeq; NP_496603.2; NM_064202.2.
DR   UniGene; Cel.13896; -.
DR   PDB; 5EGI; X-ray; 3.30 A; A/B/C=1-251.
DR   PDBsum; 5EGI; -.
DR   SMR; Q9NA75; -.
DR   STRING; 6239.Y57A10A.10; -.
DR   EPD; Q9NA75; -.
DR   PaxDb; Q9NA75; -.
DR   PeptideAtlas; Q9NA75; -.
DR   EnsemblMetazoa; Y57A10A.10; Y57A10A.10; WBGene00013255.
DR   GeneID; 174867; -.
DR   KEGG; cel:CELE_Y57A10A.10; -.
DR   UCSC; Y57A10A.10; c. elegans.
DR   CTD; 174867; -.
DR   WormBase; Y57A10A.10; CE44590; WBGene00013255; -.
DR   eggNOG; KOG3944; Eukaryota.
DR   eggNOG; ENOG410XQ0P; LUCA.
DR   GeneTree; ENSGT00390000018845; -.
DR   HOGENOM; HOG000037929; -.
DR   InParanoid; Q9NA75; -.
DR   OMA; KMSYPSK; -.
DR   OrthoDB; EOG091G0DZS; -.
DR   PhylomeDB; Q9NA75; -.
DR   PRO; PR:Q9NA75; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00013255; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IBA:GO_Central.
DR   InterPro; IPR007866; TRIC_channel.
DR   PANTHER; PTHR12454; PTHR12454; 1.
DR   Pfam; PF05197; TRIC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Endoplasmic reticulum; Ion channel;
KW   Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    295       Trimeric intracellular cation channel
FT                                type 1B.1.
FT                                /FTId=PRO_0000440241.
FT   TOPO_DOM      1     27       Lumenal. {ECO:0000305|PubMed:27698420}.
FT   TRANSMEM     28     45       Helical;Name=1.
FT                                {ECO:0000269|PubMed:27698420}.
FT   TOPO_DOM     46     56       Cytoplasmic.
FT                                {ECO:0000305|PubMed:27698420}.
FT   TRANSMEM     57     80       Discontinuously helical;Name=2.
FT                                {ECO:0000269|PubMed:27698420}.
FT   TOPO_DOM     81     89       Lumenal. {ECO:0000305|PubMed:27698420}.
FT   TRANSMEM     90    107       Helical;Name=3.
FT                                {ECO:0000269|PubMed:27698420}.
FT   TOPO_DOM    108    119       Cytoplasmic.
FT                                {ECO:0000305|PubMed:27698420}.
FT   TRANSMEM    120    148       Helical;Name=4.
FT                                {ECO:0000269|PubMed:27698420}.
FT   TOPO_DOM    149    150       Lumenal. {ECO:0000305|PubMed:27698420}.
FT   TRANSMEM    151    177       Discontinuously helical;Name=5.
FT                                {ECO:0000269|PubMed:27698420}.
FT   TOPO_DOM    178    188       Cytoplasmic.
FT                                {ECO:0000305|PubMed:27698420}.
FT   TRANSMEM    189    210       Helical;Name=6.
FT                                {ECO:0000269|PubMed:27698420}.
FT   TOPO_DOM    211    215       Lumenal. {ECO:0000305|PubMed:27698420}.
FT   TRANSMEM    216    239       Helical;Name=7.
FT                                {ECO:0000269|PubMed:27698420}.
FT   TOPO_DOM    240    295       Cytoplasmic.
FT                                {ECO:0000305|PubMed:27698420}.
FT   BINDING     129    129       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000244|PDB:5EGI,
FT                                ECO:0000269|PubMed:27698420}.
FT   BINDING     133    133       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000244|PDB:5EGI,
FT                                ECO:0000269|PubMed:27698420}.
FT   BINDING     166    166       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000244|PDB:5EGI}.
FT   MUTAGEN     129    129       K->A: Abolishes PIP2 binding, impairs
FT                                trimerization, reduces potassium current
FT                                and calcium-sensitivity; when associated
FT                                with L-133.
FT                                {ECO:0000269|PubMed:27698420}.
FT   MUTAGEN     133    133       R->L: Abolishes PIP2 binding, impairs
FT                                trimerization, reduces potassium current
FT                                and calcium-sensitivity; when associated
FT                                with A-129.
FT                                {ECO:0000269|PubMed:27698420}.
FT   MUTAGEN     180    180       W->A: Abolishes calcium-sensitivity.
FT                                {ECO:0000269|PubMed:27698420}.
FT   HELIX         9     23       {ECO:0000244|PDB:5EGI}.
FT   HELIX        29     44       {ECO:0000244|PDB:5EGI}.
FT   HELIX        47     49       {ECO:0000244|PDB:5EGI}.
FT   HELIX        50     56       {ECO:0000244|PDB:5EGI}.
FT   HELIX        58     69       {ECO:0000244|PDB:5EGI}.
FT   HELIX        71     79       {ECO:0000244|PDB:5EGI}.
FT   HELIX        86     88       {ECO:0000244|PDB:5EGI}.
FT   HELIX        91    106       {ECO:0000244|PDB:5EGI}.
FT   HELIX       108    110       {ECO:0000244|PDB:5EGI}.
FT   HELIX       111    117       {ECO:0000244|PDB:5EGI}.
FT   HELIX       121    147       {ECO:0000244|PDB:5EGI}.
FT   HELIX       152    164       {ECO:0000244|PDB:5EGI}.
FT   HELIX       166    176       {ECO:0000244|PDB:5EGI}.
FT   STRAND      186    188       {ECO:0000244|PDB:5EGI}.
FT   HELIX       190    209       {ECO:0000244|PDB:5EGI}.
FT   HELIX       217    238       {ECO:0000244|PDB:5EGI}.
SQ   SEQUENCE   295 AA;  32593 MW;  06355987AB7662AA CRC64;
     MVVPESFQLD QEILLDAGAQ LHRLKMYPYF DVAHYLLMII EVRDDLGSAA SIFSRKHPLS
     CWLSSMLMCF ADAFLANFLL GEPVIAPFKR HDDIILATII WYLVFYAPFD GIYKIAKITP
     VKCVLAVMKE VKRAYKVSHG VSHAAKLYPN SYIVQVLVGT AKGAGSGIVR TLEQLVRGVW
     LPTHNELLRP SFATKACVVA ASVLALEKSG TYLTAPHDLV YLVIVGFFVY FKLSAVILHV
     TDPFAPIENL FCAIFMGGIW DAVSRALAAS RDRRAAGAHS NENGSSISTP EKKDQ
//
ID   KCNK9_HUMAN             Reviewed;         374 AA.
AC   Q9NPC2; Q2M290; Q540F2;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   27-SEP-2017, entry version 144.
DE   RecName: Full=Potassium channel subfamily K member 9;
DE   AltName: Full=Acid-sensitive potassium channel protein TASK-3;
DE   AltName: Full=TWIK-related acid-sensitive K(+) channel 3;
DE   AltName: Full=Two pore potassium channel KT3.2;
DE            Short=Two pore K(+) channel KT3.2;
GN   Name=KCNK9; Synonyms=TASK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10747866; DOI=10.1074/jbc.M000030200;
RA   Rajan S., Wischmeyer E., Liu G.X., Preisig-Mueller R., Daut J.,
RA   Karschin A., Derst C.;
RT   "TASK-3, a novel tandem pore domain acid-sensitive K+ channel. An
RT   extracellular histidine as pH sensor.";
RL   J. Biol. Chem. 275:16650-16657(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Cerebellum;
RX   PubMed=11042359; DOI=10.1016/S0169-328X(00)00183-2;
RA   Chapman C.G., Meadows H.J., Godden R.J., Campbell D.A., Duckworth M.,
RA   Kelsell R.E., Murdock P.R., Randall A.D., Rennie G.I., Gloger I.S.;
RT   "Cloning, localisation and functional expression of a novel human,
RT   cerebellum specific, two pore domain potassium channel.";
RL   Brain Res. Mol. Brain Res. 82:74-83(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11431495;
RA   Vega-Saenz de Miera E., Lau D.H.P., Zhadina M., Pountney D.,
RA   Coetzee W.A., Rudy B.;
RT   "KT3.2 and KT3.3, two novel human two-pore K(+) channels closely
RT   related to TASK-1.";
RL   J. Neurophysiol. 86:130-142(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND OVEREXPRESSION IN BREAST CANCERS.
RX   PubMed=12676587; DOI=10.1016/S1535-6108(03)00054-0;
RA   Mu D., Chen L., Zhang X., See L.-H., Koch C.M., Yen C., Tong J.J.,
RA   Spiegel L., Nguyen K.C.Q., Servoss A., Peng Y., Pei L., Marks J.R.,
RA   Lowe S., Hoey T., Jan L.Y., McCombie W.R., Wigler M.H., Powers S.;
RT   "Genomic amplification and oncogenic properties of the KCNK9 potassium
RT   channel gene.";
RL   Cancer Cell 3:297-302(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Girard C., Lesage F., Tinel N., Lazdunski M.;
RT   "Human Task-3, a novel 2P domain potassium channel related to Task.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH KCNK1, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23169818; DOI=10.1126/scisignal.2003431;
RA   Plant L.D., Zuniga L., Araki D., Marks J.D., Goldstein S.A.;
RT   "SUMOylation silences heterodimeric TASK potassium channels containing
RT   K2P1 subunits in cerebellar granule neurons.";
RL   Sci. Signal. 5:RA84-RA84(2012).
RN   [8]
RP   VARIANT BIBAS ARG-236, AND CHARACTERIZATION OF VARIANT BIBAS ARG-236.
RX   PubMed=18678320; DOI=10.1016/j.ajhg.2008.07.010;
RA   Barel O., Shalev S.A., Ofir R., Cohen A., Zlotogora J., Shorer Z.,
RA   Mazor G., Finer G., Khateeb S., Zilberberg N., Birk O.S.;
RT   "Maternally inherited Birk Barel mental retardation dysmorphism
RT   syndrome caused by a mutation in the genomically imprinted potassium
RT   channel KCNK9.";
RL   Am. J. Hum. Genet. 83:193-199(2008).
CC   -!- FUNCTION: pH-dependent, voltage-insensitive, background potassium
CC       channel protein. {ECO:0000269|PubMed:11042359,
CC       ECO:0000269|PubMed:11431495, ECO:0000269|PubMed:23169818}.
CC   -!- SUBUNIT: Homodimer (Probable). Heterodimer with KCNK1.
CC       {ECO:0000269|PubMed:23169818, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Mainly found in the cerebellum. Also found in
CC       adrenal gland, kidney and lung. {ECO:0000269|PubMed:11042359,
CC       ECO:0000269|PubMed:11431495}.
CC   -!- DISEASE: Birk-Barel mental retardation dysmorphism syndrome
CC       (BIBAS) [MIM:612292]: A syndrome characterized by mental
CC       retardation, hypotonia, hyperactivity, and facial dysmorphism.
CC       {ECO:0000269|PubMed:18678320}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Inhibited by phorbol 12-myristate 13-acetate (PMA).
CC       TASK-3 current is strongly decreased in the presence of an
CC       extracellular pH inferior to 7.0.
CC   -!- MISCELLANEOUS: Overexpressed in a high proportion of breast
CC       cancers. May confer resistance to growth factor deprivation and
CC       hypoxia, thereby promoting tumor cell survival in poorly
CC       oxygenated areas of solid tumors.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF212829; AAF63708.1; -; mRNA.
DR   EMBL; AF248241; AAG31730.1; -; mRNA.
DR   EMBL; AF257080; AAG33126.1; -; mRNA.
DR   EMBL; AY190605; AAO38739.1; -; mRNA.
DR   EMBL; AF279809; AAF85982.1; -; mRNA.
DR   EMBL; BC075079; AAH75079.1; -; mRNA.
DR   EMBL; BC075080; AAH75080.1; -; mRNA.
DR   EMBL; BC112063; AAI12064.1; -; mRNA.
DR   EMBL; BC112065; AAI12066.1; -; mRNA.
DR   CCDS; CCDS6377.1; -.
DR   RefSeq; NP_001269463.1; NM_001282534.1.
DR   RefSeq; XP_011515404.1; XM_011517102.2.
DR   UniGene; Hs.493037; -.
DR   UniGene; Hs.553147; -.
DR   UniGene; Hs.664608; -.
DR   PDB; 3P1N; X-ray; 1.40 A; P=369-374.
DR   PDB; 3P1O; X-ray; 1.90 A; P=369-374.
DR   PDB; 3P1P; X-ray; 1.95 A; P=369-374.
DR   PDB; 3P1Q; X-ray; 1.70 A; P=369-374.
DR   PDB; 3P1R; X-ray; 1.70 A; P=369-374.
DR   PDB; 3P1S; X-ray; 1.65 A; P=369-374.
DR   PDB; 3SMK; X-ray; 2.10 A; P=369-374.
DR   PDB; 3SML; X-ray; 1.90 A; P=370-374.
DR   PDB; 3SMM; X-ray; 2.00 A; P=369-374.
DR   PDB; 3SMN; X-ray; 2.00 A; P=369-374.
DR   PDB; 3SMO; X-ray; 1.80 A; P=369-374.
DR   PDB; 3SP5; X-ray; 1.80 A; P=369-374.
DR   PDB; 3SPR; X-ray; 1.99 A; P=369-374.
DR   PDB; 3UX0; X-ray; 1.75 A; P=369-374.
DR   PDB; 4FR3; X-ray; 1.90 A; P=369-374.
DR   PDBsum; 3P1N; -.
DR   PDBsum; 3P1O; -.
DR   PDBsum; 3P1P; -.
DR   PDBsum; 3P1Q; -.
DR   PDBsum; 3P1R; -.
DR   PDBsum; 3P1S; -.
DR   PDBsum; 3SMK; -.
DR   PDBsum; 3SML; -.
DR   PDBsum; 3SMM; -.
DR   PDBsum; 3SMN; -.
DR   PDBsum; 3SMO; -.
DR   PDBsum; 3SP5; -.
DR   PDBsum; 3SPR; -.
DR   PDBsum; 3UX0; -.
DR   PDBsum; 4FR3; -.
DR   ProteinModelPortal; Q9NPC2; -.
DR   SMR; Q9NPC2; -.
DR   BioGrid; 119456; 2.
DR   STRING; 9606.ENSP00000302166; -.
DR   BindingDB; Q9NPC2; -.
DR   ChEMBL; CHEMBL2321614; -.
DR   DrugBank; DB00561; Doxapram.
DR   DrugBank; DB01159; Halothane.
DR   TCDB; 1.A.1.9.11; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9NPC2; -.
DR   PhosphoSitePlus; Q9NPC2; -.
DR   DMDM; 13431426; -.
DR   PaxDb; Q9NPC2; -.
DR   PeptideAtlas; Q9NPC2; -.
DR   PRIDE; Q9NPC2; -.
DR   Ensembl; ENST00000303015; ENSP00000302166; ENSG00000169427.
DR   Ensembl; ENST00000520439; ENSP00000430676; ENSG00000169427.
DR   Ensembl; ENST00000522317; ENSP00000429847; ENSG00000169427.
DR   GeneID; 51305; -.
DR   KEGG; hsa:51305; -.
DR   UCSC; uc003yvg.3; human.
DR   CTD; 51305; -.
DR   DisGeNET; 51305; -.
DR   EuPathDB; HostDB:ENSG00000169427.6; -.
DR   GeneCards; KCNK9; -.
DR   HGNC; HGNC:6283; KCNK9.
DR   MalaCards; KCNK9; -.
DR   MIM; 605874; gene.
DR   MIM; 612292; phenotype.
DR   neXtProt; NX_Q9NPC2; -.
DR   OpenTargets; ENSG00000169427; -.
DR   Orphanet; 166108; Intellectual disability, Birk-Barel type.
DR   PharmGKB; PA30065; -.
DR   eggNOG; KOG4404; Eukaryota.
DR   eggNOG; ENOG410XRZJ; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000231463; -.
DR   HOVERGEN; HBG052239; -.
DR   InParanoid; Q9NPC2; -.
DR   KO; K04919; -.
DR   OMA; EINLICV; -.
DR   OrthoDB; EOG091G08DH; -.
DR   PhylomeDB; Q9NPC2; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-HSA-1299316; TWIK-releated acid-sensitive K+ channel (TASK).
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   SIGNOR; Q9NPC2; -.
DR   ChiTaRS; KCNK9; human.
DR   EvolutionaryTrace; Q9NPC2; -.
DR   GeneWiki; KCNK9; -.
DR   GenomeRNAi; 51305; -.
DR   PRO; PR:Q9NPC2; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000169427; -.
DR   CleanEx; HS_KCNK9; -.
DR   ExpressionAtlas; Q9NPC2; baseline and differential.
DR   Genevisible; Q9NPC2; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:Ensembl.
DR   GO; GO:0005267; F:potassium channel activity; TAS:Reactome.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; NAS:UniProtKB.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR005407; KCNK9.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01585; TASK3CHANNEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Disease mutation;
KW   Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Mental retardation; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    374       Potassium channel subfamily K member 9.
FT                                /FTId=PRO_0000101754.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      9     29       Helical. {ECO:0000255}.
FT   TOPO_DOM     30     88       Extracellular. {ECO:0000255}.
FT   INTRAMEM     89    101       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TOPO_DOM    102    107       Extracellular. {ECO:0000255}.
FT   TRANSMEM    108    128       Helical. {ECO:0000255}.
FT   TOPO_DOM    129    158       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical. {ECO:0000255}.
FT   TOPO_DOM    180    194       Extracellular. {ECO:0000255}.
FT   INTRAMEM    195    207       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TOPO_DOM    208    218       Extracellular. {ECO:0000255}.
FT   TRANSMEM    219    239       Helical. {ECO:0000255}.
FT   TOPO_DOM    240    374       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     236    236       G -> R (in BIBAS; inactive;
FT                                dbSNP:rs121908332).
FT                                {ECO:0000269|PubMed:18678320}.
FT                                /FTId=VAR_054373.
SQ   SEQUENCE   374 AA;  42264 MW;  8A19EAEE5A4D7F38 CRC64;
     MKRQNVRTLS LIVCTFTYLL VGAAVFDALE SDHEMREEEK LKAEEIRIKG KYNISSEDYR
     QLELVILQSE PHRAGVQWKF AGSFYFAITV ITTIGYGHAA PGTDAGKAFC MFYAVLGIPL
     TLVMFQSLGE RMNTFVRYLL KRIKKCCGMR NTDVSMENMV TVGFFSCMGT LCIGAAAFSQ
     CEEWSFFHAY YYCFITLTTI GFGDYVALQT KGALQKKPLY VAFSFMYILV GLTVIGAFLN
     LVVLRFLTMN SEDERRDAEE RASLAGNRNS MVIHIPEEPR PSRPRYKADV PDLQSVCSCT
     CYRSQDYGGR SVAPQNSFSA KLAPHYFHSI SYKIEEISPS TLKNSLFPSP ISSISPGLHS
     FTDHQRLMKR RKSV
//
ID   KCNQ5_HUMAN             Reviewed;         932 AA.
AC   Q9NR82; A6NKT6; A6PVT6; A8MSQ5; B4DS33; B5MC83; B7ZL37; F5GZV0;
AC   Q17RE1; Q5VVP3; Q86W40; Q9NRN0; Q9NYA6;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 3.
DT   22-NOV-2017, entry version 152.
DE   RecName: Full=Potassium voltage-gated channel subfamily KQT member 5;
DE   AltName: Full=KQT-like 5;
DE   AltName: Full=Potassium channel subunit alpha KvLQT5;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv7.5;
GN   Name=KCNQ5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=10787416; DOI=10.1074/jbc.M002378200;
RA   Lerche C., Scherer C.R., Seebohm G., Derst C., Wei A.D., Busch A.E.,
RA   Steinmeyer K.;
RT   "Molecular cloning and functional expression of KCNQ5, a potassium
RT   channel subunit that may contribute to neuronal M-current diversity.";
RL   J. Biol. Chem. 275:22395-22400(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 19-822 (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 36-932 (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=10816588; DOI=10.1074/jbc.M003245200;
RA   Schroeder B.C., Hechenberger M., Weinreich F., Kubisch C.,
RA   Jentsch T.J.;
RT   "KCNQ5, a novel potassium channel broadly expressed in brain, mediates
RT   M-type currents.";
RL   J. Biol. Chem. 275:24089-24095(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-932.
RA   Kananura C., Biervert B., Hechenberger M., Engels H., Steinlein O.K.;
RT   "The new voltage gated potassium channel KCNQ5 and early infantile
RT   convulsions.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 72-932 (ISOFORM 1).
RC   TISSUE=Brain, and Retina;
RA   Kniazeva M., Han M.;
RT   "A new gene of the voltage-gated potassium channel KCNQ family, KCNQ5,
RT   is a candidate gene for retinal disorders.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND ACTIVATION BY RETICABINE.
RX   PubMed=11159685; DOI=10.1038/sj.bjp.0703861;
RA   Wickenden A.D., Zou A., Wagoner P.K., Jegla T.;
RT   "Characterization of KCNQ5/Q3 potassium channels expressed in
RT   mammalian cells.";
RL   Br. J. Pharmacol. 132:381-384(2001).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-831, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   INTERACTION WITH KCNQ1.
RX   PubMed=24855057; DOI=10.1161/ATVBAHA.114.303801;
RA   Oliveras A., Roura-Ferrer M., Sole L., de la Cruz A., Prieto A.,
RA   Etxebarria A., Manils J., Morales-Cano D., Condom E., Soler C.,
RA   Cogolludo A., Valenzuela C., Villarroel A., Comes N., Felipe A.;
RT   "Functional assembly of Kv7.1/Kv7.5 channels with emerging properties
RT   on vascular muscle physiology.";
RL   Arterioscler. Thromb. Vasc. Biol. 34:1522-1530(2014).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-191 AND CYS-244.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [12]
RP   INVOLVEMENT IN MRD46, VARIANTS MRD46 GLY-145; ILE-341; ARG-369 AND
RP   ILE-429, CHARACTERIZATION OF VARIANTS MRD46 GLY-145; ILE-341; ARG-369
RP   AND ILE-429, AND FUNCTION.
RX   PubMed=28669405; DOI=10.1016/j.ajhg.2017.05.016;
RG   CAUSES Study;
RG   EPGEN Study;
RA   Lehman A., Thouta S., Mancini G.M.S., Naidu S., van Slegtenhorst M.,
RA   McWalter K., Person R., Mwenifumbo J., Salvarinova R., Guella I.,
RA   McKenzie M.B., Datta A., Connolly M.B., Kalkhoran S.M., Poburko D.,
RA   Friedman J.M., Farrer M.J., Demos M., Desai S., Claydon T.;
RT   "Loss-of-function and gain-of-function mutations in KCNQ5 cause
RT   intellectual disability or epileptic encephalopathy.";
RL   Am. J. Hum. Genet. 101:65-74(2017).
CC   -!- FUNCTION: Associates with KCNQ3 to form a potassium channel which
CC       contributes to M-type current, a slowly activating and
CC       deactivating potassium conductance which plays a critical role in
CC       determining the subthreshold electrical excitability of neurons.
CC       Therefore, it is important in the regulation of neuronal
CC       excitability. May contribute, with other potassium channels, to
CC       the molecular diversity of a heterogeneous population of M-
CC       channels, varying in kinetic and pharmacological properties, which
CC       underlie this physiologically important current. Insensitive to
CC       tetraethylammonium, but inhibited by barium, linopirdine and
CC       XE991. Activated by niflumic acid and the anticonvulsant
CC       retigabine. As the native M-channel, the potassium channel
CC       composed of KCNQ3 and KCNQ5 is also suppressed by activation of
CC       the muscarinic acetylcholine receptor CHRM1.
CC       {ECO:0000269|PubMed:10787416, ECO:0000269|PubMed:11159685,
CC       ECO:0000269|PubMed:28669405}.
CC   -!- SUBUNIT: Heteromultimer with KCNQ3 (PubMed:11159685,
CC       PubMed:10787416). Heterotetramer with KCNQ1; has a voltage-gated
CC       potassium channel activity (PubMed:24855057).
CC       {ECO:0000269|PubMed:10787416, ECO:0000269|PubMed:11159685,
CC       ECO:0000269|PubMed:24855057}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10787416,
CC       ECO:0000269|PubMed:11159685}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=Q9NR82-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NR82-2; Sequence=VSP_001014;
CC       Name=3;
CC         IsoId=Q9NR82-3; Sequence=VSP_001015;
CC       Name=4;
CC         IsoId=Q9NR82-4; Sequence=VSP_022318, VSP_022319;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q9NR82-5; Sequence=VSP_045487;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q9NR82-6; Sequence=VSP_056731;
CC         Note=No experimental confirmation available.;
CC       Name=7;
CC         IsoId=Q9NR82-7; Sequence=VSP_056730;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in brain and skeletal
CC       muscle. In brain, expressed in cerebral cortex, occipital pole,
CC       frontal lobe and temporal lobe. Lower levels in hippocampus and
CC       putamen. Low to undetectable levels in medulla, cerebellum and
CC       thalamus.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250}.
CC   -!- DISEASE: Mental retardation, autosomal dominant 46 (MRD46)
CC       [MIM:617601]: A form of mental retardation, a disorder
CC       characterized by significantly below average general intellectual
CC       functioning associated with impairments in adaptive behavior and
CC       manifested during the developmental period. MRD46 patients
CC       manifest developmental delay and mild to moderate intellectual
CC       disability. {ECO:0000269|PubMed:28669405}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel family. KQT (TC
CC       1.A.1.15) subfamily. Kv7.5/KCNQ5 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG61495.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF249278; AAF91335.1; -; mRNA.
DR   EMBL; AL445569; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL049845; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL360232; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL360236; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL365232; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FO393414; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL513522; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL671823; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC050689; AAH50689.1; -; mRNA.
DR   EMBL; BC117359; AAI17360.1; -; mRNA.
DR   EMBL; BC143554; AAI43555.1; -; mRNA.
DR   EMBL; AK299550; BAG61495.1; ALT_INIT; mRNA.
DR   EMBL; AF202977; AAF69797.1; -; mRNA.
DR   EMBL; AJ272506; CAC88112.1; -; Genomic_DNA.
DR   EMBL; AJ272507; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272508; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272509; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272510; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272511; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272512; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272513; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272514; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272515; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272516; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272517; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272518; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272519; CAC88112.1; JOINED; Genomic_DNA.
DR   EMBL; AF263835; AAF73446.1; -; mRNA.
DR   CCDS; CCDS4976.1; -. [Q9NR82-1]
DR   CCDS; CCDS55034.1; -. [Q9NR82-6]
DR   CCDS; CCDS55035.1; -. [Q9NR82-5]
DR   CCDS; CCDS55037.1; -. [Q9NR82-2]
DR   RefSeq; NP_001153602.1; NM_001160130.1. [Q9NR82-2]
DR   RefSeq; NP_001153604.1; NM_001160132.1. [Q9NR82-3]
DR   RefSeq; NP_001153605.1; NM_001160133.1. [Q9NR82-6]
DR   RefSeq; NP_001153606.1; NM_001160134.1. [Q9NR82-5]
DR   RefSeq; NP_062816.2; NM_019842.3. [Q9NR82-1]
DR   UniGene; Hs.445324; -.
DR   ProteinModelPortal; Q9NR82; -.
DR   SMR; Q9NR82; -.
DR   BioGrid; 121149; 6.
DR   CORUM; Q9NR82; -.
DR   STRING; 9606.ENSP00000345055; -.
DR   BindingDB; Q9NR82; -.
DR   ChEMBL; CHEMBL2925; -.
DR   DrugBank; DB04953; Ezogabine.
DR   DrugBank; DB06089; ICA-105665.
DR   GuidetoPHARMACOLOGY; 564; -.
DR   iPTMnet; Q9NR82; -.
DR   PhosphoSitePlus; Q9NR82; -.
DR   BioMuta; KCNQ5; -.
DR   DMDM; 122065285; -.
DR   PaxDb; Q9NR82; -.
DR   PeptideAtlas; Q9NR82; -.
DR   PRIDE; Q9NR82; -.
DR   Ensembl; ENST00000342056; ENSP00000345055; ENSG00000185760. [Q9NR82-6]
DR   Ensembl; ENST00000370392; ENSP00000359419; ENSG00000185760. [Q9NR82-4]
DR   Ensembl; ENST00000370398; ENSP00000359425; ENSG00000185760. [Q9NR82-1]
DR   Ensembl; ENST00000628967; ENSP00000486187; ENSG00000185760. [Q9NR82-5]
DR   Ensembl; ENST00000629977; ENSP00000485743; ENSG00000185760. [Q9NR82-2]
DR   GeneID; 56479; -.
DR   KEGG; hsa:56479; -.
DR   UCSC; uc003pgj.5; human. [Q9NR82-1]
DR   CTD; 56479; -.
DR   DisGeNET; 56479; -.
DR   EuPathDB; HostDB:ENSG00000185760.15; -.
DR   GeneCards; KCNQ5; -.
DR   HGNC; HGNC:6299; KCNQ5.
DR   HPA; HPA016655; -.
DR   MIM; 607357; gene.
DR   MIM; 617601; phenotype.
DR   neXtProt; NX_Q9NR82; -.
DR   OpenTargets; ENSG00000185760; -.
DR   PharmGKB; PA30077; -.
DR   eggNOG; KOG1419; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00550000074513; -.
DR   HOGENOM; HOG000220839; -.
DR   HOVERGEN; HBG059014; -.
DR   InParanoid; Q9NR82; -.
DR   KO; K04930; -.
DR   OMA; RMYTSRK; -.
DR   PhylomeDB; Q9NR82; -.
DR   TreeFam; TF315186; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   ChiTaRS; KCNQ5; human.
DR   GeneWiki; KCNQ5; -.
DR   GenomeRNAi; 56479; -.
DR   PRO; PR:Q9NR82; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000185760; -.
DR   CleanEx; HS_KCNQ5; -.
DR   ExpressionAtlas; Q9NR82; baseline and differential.
DR   Genevisible; Q9NR82; HS.
DR   GO; GO:0030118; C:clathrin coat; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003937; K_chnl_volt-dep_KCNQ.
DR   InterPro; IPR013821; K_chnl_volt-dep_KCNQ_C.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF03520; KCNQ_channel; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01459; KCNQCHANNEL.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disease mutation; Ion channel; Ion transport; Membrane;
KW   Mental retardation; Phosphoprotein; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    932       Potassium voltage-gated channel subfamily
FT                                KQT member 5.
FT                                /FTId=PRO_0000054040.
FT   TOPO_DOM      1    125       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    126    146       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    147    156       Extracellular. {ECO:0000255}.
FT   TRANSMEM    157    177       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    178    200       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    201    221       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    222    229       Extracellular. {ECO:0000255}.
FT   TRANSMEM    230    252       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    253    266       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    267    287       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    288    298       Extracellular. {ECO:0000255}.
FT   INTRAMEM    299    319       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    320    325       Extracellular. {ECO:0000255}.
FT   TRANSMEM    326    346       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    347    932       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       311    316       Selectivity filter. {ECO:0000250}.
FT   MOD_RES      88     88       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JK45}.
FT   MOD_RES     447    447       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JK45}.
FT   MOD_RES     831    831       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     407    416       KKEQGEASSS -> N (in isoform 2).
FT                                {ECO:0000303|PubMed:10816588,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001014.
FT   VAR_SEQ     407    416       KKEQGEASSS -> NKFCSNKQKLFRMYTSRKQS (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:10816588}.
FT                                /FTId=VSP_001015.
FT   VAR_SEQ     408    416       KEQGEASSS -> QNQQGESQSC (in isoform 7).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_056730.
FT   VAR_SEQ     416    525       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045487.
FT   VAR_SEQ     416    427       SQKLSFKERVRM -> RFVISLLLHVCL (in isoform
FT                                4). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_022318.
FT   VAR_SEQ     416    416       S -> SKFCSNKQKLFRMYTSRKQS (in isoform 6).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_056731.
FT   VAR_SEQ     428    932       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_022319.
FT   VARIANT     145    145       V -> G (in MRD46; decreased protein
FT                                abundance; decreased potassium ion
FT                                transmembrane transport; changed voltage-
FT                                gated potassium channel activity; changed
FT                                gating properties).
FT                                {ECO:0000269|PubMed:28669405}.
FT                                /FTId=VAR_079219.
FT   VARIANT     191    191       W -> G (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035772.
FT   VARIANT     244    244       R -> C (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035773.
FT   VARIANT     341    341       L -> I (in MRD46; decreased protein
FT                                abundance; decreased potassium ion
FT                                transmembrane transport; changed voltage-
FT                                gated potassium channel activity; changed
FT                                gating properties).
FT                                {ECO:0000269|PubMed:28669405}.
FT                                /FTId=VAR_079220.
FT   VARIANT     369    369       P -> R (in MRD46; no effect on protein
FT                                abundance; no effect on potassium ion
FT                                transmembrane transport; increased
FT                                voltage-gated potassium channel activity;
FT                                changed gating properties resulting in a
FT                                gain of function).
FT                                {ECO:0000269|PubMed:28669405}.
FT                                /FTId=VAR_079221.
FT   VARIANT     429    429       S -> I (in MRD46; no effect on protein
FT                                abundance; no effect on potassium ion
FT                                transmembrane transport; changed voltage-
FT                                gated potassium channel activity; changed
FT                                gating properties).
FT                                {ECO:0000269|PubMed:28669405}.
FT                                /FTId=VAR_079222.
FT   CONFLICT     92     93       KP -> SR (in Ref. 1; AAF91335).
FT                                {ECO:0000305}.
FT   CONFLICT    109    109       R -> Q (in Ref. 4; BAG61495).
FT                                {ECO:0000305}.
FT   CONFLICT    129    129       Y -> H (in Ref. 7; AAF73446).
FT                                {ECO:0000305}.
FT   CONFLICT    727    727       A -> V (in Ref. 7; AAF73446).
FT                                {ECO:0000305}.
FT   CONFLICT    799    799       T -> P (in Ref. 7; AAF73446).
FT                                {ECO:0000305}.
FT   CONFLICT    857    857       S -> R (in Ref. 7; AAF73446).
FT                                {ECO:0000305}.
FT   CONFLICT    909    909       R -> Q (in Ref. 7; AAF73446).
FT                                {ECO:0000305}.
SQ   SEQUENCE   932 AA;  102179 MW;  CB41C243FD2B00FC CRC64;
     MPRHHAGGEE GGAAGLWVKS GAAAAAAGGG RLGSGMKDVE SGRGRVLLNS AAARGDGLLL
     LGTRAATLGG GGGGLRESRR GKQGARMSLL GKPLSYTSSQ SCRRNVKYRR VQNYLYNVLE
     RPRGWAFIYH AFVFLLVFGC LILSVFSTIP EHTKLASSCL LILEFVMIVV FGLEFIIRIW
     SAGCCCRYRG WQGRLRFARK PFCVIDTIVL IASIAVVSAK TQGNIFATSA LRSLRFLQIL
     RMVRMDRRGG TWKLLGSVVY AHSKELITAW YIGFLVLIFS SFLVYLVEKD ANKEFSTYAD
     ALWWGTITLT TIGYGDKTPL TWLGRLLSAG FALLGISFFA LPAGILGSGF ALKVQEQHRQ
     KHFEKRRNPA ANLIQCVWRS YAADEKSVSI ATWKPHLKAL HTCSPTKKEQ GEASSSQKLS
     FKERVRMASP RGQSIKSRQA SVGDRRSPST DITAEGSPTK VQKSWSFNDR TRFRPSLRLK
     SSQPKPVIDA DTALGTDDVY DEKGCQCDVS VEDLTPPLKT VIRAIRIMKF HVAKRKFKET
     LRPYDVKDVI EQYSAGHLDM LCRIKSLQTR VDQILGKGQI TSDKKSREKI TAEHETTDDL
     SMLGRVVKVE KQVQSIESKL DCLLDIYQQV LRKGSASALA LASFQIPPFE CEQTSDYQSP
     VDSKDLSGSA QNSGCLSRST SANISRGLQF ILTPNEFSAQ TFYALSPTMH SQATQVPISQ
     SDGSAVAATN TIANQINTAP KPAAPTTLQI PPPLPAIKHL PRPETLHPNP AGLQESISDV
     TTCLVASKEN VQVAQSNLTK DRSMRKSFDM GGETLLSVCP MVPKDLGKSL SVQNLIRSTE
     ELNIQLSGSE SSGSRGSQDF YPKWRESKLF ITDEEVGPEE TETDTFDAAP QPAREAAFAS
     DSLRTGRSRS SQSICKAGES TDALSLPHVK LK
//
ID   TM38B_HUMAN             Reviewed;         291 AA.
AC   Q9NVV0; Q5JR63; Q5SVN5; Q5SVN6; Q5VTE2; Q6IA97;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   27-SEP-2017, entry version 125.
DE   RecName: Full=Trimeric intracellular cation channel type B;
DE            Short=TRIC-B;
DE            Short=TRICB;
DE   AltName: Full=Transmembrane protein 38B;
GN   Name=TMEM38B; Synonyms=C9orf87;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-262, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-262, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   INVOLVEMENT IN OI14.
RX   PubMed=23054245; DOI=10.1136/jmedgenet-2012-101142;
RA   Shaheen R., Alazami A.M., Alshammari M.J., Faqeih E., Alhashmi N.,
RA   Mousa N., Alsinani A., Ansari S., Alzahrani F., Al-Owain M.,
RA   Alzayed Z.S., Alkuraya F.S.;
RT   "Study of autosomal recessive osteogenesis imperfecta in Arabia
RT   reveals a novel locus defined by TMEM38B mutation.";
RL   J. Med. Genet. 49:630-635(2012).
RN   [10]
RP   INVOLVEMENT IN OI14.
RX   PubMed=23316006; DOI=10.1002/humu.22274;
RA   Volodarsky M., Markus B., Cohen I., Staretz-Chacham O., Flusser H.,
RA   Landau D., Shelef I., Langer Y., Birk O.S.;
RT   "A deletion mutation in TMEM38B associated with autosomal recessive
RT   osteogenesis imperfecta.";
RL   Hum. Mutat. 34:582-586(2013).
CC   -!- FUNCTION: Monovalent cation channel required for maintenance of
CC       rapid intracellular calcium release. May act as a potassium
CC       counter-ion channel that functions in synchronization with calcium
CC       release from intracellular stores. {ECO:0000250|UniProtKB:Q9DAV9}.
CC   -!- SUBUNIT: Homotrimer; trimerization probably requires binding to
CC       phosphatidylinositol 4,5-bisphosphate (PIP2).
CC       {ECO:0000250|UniProtKB:A5A6S6, ECO:0000250|UniProtKB:Q9NA73}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9DAV9}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9DAV9}.
CC   -!- DISEASE: Osteogenesis imperfecta 14 (OI14) [MIM:615066]: An
CC       autosomal recessive form of osteogenesis imperfecta, a connective
CC       tissue disorder characterized by low bone mass, bone fragility and
CC       susceptibility to fractures after minimal trauma. Disease severity
CC       ranges from very mild forms without fractures to intrauterine
CC       fractures and perinatal lethality. Extraskeletal manifestations,
CC       which affect a variable number of patients, are dentinogenesis
CC       imperfecta, hearing loss, and blue sclerae. OI14 is characterized
CC       by variable degrees of severity of multiple fractures and
CC       osteopenia, with normal teeth, sclerae, and hearing. Fractures
CC       first occur prenatally or by age 6 years.
CC       {ECO:0000269|PubMed:23054245, ECO:0000269|PubMed:23316006}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the TMEM38 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAH71458.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI12390.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI12391.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI12392.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI39690.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAI39691.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI39692.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK001355; BAA91645.1; -; mRNA.
DR   EMBL; CR457258; CAG33539.1; -; mRNA.
DR   EMBL; AL592488; CAH71457.1; -; Genomic_DNA.
DR   EMBL; AL592437; CAH71457.1; JOINED; Genomic_DNA.
DR   EMBL; AL627247; CAH71457.1; JOINED; Genomic_DNA.
DR   EMBL; AL592488; CAH71458.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL592437; CAH71458.1; JOINED; Genomic_DNA.
DR   EMBL; AL627247; CAH71458.1; JOINED; Genomic_DNA.
DR   EMBL; AL627247; CAI12389.1; -; Genomic_DNA.
DR   EMBL; AL592437; CAI12389.1; JOINED; Genomic_DNA.
DR   EMBL; AL592488; CAI12389.1; JOINED; Genomic_DNA.
DR   EMBL; AL627247; CAI12390.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL592437; CAI12390.1; JOINED; Genomic_DNA.
DR   EMBL; AL592488; CAI12390.1; JOINED; Genomic_DNA.
DR   EMBL; AL627247; CAI12391.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL627247; CAI12392.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL592437; CAI12392.1; JOINED; Genomic_DNA.
DR   EMBL; AL592437; CAI39689.1; -; Genomic_DNA.
DR   EMBL; AL592488; CAI39689.1; JOINED; Genomic_DNA.
DR   EMBL; AL627247; CAI39689.1; JOINED; Genomic_DNA.
DR   EMBL; AL592437; CAI39690.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL592437; CAI39691.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL592488; CAI39691.1; JOINED; Genomic_DNA.
DR   EMBL; AL627247; CAI39691.1; JOINED; Genomic_DNA.
DR   EMBL; AL592437; CAI39692.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL627247; CAI39692.1; JOINED; Genomic_DNA.
DR   EMBL; BC000049; AAH00049.1; -; mRNA.
DR   CCDS; CCDS6768.1; -.
DR   RefSeq; NP_060582.1; NM_018112.2.
DR   UniGene; Hs.411925; -.
DR   UniGene; Hs.618078; -.
DR   ProteinModelPortal; Q9NVV0; -.
DR   BioGrid; 120454; 11.
DR   IntAct; Q9NVV0; 4.
DR   STRING; 9606.ENSP00000363824; -.
DR   TCDB; 1.A.62.1.3; the homotrimeric cation channel (tric) family.
DR   iPTMnet; Q9NVV0; -.
DR   PhosphoSitePlus; Q9NVV0; -.
DR   DMDM; 74753001; -.
DR   EPD; Q9NVV0; -.
DR   MaxQB; Q9NVV0; -.
DR   PaxDb; Q9NVV0; -.
DR   PeptideAtlas; Q9NVV0; -.
DR   PRIDE; Q9NVV0; -.
DR   DNASU; 55151; -.
DR   Ensembl; ENST00000374692; ENSP00000363824; ENSG00000095209.
DR   GeneID; 55151; -.
DR   KEGG; hsa:55151; -.
DR   UCSC; uc004bcu.3; human.
DR   CTD; 55151; -.
DR   DisGeNET; 55151; -.
DR   EuPathDB; HostDB:ENSG00000095209.11; -.
DR   GeneCards; TMEM38B; -.
DR   HGNC; HGNC:25535; TMEM38B.
DR   HPA; HPA018465; -.
DR   MalaCards; TMEM38B; -.
DR   MIM; 611236; gene.
DR   MIM; 615066; phenotype.
DR   neXtProt; NX_Q9NVV0; -.
DR   OpenTargets; ENSG00000095209; -.
DR   Orphanet; 216820; Osteogenesis imperfecta type 4.
DR   PharmGKB; PA134916126; -.
DR   eggNOG; KOG3944; Eukaryota.
DR   eggNOG; ENOG410XQ0P; LUCA.
DR   GeneTree; ENSGT00390000018845; -.
DR   HOGENOM; HOG000037929; -.
DR   HOVERGEN; HBG059853; -.
DR   InParanoid; Q9NVV0; -.
DR   OMA; KMSYPSK; -.
DR   OrthoDB; EOG091G0GQP; -.
DR   PhylomeDB; Q9NVV0; -.
DR   TreeFam; TF313483; -.
DR   ChiTaRS; TMEM38B; human.
DR   GenomeRNAi; 55151; -.
DR   PRO; PR:Q9NVV0; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000095209; -.
DR   CleanEx; HS_TMEM38B; -.
DR   ExpressionAtlas; Q9NVV0; baseline and differential.
DR   Genevisible; Q9NVV0; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031965; C:nuclear membrane; NAS:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; NAS:BHF-UCL.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005267; F:potassium channel activity; TAS:BHF-UCL.
DR   InterPro; IPR007866; TRIC_channel.
DR   PANTHER; PTHR12454; PTHR12454; 1.
DR   Pfam; PF05197; TRIC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Ion channel; Ion transport;
KW   Membrane; Osteogenesis imperfecta; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    291       Trimeric intracellular cation channel
FT                                type B.
FT                                /FTId=PRO_0000291524.
FT   TOPO_DOM      1     19       Lumenal. {ECO:0000305}.
FT   TRANSMEM     20     33       Helical;Name=1. {ECO:0000255}.
FT   TOPO_DOM     34     50       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     51     70       Helical;Name=2. {ECO:0000255}.
FT   TOPO_DOM     71     82       Lumenal. {ECO:0000305}.
FT   TRANSMEM     83     99       Helical;Name=3. {ECO:0000255}.
FT   TOPO_DOM    100    104       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    105    121       Helical;Name=4. {ECO:0000255}.
FT   TOPO_DOM    122    139       Lumenal. {ECO:0000305}.
FT   TRANSMEM    140    156       Helical;Name=5. {ECO:0000255}.
FT   TOPO_DOM    157    179       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    180    195       Helical;Name=6. {ECO:0000255}.
FT   TOPO_DOM    196    207       Lumenal. {ECO:0000305}.
FT   TRANSMEM    208    227       Helical;Name=7. {ECO:0000255}.
FT   TOPO_DOM    228    291       Cytoplasmic. {ECO:0000305}.
FT   BINDING     118    118       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000250|UniProtKB:Q9NA73}.
FT   BINDING     122    122       Phosphatidylinositol 4,5-bisphosphate
FT                                (PIP2). {ECO:0000250|UniProtKB:Q9NA73}.
FT   MOD_RES     262    262       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   VARIANT     254    254       C -> S (in dbSNP:rs35232724).
FT                                /FTId=VAR_032811.
FT   CONFLICT     32     32       A -> E (in Ref. 2; CAG33539).
FT                                {ECO:0000305}.
FT   CONFLICT    291    291       E -> D (in Ref. 2; CAG33539).
FT                                {ECO:0000305}.
SQ   SEQUENCE   291 AA;  32510 MW;  1975F1E0053EAE7B CRC64;
     MDSPWDELAL AFSRTSMFPF FDIAHYLVSV MAVKRQPGAA ALAWKNPISS WFTAMLHCFG
     GGILSCLLLA EPPLKFLANH TNILLASSIW YITFFCPHDL VSQGYSYLPV QLLASGMKEV
     TRTWKIVGGV THANSYYKNG WIVMIAIGWA RGAGGTIITN FERLVKGDWK PEGDEWLKMS
     YPAKVTLLGS VIFTFQHTQH LAISKHNLMF LYTIFIVATK ITMMTTQTST MTFAPFEDTL
     SWMLFGWQQP FSSCEKKSEA KSPSNGVGSL ASKPVDVASD NVKKKHTKKN E
//
ID   KCNK4_HUMAN             Reviewed;         393 AA.
AC   Q9NYG8; B5TJL1; Q96T94;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   25-OCT-2017, entry version 149.
DE   RecName: Full=Potassium channel subfamily K member 4;
DE   AltName: Full=TWIK-related arachidonic acid-stimulated potassium channel protein {ECO:0000303|PubMed:23341632};
DE            Short=TRAAK {ECO:0000303|PubMed:23341632};
DE   AltName: Full=Two pore potassium channel KT4.1;
DE            Short=Two pore K(+) channel KT4.1;
GN   Name=KCNK4; Synonyms=TRAAK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11042359; DOI=10.1016/S0169-328X(00)00183-2;
RA   Chapman C.G., Meadows H.J., Godden R.J., Campbell D.A., Duckworth M.,
RA   Kelsell R.E., Murdock P.R., Randall A.D., Rennie G.I., Gloger I.S.;
RT   "Cloning, localisation and functional expression of a novel human,
RT   cerebellum specific, two pore domain potassium channel.";
RL   Brain Res. Mol. Brain Res. 82:74-83(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT LEU-328.
RC   TISSUE=Frontal cortex;
RA   Gray A.T.;
RT   "Assignment of KCNK4 encoding the human potassium channel TRAAK to
RT   chromosome 11.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10767409; DOI=10.1016/S0014-5793(00)01388-0;
RA   Lesage F., Maingret F., Lazdunski M.;
RT   "Cloning and expression of human TRAAK, a polyunsaturated fatty acids-
RT   activated and mechano-sensitive K(+) channel.";
RL   FEBS Lett. 471:137-140(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=12191490; DOI=10.1016/S0169-328X(02)00157-2;
RA   Ozaita A., Vega-Saenz de Miera E.;
RT   "Cloning of two transcripts, HKT4.1a and HKT4.1b, from the human two-
RT   pore K+ channel gene KCNK4. Chromosomal localization, tissue
RT   distribution and functional expression.";
RL   Brain Res. Mol. Brain Res. 102:18-27(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORM 1).
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (3.31 ANGSTROMS) OF 1-274, FUNCTION, ENZYME
RP   REGULATION, SUBUNIT, SUBCELLULAR LOCATION, TOPOLOGY, GLYCOSYLATION,
RP   AND DISULFIDE BOND.
RX   PubMed=22282805; DOI=10.1126/science.1213808;
RA   Brohawn S.G., del Marmol J., MacKinnon R.;
RT   "Crystal structure of the human K2P TRAAK, a lipid- and mechano-
RT   sensitive K+ ion channel.";
RL   Science 335:436-441(2012).
RN   [9] {ECO:0000244|PDB:4I9W}
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 1-274, SUBCELLULAR LOCATION,
RP   SUBUNIT, TOPOLOGY, AND DISULFIDE BOND.
RX   PubMed=23341632; DOI=10.1073/pnas.1218950110;
RA   Brohawn S.G., Campbell E.B., MacKinnon R.;
RT   "Domain-swapped chain connectivity and gated membrane access in a Fab-
RT   mediated crystal of the human TRAAK K+ channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:2129-2134(2013).
RN   [10] {ECO:0000244|PDB:4WFE}
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1-264, FUNCTION, SUBCELLULAR
RP   LOCATION, SUBUNIT, TOPOLOGY, DISULFIDE BOND, AND DOMAIN.
RX   PubMed=25471887; DOI=10.1038/nature14013;
RA   Brohawn S.G., Campbell E.B., MacKinnon R.;
RT   "Physical mechanism for gating and mechanosensitivity of the human
RT   TRAAK K+ channel.";
RL   Nature 516:126-130(2014).
RN   [11] {ECO:0000244|PDB:4RUE, ECO:0000244|PDB:4RUF}
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 1-274 OF MUTANTS ILE-98 AND
RP   SER-236, FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, SUBUNIT,
RP   TOPOLOGY, DISULFIDE BOND, DOMAIN, AND MUTAGENESIS OF GLY-98 AND
RP   TRP-236.
RX   PubMed=25500157; DOI=10.1016/j.neuron.2014.11.017;
RA   Lolicato M., Riegelhaupt P.M., Arrigoni C., Clark K.A.,
RA   Minor D.L. Jr.;
RT   "Transmembrane helix straightening and buckling underlies activation
RT   of mechanosensitive and thermosensitive K(2P) channels.";
RL   Neuron 84:1198-1212(2014).
CC   -!- FUNCTION: Voltage-insensitive potassium channel (PubMed:22282805).
CC       Channel opening is triggered by mechanical forces that deform the
CC       membrane (PubMed:22282805, PubMed:25471887, PubMed:25500157).
CC       Channel opening is triggered by raising the intracellular pH to
CC       basic levels (By similarity). The channel is inactive at 24
CC       degrees Celsius (in vitro); raising the temperature to 37 degrees
CC       Celsius increases the frequency of channel opening, with a further
CC       increase in channel activity when the temperature is raised to 42
CC       degrees Celsius (By similarity). Plays a role in the perception of
CC       pain caused by heat (By similarity). Plays a role in the sensory
CC       perception of pain caused by pressure (By similarity).
CC       {ECO:0000250|UniProtKB:G3V8V5, ECO:0000250|UniProtKB:O88454,
CC       ECO:0000269|PubMed:22282805, ECO:0000269|PubMed:25471887,
CC       ECO:0000269|PubMed:25500157}.
CC   -!- ENZYME REGULATION: Activated by arachidonic acid.
CC       {ECO:0000269|PubMed:22282805, ECO:0000269|PubMed:25500157}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked.
CC       {ECO:0000269|PubMed:22282805, ECO:0000269|PubMed:23341632,
CC       ECO:0000269|PubMed:25471887, ECO:0000269|PubMed:25500157}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22282805,
CC       ECO:0000269|PubMed:23341632, ECO:0000269|PubMed:25471887,
CC       ECO:0000269|PubMed:25500157}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:22282805, ECO:0000269|PubMed:23341632,
CC       ECO:0000269|PubMed:25471887, ECO:0000269|PubMed:25500157}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=KT4.1a;
CC         IsoId=Q9NYG8-1; Sequence=Displayed;
CC       Name=2; Synonyms=KT4.1b;
CC         IsoId=Q9NYG8-2; Sequence=VSP_006689;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC   -!- DOMAIN: Channel opening is brought about by a conformation change
CC       that involves buckling of the second transmembrane helix and
CC       affects the position and orientation of the fourth transmembrane
CC       helix. {ECO:0000269|PubMed:25471887, ECO:0000269|PubMed:25500157}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:22282805}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF248242; AAG31731.1; -; mRNA.
DR   EMBL; AF247042; AAF64062.1; -; mRNA.
DR   EMBL; AF259500; AAK49389.1; -; mRNA.
DR   EMBL; AF259501; AAK49390.1; -; mRNA.
DR   EMBL; EU978935; ACH86094.1; -; mRNA.
DR   EMBL; CH471076; EAW74242.1; -; Genomic_DNA.
DR   CCDS; CCDS8067.1; -. [Q9NYG8-1]
DR   RefSeq; NP_001304019.1; NM_001317090.1. [Q9NYG8-1]
DR   RefSeq; NP_201567.1; NM_033310.2. [Q9NYG8-1]
DR   UniGene; Hs.647233; -.
DR   PDB; 3UM7; X-ray; 3.31 A; A/B=1-274.
DR   PDB; 4I9W; X-ray; 2.75 A; A/B=1-274.
DR   PDB; 4RUE; X-ray; 3.30 A; A/B=1-274.
DR   PDB; 4RUF; X-ray; 3.40 A; A/B=1-274.
DR   PDB; 4WFE; X-ray; 2.50 A; A/B=1-264.
DR   PDB; 4WFF; X-ray; 2.50 A; A/B=1-264.
DR   PDB; 4WFG; X-ray; 3.00 A; A/B=1-264.
DR   PDB; 4WFH; X-ray; 3.01 A; A/B=1-264.
DR   PDBsum; 3UM7; -.
DR   PDBsum; 4I9W; -.
DR   PDBsum; 4RUE; -.
DR   PDBsum; 4RUF; -.
DR   PDBsum; 4WFE; -.
DR   PDBsum; 4WFF; -.
DR   PDBsum; 4WFG; -.
DR   PDBsum; 4WFH; -.
DR   ProteinModelPortal; Q9NYG8; -.
DR   SMR; Q9NYG8; -.
DR   BioGrid; 119122; 2.
DR   DIP; DIP-61343N; -.
DR   IntAct; Q9NYG8; 2.
DR   STRING; 9606.ENSP00000378033; -.
DR   ChEMBL; CHEMBL3714486; -.
DR   iPTMnet; Q9NYG8; -.
DR   PhosphoSitePlus; Q9NYG8; -.
DR   BioMuta; KCNK4; -.
DR   DMDM; 13124080; -.
DR   PaxDb; Q9NYG8; -.
DR   PeptideAtlas; Q9NYG8; -.
DR   PRIDE; Q9NYG8; -.
DR   DNASU; 50801; -.
DR   Ensembl; ENST00000394525; ENSP00000378033; ENSG00000182450. [Q9NYG8-1]
DR   Ensembl; ENST00000422670; ENSP00000402797; ENSG00000182450. [Q9NYG8-1]
DR   Ensembl; ENST00000539216; ENSP00000444948; ENSG00000182450. [Q9NYG8-1]
DR   GeneID; 50801; -.
DR   KEGG; hsa:50801; -.
DR   UCSC; uc001nzj.2; human. [Q9NYG8-1]
DR   CTD; 50801; -.
DR   EuPathDB; HostDB:ENSG00000182450.12; -.
DR   GeneCards; KCNK4; -.
DR   HGNC; HGNC:6279; KCNK4.
DR   MIM; 605720; gene.
DR   neXtProt; NX_Q9NYG8; -.
DR   OpenTargets; ENSG00000182450; -.
DR   PharmGKB; PA30061; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000013106; -.
DR   HOVERGEN; HBG052234; -.
DR   InParanoid; Q9NYG8; -.
DR   KO; K04915; -.
DR   OMA; LDYPSEN; -.
DR   OrthoDB; EOG091G0E3R; -.
DR   PhylomeDB; Q9NYG8; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-HSA-1299503; TWIK related potassium channel (TREK).
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   GeneWiki; KCNK4; -.
DR   GenomeRNAi; 50801; -.
DR   PRO; PR:Q9NYG8; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000182450; -.
DR   CleanEx; HS_KCNK4; -.
DR   ExpressionAtlas; Q9NYG8; baseline and differential.
DR   Genevisible; Q9NYG8; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0034705; C:potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0098782; F:mechanically-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0097604; F:temperature-gated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0071469; P:cellular response to alkaline pH; ISS:UniProtKB.
DR   GO; GO:0071398; P:cellular response to fatty acid; IDA:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IDA:UniProtKB.
DR   GO; GO:0071502; P:cellular response to temperature stimulus; ISS:UniProtKB.
DR   GO; GO:0050976; P:detection of mechanical stimulus involved in sensory perception of touch; ISS:UniProtKB.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0019233; P:sensory perception of pain; ISS:UniProtKB.
DR   GO; GO:0050951; P:sensory perception of temperature stimulus; ISS:UniProtKB.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR008074; 2pore_dom_K_chnl_TRAAK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01691; TRAAKCHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Polymorphism; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    393       Potassium channel subfamily K member 4.
FT                                /FTId=PRO_0000101747.
FT   TOPO_DOM      1      3       Cytoplasmic.
FT                                {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   TRANSMEM      4     24       Helical. {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   TOPO_DOM     25     87       Extracellular.
FT                                {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   INTRAMEM     88    102       Helical; Name=Pore helix 1.
FT                                {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   INTRAMEM    103    109       {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   TOPO_DOM    110    117       Extracellular.
FT                                {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   TRANSMEM    118    150       Helical. {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   TOPO_DOM    151    172       Cytoplasmic.
FT                                {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   TRANSMEM    173    194       Helical. {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   TOPO_DOM    195    199       Extracellular.
FT                                {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   INTRAMEM    200    213       Helical; Name=Pore helix 2.
FT                                {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   INTRAMEM    214    219       {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   TOPO_DOM    220    233       Extracellular.
FT                                {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   TRANSMEM    234    260       Helical. {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   TOPO_DOM    261    393       Cytoplasmic.
FT                                {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   REGION      103    108       Selectivity filter 1.
FT                                {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   REGION      212    217       Selectivity filter 2.
FT                                {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   CARBOHYD     78     78       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     82     82       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     52     52       Interchain. {ECO:0000269|PubMed:22282805,
FT                                ECO:0000269|PubMed:23341632,
FT                                ECO:0000269|PubMed:25471887,
FT                                ECO:0000269|PubMed:25500157}.
FT   VAR_SEQ       1      1       M -> MTTAPQEPPARPLQAGSGAGPAPGRAM (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:12191490}.
FT                                /FTId=VSP_006689.
FT   VARIANT     328    328       P -> L (in dbSNP:rs953778).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_020206.
FT   MUTAGEN      98     98       G->I: Strongly increases basal level of
FT                                channel activity, decreases further
FT                                activation by pressure and abolishes
FT                                further activation by arachidonic acid.
FT                                {ECO:0000269|PubMed:25500157}.
FT   MUTAGEN     236    236       W->S: Increases basal level of channel
FT                                activity and decreases further activation
FT                                by pressure, but has little effect on
FT                                further activation by arachidonic acid.
FT                                {ECO:0000269|PubMed:25500157}.
FT   HELIX         3     28       {ECO:0000244|PDB:4WFE}.
FT   HELIX        29     31       {ECO:0000244|PDB:4WFE}.
FT   HELIX        34     49       {ECO:0000244|PDB:4WFE}.
FT   HELIX        55     70       {ECO:0000244|PDB:4WFE}.
FT   STRAND       87     89       {ECO:0000244|PDB:4WFE}.
FT   HELIX        90    101       {ECO:0000244|PDB:4WFE}.
FT   HELIX       114    159       {ECO:0000244|PDB:4WFE}.
FT   HELIX       164    183       {ECO:0000244|PDB:4WFE}.
FT   HELIX       185    195       {ECO:0000244|PDB:4WFE}.
FT   HELIX       199    210       {ECO:0000244|PDB:4WFE}.
FT   STRAND      216    218       {ECO:0000244|PDB:4WFE}.
FT   STRAND      221    223       {ECO:0000244|PDB:4WFE}.
FT   TURN        225    227       {ECO:0000244|PDB:4RUE}.
FT   HELIX       231    259       {ECO:0000244|PDB:4WFE}.
SQ   SEQUENCE   393 AA;  42704 MW;  7F18E53A0A9AD57D CRC64;
     MRSTTLLALL ALVLLYLVSG ALVFRALEQP HEQQAQRELG EVREKFLRAH PCVSDQELGL
     LIKEVADALG GGADPETNST SNSSHSAWDL GSAFFFSGTI ITTIGYGNVA LRTDAGRLFC
     IFYALVGIPL FGILLAGVGD RLGSSLRHGI GHIEAIFLKW HVPPELVRVL SAMLFLLIGC
     LLFVLTPTFV FCYMEDWSKL EAIYFVIVTL TTVGFGDYVA GADPRQDSPA YQPLVWFWIL
     LGLAYFASVL TTIGNWLRVV SRRTRAEMGG LTAQAASWTG TVTARVTQRA GPAAPPPEKE
     QPLLPPPPCP AQPLGRPRSP SPPEKAQPPS PPTASALDYP SENLAFIDES SDTQSERGCP
     LPRAPRGRRR PNPPRKPVRP RGPGRPRDKG VPV
//
ID   HCN3_HUMAN              Reviewed;         774 AA.
AC   Q9P1Z3; D3DV90; Q4VX12; Q8N6W6; Q9BWQ2;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   28-FEB-2003, sequence version 2.
DT   22-NOV-2017, entry version 149.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3;
GN   Name=HCN3; Synonyms=KIAA1535;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 64-774.
RC   TISSUE=Brain;
RX   PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 204-774.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND ENZYME
RP   REGULATION.
RX   PubMed=16043489; DOI=10.1074/jbc.M502508200;
RA   Stieber J., Stockl G., Herrmann S., Hassfurth B., Hofmann F.;
RT   "Functional expression of the human HCN3 channel.";
RL   J. Biol. Chem. 280:34635-34643(2005).
CC   -!- FUNCTION: Hyperpolarization-activated potassium channel. May also
CC       facilitate the permeation of sodium ions.
CC       {ECO:0000269|PubMed:16043489}.
CC   -!- ENZYME REGULATION: Inhibited by Cs(1+) and ZD7288. Is apparently
CC       not activated by cAMP. {ECO:0000269|PubMed:16043489}.
CC   -!- SUBUNIT: Homotetramer. The potassium channel is probably composed
CC       of a homo- or heterotetrameric complex of pore-forming subunits.
CC       Interacts with KCTD3 and PEX5L. {ECO:0000250|UniProtKB:O88705,
CC       ECO:0000250|UniProtKB:Q9UL51}.
CC   -!- INTERACTION:
CC       Q4ACU6-1:Shank3 (xeno); NbExp=3; IntAct=EBI-11178054, EBI-16201983;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16043489};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:16043489}.
CC   -!- TISSUE SPECIFICITY: Detected in brain.
CC       {ECO:0000269|PubMed:16043489}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH28024.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL713999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB040968; BAA96059.2; -; mRNA.
DR   EMBL; CH471121; EAW53084.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53086.1; -; Genomic_DNA.
DR   EMBL; BC000066; AAH00066.1; -; mRNA.
DR   EMBL; BC028024; AAH28024.2; ALT_INIT; mRNA.
DR   CCDS; CCDS1108.1; -.
DR   RefSeq; NP_065948.1; NM_020897.2.
DR   UniGene; Hs.706960; -.
DR   ProteinModelPortal; Q9P1Z3; -.
DR   SMR; Q9P1Z3; -.
DR   BioGrid; 121691; 3.
DR   DIP; DIP-62039N; -.
DR   IntAct; Q9P1Z3; 2.
DR   STRING; 9606.ENSP00000357342; -.
DR   BindingDB; Q9P1Z3; -.
DR   ChEMBL; CHEMBL1795173; -.
DR   GuidetoPHARMACOLOGY; 402; -.
DR   iPTMnet; Q9P1Z3; -.
DR   PhosphoSitePlus; Q9P1Z3; -.
DR   DMDM; 29840780; -.
DR   PaxDb; Q9P1Z3; -.
DR   PeptideAtlas; Q9P1Z3; -.
DR   PRIDE; Q9P1Z3; -.
DR   DNASU; 57657; -.
DR   Ensembl; ENST00000368358; ENSP00000357342; ENSG00000143630.
DR   Ensembl; ENST00000575670; ENSP00000458364; ENSG00000263324.
DR   GeneID; 57657; -.
DR   KEGG; hsa:57657; -.
DR   UCSC; uc001fjz.3; human.
DR   CTD; 57657; -.
DR   DisGeNET; 57657; -.
DR   EuPathDB; HostDB:ENSG00000143630.9; -.
DR   GeneCards; HCN3; -.
DR   H-InvDB; HIX0001125; -.
DR   HGNC; HGNC:19183; HCN3.
DR   HPA; HPA026584; -.
DR   MIM; 609973; gene.
DR   neXtProt; NX_Q9P1Z3; -.
DR   OpenTargets; ENSG00000143630; -.
DR   PharmGKB; PA38821; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039489; -.
DR   InParanoid; Q9P1Z3; -.
DR   KO; K04956; -.
DR   OMA; VMEQHLV; -.
DR   OrthoDB; EOG091G0JQU; -.
DR   PhylomeDB; Q9P1Z3; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-HSA-1296061; HCN channels.
DR   ChiTaRS; HCN3; human.
DR   GeneWiki; HCN3; -.
DR   GenomeRNAi; 57657; -.
DR   PRO; PR:Q9P1Z3; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143630; -.
DR   CleanEx; HS_HCN3; -.
DR   Genevisible; Q9P1Z3; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0044316; C:cone cell pedicle; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IMP:UniProtKB.
DR   GO; GO:1903351; P:cellular response to dopamine; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:UniProtKB.
DR   GO; GO:0072718; P:response to cisplatin; IEA:Ensembl.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IMP:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   cAMP; cAMP-binding; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome; Sodium;
KW   Sodium channel; Sodium transport; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1    774       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                3.
FT                                /FTId=PRO_0000054114.
FT   TOPO_DOM      1     97       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     98    118       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    119    124       Extracellular. {ECO:0000255}.
FT   TRANSMEM    125    145       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    146    171       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    172    192       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    193    201       Extracellular. {ECO:0000255}.
FT   TRANSMEM    202    222       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    223    253       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    254    274       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    275    297       Extracellular. {ECO:0000255}.
FT   INTRAMEM    298    319       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    320    329       Extracellular. {ECO:0000255}.
FT   TRANSMEM    330    350       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    351    774       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     492    495       cAMP. {ECO:0000250}.
FT   NP_BIND     502    503       cAMP. {ECO:0000250}.
FT   NP_BIND     543    546       cAMP. {ECO:0000250}.
FT   REGION       46     91       Involved in subunit assembly.
FT                                {ECO:0000250}.
FT   REGION      354    774       Interaction with KCTD3.
FT                                {ECO:0000250|UniProtKB:O88705}.
FT   COMPBIAS    696    765       Pro-rich.
FT   MOD_RES     634    634       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88705}.
FT   CARBOHYD    291    291       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     630    630       P -> L (in dbSNP:rs35001694).
FT                                /FTId=VAR_048746.
FT   CONFLICT    206    206       A -> G (in Ref. 4; AAH00066).
FT                                {ECO:0000305}.
FT   CONFLICT    734    734       S -> T (in Ref. 3; BAA96059).
FT                                {ECO:0000305}.
SQ   SEQUENCE   774 AA;  86032 MW;  37B9BC13E5E2C097 CRC64;
     MEAEQRPAAG ASEGATPGLE AVPPVAPPPA TAASGPIPKS GPEPKRRHLG TLLQPTVNKF
     SLRVFGSHKA VEIEQERVKS AGAWIIHPYS DFRFYWDLIM LLLMVGNLIV LPVGITFFKE
     ENSPPWIVFN VLSDTFFLLD LVLNFRTGIV VEEGAEILLA PRAIRTRYLR TWFLVDLISS
     IPVDYIFLVV ELEPRLDAEV YKTARALRIV RFTKILSLLR LLRLSRLIRY IHQWEEIFHM
     TYDLASAVVR IFNLIGMMLL LCHWDGCLQF LVPMLQDFPP DCWVSINHMV NHSWGRQYSH
     ALFKAMSHML CIGYGQQAPV GMPDVWLTML SMIVGATCYA MFIGHATALI QSLDSSRRQY
     QEKYKQVEQY MSFHKLPADT RQRIHEYYEH RYQGKMFDEE SILGELSEPL REEIINFTCR
     GLVAHMPLFA HADPSFVTAV LTKLRFEVFQ PGDLVVREGS VGRKMYFIQH GLLSVLARGA
     RDTRLTDGSY FGEICLLTRG RRTASVRADT YCRLYSLSVD HFNAVLEEFP MMRRAFETVA
     MDRLLRIGKK NSILQRKRSE PSPGSSGGIM EQHLVQHDRD MARGVRGRAP STGAQLSGKP
     VLWEPLVHAP LQAAAVTSNV AIALTHQRGP LPLSPDSPAT LLARSAWRSA GSPASPLVPV
     RAGPWASTSR LPAPPARTLH ASLSRAGRSQ VSLLGPPPGG GGRRLGPRGR PLSASQPSLP
     QRATGDGSPG RKGSGSERLP PSGLLAKPPR TAQPPRPPVP EPATPRGLQL SANM
//
ID   KCNG2_RAT               Reviewed;         480 AA.
AC   Q9QYU3;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-NOV-2017, entry version 121.
DE   RecName: Full=Potassium voltage-gated channel subfamily G member 2;
DE   AltName: Full=Cardiac potassium channel subunit;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv6.2;
GN   Name=Kcng2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain cortex;
RX   PubMed=10551266;
RA   Zhu X.-R., Netzer R., Boehlke K., Liu Q., Pongs O.;
RT   "Structural and functional characterization of Kv6.2, a new gamma-
RT   subunit of voltage-gated potassium channel.";
RL   Recept. Channels 6:337-350(1999).
CC   -!- FUNCTION: Potassium channel subunit. Modulates channel activity by
CC       shifting the threshold and the half-maximal activation to more
CC       negative values (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer with KCNB1. Does not form homomultimers (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, in particular in
CC       right and left atrium, and detected at lower levels in the right
CC       and left ventricle.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. G (TC
CC       1.A.1.2) subfamily. Kv6.2/KCNG2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ011020; CAB56852.1; -; mRNA.
DR   RefSeq; NP_001100842.1; NM_001107372.1.
DR   RefSeq; XP_006255009.1; XM_006254947.2.
DR   RefSeq; XP_006255010.1; XM_006254948.3.
DR   RefSeq; XP_006255012.1; XM_006254950.3.
DR   RefSeq; XP_008770358.1; XM_008772136.2.
DR   RefSeq; XP_008770359.1; XM_008772137.2.
DR   RefSeq; XP_017456433.1; XM_017600944.1.
DR   UniGene; Rn.163389; -.
DR   ProteinModelPortal; Q9QYU3; -.
DR   STRING; 10116.ENSRNOP00000023089; -.
DR   iPTMnet; Q9QYU3; -.
DR   PhosphoSitePlus; Q9QYU3; -.
DR   PaxDb; Q9QYU3; -.
DR   PRIDE; Q9QYU3; -.
DR   Ensembl; ENSRNOT00000088054; ENSRNOP00000069556; ENSRNOG00000053640.
DR   GeneID; 307234; -.
DR   KEGG; rno:307234; -.
DR   CTD; 26251; -.
DR   RGD; 1309521; Kcng2.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231014; -.
DR   HOVERGEN; HBG100172; -.
DR   InParanoid; Q9QYU3; -.
DR   KO; K04901; -.
DR   OMA; IINVGGC; -.
DR   OrthoDB; EOG091G0DSU; -.
DR   PhylomeDB; Q9QYU3; -.
DR   Reactome; R-RNO-1296072; Voltage gated Potassium channels.
DR   Reactome; R-RNO-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   PRO; PR:Q9QYU3; -.
DR   Proteomes; UP000002494; Chromosome 18.
DR   Bgee; ENSRNOG00000053640; -.
DR   Genevisible; Q9QYU3; RN.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003969; K_chnl_volt-dep_Kv6.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01492; KV6CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    480       Potassium voltage-gated channel subfamily
FT                                G member 2.
FT                                /FTId=PRO_0000054075.
FT   TOPO_DOM      1    190       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    191    211       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    231    251       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    252    265       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    266    286       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    301    321       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    322    334       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    335    355       Helical; Name=Segment S5. {ECO:0000255}.
FT   INTRAMEM    370    390       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TRANSMEM    398    418       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    419    480       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       382    387       Selectivity filter. {ECO:0000250}.
SQ   SEQUENCE   480 AA;  52536 MW;  601C86531B01F6FD CRC64;
     MARLPGHPEV PGAEPGSAVR GGRGGRGARA RHVIINVGGC RVRLAWAALA RCPLARLERL
     RACRGHDELL RVCDDYDVSR DEFFFDRSPC AFRAIVALLR AGKLRLLRGP CALAFRDELA
     YWGIDEARLE RCCLRRLRRR EEEAAEARAT PPARGPQTSP GRALGSGRLE RGRRRLRDVV
     ENPHSGLAGK LFAYVSVAFV AVTAVGLCLS TMPDVRAEEE RGECSTKCRN LFVLETVCVA
     WFSFEFLLRS LQAESKCAFL RTPLAIIDIL AILPFYVSLL AGLAAGPTGS KMLERAGLVL
     RLLRALRVLY VMRLARHSLG LRSLGLTVRR CAREFGLLLL FLCVAMALFA PLVHLAEREL
     GAHRDFSSVP ASYWWAVISM TTVGYGDMVP RSLPGQVVAL SSILSGILLM AFPVTSIFHT
     FSRSYSELKE QQQRAASPEP VLREDSTRDD STRSASATED SSQDPETAGA AGSLPGPVGP
//
ID   KCO5_ARATH              Reviewed;         408 AA.
AC   Q9S6Z8;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   20-DEC-2017, entry version 133.
DE   RecName: Full=Two-pore potassium channel 5;
DE            Short=AtTPK5;
DE   AltName: Full=Calcium-activated outward-rectifying potassium channel 5, chloroplastic;
DE            Short=AtKCO5;
GN   Name=TPK5; Synonyms=KCO5; OrderedLocusNames=At4g01840;
GN   ORFNames=T7B11.10;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. C24;
RA   Greven K.K., Czempinski K., Mueller-Roeber B.;
RT   "New members of the KCO family in Arabidopsis.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G.,
RA   Pohl T., Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N.,
RA   Harris B., Ansorge W., Brandt P., Grivell L.A., Rieger M.,
RA   Weichselgartner M., de Simone V., Obermaier B., Mache R., Mueller M.,
RA   Kreis M., Delseny M., Puigdomenech P., Watson M., Schmidtheini T.,
RA   Reichert B., Portetelle D., Perez-Alonso M., Boutry M., Bancroft I.,
RA   Vos P., Hoheisel J., Zimmermann W., Wedler H., Ridley P.,
RA   Langham S.-A., McCullagh B., Bilham L., Robben J.,
RA   van der Schueren J., Grymonprez B., Chuang Y.-J., Vandenbussche F.,
RA   Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R., Defoor E.,
RA   Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W.,
RA   Mooijman P., Klein Lankhorst R., Rose M., Hauf J., Koetter P.,
RA   Berneiser S., Hempel S., Feldpausch M., Lamberth S., Van den Daele H.,
RA   De Keyser A., Buysshaert C., Gielen J., Villarroel R., De Clercq R.,
RA   van Montagu M., Rogers J., Cronin A., Quail M.A., Bray-Allen S.,
RA   Clark L., Doggett J., Hall S., Kay M., Lennard N., McLay K., Mayes R.,
RA   Pettett A., Rajandream M.A., Lyne M., Benes V., Rechmann S.,
RA   Borkova D., Bloecker H., Scharfe M., Grimm M., Loehnert T.-H.,
RA   Dose S., de Haan M., Maarse A.C., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D., Herzl A.,
RA   Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R.,
RA   Schnabl S., Hiller R., Schmidt W., Lecharny A., Aubourg S.,
RA   Chefdor F., Cooke R., Berger C., Monfort A., Casacuberta E.,
RA   Gibbons T., Weber N., Vandenbol M., Bargues M., Terol J., Torres A.,
RA   Perez-Perez A., Purnelle B., Bent E., Johnson S., Tacon D., Jesse T.,
RA   Heijnen L., Schwarz S., Scholler P., Heber S., Francs P., Bielke C.,
RA   Frishman D., Haase D., Lemcke K., Mewes H.-W., Stocker S.,
RA   Zaccaria P., Bevan M., Wilson R.K., de la Bastide M., Habermann K.,
RA   Parnell L., Dedhia N., Gnoj L., Schutz K., Huang E., Spiegel L.,
RA   Sekhon M., Murray J., Sheet P., Cordes M., Abu-Threideh J.,
RA   Stoneking T., Kalicki J., Graves T., Harmon G., Edwards J.,
RA   Latreille P., Courtney L., Cloud J., Abbott A., Scott K., Johnson D.,
RA   Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D.,
RA   Du H., Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C.,
RA   Antonoiu B., Zidanic M., Strong C., Sun H., Lamar B., Yordan C.,
RA   Ma P., Zhong J., Preston R., Vil D., Shekher M., Matero A., Shah R.,
RA   Swaby I.K., O'Shaughnessy A., Rodriguez M., Hoffman J., Till S.,
RA   Granat S., Shohdy N., Hasegawa A., Hameed A., Lodhi M., Johnson A.,
RA   Chen E., Marra M.A., Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:769-777(1999).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Brover V.V., Troukhan M.E., Alexandrov N.A., Lu Y.-P., Flavell R.B.,
RA   Feldmann K.A.;
RT   "Full-length cDNA from Arabidopsis thaliana.";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [6]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=15505206; DOI=10.1073/pnas.0401502101;
RA   Becker D., Geiger D., Dunkel M., Roller A., Bertl A., Latz A.,
RA   Carpaneto A., Dietrich P., Roelfsema M.R., Voelker C., Schmidt D.,
RA   Mueller-Roeber B., Czempinski K., Hedrich R.;
RT   "AtTPK4, an Arabidopsis tandem-pore K+ channel, poised to control the
RT   pollen membrane voltage in a pH- and Ca2+-dependent manner.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15621-15626(2004).
RN   [7]
RP   TISSUE SPECIFICITY, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=16984403; DOI=10.1111/j.1365-313X.2006.02868.x;
RA   Voelker C., Schmidt D., Mueller-Roeber B., Czempinski K.;
RT   "Members of the Arabidopsis AtTPK/KCO family form homomeric vacuolar
RT   channels in planta.";
RL   Plant J. 48:296-306(2006).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17764516; DOI=10.1111/j.1365-313X.2007.03255.x;
RA   Latz A., Becker D., Hekman M., Mueller T., Beyhl D., Marten I.,
RA   Eing C., Fischer A., Dunkel M., Bertl A., Rapp U.R., Hedrich R.;
RT   "TPK1, a Ca(2+)-regulated Arabidopsis vacuole two-pore K(+) channel is
RT   activated by 14-3-3 proteins.";
RL   Plant J. 52:449-459(2007).
CC   -!- FUNCTION: Probable voltage-independent potassium-selective
CC       tonoplast ion channel.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16984403}.
CC   -!- SUBCELLULAR LOCATION: Vacuole membrane
CC       {ECO:0000269|PubMed:16984403, ECO:0000269|PubMed:17764516}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:16984403,
CC       ECO:0000269|PubMed:17764516}.
CC   -!- TISSUE SPECIFICITY: Expressed in hydathodes and the vascular
CC       tissues of roots, stems, leaves and flowers.
CC       {ECO:0000269|PubMed:16984403}.
CC   -!- DOMAIN: Each of the two pore-forming region (also called P-domain
CC       or P-loop) is enclosed by two transmembrane segments (2P/4TM) and
CC       contains the GYGD signature motif which seems to be involved in
CC       potassium selectivity.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.7) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ243456; CAB62162.1; -; mRNA.
DR   EMBL; AC007138; AAD22646.1; -; Genomic_DNA.
DR   EMBL; AL161493; CAB80677.1; -; Genomic_DNA.
DR   EMBL; CP002687; AEE82083.1; -; Genomic_DNA.
DR   EMBL; AY084857; AAM61421.1; -; mRNA.
DR   PIR; F85023; F85023.
DR   RefSeq; NP_192093.1; NM_116414.4.
DR   UniGene; At.585; -.
DR   UniGene; At.66593; -.
DR   ProteinModelPortal; Q9S6Z8; -.
DR   BioGrid; 13382; 3.
DR   STRING; 3702.AT4G01840.1; -.
DR   TCDB; 1.A.1.7.5; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9S6Z8; -.
DR   PaxDb; Q9S6Z8; -.
DR   EnsemblPlants; AT4G01840.1; AT4G01840.1; AT4G01840.
DR   GeneID; 828091; -.
DR   Gramene; AT4G01840.1; AT4G01840.1; AT4G01840.
DR   KEGG; ath:AT4G01840; -.
DR   Araport; AT4G01840; -.
DR   TAIR; locus:2141375; AT4G01840.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000238193; -.
DR   InParanoid; Q9S6Z8; -.
DR   KO; K05389; -.
DR   OMA; HRRITNW; -.
DR   OrthoDB; EOG09360JKS; -.
DR   PhylomeDB; Q9S6Z8; -.
DR   PRO; PR:Q9S6Z8; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; Q9S6Z8; baseline and differential.
DR   Genevisible; Q9S6Z8; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0009705; C:plant-type vacuole membrane; IDA:TAIR.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Vacuole.
FT   CHAIN         1    408       Two-pore potassium channel 5.
FT                                /FTId=PRO_0000035873.
FT   TOPO_DOM     22    115       Stromal. {ECO:0000255}.
FT   TRANSMEM    116    136       Helical. {ECO:0000255}.
FT   INTRAMEM    152    171       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    178    198       Helical. {ECO:0000255}.
FT   TOPO_DOM    199    248       Stromal. {ECO:0000255}.
FT   TRANSMEM    249    269       Helical. {ECO:0000255}.
FT   INTRAMEM    276    295       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    302    322       Helical. {ECO:0000255}.
FT   TOPO_DOM    323    408       Stromal. {ECO:0000255}.
FT   DOMAIN      339    374       EF-hand 1.
FT   DOMAIN      378    408       EF-hand 2.
FT   CA_BIND     352    363       1. {ECO:0000255}.
FT   CA_BIND     391    402       2. {ECO:0000255}.
SQ   SEQUENCE   408 AA;  46259 MW;  FCF22402122F8F2A CRC64;
     MEPLISPQPR FRLQPIPENP SSSSSSASIT IPRSISNTSF FHEISQERLL LHHQDLEQSV
     QDDKEDQDSD SDETNRFLSQ TRPLHRSRTA PAMVIIKDLR TKPPETKKPS PVSKSIIRQA
     IFLLIVYLTL GVSIYSFNRD HYSGIETHPV VDALYFCIVT MCTIGYGDIA PLTPWTKIFA
     VVFVLFGFGF LDILLSGVVN YVLDLQESMI LTGIQTRQHH QHHHHHRFSA KDYIIDFEKG
     RMRIRMKVCL ALCVVVLCIG VGALVLHFVE ELGFVDSVYL SVMSVTTVGY GDRAFKTLQG
     RLFAAVWLLV STLAVARAFL YLAEARIDRR HRKAVKLALN REITVDDLLK ADTYQHGFIS
     KSEYIVLKLK EMGKITQKDI DQVVIQFEKL DPNQIGKITL PDLLGDPL
//
ID   AKT5_ARATH              Reviewed;         880 AA.
AC   Q9SCX5; Q9SUU2;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   20-DEC-2017, entry version 140.
DE   RecName: Full=Probable potassium channel AKT5;
GN   Name=AKT5; OrderedLocusNames=At4g32500; ORFNames=F8B4.200;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Columbia; TISSUE=Hypocotyl;
RA   Scheuermann S., Philippar K., Becker D., Hedrich R.;
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G.,
RA   Pohl T., Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N.,
RA   Harris B., Ansorge W., Brandt P., Grivell L.A., Rieger M.,
RA   Weichselgartner M., de Simone V., Obermaier B., Mache R., Mueller M.,
RA   Kreis M., Delseny M., Puigdomenech P., Watson M., Schmidtheini T.,
RA   Reichert B., Portetelle D., Perez-Alonso M., Boutry M., Bancroft I.,
RA   Vos P., Hoheisel J., Zimmermann W., Wedler H., Ridley P.,
RA   Langham S.-A., McCullagh B., Bilham L., Robben J.,
RA   van der Schueren J., Grymonprez B., Chuang Y.-J., Vandenbussche F.,
RA   Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R., Defoor E.,
RA   Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W.,
RA   Mooijman P., Klein Lankhorst R., Rose M., Hauf J., Koetter P.,
RA   Berneiser S., Hempel S., Feldpausch M., Lamberth S., Van den Daele H.,
RA   De Keyser A., Buysshaert C., Gielen J., Villarroel R., De Clercq R.,
RA   van Montagu M., Rogers J., Cronin A., Quail M.A., Bray-Allen S.,
RA   Clark L., Doggett J., Hall S., Kay M., Lennard N., McLay K., Mayes R.,
RA   Pettett A., Rajandream M.A., Lyne M., Benes V., Rechmann S.,
RA   Borkova D., Bloecker H., Scharfe M., Grimm M., Loehnert T.-H.,
RA   Dose S., de Haan M., Maarse A.C., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D., Herzl A.,
RA   Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R.,
RA   Schnabl S., Hiller R., Schmidt W., Lecharny A., Aubourg S.,
RA   Chefdor F., Cooke R., Berger C., Monfort A., Casacuberta E.,
RA   Gibbons T., Weber N., Vandenbol M., Bargues M., Terol J., Torres A.,
RA   Perez-Perez A., Purnelle B., Bent E., Johnson S., Tacon D., Jesse T.,
RA   Heijnen L., Schwarz S., Scholler P., Heber S., Francs P., Bielke C.,
RA   Frishman D., Haase D., Lemcke K., Mewes H.-W., Stocker S.,
RA   Zaccaria P., Bevan M., Wilson R.K., de la Bastide M., Habermann K.,
RA   Parnell L., Dedhia N., Gnoj L., Schutz K., Huang E., Spiegel L.,
RA   Sekhon M., Murray J., Sheet P., Cordes M., Abu-Threideh J.,
RA   Stoneking T., Kalicki J., Graves T., Harmon G., Edwards J.,
RA   Latreille P., Courtney L., Cloud J., Abbott A., Scott K., Johnson D.,
RA   Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D.,
RA   Du H., Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C.,
RA   Antonoiu B., Zidanic M., Strong C., Sun H., Lamar B., Yordan C.,
RA   Ma P., Zhong J., Preston R., Vil D., Shekher M., Matero A., Shah R.,
RA   Swaby I.K., O'Shaughnessy A., Rodriguez M., Hoffman J., Till S.,
RA   Granat S., Shohdy N., Hasegawa A., Hameed A., Lodhi M., Johnson A.,
RA   Chen E., Marra M.A., Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:769-777(1999).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=10852932; DOI=10.1105/tpc.12.6.837;
RA   Lacombe B., Pilot G., Michard E., Gaymard F., Sentenac H.,
RA   Thibaud J.-B.;
RT   "A shaker-like K(+) channel with weak rectification is expressed in
RT   both source and sink phloem tissues of Arabidopsis.";
RL   Plant Cell 12:837-851(2000).
RN   [5]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
CC   -!- FUNCTION: Probable potassium channel. May interact with the
CC       cytoskeleton or with regulatory proteins (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming subunits. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in flowers.
CC       {ECO:0000269|PubMed:10852932}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids. The
CC       pore-forming region H5 is enclosed by the transmembrane segments
CC       S5 and S6 in the Shaker-type (1P/6TM) and contains the GYGD
CC       signature motif which seems to be involved in potassium
CC       selectivity.
CC   -!- DOMAIN: The KHA domain (rich in hydrophobic and acidic residues)
CC       present in the C-terminal part is likely to be important for
CC       tetramerization.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Plant (TC
CC       1.A.1.4) subfamily. {ECO:0000305}.
CC   -!- CAUTION: Was originally erroneously termed AKT6.
CC       {ECO:0000305|PubMed:10852932}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ249479; CAB64728.1; -; mRNA.
DR   EMBL; AL034567; CAA22577.2; -; Genomic_DNA.
DR   EMBL; AL161581; CAB79967.1; -; Genomic_DNA.
DR   EMBL; CP002687; AEE86069.1; -; Genomic_DNA.
DR   PIR; F85381; F85381.
DR   PIR; T05360; T05360.
DR   RefSeq; NP_194976.1; NM_119402.4.
DR   UniGene; At.698; -.
DR   ProteinModelPortal; Q9SCX5; -.
DR   SMR; Q9SCX5; -.
DR   BioGrid; 14671; 2.
DR   MINT; MINT-8066203; -.
DR   STRING; 3702.AT4G32500.1; -.
DR   iPTMnet; Q9SCX5; -.
DR   PaxDb; Q9SCX5; -.
DR   PRIDE; Q9SCX5; -.
DR   EnsemblPlants; AT4G32500.1; AT4G32500.1; AT4G32500.
DR   GeneID; 829385; -.
DR   Gramene; AT4G32500.1; AT4G32500.1; AT4G32500.
DR   KEGG; ath:AT4G32500; -.
DR   Araport; AT4G32500; -.
DR   TAIR; locus:2127866; AT4G32500.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238230; -.
DR   InParanoid; Q9SCX5; -.
DR   KO; K21867; -.
DR   OMA; VSHFSCL; -.
DR   OrthoDB; EOG093601WX; -.
DR   PhylomeDB; Q9SCX5; -.
DR   PRO; PR:Q9SCX5; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; Q9SCX5; baseline and differential.
DR   Genevisible; Q9SCX5; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00204; ANK; 1.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.25.40.20; -; 2.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR021789; KHA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11834; KHA; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00248; ANK; 4.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS51490; KHA; 1.
PE   2: Evidence at transcript level;
KW   ANK repeat; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    880       Probable potassium channel AKT5.
FT                                /FTId=PRO_0000054123.
FT   TOPO_DOM      1     82       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     83    103       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    104    111       Extracellular. {ECO:0000255}.
FT   TRANSMEM    112    132       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    133    153       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    154    174       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    175    182       Extracellular. {ECO:0000255}.
FT   TRANSMEM    183    203       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    204    217       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    218    238       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    239    265       Extracellular. {ECO:0000255}.
FT   INTRAMEM    266    285       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    286    291       Extracellular. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    313    880       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      541    570       ANK 1.
FT   REPEAT      574    603       ANK 2.
FT   REPEAT      607    636       ANK 3.
FT   REPEAT      637    667       ANK 4.
FT   REPEAT      671    700       ANK 5.
FT   DOMAIN      809    880       KHA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00823}.
FT   NP_BIND     396    517       cNMP.
FT   CONFLICT     18     18       E -> D (in Ref. 1; CAB64728).
FT                                {ECO:0000305}.
FT   CONFLICT    126    126       V -> F (in Ref. 1; CAB64728).
FT                                {ECO:0000305}.
SQ   SEQUENCE   880 AA;  98504 MW;  E4412913D742E081 CRC64;
     MGIEKRKKMV WFWPEKHEGG VIKEAEDVAA EHISREGTMS HYSFSKGLLP PLGVGATARS
     SRHIKLRCFI VSPFDPRYRA WDWFLVILVL YTAWASPFEF GFLQTPRAPL SILDNVVNGF
     FAVDIVLTFF VAFLDKATYL LVDDPKRIAW RYTSTWLIFD VVSTVPYELF GSLLHNTIQG
     YGIFSMLRLW RLHRVSKCFA RLEKDRKYNY FWIRCTKLLL VSLFVVHCGA CFCYSIAAHY
     PDPSMTFMAL AEANWKQKSL LIRYVTAMYW SITTFSTTGY GDIHGNNAEE RAFILFYMIF
     NLGLLAYIIG NMTNLVVHVT SRTRNFRDTI QAASAFAQRN NLPLGLQEQM VAHLSLRYRT
     DSEGLQQQEI IDSLPKAIRS SISHYLFYEV VDKTYLFHGI SNDLLFQLVS EMKAEYFPPK
     EDVILRNEAP SDFYIMVTGA VDIIARVNGV DQVVGEAQTG HVFGEVGVLC YRPQLFTVRT
     KRLSQLLRLN RTAFLNLVQA NVGDGAIIMN NLLQHLKDST DPVMKGILAE TELMLAQGKM
     DLPLSLCFAA ARGDDLLLHQ LLKRGSNPNE TDKNGRTALH IAASKGSQYC VVLLLEHGAD
     PNIRDSEGSV PLWEAIIGRH EENAKLLSEN GATLSFDTVG YFSCLAVGQN NLNALKDIVK
     YGGDISLSDV NGTTALHRAV SEGNLEIVQF LLEKGADMDK PDVYGWTARA LAEHQGHEDI
     KALFYNQRPV ERKTILVSGT PEIKPLMKHS SEPVMTHHHS REAMPPLARA VSQRRKLSNF
     KNSLFGIMSA AKTGDEGGAS TRTGISEGVG GVYPARVTIS GEASSSGKVV KLPDSLEELI
     EIGEKKLGFV ATKILSREGA EIDDIRIIRD GDFLLLLKVS
//
ID   KCO6_ARATH              Reviewed;         436 AA.
AC   Q9SVV6;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   27-SEP-2017, entry version 138.
DE   RecName: Full=Two-pore potassium channel 3;
DE            Short=AtTPK3;
DE   AltName: Full=Calcium-activated outward-rectifying potassium channel 6;
DE            Short=AtKCO6;
GN   Name=TPK3; Synonyms=KCO6; OrderedLocusNames=At4g18160;
GN   ORFNames=F15J5.130;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G.,
RA   Pohl T., Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N.,
RA   Harris B., Ansorge W., Brandt P., Grivell L.A., Rieger M.,
RA   Weichselgartner M., de Simone V., Obermaier B., Mache R., Mueller M.,
RA   Kreis M., Delseny M., Puigdomenech P., Watson M., Schmidtheini T.,
RA   Reichert B., Portetelle D., Perez-Alonso M., Boutry M., Bancroft I.,
RA   Vos P., Hoheisel J., Zimmermann W., Wedler H., Ridley P.,
RA   Langham S.-A., McCullagh B., Bilham L., Robben J.,
RA   van der Schueren J., Grymonprez B., Chuang Y.-J., Vandenbussche F.,
RA   Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R., Defoor E.,
RA   Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W.,
RA   Mooijman P., Klein Lankhorst R., Rose M., Hauf J., Koetter P.,
RA   Berneiser S., Hempel S., Feldpausch M., Lamberth S., Van den Daele H.,
RA   De Keyser A., Buysshaert C., Gielen J., Villarroel R., De Clercq R.,
RA   van Montagu M., Rogers J., Cronin A., Quail M.A., Bray-Allen S.,
RA   Clark L., Doggett J., Hall S., Kay M., Lennard N., McLay K., Mayes R.,
RA   Pettett A., Rajandream M.A., Lyne M., Benes V., Rechmann S.,
RA   Borkova D., Bloecker H., Scharfe M., Grimm M., Loehnert T.-H.,
RA   Dose S., de Haan M., Maarse A.C., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D., Herzl A.,
RA   Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R.,
RA   Schnabl S., Hiller R., Schmidt W., Lecharny A., Aubourg S.,
RA   Chefdor F., Cooke R., Berger C., Monfort A., Casacuberta E.,
RA   Gibbons T., Weber N., Vandenbol M., Bargues M., Terol J., Torres A.,
RA   Perez-Perez A., Purnelle B., Bent E., Johnson S., Tacon D., Jesse T.,
RA   Heijnen L., Schwarz S., Scholler P., Heber S., Francs P., Bielke C.,
RA   Frishman D., Haase D., Lemcke K., Mewes H.-W., Stocker S.,
RA   Zaccaria P., Bevan M., Wilson R.K., de la Bastide M., Habermann K.,
RA   Parnell L., Dedhia N., Gnoj L., Schutz K., Huang E., Spiegel L.,
RA   Sekhon M., Murray J., Sheet P., Cordes M., Abu-Threideh J.,
RA   Stoneking T., Kalicki J., Graves T., Harmon G., Edwards J.,
RA   Latreille P., Courtney L., Cloud J., Abbott A., Scott K., Johnson D.,
RA   Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D.,
RA   Du H., Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C.,
RA   Antonoiu B., Zidanic M., Strong C., Sun H., Lamar B., Yordan C.,
RA   Ma P., Zhong J., Preston R., Vil D., Shekher M., Matero A., Shah R.,
RA   Swaby I.K., O'Shaughnessy A., Rodriguez M., Hoffman J., Till S.,
RA   Granat S., Shohdy N., Hasegawa A., Hameed A., Lodhi M., Johnson A.,
RA   Chen E., Marra M.A., Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:769-777(1999).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=11821043; DOI=10.1016/S0014-5793(01)03273-2;
RA   Schoenknecht G., Spoormaker P., Steinmeyer R., Brueggeman L., Ache P.,
RA   Dutta R., Reintanz B., Godde M., Hedrich R., Palme K.;
RT   "KCO1 is a component of the slow-vacuolar (SV) ion channel.";
RL   FEBS Lett. 511:28-32(2002).
RN   [5]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=15505206; DOI=10.1073/pnas.0401502101;
RA   Becker D., Geiger D., Dunkel M., Roller A., Bertl A., Latz A.,
RA   Carpaneto A., Dietrich P., Roelfsema M.R., Voelker C., Schmidt D.,
RA   Mueller-Roeber B., Czempinski K., Hedrich R.;
RT   "AtTPK4, an Arabidopsis tandem-pore K+ channel, poised to control the
RT   pollen membrane voltage in a pH- and Ca2+-dependent manner.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15621-15626(2004).
RN   [6]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=16984403; DOI=10.1111/j.1365-313X.2006.02868.x;
RA   Voelker C., Schmidt D., Mueller-Roeber B., Czempinski K.;
RT   "Members of the Arabidopsis AtTPK/KCO family form homomeric vacuolar
RT   channels in planta.";
RL   Plant J. 48:296-306(2006).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17764516; DOI=10.1111/j.1365-313X.2007.03255.x;
RA   Latz A., Becker D., Hekman M., Mueller T., Beyhl D., Marten I.,
RA   Eing C., Fischer A., Dunkel M., Bertl A., Rapp U.R., Hedrich R.;
RT   "TPK1, a Ca(2+)-regulated Arabidopsis vacuole two-pore K(+) channel is
RT   activated by 14-3-3 proteins.";
RL   Plant J. 52:449-459(2007).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19825594; DOI=10.1093/mp/ssn064;
RA   Dunkel M., Latz A., Schumacher K., Mueller T., Becker D., Hedrich R.;
RT   "Targeting of vacuolar membrane localized members of the TPK channel
RT   family.";
RL   Mol. Plant 1:938-949(2008).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, ENZYME REGULATION, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=24009357; DOI=10.1126/science.1242113;
RA   Carraretto L., Formentin E., Teardo E., Checchetto V., Tomizioli M.,
RA   Morosinotto T., Giacometti G.M., Finazzi G., Szabo I.;
RT   "A thylakoid-located two-pore potassium channel controls
RT   photosynthetic light utilization in plants.";
RL   Science 342:114-118(2013).
CC   -!- FUNCTION: Two-pore potassium channel modulating the proton motive
CC       force (pmf) necessary to convert photochemical energy into
CC       physiological functions. Mediates the potassium efflux from the
CC       thylakoid lumen required for the regulation of the transmembrane
CC       electrical potential, the enhancement of the pH gradient for ATP
CC       synthesis, the regulation of electron flow, and pH-mediated
CC       photoprotective responses. Requires calcium for channel activity.
CC       {ECO:0000269|PubMed:24009357}.
CC   -!- ENZYME REGULATION: Inhibited by barium, but not by
CC       tetraethylammonium. {ECO:0000269|PubMed:24009357}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Vacuole membrane
CC       {ECO:0000269|PubMed:16984403, ECO:0000269|PubMed:17764516,
CC       ECO:0000269|PubMed:19825594}; Multi-pass membrane protein
CC       {ECO:0000255}. Plastid, chloroplast thylakoid membrane
CC       {ECO:0000269|PubMed:24009357}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=PubMed:24009357 shows a thylakoid location
CC       instead of the tonoplast location previously described.
CC   -!- TISSUE SPECIFICITY: Expressed in roots, stems, hypocotyls, leaves
CC       and flowers. Detected in root tips and in mesophyll cells and
CC       guard cells of the leaves. {ECO:0000269|PubMed:11821043,
CC       ECO:0000269|PubMed:16984403}.
CC   -!- DOMAIN: Each of the two pore-forming region (also called P-domain
CC       or P-loop) is enclosed by two transmembrane segments (2P/4TM) and
CC       contains the GYGD signature motif which seems to be involved in
CC       potassium selectivity. The C-terminus is not required for
CC       transport to the vacuolar membrane.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown of the protein
CC       causes no effects on germination or on plants grown under normal
CC       conditions, but decreases the rosette size, enhances the
CC       accumulation of anthocyans and desorganizes the photosynthetic
CC       membranes when the plants are grown under high light.
CC       {ECO:0000269|PubMed:24009357}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.7) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL110123; CAB53657.1; -; Genomic_DNA.
DR   EMBL; AL161548; CAB78818.1; -; Genomic_DNA.
DR   EMBL; CP002687; AEE84005.1; -; Genomic_DNA.
DR   PIR; T14816; T14816.
DR   RefSeq; NP_193550.1; NM_117926.3.
DR   UniGene; At.32938; -.
DR   ProteinModelPortal; Q9SVV6; -.
DR   SMR; Q9SVV6; -.
DR   BioGrid; 12834; 2.
DR   MINT; MINT-8066024; -.
DR   STRING; 3702.AT4G18160.1; -.
DR   TCDB; 1.A.1.7.7; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q9SVV6; -.
DR   EnsemblPlants; AT4G18160.1; AT4G18160.1; AT4G18160.
DR   GeneID; 827541; -.
DR   Gramene; AT4G18160.1; AT4G18160.1; AT4G18160.
DR   KEGG; ath:AT4G18160; -.
DR   Araport; AT4G18160; -.
DR   TAIR; locus:2117681; AT4G18160.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000238193; -.
DR   InParanoid; Q9SVV6; -.
DR   KO; K05389; -.
DR   OMA; WLIDPNY; -.
DR   OrthoDB; EOG09360JKS; -.
DR   PhylomeDB; Q9SVV6; -.
DR   PRO; PR:Q9SVV6; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; Q9SVV6; baseline and differential.
DR   Genevisible; Q9SVV6; AT.
DR   GO; GO:0009533; C:chloroplast stromal thylakoid; IDA:TAIR.
DR   GO; GO:0009535; C:chloroplast thylakoid membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0009705; C:plant-type vacuole membrane; IDA:TAIR.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005267; F:potassium channel activity; IDA:TAIR.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0010196; P:nonphotochemical quenching; IMP:TAIR.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:TAIR.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   GO; GO:0010027; P:thylakoid membrane organization; IMP:TAIR.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Chloroplast; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Metal-binding; Plastid; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Repeat; Thylakoid;
KW   Transmembrane; Transmembrane helix; Transport; Vacuole.
FT   CHAIN         1    436       Two-pore potassium channel 3.
FT                                /FTId=PRO_0000101779.
FT   TOPO_DOM      1    148       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    149    169       Helical. {ECO:0000255}.
FT   INTRAMEM    185    204       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    212    232       Helical. {ECO:0000255}.
FT   TOPO_DOM    233    274       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    275    295       Helical. {ECO:0000255}.
FT   INTRAMEM    302    321       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    328    348       Helical. {ECO:0000255}.
FT   TOPO_DOM    349    436       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      365    400       EF-hand 1.
FT   DOMAIN      404    436       EF-hand 2.
FT   CA_BIND     378    389       1. {ECO:0000255}.
FT   CA_BIND     417    428       2. {ECO:0000255}.
FT   COMPBIAS     55     88       Ser-rich.
FT   COMPBIAS     95    103       Poly-Pro.
SQ   SEQUENCE   436 AA;  48732 MW;  0F5C43B82B318761 CRC64;
     MANEGSDPLL QYMISPRLKK PPQLLFPLPE DNEVAIPMPM TPSEFKERLI FGPFSCSPRD
     SSHFIDSMKQ PSPSSSSTAV NNPFSDSSTL DPLLPPPPPQ PEPWLSDQTS SHCQGHALHR
     SKTAPAMAVI NDLHHPIRQK DPTETSRSVV RQAFALLVVY LSLGVLIYWL NRDHYVVNQT
     HPVVDGLYFC IVTMCTIGYG DITPNSVVTK LFSIMFVLVG FGFIDILLSG MVSYVLDLQE
     SYMLDSAKRR DEPEKRRSYI IDVKKGRMRI RLKVALALGV VVLCIAVGVG IMHFIEEIGW
     LDSFYLSVMS VTTVGYGDRA FKTLPGRLFA AIWLLVSTLA VARAFLYLAE ARVDKRNRER
     AKKVLCETMS VSQFFAADID NNGCVSKAEY VIYKLKEMEK ITDKDILPIS KQFDKLDRCS
     NGKITLLDLL EGGSGD
//
ID   KCNG2_HUMAN             Reviewed;         466 AA.
AC   Q9UJ96;
DT   25-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-NOV-2017, entry version 135.
DE   RecName: Full=Potassium voltage-gated channel subfamily G member 2;
DE   AltName: Full=Cardiac potassium channel subunit;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv6.2;
GN   Name=KCNG2; Synonyms=KCNF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RX   PubMed=10551266;
RA   Zhu X.-R., Netzer R., Boehlke K., Liu Q., Pongs O.;
RT   "Structural and functional characterization of Kv6.2, a new gamma-
RT   subunit of voltage-gated potassium channel.";
RL   Recept. Channels 6:337-350(1999).
CC   -!- FUNCTION: Potassium channel subunit. Modulates channel activity by
CC       shifting the threshold and the half-maximal activation to more
CC       negative values.
CC   -!- SUBUNIT: Heterodimer with KCNB1. Does not form homomultimers.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, liver, skeletal
CC       muscle, kidney and pancreas. Detected at low levels in brain, lung
CC       and placenta.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- MISCELLANEOUS: Heterodimers with KCNB1 are highly sensitive to
CC       inhibition by tetraethylammonium (TEA) and propafenone.
CC   -!- SIMILARITY: Belongs to the potassium channel family. G (TC
CC       1.A.1.2) subfamily. Kv6.2/KCNG2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ011021; CAB56834.1; -; mRNA.
DR   CCDS; CCDS12019.1; -.
DR   RefSeq; NP_036415.1; NM_012283.1.
DR   RefSeq; XP_011524220.1; XM_011525918.2.
DR   RefSeq; XP_011524222.1; XM_011525920.2.
DR   RefSeq; XP_016881194.1; XM_017025705.1.
DR   UniGene; Hs.247905; -.
DR   ProteinModelPortal; Q9UJ96; -.
DR   BioGrid; 117638; 1.
DR   STRING; 9606.ENSP00000315654; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   iPTMnet; Q9UJ96; -.
DR   PhosphoSitePlus; Q9UJ96; -.
DR   BioMuta; KCNG2; -.
DR   DMDM; 24418480; -.
DR   PaxDb; Q9UJ96; -.
DR   PeptideAtlas; Q9UJ96; -.
DR   PRIDE; Q9UJ96; -.
DR   Ensembl; ENST00000316249; ENSP00000315654; ENSG00000178342.
DR   GeneID; 26251; -.
DR   KEGG; hsa:26251; -.
DR   UCSC; uc010xfl.2; human.
DR   CTD; 26251; -.
DR   EuPathDB; HostDB:ENSG00000178342.4; -.
DR   GeneCards; KCNG2; -.
DR   HGNC; HGNC:6249; KCNG2.
DR   HPA; HPA048628; -.
DR   MIM; 605696; gene.
DR   neXtProt; NX_Q9UJ96; -.
DR   OpenTargets; ENSG00000178342; -.
DR   PharmGKB; PA30035; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118981; -.
DR   HOGENOM; HOG000231014; -.
DR   HOVERGEN; HBG100172; -.
DR   InParanoid; Q9UJ96; -.
DR   KO; K04901; -.
DR   OMA; IINVGGC; -.
DR   OrthoDB; EOG091G0DSU; -.
DR   PhylomeDB; Q9UJ96; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   GeneWiki; KCNG2; -.
DR   GenomeRNAi; 26251; -.
DR   PRO; PR:Q9UJ96; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000178342; -.
DR   CleanEx; HS_KCNG2; -.
DR   Genevisible; Q9UJ96; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; TAS:ProtInc.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0008016; P:regulation of heart contraction; TAS:ProtInc.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003969; K_chnl_volt-dep_Kv6.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01492; KV6CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    466       Potassium voltage-gated channel subfamily
FT                                G member 2.
FT                                /FTId=PRO_0000054074.
FT   TOPO_DOM      1    177       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    178    198       Helical; Name=Segment S1. {ECO:0000255}.
FT   TRANSMEM    218    238       Helical; Name=Segment S2. {ECO:0000255}.
FT   TRANSMEM    253    273       Helical; Name=Segment S3. {ECO:0000255}.
FT   TRANSMEM    288    308       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    309    321       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    322    342       Helical; Name=Segment S5. {ECO:0000255}.
FT   INTRAMEM    357    377       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TRANSMEM    385    405       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    406    466       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       369    374       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS      9     13       Poly-Gly.
SQ   SEQUENCE   466 AA;  51240 MW;  0D978934F5E71469 CRC64;
     MEPWPCSPGG GGGTRARHVI INVGGCRVRL AWAALARCPL ARLERLRACR GHDDLLRVCD
     DYDVSRDEFF FDRSPCAFRA IVALLRAGKL RLLRGPCALA FRDELAYWGI DEARLERCCL
     RRLRRREEEA AEARAGPTER GAQGSPARAL GPRGRLQRGR RRLRDVVDNP HSGLAGKLFA
     CVSVSFVAVT AVGLCLSTMP DIRAEEERGE CSPKCRSLFV LETVCVAWFS FEFLLRSLQA
     ESKCAFLRAP LNIIDILALL PFYVSLLLGL AAGPGGTKLL ERAGLVLRLL RALRVLYVMR
     LARHSLGLRS LGLTMRRCAR EFGLLLLFLC VAMALFAPLV HLAERELGAR RDFSSVPASY
     WWAVISMTTV GYGDMVPRSL PGQVVALSSI LSGILLMAFP VTSIFHTFSR SYSELKEQQQ
     RAASPEPALQ EDSTHSATAT EDSSQGPDSA GLADDSADAL WVRAGR
//
ID   HCN2_HUMAN              Reviewed;         889 AA.
AC   Q9UL51; O60742; O60743; O75267; Q9UBS2;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2006, sequence version 3.
DT   25-OCT-2017, entry version 151.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2;
DE   AltName: Full=Brain cyclic nucleotide-gated channel 2;
DE            Short=BCNG-2;
GN   Name=HCN2; Synonyms=BCNG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10524219; DOI=10.1016/S0167-4781(99)00092-5;
RA   Vaccari T., Moroni A., Rocchi M., Gorza L., Bianchi M.E., Beltrame M.,
RA   DiFrancesco D.;
RT   "The human gene coding for HCN2, a pacemaker channel of the heart.";
RL   Biochim. Biophys. Acta 1446:419-425(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], FUNCTION, ENZYME REGULATION,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=10228147; DOI=10.1093/emboj/18.9.2323;
RA   Ludwig A., Zong X., Stieber J., Hullin R., Hofmann F., Biel M.;
RT   "Two pacemaker channels from human heart with profoundly different
RT   activation kinetics.";
RL   EMBO J. 18:2323-2329(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 147-743, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9630217; DOI=10.1016/S0092-8674(00)81434-8;
RA   Santoro B., Liu D.T., Yao H., Bartsch D., Kandel E.R.,
RA   Siegelbaum S.A., Tibbs G.R.;
RT   "Identification of a gene encoding a hyperpolarization-activated
RT   'pacemaker' channel of brain.";
RL   Cell 93:717-729(1998).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 470-672 IN COMPLEX WITH CAMP,
RP   NUCLEOTIDE-BINDING, ENZYME REGULATION, AND SUBUNIT.
RX   PubMed=22006928; DOI=10.1074/jbc.M111.297606;
RA   Lolicato M., Nardini M., Gazzarrini S., Moller S., Bertinetti D.,
RA   Herberg F.W., Bolognesi M., Martin H., Fasolini M., Bertrand J.A.,
RA   Arrigoni C., Thiel G., Moroni A.;
RT   "Tetramerization dynamics of C-terminal domain underlies isoform-
RT   specific cAMP gating in hyperpolarization-activated cyclic nucleotide-
RT   gated channels.";
RL   J. Biol. Chem. 286:44811-44820(2011).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak
CC       selectivity for potassium over sodium ions. Contributes to the
CC       native pacemaker currents in heart (If) and in neurons (Ih). Can
CC       also transport ammonium in the distal nephron. Produces a large
CC       instantaneous current. Modulated by intracellular chloride ions
CC       and pH; acidic pH shifts the activation to more negative voltages
CC       (By similarity). {ECO:0000250, ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:10524219}.
CC   -!- ENZYME REGULATION: Activated by cAMP, and at 10-100 times higher
CC       concentrations, also by cGMP. cAMP binding causes a conformation
CC       change that leads to the assembly of an active tetramer and
CC       channel opening. Channel activity is modulated by intracellular
CC       chloride ions and pH; acidic pH shifts the activation to more
CC       negative voltages. {ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:22006928}.
CC   -!- SUBUNIT: The potassium channel is composed of a homo- or
CC       heterotetrameric complex of pore-forming subunits. Heterotetramer
CC       with HCN1. Forms an obligate 4:4 complex with accessory subunit
CC       PEX5L. Interacts with KCNE2 (By similarity). Homotetramer.
CC       {ECO:0000250, ECO:0000269|PubMed:22006928}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-1751885, EBI-1751885;
CC       Q4ACU6-1:Shank3 (xeno); NbExp=3; IntAct=EBI-1751885, EBI-16201983;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:10524219}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10228147, ECO:0000269|PubMed:10524219}.
CC   -!- TISSUE SPECIFICITY: Highly expressed throughout the brain.
CC       Detected at low levels in heart. {ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:9630217}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- PTM: Phosphorylation at Ser-668 by PRKG2 shifts the voltage-
CC       dependence to more negative voltages, hence counteracting the
CC       stimulatory effect of cGMP on gating. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Inhibited by extracellular cesium ions.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF065164; AAC28444.2; -; mRNA.
DR   EMBL; AJ012582; CAB42602.1; -; mRNA.
DR   EMBL; AJ133727; CAB42630.1; -; Genomic_DNA.
DR   EMBL; AJ133728; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133729; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133730; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133731; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133732; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133733; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133734; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AC004449; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005559; AAC33280.2; -; Genomic_DNA.
DR   EMBL; AF064877; AAC39760.1; -; mRNA.
DR   CCDS; CCDS12035.1; -.
DR   RefSeq; NP_001185.3; NM_001194.3.
DR   UniGene; Hs.124161; -.
DR   PDB; 2MPF; NMR; -; A=521-672.
DR   PDB; 3U10; X-ray; 2.30 A; A=470-672.
DR   PDBsum; 2MPF; -.
DR   PDBsum; 3U10; -.
DR   ProteinModelPortal; Q9UL51; -.
DR   SMR; Q9UL51; -.
DR   BioGrid; 107081; 4.
DR   DIP; DIP-52285N; -.
DR   IntAct; Q9UL51; 6.
DR   STRING; 9606.ENSP00000251287; -.
DR   BindingDB; Q9UL51; -.
DR   ChEMBL; CHEMBL1795172; -.
DR   DrugBank; DB02527; Cyclic Adenosine Monophosphate.
DR   DrugBank; DB02315; Cyclic Guanosine Monophosphate.
DR   GuidetoPHARMACOLOGY; 401; -.
DR   TCDB; 1.A.1.5.11; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9UL51; -.
DR   PhosphoSitePlus; Q9UL51; -.
DR   BioMuta; HCN2; -.
DR   DMDM; 108935843; -.
DR   MaxQB; Q9UL51; -.
DR   PaxDb; Q9UL51; -.
DR   PeptideAtlas; Q9UL51; -.
DR   PRIDE; Q9UL51; -.
DR   DNASU; 610; -.
DR   Ensembl; ENST00000251287; ENSP00000251287; ENSG00000099822.
DR   GeneID; 610; -.
DR   KEGG; hsa:610; -.
DR   UCSC; uc002lpe.3; human.
DR   CTD; 610; -.
DR   DisGeNET; 610; -.
DR   EuPathDB; HostDB:ENSG00000099822.2; -.
DR   GeneCards; HCN2; -.
DR   HGNC; HGNC:4846; HCN2.
DR   MIM; 602781; gene.
DR   neXtProt; NX_Q9UL51; -.
DR   OpenTargets; ENSG00000099822; -.
DR   PharmGKB; PA78; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039489; -.
DR   InParanoid; Q9UL51; -.
DR   KO; K04955; -.
DR   OMA; CPQVARP; -.
DR   OrthoDB; EOG091G0JQU; -.
DR   PhylomeDB; Q9UL51; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-HSA-1296061; HCN channels.
DR   GeneWiki; HCN2; -.
DR   GenomeRNAi; 610; -.
DR   PRO; PR:Q9UL51; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000099822; -.
DR   CleanEx; HS_HCN2; -.
DR   Genevisible; Q9UL51; HS.
DR   GO; GO:0098855; C:HCN channel complex; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IMP:UniProtKB.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:UniProtKB.
DR   GO; GO:0071321; P:cellular response to cGMP; IDA:UniProtKB.
DR   GO; GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:UniProtKB.
DR   GO; GO:0098719; P:sodium ion import across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IMP:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cAMP; cAMP-binding; Cell membrane; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Methylation; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Sodium; Sodium channel; Sodium transport;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    889       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                2.
FT                                /FTId=PRO_0000054111.
FT   TOPO_DOM      1    215       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    216    236       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    237    240       Extracellular. {ECO:0000255}.
FT   TRANSMEM    241    261       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    262    288       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    289    309       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    310    317       Extracellular. {ECO:0000255}.
FT   TRANSMEM    318    338       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    339    369       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    370    390       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    391    413       Extracellular. {ECO:0000255}.
FT   INTRAMEM    414    435       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    436    440       Extracellular. {ECO:0000255}.
FT   TRANSMEM    441    461       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    462    889       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     608    611       cAMP. {ECO:0000269|PubMed:22006928}.
FT   NP_BIND     618    619       cAMP. {ECO:0000269|PubMed:22006928}.
FT   NP_BIND     659    662       cAMP. {ECO:0000269|PubMed:22006928}.
FT   REGION      158    209       Involved in subunit assembly.
FT                                {ECO:0000250}.
FT   COMPBIAS     10    140       Pro-rich.
FT   COMPBIAS    715    861       Pro-rich.
FT   MOD_RES     146    146       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     161    161       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JKA9}.
FT   MOD_RES     668    668       Phosphoserine; by PKG/PRKG2.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     754    754       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JKA9}.
FT   MOD_RES     756    756       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     771    771       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     779    779       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     786    786       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     866    866       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     868    868       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   CARBOHYD    407    407       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     527    527       R -> Q (in dbSNP:rs55687900).
FT                                /FTId=VAR_061106.
FT   CONFLICT     17     20       TPAP -> SPTT (in Ref. 1; AAC28444).
FT                                {ECO:0000305}.
FT   CONFLICT     29     29       A -> R (in Ref. 1; AAC28444).
FT                                {ECO:0000305}.
FT   CONFLICT     32     32       Q -> K (in Ref. 1; AAC28444).
FT                                {ECO:0000305}.
FT   CONFLICT    294    294       D -> V (in Ref. 4; AAC39760).
FT                                {ECO:0000305}.
FT   CONFLICT    713    713       L -> F (in Ref. 4; AAC39760).
FT                                {ECO:0000305}.
FT   CONFLICT    849    849       G -> R (in Ref. 2; CAB42602/CAB42630).
FT                                {ECO:0000305}.
FT   HELIX       471    489       {ECO:0000244|PDB:3U10}.
FT   HELIX       494    508       {ECO:0000244|PDB:3U10}.
FT   HELIX       515    520       {ECO:0000244|PDB:3U10}.
FT   HELIX       524    534       {ECO:0000244|PDB:3U10}.
FT   HELIX       536    540       {ECO:0000244|PDB:3U10}.
FT   TURN        543    547       {ECO:0000244|PDB:3U10}.
FT   HELIX       550    557       {ECO:0000244|PDB:3U10}.
FT   STRAND      561    565       {ECO:0000244|PDB:3U10}.
FT   STRAND      570    572       {ECO:0000244|PDB:3U10}.
FT   STRAND      576    578       {ECO:0000244|PDB:2MPF}.
FT   STRAND      580    586       {ECO:0000244|PDB:3U10}.
FT   STRAND      589    592       {ECO:0000244|PDB:3U10}.
FT   STRAND      598    601       {ECO:0000244|PDB:3U10}.
FT   STRAND      606    608       {ECO:0000244|PDB:3U10}.
FT   HELIX       610    614       {ECO:0000244|PDB:3U10}.
FT   STRAND      619    626       {ECO:0000244|PDB:3U10}.
FT   STRAND      628    634       {ECO:0000244|PDB:3U10}.
FT   HELIX       635    644       {ECO:0000244|PDB:3U10}.
FT   HELIX       646    661       {ECO:0000244|PDB:3U10}.
FT   TURN        662    664       {ECO:0000244|PDB:3U10}.
FT   HELIX       668    670       {ECO:0000244|PDB:3U10}.
SQ   SEQUENCE   889 AA;  96950 MW;  4B263E0C06C2A47D CRC64;
     MDARGGGGRP GESPGATPAP GPPPPPPPAP PQQQPPPPPP PAPPPGPGPA PPQHPPRAEA
     LPPEAADEGG PRGRLRSRDS SCGRPGTPGA ASTAKGSPNG ECGRGEPQCS PAGPEGPARG
     PKVSFSCRGA ASGPAPGPGP AEEAGSEEAG PAGEPRGSQA SFMQRQFGAL LQPGVNKFSL
     RMFGSQKAVE REQERVKSAG AWIIHPYSDF RFYWDFTMLL FMVGNLIIIP VGITFFKDET
     TAPWIVFNVV SDTFFLMDLV LNFRTGIVIE DNTEIILDPE KIKKKYLRTW FVVDFVSSIP
     VDYIFLIVEK GIDSEVYKTA RALRIVRFTK ILSLLRLLRL SRLIRYIHQW EEIFHMTYDL
     ASAVMRICNL ISMMLLLCHW DGCLQFLVPM LQDFPRNCWV SINGMVNHSW SELYSFALFK
     AMSHMLCIGY GRQAPESMTD IWLTMLSMIV GATCYAMFIG HATALIQSLD SSRRQYQEKY
     KQVEQYMSFH KLPADFRQKI HDYYEHRYQG KMFDEDSILG ELNGPLREEI VNFNCRKLVA
     SMPLFANADP NFVTAMLTKL KFEVFQPGDY IIREGTIGKK MYFIQHGVVS VLTKGNKEMK
     LSDGSYFGEI CLLTRGRRTA SVRADTYCRL YSLSVDNFNE VLEEYPMMRR AFETVAIDRL
     DRIGKKNSIL LHKVQHDLNS GVFNNQENAI IQEIVKYDRE MVQQAELGQR VGLFPPPPPP
     PQVTSAIATL QQAAAMSFCP QVARPLVGPL ALGSPRLVRR PPPGPAPAAA SPGPPPPASP
     PGAPASPRAP RTSPYGGLPA APLAGPALPA RRLSRASRPL SASQPSLPHG APGPAASTRP
     ASSSTPRLGP TPAARAAAPS PDRRDSASPG AAGGLDPQDS ARSRLSSNL
//
ID   KCNH3_HUMAN             Reviewed;        1083 AA.
AC   Q9ULD8; Q9UQ06;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2002, sequence version 2.
DT   25-OCT-2017, entry version 156.
DE   RecName: Full=Potassium voltage-gated channel subfamily H member 3;
DE   AltName: Full=Brain-specific eag-like channel 1;
DE            Short=BEC1;
DE   AltName: Full=Ether-a-go-go-like potassium channel 2;
DE            Short=ELK channel 2;
DE            Short=ELK2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv12.2;
GN   Name=KCNH3; Synonyms=KIAA1282;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=10455180; DOI=10.1074/jbc.274.35.25018;
RA   Miyake A., Mochizuki S., Yokoi H., Kohda M., Furuichi K.;
RT   "New ether-a-go-go K+ channel family members localized in human
RT   telencephalon.";
RL   J. Biol. Chem. 274:25018-25025(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium
CC       channel. Elicits an outward current with fast inactivation.
CC       Channel properties may be modulated by cAMP and subunit assembly.
CC   -!- SUBUNIT: The potassium channel is probably composed of a homo- or
CC       heterotetrameric complex of pore-forming alpha subunits that can
CC       associate with modulating beta subunits.
CC   -!- INTERACTION:
CC       P04578:env (xeno); NbExp=3; IntAct=EBI-8079227, EBI-6163496;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Detected only in brain, in particular in the
CC       telencephalon. Detected in the cerebral cortex, occipital pole,
CC       frontal and temporal lobe, putamen, amygdala, hippocampus and
CC       caudate nucleus.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel family. H (Eag) (TC
CC       1.A.1.20) subfamily. Kv12.2/KCNH3 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86596.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB022696; BAA83590.1; -; mRNA.
DR   EMBL; AB033108; BAA86596.1; ALT_INIT; mRNA.
DR   CCDS; CCDS8786.1; -.
DR   RefSeq; NP_001300959.1; NM_001314030.1.
DR   RefSeq; NP_036416.1; NM_012284.2.
DR   UniGene; Hs.64064; -.
DR   ProteinModelPortal; Q9ULD8; -.
DR   SMR; Q9ULD8; -.
DR   IntAct; Q9ULD8; 1.
DR   MINT; MINT-7968644; -.
DR   STRING; 9606.ENSP00000257981; -.
DR   ChEMBL; CHEMBL2362996; -.
DR   GuidetoPHARMACOLOGY; 576; -.
DR   TCDB; 1.A.1.20.5; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9ULD8; -.
DR   PhosphoSitePlus; Q9ULD8; -.
DR   BioMuta; KCNH3; -.
DR   DMDM; 26006814; -.
DR   PaxDb; Q9ULD8; -.
DR   PeptideAtlas; Q9ULD8; -.
DR   PRIDE; Q9ULD8; -.
DR   Ensembl; ENST00000257981; ENSP00000257981; ENSG00000135519.
DR   GeneID; 23416; -.
DR   KEGG; hsa:23416; -.
DR   UCSC; uc001ruh.2; human.
DR   CTD; 23416; -.
DR   DisGeNET; 23416; -.
DR   EuPathDB; HostDB:ENSG00000135519.6; -.
DR   GeneCards; KCNH3; -.
DR   HGNC; HGNC:6252; KCNH3.
DR   HPA; HPA051088; -.
DR   MIM; 604527; gene.
DR   neXtProt; NX_Q9ULD8; -.
DR   OpenTargets; ENSG00000135519; -.
DR   PharmGKB; PA30038; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140833; -.
DR   HOGENOM; HOG000230794; -.
DR   HOVERGEN; HBG052232; -.
DR   InParanoid; Q9ULD8; -.
DR   KO; K04906; -.
DR   OMA; PLMAPWP; -.
DR   OrthoDB; EOG091G0OXR; -.
DR   PhylomeDB; Q9ULD8; -.
DR   TreeFam; TF313130; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   GeneWiki; KCNH3; -.
DR   GenomeRNAi; 23416; -.
DR   PRO; PR:Q9ULD8; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000135519; -.
DR   CleanEx; HS_KCNH3; -.
DR   Genevisible; Q9ULD8; HS.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; TAS:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR003950; K_chnl_volt-dep_ELK.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000700; PAS-assoc_C.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF13426; PAS_9; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   PRINTS; PR01465; ELKCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SMART; SM00086; PAC; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50113; PAC; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1083       Potassium voltage-gated channel subfamily
FT                                H member 3.
FT                                /FTId=PRO_0000054005.
FT   TOPO_DOM      1    228       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    229    249       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    250    259       Extracellular. {ECO:0000255}.
FT   TRANSMEM    260    280       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    281    302       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    303    323       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    324    331       Extracellular. {ECO:0000255}.
FT   TRANSMEM    332    352       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    353    361       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    362    382       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    383    453       Extracellular. {ECO:0000255}.
FT   INTRAMEM    454    474       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    475    479       Extracellular. {ECO:0000255}.
FT   TRANSMEM    480    500       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    501   1083       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       18     90       PAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN       93    145       PAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00141}.
FT   NP_BIND     582    697       cNMP.
FT   MOTIF       465    470       Selectivity filter. {ECO:0000250}.
FT   COMPBIAS    951   1057       Pro-rich.
FT   CARBOHYD    421    421       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    428    428       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    436    436       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   1083 AA;  117129 MW;  EF35C8968D7418CC CRC64;
     MPAMRGLLAP QNTFLDTIAT RFDGTHSNFV LGNAQVAGLF PVVYCSDGFC DLTGFSRAEV
     MQRGCACSFL YGPDTSELVR QQIRKALDEH KEFKAELILY RKSGLPFWCL LDVIPIKNEK
     GEVALFLVSH KDISETKNRG GPDRWKETGG GRRRYGRARS KGFNANRRRS RAVLYHLSGH
     LQKQPKGKHK LNKGVFGEKP NLPEYKVAAI RKSPFILLHC GALRATWDGF ILLATLYVAV
     TVPYSVCVST AREPSAARGP PSVCDLAVEV LFILDIVLNF RTTFVSKSGQ VVFAPKSICL
     HYVTTWFLLD VIAALPFDLL HAFKVNVYFG AHLLKTVRLL RLLRLLPRLD RYSQYSAVVL
     TLLMAVFALL AHWVACVWFY IGQREIESSE SELPEIGWLQ ELARRLETPY YLVGRRPAGG
     NSSGQSDNCS SSSEANGTGL ELLGGPSLRS AYITSLYFAL SSLTSVGFGN VSANTDTEKI
     FSICTMLIGA LMHAVVFGNV TAIIQRMYAR RFLYHSRTRD LRDYIRIHRI PKPLKQRMLE
     YFQATWAVNN GIDTTELLQS LPDELRADIA MHLHKEVLQL PLFEAASRGC LRALSLALRP
     AFCTPGEYLI HQGDALQALY FVCSGSMEVL KGGTVLAILG KGDLIGCELP RREQVVKANA
     DVKGLTYCVL QCLQLAGLHD SLALYPEFAP RFSRGLRGEL SYNLGAGGGS AEVDTSSLSG
     DNTLMSTLEE KETDGEQGPT VSPAPADEPS SPLLSPGCTS SSSAAKLLSP RRTAPRPRLG
     GRGRPGRAGA LKAEAGPSAP PRALEGLRLP PMPWNVPPDL SPRVVDGIED GCGSDQPKFS
     FRVGQSGPEC SSSPSPGPES GLLTVPHGPS EARNTDTLDK LRQAVTELSE QVLQMREGLQ
     SLRQAVQLVL APHREGPCPR ASGEGPCPAS TSGLLQPLCV DTGASSYCLQ PPAGSVLSGT
     WPHPRPGPPP LMAPWPWGPP ASQSSPWPRA TAFWTSTSDS EPPASGDLCS EPSTPASPPP
     SEEGARTGPA EPVSQAEATS TGEPPPGSGG LALPWDPHSL EMVLIGCHGS GTVQWTQEEG
     TGV
//
ID   KCO3_ARATH              Reviewed;         260 AA.
AC   Q9XFR0; F4KHG2;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   20-DEC-2017, entry version 136.
DE   RecName: Full=Potassium inward rectifier (Kir)-like channel 3;
DE            Short=AtKCO3;
GN   Name=KCO3; OrderedLocusNames=At5g46360; ORFNames=MPL12.16;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=cv. C24; TISSUE=Seedling;
RA   Wiese S., Czempinski K., Zimmermann S., Mueller-Roeber B.;
RT   "Association of novel structural features of a KCO-like protein with a
RT   new function for plant potassium channels?";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=9679202; DOI=10.1093/dnares/5.2.131;
RA   Kaneko T., Kotani H., Nakamura Y., Sato S., Asamizu E., Miyajima N.,
RA   Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence
RT   features of the regions of 1,381,565 bp covered by twenty one
RT   physically assigned P1 and TAC clones.";
RL   DNA Res. 5:131-145(1998).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [5]
RP   TISSUE SPECIFICITY, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=16984403; DOI=10.1111/j.1365-313X.2006.02868.x;
RA   Voelker C., Schmidt D., Mueller-Roeber B., Czempinski K.;
RT   "Members of the Arabidopsis AtTPK/KCO family form homomeric vacuolar
RT   channels in planta.";
RL   Plant J. 48:296-306(2006).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17764516; DOI=10.1111/j.1365-313X.2007.03255.x;
RA   Latz A., Becker D., Hekman M., Mueller T., Beyhl D., Marten I.,
RA   Eing C., Fischer A., Dunkel M., Bertl A., Rapp U.R., Hedrich R.;
RT   "TPK1, a Ca(2+)-regulated Arabidopsis vacuole two-pore K(+) channel is
RT   activated by 14-3-3 proteins.";
RL   Plant J. 52:449-459(2007).
CC   -!- FUNCTION: Probable calcium-activated potassium channel.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000305|PubMed:16984403}.
CC   -!- SUBCELLULAR LOCATION: Vacuole membrane
CC       {ECO:0000269|PubMed:16984403, ECO:0000269|PubMed:17764516}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:16984403,
CC       ECO:0000269|PubMed:17764516}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9XFR0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9XFR0-2; Sequence=VSP_043863;
CC   -!- TISSUE SPECIFICITY: Expressed in hydathodes and the vascular
CC       tissues of roots, stems, leaves and flowers.
CC       {ECO:0000269|PubMed:16984403}.
CC   -!- DOMAIN: The pore-forming region (also called P-domain or P-loop)
CC       is enclosed by two transmembrane segments (1P/2TM) and contains a
CC       pseudo GYGD signature motif such as GYFD which seems to be
CC       involved in potassium selectivity.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.7) family. {ECO:0000305}.
CC   -!- CAUTION: KCO3 shares similarity to the TPK family (2P/4TM) but
CC       lacks the conserved internal part including one pore-forming
CC       region and two transmembrane segments. As a result and according
CC       to its structure, KCO3 could also be classified as a member of the
CC       IRK family (1P/2TM). {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ010873; CAB40380.1; -; mRNA.
DR   EMBL; AB010698; BAB11091.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED95373.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED95374.1; -; Genomic_DNA.
DR   RefSeq; NP_001190480.1; NM_001203551.1. [Q9XFR0-2]
DR   RefSeq; NP_199448.1; NM_124006.3. [Q9XFR0-1]
DR   UniGene; At.405; -.
DR   ProteinModelPortal; Q9XFR0; -.
DR   STRING; 3702.AT5G46360.1; -.
DR   TCDB; 1.A.1.7.6; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q9XFR0; -.
DR   EnsemblPlants; AT5G46360.1; AT5G46360.1; AT5G46360. [Q9XFR0-1]
DR   EnsemblPlants; AT5G46360.2; AT5G46360.2; AT5G46360. [Q9XFR0-2]
DR   GeneID; 834679; -.
DR   Gramene; AT5G46360.1; AT5G46360.1; AT5G46360. [Q9XFR0-1]
DR   Gramene; AT5G46360.2; AT5G46360.2; AT5G46360. [Q9XFR0-2]
DR   KEGG; ath:AT5G46360; -.
DR   Araport; AT5G46360; -.
DR   TAIR; locus:2170413; AT5G46360.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000238193; -.
DR   InParanoid; Q9XFR0; -.
DR   KO; K05389; -.
DR   OMA; SVMMVTT; -.
DR   PhylomeDB; Q9XFR0; -.
DR   PRO; PR:Q9XFR0; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; Q9XFR0; differential.
DR   Genevisible; Q9XFR0; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0009705; C:plant-type vacuole membrane; IDA:TAIR.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IPI:TAIR.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Vacuole.
FT   CHAIN         1    260       Potassium inward rectifier (Kir)-like
FT                                channel 3.
FT                                /FTId=PRO_0000101777.
FT   TOPO_DOM      1     68       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     69     89       Helical. {ECO:0000255}.
FT   INTRAMEM    127    146       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    153    173       Helical. {ECO:0000255}.
FT   TOPO_DOM    174    260       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      190    225       EF-hand 1.
FT   DOMAIN      229    256       EF-hand 2.
FT   CA_BIND     203    214       1. {ECO:0000255}.
FT   CA_BIND     242    253       2. {ECO:0000255}.
FT   VAR_SEQ     237    259       QFDKLDRTQSGRITLVDLTTATS -> HNTHYNMIEDGSGK
FT                                SAVLDIVEP (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_043863.
SQ   SEQUENCE   260 AA;  29108 MW;  66A110AB5AD68414 CRC64;
     MPMTPSEFKN RLLFGSLPRS SSDPTDLQFT EPNVPPSLFS LPEHNDDTAT DMAPDQETEQ
     SVSKSIARQA LALLVVYLSL GVLIYWLTLD SDNAYQTHPV AVALYFFVVT FCGFLIVHFV
     VKIGWLDSFC FSVMMVTTVG FGDRAFNTWL GTFLAAVWLL VSTLAVARAF LFLADARADK
     RNRERAKKVL GESISISQFF AADIDNDGRL SLAEFAIYKL KQMEKITQED FIQICNQFDK
     LDRTQSGRIT LVDLTTATSV
//
ID   KCNK6_HUMAN             Reviewed;         313 AA.
AC   Q9Y257; Q9HB47;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   22-NOV-2017, entry version 155.
DE   RecName: Full=Potassium channel subfamily K member 6;
DE   AltName: Full=Inward rectifying potassium channel protein TWIK-2;
DE   AltName: Full=TWIK-originated similarity sequence;
GN   Name=KCNK6; Synonyms=TOSS, TWIK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=10359073; DOI=10.1016/S0014-5793(99)00495-0;
RA   Pountney D.J., Gulkarov I., Vega-Saenz de Miera E., Holmes D.,
RA   Saganich M., Rudy B., Artman M., Coetzee W.A.;
RT   "Identification and cloning of TWIK-originated similarity sequence
RT   (TOSS): a novel human 2-pore K+ channel principal subunit.";
RL   FEBS Lett. 450:191-196(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS OF CYS-53.
RC   TISSUE=Brain;
RX   PubMed=10075682; DOI=10.1074/jbc.274.12.7887;
RA   Chavez R.A., Gray A.T., Zhao B.B., Kindler C.H., Mazurek M.J.,
RA   Mehta Y., Forsayeth J.R., Yost C.S.;
RT   "TWIK-2, a new weak inward rectifying member of the tandem pore domain
RT   potassium channel family.";
RL   J. Biol. Chem. 274:7887-7892(1999).
RN   [3]
RP   ERRATUM.
RA   Chavez R.A., Gray A.T., Zhao B.B., Kindler C.H., Mazurek M.J.,
RA   Mehta Y., Forsayeth J.R., Yost C.S.;
RL   J. Biol. Chem. 274:24440-24440(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND CHARACTERIZATION.
RX   PubMed=10887187; DOI=10.1074/jbc.M003755200;
RA   Patel A.J., Maingret F., Magnone V., Fosset M., Lazdunski M.,
RA   Honore E.;
RT   "TWIK-2, an inactivating 2P domain K+ channel.";
RL   J. Biol. Chem. 275:28722-28730(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1).
RA   Chen A.F., Gray A.T., Chen A.H., Kindler C.H., Mhatre A.N., Yost C.S.,
RA   Lalwani A.K., Smith R.J.H.;
RT   "Genomic structure and mutation screening of the TWIK-2 gene.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Exhibits outward rectification in a physiological K(+)
CC       gradient and mild inward rectification in symmetrical K(+)
CC       conditions.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y257-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y257-2; Sequence=VSP_006692;
CC   -!- TISSUE SPECIFICITY: Widespread expression, detected in all tissues
CC       tested except for skeletal muscle. Strongest expression in
CC       placenta, pancreas, heart, colon and spleen, lower levels detected
CC       in peripheral blood leukocytes, lung, liver, kidney and thymus.
CC       Lowest expression detected in brain.
CC   -!- MISCELLANEOUS: Inhibited by internal acidification and, to a small
CC       degree, by zinc. Not inhibited by quinine, quinidine or barium.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF134149; AAD22980.1; -; mRNA.
DR   EMBL; AF117708; AAD24000.1; -; mRNA.
DR   EMBL; AF281302; AAG10506.1; -; mRNA.
DR   EMBL; AF281303; AAG10507.1; -; mRNA.
DR   EMBL; AJ297404; CAC15489.1; -; Genomic_DNA.
DR   EMBL; AJ297405; CAC15489.1; JOINED; Genomic_DNA.
DR   EMBL; BC004367; AAH04367.1; -; mRNA.
DR   CCDS; CCDS12513.1; -. [Q9Y257-1]
DR   RefSeq; NP_004814.1; NM_004823.1. [Q9Y257-1]
DR   RefSeq; XP_011525828.1; XM_011527526.1. [Q9Y257-2]
DR   UniGene; Hs.240395; -.
DR   ProteinModelPortal; Q9Y257; -.
DR   SMR; Q9Y257; -.
DR   STRING; 9606.ENSP00000263372; -.
DR   DrugBank; DB00308; Ibutilide.
DR   DrugBank; DB00908; Quinidine.
DR   TCDB; 1.A.1.8.3; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9Y257; -.
DR   PhosphoSitePlus; Q9Y257; -.
DR   BioMuta; KCNK6; -.
DR   DMDM; 13124108; -.
DR   EPD; Q9Y257; -.
DR   PaxDb; Q9Y257; -.
DR   PeptideAtlas; Q9Y257; -.
DR   PRIDE; Q9Y257; -.
DR   DNASU; 9424; -.
DR   Ensembl; ENST00000263372; ENSP00000263372; ENSG00000099337. [Q9Y257-1]
DR   GeneID; 9424; -.
DR   KEGG; hsa:9424; -.
DR   UCSC; uc002oic.4; human. [Q9Y257-1]
DR   CTD; 9424; -.
DR   DisGeNET; 9424; -.
DR   EuPathDB; HostDB:ENSG00000099337.4; -.
DR   GeneCards; KCNK6; -.
DR   H-InvDB; HIX0202814; -.
DR   HGNC; HGNC:6281; KCNK6.
DR   HPA; CAB022637; -.
DR   HPA; HPA040184; -.
DR   MIM; 603939; gene.
DR   neXtProt; NX_Q9Y257; -.
DR   OpenTargets; ENSG00000099337; -.
DR   PharmGKB; PA30063; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000286014; -.
DR   HOVERGEN; HBG052237; -.
DR   InParanoid; Q9Y257; -.
DR   KO; K04917; -.
DR   OMA; SHTDYAS; -.
DR   OrthoDB; EOG091G0DIX; -.
DR   PhylomeDB; Q9Y257; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-HSA-1299308; Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK).
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   ChiTaRS; KCNK6; human.
DR   GeneWiki; KCNK6; -.
DR   GenomeRNAi; 9424; -.
DR   PRO; PR:Q9Y257; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000099337; -.
DR   CleanEx; HS_KCNK6; -.
DR   ExpressionAtlas; Q9Y257; baseline and differential.
DR   Genevisible; Q9Y257; HS.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc.
DR   GO; GO:0005267; F:potassium channel activity; TAS:Reactome.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0003085; P:negative regulation of systemic arterial blood pressure; IEA:Ensembl.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0060075; P:regulation of resting membrane potential; IEA:Ensembl.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR005408; 2pore_dom_K_chnl_TWIK.
DR   InterPro; IPR005409; 2pore_dom_K_chnl_TWIK2.
DR   InterPro; IPR013099; K_chnl_dom.
DR   PANTHER; PTHR11003:SF28; PTHR11003:SF28; 1.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01587; TWIK2CHANNEL.
DR   PRINTS; PR01586; TWIKCHANNEL.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    313       Potassium channel subfamily K member 6.
FT                                /FTId=PRO_0000101750.
FT   TOPO_DOM      1      4       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      5     25       Helical. {ECO:0000255}.
FT   INTRAMEM     90    115       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    121    141       Helical. {ECO:0000255}.
FT   TOPO_DOM    142    172       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    173    193       Helical. {ECO:0000255}.
FT   INTRAMEM    199    223       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    236    256       Helical. {ECO:0000255}.
FT   TOPO_DOM    257    313       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     79     79       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     85     85       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    134       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10887187}.
FT                                /FTId=VSP_006692.
FT   VARIANT     150    150       T -> I (in dbSNP:rs35762773).
FT                                /FTId=VAR_052426.
FT   VARIANT     240    240       V -> I (in dbSNP:rs35496032).
FT                                /FTId=VAR_059842.
FT   VARIANT     259    259       V -> M (in dbSNP:rs34989303).
FT                                /FTId=VAR_052427.
FT   MUTAGEN      53     53       C->A: No channel activity.
FT                                {ECO:0000269|PubMed:10075682}.
SQ   SEQUENCE   313 AA;  33747 MW;  1379382DFB0575DE CRC64;
     MRRGALLAGA LAAYAAYLVL GALLVARLEG PHEARLRAEL ETLRAQLLQR SPCVAAPALD
     AFVERVLAAG RLGRVVLANA SGSANASDPA WDFASALFFA STLITTVGYG YTTPLTDAGK
     AFSIAFALLG VPTTMLLLTA SAQRLSLLLT HVPLSWLSMR WGWDPRRAAC WHLVALLGVV
     VTVCFLVPAV IFAHLEEAWS FLDAFYFCFI SLSTIGLGDY VPGEAPGQPY RALYKVLVTV
     YLFLGLVAMV LVLQTFRHVS DLHGLTELIL LPPPCPASFN ADEDDRVDIL GPQPESHQQL
     SASSHTDYAS IPR
//
ID   KCNK7_HUMAN             Reviewed;         307 AA.
AC   Q9Y2U2; Q3SYI2; Q9Y2U3; Q9Y2U4;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   20-DEC-2017, entry version 136.
DE   RecName: Full=Potassium channel subfamily K member 7;
GN   Name=KCNK7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND C).
RC   TISSUE=Brain;
RX   PubMed=10206991; DOI=10.1074/jbc.274.17.11751;
RA   Salinas M., Reyes R., Lesage F., Fosset M., Heurteaux C., Romey G.,
RA   Lazdunski M.;
RT   "Cloning of a new mouse two-P domain channel subunit and a human
RT   homologue with a unique pore structure.";
RL   J. Biol. Chem. 274:11751-11760(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Probable potassium channel subunit. No channel activity
CC       observed in vitro as protein remains in the endoplasmic reticulum.
CC       May need to associate with an as yet unknown partner in order to
CC       reach the plasma membrane.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=A;
CC         IsoId=Q9Y2U2-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q9Y2U2-2; Sequence=VSP_006693, VSP_006694;
CC       Name=C;
CC         IsoId=Q9Y2U2-3; Sequence=VSP_006695, VSP_006696;
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF110522; AAD29578.1; -; mRNA.
DR   EMBL; AF110524; AAD29580.1; -; mRNA.
DR   EMBL; AF110523; AAD29579.1; -; mRNA.
DR   EMBL; CH471076; EAW74413.1; -; Genomic_DNA.
DR   EMBL; BC103809; AAI03810.1; -; mRNA.
DR   CCDS; CCDS31608.1; -. [Q9Y2U2-1]
DR   CCDS; CCDS41673.1; -. [Q9Y2U2-3]
DR   CCDS; CCDS8106.1; -. [Q9Y2U2-2]
DR   RefSeq; NP_005705.1; NM_005714.1. [Q9Y2U2-3]
DR   RefSeq; NP_203133.1; NM_033347.1. [Q9Y2U2-1]
DR   RefSeq; NP_203134.1; NM_033348.1. [Q9Y2U2-2]
DR   RefSeq; NP_258416.1; NM_033455.1. [Q9Y2U2-2]
DR   UniGene; Hs.175218; -.
DR   ProteinModelPortal; Q9Y2U2; -.
DR   SMR; Q9Y2U2; -.
DR   STRING; 9606.ENSP00000344820; -.
DR   BioMuta; KCNK7; -.
DR   DMDM; 13124109; -.
DR   PaxDb; Q9Y2U2; -.
DR   PeptideAtlas; Q9Y2U2; -.
DR   PRIDE; Q9Y2U2; -.
DR   Ensembl; ENST00000340313; ENSP00000344820; ENSG00000173338. [Q9Y2U2-1]
DR   Ensembl; ENST00000342202; ENSP00000343923; ENSG00000173338. [Q9Y2U2-2]
DR   Ensembl; ENST00000394216; ENSP00000377764; ENSG00000173338. [Q9Y2U2-3]
DR   Ensembl; ENST00000394217; ENSP00000377765; ENSG00000173338. [Q9Y2U2-2]
DR   GeneID; 10089; -.
DR   KEGG; hsa:10089; -.
DR   UCSC; uc001oeq.3; human. [Q9Y2U2-1]
DR   CTD; 10089; -.
DR   DisGeNET; 10089; -.
DR   EuPathDB; HostDB:ENSG00000173338.12; -.
DR   GeneCards; KCNK7; -.
DR   HGNC; HGNC:6282; KCNK7.
DR   HPA; HPA077577; -.
DR   MIM; 603940; gene.
DR   neXtProt; NX_Q9Y2U2; -.
DR   OpenTargets; ENSG00000173338; -.
DR   PharmGKB; PA30064; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   GeneTree; ENSGT00760000118858; -.
DR   HOGENOM; HOG000286014; -.
DR   HOVERGEN; HBG052237; -.
DR   InParanoid; Q9Y2U2; -.
DR   KO; K04918; -.
DR   OMA; LWGLQGD; -.
DR   OrthoDB; EOG091G0DIX; -.
DR   PhylomeDB; Q9Y2U2; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-HSA-1299308; Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK).
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   GeneWiki; KCNK7; -.
DR   GenomeRNAi; 10089; -.
DR   PRO; PR:Q9Y2U2; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000173338; -.
DR   CleanEx; HS_KCNK7; -.
DR   ExpressionAtlas; Q9Y2U2; baseline and differential.
DR   Genevisible; Q9Y2U2; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005267; F:potassium channel activity; TAS:Reactome.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR005408; 2pore_dom_K_chnl_TWIK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01586; TWIKCHANNEL.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    307       Potassium channel subfamily K member 7.
FT                                /FTId=PRO_0000101751.
FT   TOPO_DOM      1     10       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     11     31       Helical. {ECO:0000255}.
FT   INTRAMEM     92    119       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    120    140       Helical. {ECO:0000255}.
FT   TOPO_DOM    141    170       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    171    191       Helical. {ECO:0000255}.
FT   INTRAMEM    199    227       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    233    253       Helical. {ECO:0000255}.
FT   TOPO_DOM    254    307       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     83     83       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     241    257       YLLLGLLAMLLAVETFS -> KSSHLTACGGRGKRSLD
FT                                (in isoform C).
FT                                {ECO:0000303|PubMed:10206991}.
FT                                /FTId=VSP_006695.
FT   VAR_SEQ     241    252       YLLLGLLAMLLA -> GGTSLQGTAWEG (in isoform
FT                                B). {ECO:0000303|PubMed:10206991,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_006693.
FT   VAR_SEQ     253    307       Missing (in isoform B).
FT                                {ECO:0000303|PubMed:10206991,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_006694.
FT   VAR_SEQ     258    307       Missing (in isoform C).
FT                                {ECO:0000303|PubMed:10206991}.
FT                                /FTId=VSP_006696.
SQ   SEQUENCE   307 AA;  31947 MW;  BD4A36DD9591ADAC CRC64;
     MGGLRPWSRY GLLVVAHLLA LGLGAVVFQA LEGPPACRLQ AELRAELAAF QAEHRACLPP
     GALEELLGTA LATQAHGVST LGNSSEGRTW DLPSALLFAA SILTTTGYGH MAPLSPGGKA
     FCMVYAALGL PASLALVATL RHCLLPVLSR PRAWVAVHWQ LSPARAALLQ AVALGLLVAS
     SFVLLPALVL WGLQGDCSLL GAVYFCFSSL STIGLEDLLP GRGRSLHPVI YHLGQLALLG
     YLLLGLLAML LAVETFSELP QVRAMGKFFR PSGPVTAEDQ GGILGQDELA LSTLPPAAPA
     SGQAPAC
//
ID   HCN4_HUMAN              Reviewed;        1203 AA.
AC   Q9Y3Q4; Q9UMQ7;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   25-OCT-2017, entry version 155.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4;
GN   Name=HCN4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=10228147; DOI=10.1093/emboj/18.9.2323;
RA   Ludwig A., Zong X., Stieber J., Hullin R., Hofmann F., Biel M.;
RT   "Two pacemaker channels from human heart with profoundly different
RT   activation kinetics.";
RL   EMBO J. 18:2323-2329(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Thalamus;
RX   PubMed=10430953; DOI=10.1073/pnas.96.16.9391;
RA   Seifert R., Scholten A., Gauss R., Mincheva A., Lichter P.,
RA   Kaupp U.B.;
RT   "Molecular characterization of a slowly gating human
RT   hyperpolarization-activated channel predominantly expressed in
RT   thalamus, heart, and testis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:9391-9396(1999).
RN   [3]
RP   FUNCTION, AND INVOLVEMENT IN BRGDA8.
RX   PubMed=19165230; DOI=10.1038/jhg.2008.16;
RA   Ueda K., Hirano Y., Higashiuesato Y., Aizawa Y., Hayashi T.,
RA   Inagaki N., Tana T., Ohya Y., Takishita S., Muratani H., Hiraoka M.,
RA   Kimura A.;
RT   "Role of HCN4 channel in preventing ventricular arrhythmia.";
RL   J. Hum. Genet. 54:115-121(2009).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 521-739 IN COMPLEX WITH CAMP,
RP   NUCLEOTIDE-BINDING, FUNCTION, ENZYME REGULATION, AND SUBUNIT.
RX   PubMed=20829353; DOI=10.1074/jbc.M110.152033;
RA   Xu X., Vysotskaya Z.V., Liu Q., Zhou L.;
RT   "Structural basis for the cAMP-dependent gating in the human HCN4
RT   channel.";
RL   J. Biol. Chem. 285:37082-37091(2010).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 521-723 IN COMPLEX WITH CAMP,
RP   NUCLEOTIDE-BINDING, ENZYME REGULATION, AND SUBUNIT.
RX   PubMed=22006928; DOI=10.1074/jbc.M111.297606;
RA   Lolicato M., Nardini M., Gazzarrini S., Moller S., Bertinetti D.,
RA   Herberg F.W., Bolognesi M., Martin H., Fasolini M., Bertrand J.A.,
RA   Arrigoni C., Thiel G., Moroni A.;
RT   "Tetramerization dynamics of C-terminal domain underlies isoform-
RT   specific cAMP gating in hyperpolarization-activated cyclic nucleotide-
RT   gated channels.";
RL   J. Biol. Chem. 286:44811-44820(2011).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 521-724, AND CHARACTERIZATION
RP   OF VARIANT SSS2 ARG-672.
RX   PubMed=23103389; DOI=10.1016/j.str.2012.09.017;
RA   Xu X., Marni F., Wu S., Su Z., Musayev F., Shrestha S., Xie C.,
RA   Gao W., Liu Q., Zhou L.;
RT   "Local and global interpretations of a disease-causing mutation near
RT   the ligand entry path in hyperpolarization-activated cAMP-gated
RT   channel.";
RL   Structure 20:2116-2123(2012).
RN   [7]
RP   VARIANT SSS2 ASN-553.
RX   PubMed=15123648; DOI=10.1074/jbc.M311953200;
RA   Ueda K., Nakamura K., Hayashi T., Inagaki N., Takahashi M.,
RA   Arimura T., Morita H., Higashiuesato Y., Hirano Y., Yasunami M.,
RA   Takishita S., Yamashina A., Ohe T., Sunamori M., Hiraoka M.,
RA   Kimura A.;
RT   "Functional characterization of a trafficking-defective HCN4 mutation,
RT   D553N, associated with cardiac arrhythmia.";
RL   J. Biol. Chem. 279:27194-27198(2004).
RN   [8]
RP   VARIANT SSS2 ARG-672, FUNCTION, ENZYME REGULATION, SUBCELLULAR
RP   LOCATION, AND CHARACTERIZATION OF VARIANT SSS2 ARG-672.
RX   PubMed=16407510; DOI=10.1056/NEJMoa052475;
RA   Milanesi R., Baruscotti M., Gnecchi-Ruscone T., DiFrancesco D.;
RT   "Familial sinus bradycardia associated with a mutation in the cardiac
RT   pacemaker channel.";
RL   N. Engl. J. Med. 354:151-157(2006).
RN   [9]
RP   VARIANT SSS2 VAL-485, AND CHARACTERIZATION OF VARIANT SSS2 VAL-485.
RX   PubMed=20662977; DOI=10.1111/j.1540-8167.2010.01844.x;
RA   Laish-Farkash A., Glikson M., Brass D., Marek-Yagel D., Pras E.,
RA   Dascal N., Antzelevitch C., Nof E., Reznik H., Eldar M., Luria D.;
RT   "A novel mutation in the HCN4 gene causes symptomatic sinus
RT   bradycardia in Moroccan Jews.";
RL   J. Cardiovasc. Electrophysiol. 21:1365-1372(2010).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel with very slow
CC       activation and inactivation exhibiting weak selectivity for
CC       potassium over sodium ions. Contributes to the native pacemaker
CC       currents in heart (If) that regulate the rhythm of heart beat. May
CC       contribute to the native pacemaker currents in neurons (Ih). May
CC       mediate responses to sour stimuli. {ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:10430953, ECO:0000269|PubMed:16407510,
CC       ECO:0000269|PubMed:19165230, ECO:0000269|PubMed:20829353}.
CC   -!- ENZYME REGULATION: Activated by cAMP. cAMP binding causes a
CC       conformation change that leads to the assembly of an active
CC       tetramer and channel opening. {ECO:0000269|PubMed:16407510,
CC       ECO:0000269|PubMed:20829353, ECO:0000269|PubMed:22006928}.
CC   -!- SUBUNIT: Homotetramer. The potassium channel is composed of a
CC       homo- or heterotetrameric complex of pore-forming subunits.
CC       {ECO:0000269|PubMed:20829353, ECO:0000269|PubMed:22006928}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-1753521, EBI-1753521;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:10430953, ECO:0000269|PubMed:16407510}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:10430953, ECO:0000269|PubMed:16407510}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in thalamus, testis and in
CC       heart, both in ventricle and atrium. Detected at much lower levels
CC       in amygdala, substantia nigra, cerebellum and hippocampus.
CC       {ECO:0000269|PubMed:10228147, ECO:0000269|PubMed:10430953}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- DISEASE: Sick sinus syndrome 2 (SSS2) [MIM:163800]: The term 'sick
CC       sinus syndrome' encompasses a variety of conditions caused by
CC       sinus node dysfunction. The most common clinical manifestations
CC       are syncope, presyncope, dizziness, and fatigue. Electrocardiogram
CC       typically shows sinus bradycardia, sinus arrest, and/or sinoatrial
CC       block. Episodes of atrial tachycardias coexisting with sinus
CC       bradycardia ('tachycardia-bradycardia syndrome') are also common
CC       in this disorder. SSS occurs most often in the elderly associated
CC       with underlying heart disease or previous cardiac surgery, but can
CC       also occur in the fetus, infant, or child without heart disease or
CC       other contributing factors. SSS2 onset is in utero or at birth.
CC       {ECO:0000269|PubMed:15123648, ECO:0000269|PubMed:16407510,
CC       ECO:0000269|PubMed:20662977, ECO:0000269|PubMed:23103389}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Brugada syndrome 8 (BRGDA8) [MIM:613123]: A
CC       tachyarrhythmia characterized by right bundle branch block and ST
CC       segment elevation on an electrocardiogram (ECG). It can cause the
CC       ventricles to beat so fast that the blood is prevented from
CC       circulating efficiently in the body. When this situation occurs,
CC       the individual will faint and may die in a few minutes if the
CC       heart is not reset. {ECO:0000269|PubMed:19165230}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- MISCELLANEOUS: Inhibited by extracellular cesium ions.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ132429; CAB42604.1; -; mRNA.
DR   EMBL; AJ238850; CAB52754.1; -; mRNA.
DR   CCDS; CCDS10248.1; -.
DR   RefSeq; NP_005468.1; NM_005477.2.
DR   UniGene; Hs.86941; -.
DR   PDB; 2MNG; NMR; -; A=579-707.
DR   PDB; 3OTF; X-ray; 2.40 A; A=521-739.
DR   PDB; 3U11; X-ray; 2.50 A; A/B=521-723.
DR   PDB; 4HBN; X-ray; 2.60 A; A=521-724.
DR   PDB; 4KL1; X-ray; 2.70 A; A/B/C/D=521-713.
DR   PDB; 4NVP; X-ray; 2.50 A; A=521-723.
DR   PDBsum; 2MNG; -.
DR   PDBsum; 3OTF; -.
DR   PDBsum; 3U11; -.
DR   PDBsum; 4HBN; -.
DR   PDBsum; 4KL1; -.
DR   PDBsum; 4NVP; -.
DR   ProteinModelPortal; Q9Y3Q4; -.
DR   SMR; Q9Y3Q4; -.
DR   BioGrid; 115338; 3.
DR   DIP; DIP-52325N; -.
DR   IntAct; Q9Y3Q4; 3.
DR   STRING; 9606.ENSP00000261917; -.
DR   BindingDB; Q9Y3Q4; -.
DR   ChEMBL; CHEMBL1250417; -.
DR   GuidetoPHARMACOLOGY; 403; -.
DR   TCDB; 1.A.1.5.10; the voltage-gated ion channel (vic) superfamily.
DR   TCDB; 1.A.1.5.11; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9Y3Q4; -.
DR   PhosphoSitePlus; Q9Y3Q4; -.
DR   BioMuta; HCN4; -.
DR   DMDM; 38605641; -.
DR   EPD; Q9Y3Q4; -.
DR   MaxQB; Q9Y3Q4; -.
DR   PaxDb; Q9Y3Q4; -.
DR   PeptideAtlas; Q9Y3Q4; -.
DR   PRIDE; Q9Y3Q4; -.
DR   DNASU; 10021; -.
DR   Ensembl; ENST00000261917; ENSP00000261917; ENSG00000138622.
DR   GeneID; 10021; -.
DR   KEGG; hsa:10021; -.
DR   UCSC; uc002avp.3; human.
DR   CTD; 10021; -.
DR   DisGeNET; 10021; -.
DR   EuPathDB; HostDB:ENSG00000138622.3; -.
DR   GeneCards; HCN4; -.
DR   GeneReviews; HCN4; -.
DR   HGNC; HGNC:16882; HCN4.
DR   MalaCards; HCN4; -.
DR   MIM; 163800; phenotype.
DR   MIM; 605206; gene.
DR   MIM; 613123; phenotype.
DR   neXtProt; NX_Q9Y3Q4; -.
DR   OpenTargets; ENSG00000138622; -.
DR   Orphanet; 130; Brugada syndrome.
DR   Orphanet; 166282; Familial sick sinus syndrome.
DR   PharmGKB; PA394; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039490; -.
DR   InParanoid; Q9Y3Q4; -.
DR   KO; K04957; -.
DR   OMA; AIPGQHV; -.
DR   OrthoDB; EOG091G0JQU; -.
DR   PhylomeDB; Q9Y3Q4; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-HSA-1296061; HCN channels.
DR   SIGNOR; Q9Y3Q4; -.
DR   EvolutionaryTrace; Q9Y3Q4; -.
DR   GeneWiki; HCN4; -.
DR   GenomeRNAi; 10021; -.
DR   PRO; PR:Q9Y3Q4; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000138622; -.
DR   CleanEx; HS_HCN4; -.
DR   Genevisible; Q9Y3Q4; HS.
DR   GO; GO:0098855; C:HCN channel complex; IDA:BHF-UCL.
DR   GO; GO:0031226; C:intrinsic component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0086041; F:voltage-gated potassium channel activity involved in SA node cell action potential depolarization; IMP:BHF-UCL.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IMP:UniProtKB.
DR   GO; GO:0008015; P:blood circulation; NAS:ProtInc.
DR   GO; GO:0006812; P:cation transport; IDA:BHF-UCL.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:UniProtKB.
DR   GO; GO:0071321; P:cellular response to cGMP; IDA:UniProtKB.
DR   GO; GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:0086046; P:membrane depolarization during SA node cell action potential; IMP:BHF-UCL.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0098909; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; IMP:BHF-UCL.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0002027; P:regulation of heart rate; IMP:UniProtKB.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0003254; P:regulation of membrane depolarization; IDA:BHF-UCL.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:UniProtKB.
DR   GO; GO:0086015; P:SA node cell action potential; IMP:BHF-UCL.
DR   GO; GO:0098719; P:sodium ion import across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IMP:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR030173; HCN4.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF375; PTHR10217:SF375; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Brugada syndrome; cAMP; cAMP-binding; Cell membrane;
KW   Complete proteome; Disease mutation; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Sodium; Sodium channel; Sodium transport;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1203       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                4.
FT                                /FTId=PRO_0000054117.
FT   TOPO_DOM      1    266       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    267    287       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    288    293       Extracellular. {ECO:0000255}.
FT   TRANSMEM    294    314       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    315    340       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    341    361       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    362    368       Extracellular. {ECO:0000255}.
FT   TRANSMEM    369    389       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    390    420       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    421    441       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    442    464       Extracellular. {ECO:0000255}.
FT   INTRAMEM    465    486       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    487    496       Extracellular. {ECO:0000255}.
FT   TRANSMEM    497    517       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    518   1203       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     659    662       cAMP. {ECO:0000269|PubMed:20829353,
FT                                ECO:0000269|PubMed:22006928}.
FT   NP_BIND     669    670       cAMP. {ECO:0000269|PubMed:20829353,
FT                                ECO:0000269|PubMed:22006928}.
FT   NP_BIND     710    713       cAMP. {ECO:0000269|PubMed:20829353,
FT                                ECO:0000269|PubMed:22006928}.
FT   REGION      209    260       Involved in subunit assembly.
FT                                {ECO:0000250}.
FT   COMPBIAS    924   1076       Pro-rich.
FT   MOD_RES     138    138       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JKA7}.
FT   MOD_RES    1105   1105       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70507}.
FT   MOD_RES    1108   1108       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70507}.
FT   CARBOHYD    458    458       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     485    485       A -> V (in SSS2; results in a significant
FT                                reduction of current density compared to
FT                                wild-type).
FT                                {ECO:0000269|PubMed:20662977}.
FT                                /FTId=VAR_066614.
FT   VARIANT     553    553       D -> N (in SSS2; dbSNP:rs104894485).
FT                                {ECO:0000269|PubMed:15123648}.
FT                                /FTId=VAR_026534.
FT   VARIANT     672    672       S -> R (in SSS2; results in decreased
FT                                affinity for cAMP but does not abolish
FT                                channel activation; shifts the current
FT                                activation range to hyperpolarized
FT                                voltages; slows channel opening and
FT                                speeds up channel closure;
FT                                dbSNP:rs104894488).
FT                                {ECO:0000269|PubMed:16407510,
FT                                ECO:0000269|PubMed:23103389}.
FT                                /FTId=VAR_026535.
FT   CONFLICT    110    110       S -> T (in Ref. 2; CAB52754).
FT                                {ECO:0000305}.
FT   HELIX       522    540       {ECO:0000244|PDB:3OTF}.
FT   HELIX       545    559       {ECO:0000244|PDB:3OTF}.
FT   HELIX       566    571       {ECO:0000244|PDB:3OTF}.
FT   HELIX       575    585       {ECO:0000244|PDB:3OTF}.
FT   HELIX       587    591       {ECO:0000244|PDB:3OTF}.
FT   HELIX       594    597       {ECO:0000244|PDB:3OTF}.
FT   HELIX       601    608       {ECO:0000244|PDB:3OTF}.
FT   STRAND      612    616       {ECO:0000244|PDB:3OTF}.
FT   STRAND      621    623       {ECO:0000244|PDB:3OTF}.
FT   STRAND      631    637       {ECO:0000244|PDB:3OTF}.
FT   STRAND      640    643       {ECO:0000244|PDB:3OTF}.
FT   STRAND      645    647       {ECO:0000244|PDB:3OTF}.
FT   STRAND      650    652       {ECO:0000244|PDB:3OTF}.
FT   HELIX       661    665       {ECO:0000244|PDB:3OTF}.
FT   STRAND      666    668       {ECO:0000244|PDB:4KL1}.
FT   STRAND      670    677       {ECO:0000244|PDB:3OTF}.
FT   STRAND      679    685       {ECO:0000244|PDB:3OTF}.
FT   HELIX       686    695       {ECO:0000244|PDB:3OTF}.
FT   HELIX       697    699       {ECO:0000244|PDB:3OTF}.
FT   HELIX       700    712       {ECO:0000244|PDB:3OTF}.
SQ   SEQUENCE   1203 AA;  129042 MW;  7EFDD2D69CF1F9D9 CRC64;
     MDKLPPSMRK RLYSLPQQVG AKAWIMDEEE DAEEEGAGGR QDPSRRSIRL RPLPSPSPSA
     AAGGTESRSS ALGAADSEGP ARGAGKSSTN GDCRRFRGSL ASLGSRGGGS GGTGSGSSHG
     HLHDSAEERR LIAEGDASPG EDRTPPGLAA EPERPGASAQ PAASPPPPQQ PPQPASASCE
     QPSVDTAIKV EGGAAAGDQI LPEAEVRLGQ AGFMQRQFGA MLQPGVNKFS LRMFGSQKAV
     EREQERVKSA GFWIIHPYSD FRFYWDLTML LLMVGNLIII PVGITFFKDE NTTPWIVFNV
     VSDTFFLIDL VLNFRTGIVV EDNTEIILDP QRIKMKYLKS WFMVDFISSI PVDYIFLIVE
     TRIDSEVYKT ARALRIVRFT KILSLLRLLR LSRLIRYIHQ WEEIFHMTYD LASAVVRIVN
     LIGMMLLLCH WDGCLQFLVP MLQDFPDDCW VSINNMVNNS WGKQYSYALF KAMSHMLCIG
     YGRQAPVGMS DVWLTMLSMI VGATCYAMFI GHATALIQSL DSSRRQYQEK YKQVEQYMSF
     HKLPPDTRQR IHDYYEHRYQ GKMFDEESIL GELSEPLREE IINFNCRKLV ASMPLFANAD
     PNFVTSMLTK LRFEVFQPGD YIIREGTIGK KMYFIQHGVV SVLTKGNKET KLADGSYFGE
     ICLLTRGRRT ASVRADTYCR LYSLSVDNFN EVLEEYPMMR RAFETVALDR LDRIGKKNSI
     LLHKVQHDLN SGVFNYQENE IIQQIVQHDR EMAHCAHRVQ AAASATPTPT PVIWTPLIQA
     PLQAAAATTS VAIALTHHPR LPAAIFRPPP GSGLGNLGAG QTPRHLKRLQ SLIPSALGSA
     SPASSPSQVD TPSSSSFHIQ QLAGFSAPAG LSPLLPSSSS SPPPGACGSP SAPTPSAGVA
     ATTIAGFGHF HKALGGSLSS SDSPLLTPLQ PGARSPQAAQ PSPAPPGARG GLGLPEHFLP
     PPPSSRSPSS SPGQLGQPPG ELSLGLATGP LSTPETPPRQ PEPPSLVAGA SGGASPVGFT
     PRGGLSPPGH SPGPPRTFPS APPRASGSHG SLLLPPASSP PPPQVPQRRG TPPLTPGRLT
     QDLKLISASQ PALPQDGAQT LRRASPHSSG ESMAAFPLFP RAGGGSGGSG SSGGLGPPGR
     PYGAIPGQHV TLPRKTSSGS LPPPLSLFGA RATSSGGPPL TAGPQREPGA RPEPVRSKLP
     SNL
//
ID   KCNE3_HUMAN             Reviewed;         103 AA.
AC   Q9Y6H6;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   22-NOV-2017, entry version 145.
DE   RecName: Full=Potassium voltage-gated channel subfamily E member 3;
DE   AltName: Full=MinK-related peptide 2;
DE   AltName: Full=Minimum potassium ion channel-related peptide 2;
DE   AltName: Full=Potassium channel subunit beta MiRP2;
GN   Name=KCNE3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Abbott G.W., Sesti F., Buck M.E., Goldstein S.A.N.;
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11104781; DOI=10.1074/jbc.M010713200;
RA   Melman Y.F., Domenech A., de La Luna S., McDonald T.V.;
RT   "Structural determinants of KvLQT1 control by the KCNE family of
RT   proteins.";
RL   J. Biol. Chem. 276:6439-6444(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=10646604; DOI=10.1038/35003200;
RA   Schroeder B.C., Waldegger S., Fehr S., Bleich M., Warth R., Greger R.,
RA   Jentsch T.J.;
RT   "A constitutively open potassium channel formed by KCNQ1 and KCNE3.";
RL   Nature 403:196-199(2000).
RN   [5]
RP   ASSOCIATION WITH KCNC4, AND VARIANT HIS-83.
RX   PubMed=11207363; DOI=10.1016/S0092-8674(01)00207-0;
RA   Abbott G.W., Butler M.H., Bendahhou S., Dalakas M.C., Ptacek L.J.,
RA   Goldstein S.A.N.;
RT   "MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is
RT   associated with periodic paralysis.";
RL   Cell 104:217-231(2001).
RN   [6]
RP   MUTAGENESIS OF ASP-90.
RX   PubMed=11874988; DOI=10.1096/fj.01-0520hyp;
RA   Abbott G.W., Goldstein S.A.N.;
RT   "Disease-associated mutations in KCNE potassium channel subunits
RT   (MiRPs) reveal promiscuous disruption of multiple currents and
RT   conservation of mechanism.";
RL   FASEB J. 16:390-400(2002).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12954870;
RA   McCrossan Z.A., Lewis A., Panaghie G., Jordan P.N., Christini D.J.,
RA   Lerner D.J., Abbott G.W.;
RT   "MinK-related peptide 2 modulates Kv2.1 and Kv3.1 potassium channels
RT   in mammalian brain.";
RL   J. Neurosci. 23:8077-8091(2003).
RN   [8]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH KCNQ1.
RX   PubMed=20533308; DOI=10.1002/jcp.22265;
RA   Roura-Ferrer M., Sole L., Oliveras A., Dahan R., Bielanska J.,
RA   Villarroel A., Comes N., Felipe A.;
RT   "Impact of KCNE subunits on KCNQ1 (Kv7.1) channel membrane surface
RT   targeting.";
RL   J. Cell. Physiol. 225:692-700(2010).
RN   [9]
RP   VARIANT HIS-83.
RX   PubMed=12414843; DOI=10.1210/jc.2002-020698;
RA   Dias Da Silva M.R., Cerutti J.M., Arnaldi L.A.T., Maciel R.M.B.;
RT   "A mutation in the KCNE3 potassium channel gene is associated with
RT   susceptibility to thyrotoxic hypokalemic periodic paralysis.";
RL   J. Clin. Endocrinol. Metab. 87:4881-4884(2002).
RN   [10]
RP   LACK OF ASSOCIATION OF VARIANT HIS-83 WITH PERIODIC PARALISIS.
RX   PubMed=14504341; DOI=10.1212/01.WNL.0000082392.66713.E3;
RA   Sternberg D., Tabti N., Fournier E., Hainque B., Fontaine B.;
RT   "Lack of association of the potassium channel-associated peptide
RT   MiRP2-R83H variant with periodic paralysis.";
RL   Neurology 61:857-859(2003).
RN   [11]
RP   LACK OF ASSOCIATION OF VARIANT HIS-83 WITH PERIODIC PARALISIS.
RX   PubMed=15037716; DOI=10.1212/01.WNL.0000119392.29624.88;
RA   Jurkat-Rott K., Lehmann-Horn F.;
RT   "Periodic paralysis mutation MiRP2-R83H in controls: Interpretations
RT   and general recommendation.";
RL   Neurology 62:1012-1015(2004).
RN   [12]
RP   VARIANT BRGDA6 HIS-99.
RX   PubMed=19122847; DOI=10.1161/CIRCEP.107.748103;
RA   Delpon E., Cordeiro J.M., Nunez L., Thomsen P.E., Guerchicoff A.,
RA   Pollevick G.D., Wu Y., Kanters J.K., Larsen C.T., Hofman-Bang J.,
RA   Burashnikov E., Christiansen M., Antzelevitch C.;
RT   "Functional effects of KCNE3 mutation and its role in the development
RT   of Brugada syndrome.";
RL   Circ. Arrhythm. Electrophysiol. 1:209-218(2008).
RN   [13]
RP   VARIANTS ALA-4; ARG-39 AND HIS-99.
RX   PubMed=19306396; DOI=10.1002/humu.20834;
RA   Ohno S., Toyoda F., Zankov D.P., Yoshida H., Makiyama T., Tsuji K.,
RA   Honda T., Obayashi K., Ueyama H., Shimizu W., Miyamoto Y.,
RA   Kamakura S., Matsuura H., Kita T., Horie M.;
RT   "Novel KCNE3 mutation reduces repolarizing potassium current and
RT   associated with long QT syndrome.";
RL   Hum. Mutat. 30:557-563(2009).
CC   -!- FUNCTION: Ancillary protein that assembles as a beta subunit with
CC       a voltage-gated potassium channel complex of pore-forming alpha
CC       subunits. Modulates the gating kinetics and enhances stability of
CC       the channel complex. Assembled with KCNB1 modulates the gating
CC       characteristics of the delayed rectifier voltage-dependent
CC       potassium channel KCNB1 (PubMed:12954870). Associated with
CC       KCNC4/Kv3.4 is proposed to form the subthreshold voltage-gated
CC       potassium channel in skeletal muscle and to establish the resting
CC       membrane potential (RMP) in muscle cells. Associated with
CC       KCNQ1/KCLQT1 may form the intestinal cAMP-stimulated potassium
CC       channel involved in chloride secretion that produces a current
CC       with nearly instantaneous activation with a linear current-voltage
CC       relationship. {ECO:0000250|UniProtKB:Q9JJV7,
CC       ECO:0000269|PubMed:10646604, ECO:0000269|PubMed:12954870}.
CC   -!- SUBUNIT: Interacts with KCNB1. Interacts with KCNC2 (By
CC       similarity). Associates with KCNC4/Kv3.4 (PubMed:11207363).
CC       Interacts with KCNQ1; produces a current with nearly instantaneous
CC       activation with a linear current-voltage relationship and alters
CC       membrane raft localization (By similarity) (PubMed:20533308).
CC       {ECO:0000250|UniProtKB:Q9JJV7, ECO:0000269|PubMed:11207363,
CC       ECO:0000269|PubMed:20533308}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12954870};
CC       Single-pass type I membrane protein {ECO:0000305}. Cytoplasm
CC       {ECO:0000269|PubMed:12954870}. Perikaryon
CC       {ECO:0000269|PubMed:12954870}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:12954870}. Membrane raft
CC       {ECO:0000269|PubMed:20533308}. Note=Colocalizes with KCNB1 at
CC       high-density somatodendritic clusters on the surface of
CC       hippocampal neurons. {ECO:0000269|PubMed:12954870}.
CC   -!- TISSUE SPECIFICITY: Expressed in hippocampal neurons (at protein
CC       level) (PubMed:12954870). Widely expressed with highest levels in
CC       kidney and moderate levels in small intestine.
CC       {ECO:0000269|PubMed:10646604, ECO:0000269|PubMed:12954870}.
CC   -!- SIMILARITY: Belongs to the potassium channel KCNE family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Variant His-83 has been associated with periodic
CC       paralysis (PubMed:11207363 and PubMed:12414843). The association
CC       could not be confirmed by further studies leading to the
CC       conclusion that His-83 does not play a causative role in the
CC       disease (PubMed:14504341 and PubMed:15037716). {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF076531; AAD28089.1; -; mRNA.
DR   EMBL; AF302494; AAG16255.1; -; mRNA.
DR   EMBL; BC032235; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS8232.1; -.
DR   RefSeq; NP_005463.1; NM_005472.4.
DR   RefSeq; XP_016872536.1; XM_017017047.1.
DR   RefSeq; XP_016872537.1; XM_017017048.1.
DR   RefSeq; XP_016872538.1; XM_017017049.1.
DR   RefSeq; XP_016872539.1; XM_017017050.1.
DR   RefSeq; XP_016872540.1; XM_017017051.1.
DR   RefSeq; XP_016872541.1; XM_017017052.1.
DR   UniGene; Hs.523899; -.
DR   PDB; 2NDJ; NMR; -; A=1-103.
DR   PDBsum; 2NDJ; -.
DR   ProteinModelPortal; Q9Y6H6; -.
DR   SMR; Q9Y6H6; -.
DR   BioGrid; 115326; 10.
DR   CORUM; Q9Y6H6; -.
DR   IntAct; Q9Y6H6; 10.
DR   MINT; MINT-8247512; -.
DR   STRING; 9606.ENSP00000310557; -.
DR   iPTMnet; Q9Y6H6; -.
DR   PhosphoSitePlus; Q9Y6H6; -.
DR   BioMuta; KCNE3; -.
DR   PaxDb; Q9Y6H6; -.
DR   PRIDE; Q9Y6H6; -.
DR   DNASU; 10008; -.
DR   Ensembl; ENST00000310128; ENSP00000310557; ENSG00000175538.
DR   Ensembl; ENST00000525550; ENSP00000433633; ENSG00000175538.
DR   GeneID; 10008; -.
DR   KEGG; hsa:10008; -.
DR   UCSC; uc001ovc.4; human.
DR   CTD; 10008; -.
DR   DisGeNET; 10008; -.
DR   EuPathDB; HostDB:ENSG00000175538.10; -.
DR   GeneCards; KCNE3; -.
DR   GeneReviews; KCNE3; -.
DR   HGNC; HGNC:6243; KCNE3.
DR   HPA; HPA014849; -.
DR   MalaCards; KCNE3; -.
DR   MIM; 604433; gene.
DR   MIM; 613119; phenotype.
DR   neXtProt; NX_Q9Y6H6; -.
DR   OpenTargets; ENSG00000175538; -.
DR   Orphanet; 130; Brugada syndrome.
DR   Orphanet; 681; Hypokalemic periodic paralysis.
DR   PharmGKB; PA393; -.
DR   eggNOG; ENOG410IZ1X; Eukaryota.
DR   eggNOG; ENOG410XU3Y; LUCA.
DR   GeneTree; ENSGT00390000008537; -.
DR   HOGENOM; HOG000113209; -.
DR   HOVERGEN; HBG052228; -.
DR   InParanoid; Q9Y6H6; -.
DR   KO; K04897; -.
DR   OMA; YKSLHAV; -.
DR   OrthoDB; EOG091G0Z41; -.
DR   PhylomeDB; Q9Y6H6; -.
DR   TreeFam; TF335981; -.
DR   Reactome; R-HSA-5576890; Phase 3 - rapid repolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   ChiTaRS; KCNE3; human.
DR   GeneWiki; KCNE3; -.
DR   GenomeRNAi; 10008; -.
DR   PRO; PR:Q9Y6H6; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000175538; -.
DR   CleanEx; HS_KCNE3; -.
DR   ExpressionAtlas; Q9Y6H6; baseline and differential.
DR   Genevisible; Q9Y6H6; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IDA:UniProtKB.
DR   GO; GO:0031982; C:vesicle; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:Ensembl.
DR   GO; GO:0044325; F:ion channel binding; IEA:Ensembl.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   GO; GO:1902260; P:negative regulation of delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:1905025; P:negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:1903765; P:negative regulation of potassium ion export across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:1903817; P:negative regulation of voltage-gated potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:1901387; P:positive regulation of voltage-gated calcium channel activity; IEA:Ensembl.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   InterPro; IPR000369; K_chnl_KCNE.
DR   InterPro; IPR005426; K_chnl_volt-dep_bsu_KCNE3.
DR   PANTHER; PTHR15282; PTHR15282; 1.
DR   PANTHER; PTHR15282:SF6; PTHR15282:SF6; 1.
DR   Pfam; PF02060; ISK_Channel; 1.
DR   PRINTS; PR01606; KCNE3CHANNEL.
DR   PRINTS; PR00168; KCNECHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Brugada syndrome; Cell membrane; Cell projection;
KW   Complete proteome; Cytoplasm; Disease mutation; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    103       Potassium voltage-gated channel subfamily
FT                                E member 3.
FT                                /FTId=PRO_0000144289.
FT   TRANSMEM     58     78       Helical. {ECO:0000255}.
FT   TOPO_DOM     79    103       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD      5      5       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     22     22       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     41     41       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT       4      4       T -> A (in dbSNP:rs200856070).
FT                                {ECO:0000269|PubMed:19306396}.
FT                                /FTId=VAR_058635.
FT   VARIANT      39     39       P -> R (in dbSNP:rs34604640).
FT                                {ECO:0000269|PubMed:19306396}.
FT                                /FTId=VAR_058636.
FT   VARIANT      83     83       R -> H (in some patients with periodic
FT                                paralysis; unknown pathological
FT                                significance; alters voltage dependence,
FT                                lowers current and diminishes open
FT                                probability in KCNC4/KCNE3 channel;
FT                                lowers current in KCNQ1/KCNE3 channel;
FT                                dbSNP:rs17215437).
FT                                {ECO:0000269|PubMed:11207363,
FT                                ECO:0000269|PubMed:12414843}.
FT                                /FTId=VAR_015064.
FT   VARIANT      99     99       R -> H (in BRGDA6; also in a patient
FT                                suffering from drug-induced torsades de
FT                                pointes; dbSNP:rs121908441).
FT                                {ECO:0000269|PubMed:19122847,
FT                                ECO:0000269|PubMed:19306396}.
FT                                /FTId=VAR_058637.
FT   MUTAGEN      90     90       D->N: Decreases current 4-fold in
FT                                KCNH2/KCNE3 channel.
FT                                {ECO:0000269|PubMed:11874988}.
FT   HELIX         8     29       {ECO:0000244|PDB:2NDJ}.
FT   HELIX        55     80       {ECO:0000244|PDB:2NDJ}.
FT   TURN         91     95       {ECO:0000244|PDB:2NDJ}.
SQ   SEQUENCE   103 AA;  11710 MW;  5235385E8D08BF10 CRC64;
     METTNGTETW YESLHAVLKA LNATLHSNLL CRPGPGLGPD NQTEERRASL PGRDDNSYMY
     ILFVMFLFAV TVGSLILGYT RSRKVDKRSD PYHVYIKNRV SMI
//
ID   KCNE2_HUMAN             Reviewed;         123 AA.
AC   Q9Y6J6; A5H1P3; D3DSF8; Q52LJ5;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   22-NOV-2017, entry version 160.
DE   RecName: Full=Potassium voltage-gated channel subfamily E member 2;
DE   AltName: Full=MinK-related peptide 1;
DE   AltName: Full=Minimum potassium ion channel-related peptide 1;
DE   AltName: Full=Potassium channel subunit beta MiRP1;
GN   Name=KCNE2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS LQT6 THR-54 AND THR-57, VARIANTS
RP   ALA-8 AND GLU-9, FUNCTION, CHARACTERIZATION OF VARIANTS LQT6 THR-54
RP   AND THR-57, CHARACTERIZATION OF VARIANT GLU-9, AND INTERACTION WITH
RP   KCNH2.
RC   TISSUE=Heart;
RX   PubMed=10219239; DOI=10.1016/S0092-8674(00)80728-X;
RA   Abbott G.W., Sesti F., Splawski I., Buck M.E., Lehmann M.H.,
RA   Timothy K.W., Keating M.T., Goldstein S.A.N.;
RT   "MiRP1 forms IKr potassium channels with HERG and is associated with
RT   cardiac arrhythmia.";
RL   Cell 97:175-187(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Domenech A., Estivill X., de la Luna S.;
RT   "Cloning of human MIRP1 cDNA.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   ASSOCIATION WITH KCNQ2/KCNQ3, AND TISSUE SPECIFICITY.
RX   PubMed=11034315; DOI=10.1016/S0014-5793(00)01918-9;
RA   Tinel N., Diochot S., Lauritzen I., Barhanin J., Lazdunski M.,
RA   Borsotto M.;
RT   "M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2
RT   subunit.";
RL   FEBS Lett. 480:137-141(2000).
RN   [7]
RP   INTERACTION WITH KCNQ1, AND FUNCTION.
RX   PubMed=11101505; DOI=10.1093/emboj/19.23.6326;
RA   Tinel N., Diochot S., Borsotto M., Lazdunski M., Barhanin J.;
RT   "KCNE2 confers background current characteristics to the cardiac KCNQ1
RT   potassium channel.";
RL   EMBO J. 19:6326-6330(2000).
RN   [8]
RP   MUTAGENESIS OF LYS-75.
RX   PubMed=11874988; DOI=10.1096/fj.01-0520hyp;
RA   Abbott G.W., Goldstein S.A.N.;
RT   "Disease-associated mutations in KCNE potassium channel subunits
RT   (MiRPs) reveal promiscuous disruption of multiple currents and
RT   conservation of mechanism.";
RL   FASEB J. 16:390-400(2002).
RN   [9]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH KCNQ1.
RX   PubMed=20533308; DOI=10.1002/jcp.22265;
RA   Roura-Ferrer M., Sole L., Oliveras A., Dahan R., Bielanska J.,
RA   Villarroel A., Comes N., Felipe A.;
RT   "Impact of KCNE subunits on KCNQ1 (Kv7.1) channel membrane surface
RT   targeting.";
RL   J. Cell. Physiol. 225:692-700(2010).
RN   [10]
RP   VARIANT LQT6 MET-65.
RX   PubMed=12185453; DOI=10.1007/s00109-002-0364-0;
RA   Isbrandt D., Friederich P., Solth A., Haverkamp W., Ebneth A.,
RA   Borggrefe M., Funke H., Sauter K., Breithardt G., Pongs O.,
RA   Schulze-Bahr E.;
RT   "Identification and functional characterization of a novel KCNE2
RT   (MiRP1) mutation that alters HERG channel kinetics.";
RL   J. Mol. Med. 80:524-532(2002).
RN   [11]
RP   VARIANT ATFB4 CYS-27, AND CHARACTERIZATION OF VARIANT ATFB4 CYS-27.
RX   PubMed=15368194; DOI=10.1086/425342;
RA   Yang Y., Xia M., Jin Q., Bendahhou S., Shi J., Chen Y., Liang B.,
RA   Lin J., Liu Y., Liu B., Zhou Q., Zhang D., Wang R., Ma N., Su X.,
RA   Niu K., Pei Y., Xu W., Chen Z., Wan H., Cui J., Barhanin J., Chen Y.;
RT   "Identification of a KCNE2 gain-of-function mutation in patients with
RT   familial atrial fibrillation.";
RL   Am. J. Hum. Genet. 75:899-905(2004).
RN   [12]
RP   VARIANTS LQT6 THR-57; LEU-60 AND TRP-77, AND VARIANT ALA-8.
RX   PubMed=16922724; DOI=10.1111/j.1399-0004.2006.00671.x;
RA   Millat G., Chevalier P., Restier-Miron L., Da Costa A., Bouvagnet P.,
RA   Kugener B., Fayol L., Gonzalez Armengod C., Oddou B., Chanavat V.,
RA   Froidefond E., Perraudin R., Rousson R., Rodriguez-Lafrasse C.;
RT   "Spectrum of pathogenic mutations and associated polymorphisms in a
RT   cohort of 44 unrelated patients with long QT syndrome.";
RL   Clin. Genet. 70:214-227(2006).
RN   [13]
RP   VARIANTS LQT6 ILE-14; ASN-20; HIS-27; THR-54; THR-57; LEU-65; GLN-77
RP   AND GLY-94.
RX   PubMed=19716085; DOI=10.1016/j.hrthm.2009.05.021;
RA   Kapplinger J.D., Tester D.J., Salisbury B.A., Carr J.L.,
RA   Harris-Kerr C., Pollevick G.D., Wilde A.A., Ackerman M.J.;
RT   "Spectrum and prevalence of mutations from the first 2,500 consecutive
RT   unrelated patients referred for the FAMILION long QT syndrome genetic
RT   test.";
RL   Heart Rhythm 6:1297-1303(2009).
CC   -!- FUNCTION: Ancillary protein that assembles as a beta subunit with
CC       a voltage-gated potassium channel complex of pore-forming alpha
CC       subunits. Modulates the gating kinetics and enhances stability of
CC       the channel complex. Assembled with KCNB1 modulates the gating
CC       characteristics of the delayed rectifier voltage-dependent
CC       potassium channel KCNB1. Associated with KCNH2/HERG is proposed to
CC       form the rapidly activating component of the delayed rectifying
CC       potassium current in heart (IKr). May associate with KCNQ2 and/or
CC       KCNQ3 and modulate the native M-type current. May associate with
CC       HCN1 and HCN2 and increase potassium current. Interacts with
CC       KCNQ1; forms a heterooligomer complex leading to currents with an
CC       apparently instantaneous activation, a rapid deactivation process
CC       and a linear current-voltage relationship and decreases the
CC       amplitude of the outward current (PubMed:11101505).
CC       {ECO:0000250|UniProtKB:P63161, ECO:0000269|PubMed:10219239,
CC       ECO:0000269|PubMed:11101505}.
CC   -!- SUBUNIT: Interacts with KCNB1 (By similarity). Associates with
CC       KCNH2/ERG1 (PubMed:10219239). May associate with KCNQ2 and KCNQ3
CC       (PubMed:11034315,). Associates with HCN1 and probably HCN2.
CC       Heteromultimer with KCNC2. Interacts with KCNC2 (By similarity).
CC       Interacts with KCNQ1; forms a heterooligomer complex that targets
CC       to the membrane raft and leading to currents with an apparently
CC       instantaneous activation, a rapid deactivation process and a
CC       linear current-voltage relationship and decreases the amplitude of
CC       the outward current (PubMed:11101505, PubMed:20533308).
CC       {ECO:0000250|UniProtKB:P63161, ECO:0000269|PubMed:10219239,
CC       ECO:0000269|PubMed:11034315, ECO:0000269|PubMed:11101505,
CC       ECO:0000269|PubMed:20533308}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20533308};
CC       Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:P63161}. Note=Colocalizes with KCNB1 at the
CC       plasma membrane. {ECO:0000250|UniProtKB:P63161}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, heart, skeletal
CC       muscle, pancreas, placenta, kidney, colon and thymus. A small but
CC       significant expression is found in liver, ovary, testis, prostate,
CC       small intestine and leukocytes. Very low expression, nearly
CC       undetectable, in lung and spleen. {ECO:0000269|PubMed:11034315}.
CC   -!- DISEASE: Long QT syndrome 6 (LQT6) [MIM:613693]: A heart disorder
CC       characterized by a prolonged QT interval on the ECG and
CC       polymorphic ventricular arrhythmias. They cause syncope and sudden
CC       death in response to exercise or emotional stress, and can present
CC       with a sentinel event of sudden cardiac death in infancy.
CC       {ECO:0000269|PubMed:10219239, ECO:0000269|PubMed:12185453,
CC       ECO:0000269|PubMed:16922724, ECO:0000269|PubMed:19716085}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Atrial fibrillation, familial, 4 (ATFB4) [MIM:611493]: A
CC       familial form of atrial fibrillation, a common sustained cardiac
CC       rhythm disturbance. Atrial fibrillation is characterized by
CC       disorganized atrial electrical activity and ineffective atrial
CC       contraction promoting blood stasis in the atria and reduces
CC       ventricular filling. It can result in palpitations, syncope,
CC       thromboembolic stroke, and congestive heart failure.
CC       {ECO:0000269|PubMed:15368194}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel KCNE family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF071002; AAD28086.1; -; mRNA.
DR   EMBL; AF302095; AAG13416.1; -; mRNA.
DR   EMBL; DQ784804; ABQ01239.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09791.1; -; Genomic_DNA.
DR   EMBL; BC093892; AAH93892.1; -; mRNA.
DR   EMBL; BC112087; AAI12088.1; -; mRNA.
DR   CCDS; CCDS13635.1; -.
DR   RefSeq; NP_751951.1; NM_172201.1.
DR   UniGene; Hs.551521; -.
DR   UniGene; Hs.736062; -.
DR   PDB; 2M0Q; NMR; -; A=1-123.
DR   PDBsum; 2M0Q; -.
DR   ProteinModelPortal; Q9Y6J6; -.
DR   SMR; Q9Y6J6; -.
DR   BioGrid; 115313; 2.
DR   CORUM; Q9Y6J6; -.
DR   STRING; 9606.ENSP00000290310; -.
DR   iPTMnet; Q9Y6J6; -.
DR   PhosphoSitePlus; Q9Y6J6; -.
DR   BioMuta; KCNE2; -.
DR   DMDM; 6685661; -.
DR   PaxDb; Q9Y6J6; -.
DR   PeptideAtlas; Q9Y6J6; -.
DR   PRIDE; Q9Y6J6; -.
DR   DNASU; 9992; -.
DR   Ensembl; ENST00000290310; ENSP00000290310; ENSG00000159197.
DR   GeneID; 9992; -.
DR   KEGG; hsa:9992; -.
DR   UCSC; uc002ytt.2; human.
DR   CTD; 9992; -.
DR   DisGeNET; 9992; -.
DR   EuPathDB; HostDB:ENSG00000159197.3; -.
DR   GeneCards; KCNE2; -.
DR   GeneReviews; KCNE2; -.
DR   HGNC; HGNC:6242; KCNE2.
DR   HPA; HPA029706; -.
DR   HPA; HPA051553; -.
DR   MalaCards; KCNE2; -.
DR   MIM; 603796; gene.
DR   MIM; 611493; phenotype.
DR   MIM; 613693; phenotype.
DR   neXtProt; NX_Q9Y6J6; -.
DR   OpenTargets; ENSG00000159197; -.
DR   Orphanet; 334; Familial atrial fibrillation.
DR   Orphanet; 101016; Romano-Ward syndrome.
DR   PharmGKB; PA392; -.
DR   eggNOG; ENOG410IX4Y; Eukaryota.
DR   eggNOG; ENOG411297Y; LUCA.
DR   GeneTree; ENSGT00510000048894; -.
DR   HOGENOM; HOG000113208; -.
DR   HOVERGEN; HBG052227; -.
DR   InParanoid; Q9Y6J6; -.
DR   KO; K04896; -.
DR   OMA; NWRRNTT; -.
DR   OrthoDB; EOG091G0UDJ; -.
DR   PhylomeDB; Q9Y6J6; -.
DR   TreeFam; TF336058; -.
DR   Reactome; R-HSA-5576890; Phase 3 - rapid repolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   GeneWiki; KCNE2; -.
DR   GenomeRNAi; 9992; -.
DR   PRO; PR:Q9Y6J6; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000159197; -.
DR   CleanEx; HS_KCNE2; -.
DR   Genevisible; Q9Y6J6; HS.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IEA:Ensembl.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IEA:Ensembl.
DR   GO; GO:0044325; F:ion channel binding; IDA:BHF-UCL.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:1902282; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL.
DR   GO; GO:0035690; P:cellular response to drug; IDA:BHF-UCL.
DR   GO; GO:0086009; P:membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:0086011; P:membrane repolarization during action potential; IMP:BHF-UCL.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:1902260; P:negative regulation of delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:1901800; P:positive regulation of proteasomal protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:1901387; P:positive regulation of voltage-gated calcium channel activity; IEA:Ensembl.
DR   GO; GO:0071435; P:potassium ion export; IDA:BHF-UCL.
DR   GO; GO:0010107; P:potassium ion import; IMP:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:1902159; P:regulation of cyclic nucleotide-gated ion channel activity; IEA:Ensembl.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:1901979; P:regulation of inward rectifier potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0043586; P:tongue development; IEA:Ensembl.
DR   GO; GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   InterPro; IPR000369; K_chnl_KCNE.
DR   InterPro; IPR005425; K_chnl_volt-dep_bsu_KCNE2.
DR   PANTHER; PTHR15282; PTHR15282; 1.
DR   Pfam; PF02060; ISK_Channel; 1.
DR   PRINTS; PR01605; KCNE2CHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Atrial fibrillation; Cell membrane; Complete proteome;
KW   Disease mutation; Glycoprotein; Ion channel; Ion transport;
KW   Long QT syndrome; Membrane; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    123       Potassium voltage-gated channel subfamily
FT                                E member 2.
FT                                /FTId=PRO_0000144285.
FT   TRANSMEM     49     69       Helical. {ECO:0000255}.
FT   TOPO_DOM     70    123       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD      6      6       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     29     29       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT       8      8       T -> A (in dbSNP:rs2234916).
FT                                {ECO:0000269|PubMed:10219239,
FT                                ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_008375.
FT   VARIANT       8      8       T -> I (in dbSNP:rs35759083).
FT                                /FTId=VAR_037794.
FT   VARIANT       9      9       Q -> E (polymorphism; risk factor for
FT                                drug-induced arrhythmia; impedes
FT                                activation and increases sensitivity to
FT                                macrolide antibiotics; may lower current
FT                                in KCNQ1/KCNE2 channel;
FT                                dbSNP:rs16991652).
FT                                {ECO:0000269|PubMed:10219239}.
FT                                /FTId=VAR_008376.
FT   VARIANT      14     14       V -> I (in LQT6; unknown pathological
FT                                significance; dbSNP:rs142153692).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074921.
FT   VARIANT      20     20       I -> N (in LQT6; unknown pathological
FT                                significance; dbSNP:rs199473363).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074922.
FT   VARIANT      27     27       R -> C (in ATFB4; gain-of-function
FT                                mutation associated with the initiation
FT                                and/or maintenance of AF;
FT                                dbSNP:rs74315449).
FT                                {ECO:0000269|PubMed:15368194}.
FT                                /FTId=VAR_037795.
FT   VARIANT      27     27       R -> H (in LQT6; unknown pathological
FT                                significance; dbSNP:rs148968498).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074923.
FT   VARIANT      54     54       M -> T (in LQT6; forms I(KR) channels
FT                                that deactivate twice as fast as wild
FT                                type; dbSNP:rs74315447).
FT                                {ECO:0000269|PubMed:10219239,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008377.
FT   VARIANT      57     57       I -> T (in LQT6; may affect KCNQ1/KCNE2
FT                                channel; dbSNP:rs74315448).
FT                                {ECO:0000269|PubMed:10219239,
FT                                ECO:0000269|PubMed:16922724,
FT                                ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_008378.
FT   VARIANT      60     60       F -> L (in LQT6; may be a rare
FT                                polymorphism; dbSNP:rs16991654).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_029334.
FT   VARIANT      65     65       V -> L (in LQT6; unknown pathological
FT                                significance; dbSNP:rs199473364).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074924.
FT   VARIANT      65     65       V -> M (in LQT6; dbSNP:rs199473364).
FT                                {ECO:0000269|PubMed:12185453}.
FT                                /FTId=VAR_015063.
FT   VARIANT      66     66       A -> V (in dbSNP:rs16991656).
FT                                /FTId=VAR_022052.
FT   VARIANT      77     77       R -> Q (in LQT6; unknown pathological
FT                                significance; dbSNP:rs199473365).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074925.
FT   VARIANT      77     77       R -> W (in LQT6; dbSNP:rs141423405).
FT                                {ECO:0000269|PubMed:16922724}.
FT                                /FTId=VAR_035386.
FT   VARIANT      94     94       E -> G (in LQT6; unknown pathological
FT                                significance; dbSNP:rs74424227).
FT                                {ECO:0000269|PubMed:19716085}.
FT                                /FTId=VAR_074926.
FT   MUTAGEN      75     75       K->H: Increases tail current in
FT                                KCNH2/KCNE2 channel.
FT                                {ECO:0000269|PubMed:11874988}.
FT   HELIX         3     38       {ECO:0000244|PDB:2M0Q}.
FT   HELIX        46     74       {ECO:0000244|PDB:2M0Q}.
FT   HELIX        88    114       {ECO:0000244|PDB:2M0Q}.
SQ   SEQUENCE   123 AA;  14472 MW;  C3016415E1B44890 CRC64;
     MSTLSNFTQT LEDVFRRIFI TYMDNWRQNT TAEQEALQAK VDAENFYYVI LYLMVMIGMF
     SFIIVAILVS TVKSKRREHS NDPYHQYIVE DWQEKYKSQI LNLEESKATI HENIGAAGFK
     MSP
//
ID   KVAP_AERPE              Reviewed;         295 AA.
AC   Q9YDF8;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   25-OCT-2017, entry version 112.
DE   RecName: Full=Voltage-gated potassium channel;
DE   AltName: Full=KvAP;
GN   OrderedLocusNames=APE_0955;
OS   Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC
OS   100138 / K1).
OC   Archaea; Crenarchaeota; Thermoprotei; Desulfurococcales;
OC   Desulfurococcaceae; Aeropyrum.
OX   NCBI_TaxID=272557;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700893 / DSM 11879 / JCM 9820 / NBRC 100138 / K1;
RX   PubMed=10382966; DOI=10.1093/dnares/6.2.83;
RA   Kawarabayasi Y., Hino Y., Horikawa H., Yamazaki S., Haikawa Y.,
RA   Jin-no K., Takahashi M., Sekine M., Baba S., Ankai A., Kosugi H.,
RA   Hosoyama A., Fukui S., Nagai Y., Nishijima K., Nakazawa H.,
RA   Takamiya M., Masuda S., Funahashi T., Tanaka T., Kudoh Y.,
RA   Yamazaki J., Kushida N., Oguchi A., Aoki K., Kubota K., Nakamura Y.,
RA   Nomura N., Sako Y., Kikuchi H.;
RT   "Complete genome sequence of an aerobic hyper-thermophilic
RT   crenarchaeon, Aeropyrum pernix K1.";
RL   DNA Res. 6:83-101(1999).
RN   [2]
RP   FUNCTION.
RX   PubMed=12629550; DOI=10.1038/nature01473;
RA   Ruta V., Jiang Y., Lee A., Chen J., MacKinnon R.;
RT   "Functional analysis of an archaebacterial voltage-dependent K+
RT   channel.";
RL   Nature 422:180-185(2003).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 31-253.
RX   PubMed=12721618; DOI=10.1038/nature01580;
RA   Jiang Y., Lee A., Chen J., Ruta V., Cadene M., Chait B.T.,
RA   MacKinnon R.;
RT   "X-ray structure of a voltage-dependent K(+) channel.";
RL   Nature 423:33-41(2003).
CC   -!- FUNCTION: Mediates a strong voltage-dependent potassium ion
CC       permeability of excitable membranes. Assuming opened or closed
CC       conformations in response to the voltage difference across the
CC       membrane, the protein forms a potassium-selective channel through
CC       which potassium ions may pass in accordance with their
CC       electrochemical gradient. {ECO:0000269|PubMed:12629550}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-15692219, EBI-15692219;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- DOMAIN: Contains a central ion-conduction pore surrounded by four
CC       voltage sensors which form the voltage-sensor paddles that move in
CC       response to membrane voltage changes through the fluid membrane
CC       interior, each voltage-sensor carrying their four positive charges
CC       across the membrane. It is thought that the S4 arginine residues
CC       move through the membrane's electric field to open the pore.
CC   -!- SIMILARITY: Belongs to the potassium channel family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000002; BAA79939.1; -; Genomic_DNA.
DR   PIR; C72692; C72692.
DR   PDB; 1ORQ; X-ray; 3.20 A; C=31-253.
DR   PDB; 1ORS; X-ray; 1.90 A; C=33-161.
DR   PDB; 2A0L; X-ray; 3.90 A; A/B=20-259.
DR   PDB; 2KYH; NMR; -; A=18-160.
DR   PDBsum; 1ORQ; -.
DR   PDBsum; 1ORS; -.
DR   PDBsum; 2A0L; -.
DR   PDBsum; 2KYH; -.
DR   ProteinModelPortal; Q9YDF8; -.
DR   SMR; Q9YDF8; -.
DR   DIP; DIP-29648N; -.
DR   STRING; 272557.APE_0955; -.
DR   TCDB; 1.A.1.17.1; the voltage-gated ion channel (vic) superfamily.
DR   EnsemblBacteria; BAA79939; BAA79939; APE_0955.
DR   KEGG; ape:APE_0955; -.
DR   eggNOG; arCOG01964; Archaea.
DR   eggNOG; COG1226; LUCA.
DR   KO; K10716; -.
DR   OMA; RFYLLDH; -.
DR   OrthoDB; POG093Z0B4R; -.
DR   EvolutionaryTrace; Q9YDF8; -.
DR   Proteomes; UP000002518; Chromosome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF00520; Ion_trans; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    295       Voltage-gated potassium channel.
FT                                /FTId=PRO_0000054097.
FT   TOPO_DOM      1     38       Cytoplasmic.
FT   TRANSMEM     39     63       Helical; Name=Segment S1.
FT   TOPO_DOM     64     67       Extracellular. {ECO:0000255}.
FT   TRANSMEM     68     92       Helical; Name=Segment S2.
FT   TOPO_DOM     93     96       Cytoplasmic.
FT   INTRAMEM     97    105       Helical; Name=Segment S3A.
FT   TOPO_DOM    106    108       Extracellular. {ECO:0000255}.
FT   TRANSMEM    109    125       Helical; Voltage-sensor; Name=Segment
FT                                S3B.
FT   TOPO_DOM    126    128       Cytoplasmic.
FT   TRANSMEM    129    145       Helical; Voltage-sensor; Name=Segment S4.
FT   TOPO_DOM    146    159       Cytoplasmic.
FT   TRANSMEM    160    184       Helical; Name=Segment S5.
FT   TOPO_DOM    185    195       Extracellular. {ECO:0000255}.
FT   INTRAMEM    196    208       Pore-forming. {ECO:0000255}.
FT   TOPO_DOM    209    221       Extracellular. {ECO:0000255}.
FT   TRANSMEM    222    253       Helical; Name=Segment S6.
FT   TOPO_DOM    254    295       Cytoplasmic.
FT   MOTIF       209    214       Selectivity filter.
FT   TURN         32     34       {ECO:0000244|PDB:1ORQ}.
FT   HELIX        38     60       {ECO:0000244|PDB:1ORS}.
FT   HELIX        66     92       {ECO:0000244|PDB:1ORS}.
FT   TURN         96    102       {ECO:0000244|PDB:1ORS}.
FT   HELIX       104    106       {ECO:0000244|PDB:1ORS}.
FT   HELIX       108    110       {ECO:0000244|PDB:1ORS}.
FT   HELIX       113    125       {ECO:0000244|PDB:1ORS}.
FT   HELIX       129    161       {ECO:0000244|PDB:1ORS}.
FT   STRAND      186    188       {ECO:0000244|PDB:1ORQ}.
FT   HELIX       196    207       {ECO:0000244|PDB:1ORQ}.
FT   HELIX       220    251       {ECO:0000244|PDB:1ORQ}.
SQ   SEQUENCE   295 AA;  32535 MW;  1EC8CE1E39E24D0F CRC64;
     MSVERWVFPG CSVMARFRRG LSDLGGRVRN IGDVMEHPLV ELGVSYAALL SVIVVVVEYT
     MQLSGEYLVR LYLVDLILVI ILWADYAYRA YKSGDPAGYV KKTLYEIPAL VPAGLLALIE
     GHLAGLGLFR LVRLLRFLRI LLIISRGSKF LSAIADAADK IRFYHLFGAV MLTVLYGAFA
     IYIVEYPDPN SSIKSVFDAL WWAVVTATTV GYGDVVPATP IGKVIGIAVM LTGISALTLL
     IGTVSNMFQK ILVGEPEPSC SPAKLAEMVS SMSEEEFEEF VRTLKNLRRL ENSMK
//
ID   KCNK7_MOUSE             Reviewed;         307 AA.
AC   Q9Z2T1; Q9QXY0; Q9QYE8; Q9R1V1; Q9R242;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 3.
DT   27-SEP-2017, entry version 124.
DE   RecName: Full=Potassium channel subfamily K member 7;
DE   AltName: Full=Double-pore K(+) channel 3;
DE   AltName: Full=Neuromuscular two p domain potassium channel;
DE   AltName: Full=Putative potassium channel DP3;
GN   Name=Kcnk7; Synonyms=Dpkch3, Kcnk6, Kcnk8, Knot1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain, and Lung;
RX   PubMed=10206991; DOI=10.1074/jbc.274.17.11751;
RA   Salinas M., Reyes R., Lesage F., Fosset M., Heurteaux C., Romey G.,
RA   Lazdunski M.;
RT   "Cloning of a new mouse two-P domain channel subunit and a human
RT   homologue with a unique pore structure.";
RL   J. Biol. Chem. 274:11751-11760(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Ishibashi K., Suzuki M., Imai M.;
RT   "Cloning of a new double-pore K channel expressed predominantly in
RT   tesis.";
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE OF 1-289.
RA   Bockenhauer D., Nimmakayalu M.A., Ward D.C., Goldstein S.A.N.,
RA   Gallagher P.G.;
RT   "Cloning, localization, and expression of the murine 2 P domain
RT   potassium channel KCNK6.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 2-307.
RA   Gan L., Joiner W.J., Quinn A.M., Wang L.-Y., Hughes T.,
RA   Kaczmarek L.K.;
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 15-307.
RC   TISSUE=Brain;
RA   Lopes C.M.B., Buck M., Goldstein S.A.N.;
RT   "A new two P domain potassium channel subfamily from mouse excitable
RT   tissues.";
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable potassium channel subunit. No channel activity
CC       observed in vitro as protein remains in the endoplasmic reticulum.
CC       May need to associate with an as yet unknown partner in order to
CC       reach the plasma membrane.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Detected in embryo, eye, lung and liver.
CC       Weakly expressed in colon, testis, atria, kidney, intestine,
CC       bladder, uterus, ovary, salivary gland, thymus and brain stem. Not
CC       detected in brain, cerebellum, spinal cord, heart, ventricle,
CC       skeletal muscle, liver, placenta and pancreas. In the eye, highly
CC       expressed in the retinal ganglion cell layer and inner nuclear
CC       layer.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF110521; AAD29577.1; ALT_TERM; mRNA.
DR   EMBL; AB015729; BAA35074.1; -; mRNA.
DR   EMBL; AF158234; AAF14528.1; -; Genomic_DNA.
DR   EMBL; AF022820; AAD09337.1; -; mRNA.
DR   EMBL; AF012324; AAF21603.1; -; mRNA.
DR   RefSeq; NP_034739.2; NM_010609.3.
DR   UniGene; Mm.440033; -.
DR   ProteinModelPortal; Q9Z2T1; -.
DR   SMR; Q9Z2T1; -.
DR   STRING; 10090.ENSMUSP00000051278; -.
DR   PaxDb; Q9Z2T1; -.
DR   PRIDE; Q9Z2T1; -.
DR   GeneID; 16530; -.
DR   KEGG; mmu:16530; -.
DR   CTD; 10089; -.
DR   MGI; MGI:1341841; Kcnk7.
DR   eggNOG; KOG1418; Eukaryota.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000286014; -.
DR   HOVERGEN; HBG052237; -.
DR   InParanoid; Q9Z2T1; -.
DR   KO; K04918; -.
DR   PRO; PR:Q9Z2T1; -.
DR   Proteomes; UP000000589; Unplaced.
DR   CleanEx; MM_KCNK7; -.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:MGI.
DR   GO; GO:0005267; F:potassium channel activity; ISS:MGI.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR005408; 2pore_dom_K_chnl_TWIK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01586; TWIKCHANNEL.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    307       Potassium channel subfamily K member 7.
FT                                /FTId=PRO_0000101752.
FT   TOPO_DOM      1     10       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     11     31       Helical. {ECO:0000255}.
FT   INTRAMEM     92    118       Pore-forming; Name=Pore-forming 1.
FT                                {ECO:0000255}.
FT   TRANSMEM    120    140       Helical. {ECO:0000255}.
FT   TOPO_DOM    141    172       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    173    193       Helical. {ECO:0000255}.
FT   INTRAMEM    199    227       Pore-forming; Name=Pore-forming 2.
FT                                {ECO:0000255}.
FT   TRANSMEM    233    253       Helical. {ECO:0000255}.
FT   TOPO_DOM    254    307       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     83     83       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT      1      3       MGS -> MTHSREFGPRGQEFGTR (in Ref. 2).
FT                                {ECO:0000305}.
FT   CONFLICT      2      3       GS -> TR (in Ref. 4). {ECO:0000305}.
FT   CONFLICT     84     84       S -> G (in Ref. 1; AAD29577).
FT                                {ECO:0000305}.
FT   CONFLICT    231    232       YH -> SP (in Ref. 2; BAA35074).
FT                                {ECO:0000305}.
FT   CONFLICT    293    293       T -> P (in Ref. 2; BAA35074).
FT                                {ECO:0000305}.
SQ   SEQUENCE   307 AA;  32199 MW;  83EC6BB7E4C6BD9B CRC64;
     MGSLKPWARY LLLLMAHLLA MGLGAVVLQA LEGPPARHLQ AQVQAELASF QAEHRACLPP
     EALEELLGAV LRAQAHGVSS LGNSSETSNW DLPSALLFTA SILTTTGYGH MAPLSSGGKA
     FCVVYAALGL PASLALVAAL RHCLLPVFSR PGDWVAIRWQ LAPAQAALLQ AAGLGLLVAC
     VFMLLPALVL WGVQGDCSLL EAIYFCFGSL STIGLGDLLP AHGRGLHPAI YHLGQFALLG
     YLLLGLLAML LAVETFSELP QVRAMVKFFG PSGSRTDEDQ DGILGQDELA LSTVLPDAPV
     LGPTTPA
//
ID   TM175_STRC3             Reviewed;         206 AA.
AC   S5VBU1;
DT   11-NOV-2015, integrated into UniProtKB/Swiss-Prot.
DT   16-OCT-2013, sequence version 1.
DT   25-OCT-2017, entry version 22.
DE   RecName: Full=Potassium channel B446_29190;
GN   ORFNames=B446_29190 {ECO:0000312|EMBL:AGS72644.1};
OS   Streptomyces collinus (strain DSM 40733 / Tu 365).
OC   Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC   Streptomyces.
OX   NCBI_TaxID=1214242;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=DSM 40733 / Tu 365 {ECO:0000312|EMBL:AGS72644.1};
RA   Ruckert C., Szczepanowski R., Goesmann A., Pross E.K., Musiol E.M.,
RA   Blin K., Wohlleben W., Puhler A., Weber T., Kalinowski J.;
RT   "The complete genome sequence of Streptomyces collinus Tu 365.";
RL   Submitted (OCT-2012) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION.
RX   PubMed=26317472; DOI=10.1016/j.cell.2015.08.002;
RA   Cang C., Aranda K., Seo Y.J., Gasnier B., Ren D.;
RT   "TMEM175 is an organelle K(+) channel regulating lysosomal function.";
RL   Cell 162:1101-1112(2015).
RN   [3]
RP   SUBUNIT.
RX   PubMed=28723891; DOI=10.1038/nature23269;
RA   Lee C., Guo J., Zeng W., Kim S., She J., Cang C., Ren D., Jiang Y.;
RT   "The lysosomal potassium channel TMEM175 adopts a novel tetrameric
RT   architecture.";
RL   Nature 547:472-475(2017).
CC   -!- FUNCTION: Potassium channel. {ECO:0000305|PubMed:26317472}.
CC   -!- SUBUNIT: Homotetramer (PubMed:28723891).
CC       {ECO:0000269|PubMed:28723891}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane
CC       protein {ECO:0000255}.
CC   -!- DOMAIN: The six transmembrane regions are tightly packed within
CC       each subunit without undergoing domain swapping. Transmembranes
CC       TM1-TM3 are positioned on the inner circle of the channel tetramer
CC       and participate in inter-subunit interactions that are central to
CC       the assembly of the ion conduction pore. The RxxxFSD motif within
CC       transmembrane TM1 coordinates a network of specific inter- and
CC       intra-subunit interactions with other conserved residues on TM2
CC       and TM3 and plays a key role in the tetrameric assembly of the
CC       channel. Transmembrane TM4-TM6 are positioned on the periphery of
CC       the channel and do not contribute contacts with neighboring
CC       subunits. Transmembranes TM1 and TM2 are linked by an extended
CC       strand-like tail and two short helices (H1 and H2) which protrude
CC       outwards from the main body of the transmembrane domain and
CC       enclose the external open entrance of the ion conduction pore in
CC       the channel tetramer. Transmembrane TM1 forms the pore-lining
CC       inner helix at the center of the channel, creating an hourglass-
CC       shaped ion permeation pathway in the channel tetramer. Three
CC       hydrophobic residues on the C-terminal half of the TM1 helix form
CC       a bottleneck along the ion conduction pathway and serve as the
CC       selectivity filter of the channel. Ile-17 is probably responsible
CC       for channel selectivity. {ECO:0000250|UniProtKB:K9UJK2}.
CC   -!- SIMILARITY: Belongs to the TMEM175 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP006259; AGS72644.1; -; Genomic_DNA.
DR   RefSeq; WP_020943054.1; NC_021985.1.
DR   SMR; S5VBU1; -.
DR   TCDB; 1.A.78.2.3; the k+-selective channel in endosomes and lysosomes (kel) family.
DR   EnsemblBacteria; AGS72644; AGS72644; B446_29190.
DR   GeneID; 32538565; -.
DR   KEGG; sci:B446_29190; -.
DR   PATRIC; fig|1214242.5.peg.5979; -.
DR   OrthoDB; POG091H0CJC; -.
DR   BioCyc; SCOL1214242:G13G0-5887-MONOMER; -.
DR   Proteomes; UP000015423; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0022841; F:potassium ion leak channel activity; TAS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; TAS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   InterPro; IPR010617; TMEM175.
DR   Pfam; PF06736; DUF1211; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    206       Potassium channel B446_29190.
FT                                /FTId=PRO_0000434744.
FT   TOPO_DOM      1      1       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TRANSMEM      2     25       Helical; Name=TM1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM     26     44       Extracellular.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TRANSMEM     45     70       Helical; Name=TM2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM     71     76       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TRANSMEM     77    102       Helical; Name=TM3.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM    103    110       Extracellular.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TRANSMEM    111    135       Helical; Name=TM4.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM    136    147       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TRANSMEM    148    174       Helical; Name=TM5.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM    175    176       Extracellular.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TRANSMEM    177    192       Helical; Name=TM6.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   TOPO_DOM    193    206       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   REGION       31     34       Short helix H1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   REGION       36     42       Short helix H2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   MOTIF         6     12       RxxxFSD motif.
FT                                {ECO:0000250|UniProtKB:Q9BSA9}.
FT   SITE         17     17       Hydrophobic filter residue 1.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   SITE         21     21       Hydrophobic filter residue 2.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
FT   SITE         24     24       Hydrophobic filter residue 3.
FT                                {ECO:0000250|UniProtKB:K9UJK2}.
SQ   SEQUENCE   206 AA;  22387 MW;  C43BD455A7A082F4 CRC64;
     MNESGRVEAF SDGVFAIAIT LLILDIKVPK ADGPGGLWHA LGAQWPSYAA YVVSFLVIGI
     MWVNHHQVFS YVARVDRALM FLNLLVLMVV AAVPWPTAML AEYLREDRAS HVAAAVYSLV
     MVAMALAFQA LWWHLTRTGH LFDPRVDAPA ARATRIRFAL GSLGYPLTVG LAFVSAPLTL
     AAHGLLALYY GFNQVPVPTR EAAAPS
//
